PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tang, W; Zeve, D; Suh, JM; Bosnakovski, D; Kyba, M; Hammer, RE; Tallquist, MD; Graff, JM				Tang, Wei; Zeve, Daniel; Suh, Jae Myoung; Bosnakovski, Darko; Kyba, Michael; Hammer, Robert E.; Tallquist, Michelle D.; Graff, Jonathan M.			White fat progenitor cells reside in the adipose vasculature	SCIENCE			English	Article							STEM-CELL; GENE-EXPRESSION; OBESITY; TISSUE; DIFFERENTIATION; ADIPOCYTES; PERICYTES	White adipose (fat) tissues regulate metabolism, reproduction, and life span. Adipocytes form throughout life, with the most marked expansion of the lineage occurring during the postnatal period. Adipocytes develop in coordination with the vasculature, but the identity and location of white adipocyte progenitor cells in vivo are unknown. We used genetically marked mice to isolate proliferating and renewing adipogenic progenitors. We found that most adipocytes descend from a pool of these proliferating progenitors that are already committed, either prenatally or early in postnatal life. These progenitors reside in the mural cell compartment of the adipose vasculature, but not in the vasculature of other tissues. Thus, the adipose vasculature appears to function as a progenitor niche and may provide signals for adipocyte development.	[Tang, Wei; Zeve, Daniel; Suh, Jae Myoung; Bosnakovski, Darko; Kyba, Michael; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Tallquist, Michelle D.; Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Graff, Jonathan M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graff, JM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	jon.graff@utsouthwestern.edu	Bosnakovski, Darko/T-8292-2019; Tallquist, Michelle/AAU-5277-2021; Suh, Jae Myoung/B-3268-2015	Tallquist, Michelle/0000-0002-1383-144X; Suh, Jae Myoung/0000-0001-8097-4662; Zeve, Daniel/0000-0002-4117-1282; Bosnakovski, Darko/0000-0002-7198-2019; Kyba, Michael/0000-0002-5579-7534; Hammer, Robert E./0000-0001-5487-7551	NIH; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK064261, 1R01DK066556]; University of Texas Southwestern Medical Center Excellence in Education Fund; University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064261, R01DK066556] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Texas Southwestern Medical Center Excellence in Education Fund; University of Texas Southwestern Medical Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Kennedy, T. Wang, R. Adams, R. Evans, S. Kernie, L. Monteggia, M. Osawa, R. Perlingeiro, Q. LaPlant, and M. Iacovino, as well as members of the Graff lab. J.M.G. is a founder of Reata Pharmaceuticals, a privately held company designed to address unmet needs in cancer, neurodegenerative, and inflammatory conditions. This work was supported by NIH and the National Institute of Diabetes and Digestive and Kidney Diseases (grants 1R01DK064261 and 1R01DK066556) and the University of Texas Southwestern Medical Center Excellence in Education Fund. W.T., J.M.G., and the University of Texas Southwestern Medical Center may file. a patent application related to the work reported here.	AILHAUD G, 1992, ANNU REV NUTR, V12, P207, DOI 10.1146/annurev.nu.12.070192.001231; Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; CINTI S, 1984, J SUBMICR CYTOL PATH, V16, P243; COOK JR, 1982, DEV BIOL, V92, P440, DOI 10.1016/0012-1606(82)90189-0; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; GRAVES RA, 1992, J CELL BIOCHEM, V49, P219, DOI 10.1002/jcb.240490303; IYAMA KI, 1979, VIRCHOWS ARCH B, V31, P143, DOI 10.1007/BF02889932; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Kistner A, 1996, P NATL ACAD SCI USA, V93, P10933, DOI 10.1073/pnas.93.20.10933; KLAUS S, 1991, J CELL BIOL, V115, P1783, DOI 10.1083/jcb.115.6.1783; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Kuo LE, 2007, NAT MED, V13, P803, DOI 10.1038/nm1611; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Ntambi JM, 2000, J NUTR, V130, p3122S, DOI 10.1093/jn/130.12.3122S; Otto TC, 2005, CRIT REV BIOCHEM MOL, V40, P229, DOI 10.1080/10409230591008189; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110	28	794	817	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					583	586		10.1126/science.1156232	http://dx.doi.org/10.1126/science.1156232			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18801968	Green Accepted			2022-12-28	WOS:000260299100042
J	Tay, Y; Zhang, JQ; Thomson, AM; Lim, B; Rigoutsos, I				Tay, Yvonne; Zhang, Jinqiu; Thomson, Andrew M.; Lim, Bing; Rigoutsos, Isidore			MicroRNAs to Nanog, Oct4 and Sox2 coding regions modulate embryonic stem cell differentiation	NATURE			English	Article							RNA INTERFERENCE; GENE-REGULATION; BINDING-SITES; ES CELLS; PLURIPOTENCY; EXPRESSION; TARGETS; IDENTIFICATION; MECHANISMS; PATHWAY	MicroRNAs ( miRNAs) are short RNAs that direct messenger RNA degradation or disrupt mRNA translation in a sequence- dependent manner(1-7). For more than a decade, attempts to study the interaction of miRNAs with their targets were confined to the 3' untranslated regions of mRNAs(1), fuelling an underlying assumption that these regions are the principal recipients of miRNA activity. Here we focus on the mouse Nanog, Oct4 ( also known as Pou5f1) and Sox2 genes(8-11) and demonstrate the existence of many naturally occurring miRNA targets in their amino acid coding sequence ( CDS). Some of the mouse targets analysed do not contain the miRNA seed, whereas others span exon - exon junctions or are not conserved in the human and rhesus genomes. miR-134, miR- 296 and miR- 470, upregulated on retinoic- acid- induced differentiation of mouse embryonic stem cells, target the CDS of each transcription factor in various combinations, leading to transcriptional and morphological changes characteristic of differentiating mouse embryonic stem cells, and resulting in a new phenotype. Silent mutations at the predicted targets abolish miRNA activity, prevent the down regulation of the corresponding genes and delay the induced phenotype. Our findings demonstrate the abundance of CDS- located miRNA targets, some of which can be species- specific, and support an augmented model whereby animal miRNAs exercise their control on mRNAs through targets that can reside beyond the 39 untranslated region.	[Rigoutsos, Isidore] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA; [Tay, Yvonne; Zhang, Jinqiu; Thomson, Andrew M.; Lim, Bing] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Beth Israel Med Ctr, Boston, MA 02215 USA	International Business Machines (IBM); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Rigoutsos, I (corresponding author), IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, POB 218, Yorktown Hts, NY 10598 USA.	rigoutso@us.ibm.com	Rigoutsos, Isidore/C-5381-2012; Kumar, Rajesh/E-7957-2010	Rigoutsos, Isidore/0000-0003-1529-8631	Agency for Science, Technology and Research of Singapore; A*STAR graduate scholarship; National Institutes of Health [DK47636, AI54973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR graduate scholarship(Agency for Science Technology & Research (A*STAR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Huynh for assistance with building the rna22 pipeline that was used to make the miRNA target predictions, and H. Zhang and Y.L. Lee for their help with some of the constructs. The work of Y.T., J.Z., A.M.T. and B.L. was supported by the Agency for Science, Technology and Research of Singapore. Y.T. was the recipient of an A*STAR graduate scholarship. B.L. was also partially supported by National Institutes of Health grants DK47636 and AI54973.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, FEBS LETT, V579, P5904, DOI 10.1016/j.febslet.2005.09.040; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138; Duursma AM, 2008, RNA, V14, P872, DOI 10.1261/rna.972008; Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Hammond SM, 2005, FEBS LETT, V579, P5822, DOI 10.1016/j.febslet.2005.08.079; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, RNA, V11, P1753, DOI 10.1261/rna.2248605; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Slack FJ, 2000, MOL CELL, V5, P659, DOI 10.1016/S1097-2765(00)80245-2; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson AM, 2005, J BIOL CHEM, V280, P30032, DOI 10.1074/jbc.M502951200	30	1078	1157	0	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1124	U12		10.1038/nature07299	http://dx.doi.org/10.1038/nature07299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806776				2022-12-28	WOS:000260252600048
J	Hollinghurst, S; Redmond, N; Costelloe, C; Montgomery, A; Fletcher, M; Peters, TJ; Hay, AD				Hollinghurst, Sandra; Redmond, Niamh; Costelloe, Ceire; Montgomery, Alan; Fletcher, Margaret; Peters, Tim J.; Hay, Alastair D.			Paracetamol plus ibuprofen for the treatment of fever in children (PITCH): economic evaluation of a randomised controlled trial	BRITISH MEDICAL JOURNAL			English	Article							PRESCHOOL-CHILDREN; PARENTS	Objective To estimate the cost to the NHS and to parents and carers of treating febrile preschool children with paracetamol, ibuprofen, or both, and to compare these costs with the benefits of each treatment regimen. Design Cost consequences analysis and cost effectiveness analysis conducted as part of a three arm, randomised controlled trial. Participants Children between the ages of 6 months and 6 years recruited from primary care and the community with axillary temperatures = >= 37.8 degrees C and <= 41 degrees C. Interventions Paracetamol, ibuprofen, or both drugs. Main outcome measures Costs to the NHS and to parents and carers. Cost consequences analysis at 48 hours and 5 days comparing cost with children's temperature, discomfort, activity, appetite, and sleep; cost effectiveness analysis at 48 hours comparing cost with percentage of children "recovered." Results Difficulties in recruiting children to the trial lowered the precision of the estimates of cost and some outcomes. At 48 hours, cost to the NHS was 11.33 pound for paracetamol, 8.49 pound for ibuprofen, and 8.16 pound for both drugs. By day 5 these costs rose to 19.63 pound, 18.36 pound, and 13.92 pound respectively. For parents and carers, the 48 hour costs were 23.86 pound for paracetamol, 20.60 pound for ibuprofen, and 25.07 pound for both, and the day 5 costs were 26.35 pound, 29.90 pound, and 24.02 pound respectively. Outcomes measured at 48 hours and 5 days were inconclusive because of lack of power; the cost effectiveness analysis at 48 hours provided little evidence that one treatment choice was significantly more cost effective than another. At 4 hours ibuprofen and the combined treatment were superior to paracetamol in terms of the trial primary outcome of time without fever; at 24 hours the combined treatment performed best on this outcome. Conclusions There is no strong evidence of a difference in cost between the treatments, but clinical and cost data together indicate that using both drugs together may be most cost effective over the course of the illness. This treatment option performs best and is no more expensive because of less use of healthcare resources, resulting in lower costs to the NHS and to parents.	[Hollinghurst, Sandra; Redmond, Niamh; Costelloe, Ceire; Montgomery, Alan; Peters, Tim J.; Hay, Alastair D.] Univ Bristol, Acad Unit Primary Hlth Care, NIHR Natl Sch Primary Care Res, Dept Community Based Med, Bristol BS8 2AA, Avon, England; [Fletcher, Margaret] Univ W England, Fac Hlth & Social Care, Bristol BS16 1QY, Avon, England	University of Bristol; University of West England	Hollinghurst, S (corresponding author), Univ Bristol, Acad Unit Primary Hlth Care, NIHR Natl Sch Primary Care Res, Dept Community Based Med, Bristol BS8 2AA, Avon, England.	s.p.hollinghurst@bristol.ac.uk	Hay, Alastair/L-1818-2019	Peters, Tim/0000-0003-2881-4180; Montgomery, Alan/0000-0003-0450-1606; Hay, Alastair/0000-0003-3012-375X; Redmond, Niamh M/0000-0001-8814-3396	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme [03/09/01]; National Institute for Health Research [03/09/01, PC6/PDA04/10] Funding Source: researchfish	National Institute for Health Research Health Technology Assessment (NIHR HTA) programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	The study was funded by the National Institute for Health Research Health Technology Assessment (NIHR HTA) programme (project number 03/09/01). The final study design, data collection and analysis, interpretation of results and paper writing was the sole responsibility of the authors. For the duration of the trial, AH held a postdoctoral award from the National Coordinating Centre for Research Capacity Development (NCCRCD), Department of Health. The views and opinions expressed in this paper do not necessarily reflect those of the NIHR HTA, NCCRCD, or Department of Health. The active drugs and matched placebos were purchased from Pfizer and DHP Investigational Medicinal Products respectively. Neither had any other role in the design, conduct, analysis, or reporting of the trial.	Beale N, 2005, FAM PRACT, V22, P317, DOI 10.1093/fampra/cmi014; *BRIT MED ASS ROYA, 2008, BRIT NAT FORM; Curtis L, 2007, UNIT COSTS HLTH SOCI; *DEP HLTH, NAT TAR 2006 07; *DEP HLTH, REF COST IND 2004; Department of Health, 2004, PRESCR COST AN ENGL; Hay AD, 2005, FAM PRACT, V22, P367, DOI 10.1093/fampra/cmi035; Hay AD, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1302; Hollinghurst S, 2008, BMC FAM PRACT, V9, DOI 10.1186/1471-2296-9-10; Kai J, 1996, BRIT MED J, V313, P983; Munro J, 2001, EVALUATION NHS DIREC; SALISBURY C, 2002, NATL EVALUATION NHS; Sarrell EM, 2006, ARCH PEDIAT ADOL MED, V160, P197, DOI 10.1001/archpedi.160.2.197; The Automobile Association, AA SCHED MOT COSTS; *UK STAT AUTH, POP EST ENGL WAL	15	9	9	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2008	337	7672							a1490	10.1136/bmj.a1490	http://dx.doi.org/10.1136/bmj.a1490			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18782838	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000259797600038
J	Goldston, D				Goldston, David			US election: Not the best advice	NATURE			English	News Item									[Goldston, David] Bipartisan Policy Ctr, Washington, DC USA		Goldston, D (corresponding author), Bipartisan Policy Ctr, Washington, DC USA.	partyofone@gmail.com							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					453	453		10.1038/455453a	http://dx.doi.org/10.1038/455453a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818626				2022-12-28	WOS:000259449600013
J	Jackson, M				Jackson, Mark			The art of medicine - Asthma, illness, and identity	LANCET			English	Editorial Material									[Jackson, Mark] Univ Exeter, Ctr Med Hist, Exeter EX4 4RJ, Devon, England	University of Exeter	Jackson, M (corresponding author), Univ Exeter, Ctr Med Hist, Exeter EX4 4RJ, Devon, England.							Brookes T., 1994, CATCHING MY BREATH; Cheyne George, 1733, ENGLISH MALADY TREAT; Floyer J., 1698, TREATISE ASTHMA; JACKSON M, 2009, IN PRESS ASTHMA BIOG; WITHERS T, 1786, TREATISE ASTHMA	5	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1030	1031		10.1016/S0140-6736(08)61429-4	http://dx.doi.org/10.1016/S0140-6736(08)61429-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18810804				2022-12-28	WOS:000259648500014
J	Curran, DP				Curran, Dennis P.			Chemistry - Fluorous tags unstick messy chemical biology problems	SCIENCE			English	Editorial Material							MASS-SPECTROMETRY; MICROARRAYS		[Curran, Dennis P.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15208 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Curran, DP (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15208 USA.	curran@pitt.edu						Brittain SM, 2005, NAT BIOTECHNOL, V23, P463, DOI 10.1038/nbt1076; Jaipuri FA, 2008, ANGEW CHEM INT EDIT, V47, P1707, DOI 10.1002/anie.200704262; Ko KS, 2005, J AM CHEM SOC, V127, P13162, DOI 10.1021/ja054811k; KOBOS RK, 1989, TRENDS BIOTECHNOL, V7, P101, DOI 10.1016/0167-7799(89)90008-5; Northen TR, 2008, P NATL ACAD SCI USA, V105, P3678, DOI 10.1073/pnas.0712332105; Vegas AJ, 2007, ANGEW CHEM INT EDIT, V46, P7960, DOI 10.1002/anie.200703198; Zhang W, 2006, TETRAHEDRON, V62, P11837, DOI 10.1016/j.tet.2006.08.051	7	51	52	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1645	1646		10.1126/science.1158721	http://dx.doi.org/10.1126/science.1158721			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801990				2022-12-28	WOS:000259300400024
J	Dai, J; Hyland, EM; Yuan, DS; Huang, HL; Bader, JS; Boeke, JD				Dai, Junbiao; Hyland, Edel M.; Yuan, Daniel S.; Huang, Hailiang; Bader, Joel S.; Boeke, Jef D.			Probing nucleosome function: A highly versatile library of synthetic histone H3 and H4 mutants	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; LYSINE METHYLATION; H2B UBIQUITYLATION; GLOBULAR DOMAIN; GENE-EXPRESSION; MATING-TYPE; DNA-REPAIR; CELL-CYCLE; YEAST; ACETYLATION	Nucleosome structural integrity underlies the regulation of DNA metabolism and transcription. Using a synthetic approach, a versatile library of 486 systematic histone H3 and H4 substitution and deletion mutants that probes the contribution of each residue to nucleosome function was generated in Saccharomyces cerevisiae. We probed fitness contributions of each residue to perturbations of chromosome integrity and transcription, mapping global patterns of chemical sensitivities and requirements for transcriptional silencing onto the nucleosome surface. Each histone mutant was tagged with unique molecular barcodes, facilitating identification of histone mutant pools through barcode amplification, labeling, and TAG microarray hybridization. Barcodes were used to score complex phenotypes such as competitive fitness in a chemostat, DNA repair proficiency, and synthetic genetic interactions, revealing new functions for distinct histone residues and new interdependencies among nucleosome components and their modifiers.	[Dai, Junbiao; Hyland, Edel M.; Yuan, Daniel S.; Huang, Hailiang; Bader, Joel S.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA; [Huang, Hailiang; Bader, Joel S.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21205 USA.	jboeke@jhmi.edu	Dai, Junbiao/AAB-8328-2021; Bader, Joel/A-1818-2009	Dai, Junbiao/0000-0002-5299-4700; Bader, Joel/0000-0002-6020-4625; Huang, Hailiang/0000-0003-1461-5762; Boeke, Jef/0000-0001-5322-4946	NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020839] Funding Source: NIH RePORTER; NCRR NIH HHS [U54 RR020839, U54 RR020839-04, RR020839] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adkins MW, 2007, J BIOL CHEM, V282, P1334, DOI 10.1074/jbc.M608025200; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Bryk M, 1997, GENE DEV, V11, P255, DOI 10.1101/gad.11.2.255; Celic I, 2006, CURR BIOL, V16, P1280, DOI 10.1016/j.cub.2006.06.023; CHATTOO BB, 1979, GENETICS, V93, P51; Cheung WL, 2005, CURR BIOL, V15, P656, DOI 10.1016/j.cub.2005.02.049; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Ferea TL, 1999, P NATL ACAD SCI USA, V96, P9721, DOI 10.1073/pnas.96.17.9721; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; HORIUCHI T, 1962, BIOCHIM BIOPHYS ACTA, V55, P152; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Hyland EA, 2005, MOL CELL BIOL, V25, P10060, DOI 10.1128/MCB.25.22.10060-10070.2005; Jazayeri A, 2004, P NATL ACAD SCI USA, V101, P1644, DOI 10.1073/pnas.0304797101; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Jessulat M, 2008, ARCH BIOCHEM BIOPHYS, V469, P157, DOI 10.1016/j.abb.2007.11.001; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Kamiya K, 2007, MOL CELL BIOL, V27, P3489, DOI 10.1128/MCB.00665-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lee SE, 1999, CURR BIOL, V9, P767, DOI 10.1016/S0960-9822(99)80339-X; Maas NL, 2006, MOL CELL, V23, P109, DOI 10.1016/j.molcel.2006.06.006; Masumoto H, 2005, NATURE, V436, P294, DOI 10.1038/nature03714; Matsubara K, 2007, GENES CELLS, V12, P13, DOI 10.1111/j.1365-2443.2007.01031.x; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Morillon A, 2005, MOL CELL, V18, P723, DOI 10.1016/j.molcel.2005.05.009; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Natsume R, 2007, NATURE, V446, P338, DOI 10.1038/nature05613; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; NOVICK A, 1950, SCIENCE, V112, P715, DOI 10.1126/science.112.2920.715; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ooi SL, 2003, NAT GENET, V35, P277, DOI 10.1038/ng1258; Ooi SL, 2001, SCIENCE, V294, P2552, DOI 10.1126/science.1065672; Ozdemir A, 2006, CELL CYCLE, V5, P2602, DOI 10.4161/cc.5.22.3473; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; PAQUIN CE, 1983, NATURE, V306, P368, DOI 10.1038/306368a0; PARK EC, 1990, MOL CELL BIOL, V10, P4932, DOI 10.1128/MCB.10.9.4932; Park JH, 2002, NAT GENET, V32, P273, DOI 10.1038/ng982; Qin S, 2002, MOL CELL BIOL, V22, P8353, DOI 10.1128/MCB.22.23.8353-8365.2002; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; SAUER B, 1987, MOL CELL BIOL, V7, P2087, DOI 10.1128/MCB.7.6.2087; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schwartz BE, 2006, CURR TOP DEV BIOL, V74, P31, DOI 10.1016/S0070-2153(06)74002-9; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Smith JS, 1997, GENE DEV, V11, P241, DOI 10.1101/gad.11.2.241; Smith JS, 1998, GENETICS, V149, P1205; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Utley RT, 2005, MOL CELL BIOL, V25, P8179, DOI 10.1128/MCB.25.18.8179-8190.2005; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Xu F, 2005, CELL, V121, P375, DOI 10.1016/j.cell.2005.03.011; Ye JX, 2005, MOL CELL, V18, P123, DOI 10.1016/j.molcel.2005.02.031; Yu CL, 2006, J BIOL CHEM, V281, P9755, DOI 10.1074/jbc.M513178200; Yuan DS, 2006, BIOINFORMATICS, V22, P3054, DOI 10.1093/bioinformatics/btl542; Yuan DS, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni105; Zhou H, 2006, BIOCHEMISTRY-US, V45, P2852, DOI 10.1021/bi0521083	65	156	158	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1066	1078		10.1016/j.cell.2008.07.019	http://dx.doi.org/10.1016/j.cell.2008.07.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805098	Green Accepted, Bronze			2022-12-28	WOS:000259318100025
J	Navarro, P; Chambers, I; Karwacki-Neisius, V; Chureau, C; Morey, C; Rougeulle, C; Avner, P				Navarro, Pablo; Chambers, Ian; Karwacki-Neisius, Violetta; Chureau, Corinne; Morey, Celine; Rougeulle, Claire; Avner, Philip			Molecular coupling of Xist regulation and pluripotency	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME INACTIVATION; EARLY MOUSE EMBRYOS; TSIX TRANSCRIPTION; ES CELLS; NANOG; EXPRESSION; DIFFERENTIATION; DETERMINES; OCT3/4	During mouse embryogenesis, reversion of imprinted X chromosome inactivation in the pluripotent inner cell mass of the female blastocyst is initiated by the repression of Xist from the paternal X chromosome. Here we report that key factors supporting pluripotency-Nanog, Oct3/4, and Sox2-bind within Xist intron 1 in undifferentiated embryonic stem ( ES) cells. Whereas Nanog null ES cells display a reversible and moderate up- regulation of Xist in the absence of any apparent modification of Oct3/4 and Sox2 binding, the drastic release of all three factors from Xist intron 1 triggers rapid ectopic accumulation of Xist RNA. We conclude that the three main genetic factors underlying pluripotency cooperate to repress Xist and thus couple X inactivation reprogramming to the control of pluripotency during embryogenesis.	[Navarro, Pablo; Chureau, Corinne; Morey, Celine; Rougeulle, Claire; Avner, Philip] CNRS, Inst Pasteur, Unite Genet Mol Murine, URA2578, F-75015 Paris, France; [Chambers, Ian; Karwacki-Neisius, Violetta] Univ Edinburgh, MRC, Ctr Dev Stem Cell Biol, Inst Stem Cell Res,Sch Biol Sci, Edinburgh EH9 3JQ, Midlothian, Scotland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Edinburgh	Rougeulle, C (corresponding author), CNRS, Inst Pasteur, Unite Genet Mol Murine, URA2578, F-75015 Paris, France.	rougeull@pasteur.fr; pavner@pasteur.fr	, Celine/ABB-7420-2020; Morey, Celine/N-5179-2018; Chambers, Ian/H-5416-2011	, Celine/0000-0001-9513-0278; Chambers, Ian/0000-0003-2605-1597; Rougeulle, Claire/0000-0003-3861-4940	CNRS; Institut Pasteur [05-JCJC-0166-01, 07-BLAN-0047-01]; EU Epigenome Network of Excellence; Wellcome Trust; Juvenile Diabetes Research Foundation; Biotechnological and Biological Sciences and Medical Research Councils of the UK; Medical Research Council [G0700711B] Funding Source: researchfish	CNRS(Centre National de la Recherche Scientifique (CNRS)); Institut Pasteur(European Commission); EU Epigenome Network of Excellence; Wellcome Trust(Wellcome Trust); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Biotechnological and Biological Sciences and Medical Research Councils of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank D. Colby for technical assistance, members of our laboratories for stimulating discussion, and A. Smith for the gift of the ZHBTc4 ES cell line. P.N., C.C., C.R., and P.A. were supported by recurrent funding from the CNRS and the Institut Pasteur, contracts 05-JCJC-0166-01 and 07-BLAN-0047-01 from the Agence Nationale de Recherche, and funding from the EU Epigenome Network of Excellence. Research in I.C.'s laboratory was supported by the Wellcome Trust, the Juvenile Diabetes Research Foundation, and the Biotechnological and Biological Sciences and Medical Research Councils of the UK.	Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Huynh KD, 2003, NATURE, V426, P857, DOI 10.1038/nature02222; Kalantry S, 2006, PLOS GENET, V2, P656, DOI 10.1371/journal.pgen.0020066; Lee JT, 1999, CELL, V99, P47, DOI 10.1016/S0092-8674(00)80061-6; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luikenhuis S, 2001, MOL CELL BIOL, V21, P8512, DOI 10.1128/MCB.21.24.8512-8520.2001; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Navarro P, 2005, GENE DEV, V19, P1474, DOI 10.1101/gad.341105; Navarro P, 2006, GENE DEV, V20, P2787, DOI 10.1101/gad.389006; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tsai CL, 2008, DEV BIOL, V319, P416, DOI 10.1016/j.ydbio.2008.04.010; Vigneau S, 2006, P NATL ACAD SCI USA, V103, P7390, DOI 10.1073/pnas.0602381103	24	257	263	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1693	1695		10.1126/science.1160952	http://dx.doi.org/10.1126/science.1160952			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802003				2022-12-28	WOS:000259300400041
J	Chan, M				Chan, Margaret			Return to Alma-Ata	LANCET			English	Editorial Material									[Chan, Margaret] WHO, CH-1211 Geneva 27, Switzerland	World Health Organization	Chan, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	chanm@who.int						Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Cahn P, 2008, LANCET, V372, P265, DOI 10.1016/S0140-6736(08)61085-5; *COMM SOC DET CHAN, 2008, FIN REP CLOS GAP GEN; FREEDMAN LP, 2005, UN MILLENNIUM PROJEC; Tarimo E., 1997, PRIMARY HLTH CARE CO	5	75	81	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					865	866		10.1016/S0140-6736(08)61372-0	http://dx.doi.org/10.1016/S0140-6736(08)61372-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790292				2022-12-28	WOS:000259266900004
J	Loaiza, E; Wardlaw, T; Salama, P				Loaiza, Edilberto; Wardlaw, Tessa; Salama, Peter			Child mortality 30 years after the Alma-Ata Declaration	LANCET			English	Editorial Material							SURVIVAL; NEWBORN		[Loaiza, Edilberto; Wardlaw, Tessa; Salama, Peter] UNICEF, New York, NY 10017 USA	UNICEF	Loaiza, E (corresponding author), UNICEF, 3 United Nations Plaza, New York, NY 10017 USA.	eloaiza@unicef.org						Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bustreo F, 2008, LANCET, V371, P1221, DOI 10.1016/S0140-6736(08)60535-8; UNICEF, 2007, 6 UNICEF; *UNICEF, 2008, MON SIT CHILDR WOM; *UNICEF UNAIDS WHO, 2008, UN ACC SCAL HIV SERV; *UNICEF WHO WORLD, 2007, LEV TRENDS CHILD MOR; 2008, COUNTDOWN 2015 TRACK	7	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					874	876		10.1016/S0140-6736(08)61378-1	http://dx.doi.org/10.1016/S0140-6736(08)61378-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790298				2022-12-28	WOS:000259266900010
J	Christe, KO				Christe, Karl O.			Neil Bartlett (1932-2008) - Obituary	NATURE			English	Biographical-Item									[Christe, Karl O.] Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA	University of Southern California	Christe, KO (corresponding author), Univ So Calif, Loker Hydrocarbon Res Inst, Los Angeles, CA 90089 USA.	kchriste@usc.edu	Christe, Karl/O-4885-2014	Christe, Karl/0000-0003-0661-5519					0	5	5	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					182	182		10.1038/455182a	http://dx.doi.org/10.1038/455182a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784717	Bronze			2022-12-28	WOS:000259090800033
J	Englund, M; Guermazi, A; Gale, D; Hunter, DJ; Aliabadi, P; Clancy, M; Felson, DT				Englund, Martin; Guermazi, Ali; Gale, Daniel; Hunter, David J.; Aliabadi, Piran; Clancy, Margaret; Felson, David T.			Incidental meniscal findings on knee MRI in middle-aged and elderly persons	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FIXED-FLEXION RADIOGRAPHY; JOINT SPACE WIDTH; IMAGING FINDINGS; CARTILAGE LOSS; LOAD-BEARING; RISK-FACTORS; FOLLOW-UP; OSTEOARTHRITIS; PREVALENCE; ABNORMALITIES	Background: Magnetic resonance imaging (MRI) of the knee is often performed in patients who have knee symptoms of unclear cause. When meniscal tears are found, it is commonly assumed that the symptoms are attributable to them. However, there is a paucity of data regarding the prevalence of meniscal damage in the general population and the association of meniscal tears with knee symptoms and with radiographic evidence of osteoarthritis. Methods: We studied persons from Framingham, Massachusetts, who were drawn from census-tract data and random-digit telephone dialing. Subjects were 50 to 90 years of age and ambulatory; selection was not made on the basis of knee or other joint problems. We assessed the integrity of the menisci in the right knee on 1.5-tesla MRI scans obtained from 991 subjects (57% of whom were women). Symptoms involving the right knee were evaluated by questionnaire. Results: The prevalence of a meniscal tear or of meniscal destruction in the right knee as detected on MRI ranged from 19% (95% confidence interval [CI], 15 to 24) among women 50 to 59 years of age to 56% (95% CI, 46 to 66) among men 70 to 90 years of age; prevalences were not materially lower when subjects who had had previous knee surgery were excluded. Among persons with radiographic evidence of osteoarthritis (Kellgren-Lawrence grade 2 or higher, on a scale of 0 to 4, with higher numbers indicating more definite signs of osteoarthritis), the prevalence of a meniscal tear was 63% among those with knee pain, aching, or stiffness on most days and 60% among those without these symptoms. The corresponding prevalences among persons without radiographic evidence of osteoarthritis were 32% and 23%. Sixty-one percent of the subjects who had meniscal tears in their knees had not had any pain, aching, or stiffness during the previous month. Conclusions: Incidental meniscal findings on MRI of the knee are common in the general population and increase with increasing age.	[Englund, Martin; Hunter, David J.; Clancy, Margaret; Felson, David T.] Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, Boston, MA 02118 USA; [Guermazi, Ali] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Gale, Daniel] Vet Affairs Med Ctr, Dept Radiol, Boston, MA USA; [Aliabadi, Piran] Harvard Univ, Sch Med, Dept Radiol, Brigham & Womens Hosp, Boston, MA 02115 USA; [Englund, Martin] Lund Univ, Dept Orthoped, Lund, Sweden	Boston University; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Brigham & Women's Hospital; Harvard Medical School; Lund University	Englund, M (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Res & Training Unit, 650 Albany St,Suite X200, Boston, MA 02118 USA.	englund@bu.edu	Hunter, David J/A-4622-2010; Englund, Martin/J-7245-2012	Hunter, David J/0000-0003-3197-752X; Englund, Martin/0000-0003-3320-2437; Felson, David/0000-0002-2668-2447	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018393] Funding Source: NIH RePORTER; NIAMS NIH HHS [P60 AR047785-01S1, P60 AR047785-07, P60 AR047785, AR47785] Funding Source: Medline; NIA NIH HHS [R01 AG018393-05, AG18393, R01 AG018393] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Ball J, 1963, ATLAS STANDARD RADIO, V2; Beattie KA, 2005, OSTEOARTHR CARTILAGE, V13, P181, DOI 10.1016/j.joca.2004.11.001; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; Boks SS, 2006, AM J SPORT MED, V34, P1984, DOI 10.1177/0363546506290189; De Smet AA, 2006, AM J ROENTGENOL, V187, P911, DOI 10.2214/AJR.05.1354; Ding CH, 2007, J RHEUMATOL, V34, P776; Englund M, 2007, ARTHRITIS RHEUM, V56, P4048, DOI 10.1002/art.23071; Englund M, 2003, ARTHRITIS RHEUM-US, V48, P2178, DOI 10.1002/art.11088; Englund M, 2004, ARTHRITIS RHEUM-US, V50, P2811, DOI 10.1002/art.20489; FAIRBANK HAT, 1948, J BONE JOINT SURG BR, V30, P164, DOI 10.1302/0301-620X.30B1.164; Felson DT, 2001, ANN INTERN MED, V134, P541, DOI 10.7326/0003-4819-134-7-200104030-00007; FELSON DT, 1987, ARTHRITIS RHEUM, V30, P914, DOI 10.1002/art.1780300811; Fox MG, 2007, RADIOL CLIN N AM, V45, P1033, DOI 10.1016/j.rcl.2007.08.009; HALL MJ, 1998, ADV DATA VITAL HLTH, V300; Hayes CW, 2005, RADIOLOGY, V237, P998, DOI 10.1148/radiol.2373041989; HEDE A, 1992, J BONE JOINT SURG BR, V74, P118, DOI 10.1302/0301-620X.74B1.1732238; HOWELL JR, 2000, COCHRANE DB SYST REV, V2; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P2488, DOI 10.1002/art.22016; Hunter DJ, 2006, ARTHRITIS RHEUM-US, V54, P795, DOI 10.1002/art.21724; Jee WH, 2003, AM J ROENTGENOL, V180, P93, DOI 10.2214/ajr.180.1.1800093; Jordan JM, 2007, J RHEUMATOL, V34, P172; Karlson Elizabeth W., 1995, Annals of Epidemiology, V5, P297, DOI 10.1016/1047-2797(94)00096-C; Kornaat PR, 2006, RADIOLOGY, V239, P811, DOI 10.1148/radiol.2393050253; Kothari M, 2004, EUR RADIOL, V14, P1568, DOI 10.1007/s00330-004-2312-6; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Link TM, 2003, RADIOLOGY, V226, P373, DOI 10.1148/radiol.2262012190; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Nevitt MC, 2007, ARTHRITIS RHEUM-US, V56, P1512, DOI 10.1002/art.22557; NOBLE J, 1975, J BONE JOINT SURG BR, V57, P180, DOI 10.1302/0301-620X.57B2.180; Peat G, 2001, ANN RHEUM DIS, V60, P91, DOI 10.1136/ard.60.2.91; POEHLING GG, 1990, CLIN SPORT MED, V9, P539; SHRIVE NG, 1978, CLIN ORTHOP RELAT R, P279; SMILLIE IS, 1962, INJURIES KNEE JOINT, P51; Vande Berg BC, 2001, AM J ROENTGENOL, V176, P771, DOI 10.2214/ajr.176.3.1760771; WALKER PS, 1975, CLIN ORTHOP RELAT R, P184; Zanetti M, 2003, AM J ROENTGENOL, V181, P635, DOI 10.2214/ajr.181.3.1810635	40	587	596	1	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1108	1115		10.1056/NEJMoa0800777	http://dx.doi.org/10.1056/NEJMoa0800777			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784100	Green Accepted			2022-12-28	WOS:000259078200006
J	Marks, JH				Marks, Jonathan H.			The ethics of interrogation - The US Military's ongoing use of psychiatrists	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Marks, Jonathan H.] Penn State Univ, University Pk, PA 16802 USA; [Marks, Jonathan H.] Coll Med, Hershey, PA USA; [Marks, Jonathan H.] Matrix Chambers, London, England	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Marks, JH (corresponding author), Penn State Univ, University Pk, PA 16802 USA.		Marks, Jonathan/A-9696-2009					*AM MED ASS, 10A06 COUNC ETH JUD; American Psychiatric Association, 2006, PSYCH PART INT DET P	2	13	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1090	1092		10.1056/NEJMp0806689	http://dx.doi.org/10.1056/NEJMp0806689			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346ON	18784097				2022-12-28	WOS:000259078200003
J	Tugnoli, G; Di Saverio, S; Casadei, GP; Biscardi, A; Baldoni, F				Tugnoli, Gregorio; Di Saverio, Salomone; Casadei, Gian Piero; Biscardi, Andrea; Baldoni, Franco			Houdini's last deception (or, Aristotle's bowel)	LANCET			English	Editorial Material							TRAUMA		[Tugnoli, Gregorio; Di Saverio, Salomone; Biscardi, Andrea; Baldoni, Franco] Maggiore Hosp, Emergency Surg & Trauma Surg Unit, Dept Surg, Bologna, Italy; [Casadei, Gian Piero] Maggiore Hosp, Dept Pathol, Bologna, Italy	AUSL di Bologna; AUSL di Bologna	Di Saverio, S (corresponding author), Maggiore Hosp, Emergency Surg & Trauma Surg Unit, Dept Surg, Bologna, Italy.	salo75@inwind.it	Di Saverio, Salomone/G-1437-2012	Di Saverio, Salomone/0000-0001-5685-5022				AMANO H, 1980, SURG FORUM, V31, P157; Doyle, 1930, EDGE UNKNOWN; Frick EJ, 1999, J TRAUMA, V46, P920, DOI 10.1097/00005373-199905000-00024; HENNINGTON MH, 1991, ANN SURG, V214, P61; LORIA F L, 1948, Surg Gynecol Obstet, V87, P521	5	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					862	862		10.1016/S0140-6736(08)61338-0	http://dx.doi.org/10.1016/S0140-6736(08)61338-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774420				2022-12-28	WOS:000259124900029
J	Pryor, PR; Jackson, L; Gray, SR; Edeling, MA; Thompson, A; Sanderson, CM; Evans, PR; Owen, DJ; Luzio, JP				Pryor, Paul R.; Jackson, Lauren; Gray, Sally R.; Edeling, Melissa A.; Thompson, Amanda; Sanderson, Christopher M.; Evans, Philip R.; Owen, David J.; Luzio, J. Paul			Molecular basis for the sorting of the SNARE VAMP7 into endocytic clathrin-coated vesicles by the ArfGAP Hrb	CELL			English	Article							MEMBRANE-FUSION; TI-VAMP; PROTEINS; COMPLEX; DOMAIN; LOCALIZATION; SPECIFICITY; LYSOSOMES; TRANSPORT; ADAPTER	SNAREs provide the specificity and energy for the fusion of vesicles with their target membrane, but how they are sorted into the appropriate vesicles on post-Golgi trafficking pathways is largely unknown. We demonstrate that the clathrin-mediated endocytosis of the SNARE VAMP7 is directly mediated by Hrb, a clathrin adaptor and ArfGAP. Hrb wraps 20 residues of its unstructured C-terminal tail around the folded VAMP7 longin domain, demonstrating that unstructured regions of clathrin adaptors can select cargo. Disrupting this interaction by mutation of the VAMP7 longin domain or depletion of Hrb causes VAMP7 to accumulate on the cell's surface. However, the SNARE helix of VAMP7 binds back onto its longin domain, outcompeting Hrb for binding to the same groove and suggesting that Hrb-mediated endocytosis of VAMP7 occurs only when VAMP7 is incorporated into a cis-SNARE complex. These results elucidate the mechanism of retrieval of a postfusion SNARE complex in clathrin-coated vesicles.	[Pryor, Paul R.; Gray, Sally R.; Edeling, Melissa A.; Owen, David J.; Luzio, J. Paul] Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Pryor, Paul R.; Gray, Sally R.; Edeling, Melissa A.; Owen, David J.; Luzio, J. Paul] Univ Cambridge, Addenbrookes Hosp, Dept Clin Biochem, Cambridge CB2 0XY, England; [Jackson, Lauren; Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Thompson, Amanda; Sanderson, Christopher M.] MRC, Rosalind Franklin Ctr Genom Res, Cambridge CB10 1SB, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; MRC Laboratory Molecular Biology	Owen, DJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	djo30@cam.ac.uk; jpl10@cam.ac.uk		Pryor, Paul Robert/0000-0001-9123-8329; Jackson, Lauren/0000-0002-3705-6126	MRC [G9310915]; Wellcome Trust [079895]; MRC [MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105178845, G9310915] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by MRC programme grant G9310915 to J. P. L., a Wellcome Trust Senior Research Fellowship to D. J. O., and Wellcome Trust Strategic Award 079895 to CIMR. We thank beamline staff at the ESRF and Maria Jose Sanchez Barena for help with data collection, Jenny Martin (IMB Brisbane) for the SNAP23 and syntaxin4 clones, Celina Whalley and Naveed Aziz of the York Technology Facility at the University of York for help with qPCR, Sally Raines and Brett Collins for technical assistance, and Andrew Peden, Katherine Bowers, Margaret Robinson, and Sean Munro for helpful discussions.	Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cuff JA, 1998, BIOINFORMATICS, V14, P892, DOI 10.1093/bioinformatics/14.10.892; Doria M, 1999, J CELL BIOL, V147, P1379, DOI 10.1083/jcb.147.7.1379; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Filippini F, 2001, TRENDS BIOCHEM SCI, V26, P407, DOI 10.1016/S0968-0004(01)01861-8; French AP, 2008, NAT PROTOC, V3, P619, DOI 10.1038/nprot.2008.31; FRITZ CC, 1995, NATURE, V376, P530, DOI 10.1038/376530a0; Gonzalez LC, 2001, J BIOL CHEM, V276, P24203, DOI 10.1074/jbc.M101584200; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; HONG W, 2005, GENETICS, V144, P1425; KRISSINEL E, 2005, DETECTION PROTEIN AS; Lehner B, 2004, GENOMICS, V83, P153, DOI 10.1016/S0888-7543(03)00235-0; Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017; Martinez-Arca S, 2000, J CELL BIOL, V149, P889, DOI 10.1083/jcb.149.4.889; Martinez-Arca S, 2003, J CELL SCI, V116, P2805, DOI 10.1242/jcs.00467; Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Peden AA, 2004, J CELL BIOL, V164, P1065, DOI 10.1083/jcb.200311064; Pelham HRB, 2001, TRENDS CELL BIOL, V11, P99, DOI 10.1016/S0962-8924(01)01929-8; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Rao SK, 2004, J BIOL CHEM, V279, P20471, DOI 10.1074/jbc.M400798200; Reaves BJ, 1996, J CELL SCI, V109, P749; Reid E, 2005, HUM MOL GENET, V14, P19, DOI 10.1093/hmg/ddi003; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Schwartz T, 2003, CELL, V112, P793, DOI 10.1016/S0092-8674(03)00161-2; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Wen WY, 2006, MOL BIOL CELL, V17, P4282, DOI 10.1091/mbc.E06-02-0128; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649	39	119	119	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					817	827		10.1016/j.cell.2008.07.023	http://dx.doi.org/10.1016/j.cell.2008.07.023			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775314	hybrid, Green Published			2022-12-28	WOS:000258947500021
J	Balkenende, JP; Kikwete, J; Stoltenberg, J; Zoellick, R				Balkenende, Jan Peter; Kikwete, Jakaya; Stoltenberg, Jens; Zoellick, Robert			Innovative finance for women and children	LANCET			English	Editorial Material									[Zoellick, Robert] World Bank, Washington, DC 20433 USA	The World Bank		Tore.Godal@smk.dep.no						*INSR ORC MACR, 2006, RWAND DEM HLTH SURV; Mavalankar D, 2008, LANCET, V371, P631, DOI 10.1016/S0140-6736(08)60282-2; *MIN HLTH FAM WELF, 2008, GOV IND; National Institute of Statistics of Rwanda (NISR) ORC Macro., 2008, RWAND INT DEM HLTH S; *UN, 2005, END POV 2015; *UN EC SOC DEV, 2008, FIN DEV DOH REV C FI; *WHO UNICEF UNFPA, 2007, MAT MORT 2005 EST DE; *WIK CONTR, 2008, FREE ENC; 2008, GLOBAL CAMPAIGN HLTH; 2008, INT HLTH PARTNERSHIP	10	5	5	2	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP-OCT	2008	372	9644					1123	1124		10.1016/S0140-6736(08)61454-3	http://dx.doi.org/10.1016/S0140-6736(08)61454-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	355UN	18819706				2022-12-28	WOS:000259734700004
J	Hejnol, A; Martindale, MQ				Hejnol, Andreas; Martindale, Mark Q.			Acoel development indicates the independent evolution of the bilaterian mouth and anus	NATURE			English	Article							GENE-EXPRESSION; NERVOUS-SYSTEM; GASTRULATION; BRACHYURY; DROSOPHILA; FLATWORMS; SUGGESTS; ORIGINS; PATTERN	Most bilaterian animals possess a through gut with a separate mouth and anus(1). It is commonly believed that during the transition from radial to bilateral symmetry, both openings evolved simultaneously by the lateral closure of a slit- like blastopore(1-4). Molecular phylogenies however, place the acoel flatworms, which have only one opening to their digestive system, as the sister group to all remaining Bilateria(5-7). To address how this single body opening is related to the mouth and anus of the protostomes and deuterostomes, we studied the expression of genes involved in bilaterian foregut and hindgut patterning during the development of the acoel Convolutriloba longifissura. Here we show that the genes brachyury and goosecoid are expressed in association with the acoel mouth, suggesting that this single opening is homologous to the mouth of other bilaterians(8). In addition, we find that the genes caudal, orthopedia and brachyury - which are expressed in various bilaterian hindguts(8-10) - are expressed in a small region at the posterior end of the animal, separated from the anterior oral brachyury- expressing region by a dorsal domain of ectodermal bmp2/4 expression. These results contradict the hypothesis that the bilaterian mouth and anus evolved simultaneously from a common blastoporal opening, and suggest that a through gut might have evolved independently in different animal lineages.	[Hejnol, Andreas; Martindale, Mark Q.] Univ Hawaii, Kewalo Marine Lab, PBRC, Honolulu, HI 96813 USA	University of Hawaii System	Hejnol, A (corresponding author), Univ Hawaii, Kewalo Marine Lab, PBRC, 41 Ahui St, Honolulu, HI 96813 USA.	hejnol@hawaii.edu	Hejnol, Andreas/C-5577-2012	Hejnol, Andreas/0000-0003-2196-8507	National Science Foundation; AToL program [EF05-31558]; NASA; Deutsche Forschungsgemeinschaft [HE5183/2-1]	National Science Foundation(National Science Foundation (NSF)); AToL program; NASA(National Aeronautics & Space Administration (NASA)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work is supported by the National Science Foundation under the AToL program (EF05-31558) and NASA to M. Q. M. A. H. received further support from the Deutsche Forschungsgemeinschaft (HE5183/2-1). We thank K. Pang for improving the manuscript and A. Okuso for the drawings of the cnidarian and annelid.	Arendt D, 1997, MECH DEVELOP, V61, P7, DOI 10.1016/S0925-4773(96)00620-X; Arendt D, 2001, NATURE, V409, P81, DOI 10.1038/35051075; Baguna J, 2004, BIOESSAYS, V26, P1046, DOI 10.1002/bies.20113; Christiaen L, 2007, SEMIN CELL DEV BIOL, V18, P502, DOI 10.1016/j.semcdb.2007.06.002; Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Frobius AC, 2006, DEV GENES EVOL, V216, P81, DOI 10.1007/s00427-005-0049-0; Graff Ludwig von, 1891, ORG TURBELLARIA ACOE; Grobben K, 1909, VERH ZOOL BOT GES WI, V58, P491; Haeckel E., 1874, JENAISCHE Z NATURWIS, P1; Haszprunar G, 1996, J ZOOL SYST EVOL RES, V34, P41; Henry JQ, 2000, DEV BIOL, V220, P285, DOI 10.1006/dbio.2000.9628; Hyman L., 1951, INVERTEBRATES, VII; JAGERSTEN GOSTA, 1955, ZOOL BIDRAG UPPSALA, V30, P321; Lartillot N, 2002, DEVELOPMENT, V129, P1411; Lowe CJ, 2006, PLOS BIOL, V4, P1603, DOI 10.1371/journal.pbio.0040291; Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0; Marcellini S, 2006, BIOESSAYS, V28, P413, DOI 10.1002/bies.20387; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Neidert AH, 2000, EVOL DEV, V2, P303, DOI 10.1046/j.1525-142x.2000.00073.x; Nielsen C, 2001, ANIMAL EVOLUTION, VSecond; Reisinger E., 1961, FORTSCHR ZOOL, V13, P1; Remane A., 1950, ZOOL ANZ, V14, P18; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; SALVINIPLAWEN LV, 1978, Z ZOOL SYST EVOL, V16, P40; SEDGWICK W, 1884, Q J MICROSC SCI, V24, P43; SIMEONE A, 1994, NEURON, V13, P83, DOI 10.1016/0896-6273(94)90461-8; Tagawa K, 1998, MECH DEVELOP, V75, P139, DOI 10.1016/S0925-4773(98)00078-1; Wallberg A, 2007, ZOOL SCR, V36, P509, DOI 10.1111/j.1463-6409.2007.00295.x; Wu LH, 1998, DEVELOPMENT, V125, P2433	30	99	102	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 20	2008	456	7220					382	U45		10.1038/nature07309	http://dx.doi.org/10.1038/nature07309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JM	18806777				2022-12-28	WOS:000261039600042
J	Qayyum, R; Bolen, S; Maruthur, N; Feldman, L; Wilson, LM; Marinopoulos, SS; Ranasinghe, P; Amer, M; Bass, EB				Qayyum, Rehan; Bolen, Shari; Maruthur, Nisa; Feldman, Leonard; Wilson, Lisa M.; Marinopoulos, Spyridon S.; Ranasinghe, Padmini; Amer, Muhammed; Bass, Eric B.			Systematic Review: Comparative Effectiveness and Safety of Premixed Insulin Analogues in Type 2 Diabetes	ANNALS OF INTERNAL MEDICINE			English	Review							POSTPRANDIAL GLYCEMIC CONTROL; TWICE-DAILY BIPHASIC-INSULIN-ASPART-30; ASSOCIATION DETECTION PROJECT; BIPHASIC HUMAN INSULIN; DOUBLE-BLIND CROSSOVER; BASAL INSULIN; OPEN-LABEL; BLOOD-GLUCOSE; PLASMA-GLUCOSE; PLUS METFORMIN	Background: Evidence comparing premixed insulin analogues (a mixture of rapid-acting and intermediate-acting insulin analogues) with other antidiabetic agents is urgently required to guide appropriate therapy. Purpose: To summarize the English-language literature on the effectiveness and safety of premixed insulin analogues compared with other antidiabetic agents in adults with type 2 diabetes. Data Sources: The authors searched MEDLINE, EMBASE, CINAHL, and the Cochrane Central Register of Controlled Trials from inception to February 2008 and sought unpublished data from the U. S. Food and Drug Administration, European Medicines Agency, and industry. Study Selection: Studies with control groups that compared premixed insulin analogues with another antidiabetic medication in adults with type 2 diabetes. Data Extraction: 2 reviewers using standardized protocols performed serial abstraction. Data Synthesis: Evidence from clinical trials was inconclusive for clinical outcomes, such as mortality. Therefore, the review focused on intermediate outcomes. Premixed insulin analogues were similar to premixed human insulin in decreasing fasting glucose levels, hemoglobin A(1c) levels, and the incidence of hypoglycemia but were more effective in decreasing postprandial glucose levels (mean difference, -1.1 mmol/L; 95% CI, -1.4 to -0.7 mmol/L [-19.2 mg/dL; 95% CI, -25.9 to -12.5 mg/dL]). Compared with long-acting insulin analogues, premixed insulin analogues were superior in decreasing postprandial glucose levels (mean difference, -1.5 mmol/L; CI, -1.9 to -1.2 mmol/L [-27.9 mg/dL; CI, -34.3 to -21.5 mg/dL]) and hemoglobin A1c levels (mean difference, -0.39% [CI, -0.50% to -0.28%]) but were inferior in decreasing fasting glucose levels (mean difference, 0.7 mmol/L; CI, 0.3 to 1.0 mmol/L [12.0 mg/dL; CI, 6.0 to 18.1 mg/dL]) and were associated with a higher incidence of hypoglycemia. Compared with non-insulin antidiabetic agents, premixed insulin analogues were more effective in decreasing fasting glucose levels (mean difference, -1.1 mmol/L; CI, -1.7 to -0.6 mmol/L [-20.5 mg/dL; CI, -29.9 to -11.2 mg/dL]), postprandial glucose levels (mean difference, -2.1 mmol/L; CI, -3.4 to -0.8 mmol/L [-37.4 mg/dL; CI, -61.0 to -13.7 mg/dL]), and hemoglobin A1c levels (mean difference, -0.49% [CI, -0.86% to -0.12%]) but were associated with a higher incidence of hypoglycemia. Limitations: The literature search was restricted to studies published in English. Data on clinical outcomes were limited. The small number of studies for each comparison limited assessment of between-study heterogeneity. Conclusion: Premixed insulin analogues provide glycemic control similar to that of premixed human insulin and may provide tighter glycemic control than long-acting insulin analogues and non-insulin antidiabetic agents.	Johns Hopkins Univ, Evidence based Practice Ctr, Baltimore, MD USA	Johns Hopkins University	Qayyum, R (corresponding author), Johns Hopkins Univ Hosp, Hospitalist Program, 600 N Wolfe St,Pk 307-A, Baltimore, MD 21287 USA.	rqayyum@jhmi.edu		Qayyum, Rehan/0000-0003-3086-8014; Feldman, Leonard/0000-0002-4444-6624; Bass, Eric/0000-0001-9106-527X	Johns Hopkins Evidence-based Practice Center [290-02-0018]; Agency for Healthcare Research and Quality, Rockville, Maryland; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007024] Funding Source: NIH RePORTER	Johns Hopkins Evidence-based Practice Center; Agency for Healthcare Research and Quality, Rockville, Maryland(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant Support: This article is based on research conducted by the Johns Hopkins Evidence-based Practice Center under contract number 290-02-0018 with the Agency for Healthcare Research and Quality, Rockville, Maryland.	Abrahamian H, 2005, HORM METAB RES, V37, P684, DOI 10.1055/s-2005-870579; Agency for Healthcare Research and Quality, 2007, METH REF GUID EFF CO; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bebakar WMW, 2007, DIABETES OBES METAB, V9, P724, DOI 10.1111/j.1463-1326.2007.00743.x; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Boden-Albala B, 2008, DIABETES CARE, V31, P1132, DOI 10.2337/dc07-0797; Boehm Bernhard O, 2004, Eur J Intern Med, V15, P496, DOI 10.1016/j.ejim.2004.10.001; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; *CDCP, 2005, NAT DIAB FACT SHEET; Christiansen JS, 2003, DIABETES OBES METAB, V5, P446, DOI 10.1046/j.1463-1326.2003.00300.x; Coscelli C, 2003, ACTA DIABETOL, V40, P187, DOI 10.1007/s00592-003-0110-2; Cox DJ, 2007, DIABETES CARE, V30, P2001, DOI 10.2337/dc06-2480; CURB JD, 1995, CIRCULATION, V91, P2591, DOI 10.1161/01.CIR.91.10.2591; de Vegt F, 1999, DIABETOLOGIA, V42, P926, DOI 10.1007/s001250051249; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gregg EW, 2004, DIABETES CARE, V27, P2806, DOI 10.2337/diacare.27.12.2806; Hermansen K, 2002, DIABETES CARE, V25, P883, DOI 10.2337/diacare.25.5.883; Herz M, 2003, SAMJ S AFR MED J, V93, P219; Herz M, 2002, CURR MED RES OPIN, V18, P188, DOI 10.1185/030079902125000615; Herz M, 2002, CLIN THER, V24, P73, DOI 10.1016/S0149-2918(02)85006-8; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirao K, 2008, DIABETES RES CLIN PR, V79, P171, DOI 10.1016/j.diabres.2007.08.011; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Jacober SJ, 2006, DIABETES OBES METAB, V8, P448, DOI 10.1111/j.1463-1326.2006.00605.x; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Joshi S R, 2005, J Assoc Physicians India, V53, P775; Kann PH, 2006, EXP CLIN ENDOCR DIAB, V114, P527, DOI 10.1055/s-2006-949655; Kapitza C, 2004, DIABETIC MED, V21, P500, DOI 10.1111/j.1464-5491.2004.01190.x; Kazda C, 2006, J DIABETES COMPLICAT, V20, P145, DOI 10.1016/j.jdiacomp.2005.09.004; Kilo C, 2003, J DIABETES COMPLICAT, V17, P307, DOI 10.1016/S1056-8727(03)00076-X; Kvapil A, 2006, DIABETES OBES METAB, V8, P39, DOI 10.1111/j.1463-1326.2005.00492.x; Lowe LP, 1997, DIABETES CARE, V20, P163, DOI 10.2337/diacare.20.2.163; Malone JK, 2000, CLIN THER, V22, P222, DOI 10.1016/S0149-2918(00)88480-5; Malone JK, 2005, DIABETIC MED, V22, P374, DOI 10.1111/j.1464-5491.2005.01511.x; Malone JK, 2004, CLIN THER, V26, P2034, DOI 10.1016/j.clinthera.2004.12.015; Malone JK, 2003, DIABETES RES CLIN PR, V62, P187, DOI 10.1016/j.diabres.2003.08.003; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mattoo V, 2003, DIABETES RES CLIN PR, V59, P137, DOI 10.1016/S0168-8227(02)00202-4; McNally PG, 2007, DIABETES CARE, V30, P1044, DOI 10.2337/dc06-1328; McSorley PT, 2002, CLIN THER, V24, P530, DOI 10.1016/S0149-2918(02)85129-3; Monnier Louis, 2006, Endocr Pract, V12 Suppl 1, P42; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Niskanen L, 2004, CLIN THER, V26, P531, DOI 10.1016/S0149-2918(04)90055-0; Orencia AJ, 1997, J CLIN EPIDEMIOL, V50, P1369, DOI 10.1016/S0895-4356(97)00201-1; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; RASKIN P, 2007, DIABETES OBES METAB; Raskin PR, 2007, EUR J INTERN MED, V18, P56, DOI 10.1016/j.ejim.2006.09.006; Raz I, 2005, CLIN THER, V27, P1432, DOI 10.1016/j.clinthera.2005.09.001; Raz I, 2003, CLIN THER, V25, P3109, DOI 10.1016/S0149-2918(03)90095-6; Roach P, 1999, DIABETES CARE, V22, P1258, DOI 10.2337/diacare.22.8.1258; Roach P, 2006, DIABETIC MED, V23, P743, DOI 10.1111/j.1464-5491.2006.01895.x; Roach P, 2003, DIABETES OBES METAB, V5, P311, DOI 10.1046/j.1463-1326.2003.00277.x; Roach P, 1999, CLIN THER, V21, P523, DOI 10.1016/S0149-2918(00)88307-1; Robbins DC, 2007, CLIN THER, V29, P2349, DOI 10.1016/j.clinthera.2007.11.016; ROBINS J, 1986, AM J EPIDEMIOL, V124, P719, DOI 10.1093/oxfordjournals.aje.a114447; Rosenstock J, 2008, DIABETES CARE, V31, P20, DOI 10.2337/dc07-1122; Saudek CD, 2006, JAMA-J AM MED ASSOC, V295, P1688, DOI 10.1001/jama.295.14.1688; Schernthaner G, 2004, HORM METAB RES, V36, P188, DOI 10.1055/s-2004-814345; Schwartz S, 2006, CLIN THER, V28, P1649, DOI 10.1016/j.clinthera.2006.10.017; Sun P, 2007, CURR MED RES OPIN, V23, P3017, DOI 10.1185/030079907X242845; Tamemoto H, 2007, DIABETES TECHNOL THE, V9, P246, DOI 10.1089/dia.2006.0016; Tirgoviste C Ionescu, 2003, Rom J Intern Med, V41, P153; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Ushakova O, 2007, CLIN THER, V29, P2374, DOI 10.1016/j.clinthera.2007.11.017; Wells G. A., 2007, NEWCASTLE OTTAWA SCA; White JR, 2004, CLIN THER, V26, P1179, DOI 10.1016/S0149-2918(04)90190-7; Yamada S, 2007, INTERNAL MED, V46, P1513, DOI 10.2169/internalmedicine.46.0236; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	72	70	78	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 21	2008	149	8					549	W106		10.7326/0003-4819-149-8-200810210-00242	http://dx.doi.org/10.7326/0003-4819-149-8-200810210-00242			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	367XJ	18794553	Green Accepted			2022-12-28	WOS:000260585600004
J	Dartington, T; Brennan, M; Sampson, EL; Coupe, K; Malloy, L				Dartington, Tim; Brennan, Mary; Sampson, Elizabeth L.; Coupe, Kate; Malloy, Lynn			Dying from dementia - a patient's journey	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sampson, Elizabeth L.] UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England; [Dartington, Tim] Tavistock Inst, London EC2A 4UE, England; [Coupe, Kate; Malloy, Lynn] Bamet Enfield & Haringey Mental Hlth Trust, London N15 3TH, England	University of London; University College London; UCL Medical School	Sampson, EL (corresponding author), UCL Royal Free & Univ Coll Med Sch, London NW3 2PF, England.	mary.brennan@nmh.nhs.uk; e.sampson@medsch.ucl.ac.uk; Kate.coupe@beh-mht.nhs.uk; lynn.malloy@beh-mht.nhs.uk	Sampson, Elizabeth L/B-8647-2009	Sampson, Elizabeth L/0000-0001-8929-7362					0	5	5	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1712	10.1136/bmj.a1712	http://dx.doi.org/10.1136/bmj.a1712			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360YE	18818258				2022-12-28	WOS:000260093900041
J	Haq, BU; Schutter, SR				Haq, Bilal U.; Schutter, Stephen R.			A chronology of Paleozoic sea-level changes	SCIENCE			English	Article							CYCLES; AGE	Sea levels have been determined for most of the Paleozoic Era ( 542 to 251 million years ago), but an integrated history of sea levels has remained unrealized. We reconstructed a history of sea- level fluctuations for the entire Paleozoic by using stratigraphic sections from pericratonic and cratonic basins. Evaluation of the timing and amplitude of individual sea- level events reveals that the magnitude of change is the most problematic to estimate accurately. The long- term sea level shows a gradual rise through the Cambrian, reaching a zenith in the Late Ordovician, then a short- lived but prominent withdrawal in response to Hirnantian glaciation. Subsequent but decreasingly substantial eustatic highs occurred in the mid- Silurian, near the Middle/ Late Devonian boundary, and in the latest Carboniferous. Eustatic lows are recorded in the early Devonian, near the Mississippian/ Pennsylvanian boundary, and in the Late Permian. One hundred and seventy- two eustatic events are documented for the Paleozoic, varying in magnitude from a few tens of meters to similar to 125 meters.	[Haq, Bilal U.] Natl Sci Fdn, Arlington, VA 22230 USA; [Schutter, Stephen R.] Murphy Oil Int, Houston, TX 77094 USA	National Science Foundation (NSF)	Haq, BU (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	bhaq@nsf.gov	Haq, Bilal U./B-2836-2017; Haq, Bilal/Q-8112-2019					Algeo T. J., 1995, SEQUENCE STRATIGRAPH, P209; [Anonymous], 1974, MAINMISE, V45, P32, DOI DOI 10.1007/978-3-662-01141-6_4; BOND GC, 1984, GEOL SOC AM BULL, V95, P155, DOI 10.1130/0016-7606(1984)95<155:COTSCF>2.0.CO;2; CAPUTO MV, 1985, GEOL SOC AM BULL, V96, P1020, DOI 10.1130/0016-7606(1985)96<1020:MOGCAG>2.0.CO;2; Cogne JP, 2008, EARTH PLANET SC LETT, V273, P251, DOI 10.1016/j.epsl.2008.06.030; Cogne JP, 2006, EARTH PLANET SC LETT, V245, P115, DOI 10.1016/j.epsl.2006.03.020; Eyles N., 1994, INT GEOL CORREL PROG, P1, DOI DOI 10.1017/CBO9780511628900.002; GRADSTEIN FM, 2004, GEOLOGIC TIME SCALE, P1; GURNIS M, 1990, NATURE, V344, P754, DOI 10.1038/344754a0; Hallam A., 1992, PHANEROZOIC SEA LEVE; Haq B. U., 1988, SOC ECON PALEONT MIN, V42, P71, DOI DOI 10.2110/PEC.88.01.0071; Haq BU, 2005, GEOARABIA, V10, P127; Hardenbol J., 1998, SEPM SPEC PUBL, V60, P3, DOI DOI 10.2110/PEC.98.02.0003; Isbell J.L., 2003, EXTREME DEPOSITIONAL, V370, P5; JOHNSON ME, 1998, NEW YORK STATE MUSEU, V491, P3; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Kuiper KF, 2008, SCIENCE, V320, P500, DOI 10.1126/science.1154339; MCCLURE HA, 1978, PALAEOGEOGR PALAEOCL, V25, P315, DOI 10.1016/0031-0182(78)90047-0; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Muller RD, 2008, SCIENCE, V319, P1357, DOI 10.1126/science.1151540; Ogg JG, 2016, CONCISE GEOLOGIC TIME SCALE 2016, P1; RAMSBOTTOM W.H.C., 1981, P YORKS GEOL SOC, V43, P473, DOI [DOI 10.1144/PYGS.43.4.473, 10.1144/pygs.43.4.473]; RONOV AB, 1994, AM J SCI, V294, P777, DOI 10.2475/ajs.294.7.777; Rygel MC, 2008, J SEDIMENT RES, V78, P500, DOI 10.2110/jsr.2008.058; SLOSS LL, 1963, GEOL SOC AM BULL, V74, P93, DOI 10.1130/0016-7606(1963)74[93:SITCIO]2.0.CO;2; Smith LB, 2001, J SEDIMENT RES, V71, P985, DOI 10.1306/040501710985; Soreghan GS, 1999, GEOLOGY, V27, P255, DOI 10.1130/0091-7613(1999)027<0255:AOLPG>2.3.CO;2; Vail P.R., 1977, AAPG BULL, P63, DOI DOI 10.1306/M26490C5; Van Sickel WA, 2004, BASIN RES, V16, P451, DOI 10.1111/j.1365-2117.2004.00242.x; Van Wagoner J. C., 1990, AM ASS PETROLEUM GEO, V7, P55; VASLET D, 1990, EPISODES, V13, P147, DOI 10.18814/epiiugs/1990/v13i3/002; Veevers J.J, 1984, PHANEROZOIC EARTH HI, P1; Witzke B. J., 1996, GEOLOGICAL SOC AM SP, P307	33	960	1088	7	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					64	68		10.1126/science.1161648	http://dx.doi.org/10.1126/science.1161648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832639				2022-12-28	WOS:000259680200036
J	Zhang, J; Liu, X; Blume, R; Zhang, AH; Schlogl, R; Su, DS				Zhang, Jian; Liu, Xi; Blume, Raoul; Zhang, Aihua; Schloegl, Robert; Su, Dang Sheng			Surface-modified carbon nanotubes catalyze oxidative dehydrogenation of n-butane	SCIENCE			English	Article							OXIDE CATALYSTS; ACTIVATED CARBON; ETHYLBENZENE; OXYGEN; CHEMISTRY; PROPANE; STYRENE; XPS	Butenes and butadiene, which are useful intermediates for the synthesis of polymers and other compounds, are synthesized traditionally by oxidative dehydrogenation ( ODH) of n- butane over complex metal oxides. Such catalysts require high O(2)/ butane ratios to maintain the activity, which leads to unwanted product oxidation. We show that carbon nanotubes with modified surface functionality efficiently catalyze the oxidative dehydrogenation of n- butane to butenes, especially butadiene. For low O(2)/ butane ratios, a high selectivity to alkenes was achieved for periods as long as 100 hours. This process is mildly catalyzed by ketonic C= O groups and occurs via a combination of parallel and sequential oxidation steps. A small amount of phosphorus greatly improved the selectivity by suppressing the combustion of hydrocarbons.	[Zhang, Jian; Liu, Xi; Blume, Raoul; Zhang, Aihua; Schloegl, Robert; Su, Dang Sheng] Max Planck Soc, Fritz Haber Inst, D-14195 Berlin, Germany	Max Planck Society; Fritz Haber Institute of the Max Planck Society	Su, DS (corresponding author), Max Planck Soc, Fritz Haber Inst, Faradayweg 4-6, D-14195 Berlin, Germany.	dangsheng@fhi-berlin.mpg.de		Zhang, Aihua/0000-0002-0517-4806	CANAPE project of the 6th Framework Programme of European Commission; ENERCHEM project of the Max Planck Society	CANAPE project of the 6th Framework Programme of European Commission(European Commission); ENERCHEM project of the Max Planck Society(Max Planck Society)	We thank the Max Planck Society; U. Wild, A. Klein- Hoffmann, and J. Thielemann for technical assistance; Berliner Elektronenspeicherring-Gesellschaft fur Synchrotronstrahlung for support of in situ XPS measurements; and M. A Smith for helpful discussions. Supported by the CANAPE project of the 6th Framework Programme of European Commission and the ENERCHEM project of the Max Planck Society.	Alkhazov T. G., 1978, KINET KATAL, V19, P611; ATAMNY F, 1992, MOL PHYS, V76, P851, DOI 10.1080/00268979200101731; Cavani F, 1995, APPL CATAL A-GEN, V133, P219, DOI 10.1016/0926-860X(95)00218-9; Chen KD, 2002, J CATAL, V209, P35, DOI 10.1006/jcat.2002.3620; Chen KD, 2001, J PHYS CHEM B, V105, P646, DOI 10.1021/jp002100x; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Grabowski R, 2006, CATAL REV, V48, P199, DOI 10.1080/01614940600631413; Kane MS, 1996, IND ENG CHEM RES, V35, P3319, DOI 10.1021/ie950762g; Kondratenko EV, 2005, CATAL TODAY, V99, P59, DOI 10.1016/j.cattod.2004.09.024; Madeira LM, 2002, CATAL REV, V44, P247, DOI 10.1081/CR-120001461; Mestl G, 2001, ANGEW CHEM INT EDIT, V40, P2066, DOI 10.1002/1521-3773(20010601)40:11<2066::AID-ANIE2066>3.0.CO;2-I; Miyakoshi A, 2001, APPL CATAL A-GEN, V219, P249, DOI 10.1016/S0926-860X(01)00697-4; Okpalugo TIT, 2005, CARBON, V43, P153, DOI 10.1016/j.carbon.2004.08.033; Panov GI, 2006, CATAL TODAY, V117, P148, DOI 10.1016/j.cattod.2006.05.019; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Pereira MFR, 2001, APPL CATAL A-GEN, V218, P307, DOI 10.1016/S0926-860X(01)00657-3; Puziy AM, 2006, APPL SURF SCI, V252, P8036, DOI 10.1016/j.apsusc.2005.10.044; Resini C, 2005, CATAL TODAY, V99, P105, DOI 10.1016/j.cattod.2004.09.029; Salmeron M, 2008, SURF SCI REP, V63, P169, DOI 10.1016/j.surfrep.2008.01.001; TAPIA LB, 2005, J CATAL, V107, P371; Toebes ML, 2004, CARBON, V42, P307, DOI 10.1016/j.carbon.2003.10.036; Zhang J, 2007, ANGEW CHEM INT EDIT, V46, P7319, DOI 10.1002/anie.200702466; ZHOU JH, 2007, CARBON, V9, P1379	23	675	725	22	881	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					73	77		10.1126/science.1161916	http://dx.doi.org/10.1126/science.1161916			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832641	Green Submitted			2022-12-28	WOS:000259680200039
J	Pedersen, S; O'Byrne, PM				Pedersen, Soren; O'Byrne, Paul M.			Exhaled nitric oxide in guideline-based asthma management	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; THERAPY		[Pedersen, Soren] Kolding Cty Hosp, Paediat Res Unit, DK-6000 Kolding, Denmark; [O'Byrne, Paul M.] McMaster Univ, Dept Med, Michael G DeGroote Sch Med, Hamilton, ON, Canada	Kolding Hospital; McMaster University	Pedersen, S (corresponding author), Kolding Cty Hosp, Paediat Res Unit, DK-6000 Kolding, Denmark.	spconsult@post1.tele.dk		O'Byrne, Paul/0000-0003-0979-281X				Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; Fritsch M, 2006, PEDIATR PULM, V41, P855, DOI 10.1002/ppul.20455; Pauwels RA, 2003, LANCET, V361, P1071, DOI 10.1016/S0140-6736(03)12891-7; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Rabe KF, 2000, EUR RESPIR J, V16, P802, DOI 10.1183/09031936.00.16580200; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Silkoff PE, 2004, J ALLERGY CLIN IMMUN, V114, P1241, DOI 10.1016/j.jaci.2004.08.042; Silkoff PE, 2001, CHEST, V119, P1322, DOI 10.1378/chest.119.5.1322; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Stirling RG, 1998, THORAX, V53, P1030, DOI 10.1136/thx.53.12.1030; Szefler S, 2008, LANCET, V372, P1065, DOI 10.1016/S0140-6736(08)61448-8	12	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1015	1017		10.1016/S0140-6736(08)61420-8	http://dx.doi.org/10.1016/S0140-6736(08)61420-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805314				2022-12-28	WOS:000259648500007
J	Sly, PD; Boner, AL; Bjorksten, B; Bush, A; Custovic, A; Eigenmann, PA; Gern, JE; Gerritsen, J; Hamelmann, E; Helms, PJ; Lemanske, RF; Martinez, F; Pedersen, S; Renz, H; Sampson, H; von Mutius, E; Wahn, U; Holt, PG				Sly, Peter D.; Boner, Attilio L.; Bjorksten, Bengt; Bush, Andy; Custovic, Adnan; Eigenmann, Philippe A.; Gern, James E.; Gerritsen, Jorrit; Hamelmann, Eckard; Helms, Peter J.; Lemanske, Robert F.; Martinez, Fernando; Pedersen, Soren; Renz, Harald; Sampson, Hugh; von Mutius, Erika; Wahn, Ulrich; Holt, Patrick G.			Early identification of atopy in the prediction of persistent asthma in children	LANCET			English	Review							RESPIRATORY SYNCYTIAL VIRUS; EARLY-LIFE; POSTNATAL MATURATION; AIRWAY EPITHELIUM; EARLY-CHILDHOOD; RISK-FACTORS; FOLLOW-UP; ALLERGEN SENSITIZATION; SUBSEQUENT DEVELOPMENT; HOSPITAL ADMISSIONS	The long-term solution to the asthma epidemic is thought to be prevention, and not treatment of established disease. Atopic asthma arises from gene-environment interactions, which mainly take place during a short period in prenatal and postnatal development. These interactions are not completely understood, and hence primary prevention remains an elusive goal. We argue that primary-care physicians, paediatricians, and specialists lack knowledge of the role of atopy in early life in the development of persistent asthma in children. In this review, we discuss how early identification of children at high risk is feasible on the basis of available technology and important for potential benefits to the children. Identification of an asthmatic child's atopic status in early life has practical clinical and prognostic implications, and sets the basis for future preventative strategies.	[Sly, Peter D.; Holt, Patrick G.] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia; [Boner, Attilio L.] Univ Verona, I-37100 Verona, Italy; [Bjorksten, Bengt] Karolinska Inst, Natl Inst Environm Med, Stockholm, Sweden; [Bush, Andy] Royal Brompton Hosp, London SW3 6LY, England; [Custovic, Adnan] Univ Manchester, Wythenshawe Hosp, Manchester, Lancs, England; [Eigenmann, Philippe A.] Univ Childrens Hosp Geneva, Geneva, Switzerland; [Gern, James E.; Lemanske, Robert F.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Gerritsen, Jorrit] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Hamelmann, Eckard; Wahn, Ulrich] Charite, D-13353 Berlin, Germany; [Helms, Peter J.] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland; [Martinez, Fernando] Arizona Resp Ctr, Tucson, AZ USA; [Pedersen, Soren] Univ So Denmark, Kolding Hosp, Kolding, Denmark; [Renz, Harald] Univ Hosp Giessen, Marburg, Germany; [Renz, Harald] Marburg GmbH, Marburg, Germany; [Sampson, Hugh] Mt Sinai Sch Med, Dept Pediat, New York, NY USA; [von Mutius, Erika] Univ Munich, Childrens Hosp, D-8000 Munich, Germany	Telethon Kids Institute; University of Western Australia; University of Verona; Karolinska Institutet; Royal Brompton Hospital; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; University of Geneva; University of Wisconsin System; University of Wisconsin Madison; University of Groningen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Aberdeen; Kolding Hospital; University of Southern Denmark; University Hospital of Giessen & Marburg; Icahn School of Medicine at Mount Sinai; University of Munich	Sly, PD (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, POB 855, Perth, WA 6009, Australia.	peters@ichr.uwa.edu.au	Custovic, Adnan/A-2435-2012; Holt, Patrick G/H-1548-2011; Eigenmann, Philippe/A-6569-2017; Sly, Peter D/F-1486-2010; Study, Raine/K-4517-2013; Hamelmann, Eckard/AAJ-9124-2021	Custovic, Adnan/0000-0001-5218-7071; Holt, Patrick G/0000-0003-1193-0935; Eigenmann, Philippe/0000-0003-1738-1826; Sly, Peter D/0000-0001-6305-2201; von Mutius, Erika/0000-0002-8893-4515	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL070831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070503] Funding Source: NIH RePORTER; Medical Research Council [G0400503B] Funding Source: researchfish; NHLBI NIH HHS [P01 HL070831] Funding Source: Medline; NIAID NIH HHS [U19 AI070503] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adcock IM, 2007, CURR OPIN IMMUNOL, V19, P694, DOI 10.1016/j.coi.2007.07.016; ANDERSON HR, 1992, THORAX, V47, P537, DOI 10.1136/thx.47.7.537; Arbes SJ, 2007, J ALLERGY CLIN IMMUN, V120, P1139, DOI 10.1016/j.jaci.2007.07.056; BJORKSTEN B, 1994, ALLERGY, V49, P400, DOI 10.1111/j.1398-9995.1994.tb00831.x; Brauer M, 2007, EUR RESPIR J, V29, P879, DOI 10.1183/09031936.00083406; Brauer M, 2002, AM J RESP CRIT CARE, V166, P1092, DOI 10.1164/rccm.200108-007OC; Braunholtz DA, 2001, J CLIN EPIDEMIOL, V54, P217, DOI 10.1016/S0895-4356(00)00305-X; BURROWS B, 1989, NEW ENGL J MED, V320, P271, DOI 10.1056/NEJM198902023200502; Carroll WD, 2006, ARCH DIS CHILD, V91, P405, DOI 10.1136/adc.2005.088278; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Clough JB, 1999, AM J RESP CRIT CARE, V160, P1473, DOI 10.1164/ajrccm.160.5.9807019; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Copenhaver CC, 2004, AM J RESP CRIT CARE, V170, P175, DOI 10.1164/rccm.200312-1647OC; Devulapalli CS, 2008, THORAX, V63, P8, DOI 10.1136/thx.2006.060616; Dimova-Yaneva D, 2004, CLIN EXP ALLERGY, V34, P555, DOI 10.1111/j.1365-2222.2004.1918.x; Douglas TA, 2007, ALLERGY, V62, P401, DOI 10.1111/j.1398-9995.2007.01329.x; EVERARD ML, 1995, ARCH DIS CHILD, V72, P64, DOI 10.1136/adc.72.1.64; Fernandes R, 2008, PEDIATR ALLERGY IMMU, V19, P239, DOI 10.1111/j.1399-3038.2007.00615.x; Gereda JE, 2000, LANCET, V355, P1680, DOI 10.1016/S0140-6736(00)02239-X; Gern JE, 2006, J ALLERGY CLIN IMMUN, V117, P72, DOI 10.1016/j.jaci.2005.10.002; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Harrison AM, 1999, AM J RESP CRIT CARE, V159, P1918, DOI 10.1164/ajrccm.159.6.9805083; Holt PG, 2008, NAT REV IMMUNOL, V8, P142, DOI 10.1038/nri2236; Holt PG, 2007, CURR OPIN ALLERGY CL, V7, P547, DOI 10.1097/ACI.0b013e3282f14a17; HOLT PG, 1992, CLIN EXP ALLERGY, V22, P1093, DOI 10.1111/j.1365-2222.1992.tb00135.x; Holt PG, 2005, J ALLERGY CLIN IMMUN, V116, P16, DOI 10.1016/j.jaci.2005.04.017; Holt PG, 2005, NAT IMMUNOL, V6, P957, DOI 10.1038/ni1005-957; HOLT PG, 1995, PEDIAT ALLERG IMM-UK, V6, P59, DOI 10.1111/j.1399-3038.1995.tb00261.x; Holt PG, 2002, J EXP MED, V196, P1271, DOI 10.1084/jem.20021572; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Ising H, 2004, Noise Health, V6, P21; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Jakiela B, 2008, AM J RESP CELL MOL, V38, P517, DOI 10.1165/rcmb.2007-0050OC; Johnson CC, 2004, J ALLERGY CLIN IMMUN, V114, P105, DOI 10.1016/j.jaci.2004.04.007; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Jones A, 2002, EUR RESPIR J, V20, P651, DOI 10.1183/09031936.02.00278902; Joseph-Bowen J, 2004, J ALLERGY CLIN IMMUN, V114, P1040, DOI 10.1016/j.jaci.2004.07.051; Kawasaki Y, 2006, PEDIATR INT, V48, P257, DOI 10.1111/j.1442-200X.2006.02199.x; Klinnert MD, 2001, PEDIATRICS, V108, part. no., DOI 10.1542/peds.108.4.e69; Kristjansson S, 2005, J ALLERGY CLIN IMMUN, V116, P805, DOI 10.1016/j.jaci.2005.07.012; Kulig M, 1998, PEDIAT ALLERG IMM-UK, V9, P61, DOI 10.1111/j.1399-3038.1998.tb00305.x; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Kusel MMH, 2005, J ALLERGY CLIN IMMUN, V116, P1067, DOI 10.1016/j.jaci.2005.06.038; Lane J, 2005, CLIN EXP ALLERGY, V35, P479, DOI 10.1111/j.1365-2222.2005.02202.x; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lemanske RF, 2005, J ALLERGY CLIN IMMUN, V116, P571, DOI 10.1016/j.jaci.2005.06.024; Lindemans CA, 2006, CLIN EXP IMMUNOL, V144, P409, DOI 10.1111/j.1365-2249.2006.03084.x; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Lowe AJ, 2007, CLIN EXP ALLERGY, V37, P1624, DOI 10.1111/j.1365-2222.2007.02822.x; Macaubas C, 2003, LANCET, V362, P1192, DOI 10.1016/S0140-6736(03)14542-4; Marinho S, 2007, ALLERGY, V62, P1379, DOI 10.1111/j.1398-9995.2007.01502.x; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Martinez FD, 1998, J ALLERGY CLIN IMMUN, V102, P915, DOI 10.1016/S0091-6749(98)70328-8; Matheson MC, 2005, CLIN EXP ALLERGY, V35, P907, DOI 10.1111/j.1365-2222.2005.02272.x; McWilliam AS, 1997, J VIROL, V71, P226, DOI 10.1128/JVI.71.1.226-236.1997; McWilliam AS, 1996, J EXP MED, V184, P2429, DOI 10.1084/jem.184.6.2429; Michel O, 1996, AM J RESP CRIT CARE, V154, P1641, DOI 10.1164/ajrccm.154.6.8970348; Montalbano MM, 2002, CURR OPIN PEDIATR, V14, P334, DOI 10.1097/00008480-200206000-00010; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Mrazek DA, 1999, PEDIATR PULM, V27, P85, DOI 10.1002/(SICI)1099-0496(199902)27:2<85::AID-PPUL4>3.0.CO;2-B; Murray CS, 2006, THORAX, V61, P376, DOI 10.1136/thx.2005.042523; Nagayama Y, 2006, PEDIAT ALLERG IMM-UK, V17, P376, DOI 10.1111/j.1399-3038.2006.00404.x; Niggemann B, 2006, ALLERGY, V61, P855, DOI 10.1111/j.1398-9995.2006.01068.x; Oddy WH, 2002, EUR RESPIR J, V19, P899, DOI 10.1183/09031936.02.00103602; Oymar K, 1996, PEDIATR ALLERGY IMMU, V7, P180, DOI 10.1111/j.1399-3038.1996.tb00130.x; Papadopoulos NG, 2007, ALLERGY, V62, P457, DOI 10.1111/j.1398-9995.2007.01341.x; Parry DE, 2000, J ALLERGY CLIN IMMUN, V105, P692, DOI 10.1067/mai.2000.104785; PEAT JK, 1990, J ALLERGY CLIN IMMUN, V85, P65, DOI 10.1016/0091-6749(90)90223-Q; Pereira MU, 2007, EUR RESPIR J, V29, P1154, DOI 10.1183/09031936.00127606; Phipps S, 2007, BLOOD, V110, P1578, DOI 10.1182/blood-2007-01-071340; Piedimonte G, 2001, AM J RESP CRIT CARE, V163, pS18, DOI 10.1164/ajrccm.163.supplement_1.2011113; Ponsonby AL, 2003, EPIDEMIOLOGY, V14, P37, DOI 10.1097/00001648-200301000-00012; Rakes CP, 1999, AM J RESP CRIT CARE, V159, P785, DOI 10.1164/ajrccm.159.3.9801052; Rhodes HL, 2002, AM J RESP CRIT CARE, V165, P176, DOI 10.1164/ajrccm.165.2.2104032; Rowe J, 2001, J INFECT DIS, V184, P80, DOI 10.1086/320996; Schwartz DA, 2004, HUM MOL GENET, V13, pR217, DOI 10.1093/hmg/ddh228; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sherrill D, 1999, CLIN EXP ALLERGY, V29, P905; SIGURS N, 1995, PEDIATRICS, V95, P500; Sigurs N, 2000, AM J RESP CRIT CARE, V161, P1501, DOI 10.1164/ajrccm.161.5.9906076; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Simpson A, 2005, J ALLERGY CLIN IMMUN, V116, P744, DOI 10.1016/j.jaci.2005.06.032; Simpson A, 2006, AM J RESP CRIT CARE, V174, P386, DOI 10.1164/rccm.200509-1380OC; Singh AM, 2007, AM J RESP CRIT CARE, V175, P108, DOI 10.1164/rccm.200603-435PP; Smaldone A, 2007, PEDIATRICS, V119, pS29, DOI 10.1542/peds.2006-2089F; Smith PK, 2001, J PAEDIATR CHILD H, V37, P146, DOI 10.1046/j.1440-1754.2001.00618.x; Stein MA, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e60; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Stick SM, 1996, LANCET, V348, P1060, DOI 10.1016/S0140-6736(96)04446-7; Strunk RC, 2006, J ALLERGY CLIN IMMUN, V118, P1040, DOI 10.1016/j.jaci.2006.07.053; TEPPER RS, 1986, AM REV RESPIR DIS, V134, P513; Trevillian LF, 2004, PAEDIATR PERINAT EP, V18, P281, DOI 10.1111/j.1365-3016.2004.00563.x; Turner SW, 2007, CLIN EXP ALLERGY, V37, P371, DOI 10.1111/j.1365-2222.2007.02668.x; Ulrik CS, 1999, AM J RESP CRIT CARE, V160, P40, DOI 10.1164/ajrccm.160.1.9806059; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Vork KL, 2007, ENVIRON HEALTH PERSP, V115, P1394, DOI 10.1289/ehp.10155; Woodcock A, 2004, AM J RESP CRIT CARE, V170, P433, DOI 10.1164/rccm.200401-083OC; Xatzipsaiti M, 2005, AM J RESP CRIT CARE, V172, P1037, DOI 10.1164/rccm.200502-315OC; Xuan W, 2002, THORAX, V57, P104, DOI 10.1136/thorax.57.2.104; YUFEN L, 2005, CHEST, V127, P1232	104	263	275	0	37	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1100	1106		10.1016/S0140-6736(08)61451-8	http://dx.doi.org/10.1016/S0140-6736(08)61451-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805338	Green Accepted			2022-12-28	WOS:000259648500036
J	Bowman, GR; Comolli, LR; Zhu, J; Eckart, M; Koenig, M; Downing, KH; Moerner, WE; Earnest, T; Shapiro, L				Bowman, Grant R.; Comolli, Luis R.; Zhu, Jian; Eckart, Michael; Koenig, Marcelle; Downing, Kenneth H.; Moerner, W. E.; Earnest, Thomas; Shapiro, Lucy			A polymeric protein anchors the chromosomal origin/ParB complex at a bacterial cell pole	CELL			English	Article							BACILLUS-SUBTILIS; CAULOBACTER-CRESCENTUS; ACTIN HOMOLOG; SEGREGATION; CYCLE; MREB; MORPHOGENESIS; LOCALIZATION; DIVISION; POLARITY	Bacterial replication origins move towards opposite ends of the cell during DNA segregation. We have identified a proline-rich polar protein, PopZ, required to anchor the separated Caulobacter crescentus chromosome origins at the cell poles, a function that is essential for maintaining chromosome organization and normal cell division. PopZ interacts directly with the ParB protein bound to specific DNA sequences near the replication origin. As the origin/ParB complex is being replicated and moved across the cell, PopZ accumulates at the cell pole and tethers the origin in place upon arrival. The polar accumulation of PopZ occurs by a diffusion/capture mechanism that requires the MreB cytoskeleton. High molecular weight oligomers of PopZ assemble in vitro into a filamentous network with trimer junctions, suggesting that the PopZ network and ParB-bound DNA interact in an adhesive complex, fixing the chromosome origin at the cell pole.	[Bowman, Grant R.; Shapiro, Lucy] Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Comolli, Luis R.; Downing, Kenneth H.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Zhu, Jian; Earnest, Thomas] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Eckart, Michael] Stanford Univ, Stanford Prot & Nucle Acid Facil, Sch Med, Beckman Ctr, Stanford, CA 94305 USA; [Koenig, Marcelle; Moerner, W. E.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; Stanford University	Shapiro, L (corresponding author), Stanford Univ, Dept Dev Biol, Sch Med, Beckman Ctr, Stanford, CA 94305 USA.	shapiro@stanford.edu	Moerner, William E/C-3260-2008; Comolli, Luis Raul/C-5907-2017	Moerner, William E/0000-0002-2830-209X; Zhu, Jian/0000-0001-6679-8498; Comolli, Luis Raul/0000-0002-9313-6550; Bowman, Grant/0000-0002-8817-8262	National Institutes of Health [GM32506, GM051426, 5R24GM73011-3, F32GM080008, 5 P20 HG003638-02]; Department of Energy [DE-AC02-05CH11231, DE-FG02-01ER63219]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P20HG003638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R24GM073011, R01GM051426, F32GM080008, R01GM032506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Balaji Srinivasan and Esteban Toro for developing bioinformatics tools. We thank Martin Thanbichler for purified ParB. Mike Fero designed software used for fluorescence microscopy, Bob Glaeser and Byong-Gyoon Han provided advice on EM sample preparation, Greg Hura assisted in SAXS analysis, and James Gober and Christine Jacobs-Wagner provided antibodies and strains. This work is supported by National Institutes of Health grants GM32506, GM051426, and 5R24GM73011-3 to L. S., F32GM080008 to G. B., and 5 P20 HG003638-02 to M. K. and W. E. M.; and Department of Energy grants DE-AC02-05CH11231 to L. R. C., J.X., and T. E., and DE-FG02-01ER63219 to L. S.	Barak I, 2005, MOL MICROBIOL, V57, P611, DOI 10.1111/j.1365-2958.2005.04687.x; Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Carballido-Lopez R, 2006, DEV CELL, V11, P399, DOI 10.1016/j.devcel.2006.07.017; Divakaruni AV, 2007, MOL MICROBIOL, V66, P174, DOI 10.1111/j.1365-2958.2007.05910.x; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2006, MOL MICROBIOL, V61, P1428, DOI 10.1111/j.1365-2958.2006.05322.x; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Figge RM, 2003, MOL MICROBIOL, V47, P1225, DOI 10.1046/j.1365-2958.2003.03367.x; Fogel MA, 2005, MOL MICROBIOL, V55, P125, DOI 10.1111/j.1365-2958.2004.04379.x; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gitai Z, 2004, P NATL ACAD SCI USA, V101, P8643, DOI 10.1073/pnas.0402638101; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Kim SY, 2006, P NATL ACAD SCI USA, V103, P10929, DOI 10.1073/pnas.0604503103; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Mohl DA, 2001, MOL MICROBIOL, V42, P741, DOI 10.1046/j.1365-2958.2001.02643.x; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Nilsen T, 2005, J BACTERIOL, V187, P6187, DOI 10.1128/JB.187.17.6187-6196.2005; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Perry SE, 2006, J BACTERIOL, V188, P6039, DOI 10.1128/JB.01750-05; Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290; Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163; Srinivasan BS, 2006, LECT NOTES COMPUT SC, V3909, P1, DOI 10.1007/11732990_1; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; Teleman AA, 1998, CURR BIOL, V8, P1102, DOI 10.1016/S0960-9822(98)70464-6; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x	34	226	226	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					945	955		10.1016/j.cell.2008.07.015	http://dx.doi.org/10.1016/j.cell.2008.07.015			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805088	Green Accepted, Bronze			2022-12-28	WOS:000259318100015
J	Gierlinski, M; Middleton, M; Ward, M; Done, C				Gierlinski, Marek; Middleton, Matthew; Ward, Martin; Done, Chris			A periodicity of similar to 1 hour in X-ray emission from the active galaxy RE J1034+396	NATURE			English	Article							GALACTIC NUCLEI; SEYFERT-1 GALAXIES; RED NOISE; SPECTRUM; MASS	Active galactic nuclei and quasars are thought to be scaled- up versions of Galactic black hole binaries, powered by accretion onto supermassive black holes with masses of 10(6)-10(9) M., as opposed to the similar to 10 M. in binaries (here M. is the solar mass). One example of the similarities between these two types of systems is the characteristic rapid X- ray variability seen from the accretion flow(1). The power spectrum of this variability in black hole binaries consists of a broad noise with multiple quasi- periodic oscillations superimposed on it. Although the broad noise component has been observed in many active galactic nuclei(2,3), there have hitherto been no significant detections of quasi- periodic oscillations(4-6). Here we report the discovery of an similar to 1- hour X- ray periodicity in a bright active galaxy, RE J1034+396. The signal is highly statistically significant ( at the 5.6 sigma level) and very coherent, with quality factorQ > 16. The X- ray modulation arises from the direct vicinity of the black hole.	[Gierlinski, Marek; Middleton, Matthew; Ward, Martin; Done, Chris] Univ Durham, Dept Phys, Durham DH1 3LE, England	Durham University	Gierlinski, M (corresponding author), Univ Durham, Dept Phys, South Rd, Durham DH1 3LE, England.	marek.gierlinski@durham.ac.uk	done, chris/D-4605-2016	done, chris/0000-0002-1065-7239; Gierlinski, Marek/0000-0001-9149-3514	Polish MNiSW [NN203065933]; PPARC senior fellowship; STFC [ST/F002963/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/F002963/1] Funding Source: researchfish	Polish MNiSW(Ministry of Science and Higher Education, Poland); PPARC senior fellowship; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	M. G. was supported in part by the Polish MNiSW (NN203065933). C. D. acknowledges financial support through a PPARC senior fellowship.	Abramowicz MA, 2001, ASTRON ASTROPHYS, V374, pL19, DOI 10.1051/0004-6361:20010791; Benlloch S, 2001, ASTROPHYS J, V562, pL121, DOI 10.1086/338252; Bian W, 2004, MON NOT R ASTRON SOC, V352, P823, DOI 10.1111/j.1365-2966.2004.07967.x; Boller T, 1996, ASTRON ASTROPHYS, V305, P53; Casebeer DA, 2006, ASTROPHYS J, V637, P157, DOI 10.1086/498125; Edelson R, 1999, ASTROPHYS J, V514, P682, DOI 10.1086/306980; Grupe D, 2004, ASTROPHYS J, V606, pL41, DOI 10.1086/420975; Kaspi S, 2000, ASTROPHYS J, V533, P631, DOI 10.1086/308704; Klein-Wolt M, 2008, ASTROPHYS J, V675, P1407, DOI 10.1086/525843; MADEJSKI GM, 1993, NATURE, V365, P626, DOI 10.1038/365626a0; Markowitz A, 2003, ASTROPHYS J, V593, P96, DOI 10.1086/375330; McHardy IM, 2006, NATURE, V444, P730, DOI 10.1038/nature05389; PAPADAKIS IE, 1993, MON NOT R ASTRON SOC, V261, P612, DOI 10.1093/mnras/261.3.612; POUNDS KA, 1995, MON NOT R ASTRON SOC, V277, pL5; TIMMER J, 1995, ASTRON ASTROPHYS, V300, P707; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; Vaughan S, 2003, MON NOT R ASTRON SOC, V345, P1271, DOI 10.1046/j.1365-2966.2003.07042.x; Vaughan S, 2005, MON NOT R ASTRON SOC, V362, P235, DOI 10.1111/j.1365-2966.2005.09296.x; Vaughan S, 2005, ASTRON ASTROPHYS, V431, P391, DOI 10.1051/0004-6361:20041453; Vaughan S, 2006, ADV SPACE RES-SERIES, V38, P1405, DOI 10.1016/j.asr.2005.02.064; Verbunt F, 1997, ASTRON ASTROPHYS, V327, P602	22	203	205	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					369	371		10.1038/nature07277	http://dx.doi.org/10.1038/nature07277			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800134				2022-12-28	WOS:000259265200039
J	Reed, DA; West, CP; Mueller, PS; Ficalora, RD; Engstler, GJ; Beckman, TJ				Reed, Darcy A.; West, Colin P.; Mueller, Paul S.; Ficalora, Robert D.; Engstler, Gregory J.; Beckman, Thomas J.			Behaviors of highly professional resident physicians	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-EVALUATION EXERCISE; GRADUATE MEDICAL-EDUCATION; IN-TRAINING EXAMINATION; PEER ASSESSMENT; DISCIPLINARY ACTION; GRADE INFLATION; MINI-CEX; STUDENTS; VALIDITY; SCHOOL	Context Unprofessional behaviors in medical school predict high stakes consequences for practicing physicians, yet little is known about specific behaviors associated with professionalism during residency. Objective To identify behaviors that distinguish highly professional residents from their peers. Design, Setting, and Participants Comparative study of 148 first- year internal medicine residents at Mayo Clinic from July 1, 2004, through June 30, 2007. Main Outcome Measures Professionalism as determined by multiple observation-based assessments by peers, senior residents, faculty, medical students, and nonphysician professionals over 1 year. Highly professional residents were defined as those who received a total professionalism score at the 80th percentile or higher of observation-based assessments on a 5- point scale ( 1, needs improvement; 5, exceptional). They were compared with residents who received professionalism scores below the 80th percentile according to In- Training Examination ( ITE) scores, Mini- Clinical Evaluation Exercise ( mini-CEX) scores, conscientious behaviors ( percentage of completed evaluations and conference attendance), and receipt of a warning or probation from the residency program. Results The median total professionalism score among highly professional residents was 4.39 ( interquartile range [ IQR], 4.32- 4.44) vs 4.07 ( IQR, 3.91- 4.17) among comparison residents. Highly professional residents achieved higher median scores on the ITE ( 65.5; IQR, 60.5- 73.0 vs 63.0; IQR, 59.0- 67.0; P=. 03) and on the mini- CEX ( 3.95; IQR, 3.63- 4.20 vs 3.69; IQR, 3.36- 3.90; P=. 002), and they completed a greater percentage of required evaluations ( 95.6%; IQR, 88.1%- 99.0% vs 86.1%; IQR, 70.6%-95.0%; P <. 001) compared with residents with lower professionalism scores. In multivariate analysis, a professionalism score in the top 20% of residents was independently associated with ITE scores ( odds ratio [ OR] per 1- point increase, 1.07; 95% confidence interval [ CI], 1.01- 1.14; P=. 046), mini- CEX scores ( OR, 4.64; 95% CI, 1.23-17.48; P=. 02), and completion of evaluations ( OR, 1.07; 95% CI, 1.01- 1.13; P=. 02). Six of the 8 residents who received a warning or probation had total professionalism scores in the bottom 20% of residents. Conclusion Observation- based assessments of professionalism were associated with residents' knowledge, clinical skills, and conscientious behaviors.	[Reed, Darcy A.] Mayo Clin, Coll Med, Div Primary Care Internal Med, Dept Internal Med, Rochester, MN 55905 USA; [West, Colin P.; Mueller, Paul S.; Ficalora, Robert D.; Beckman, Thomas J.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA; [West, Colin P.] Mayo Clin, Coll Med, Div Biostat, Rochester, MN 55905 USA; [Engstler, Gregory J.] Mayo Clin, Coll Med, Div Informat Serv, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Reed, DA (corresponding author), Mayo Clin, Coll Med, Div Primary Care Internal Med, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	reed.darcy@mayo.edu			Educational Innovations Award; Mayo Clinic	Educational Innovations Award; Mayo Clinic	Dr Reed received support from an Educational Innovations Award from the Mayo Clinic.	*ACGME, 2001 OUTC PROJ; *AM BOARD INT MED, 1994, PROJ PROF; Anderson MB, 1999, ACAD MED, V74, P13; [Anonymous], 2005, JAMA, V294, P1129; Arnold L, 2002, ACAD MED, V77, P502, DOI 10.1097/00001888-200206000-00006; Arnold L, 2005, J GEN INTERN MED, V20, P819, DOI 10.1111/j.1525-1497.2005.0162.x; Arnold L., 2006, MEASURING MED PROFES, P15; Arnold L, 2007, ACAD MED, V82, P578, DOI 10.1097/ACM.0b013e3180555d4e; Brotherton SE, 2007, JAMA-J AM MED ASSOC, V298, P1081, DOI 10.1001/jama.298.9.1081; Brotherton SE, 2006, JAMA-J AM MED ASSOC, V296, P1154, DOI 10.1001/jama.296.9.1154; Cacamese SM, 2007, TEACH LEARN MED, V19, P343, DOI 10.1080/10401330701542529; Cooke M, 2006, NEW ENGL J MED, V355, P1339, DOI 10.1056/NEJMra055445; Cruess SR, 1997, BRIT MED J, V315, P1674, DOI 10.1136/bmj.315.7123.1674; Dannefer EF, 2005, MED EDUC, V39, P713, DOI 10.1111/j.1365-2929.2005.02193.x; DEVELLIS RF, 2003, SCALE DEV THEORY APP, P113; Durning SJ, 2002, ACAD MED, V77, P900, DOI 10.1097/00001888-200209000-00020; Elman D, 2004, MED EDUC, V38, P969, DOI 10.1111/j.1365-2929.2004.01919.x; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; GARIBALDI RA, 1994, ANN INTERN MED, V121, P117, DOI 10.7326/0003-4819-121-2-199407150-00008; GORSUCH RL, 1983, FACTOR ANAL, P208; Greenburg DL, 2007, J GEN INTERN MED, V22, P1711, DOI 10.1007/s11606-007-0405-z; GROSSMAN RS, 1992, J GEN INTERN MED, V7, P63, DOI 10.1007/BF02599105; HOSMER DW, 2000, WILEY PS TX, P1; JOLLY P, CHARTING OUTCOMES MA; Kao A, 2003, JAMA-J AM MED ASSOC, V290, P1151, DOI 10.1001/jama.290.9.1151; Ludmerer KM, 1999, JAMA-J AM MED ASSOC, V282, P881, DOI 10.1001/jama.282.9.881; Lurie SJ, 2007, J GEN INTERN MED, V22, P13, DOI 10.1007/s11606-007-0117-4; Nadolski Gregory J, 2006, BMC Med Educ, V6, P23, DOI 10.1186/1472-6920-6-23; Norcini J, 2006, MEASURING MED PROFES, P147; Norcini JJ, 2003, ANN INTERN MED, V138, P476, DOI 10.7326/0003-4819-138-6-200303180-00012; NORCINI JJ, 1995, ANN INTERN MED, V123, P795, DOI 10.7326/0003-4819-123-10-199511150-00008; Pangaro LN, 2006, CLIN ANAT, V19, P419, DOI 10.1002/ca.20257; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Papadakis MA, 2005, NEW ENGL J MED, V353, P2673, DOI 10.1056/NEJMsa052596; REYNOLDS PP, 1994, ANN INTERN MED, V120, P609, DOI 10.7326/0003-4819-120-7-199404010-00013; Roman BJB, 2006, ACAD PSYCHIATR, V30, P110, DOI 10.1176/appi.ap.30.2.110; Scalese RJ, 2008, J GEN INTERN MED, V23, P46, DOI 10.1007/s11606-007-0283-4; Schuster B, 2007, ARCH INTERN MED, V167, P1453, DOI 10.1001/archinte.167.14.1453; STEM DT, 2006, MEASURING MED PROFES, P8; Stern DT, 2005, MED EDUC, V39, P75, DOI 10.1111/j.1365-2929.2004.02035.x; Swick HM, 1999, JAMA-J AM MED ASSOC, V282, P830, DOI 10.1001/jama.282.9.830; Thomas EJ, 2003, CRIT CARE MED, V31, P956, DOI 10.1097/01.CCM.0000056183.89175.76; West Colin P, 2007, BMC Med Educ, V7, P29, DOI 10.1186/1472-6920-7-29	43	59	61	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1326	1333		10.1001/jama.300.11.1326	http://dx.doi.org/10.1001/jama.300.11.1326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799445	Bronze			2022-12-28	WOS:000259231100028
J	Bell, LE				Bell, Lon E.			Cooling, heating, generating power, and recovering waste heat with thermoelectric systems	SCIENCE			English	Review							PERFORMANCE; FIGURE	Thermoelectric materials are solid- state energy converters whose combination of thermal, electrical, and semiconducting properties allows them to be used to convert waste heat into electricity or electrical power directly into cooling and heating. These materials can be competitive with fluid- based systems, such as two- phase air- conditioning compressors or heat pumps, or used in smaller- scale applications such as in automobile seats, night- vision systems, and electrical- enclosure cooling. More widespread use of thermoelectrics requires not only improving the intrinsic energy- conversion efficiency of the materials but also implementing recent advancements in system architecture. These principles are illustrated with several proven and potential applications of thermoelectrics.	[Bell, Lon E.] BSST, Irwindale, CA 91706 USA		Bell, LE (corresponding author), BSST, Irwindale, CA 91706 USA.			Bell, Lon/0000-0001-6346-8039				Abelson R, 2006, THERMOELECTRICS HDB, P1; ANGRIST SW, 1965, DIRECT ENERGY CONVER, P144; BASS J, 1994, 13 INT C THERM KANS; BELL LE, 2003, 22 INT C THERM HER F; BELL LE, 2002, 21 INT C THERM LONG; BELL LE, 2004, 23 INT C THERM AD AU; BOETTNER H, 2006, THERMOELECTRICS HDB, P1; Boukai AI, 2008, NATURE, V451, P168, DOI 10.1038/nature06458; BOWERS J, 2007, MAT RES SOC F M MAT, V1044; DILLER RW, 2002, 21 INT C THERM LONG; DiSalvo FJ, 1999, SCIENCE, V285, P703, DOI 10.1126/science.285.5428.703; FORESTER P, 2007, CLIMATE CHANGE 2007, P212; *GLOB THERM, THERM GEN CATH PROT; Harman TC, 2002, SCIENCE, V297, P2229, DOI 10.1126/science.1072886; Heremans JP, 2008, SCIENCE, V321, P554, DOI 10.1126/science.1159725; HICKS LD, 1993, PHYS REV B, V47, P16631, DOI 10.1103/PhysRevB.47.16631; Hochbaum AI, 2008, NATURE, V451, P163, DOI 10.1038/nature06381; Hsu KF, 2004, SCIENCE, V303, P818, DOI 10.1126/science.1092963; IKOMA K, 1998, 17 INT C THERM NAG J; *IND TECHN PROGR, 2006, ENG SCOP STUD THERM; JAIN S, 2006, INT C THERM THERM PH; LOFY J, 2002, 21 INT C THERM LONG; MIKALAUSKIS GS, SELECTING THERMOELEC; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Sales BC, 2002, SCIENCE, V295, P1248, DOI 10.1126/science.1069895; Snyder GJ, 2008, NAT MATER, V7, P105, DOI 10.1038/nmat2090; Snyder GJ, 2004, APPL PHYS LETT, V84, P2436, DOI 10.1063/1.1689396; Tritt TM, 2008, MRS BULL, V33, P366, DOI 10.1557/mrs2008.73; Tritt TM, 2006, MRS BULL, V31, P188, DOI 10.1557/mrs2006.44; Venkatasubramanian R, 2001, NATURE, V413, P597, DOI 10.1038/35098012; VINING CB, 2007, EUR C THERM OD UKR 1	31	3995	4101	145	2685	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1457	1461		10.1126/science.1158899	http://dx.doi.org/10.1126/science.1158899			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787160	Green Submitted			2022-12-28	WOS:000259121800030
J	Grewal, D; Davidson, HA				Grewal, Daisy; Davidson, Heather A.			Emotional intelligence and Graduate Medical Education	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SKILLS; STUDENTS		[Grewal, Daisy; Davidson, Heather A.] Stanford Univ, Med Ctr, Dept Grad Med Educ, Stanford Hosp & Clin, Stanford, CA 94305 USA	Stanford University	Grewal, D (corresponding author), Stanford Univ, Med Ctr, Dept Grad Med Educ, Stanford Hosp & Clin, 300 Pasteur Dr, Stanford, CA 94305 USA.	dgrewal@stanfordmed.org						Accreditation Council for Graduate Medical Education, PROGR DIR GUID COMM; Brackett MA, 2003, PERS SOC PSYCHOL B, V29, P1147, DOI 10.1177/0146167203254596; Brown RF, 2008, ACAD MED, V83, P37, DOI 10.1097/ACM.0b013e31815c631e; Codier Estelle, 2008, Nurs Adm Q, V32, P8; Goleman D, 2020, EMOTIONAL INTELLIGEN, V25th; Mayer J, 2007, EMOTIONAL DEV EMOTIO, P3; Mayer JD, 2003, EMOTION, V3, P97, DOI 10.1037/1528-3542.3.1.97; Meyer Barbara B, 2004, Health Care Manag (Frederick), V23, P225; Murphy K. R., 2006, CRITIQUE EMOTIONAL I; Pau Allan K H, 2003, J Dent Educ, V67, P1023; Satterfield JM, 2007, MED EDUC, V41, P935, DOI 10.1111/j.1365-2923.2007.02835.x; Shapiro J, 2004, MED TEACH, V26, P733, DOI 10.1080/01421590400016431; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Tamblyn R, 2007, JAMA-J AM MED ASSOC, V298, P993, DOI 10.1001/jama.298.9.993; Wagner PJ, 2002, FAM MED, V34, P750	15	61	63	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1200	1202		10.1001/jama.300.10.1200	http://dx.doi.org/10.1001/jama.300.10.1200			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780849				2022-12-28	WOS:000259038700013
J	Mak, TK; Hesseling, AC; Hussey, GD; Cotton, MF				Mak, Tippi K.; Hesseling, Anneke C.; Hussey, Gregory D.; Cotton, Mark F.			Making BCG vaccination programmes safer in the HIV era	LANCET			English	Editorial Material							TO-CHILD TRANSMISSION; CLINICS; HEALTH		[Mak, Tippi K.] Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland; [Hesseling, Anneke C.] Univ Stellenbosch, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, ZA-7505 Tygerberg, South Africa; [Hesseling, Anneke C.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Hussey, Gregory D.] Univ Cape Town, Inst Infect Dis & Mol Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Childrens Infect Dis Clin Res Unit, Dept Pediat & Child Hlth, ZA-7505 Tygerberg, South Africa	University of Basel; Swiss Tropical & Public Health Institute; Stellenbosch University; University of London; London School of Hygiene & Tropical Medicine; University of Cape Town; Stellenbosch University	Mak, TK (corresponding author), Swiss Trop Inst, Dept Publ Hlth & Epidemiol, CH-4002 Basel, Switzerland.	tippi.mak@unibas.ch	Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034				Chersich MF, 2008, INT J STD AIDS, V19, P42, DOI 10.1258/ijsa.2007.007117; Enserink M, 2007, SCIENCE, V318, P1059, DOI 10.1126/science.318.5853.1059; FALLO A, 2005, INT AIDS SOC C RIO J; Hesseling AC, 2007, VACCINE, V25, P14, DOI 10.1016/j.vaccine.2006.07.020; Infuso A, 2006, Euro Surveill, V11, P6, DOI 10.2807/esm.11.03.00604-en; Lotte A, 1988, Bull Int Union Tuberc Lung Dis, V63, P47; Rollins N, 2007, AIDS, V21, P1341, DOI 10.1097/QAD.0b013e32814db7d4; SALISBURY D, 2006, TUBERCULOSIS IMMUNIS, pCH32; Trunz BB, 2006, LANCET, V367, P1173, DOI 10.1016/S0140-6736(06)68507-3; *UNAIDS WHO, AIDS EP UPD DEC 2007, P1; VIOLARI A, 2007, 4 INT AIDS SOC C JUL; Weidle PJ, 2006, LANCET, V368, P1587, DOI 10.1016/S0140-6736(06)69118-6; *WHO, 2007, REV BCG VACC GUID IN, V82, P193; *WHO UNAIDS, 2007, GUID PROV IN HIV TES; World Health Organization, 2008, PAED HIV ART CAR GUI	15	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					786	787		10.1016/S0140-6736(08)61318-5	http://dx.doi.org/10.1016/S0140-6736(08)61318-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774406				2022-12-28	WOS:000259124900008
J	Alexandru, G; Graumann, J; Smith, GT; Kolawa, NJ; Fang, RH; Deshaies, RJ				Alexandru, Gabriela; Graumann, Johannes; Smith, Geoffrey T.; Kolawa, Natalie J.; Fang, Ruihua; Deshaies, Raymond J.			UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1 alpha turnover	CELL			English	Article							AAA-ATPASE CDC48/P97; RETICULUM-ASSOCIATED DEGRADATION; VALOSIN-CONTAINING PROTEIN; POLYUBIQUITIN CHAINS; TRANSCRIPTION FACTOR; SELECTIVE CHAPERONE; MEMBRANE-FUSION; 26S PROTEASOME; ER; COMPLEX	p97 is an ATP-dependent chaperone that plays an important role in endoplasmic reticulum-associated degradation but whose connections to turnover of soluble proteins remain sparse. Binding of p97 to substrates is mediated by cofactors that contain ubiquitin-binding domains. We employed "network proteomics'' to show that p97 assembles with all of the 13 mammalian UBX-domain proteins. The UBX proteins that bind ubiquitin conjugates also interact with dozens of E3 ubiquitin ligases, only one of which had been previously linked to p97. In particular, UBXD7 links p97 to the ubiquitin ligase CUL2/VHL and its substrate hypoxia-inducible factor 1 alpha (HIF1 alpha). Depletion of p97 leads to accumulation of endogenous HIF1 alpha and increased expression of a HIF1 alpha target gene. The large number of ubiquitin ligases found associated with UBX proteins suggests that p97 plays a far broader role than previously anticipated in the global regulation of protein turnover.	[Alexandru, Gabriela; Graumann, Johannes; Smith, Geoffrey T.; Kolawa, Natalie J.; Fang, Ruihua; Deshaies, Raymond J.] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Alexandru, G (corresponding author), CALTECH, Div Biol, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	galex@caltech.edu; deshaies@caltech.edu	Graumann, Johannes/C-5241-2008; Deshaies, Raymond/B-8354-2014	Graumann, Johannes/0000-0002-3015-5850; Deshaies, Raymond/0000-0002-3671-9354; Alexandru, Gabriela/0000-0002-7058-5644	Damon Runyon Cancer Research Foundation [DRG-1745-02]; Howard Hughes Medical Institute (HHMI); HHMI	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); HHMI(Howard Hughes Medical Institute)	We thank G. Kleiger and T. Chou for help with gel filtration, J. Quimby for help with DNA cloning, S. Schwarz for advice on cell culture, R. Oania for technical assistance, and S. Buonomo for experimental protocols. We also thank T. Nagase, G. Warren, H. Katoh, and S. Buonomo for plasmids and Millipore, J. Pastorek, S. Pastorekova, and Z. Xia for antibodies. We are grateful to A. Varshavsky and members of the Deshaies' lab for critical reading of the manuscript. G. A. was supported by DRG-1745-02 of the Damon Runyon Cancer Research Foundation and the Howard Hughes Medical Institute (HHMI). R. J. D. is an HHMI Investigator, and this work was funded by HHMI. R. J. D. is a founder, shareholder, and consultant for Proteolix.	Bar-Nun S, 2005, CURR TOP MICROBIOL, V300, P95; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Cao K, 2003, CELL, V115, P355, DOI 10.1016/S0092-8674(03)00815-8; Carim-Todd L, 2001, BBA-GENE STRUCT EXPR, V1517, P298, DOI 10.1016/S0167-4781(00)00248-7; Cripps D, 2006, J BIOL CHEM, V281, P10825, DOI 10.1074/jbc.M512786200; Doolman R, 2004, J BIOL CHEM, V279, P38184, DOI 10.1074/jbc.M405935200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Graumann J, 2004, MOL CELL PROTEOMICS, V3, P226, DOI 10.1074/mcp.M300099-MCP200; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Hirabayashi M, 2001, CELL DEATH DIFFER, V8, P977, DOI 10.1038/sj.cdd.4400907; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Ivan M, 2001, CURR OPIN GENET DEV, V11, P27, DOI 10.1016/S0959-437X(00)00152-0; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; Kaluz S, 2008, J CELL BIOCHEM, V104, P536, DOI 10.1002/jcb.21644; Katoh H, 2002, MOL CELL BIOL, V22, P2952, DOI 10.1128/MCB.22.9.2952-2964.2002; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Link AJ, 1999, NAT BIOTECHNOL, V17, P676, DOI 10.1038/10890; Lowe ED, 2006, ACTA CRYSTALLOGR D, V62, P177, DOI 10.1107/S0907444905037777; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Mizuno Y, 2003, NEUROSCI LETT, V343, P77, DOI 10.1016/S0304-3940(03)00280-5; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Parker Carol E., 2005, V301, P153; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; PETERS JM, 1990, EMBO J, V9, P1757, DOI 10.1002/j.1460-2075.1990.tb08300.x; Pickart CM, 1997, FASEB J, V11, P1055, DOI 10.1096/fasebj.11.13.9367341; Pye VE, 2006, J STRUCT BIOL, V156, P12, DOI 10.1016/j.jsb.2006.03.003; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; Shcherbik N, 2007, MOL CELL, V25, P385, DOI 10.1016/j.molcel.2007.01.024; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Wykoff CC, 2000, CANCER RES, V60, P7075; Yamabe Y, 1997, GENOMICS, V39, P198, DOI 10.1006/geno.1996.4480; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005; Yeung HO, 2008, BIOCHEM SOC T, V36, P62, DOI 10.1042/BST0360062; Yuan XM, 2001, J MOL BIOL, V311, P255, DOI 10.1006/jmbi.2001.4864; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	62	243	252	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					804	816		10.1016/j.cell.2008.06.048	http://dx.doi.org/10.1016/j.cell.2008.06.048			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775313	Green Accepted, Bronze			2022-12-28	WOS:000258947500020
J	Farmer, SR				Farmer, Stephen R.			Brown fat and skeletal muscle: Unlikely cousins?	CELL			English	Editorial Material							ADIPOSE-TISSUE; WHITE FAT; ADIPOCYTES; MICE	Although the functions of white fat and brown fat are increasingly well understood, their developmental origins remain unclear. A recent study published in Nature (Seale et al., 2008) identifies a population of progenitor cells that gives rise to brown fat and skeletal muscle but not white fat.	Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Farmer, SR (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	farmer@biochem.bumc.bu.edu		Farmer, Stephen/0000-0003-2483-2795				Almind K, 2007, P NATL ACAD SCI USA, V104, P2366, DOI 10.1073/pnas.0610416104; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Guerra C, 1998, J CLIN INVEST, V102, P412, DOI 10.1172/JCI3155; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104	10	42	68	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					726	727		10.1016/j.cell.2008.08.018	http://dx.doi.org/10.1016/j.cell.2008.08.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775306	Bronze			2022-12-28	WOS:000258947500013
J	Holmes, E; Wilson, ID; Nicholson, JK				Holmes, Elaine; Wilson, Ian D.; Nicholson, Jeremy K.			Metabolic phenotyping in health and disease	CELL			English	Editorial Material							GENE	Analyzing metabolites (small molecules <1 kDa) in body fluids such as urine and plasma using various spectroscopic methods provides information on the metabotype (metabolic phenotype) of individuals or populations, information that can be applied to personalized medicine or public healthcare.	[Holmes, Elaine; Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet, Dept Biomol Med, London SW7 2AZ, England; [Wilson, Ian D.] AstraZeneca, Dept Safety Med, Macclesfield SK10 4TG, Cheshire, England	Imperial College London; AstraZeneca	Nicholson, JK (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Div Surg Oncol Reprod Biol & Anaesthet, Dept Biomol Med, London SW7 2AZ, England.	j.nicholson@imperial.ac.uk	Nicholson, Jeremy K/B-3395-2012; Holmes, Elaine/ABE-6606-2020; Wilson, Ian David/ABG-4451-2021; Wilson, Ian/Z-3019-2019; Holmes, Elaine/A-2189-2015	Nicholson, Jeremy K/0000-0002-8123-8349; Holmes, Elaine/0000-0002-0556-8389; 				Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Daviglus ML, 2004, JAMA-J AM MED ASSOC, V292, P1588, DOI 10.1001/jama.292.13.1588; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Loscalzo J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100163; Nebert Daniel W, 2003, Am J Pharmacogenomics, V3, P361, DOI 10.2165/00129785-200303060-00002; Nicholson JK, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100095; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Sindic A, 2007, CURR OPIN NEPHROL HY, V16, P484; Westhoff M, 2007, J PHYSIOL PHARMACOL, V58, P739	15	537	561	2	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					714	717		10.1016/j.cell.2008.08.026	http://dx.doi.org/10.1016/j.cell.2008.08.026			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775301	Bronze			2022-12-28	WOS:000258947500008
J	Rooker, JR; Secor, DH; De Metrio, G; Schloesser, R; Block, BA; Neilson, JD				Rooker, Jay R.; Secor, David H.; De Metrio, Gregorio; Schloesser, Ryan; Block, Barbara A.; Neilson, John D.			Natal Homing and Connectivity in Atlantic Bluefin Tuna Populations	SCIENCE			English	Article							MARINE FISH; DELTA-C-13; OTOLITHS	Atlantic bluefin tuna populations are in steep decline, and an improved understanding of connectivity between individuals from eastern ( Mediterranean Sea) and western ( Gulf of Mexico) spawning areas is needed to manage remaining fisheries. Chemical signatures in the otoliths of yearlings from regional nurseries were distinct and served as natural tags to assess natal homing and mixing. Adults showed high rates of natal homing to both eastern and western spawning areas. Trans- Atlantic movement ( east to west) was significant and size- dependent, with individuals of Mediterranean origin mixing with the western population in the U. S. Atlantic. The largest ( oldest) bluefin tuna collected near the northern extent of their range in North American waters were almost exclusively of western origin, indicating that this region represents critical habitat for the western population.	[Rooker, Jay R.; Schloesser, Ryan] Texas A&M Univ, Dept Marine Biol, Galveston, TX 77551 USA; [Secor, David H.] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA; [De Metrio, Gregorio] Univ Bari, Dept Anim Hlth & Well Being, I-70010 Bari, Italy; [Block, Barbara A.] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Neilson, John D.] St Andrews Biol Stn, Populat Ecol Sect, Dept Fisheries & Oceans, St Andrews, NB, Canada	Texas A&M University System; University System of Maryland; University of Maryland Center for Environmental Science; Universita degli Studi di Bari Aldo Moro; Stanford University; Fisheries & Oceans Canada	Rooker, JR (corresponding author), Texas A&M Univ, Dept Marine Biol, 5007 Ave U, Galveston, TX 77551 USA.	rookerj@tamug.edu	Secor, David H./D-4367-2012; Rooker, Jay/M-3197-2013	Secor, David H./0000-0001-6007-4827; Rooker, Jay/0000-0002-5934-7688; Schloesser, Ryan/0000-0002-1004-554X	NOAA Observer Program; NOAA (Southeast Fisheries Science Center and Saltonstall-Kennedy Program); International Fisheries Governance Program of Fisheries and Oceans Canada; Monterey Bay Aquarium; Tag-A-Giant Foundation; Large Pelagic Research Center (University of New Hampshire)	NOAA Observer Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA (Southeast Fisheries Science Center and Saltonstall-Kennedy Program)(National Oceanic Atmospheric Admin (NOAA) - USA); International Fisheries Governance Program of Fisheries and Oceans Canada; Monterey Bay Aquarium; Tag-A-Giant Foundation; Large Pelagic Research Center (University of New Hampshire)	We thank S. Campana, J. Graves, and R. D. Wells for insightful comments on earlier versions of the manuscript. Special thanks to A. Belmonte, A. Boustany, B. Campbell, A. Corriero, M. DeFlorio, D. Dettman, J. Kaufman, M. Lutcavage, E. Rodriguez-Marin, P. Mace, E. Prince, N. Santamaria, G. Skomal, M. Stokesbury, S. Teo, P. Thompson, S. Turner, V. Ticina, R. Wingate, NOAA Observer Program, T. F. M. Tuna Farms of the Mediterraneo S. L., Tuna Graso, S. A., and Fish and Fish Ltd. for their assistance. Funding for this study was provided by NOAA ( Southeast Fisheries Science Center and Saltonstall-Kennedy Program), the International Fisheries Governance Program of Fisheries and Oceans Canada, Monterey Bay Aquarium, Tag-A-Giant Foundation, and the Large Pelagic Research Center (University of New Hampshire).	Almany GR, 2007, SCIENCE, V316, P742, DOI 10.1126/science.1140597; Ashford J, 2007, GEOCHIM COSMOCHIM AC, V71, P87, DOI 10.1016/j.gca.2006.08.030; BAKER JD, 1995, ANIM BEHAV, V50, P237, DOI 10.1006/anbe.1995.0236; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; Cushing D.H., 1995, POPULATION PRODUCTIO; Fonteneau A., 2007, COL VOL SCI PAP ICCA, V60, P1027; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; LeGrande AN, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026011; Maffucci F, 2006, BIOL CONSERV, V127, P183, DOI 10.1016/j.biocon.2005.08.009; Magnuson J. J., 1994, ASSESSMENT ATLANTIC; MILLAR RB, 1987, CAN J FISH AQUAT SCI, V44, P583, DOI 10.1139/f87-071; QUINN TP, 1993, FISH RES, V18, P29, DOI 10.1016/0165-7836(93)90038-9; RAU GH, 1989, NATURE, V341, P516, DOI 10.1038/341516a0; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; TEA SLH, 2007, MAR BIOL BERLIN, V151, P1; Thorrold SR, 1997, GEOCHIM COSMOCHIM AC, V61, P2909, DOI 10.1016/S0016-7037(97)00141-5; Thorrold SR, 2001, SCIENCE, V291, P297, DOI 10.1126/science.291.5502.297	18	227	232	0	98	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					742	744		10.1126/science.1161473	http://dx.doi.org/10.1126/science.1161473			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18832611				2022-12-28	WOS:000260605200049
J	Wang, Z; Smith, KS; Murphy, M; Piloto, O; Somervaille, TCP; Cleary, ML				Wang, Zhong; Smith, Kevin S.; Murphy, Mark; Piloto, Obdulio; Somervaille, Tim C. P.; Cleary, Michael L.			Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy	NATURE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; STEM-CELLS; BETA-CATENIN; PROTEIN; PROGENITORS; MENIN; PHOSPHORYLATES; REARRANGEMENTS; TRANSFORMATION; SPECIFICATION	Glycogen synthase kinase 3 ( GSK3) is a multifunctional serine/ threonine kinase that participates in numerous signalling pathways involved in diverse physiological processes. Several of these pathways are implicated in disease pathogenesis, which has prompted efforts to develop GSK3- specific inhibitors for therapeutic applications. However, before now, there has been no strong rationale for targeting GSK3 in malignancies. Here we report pharmacological, physiological and genetic studies that demonstrate an oncogenic requirement for GSK3 in the maintenance of a specific subtype of poor prognosis human leukaemia, genetically defined by mutations of the MLL proto- oncogene. In contrast to its previously characterized roles in suppression of neoplasia- associated signalling pathways, GSK3 paradoxically supports MLL leukaemia cell proliferation and transformation by a mechanism that ultimately involves destabilization of the cyclin- dependent kinase inhibitor p27(Kip1). Inhibition of GSK3 in a preclinical murine model of MLL leukaemia provides promising evidence of efficacy and earmarks GSK3 as a candidate cancer drug target.	[Wang, Zhong; Smith, Kevin S.; Murphy, Mark; Piloto, Obdulio; Somervaille, Tim C. P.; Cleary, Michael L.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Cleary, ML (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu		Somervaille, Tim/0000-0002-9188-4379	Children's Health Initiative of the Packard Foundation; PHS [CA55029, CA116606]; Leukemia and Lymphoma Society; Williams Lawrence Foundation; Developmental Research Award from the Stanford Cancer Center; NATIONAL CANCER INSTITUTE [R01CA055029, R01CA116606] Funding Source: NIH RePORTER	Children's Health Initiative of the Packard Foundation; PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Williams Lawrence Foundation; Developmental Research Award from the Stanford Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Roth for providing AKT constructs, P. J. Roach for providing GSK3 constructs, D. G. Gilliland for providing a TEL-AML1 construct, M. Iwasaki for NUP98-HOXA9 cells, M. Ambrus and C. Nicolas for technical assistance, and members of the Cleary laboratory for discussions. We acknowledge support from the Children's Health Initiative of the Packard Foundation, PHS grants CA55029 and CA116606, the Leukemia and Lymphoma Society, the Williams Lawrence Foundation and a Developmental Research Award from the Stanford Cancer Center.	AMLAK MG, 2002, BIOCHEM BIOPH RES CO, V297, P760; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; CHEN CS, 1993, BLOOD, V81, P2386; Cohen P, 2001, NAT REV MOL CELL BIO, V2, P769, DOI 10.1038/35096075; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; DiMartino JF, 1999, BRIT J HAEMATOL, V106, P614, DOI 10.1046/j.1365-2141.1999.01439.x; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; Hess JL, 2004, TRENDS MOL MED, V10, P500, DOI 10.1016/j.molmed.2004.08.005; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jia JH, 2002, NATURE, V416, P548, DOI 10.1038/nature733; Kaidanovich Oksana, 2002, Expert Opin Ther Targets, V6, P555; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kim L, 2006, CURR DRUG TARGETS, V7, P1411, DOI 10.2174/1389450110607011411; Kohn AD, 1998, J BIOL CHEM, V273, P11937, DOI 10.1074/jbc.273.19.11937; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Millar JBA, 2002, GENOME BIOL, V3; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Milne TA, 2005, P NATL ACAD SCI USA, V102, P749, DOI 10.1073/pnas.0408836102; Nickeleit I, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-13; NIKOLAKAKI E, 1993, ONCOGENE, V8, P833; Polakis P, 1999, CURR OPIN GENET DEV, V9, P15, DOI 10.1016/S0959-437X(99)80003-3; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Smith KS, 1997, ONCOGENE, V14, P2917, DOI 10.1038/sj.onc.1201249; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; So CW, 2002, MOL CELL BIOL, V22, P6542, DOI 10.1128/MCB.22.18.6542-6552.2002; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Surjit M, 2007, CELL CYCLE, V6, P580, DOI 10.4161/cc.6.5.3899; Testa JR, 2005, ONCOGENE, V24, P7391, DOI 10.1038/sj.onc.1209100; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Watase K, 2007, PLOS MED, V4, P836, DOI 10.1371/journal.pmed.0040182; Xia ZB, 2005, P NATL ACAD SCI USA, V102, P14028, DOI 10.1073/pnas.0506464102; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	43	220	238	0	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1205	U29		10.1038/nature07284	http://dx.doi.org/10.1038/nature07284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18806775	Green Accepted			2022-12-28	WOS:000260462100036
J	Kenyon, S; Pike, K; Jones, DR; Brocklehurst, P; Marlow, N; Salt, A; Taylor, DJ				Kenyon, S.; Pike, K.; Jones, D. R.; Brocklehurst, P.; Marlow, N.; Salt, A.; Taylor, D. J.			Childhood outcomes after prescription of antibiotics to pregnant women with preterm rupture of the membranes: 7-year follow-up of the ORACLE I trial	LANCET			English	Article							BEHAVIORAL OUTCOMES; PREMATURE RUPTURE; BRAIN-DAMAGE; AGE; INFECTION; CHILDREN; BIRTH; QUESTIONNAIRE; HEALTH	Background The ORACLE I trial compared the use of erythromycin and/or amoxicillin-clavulanate (co-amoxiclav) with that of placebo for women with preterm rupture of the membranes without overt signs of clinical infection, by use of a factorial randomised design. The aim of the present study-the ORACLE Children Study I-was to determine the long-term effects on children of these interventions. Methods We assessed children at age 7 years born to the 4148 women who had completed the ORACLE I trial and who were eligible for follow-up with a structured parental questionnaire to assess the child's health status. Functional impairment was defined as the presence of any level of functional impairment (severe, moderate, or mild) derived from the mark III Multi-Attribute Health Status classification system. Educational outcomes were assessed with national curriculum test results for children resident in England. Findings Outcome was determined for 3298 (75%) eligible children. There was no difference in the proportion of children with any functional impairment after prescription of erythromycin, with or without co-amoxiclav, compared with those born to mothers who received no erythromycin (594 [38.3%] of 1551 children vs 655 [40.4%] of 1620; odds ratio 0.91, 95% CI 0.79-1.05) or after prescription of co-amoxiclav, with or without erythromycin, compared with those born to mothers who received no co-amoxiclav (645 [40.6%] of 1587 vs 604 [38.1%] of 1584; 1.11, 0.96-1.28). Neither antibiotic had a significant effect on the overall level of behavioural difficulties experienced, on specific medical conditions, or on the proportions of children achieving each level in reading, writing, or mathematics at key stage one. Interpretation The prescription of antibiotics for women with preterm rupture of the membranes seems to have little effect on the health of children at 7 years of age. Funding UK Medical Research Council.	[Kenyon, S.; Pike, K.; Taylor, D. J.] Univ Leicester, Reprod Sci Sect, Leicester LE1 6TP, Leics, England; [Jones, D. R.] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Brocklehurst, P.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Marlow, N.] Univ Nottingham, Acad Div Child Hlth, Nottingham NG7 2RD, England; [Salt, A.] UCL, Great Ormond St Hosp Children, London, England; [Salt, A.] UCL, Inst Child Hlth, London, England	University of Leicester; University of Leicester; University of Oxford; University of Nottingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Kenyon, S (corresponding author), Univ Leicester, Reprod Sci Sect, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	oracle@leicester.ac.uk	Brocklehurst, Peter/B-5804-2011; Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953; Kenyon, Sara/0000-0002-0756-9617	UK Medical Research Council; University Hospitals of Leicester; Medical Research Council [G9226450] Funding Source: researchfish; MRC [G9226450] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University Hospitals of Leicester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the UK Medical Research Council and sponsored by University Hospitals of Leicester and approved by their research and development directorate. We thank all the women and children who took part in the study and the obstetricians and midwives who recruited them to the original ORACLE trials. We thank the Office of National Statistics, the NHS National Strategic Tracing Service, and the Data Services Group within the Department of Children, Schools and Families. We also thank the key stage one group (Maggie McLean, John Crookes, Peter Tymms, and Tony Cline) for helpful comments on educational aspects. We thank Steve Gould, Barbara Farrell, Phil Edwards, and Martin Rosser for advice on questionnaire design. We convened a group of experts from within the field to help us understand and interpret these finding before publication. This group consisted of Martin Whittle, Alison Bedford Russell, Phil Bennett, Kate Costeloe, Francis Cowan, Olaf Dammann, Diana Elbourne, Catherine Elliott, Mike Millar, lane Norman, Micheal O'Shea, Max Parmar, Roberto Romero, and Dieter Wolke.	Altman DG, 2006, PRACTICAL STAT MED R; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Cuffe Steven P, 2005, J Atten Disord, V9, P392, DOI 10.1177/1087054705280413; Dammann O, 2005, BJOG-INT J OBSTET GY, V112, P4, DOI 10.1111/j.1471-0528.2005.00576.x; Dammann O, 2007, DEV NEUROSCI-BASEL, V29, P280, DOI 10.1159/000105469; Edwards P, 2002, BRIT MED J, V324, P1183, DOI 10.1136/bmj.324.7347.1183; Feeny D, 2004, SOC SCI MED, V58, P799, DOI 10.1016/S0277-9536(03)00254-5; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Gomez R, 1997, PRETERM LABOR, P85; Gomez R, 2007, J MATERN-FETAL NEO M, V20, P167, DOI 10.1080/14767050601135485; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gotsch F, 2007, CLIN OBSTET GYNECOL, V50, P652, DOI 10.1097/GRF.0b013e31811ebef6; Jobe A H, 2001, Semin Neonatol, V6, P331, DOI 10.1053/siny.2001.0068; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Kenyon S, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-55; KENYON S, 2008, BMC PREGNANCY CHILDB, V8, P14; KENYON S, 2008, LANCET          0918, DOI DOI 10.1016/S0140-6736(08)61203-9; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; Marlow N, 2004, ARCH DIS CHILD-FETAL, V89, pF224, DOI 10.1136/adc.2002.019752; Marlow N, 2007, PEDIATRICS, V120, P793, DOI 10.1542/peds.2007-0440; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Miralles R, 2005, PEDIATR RES, V57, P570, DOI 10.1203/01.PDR.0000155944.48195.97; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; *QUAL CURR AUTH, 2007, KEY STAG 1 ASS REP A; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P661, DOI 10.1016/S0002-9378(88)80030-9; Royal College of Obstetricians and Gynaecologists, 2006, PRET PREL RUPT MEMBR; SAIGAL S, 1994, J PEDIATR-US, V125, P411, DOI 10.1016/S0022-3476(05)83288-3; Salt A, 2006, EARLY HUM DEV, V82, P185, DOI 10.1016/j.earlhumdev.2005.12.015; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83	33	94	99	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2008	372	9646					1310	1318		10.1016/S0140-6736(08)61202-7	http://dx.doi.org/10.1016/S0140-6736(08)61202-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18804274	Green Submitted			2022-12-28	WOS:000260060500029
J	McCain, J				McCain, John			Access to quality and affordable health care for every American	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1537	1541		10.1056/NEJMp0807607	http://dx.doi.org/10.1056/NEJMp0807607			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	358FS	18815389				2022-12-28	WOS:000259903100002
J	Soukup, V; Epperlein, HH; Horacek, I; Cerny, R				Soukup, Vladimir; Epperlein, Hans-Henning; Horacek, Ivan; Cerny, Robert			Dual epithelial origin of vertebrate oral teeth	NATURE			English	Article							CRANIAL NEURAL CREST; EVOLUTIONARY ORIGINS; TOOTH; DENTITIONS; ENDODERM; GENES; MOUTH; JAWS	The oral cavity of vertebrates is generally thought to arise as an ectodermal invagination(1,2). Consistent with this, oral teeth are proposed to arise exclusively from ectoderm, contributing to tooth enamel epithelium, and from neural crest derived mesenchyme, contributing to dentin and pulp(3-5). Yet in many vertebrate groups, teeth are not restricted only to the oral cavity(6-9), but extend posteriorly as pharyngeal teeth that could be derived either directly from the endodermal epithelium, or from the ectodermal epithelium that reached this location through the mouth or through the pharyngeal slits(6). However, when the oropharyngeal membrane, which forms a sharp ecto/ endodermal border(10), is broken, the fate of these cells is poorly known. Here, using transgenic axolotls with a combination of fate- mapping approaches, we present reliable evidence of oral teeth derived from both the ectoderm and endoderm and, moreover, demonstrate teeth with a mixed ecto/ endodermal origin. Despite the enamel epithelia having a different embryonic source, oral teeth in the axolotl display striking developmental uniformities and are otherwise identical. This suggests a dominant role for the neural crest mesenchyme over epithelia in tooth initiation and, from an evolutionary point of view, that an essential factor in teeth evolution was the odontogenic capacity of neural crest cells, regardless of possible 'outside-in'(11) or 'inside-out'(12) influx of the epithelium.	[Soukup, Vladimir; Horacek, Ivan; Cerny, Robert] Charles Univ Prague, Dept Zool, CR-12844 Prague, Czech Republic; [Epperlein, Hans-Henning] Tech Univ Dresden, Dept Anat, D-01307 Dresden, Germany	Charles University Prague; Technische Universitat Dresden	Cerny, R (corresponding author), Charles Univ Prague, Dept Zool, Vinicna 7, CR-12844 Prague, Czech Republic.	cerny8@natur.cuni.cz	Cerny, Robert/H-3801-2017; Soukup, Vladimir/G-3599-2014; Horacek, Ivan/V-9741-2017	Cerny, Robert/0000-0002-0022-0199; Soukup, Vladimir/0000-0002-1914-283X; Horacek, Ivan/0000-0002-8356-5554	Ministry of Youth, Education and Sport of the Czech Republic [MSMT 0021620828]; SMWK (Dresden); COST Action B23	Ministry of Youth, Education and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); SMWK (Dresden); COST Action B23	We wish to thank E. Tanaka and H. Andreas for supplying us with GFP axolotl embryos, L. Mchedlishvili for technical advice and O. Sebesta for help with confocal microscopy. We are grateful to M. Bronner-Fraser, R. Ericsson, D. Meulemans Medeiros, L. Olsson, P. D. Polly, D. W. Stock and A. Tucker for comments on the manuscript. Grants from the Ministry of Youth, Education and Sport of the Czech Republic (MSMT 0021620828), SMWK (Dresden) and COST Action B23 'Oral facial development and regeneration' are gratefully acknowledged.	Adams AE, 1924, J EXP ZOOL, V40, P311, DOI 10.1002/jez.1400400302; BARLOW LA, 1995, DEV BIOL, V169, P273, DOI 10.1006/dbio.1995.1143; Barlow LA, 1997, DEVELOPMENT, V124, P949; Cerny R, 2004, DEV BIOL, V276, P225, DOI 10.1016/j.ydbio.2004.08.046; Cerny R, 2004, DEV BIOL, V266, P252, DOI 10.1016/j.ydbio.2003.09.039; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chibon P., 1966, Memoires de la Societe Zoologique de France, V36, P1; Debiais-Thibaud M, 2007, J EXP ZOOL PART B, V308B, P693, DOI 10.1002/jez.b.21183; Dickinson AJG, 2006, DEV BIOL, V295, P700, DOI 10.1016/j.ydbio.2006.03.054; Epperlein HH, 2000, DEVELOPMENT, V127, P2751; Fraser GJ, 2004, P ROY SOC B-BIOL SCI, V271, P2311, DOI 10.1098/rspb.2004.2878; HALL BK, 1947, P ROY SOC LOND B BIO, V134, P377; Huysseune A, 2002, CONNECT TISSUE RES, V43, P98, DOI 10.1080/03008200290000808; Imai H, 1998, EUR J ORAL SCI, V106, P19, DOI 10.1111/j.1600-0722.1998.tb02148.x; Jackman WR, 2004, DEV BIOL, V274, P139, DOI 10.1016/j.ydbio.2004.07.003; Janvier P., 1996, EARLY VERTEBRATES; Kardong K.V., 1995, VERTEBRADOSANATOMIA; Mitsiadis TA, 2006, J EXP ZOOL PART B, V306B, P227, DOI 10.1002/jez.b.21094; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; REIF WE, 1982, EVOL BIOL, V15, P287; Reiss JO, 1997, J MORPHOL, V231, P63, DOI 10.1002/(SICI)1097-4687(199701)231:1<63::AID-JMOR6>3.0.CO;2-P; Romer A.S., 1962, VERTEBRATE BODY; Sharpe PT, 1995, CONNECT TISSUE RES, V32, P17, DOI 10.3109/03008209509013701; Sire JY, 2002, MICROSC RES TECHNIQ, V59, P408, DOI 10.1002/jemt.10220; Smith MM, 2003, SCIENCE, V299, P1235, DOI 10.1126/science.1079623; Smith MM, 2001, SYST ASSOC SPEC VOL, V61, P223; Smith MM, 2003, EVOL DEV, V5, P394, DOI 10.1046/j.1525-142X.2003.03047.x; Smith MM, 1998, EUR J ORAL SCI, V106, P482, DOI 10.1111/j.1600-0722.1998.tb02212.x; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Stock DW, 2001, PHILOS T R SOC B, V356, P1633, DOI 10.1098/rstb.2001.0917; Tucker A, 2004, NAT REV GENET, V5, P499, DOI 10.1038/nrg1380	31	63	63	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					795	U6		10.1038/nature07304	http://dx.doi.org/10.1038/nature07304			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18794902				2022-12-28	WOS:000259854900046
J	Kendall, T; Taylor, E; Perez, A; Taylor, C				Kendall, Tim; Taylor, Eric; Perez, Alejandra; Taylor, Clare		Guideline Dev Grp	Guidelines - Diagnosis and management of attention-deficit/hyperactivity disorder in children, young people, and adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERACTIVITY		[Perez, Alejandra] UCL, British Psychol Soc CORE, Subdept Clin Hlth Psychol, London WC1E 7HB, England; [Kendall, Tim; Taylor, Clare] Natl Collaborating Ctr Mental Hlth, Res & Training Unit, London E1 8AA, England; [Kendall, Tim] Royal Coll Psychiatrists, Res & Training Unit, London E1 8AA, England; [Kendall, Tim] Sheffield Care Trust, Sheffield, S Yorkshire, England; [Taylor, Eric] Kings Coll London, Inst Psychiat, Dept Child & Adolescent Psychiat, London SE5 8AF, England	University of London; University College London; University of London; University College London; University of London; King's College London	Perez, A (corresponding author), UCL, British Psychol Soc CORE, Subdept Clin Hlth Psychol, London WC1E 7HB, England.	a.perez@ucl.ac.uk			National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Mental Health was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Biederman J, 2006, PSYCHOL MED, V36, P167, DOI 10.1017/S0033291705006410; Cox ER, 2003, PEDIATRICS, V111, P237, DOI 10.1542/peds.111.2.237; MCCARTHY S, IN PRESS BR J PSYCHI; MOFFITT TE, 1990, CHILD DEV, V61, P893, DOI 10.1111/j.1467-8624.1990.tb02830.x; National Institute for Health and Clinical Excellence, METH AT DEX TREATM A; National Institute for Health and Clinical Excellence, 2008, ATT DEF HYP DIS DIAG; Sayal K, 2006, J CHILD PSYCHOL PSYC, V47, P744, DOI 10.1111/j.1469-7610.2005.01553.x; SHAFFER D, 1983, ARCH GEN PSYCHIAT, V40, P1228; Taylor E, 1996, J AM ACAD CHILD PSY, V35, P1213, DOI 10.1097/00004583-199609000-00019; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR	10	78	79	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1239	10.1136/bmj.a1239	http://dx.doi.org/10.1136/bmj.a1239			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SJ	18815170				2022-12-28	WOS:000259797600042
J	Barennes, H; Andriatahina, T; Latthaphasavang, V; Anderson, M; Srour, LM				Barennes, Hubert; Andriatahina, Todisoa; Latthaphasavang, Vattanaphone; Anderson, Margot; Srour, Leila M.			Misperceptions and misuse of Bear Brand coffee creamer as infant food: national cross sectional survey of consumers and paediatricians in Laos	BRITISH MEDICAL JOURNAL			English	Article							BREAST-MILK SUBSTITUTES; INTERNATIONAL CODE; NUTRITIONAL-STATUS; CHILDREN; VIOLATIONS; FORMULA; PDR; COUNTRIES; OBESITY	Objective To investigate the use of Bear Brand coffee creamer as a food for infants and the impact on consumers of the logo of a cartoon baby bear held by its mother in the breastfeeding position. Design Interviews with paediatricians throughout the country and a national survey of potential consumers regarding their perceptions and use of the Bear Brand coffee creamer. Setting 84 randomised villages in south, central, and northern Laos. Participants 26 Lao paediatricians and 1098 adults in households in a cluster sampling. Results Of the 26 paediatricians, 24 said that parents "often" or "sometimes" fed this product to infants as a substitute for breast milk. In the capital city, paediatricians said that mothers used the product when they returned to work. In the countryside, they reported that poor families used it when the mother was ill or died. Of 1098 adults surveyed, 96% believed that the can contains milk; 46% believed the Bear Brand logo indicates that the product is formulated for feeding to infants or to replace breast milk; 80% had not read the written warning on the can; and over 18% reported giving the product to their infant at a mean age of 4.7 months (95% confidence interval 4.1 to 5.3). Conclusion The Bear Brand coffee creamer is used as a breast milk substitute in Laos. The cartoon logo influences people's perception of the product that belies the written warning "This product is not to be used as a breast milk substitute." Use of this logo on coffee creamer is misleading to the local population and places the health of infants at risk.	[Barennes, Hubert; Andriatahina, Todisoa; Latthaphasavang, Vattanaphone] Inst Francophonie Med Trop, Viangchan, Laos; [Anderson, Margot; Srour, Leila M.] Univ Hlth Sci, Viangchan, Laos		Barennes, H (corresponding author), Inst Francophonie Med Trop, BP 9519, Viangchan, Laos.	hubert.barennes@auf.org	Barennes, hubert/E-9728-2011		Agence Universitaire de la Francophonie	Agence Universitaire de la Francophonie	Agence Universitaire de la Francophonie (AUF).	Aguayo VM, 2003, BRIT MED J, V326, P127, DOI 10.1136/bmj.326.7381.127; BARENNES H, 2007, EUR J CLIN NUTR 1114; Caballero B, 2005, NEW ENGL J MED, V352, P1514, DOI 10.1056/NEJMp048310; Delpeuch F, 1997, Med Trop (Mars), V57, P380; Holmes W, 2007, ASIA PAC J CLIN NUTR, V16, P537; Kaufmann S., 2003, FAO NUTR COUNTRY LAO; Koletzko B, 2005, J PEDIATR GASTR NUTR, V41, P584, DOI 10.1097/01.mpg.0000187817.38836.42; Lauer JA, 2006, PUBLIC HEALTH NUTR, V9, P673, DOI 10.1079/PHN2005891; Mayor S, 2004, BRIT MED J, V328, P1218, DOI 10.1136/bmj.328.7450.1218-b; *MIN HLTH SOC SERV, 2001, HLTH NAM, P1; Miyoshi M, 2005, EUR J CLIN NUTR, V59, P887, DOI 10.1038/sj.ejcn.1602160; Mizuno K, 2006, INT BREASTFEED J, V1, DOI 10.1186/1746-4358-1-12; *NAT STAT CTR, POP CENS 2005; Nestle M, 2006, NEW ENGL J MED, V354, P2527, DOI 10.1056/NEJMp068014; Parrilla-Rodriguez AM, 2008, P R HEALTH SCI J, V27, P49; Perks C, 2006, B WORLD HEALTH ORGAN, V84, P132, DOI 10.2471/BLT.05.025403; Phengxay M, 2007, PEDIATR INT, V49, P260, DOI 10.1111/j.1442-200X.2007.02354.x; Phimmasone K, 1996, J TROP PEDIATRICS, V42, P5, DOI 10.1093/tropej/42.1.5; Sayasone Somphou, 2004, Southeast Asian J Trop Med Public Health, V35 Suppl 2, P50; Soukaloun D, 2003, ANN TROP PAEDIATR, V23, P181, DOI 10.1179/027249303322296493; Taylor A, 1998, BMJ-BRIT MED J, V316, P1117, DOI 10.1136/bmj.316.7138.1117; United Nations Development Programme, 2004, HUM DEV REP 2004 CUL; Waterston T, 2003, BRIT MED J, V326, P113, DOI 10.1136/bmj.326.7381.113; *WHO, 1981, PEDIATRICS, V68, P432; 2007, LAO PDR COMPR FOOD S	25	19	19	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2008	337	7671							a1379	10.1136/bmj.a1379	http://dx.doi.org/10.1136/bmj.a1379			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18782843	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000259622000033
J	[Anonymous]				[Anonymous]			Asthma: still more questions than answers	LANCET			English	Editorial Material																			0	17	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1009	1009						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805308	Bronze			2022-12-28	WOS:000259648500001
J	Lack, G				Lack, Gideon			Food allergy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LIFE-THREATENING ASTHMA; AGE 7 YEARS; EGG ALLERGY; ANAPHYLACTIC REACTIONS; ATOPIC-DERMATITIS; PEANUT ALLERGY; EUROPEAN-ACADEMY; NATURAL COURSE; CHILDREN; CHILDHOOD		[Lack, Gideon] Kings Coll London, Dept Paediat Allergy, London WC2R 2LS, England; [Lack, Gideon] Guys & St Thomas Natl Hlth Serv Fdn Trust, Childrens Allergy Serv, London, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Lack, G (corresponding author), St Thomas Hosp, Childrens Allergy Serv, 2nd Fl,South Wing,Westminster Bridge Rd, London SE1 7EH, England.	gideon.lack@kcl.ac.uk		Lack, Gideon/0000-0001-7350-4021	Novartis; Synovate; Nutricia; ALK-Abello; Nestle	Novartis(Novartis); Synovate; Nutricia(Danone Nutricia); ALK-Abello; Nestle(Nestle SA)	Dr. Lack reports receiving consulting or lecture fees from Novartis, Synovate, Nutricia, ALK-Abello, and Nestle, and serving as an expert witness for several medical cases involving food allergy. No other potential conflict of interest relevant to this article was reported. I thank Drs. L. G. Du Toit, A. T. Fox, and S. Chan for critical review of an earlier version of the manuscript.	*54 WORLD HLTH ASS, 2001, GLOB STRAT INF YOUNG; Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P724; Akdis CA, 2006, J ALLERGY CLIN IMMUN, V118, P152, DOI 10.1016/j.jaci.2006.03.045; Allen CW, 2007, J PAEDIATR CHILD H, V43, P214, DOI 10.1111/j.1440-1754.2007.00996.x; BOCK SA, 1987, PEDIATRICS, V79, P683; BOCK SA, 1990, J PEDIATR-US, V117, P561, DOI 10.1016/S0022-3476(05)80689-4; Boyano-Martinez T, 2002, J ALLERGY CLIN IMMUN, V110, P304, DOI 10.1067/mai.2002.126081; Buchanan A. D., 2004, Journal of Allergy and Clinical Immunology, V113, pS150, DOI 10.1016/j.jaci.2003.12.544; Burkill GJC, 2001, CLIN RADIOL, V56, P67, DOI 10.1053/crad.2000.0605; Christie L, 2002, J AM DIET ASSOC, V102, P1648, DOI 10.1016/S0002-8223(02)90351-2; Dalal I, 2003, PEDIATR ALLERGY IMMU, V14, P312, DOI 10.1034/j.1399-3038.2003.00040.x; DEMAATBLEEKER F, 1985, ANN ALLERGY, V54, P245; Eggesbo M, 2001, ALLERGY, V56, P403, DOI 10.1034/j.1398-9995.2001.056005403.x; Eigenmann PA, 2000, J ALLERGY CLIN IMMUN, V105, P587, DOI 10.1067/mai.2000.104255; Ellis AK, 2007, ANN ALLERG ASTHMA IM, V98, P64, DOI 10.1016/S1081-1206(10)60861-7; ERNST P, 1993, AM REV RESPIR DIS, V148, P75, DOI 10.1164/ajrccm/148.1.75; Ewan PW, 2005, CLIN EXP ALLERGY, V35, P751, DOI 10.1111/j.1365-2222.2005.02266.x; Fiocchi A, 2004, ALLERGY, V59, P78, DOI 10.1111/j.1398-9995.2004.00653.x; *GLOB INT ASTHM, 2006, GLOB STRAT ASTHM MAN; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; HATTEVIG G, 1987, CLIN ALLERGY, V17, P571, DOI 10.1111/j.1365-2222.1987.tb02053.x; Hill DJ, 2004, PEDIAT ALLERG IMM-UK, V15, P421, DOI 10.1111/j.1399-3038.2004.00178.x; Illi S, 2004, J ALLERGY CLIN IMMUN, V113, P925, DOI 10.1016/j.jaci.2004.01.778; James JM, 1998, J PEDIATR-US, V133, P624, DOI 10.1016/S0022-3476(98)70101-5; KAJOSAARI M, 1982, ACTA PAEDIATR SCAND, V71, P815, DOI 10.1111/j.1651-2227.1982.tb09525.x; Kapoor S, 2004, ALLERGY, V59, P185, DOI 10.1046/j.1398-9995.2003.00365.x; Khakoo A., 2000, Food intolerance and the food industry, P163, DOI 10.1533/9781855736344.163; Kulig M, 1999, J ALLERGY CLIN IMMUN, V103, P1173, DOI 10.1016/S0091-6749(99)70195-8; Kull I, 2006, ALLERGY, V61, P1009, DOI 10.1111/j.1398-9995.2006.01115.x; Lack G, 2003, NEW ENGL J MED, V348, P977, DOI 10.1056/NEJMoa013536; Lack G, 2008, J ALLERGY CLIN IMMUN, V121, P1331, DOI 10.1016/j.jaci.2008.04.032; Lee JM, 2000, PEDIATRICS, V106, P762, DOI 10.1542/peds.106.4.762; Leung DYM, 2003, NEW ENGL J MED, V348, P986, DOI 10.1056/NEJMoa022613; Lucas JSA, 2003, PEDIAT ALLERG IMM-UK, V14, P420, DOI 10.1046/j.0905-6157.2003.00095.x; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; NGAN J, 1978, J IMMUNOL, V120, P861; PICKERING LK, 2006, RED BOOK 2006 REPORT, P35; Poole JA, 2006, PEDIATRICS, V117, P2175, DOI 10.1542/peds.2005-1803; Rance F, 2003, ALLERGY, V58, P287, DOI 10.1034/j.1398-9995.2003.00109.x; REED CE, 1990, CHEST, V98, P261, DOI 10.1378/chest.98.2.261; Rhodes HL, 2001, J ALLERGY CLIN IMMUN, V108, P720, DOI 10.1067/mai.2001.119151; Roberts G, 2003, J ALLERGY CLIN IMMUN, V112, P168, DOI 10.1067/mai.2003.1569; Roberts G, 2003, J ALLERGY CLIN IMMUN, V111, P491, DOI 10.1067/mai.2003.138; Sampson HA, 1997, J ALLERGY CLIN IMMUN, V100, P444, DOI 10.1016/S0091-6749(97)70133-7; Sampson HA, 2002, NEW ENGL J MED, V346, P1294, DOI 10.1056/NEJMcp012667; SAMPSON HA, 1992, NEW ENGL J MED, V327, P380, DOI 10.1056/NEJM199208063270603; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Savage JH, 2007, J ALLERGY CLIN IMMUN, V120, P1413, DOI 10.1016/j.jaci.2007.09.040; Shek LPC, 2004, J ALLERGY CLIN IMMUN, V114, P387, DOI 10.1016/j.jaci.2004.04.032; Simons FER, 2004, J ALLERGY CLIN IMMUN, V113, P837, DOI 10.1016/j.jaci.2004.01.079; Simons FER., 2004, J ALLERGY CLIN IMMUN, V113, P1039; Sporik R, 2000, CLIN EXP ALLERGY, V30, P1540, DOI 10.1046/j.1365-2222.2000.00928.x; Strid J, 2004, EUR J IMMUNOL, V34, P2100, DOI 10.1002/eji.200425196; SZEPFALUSI Z, 1994, J ALLERGY CLIN IMMUN, V93, P932, DOI 10.1016/0091-6749(94)90388-3; Tariq SM, 2000, PEDIATR ALLERGY IMMU, V11, P162, DOI 10.1034/j.1399-3038.2000.00077.x; ZEIGER RS, 1995, J ALLERGY CLIN IMMUN, V95, P1179, DOI 10.1016/S0091-6749(95)70074-9; 1999, ALLERGIC RHINITIS IT	57	128	140	4	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1252	1260		10.1056/NEJMcp0800871	http://dx.doi.org/10.1056/NEJMcp0800871			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799559				2022-12-28	WOS:000259259900008
J	Kaser, A; Lee, AH; Franke, A; Glickman, JN; Zeissig, S; Tilg, H; Nieuwenhuis, EES; Higgins, DE; Schreiber, S; Glimcher, LH; Blumberg, RS				Kaser, Arthur; Lee, Ann-Hwee; Franke, Andre; Glickman, Jonathan N.; Zeissig, Sebastian; Tilg, Herbert; Nieuwenhuis, Edward E. S.; Higgins, Darren E.; Schreiber, Stefan; Glimcher, Laurie H.; Blumberg, Richard S.			XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN RESPONSE; ALPHA-DEFENSINS; CROHN-DISEASE; PANETH CELLS; GENOME; ASSOCIATION; ACTIVATION; EXPRESSION	Inflammatory bowel disease (IBD) has been attributed to aberrant mucosal immunity to the intestinal microbiota. The transcription factor XBP1, a key component of the endoplasmic reticulum (ER) stress response, is required for development and maintenance of secretory cells and linked to JNK activation. We hypothesized that a stressful environmental milieu in a rapidly proliferating tissue might instigate a proinflammatory response. We report that Xbp1 deletion in intestinal epithelial cells (IECs) results in spontaneous enteritis and increased susceptibility to induced colitis secondary to both Paneth cell dysfunction and an epithelium that is overly reactive to inducers of IBD such as bacterial products (flagellin) and TNF alpha. An association of XBP1 variants with both forms of human IBD (Crohn's disease and ulcerative colitis) was identified and replicated (rs35873774; p value 1.6 x 10(-5)) with novel, private hypomorphic variants identified as susceptibility factors. Hence, intestinal inflammation can originate solely from XBP1 abnormalities in IECs, thus linking cell-specific ER stress to the induction of organ-specific inflammation.	[Lee, Ann-Hwee; Glimcher, Laurie H.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Kaser, Arthur; Zeissig, Sebastian; Blumberg, Richard S.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Gastroenterol,Dept Med, Boston, MA 02115 USA; [Glickman, Jonathan N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Franke, Andre; Schreiber, Stefan] Univ Kiel, Inst Clin Mol Biol, D-24105 Kiel, Germany; [Tilg, Herbert] Innsbruck Med Univ, Dept Med, Christian Doppler Res Lab Gut Inflammat, A-6020 Innsbruck, Austria; [Tilg, Herbert] Innsbruck Med Univ, Dept Med, Div Gastroenterol & Hepatol, A-6020 Innsbruck, Austria; [Nieuwenhuis, Edward E. S.] Erasmus MC Sophia Childrens Hosp, Div Pediat Gastroenterol, NL-3000 GE Rotterdam, Netherlands; [Higgins, Darren E.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Schreiber, Stefan] Univ Hosp Schleswig Holstein, Dept Med 1, D-24105 Kiel, Germany	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Kiel; Medical University of Innsbruck; Medical University of Innsbruck; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard Medical School; University of Kiel; Schleswig Holstein University Hospital	Glimcher, LH (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, 651 Huntington Ave, Boston, MA 02115 USA.	lglimche@hsph.harvard.edu; rblumberg@partners.org	Longo, Kenneth A/A-5631-2010; Franke, Andre/B-2151-2010; Zeissig, Sebastian/B-6297-2012	Franke, Andre/0000-0003-1530-5811; Zeissig, Sebastian/0000-0001-5124-0897	Crohn's and Colitis Foundation of America; NIH [DK44319, P30 DK034854, AI32412, P01 AI56296]; Ellison Medical Foundation [CDA 1P50CA100707]; Austrian Science Fund; Max Kade Foundation; DFG/BMBF Excellence Cluster "Inflammation at Interfaces"; German Ministry of Education and Research (BMBF); PopGen Biobank; NATIONAL CANCER INSTITUTE [P50CA100707] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032412, P01AI056296] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319, P30DK034854, R37DK044319] Funding Source: NIH RePORTER	Crohn's and Colitis Foundation of America; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Austrian Science Fund(Austrian Science Fund (FWF)); Max Kade Foundation; DFG/BMBF Excellence Cluster "Inflammation at Interfaces"(German Research Foundation (DFG)Federal Ministry of Education & Research (BMBF)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); PopGen Biobank; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. S. Robine and N. Davidson for VCre-ER<SUP>T2</SUP> mice; Dr. S. Ito for help with EM; Drs. J. Rioux, A. Ouelette, and M. Starnbach for helpful discussions; P. Gupta, B. Enrich, and D. Lindenbergh-Kortleve for technical support; and Dr. S. Snapper for critical reading of the manuscript. This work was supported by grants from the Crohn's and Colitis Foundation of America (R. S. B. and A. K.), NIH grants DK44319 (R. S. B.), P30 DK034854 (R. S. B.; Harvard Digestive Diseases Center), and AI32412 and P01 AI56296 (L. H. G.), the Ellison Medical Foundation (L. H. G.), CDA 1P50CA100707(A.- H. L.), the Austrian Science Fund (A. K. and H. T.), the Max Kade Foundation (A. K.), and the DFG/BMBF Excellence Cluster "Inflammation at Interfaces" (S. S. and A. F.). The authors wish to thank the patients, families, and physicians for their cooperation. The cooperativeness of the German Crohn and Colitis patient association (Deutsche Morbus Crohn und Colitis Vereinigung e. V.) and of the German "Kompetenznetz Darmerkrankungen'' are gratefully acknowledged. Genotyping in this study was supported by the German Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN) and the PopGen Biobank.	Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ayabe T, 2002, J BIOL CHEM, V277, P5219, DOI 10.1074/jbc.M109410200; Ayabe T, 2000, NAT IMMUNOL, V1, P113, DOI 10.1038/77783; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P513, DOI 10.1097/00054725-200409000-00004; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Franke A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000691; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Gorlov IP, 2008, AM J HUM GENET, V82, P100, DOI 10.1016/j.ajhg.2007.09.006; Halfvarson J, 2003, GASTROENTEROLOGY, V124, P1767, DOI 10.1016/S0016-5085(03)00385-8; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Kojouharoff G, 1997, CLIN EXP IMMUNOL, V107, P353, DOI 10.1111/j.1365-2249.1997.291-ce1184.x; Krawczak M, 2006, COMMUNITY GENET, V9, P55, DOI 10.1159/000090694; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Libioulle C, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030058; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Mathew CG, 2008, NAT REV GENET, V9, P9, DOI 10.1038/nrg2203; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Nikolaus S, 2007, GASTROENTEROLOGY, V133, P1670, DOI 10.1053/j.gastro.2007.09.001; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Song F, 1999, J IMMUNOL, V162, P2275; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Tashiro E, 2007, J ANTIBIOT, V60, P547, DOI 10.1038/ja.2007.69; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van de Wal Y, 2003, GASTROENTEROLOGY, V124, P1420, DOI 10.1016/S0016-5085(03)00219-1; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Wehkamp J, 2005, P NATL ACAD SCI USA, V102, P18129, DOI 10.1073/pnas.0505256102; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	47	1010	1051	4	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					743	756		10.1016/j.cell.2008.07.021	http://dx.doi.org/10.1016/j.cell.2008.07.021			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775308	Bronze, Green Accepted			2022-12-28	WOS:000258947500015
J	Singh, R; Jamieson, A; Cresswell, P				Singh, Reshma; Jamieson, Amanda; Cresswell, Peter			GILT is a critical host factor for Listeria monocytogenes infection	NATURE			English	Article							THIOL REDUCTASE GILT; MATURATION; HEPATOCYTES; CYTOLYSINS; MUTANTS; PEPTIDE; COMPLEX; PREPORE; SPREAD; GROWTH	Listeria monocytogenes is a Gram- positive, intracellular, foodborne pathogen that can cause severe illness in humans and animals. On infection, it is actively phagocytosed by macrophages(1); it then escapes from the phagosome, replicates in the cytosol, and subsequently spreads from cell to cell by a non- lytic mechanism driven by actin polymerization(2). Penetration of the phagosomal membrane is initiated by the secreted haemolysin listeriolysin O ( LLO), which is essential for vacuolar escape in vitro and for virulence in animal models of infection(3). Reduction is required to activate the lytic activity of LLO in vitro(4-6), and we show here that reduction by the enzyme gamma-interferon- inducible lysosomal thiol reductase ( GILT, also called Ifi30) is responsible for the activation of LLO in vivo. GILT is a soluble thiol reductase expressed constitutively within the lysosomes of antigen- presenting cells(7,8), and it accumulates in macrophage phagosomes as they mature into phagolysosomes(9). The enzyme is delivered by a mannose-6-phosphate receptor- dependent mechanism to the endocytic pathway, where amino- and carboxy- terminal pro- peptides are cleaved to generate a 30- kDa mature enzyme(7,8,10). The active site of GILT contains two cysteine residues in a CXXC motif that catalyses the reduction of disulphide bonds(7,8). Mice lacking GILT are deficient in generating major histocompatibility complex class- II- restricted CD4(+) T-cell responses to protein antigens that contain disulphide bonds(11,12). Here we show that these mice are resistant to L. monocytogenes infection. Replication of the organism in GILT- negative macrophages, or macrophages expressing an enzymatically inactive GILT mutant, is impaired because of delayed escape from the phagosome. GILT activates LLO within the phagosome by the thiol reductase mechanism shared by members of the thioredoxin family. In addition, purified GILT activates recombinant LLO, facilitating membrane permeabilization and red blood cell lysis. The data show that GILT is a critical host factor that facilitates L. monocytogenes infection.	[Singh, Reshma; Jamieson, Amanda; Cresswell, Peter] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06250 USA; [Singh, Reshma; Cresswell, Peter] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06250 USA	Yale University; Howard Hughes Medical Institute; Yale University	Cresswell, P (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 300 Cedar St, New Haven, CT 06250 USA.	peter.cresswell@yale.edu	Jamieson, Amanda/U-7169-2019	Jamieson, Amanda/0000-0002-5781-9231	NIH [AI023081]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023081, R37AI023081] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to D. Portnoy for advice and reagents, and to N. Dometios for manuscript preparation. We acknowledge the valuable contribution of the late M. Pypaert to the electron microscopy. This work was supported by NIH AI023081 (P.C.) and the Howard Hughes Medical Institute (P.C., R.S.).	Agaisse H, 2005, SCIENCE, V309, P1248, DOI 10.1126/science.1116008; ALOUF JE, 2005, BACT TOXINS COMPREHE, P643; Arunachalam B, 2000, P NATL ACAD SCI USA, V97, P745, DOI 10.1073/pnas.97.2.745; BARRY RA, 1992, INFECT IMMUN, V60, P1625, DOI 10.1128/IAI.60.4.1625-1632.1992; Billington SJ, 2000, FEMS MICROBIOL LETT, V182, P197, DOI 10.1016/S0378-1097(99)00536-4; Bouwer HGA, 1998, INFECT IMMUN, V66, P2814, DOI 10.1128/IAI.66.6.2814-2817.1998; BRYANT RE, 1980, J INFECT DIS, V142, P594, DOI 10.1093/infdis/142.4.594; Garin J, 2001, J CELL BIOL, V152, P165, DOI 10.1083/jcb.152.1.165; Gedde MM, 2000, INFECT IMMUN, V68, P999, DOI 10.1128/IAI.68.2.999-1003.2000; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; Haschtmann D, 2005, MICROBES INFECT, V7, P1177, DOI 10.1016/j.micinf.2005.03.031; Hastings KT, 2006, J IMMUNOL, V177, P8569, DOI 10.4049/jimmunol.177.12.8569; Heuck AP, 2003, J BIOL CHEM, V278, P31218, DOI 10.1074/jbc.M303151200; Lackman RL, 2007, TRAFFIC, V8, P1179, DOI 10.1111/j.1600-0854.2007.00600.x; Lackman RL, 2006, J IMMUNOL, V177, P4833, DOI 10.4049/jimmunol.177.7.4833; Maric M, 2001, SCIENCE, V294, P1361, DOI 10.1126/science.1065500; MICHEL E, 1990, MOL MICROBIOL, V4, P2167, DOI 10.1111/j.1365-2958.1990.tb00578.x; PAMER EG, 1992, CELL, V70, P215, DOI 10.1016/0092-8674(92)90097-V; Phan UT, 2002, P NATL ACAD SCI USA, V99, P12298, DOI 10.1073/pnas.182430499; Phan UT, 2000, J BIOL CHEM, V275, P25907, DOI 10.1074/jbc.M003459200; PINKNEY M, 1989, INFECT IMMUN, V57, P2553, DOI 10.1128/IAI.57.8.2553-2558.1989; Pizarro-Cerda J, 2004, CR BIOL, V327, P521, DOI 10.1016/j.crvi.2004.05.001; PORTNOY DA, 1992, INFECT IMMUN, V60, P1263, DOI 10.1128/IAI.60.4.1263-1267.1992; Sealy R, 2008, CLIN VACCINE IMMUNOL, V15, P713, DOI 10.1128/CVI.00412-07; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; Walker KW, 1997, J BIOL CHEM, V272, P8845; Yates RM, 2005, TRAFFIC, V6, P413, DOI 10.1111/j.1600-0854.2005.00284.x; Yates RM, 2007, TRAFFIC, V8, P241, DOI 10.1111/j.1600-0854.2006.00528.x	30	112	116	1	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1244	U55		10.1038/nature07344	http://dx.doi.org/10.1038/nature07344			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815593	Green Accepted			2022-12-28	WOS:000260462100045
J	Head, J; Ferrie, JE; Alexanderson, K; Westerlund, H; Vahtera, J; Kivimaki, M				Head, Jenny; Ferrie, Jane E.; Alexanderson, Kristina; Westerlund, Hugo; Vahtera, Jussi; Kivimaki, Mika			Diagnosis-specific sickness absence as a predictor of mortality: the Whitehall II prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							BREAST-CANCER; DEPRESSION; DISEASE; HEALTH; ANXIETY	Objective To investigate whether knowing the diagnosis for sickness absence improves prediction of mortality. Design Prospective cohort study established in 1985- 8. Sickness absence records including diagnoses were obtained from computerised registers. Setting 20 civil service departments in London. Participants 6478 civil servants aged 35- 55 years. Main outcome measures All cause, cardiovascular, and cancer mortality until 2004, average follow- up 13 years. Results After adjustment for age, sex, and employment grade, employees who had one or more medically certified spells of sickness absence (> 7 days) in a three year period had a mortality 1.7 ( 95% CI 1.3 to 2.1) times greater than those with no medically certified spells. Inclusion of diagnoses improved the prediction of all cause mortality ( P= 0.03). The hazard ratio for mortality was 4.7 ( 2.6 to 8.5) for absences with circulatory disease diagnoses, 2.2 ( 1.4 to 3.3) for surgical operations, and 1.9 ( 1.2 to 3.1) for psychiatric diagnoses. Psychiatric absences were also predictive of cancer mortality ( 2.5 ( 1.3 to 4.7)). Associations of infectious, respiratory, and injury absences with overall mortality were less marked ( hazard ratios from 1.5 to 1.7), and there was no association between musculoskeletal absences and mortality. Conclusions Major diagnoses for medically certified absences were associated with increased mortality, with the exception of musculoskeletal disease. Data on sickness absence diagnoses may provide useful information to identify groups with increased health risk and a need for targeted interventions.	[Head, Jenny; Ferrie, Jane E.; Kivimaki, Mika] UCL, Dept Epidemiol & Publ Hlth, London, England; [Alexanderson, Kristina] Karolinska Inst, Dept Clin Neurosci, Sect Personal Injury Prevent, S-17177 Stockholm, Sweden; [Westerlund, Hugo] Stockholm Univ, Stress Res Inst, SE-10691 Stockholm, Sweden; [Vahtera, Jussi; Kivimaki, Mika] Finnish Inst Occupat Hlth, FIN-00250 Helsinki, Finland	University of London; University College London; Karolinska Institutet; Stockholm University; Finnish Institute of Occupational Health	Head, J (corresponding author), UCL, Dept Epidemiol & Publ Hlth, London, England.	j.head@ucl.ac.uk	Ferrie, Jane/AAZ-2009-2020; Head, Jenny/GYA-2625-2022; Kivimaki, Mika/B-3607-2012; Alexanderson, Kristina A/J-3429-2013; Vahtera, Jussi/J-3271-2013; Westerlund, Hugo/A-3049-2012	Kivimaki, Mika/0000-0002-4699-5627; Westerlund, Hugo/0000-0002-8806-5698; Head, Jennifer/0000-0002-6054-0872; Alexanderson, Kristina/0000-0002-9313-3413	Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute [HL36310]; NIH; National Institute on Aging [AG13196]; Agency for Health Care Policy Research [HS06516]; John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio- economic Status and Health; MRC [G8802774]; Swedish Council forWorking life and Social Research; Swedish Council for Working Life and Social Research [FAS 2004- 2021]; Academy of Finland [117614, 124322, 124271]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS006516] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG013196, R01AG013196] Funding Source: NIH RePORTER; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [RES-451-26-0491] Funding Source: researchfish; Medical Research Council [G19/35, G0100222, G8802774] Funding Source: researchfish; ESRC [RES-451-26-0491] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Agency for Health Care Policy Research(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio- economic Status and Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Council forWorking life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Council for Working Life and Social Research(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Academy of Finland(Academy of Finland); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The Whitehall II study has been supported by grants from the Medical Research Council; British Heart Foundation; Health and Safety Executive; Department of Health; National Heart Lung and Blood Institute ( HL36310), US, NIH: National Institute on Aging ( AG13196), US, NIH; Agency for Health Care Policy Research (HS06516); and the John D and Catherine T MacArthur Foundation Research Networks on Successful Midlife Development and Socio- economic Status and Health. JEF is supported by the MRC (grant No G8802774), KA is supported by the Swedish Council forWorking life and Social Research, HW is supported by a programme grant from the Swedish Council for Working Life and Social Research (FAS grant No 2004- 2021), and MK and JV are supported by the Academy of Finland ( Projects No 117614, 124322, and 124271).	Alexanderson K., 2004, Scandinavian Journal of Public Health, V32, P1; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854, DOI 10.1093/oxfordjournals.aje.a116381; Falagas ME, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1744; Feeney A, 1998, OCCUP ENVIRON MED, V55, P91, DOI 10.1136/oem.55.2.91; GJESDAL S, 2008, EUR J PUBLIC HLTH; Goodwin RD, 2006, J BEHAV MED, V29, P229, DOI 10.1007/s10865-006-9048-5; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Kivimaki M, 2003, BRIT MED J, V327, P364, DOI 10.1136/bmj.327.7411.364; Kubzansky LD, 1997, CIRCULATION, V95, P818; MARMOT M, 1995, J EPIDEMIOL COMMUN H, V49, P124, DOI 10.1136/jech.49.2.124; MARMOT MG, 1991, LANCET, V337, P1387, DOI 10.1016/0140-6736(91)93068-K; Mykletun A, 2007, PSYCHOSOM MED, V69, P323, DOI 10.1097/PSY.0b013e31803cb862; Nielsen NR, 2006, NAT CLIN PRACT ONCOL, V3, P612, DOI 10.1038/ncponc0652; Smith GD, 1998, BMJ-BRIT MED J, V317, P1351, DOI 10.1136/bmj.317.7169.1351; Spiegel D, 2003, BIOL PSYCHIAT, V54, P269, DOI 10.1016/S0006-3223(03)00566-3; STANSFELD S, 1995, SOC SCI MED, V40, P189, DOI 10.1016/0277-9536(94)E0064-Y; Suls J, 2005, PSYCHOL BULL, V131, P260, DOI 10.1037/0033-2909.131.2.260; Vahtera J, 2004, J EPIDEMIOL COMMUN H, V58, P321, DOI 10.1136/jech.2003.011817	18	100	100	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1469	10.1136/bmj.a1469	http://dx.doi.org/10.1136/bmj.a1469			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	358FU	18832415	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000259903300034
J	Deckert, R; Dameris, M				Deckert, Rudolf; Dameris, Martin			Atmospheric science - From ocean to stratosphere	SCIENCE			English	Editorial Material							BREWER-DOBSON CIRCULATION; CLIMATE; OZONE; MODEL		[Deckert, Rudolf; Dameris, Martin] Inst Atmospher Phys, Deutsch Zentrum Luft & Raumfahrt, D-82234 Oberpfaffenhofen, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Deckert, R (corresponding author), Inst Atmospher Phys, Deutsch Zentrum Luft & Raumfahrt, D-82234 Oberpfaffenhofen, Germany.	rudolf.deckert@dlr.de		Dameris, Martin/0000-0001-6700-0628				Austin J, 2007, J ATMOS SCI, V64, P905, DOI 10.1175/JAS3866.1; Butchart N, 2006, CLIM DYNAM, V27, P727, DOI 10.1007/s00382-006-0162-4; Deckert R, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL033719; Dima IM, 2007, J ATMOS SCI, V64, P2862, DOI 10.1175/JAS3985.1; Eyring V, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008332; Fomichev VI, 2007, J CLIMATE, V20, P1121, DOI 10.1175/JCLI4030.1; Forster PM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031994; Garcia RR, 2008, J ATMOS SCI, V65, P2731, DOI 10.1175/2008JAS2712.1; Gillett NP, 2003, SCIENCE, V302, P273, DOI 10.1126/science.1087440; Grewe V, 2006, ATMOS CHEM PHYS, V6, P1495, DOI 10.5194/acp-6-1495-2006; HAYNES PH, 1991, J ATMOS SCI, V48, P651, DOI 10.1175/1520-0469(1991)048<0651:OTCOED>2.0.CO;2; Kerr-Munslow AM, 2006, J ATMOS SCI, V63, P1410, DOI 10.1175/JAS3697.1; Olsen MA, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008012; Plumb RA, 1999, J ATMOS SCI, V56, P868, DOI 10.1175/1520-0469(1999)056<0868:TBDCDO>2.0.CO;2; Randel WJ, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006744; RANDEL WJ, 2008, J ATMOS SCI; Rind D, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002483; Rosenlof KH, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009109; Thompson DWJ, 2005, J CLIMATE, V18, P4785, DOI 10.1175/JCLI3585.1	19	12	12	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					53	55		10.1126/science.1163709	http://dx.doi.org/10.1126/science.1163709			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832634				2022-12-28	WOS:000259680200031
J	van Dam, RM; Li, T; Spiegelman, D; Franco, OH; Hu, FB				van Dam, Rob M.; Li, Tricia; Spiegelman, Donna; Franco, Oscar H.; Hu, Frank B.			Combined impact of lifestyle factors on mortality: prospective cohort study in US women	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; TYPE-2 DIABETES-MELLITUS; ALCOHOL-CONSUMPTION; PHYSICAL-ACTIVITY; ATTRIBUTABLE RISK; DIETARY-FAT; PREVENTION; METAANALYSIS; MEN; CANCER	Objective To evaluate the impact of combinations of lifestyle factors on mortality in middle aged women. Design Prospective cohort study. Setting Nurses' health study, United States. Participants 77 782 women aged 34 to 59 years and free from cardiovascular disease and cancer in 1980. Main outcome measure Relative risk of mortality during 24 years of follow- up in relation to five lifestyle factors ( cigarette smoking, being overweight, taking little moderate to vigorous physical activity, no light to moderate alcohol intake, and low diet quality score). Results 8882 deaths were documented, including 1790 from cardiovascular disease and 4527 from cancer. Each lifestyle factor independently and significantly predicted mortality. Relative risks for five compared with zero lifestyle risk factors were 3.26 ( 95% confidence interval 2.45 to 4.34) for cancer mortality, 8.17 ( 4.96 to 13.47) for cardiovascular mortality, and 4.31 ( 3.51 to 5.31) for all cause mortality. A total of 28% ( 25% to 31%) of deaths during follow- up could be attributed to smoking and 55% ( 47% to 62%) to the combination of smoking, being overweight, lack of physical activity, and a low diet quality. Additionally considering alcohol intake did not substantially change this estimate. Conclusions These results indicate that adherence to lifestyle guidelines is associated with markedly lower mortality in middle aged women. Both efforts to eradicate cigarette smoking and those to stimulate regular physical activity and a healthy diet should be intensified.	[van Dam, Rob M.; Li, Tricia; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [van Dam, Rob M.; Hu, Frank B.] Brigham & Womens Hosp, Channing Lab, Dept Med, Boston, MA 02115 USA; [van Dam, Rob M.; Hu, Frank B.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Spiegelman, Donna; Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Spiegelman, Donna] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Franco, Oscar H.] Unilever Corp Res, Sharnbrook MK44 1LQ, Beds, England	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Unilever	van Dam, RM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Nutr, 665 Huntington Ave, Boston, MA 02115 USA.	rvandam@hsph.harvard.edu	van Dam, Rob M/F-9674-2010; Hu, Frank/C-1919-2013; Franco, Óscar H/ABE-2305-2020	van Dam, Rob M/0000-0002-7354-8734; Franco, Óscar H/0000-0002-4606-4929	National Institutes of Health [CA87969, HL60712]; Peanut Foundation; NATIONAL CANCER INSTITUTE [P01CA087969] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Peanut Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by National Institutes of Health (NIH) grants CA87969 and HL60712. RMvD was partly supported by an unrestricted research grant from the Peanut Foundation. The funding sources had no role in the collection, management, analysis, or interpretation of the data and had no role in the preparation, review, or approval of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Anthonisen NR, 2005, ANN INTERN MED, V142, P233, DOI 10.7326/0003-4819-142-4-200502150-00005; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Colhoun H, 1997, BRIT MED J, V314, P1164, DOI 10.1136/bmj.314.7088.1164; Corrao G, 2004, PREV MED, V38, P613, DOI 10.1016/j.ypmed.2003.11.027; DAGOSTINO RB, 1990, STAT MED, V9, P1501, DOI 10.1002/sim.4780091214; DELORGERIL M, 1994, LANCET, V343, P1454, DOI 10.1016/S0140-6736(94)92580-1; Di Castelnuovo A, 2006, ARCH INTERN MED, V166, P2437, DOI 10.1001/archinte.166.22.2437; Ezzati M, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P241; FUCHS CS, 1995, NEW ENGL J MED, V332, P1245, DOI 10.1056/NEJM199505113321901; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Graubard BI, 2005, BIOMETRICS, V61, P847, DOI 10.1111/j.1541-0420.2005.00355.x; GREENLAND S, 1993, BIOMETRICS, V49, P865, DOI 10.2307/2532206; Hu FB, 1999, AM J EPIDEMIOL, V149, P531, DOI 10.1093/oxfordjournals.aje.a009849; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Key T, 2004, PUBLIC HEALTH NUTR, V7, P187, DOI 10.1079/PHN2003588; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Knoops KTB, 2004, JAMA-J AM MED ASSOC, V292, P1433, DOI 10.1001/jama.292.12.1433; MANSON JE, 1987, JAMA-J AM MED ASSOC, V257, P353, DOI 10.1001/jama.257.3.353; Martinez ME, 1997, J NATL CANCER I, V89, P948, DOI 10.1093/jnci/89.13.948; McCullough ML, 2002, AM J CLIN NUTR, V76, P1261, DOI 10.1093/ajcn/76.6.1261; Mensink RP, 2003, AM J CLIN NUTR, V77, P1146, DOI 10.1093/ajcn/77.5.1146; Mokdad AH, 2005, JAMA-J AM MED ASSOC, V293, P293, DOI 10.1001/jama.293.3.293; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Pereira MA, 2002, AM J CLIN NUTR, V75, P848, DOI 10.1093/ajcn/75.5.848; Rehm J, 2003, ALCOHOL RES HEALTH, V27, P39; RICHEDWARDS JW, 1994, AM J EPIDEMIOL, V140, P1016, DOI 10.1093/oxfordjournals.aje.a117191; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; Rimm EB, 1999, BMJ-BRIT MED J, V319, P1523, DOI 10.1136/bmj.319.7224.1523; Sacks FM, 2002, AM J MED, V113, P13, DOI 10.1016/S0002-9343(01)00987-1; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Smith-Warner SA, 1998, JAMA-J AM MED ASSOC, V279, P535, DOI 10.1001/jama.279.7.535; Spiegelman D, 2007, CANCER CAUSE CONTROL, V18, P571, DOI 10.1007/s10552-006-0090-y; Stampfer MJ, 2000, NEW ENGL J MED, V343, P16, DOI 10.1056/NEJM200007063430103; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; VANDERWILK EA, 2008, PREVALENCE OVERWEIGH; Vineis P, 2004, JNCI-J NATL CANCER I, V96, P99, DOI 10.1093/jnci/djh014; WACHOLDER S, 1994, AM J EPIDEMIOL, V140, P303, DOI 10.1093/oxfordjournals.aje.a117252; Wannamethee SG, 1998, ARCH INTERN MED, V158, P2433, DOI 10.1001/archinte.158.22.2433; Willett WC, 1998, OXFORD SCHOLARSHIP O; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; World Health Organization, 1997, WHO PUBL, VWHO/NUT/NCD/98.1	42	91	93	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1440	10.1136/bmj.a1440	http://dx.doi.org/10.1136/bmj.a1440			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18796495	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000259797600040
J	O'Neil, J; Carlson, RW; Francis, D; Stevenson, RK				O'Neil, Jonathan; Carlson, Richard W.; Francis, Don; Stevenson, Ross K.			Neodymium-142 evidence for hadean mafic crust	SCIENCE			English	Article							EARTHS MANTLE; EARLY DIFFERENTIATION; CONTINENTAL-CRUST; ISOTOPIC EVIDENCE; DEPLETED MANTLE; CONSTRAINTS; ROCKS	Neodymium-142 data for rocks from the Nuvvuagittuq greenstone belt in northern Quebec, Canada, show that some rock types have lower Nd-142/Nd-144 ratios than the terrestrial standard (epsilon Nd-142 = - 0.07 to - 0.15). Within a mafic amphibolite unit, 142Nd/144Nd ratios correlate positively with Sm/Nd ratios and produce a Sm-146-Nd-142 isochron with an age of 4280(-81)(vertical bar) (53) million years. These rocks thus sample incompatible- element- enriched material formed shortly after Earth formation and may represent the oldest preserved crustal section on Earth.	[O'Neil, Jonathan; Francis, Don] McGill Univ, Dept Earth & Planetary Sci, Montreal, PQ H3A 2A7, Canada; [Carlson, Richard W.] Carnegie Inst Washington, Dept Terr Magnetism, Washington, DC 20015 USA; [Stevenson, Ross K.] Univ Quebec, Geotop, Ctr Rech Geochem & Geodynam, Montreal, PQ H3C 3P8, Canada	McGill University; Carnegie Institution for Science; University of Quebec; University of Quebec Montreal	O'Neil, J (corresponding author), McGill Univ, Dept Earth & Planetary Sci, 3450 Univ St, Montreal, PQ H3A 2A7, Canada.	oneil_jo@eps.mcgill.ca		Stevenson, Ross/0000-0002-6704-234X	National Science and Engineering Research Council of Canada (NSERC) Discovery [RGPIN 7977-00]; NSF [EAR-0320589]	National Science and Engineering Research Council of Canada (NSERC) Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF))	This research was supported by National Science and Engineering Research Council of Canada (NSERC) Discovery grants to D. F. (RGPIN 7977-00). We thank the municipality of Inukjuak and the Pituvik Landholding Corporation for permission to work on their territory; J. Mina, M. Carroll, V. Inukpuk Morkill, R. Kasudluak, and J. Williams for their hospitality and support; and M. Horan and T. Mock for analytical support. The Department of Terrestrial Magnetism Thermo-Fisher Scientific Triton (Bremen, Germany) was purchased with partial support from the NSF grant EAR-0320589.	Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; BENNETT VC, 1993, EARTH PLANET SC LETT, V119, P299, DOI 10.1016/0012-821X(93)90140-5; Bennett VC, 2007, SCIENCE, V318, P1907, DOI 10.1126/science.1145928; Bowring SA, 1999, CONTRIB MINERAL PETR, V134, P3, DOI 10.1007/s004100050465; Boyet M, 2003, EARTH PLANET SC LETT, V214, P427, DOI 10.1016/S0012-821X(03)00423-0; Boyet M, 2005, SCIENCE, V309, P576, DOI 10.1126/science.1113634; Boyet M, 2006, EARTH PLANET SC LETT, V250, P254, DOI 10.1016/j.epsl.2006.07.046; Caro G, 2006, GEOCHIM COSMOCHIM AC, V70, P164, DOI 10.1016/j.gca.2005.08.015; Caro G, 2003, NATURE, V423, P428, DOI 10.1038/nature01668; Cates NL, 2007, EARTH PLANET SC LETT, V255, P9, DOI 10.1016/j.epsl.2006.11.034; DAVID J, GEOL SOC AM IN PRESS; GOLDSTEIN SL, 1984, EARTH PLANET SC LETT, V70, P221, DOI 10.1016/0012-821X(84)90007-4; LUGMAIR GW, 1992, GEOCHIM COSMOCHIM AC, V56, P1673, DOI 10.1016/0016-7037(92)90234-A; MCCULLOCH MT, 1994, GEOCHIM COSMOCHIM AC, V58, P4717, DOI 10.1016/0016-7037(94)90203-8; MCCULLOCH MT, 1998, GEOCHIM COSMOCHIM AC, P127; O'Neil J, 2007, DEV PREC G, V15, P219, DOI 10.1016/S0166-2635(07)15034-9; Simard M., 2003, 200210 RG MIN RESS N; Wilde SA, 2001, NATURE, V409, P175, DOI 10.1038/35051550	18	247	249	2	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1828	1831		10.1126/science.1161925	http://dx.doi.org/10.1126/science.1161925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818357				2022-12-28	WOS:000259501300036
J	Stamler, J; Neaton, JD				Stamler, Jeremiah; Neaton, James D.			The Multiple Risk Factor Intervention Trial (MRFIT) - Importance then and now	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-PRESSURE; SERUM-LIPIDS; CHOLESTEROL; METAANALYSIS; FAT		[Stamler, Jeremiah] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Neaton, James D.] Univ Minnesota, Sch Publ Hlth, Dept Biostat, Minneapolis, MN USA	Northwestern University; Feinberg School of Medicine; University of Minnesota System; University of Minnesota Twin Cities	Stamler, J (corresponding author), Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, 680 N Lake Shore Dr,Ste 1102-D335, Chicago, IL 60611 USA.	j-stamler@northwestern.edu			NHLBI NIH HHS [R01-HL68140] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068140] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ackerknecht Erwin, 1953, R VIRCHOW DOCTOR STA; Anitschkow N.N., 1933, ARTERIOSCLEROSIS, P271; Appel LJ, 2005, JAMA-J AM MED ASSOC, V294, P2455, DOI 10.1001/jama.294.19.2455; Clarke R, 1997, BRIT MED J, V314, P112, DOI 10.1136/bmj.314.7074.112; *EXP PAN DET EV TR, 1988, ARCH INTERN MED, V148, P66; *EXP PAN POP STRAT, 1990, NIH PUBL US DEP HHS; *FOOD NUTR BOARD, 2005, FOOD NUTR BOARD DIET, P542; HEGSTED DM, 1993, AM J CLIN NUTR, V57, P875, DOI 10.1093/ajcn/57.6.875; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STAMLER J, 1986, JAMA-J AM MED ASSOC, V256, P2823, DOI 10.1001/jama.256.20.2823; STAMLER J, 2006, PEDIAT PREVENTION AT, P27; STAMLER J, 2005, CORONARY HEART DIS E, P32; Stamler J, 2007, ARCH INTERN MED, V167, P537, DOI 10.1001/archinte.167.6.537	14	50	52	0	7	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1343	1345		10.1001/jama.300.11.1343	http://dx.doi.org/10.1001/jama.300.11.1343			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799447				2022-12-28	WOS:000259231100030
J	Kutner, JS; Smith, MC; Corbin, L; Hemphill, L; Benton, K; Mellis, BK; Beaty, B; Felton, S; Yamashita, TE; Bryant, LL; Fairclough, DL				Kutner, Jean S.; Smith, Marlaine C.; Corbin, Lisa; Hemphill, Linnea; Benton, Kathryn; Mellis, B. Karen; Beaty, Brenda; Felton, Sue; Yamashita, Traci E.; Bryant, Lucinda L.; Fairclough, Diane L.			Massage therapy versus simple touch to improve pain and mood in patients with advanced cancer	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; SYMPTOM ASSESSMENT SCALE; AROMATHERAPY MASSAGE; END; CARE; MANAGEMENT; VALIDITY; TRIALS; COMPLEMENTARY; QUESTIONNAIRE	Background: Small studies of variable quality suggest that massage therapy may relieve pain and other symptoms. Objective: To evaluate the efficacy of massage for decreasing pain and symptom distress and improving quality of life among persons with advanced cancer. Design: Multisite, randomized clinical trial. Setting: Population-based Palliative Care Research Network. Patients: 380 adults with advanced cancer who were experiencing moderate-to-severe pain; 90% were enrolled in hospice. Intervention: Six 30-minute massage or simple-touch sessions over 2 weeks. Measurements: Primary outcomes were immediate ( Memorial Pain Assessment Card, 0- to 10-point scale) and sustained ( Brief Pain Inventory [BPI], 0- to 10-point scale) change in pain. Secondary outcomes were immediate change in mood (Memorial Pain Assessment Card) and 60-second heart and respiratory rates and sustained change in quality of life ( McGill Quality of Life Questionnaire, 0- to 10-point scale), symptom distress (Memorial Symptom Assessment Scale, 0- to 4-point scale), and analgesic medication use (parenteral morphine equivalents [mg/d]). Immediate outcomes were obtained just before and after each treatment session. Sustained outcomes were obtained at baseline and weekly for 3 weeks. Results: 298 persons were included in the immediate outcome analysis and 348 in the sustained outcome analysis. A total of 82 persons did not receive any allocated study treatments ( 37 massage patients, 45 control participants). Both groups demonstrated immediate improvement in pain (massage, -1.87 points [95% CI, -2.07 to -1.67 points]; control, -0.97 point [CI, -1.18 to -0.76 points]) and mood (massage, 1.58 points [CI, 1.40 to 1.76 points]; control, 0.97 point [CI, 0.78 to 1.16 points]). Massage was superior for both immediate pain and mood (mean difference, 0.90 and 0.61 points, respectively; P < 0.001). No between-group mean differences occurred over time in sustained pain (BPI mean pain, 0.07 point [CI, -0.23 to 0.37 points]; BPI worst pain, -0.14 point CI, -0.59 to 0.31 points]), quality of life (McGill Quality of Life Questionnaire overall, 0.08 point [CI, -0.37 to 0.53 points]), symptom distress (Memorial Symptom Assessment Scale global distress index, -0.002 point [CI, -0.12 to 0.12 points]), or analgesic medication use (parenteral morphine equivalents, -0.10 mg/d [CI, -0.25 to 0.05 mg/d]). Limitations: The immediate outcome measures were obtained by unblinded study therapists, possibly leading to reporting bias and the overestimation of a beneficial effect. The generalizability to all patients with advanced cancer is uncertain. The differential beneficial effect of massage therapy over simple touch is not conclusive without a usual care control group. Conclusion: Massage may have immediately beneficial effects on pain and mood among patients with advanced cancer. Given the lack of sustained effects and the observed improvements in both study groups, the potential benefits of attention and simple touch should also be considered in this patient population.	Univ Colorado, Sch Med, Coll Nursing, Denver, CO 80202 USA; Univ Colorado, Sch Publ Hlth, Denver, CO 80202 USA; [Kutner, Jean S.] Univ Colorado Denver, Div Gen Internal Med, Sch Med, Coll Nursing, Aurora, CO 80045 USA; Univ Colorado Denver, Sch Publ Hlth, Aurora, CO 80045 USA; Florida Atlantic Univ, Boca Raton, FL 33431 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Colorado School of Public Health; University of Colorado System; University of Colorado Denver; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; Florida Atlantic University	Kutner, JS (corresponding author), Univ Colorado Denver, Div Gen Internal Med, Sch Med, Coll Nursing, B180,POB 6511,Acad Off 1, Aurora, CO 80045 USA.	jean.kutner@ucdenver.edu; diane.fairclough@ucdenver.edu			the National Institutes of Health; National Center for Complementary and Alternative Medicine [1R01AT0100601A2]; Mendel/Asarch Lung Cancer Family Foundation; Paul Beeson Physician Faculty Scholars; Robert Wood Johnson Generalist Physician Faculty Scholars Program; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT001006] Funding Source: NIH RePORTER	the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Complementary and Alternative Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); Mendel/Asarch Lung Cancer Family Foundation; Paul Beeson Physician Faculty Scholars; Robert Wood Johnson Generalist Physician Faculty Scholars Program(Robert Wood Johnson Foundation (RWJF)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	By the National Institutes of Health and National Center for Complementary and Alternative Medicine (1R01AT0100601A2), Mendel/Asarch Lung Cancer Family Foundation Grants Program, Paul Beeson Physician Faculty Scholars in Aging Research Award, and Robert Wood Johnson Generalist Physician Faculty Scholars Program (Dr. Kutner).	Ahmedzai S, 1997, J PAIN SYMPTOM MANAG, V13, P254, DOI 10.1016/S0885-3924(97)00082-1; *AM MESS THER ASS, 2008, GLOSS MESS TERMS; Billhult A, 2001, CANCER NURS, V24, P180, DOI 10.1097/00002820-200106000-00003; Billhult Annika, 2007, Clin Nurs Res, V16, P85, DOI 10.1177/1054773806298488; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; BRUERA E, 1998, OXFORD TXB PALLIATIV, P179; Buss Mary Kathleen, 2004, J Palliat Med, V7, P405, DOI 10.1089/1096621041349437; Casarett David J, 2002, J Palliat Med, V5, P397, DOI 10.1089/109662102320135289; Cassileth BR, 2004, J PAIN SYMPTOM MANAG, V28, P244, DOI 10.1016/j.jpainsymman.2003.12.016; Chang Victor T, 2004, Expert Rev Pharmacoecon Outcomes Res, V4, P171, DOI 10.1586/14737167.4.2.171; Chang VT, 1998, CANCER, V83, P173, DOI 10.1002/(SICI)1097-0142(19980701)83:1<173::AID-CNCR23>3.0.CO;2-T; Chang VT, 2004, CANCER INVEST, V22, P526, DOI 10.1081/CNV-200026487; Chang VT, 2000, CANCER, V89, P1162, DOI 10.1002/1097-0142(20000901)89:5<1162::AID-CNCR26>3.0.CO;2-Y; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Cohen SR, 2001, PALLIATIVE MED, V15, P363, DOI 10.1191/026921601680419401; Cohen SR, 1997, PALLIATIVE MED, V11, P3; Cohen SR, 2000, CANCER-AM CANCER SOC, V89, P1854, DOI 10.1002/1097-0142(20001015)89:8<1854::AID-CNCR28>3.0.CO;2-C; *COMM CAR END LIF, 1997, APPR DEATH IMPR CAR; Diehr P, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-51; Du Pen SL, 1999, J CLIN ONCOL, V17, P361, DOI 10.1200/JCO.1999.17.1.361; Elliott BA, 1996, J PAIN SYMPTOM MANAG, V12, P209, DOI 10.1016/0885-3924(96)00124-8; Ernst E, 2000, BRIT MED J, V320, P513, DOI 10.1136/bmj.320.7233.513; EVANS C, 1985, LANCET, V1, P1204; Fellowes, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002287, DOI 10.1002/14651858.CD002287.PUB2]; FERRELLTORRY AT, 1993, CANCER NURS, V16, P93; Field TM, 1998, AM PSYCHOL, V53, P1270, DOI 10.1037/0003-066X.53.12.1270; FISHMAN B, 1987, CANCER-AM CANCER SOC, V60, P1151, DOI 10.1002/1097-0142(19870901)60:5<1151::AID-CNCR2820600538>3.0.CO;2-G; Fitzmaurice GM, 2001, STAT MED, V20, P1009, DOI 10.1002/sim.718; Galer BS, 1997, NEUROLOGY, V48, P332, DOI 10.1212/WNL.48.2.332; Goldstone L A, 2000, Complement Ther Nurs Midwifery, V6, P169, DOI 10.1054/ctnm.2000.0493; Hernandez-Reif M, 2004, J PSYCHOSOM RES, V57, P45, DOI 10.1016/S0022-3999(03)00500-2; Hwang SS, 2004, CANCER INVEST, V22, P678, DOI 10.1081/CNV-200032911; INGHAM J, 1998, OXFORD TXB PALLIATIV, P203; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; KELLER E, 1986, NURS RES, V35, P101; Kelly AM, 2001, EMERG MED J, V18, P205, DOI 10.1136/emj.18.3.205; Kutner Jean S, 2003, Palliat Support Care, V1, P231; Kutner JS, 2007, J PAIN SYMPTOM MANAG, V34, P227, DOI 10.1016/j.jpainsymman.2006.11.016; Kutner Jean S, 2005, Cancer Control, V12, P186; Kutner JS, 2001, J PAIN SYMPTOM MANAG, V21, P473, DOI 10.1016/S0885-3924(01)00281-0; Longworth J C, 1982, ANS Adv Nurs Sci, V4, P44; McMillan SC, 2000, CANCER NURS, V23, P327, DOI 10.1097/00002820-200010000-00001; Miller MG, 1999, J PAIN SYMPTOM MANAG, V18, P9, DOI 10.1016/S0885-3924(99)00036-6; Myers Cynthia D, 2008, J Soc Integr Oncol, V6, P19; Nelson JP, 2006, J HOLIST NURS, V24, P152, DOI 10.1177/0898010105282524; *NIH, 2004, NAT I HLTH STAT OF T; Owens M K, 1991, Holist Nurs Pract, V6, P24; Pan CX, 2000, J PAIN SYMPTOM MANAG, V20, P374, DOI 10.1016/S0885-3924(00)00190-1; Philip J, 1998, SUPPORT CARE CANCER, V6, P539, DOI 10.1007/s005200050212; PORTENOY RK, 1994, EUR J CANCER, V30A, P1326, DOI 10.1016/0959-8049(94)90182-1; PORTENOY RK, 1994, QUAL LIFE RES, V3, P183, DOI 10.1007/BF00435383; Portenoy RK, 1999, PAIN, V81, P129, DOI 10.1016/S0304-3959(99)00006-8; Post-White Janice, 2003, Integr Cancer Ther, V2, P332, DOI 10.1177/1534735403259064; Quinn J F, 1984, ANS Adv Nurs Sci, V6, P42; Richards K C, 2000, AACN Clin Issues, V11, P77, DOI 10.1097/00044067-200002000-00010; Sagar SM, 2008, CURR ONCOL, V15, P42, DOI 10.3747/co.2008.197; SERLIN RC, 1995, PAIN, V61, P277, DOI 10.1016/0304-3959(94)00178-H; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Smith Marlaine, 2007, J Soc Integr Oncol, V5, P139, DOI 10.2310/7200.2007.014; Soden K, 2004, PALLIATIVE MED, V18, P87, DOI 10.1191/0269216304pm874oa; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Twycross R, 1996, J PAIN SYMPTOM MANAG, V12, P273, DOI 10.1016/S0885-3924(96)00149-2; Westcombe AM, 2003, PALLIATIVE MED, V17, P300, DOI 10.1191/0269216303pm769rr; *WHO EXP COMM, 1990, CANC PAIN REL PALL C; Wilkie D J, 2000, Hosp J, V15, P31	66	143	148	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					369	W72		10.7326/0003-4819-149-6-200809160-00003	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00003			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	348SM	18794556	Green Accepted			2022-12-28	WOS:000259230200001
J	Power, C; Rasko, JEJ				Power, Carl; Rasko, John E. J.			Whither prometheus' liver? Greek myth and the science of regeneration	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								Stem-cell biologists and those involved in regenerative medicine are fascinated by the story of Prometheus, the Greek god whose immortal liver was feasted on day after day by Zeus' eagle. This myth invariably provokes the question: Did the ancient Greeks know about the liver's amazing capacity for self-repair? The authors address this question by exploring the origins of Greek myth and medicine, adopting a 2-fold strategy. First, the authors consider what opportunities the ancient Greeks had to learn about the liver's structure and function. This involves a discussion of early battlefield surgery, the beginnings of anatomical research, and the ancient art of liver augury. In addition, the authors consider how the Greeks understood Prometheus' immortal liver. Not only do the authors examine the general theme of regeneration in Greek mythology, they survey several scholarly interpretations of Prometheus' torture.	[Rasko, John E. J.] Univ Sydney, Centenary Inst, Newtown, NSW 2042, Australia; Royal Prince Alfred Hosp, Sydney, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney	Rasko, JEJ (corresponding author), Univ Sydney, Centenary Inst, Locked Bag 6, Newtown, NSW 2042, Australia.	j.rasko@cenint.org	Rasko, John EJ/F-5754-2013	rasko, John/0000-0003-2975-807X				AESCHYLUS, 1952, COMPLETE PLAYS AESCH, P43; ALLEN DS, 2000, WORLD PROMETHEUS POL, P33; ANDRAL G, 1843, MED CLIN, V1, P345; ARISTOTLE, 1965, HIST ANIMALIUM, V1, P57; AURELIANUS C, 1950, ACUTE DIS CHRONIC DI, P752; BURKERT W, 1992, ORIENTALIZING REVOLU, P46; CALDWELL RS, 1987, HESIODS THEOGONY, P58; CHEN TSN, 1994, J ROY SOC MED, V87, P754; CRUVEILHIER LJB, 1829, ANATOMIE PATHOLOGIQU, V33, P398; EDMUNDS L, 1990, APPROACHES GREEK MYT, P141; FULGENTIUS FP, 1971, FULGENTIUS MYTHOGRAP, P71; Gluck T, 1883, ARCH KLIN CHIR, V29, P139; Goss Richard J., 1991, P7; HOMER, 2003, ODYSSEY, P154; Homer, 1999, ILIAD; JASTROW M, 1907, T COLL PHYS PHILA, V29, P117; Koniaris LG, 2003, J AM COLL SURGEONS, V197, P634, DOI 10.1016/S1072-7515(03)00374-0; KORNER O, 1922, MUNCHEN MED WCHNSHCR, V69, P1484; LONGRIGG J, 1993, GREEK RATIONAL MED P, P184; LONGRIGG J, 1998, GREEK MED HEROIC HEL, P176; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Milne LS, 1909, J PATHOL BACTERIOL, V13, P127, DOI 10.1002/path.1700130121; PENGLASE C, 1994, GREEK MYTHS MESOPOTA, P197; Pistoi S, 1996, FASEB J, V10, P819, DOI 10.1096/fasebj.10.8.8666158; PONFICK E, 1889, VIRCHOWS ARCH PATH A, V118, P209; PRIORESCHI P, 1996, HIST MED, V1, P38; Reuben A, 2004, HEPATOLOGY, V39, P1460, DOI 10.1002/hep.20227; Richardson N. J., 1985, GREEK RELIG SOC, P50; Rosenthal N, 2003, NEW ENGL J MED, V349, P267, DOI 10.1056/NEJMra020849; SALAZAR CF, 2000, TREATMENT WAR WOUNDS, P20; Saunders KB, 1999, CLASSICAL QUART, V49, P345, DOI 10.1093/cq/49.2.345; Schneider MD, 2004, NATURE, V432, P451, DOI 10.1038/432451a; Spyridonidis A, 2005, STEM CELL REV, V1, P37, DOI 10.1385/SCR:1:1:037; TILLMANNS H, 1879, VIRCHOWS ARCH, V78, P437; van Gend D, 2006, HUM LIFE REV, V32, P15; Vernant J. P., 1989, CUISINE SACRIFICE GR, P21; Vernant Jean-Pierre, 1991, MORTALS IMMORTALS CO, P27; VONMEISTER E, 1994, BEITR PATHOL ANAT, V15, P1; VONSTADEN H, 1989, HEROPHILUS ART MED E, P162; West M. L., 1966, HESIOD THEOGONY; West Stephanie, 1994, MUSEUM HELVETICUM, V51, P129; 1931, HIPPOCRATES, P203	42	22	22	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					421	W79		10.7326/0003-4819-149-6-200809160-00009	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00009			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794562				2022-12-28	WOS:000259230200007
J	Beaglehole, R; Epping-Jordan, J; Patel, V; Chopra, M; Ebrahim, S; Kidd, M; Haines, A				Beaglehole, Robert; Epping-Jordan, JoAnne; Patel, Vikram; Chopra, Mickey; Ebrahim, Shah; Kidd, Michael; Haines, Andy			Alma-Ata: Rebirth and revision 3 - Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care	LANCET			English	Review							COMMON MENTAL-DISORDERS; CARDIOVASCULAR-DISEASE; COST-EFFECTIVENESS; MAINTENANCE ORGANIZATION; ANTIRETROVIRAL TREATMENT; PSYCHIATRIC KNOWLEDGE; DIABETES PREVENTION; INTEGRATED CARE; HUMAN-RESOURCES; DEPRESSION	The burden of chronic diseases, such as heart disease, cancer, diabetes, and mental disorders is high in low-income and middle-income countries and is predicted to increase with the ageing of populations, urbanisation, and globalisation of risk factors. Furthermore, HIV/AIDS is increasingly becoming a chronic disorder. An integrated approach to the management of chronic diseases, irrespective of cause, is needed in primary health care. Management of chronic diseases is fundamentally different from acute care, relying on several features: opportunistic case finding for assessment of risk factors, detection of early disease, and identification of high risk status; a combination of pharmacological and psychosocial interventions, often in a stepped-care fashion; and long-term follow-up with regular monitoring and promotion of adherence to treatment. To meet the challenge of chronic diseases, primary health care will have to be strengthened substantially. In the many countries with shortages of primary-care doctors, non-physician clinicians will have a leading role in preventing and managing chronic diseases, and these personnel need appropriate training and continuous quality assurance mechanisms. More evidence is needed about the cost-effectiveness of prevention and treatment strategies in primary health care. Research on scaling-up should be embedded in large-scale delivery programmes for chronic diseases with a strong emphasis on assessment.	[Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand; [Patel, Vikram; Ebrahim, Shah; Haines, Andy] London Sch Hyg & Trop Med, London WC1, England; [Chopra, Mickey] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Kidd, Michael] Univ Sydney, Dept Gen Practice, Sydney, NSW 2006, Australia	University of Auckland	Beaglehole, R (corresponding author), 42 Albert Rd, N Shore City 0624, New Zealand.	r.beaglehole@auckland.ac.nz		Patel, Vikram/0000-0003-1066-8584; Haines, Andy/0000-0002-8053-4605	Wellcome Trust Senior Clinical Research Fellowship	Wellcome Trust Senior Clinical Research Fellowship(Wellcome Trust)	We thank Donna Bowers for help with references. VP is supported by a Wellcome Trust Senior Clinical Research Fellowship.	Abegunde DO, 2007, B WORLD HEALTH ORGAN, V85, P432, DOI 10.2471/BLT.06.032177; [Anonymous], 2007, LANCET; [Anonymous], INT DRUG PRIC IND GU; [Anonymous], 2005, PREV CHRON DIS VIT I; Anyangwe Stella C E, 2007, Int J Environ Res Public Health, V4, P93, DOI 10.3390/ijerph2007040002; Araya R, 2006, AM J PSYCHIAT, V163, P1379, DOI 10.1176/appi.ajp.163.8.1379; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Aubert RE, 1998, ANN INTERN MED, V129, P605, DOI 10.7326/0003-4819-129-8-199810150-00004; BABOR TF, 1994, ADDICTION, V89, P657, DOI 10.1111/j.1360-0443.1994.tb00944.x; Beaglehole R, 2007, LANCET, V370, P2152, DOI 10.1016/S0140-6736(07)61700-0; Berwick DM, 2004, BRIT MED J, V328, P1124, DOI 10.1136/bmj.328.7448.1124; Bodenheimer T, 2002, JAMA-J AM MED ASSOC, V288, P1909, DOI 10.1001/jama.288.15.1909; Bower P, 2006, BRIT J PSYCHIAT, V189, P484, DOI 10.1192/bjp.bp.106.023655; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brownstein JN, 2007, AM J PREV MED, V32, P435, DOI 10.1016/j.amepre.2007.01.011; Chatterjee S, 2008, WORLD PSYCHIATRY, V7, P39; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chisholm D, 2007, BRIT J PSYCHIAT, V191, P528, DOI 10.1192/bjp.bp.107.038463; Coleman R, 1998, B WORLD HEALTH ORGAN, V76, P633; Collins PY, 2006, AIDS, V20, P1571, DOI 10.1097/01.aids.0000238402.70379.d4; Croudace T, 2003, BRIT J PSYCHIAT, V182, P20, DOI 10.1192/bjp.182.1.20; Davis RM, 2000, BRIT MED J, V320, P525, DOI 10.1136/bmj.320.7234.525; Deakin T, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003417.pub2; EBRAHIM S, 1996, HLTH PROMOTION OLDER; Ebrahim S, 2008, INT J EPIDEMIOL, V37, P225, DOI 10.1093/ije/dyn016; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Feachem RGA, 2002, BMJ-BRIT MED J, V324, P135, DOI 10.1136/bmj.324.7330.135; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Foster G, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD005108.PUB2; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Funk M, 2004, INT J MENT HLTH, V33, P4, DOI DOI 10.1080/00207411.2004.11043367; Gaziano TA, 2008, LANCET, V371, P923, DOI 10.1016/S0140-6736(08)60418-3; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Gilbody S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002792.pub2; Gilbody S, 2003, JAMA-J AM MED ASSOC, V289, P3145, DOI 10.1001/jama.289.23.3145; Gilbody S, 2006, BRIT J PSYCHIAT, V189, P297, DOI 10.1192/bjp.bp.105.016006; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Glasgow RE, 2004, AM J PREV MED, V27, P88, DOI 10.1016/j.amepre.2004.04.019; Global Health Workforce Alliance, HLTH WORK ALL ALL HL; Gureje O, 2007, WORLD PSYCHIATRY, V6, P42; Harries AD, 2006, LANCET, V367, P1870, DOI 10.1016/S0140-6736(06)68809-0; Harries AD, 2008, PLOS MED, V5, P859, DOI 10.1371/journal.pmed.0050124; Henderson DC, 2005, J NERV MENT DIS, V193, P551, DOI 10.1097/01.nmd.0000172869.01711.33; Hodges B, 2001, AM J PSYCHIAT, V158, P1579, DOI 10.1176/appi.ajp.158.10.1579; Improving Chronic Illness Care, ICIC OUR WORK; *INT DIAB FED, 2007, DIAB ATL; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Jha P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P869; *JOINT UN PROGR HI, 2003, STIGMA DISCRIMINATIO; KANER EFS, 2008, COCHRANE DB SYST REV, V2, P4148; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kripalani S, 2007, ARCH INTERN MED, V167, P540, DOI 10.1001/archinte.167.6.540; Li GW, 2008, LANCET, V371, P1783, DOI 10.1016/S0140-6736(08)60766-7; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lorig KR, 2001, MED CARE, V39, P1217, DOI 10.1097/00005650-200111000-00008; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; Nash D, 2008, 15 C RETR OPP INF BO; National Health Priority Action Council, 2006, NAT CHRON DIS STRAT; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Norris SL, 2001, DIABETES CARE, V24, P561, DOI 10.2337/diacare.24.3.561; Ouwens M, 2005, INT J QUAL HEALTH C, V17, P141, DOI 10.1093/intqhc/mzi016; Pan American Health Organization, 2007, VER PROJ IMPR DIAB C; Patel V, 2008, PSYCHOL MED, V38, P221, DOI 10.1017/S0033291707002334; Patel V, 2003, LANCET, V361, P33, DOI 10.1016/S0140-6736(03)12119-8; Patel V., 2003, WHERE THERE IS NO PS; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Patel VH, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-4; Pruitt SD, 2005, BMJ-BRIT MED J, V330, P637, DOI 10.1136/bmj.330.7492.637; Qureshi NA, 2006, EDUC HEALTH, V19, P52, DOI 10.1080/13576280500525527; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Renders CM, 2001, DIABETES CARE, V24, P1821, DOI 10.2337/diacare.24.10.1821; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rueda S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001442.pub2; Sadur CN, 1999, DIABETES CARE, V22, P2011, DOI 10.2337/diacare.22.12.2011; Samb B, 2007, NEW ENGL J MED, V357, P2510, DOI 10.1056/NEJMsb071889; Saraceno B, 2007, LANCET, V370, P1164, DOI 10.1016/S0140-6736(07)61263-X; *SCOTT GOV, PARTN CAR SCOTL HLTH; Simon GE, 1999, GEN HOSP PSYCHIAT, V21, P97, DOI 10.1016/S0163-8343(98)00072-3; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P328, DOI 10.1016/S0163-8343(02)00201-3; Simon GE, 2002, GEN HOSP PSYCHIAT, V24, P213, DOI 10.1016/S0163-8343(02)00198-6; Singh D, 2006, IMPROVING CARE PEOPL; Smith SM, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004910.PUB2; Stead LF, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000165.pub3; Stead L. F., 2008, COCHRANE DATABASE SY, V1; Strong K, 2005, LANCET, V366, P1578, DOI 10.1016/S0140-6736(05)67341-2; Thompson C, 2000, LANCET, V355, P185, DOI 10.1016/S0140-6736(99)03171-2; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; Tsai AC, 2005, AM J MANAG CARE, V11, P478; UK Department of Health, 2001, EXP PAT NEW APPR CHR; Vergouwen ACM, 2003, J CLIN PSYCHIAT, V64, P1415, DOI 10.4088/JCP.v64n1203; Von Korff M, 2002, BRIT MED J, V325, P92, DOI 10.1136/bmj.325.7355.92; Wagner E H, 1999, Manag Care Q, V7, P56; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419; *WHO, 2004, INT MAN AD ILLN EXT; WHO, 2001, WORLD HLTH REPORT 20; *WHO, 2005, PREP WORKF 21 CENT C; WHO WONCA, 2008, INT MENT HLTH PRIM C; Wilson IB, 2005, ANN INTERN MED, V143, P729, DOI 10.7326/0003-4819-143-10-200511150-00010; World Health Organization, 1995, MENT ILLN GEN HLTH C; World Health Organization, 1998, MENT DIS PRIM CAR WH; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	106	367	376	5	63	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					940	949		10.1016/S0140-6736(08)61404-X	http://dx.doi.org/10.1016/S0140-6736(08)61404-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790317				2022-12-28	WOS:000259266900034
J	Hochberg, LR				Hochberg, Leigh R.			Turning thought into action	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CORTICAL CONTROL; DEVICES; ARM		[Hochberg, Leigh R.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Hochberg, Leigh R.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hochberg, Leigh R.] Dept Vet Affairs Rehabil Res & Dev Serv, Providence, RI USA; [Hochberg, Leigh R.] Brown Univ, Providence, RI 02912 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Brown University	Hochberg, LR (corresponding author), Massachusetts Gen Hosp, Boston, MA 02114 USA.		Hochberg, Leigh/R-6872-2019	Hochberg, Leigh/0000-0003-0261-2273				GEORGOPOULOS AP, 1982, J NEUROSCI, V2, P1527; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; HUMPHREY DR, 1970, SCIENCE, V170, P758, DOI 10.1126/science.170.3959.758; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996	6	12	13	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1175	1177		10.1056/NEJMcibr0805122	http://dx.doi.org/10.1056/NEJMcibr0805122			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346ON	18784110				2022-12-28	WOS:000259078200016
J	Luyssaert, S; Schulze, ED; Borner, A; Knohl, A; Hessenmoller, D; Law, BE; Ciais, P; Grace, J				Luyssaert, Sebastiaan; Schulze, E. -Detlef; Boerner, Annett; Knohl, Alexander; Hessenmoeller, Dominik; Law, Beverly E.; Ciais, Philippe; Grace, John			Old-growth forests as global carbon sinks	NATURE			English	Article							NET PRIMARY PRODUCTION; STORAGE; BOREAL; TEMPERATE; EXCHANGE; DIOXIDE; DECLINE; BIOMASS; FLUXES; PINE	Old- growth forests remove carbon dioxide from the atmosphere(1,2) at rates that vary with climate and nitrogen deposition(3). The sequestered carbon dioxide is stored in live woody tissues and slowly decomposing organic matter in litter and soil(4). Old- growth forests therefore serve as a global carbon dioxide sink, but they are not protected by international treaties, because it is generally thought that ageing forests cease to accumulate carbon(5,6). Here we report a search of literature and databases for forest carbon- flux estimates. We find that in forests between 15 and 800 years of age, net ecosystem productivity ( the net carbon balance of the forest including soils) is usually positive. Our results demonstrate that old- growth forests can continue to accumulate carbon, contrary to the long-standing view that they are carbon neutral. Over 30 per cent of the global forest area is unmanaged primary forest, and this area contains the remaining old- growth forests(7). Half of the primary forests (6 x 10(8) hectares) are located in the boreal and temperate regions of the Northern Hemisphere. On the basis of our analysis, these forests alone sequester about 1.3 +/- 0.5 gigatonnes of carbon per year. Thus, our findings suggest that 15 per cent of the global forest area, which is currently not considered when offsetting increasing atmospheric carbon dioxide concentrations, provides at least 10 per cent of the global net ecosystem productivity(8). Old- growth forests accumulate carbon for centuries and contain large quantities of it. We expect, however, that much of this carbon, even soil carbon(9), will move back to the atmosphere if these forests are disturbed.	[Luyssaert, Sebastiaan] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Luyssaert, Sebastiaan; Law, Beverly E.] Oregon State Univ, Coll Forestry, Corvallis, OR 97331 USA; [Schulze, E. -Detlef; Boerner, Annett; Hessenmoeller, Dominik] Max Planck Inst Biogeochem, D-07701 Jena, Germany; [Knohl, Alexander] ETH, Inst Plant Sci, CH-8092 Zurich, Switzerland; [Ciais, Philippe] CEA CNRS UVSQ, IPSL LSCE, Lab Sci Climat & Environm, F-91191 Gif Sur Yvette, France; [Grace, John] Univ Edinburgh, Sch Geosci, Edinburgh EH9 3JN, Midlothian, Scotland	University of Antwerp; Oregon State University; Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); University of Edinburgh	Luyssaert, S (corresponding author), Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium.	sebastiaan.luyssaert@ua.ac.be	Knohl, Alexander/F-9453-2014; Grace, John/N-9280-2013; Schulze, Ernst-Detlef/K-9627-2014; Law, Beverly Elizabeth/G-3882-2010; Ciais, Philippe/A-6840-2011; Luyssaert, Sebastiaan/F-6684-2011	Knohl, Alexander/0000-0002-7615-8870; Law, Beverly Elizabeth/0000-0002-1605-1203; Ciais, Philippe/0000-0001-8560-4943; Luyssaert, Sebastiaan/0000-0003-1121-1869	CoE ECO UA-Methusalem and the Research Foundation - Flanders (FWO-Vlaanderen); European Union with a Marie Curie fellowship; North American Carbon Program project ORCA; US Department of Energy, Terrestrial Carbon Program [DE-FG02-04ER63917]; DFG-Exploratories.; CarboEuropeIP [GOCE-CT-2003-505572]; Ameriflux; NERC [earth010003] Funding Source: UKRI; Natural Environment Research Council [earth010003] Funding Source: researchfish	CoE ECO UA-Methusalem and the Research Foundation - Flanders (FWO-Vlaanderen)(FWO); European Union with a Marie Curie fellowship(European Commission); North American Carbon Program project ORCA; US Department of Energy, Terrestrial Carbon Program(United States Department of Energy (DOE)); DFG-Exploratories.(German Research Foundation (DFG)); CarboEuropeIP(European Commission); Ameriflux; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all site investigators, their funding agencies and the various regional flux networks (Afriflux, AmeriFlux, AsiaFlux, CarboAfrica, CarboEuropeIP, ChinaFlux, Fluxnet-Canada, KoFlux, LBA, NECC, OzFlux, TCOS-Siberia and USCCC), and the Fluxnet project, whose support was essential for obtaining our measurements. S. L. was supported by CoE ECO UA-Methusalem and the Research Foundation - Flanders (FWO-Vlaanderen) with a post-doctoral fellowship and a research grant. A. K. was supported by the European Union with a Marie Curie fellowship, and B. E. L. was supported by the regional North American Carbon Program project ORCA ( US Department of Energy, Terrestrial Carbon Program, award number DE-FG02-04ER63917). E.-D.S. was supported by DFG-Exploratories. Additional funding for this study was received from CarboEuropeIP (project number GOCE-CT-2003-505572) and Ameriflux.	Acker SA, 2002, TREE PHYSIOL, V22, P213, DOI 10.1093/treephys/22.2-3.213; Binkley D, 2002, ECOSYSTEMS, V5, P58, DOI 10.1007/s10021-001-0055-7; Carey EV, 2001, GLOBAL CHANGE BIOL, V7, P339, DOI 10.1046/j.1365-2486.2001.00418.x; Chapin FS, 2006, ECOSYSTEMS, V9, P1041, DOI 10.1007/s10021-005-0105-7; CIAIS P, 2005, CARBON BALANCE FORES, P109; Ciais P., 2000, IPCC LAND USE LAND U, P23; Desai AR, 2005, AGR FOREST METEOROL, V128, P33, DOI 10.1016/j.agrformet.2004.09.005; *FAO, 2006, 147 FAO UN; Fontaine S, 2007, NATURE, V450, P277, DOI 10.1038/nature06275; Gower ST, 1996, TRENDS ECOL EVOL, V11, P378, DOI 10.1016/0169-5347(96)10042-2; HARMON ME, 1990, SCIENCE, V247, P699, DOI 10.1126/science.247.4943.699; Irvine J, 2007, GLOBAL CHANGE BIOL, V13, P1748, DOI 10.1111/j.1365-2486.2007.01368.x; Janisch JE, 2002, TREE PHYSIOL, V22, P77, DOI 10.1093/treephys/22.2-3.77; Jomura M, 2007, TELLUS B, V59, P211, DOI 10.1111/j.1600-0889.2006.00234.x; KIRA TATUO, 1967, JAP J ECOL, V17, P70; Knohl A, 2003, AGR FOREST METEOROL, V118, P151, DOI 10.1016/S0168-1923(03)00115-1; Knohl A, 2002, GLOBAL CHANGE BIOL, V8, P231, DOI 10.1046/j.1365-2486.2002.00475.x; Kowalski AS, 2004, GLOBAL CHANGE BIOL, V10, P1707, DOI 10.1111/j.1365-2486.2004.00846.x; Law BE, 2003, GLOBAL CHANGE BIOL, V9, P510, DOI 10.1046/j.1365-2486.2003.00624.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Magnani F, 2007, NATURE, V447, P848, DOI 10.1038/nature05847; MLADENOFF DJ, 1993, ECOL APPL, V3, P294, DOI 10.2307/1941832; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Pregitzer KS, 2004, GLOBAL CHANGE BIOL, V10, P2052, DOI 10.1111/j.1365-2486.2004.00866.x; Preston CM, 2006, BIOGEOSCIENCES, V3, P397, DOI 10.5194/bg-3-397-2006; Van Tuyl S, 2005, FOREST ECOL MANAG, V209, P273, DOI 10.1016/j.foreco.2005.02.002; Wirth C, 2002, TELLUS B, V54, P611, DOI 10.1034/j.1600-0889.2002.01343.x; YODA KYOJI, 1963, J BIOL OSAKA CITY UNIV, V14, P107; Zhou GY, 2006, SCIENCE, V314, P1417, DOI 10.1126/science.1130168	29	1060	1152	52	847	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					213	215		10.1038/nature07276	http://dx.doi.org/10.1038/nature07276			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784722	Green Submitted			2022-12-28	WOS:000259090800044
J	Mu, TW; Ong, DST; Wang, YJ; Balch, WE; Yates, JR; Segatori, L; Kelly, JW				Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Balch, William E.; Yates, John R.; Segatori, Laura; Kelly, Jeffery W.			Chemical and biological approaches synergize to ameliorate protein-folding diseases	CELL			English	Article							HEAT-SHOCK RESPONSE; LYSOSOMAL STORAGE DISORDERS; GAUCHER-DISEASE; ENDOPLASMIC-RETICULUM; PROTEASOME INHIBITION; PHARMACOLOGICAL CHAPERONE; MOLECULAR CHAPERONES; ENZYME REPLACEMENT; ER STRESS; GLUCOCEREBROSIDASE	Loss-of-function diseases are often caused by a mutation in a protein traversing the secretory pathway that compromises the normal balance between protein folding, trafficking, and degradation. We demonstrate that the innate cellular protein homeostasis, or proteostasis, capacity can be enhanced to fold mutated enzymes that would otherwise misfold and be degraded, using small molecule proteostasis regulators. Two proteostasis regulators are reported that alter the composition of the proteostasis network in the endoplasmic reticulum through the unfolded protein response, increasing the mutant folded protein concentration that can engage the trafficking machinery, restoring function to two nonhomologous mutant enzymes associated with distinct lysosomal storage diseases. Coapplication of a pharmacologic chaperone and a proteostasis regulator exhibits synergy because of the former's ability to further increase the concentration of trafficking-competent mutant folded enzymes. It may be possible to ameliorate loss-of-function diseases by using proteostasis regulators alone or in combination with a pharmacologic chaperone.	[Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Segatori, Laura; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wang, Ya-Juan; Balch, William E.; Yates, John R.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Balch, William E.] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Mu, Ting-Wei; Ong, Derrick Sek Tong; Wang, Ya-Juan; Segatori, Laura; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Segatori, L (corresponding author), Rice Univ, Dept Chem & Biomol Engn, 6100 Main St,MS-362, Houston, TX 77005 USA.	segatori@rice.edu; jkelly@scripps.edu	Mu, Tingwei/AAU-8596-2020; Longo, Kenneth A/A-5631-2010	Mu, Tingwei/0000-0002-6419-9296; Wang, Yajuan (Megan)/0000-0002-3284-9012	NIH [DK75295]; Skaggs Institute of Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075295] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute of Chemical Biology; Lita Annenberg Hazen Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the reviewers for their insight, Professors Jonathan Weissman and Ernest Beutler for helpful discussions, Professor Evan Powers for the latter and for creating the three-dimensional plots used herein, and Jonathan Zhu for significant help with the figures. This work was supported by the NIH (DK75295), the Skaggs Institute of Chemical Biology, and the Lita Annenberg Hazen Foundation and is dedicated to Ernest Beutler on the occasion of his upcoming 80th birthday. J. W. K. is a founder of, has equity in, and has a paid consulting relationship with two biotechnology companies: FoldRx Pharmaceuticals Inc., which specializes in the development of drug therapies for diseases of protein misfolding and amyloidosis, and Proteostasis Therapeutics Inc., which is focused on understanding the proteostasis network for the development of therapeutics for diseases associated with a loss of proteostasis. Neither company is currently pursuing therapies for lysosomal storage diseases, although this could change in the future.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Awasthi N, 2005, INVEST OPHTH VIS SCI, V46, P2082, DOI 10.1167/iovs.05-0002; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BEUTLER E, 1977, P NATL ACAD SCI USA, V74, P4620, DOI 10.1073/pnas.74.10.4620; Beutler E, 2005, BLOOD CELL MOL DIS, V35, P355, DOI 10.1016/j.bcmd.2005.07.005; Beutler E, 2006, MOL GENET METAB, V88, P208, DOI 10.1016/j.ymgme.2006.01.010; Bouvier M, 2007, CHEM BIOL, V14, P241, DOI 10.1016/j.chembiol.2007.03.004; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brady RO, 2006, ANNU REV MED, V57, P283, DOI 10.1146/annurev.med.57.110104.115650; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Brown CR, 1997, J CLIN INVEST, V99, P1432, DOI 10.1172/JCI119302; Bush KT, 1997, J BIOL CHEM, V272, P9086; Chillaron J, 2000, MOL BIOL CELL, V11, P217, DOI 10.1091/mbc.11.1.217; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; CONZELMANN E, 1984, DEV NEUROSCI-BASEL, V6, P58, DOI 10.1159/000112332; Deuerling E, 2004, CRIT REV BIOCHEM MOL, V39, P261, DOI 10.1080/10409230490892496; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; HORWICH AL, 2004, ENCY BIOL CHEM, V1, P393; Imai J, 2003, CELL CYCLE, V2, P585, DOI 10.4161/cc.2.6.586; JENSEN TJ, 1995, CELL, V83, P129, DOI 10.1016/0092-8674(95)90241-4; Jeyakumar M, 2002, NEUROPATH APPL NEURO, V28, P343, DOI 10.1046/j.1365-2990.2002.00422.x; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Leclerc D, 2008, J BIOL CHEM, V283, P3151, DOI 10.1074/jbc.M708598200; Liao L, 2007, J PROTEOME RES, V6, P1059, DOI 10.1021/pr060358f; Liao W, 2006, J CELL BIOCHEM, V99, P1085, DOI 10.1002/jcb.20996; LINDQUIST S, 1986, ANNU REV BIOCHEM, V55, P1151, DOI 10.1146/annurev.bi.55.070186.005443; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Y, 2008, EMBO J, V27, P1049, DOI 10.1038/emboj.2008.42; Maegawa GHB, 2007, J BIOL CHEM, V282, P9150, DOI 10.1074/jbc.M609304200; Morimoto RI, 1998, GENE DEV, V12, P3788, DOI 10.1101/gad.12.24.3788; Moyer B D, 2001, Expert Opin Ther Targets, V5, P165, DOI 10.1517/14728222.5.2.165; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ron I, 2005, HUM MOL GENET, V14, P2387, DOI 10.1093/hmg/ddi240; Sawkar AR, 2006, CELL MOL LIFE SCI, V63, P1179, DOI 10.1007/s00018-005-5437-0; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Sawkar AR, 2005, CHEM BIOL, V12, P1235, DOI 10.1016/j.chembiol.2005.09.007; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Schmitz M, 2005, INT J BIOCHEM CELL B, V37, P2310, DOI 10.1016/j.biocel.2005.05.008; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Schueler UH, 2004, J INHERIT METAB DIS, V27, P649, DOI 10.1023/B:BOLI.0000042959.44318.7c; Tropak MB, 2004, J BIOL CHEM, V279, P13478, DOI 10.1074/jbc.M308523200; Ulloa-Aguirre A, 2004, TRAFFIC, V5, P821, DOI 10.1111/j.1600-0854.2004.00232.x; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Westerheide SD, 2004, J BIOL CHEM, V279, P56053, DOI 10.1074/jbc.M409267200; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Wiseman RL, 2007, CELL, V131, P809, DOI 10.1016/j.cell.2007.10.025; Yam GHF, 2006, AM J PHYSIOL-CELL PH, V290, pC1076, DOI 10.1152/ajpcell.00426.2005; Yan FF, 2005, AM J PHYSIOL-CELL PH, V289, pC1351, DOI 10.1152/ajpcell.00240.2005; Yang HJ, 2006, CANCER RES, V66, P4758, DOI 10.1158/0008-5472.CAN-05-4529; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492; Yu ZQ, 2007, J MED CHEM, V50, P94, DOI 10.1021/jm060677i	54	301	310	0	54	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					769	781		10.1016/j.cell.2008.06.037	http://dx.doi.org/10.1016/j.cell.2008.06.037			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775310	Green Accepted, Bronze			2022-12-28	WOS:000258947500017
J	Mathers, BM; Degenhardt, L; Phillips, B; Wiessing, L; Hickman, M; Strathdee, SA; Wodak, A; Panda, S; Tyndall, M; Toufik, A; Mattick, RP				Mathers, Bradley M.; Degenhardt, Louisa; Phillips, Benjamin; Wiessing, Lucas; Hickman, Matthew; Strathdee, Steffanie A.; Wodak, Alex; Panda, Samiran; Tyndall, Mark; Toufik, Abdalla; Mattick, Richard P.		2007 Reference Grp UN HIV Injectin	Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review	LANCET			English	Article							HEALTH	Background Injecting drug use is an increasingly important cause of HIV transmission in most countries worldwide. Our aim was to determine the prevalence of injecting drug use among individuals aged 15-64 years, and of HIV among people who inject drugs. Methods We did a systematic search of peer-reviewed (Medline, EmBase, and PubMed/BioMed Central), internet, and grey literature databases; and data requests were made to UN agencies and international experts. 11022 documents were reviewed, graded, and catalogued by the Reference Group to the UN on HIV and Injecting Drug Use. Findings Injecting drug use was identified in 148 countries; data for the extent of injecting drug use was absent for many countries in Africa, the Middle East, and Latin America. The presence of HIV infection among injectors had been reported in 120 of these countries. Prevalence estimates of injecting drug use could be ascertained for 61 countries, containing 77% of the world's total Population aged 15-64 years. Extrapolated estimates suggest that 15.9 million (range 11 . 0-21.2 million) people might inject drugs worldwide; the largest numbers of injectors were found in China, the USA, and Russia, where mid-estimates of HIV prevalence among injectors were 12%,16%, and 37%, respectively. HIV prevalence among injecting drug users was 20-40% in five countries and over 40% in nine. We estimate that, worldwide, about 3 . 0 million (range 0 . 8-6.6 million) people who inject drugs might be HIV positive. Interpretation The number of countries in which the injection of drugs has been reported has increased over the last decade. The high prevalence of HIV among many populations of injecting drug users represents a substantial global health challenge. However, existing data are far from adequate, in both quality and quantity, particularly in view of the increasing importance of injecting drug use as a mode of HIV transmission in many regions. Funding UN Office on Drugs and Crime; Australian National Drug and Alcohol Research Centre, University of New South Wales.	[Mathers, Bradley M.; Degenhardt, Louisa; Phillips, Benjamin; Wodak, Alex; Mattick, Richard P.] Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia; [Mathers, Bradley M.; Degenhardt, Louisa; Wodak, Alex; Mattick, Richard P.] Univ New S Wales, Secretariat Reference Grp UN HIV & Injecting Drug, Sydney, NSW 2052, Australia; [Wiessing, Lucas] European Monitoring Ctr Drugs & Drug Addict, Crime & Markets Unit, Lisbon, Portugal; [Hickman, Matthew] Univ Bristol, Bristol, Avon, England; [Strathdee, Steffanie A.] Univ Calif San Diego, Div Int Hlth & Cross Cultural Med, San Diego, CA 92103 USA; [Wodak, Alex] St Vincents Hosp, Alcohol & Drug Serv, Sydney, NSW 2010, Australia; [Panda, Samiran] Indian Council Med Res, Natl Inst Cholera & Enter Dis, W Bengal, India; [Panda, Samiran] Soc Posit Atmosphere & Related Support HIV AIDS S, W Bengal, India; [Tyndall, Mark] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Toufik, Abdalla] French Monitoring Ctr Drugs & Drug Addict, Emerging Trends Dept, Paris, France	University of New South Wales Sydney; University of New South Wales Sydney; University of Bristol; University of California System; University of California San Diego; St Vincents Hospital Sydney; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); B.C. Centre for Excellence in HIV/AIDS	Mathers, BM (corresponding author), Univ New S Wales, Natl Drug & Alcohol Res Ctr, Sydney, NSW 2052, Australia.	b.mathers@med.unsw.edu.au	Mathers, Bradley M/J-6118-2012; Hickman, Matthew/Y-2400-2019; Degenhardt, Louisa J/D-4515-2012; Strathdee, Steffanie A/B-9042-2009	Mathers, Bradley M/0000-0003-2827-0697; Hickman, Matthew/0000-0001-9864-459X; Degenhardt, Louisa J/0000-0002-8513-2218; Tyndall, Mark/0000-0003-4450-5679; Strathdee, Steffanie/0000-0002-7724-691X; Mesquita, Fabio/0000-0002-8297-0224	UN Office oil Drugs arid Crime; Australian National Drug and Alcohol Research Centre; Australian Department of Health and Ageing; Australian NHMRC Senior Research Fellowship; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA019829] Funding Source: NIH RePORTER	UN Office oil Drugs arid Crime; Australian National Drug and Alcohol Research Centre; Australian Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Australian NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was done as part of the work of the 2007 Reference Group to the UN on HIV and Injecting Drug Use, an independent group of international experts established to provide technical advice to the co-sponsors of the UN Joint Programme on HIV/AIDS on effective approaches to HIV prevention and care among people who inject drugs The Secretariat for the Reference Group is funded by the UN Office oil Drugs arid Crime (UNODC). This work was also financially supported by Australian National Drug and Alcohol Research Centre, which receives funding from the Australian Department of Health and Ageing. LD is the recipient of an Australian NHMRC Senior Research Fellowship. Eva Congreve, Anna Roberts, Amanda Roxburgh, and Jessica Singleton assisted with the literature search and the review of the collected material.	Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; Amorim C, 2007, LANCET, V369, P1373, DOI 10.1016/S0140-6736(07)60498-X; BALL AL, 1998, PUBLIC HLTH REPORTS, V113, P12; BORSCHEVSKAYA V, 2006, COUNTRY REPORT RUSSI; Buve A, 2002, LANCET, V359, P2011, DOI 10.1016/S0140-6736(02)08823-2; CALABRIA B, 2008, 293 NDARC; Degenhardt L., 2004, COMP QUANTIFICATION; *EMCDAA, 2007, 2007 ANN REP STAT DR; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Hall WD, 2000, MED J AUSTRALIA, V173, P528, DOI 10.5694/j.1326-5377.2000.tb139321.x; HICKMAN M, 2005, EPIDEMIOLOGY DRUG AB; *INT NARC CONTR BO, 2008, REP INT NARC CONTR B; Lu F, 2006, SEX TRANSM INFECT, V82, pIII87, DOI 10.1136/sti.2006.020404; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Murray CJL, 2008, LANCET, V371, P1191, DOI 10.1016/S0140-6736(08)60526-7; *NAT CTR HIV EP CL, 2008, AUSTR NSP SURV NAT D; Renton A, 2006, INT J DRUG POLICY, V17, P494, DOI 10.1016/j.drugpo.2006.09.003; Sendziuk P, 2007, CAN BULL MED HIST, V24, P113, DOI 10.3138/cbmh.24.1.113; The United Nations Population Division, 2007, WORLD POP PROSP 2006; UNAIDS, 2006, REP GLOB AIDS EP; United Nations June, 2001, DECL COMM HIV AIDS U; *UNODC, 2007, WORLD DRUG REP	22	949	963	2	88	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1733	1745		10.1016/S0140-6736(08)61311-2	http://dx.doi.org/10.1016/S0140-6736(08)61311-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	18817968				2022-12-28	WOS:000261077900023
J	Pearce, MJ; Mintseris, J; Ferreyra, J; Gygi, SP; Darwin, KH				Pearce, Michael J.; Mintseris, Julian; Ferreyra, Jessica; Gygi, Steven P.; Darwin, K. Heran			Ubiquitin-Like Protein Involved in the Proteasome Pathway of Mycobacterium tuberculosis	SCIENCE			English	Article							NUCLEAR-PORE COMPLEX; 20S PROTEASOME; RESOLUTION; PROGRAMS; RANGAP1; SYSTEM	The protein modifier ubiquitin is a signal for proteasome-mediated degradation in eukaryotes. Proteasome- bearing prokaryotes have been thought to degrade proteins via a ubiquitinin-dependent pathway. We have identified a prokaryotic ubiquitin- like protein, Pup ( Rv2111c), which was specifically conjugated to proteasome substrates in the pathogen Mycobacterium tuberculosis. Pupylation occurred on lysines and required proteasome accessory factor A (PafA). In a pafA mutant, pupylated proteins were absent and substrates accumulated, thereby connecting pupylation with degradation. Although analogous to ubiquitylation, pupylation appears to proceed by a different chemistry. Thus, like eukaryotes, bacteria may use a small- protein modifier to control protein stability.	[Pearce, Michael J.; Ferreyra, Jessica; Darwin, K. Heran] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Mintseris, Julian; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	New York University; Harvard University; Harvard Medical School	Darwin, KH (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.	heran.darwin@med.nyu.edu		Darwin, K Heran/0000-0002-5043-7548	NIH [AI065437, HL092774, GM67945, HG3456, HG3616];  [5T32AI07189-25]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092774] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003616, R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI007189, R56AI065437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067945] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Ehrt, D. Ladant, V. Miller, and A. Steyn for plasmids used in this study. We are grateful to C. Arias and C. Perez for advice on pulse- labeling experiments and to T. Huang, I. Mohr, and M. Pagano for helpful discussions. We thank A. Darwin and M. Pagano for critical review of this manuscript. This work was supported by NIH grants AI065437 and HL092774 ( to K. H. D.) and GM67945, HG3456, and HG3616 ( to S. P. G.). M. J. P. was supported by grant 5T32AI07189-25.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Darwin KH, 2001, J BACTERIOL, V183, P1452, DOI 10.1128/JB.183.4.1452-1454.2001; Festa RA, 2007, J BACTERIOL, V189, P3044, DOI 10.1128/JB.01597-06; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hochstrasser M, 2000, NAT CELL BIOL, V2, pE153, DOI 10.1038/35019643; Hu GQ, 2006, MOL MICROBIOL, V59, P1417, DOI 10.1111/j.1365-2958.2005.05036.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Kirkpatrick DS, 2005, NAT CELL BIOL, V7, P750, DOI 10.1038/ncb0805-750; Knipfer N, 1997, MOL MICROBIOL, V25, P375, DOI 10.1046/j.1365-2958.1997.4721837.x; Lin G, 2006, MOL MICROBIOL, V59, P1405, DOI 10.1111/j.1365-2958.2005.05035.x; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405; Singh A, 2006, P NATL ACAD SCI USA, V103, P11346, DOI 10.1073/pnas.0602817103; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7	22	290	318	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	NOV 14	2008	322	5904					1104	1107		10.1126/science.1163885	http://dx.doi.org/10.1126/science.1163885			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	371YD	18832610	Green Accepted			2022-12-28	WOS:000260867700038
J	Serganov, A; Huang, LL; Patel, DJ				Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.			Structural insights into amino acid binding and gene control by a lysine riboswitch	NATURE			English	Article							CRYSTAL-STRUCTURE; S-ADENOSYLMETHIONINE; RNA; EXPRESSION; REFINEMENT; BIOSYNTHESIS; RECOGNITION; BACTERIA; ANALOGS; DOMAIN	In bacteria, the intracellular concentration of several amino acids is controlled by riboswitches(1-4). One of the important regulatory circuits involves lysine- specific riboswitches, which direct the biosynthesis and transport of lysine and precursors common for lysine and other amino acids(1-3). To understand the molecular basis of amino acid recognition by riboswitches, here we present the crystal structure of the 174- nucleotide sensing domain of the Thermotoga maritima lysine riboswitch in the lysine- bound (1.9 angstrom (angstrom)) and free (3.1 angstrom) states. The riboswitch features an unusual and intricate architecture, involving three-helical and two- helical bundles connected by a compact five- helical junction and stabilized by various long- range tertiary interactions. Lysine interacts with the junctional core of the riboswitch and is specifically recognized through shape- complementarity within the elongated binding pocket and through several direct and K(+)-mediated hydrogen bonds to its charged ends. Our structural and biochemical studies indicate preformation of the riboswitch scaffold and identify conformational changes associated with the formation of a stable lysine- bound state, which prevents alternative folding of the riboswitch and facilitates formation of downstream regulatory elements. We have also determined several structures of the riboswitch bound to different lysine analogues(5), including antibiotics, in an effort to understand the ligand-binding capabilities of the lysine riboswitch and understand the nature of antibiotic resistance. Our results provide insights into a mechanism of lysine- riboswitch- dependent gene control at the molecular level, thereby contributing to continuing efforts at exploration of the pharmaceutical and biotechnological potential of riboswitches.	[Serganov, Alexander; Huang, Lili; Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Serganov, A (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA.	serganoa@mskcc.org; pateld@mskcc.org		Serganov, Alexander/0000-0001-8328-9310	US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073618] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank personnel of beamline X29 at the Brookhaven National Laboratory and beamlines 24-ID-C/E at the Advanced Photon Source, Argonne National Laboratory, funded by the US Department of Energy. We thank O. Ouerfelli for the synthesis of iridium hexamine. D.J.P. was supported by funds from the National Institutes of Health.	Ataide SF, 2007, ACS CHEM BIOL, V2, P819, DOI 10.1021/cb7002253; Basu S, 1998, NAT STRUCT BIOL, V5, P986, DOI 10.1038/2960; Batey RT, 2004, NATURE, V432, P411, DOI 10.1038/nature03037; Blouin S, 2007, RNA, V13, P1256, DOI 10.1261/rna.560307; Blount KF, 2007, NAT CHEM BIOL, V3, P44, DOI 10.1038/nchembio842; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Cochrane JC, 2007, CHEM BIOL, V14, P97, DOI 10.1016/j.chembiol.2006.12.005; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Feig A. L., 1999, RNA WORLD, P287; Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371; Grundy FJ, 2003, P NATL ACAD SCI USA, V100, P12057, DOI 10.1073/pnas.2133705100; Klein DJ, 2006, SCIENCE, V313, P1752, DOI 10.1126/science.1129666; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Leontis NB, 1998, RNA, V4, P1134, DOI 10.1017/S1355838298980566; LU Y, 1992, FEMS MICROBIOL LETT, V92, P23, DOI 10.1016/0378-1097(92)90536-W; Mandal M, 2004, SCIENCE, V306, P275, DOI 10.1126/science.1100829; Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Patte JC, 1998, FEMS MICROBIOL LETT, V169, P165, DOI 10.1016/S0378-1097(98)00479-0; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rodionov DA, 2003, NUCLEIC ACIDS RES, V31, P6748, DOI 10.1093/nar/gkg900; Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Serganov A, 2006, NATURE, V441, P1167, DOI 10.1038/nature04740; Sudarsan N, 2003, GENE DEV, V17, P2688, DOI 10.1101/gad.1140003; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Weixlbaumer A, 2007, NAT STRUCT MOL BIOL, V14, P733, DOI 10.1038/nsmb1282; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336	32	185	190	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1263	U76		10.1038/nature07326	http://dx.doi.org/10.1038/nature07326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18784651	Green Accepted			2022-12-28	WOS:000260462100050
J	Styer, KL; Singh, V; Macosko, E; Steele, SE; Bargmann, CI; Aballay, A				Styer, Katie L.; Singh, Varsha; Macosko, Evan; Steele, Sarah E.; Bargmann, Cornelia I.; Aballay, Alejandro			Innate immunity in Caenorhabditis elegans is regulated by neurons expressing NPR-1/GPCR	SCIENCE			English	Article							C-ELEGANS; SIGNALING PATHWAY; BACILLUS-THURINGIENSIS; SALMONELLA-TYPHIMURIUM; CHEMOSENSORY NEURONS; INFLAMMATORY REFLEX; LARVAL DEVELOPMENT; GENE FAMILIES; MODEL HOST; BODY-FLUID	A large body of evidence indicates that metazoan innate immunity is regulated by the nervous system, but the mechanisms involved in the process and the biological importance of such control remain unclear. We show that a neural circuit involving npr-1, which encodes a G protein-coupled receptor (GPCR) related to mammalian neuropeptide Y receptors, functions to suppress innate immune responses. The immune inhibitory function requires a guanosine 3',5'-monophosphategated ion channel encoded by tax-2 and tax-4 as well as the soluble guanylate cyclase GCY-35. Furthermore, we show that npr-1- and gcy-35-expressing sensory neurons actively suppress immune responses of nonneuronal tissues. A full-genome microarray analysis on animals with altered neural function due to mutation in npr-1 shows an enrichment in genes that are markers of innate immune responses, including those regulated by a conserved PMK-1/p38 mitogen-activated protein kinase signaling pathway. These results present evidence that neurons directly control innate immunity in C. elegans, suggesting that GPCRs may participate in neural circuits that receive inputs from either pathogens or infected sites and integrate them to coordinate appropriate immune responses.	[Styer, Katie L.; Singh, Varsha; Steele, Sarah E.; Aballay, Alejandro] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Macosko, Evan; Bargmann, Cornelia I.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Macosko, Evan; Bargmann, Cornelia I.] Rockefeller Univ, Lab Neural Circuits & Behav, New York, NY 10021 USA	Duke University; Howard Hughes Medical Institute; Rockefeller University; Rockefeller University	Aballay, A (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.	a.aballay@duke.edu	Macosko, Evan/X-4664-2019	Bargmann, Cornelia/0000-0002-8484-0618; Jeney, Sarah Elizabeth Steele/0000-0001-5222-2981	Whitehead Scholars Program; NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense [U54 AI057157]; NIH [GM070977]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057157] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070977] Funding Source: NIH RePORTER	Whitehead Scholars Program; NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the Caenorhabditis Genetics Center (University of Minnesota) for strains used in this study. A.A. is funded by the Whitehead Scholars Program, the NIH Southeast Regional Center of Excellence for Emerging Infections and Biodefense (grant U54 AI057157), and NIH grant GM070977. C.I.B. is an Investigator of the Howard Hughes Medical Institute.	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Aballay A, 2003, CURR BIOL, V13, P47, DOI 10.1016/S0960-9822(02)01396-9; Alcedo J, 2004, NEURON, V41, P45, DOI 10.1016/S0896-6273(03)00816-X; Andersson J, 2005, J INTERN MED, V257, P122, DOI 10.1111/j.1365-2796.2004.01440.x; BARGMANN CI, 1991, SCIENCE, V251, P1243, DOI 10.1126/science.2006412; Beale E, 2006, APPL ENVIRON MICROB, V72, P5135, DOI 10.1128/AEM.00611-06; Bishop NA, 2007, NATURE, V447, P545, DOI 10.1038/nature05904; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cheung BHH, 2004, CURR BIOL, V14, P1105, DOI 10.1016/j.cub.2004.06.027; Coates JC, 2002, NATURE, V419, P925, DOI 10.1038/nature01170; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Hasshoff M, 2007, FASEB J, V21, P1801, DOI 10.1096/fj.06-6551com; Huffman DL, 2004, P NATL ACAD SCI USA, V101, P10995, DOI 10.1073/pnas.0404073101; Kerry S, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000077; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Labrousse A, 2000, CURR BIOL, V10, P1543, DOI 10.1016/S0960-9822(00)00833-2; Laws TR, 2006, MICROB PATHOGENESIS, V40, P293, DOI 10.1016/j.micpath.2006.03.001; Li C, 1999, ANN NY ACAD SCI, V897, P239, DOI 10.1111/j.1749-6632.1999.tb07895.x; Li WQ, 2003, GENE DEV, V17, P844, DOI 10.1101/gad.1066503; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; O'Rourke D, 2006, GENOME RES, V16, P1005, DOI 10.1101/gr.50823006; Pierce SB, 2001, GENE DEV, V15, P672, DOI 10.1101/gad.867301; Pradel E, 2007, P NATL ACAD SCI USA, V104, P2295, DOI 10.1073/pnas.0610281104; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Ren PF, 1996, SCIENCE, V274, P1389, DOI 10.1126/science.274.5291.1389; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Sattelle David B., 2006, Invertebrate Neuroscience, V6, P1, DOI 10.1007/s10158-005-0014-7; Schackwitz WS, 1996, NEURON, V17, P719, DOI 10.1016/S0896-6273(00)80203-2; Schulenburg H, 2004, PARASITOLOGY, V128, P433, DOI 10.1017/S003118200300461X; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Sicard M, 2007, ENVIRON MICROBIOL, V9, P12, DOI 10.1111/j.1462-2920.2006.01099.x; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Wong D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r194; Yook K, 2007, GENETICS, V175, P681, DOI 10.1534/genetics.106.060087; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	47	157	219	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					460	464		10.1126/science.1163673	http://dx.doi.org/10.1126/science.1163673			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18801967	Green Accepted			2022-12-28	WOS:000260094500052
J	Holman, RR; Paul, SK; Bethel, MA; Matthews, DR; Neil, HAW				Holman, Rury R.; Paul, Sanjoy K.; Bethel, M. Angelyn; Matthews, David R.; Neil, H. Andrew W.			10-year follow-up of intensive glucose control in type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; METAANALYSIS; MELLITUS; DISEASE; UKPDS	Background: During the United Kingdom Prospective Diabetes Study (UKPDS), patients with type 2 diabetes mellitus who received intensive glucose therapy had a lower risk of microvascular complications than did those receiving conventional dietary therapy. We conducted post-trial monitoring to determine whether this improved glucose control persisted and whether such therapy had a long-term effect on macrovascular outcomes. Methods: Of 5102 patients with newly diagnosed type 2 diabetes, 4209 were randomly assigned to receive either conventional therapy (dietary restriction) or intensive therapy (either sulfonylurea or insulin or, in overweight patients, metformin) for glucose control. In post-trial monitoring, 3277 patients were asked to attend annual UKPDS clinics for 5 years, but no attempts were made to maintain their previously assigned therapies. Annual questionnaires were used to follow patients who were unable to attend the clinics, and all patients in years 6 to 10 were assessed through questionnaires. We examined seven prespecified aggregate clinical outcomes from the UKPDS on an intention-to-treat basis, according to previous randomization categories. Results: Between-group differences in glycated hemoglobin levels were lost after the first year. In the sulfonylurea-insulin group, relative reductions in risk persisted at 10 years for any diabetes-related end point (9%, P=0.04) and microvascular disease (24%, P=0.001), and risk reductions for myocardial infarction (15%, P=0.01) and death from any cause (13%, P=0.007) emerged over time, as more events occurred. In the metformin group, significant risk reductions persisted for any diabetes-related end point (21%, P=0.01), myocardial infarction (33%, P=0.005), and death from any cause (27%, P=0.002). Conclusions: Despite an early loss of glycemic differences, a continued reduction in microvascular risk and emergent risk reductions for myocardial infarction and death from any cause were observed during 10 years of post-trial follow-up. A continued benefit after metformin therapy was evident among overweight patients. (UKPDS 80; Current Controlled Trials number, ISRCTN75451837.).	[Holman, Rury R.; Paul, Sanjoy K.; Bethel, M. Angelyn; Matthews, David R.; Neil, H. Andrew W.] Churchill Hosp, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Neil, H. Andrew W.] Div Publ Hlth & Primary Hlth Care, Oxford, England; [Neil, H. Andrew W.] NIHR, Sch Primary Care Res, Oxford, England; [Holman, Rury R.; Matthews, David R.; Neil, H. Andrew W.] NIHR, Oxford Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Holman, RR (corresponding author), Churchill Hosp, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	Paul, Sanjoy K/F-8199-2010; Greiver, Michelle/N-8764-2015	Paul, Sanjoy K/0000-0003-0848-7194; Greiver, Michelle/0000-0001-8957-0285	U.K. Medical Research Council; U.K. Department of Health; Diabetes UK; British Heart Foundation; U.K. National Institute for Health; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Novartis; Novo Nordisk; Pfizer; British Diabetic Association; U.S. National Eye Institute; U.S. National Institute of Diabetes and Digestive and Kidney Diseases; Wellcome Trust; Charles Wolfson Charitable Trust; Clothworkers' Foundation; Health Promotion Research Trust; Alan and Babette Sainsbury Trust; Oxford University Medical Research Fund Committee; Bayer; Hoechst; Lilly; Lipha; Farmitalia Carlo Erba; Boehringer Mannheim; Becton Dickinson; Owen Mumford; Securicor; Kodak; Cortecs Diagnostics; Glaxo Wellcome; SmithKline Beecham; Zeneca; Pharmacia; Upjohn; Roche; Asahi Kasei Pharma; Bayer Healthcare; Bayer Schering Pharma; Merck; Sanofi- ventis; Astella; King Pharmaceuticals; Takeda; ScheringPlough; Solvay Healthcare	U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); U.K. Department of Health; Diabetes UK(Diabetes UK); British Heart Foundation(British Heart Foundation); U.K. National Institute for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); British Diabetic Association(Diabetes UK); U.S. National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); U.S. National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wellcome Trust(Wellcome TrustEuropean Commission); Charles Wolfson Charitable Trust; Clothworkers' Foundation; Health Promotion Research Trust; Alan and Babette Sainsbury Trust; Oxford University Medical Research Fund Committee; Bayer(Bayer AG); Hoechst; Lilly(Eli Lilly); Lipha; Farmitalia Carlo Erba; Boehringer Mannheim; Becton Dickinson; Owen Mumford; Securicor; Kodak; Cortecs Diagnostics; Glaxo Wellcome; SmithKline Beecham(GlaxoSmithKline); Zeneca; Pharmacia; Upjohn; Roche(Roche Holding); Asahi Kasei Pharma; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Schering Pharma(Bayer AG); Merck(Merck & Company); Sanofi- ventis; Astella; King Pharmaceuticals; Takeda(Takeda Pharmaceutical Company Ltd); ScheringPlough(Merck & CompanySchering Plough Corporation); Solvay Healthcare(Solvay SA)	Supported for the first 5 years of post-trial monitoring by the U.K. Medical Research Council, U.K. Department of Health, Diabetes UK, the British Heart Foundation, and the U.K. National Institute for Health and for the final 5 years by Bristol-Myers Squibb, GlaxoSmithKline, Merck Serono, Novartis, Novo Nordisk and Pfizer. The original UKDPS interventional trial was supported by the U.K. Medical Research Council, British Diabetic Association, U.K. Department of Health, U.S. National Eye Institute, U.S. National Institute of Diabetes and Digestive and Kidney Diseases, British Heart Foundation, Wellcome Trust, Charles Wolfson Charitable Trust, Clothworkers' Foundation, Health Promotion Research Trust, Alan and Babette Sainsbury Trust, Oxford University Medical Research Fund Committee, Novo Nordisk, Bayer, Bristol-Myers Squibb, Hoechst, Lilly, Lipha, and Farmitalia Carlo Erba, with consumables or logistical support from Boehringer Mannheim, Becton Dickinson, Owen Mumford, Securicor, Kodak, Cortecs Diagnostics, Glaxo Wellcome, SmithKline Beecham, Pfizer, Zeneca, Pharmacia, Upjohn, and Roche.; Dr. Holman reports receiving grant support from Asahi Kasei Pharma, Bayer Healthcare, Bayer Schering Pharma, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Merck Serono, Novartis, Novo Nordisk, Pfizer, and Sanofi- ventis, consulting fees from Amylin, Eli Lilly, GlaxoSmithKline, Merck, and Novartis, and lecture fees from Astella, Bayer, GlaxoSmithKline, King Pharmaceuticals, Eli Lilly, Merck, Merck Serono, Novo Nordisk, Takeda, and Sanofi-Aventis, and owning shares in Glyme Valley Technology, Glyox, and Oxtech; Dr. Paul, receiving consulting fees from Amylin; Dr. Bethel, receiving grant support from Novartis and Sanofi-Aventis and lecture fees from Merck and Sanofi- Aventis; Dr. Matthews, receiving lecture and advisory fees from Novo Nordisk, GlaxoSmithKline, Servier, Merck, Novartis, Novo Nordisk, Eli Lilly, Takeda, and Roche and owning shares in OSI Pharmaceuticals and Particle Therapeutics; and Dr. Neil, receiving consulting fees from Merck, Pfizer, ScheringPlough, and Solvay Healthcare. The Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) has a Partnership for the Foundation of OCDEM, with Novo Nordisk, Takeda and Servier. No other potential conflict of interest relevant to this article was reported.; We thank the patients and staff at the participating centers: Radcliffe Infirmary, Oxford; Royal Infirmary, Aberdeen; Selly Oak Hospital, Birmingham; St. George's Hospital and Hammersmith Hospital, London; City Hospital, Belfast; North Staffordshire City General Hospital, Stoke- on- Trent; Royal Victoria Hospital, Belfast; St. Helier Hospital, Carshalton; Whittington Hospital, London; Norfolk and Norwich Hospital, Norwich; Lister Hospital, Stevenage; Ipswich Hospital, Ipswich; Ninewells Hospital, Dundee; Northampton Hospital, Northampton; Torbay Hospital, Torquay; Peterborough District Hospital, Peterborough; Scarborough Hospital, Scarborough; Derbyshire Royal Infirmary, Derby; Manchester Royal Infirmary, Manchester; Hope Hospital, Salford; Leicester General Hospital, Leicester; and Royal Devon and Exeter Hospital, Exeter (all in the United Kingdom); and the Northern Ireland General Register Office for provision of vital- status data. We acknowledge the major contribution of the late Carole Cull and the efforts of members of the Endpoint Adjudication Committee (Charles Fox and Alex Wright).	Baigent C, 2008, LANCET, V371, P2084; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; De Giorgio L, 2000, NEW ENGL J MED, V342, P1376; Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P997; Engel S, 2003, NEW ENGL J MED, V348, P2294; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Genuth S, 2008, DIABETIC MED, V25, P57, DOI 10.1111/j.1464-5491.2008.02504.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Goh SY, 2008, J CLIN ENDOCR METAB, V93, P1143, DOI 10.1210/jc.2007-1817; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Home PD, 2008, DIABETIC MED, V25, P2, DOI 10.1111/j.1464-5491.2008.02501.x; MANLEY SE, 1994, DIABETIC MED, V11, P534; Metropolitan Life Foundation New weight standards for men and women, 1959, STAT B, V40, P1; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Shannon H, 2000, NEW ENGL J MED, V342, P381; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Stettler C, 2006, AM HEART J, V152, P27, DOI 10.1016/j.ahj.2005.09.015; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospect Diabet Study Grp, 1999, BMJ-BRIT MED J, V318, P29; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yusuf S, 2000, NEW ENGL J MED, V342, P145; YUSUF S, 2000, NEW ENGL J MED, V342, P1376	29	5004	5334	5	365	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1577	1589		10.1056/NEJMoa0806470	http://dx.doi.org/10.1056/NEJMoa0806470			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18784090				2022-12-28	WOS:000259903100006
J	Coombes, R				Coombes, Rebecca			Dr Nurse will see you now	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmj.com						*NURS MIDW COUNC, STAT AN REG APR 2006	1	8	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 20	2008	337	7671							a1522	10.1136/bmj.a1522	http://dx.doi.org/10.1136/bmj.a1522			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18782840				2022-12-28	WOS:000259622000026
J	Ebersbach, G; Briegel, A; Jensen, GJ; Jacobs-Wagner, C				Ebersbach, Gitte; Briegel, Ariane; Jensen, Grant J.; Jacobs-Wagner, Christine			A self-associating protein critical for chromosome attachment, division, and polar organization in Caulobacter	CELL			English	Article							CELL-CYCLE PROGRESSION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; BACTERIAL-CELL; DNA-REPLICATION; ROD-SHAPE; SEGREGATION; CRESCENTUS; LOCALIZATION; DIVIVA	Cell polarization is an integral part of many unrelated bacterial processes. How intrinsic cell polarization is achieved is poorly understood. Here, we provide evidence that Caulobacter crescentus uses a multimeric pole-organizing factor (PopZ) that serves as a hub to concurrently achieve several polarizing functions. During chromosome segregation, polar PopZ captures the ParB.ori complex and thereby anchors sister chromosomes at opposite poles. This step is essential for stabilizing bipolar gradients of a cell division inhibitor and setting up division near midcell. PopZ also affects polar stalk morphogenesis and mediates the polar localization of the morphogenetic and cell cycle signaling proteins CckA and DivJ. Polar accumulation of PopZ, which is central to its polarizing activity, can be achieved independently of division and does not appear to be dictated by the pole curvature. Instead, evidence suggests that localization of PopZ largely relies on PopZ multimerization in chromosome-free regions, consistent with a self-organizing mechanism.	[Ebersbach, Gitte; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Briegel, Ariane; Jensen, Grant J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Jacobs-Wagner, Christine] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; California Institute of Technology; Howard Hughes Medical Institute	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	Briegel, Ariane/AAC-1085-2021	Briegel, Ariane/0000-0003-3733-3725; Jacobs-Wagner, Christine/0000-0003-0980-5334	Villum Kann Rasmussen Foundation; Danish Natural Science Research Council; National Institutes of Health [GM065835, AI067548]; Pew Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI067548] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	Villum Kann Rasmussen Foundation(Villum Fonden); Danish Natural Science Research Council(Danish Natural Science Research Council); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Charitable trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Mooseker, E. Dufresne, T. Emonet, and J. Wolenski for valuable discussions; K. Gerdes, J. Gober, A. Newton, N. Ohta, L. Shapiro, M. Thanbichler, and P. Viollier for supplying strains or antibody; P. Angelastro, A. Jackson, H. Lam, and W. Schofield for construction of strains; H. J. Ding and D. Rosenman for computational help; M. Mooseker, Z. Jiang, and G. Charbon for assistance with EM; E. Folta-Stogniew and the Keck Foundation Biotechnology Resource Laboratory at Yale for the biophysical analyses, and the Jacobs-Wagner laboratory and T. Emonet for critical reading of the manuscript. G. E. was supported by postdoctoral fellowships from the Villum Kann Rasmussen Foundation and the Danish Natural Science Research Council. This work was funded in part by National Institutes of Health (GM065835 to C.J.-W. and AI067548 to G. J. J.), gifts to Caltech from the Gordon and Betty Moore Foundation and Agouron Institute (to G. J. J.) and the Pew Scholars Program in the Biological Sciences sponsored by the Pew Charitable trust (to C.J.-W.). C.J.-W. is a Howard Hughes Medical Institute investigator.	Bardy SL, 2007, CURR OPIN MICROBIOL, V10, P617, DOI 10.1016/j.mib.2007.10.006; Ben-Yehuda S, 2003, SCIENCE, V299, P532, DOI 10.1126/science.1079914; Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321; Bohm J, 2000, P NATL ACAD SCI USA, V97, P14245, DOI 10.1073/pnas.230282097; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Dai MH, 2005, METAB ENG, V7, P45, DOI 10.1016/j.ymben.2004.09.002; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Ebersbach G, 2007, TRENDS MICROBIOL, V15, P101, DOI 10.1016/j.tim.2007.01.004; Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719; ELY B, 1991, METHOD ENZYMOL, V204, P372; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Folta-Stogniew Ewa, 2006, V328, P97; Gital Z, 2005, CELL, V120, P329, DOI 10.1016/j.cell.2005.01.007; Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967; Hallez R, 2004, TRENDS MICROBIOL, V12, P361, DOI 10.1016/j.tim.2004.06.002; Hamoen LW, 2003, J BACTERIOL, V185, P693, DOI 10.1128/JB.185.2.693-697.2003; Harry EJ, 2003, MOL MICROBIOL, V47, P37, DOI 10.1046/j.1365-2958.2003.03253.x; Howard M, 2004, J MOL BIOL, V335, P655, DOI 10.1016/j.jmb.2003.10.058; Huang KC, 2006, PLOS COMPUT BIOL, V2, P1357, DOI 10.1371/journal.pcbi.0020151; Huitema E, 2006, CELL, V124, P1025, DOI 10.1016/j.cell.2006.01.019; Iwai N, 2002, BIOSCI BIOTECH BIOCH, V66, P2658, DOI 10.1271/bbb.66.2658; Jacobs C, 1999, CELL, V97, P111, DOI 10.1016/S0092-8674(00)80719-9; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Lam H, 2006, CELL, V124, P1011, DOI 10.1016/j.cell.2005.12.040; Lawler ML, 2007, CURR OPIN MICROBIOL, V10, P630, DOI 10.1016/j.mib.2007.09.007; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019; Mohl DA, 1997, CELL, V88, P675, DOI 10.1016/S0092-8674(00)81910-8; Ortiz JO, 2006, J STRUCT BIOL, V156, P334, DOI 10.1016/j.jsb.2006.04.014; SOMMER JM, 1991, GENETICS, V129, P623; Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x; TAMAKI S, 1980, J BACTERIOL, V141, P52, DOI 10.1128/JB.141.1.52-57.1980; Thanbichler M, 2006, J STRUCT BIOL, V156, P292, DOI 10.1016/j.jsb.2006.05.007; Thanbichler M, 2006, CELL, V126, P147, DOI 10.1016/j.cell.2006.05.038; Thomaides HB, 2001, GENE DEV, V15, P1662, DOI 10.1101/gad.197501; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; Wu LJ, 2003, MOL MICROBIOL, V49, P1463, DOI 10.1046/j.1365-2958.2003.03643.x; Zheng SQ, 2007, J STRUCT BIOL, V157, P138, DOI 10.1016/j.jsb.2006.06.005	42	213	213	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					956	968		10.1016/j.cell.2008.07.016	http://dx.doi.org/10.1016/j.cell.2008.07.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805089	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000259318100016
J	Berg, P				Berg, Paul			Meetings that changed the world: Asilomar 1975: DNA modification secured	NATURE			English	Editorial Material									[Berg, Paul] Stanford Univ, Beckman Ctr, Stanford, CA 94305 USA	Stanford University	Berg, P (corresponding author), Stanford Univ, Beckman Ctr, 279 Campus Dr, Stanford, CA 94305 USA.	pberg@stanford.edu							0	66	72	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					290	291		10.1038/455290a	http://dx.doi.org/10.1038/455290a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800118	Green Submitted, Bronze			2022-12-28	WOS:000259265200021
J	Sarkar, M; Hennessy, S; Yang, YX				Sarkar, Monika; Hennessy, Sean; Yang, Yu-Xiao			Proton-pump inhibitor use and the risk for community-acquired pneumonia	ANNALS OF INTERNAL MEDICINE			English	Article							POPULATION; DRUGS; CANCER	Background: Recent studies suggest that proton-pump inhibitors (PPIs) may increase the risk for community-acquired pneumonia (CAP). Objective: To examine the association between PPI use and CAP in adults followed in general practices in the United Kingdom. Design: Nested case-control study. Setting: The General Practice Research Database (1987 to 2002) in the United Kingdom. Participants: Patients age 18 years or older with at least 6 months of initial pneumonia-free follow-up in the database. Case patients (n = 80 066) were defined as those who received an incident diagnosis of CAP. Control participants (n = 799 881) were selected by using incidence density sampling, matching on practice site, calendar period, and follow-up duration. Measurements: Use of PPIs within 30 days before the index date. Adjusted odds ratios (ORs) were estimated by using conditional logistic regression, adjusting for potential confounders. Results: Overall, current PPI use was not associated with an increased risk for CAP (adjusted OR, 1.02 [95% CI, 0.97 to 1.08]) or risk for CAP that required hospitalization (adjusted OR, 1.01 [CI, 0.91 to 1.12]). There was a strong increase in risk for CAP associated with current use of PPI therapy that was started within the previous 2 days (adjusted OR, 6.53 [CI, 3.95 to 10.80]), 7 days (adjusted OR, 3.79 [CI, 2.66 to 5.42]), and 14 days (adjusted OR, 3.21 [CI, 2.46 to 4.18]), but there was no statistically significant association for longer-term current PPI therapy. A separate matched case-control analysis, which included the 3 strongest confounders as additional matching factors, yielded similar results as the primary analysis (adjusted OR, 0.96 [CI, 0.91 to 1.02]). Limitations: Adherence to PPI prescription was assumed to be 100%. No radiographic evidence was available to corroborate a diagnosis of CAP. Conclusion: Proton-pump inhibitor therapy started within the past 30 days was associated with an increased risk for CAP, whereas longer-term current use was not.	[Yang, Yu-Xiao] Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Yang, YX (corresponding author), Univ Penn, Ctr Clin Epidemiol & Biostat, Sch Med, 722 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	yangy@mail.med.upenn.edu	yang, yx/GZM-0464-2022		the Department of Medicine, University of Pennsylvania	the Department of Medicine, University of Pennsylvania	By an Academic Development Fund by the Department of Medicine, University of Pennsylvania (Dr. Yang).	Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954; de Abajo F J, 2001, BMC Clin Pharmacol, V1, P1, DOI 10.1186/1472-6904-1-1; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Hartmann M, 1996, ALIMENT PHARM THERAP, V10, P359, DOI 10.1111/j.0953-0673.1996.00359.x; Hollowell J, 1997, Popul Trends, P36; HORWITZ RI, 1980, AM J MED, V68, P255, DOI 10.1016/0002-9343(80)90363-0; Ip S, 2005, COMP EFFECTIVENESS R, V1; Irwin RS, 2006, CHEST, V129, p80S, DOI 10.1378/chest.129.1_suppl.80S; Jackson ML, 2004, CLIN INFECT DIS, V39, P1642, DOI 10.1086/425615; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick H., 1992, PHARMACOEPIDEM DR S, V1, P347, DOI DOI 10.1002/PDS.2630010607; JOKINEN C, 1993, AM J EPIDEMIOL, V137, P977, DOI 10.1093/oxfordjournals.aje.a116770; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Martin RM, 1998, ALIMENT PHARM THERAP, V12, P797; Meier CR, 2002, PHARMACOTHERAPY, V22, P303, DOI 10.1592/phco.22.5.303.33189; Morice AH, 2006, THORAX, V61, pI1, DOI 10.1136/thx.2006.065144; *NAT I HEALTH CAR, 2008, PRESCR DRUG EXP 2001; Perry J, 1978, OXMIS PROBLEM CODES; Rodriguez LAG, 2001, EPIDEMIOLOGY, V12, P88, DOI 10.1097/00001648-200101000-00015; Van Staa TP, 1994, PHARMACOEPIDEM DR S, V3, P15, DOI DOI 10.1002/PDS.2630030106; WEIL J, 1995, BMJ-BRIT MED J, V310, P827, DOI 10.1136/bmj.310.6983.827; WESSLING A, 1990, EUR J CLIN PHARMACOL, V39, P207, DOI 10.1007/BF00315097; Yang YX, 2007, GASTROENTEROLOGY, V133, P748, DOI 10.1053/j.gastro.2007.06.022; Yood MU, 2007, PHARMACOEPIDEM DR S, V16, P961, DOI 10.1002/pds.1454	27	202	215	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					391	W75		10.7326/0003-4819-149-6-200809160-00005	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794558				2022-12-28	WOS:000259230200003
J	Boseley, S				Boseley, Sarah			Mirai Chatterjee: securing work and health care for women in India	LANCET			English	Biographical-Item												sarah.boseley@guardian.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					883	883		10.1016/S0140-6736(08)61384-7	http://dx.doi.org/10.1016/S0140-6736(08)61384-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790299				2022-12-28	WOS:000259266900014
J	Ekman, B; Pathmanathan, I; Liljestrand, J				Ekman, Bjorn; Pathmanathan, Indra; Liljestrand, Jerker			Alma-Ata: Rebirth and revision 7 - Integrating health interventions for women, newborn babies, and children: a framework for action	LANCET			English	Article							DEVELOPING-COUNTRIES; SAFE MOTHERHOOD; REPRODUCTIVE HEALTH; MATERNAL MORTALITY; CHILDHOOD ILLNESS; SURVIVAL 1; SERVICES; SYSTEMS; POLICY; CARE	For women and children, especially those who are poor and disadvantaged, to benefit from primary health care, they need to access and use cost-effective interventions for maternal, newborn, and child health. The challenge facing weak health systems is how to deliver such packages. Experiences from countries such as Iran, Malaysia, Sri Lanka, and China, and from projects in countries like Tanzania and India, show that outcomes in maternal, newborn, and child health can be improved through integrated packages of cost-effective health-care interventions that are implemented incrementally in accordance with the capacity of health systems. Such packages should include community-based interventions that act in combination with social protection and intersectoral action in education, infrastructure, and poverty reduction. Interventions need to be planned and implemented at the district level, which requires strengthening of district planning and management skills. Furthermore, districts need to be supported by national strategies and policies, and, in the case of the least developed countries, also by international donors and other partners. If packages for maternal, newborn and child health care can be integrated within a gradually strengthened primary health-care system, continuity of care will be improved, including access to basic referral care before and during pregnancy, birth, the postpartum period, and throughout childhood.	[Ekman, Bjorn] Lund Univ, Lund, Sweden	Lund University	Liljestrand, J (corresponding author), Gotgangen 12, S-27144 Ystad, Sweden.	jerker@ystad.nu	Sandall, Jane/D-4146-2009; Ekman, Björn/AAB-9240-2022	Sandall, Jane/0000-0003-2000-743X; Ekman, Björn/0000-0001-7630-7904	Partnership for Maternal, Newborn and Child Health; Norwegian Agency for Development Cooperation (Norad); Aga Khan University	Partnership for Maternal, Newborn and Child Health; Norwegian Agency for Development Cooperation (Norad); Aga Khan University	This research was funded by the Partnership for Maternal, Newborn and Child Health, the Norwegian Agency for Development Cooperation (Norad), and the Aga Khan University. The Lancet Alma-Ata Revitalisation Alliance (LAARA) provided valuable comments on an earlier version of the paper.	Barker CE, 2007, REPROD HEALTH MATTER, V15, P81, DOI 10.1016/S0968-8080(07)30331-5; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Borghi J, 2006, LANCET, V368, P1457, DOI 10.1016/S0140-6736(06)69383-5; Bos E, 2007, OBSTET CARE POOR SET; Brinkerhoff DW, 2004, HEALTH POLICY PLANN, V19, P371, DOI 10.1093/heapol/czh052; Burall Simon, 2006, REFORMING INT AID AR; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Cavagnero E, 2008, LANCET, V371, P1284, DOI 10.1016/S0140-6736(08)60563-2; Costello A, 2005, LANCET, V366, P603, DOI 10.1016/S0140-6736(05)66703-7; DESAVIGNY D, 2004, FIXING HLTH SYSTEMS; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; Ensor T, 2004, SOC SCI MED, V58, P237, DOI 10.1016/S0277-9536(03)00007-8; Ensor T, 2005, HEALTH POLICY, V75, P49, DOI 10.1016/j.healthpol.2005.02.002; ERULKAR A, 2007, REACHING DISADVANTAG; *FED REP ETH, 2008, REP PROGR IMPL UN DE; Fofana P, 1997, INT J GYNECOL OBSTET, V59, pS225, DOI 10.1016/S0020-7292(97)00169-0; Freedman LP, 2005, LANCET, V365, P997, DOI 10.1016/S0140-6736(05)71090-4; FREEDMAN LP, 2005, MDG TASK FORCE; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; Germain A, 2004, LANCET, V363, P65, DOI 10.1016/S0140-6736(03)15173-2; GOTTRET P, 2006, HLTH CARE FINANCING; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Green A., 2007, INTRO HLTH PLANNING; Greene M.E., 2005, POVERTY REDUCTION DO; Gwatkin DR, 2004, LANCET, V364, P1557, DOI 10.1016/S0140-6736(04)17324-8; JOHNS B, 2006, B WORLD HEALTH ORGAN, V85, P256; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Klugman Jeni, 2002, SOURCEBOOK POVERTY R; Koblinsky M., 2003, REDUCING MATERNAL MO; Kowalewski Marga, 2002, Afr J Reprod Health, V6, P65, DOI 10.2307/3583147; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; LEVINE R, 2007, ESSENTIAL PUBLIC HLT; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Mayhew SH, 2002, INT FAM PLAN PERSPEC, V28, P220, DOI 10.2307/3088225; Mcnamara P, 2006, HEALTH POLICY PLANN, V21, P101, DOI 10.1093/heapol/czj009; MCPAKE B, 1993, SOC SCI MED, V36, P1397, DOI 10.1016/0277-9536(93)90382-E; *MIN HLTH FAM WELF, 2008, TECHN ANN MAIN REP I; PATHMANATHAN I, 2003, IVNESTING MATERNAL H; Pearson M., 2002, ALLOCATING PUBLIC RE; Powell-Jackson T, 2006, LANCET, V368, P1077, DOI 10.1016/S0140-6736(06)69338-0; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Simms Chris, 2001, BITTEREST PILL ALL C; STENBERG K, 2006, B WORLD HEALTH ORGAN, V85, P305; Stephens C, 2006, LANCET, V367, P2019, DOI 10.1016/S0140-6736(06)68892-2; Tarimo E, 1996, EUR J OBSTET GYN R B, V69, P5, DOI 10.1016/0301-2115(95)02527-8; *UNICEF, 2008, PARTN MAT NEWB CHILD; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; *WHO, 2005, ACH UN HLTH CAR COV; *WHO, 2002, EXPCAP OP RES REPR H; Witter S, 2007, REPROD HEALTH MATTER, V15, P61, DOI 10.1016/S0968-8080(07)30325-X; World Bank, 2004, WORLD DEV REP 2004 M, DOI [10.1596/0-8213-5468-x, DOI 10.1596/0-8213-5468-X]; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization, 2000, WORLD HLTH REP 2000	57	82	84	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					990	1000		10.1016/S0140-6736(08)61408-7	http://dx.doi.org/10.1016/S0140-6736(08)61408-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790321				2022-12-28	WOS:000259266900038
J	Drogemuller, C; Karlsson, EK; Hytonen, MK; Perloski, M; Dolf, G; Sainio, K; Lohi, H; Lindblad-Toh, K; Leeb, T				Droegemueller, Cord; Karlsson, Elinor K.; Hytonen, Marjo K.; Perloski, Michele; Dolf, Gaudenz; Sainio, Kirsi; Lohi, Hannes; Lindblad-Toh, Kerstin; Leeb, Tosso			A mutation in hairless dogs implicates FOXI3 in ectodermal development	SCIENCE			English	Article									[Droegemueller, Cord; Dolf, Gaudenz; Leeb, Tosso] Univ Bern, CH-3001 Bern, Switzerland; [Karlsson, Elinor K.; Perloski, Michele; Lindblad-Toh, Kerstin] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Karlsson, Elinor K.; Perloski, Michele; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02142 USA; [Hytonen, Marjo K.; Sainio, Kirsi] Inst Biomed, Helsinki 00014, Finland; [Hytonen, Marjo K.; Lohi, Hannes] Univ Helsinki, FIN-00014 Helsinki, Finland; [Lindblad-Toh, Kerstin] Uppsala Univ, S-75124 Uppsala, Sweden	University of Bern; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); University of Helsinki; Uppsala University	Leeb, T (corresponding author), Univ Bern, CH-3001 Bern, Switzerland.	Tosso.Leeb@itz.unibe.ch	Leeb, Tosso/G-3187-2014; Lohi, Hannes/F-4596-2011	Leeb, Tosso/0000-0003-0553-4880; Lohi, Hannes/0000-0003-1087-5532; Karlsson, Elinor/0000-0002-4343-3776; Hytonen, Marjo/0000-0003-1976-5874; Drogemuller, Cord/0000-0001-9773-522X	UniBern Research Foundation; Academy of Finland; Sigrid Juselius Foundation.	UniBern Research Foundation; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation.(Sigrid Juselius Foundation)	Supported by the UniBern Research Foundation, the Academy of Finland, and the Sigrid Juselius Foundation.	Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kimura T, 1996, EXP ANIM TOKYO, V45, P1, DOI 10.1538/expanim.45.1; O'Brien DP, 2005, J HERED, V96, P727, DOI 10.1093/jhered/esi086; Ohyama T, 2004, DEV DYNAM, V231, P640, DOI 10.1002/dvdy.20160; ROBINSON R, 1985, J HERED, V76, P217, DOI 10.1093/oxfordjournals.jhered.a110074; VONLINNE C, 1958, SYSTEMA NATURAE, P39	6	118	121	1	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1462	1462		10.1126/science.1162525	http://dx.doi.org/10.1126/science.1162525			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787161				2022-12-28	WOS:000259121800031
J	Cook, DA; Levinson, AJ; Garside, S; Dupras, DM; Erwin, PJ; Montori, VM				Cook, David A.; Levinson, Anthony J.; Garside, Sarah; Dupras, Denise M.; Erwin, Patricia J.; Montori, Victor M.			Internet-based learning in the health professions - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							COMPUTER-BASED INSTRUCTION; MEDICAL-EDUCATION; WEB; IMPACT; QUALITY; STUDENTS; OUTCOMES; REASONS; TRIALS; CARE	Context The increasing use of Internet- based learning in health professions education may be informed by a timely, comprehensive synthesis of evidence of effectiveness. Objectives To summarize the effect of Internet- based instruction for health professions learners compared with no intervention and with non- Internet interventions. Data Sources Systematic search of MEDLINE, Scopus, CINAHL, EMBASE, ERIC, TimeLit, Web of Science, Dissertation Abstracts, and the University of Toronto Research and Development Resource Base from 1990 through 2007. Study Selection Studies in any language quantifying the association of Internet-based instruction and educational outcomes for practicing and student physicians, nurses, pharmacists, dentists, and other health care professionals compared with a no-intervention or non- Internet control group or a preintervention assessment. Data Extraction Two reviewers independently evaluated study quality and abstracted information including characteristics of learners, learning setting, and intervention ( including level of interactivity, practice exercises, online discussion, and duration). Data Synthesis There were 201 eligible studies. Heterogeneity in results across studies was large ( I-2 >= 79%) in all analyses. Effect sizes were pooled using a random effects model. The pooled effect size in comparison to no intervention favored Internet- based interventions and was 1.00 ( 95% confidence interval [ CI], 0.90- 1.10; P < .001; n= 126 studies) for knowledge outcomes, 0.85 ( 95% CI, 0.49- 1.20; P <.001; n= 16) for skills, and 0.82 ( 95% CI, 0.63- 1.02; P <.001; n= 32) for learner behaviors and patient effects. Compared with non- Internet formats, the pooled effect sizes ( positive numbers favoring Internet) were 0.10 ( 95% CI, - 0.12 to 0.32; P=. 37; n= 43) for satisfaction, 0.12 ( 95% CI, 0.003 to 0.24; P=. 045; n= 63) for knowledge, 0.09 ( 95% CI, - 0.26 to 0.44; P=. 61; n= 12) for skills, and 0.51 ( 95% CI, - 0.24 to 1.25; P=. 18; n= 6) for behaviors or patient effects. No important treatment- subgroup interactions were identified. Conclusions Internet- based learning is associated with large positive effects compared with no intervention. In contrast, effects compared with non- Internet instructional methods are heterogeneous and generally small, suggesting effectiveness similar to traditional methods. Future research should directly compare different Internet- based interventions.	[Cook, David A.; Dupras, Denise M.; Erwin, Patricia J.; Montori, Victor M.] Mayo Clin, Coll Med, Div Gen Internal Med, Rochester, MN 55905 USA; [Cook, David A.] Mayo Clin, Off Educ Res, Rochester, MN 55905 USA; [Montori, Victor M.] Mayo Clin, Knowledge & Encounter Res Unit, Rochester, MN 55905 USA; [Levinson, Anthony J.; Garside, Sarah] McMaster Univ, Hamilton, ON, Canada	Mayo Clinic; Mayo Clinic; Mayo Clinic; McMaster University	Cook, DA (corresponding author), Mayo Clin, Coll Med, Div Gen Internal Med, Baldwin 4-A,200 1st St SW, Rochester, MN 55905 USA.	cook.david33@mayo.edu	Levinson, Anthony J./AAB-2735-2019	Levinson, Anthony J./0000-0001-5240-6449; Montori, Victor/0000-0003-0595-2898	Mayo Foundation Education Innovation award	Mayo Foundation Education Innovation award	This work was supported by intramural funds and a Mayo Foundation Education Innovation award.	*ASS AM MED COLL, 2007, EFF US ED TECHN MED; BERNERSLEE T, 1994, COMMUN ACM, V37, P76, DOI 10.1145/179606.179671; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; Chaffin AJ, 2004, CIN-COMPUT INFORM NU, V22, P132, DOI 10.1097/00024665-200405000-00007; Chumley-Jones HS, 2002, ACAD MED, V77, pS86, DOI 10.1097/00001888-200210001-00028; CLARK RE, 1983, REV EDUC RES, V53, P445, DOI 10.2307/1170217; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; COHEN PA, 1992, EVAL HEALTH PROF, V15, P259, DOI 10.1177/016327879201500301; COHEN PA, 1994, COMPUT NURS, V12, P89; Cook DA, 2006, ACAD MED, V81, P231, DOI 10.1097/00001888-200603000-00005; Cook DA, 2005, ACAD MED, V80, P541, DOI 10.1097/00001888-200506000-00005; Cook DA, 2008, PERSPECT BIOL MED, V51, P5, DOI 10.1353/pbm.2008.0007; Cook DA, 2006, MED TEACH, V28, P594, DOI 10.1080/01421590601028854; Cook DA, 2007, CLIN MED, V7, P37, DOI 10.7861/clinmedicine.7-1-37; Cook DA, 2007, MED EDUC, V41, P737, DOI 10.1111/j.1365-2923.2007.02777.x; Curran V, 2006, ACAD MED, V81, pS30, DOI 10.1097/01.ACM.0000236509.32699.f5; Curran VR, 2005, MED EDUC, V39, P561, DOI 10.1111/j.1365-2929.2005.02173.x; Curtin F, 2002, STAT MED, V21, P2131, DOI 10.1002/sim.1205; Davis D, 1999, JAMA-J AM MED ASSOC, V282, P867, DOI 10.1001/jama.282.9.867; Davis MH, 2001, MED TEACH, V23, P441, DOI 10.3109/01421590109177941; Dunlap WP, 1996, PSYCHOL METHODS, V1, P170, DOI 10.1037/1082-989X.1.2.170; FRIEDMAN CP, 1994, ACAD MED, V69, P455, DOI 10.1097/00001888-199406000-00005; Friedman RB, 1996, ACAD MED, V71, P979, DOI 10.1097/00001888-199609000-00013; Greenhalgh T, 2001, BRIT MED J, V322, P40, DOI 10.1136/bmj.322.7277.40; Hammoud M, 2006, AM J OBSTET GYNECOL, V194, P1064, DOI 10.1016/j.ajog.2005.08.023; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Hunter J. E., 2004, METHODS METAANALYSIS; Issenberg SB, 2005, MED TEACH, V27, P10, DOI 10.1080/01421590500046924; KEANE DR, 1991, ACAD MED, V66, P444, DOI 10.1097/00001888-199108000-00005; Kirkpatrick D, 1996, TRAINING DEV, V50, P54; Kobak KA, 2006, J PSYCHIATR RES, V40, P192, DOI 10.1016/j.jpsychires.2005.07.012; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Lewis MJ, 2003, MED TEACH, V25, P204; Lewis MJ, 2001, NURS EDUC TODAY, V21, P26, DOI 10.1054/nedt.2000.0494; MacKenzie J D, 1997, JAMA, V278, P1785, DOI 10.1001/jama.278.21.1785; Marinopoulos Spyridon S, 2007, Evid Rep Technol Assess (Full Rep), P1; Mayer RE, 2005, CAMBRIDGE HDB MULTIM, P31; Mehta M P, 1998, J Cancer Educ, V13, P197; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Morris SB, 2002, PSYCHOL METHODS, V7, P105, DOI 10.1037//1082-989X.7.1.105; Oxman A, 2002, USERS GUIDES INTERAC; Patterson R, 2001, J AM MED INFORM ASSN, V8, P111, DOI 10.1136/jamia.2001.0080111; Potomkova Jarmila, 2006, Biomedical Papers (Olomouc), V150, P357; Reed DA, 2007, JAMA-J AM MED ASSOC, V298, P1002, DOI 10.1001/jama.298.9.1002; Ruiz JG, 2006, ACAD MED, V81, P207, DOI 10.1097/00001888-200603000-00002; Shea JA, 2001, MED EDUC, V35, P319, DOI 10.1046/j.1365-2923.2001.00913.x; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tegtmeyer K, 2001, CRIT CARE MED, V29, pN177, DOI 10.1097/00003246-200108001-00006; Wells G., NEWCASTLE OTTAWA SCA; Wutoh Rita, 2004, J Contin Educ Health Prof, V24, P20, DOI 10.1002/chp.1340240105	52	938	956	9	201	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1181	1196		10.1001/jama.300.10.1181	http://dx.doi.org/10.1001/jama.300.10.1181			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	345ZR	18780847				2022-12-28	WOS:000259038700011
J	Majo, F; Rochat, A; Nicolas, M; Abou Jaoude, G; Barrandon, Y				Majo, Francois; Rochat, Ariane; Nicolas, Michael; Abou Jaoude, Georges; Barrandon, Yann			Oligopotent stem cells are distributed throughout the mammalian ocular surface	NATURE			English	Article							HAIR-FOLLICLES; CORNEAL EPITHELIUM; BASAL CELLS; RENEWAL; LOCATION; KERATINOCYTE; CULTURE; REPAIR	The integrity of the cornea, the most anterior part of the eye, is indispensable for vision. Forty- five million individuals worldwide are bilaterally blind and another 135 million have severely impaired vision in both eyes because of loss of corneal transparency(1); treatments range from local medications to corneal transplants, and more recently to stem cell therapy(2). The corneal epithelium is a squamous epithelium that is constantly renewing, with a vertical turnover of 7 to 14 days in many mammals(3). Identification of slow cycling cells ( label- retaining cells) in the limbus of the mouse has led to the notion that the limbus is the niche for the stem cells responsible for the long- term renewal of the cornea(4); hence, the corneal epithelium is supposedly renewed by cells generated at and migrating from the limbus, in marked opposition to other squamous epithelia in which each resident stem cell has in charge a limited area of epithelium(5,6). Here we show that the corneal epithelium of the mouse can be serially transplanted, is self- maintained and contains oligopotent stem cells with the capacity to generate goblet cells if provided with a conjunctival environment. Furthermore, the entire ocular surface of the pig, including the cornea, contains oligopotent stem cells (holoclones)(7,8) with the capacity to generate individual colonies of corneal and conjunctival cells. Therefore, the limbus is not the only niche for corneal stem cells and corneal renewal is not different from other squamous epithelia. We propose a model that unifies our observations with the literature and explains why the limbal region is enriched in stem cells.	[Majo, Francois; Rochat, Ariane; Nicolas, Michael; Barrandon, Yann] Ecole Polytech Fed Lausanne, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland; [Abou Jaoude, Georges] Ecole Polytech Fed Lausanne, Lab Informat & Visualizat, CH-1015 Lausanne, Switzerland; [Majo, Francois; Rochat, Ariane; Nicolas, Michael; Barrandon, Yann] Univ Lausanne Hosp, CHU Vaudois, Dept Expt Surg, CH-1011 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Barrandon, Y (corresponding author), Ecole Polytech Fed Lausanne, Lab Stem Cell Dynam, CH-1015 Lausanne, Switzerland.	yann.barrandon@epfl.ch			Swiss National Science Foundation [3100A0-104160]; EPFL; CHUV; EuroStemCell; Institut National de la Sante et de la Recherche Medicale (INSERM); Association pour la Recherche contre le Cancer; Association Francaise contre les Myopathies; Federation des Aveugles et Handicapes Visuels de France; INSERM	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL; CHUV; EuroStemCell(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Federation des Aveugles et Handicapes Visuels de France; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	We are grateful to F. Radtke and S. Vauclair for Notch1<SUP>lox/lox</SUP> K14Cre ROSA26R mice, to A. Smith for critical reading of the manuscript, to T. Hoang-Xuan, L. Zografos, F. Munier and S. Kinoshita for continuous support and to L. Schnell, J. Vannod and S. Vermot for excellent technical help. The work was supported by grants to Y. B. from the Swiss National Science Foundation (grant 3100A0-104160), the EPFL, the CHUV and EuroStemCell. The early part of the work was supported by grants to Y. B. from the Institut National de la Sante et de la Recherche Medicale (INSERM), the Association pour la Recherche contre le Cancer and the Association Francaise contre les Myopathies. F. M. was supported by fellowships from the Federation des Aveugles et Handicapes Visuels de France, the INSERM and then the CHUV.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; BARRANDON Y, 1985, P NATL ACAD SCI USA, V82, P5390, DOI 10.1073/pnas.82.16.5390; BUCK RC, 1979, INVEST OPHTH VIS SCI, V18, P767; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Ferraris C, 2000, DEVELOPMENT, V127, P5487; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Haddad A, 2000, CORNEA, V19, P378, DOI 10.1097/00003226-200005000-00024; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kawasaki S, 2006, INVEST OPHTH VIS SCI, V47, P1359, DOI 10.1167/iovs.05-1084; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Nakamura T, 2004, ACTA OPHTHALMOL SCAN, V82, P468, DOI 10.1111/j.1395-3907.2004.00285.x; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; POTTEN CS, 1979, BIOCHIM BIOPHYS ACTA, V560, P281, DOI 10.1016/0304-419X(79)90022-2; PUANGSRICHARERN V, 1995, OPHTHALMOLOGY, V102, P1476; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; SHAPIRO MS, 1981, INVEST OPHTH VIS SCI, V21, P135; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tanioka H, 2006, INVEST OPHTH VIS SCI, V47, P3820, DOI 10.1167/iovs.06-0293; THOFT RA, 1984, AM J OPHTHALMOL, V97, P1; Vauclair S, 2007, DEV CELL, V13, P242, DOI 10.1016/j.devcel.2007.06.012; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214	35	297	307	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 13	2008	456	7219					250	U51		10.1038/nature07406	http://dx.doi.org/10.1038/nature07406			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374JJ	18830243				2022-12-28	WOS:000261039300042
J	McLellan, JS; Zheng, XY; Hauk, G; Ghirlando, R; Beachy, PA; Leahy, DJ				McLellan, Jason S.; Zheng, Xiaoyan; Hauk, Glenn; Ghirlando, Rodolfo; Beachy, Philip A.; Leahy, Daniel J.			The mode of Hedgehog binding to Ihog homologues is not conserved across different phyla	NATURE			English	Article							SONIC HEDGEHOG; CANDIDATE GENE; PROTEINS; CDO; GAS1; ULTRACENTRIFUGATION; EXPRESSION; MUTATIONS; PATHWAY; COMPLEX	Hedgehog ( Hh) proteins specify tissue pattern in metazoan embryos by forming gradients that emanate from discrete sites of expression and elicit concentration- dependent cellular differentiation or proliferation responses(1,2). Cellular responses to Hh and the movement of Hh through tissues are both precisely regulated, and abnormal Hh signalling has been implicated in human birth defects and cancer(3-7). Hh signalling is mediated by its amino- terminal domain ( HhN), which is dually lipidated and secreted as part of a multivalent lipoprotein particle(8-10). Reception of the HhN signal is modulated by several cell- surface proteins on responding cells, including Patched ( Ptc), Smoothened ( Smo), Ihog ( known as CDO or CDON in mammals) and the vertebrate- specific proteins Hip ( also known as Hhip) and Gas1 ( ref. 11). Drosophila Ihog and its vertebrate homologues CDO and BOC contain multiple immunoglobulin and fibronectin type III ( FNIII) repeats, and the first FNIII repeat of Ihog binds Drosophila HhN in a heparin-dependent manner(12,13). Surprisingly, pull- down experiments suggest that a mammalian Sonic hedgehog N- terminal domain ( ShhN) binds a non- orthologous FNIII repeat of CDO12,14. Here we report biochemical, biophysical and X- ray structural studies of a complex between ShhN and the third FNIII repeat of CDO. We show that the ShhN - CDO interaction is completely unlike the HhN - Ihog interaction and requires calcium, which binds at a previously undetected site on ShhN. This site is conserved in nearly all Hh proteins and is a hotspot for mediating interactions between ShhN and CDO, Ptc, Hip and Gas1. Mutations in vertebrate Hh proteins causing holoprosencephaly and brachydactyly type A1 map to this calcium-binding site and disrupt interactions with these partners.	[McLellan, Jason S.; Hauk, Glenn; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zheng, Xiaoyan; Beachy, Philip A.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Beachy, Philip A.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Ghirlando, Rodolfo] NIDDKD, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	Johns Hopkins University; Stanford University; Howard Hughes Medical Institute; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	dleahy@jhmi.edu	Ghirlando, Rodolfo/A-8880-2009; Zheng, Xiaoyan/AAG-1251-2020; McLellan, Jason/A-6874-2010	Zheng, Xiaoyan/0000-0003-4983-5503; McLellan, Jason/0000-0003-3991-542X	Intramural Research Program of the NIH; National Institute of Diabetes and Digestive and Kidney Diseases; National Science Foundation Graduate Research Fellowship; Damon Runyon Cancer Research Foundation [DRG-1915-06];  [R01 HD055545]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD055545] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank R. Abramowitz and J. Schwanof of beamline X4C at the National Synchroton Light Source for assistance with X- ray data collection, C. W. Vander Kooi for suggesting ions may promote Shh - CDO interactions, W. Yang, J. Nathans, W.I. Weis, K.C. Garcia, P.A. Cole and L. M. Amzel for comments on the manuscript, and D. Chan and K. Cheah for communicating results before publication. We thank A. P. McMahon and C. M. Fan for the mouse Hip1 and mouse Gas1 - Fc complementary DNAs, respectively. This research was supported in part by the Intramural Research Program of the NIH, National Institute of Diabetes and Digestive and Kidney Diseases (R.G.). D.J.L. is supported by R01 HD055545 and P.A.B. is an HHMI investigator. J.S.M. is supported by a National Science Foundation Graduate Research Fellowship. X.Z. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-1915-06).	Allen BL, 2007, GENE DEV, V21, P1244, DOI 10.1101/gad.1543607; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Belloni E, 1996, NAT GENET, V14, P353, DOI 10.1038/ng1196-353; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen MH, 2004, GENE DEV, V18, P641, DOI 10.1101/gad.1185804; Chimento DP, 2003, NAT STRUCT BIOL, V10, P394, DOI 10.1038/nsb914; Chuang PT, 1999, NATURE, V397, P617, DOI 10.1038/17611; de la Torre JG, 2000, BIOPHYS J, V78, P719, DOI 10.1016/S0006-3495(00)76630-6; DELSAL G, 1992, CELL, V70, P595, DOI 10.1016/0092-8674(92)90429-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gao B, 2004, CELL RES, V14, P179, DOI 10.1038/sj.cr.7290218; Geisbrecht BV, 2006, PROTEIN EXPRES PURIF, V46, P23, DOI 10.1016/j.pep.2005.09.003; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HALL TMT, 1995, NATURE, V378, P212, DOI 10.1038/378212a0; Harding MM, 1999, ACTA CRYSTALLOGR D, V55, P1432, DOI 10.1107/S0907444999007374; Heussler HS, 2002, ARCH DIS CHILD, V86, P293, DOI 10.1136/adc.86.4.293; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kang JS, 1997, J CELL BIOL, V138, P203, DOI 10.1083/jcb.138.1.203; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; KANG JS, 2007, SCI STKE, V403, pPE50; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Ma Y, 2002, CELL, V111, P63, DOI 10.1016/S0092-8674(02)00977-7; Mann RK, 2004, ANNU REV BIOCHEM, V73, P891, DOI 10.1146/annurev.biochem.73.011303.073933; Martinelli DC, 2007, GENE DEV, V21, P1231, DOI 10.1101/gad.1546307; McLellan JS, 2006, P NATL ACAD SCI USA, V103, P17208, DOI 10.1073/pnas.0606738103; Niedermaier M, 2005, J CLIN INVEST, V115, P900, DOI 10.1172/JCI200523675; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Roessler E, 1996, NAT GENET, V14, P357, DOI 10.1038/ng1196-357; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Tenzen T, 2006, DEV CELL, V10, P647, DOI 10.1016/j.devcel.2006.04.004; Yao SQ, 2006, CELL, V125, P343, DOI 10.1016/j.cell.2006.02.040	38	123	126	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					979	U62		10.1038/nature07358	http://dx.doi.org/10.1038/nature07358			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18794898	Green Accepted			2022-12-28	WOS:000260038300053
J	Annas, GJ				Annas, George J.			Toxic tinkering - Lethal-injection execution and the constitution	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PHYSICIANS PARTICIPATE; ETHICS		[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Annas GJ, 2005, NEW ENGL J MED, V352, P2127, DOI 10.1056/NEJMlim044131; ANNAS GJ, 1985, AM J PUBLIC HEALTH, V75, P1096, DOI 10.2105/AJPH.75.9.1096; [Anonymous], 2006, SO LONG THEY DIE LET; Bybee Jay S., 2005, TORTURE PAPERS ROAD, P172; Caplan, 2007, MAYO CLIN PROC, V82, P1291; Caplan AL, 2007, MAYO CLIN PROC, V82, P1047, DOI 10.4065/82.9.1047-a; Curfman GD, 2008, NEW ENGL J MED, V358, P403, DOI 10.1056/NEJMe0800032; CURRAN WJ, 1980, NEW ENGL J MED, V302, P226, DOI 10.1056/NEJM198001243020410; Denno, 2002, OHIO ST LJ, V63, P63; Denno DW, 2007, FORDHAM LAW REV, V76, P49; Foucault M., 1975, DISCIPLINE PUNISH BI; Gawande A, 2006, NEW ENGL J MED, V354, P1221, DOI 10.1056/NEJMp068042; Gawande A, 2008, NEW ENGL J MED, V358, P448, DOI 10.1056/NEJMp0800378; Groner J.I., 2008, FORDHAM URBAN LAW J, V35, P883; Koniaris LG, 2008, PLOS MED, V5, P845, DOI 10.1371/journal.pmed.0050126; Koniaris LG, 2005, LANCET, V365, P1412, DOI 10.1016/S0140-6736(05)66377-5; LeGraw JM, 2002, HUM RIGHTS QUART, V24, P382, DOI 10.1353/hrq.2002.0027; Liptak Adam Liptak, 2008, NY TIMES        0611; Shah S, 2008, AM CRIM LAW REV, V45, P1101; TRUOG RD, 1993, NEW ENGL J MED, V329, P1346, DOI 10.1056/NEJM199310283291812; VEATCH RM, 1981, THEORY MED ETHICS, P293; Waisel D, 2007, MAYO CLIN PROC, V82, P1073, DOI 10.4065/82.9.1073	22	0	0	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1512	1518		10.1056/NEJMhle0804933	http://dx.doi.org/10.1056/NEJMhle0804933			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354ID	18832251				2022-12-28	WOS:000259631700014
J	Ramamurthi, KS; Losick, R				Ramamurthi, Kumaran S.; Losick, Richard			Grasping at origins	CELL			English	Editorial Material							BACILLUS-SUBTILIS; BIPOLAR LOCALIZATION; CHROMOSOME; PROTEIN; SEGREGATION; REPLICATION; REGIONS; CELLS; DNA	Chromosome segregation in the bacterium Caulobacter crescentus involves propulsion of the replication origin and its capture at one pole of the cell. Bowman et al. (2008) and Ebersbach et al. (2008) now report the discovery of a protein called PopZ that mediates this chromosome capture.	[Ramamurthi, Kumaran S.; Losick, Richard] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Ramamurthi, KS (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	kumaran@mcb.harvard.edu; losick@mcb.harvard.edu	Ramamurthi, Kumaran/P-3516-2015					Ben-Yehuda S, 2005, MOL CELL, V17, P773, DOI 10.1016/j.molcel.2005.02.023; Burton BM, 2007, CELL, V131, P1301, DOI 10.1016/j.cell.2007.11.009; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Lewis PJ, 1997, MOL MICROBIOL, V25, P945, DOI 10.1111/j.1365-2958.1997.mmi530.x; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Reyes-Lamothe R, 2008, CELL, V133, P90, DOI 10.1016/j.cell.2008.01.044; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; Webb CD, 1997, CELL, V88, P667, DOI 10.1016/S0092-8674(00)81909-1	8	2	2	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					916	918		10.1016/j.cell.2008.09.004	http://dx.doi.org/10.1016/j.cell.2008.09.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805084	Bronze			2022-12-28	WOS:000259318100011
J	Arnone, JA; Verburg, PSJ; Johnson, DW; Larsen, JD; Jasoni, RL; Lucchesi, AJ; Batts, CM; von Nagy, C; Coulombe, WG; Schorran, DE; Buck, PE; Braswell, BH; Coleman, JS; Sherry, RA; Wallace, LL; Luo, YQ; Schimel, DS				Arnone, John A., III; Verburg, Paul S. J.; Johnson, Dale W.; Larsen, Jessica D.; Jasoni, Richard L.; Lucchesi, Annmarie J.; Batts, Candace M.; von Nagy, Christopher; Coulombe, William G.; Schorran, David E.; Buck, Paul E.; Braswell, Bobby H.; Coleman, James S.; Sherry, Rebecca A.; Wallace, Linda L.; Luo, Yiqi; Schimel, David S.			Prolonged suppression of ecosystem carbon dioxide uptake after an anomalously warm year	NATURE			English	Article							WATER-VAPOR EXCHANGE; TEMPERATE GRASSLAND; TERRESTRIAL ECOSYSTEMS; TALLGRASS PRAIRIE; PLANT-GROWTH; CO2; VARIABILITY; FLUXES; PRODUCTIVITY; RESPIRATION	Terrestrial ecosystems control carbon dioxide fluxes to and from the atmosphere(1,2) through photosynthesis and respiration, a balance between net primary productivity and heterotrophic respiration, that determines whether an ecosystem is sequestering carbon or releasing it to the atmosphere. Global(1,3-5) and site-specific(6) data sets have demonstrated that climate and climate variability influence biogeochemical processes that determine net ecosystem carbon dioxide exchange (NEE) at multiple timescales. Experimental data necessary to quantify impacts of a single climate variable, such as temperature anomalies, on NEE and carbon sequestration of ecosystems at interannual timescales have been lacking. This derives from an inability of field studies to avoid the confounding effects of natural intra- annual and interannual variability in temperature and precipitation. Here we present results from a four-year study using replicate 12,000-kg intact tallgrass prairie monoliths located in four 184-m(3) enclosed lysimeters(7). We exposed 6 of 12 monoliths to an anomalously warm year in the second year of the study(8) and continuously quantified rates of ecosystem processes, including NEE. We find that warming decreases NEE in both the extreme year and the following year by inducing drought that suppresses net primary productivity in the extreme year and by stimulating heterotrophic respiration of soil biota in the subsequent year. Our data indicate that two years are required for NEE in the previously warmed experimental ecosystems to recover to levels measured in the control ecosystems. This time lag caused net ecosystem carbon sequestration in previously warmed ecosystems to be decreased threefold over the study period, compared with control ecosystems. Our findings suggest that more frequent anomalously warm years(9), a possible consequence of increasing anthropogenic carbon dioxide levels(10), may lead to a sustained decrease in carbon dioxide uptake by terrestrial ecosystems.	[Arnone, John A., III; Verburg, Paul S. J.; Larsen, Jessica D.; Jasoni, Richard L.; Lucchesi, Annmarie J.; Batts, Candace M.; von Nagy, Christopher; Coulombe, William G.; Schorran, David E.; Buck, Paul E.] Univ Nevada, Desert Res Inst, Reno, NV 89512 USA; [Johnson, Dale W.] Univ Nevada, Dept Nat Resources & Environm Sci, Reno, NV 89557 USA; [Braswell, Bobby H.] Univ New Hampshire, Inst Study Earth Oceans & Space, Durham, NH 03824 USA; [Coleman, James S.] Rice Univ, Res Off, Houston, TX 77251 USA; [Coleman, James S.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77251 USA; [Sherry, Rebecca A.; Wallace, Linda L.; Luo, Yiqi] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Schimel, David S.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA	Nevada System of Higher Education (NSHE); Desert Research Institute NSHE; University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno; University System Of New Hampshire; University of New Hampshire; Rice University; Rice University; University of Oklahoma System; University of Oklahoma - Norman; National Center Atmospheric Research (NCAR) - USA	Arnone, JA (corresponding author), Univ Nevada, Desert Res Inst, Reno, NV 89512 USA.	jarnone@dri.edu	Verburg, Paul/B-6351-2014; Braswell, Bobby H/D-6411-2016	Braswell, Bobby H/0000-0002-4061-9516	US National Science Foundation's Integrated Research Challenges in Environmental Biology program; Desert Research Institute (DRI)	US National Science Foundation's Integrated Research Challenges in Environmental Biology program(National Science Foundation (NSF)); Desert Research Institute (DRI)	We thank E. Kessler and the University of Oklahoma for the use of the Kessler Farm Field Laboratory; R. Kreidberg for editorial assistance; and J. Amthor, M. Bahn, C. Korner, D. Obrist and G. Wohlfahrt, for critical review of an early draft of this manuscript. This study was funded by the US National Science Foundation's Integrated Research Challenges in Environmental Biology program, with additional support from the Desert Research Institute (DRI) for necessary upgrades to the EcoCELL facility. We are very grateful to DRI, the University of Oklahoma, and the University of Nevada-Reno teams for technical assistance, facilities support, and administrative expertise (also see Supplementary Information).	350-368, 2005, HIST ATMOSPHERIC CO2, P350; Braswell BH, 1997, SCIENCE, V278, P870, DOI 10.1126/science.278.5339.870; BUNCE JA, 1982, OECOLOGIA, V54, P233, DOI 10.1007/BF00378397; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Grace J, 1998, AUST J PLANT PHYSIOL, V25, P519, DOI 10.1071/PP97120; Griffin KL, 1996, PLANT CELL ENVIRON, V19, P1210, DOI 10.1111/j.1365-3040.1996.tb00437.x; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 PHYS; Keeling CD, 1996, NATURE, V382, P146, DOI 10.1038/382146a0; Knapp AK, 2001, ECOSYSTEMS, V4, P19, DOI 10.1007/s100210000057; Korner Ch, 1994, ECOPHYSIOLOGY PHOTOS, P463; Law BE, 2002, AGR FOREST METEOROL, V113, P97, DOI 10.1016/S0168-1923(02)00104-1; Myneni RB, 1997, NATURE, V386, P698, DOI 10.1038/386698a0; Novick KA, 2004, OECOLOGIA, V138, P259, DOI 10.1007/s00442-003-1388-z; Oren R, 1999, PLANT CELL ENVIRON, V22, P1515, DOI 10.1046/j.1365-3040.1999.00513.x; Randerson JT, 1997, GLOBAL BIOGEOCHEM CY, V11, P535, DOI 10.1029/97GB02268; Reichstein M, 2007, GLOBAL CHANGE BIOL, V13, P634, DOI 10.1111/j.1365-2486.2006.01224.x; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Saleska SR, 1999, GLOB CHANGE BIOL, V5, P125, DOI 10.1046/j.1365-2486.1999.00216.x; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Suyker AE, 2003, GLOBAL CHANGE BIOL, V9, P255, DOI 10.1046/j.1365-2486.2003.00567.x; Tian HQ, 1998, NATURE, V396, P664, DOI 10.1038/25328; Verburg PSJ, 2005, GLOBAL CHANGE BIOL, V11, P1720, DOI 10.1111/j.1365-2486.2005.001032.x; Vourlitis GL, 1999, ECOLOGY, V80, P686, DOI 10.1890/0012-9658(1999)080[0686:ECMOCA]2.0.CO;2; Vukicevic T, 2001, TELLUS B, V53, P150, DOI 10.1034/j.1600-0889.2001.d01-13.x; Wever LA, 2002, AGR FOREST METEOROL, V112, P31, DOI 10.1016/S0168-1923(02)00041-2	26	122	123	10	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					383	386		10.1038/nature07296	http://dx.doi.org/10.1038/nature07296			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800137				2022-12-28	WOS:000259265200043
J	Zerrouki, D; Baudry, J; Pine, D; Chaikin, P; Bibette, J				Zerrouki, D.; Baudry, J.; Pine, D.; Chaikin, P.; Bibette, J.			Chiral colloidal clusters	NATURE			English	Article							PARTICLES; GROWTH	Chirality is an important element of biology, chemistry and physics. Once symmetry is broken and a handedness is established, biochemical pathways are set. In DNA, the double helix arises from the existence of two competing length scales, one set by the distance between monomers in the sugar backbone, and the other set by the stacking of the base pairs(1). Here we use a colloidal system to explore a simple forcing route to chiral structures. To do so we have designed magnetic colloids that, depending on both their shape and induced magnetization, self- assemble with controlled helicity. We model the two length scales with asymmetric colloidal dumbbells linked by a magnetic belt at their waist. In the presence of a magnetic field the belts assemble into a chain and the steric constraints imposed by the asymmetric spheres force the chain to coil. We show that if the size ratio between the spheres is large enough, a single helicity is adopted, right or left. The realization of chiral colloidal clusters opens up a new link between colloidal science and chemistry. These colloidal clusters may also find use as mesopolymers, as optical and light- activated structures(2), and as models for enantiomeric separation.	[Zerrouki, D.; Baudry, J.; Bibette, J.] UPMC, CNRS, ESPCI, Lab Colloides & Mat Divises, F-75005 Paris, France; [Pine, D.; Chaikin, P.] NYU, Dept Phys, Ctr Soft Matter Res, New York, NY 10003 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); Sorbonne Universite; New York University	Bibette, J (corresponding author), UPMC, CNRS, ESPCI, Lab Colloides & Mat Divises, 10 Rue Vauquelin, F-75005 Paris, France.	jerome.bibette@espci.fr	Baudry, Jean/AAX-6267-2020; Pine, David J/B-7740-2016; Zerrouki, Djamal/W-7183-2019; Baudry, Jean/A-7344-2016	Baudry, Jean/0000-0002-5526-499X; Pine, David J/0000-0002-3304-6684; Zerrouki, Djamal/0000-0001-8038-9877; Baudry, Jean/0000-0002-5526-499X				[Anonymous], 1991, INTRO POLYM; BIBETTE J, 1992, PHYS REV LETT, V69, P981, DOI 10.1103/PhysRevLett.69.981; Dreyfus R, 2005, NATURE, V437, P862, DOI 10.1038/nature04090; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Goubault C, 2005, LANGMUIR, V21, P3725, DOI 10.1021/la0471442; Leunissen ME, 2005, NATURE, V437, P235, DOI 10.1038/nature03946; Manoharan VN, 2003, SCIENCE, V301, P483, DOI 10.1126/science.1086189; Savage JR, 2006, SCIENCE, V314, P795, DOI 10.1126/science.1128649; STOBER W, 1968, J COLLOID INTERF SCI, V26, P62, DOI 10.1016/0021-9797(68)90272-5; Stradner A, 2004, NATURE, V432, P492, DOI 10.1038/nature03109; Tandon S, 2004, J MAGN MAGN MATER, V271, P27, DOI 10.1016/j.jmmm.2003.09.010; Warren S., 2000, ORGANIC CHEM; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Yin YD, 2003, J AM CHEM SOC, V125, P2048, DOI 10.1021/ja029408h; Zerrouki D, 2006, LANGMUIR, V22, P57, DOI 10.1021/la051765t	15	292	298	9	222	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					380	382		10.1038/nature07237	http://dx.doi.org/10.1038/nature07237			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800136	Green Submitted			2022-12-28	WOS:000259265200042
J	Qaseem, A; Snow, V; Shekelle, P; Hopkins, R; Forciea, MA; Owens, DK				Qaseem, Amir; Snow, Vincenza; Shekelle, Paul; Hopkins, Robert, Jr.; Forciea, Mary Ann; Owens, Douglas K.		Clinical Efficacy Assessment Subco	Pharmacologic treatment of low bone density or osteoporosis to prevent fractures: A clinical practice guideline from the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIAL; CYCLICAL ETIDRONATE THERAPY; CORTICOSTEROID-INDUCED OSTEOPOROSIS; HORMONE REPLACEMENT THERAPY; EARLY POSTMENOPAUSAL WOMEN; VITAMIN-D SUPPLEMENTATION; ESTROGEN PLUS PROGESTIN; ONCE-WEEKLY ALENDRONATE; PRIMARY BILIARY-CIRRHOSIS; PLACEBO-CONTROLLED TRIAL	Description: The American College of Physicians (ACP) developed this guideline to present the available evidence on various pharmacologic treatments to prevent fractures in men and women with low bone density or osteoporosis. Methods: Published literature on this topic was identified by using MEDLINE (1966 to December 2006), the ACP Journal Club database, the Cochrane Central Register of Controlled Trials (no date limits), the Cochrane Database of Systematic Reviews (no date limits), Web sites of the United Kingdom National Institute of Health and Clinical Excellence (no date limits), and the United Kingdom Health Technology Assessment Program (January 1998 to December 2006). Searches were limited to English-language publications and human studies. Keywords for search included terms for osteoporosis, osteopenia, low bone density, and the drugs listed in the key questions. This guideline grades the evidence and recommendations according to the ACP's clinical practice guidelines grading system.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Univ Penn, Philadelphia, PA 19104 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Santa Monica, CA USA; RAND, Santa Monica, CA USA; Univ Arkansas, Little Rock, AR 72204 USA; Stanford Univ, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Stanford, CA USA	American College of Physicians; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; RAND Corporation; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org			the American College of Physicians' operating budget	the American College of Physicians' operating budget	Financial support for the development of this guideline comes exclusively from the American College of Physicians' operating budget.	Adachi JD, 1997, NEW ENGL J MED, V337, P382, DOI 10.1056/NEJM199708073370603; Adachi JD, 2001, ARTHRITIS RHEUM, V44, P202, DOI 10.1002/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W; Adami S, 2000, J ENDOCRINOL INVEST, V23, P310, DOI 10.1007/BF03343728; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Aris RM, 2000, AM J RESP CRIT CARE, V162, P941, DOI 10.1164/ajrccm.162.3.2002051; Avenell A, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000227.pub2; Bischoff-Ferrari HA, 2005, JAMA-J AM MED ASSOC, V293, P2257, DOI 10.1001/jama.293.18.2257; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Blair MM, 2000, J FAM PRACTICE, V49, P839; Body JJ, 2002, J CLIN ENDOCR METAB, V87, P4528, DOI 10.1210/jc.2002-020334; Bone HG, 2000, J CLIN ENDOCR METAB, V85, P720, DOI 10.1210/jc.85.2.720; Bonnick S, 2006, J CLIN ENDOCR METAB, V91, P2631, DOI 10.1210/jc.2005-2602; Boonen S, 2005, OSTEOPOROSIS INT, V16, P1291, DOI 10.1007/s00198-005-1945-x; Boutsen Y, 1997, CALCIFIED TISSUE INT, V61, P266, DOI 10.1007/s002239900334; Brumsen C, 2002, J BONE MINER RES, V17, P1057, DOI 10.1359/jbmr.2002.17.6.1057; Campbell IA, 2004, THORAX, V59, P761, DOI 10.1136/thx.2003.013839; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cherry N, 2002, LANCET, V360, P2001; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; Coco M, 2003, J AM SOC NEPHROL, V14, P2669, DOI 10.1097/01.ASN.0000087092.53894.80; Cohen S, 1999, ARTHRITIS RHEUM, V42, P2309, DOI 10.1002/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K; Cortet B, 1999, REV RHUM, V66, P214; Cranney A, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003376.pub2; Cranney A, 2000, Cochrane Database Syst Rev, pCD001983; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Cranney A, 2002, ENDOCR REV, V23, P517, DOI 10.1210/er.2001-3002; Cranney A, 2002, ENDOCR REV, V23, P540, DOI 10.1210/er.2001-6002; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Draper MW, 1996, J BONE MINER RES, V11, P835; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Fukunaga M, 2002, OSTEOPOROSIS INT, V13, P971, DOI 10.1007/s001980200135; Gallagher JC, 2005, J CLIN ENDOCR METAB, V90, P1583, DOI 10.1210/jc.2004-0826; GarciaDelgado I, 1997, CALCIFIED TISSUE INT, V60, P155, DOI 10.1007/s002239900206; Geusens P, 1998, ANN RHEUM DIS, V57, P724, DOI 10.1136/ard.57.12.724; Geusens P., 1997, Bone (New York), V20, p9S; Grady D, 2004, OBSTET GYNECOL, V104, P837, DOI 10.1097/01.AOG.0000137349.79204.b8; Grant AM, 2005, LANCET, V365, P1621, DOI 10.1016/S0140-6736(05)63013-9; Greenspan SL, 2003, JAMA-J AM MED ASSOC, V289, P2525, DOI 10.1001/jama.289.19.2525; Greenspan SL, 2007, J CLIN ENDOCR METAB, V92, P131, DOI 10.1210/jc.2006-1272; Grotz W, 2001, J AM SOC NEPHROL, V12, P1530, DOI 10.1681/ASN.V1271530; Guanabens N, 2003, AM J GASTROENTEROL, V98, P2268, DOI 10.1016/S0002-9270(03)00550-1; Hay JE, 2001, J HEPATOL, V34, P292, DOI 10.1016/S0168-8278(00)00093-3; Heath DA, 2000, J CLIN DENSITOM, V3, P27, DOI 10.1385/JCD:3:1:027; Heckbert SR, 2008, ARCH INTERN MED, V168, P826, DOI 10.1001/archinte.168.8.826; Herd RJM, 1997, AM J MED, V103, P92, DOI 10.1016/S0002-9343(97)00019-3; Homik J, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001347, DOI 10.1002/14651858.CD001347]; Homik JE, 1999, J RHEUMATOL, V26, P1148; Hooper MJ, 2005, CLIMACTERIC, V8, P251, DOI 10.1080/13697130500118126; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Hosking D, 2003, CURR MED RES OPIN, V19, P383, DOI 10.1185/030079903125002009; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Ishida Y, 2004, AM J MED, V117, P549, DOI 10.1016/j.amjmed.2004.05.019; Iwamoto Jun, 2003, Keio Journal of Medicine, V52, P230; Jackson RD, 2006, NEW ENGL J MED, V354, P669, DOI 10.1056/NEJMoa055218; Jamal SA, 2007, J BONE MINER RES, V22, P503, DOI 10.1359/JBMR.070112; Johnell O, 2002, J CLIN ENDOCR METAB, V87, P985, DOI 10.1210/jc.87.3.985; Johnston CC, 2000, ARCH INTERN MED, V160, P3444, DOI 10.1001/archinte.160.22.3444; Jolly EE, 2003, MENOPAUSE, V10, P337, DOI 10.1097/01.GME.0000058772.59606.2A; Kanaji A, 2006, LEPROSY REV, V77, P147; Kananen K, 2005, J CLIN ENDOCR METAB, V90, P3877, DOI 10.1210/jc.2004-2161; Kanis JA, 1999, QJM-MON J ASSOC PHYS, V92, P143, DOI 10.1093/qjmed/92.3.143; Karpf DB, 1997, JAMA-J AM MED ASSOC, V277, P1159; Kaufman JM, 2005, OSTEOPOROSIS INT, V16, P510, DOI 10.1007/s00198-004-1713-3; Kim SH, 2004, AM J MED, V116, P524, DOI 10.1016/j.amjmed.2003.12.019; Kung AWC, 2003, J CLIN ENDOCR METAB, V88, P3130, DOI 10.1210/jc.2002-021855; Kushida K, 2004, J BONE MINER METAB, V22, P469, DOI 10.1007/s00774-004-0509-z; Lees B, 1996, OSTEOPOROSIS INT, V6, P480, DOI 10.1007/BF01629581; Luckey M, 2004, MENOPAUSE, V11, P405, DOI 10.1097/01.GME.0000119981.77837.1F; Lufkin EG, 1998, J BONE MINER RES, V13, P1747, DOI 10.1359/jbmr.1998.13.11.1747; LUFKIN EG, 1992, ANN INTERN MED, V117, P1, DOI 10.7326/0003-4819-117-1-1; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Lyons RA, 2007, OSTEOPOROSIS INT, V18, P811, DOI 10.1007/s00198-006-0309-5; MACLEAN C, COMP EFFECTIVENESS R, V12; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; McClung MR, 2004, J BONE MINER RES, V19, P11, DOI 10.1359/JBMR.0301202; Meunier PJ, 1999, OSTEOPOROSIS INT, V10, P330, DOI 10.1007/s001980050236; Meunier PJ, 1997, J CLIN ENDOCR METAB, V82, P2784, DOI 10.1210/jc.82.9.2784; Michalska D, 2006, J CLIN ENDOCR METAB, V91, P870, DOI 10.1210/jc.2004-2212; Milgrom C, 2004, BONE, V35, P418, DOI 10.1016/j.bone.2004.04.016; Miller PD, 2005, J BONE MINER RES, V20, P2105, DOI 10.1359/JBMR.050817; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mosekilde L, 2000, MATURITAS, V36, P181, DOI 10.1016/S0378-5122(00)00158-4; Muscoso E, 2004, Eur Rev Med Pharmacol Sci, V8, P97; Nguyen ND, 2006, J BONE MINER RES, V21, P340, DOI 10.1359/JBMR.050903; *NIH CONS DEV PROG, 2007, OST PREV DIAGN THER; Ninkovic M, 2002, J HEPATOL, V37, P93, DOI 10.1016/S0168-8278(02)00100-9; Notelovitz M, 2002, MENOPAUSE, V9, P343, DOI 10.1097/00042192-200209000-00007; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Palmer SC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005015.pub2; Palomba S, 2005, OSTEOPOROSIS INT, V16, P1141, DOI 10.1007/s00198-005-1927-z; Papadimitropoulos E, 2002, ENDOCR REV, V23, P560, DOI 10.1210/er.2001-8002; Papapoulos SE, 2005, OSTEOPOROSIS INT, V16, P468, DOI 10.1007/s00198-004-1725-z; Pitt P, 1998, THORAX, V53, P351, DOI 10.1136/thx.53.5.351; Porthouse J, 2005, BMJ-BRIT MED J, V330, P1003, DOI 10.1136/bmj.330.7498.1003; Prince RL, 2006, ARCH INTERN MED, V166, P869, DOI 10.1001/archinte.166.8.869; Qaseem A, 2008, ANN INTERN MED, V148, P680, DOI 10.7326/0003-4819-148-9-200805060-00008; Quandt SA, 2005, MAYO CLIN PROC, V80, P343, DOI 10.4065/80.3.343; Ravn P, 1996, BONE, V19, P527, DOI 10.1016/S8756-3282(96)00229-3; Recker R, 2004, BONE, V34, P890, DOI 10.1016/j.bone.2004.01.008; Recker RR, 2007, BONE, V40, P843, DOI 10.1016/j.bone.2006.11.001; Recker RR, 1999, ANN INTERN MED, V130, P897, DOI 10.7326/0003-4819-130-11-199906010-00005; Reid DM, 2000, J BONE MINER RES, V15, P1006, DOI 10.1359/jbmr.2000.15.6.1006; Reid IR, 2006, AM J MED, V119, P777, DOI 10.1016/j.amjmed.2006.02.038; Reid IR, 2004, ARCH INTERN MED, V164, P871, DOI 10.1001/archinte.164.8.871; REID IR, 1988, LANCET, V1, P143; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; REID IR, 1994, J CLIN ENDOCR METAB, V79, P1595, DOI 10.1210/jc.79.6.1595; Richy F, 2004, OSTEOPOROSIS INT, V15, P301, DOI 10.1007/s00198-003-1570-5; Richy F, 2005, CALCIFIED TISSUE INT, V76, P176, DOI 10.1007/s00223-004-0005-4; Rosen CJ, 2005, J BONE MINER RES, V20, P141, DOI 10.1359/jbmr.2005.20.1.141; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Roux C, 1998, J CLIN ENDOCR METAB, V83, P1128, DOI 10.1210/jc.83.4.1128; Rubin MR, 2003, J CLIN ENDOCR METAB, V88, P1174, DOI 10.1210/jc.2002-020667; Ryan PJ, 2000, OSTEOPOROSIS INT, V11, P171, DOI 10.1007/PL00004179; Saag KG, 1998, NEW ENGL J MED, V339, P292, DOI 10.1056/NEJM199807303390502; Sato S, 2003, J RHEUMATOL, V30, P2673; Sato Y, 2000, J BONE MINER RES, V15, P2487, DOI 10.1359/jbmr.2000.15.12.2487; Sato Y, 2005, ARCH INTERN MED, V165, P1737, DOI 10.1001/archinte.165.15.1737; Sato Y, 2005, NEUROLOGY, V64, P811, DOI 10.1212/01.WNL.0000152871.65027.76; Sato Y, 2005, ARCH INTERN MED, V165, P1743, DOI 10.1001/archinte.165.15.1743; Sato Y, 2004, AM J PHYS MED REHAB, V83, P298, DOI 10.1097/01.PHM.0000122877.28631.23; Sato Y, 2006, BONE, V39, P1080, DOI 10.1016/j.bone.2006.04.025; Sato Y, 2006, MOVEMENT DISORD, V21, P924, DOI 10.1002/mds.20825; Sawka AM, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-39; Seeman E, 2006, OSTEOPOROSIS INT, V17, P313, DOI 10.1007/s00198-005-2030-1; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; SILBERSTEIN EB, 1992, J NUCL MED, V33, P1; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Sorensen OH, 2003, BONE, V32, P120, DOI 10.1016/S8756-3282(02)00946-8; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Stevenson M, 2005, HEALTH TECHNOL ASSES, V9, P1; Tang BMP, 2007, LANCET, V370, P657, DOI 10.1016/S0140-6736(07)61342-7; Tauchmanova L, 2006, BONE MARROW TRANSPL, V37, P81, DOI 10.1038/sj.bmt.1705196; Torgerson D J, 2001, BMC Musculoskelet Disord, V2, P7, DOI 10.1186/1471-2474-2-7; Torgerson DJ, 2001, JAMA-J AM MED ASSOC, V285, P2891, DOI 10.1001/jama.285.22.2891; Toth E, 2005, BONE, V36, P47, DOI 10.1016/j.bone.2004.09.003; Trovas GP, 2002, J BONE MINER RES, V17, P521, DOI 10.1359/jbmr.2002.17.3.521; U.S. Preventive Services Task Force, 2002, SCREEN OST POSTM WOM; Uchida S, 2005, J BONE MINER METAB, V23, P382, DOI 10.1007/s00774-005-0616-5; Ushiroyama T, 2001, MATURITAS, V40, P229, DOI 10.1016/S0378-5122(01)00243-2; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; Vogel VG, 2006, JAMA-J AM MED ASSOC, V295, P2727, DOI 10.1001/jama.295.23.joc60074; Wallach S, 2000, CALCIFIED TISSUE INT, V67, P277, DOI 10.1007/s002230001146; Wells G, 2002, ENDOCR REV, V23, P529, DOI 10.1210/er.2001-5002; Wimalawansa SJ, 1998, AM J MED, V104, P219, DOI 10.1016/S0002-9343(98)00029-1; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; World Health Organization, 2007, REPORT WORLD HLTH OR; Zein CO, 2005, HEPATOLOGY, V42, P762, DOI 10.1002/hep.20866; Zheng SR, 2003, CHINESE MED J-PEKING, V116, P1127	151	137	139	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					404	W77		10.7326/0003-4819-149-6-200809160-00007	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00007			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794560				2022-12-28	WOS:000259230200005
J	Bertucci, C; Achilleos, N; Dougherty, MK; Modolo, R; Coates, AJ; Szego, K; Masters, A; Ma, Y; Neubauer, FM; Garnier, P; Wahlund, JE; Young, DT				Bertucci, C.; Achilleos, N.; Dougherty, M. K.; Modolo, R.; Coates, A. J.; Szego, K.; Masters, A.; Ma, Y.; Neubauer, F. M.; Garnier, P.; Wahlund, J. -E.; Young, D. T.			The magnetic memory of Titan's ionized atmosphere	SCIENCE			English	Article							PLASMA	After 3 years and 31 close flybys of Titan by the Cassini Orbiter, Titan was finally observed in the shocked solar wind, outside of Saturn's magnetosphere. These observations revealed that Titan's flow- induced magnetosphere was populated by "fossil" fields originating from Saturn, to which the satellite was exposed before its excursion through the magnetopause. In addition, strong magnetic shear observed at the edge of Titan's induced magnetosphere suggests that reconnection may have been involved in the replacement of the fossil fields by the interplanetary magnetic field.	[Bertucci, C.; Dougherty, M. K.; Masters, A.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Space & Atmospher Phys Grp, London SW7 2AZ, England; [Achilleos, N.] UCL, Atmospher Phys Lab, Dept Phys & Astron, London WC1E 6BT, England; [Achilleos, N.; Coates, A. J.] UCL, Ctr Planetary Sci, London WC1E 6BT, England; [Modolo, R.] Univ Iowa, Dept Phys & Astron, Iowa City, IA 52242 USA; [Coates, A. J.] UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Szego, K.] KFKI Res Inst Particle & Nucl Phys, H-1121 Budapest, Hungary; [Ma, Y.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90025 USA; [Neubauer, F. M.] Univ Cologne, Inst Geophys & Meteorol, D-50923 Cologne, Germany; [Garnier, P.; Wahlund, J. -E.] Swedish Inst Space Phys, SE-75121 Uppsala, Sweden; [Young, D. T.] SW Res Inst, San Antonio, TX 78227 USA	Imperial College London; University of London; University College London; University of London; University College London; University of Iowa; University of London; University College London; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Wigner Research Centre for Physics; University of California System; University of California Los Angeles; University of Cologne; Southwest Research Institute	Bertucci, C (corresponding author), Inst Astron & Fis Espacio, Ciudad Univ, RA-1428 Buenos Aires, DF, Argentina.	cbertucci@iafe.uba.ar	Ma, Yingjuan/B-4895-2017; Bertucci, Cesar/GOG-8941-2022; Wahlund, Jan-Erik/AAL-6439-2021; Achilleos, Nicholas/C-1647-2008; Coates, Andrew/C-2396-2008	Ma, Yingjuan/0000-0003-2584-7091; Coates, Andrew/0000-0002-6185-3125; Bertucci, Cesar/0000-0002-2540-5384; Masters, Adam/0000-0002-7209-7732; Achilleos, Nicholas/0000-0002-5886-3509	Science and Technology Facilities Council Postdoctoral Fellowship; Science and Technology Facilities Council [PP/E001076/1, PP/D000912/1, PP/E001173/1] Funding Source: researchfish; UK Space Agency [PP/D00084X/1] Funding Source: researchfish; STFC [PP/E001173/1, PP/E001076/1, PP/D000912/1] Funding Source: UKRI	Science and Technology Facilities Council Postdoctoral Fellowship(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency; STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank A. Balogh, T. Horbury, W.S. Kurth, C. Mazelle, S.J. Schwartz, and C.T. Russell for useful discussions, and N. Powell for artwork. C. B. was supported by a Science and Technology Facilities Council Postdoctoral Fellowship.	Arridge CS, 2006, J GEOPHYS RES-SPACE, V111, DOI 10.1029/2005JA011574; Backes H, 2005, SCIENCE, V308, P992, DOI 10.1126/science.1109763; BACKES H, 2005, THESIS U COLOGNE GER; Coates AJ, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030919; Dougherty MK, 2004, SPACE SCI REV, V114, P331, DOI 10.1007/s11214-004-1432-2; Gurnett DA, 2004, SPACE SCI REV, V114, P395, DOI 10.1007/s11214-004-1434-0; Hartle RE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024817; Kivelson MG, 2006, SCIENCE, V311, P1391, DOI 10.1126/science.1124494; Masters A, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013276; McAndrews HJ, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012581; NESS NF, 1982, J GEOPHYS RES-SPACE, V87, P1369, DOI 10.1029/JA087iA03p01369; Neubauer F.M., 1984, SATURN, P760; NIEDNER MB, 1978, ASTROPHYS J, V223, P655, DOI 10.1086/156299; SZEGO K, 2007, GEOPHYS RES LETT, V34; Wahlund JE, 2005, SCIENCE, V308, P986, DOI 10.1126/science.1109807; Young DT, 2004, SPACE SCI REV, V114, P1, DOI 10.1007/s11214-004-1406-4	16	105	105	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1475	1478		10.1126/science.1159780	http://dx.doi.org/10.1126/science.1159780			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787164				2022-12-28	WOS:000259121800036
J	Finke, DL; Snyder, WE				Finke, Deborah L.; Snyder, William E.			Niche partitioning increases resource exploitation by diverse communities	SCIENCE			English	Article							BIODIVERSITY; NITROGEN; IMPACTS; PREY	Classical ecological theory suggests that the coexistence of consumer species is fostered by resource- use differences, leading to greater resource use in communities with more species. However, explicit empirical support for this idea is lacking, because resource use by species is generally confounded with other species- specific attributes. We overcame this obstacle by co- opting behavioral plasticity in food choice among a group of animal consumers, allowing us to manipulate patterns of resource use while controlling for the effects of species identity and diversity. Within an aphid- parasitoid- radish community, we created a fully factorial manipulation of consumer resource- use breadth ( specialist versus generalist) and species diversity ( one versus three species) and found that resource exploitation improved with greater specialist, but not generalist, diversity. Therefore, resource partitioning, and not diversity per se, fostered greater overall resource consumption in our multispecies consumer communities.	[Finke, Deborah L.; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Finke, Deborah L.] Univ Missouri, Div Plant Sci, Columbia, MO 65211 USA	Washington State University; University of Missouri System; University of Missouri Columbia	Finke, DL (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	finked@missouri.edu		Snyder, William/0000-0002-2747-3102	National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service [2004-01215]	National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	We thank A. Ives, J. Owen, A. Storfer, C. Straub, and anonymous reviewers for comments. This project was supported by the National Research Initiative of the U. S. Department of Agriculture Cooperative Research, Education and Extension Service, grant 2004-01215.	Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; Bukovinszky T, 2008, SCIENCE, V319, P804, DOI 10.1126/science.1148310; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Chalcraft DR, 2003, ECOLOGY, V84, P2407, DOI 10.1890/02-0550; Chase J.M., 2009, ECOLOGICAL NICHES LI; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Fridley JD, 2003, J ECOL, V91, P396, DOI 10.1046/j.1365-2745.2003.00775.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; May R.M., 1973, STABILITY COMPLEXITY; McKane RB, 2002, NATURE, V415, P68, DOI 10.1038/415068a; Nufio CR, 2001, ENTOMOL EXP APPL, V99, P273, DOI 10.1023/A:1019204817341; Pike KS, 2000, P ENTOMOL SOC WASH, V102, P688; Snyder WE, 2006, ECOL LETT, V9, P789, DOI 10.1111/j.1461-0248.2006.00922.x; Tilman D, 1997, SCIENCE, V277, P1300, DOI 10.1126/science.277.5330.1300; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Tunings T.C., 1992, INSECT LEARNING ECOL, P51; Wilby A, 2002, ECOL LETT, V5, P353, DOI 10.1046/j.1461-0248.2002.00331.x; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	30	269	277	4	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1488	1490		10.1126/science.1160854	http://dx.doi.org/10.1126/science.1160854			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787167	Green Submitted			2022-12-28	WOS:000259121800040
J	Roy, K				Roy, Kaustuv			Evolution - Dynamics of body size evolution	SCIENCE			English	Editorial Material							COPES RULE; CLIMATE-CHANGE; EXTINCTION; DISTRIBUTIONS; TEMPERATURE; SELECTIVITY; PATTERNS		[Roy, Kaustuv] Univ Calif San Diego, Sect Ecol Behav & Evolut, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Roy, K (corresponding author), Univ Calif San Diego, Sect Ecol Behav & Evolut, 9500 Gilman Dr, La Jolla, CA 92093 USA.	kroy@ucsd.edu						Allen CR, 2006, ECOL LETT, V9, P630, DOI 10.1111/j.1461-0248.2006.00902.x; BLACKBURN TM, 1994, TRENDS ECOL EVOL, V9, P471, DOI 10.1016/0169-5347(94)90311-5; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Clauset A, 2008, SCIENCE, V321, P399, DOI 10.1126/science.1157534; Fenberg PB, 2008, MOL ECOL, V17, P209, DOI 10.1111/j.1365-294X.2007.03522.x; GASTON KJ, 1995, PHILOS T R SOC B, V347, P205, DOI 10.1098/rstb.1995.0022; Hunt G, 2006, P NATL ACAD SCI USA, V103, P1347, DOI 10.1073/pnas.0510550103; JABLONSKI D, 1995, SCIENCE, V268, P389, DOI 10.1126/science.11536722; Jablonski D, 1997, NATURE, V385, P250, DOI 10.1038/385250a0; Kammenga JE, 2007, PLOS GENET, V3, P358, DOI 10.1371/journal.pgen.0030034; Kingsolver JG, 2008, EVOL ECOL RES, V10, P251; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; Myers RA, 2005, PHILOS T R SOC B, V360, P13, DOI 10.1098/rstb.2004.1573; SMITH FA, 1995, SCIENCE, V270, P2012, DOI 10.1126/science.270.5244.2012; Smith JT, 2006, PALEOBIOLOGY, V32, P408, DOI 10.1666/05078.1; STANLEY SM, 1973, EVOLUTION, V27, P1, DOI 10.1111/j.1558-5646.1973.tb05912.x	16	21	22	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1451	1452		10.1126/science.1163097	http://dx.doi.org/10.1126/science.1163097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787156	Green Submitted			2022-12-28	WOS:000259121800026
J	Zheng, XW; Pontes, O; Zhu, JH; Miki, D; Zhang, F; Li, WX; Iida, K; Kapoor, A; Pikaard, CS; Zhu, JK				Zheng, Xianwu; Pontes, Olga; Zhu, Jianhua; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Pikaard, Craig S.; Zhu, Jian-Kang			ROS3 is an RNA-binding protein required for DNA demethylation in Arabidopsis	NATURE			English	Article							GLYCOSYLASE/LYASE ROS1; METHYLATION PATTERNS; ABSCISIC-ACID; HUMAN-CELLS; PLANTS; PATHWAYS; REPLICATION; MICRORNAS; DEMETER; TARGETS	DNA methylation is an important epigenetic mark for transcriptional gene silencing ( TGS) in diverse organisms(1-6). Recent studies suggest that the methylation status of a number of genes is dynamically regulated by methylation and demethylation(7-10). In Arabidopsis, active DNA demethylation is mediated by the ROS1 ( repressor of silencing 1) subfamily of 5- methylcytosine DNA glycosylases through a base excision repair pathway(8,10-13). These demethylases have critical roles in erasing DNA methylation and preventing TGS of target genes(7,8,10). However, it is not known how the demethylases are targeted to specific sequences. Here we report the identification of ROS3, an essential regulator of DNA demethylation that contains an RNA recognition motif. Analysis of ros3 mutants and ros1ros3 double mutants suggests that ROS3 acts in the same genetic pathway as ROS1 to prevent DNA hypermethylation and TGS. Gel mobility shift assays and analysis of ROS3 immunoprecipitate from plant extracts shows that ROS3 binds to small RNAs in vitro and in vivo. Immunostaining shows that ROS3 and ROS1 proteins co-localize in discrete foci dispersed throughout the nucleus. These results demonstrate a critical role for ROS3 in preventing DNA hypermethylation and suggest that DNA demethylation by ROS1 may be guided by RNAs bound to ROS3.	[Zheng, Xianwu; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA; [Zheng, Xianwu; Miki, Daisuke; Zhang, Fei; Li, Wen-Xue; Iida, Kei; Kapoor, Avnish; Zhu, Jian-Kang] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Pontes, Olga; Pikaard, Craig S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Zhu, Jianhua] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Zhang, Fei] Shanghai Jiao Tong Univ, Plant Biotechnol Res Ctr, Sch Agr & Biol, Shanghai 200240, Peoples R China	University of California System; University of California Riverside; University of California System; University of California Riverside; Washington University (WUSTL); University System of Maryland; University of Maryland College Park; Shanghai Jiao Tong University	Zhu, JK (corresponding author), Univ Calif Riverside, Ctr Plant Cell Biol, Riverside, CA 92521 USA.	jian-kang.zhu@ucr.edu	Zhu, Jianhua/F-7127-2013; Zhu, Jian-Kang/F-7658-2011; Pontes, Olga MF/F-9768-2011; Grieshaber-Bouyer, Ricardo/R-7512-2016; Pikaard, Craig S/K-8772-2012	Zhu, Jian-Kang/0000-0001-5134-731X; Pontes, Olga MF/0000-0003-3316-1145; Grieshaber-Bouyer, Ricardo/0000-0002-2873-5135; Pikaard, Craig S/0000-0001-8204-7459; Miki, Daisuke/0000-0001-6066-3357; IIDA, Kei/0000-0001-7130-8705	National Institutes of Health [R01GM070795, R01GM059138, R01GM077590, 1R01GM060380]; Edward Mallinckrodt Foundation; China Scholarship Council [2007104542]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077590, R01GM059138, R01GM070795, R01GM060380] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward Mallinckrodt Foundation; China Scholarship Council(China Scholarship Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grants R01GM070795 and R01GM059138 (J.-K.Z.), R01GM077590 and 1R01GM060380 (C.S.P.), Edward Mallinckrodt Foundation (O.P.) and China Scholarship Council scholarship 2007104542 (F.Z.).	Agius F, 2006, P NATL ACAD SCI USA, V103, P11796, DOI 10.1073/pnas.0603563103; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, ANNU REV PLANT BIOL, V55, P41, DOI 10.1146/annurev.arplant.55.031903.141641; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chan SWL, 2005, NAT REV GENET, V6, P351, DOI 10.1038/nrg1601; Dorweiler JE, 2000, PLANT CELL, V12, P2101, DOI 10.1105/tpc.12.11.2101; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Huettel B, 2006, EMBO J, V25, P2828, DOI 10.1038/sj.emboj.7601150; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jasencakova Z, 2000, PLANT CELL, V12, P2087, DOI 10.1105/tpc.12.11.2087; Kapoor A, 2005, FEBS LETT, V579, P5889, DOI 10.1016/j.febslet.2005.08.039; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Matzke MA, 2005, NAT REV GENET, V6, P24, DOI 10.1038/nrg1500; Morales-Ruiz T, 2006, P NATL ACAD SCI USA, V103, P6853, DOI 10.1073/pnas.0601109103; Penterman J, 2007, P NATL ACAD SCI USA, V104, P6752, DOI 10.1073/pnas.0701861104; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Sunkar R, 2004, PLANT CELL, V16, P2001, DOI 10.1105/tpc.104.022830; Tariq M, 2004, TRENDS GENET, V20, P244, DOI 10.1016/j.tig.2004.04.005; Vaucheret H, 2001, TRENDS GENET, V17, P29, DOI 10.1016/S0168-9525(00)02166-1; Wassenegger M, 2000, PLANT MOL BIOL, V43, P203, DOI 10.1023/A:1006479327881; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603; Zhu JH, 2007, CURR BIOL, V17, P54, DOI 10.1016/j.cub.2006.10.059	34	113	124	2	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1259	U70		10.1038/nature07305	http://dx.doi.org/10.1038/nature07305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815596	Green Accepted			2022-12-28	WOS:000260462100049
J	Mitchell, P; Wong, TY				Mitchell, Paul; Wong, Tien Y.			DIRECT new treatments for diabetic retinopathy	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE CONTROL; COMPLICATIONS; RISK; FENOFIBRATE; PROGRESSION; MELLITUS		[Mitchell, Paul] Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia; [Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Westmead, NSW 2145, Australia; [Wong, Tien Y.] Univ Melbourne, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Wong, Tien Y.] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 117548, Singapore	University of Sydney; University of Sydney; Westmead Institute for Medical Research; Centre for Eye Research Australia; University of Melbourne; National University of Singapore; Singapore National Eye Center	Mitchell, P (corresponding author), Univ Sydney, Dept Ophthalmol, Ctr Vis Res, Westmead, NSW 2145, Australia.	paul_mitchell@wmi.usyd.edu.au	Mitchell, Paul/P-1498-2014; Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264				Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; CHATURVEDI N, 2008, LANCET          0926, DOI DOI 10.1016/S0140-6736(08)61412-9; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; SCHRIER RW, 1992, AM J KIDNEY DIS, V20, P653, DOI 10.1016/S0272-6386(12)70236-6; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Simo R, 2007, LANCET, V370, P1667, DOI 10.1016/S0140-6736(07)61608-0; SJOLIE AK, 2008, LANCET          0926, DOI DOI 10.1016/S0140-6736(08)61411-7; Sjolie AK, 2007, DIABETES RES CLIN PR, V76, pS31, DOI 10.1016/j.diabres.2007.01.015; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Wong T, 2007, LANCET, V369, P425, DOI 10.1016/S0140-6736(07)60198-6; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wong TY, 2005, JAMA-J AM MED ASSOC, V293, P63, DOI 10.1001/jama.293.1.63	17	16	16	2	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 18	2008	372	9647					1361	1363		10.1016/S0140-6736(08)61413-0	http://dx.doi.org/10.1016/S0140-6736(08)61413-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18823657				2022-12-28	WOS:000260228200004
J	Howden-Chapman, P; Pierse, N; Nicholls, S; Gillespie-Bennett, J; Viggers, H; Cunningham, M; Phipps, R; Boulic, M; Fjallstrom, P; Free, S; Chapman, R; Lloyd, B; Wickens, K; Shields, D; Baker, M; Cunningham, C; Woodward, A; Bullen, C; Crane, J				Howden-Chapman, Philippa; Pierse, Nevil; Nicholls, Sarah; Gillespie-Bennett, Julie; Viggers, Helen; Cunningham, Malcolm; Phipps, Robyn; Boulic, Mikael; Fjallstrom, Par; Free, Sarah; Chapman, Ralph; Lloyd, Bob; Wickens, Kristin; Shields, David; Baker, Michael; Cunningham, Chris; Woodward, Alistair; Bullen, Chris; Crane, Julian			Effects of improved home heating on asthma in community dwelling children: randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RESPIRATORY SYMPTOMS; INDOOR AIR; CHILDHOOD ASTHMA; LUNG-FUNCTION; HEALTH; GAS; EXPOSURE; ASSOCIATION; ENVIRONMENT; SEVERITY	Objective To assess whether non- polluting, more effective home heating (heat pump, wood pellet burner, flued gas) has a positive effect on the health of children with asthma. Design Randomised controlled trial. Setting Households in five communities in New Zealand. Participants 409 children aged 6- 12 years with doctor diagnosed asthma. Interventions Installation of a non- polluting, more effective home heater before winter. The control group received a replacement heater at the end of the trial. Main outcome measures The primary outcome was change in lung function ( peak expiratory flow rate and forced expiratory volume in one second, FEV1). Secondary outcomes were child reported respiratory tract symptoms and daily use of preventer and reliever drugs. At the end of winter 2005 ( baseline) and winter 2006 ( follow- up) parents reported their child's general health, use of health services, overall respiratory health, and housing conditions. Nitrogen dioxide levels were measured monthly for four months and temperatures in the living room and child's bedroom were recorded hourly. Results Improvements in lung function were not significant ( difference in mean FEV1 130.7 ml, 95% confidence interval - 20.3 to 281.7). Compared with children in the control group, however, children in the intervention group had 1.80 fewer days off school ( 95% confidence interval 0.11 to 3.13), 0.40 fewer visits to a doctor for asthma ( 0.11 to 0.62), and 0.25 fewer visits to a pharmacist for asthma ( 0.09 to 0.32). Children in the intervention group also had fewer reports of poor health ( adjusted odds ratio 0.48, 95% confidence interval 0.31 to 0.74), less sleep disturbed by wheezing ( 0.55, 0.35 to 0.85), less dry cough at night ( 0.52, 0.32 to 0.83), and reduced scores for lower respiratory tract symptoms( 0.77, 0.73 to 0.81) than children in the control group. The intervention was associated with a mean temperature rise in the living room of 1.10 degrees C ( 95% confidence interval 0.54 to 1.64 degrees C) and in the child's bedroom of 0.57 degrees C ( 0.05 degrees C to 1.08 degrees C). Lower levels of nitrogen dioxide were measured in the living rooms of the intervention households than in those of the control households ( geometric mean 8.5 mu/m(3)v 15.7 mu/m(3), P< 0.001). A similar effect was found in the children's bedrooms ( 7.3 mu g m(3)v 10.9 mu g/m(3), P< 0.001). Conclusion Installing non- polluting, more effective heating in the homes of children with asthma did not significantly improve lung function but did significantly reduce symptoms of asthma, days off school, healthcare utilisation, and visits to a pharmacist. Trial registration Clinical Trials NCT00489762.	[Howden-Chapman, Philippa; Pierse, Nevil; Nicholls, Sarah; Gillespie-Bennett, Julie; Viggers, Helen; Free, Sarah; Shields, David; Baker, Michael; Crane, Julian] Univ Otago, He Kainga Oranga Housing & Hlth Res Programme, Wellington, New Zealand; [Cunningham, Malcolm] BRANZ, Porirua City, New Zealand; [Phipps, Robyn; Boulic, Mikael; Fjallstrom, Par] Massey Univ, Sch Engn & Adv Technol, Palmerston North, New Zealand; [Chapman, Ralph] Victoria Univ, Sch Geog Environm & Earth Sci, Wellington, New Zealand; [Lloyd, Bob] Univ Otago, Dept Phys, Dunedin, New Zealand; [Wickens, Kristin] Univ Otago, Wellington Asthma Res Grp, Wellington, New Zealand; [Cunningham, Chris] Massey Univ, Res Ctr Maori Hlth & Dev, Wellington, New Zealand; [Woodward, Alistair; Bullen, Chris] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	University of Otago; Massey University; Victoria University Wellington; University of Otago; University of Otago; Massey University; University of Auckland	Howden-Chapman, P (corresponding author), Univ Otago, He Kainga Oranga Housing & Hlth Res Programme, POB 7343, Wellington, New Zealand.	philippa.howden-chapman@otago.ac.nz	BOULIC, MIKAEL/D-4440-2012; Phipps, Robyn/AAG-6243-2020; Health, Hauora/HCH-4744-2022; viggers, helen/AAN-9442-2020; Bullen, Chris/E-4594-2017; Bennett, Julie/I-6757-2019	BOULIC, MIKAEL/0000-0002-2184-0506; Phipps, Robyn/0000-0003-2810-7662; viggers, helen/0000-0001-7325-6865; Bullen, Chris/0000-0001-6807-2930; Bennett, Julie/0000-0002-3461-7223; Woodward, Alistair/0000-0001-5425-6018; Chapman, Ralph/0000-0002-3437-8525	Health Research Council of New Zealand; Contact Energy; Ministry for the Environment; Hutt Valley district health board; Capital and Coast district health board; Housing New Zealand; Energy Efficiency and Conservation Authority; LPG Association	Health Research Council of New Zealand(Health Research Council of New Zealand); Contact Energy; Ministry for the Environment; Hutt Valley district health board; Capital and Coast district health board; Housing New Zealand; Energy Efficiency and Conservation Authority; LPG Association	Health Research Council of New Zealand, Contact Energy; Ministry for the Environment, Hutt Valley district health board, Capital and Coast district health board, Housing New Zealand, Energy Efficiency and Conservation Authority, and the LPG Association. The authors had complete independence from the funders.	[Anonymous], 2004, ETHN DAT PROT HLTH D; Asher I, 2006, TRYING CATCH OUR BRE; Baker M, 2007, NEW ZEAL MED J, V120; Bennett DH, 2002, ENVIRON SCI TECHNOL, V36, p206A, DOI 10.1021/es0222770; Bornehag CG, 2001, INDOOR AIR, V11, P72; Bothwell JE, 2003, ARCH ENVIRON HEALTH, V58, P549, DOI 10.3200/AEOH.58.9.549-553; BRUNEKREEF B, 2000, EUR RESP MON, V5, P384; Burr ML, 1999, THORAX, V54, P27, DOI 10.1136/thx.54.1.27; Carrer P, 2001, SCI TOTAL ENVIRON, V270, P33, DOI 10.1016/S0048-9697(00)00791-9; Chauhan AJ, 2003, LANCET, V361, P1939, DOI 10.1016/S0140-6736(03)13582-9; Cowen MK, 2007, J ASTHMA, V44, P711, DOI 10.1080/02770900701595576; DEKKER C, 1991, CHEST, V100, P922, DOI 10.1378/chest.100.4.922; Fuhlbrigge A, 1997, THORAX, V52, pS58, DOI 10.1136/thx.52.2008.S58; GILLESPIEBENNET.J, IN PRESS INDOOR AIR; HASSELBLAD V, 1992, J AIR WASTE MANAGE, V42, P662, DOI 10.1080/10473289.1992.10467018; Holt S, 2002, BURDEN ASTHMA NZ; Howden-Chapman P, 2005, SOC SCI MED, V61, P2600, DOI 10.1016/j.socscimed.2005.04.049; Howden-Chapman P, 2007, BMJ-BRIT MED J, V334, P460, DOI 10.1136/bmj.39070.573032.80; Isaacs N, 2003, ENERGY USE NZ HOUSEH; Jarvis D, 1996, LANCET, V347, P426, DOI 10.1016/S0140-6736(96)90009-4; Juniper EF, 2000, AM J RESP CRIT CARE, V162, P1330, DOI 10.1164/ajrccm.162.4.9912138; Krieger J, 2002, ENVIRON HEALTH PERSP, V110, P311, DOI 10.1289/ehp.02110s2311; Laforest L, 2004, ANN ALLERG ASTHMA IM, V93, P265, DOI 10.1016/S1081-1206(10)61499-8; Lai ACK, 2000, J AIR WASTE MANAGE, V50, P1688, DOI 10.1080/10473289.2000.10464196; Lloyd CR, 2008, ENERG BUILDINGS, V40, P1228, DOI 10.1016/j.enbuild.2007.11.006; MACKENZIE I, 2000, CUTTING COST COLD AF, P155; Moran SE, 1999, CLIN EXP ALLERGY, V29, P1033, DOI 10.1046/j.1365-2222.1999.00561.x; *NAT AC I MED, 2004, DAMP IND SPAC HLTH; ONO M, 1989, J JAPAN SOC AIR POLL, V24, P90; Phoa LL, 2004, THORAX, V59, P741, DOI 10.1136/thx.2003.014241; Pilotto LS, 2004, INT J EPIDEMIOL, V33, P208, DOI 10.1093/ije/dyh018; Ponsonby AL, 2000, EPIDEMIOLOGY, V11, P128, DOI 10.1097/00001648-200003000-00008; Pope CA, 2000, ENVIRON HEALTH PERSP, V108, P713, DOI 10.2307/3454408; SAMET JM, 1988, AM REV RESPIR DIS, V137, P221, DOI 10.1164/ajrccm/137.1.221; Smith BJ, 2000, EUR RESPIR J, V16, P879, DOI 10.1183/09031936.00.16587900; Smith K.R., 1988, ENV SCI POLICY SUSTA, V30, P10, DOI [10.1080/00139157.1988.9932540, DOI 10.1080/00139157.1988.9932540]; Somerville Margaret, 2002, Health Expect, V5, P127, DOI 10.1046/j.1369-6513.2002.00167.x; Stahl E, 2000, RESP MED, V94, P735, DOI 10.1053/rmed.2000.0814; *STAT NZ, 2004, 2004 NZ CENS; Strachan DP, 2000, BRIT MED BULL, V56, P865, DOI 10.1258/0007142001903562; Sundell J, 2004, INDOOR AIR, V14, P51, DOI 10.1111/j.1600-0668.2004.00273.x; Taras H, 2005, J SCHOOL HEALTH, V75, P296, DOI 10.1111/j.1746-1561.2005.00041.x; Thomson H, 2001, BRIT MED J, V323, P187, DOI 10.1136/bmj.323.7306.187; Walker JJ, 2006, EUR J PUBLIC HEALTH, V16, P463, DOI 10.1093/eurpub/cki186; Wilkinson P, 2001, COLD COMFORT SOCIAL; Wilkinson P, 2007, LANCET, V370, P1175, DOI 10.1016/S0140-6736(07)61255-0	47	160	162	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a1411	10.1136/bmj.a1411	http://dx.doi.org/10.1136/bmj.a1411			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18812366	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000259903300033
J	Arita, K; Ariyoshi, M; Tochio, H; Nakamura, Y; Shirakawa, M				Arita, Kyohei; Ariyoshi, Mariko; Tochio, Hidehito; Nakamura, Yusuke; Shirakawa, Masahiro			Recognition of hemi-methylated DNA by the SRA protein UHRF1 by a base-flipping mechanism	NATURE			English	Article							BINDING; DOMAIN; DNMT1	DNA methylation of CpG dinucleotides is an important epigenetic modification of mammalian genomes and is essential for the regulation of chromatin structure, of gene expression and of genome stability(1,2). Differences in DNA methylation patterns underlie a wide range of biological processes, such as genomic imprinting, inactivation of the X chromosome, embryogenesis, and carcinogenesis(3-6). Inheritance of the epigenetic methylation pattern is mediated by the enzyme DNA methyltransferase 1 ( Dnmt1), which methylates newly synthesized CpG sequences during DNA replication, depending on the methylation status of the template strands(7,8). The protein UHRF1 ( also known as Np95 and ICBP90) recognizes hemi- methylation sites via a SET and RING- associated ( SRA) domain and directs Dnmt1 to these sites(9-11). Here we report the crystal structures of the SRA domain in free and hemi- methylated DNA- bound states. The SRA domain folds into a globular structure with a basic concave surface formed by highly conserved residues. Binding of DNA to the concave surface causes a loop and an amino- terminal tail of the SRA domain to fold into DNA interfaces at the major and minor grooves of the methylation site. In contrast to fully methylated CpG sites recognized by the methyl- CpG- binding domain(12,13), the methylcytosine base at the hemi- methylated site is flipped out of the DNA helix in the SRA - DNA complex and fits tightly into a protein pocket on the concave surface. The complex structure suggests that the successive flip out of the pre- existing methylated cytosine and the target cytosine to be methylated is associated with the coordinated transfer of the hemi- methylated CpG site from UHRF1 to Dnmt1.	[Arita, Kyohei; Ariyoshi, Mariko; Tochio, Hidehito; Shirakawa, Masahiro] Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan; [Tochio, Hidehito; Shirakawa, Masahiro] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama 3320012, Japan; [Nakamura, Yusuke] Univ Tokyo, Mol Med Lab, Ctr Human Genome, Inst Med Sci,Minato Ku, Tokyo 1088639, Japan; [Shirakawa, Masahiro] RIKEN, Yokohama Inst, Yokohama, Kanagawa 2300045, Japan	Kyoto University; Japan Science & Technology Agency (JST); University of Tokyo; RIKEN	Shirakawa, M (corresponding author), Kyoto Univ, Grad Sch Engn, Kyoto 6158510, Japan.	ma4@eng.mbox.media.kyoto-u.ac.jp; shirakawa@moleng.kyoto-u.ac.jp	Arita, Kyohei/AAJ-6402-2020; Tochio, Hidehito/F-6109-2011	Arita, Kyohei/0000-0002-9762-8405; Ariyoshi, Mariko/0000-0002-1361-2642; Tochio, Hidehito/0000-0003-3843-3330	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Science and Technology Agency; Japan Society for the Promotion of Science; Global COE Program 'Integrated Materials Science' of MEXT of Japan	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program 'Integrated Materials Science' of MEXT of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank K. Morikawa for discussion, and N. Matsugaki, N. Igarashi, Y. Yamada, M. Suzuki and S. Wakatsuki for data collection at PF-BL5. This work was supported by grants to M.S. from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and the Japan Science and Technology Agency, and by a Grant- in- Aid for Scientific Research to K. A. from the Japan Society for the Promotion of Science. The authors acknowledge support from the Global COE Program 'Integrated Materials Science' of MEXT of Japan.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ballabio A, 1992, CURR OPIN GENET DEV, V2, P439, DOI 10.1016/S0959-437X(05)80155-8; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Chen RZ, 1998, NATURE, V395, P89, DOI 10.1038/25779; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Costello JF, 2000, NAT GENET, V24, P132, DOI 10.1038/72785; DeLano W.L, PYMOL MOL GRAPHICS S; Hermann A, 2004, CELL MOL LIFE SCI, V61, P2571, DOI 10.1007/s00018-004-4201-1; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OGara M, 1996, J MOL BIOL, V263, P597, DOI 10.1006/jmbi.1996.0601; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; SUCK D, 1994, CURR BIOL, V4, P252, DOI 10.1016/S0960-9822(00)00057-9; Surani MA, 1998, CELL, V93, P309, DOI 10.1016/S0092-8674(00)81156-3; Tajima S, 1998, J BIOCHEM-TOKYO, V123, P993, DOI 10.1093/oxfordjournals.jbchem.a022066; Tubbs JL, 2007, DNA REPAIR, V6, P1100, DOI 10.1016/j.dnarep.2007.03.011; Xu GL, 1999, NATURE, V402, P187, DOI 10.1038/46052	27	340	354	3	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					818	U12		10.1038/nature07249	http://dx.doi.org/10.1038/nature07249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18772891				2022-12-28	WOS:000259854900051
J	Steinberg, D				Steinberg, Daniel			The statins in preventive cardiology	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Steinberg, Daniel] Univ Calif San Diego, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Steinberg, D (corresponding author), Univ Calif San Diego, Sch Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.							Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; Steinberg D, 2008, CIRCULATION, V118, P672, DOI 10.1161/CIRCULATIONAHA.107.753152	4	27	30	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1426	1427		10.1056/NEJMp0806479	http://dx.doi.org/10.1056/NEJMp0806479			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832243				2022-12-28	WOS:000259631700003
J	Castro-Tirado, AJ; Postigo, AD; Gorosabel, J; Jelinek, M; Fatkhullin, TA; Sokolov, VV; Ferrero, P; Kann, DA; Klose, S; Sluse, D; Bremer, M; Winters, JM; Nuernberger, D; Perez-Ramirez, D; Guerrero, MA; French, J; Melady, G; Hanlon, L; McBreen, B; Leventis, K; Markoff, SB; Leon, S; Kraus, A; Aceituno, FJ; Cunniffe, R; Kubanek, P; Vitek, S; Schulze, S; Wilson, AC; Hudec, R; Durant, M; Gonzalez-Perez, JM; Shahbaz, T; Guziy, S; Pandey, SB; Pavlenko, L; Sonbas, E; Trushkin, SA; Bursov, NN; Nizhelskij, NA; Sanchez-Fernandez, C; Sabau-Graziati, L				Castro-Tirado, A. J.; de Ugarte Postigo, A.; Gorosabel, J.; Jelinek, M.; Fatkhullin, T. A.; Sokolov, V. V.; Ferrero, P.; Kann, D. A.; Klose, S.; Sluse, D.; Bremer, M.; Winters, J. M.; Nuernberger, D.; Perez-Ramirez, D.; Guerrero, M. A.; French, J.; Melady, G.; Hanlon, L.; McBreen, B.; Leventis, K.; Markoff, S. B.; Leon, S.; Kraus, A.; Aceituno, F. J.; Cunniffe, R.; Kubanek, P.; Vitek, S.; Schulze, S.; Wilson, A. C.; Hudec, R.; Durant, M.; Gonzalez-Perez, J. M.; Shahbaz, T.; Guziy, S.; Pandey, S. B.; Pavlenko, L.; Sonbas, E.; Trushkin, S. A.; Bursov, N. N.; Nizhelskij, N. A.; Sanchez-Fernandez, C.; Sabau-Graziati, L.			Flares from a candidate Galactic magnetar suggest a missing link to dim isolated neutron stars	NATURE			English	Article							XMM-NEWTON OBSERVATIONS; SOFT GAMMA REPEATERS; X-RAY; V4641 SAGITTARII; TRANSIENT; SGR; DISCOVERY; EMISSION; SGR1806-20; OUTBURST	Magnetars(1) are young neutron stars with very strong magnetic fields of the order of 10(14)-10(15) G. They are detected in our Galaxy either as soft gamma-ray repeaters or anomalous X-ray pulsars. Soft gamma-ray repeaters are a rare type of gamma-ray transient sources that are occasionally detected as bursters in the high-energy sky(2-4). No optical counterpart to the gamma-ray flares or the quiescent source has yet been identified. Here we report multi-wavelength observations of a puzzling source, SWIFT J195509+261406. We detected more than 40 flaring episodes in the optical band over a time span of three days, and a faint infrared flare 11 days later, after which the source returned to quiescence. Our radio observations confirm a Galactic nature and establish a lower distance limit of similar to 3.7 kpc. We suggest that SWIFT J195509+261406 could be an isolated magnetar whose bursting activity has been detected at optical wavelengths, and for which the long- term X- ray emission is short- lived. In this case, a new manifestation of magnetar activity has been recorded and we can consider SWIFT J195509+261406 to be a link between the 'persistent' soft gamma-ray repeaters/anomalous X- ray pulsars and dim isolated neutron stars.	[Castro-Tirado, A. J.; de Ugarte Postigo, A.; Gorosabel, J.; Jelinek, M.; Guerrero, M. A.; Aceituno, F. J.; Cunniffe, R.; Kubanek, P.; Vitek, S.] CSIC, Inst Astrofis Andalucia, E-18080 Granada, Spain; [de Ugarte Postigo, A.; Nuernberger, D.] European So Observ, Santiago 19, Chile; [Fatkhullin, T. A.; Sokolov, V. V.; Sonbas, E.; Trushkin, S. A.; Bursov, N. N.; Nizhelskij, N. A.] Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz 369167, Russia; [Ferrero, P.; Kann, D. A.; Klose, S.; Schulze, S.] Thuringer Landessternwarte Tautenburg, D-07778 Tautenburg, Germany; [Sluse, D.] EPFL Observ, Lab Astrophys, CH-1290 Sauverny, Switzerland; [Bremer, M.; Winters, J. M.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Perez-Ramirez, D.] Univ Jaen, Fac Ciencias Expt, E-23071 Jaen, Spain; [Perez-Ramirez, D.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [French, J.; Melady, G.; Hanlon, L.; McBreen, B.] Univ Coll Dublin, Sch Phys, Dublin 4, Ireland; [Leventis, K.; Markoff, S. B.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Leon, S.] IRAM, E-18012 Granada, Spain; [Kraus, A.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Cunniffe, R.] Cork Inst Technol, Cork, Ireland; [Kubanek, P.] Univ Valencia, Edif Inst Invest, GACE ICMOL, E-46980 Valencia, Spain; [Wilson, A. C.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Hudec, R.] Acad Sci Czech Republic, Inst Astron, CS-25165 Ondrejov, Czech Republic; [Durant, M.; Gonzalez-Perez, J. M.; Shahbaz, T.] Inst Astrofis Canarias, E-38205 Tenerife, Spain; [Guziy, S.] Nikolaev State Univ, UA-54030 Nikolayev, Ukraine; [Pandey, S. B.] Aryabhatta Res Inst Observ Sci ARIES, Naini Tal 263129, India; [Pavlenko, L.] Crimean Astrophys Observ, UA-98409 Nauchnyi, Ukraine; [Sonbas, E.] Cukurova Univ, Dept Phys, TR-01330 Adana, Turkey; [Sanchez-Fernandez, C.] ESAC, E-28691 Madrid, Spain; [Sabau-Graziati, L.] INTA, E-28750 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); European Southern Observatory; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universidad de Jaen; University of Leicester; University College Dublin; University of Amsterdam; Max Planck Society; Cork Institute of Technology; University of Valencia; University of Texas System; University of Texas Austin; Czech Academy of Sciences; Astronomical Institute of the Czech Academy of Sciences; Instituto de Astrofisica de Canarias; Ministry of Education & Science of Ukraine; Mykolayiv National Agrarian University (MNAU); V.O. Sukhomlynskyi Mykolaiv National University; Department of Science & Technology (India); Aryabhatta Research Institute of Observational Sciences (ARIES); Russian Academy of Sciences; Crimean Astrophysical Observatory; Cukurova University; European Space Agency; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA)	Castro-Tirado, AJ (corresponding author), CSIC, Inst Astrofis Andalucia, POB 03004, E-18080 Granada, Spain.	ajct@iaa.es	Guziy, Sergiy/HGC-0149-2022; Gonzalez, Josefa M/O-4395-2014; Vitek, Stanislav/B-3332-2015; Sluse, Dominique/ABF-3723-2020; Kubánek, Petr/G-7209-2014; Фатхуллин, Тимур/AAO-5319-2021; Jelínek, Martin/E-5290-2016; Sonbas, Eda/AAJ-5517-2021; Sokolov, Vladimir/AAM-5469-2021; Bursov, Nikolaj/AAM-6127-2021; Hudec, Rene/G-9018-2014; Shahbaz, Tariq/Z-3108-2019; Trushkin, Sergei Anatol'evich/AAM-3444-2021; Trushkin, Sergei A/I-6384-2017; Guerrero, Martin/L-1482-2014	Vitek, Stanislav/0000-0002-3185-1495; Sluse, Dominique/0000-0001-6116-2095; Kubánek, Petr/0000-0002-1877-1386; Jelínek, Martin/0000-0003-3922-7416; Shahbaz, Tariq/0000-0003-1331-5442; Trushkin, Sergei A/0000-0002-7586-5856; Sokolov, Vladimir/0000-0003-2983-2874; Kann, David Alexander/0000-0003-2902-3583; Sonbas, Eda/0000-0002-6909-192X; Schulze, Steve/0000-0001-6797-1889; Nizhel'skij, Nikolay/0000-0002-6419-7223; Guerrero, Martin/0000-0002-7759-106X; Castro-Tirado, A. J./0000-0003-2999-3563; Pavlenko, Elena/0000-0003-4612-3703; de Ugarte Postigo, Antonio/0000-0001-7717-5085; Aleksej, Sosnovskij/0000-0003-3771-4974	INSU/CNRS (France); MPG (Germany); IGN (Spain); DFG; D.P.R; IRCSET; SFI; PECs; GACR; Spanish Ministry of Science and Innovation	INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); MPG (Germany)(Max Planck Society); IGN (Spain); DFG(German Research Foundation (DFG)); D.P.R; IRCSET(Irish Research Council for Science, Engineering and Technology); SFI(Science Foundation Ireland); PECs; GACR(Grant Agency of the Czech Republic); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work is based on observations carried out with the 0.3-m robotic telescope at the Spanish BOOTES-2 astronomical station of the Estacion Experimental de La Mayora (CSIC), the 0.4-m WATCHER telescope operated by UCD at Boyden Observatory (South Africa), the 0.8-m IAC telescope at the Spanish Observatorio de Izana of the Instituto de Astrofisica de Canarias (IAC), the 1.2-m Mercator telescope operated by the Flemish Community at the Spanish Observatorio del Roque de los Muchachos of the IAC, the 1.34-m telescope at the Tautenburg Observatory (Germany), the 1.5-m OSN telescope at the Spanish Observatorio de Sierra Nevada of the Instituto de Astrofisica de Andalucia (CSIC), the 6.0-m BTA telescope at the Special Astrophysical Observatory of the Russian Academy of Sciences, the 8.2-m VLT telescope of the European Southern Observatory at Paranal (Chile), the IRAM 30-m and Plateau de Bure Telescopes and the 100-m telescope of the Max-Planck-Institut fur Radioastronomie at Effelsberg (Germany). IRAM is supported by INSU/CNRS (France), MPG (Germany) and IGN (Spain). We thank both the SAO-RAS Director and the ESO Director's Discretionary Time Committee for accepting the observation a few days after the onset of the event. We also thank N. Schartel for allotting XMM- Newton DDT time for a late-time X-ray observation. We acknowledge the use of public data from the Swift data archives and the service provided by the gamma-ray burst Coordinates Network (GRB) and BACODINE system, maintained by S. Barthelmy. A.J.C.T. acknowledges discussions with E. Alfaro, Y. Beletski, A.M. Belobodorov, W. Cui, S. Digel, R. Fernandez-Munoz, P. Gandhi, S. Gottlieb, M. Lyutikov, A. Merloni, M. A. Perez-Torres, V. Reglero, E. Ros and G. Sala. P.F., D.A.K. and S.K. acknowledge financial support by DFG and D.P.R. from Junta de Andaluci A.L.H. acknowledges support from IRCSET and SFI. R.H. acknowledges support from PECs and GACR. This work was partially supported by the Spanish Ministry of Science and Innovation.	Dahn CC, 2002, ASTRON J, V124, P1170, DOI 10.1086/341646; Gogus E, 1999, ASTROPHYS J, V526, pL93, DOI 10.1086/312380; Hjellming RM, 2000, ASTROPHYS J, V544, P977, DOI 10.1086/317255; Hurley K, 2000, AIP CONF PROC, V526, P763; HURLEY KJ, 1995, ASTROPHYS SPACE SCI, V231, P81, DOI 10.1007/BF00658592; Ibrahim AI, 2004, ASTROPHYS J, V609, pL21, DOI 10.1086/422636; Israel GI, 2005, ASTRON ASTROPHYS, V438, pL1, DOI 10.1051/0004-6361:200500138; KANN DA, 2007, 6505 GCN; Kasliwal MM, 2008, ASTROPHYS J, V678, P1127, DOI 10.1086/526407; Kouveliotou C, 1996, NATURE, V379, P799, DOI 10.1038/379799a0; KOUVELIOTOU C, 1994, NATURE, V368, P125, DOI 10.1038/368125a0; MARKWARDT CB, 2007, ASTRONOM TELEGR, P1102; MAZETS EP, 1982, ASTROPHYS SPACE SCI, V84, P173, DOI 10.1007/BF00713635; *MCGILL PULS GROUP, SGR AXP ONL CAT; Mereghetti S, 2007, ASTROPHYS SPACE SCI, V308, P13, DOI 10.1007/s10509-007-9384-0; Merloni A, 2000, MON NOT R ASTRON SOC, V318, pL15, DOI 10.1046/j.1365-8711.2000.03943.x; Muno MP, 2008, ASTROPHYS J, V680, P639, DOI 10.1086/527316; PAGANI C, 2007, 6490 GCN; POSTIGO AD, 2007, 6501 GCN; Revnivtsev M, 2002, ASTRON ASTROPHYS, V391, P1013, DOI 10.1051/0004-6361:20020865; SAZONOV S, 2005, ASTRON LETT+, V23, P326; Thompson C, 1996, ASTROPHYS J, V473, P322, DOI 10.1086/178147; Thompson C, 2005, ASTROPHYS J, V634, P565, DOI 10.1086/432245; Treves A, 2000, PUBL ASTRON SOC PAC, V112, P297, DOI 10.1086/316529; TUELLER J, 2007, 6491 GCN; Uemura M, 2002, PUBL ASTRON SOC JPN, V54, P95, DOI 10.1093/pasj/54.1.95; Woods PM, 1999, ASTROPHYS J, V519, pL139, DOI 10.1086/312124; Woods PM, 1999, ASTROPHYS J, V527, pL47, DOI 10.1086/312399; Zand JJMI, 2007, ASTRON ASTROPHYS, V465, P953, DOI 10.1051/0004-6361:20066678	29	33	33	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					506	509		10.1038/nature07328	http://dx.doi.org/10.1038/nature07328			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818652	Green Submitted			2022-12-28	WOS:000259449600040
J	Shaaban, R; Zureik, M; Soussan, D; Neukirch, C; Heinrich, J; Sunyer, J; Wjst, M; Cerveri, I; Pin, I; Bousquet, J; Jarvis, D; Burney, PG; Neukirch, F; Leynaert, B				Shaaban, Rafea; Zureik, Mahmoud; Soussan, David; Neukirch, Catherine; Heinrich, Joachim; Sunyer, Jordi; Wjst, Matthias; Cerveri, Isa; Pin, Isabelle; Bousquet, Jean; Jarvis, Deborah; Burney, Peter G.; Neukirch, Francoise; Leynaert, Benedicte			Rhinitis and onset of asthma: a longitudinal population-based study	LANCET			English	Article							ASYMPTOMATIC AIRWAY HYPERRESPONSIVENESS; INDEPENDENT RISK-FACTOR; ALLERGIC RHINITIS; BRONCHIAL HYPERRESPONSIVENESS; FOLLOW-UP; PERENNIAL RHINITIS; LUNG-FUNCTION; HEALTH; SENSITIZATION; PERSISTENCE	Background A close relation between asthma and allergic rhinitis has been reported by several epidemiological and clinical studies. However, the nature of this relation remains unclear. We used the follow-up data from the European Community Respiratory Health Survey to investigate the onset of asthma in patients with allergic and non-allergic rhinitis during an 8 . 8-year period. Methods We did a longitudinal population-based study, which included 29 centres (14 countries) mostly in western Europe. Frequency of asthma was studied in 6461 participants, aged 20-44 years, without asthma at baseline. incident asthma was defined as reporting ever having had asthma confirmed by a physician between the two surveys. Atopy was defined as a positive skin-prick test to mites, cat, Alternaria, Cladosporium, grass, birch, Parietaria, olive, or 44 ragweed. Participants were classified into four groups at baseline: controls (no atopy, no rhinitis; n=3163), atopy only (atopy, no rhinitis; n=704), non-allergic rhinitis (rhinitis, no atopy; n=1377), and allergic rhinitis (atopy+rhinitis; 49 n=1217). Cox proportional hazards models were used to study asthma onset in the four groups. Findings The 8.8-year cumulative incidence of asthma was 2.2% (140 events), and was different in the four groups (1 . 1% (36), 1.9% (13), 3.1% (42), and 4.0% (49), respectively; p<0 . 0001). After controlling for country, sex, baseline age, body-mass index, forced expiratory volume in 1 s (FEV1), log total IgE, family history of asthma, and smoking, the adjusted relative risk for asthma was 1.63 (95% CI 0.82-3.24) for atopy only, 2.71 (1.64-4.46) for non-allergic rhinitis, and 3.53 (2.11-5.91) for allergic rhinitis. Only allergic rhinitis with sensitisation to mite was associated with increased risk of asthma independently of other allergens (2.79 [1.57-4.96]). Interpretation Rhinitis, even in the absence of atopy, is a powerful predictor of adult-onset asthma Funding UCB Institute of Allergy and Agence Nationale de la Recherche.	[Shaaban, Rafea; Zureik, Mahmoud; Soussan, David; Neukirch, Catherine; Neukirch, Francoise; Leynaert, Benedicte] Univ Paris 07, Fac Med, Unite 700, INSERM, F-75870 Paris 18, France; [Neukirch, Catherine] Bichat Teaching Hosp, Dept Pneumol, Paris, France; [Heinrich, Joachim; Wjst, Matthias] Natl Res Ctr Environm & Hlth, Inst Epidemiol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Sunyer, Jordi] Inst Municipal Invest Med, CREAL, E-08003 Barcelona, Spain; [Jarvis, Deborah; Burney, Peter G.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Resp Epidemiol & Publ Hlth Grp, London, England; [Cerveri, Isa] Univ Pavia, I-27100 Pavia, Italy; [Pin, Isabelle] INSERM, Natl Inst Hlth & Med Res, Unit 823, Grenoble, France; [Pin, Isabelle] Grenoble Teaching Hosp, Grenoble, France; [Bousquet, Jean] Hosp Arnaud De Villeneuve, Dept Pneumol, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Pompeu Fabra University; Imperial College London; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes	Zureik, M (corresponding author), Univ Paris 07, Fac Med, Unite 700, INSERM, Site Bichat,BP 416, F-75870 Paris 18, France.	mahmoud.zureik@inserm.fr	Jarvis, Deborah/E-6494-2011; PIN, Isabelle/N-3020-2013; Heinrich, Joachim/N-1720-2013; Leynaert, Benedicte/N-5251-2018; Sunyer, Jordi/G-6909-2014; Zureik, Mahmoud/F-7855-2018	Heinrich, Joachim/0000-0002-9620-1629; Sunyer, Jordi/0000-0002-2602-4110; Jarvis, Deborah/0000-0002-1753-3896; Leynaert, Benedicte/0000-0001-5045-2492; Cerveri, Isa/0000-0003-0337-043X; Burney, Peter/0000-0001-8635-5678; Zureik, Mahmoud/0000-0002-8393-4217	Educational Grant; UCB Institute; Agence Nationale de la Recherche (ANR-SEST); Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris; European Commission; Fondo de Investigaciones Santarias [97/0035-01, 99/0034-01, 99/0034-02]; Hospital Universitario de Albacete; Consejeria de Sanidad; FWO (Fund for Scientific Research)-Flanders Belgium [G.0402.00]; University of Antwerp; Flemish Health Ministry; SEPAR; Public Health Service [ROI HL62633-01]; CIRIT [1999SGR 00241]; Swiss National Science Foundation [4026-28099]; Swiss Federal Office for Education Science; Swiss National Accident Insurance Fund (SUVA); Norwegian Research Council; Norwegian Asthma & Allergy Association (NAAF); Glaxo Wellcome AS; Norway Research Fund; Institut Pneumologique d'Aquitaine; GSF-National Research Centre for Environment Health; Deutsche Forschungsgemeinschaft [FR 1526/1-1, MA 711/4-1]; Basque Health Dept; Swedish Heart Lung Foundation; Swedish Foundation for Health Care Sciences & Allergy Reserch; Swedish Asthma & Allergy Foundation; Swedish Cancer & Allergy Foundation; Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 [2610]; Ministry of Health, Direction de la Recherche Clinique; Ministere de l'Emploi et de la Solidarite; Direction Generale de la Saute; CHU de Grenoble; Comite des Maladies Respiratoires de l'lsere, Hamburg; GSF-National Reasearch Centre for Environment Health; Asthma UK (formerly known as National Asthma Campaign); Aventis (France); Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; UCB-Pharma (France); Glaxo France; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; GlaxoSmithKline Italy; Italian Ministry of University and Scientific and Technological Research (MURST); American Lung Association of Oregon; Northwest Health Foundation; Collins Foundation; Merck Pharmaceutical; Icelandic Research Counci; Icelandic University Hospital Fund; Estonian Science Foundation; ASL 4 Regione Piemonte (Italy); AO CTO/ICORMA Regione Piemonte (Italy); Ministero dell' Universita e della Ricerca Scientifica (Italy); Glaxo Wellcome spa (Verona, Italy); Swedish Foundation for Health Care Sciences & Allergy Research; University of Verona; National Fund for Scientific Research; Ministere de la Sante Glaxo France; Insitut Pneumologique d'Aquitaine; CNMATS; CNMRT [901MR/10, 91AF/6]; Ministre delegue de la sante; RNSP, France; GSF; Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica; CNR; Regione Veneto grant [RSF n. 381/05.93]; Norwegian Research Council [101422/310]; Dutch Ministry of Wellbeing; Public Health and Culture, Netherlands; Ministero, Sanidad y Consumo FIS [#91/0016060/00E-05E, #93/0393]; Hospital General de Albacete; Hospital General Juan Ramon Jimenenz; Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council; Swedish Association against Asthma and Allergy; National Asthma Campaign; British Lung Foundation; Department of Health; South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service [#2 S07 RR05521-28]	Educational Grant; UCB Institute; Agence Nationale de la Recherche (ANR-SEST)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris; European Commission(European CommissionEuropean Commission Joint Research Centre); Fondo de Investigaciones Santarias(Instituto de Salud Carlos III); Hospital Universitario de Albacete; Consejeria de Sanidad; FWO (Fund for Scientific Research)-Flanders Belgium(FWO); University of Antwerp; Flemish Health Ministry; SEPAR; Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); CIRIT; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Federal Office for Education Science; Swiss National Accident Insurance Fund (SUVA)(Swiss National Science Foundation (SNSF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Asthma & Allergy Association (NAAF); Glaxo Wellcome AS; Norway Research Fund; Institut Pneumologique d'Aquitaine; GSF-National Research Centre for Environment Health; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Basque Health Dept; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Health Care Sciences & Allergy Reserch; Swedish Asthma & Allergy Foundation; Swedish Cancer & Allergy Foundation; Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000; Ministry of Health, Direction de la Recherche Clinique; Ministere de l'Emploi et de la Solidarite; Direction Generale de la Saute; CHU de Grenoble; Comite des Maladies Respiratoires de l'lsere, Hamburg; GSF-National Reasearch Centre for Environment Health(German Research Foundation (DFG)); Asthma UK (formerly known as National Asthma Campaign); Aventis (France)(Sanofi-Aventis); Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; UCB-Pharma (France)(UCB Pharma SA); Glaxo France; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; GlaxoSmithKline Italy(GlaxoSmithKline); Italian Ministry of University and Scientific and Technological Research (MURST)(Ministry of Education, Universities and Research (MIUR)); American Lung Association of Oregon; Northwest Health Foundation; Collins Foundation; Merck Pharmaceutical(Merck & Company); Icelandic Research Counci; Icelandic University Hospital Fund; Estonian Science Foundation; ASL 4 Regione Piemonte (Italy); AO CTO/ICORMA Regione Piemonte (Italy); Ministero dell' Universita e della Ricerca Scientifica (Italy)(Ministry of Education, Universities and Research (MIUR)); Glaxo Wellcome spa (Verona, Italy); Swedish Foundation for Health Care Sciences & Allergy Research; University of Verona; National Fund for Scientific Research; Ministere de la Sante Glaxo France; Insitut Pneumologique d'Aquitaine; CNMATS; CNMRT; Ministre delegue de la sante; RNSP, France; GSF; Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica(Ministry of Education, Universities and Research (MIUR)); CNR(Consiglio Nazionale delle Ricerche (CNR)); Regione Veneto grant; Norwegian Research Council(Research Council of NorwayEuropean Commission); Dutch Ministry of Wellbeing; Public Health and Culture, Netherlands(Netherlands Government); Ministero, Sanidad y Consumo FIS; Hospital General de Albacete; Hospital General Juan Ramon Jimenenz; Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Association against Asthma and Allergy; National Asthma Campaign; British Lung Foundation; Department of Health; South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	This work was supported by an Educational Grant From the UCB Institute, and by the Agence Nationale de la Recherche (ANR-SEST). MZ of Allergy is a recipient of a Contrat d'Interface grant from Institut National de la Sante et de la Recherche Medicale-Assistatice Publique/Hopitaux de Paris. The coordination of ECRHS II was supported by the European Commission, as part of their Quality of Life programme. The following bodies funded the local studies in ECRHS II included in this paper Albacete: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02), Hospital Universitario de Albacete, Consejeria de Sanidad; Antwerp: FWO (Fund for Scientific Research)-Flanders Belgium (grant code: G.0402.00), University of Antwerp, Flemish Health Ministry; Barcelona: SEPAR, Public Health Service (grant code: ROI HL62633-01), Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02) CIRIT (grant code: 1999SGR 00241); Basel: Swiss National Science Foundation. Swiss Federal Office for Education & Science, Swiss National Accident Insurance Fund (SUVA); Bergen: Norwegian Research Council, Norwegian Asthma & Allergy Association (NAAF), Glaxo Wellcome AS, Norway Research Fund; Bordeaux: Institut Pneurnologique d'Aquitaine; Erfurt: GSF-NationaI Research Centre for Environment & Health, Deutsche Forschungsgerneinschaft (DFG) (grant code FR 1526/1-1); Galdakao: Basque Health Dept: Goteborg: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Reserch, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Grenoble: Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no. 2610, Ministry of Health, Direction de la Recherche Clinique, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Saute, CHU de Grenoble, Comite des Maladies Respiratoires de l'lsere, Hamburg: GSF-National Reasearch Centre for Environment & Health. Deutsche Forschungsgemeinschaft (DFG) (grant code MA 711/4-1); Ipswich and Norwich: Asthma UK (formerly known as National Asthma Campaign); Huelva: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Montpellier, Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no. 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble, Ministere de l'Emploi et de la Solidarite, Direction Generale de la Saute, Aventis (France), Direction Regionale des Affaires Sanitaires et Sociales Languedoc-Roussillon; Oviedo: Fondo de Investigaciones Santarias (FIS) (grant code: 97/0035-01, 99/0034-01 and 99/0034-02); Paris: Ministere de l'Emploi et de la Solidarite, Direction Generale de la Same, UCB-Pharma (France), Aventis (France), Glaxo France, Programme Hospitalier de Recherche Clinique-DRC de Grenoble 2000 no.; 2610, Ministry of Health, Direction de la Recherche Clinique, CHU de Grenoble; Center of Clinical Investigations (CIC) of Bichat Teaching Hospital, Paris; Pavia: GlaxoSmithKline Italy, Italian Ministry of University and Scientific and Technological Research (MURST), Local University Funding for research 1998 & 1999 (Pavia, Italy); Portland: American Lung Association of Oregon, Northwest Health Foundation, Collins Foundation, Merck Pharmaceutical; Reykjavik: Icelandic Research Council, Icelandic University Hospital Fund; Tartu: Estonian Science Foundation: Turin: ASL 4 Regione Piemonte (Italy), AO CTO/ICORMA Regione Piemonte (Italy), Ministero dell' Universita e della Ricerca Scientifica (Italy), Glaxo Wellcome spa (Verona, Italy); Umea: Swedis Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Research, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Uppsala: Swedish Heart Lung Foundation, Swedish Foundation for Health Care Sciences & Allergy Research, Swedish Asthma & Allergy Foundation, Swedish Cancer & Allergy Foundation; Verona: University of Verona; Italian Ministry of University and Scientific and Technological Research (MURST); GlaxoSmith Kline Italy. Financial support for ECRHS I for centres in ECRHS II: Belgian Science Policy Office, National Fund for Scientific Research; Ministere de la Sante Glaxo France, Insitut Pneumologique d'Aquitaine, Contrat de Plan Etat-Region Languedoc-Rousillon, CNMATS, CNMRT (901MR/10, 91AF/6), Ministre delegue de la sante, RNSP, France; GSF, and the Bundesminister fur Forschung und Technologie, Bonn, Germany; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, CNR, Regione Veneto grant RSF n. 381/05.93, Italy; Norwegian Research Council project no. 101422/310; Dutch Ministry of Wellbeing, Public Health and Culture, Netherlands; Ministero, Sanidad y Consumo FIS (grants #91/0016060/00E-05E and #93/0393), and grants from Hospital General de Albacete, Hospital General Juan Ramon Jimenenz, Consejeria de Sanidad Principado de Asturias, Spain; The Swedish Medical Research Council, the Swedish Heart Lung Foundation, the Swedish Association against Asthma and Allergy; Swiss national Science Foundation grant 4026-28099; National Asthma Campaign, British Lung Foundation, Department of Health, South Thames Regional Health Authority, UK; United States Department of Health, Education and Welfare Public Health Service (grant #2 S07 RR05521-28).	[Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; [Anonymous], 1991, AM REV RESPIR DIS, V144, P1202, DOI 10.1164/ajrccm/144.5.1202; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; BARDIN PG, 1990, J ALLERGY CLIN IMMUN, V86, P82, DOI 10.1016/S0091-6749(05)80126-5; Boulet LP, 2003, AM J RESP CRIT CARE, V167, P371, DOI 10.1164/rccm.200111-084PP; Bousquet J, 2001, J ALLERGY CLIN IMMUN, V108, pS147, DOI 10.1067/mai.2001.118891; Bousquet PJ, 2007, CLIN EXP ALLERGY, V37, P780, DOI 10.1111/j.1365-2222.2007.02714.x; Braunstahl GJ, 2005, J ALLERGY CLIN IMMUN, V115, P142, DOI 10.1016/j.jaci.2004.10.041; Braunstahl GJ, 2001, J ALLERGY CLIN IMMUN, V107, P469, DOI 10.1067/mai.2001.113046; Brutsche MH, 2006, THORAX, V61, P671, DOI 10.1136/thx.2005.052241; BUCCA C, 1995, LANCET, V346, P791, DOI 10.1016/S0140-6736(95)91617-2; Burgess JA, 2007, J ALLERGY CLIN IMMUN, V120, P863, DOI 10.1016/j.jaci.2007.07.020; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Celedon JC, 2007, J ALLERGY CLIN IMMUN, V120, P144, DOI 10.1016/j.jaci.2007.03.037; Chinn S, 2005, AM J RESP CRIT CARE, V172, P956, DOI 10.1164/rccm.200503-323OC; Chinn S, 1996, EUR J EPIDEMIOL, V12, P155, DOI 10.1007/BF00145501; Colantonio D, 2002, CLIN EXP ALLERGY, V32, P698, DOI 10.1046/j.1365-2222.2002.01379.x; Corren J, 1997, J ALLERGY CLIN IMMUN, V99, pS781, DOI 10.1016/S0091-6749(97)70127-1; Daly LE, 1998, AM J EPIDEMIOL, V147, P783; Durham SR, 1999, ALLERGY, V54, P124, DOI 10.1111/j.1398-9995.1999.tb04414.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Fontanari P, 1997, EUR RESPIR J, V10, P2250, DOI 10.1183/09031936.97.10102250; GLINDMEYER HW, 1995, AM J RESP CRIT CARE, V151, P412, DOI 10.1164/ajrccm.151.2.7842200; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Greisner WA, 1998, ALLERGY ASTHMA PROC, V19, P185, DOI 10.2500/108854198778557836; Grossman J, 1997, CHEST, V111, pS11, DOI 10.1378/chest.111.2_Supplement.11S; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; HOPP RJ, 1990, AM REV RESPIR DIS, V141, P2, DOI 10.1164/ajrccm/141.1.2; Huovinen E, 1999, CHEST, V115, P928, DOI 10.1378/chest.115.4.928; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; James AL, 2005, AM J RESP CRIT CARE, V171, P109, DOI 10.1164/rccm.200402-230OC; Jarvis D, 2002, EUR RESPIR J, V20, P1071, DOI 10.1183/09031936.02.00046802; Laprise C, 1999, EUR RESPIR J, V14, P63, DOI 10.1034/j.1399-3003.1999.14a12.x; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Leynaert N, 2004, J ALLERGY CLIN IMMUN, V113, P86, DOI 10.1016/j.jaci.2003.10.010; MCNICHOL KN, 1973, BRIT MED J, V4, P12, DOI 10.1136/bmj.4.5883.12; Molgaard E, 2007, ALLERGY, V62, P1033, DOI 10.1111/j.1398-9995.2007.01355.x; Panettieri RA, 2008, J ALLERGY CLIN IMMUN, V121, P607, DOI 10.1016/j.jaci.2008.01.006; Plaschke PP, 2000, AM J RESP CRIT CARE, V162, P920, DOI 10.1164/ajrccm.162.3.9912030; Polosa R, 2008, J ALLERGY CLIN IMMUN, V121, P1428, DOI 10.1016/j.jaci.2008.02.041; Riccioni G, 2002, INT J IMMUNOPATH PH, V15, P69, DOI 10.1177/039463200201500110; SETTIPANE RJ, 1994, ALLERGY PROC, V15, P21, DOI 10.2500/108854194778816634; Shaaban R, 2007, AM J RESP CRIT CARE, V176, P659, DOI 10.1164/rccm.200703-427OC; Stirling RG, 2001, AM J RESP CRIT CARE, V164, P1403, DOI 10.1164/ajrccm.164.8.2010002; STRAUSS RH, 1977, NEW ENGL J MED, V297, P743, DOI 10.1056/NEJM197710062971402; Togias A, 2003, J ALLERGY CLIN IMMUN, V111, P1171, DOI 10.1067/mai.2003.1592; Undem BJ, 1999, ALLERGY, V54, P81, DOI 10.1111/j.1398-9995.1999.tb04409.x; Walter RE, 2003, AM J RESP CRIT CARE, V167, P911, DOI 10.1164/rccm.2203022; Wang J, 1998, J CLIN INVEST, V102, P1132, DOI 10.1172/JCI2686; ZHONG NS, 1992, CHEST, V102, P1104, DOI 10.1378/chest.102.4.1104	52	404	440	1	26	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1049	1057		10.1016/S0140-6736(08)61446-4	http://dx.doi.org/10.1016/S0140-6736(08)61446-4			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805333				2022-12-28	WOS:000259648500031
J	Neilson, JR; Sharp, PA				Neilson, Joel R.; Sharp, Phillip A.			Small RNA regulators of gene expression	CELL			English	Editorial Material							CAENORHABDITIS-ELEGANS; LIN-14; PLANTS; SEQUENCE		[Neilson, Joel R.; Sharp, Phillip A.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Sharp, Phillip A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sharp, PA (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sharppa@mit.edu		Neilson, Joel R./0000-0002-3408-608X	NCI NIH HHS [K99 CA131474] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K99CA131474] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; English JJ, 1996, PLANT CELL, V8, P179, DOI 10.1105/tpc.8.2.179; Ha I, 1996, GENE DEV, V10, P3041, DOI 10.1101/gad.10.23.3041; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; MUELLER E, 1995, PLANT J, V7, P1001, DOI 10.1046/j.1365-313X.1995.07061001.x; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Voinnet O, 1997, NATURE, V389, P553, DOI 10.1038/39215; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4	15	56	58	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					899	902		10.1016/j.cell.2008.09.006	http://dx.doi.org/10.1016/j.cell.2008.09.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805079	Bronze			2022-12-28	WOS:000259318100006
J	Zhu, Z; Chung, WH; Shim, EY; Lee, SE; Ira, G				Zhu, Zhu; Chung, Woo-Hyun; Shim, Eun Yong; Lee, Sang Eun; Ira, Grzegorz			Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends	CELL			English	Article							STALLED REPLICATION FORKS; ESSENTIAL IN-VIVO; SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-III; ESCHERICHIA-COLI; MITOTIC RECOMBINATION; CHECKPOINT ACTIVATION; ENDONUCLEASE ACTIVITY; GENOME INSTABILITY	Formation of single-strand DNA (ssDNA) tails at a double-strand break (DSB) is a key step in homologous recombination and DNA-damage signaling. The enzyme(s) producing ssDNA at DSBs in eukaryotes remain unknown. We monitored 5'-strand resection at inducible DSB ends in yeast and identified proteins required for two stages of resection: initiation and long-range 50-strand resection. We show that the Mre11-Rad50-Xrs2 complex (MRX) initiates 50 degradation, whereas Sgs1 and Dna2 degrade 50 strands exposing long 30 strands. Deletion of SGS1 or DNA2 reduces resection and DSB repair by single-strand annealing between distant repeats while the remaining long-range resection activity depends on the exonuclease Exo1. In exo1 Delta sgs1 Delta double mutants, the MRX complex together with Sae2 nuclease generate, in a stepwise manner, only few hundred nucleotides of ssDNA at the break, resulting in inefficient gene conversion and G2/M damage checkpoint arrest. These results provide important insights into the early steps of DSB repair in eukaryotes.	[Zhu, Zhu; Chung, Woo-Hyun; Ira, Grzegorz] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, San Antonio, TX 78245 USA; [Shim, Eun Yong; Lee, Sang Eun] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, San Antonio, TX 78245 USA	Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Ira, G (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, 1 Baylor Plaza, Houston, TX 77030 USA.	gira@bcm.edu	Ira, Grzegorz/B-7912-2010		NIH [GM80600-02, GM071011]; Texas Advanced Research Program;  [GM20056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071011, R01GM120056, R01GM080600, R37GM020056, R01GM020056] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Texas Advanced Research Program; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to James Haber, Virginia Zakian, Steve Brill, Rodney Rothstein, and Judith Campbell for strains and plasmids and to Alma Papusha for technical support. We thank James Haber, Phil Hastings, and Neil Hunter for critical comments on the manuscript. This work was supported by NIH grants GM80600-02 (to G. I.) and GM071011 and Texas Advanced Research Program (to S. E. L.). The preliminary work was supported by GM20056 to J.E. Haber. S. E. L. is a scholar of the Leukemia and Lymphoma Society.	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Aravind L, 2000, NUCLEIC ACIDS RES, V28, P3417, DOI 10.1093/nar/28.18.3417; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Bae SH, 1998, J BIOL CHEM, V273, P26880, DOI 10.1074/jbc.273.41.26880; Bae SH, 2001, NATURE, V412, P456, DOI 10.1038/35086609; Branzei D, 2007, GENE DEV, V21, P3019, DOI 10.1101/gad.1624707; Budd ME, 2006, MOL CELL BIOL, V26, P2490, DOI 10.1128/MCB.26.7.2490-2500.2006; BUDD ME, 1995, P NATL ACAD SCI USA, V92, P7642, DOI 10.1073/pnas.92.17.7642; Budd ME, 2000, J BIOL CHEM, V275, P16518, DOI 10.1074/jbc.M909511199; BUDD ME, 1995, J BIOL CHEM, V270, P26766, DOI 10.1074/jbc.270.45.26766; Budd ME, 2000, MUTAT RES-DNA REPAIR, V459, P173, DOI 10.1016/S0921-8777(99)00072-5; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen CF, 2007, J BIOL CHEM, V282, P28971, DOI 10.1074/jbc.M705427200; Chiolo I, 2005, MOL CELL BIOL, V25, P5738, DOI 10.1128/MCB.25.13.5738-5751.2005; Church G M, 1985, Prog Clin Biol Res, V177, P17; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Cotta-Ramusino C, 2005, MOL CELL, V17, P153, DOI 10.1016/j.molcel.2004.11.032; Courcelle CT, 2006, P NATL ACAD SCI USA, V103, P9154, DOI 10.1073/pnas.0600785103; Davis AP, 2004, MOL CELL BIOL, V24, P2344, DOI 10.1128/MCB.24.6.2344-2351.2004; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Formosa T, 1999, GENETICS, V151, P1459; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Furuse M, 1998, EMBO J, V17, P6412, DOI 10.1093/emboj/17.21.6412; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Harrison JC, 2006, ANNU REV GENET, V40, P209, DOI 10.1146/annurev.genet.40.051206.105231; Hishida T, 2004, GENE DEV, V18, P1886, DOI 10.1101/gad.1223804; Inbar O, 1999, MOL CELL BIOL, V19, P4134; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Ira G, 2002, MOL CELL BIOL, V22, P6384, DOI 10.1128/MCB.22.18.6384-6392.2002; IVANOV EL, 1994, MOL CELL BIOL, V14, P3414, DOI 10.1128/MCB.14.5.3414; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; JINKSROBERTSON S, 1993, MOL CELL BIOL, V13, P3937, DOI 10.1128/MCB.13.7.3937; Kim JH, 2006, NUCLEIC ACIDS RES, V34, P1854, DOI 10.1093/nar/gkl102; Lee KH, 2000, NUCLEIC ACIDS RES, V28, P2873, DOI 10.1093/nar/28.15.2873; Lee SE, 2002, DNA REPAIR, V1, P27, DOI 10.1016/S1568-7864(01)00003-9; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Magner DB, 2007, MOL CELL, V26, P273, DOI 10.1016/j.molcel.2007.03.012; Maringele L, 2002, GENE DEV, V16, P1919, DOI 10.1101/gad.225102; Masuda-Sasa T, 2006, NUCLEIC ACIDS RES, V34, P1865, DOI 10.1093/nar/gkl070; Melo JA, 2001, GENE DEV, V15, P2809; Mnaimneh S, 2004, CELL, V118, P31, DOI 10.1016/j.cell.2004.06.013; Moreau S, 1999, MOL CELL BIOL, V19, P556; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Raynard S, 2006, J BIOL CHEM, V281, P13861, DOI 10.1074/jbc.C600051200; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; SCHULZ VP, 1994, CELL, V76, P145, DOI 10.1016/0092-8674(94)90179-1; Shim EY, 2007, MOL CELL BIOL, V27, P1602, DOI 10.1128/MCB.01956-06; Shroff R, 2004, CURR BIOL, V14, P1703, DOI 10.1016/j.cub.2004.09.047; Spies Maria, 2005, P389; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; Trujillo KM, 1998, J BIOL CHEM, V273, P21447, DOI 10.1074/jbc.273.34.21447; Tsubouchi H, 1998, MOL CELL BIOL, V18, P260, DOI 10.1128/MCB.18.1.260; Tsubouchi H, 2000, MOL BIOL CELL, V11, P2221, DOI 10.1091/mbc.11.7.2221; Usui T, 1998, CELL, V95, P705, DOI 10.1016/S0092-8674(00)81640-2; van Attikum H, 2004, CELL, V119, P777, DOI 10.1016/j.cell.2004.11.033; VanHulle K, 2007, MOL CELL BIOL, V27, P2601, DOI 10.1128/MCB.01740-06; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; Watt PM, 1996, GENETICS, V144, P935; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622; Zeng PY, 2006, BIOTECHNIQUES, V41, P694, DOI 10.2144/000112297; Zhou JQ, 2000, SCIENCE, V289, P771, DOI 10.1126/science.289.5480.771; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	75	772	778	2	61	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					981	994		10.1016/j.cell.2008.08.037	http://dx.doi.org/10.1016/j.cell.2008.08.037			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805091	Green Accepted, Bronze			2022-12-28	WOS:000259318100018
J	Mao, JH; Kim, IJ; Wu, D; Climent, J; Kang, HC; DelRosario, R; Balmain, A				Mao, Jian-Hua; Kim, Il-Jin; Wu, Di; Climent, Joan; Kang, Hio Chung; DelRosario, Reyno; Balmain, Allan			FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression	SCIENCE			English	Article							FBW7 UBIQUITIN LIGASE; C-MYC; HCDC4	The enzyme mTOR ( mammalian target of rapamycin) is a major target for therapeutic intervention to treat many human diseases, including cancer, but very little is known about the processes that control levels of mTOR protein. Here, we show that mTOR is targeted for ubiquitination and consequent degradation by binding to the tumor suppressor protein FBXW7. Human breast cancer cell lines and primary tumors showed a reciprocal relation between loss of FBXW7 and deletion or mutation of PTEN ( phosphatase and tensin homolog), which also activates mTOR. Tumor cell lines harboring deletions or mutations in FBXW7 are particularly sensitive to rapamycin treatment, which suggests that loss of FBXW7 may be a biomarker for human cancers susceptible to treatment with inhibitors of the mTOR pathway.	[Mao, Jian-Hua; Kim, Il-Jin; Wu, Di; Climent, Joan; Kang, Hio Chung; DelRosario, Reyno; Balmain, Allan] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Balmain, Allan] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Balmain, A (corresponding author), Univ Calif San Francisco, Canc Res Inst, 2340 Sutter St, San Francisco, CA 94143 USA.	abalmain@cc.ucsf.edu	高, 雨莉/HGU-8187-2022; Mao, Jian-Hua/EIZ-8595-2022; Climent, Joan/O-5877-2017	Mao, Jian-Hua/0000-0001-9320-6021; Climent, Joan/0000-0002-8927-6614	NCI [U01 CA84244]; U. S. Department of Energy [DE-FG02-03ER63630]; University of California at San Francisco Research-Evaluation Allocation Committee (REAC); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE [U01CA084244, R01CA116481] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U. S. Department of Energy(United States Department of Energy (DOE)); University of California at San Francisco Research-Evaluation Allocation Committee (REAC); Barbara Bass Bakar Chair of Cancer Genetics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank B. Vogelstein for providing us with the HCT116 WT, HCT116 FBXW7<SUP>-/-</SUP>, DLD1 wild-type, and DLD1 FBXW7<SUP>-/-</SUP> cell lines; K. I. Nakayama for providing Fbxw7 knockout mice and vectors (HA-FBXW7 and HA-FBXW7 Delta F); and O. Tetsu for vector encoding HA-ubiquitin. These studies were supported by NCI grant U01 CA84244 and the U. S. Department of Energy (DE-FG02-03ER63630) to A. B., the University of California at San Francisco Research-Evaluation Allocation Committee (REAC) to J.-H.M.A.B. acknowledges support from the Barbara Bass Bakar Chair of Cancer Genetics.	Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Buolamwini JK, 2005, CURR CANCER DRUG TAR, V5, P57, DOI 10.2174/1568009053332672; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Climent J, 2007, CANCER RES, V67, P818, DOI 10.1158/0008-5472.CAN-06-3307; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Fridlyand J, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-96; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2003, ONCOGENE, V22, P8379, DOI 10.1038/sj.onc.1207083; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2004, P NATL ACAD SCI USA, V101, P9085, DOI 10.1073/pnas.0402770101; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217	18	312	325	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1499	1502		10.1126/science.1162981	http://dx.doi.org/10.1126/science.1162981			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787170	Green Accepted			2022-12-28	WOS:000259121800044
J	de Rose, F				de Rose, Francois			Meetings that changed the world: Paris 1951: The birth of CERN	NATURE			English	Editorial Material																			0	0	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					174	175		10.1038/455174a	http://dx.doi.org/10.1038/455174a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784709	Bronze			2022-12-28	WOS:000259090800026
J	Racusin, JL; Karpov, SV; Sokolowski, M; Granot, J; Wu, XF; Pal'shin, V; Covino, S; van der Horst, AJ; Oates, SR; Schady, P; Smith, RJ; Cummings, J; Starling, RLC; Piotrowski, LW; Zhang, B; Evans, PA; Holland, ST; Malek, K; Page, MT; Vetere, L; Margutti, R; Guidorzi, C; Kamble, AP; Curran, PA; Beardmore, A; Kouveliotou, C; Mankiewicz, L; Melandri, A; O'Brien, PT; Page, KL; Piran, T; Tanvir, NR; Wrochna, G; Aptekar, RL; Barthelmy, S; Bartolini, C; Beskin, GM; Bondar, S; Bremer, M; Campana, S; Castro-Tirado, A; Cucchiara, A; Cwiok, M; D'Avanzo, P; D'Elia, V; Della Valle, M; Postigo, AD; Dominik, W; Falcone, A; Fiore, F; Fox, DB; Frederiks, DD; Fruchter, AS; Fugazza, D; Garrett, MA; Gehrels, N; Golenetskii, S; Gomboc, A; Gorosabel, J; Greco, G; Guarnieri, A; Immler, S; Jelinek, M; Kasprowicz, G; La Parola, V; Levan, AJ; Mangano, V; Mazets, EP; Molinari, E; Moretti, A; Nawrocki, K; Oleynik, PP; Osborne, JP; Pagani, C; Pandey, SB; Paragi, Z; Perri, M; Piccioni, A; Ramirez-Ruiz, E; Roming, PWA; Steele, IA; Strom, RG; Testa, V; Tosti, G; Ulanov, MV; Wiersema, K; Wijers, RAMJ; Winters, JM; Zarnecki, AF; Zerbi, F; Meszaros, P; Chincarini, G; Burrows, DN				Racusin, J. L.; Karpov, S. V.; Sokolowski, M.; Granot, J.; Wu, X. F.; Pal'shin, V.; Covino, S.; van der Horst, A. J.; Oates, S. R.; Schady, P.; Smith, R. J.; Cummings, J.; Starling, R. L. C.; Piotrowski, L. W.; Zhang, B.; Evans, P. A.; Holland, S. T.; Malek, K.; Page, M. T.; Vetere, L.; Margutti, R.; Guidorzi, C.; Kamble, A. P.; Curran, P. A.; Beardmore, A.; Kouveliotou, C.; Mankiewicz, L.; Melandri, A.; O'Brien, P. T.; Page, K. L.; Piran, T.; Tanvir, N. R.; Wrochna, G.; Aptekar, R. L.; Barthelmy, S.; Bartolini, C.; Beskin, G. M.; Bondar, S.; Bremer, M.; Campana, S.; Castro-Tirado, A.; Cucchiara, A.; Cwiok, M.; D'Avanzo, P.; D'Elia, V.; Della Valle, M.; de Ugarte Postigo, A.; Dominik, W.; Falcone, A.; Fiore, F.; Fox, D. B.; Frederiks, D. D.; Fruchter, A. S.; Fugazza, D.; Garrett, M. A.; Gehrels, N.; Golenetskii, S.; Gomboc, A.; Gorosabel, J.; Greco, G.; Guarnieri, A.; Immler, S.; Jelinek, M.; Kasprowicz, G.; La Parola, V.; Levan, A. J.; Mangano, V.; Mazets, E. P.; Molinari, E.; Moretti, A.; Nawrocki, K.; Oleynik, P. P.; Osborne, J. P.; Pagani, C.; Pandey, S. B.; Paragi, Z.; Perri, M.; Piccioni, A.; Ramirez-Ruiz, E.; Roming, P. W. A.; Steele, I. A.; Strom, R. G.; Testa, V.; Tosti, G.; Ulanov, M. V.; Wiersema, K.; Wijers, R. A. M. J.; Winters, J. M.; Zarnecki, A. F.; Zerbi, F.; Meszaros, P.; Chincarini, G.; Burrows, D. N.			Broadband observations of the naked-eye gamma-ray burst GRB 080319B	NATURE			English	Article							AFTERGLOW EMISSION; OPTICAL-EMISSION; 2-COMPONENT JET; REVERSE SHOCK; LIGHT CURVES; GRB 990123; TELESCOPE; SPECTRA; MODELS; FLASH	Long- duration gamma-ray bursts ( GRBs) release copious amounts of energy across the entire electromagnetic spectrum, and so provide a window into the process of black hole formation from the collapse of massive stars. Previous early optical observations of even the most exceptional GRBs ( 990123 and 030329) lacked both the temporal resolution to probe the optical flash in detail and the accuracy needed to trace the transition from the prompt emission within the outflow to external shocks caused by interaction with the progenitor environment. Here we report observations of the extraordinarily bright prompt optical and gamma-ray emission of GRB 080319B that provide diagnostics within seconds of its formation, followed by broadband observations of the afterglow decay that continued for weeks. We show that the prompt emission stems from a single physical region, implying an extremely relativistic outflow that propagates within the narrow inner core of a two- component jet.	[Racusin, J. L.; Wu, X. F.; Vetere, L.; Cucchiara, A.; Falcone, A.; Fox, D. B.; Pagani, C.; Roming, P. W. A.; Meszaros, P.; Burrows, D. N.] Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; [Karpov, S. V.; Beskin, G. M.] Russian Acad Sci, Special Astrophys Observ, Nizhnii Arkhyz 369167, Russia; [Sokolowski, M.; Wrochna, G.; Nawrocki, K.] Soltan Inst Nucl Studies, PL-05400 Otwock, Poland; [Granot, J.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England; [Wu, X. F.] Chinese Acad Sci, Purple Mt Observ, Nanjing 210008, Peoples R China; [Pal'shin, V.; Aptekar, R. L.; Frederiks, D. D.; Golenetskii, S.; Mazets, E. P.; Oleynik, P. P.; Ulanov, M. V.] AF Ioffe Phys Tech Inst, Expt Astrophys Lab, St Petersburg 194021, Russia; [Covino, S.; Guidorzi, C.; Campana, S.; D'Avanzo, P.; Fugazza, D.; Molinari, E.; Moretti, A.; Zerbi, F.; Chincarini, G.] INAF Osserv Astron Brera, I-23807 Merate, LC, Italy; [Oates, S. R.; Schady, P.; Page, M. T.] UCL, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Smith, R. J.; Guidorzi, C.; Melandri, A.; Steele, I. A.] Liverpool John Moores Univ, Astrophys Res Inst, Birkenhead CH41 1LD, Merseyside, England; [Cummings, J.; Barthelmy, S.; Gehrels, N.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Starling, R. L. C.; Evans, P. A.; Beardmore, A.; O'Brien, P. T.; Page, K. L.; Tanvir, N. R.; Osborne, J. P.; Wiersema, K.] Univ Leicester, Dept Phys & Astron, Leicester LE1 7RH, Leics, England; [Piotrowski, L. W.; Cwiok, M.; Dominik, W.; Zarnecki, A. F.] Univ Warsaw, Inst Expt Phys, PL-00681 Warsaw, Poland; [Zhang, B.] Univ Nevada, Dept Phys & Astron, Las Vegas, NV 89154 USA; [Holland, S. T.; Immler, S.] NASA, Goddard Space Flight Ctr, Astrophys Sci Div, Greenbelt, MD 20771 USA; [Holland, S. T.] Univ Space Res Assoc, Columbia, MD 21044 USA; [Holland, S. T.; Immler, S.] NASA, Goddard Space Flight Ctr, Ctr Res & Explorat Space Sci & Technol, Greenbelt, MD 20771 USA; [Malek, K.; Mankiewicz, L.] Polish Acad Sci, Ctr Theoret Phys, PL-02668 Warsaw, Poland; [Margutti, R.; Chincarini, G.] Univ Milano Bicocca, Dept Phys, I-20126 Milan, Italy; [Kamble, A. P.; Curran, P. A.; Strom, R. G.; Wijers, R. A. M. J.] Univ Amsterdam, Astron Inst Anton Pannekoek, NL-1098 SJ Amsterdam, Netherlands; [Kouveliotou, C.] NASA, George C Marshall Space Flight Ctr, NSSTC, Huntsville, AL 35805 USA; [Piran, T.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Bartolini, C.; Greco, G.; Guarnieri, A.; Piccioni, A.] Univ Bologna, I-40126 Bologna, Italy; [Bondar, S.] Inst Precise Instrumentat, Nizhnii Arkhyz 369167, Russia; [Bremer, M.; Winters, J. M.] Inst Radio Astron Millimetr, F-38406 St Martin Dheres, France; [Castro-Tirado, A.; Gorosabel, J.; Jelinek, M.] Inst Astrofis Andalucia, CSIC, E-18080 Granada, Spain; [D'Elia, V.; Fiore, F.; Testa, V.] Osserv Astron Roma, INAF, I-00040 Monte Porzio Catone, Italy; [Della Valle, M.] European So Observ, D-85748 Garching, Germany; [Della Valle, M.] Osserv Astron Capodimonte, INAF, I-80131 Naples, Italy; [de Ugarte Postigo, A.] European So Observ, Santiago 19, Chile; [Fruchter, A. S.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Garrett, M. A.; Strom, R. G.] Netherlands Inst Radio Astron ASTRON, NL-7990 AA Dwingeloo, Netherlands; [Garrett, M. A.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Garrett, M. A.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Gomboc, A.] Univ Ljubljana, Fac Math & Phys, SI-1000 Ljubljana, Slovenia; [Kasprowicz, G.] Warsaw Univ Technol, Inst Elect Syst, PL-00665 Warsaw, Poland; [La Parola, V.; Mangano, V.] INAF IASF PA, I-90146 Palermo, Italy; [Levan, A. J.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Pandey, S. B.] Aryabhatta Res Inst Observ Sci ARIES, Naini Tal 263129, India; [Paragi, Z.] JIVE, NL-7990 AA Dwingeloo, Netherlands; [Perri, M.] ESRIN, ASI Sci Data Ctr, I-00044 Frascati, Italy; [Ramirez-Ruiz, E.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Tosti, G.] Univ Perugia, I-06100 Perugia, Italy; [Meszaros, P.] Penn State Univ, Dept Phys, Davey Lab 104, University Pk, PA 16801 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Russian Academy of Sciences; Special Astrophysics Observatory of the Russian Academy of Sciences; Soltan Institute for Nuclear Studies; University of Hertfordshire; Chinese Academy of Sciences; Nanjing Institute of Astronomical Optics & Technology, NAOC, CAS; Purple Mountain Observatory, CAS; Russian Academy of Sciences; St. Petersburg Scientific Centre of the Russian Academy of Sciences; Ioffe Physical Technical Institute; Istituto Nazionale Astrofisica (INAF); University of London; University College London; Liverpool John Moores University; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University of Leicester; University of Warsaw; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Universities Space Research Association (USRA); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Polish Academy of Sciences; Center for Theoretical Physics - Polish Academy of Sciences; University of Milano-Bicocca; University of Amsterdam; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Hebrew University of Jerusalem; University of Bologna; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); Istituto Nazionale Astrofisica (INAF); European Southern Observatory; Istituto Nazionale Astrofisica (INAF); European Southern Observatory; Space Telescope Science Institute; Leiden University; Leiden University - Excl LUMC; Swinburne University of Technology; University of Ljubljana; Warsaw University of Technology; Istituto Nazionale Astrofisica (INAF); University of Warwick; Department of Science & Technology (India); Aryabhatta Research Institute of Observational Sciences (ARIES); Agenzia Spaziale Italiana (ASI); European Space Agency; University of California System; University of California Santa Cruz; University of Perugia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Racusin, JL (corresponding author), Penn State Univ, Dept Astron & Astrophys, 525 Davey Lab, University Pk, PA 16802 USA.	racusin@astro.psu.edu	Oleynik, Philipp Petrovich/C-1104-2014; Mankiewicz, Lech/G-4171-2011; Oleynik, Philipp/AAH-6443-2019; Covino, Stefano/AAQ-5188-2021; Tosti, Gino/E-9976-2013; Curran, Peter A/B-5293-2013; Wu, Xuefeng/G-5316-2015; Golenetskii, Sergey/B-3818-2015; Jelínek, Martin/E-5290-2016; Racusin, Judith L/D-2935-2012; MAŁEK, KATARZYNA/A-1254-2012; Ulanov, Mikhail/B-3467-2015; Campana, Sergio/AAL-6012-2020; Molinari, Emilio/GYR-1322-2022; Pal'shin, Valentin/F-3973-2014; Zhang, Bing/AAG-2824-2019; Aptekar, Raphail/B-3456-2015; Barthelmy, Scott D/D-2943-2012; Gehrels, Neil/D-2971-2012; Della Valle, Massimo/AAE-8884-2021; Sokolowski, Marcin/B-5584-2013; Frederiks, Dmitry D/C-7612-2014; Karpov, Sergey/AAC-8533-2020; Levan, Andrew/F-6179-2014	Oleynik, Philipp Petrovich/0000-0003-0794-7742; Oleynik, Philipp/0000-0003-0794-7742; Covino, Stefano/0000-0001-9078-5507; Curran, Peter A/0000-0003-3003-4626; Wu, Xuefeng/0000-0002-6299-1263; Jelínek, Martin/0000-0003-3922-7416; MAŁEK, KATARZYNA/0000-0003-3080-9778; Ulanov, Mikhail/0000-0002-0076-5228; Campana, Sergio/0000-0001-6278-1576; Molinari, Emilio/0000-0002-1742-7735; Della Valle, Massimo/0000-0003-3142-5020; Sokolowski, Marcin/0000-0001-5772-338X; Karpov, Sergey/0000-0003-0035-651X; de Ugarte Postigo, Antonio/0000-0001-7717-5085; Mankiewicz, Lech/0000-0002-2572-9477; Schady, Patricia/0000-0002-1214-770X; Zerbi, Filippo Maria/0000-0002-9996-973X; Wijers, Ralph/0000-0002-3101-1808; Kasprowicz, Grzegorz/0000-0001-6128-0788; Castro-Tirado, A. J./0000-0003-2999-3563; Testa, Vincenzo/0000-0003-1033-1340; D'Elia, Valerio/0000-0002-7320-5862; Perri, Matteo/0000-0003-3613-4409; La Parola, Valentina/0000-0002-8087-6488; Zarnecki, Aleksander Filip/0000-0001-8975-9483; Beardmore, Andrew/0000-0001-5186-5950; Dominik, Wojciech/0000-0001-7444-9239; Fiore, Fabrizio/0000-0002-4031-4157; Levan, Andrew/0000-0001-7821-9369; Mangano, Vanessa/0000-0003-4262-8616; Melandri, Andrea/0000-0002-2810-2143; Frederiks, Dmitry/0000-0002-1153-6340	NASA; National Science Foundation (NSF); Agenzia Spaziale Italiana, the Ministero dell'Universita` e della Ricerca ( MUR); Ministero degli Affari Esteri, the Netherlands Organization for Scientific Research; National Science Foundation of China; Russian Space Agency; Science and Technology and Facilities Council ( STFC); Slovenian Research Agency; Ministry for Higher Education, Science, and Technology, Slovenia; Polish Ministry of Science and Higher Education; Science and Technology Facilities Council [PP/E002064/1, PP/E001149/1, ST/F002599/1, PP/E001173/1, PP/D000920/1, ST/F006489/1, PP/E003303/1] Funding Source: researchfish; STFC [PP/E001173/1, PP/E001149/1, ST/F006489/1, PP/D000920/1, ST/F002599/1, PP/E002064/1, PP/E003303/1] Funding Source: UKRI	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF)); Agenzia Spaziale Italiana, the Ministero dell'Universita` e della Ricerca ( MUR)(Ministry of Education, Universities and Research (MIUR)); Ministero degli Affari Esteri, the Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Russian Space Agency; Science and Technology and Facilities Council ( STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Ministry for Higher Education, Science, and Technology, Slovenia; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank E. Rol for comments. This research was supported by NASA, the National Science Foundation (NSF), the Agenzia Spaziale Italiana, the Ministero dell'Universita` e della Ricerca ( MUR), the Ministero degli Affari Esteri, the Netherlands Organization for Scientific Research ( NWO), the National Science Foundation of China, the Russian Space Agency, Science and Technology and Facilities Council ( STFC), the Slovenian Research Agency, the Ministry for Higher Education, Science, and Technology, Slovenia, and the Polish Ministry of Science and Higher Education.	Akerlof C, 1999, NATURE, V398, P400, DOI 10.1038/18837; APTEKAR RL, 1995, SPACE SCI REV, V71, P265, DOI 10.1007/BF00751332; BAND D, 1993, ASTROPHYS J, V413, P281, DOI 10.1086/172995; Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Berger E, 2003, NATURE, V426, P154, DOI 10.1038/nature01998; Blake CH, 2005, NATURE, V435, P181, DOI 10.1038/nature03520; BLOOM J, 2008, OBSERVATIONS NAKED E; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Castro-Tirado AJ, 1999, SCIENCE, V283, P2069, DOI 10.1126/science.283.5410.2069; Chevalier RA, 2000, ASTROPHYS J, V536, P195, DOI 10.1086/308914; Cordes J. M., 2001, NE2001 I NEW MODEL G; Cwiok M, 2007, ASTROPHYS SPACE SCI, V309, P531, DOI 10.1007/s10509-007-9422-y; Frail DA, 2001, ASTROPHYS J, V562, pL55, DOI 10.1086/338119; Frail DA, 2000, ASTROPHYS J, V538, pL129, DOI 10.1086/312807; GOLENETSKII S, 2008, 7482 GCN; Huang YF, 2004, ASTROPHYS J, V605, P300, DOI 10.1086/382202; Kobayashi S, 2000, ASTROPHYS J, V545, P807, DOI 10.1086/317869; Kumar P, 2000, ASTROPHYS J, V541, pL51, DOI 10.1086/312905; Kumar P, 2003, MON NOT R ASTRON SOC, V346, P905, DOI 10.1111/j.1365-2966.2003.07138.x; Kumar P, 2000, ASTROPHYS J, V535, P152, DOI 10.1086/308847; KUMAR P, 2008, WHAT DID WE LEARN GA; Kumar P, 2008, MON NOT R ASTRON SOC, V384, P33, DOI 10.1111/j.1365-2966.2007.12621.x; Meszaros P, 1997, ASTROPHYS J, V476, P232, DOI 10.1086/303625; Meszaros P, 1999, MON NOT R ASTRON SOC, V306, pL39, DOI 10.1046/j.1365-8711.1999.02800.x; Molinari E, 2006, NUOVO CIM B, V121, P1525, DOI [10.1393/ucb/i2007-10330-x, 10.1393/ncb/i2007-10330-x]; Nakar E, 2004, MON NOT R ASTRON SOC, V353, P647, DOI 10.1111/j.1365-2966.2004.08099.x; PAGANI C, 2008, 1211 GCN; Panaitescu A, 2000, ASTROPHYS J, V544, pL17, DOI 10.1086/317301; Pedersen H, 1998, ASTROPHYS J, V496, P311, DOI 10.1086/305385; Peng F, 2005, ASTROPHYS J, V626, P966, DOI 10.1086/430045; RACUSIN JL, 2008, 7427 GCN; Ramirez-Ruiz E, 2002, MON NOT R ASTRON SOC, V337, P1349, DOI 10.1046/j.1365-8711.2002.05995.x; Ramirez-Ruiz E, 2000, ASTROPHYS J, V539, P712, DOI 10.1086/309260; REES MJ, 1992, MON NOT R ASTRON SOC, V258, pP41, DOI 10.1093/mnras/258.1.41P; Roming PWA, 2005, SPACE SCI REV, V120, P95, DOI 10.1007/s11214-005-5095-4; Sari R, 1999, ASTROPHYS J, V519, pL17, DOI 10.1086/312109; Sari R, 1999, ASTROPHYS J, V517, pL109, DOI 10.1086/312039; Sari R, 1998, ASTROPHYS J, V497, pL17, DOI 10.1086/311269; SODERBERG A, 2008, 7506 GCN; Steinle H, 2006, CHINESE J ASTRON AST, V6, P365, DOI 10.1088/1009-9271/6/S1/48; Vestrand WT, 2005, NATURE, V435, P178, DOI 10.1038/nature03515; VREESWIJK PM, 2008, 7444 GCN; Walker MA, 1998, MON NOT R ASTRON SOC, V294, P307, DOI 10.1046/j.1365-8711.1998.01238.x; Wijers R., 1997, MNRAS, V288, P51; Zerbi FM, 2001, ASTRON NACHR, V322, P275, DOI 10.1002/1521-3994(200112)322:5/6<275::AID-ASNA275>3.0.CO;2-N; Zhang B, 2004, INT J MOD PHYS A, V19, P2385, DOI 10.1142/S0217751X0401746X; Zhang B, 2005, ASTROPHYS J, V628, P315, DOI 10.1086/429787; Zhang B, 2003, ASTROPHYS J, V595, P950, DOI 10.1086/377363; Zhang WQ, 2003, ASTROPHYS J, V586, P356, DOI 10.1086/367609	50	406	413	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					183	188		10.1038/nature07270	http://dx.doi.org/10.1038/nature07270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784718	Green Submitted			2022-12-28	WOS:000259090800038
J	Salay, R; Lincoln, P				Salay, Rebecca; Lincoln, Paul			Health impact assessments in the European Union	LANCET			English	Editorial Material									[Salay, Rebecca; Lincoln, Paul] Natl Heart Forum, London WC1H 9LG, England		Salay, R (corresponding author), Natl Heart Forum, Tavistock House,S Tavistock Sq, London WC1H 9LG, England.	rebecca.salay@heartforum.org.uk						European Centre for Health Policy W, 1999, HLTH IMP ASS MAIN CO	1	18	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					860	861		10.1016/S0140-6736(08)61337-9	http://dx.doi.org/10.1016/S0140-6736(08)61337-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	347FB	18774419				2022-12-28	WOS:000259124900028
J	Zimyanin, VL; Belaya, K; Pecreaux, J; Gilchrist, MJ; Clark, A; Davis, I; St Johnston, D				Zimyanin, Vitaly L.; Belaya, Katsiaryna; Pecreaux, Jacques; Gilchrist, Michael J.; Clark, Alejandra; Davis, Ilan; St Johnston, Daniel			In vivo Imaging of oskar mRNA transport reveals the mechanism of posterior localization	CELL			English	Article							DROSOPHILA OOCYTE; MAGO NASHI; KINESIN-I; MAMMALIAN-CELLS; BINDING PROTEIN; AXIS FORMATION; POLE PLASM; GERM PLASM; DYNEIN; STAUFEN	oskar mRNA localization to the posterior of the Drosophila oocyte defines where the abdomen and germ cells form in the embryo. Although this localization requires microtubules and the plus end-directed motor, kinesin, its mechanism is controversial and has been proposed to involve active transport to the posterior, diffusion and trapping, or exclusion from the anterior and lateral cortex. By following oskar mRNA particles in living oocytes, we show that the mRNA is actively transported along microtubules in all directions, with a slight bias toward the posterior. This bias is sufficient to localize the mRNA and is reversed in mago, barentsz, and Tropomyosin II mutants, which mislocalize the mRNA anteriorly. Since almost all transport is mediated by kinesin, oskar mRNA localizes by a biased random walk along a weakly polarized cytoskeleton. We also show that each component of the oskar mRNA complex plays a distinct role in particle formation and transport.	[Zimyanin, Vitaly L.; Belaya, Katsiaryna; Gilchrist, Michael J.; St Johnston, Daniel] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Zimyanin, Vitaly L.; Belaya, Katsiaryna; Gilchrist, Michael J.; St Johnston, Daniel] Univ Cambridge, Dept Genet, Cambridge CB2 1QN, England; [Clark, Alejandra; Davis, Ilan] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	St Johnston, D (corresponding author), Univ Cambridge, Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	ds139@mole.bio.cam.ac.uk	St Johnston, Daniel/C-9568-2009; Davis, Ilan/F-4975-2010; Pecreaux, Jacques/A-4248-2008	Pecreaux, Jacques/0000-0001-9998-4844; St Johnston, Daniel/0000-0001-5582-3301; Davis, Ilan/0000-0002-5385-3053	Wellcome Trust; MRC [G0001292] Funding Source: UKRI; Medical Research Council [G0001292] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Liz Gavis and Bill Saxton for providing fly stocks, Simon Bullock for help with the statistical analysis of particle movement, and I. Palacios and C. P. Heisenberg for support during writing. V. L. Z. and K. B. were supported by the Darwin Trust. This work was supported by the Wellcome Trust.	Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Beach DL, 1999, CURR BIOL, V9, P569, DOI 10.1016/S0960-9822(99)80260-7; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; BOSWELL RE, 1991, DEVELOPMENT, V113, P373; Brendza KM, 1999, J BIOL CHEM, V274, P31506, DOI 10.1074/jbc.274.44.31506; Brendza RP, 2000, SCIENCE, V289, P2120, DOI 10.1126/science.289.5487.2120; Brendza RP, 2002, CURR BIOL, V12, P1541, DOI 10.1016/S0960-9822(02)01108-9; Bullock SL, 2006, CURR BIOL, V16, P1447, DOI 10.1016/j.cub.2006.05.055; Bullock SL, 2001, NATURE, V414, P611, DOI 10.1038/414611a; Cha BJ, 2002, NAT CELL BIOL, V4, P592, DOI 10.1038/ncb832; Cha BJ, 2001, CELL, V106, P35, DOI 10.1016/S0092-8674(01)00419-6; Chou TB, 1996, GENETICS, V144, P1673; Clark A, 2007, DEVELOPMENT, V134, P1955, DOI 10.1242/dev.02832; CLARK I, 1994, CURR BIOL, V4, P289, DOI 10.1016/S0960-9822(00)00068-3; Clark IE, 1997, DEVELOPMENT, V124, P461; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; ERDELYI M, 1995, NATURE, V377, P524, DOI 10.1038/377524a0; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; Glotzer JB, 1997, CURR BIOL, V7, P326, DOI 10.1016/S0960-9822(06)00156-4; Hachet O, 2004, NATURE, V428, P959, DOI 10.1038/nature02521; Hachet O, 2001, CURR BIOL, V11, P1666, DOI 10.1016/S0960-9822(01)00508-5; Huynh JR, 2004, DEV CELL, V6, P625, DOI 10.1016/S1534-5807(04)00130-3; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jenny A, 2006, DEVELOPMENT, V133, P2827, DOI 10.1242/dev.02456; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Macchi P, 2003, J NEUROSCI, V23, P5778; MacDougall N, 2003, DEV CELL, V4, P307, DOI 10.1016/S1534-5807(03)00058-3; Manseau L, 1996, DEVELOPMENT, V122, P2109; MARKUSSEN FH, 1995, DEVELOPMENT, V121, P3723; Martin SG, 2003, DEVELOPMENT, V130, P4201, DOI 10.1242/dev.00630; McGrail M, 1997, DEVELOPMENT, V124, P2409; Micklem DR, 2000, EMBO J, V19, P1366, DOI 10.1093/emboj/19.6.1366; Mische S, 2007, MOL BIOL CELL, V18, P2254, DOI 10.1091/mbc.E06-10-0959; Mohr SE, 2001, GENE DEV, V15, P2886; Munro TP, 2006, J CELL BIOL, V172, P577, DOI 10.1083/jcb.200510044; NEWMARK PA, 1994, DEVELOPMENT, V120, P1303; Oleynikov Y, 2003, CURR BIOL, V13, P199, DOI 10.1016/S0960-9822(03)00044-7; Palacios IM, 2002, DEVELOPMENT, V129, P5473, DOI 10.1242/dev.00119; Palacios IM, 2004, NATURE, V427, P753, DOI 10.1038/nature02351; POKRYWKA NJ, 1995, DEV BIOL, V167, P363, DOI 10.1006/dbio.1995.1030; Rook MS, 2000, J NEUROSCI, V20, P6385, DOI 10.1523/JNEUROSCI.20-17-06385.2000; SERANO TL, 1995, DEVELOPMENT, V121, P3013; Serbus LR, 2005, DEVELOPMENT, V132, P3743, DOI 10.1242/dev.01956; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; STJOHNSTON D, 1991, CELL, V66, P51, DOI 10.1016/0092-8674(91)90138-O; Theurkauf WE, 1998, DEVELOPMENT, V125, P3655; van Eeden FJM, 2001, J CELL BIOL, V154, P511, DOI 10.1083/jcb.200105056; Weil TT, 2006, DEV CELL, V11, P251, DOI 10.1016/j.devcel.2006.06.006; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wilkie GS, 2001, CELL, V105, P209, DOI 10.1016/S0092-8674(01)00312-9	54	239	242	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					843	853		10.1016/j.cell.2008.06.053	http://dx.doi.org/10.1016/j.cell.2008.06.053			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775316	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000258947500023
J	Dunger, DB; Todd, JA				Dunger, David B.; Todd, John A.			Prevention of type 1 diabetes: what next?	LANCET			English	Editorial Material							TRANSLATIONAL MINIREVIEW SERIES; EARLY-CHILDHOOD; INCREASED RISK; AUTOIMMUNITY		[Dunger, David B.] Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England; [Dunger, David B.] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Todd, John A.] Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Wellcome Trust Diabet & Inflammat Lab, Cambridge, England	University of Cambridge; University of Cambridge; University of Cambridge	Dunger, DB (corresponding author), Univ Cambridge, Dept Paediat, Cambridge CB2 0QQ, England.	dbd25@cam.ac.uk	; Todd, John/A-3542-2010	Dunger, Professor David/0000-0002-2566-9304; Todd, John/0000-0003-2740-8148				Achenbach P, 2008, CURR DIABETES REP, V8, P87, DOI 10.1007/s11892-008-0017-y; Akerblom HK, 2005, DIABETOLOGIA, V48, P829, DOI 10.1007/s00125-005-1733-3; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; *DIAB PREV TRIAL T, 2005, DIABETES CARE, V28, P1068; Gale EAM, 2002, DIABETES, V51, P3353, DOI 10.2337/diabetes.51.12.3353; NANTOSALONEN K, 2008, LANCET          0923, DOI DOI 10.1016/S0140-6736(08)61309-4; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Norris JM, 2007, JAMA-J AM MED ASSOC, V298, P1420, DOI 10.1001/jama.298.12.1420; Roll U, 1996, DIABETES, V45, P967, DOI 10.2337/diabetes.45.7.967; Staeva-Vieira T, 2007, CLIN EXP IMMUNOL, V148, P17, DOI 10.1111/j.1365-2249.2007.03328.x; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579	12	1	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1710	1711		10.1016/S0140-6736(08)61310-0	http://dx.doi.org/10.1016/S0140-6736(08)61310-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18814907				2022-12-28	WOS:000261077900005
J	Fivian, MD; Hudson, HS; Lin, RP; Zahid, HA				Fivian, Martin D.; Hudson, Hugh S.; Lin, Robert P.; Zahid, H. Abran			A large excess in apparent solar oblateness due to surface magnetism	SCIENCE			English	Article							LIMB SHAPE DISTORTIONS; DISK SEXTANT; SOHO MISSION; RELATIVITY; BRIGHTNESS; DIAMETER; SUN	The shape of the Sun subtly reflects its rotation and internal flows. The surface rotation rate similar to 2 kilometers per second at the equator, predicts an oblateness (equator-pole radius difference) of 7.8 milli-arc seconds, or similar to 0.001%. observations from the Reuven Ramaty High-Energy Solar Spectroscopic Imager satellite show unexpectedly large flattening, relative to the expectation from surface rotation. This excess is dominated by the quadrupole term and gives a total oblateness of 10.77 +/- 0.44 milli-arc seconds. The position of the limb correlates with a sensitive extreme ultraviolet proxy, the 284 angstrom limb brightness. We relate the larger radius values to magnetic elements in the enhanced network and use the correlation to correct for it as a systematic error term in the oblateness measurement. The corrected oblateness of the nonmagnetic Sun is 8.01 +/- 0.14 milli-arc seconds, which is near the value expected from rotation.	[Fivian, Martin D.; Hudson, Hugh S.; Lin, Robert P.; Zahid, H. Abran] Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA; [Lin, Robert P.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Zahid, H. Abran] Univ Hawaii, Inst Astron, Honolulu, HI 96822 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Hawaii System	Fivian, MD (corresponding author), Univ Calif Berkeley, Space Sci Lab, Berkeley, CA 94720 USA.	mfivian@ssl.berkeley.edu			NASA [NAG5-12878, NNX07A141G]	NASA(National Aeronautics & Space Administration (NASA))	We thank NASA for support under grants NAG5-12878 and NNX07A141G.	Armstrong J, 1999, ASTROPHYS J, V525, P533, DOI 10.1086/307879; Auwers A., 1891, ASTRON NACHR, V128, P361, DOI [10.1002/asna.18911282002, DOI 10.1002/ASNA.18911282002]; Chapman GA, 1996, SOL PHYS, V168, P259, DOI 10.1007/BF00148054; Delaboudiniere JP, 1995, SOL PHYS, V162, P291, DOI 10.1007/BF00733432; DICKE RH, 1967, PHYS REV LETT, V18, P313, DOI 10.1103/PhysRevLett.18.313; DICKE RH, 1970, ASTROPHYS J, V159, P1, DOI 10.1086/150286; DICKE RH, 1987, ASTROPHYS J, V318, P451, DOI 10.1086/165382; Domingo V, 1995, SOL PHYS, V162, P1, DOI 10.1007/BF00733425; Egidi A, 2006, SOL PHYS, V235, P407, DOI 10.1007/s11207-006-0073-x; Emilio M, 2007, ASTROPHYS J, V660, pL161, DOI 10.1086/518212; Fivian M, 2002, SOL PHYS, V210, P87, DOI 10.1023/A:1022448632344; FIVIAN M, 2003, SPIE, V4853, P60; HILL HA, 1974, PHYS REV LETT, V33, P1497, DOI 10.1103/PhysRevLett.33.1497; Kuhn JR, 1998, NATURE, V392, P155, DOI 10.1038/32361; KUHN JR, 1988, SCIENCE, V242, P908, DOI 10.1126/science.242.4880.908; Roxburgh IW, 2001, ASTRON ASTROPHYS, V377, P688, DOI 10.1051/0004-6361:20011104; Rozelot JP, 2003, SOL PHYS, V217, P39, DOI 10.1023/A:1027363803045; Scherrer PH, 1995, SOL PHYS, V162, P129, DOI 10.1007/BF00733429; SOFIA S, 1994, ASTROPHYS J, V427, P1048, DOI 10.1086/174211; Will CM, 2006, LIVING REV RELATIV, V9, DOI 10.12942/lrr-2006-3; WILLSON RC, 1991, NATURE, V351, P42, DOI 10.1038/351042a0; ZWAAN C, 1987, ANNU REV ASTRON ASTR, V25, P83, DOI 10.1146/annurev.aa.25.090187.000503	22	33	35	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 24	2008	322	5901					560	562		10.1126/science.1160863	http://dx.doi.org/10.1126/science.1160863			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18832608				2022-12-28	WOS:000260299100035
J	Reza, A; Tomczyk, B; Aguayo, VM; Zagre, NM; Goumbi, K; Blanton, C; Talley, L				Reza, Avid; Tomczyk, Basia; Aguayo, Victor M.; Zagre, Noel M.; Goumbi, Kadade; Blanton, Curtis; Talley, Leisel			Retrospective determination of whether famine existed in Niger, 2005: two stage cluster survey	BMJ-BRITISH MEDICAL JOURNAL			English	Article							HEALTH; MALNUTRITION; CHILDREN	Objective To apply the famine scale by Howe and Devereux to the situation in Niger, west Africa, in 2005 to retrospectively determine whether famine existed. Design Two stage cluster survey. Setting Survey of households in each of Niger's eight regions. Participants 4003 households. Main outcome measures Crude mortality, mortality in children under 5, and the proportion of caregivers both nationally and regionally adopting coping strategies to deal with insufficient food needs. Results The estimated national crude mortality rate was 0.4 (0.4 to 0.5) deaths per 10 000 per day and under 5 mortality rate was 1.7 (1.4 to 1.9) deaths per 10 000 per day. Nationally, 22.3% (95% confidence interval 19.9% to 24.8%) of caregivers of under 5s did not resort to any coping strategies to deal with insufficient food needs. Reversible coping strategies were, however, used by 5.8% (4.7% to 7.0%) of caregivers, whereas 49.4% (46.9% to 51.8%) relied on irreversible coping strategies and 22.6% (20.0% to 25.4%) on survival strategies. Conclusion On the basis of the famine scale proposed by Howe and Devereux, most regions in Niger experienced food crisis conditions and some areas approached famine proportions.	[Reza, Avid; Tomczyk, Basia; Blanton, Curtis; Talley, Leisel] Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, Atlanta, GA 30341 USA; [Aguayo, Victor M.] UNICEF, New Delhi, India; [Zagre, Noel M.] UNICEF, Niamey, Niger	Centers for Disease Control & Prevention - USA	Reza, A (corresponding author), Ctr Dis Control & Prevent, Int Emergency & Refugee Hlth Branch, 4770 Buford Highway NE MS F-60, Atlanta, GA 30341 USA.	afr6@cdc.gov			Office of US Foreign Disaster Assistance; Unicef	Office of US Foreign Disaster Assistance; Unicef	Office of US Foreign Disaster Assistance and Unicef funded the survey.	Aguayo V., 2006, Morbidity and Mortality Weekly Report, V55, P1172; Anker M, STANDARD VERBAL AUTO; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BRIEND A, 1988, BRIT MED J, V296, P879, DOI 10.1136/bmj.296.6626.879; *CDCP, 1992, MMWR-MORBID MORTAL W, P41; *CENTR INT AG, 2007, WORLD FACTB SWAZ; *EARL WARN DEP, 2002, GUID EM NUTR ASS; *FAM EARL WARN SYS, 2005, NIG EV BAS UND CURR; Frongillo EA, 1997, J NUTR, V127, P2302, DOI 10.1093/jn/127.12.2302; GABOULAUD V, 2005, STATUT NUTR MORTALIT; Howe P, 2004, DISASTERS, V28, P353, DOI 10.1111/j.0361-3666.2004.00263.x; MAXWELL D, 2003, COPING STRATEGIES IN; *MED SANS FRONT, 2005, AL RES NIG NUTR SURV; Muller O, 2005, CAN MED ASSOC J, V173, P279, DOI 10.1503/cmaj.050342; *OV DEV I, 2005, HUM ISS NIG; *REP NIG UN, 2000, ENQ IND MULT 2000 MI; Salama P, 2001, JAMA-J AM MED ASSOC, V286, P563, DOI 10.1001/jama.286.5.563; Sheckler A. C., 2004, SYNTHESIS REPORT FAM; Smith L.C., 2000, EXPLAINING CHILD MAL; *UN CHILDR FUND, 2008, GLANC NIG BAS IND; *UN SECR GEN HIGH, 2008, HIGH LEV TASK FORC G; *UN WORLD FOOD PRO, 2005, WFPS NIG APP TRIPL H; Watkins K, 2005, HUMAN DEV REPORT 200; World Health Organization, 2000, MAN NUTR MAJ EM; Young H, 2006, MEANING MEASUREMENT	25	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1622	10.1136/bmj.a1622	http://dx.doi.org/10.1136/bmj.a1622			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18832413	hybrid, Green Published			2022-12-28	WOS:000260093900036
J	Kenyon, S; Pike, K; Jones, DR; Brocklehurst, P; Marlow, N; Salt, A; Taylor, DJ				Kenyon, S.; Pike, K.; Jones, D. R.; Brocklehurst, P.; Marlow, N.; Salt, A.; Taylor, D. J.			Childhood outcomes after prescription of antibiotics to pregnant women with spontaneous preterm labour: 7-year follow-up of the ORACLE II trial	LANCET			English	Article							BEHAVIORAL OUTCOMES; CHILDREN; BIRTH; AGE	Background The ORACLE II trial compared the use of erythromycin and/or amoxicillin-clavulanate (co-amoxiclav) with that of placebo for women in spontaneous preterm labour and intact membranes, without overt signs of clinical infection, by use of a factorial randomised design. The aim of the present study-the ORACLE Children Study II-was to determine the long-term effects on children after exposure to antibiotics in this clinical situation. Methods We assessed children at age 7 years born to the 4221 women who had completed the ORACLE 11 study and who were eligible for follow-up with a structured parental questionnaire to assess the child's health status. Functional impairment was defined as the presence of any level of functional impairment (severe, moderate, or mild) derived from the mark III Multi-Attribute Health Status classification system. Educational outcomes were assessed with national curriculum test results for children resident in England. Findings Outcome was determined for 3196 (71%) eligible children. Overall, a greater proportion of children whose mothers had been prescribed erythromycin, with or without co-amoxiclav, had any functional impairment than did those whose mothers had received no erythromycin (658 [42.3%] of 1554 children vs 574 [38.3%] of 1498; odds ratio 1.18, 95% CI 1.02-1.37). Co-amoxiclav (with or without erythromycin) had no effect on the proportion of children with any functional impairment, compared with receipt of no co-amoxiclav (624 [40.7%] of 1523 vs 608 [40.0%] of 1520; 1.03, 0.89-1.19). No effects were seen with either antibiotic on the number of deaths, other medical conditions, behavioural patterns, or educational attainment. However, more children whose mothers had received erythromycin or co-amoxiclav developed cerebral palsy than did those born to mothers who received no erythromycin or no co-amoxiclav, respectively (erythromycin: 53 [3.3%] of 1611 vs 27 [1.7%] of 1562, 1.93, 1.21-3.09; co-amoxiclav: 50 [3.2%] of 1587 vs 30 [1.9%] of 1586, 1.69, 1.07-2.67). The number needed to harm with erythromycin was 64 (95% CI 37-209) and with co-amoxiclav 79 (42-591). Interpretation The prescription of erythromycin for women in spontaneous preterm labour with intact membranes was associated with an increase in functional impairment among their children at 7 years of age. The risk of cerebral palsy was increased by either antibiotic, although the overall risk of this condition was low. Funding UK Medical Research Council.	[Kenyon, S.; Pike, K.; Taylor, D. J.] Univ Leicester, Reprod Sci Sect, Leicester LE1 6TP, Leics, England; [Jones, D. R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Brocklehurst, P.] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford, England; [Marlow, N.] Univ Nottingham, Acad Div Child Hlth, Nottingham NG7 2RD, England; [Salt, A.] UCL, Great Ormond St Hosp Children, London, England; [Salt, A.] UCL, Inst Child Hlth, London, England	University of Leicester; University of Leicester; University of Oxford; University of Nottingham; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Kenyon, S (corresponding author), Univ Leicester, Reprod Sci Sect, 22-28 Princess Rd W, Leicester LE1 6TP, Leics, England.	oracle@leicester.ac.uk	Brocklehurst, Peter/B-5804-2011; Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953; Kenyon, Sara/0000-0002-0756-9617	UK Medical Research Council; University Hospitals of Leicester; Medical Research Council [G9226450] Funding Source: researchfish; MRC [G9226450] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University Hospitals of Leicester; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the UK Medical Research Council and sponsored by University Hospitals of Leicester and approved by their research and development directorate. We thank all the women and children who took part in the study and the obstetricians and midwives who recruited them to the original ORACLE trials. We thank the Office of National Statistics, the NHS National Strategic Tracing Service, and the Data Services Group within the Department of Children, Schools and Families. We also thank the key stage one group (Maggie McLean, John Crookes, Peter Tymms, and Tony Cline) for helpful comments on educational aspects. We thank Steve Gould, Barbara Farrell, Phil Edwards, and Martin Rosser for advice on questionnaire design. We convened a group of experts from within the field to help us understand and interpret these finding before publication. This group consisted of Martin Whittle, Alison Bedford Russell, Phil Bennett, Kate Costeloe, Francis Cowan, Olaf Dammann, Diana Elbourne, Catherine Elliott, Mike Millar, Jane Norman. Micheal O'Shea, Max Parmar, Roberto Romero, and Dieter Wolke.	Altman DG, 2006, PRACTICAL STAT MED R; American College of Obstetricians and Gynecologists Committee on Practice Bulletins, 2003, OBSTET GYNECOL, V101, P1039; [Anonymous], LANCET; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bhutta AT, 2002, JAMA-J AM MED ASSOC, V288, P728, DOI 10.1001/jama.288.6.728; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Cuffe Steven P, 2005, J Atten Disord, V9, P392, DOI 10.1177/1087054705280413; Dammann O, 2006, SEMIN FETAL NEONAT M, V11, P363, DOI 10.1016/j.siny.2006.02.003; Feeny D, 2004, SOC SCI MED, V58, P799, DOI 10.1016/S0277-9536(03)00254-5; Gates S, 2004, BJOG-INT J OBSTET GY, V111, P213, DOI 10.1111/j.1471-0528.2004.00059.x; Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Jobe A H, 2001, Semin Neonatol, V6, P331, DOI 10.1053/siny.2001.0068; Johnson S, 2007, SEMIN FETAL NEONAT M, V12, P363, DOI 10.1016/j.siny.2007.05.004; Kallen BAJ, 2005, REPROD TOXICOL, V20, P209, DOI 10.1016/j.reprotox.2005.01.010; KENYON S, 2008, LANCET          0918, DOI DOI 10.1016/S0140-6736(08)61202-7; King J, 2002, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000246; Marlow N, 2005, NEW ENGL J MED, V352, P9, DOI 10.1056/NEJMoa041367; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; Montgomery Alan A, 2003, BMC Med Res Methodol, V3, P26, DOI 10.1186/1471-2288-3-26; *QUAL CURR AUTH, 2007, KEY STAG 1 ASS REP A; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P118, DOI 10.1111/j.1471-0528.2006.01150.x; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; SAIGAL S, 1994, J PEDIATR-US, V125, P411, DOI 10.1016/S0022-3476(05)83288-3; Salt A, 2006, EARLY HUM DEV, V82, P185, DOI 10.1016/j.earlhumdev.2005.12.015; Tin W, 1998, ARCH DIS CHILD-FETAL, V79, pF83, DOI 10.1136/fn.79.2.F83	26	223	230	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 11	2008	372	9646					1319	1327		10.1016/S0140-6736(08)61203-9	http://dx.doi.org/10.1016/S0140-6736(08)61203-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18804276	Bronze, Green Submitted			2022-12-28	WOS:000260060500030
J	Drucker, DJ; Buse, JB; Taylor, K; Kendall, DM; Trautmann, M; Zhuang, DL; Porter, L				Drucker, Daniel J.; Buse, John B.; Taylor, Kristin; Kendall, David M.; Trautmann, Michael; Zhuang, Dangliang; Porter, Lisa		DURATION 1 Study Grp	Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; SYNTHETIC EXENDIN-4; INSULIN GLARGINE; TREATED PATIENTS; SULFONYLUREA; METFORMIN; EFFICACY; MELLITUS; FAILURE	Background Exenatide is an incretin mimetic that shares glucoregulatory properties with glucagon-like peptide 1 (GLP-1), and improves glycaemic control, with progressive bodyweight reductions, when administered twice a day in patients with type 2 diabetes. We compared the efficacy of a once-weekly formulation of exenatide to that of a twice daily dose. Methods A 30-week, randomised, non-inferiority study compared a long-acting release formulation of exenatide 2 mg administered once weekly to 10 pg exenatide administered twice a day, in 295 patients with type 2 diabetes (haemoglobin A(1c) [HbA(1c)] 8.3% [SD 1.0], mean fasting plasma glucose 9 [SD 2] mmol/L, weight 102 [SD 20] kg, diabetes duration 6.7 [ S D 5 .0] years). The patients were naive to drug therapy, or on one or more oral antidiabetic agents. The primary endpoint was the change in HbA(1c) at 30 weeks. This study is registered with ClinicalTrials.gov, number NCT00308139. Findings At 30 weeks, the patients given exenatide once a week had significantly greater changes in HbA,, than those given exenatide twice a day (-1. 9 [SE 0.1%] vs -1. 5 [0.1%], 95% CI -0 . 54% to -0 . 12%; p=0.0023). A significantly greater proportion of patients receiving treatment once a week versus twice a day achieved target HbA(1c) levels of 7 .0% or less (77% vs 61% of evaluable patients, p=0. 0039). Interpretation Exenatide once weekly resulted in significantly greater improvements in glycaemic control than exenaticle given twice a day, with no increased risk of hypoglycaernia and similar reductions in bodyweight. Funding Amylin Pharmaceuticals Inc and Eli Lilly and Company.	[Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Banting & Best Diabet Ctr, Dept Med,Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Buse, John B.] Univ N Carolina, Sch Med, Div Endocrinol, Dept Med, Chapel Hill, NC USA; [Taylor, Kristin; Kendall, David M.; Zhuang, Dangliang; Porter, Lisa] Amylin Pharmaceut Inc, San Diego, CA USA; [Trautmann, Michael] Eli Lilly & Co, Lilly Res, Indianapolis, IN 46285 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Bristol-Myers Squibb; Amylin Pharmaceuticals, LLC; Eli Lilly	Drucker, DJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Banting & Best Diabet Ctr, Dept Med,Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada.	d.drucker@utoronto.ca	Buse, John Bernard/J-9742-2019; Drucker, Daniel J/A-4092-2010	Buse, John Bernard/0000-0002-9723-3876; 				Barnett AH, 2007, CLIN THER, V29, P2333, DOI 10.1016/j.clinthera.2007.11.006; BOLEN S, 2005, COMP EFFECTIVENESS S; Brown JB, 2004, DIABETES CARE, V27, P1535, DOI 10.2337/diacare.27.7.1535; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; DAVIS JE, 1978, DIABETES, V27, P102, DOI 10.2337/diabetes.27.2.102; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fineman MS, 2003, DIABETES CARE, V26, P2370, DOI 10.2337/diacare.26.8.2370; Fonseca V, 2000, JAMA-J AM MED ASSOC, V283, P1695, DOI 10.1001/jama.283.13.1695; Garbutt JC, 2005, JAMA-J AM MED ASSOC, V293, P1617, DOI 10.1001/jama.293.13.1617; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Hermansen K, 2007, DIABETES OBES METAB, V9, P733, DOI 10.1111/j.1463-1326.2007.00744.x; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Kane JM, 2003, AM J PSYCHIAT, V160, P1125, DOI 10.1176/appi.ajp.160.6.1125; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; KLEIN R, 1995, DIABETES CARE, V18, P258, DOI 10.2337/diacare.18.2.258; Koro CE, 2004, DIABETES CARE, V27, P17, DOI 10.2337/diacare.27.1.17; Larsen J, 2001, DIABETES CARE, V24, P1416, DOI 10.2337/diacare.24.8.1416; Matthews DR, 1998, DIABETIC MED, V15, P297, DOI 10.1002/(SICI)1096-9136(199804)15:4<297::AID-DIA572>3.3.CO;2-N; Morrish NJ, 2001, DIABETOLOGIA, V44, pS14, DOI 10.1007/PL00002934; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nielsen LL, 2004, REGUL PEPTIDES, V117, P77, DOI 10.1016/j.regpep.2003.10.028; PONTIROLI AE, 1994, DIABETES METAB REV, V10, P31, DOI 10.1002/dmr.5610100104; Rosenstock J, 2007, DIABETES CARE, V30, P217, DOI 10.2337/dc06-1815; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Schnabel CA, 2006, PEPTIDES, V27, P1902, DOI 10.1016/j.peptides.2006.01.019; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tracy MA, 1999, BIOMATERIALS, V20, P1057, DOI 10.1016/S0142-9612(99)00002-2; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	35	773	801	3	56	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1240	1250		10.1016/S0140-6736(08)61206-4	http://dx.doi.org/10.1016/S0140-6736(08)61206-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	357YB	18782641				2022-12-28	WOS:000259882000030
J	Klein, CA				Klein, Christoph A.			Cancer - The metastasis cascade	SCIENCE			English	Editorial Material							CELLS; PROGRESSION		[Klein, Christoph A.] Univ Regensburg, Dept Pathol, Div Oncogenom, D-93053 Regensburg, Germany	University of Regensburg	Klein, CA (corresponding author), Univ Regensburg, Dept Pathol, Div Oncogenom, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany.	christoph.klein@klinik.uni-regensburg.de		Klein, Christoph A./0000-0001-7128-1725				Ansieau S, 2008, CANCER CELL, V14, P79, DOI 10.1016/j.ccr.2008.06.005; Bernards R, 2002, NATURE, V418, P823, DOI 10.1038/418823a; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Giudice LC, 2004, LANCET, V364, P1789, DOI 10.1016/S0140-6736(04)17403-5; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Klein CA, 2003, ADV CANCER RES, V89, P35, DOI 10.1016/S0065-230X(03)01002-9; Kuhn T.S., 1974, STRUCTURE SCI THEORI, P459; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; SCHLIMOK G, 1987, P NATL ACAD SCI USA, V84, P8672, DOI 10.1073/pnas.84.23.8672; TARIN D, 1984, CANCER RES, V44, P3584	11	212	222	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1785	1787		10.1126/science.1164853	http://dx.doi.org/10.1126/science.1164853			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818347				2022-12-28	WOS:000259501300023
J	Fischer, SEJ; Butler, MD; Pan, Q; Ruvkun, G				Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary			Trans-splicing in C. elegans generates the negative RNAi regulator ERI-6/7	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GENETIC INTERFERENCE; DROSOPHILA; PROTEIN; ARGONAUTE; HELICASE; IDENTIFICATION; PATHWAYS; REVEALS; ENCODES	Mutations that enhance the response to double- stranded RNA ( dsRNA) have revealed components of the RNA interference ( RNAi) pathway or related small RNA pathways. To explore these small RNA pathways, we screened for Caenorhabditis elegans mutants displaying an enhanced response to exogenous dsRNAs. Here we describe the isolation of mutations in two adjacent, divergently transcribed open reading frames ( eri-6 and eri-7) that fail to complement. eri-6 and eri- 7 produce separate pre- messenger RNAs ( pre- mRNAs) that are trans- spliced to form a functional mRNA, eri- 6/ 7. Trans- splicing of eri6/7 is mediated by a direct repeat that flanks the eri- 6 gene. Adenosine to inosine editing within untranslated regions of eri- 6 and eri- 7 pre- mRNAs reveals a double- stranded pre- mRNA intermediate, forming in the nucleus before splicing occurs. The ERI-6/7 protein is a superfamily I helicase that both negatively regulates the exogenous RNAi pathway and functions in an endogenous RNAi pathway.	[Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Fischer, Sylvia E. J.; Butler, Maurice D.; Pan, Qi; Ruvkun, Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Ruvkun, G (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	ruvkun@molbio.mgh.harvard.edu			Leukemia and Lymphoma Society; EMBO; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044619] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank: S. Kennedy for advice and initiating the enhanced RNAi screen; M. Finney for advice on advanced PCR; C. Zhang for mg441 Eri characterization; Y. Kohara, D. Thierry-Mieg and J. Thierry-Mieg for EST sequences and clones; the Mitani laboratory for deletion strains; the Caenorhabditis Genetics Center for strains; Ruvkun laboratory members for reading the manuscript and many discussions; the laboratories of J. Kaplan and F. Ausubel for discussions; and the Leukemia and Lymphoma Society, and EMBO for funding to S.E.J.F.	Alder MN, 2003, RNA, V9, P25, DOI 10.1261/rna.2650903; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Beitel GJ, 1995, GENE DEV, V9, P3149, DOI 10.1101/gad.9.24.3149; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Caplen NJ, 2002, HUM MOL GENET, V11, P175, DOI 10.1093/hmg/11.2.175; Costa M, 1998, J CELL BIOL, V141, P297, DOI 10.1083/jcb.141.1.297; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; Dorn R, 2001, P NATL ACAD SCI USA, V98, P9724, DOI 10.1073/pnas.151268698; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Felix MA, 2004, CURR BIOL, V14, pR75, DOI 10.1016/j.cub.2003.12.050; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Horiuchi T, 2003, GENE DEV, V17, P2496, DOI 10.1101/gad.1137303; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Ketting RF, 1999, CELL, V99, P133, DOI 10.1016/S0092-8674(00)81645-1; Knight SW, 2002, MOL CELL, V10, P809, DOI 10.1016/S1097-2765(02)00649-4; Labrador M, 2001, NATURE, V409, P1000, DOI 10.1038/35059000; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Schott DH, 2005, P NATL ACAD SCI USA, V102, P18420, DOI 10.1073/pnas.0507123102; Sempere LF, 2002, DEV BIOL, V244, P170, DOI 10.1006/dbio.2002.0594; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stiernagle T., 2006, MAINTENANCE C ELEGAN; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Tavernarakis N, 2000, NAT GENET, V24, P180, DOI 10.1038/72850; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; VONMENDE N, 1988, CELL, V55, P567, DOI 10.1016/0092-8674(88)90215-2; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Wilkins C, 2005, NATURE, V436, P1044, DOI 10.1038/nature03957; *WORMBASE, 2007, WORMBASE REL WS170; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444	43	70	83	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					491	U23		10.1038/nature07274	http://dx.doi.org/10.1038/nature07274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18784652	Green Accepted			2022-12-28	WOS:000259449600037
J	Kareiva, P; Chang, A; Marvier, M				Kareiva, Peter; Chang, Amy; Marvier, Michelle			Environmental economics - Development and conservation goals in World Bank projects	SCIENCE			English	Editorial Material							NEEDS; HELP		[Kareiva, Peter] Nature Conservancy, Seattle, WA 98105 USA; [Kareiva, Peter; Marvier, Michelle] Santa Clara Univ, Inst Environm Studies, Santa Clara, CA 95053 USA; [Chang, Amy] Nature Conservancy, Santa Clara, CA 95053 USA	Nature Conservancy; Santa Clara University	Kareiva, P (corresponding author), Nature Conservancy, Seattle, WA 98105 USA.	pkareiva@tnc.org		Marvier, Michelle/0000-0001-8360-9265				Agrawal A., 2006, 26 WCS; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Carpenter SR, 2006, SCIENCE, V314, P257, DOI 10.1126/science.1131946; Kaimowitz D, 2007, BIOTROPICA, V39, P567, DOI 10.1111/j.1744-7429.2007.00332.x; Koziell I, 2002, PHILOS T ROY SOC A, V360, P1807, DOI 10.1098/rsta.2002.1033; MACKINNON K, 2006, WORLD BANK BIODIVERS; Millennium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL, P137; Pagiola S, 2005, WORLD DEV, V33, P237, DOI 10.1016/j.worlddev.2004.07.011; Robinson J., 2004, GETTING BIODIVERSITY, P10; Sachs JD, 2006, SCIENCE, V312, P1002, DOI 10.1126/science.1124822; Tallis H, 2008, P NATL ACAD SCI USA, V105, P9457, DOI 10.1073/pnas.0705797105; Turner RK, 2003, ECOL ECON, V46, P493, DOI 10.1016/S0921-8009(03)00189-7	12	46	47	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1638	1639		10.1126/science.1162756	http://dx.doi.org/10.1126/science.1162756			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	349RG	18801985				2022-12-28	WOS:000259300400019
J	Raschle, M; Knipscheer, P; Enoiu, M; Angelov, T; Sun, JC; Griffith, JD; Ellenberger, TE; Scharer, OD; Walter, JC				Raeschle, Markus; Knipscheer, Puck; Enoiu, Milica; Angelov, Todor; Sun, Jingchuan; Griffith, Jack D.; Ellenberger, Tom E.; Schaerer, Orlando D.; Walter, Johannes C.			Mechanism of replication-coupled DNA interstrand crosslink repair	CELL			English	Article							FANCONI-ANEMIA; RECOMBINATION; RECRUITMENT; ACTIVATION; TOLERANCE; CISPLATIN; PROTEIN; MCM2-7; REV1	DNA interstrand crosslinks (ICLs) are toxic DNA lesions whose repair occurs in the S phase of metazoans via an unknown mechanism. Here, we describe a cell-free system based on Xenopus egg extracts that supports ICL repair. During DNA replication of a plasmid containing a site-specific ICL, two replication forks converge on the crosslink. Subsequent lesion bypass involves advance of a nascent leading strand to within one nucleotide of the ICL, followed by incisions, translesion DNA synthesis, and extension of the nascent strand beyond the lesion. Immunodepletion experiments suggest that extension requires DNA polymerase zeta. Ultimately, a significant portion of the input DNA is fully repaired, but not if DNA replication is blocked. Our experiments establish a mechanism for ICL repair that reveals how this process is coupled to DNA replication.	[Raeschle, Markus; Knipscheer, Puck; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Enoiu, Milica; Angelov, Todor; Schaerer, Orlando D.] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Sun, Jingchuan; Griffith, Jack D.] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA; [Ellenberger, Tom E.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Schaerer, Orlando D.] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA	Harvard University; Harvard Medical School; University of Zurich; University of North Carolina; University of North Carolina Chapel Hill; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Walter, JC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	johannes_walter@hms.harvard.edu	Scharer, Orlando/B-8908-2008; Schärer, Orlando D./AAF-8613-2021	Scharer, Orlando/0000-0003-2425-2715; Walter, Johannes/0000-0002-4186-7570	NIH [GM62267, GM55390, GM31819]; Leukemia and Lymphoma Scholar Award; Dutch Cancer Society Fellowship; New York State Office of Science and Technology and Academic Research NYSTAR [C040069]; Swiss Cancer League [OCS-01413-080-2003]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM055390, R01GM062267] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); Dutch Cancer Society Fellowship(KWF Kankerbestrijding); New York State Office of Science and Technology and Academic Research NYSTAR; Swiss Cancer League; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Alan D'Andrea for advice and encouragement during early stages of this project. This work was supported by NIH grants GM62267 (J.C.W.), GM55390 (T. E. E.), and GM31819 (J. D. G.), a Leukemia and Lymphoma Scholar Award (J. C. W.), a Dutch Cancer Society Fellowship (P. K.), and grants from the New York State Office of Science and Technology and Academic Research NYSTAR, C040069 (O.D.S.) and the Swiss Cancer League OCS-01413-080-2003 (O.D.S.). We thank Agata Smogorzewska, Ralph Scully, and Alan D'Andrea for critical reading of the manuscript.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Akkari YMN, 2001, MOL GENET METAB, V74, P403, DOI 10.1006/mgme.2001.3259; Berezney R, 2000, CHROMOSOMA, V108, P471, DOI 10.1007/s004120050399; Bessho T, 2003, J BIOL CHEM, V278, P5250, DOI 10.1074/jbc.M212323200; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Dronkert MLG, 2001, MUTAT RES-DNA REPAIR, V486, P217, DOI 10.1016/S0921-8777(01)00092-1; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Hazrati A, 2008, DNA REPAIR, V7, P230, DOI 10.1016/j.dnarep.2007.09.013; Hofr C, 2001, J BIOL CHEM, V276, P9655, DOI 10.1074/jbc.M010205200; HUANG HF, 1995, SCIENCE, V270, P1842, DOI 10.1126/science.270.5243.1842; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li L, 1999, MOL CELL BIOL, V19, P5619; McHugh PJ, 2001, LANCET ONCOL, V2, P483, DOI 10.1016/S1470-2045(01)00454-5; Mu D, 2000, MOL CELL BIOL, V20, P2446, DOI 10.1128/MCB.20.7.2446-2454.2000; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Niedernhofer LJ, 2005, CELL, V123, P1191, DOI 10.1016/j.cell.2005.12.009; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Scharer OD, 2005, CHEMBIOCHEM, V6, P27, DOI 10.1002/cbic.200400287; Simpson LJ, 2003, EMBO J, V22, P1654, DOI 10.1093/emboj/cdg161; Sobeck A, 2007, MOL CELL BIOL, V27, P4283, DOI 10.1128/MCB.02196-06; Sobeck A, 2006, MOL CELL BIOL, V26, P425, DOI 10.1128/MCB.26.2.425-437.2006; Takahashi TS, 2005, TRENDS BIOCHEM SCI, V30, P437, DOI 10.1016/j.tibs.2005.06.007; Takahashi TS, 2004, NAT CELL BIOL, V6, P991, DOI 10.1038/ncb1177; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; THRESHER R, 1992, METHOD ENZYMOL, V211, P481; Toczylowski T, 2006, J BIOL CHEM, V281, P33198, DOI 10.1074/jbc.M605044200; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Washington MT, 2004, MOL CELL BIOL, V24, P6900, DOI 10.1128/MCB.24.16.6900-6906.2004	33	368	375	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					969	980		10.1016/j.cell.2008.08.030	http://dx.doi.org/10.1016/j.cell.2008.08.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805090	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000259318100017
J	Schroeder, BC; Cheng, T; Jan, YN; Jan, LY				Schroeder, Bjoern Christian; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh			Expression cloning of TMEM16A as a calcium-activated chloride channel subunit	CELL			English	Article							CYSTIC-FIBROSIS AIRWAY; XENOPUS-LAEVIS OOCYTES; PROTEIN-KINASE-C; TRANSMEMBRANE PROTEIN; GNATHODIAPHYSEAL-DYSPLASIA; TRANSCRIPTOME ANALYSIS; PLASMA-MEMBRANE; SURFACE LIQUID; ION CHANNELS; CELLS	Calcium-activated chloride channels (CaCCs) are major regulators of sensory transduction, epithelial secretion, and smooth muscle contraction. Other crucial roles of CaCCs include action potential generation in Characean algae and prevention of polyspermia in frog egg membrane. None of the known molecular candidates share properties characteristic of most CaCCs in native cells. Using Axolotl oocytes as an expression system, we have identified TMEM16A as the Xenopus oocyte CaCC. The TMEM16 family of "transmembrane proteins with unknown function'' is conserved among eukaryotes, with family members linked to tracheomalacia (mouse TMEM16A), gnatho-diaphyseal dysplasia (human TMEM16E), aberrant X segregation (a Drosophila TMEM16 family member), and increased sodium tolerance (yeast TMEM16). Moreover, mouse TMEM16A and TMEM16B yield CaCCs in Axolotl oocytes and mammalian HEK293 cells and recapitulate the broad CaCC expression. The identification of this new family of ion channels may help the development of CaCC modulators for treating diseases including hypertension and cystic fibrosis.	[Schroeder, Bjoern Christian; Cheng, Tong; Jan, Yuh Nung; Jan, Lily Yeh] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Jan, LY (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Physiol, San Francisco, CA 94143 USA.	lily.jan@ucsf.edu		Jan, Yuh Nung/0000-0003-1367-6299; Jan, Lily/0000-0003-3938-8498	Human Frontier Science Program; National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH065334] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank J.Adelman for SK2 cDNA and N.V. Ravin for the pG591 clone. We are grateful for the help of C. Han with confocal images, T. Muller with image acquisition, X. Qian with patch-clamp experiments, and D. Wang with in situ hybridizations. We also thank P. Lu and P. Soba for discussion. This work was supported by a Human Frontier Science Program fellowship to B.C. S. and a National Institute of Mental Health grant to L.Y.J. L.Y.J. and Y.N.J. are Howard Hughes Medical Institute investigators.	ANDERSON MP, 1992, AM J PHYSIOL, V263, pL1, DOI 10.1152/ajplung.1992.263.1.L1; ARREOLA J, 1995, J MEMBRANE BIOL, V147, P95; BADER CR, 1982, J PHYSIOL-LONDON, V331, P253, DOI 10.1113/jphysiol.1982.sp014372; BARISH ME, 1983, J PHYSIOL-LONDON, V342, P309, DOI 10.1113/jphysiol.1983.sp014852; BARISH ME, 1984, J PHYSIOL-LONDON, V352, P243, DOI 10.1113/jphysiol.1984.sp015289; BARROSORIA R, 2008, BIOCH BIOPH IN PRESS; Bera TK, 2004, P NATL ACAD SCI USA, V101, P3059, DOI 10.1073/pnas.0308746101; Blaug S, 2003, AM J PHYSIOL-CELL PH, V284, pC897, DOI 10.1152/ajpcell.00238.2002; BOTON R, 1989, J PHYSIOL-LONDON, V408, P511, DOI 10.1113/jphysiol.1989.sp017473; BOUCHER RC, 1989, J CLIN INVEST, V84, P1424, DOI 10.1172/JCI114316; Callamaras N, 2000, AM J PHYSIOL-CELL PH, V278, pC667, DOI 10.1152/ajpcell.2000.278.4.C667; Carles A, 2006, ONCOGENE, V25, P1821, DOI 10.1038/sj.onc.1209203; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; Eggermont Jan, 2004, Proc Am Thorac Soc, V1, P22, DOI 10.1513/pats.2306010; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; EVANS MG, 1986, J PHYSIOL-LONDON, V378, P437, DOI 10.1113/jphysiol.1986.sp016229; Frings S, 2000, PROG NEUROBIOL, V60, P247, DOI 10.1016/S0301-0082(99)00027-1; Fromm J, 2007, PLANT CELL ENVIRON, V30, P249, DOI 10.1111/j.1365-3040.2006.01614.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; Hartzell C, 2005, ANNU REV PHYSIOL, V67, P719, DOI 10.1146/annurev.physiol.67.032003.154341; Huang X, 2006, GENE CHROMOSOME CANC, V45, P1058, DOI 10.1002/gcc.20371; Jego P., 1986, Advances in Experimental Medicine and Biology, V207, P205; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Khakh BS, 1999, NEURON, V23, P653, DOI 10.1016/S0896-6273(01)80025-8; Kramer J, 2003, NAT CELL BIOL, V5, P261, DOI 10.1038/ncb944; Kuruma A, 1999, AM J PHYSIOL-CELL PH, V276, pC161, DOI 10.1152/ajpcell.1999.276.1.C161; Large WA, 1996, AM J PHYSIOL-CELL PH, V271, pC435; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; LUPUMEIRI M, 1989, PFLUG ARCH EUR J PHY, V413, P498, DOI 10.1007/BF00594180; Melvin JE, 2005, ANNU REV PHYSIOL, V67, P445, DOI 10.1146/annurev.physiol.67.041703.084745; MILEDI R, 1982, PROC R SOC SER B-BIO, V215, P491, DOI 10.1098/rspb.1982.0056; Mizuta K, 2007, BIOCHEM BIOPH RES CO, V357, P126, DOI 10.1016/j.bbrc.2007.03.108; Nilius B, 1997, J PHYSIOL-LONDON, V498, P381, DOI 10.1113/jphysiol.1997.sp021865; Perez-Cornejo P, 2004, J MEMBRANE BIOL, V198, P125, DOI 10.1007/s00232-004-0659-x; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Pusch M, 2004, J GEN PHYSIOL, V123, P323, DOI 10.1085/jgp.200409053; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Ravin NV, 2003, NUCLEIC ACIDS RES, V31, P6552, DOI 10.1093/nar/gkg856; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Runft LL, 1999, DEV BIOL, V214, P399, DOI 10.1006/dbio.1999.9415; SAMEJIMA M, 1982, PLANT CELL PHYSL, V27, P1081; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; TAKAHASHI T, 1987, P NATL ACAD SCI USA, V84, P5063, DOI 10.1073/pnas.84.14.5063; Takizawa PA, 2000, SCIENCE, V290, P341, DOI 10.1126/science.290.5490.341; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tsutsumi S, 2004, AM J HUM GENET, V74, P1255, DOI 10.1086/421527; West RB, 2004, AM J PATHOL, V165, P107, DOI 10.1016/S0002-9440(10)63279-8; Widdicombe JH, 2002, J ANAT, V201, P313, DOI 10.1046/j.1469-7580.2002.00098.x; YANG YD, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07313	54	882	931	1	75	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1019	1029		10.1016/j.cell.2008.09.003	http://dx.doi.org/10.1016/j.cell.2008.09.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805094	Green Accepted, Bronze			2022-12-28	WOS:000259318100021
J	Lang, IA; Galloway, TS; Scarlett, A; Henley, WE; Depledge, M; Wallace, RB; Melzer, D				Lang, Iain A.; Galloway, Tamara S.; Scarlett, Alan; Henley, William E.; Depledge, Michael; Wallace, Robert B.; Melzer, David			Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN EXPOSURE; ENDOCRINE DISRUPTORS; US POPULATION; HEALTH; LIVER; METABOLISM; MECHANISMS; REGRESSION; BINDING; OBESITY	Context Bisphenol A ( BPA) is widely used in epoxy resins lining food and beverage containers. Evidence of effects in animals has generated concern over low- level chronic exposures in humans. Objective To examine associations between urinary BPA concentrations and adult health status. Design, Setting, and Participants Cross- sectional analysis of BPA concentrations and health status in the general adult population of the United States, using data from the National Health and Nutrition Examination Survey 2003- 2004. Participants were 1455 adults aged 18 through 74 years with measured urinary BPA and urine creatinine concentrations. Regression models were adjusted for age, sex, race/ ethnicity, education, income, smoking, body mass index, waist circumference, and urinary creatinine concentration. The sample provided 80% power to detect unadjusted odds ratios ( ORs) of 1.4 for diagnoses of 5% prevalence per 1- SD change in BPA concentration, or standardized regression coefficients of 0.075 for liver enzyme concentrations, at a significance level of P <. 05. Main Outcome Measures Chronic disease diagnoses plus blood markers of liver function, glucose homeostasis, inflammation, and lipid changes. Results Higher urinary BPA concentrations were associated with cardiovascular diagnoses in age-, sex-, and fully adjusted models ( OR per 1- SD increase in BPA concentration, 1.39; 95% confidence interval [ CI], 1.18- 1.63; P=. 001 with full adjustment). Higher BPA concentrations were also associated with diabetes ( OR per 1- SD increase in BPA concentration, 1.39; 95% confidence interval [ CI], 1.21- 1.60; P <. 001) but not with other studied common diseases. In addition, higher BPA concentrations were associated with clinically abnormal concentrations of the liver enzymes gamma- glutamyltransferase ( OR per 1- SD increase in BPA concentration, 1.29; 95% CI, 1.14- 1.46; P <. 001) and alkaline phosphatase ( OR per 1- SD increase in BPA concentration, 1.48; 95% CI, 1.18- 1.85; P=. 002). Conclusion Higher BPA exposure, reflected in higher urinary concentrations of BPA, may be associated with avoidable morbidity in the community- dwelling adult population.	[Lang, Iain A.; Melzer, David] Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Exeter EX2 5DW, Devon, England; [Depledge, Michael] Peninsula Med Sch, Environm & Human Hlth Grp, Exeter EX2 5DW, Devon, England; [Galloway, Tamara S.; Scarlett, Alan] Univ Exeter, Sch Biosci, Exeter, Devon, England; [Henley, William E.] Univ Plymouth, Sch Math & Stat, Plymouth PL4 8AA, Devon, England; [Wallace, Robert B.] Univ Iowa, Coll Publ Hlth, Iowa City, IA USA	University of Exeter; University of Exeter; University of Exeter; University of Plymouth; University of Iowa	Melzer, D (corresponding author), Peninsula Med Sch, Epidemiol & Publ Hlth Grp, Barrack Rd, Exeter EX2 5DW, Devon, England.	david.melzer@pms.ac.uk	Galloway, Tamara/C-1662-2009; Lang, Iain A/B-8255-2008; Rose, Rebecca J/B-7812-2011; Scarlett, Alan G/M-3235-2017	Scarlett, Alan G/0000-0002-9559-2154; Lang, Iain/0000-0002-8473-2350; Melzer, David/0000-0002-0170-3838; Depledge, Michael/0000-0002-7216-0439	United Kingdom National Health Service South West Region Public Health Training Scheme	United Kingdom National Health Service South West Region Public Health Training Scheme	Resources for this analysis were provided by the Peninsula College of Medicine and Dentistry. Dr Lang is an Academic Specialty Trainee in Public Health supported by the United Kingdom National Health Service South West Region Public Health Training Scheme.	Alonso-Magdalena P, 2006, ENVIRON HEALTH PERSP, V114, P106, DOI [10.1289/ehp.8451, 10.1289/ehp.8062]; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Bindhumol V, 2003, TOXICOLOGY, V188, P117, DOI 10.1016/S0300-483X(03)00056-8; Birnbaum LS, 2018, TESTIMONY FEDERAL RO; Burridge E., 2003, EUR CHEM NEWS, V78, P17; Calafat AM, 2005, ENVIRON HEALTH PERSP, V113, P391, DOI 10.1289/ehp.7534; Calafat AM, 2008, ENVIRON HEALTH PERSP, V116, P39, DOI 10.1289/ehp.10753; *CDCP, 2005, 20032004 NHANES CDCP; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2005, 3 CDCP; Centers for Disease Control and Prevention (CDC), 2004, NAT HLTH NUTR EX SUR; Dekant W, 2008, TOXICOL APPL PHARM, V228, P114, DOI 10.1016/j.taap.2007.12.008; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Elsby R, 2001, J PHARMACOL EXP THER, V297, P103; Goodman JE, 2006, CRIT REV TOXICOL, V36, P387, DOI 10.1080/10408440600758317; Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x; Hsieh FY, 1998, STAT MED, V17, P1623, DOI 10.1002/(SICI)1097-0258(19980730)17:14<1623::AID-SIM871>3.0.CO;2-S; KORN EL, 1995, J ROY STAT SOC A STA, V158, P263, DOI 10.2307/2983292; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Mahalingaiah S, 2008, ENVIRON HEALTH PERSP, V116, P173, DOI 10.1289/ehp.10605; Matsumoto A, 2003, ENVIRON HEALTH PERSP, V111, P101, DOI 10.1289/ehp.5512; Matsumoto J, 2002, ENVIRON HEALTH PERSP, V110, P193, DOI 10.1289/ehp.02110193; Moriyama K, 2002, J CLIN ENDOCR METAB, V87, P5185, DOI 10.1210/jc.2002-020209; Nakagawa Y, 2000, ARCH TOXICOL, V74, P99, DOI 10.1007/s002040050659; Newbold RR, 2008, INT J ANDROL, V31, P201, DOI 10.1111/j.1365-2605.2007.00858.x; Oehlmann J, 2006, ENVIRON HEALTH PERSP, V114, P127, DOI 10.1289/ehp.8065; Okada H, 2008, ENVIRON HEALTH PERSP, V116, P32, DOI 10.1289/ehp.10587; Ouchi K, 2002, J CHROMATOGR B, V780, P365, DOI 10.1016/S1570-0232(02)00547-0; Ropero AB, 2008, INT J ANDROL, V31, P194, DOI 10.1111/j.1365-2605.2007.00832.x; Roy D, 1997, J TOXICOL ENV HEALTH, V50, P1, DOI 10.1080/009841097160573; Takeuchi T, 2004, ENDOCR J, V51, P165, DOI 10.1507/endocrj.51.165; Teeguarden JG, 2005, TOXICOL SCI, V85, P823, DOI 10.1093/toxsci/kfi135; Tyl RW, 2002, TOXICOL SCI, V68, P121, DOI 10.1093/toxsci/68.1.121; *U OXF DIAB TRIALS, 2007, HOMA CALC; *VAN U, PS POW SAMPL SIZ CAL; Vandenberg LN, 2007, REPROD TOXICOL, V24, P139, DOI 10.1016/j.reprotox.2007.07.010; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; Vokel W, 2002, CHEM RES TOXICOL, V15, P1281, DOI 10.1021/tx025548t; vom Saal FS, 2007, REPROD TOXICOL, V24, P131, DOI 10.1016/j.reprotox.2007.07.005; vom Saal FS, 2005, ENVIRON HEALTH PERSP, V113, P926, DOI 10.1289/ehp.7713; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Welshons WV, 2006, ENDOCRINOLOGY, V147, pS56, DOI 10.1210/en.2005-1159; Yoshihara S, 2004, TOXICOL SCI, V78, P50, DOI 10.1093/toxsci/kfh047	43	960	997	5	257	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1303	1310		10.1001/jama.300.11.1303	http://dx.doi.org/10.1001/jama.300.11.1303			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799442	Green Published			2022-12-28	WOS:000259231100025
J	Brantley, SL				Brantley, Susan L.			Geology - Understanding soil time	SCIENCE			English	Editorial Material							CHEMISTRY; FOREST		[Brantley, Susan L.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Brantley, SL (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.	brantley@eesi.psu.edu	Brantley, Susan L/ABE-4479-2020					Bellamy PH, 2005, NATURE, V437, P245, DOI 10.1038/nature04038; BROWN ET, 1995, EARTH PLANET SC LETT, V129, P193, DOI 10.1016/0012-821X(94)00249-X; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Filippelli GM, 2002, REV MINERAL GEOCHEM, V48, P391, DOI 10.2138/rmg.2002.48.10; Fletcher RC, 2006, EARTH PLANET SC LETT, V244, P444, DOI 10.1016/j.epsl.2006.01.055; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; Trumbore SE, 2008, SCIENCE, V321, P1455, DOI 10.1126/science.1160232; TURNER MG, 1993, LANDSCAPE ECOL, V8, P213, DOI 10.1007/BF00125352; Van Oost K, 2007, SCIENCE, V318, P626, DOI 10.1126/science.1145724; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; von Blanckenburg F, 2005, EARTH PLANET SC LETT, V237, P462, DOI 10.1016/j.epsl.2005.06.030; Wardle DA, 2004, SCIENCE, V305, P509, DOI 10.1126/science.1098778; White AF, 2003, CHEM GEOL, V202, P479, DOI 10.1016/j.chemgeo.2003.03.001; WHITE AF, 2008, KINETICS WATER ROCK, P463; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wilkinson BH, 2007, GEOL SOC AM BULL, V119, P140, DOI 10.1130/B25899.1	17	50	57	2	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1454	1455		10.1126/science.1161132	http://dx.doi.org/10.1126/science.1161132			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787158				2022-12-28	WOS:000259121800028
J	Brenguier, F; Campillo, M; Hadziioannou, C; Shapiro, NM; Nadeau, RM; Larose, E				Brenguier, F.; Campillo, M.; Hadziioannou, C.; Shapiro, N. M.; Nadeau, R. M.; Larose, E.			Postseismic relaxation along the San Andreas fault at Parkfield from continuous seismological observations	SCIENCE			English	Article							SEISMIC NOISE; HECTOR MINE; EARTHQUAKE; CALIFORNIA; ZONE	Seismic velocity changes and nonvolcanic tremor activity in the Parkfield area in California reveal that large earthquakes induce long- term perturbations of crustal properties in the San Andreas fault zone. The 2003 San Simeon and 2004 Parkfield earthquakes both reduced seismic velocities that were measured from correlations of the ambient seismic noise and induced an increased nonvolcanic tremor activity along the San Andreas fault. After the Parkfield earthquake, velocity reduction and nonvolcanic tremor activity remained elevated for more than 3 years and decayed over time, similarly to afterslip derived from GPS ( Global Positioning System) measurements. These observations suggest that the seismic velocity changes are related to co- seismic damage in the shallow layers and to deep co- seismic stress change and postseismic stress relaxation within the San Andreas fault zone.	[Brenguier, F.; Shapiro, N. M.] Inst Phys Globe, F-75252 Paris, France; [Brenguier, F.; Shapiro, N. M.] CNRS, F-75252 Paris, France; [Brenguier, F.; Campillo, M.; Hadziioannou, C.; Larose, E.] Univ Grenoble 1, Lab Geophys Interne & Tectonophys, F-38041 Grenoble, France; [Brenguier, F.; Campillo, M.; Hadziioannou, C.; Larose, E.] CNRS, F-38041 Grenoble, France; [Nadeau, R. M.] Univ Calif Berkeley, Berkeley Seismol Lab, Berkeley, CA 94760 USA	UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of California System; University of California Berkeley	Brenguier, F (corresponding author), Inst Phys Globe, 4 Pl Jussieu, F-75252 Paris, France.	fbrengui@ipgp.jussieu.fr	Shapiro, Nikolai M/G-1049-2010; Campillo, Michel/K-6231-2012; Brenguier, Florent/E-4843-2017; Nadeau, Robert/G-1884-2017; Campillo, Michel/AAC-5666-2019	Shapiro, Nikolai M/0000-0002-0144-723X; Campillo, Michel/0000-0001-6971-4499; Brenguier, Florent/0000-0001-8684-7613; Nadeau, Robert/0000-0003-1255-0643; Campillo, Michel/0000-0001-6971-4499; larose, eric/0000-0001-8353-5470; Hadziioannou, Celine/0000-0002-5312-2226	USGS [07HQAG0014, 06HQGR0167]; Agence Nationale de la Recherche (France) [05-CATT-010-01 (PRECORSIS), ANR-06-CEXC-005 (COHERSIS)]; NSF [EAR-0537641, EAR-0544730]	USGS(United States Geological Survey); Agence Nationale de la Recherche (France)(French National Research Agency (ANR)); NSF(National Science Foundation (NSF))	All of the data used in this study came from the Parkfield HRSN and were collected by the Berkeley Seismological Laboratory (BSL) with support from the USGS under grant 07HQAG0014. We are grateful to the BSL staff. We thank P. Bernard and J.P. Gratier for discussions, O. Coutant for providing us with the doublet analysis code, and G. Moguilny for maintaining the Cohersis cluster. We acknowledge the December 2007 joint BSL/IPGP workshop. This work was supported by Agence Nationale de la Recherche (France) under contracts 05-CATT-010-01 (PRECORSIS) and ANR-06-CEXC-005 (COHERSIS); by NSF under grants EAR-0537641 and EAR-0544730; and by USGS under grant 06HQGR0167. This is Institut de Physique du Globe de Paris ( IPGP) contribution no. 2393.	Allmann BP, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004395; Brenguier F, 2008, NAT GEOSCI, V1, P126, DOI 10.1038/ngeo104; Li YG, 2003, B SEISMOL SOC AM, V93, P854, DOI 10.1785/0120020131; Niu FL, 2008, NATURE, V454, P204, DOI 10.1038/nature07111; POUPINET G, 1984, J GEOPHYS RES, V89, P5719, DOI 10.1029/JB089iB07p05719; Sens-Schonfelder C, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027797; Shapiro NM, 2005, SCIENCE, V307, P1615, DOI 10.1126/science.1108339; Vidale JE, 2003, NATURE, V421, P524, DOI 10.1038/nature01354; Wegler U, 2007, GEOPHYS J INT, V168, P1029, DOI 10.1111/j.1365-246X.2006.03284.x	9	494	537	9	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1478	1481		10.1126/science.1160943	http://dx.doi.org/10.1126/science.1160943			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787165				2022-12-28	WOS:000259121800037
J	Salsberg, E; Rockey, PH; Rivers, KL; Brotherton, SE; Jackson, GR				Salsberg, Edward; Rockey, Paul H.; Rivers, Kerri L.; Brotherton, Sarah E.; Jackson, Gregory R.			US residency training before and after the 1997 Balanced Budget Act	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GRADUATE MEDICAL-EDUCATION; PRIMARY-CARE; TRENDS	Context Graduate medical education ( GME) determines the size and characteristics of the future workforce. The 1997 Balanced Budget Act ( BBA) limited Medicare funding for additional trainees in GME. There has been concern that because Medicare is the primary source of GME funding, the BBA would discourage growth in GME. Objective To examine the number of residents in training before and after the BBA, as well as more recent changes in GME by specialty, sex, and type and location of education. Design Descriptive study using the American Medical Association/ Association of American Medical Colleges National GME Census on physicians in Accreditation Council for Graduate Medical Education ( ACGME) - accredited programs to examine changes in the number and characteristics of residents before and after the BBA. Main Outcome Measures Differences in the number of physicians in ACGME- accredited training programs overall, by specialty, and by location and type of education. Results The number of residents and fellows changed little between academic year ( AY) 1997 ( n= 98 143) and AY 2002 ( n= 98 258) but increased to 106 012 in AY 2007, a net increase of 7869 ( 8.0%) over the decade. The annual number of new entrants into GME increased by 7.6%, primarily because of increasing international medical graduates ( IMGs). United States medical school graduates ( MDs) comprised 44.0% of the overall growth from 2002 to 2007, followed by IMGs ( 39.2%) and osteopathic school graduates ( 18.8%). United States MD growth largely resulted from selection of specialties with longer training periods. From 2002 to 2007, US MDs training in primary care specialties decreased by 2641, while IMGs increased by 3286. However, increasing subspecialization rates led to fewer physicians entering generalist careers. Conclusion After the 1997 BBA, there appears to have been a temporary halt in the growth of physicians training in ACGME programs; however, the number increased from 2002 to 2007.	[Salsberg, Edward; Rivers, Kerri L.] Assoc Amer Med Coll, Ctr Workforce Studies, Washington, DC 20037 USA; [Jackson, Gregory R.] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Rockey, Paul H.; Brotherton, Sarah E.] Amer Med Assoc, Chicago, IL 60610 USA	Association of American Medical Colleges; George Washington University; American Medical Association	Salsberg, E (corresponding author), Assoc Amer Med Coll, Ctr Workforce Studies, 2450 N St NW, Washington, DC 20037 USA.	esalsberg@aamc.org	Jackson, Gregory/GXV-4256-2022		AAMC; AMA	AAMC; AMA	The AAMC provided support for Mr Salsberg, Ms Rivers, and Mr Jackson for this research. The AMA provided support for Drs Rockey and Brotherton for this research.	American College of Physicians, 2006, IMP COLL PRIM CAR ME; *ASS AM MED COLL, 2006, AAMC STAT PHYS WORKF; *ASS AM MED COLL, 2008, REC STUD REP PHYS SH; *ASS AM MED COLL, CHILDR HOSP GRAD MED; *ASS AM MED COLL, 2008, MED SCH EXP PLANS RE; *ASS AM MED COLL O, REP SURV OST MED SCH; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Brotherton SE, 2008, JAMA-J AM MED ASSOC, V300, P1228, DOI 10.1001/jama.300.10.1228; Brotherton SE, 2005, JAMA-J AM MED ASSOC, V294, P1075, DOI 10.1001/jama.294.9.1075; Burkhart DN, 2008, J AM OSTEOPATH ASSOC, V108, P127; Centers for Medicare and Medicaid Services, IND MED ED IME; Committee on the Future of Emergency Care in the US Health System, 2006, EM MED SERV CROSSR; *COUNC GRAD MED ED, 2007, ENH FLEX GRAD MED ED, P1; *CTR MED MED SERV, 2008, HOSP COST REP; Desbiens NA, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-35; Dickler R, 2000, ANN INTERN MED, V132, P820, DOI 10.7326/0003-4819-132-10-200005160-00010; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Dunn MR, 1998, JAMA-J AM MED ASSOC, V280, P809, DOI 10.1001/jama.280.9.809; Fye WB, 2004, CIRCULATION, V109, P813, DOI 10.1161/01.CIR.0000118641.54694.4C; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; HENDERSON TM, 2006, MED DIRECT INDIRECT; Iglehart JK, 1999, NEW ENGL J MED, V341, P299, DOI 10.1056/NEJM199907223410424; Iglehart JK, 2008, NEW ENGL J MED, V358, P1741, DOI 10.1056/NEJMhpr0800058; *MAT CHILD HLTH PO, PED SUBSP CAP IN; McMurray Julia E, 2002, J Am Med Womens Assoc (1972), V57, P185; *MED GROUP MAN ASS, 2007, PHYS COMP PROD SURV, P18; Rizza Robert A, 2003, Endocr Pract, V9, P210; Schubert A, 2003, ANESTH ANALG, V96, P207, DOI 10.1097/00000539-200301000-00043; Scully JH, 2003, ACAD PSYCHIATR, V27, P247, DOI 10.1176/appi.ap.27.4.247; *US BUR CENS, 2001, MONTHL EST US POP AP; *US BUR CENS, 2007, TABL 1 ANN EST POP U; *US DEP HHS, 2006, PHYS SUPPL DEM PROJ; *US DEP VET AFF, MED DENT ED; Wachter RM, 2002, JAMA-J AM MED ASSOC, V287, P487, DOI 10.1001/jama.287.4.487; Weeks WB, 2006, J AM BOARD FAM MED, V19, P548, DOI 10.3122/jabfm.19.6.548; Whitcomb ME, 2006, ACAD MED, V81, P593, DOI 10.1097/01.ACM.0000232407.30573.cb; 2003, JAMA, V29, P1246	37	69	70	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1174	1180		10.1001/jama.300.10.1174	http://dx.doi.org/10.1001/jama.300.10.1174			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780846				2022-12-28	WOS:000259038700010
J	Boisvert, CA; Mark-Kurik, E; Ahlberg, PE				Boisvert, Catherine A.; Mark-Kurik, Elga; Ahlberg, Per E.			The pectoral fin of Panderichthys and the origin of digits	NATURE			English	Article							TETRAPOD LIMB; EVOLUTION; FISH; EXPRESSION	One of the identifying characteristics of tetrapods ( limbed vertebrates) is the presence of fingers and toes. Whereas the proximal part of the tetrapod limb skeleton can easily be homologized with the paired fin skeletons of sarcopterygian ( lobe- finned) fish, there has been much debate about the origin of digits. Early hypotheses(1) interpreted digits as derivatives of fin radials, but during the 1990s the idea gained acceptance that digits are evolutionary novelties without direct equivalents in fish fin skeletons. This was partly based on developmental genetic data(2), but also substantially on the pectoral fin skeleton of the elpistostegid ( transitional fish/ tetrapod) Panderichthys, which appeared to lack distal digit- like radials(3). Here we present a CT scan study of an undisturbed pectoral fin of Panderichthys demonstrating that the plate- like 'ulnare' of previous reconstructions is an artefact and that distal radials are in fact present. This distal portion is more tetrapod- like than that found in Tiktaalik(4) and, in combination with new data about fin development in basal actinopterygians(5), sharks(6) and lungfish(7), makes a strong case for fingers not being a novelty of tetrapods but derived from pre- existing distal radials present in all sarcopterygian fish.	[Boisvert, Catherine A.; Ahlberg, Per E.] Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Evolutionary Biol Ctr, S-75236 Uppsala, Sweden; [Mark-Kurik, Elga] Tallinn Univ Technol, Inst Geol, EE-19086 Tallinn, Estonia	Uppsala University; Tallinn University of Technology	Boisvert, CA (corresponding author), Uppsala Univ, Subdept Evolutionary Organismal Biol, Dept Physiol & Dev Biol, Evolutionary Biol Ctr, Norbyvagen 18A, S-75236 Uppsala, Sweden.	catherine.boisvert@ebc.uu.se	Boisvert, Catherine A/A-9782-2019; Ahlberg, Per/E-8086-2013	Boisvert, Catherine A/0000-0002-0618-7270; Ahlberg, Per/0000-0001-9054-2900	Vetenskapsradet	Vetenskapsradet(Swedish Research Council)	We thank P. Ross and the team at East-Tallinn Central Hospital, Estonia for the CT-scanning, E. Vorobyeva for permission to examine the Panderichthys material in her care, N. Shubin for access to Tiktaalik, and M.I. Coates for valuable discussions. C.A.B. and P.E.A. are supported by Vetenskapsradet.	ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P207; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; BOISVERT CA, 40 YEARS EARLY VERTE; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Dahn RD, 2007, NATURE, V445, P311, DOI 10.1038/nature05436; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Davis MC, 2004, J VERTEBR PALEONTOL, V24, P26, DOI 10.1671/1920-3; Gegenbaur C., 1874, GRUNDRISS VERGLEICHE; GREGORY WILLIAM K., 1941, ANN NEW YORK ACAD SCI, V42, P273, DOI 10.1111/j.1749-6632.1941.tb55396.x; Jarvik Erik, 1996, Fossils and Strata, V40, P1; Johanson Z, 2007, J EXP ZOOL PART B, V308B, P757, DOI 10.1002/jez.b.21197; Long JA, 2006, NATURE, V444, P199, DOI 10.1038/nature05243; Shubin N, 1997, NATURE, V388, P639, DOI 10.1038/41710; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Vorobyeva E., 1991, P68; Vorobyeva E. I., 2000, PALEONTOL J, V34, P632; VOROBYEVA EI, 1980, ZOOL J LINN SOC-LOND, V70, P191, DOI 10.1111/j.1096-3642.1980.tb00851.x; VOROBYEVA EI, 1992, ZH OBSHCH BIOL, V53, P149; Westoll TS, 1943, PROC R SOC SER B-BIO, V131, P373, DOI 10.1098/rspb.1943.0013	21	91	93	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 4	2008	456	7222					636	638		10.1038/nature07339	http://dx.doi.org/10.1038/nature07339			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18806778	Green Published			2022-12-28	WOS:000261340000040
J	de Godoy, LMF; Olsen, JV; Cox, J; Nielsen, ML; Hubner, NC; Frohlich, F; Walther, TC; Mann, M				de Godoy, Lyris M. F.; Olsen, Jesper V.; Cox, Juergen; Nielsen, Michael L.; Hubner, Nina C.; Froehlich, Florian; Walther, Tobias C.; Mann, Matthias			Comprehensive mass-spectrometry-based proteome quantification of haploid versus diploid yeast	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; SEQUENCE DATABASES; GLOBAL ANALYSIS; IDENTIFICATION; EXPRESSION; SILAC; PROTEINS; GENOMICS; PATHWAY; GELS	Mass spectrometry is a powerful technology for the analysis of large numbers of endogenous proteins(1,2). However, the analytical challenges associated with comprehensive identification and relative quantification of cellular proteomes have so far appeared to be insurmountable(3). Here, using advances in computational proteomics, instrument performance and sample preparation strategies, we compare protein levels of essentially all endogenous proteins in haploid yeast cells to their diploid counterparts. Our analysis spans more than four orders of magnitude in protein abundance with no discrimination against membrane or low level regulatory proteins. Stable- isotope labelling by amino acids in cell culture (SILAC) quantification(4,5) was very accurate across the proteome, as demonstrated by one- to- one ratios of most yeast proteins. Key members of the pheromone pathway were specific to haploid yeast but others were unaltered, suggesting an efficient control mechanism of the mating response. Several retrotransposon- associated proteins were specific to haploid yeast. Gene ontology analysis pinpointed a significant change for cell wall components in agreement with geometrical considerations: diploid cells have twice the volume but not twice the surface area of haploid cells. Transcriptome levels agreed poorly with proteome changes overall. However, after filtering out low confidence microarray measurements, messenger RNA changes and SILAC ratios correlated very well for pheromone pathway components. Systems- wide, precise quantification directly at the protein level opens up new perspectives in post- genomics and systems biology.	[de Godoy, Lyris M. F.; Olsen, Jesper V.; Cox, Juergen; Nielsen, Michael L.; Hubner, Nina C.; Froehlich, Florian; Walther, Tobias C.; Mann, Matthias] Max Planck Inst Biochem, D-82152 Martinsried, Germany	Max Planck Society	Walther, TC (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	twalther@biochem.mpg.de; mmann@biochem.mpg.de	Olsen, Jesper/ABH-4638-2020; de Godoy, Lyris/C-4256-2008; Cox, Jurgen/B-9481-2008; Nielsen, Michael/C-4418-2008; Olsen, Jesper/C-4738-2008; Hubner, Nina C/C-4298-2008; Mann, Matthias/A-3454-2013	Olsen, Jesper/0000-0002-4747-4938; Cox, Jurgen/0000-0001-8597-205X; Hubner, Nina C/0000-0002-7864-2877; Mann, Matthias/0000-0003-1292-4799; Walther, Tobias/0000-0003-1442-1327; Frohlich, Florian/0000-0001-8307-2189; Nielsen, Michael/0000-0002-0067-9039	Human Frontier Science Program; European Molecular Biology Organization (EMBO)	Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO))	G. de Souza measured part of the yeast proteome; C. Kumar contributed to bioinformatic analysis, G. Stoehr to proteome analysis. Z. Storchova provided the pGAL-HO plasmid. L.M.F.d.G. thanks D. Bertozzi for support and discussions. The Max-Planck Society and the DC-Thera and Interaction Proteome 6th framework projects of the European Union provided funding; T. C. W. is supported by the Human Frontier Science Program and M.L.N. by the European Molecular Biology Organization (EMBO).	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Blanc VM, 2003, GENETICS, V165, P975; COMPANY M, 1988, MOL CELL BIOL, V8, P5299, DOI 10.1128/MCB.8.12.5299; Cox J, 2007, CELL, V130, P395, DOI 10.1016/j.cell.2007.07.032; Cravatt BF, 2007, NATURE, V450, P991, DOI 10.1038/nature06525; de Godoy LMF, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-r50; Dohlman Henrik G, 2006, Sci STKE, V2006, pcm6; Figeys D, 1996, NAT BIOTECHNOL, V14, P1579, DOI 10.1038/nbt1196-1579; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ke N, 1997, EMBO J, V16, P6272, DOI 10.1093/emboj/16.20.6272; King NL, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r106; Malmstrom J, 2007, CURR OPIN BIOTECH, V18, P378, DOI 10.1016/j.copbio.2007.07.005; MANN M, 1994, ANAL CHEM, V66, P4390, DOI 10.1021/ac00096a002; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schwartz MA, 2004, ANNU REV GENET, V38, P725, DOI 10.1146/annurev.genet.39.073003.112634; Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Tyers M, 2003, NATURE, V422, P193, DOI 10.1038/nature01510; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686	28	716	721	2	159	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1251	U60		10.1038/nature07341	http://dx.doi.org/10.1038/nature07341			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18820680				2022-12-28	WOS:000260462100047
J	Mullighan, CG				Mullighan, Charles G.			JAK2-a new player in acute lymphoblastic leukaemia	LANCET			English	Editorial Material							DOWN-SYNDROME; MUTATIONS; JAK1		[Mullighan, Charles G.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Mullighan, CG (corresponding author), St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.	charles.mullighan@stjude.org	Mullighan, Charles/H-3253-2011	Mullighan, Charles/0000-0002-1871-1850				Arico M, 2008, CANCER-AM CANCER SOC, V113, P515, DOI 10.1002/cncr.23587; ERCOVICH D, 2008, LANCET          0920, DOI DOI 10.1016/S0140-6736(08)61341-0; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Jeong EG, 2008, CLIN CANCER RES, V14, P3716, DOI 10.1158/1078-0432.CCR-07-4839; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2007, NAT REV CANCER, V7, P673, DOI 10.1038/nrc2210; Lo KC, 2008, BRIT J HAEMATOL, V142, P934, DOI 10.1111/j.1365-2141.2008.07280.x; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Pui C, 2004, NEW ENGL J MED, V350, P1535, DOI 10.1056/NEJMra023001; Wiemels JL, 1999, LANCET, V354, P1499, DOI 10.1016/S0140-6736(99)09403-9; Zwaan MC, 2008, PEDIATR CLIN N AM, V55, P53, DOI 10.1016/j.pcl.2007.11.001	12	11	12	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 25	2008	372	9648					1448	1450		10.1016/S0140-6736(08)61342-2	http://dx.doi.org/10.1016/S0140-6736(08)61342-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18805580				2022-12-28	WOS:000260801300009
J	Tsivgoulis, G; Alexandrov, AV				Tsivgoulis, Georgios; Alexandrov, Andrei V.			Timeframe for thrombolysis in acute ischaemic stroke	LANCET			English	Editorial Material							ASSOCIATION; GUIDELINES; MANAGEMENT; ALTEPLASE; THERAPY		[Tsivgoulis, Georgios; Alexandrov, Andrei V.] Univ Alabama, Birmingham Hosp, Comprehens Stroke Ctr, Birmingham, AL 35294 USA; [Tsivgoulis, Georgios] Democritus Univ Thrace, Univ Hosp Alexandroupolis, Dept Neurol, Alexandroupolis, Greece	University of Alabama System; University of Alabama Birmingham; Democritus University of Thrace	Alexandrov, AV (corresponding author), Univ Alabama, Birmingham Hosp, Comprehens Stroke Ctr, Birmingham, AL 35294 USA.	avalexandrov@att.net	Tsivgoulis, Georgios/AAD-7467-2019; Tsivgoulis, Georgios/AAD-5360-2020	Tsivgoulis, Georgios/0000-0002-0640-3797; Alexandrov, Andrei V/0000-0001-8871-1023				Adams HP, 2003, STROKE, V34, P1056, DOI 10.1161/01.STR.0000064841.47697.22; Davis SM, 2008, LANCET NEUROL, V7, P299, DOI 10.1016/S1474-4422(08)70044-9; *ECASS 3, ECASS 3 EUR COOP AC; Hacke W, 2004, LANCET, V363, P768; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; *IST 3, 3 INT STROK TRIAL TH; Saver JL, 2004, ARCH NEUROL-CHICAGO, V61, P1066, DOI 10.1001/archneur.61.7.1066; Schellinger PD, 2007, STROKE, V38, P2640, DOI 10.1161/STROKEAHA.107.483255; Uyttenboogaart M, 2007, J NEUROL SCI, V254, P28, DOI 10.1016/j.jns.2006.12.011; Wahlgren N, 2008, LANCET; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4	11	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1275	1276		10.1016/S0140-6736(08)61340-9	http://dx.doi.org/10.1016/S0140-6736(08)61340-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18790526				2022-12-28	WOS:000260060500004
J	Brennecke, F; Ritter, S; Donner, T; Esslinger, T				Brennecke, Ferdinand; Ritter, Stephan; Donner, Tobias; Esslinger, Tilman			Cavity optomechanics with a Bose-Einstein condensate	SCIENCE			English	Article							ATOM	Cavity optomechanics studies the coupling between a mechanical oscillator and the electromagnetic field in a cavity. We report on a cavity optomechanical system in which a collective density excitation of a Bose-Einstein condensate serves as the mechanical oscillator coupled to the cavity field. A few photons inside the ultrahigh-finesse cavity trigger strongly driven back-action dynamics, in quantitative agreement with a cavity optomechanical model. We approach the strong coupling regime of cavity optomechanics, where a single excitation of the mechanical oscillator substantially influences the cavity field. The results open up new directions for investigating mechanical oscillators in the quantum regime and the border between classical and quantum physics.	[Brennecke, Ferdinand; Ritter, Stephan; Donner, Tobias; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Esslinger, T (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Donner, Tobias/A-2845-2011; Ritter, Stephan/F-1579-2010; Esslinger, Tilman/M-9022-2016	Donner, Tobias/0000-0001-7016-587X; Ritter, Stephan/0000-0001-9002-7407; Esslinger, Tilman/0000-0002-8333-107X	SCALA Integrated Project (European Union); QSIT (ETH Zurich)	SCALA Integrated Project (European Union)(European Commission); QSIT (ETH Zurich)(ETH Zurich)	We thank K. Baumann, P. Domokos, C. Guerlin, I. Mekhov, H. Ritsch, and A. Vukics for stimulating discussions. Supported by the SCALA Integrated Project (European Union) and QSIT (ETH Zurich).	Arcizet O, 2006, NATURE, V444, P71, DOI 10.1038/nature05244; Black AT, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203001; BRAGINSKY VB, 1980, SCIENCE, V209, P547, DOI 10.1126/science.209.4456.547; Brennecke F, 2007, NATURE, V450, P268, DOI 10.1038/nature06120; Colombe Y, 2007, NATURE, V450, P272, DOI 10.1038/nature06331; Corbitt T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.150802; DORSEL A, 1983, PHYS REV LETT, V51, P1550, DOI 10.1103/PhysRevLett.51.1550; Gigan S, 2006, NATURE, V444, P67, DOI 10.1038/nature05273; Gupta S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213601; Hood CJ, 2000, SCIENCE, V287, P1447, DOI 10.1126/science.287.5457.1447; Horak P, 2000, PHYS REV A, V61, DOI 10.1103/PhysRevA.61.033609; Kippenberg TJ, 2007, OPT EXPRESS, V15, P17172, DOI 10.1364/OE.15.017172; Larson J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050401; Mancini S, 1997, PHYS REV A, V55, P3042, DOI 10.1103/PhysRevA.55.3042; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; Maschler C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.260401; Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118; MEYSTRE P, 1985, J OPT SOC AM B, V2, P1830, DOI 10.1364/JOSAB.2.001830; MOORE FL, 1995, PHYS REV LETT, V75, P4598, DOI 10.1103/PhysRevLett.75.4598; Murch KW, 2008, NAT PHYS, V4, P561, DOI 10.1038/nphys965; Nagorny B, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.153003; Nagy D, 2008, EUR PHYS J D, V48, P127, DOI 10.1140/epjd/e2008-00074-6; Ottl A, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2216907; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; Schliesser A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.243905; Slama S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.053603; Stenger J, 2000, PHYS REV LETT, V84, P2283, DOI 10.1103/PhysRevLett.84.2283; Stenger J, 1999, PHYS REV LETT, V82, P4569, DOI 10.1103/PhysRevLett.82.4569; Thompson JD, 2008, NATURE, V452, P72, DOI 10.1038/nature06715	29	459	466	2	101	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					235	238		10.1126/science.1163218	http://dx.doi.org/10.1126/science.1163218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18787133	Green Submitted			2022-12-28	WOS:000259902300041
J	Holman, RR; Paul, SK; Bethel, MA; Neil, HAW; Matthews, DR				Holman, Rury R.; Paul, Sanjoy K.; Bethel, M. Angelyn; Neil, H. Andrew W.; Matthews, David R.			Long-term follow-up after tight control of blood pressure in type 2 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTIFACTORIAL INTERVENTION; RISK-FACTORS; MORTALITY; HYPERTENSION; ENALAPRIL; MELLITUS; OUTCOMES; DISEASE; TRIAL	Background: Post-trial monitoring of patients in the United Kingdom Prospective Diabetes Study (UKPDS) examined whether risk reductions for microvascular and macrovascular disease, achieved with the use of improved blood-pressure control during the trial, would be sustained. Methods: Among 5102 UKPDS patients with newly diagnosed type 2 diabetes mellitus, we randomly assigned, over a 4-year period beginning in 1987, 1148 patients with hypertension to tight or less-tight blood-pressure control regimens. The 884 patients who underwent post-trial monitoring were asked to attend annual UKPDS clinics for the first 5 years, but no attempt was made to maintain their previously assigned therapies. Annual questionnaires completed by patients and general practitioners were used to follow patients who were unable to attend the clinic in years 1 through 5, and questionnaires were used for all patients in years 6 to 10. Seven prespecified aggregate clinical end points were examined on an intention-to-treat basis, according to the previous randomization categories. Results: Differences in blood pressure between the two groups during the trial disappeared within 2 years after termination of the trial. Significant relative risk reductions found during the trial for any diabetes-related end point, diabetes-related death, microvascular disease, and stroke in the group receiving tight, as compared with less tight, blood-pressure control were not sustained during the post-trial follow-up. No risk reductions were seen during or after the trial for myocardial infarction or death from any cause, but a risk reduction for peripheral vascular disease associated with tight blood-pressure control became significant (P=0.02). Conclusions: The benefits of previously improved blood-pressure control were not sustained when between-group differences in blood pressure were lost. Early improvement in blood-pressure control in patients with both type 2 diabetes and hypertension was associated with a reduced risk of complications, but it appears that good blood-pressure control must be continued if the benefits are to be maintained. (UKPDS 81; Current Controlled Trials number, ISRCTN75451837.).	[Holman, Rury R.; Paul, Sanjoy K.; Bethel, M. Angelyn; Neil, H. Andrew W.; Matthews, David R.] Churchill Hosp, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Neil, H. Andrew W.] Div Publ Hlth & Primary Hlth Care, Oxford, England; [Neil, H. Andrew W.] NIHR, Sch Primary Care Res, Oxford, England; [Holman, Rury R.; Neil, H. Andrew W.; Matthews, David R.] NIHR, Oxford Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Holman, RR (corresponding author), Churchill Hosp, Diabet Trials Unit, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	rury.holman@dtu.ox.ac.uk	Paul, Sanjoy K/F-8199-2010; Greiver, Michelle/N-8764-2015	Paul, Sanjoy K/0000-0003-0848-7194; Greiver, Michelle/0000-0001-8957-0285	Asahi Kasei Pharma; Bayer Healthcare; Bayer Schering Pharma; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Merck Serono; Novartis; Novo Nordisk; Pfizer; Sanofi-Aventis; Amylin; Eli Lilly; Astella; Bayer; King Pharmaceuticals; Takeda; ScheringPlough; Solvay Healthcare; Servier; Roche	Asahi Kasei Pharma; Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals); Bayer Schering Pharma(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Merck Serono(Merck & Company); Novartis(Novartis); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Amylin; Eli Lilly(Eli Lilly); Astella; Bayer(Bayer AG); King Pharmaceuticals; Takeda(Takeda Pharmaceutical Company Ltd); ScheringPlough(Merck & CompanySchering Plough Corporation); Solvay Healthcare(Solvay SA); Servier(Servier); Roche(Roche Holding)	Dr. Holman reports receiving grant support from Asahi Kasei Pharma, Bayer Healthcare, Bayer Schering Pharma, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Merck Serono, Novartis, Novo Nordisk, Pfizer, and Sanofi-Aventis, consulting fees from Amylin, Eli Lilly, GlaxoSmithKline, Merck, and Novartis, and lecture fees from Astella, Bayer, GlaxoSmithKline, King Pharmaceuticals, Eli Lilly, Merck, Merck Serono, Novo Nordisk, Takeda, and Sanofi-Aventis, and owning shares in Glyme Valley Technology, Glyox, and Oxtech; Dr. Paul, receiving consulting fees from Amylin; Dr. Bethel, receiving grant support from Novartis and Sanofi-Aventis and lecture fees from Merck and Sanofi- Aventis; Dr. Neil, receiving consulting fees from Merck, Pfizer, ScheringPlough, and Solvay Healthcare; and Dr. Matthews, receiving lecture and advisory fees from Novo Nordisk, GlaxoSmithKline, Servier, Merck, Novartis, Novo Nordisk, Eli Lilly, Takeda, and Roche, and owning shares in OSI Pharmaceuticals and Particle Therapeutics. The Oxford Centre for Diabetes, Endocrinology, and Metabolism (OCDEM) has a Partnership for the Foundation of OCDEM, with Novo Nordisk, Takeda, and Servier. No other potential conflict of interest relevant to this article was reported.; We thank the patients and staff at the participating centers: Radcliffe Infirmary, Oxford; Royal Infirmary, Aberdeen; Selly Oak Hospital, Birmingham; St. George's Hospital and Hammersmith Hospital, London; City Hospital, Belfast; North Staffordshire City General Hospital, Stoke- on- Trent; Royal Victoria Hospital, Belfast; St. Helier Hospital, Carshalton; Whittington Hospital, London; Norfolk and Norwich Hospital, Norwich; Lister Hospital, Stevenage; Ipswich Hospital, Ipswich; Ninewells Hospital, Dundee; Northampton Hospital, Northampton; Torbay Hospital, Torquay; Peterborough District Hospital, Peterborough; Scarborough Hospital, Scarborough; Derbyshire Royal Infirmary, Derby; Manchester Royal Infirmary, Manchester; Hope Hospital, Salford; Leicester General Hospital, Leicester; and Royal Devon and Exeter Hospital, Exeter. all in the United Kingdom; the Northern Ireland General Register Office for provision of vitalstatus data; and John McMurray for helpful advice. We acknowledge the major contribution of the late Carole Cull and the efforts of members of the Endpoint Adjudication Committee ( Charles Fox and Alex Wright).	[Anonymous], 1994, Diabet Med, V11, P773; [Anonymous], 1991, JAMA, V265, P3255; Estacio RO, 1998, NEW ENGL J MED, V338, P645, DOI 10.1056/NEJM199803053381003; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; MANLEY SE, 1994, DIABETIC MED, V11, P534; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Pahor M, 2000, DIABETES CARE, V23, P888, DOI 10.2337/diacare.23.7.888; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stearne MR, 1998, BRIT MED J, V317, P713; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton I, 1996, DIABETOLOGIA, V39, P1554, DOI 10.1007/s001250050614; Stratton IM, 2006, DIABETOLOGIA, V49, P1761, DOI 10.1007/s00125-006-0297-1; Swedberg K, 1999, EUR HEART J, V20, P136, DOI 10.1053/euhj.1998.1098; SWEDBERG K, 1987, NEW ENGL J MED, V316, P1429; Tatti P, 1998, DIABETES CARE, V21, P597, DOI 10.2337/diacare.21.4.597; TURNER RC, 1993, J HYPERTENS, V11, P319; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823; TURNER RC, 1993, J HYPERTENS, V11, P309; TURNER RC, 1991, DIABETOLOGIA, V34, P877; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; UK Prospect Diabet Study Grp, 1999, BMJ-BRIT MED J, V318, P29; WILLIAMS A, 1990, HEALTH POLICY, V16, P199	26	514	554	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1565	1576		10.1056/NEJMoa0806359	http://dx.doi.org/10.1056/NEJMoa0806359			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18784091				2022-12-28	WOS:000259903100005
J	Smith, SA; Donoghue, MJ				Smith, Stephen A.; Donoghue, Michael J.			Rates of molecular evolution are linked to life history in flowering plants	SCIENCE			English	Article							ESTIMATING DIVERGENCE TIMES; GENERATION-TIME; BIODIVERSITY HOTSPOTS; METABOLIC-RATE; BODY-SIZE; SEQUENCES; CLOCK; DIVERSIFICATION; ANGIOSPERMS; MALVACEAE	Variable rates of molecular evolution have been documented across the tree of life, but the cause of this observed variation within and among clades remains uncertain. In plants, it has been suggested that life history traits are correlated with the rate of molecular evolution, but previous studies have yielded conflicting results. Exceptionally large phylogenies of five major angiosperm clades demonstrate that rates of molecular evolution are consistently low in trees and shrubs, with relatively long generation times, as compared with related herbaceous plants, which generally have shorter generation times. Herbs show much higher rates of molecular change but also much higher variance in rates. Correlates of life history attributes have long been of interest to biologists, and our results demonstrate how changes in the rate of molecular evolution that are linked to life history traits can affect measurements of the tempo of evolution as well as our ability to identify and conserve biodiversity.	[Smith, Stephen A.; Donoghue, Michael J.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	Yale University	Smith, SA (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St,POB 208105, New Haven, CT 06520 USA.	stephen.smith@yale.edu	Smith, Stephen/AAE-8623-2019; Smith, Stephen/B-3451-2010	Smith, Stephen/0000-0003-2035-9531; 	NSF; Cyberinfrastructure for Phylogenetic Research [EF-0331654]; angiosperm Assembling the Tree of Life [EF-0431258]	NSF(National Science Foundation (NSF)); Cyberinfrastructure for Phylogenetic Research; angiosperm Assembling the Tree of Life	We thank D. Tank, J. Beaulieu, S. Stearns, D. Weinreich, C. Dunn, and E. Edwards for helpful discussions. Funded by the NSF through the Cyberinfrastructure for Phylogenetic Research (EF-0331654) and the angiosperm Assembling the Tree of Life (EF-0431258) projects.	Andreasen K, 2005, CONSERV GENET, V6, P399, DOI 10.1007/s10592-005-4977-z; Andreasen K, 2001, MOL BIOL EVOL, V18, P936, DOI 10.1093/oxfordjournals.molbev.a003894; Barraclough TG, 2001, EVOLUTION, V55, P677, DOI 10.1554/0014-3820(2001)055[0677:ERASDI]2.0.CO;2; Bell CD, 2005, AM J BOT, V92, P284, DOI 10.3732/ajb.92.2.284; BOUSQUET J, 1992, P NATL ACAD SCI USA, V89, P7844, DOI 10.1073/pnas.89.16.7844; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Chase Mark W., 2006, Aliso, V22, P63; Davies TJ, 2006, EVOLUTION, V60, P476; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P140, DOI 10.1073/pnas.0407735101; Hietz P, 2002, J TROP ECOL, V18, P177, DOI 10.1017/S0266467402002122; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KLEKOWSKI EJ, 1989, NATURE, V340, P389, DOI 10.1038/340389a0; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Laroche J, 1997, P NATL ACAD SCI USA, V94, P5722, DOI 10.1073/pnas.94.11.5722; MARTIN AP, 1993, P NATL ACAD SCI USA, V90, P4087, DOI 10.1073/pnas.90.9.4087; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; MOOERS AO, 1994, MOL PHYLOGENET EVOL, V3, P344, DOI 10.1006/mpev.1994.1040; OHTA T, 1993, P NATL ACAD SCI USA, V90, P10676, DOI 10.1073/pnas.90.22.10676; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; RENNER SS, 1995, AM J BOT, V82, P596, DOI 10.2307/2445418; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sinnott EW, 1916, AM NAT, V50, P466, DOI 10.1086/279557; Soltis D, 2005, PHYLOGENY EVOLUTION; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stevens PF, 2008, ANGIOSPERM PHYLOGENY; Verdu M, 2002, EVOLUTION, V56, P1352, DOI 10.1111/j.0014-3820.2002.tb01449.x; Whittle CA, 2003, J MOL EVOL, V56, P223, DOI 10.1007/s00239-002-2395-0; Zerega NJC, 2005, MOL PHYLOGENET EVOL, V37, P402, DOI 10.1016/j.ympev.2005.07.004	36	545	562	5	169	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					86	89		10.1126/science.1163197	http://dx.doi.org/10.1126/science.1163197			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832643	Green Published			2022-12-28	WOS:000259680200043
J	Topal, J; Gergely, G; Miklosi, A; Erdohegyi, A; Csibra, G				Topal, Jozsef; Gergely, Gyoergy; Miklosi, Adam; Erdohegyi, Agnes; Csibra, Gergely			Infants' perseverative search errors are induced by pragmatic misinterpretation	SCIENCE			English	Article							B ERRORS; TASK; DYNAMICS; MEMORY	Having repeatedly retrieved an object from a location, human infants tend to search the same place even when they observe the object being hidden at another location. This perseverative error is usually explained by infants' inability to inhibit a previously rewarded search response or to recall the new location. We show that the tendency to commit this error is substantially reduced ( from 81 to 41%) when the object is hidden in front of 10- month- old infants without the experimenter using the communicative cues that normally accompany object hiding in this task. We suggest that this improvement is due to an interpretive bias that normally helps infants learn from demonstrations but misleads them in the context of a hiding game. Our finding provides an alternative theoretical perspective on the nature of infants' perseverative search errors.	[Topal, Jozsef; Gergely, Gyoergy] Hungarian Acad Sci, Res Inst Psychol, H-1132 Budapest, Hungary; [Gergely, Gyoergy; Csibra, Gergely] Cent European Univ, Dept Philosophy, H-1051 Budapest, Hungary; [Miklosi, Adam; Erdohegyi, Agnes] Eotvos Lorand Univ, Dept Ethol, H-1117 Budapest, Hungary; [Csibra, Gergely] Univ London Birkbeck Coll, Dept Psychol, London WC1E 7HX, England	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Central European University; Eotvos Lorand University; University of London; Birkbeck University London	Topal, J (corresponding author), Hungarian Acad Sci, Res Inst Psychol, H-1132 Budapest, Hungary.	topaljozsef@gmail.com	Csibra, Gergely/C-4345-2008; Galantucci, Bruno/E-5770-2010; Miklosi, Adam/N-5147-2017	Csibra, Gergely/0000-0002-7044-3056; Miklosi, Adam/0000-0003-4831-8985; Gergely, Gyorgy/0000-0002-2094-4258	Hungarian Scientific Research Fund [T049615]; EU6 Framework Programme; NEUROCOM [12738]; EDICI [12929]; Bolyai Foundation of the Hungarian Academy of Sciences; Medical Research Council [G9715587] Funding Source: researchfish; MRC [G9715587] Funding Source: UKRI	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); EU6 Framework Programme; NEUROCOM; EDICI; Bolyai Foundation of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. Bogn r for her assistance in data collection, and V. Southgate and J. Watson for helpful comments. Supported by the Hungarian Scientific Research Fund (T049615), the EU6 Framework Programme (NEUROCOM grant 12738, EDICI grant 12929), and the Bolyai Foundation of the Hungarian Academy of Sciences.	Ahmed A, 1998, DEV PSYCHOL, V34, P441, DOI 10.1037/0012-1649.34.3.441; Brugger A, 2007, CHILD DEV, V78, P806, DOI 10.1111/j.1467-8624.2007.01034.x; Csibra G, 2006, ATTENTION PERFORM, P249; CUMMINGS EM, 1984, MEM COGNITION, V12, P1; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P267, DOI 10.1111/j.1749-6632.1990.tb48900.x; DIAMOND A, 1989, EXP BRAIN RES, V74, P24; DIAMOND A, 1994, DEV PSYCHOL, V30, P192, DOI 10.1037/0012-1649.30.2.192; Gergely G., 2006, ROOTS HUMAN SOCIALIT, P229; Gergely G, 2007, DEVELOPMENTAL SCI, V10, P139, DOI 10.1111/j.1467-7687.2007.00576.x; HARRIS PL, 1989, INFANT DEV, P103; Herrmann E, 2007, SCIENCE, V317, P1360, DOI 10.1126/science.1146282; Keen R, 2003, DEVELOPMENTAL SCI, V6, P221, DOI 10.1111/1467-7687.00274; Longo MR, 2006, INFANCY, V10, P43, DOI 10.1207/s15327078in1001_3; Marcovitch S, 1999, CHILD DEV, V70, P1297, DOI 10.1111/1467-8624.00095; Nielsen M, 2006, DEV PSYCHOL, V42, P555, DOI 10.1037/0012-1649.42.3.555; Piaget, 1954, CONSTR REALITY CHILD; Ruffman T, 2005, CHILD DEV, V76, P122, DOI 10.1111/j.1467-8624.2005.00834.x; Smith LB, 1999, PSYCHOL REV, V106, P235, DOI 10.1037/0033-295X.106.2.235; Thelen E, 2001, BEHAV BRAIN SCI, V24, P1, DOI 10.1017/S0140525X01003910; WELLMAN HM, 1986, MONOGRAPHS SOC RES C, V51, P3; Yoon JMD, 2008, P NATL ACAD SCI USA, V105, P13690, DOI 10.1073/pnas.0804388105	21	123	123	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1831	1834		10.1126/science.1161437	http://dx.doi.org/10.1126/science.1161437			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818358				2022-12-28	WOS:000259501300037
J	Sasson, C; Hegg, AJ; Macy, M; Park, A; Kellermann, A; McNally, B				Sasson, Comilla; Hegg, A. J.; Macy, Michelle; Park, Allison; Kellermann, Arthur; McNally, Bryan		CARES Surveillance Grp	Prehospital termination of resuscitation in cases of refractory out-of-hospital cardiac arrest	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	Annual Meeting of the Society-for-Academic-Emergency-Medicine (SAEM)	MAY 29-JUN 02, 2008	Washington, DC	Soc Acad Emergency Med (SAEM)			EMERGENCY MEDICAL-SERVICES; AMERICAN-HEART-ASSOCIATION; FIELD TERMINATION; DERIVATION; COMMITTEE; SURVIVAL; OUTCOMES; UPDATE; RULE; TIME	Context Identifying patients in the out- of- hospital setting who have no realistic hope of surviving an out- of- hospital cardiac arrest could enhance utilization of scarce health care resources. Objective To validate 2 out- of- hospital termination- of- resuscitation rules developed by the Ontario Prehospital Life Support ( OPALS) study group, one for use by responders providing basic life support ( BLS) and the other for those providing advanced life support ( ALS). Design, Setting, and Patients Retrospective cohort study using surveillance data prospectively submitted by emergency medical systems and hospitals in 8 US cities to the Cardiac Arrest Registry to Enhance Survival ( CARES) between October 1, 2005, and April 30, 2008. Case patients were 7235 adults with out- of- hospital cardiac arrest; of these, 5505 met inclusion criteria. Main Outcome Measures Specificity and positive predictive value of each termination-of-resuscitation rule for identifying patients who likely will not survive to hospital discharge. Results The overall rate of survival to hospital discharge was 7.1% ( n= 392). Of 2592 patients ( 47.1%) who met BLS criteria for termination of resuscitation efforts, only 5( 0.2%) patients survived to hospital discharge. Of 1192 patients ( 21.7%) who met ALS criteria, none survived to hospital discharge. The BLS rule had a specificity of 0.987( 95% confidence interval [ CI], 0.970- 0.996) and a positive predictive value of 0.998( 95% CI, 0.996- 0.999) for predicting lack of survival. The ALS rule had a specificity of 1.000( 95% CI, 0.991- 1.000) and positive predictive value of 1.000( 95% CI, 0.997- 1.000) for predicting lack of survival. Conclusion In this validation study, the BLS and ALS termination- of- resuscitation rules performed well in identifying patients with out- of- hospital cardiac arrest who have little or no chance of survival.	[Sasson, Comilla; Macy, Michelle] Univ Michigan, Dept Emergency Med, Ann Arbor, MI 48109 USA; [Sasson, Comilla] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; [Hegg, A. J.] Henry Ford Hlth Syst, Dept Emergency Med Internal Med, Detroit, MI USA; [Park, Allison] Emory Univ, CARES Project, Atlanta, GA 30322 USA; [Kellermann, Arthur; McNally, Bryan] Emory Univ, Dept Emergency Med, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Henry Ford Health System; Henry Ford Hospital; Emory University; Emory University	Sasson, C (corresponding author), 6312 Med Sci Bldg 1,1150 W Med Ctr Dr,SPC 5604, Ann Arbor, MI 48109 USA.	comilla@umich.edu	McNally, Bryan/AAE-9332-2020	Macy, Michelle/0000-0003-4401-7384	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007534] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bailey E D, 2000, Prehosp Emerg Care, V4, P190, DOI 10.1080/10903120090941498; BONNIN MJ, 1993, JAMA-J AM MED ASSOC, V270, P1457, DOI 10.1001/jama.270.12.1457; *CARD ARR REG ENH, CARES IRB APPR MOD; Cheung M, 2001, CJEM, V3, P19; Davies CS, 2005, HEART, V91, P1299, DOI 10.1136/hrt.2003.032631; Delbridge TR, 1996, ANN EMERG MED, V27, P649, DOI 10.1016/S0196-0644(96)70170-1; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; Eckstein M, 2005, ACAD EMERG MED, V12, P65, DOI 10.1197/j.aem.2004.07.020; EISENBERG M, 1981, JAMA-J AM MED ASSOC, V246, P50, DOI 10.1001/jama.246.1.50; EISENBERG M, 1979, AM J PUBLIC HEALTH, V69, P30, DOI 10.2105/AJPH.69.1.30; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; Feder S, 2006, ANN INTERN MED, V144, P634, DOI 10.7326/0003-4819-144-9-200605020-00006; Hallstrom AP, 2002, CRIT CARE MED, V30, pS127, DOI 10.1097/00003246-200204001-00001; Herlitz J, 2004, HEART, V90, P1114, DOI 10.1136/hrt.2003.029348; Hick JL, 1998, ANN EMERG MED, V32, P19, DOI 10.1016/S0196-0644(98)70094-0; Int Liaison Comm Resuscitation, 2005, RESUSCITATION, V67, P181, DOI 10.1016/j.resuscitation.2005.09.010; Isaacs E, 2000, ANN EMERG MED, V35, P147, DOI 10.1016/S0196-0644(00)70134-X; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Jaslow D, 1997, ACAD EMERG MED, V4, P904, DOI 10.1111/j.1553-2712.1997.tb03817.x; KELLERMANN AL, 1993, JAMA-J AM MED ASSOC, V270, P1433, DOI 10.1001/jama.270.12.1433; Kirves H, 2007, EUR J EMERG MED, V14, P75, DOI 10.1097/MEJ.0b013e328013f88c; Lindholm D J, 1998, Prehosp Disaster Med, V13, P51; Lockey AS, 2002, EMERG MED J, V19, P345, DOI 10.1136/emj.19.4.345; Maguire BJ, 2002, ANN EMERG MED, V40, P625, DOI 10.1067/mem.2002.128681; Marco CA, 2003, J EMERG MED, V24, P101, DOI 10.1016/S0736-4679(02)00688-1; Marco CA, 2002, AM J EMERG MED, V20, P207, DOI 10.1053/ajem.2002.32626; MARCUS R, 1995, ANN EMERG MED, V25, P776, DOI 10.1016/S0196-0644(95)70206-7; MARSDEN AK, 1995, BRIT MED J, V311, P49, DOI 10.1136/bmj.311.6996.49; Morrison LJ, 2007, RESUSCITATION, V74, P266, DOI 10.1016/j.resuscitation.2007.01.009; Morrison LJ, 2006, NEW ENGL J MED, V355, P478, DOI 10.1056/NEJMoa052620; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; O'Brien E, 2008, PREHOSP EMERG CARE, V12, P57, DOI 10.1080/10903120701707989; Pepe P E, 2001, Prehosp Emerg Care, V5, P79, DOI 10.1080/10903120190940399; Petrie D A, 2001, CJEM, V3, P186; Richman PB, 2008, ACAD EMERG MED, V15, P517, DOI 10.1111/j.1553-2712.2008.00110.x; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; SCHMIDT TA, 1995, ACAD EMERG MED, V2, P513, DOI 10.1111/j.1553-2712.1995.tb03250.x; SCHNEIDERMAN LJ, 1990, ANN INTERN MED, V112, P949, DOI 10.7326/0003-4819-112-12-949; SORELLE R, 2008, EMERG MED NEWS, V30, P10; SORELLE R, 2008, EMERG MED NEWS, V30, P15; SORELLE R, 2008, EMERG MED NEWS, V30, P1; Swor RA, 2000, ACAD EMERG MED, V7, P762, DOI 10.1111/j.1553-2712.2000.tb02266.x; Verbeek PR, 2002, ACAD EMERG MED, V9, P671, DOI 10.1197/aemj.9.7.671	43	145	148	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1432	1438		10.1001/jama.300.12.1432	http://dx.doi.org/10.1001/jama.300.12.1432			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	351FR	18812534	Bronze			2022-12-28	WOS:000259410400021
J	Buchman, JJ; Tsai, LH				Buchman, Joshua J.; Tsai, Li-Huei			Putting a Notch in our understanding of nuclear migration	CELL			English	Editorial Material							PHOTORECEPTORS	The nuclei of progenitor cells in developing neural epithelia change their position during the cell cycle through a process called interkinetic nuclear migration. Del Bene et al. (2008) report that defects in the machinery controlling this process lead to altered exposure to Notch signals and systemic effects on neurogenesis in the retina.	[Buchman, Joshua J.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Buchman, Joshua J.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Buchman, Joshua J.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu						Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Doerre G, 2001, J NEUROSCI, V21, P6745, DOI 10.1523/JNEUROSCI.21-17-06745.2001; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026	8	11	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					912	914		10.1016/j.cell.2008.09.007	http://dx.doi.org/10.1016/j.cell.2008.09.007			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805082	Bronze			2022-12-28	WOS:000259318100009
J	Toyama, Y; Peralta, XG; Wells, AR; Kiehart, DP; Edwards, GS				Toyama, Yusuke; Peralta, Xomalin G.; Wells, Adrienne R.; Kiehart, Daniel P.; Edwards, Glenn S.			Apoptotic force and tissue dynamics during Drosophila embryogenesis	SCIENCE			English	Article							PROGRAMMED CELL-DEATH; DORSAL CLOSURE; MORPHOGENESIS; GENE; MECHANISMS	Understanding cell morphogenesis during metazoan development requires knowledge of how cells and the extracellular matrix produce and respond to forces. We investigated how apoptosis, which remodels tissue by eliminating supernumerary cells, also contributes forces to a tissue ( the amnioserosa) that promotes cell- sheet fusion ( dorsal closure) in the Drosophila embryo. We showed that expression in the amnioserosa of proteins that suppress or enhance apoptosis slows or speeds dorsal closure, respectively. These changes correlate with the forces produced by the amnioserosa and the rate of seam formation between the cell sheets ( zipping), key processes that contribute to closure. This apoptotic force is used by the embryo to drive cell- sheet movements during development, a role not classically attributed to apoptosis.	[Wells, Adrienne R.; Kiehart, Daniel P.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Toyama, Yusuke; Peralta, Xomalin G.; Edwards, Glenn S.] Duke Univ, Dept Phys, Durham, NC 27708 USA; [Toyama, Yusuke; Peralta, Xomalin G.; Edwards, Glenn S.] Duke Univ, Free Elect Laser Lab, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Kiehart, DP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	dkiehart@duke.edu; edwards@fel.duke.edu	Wells, Adrienne/E-3500-2018; Toyama, Yusuke/H-8023-2012; Peralta, Xomalin/F-3710-2014	Wells, Adrienne/0000-0003-3372-5588; Toyama, Yusuke/0000-0003-3230-1062; Peralta, Xomalin/0000-0002-4034-3214	NIH [GM33830]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033830] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Venakides, U. S. Tulu, and A. Rodiriguez-Diaz for useful discussions and A. Boury and R. Montangue for fly husbandry. This research was supported by NIH grant GM33830.	ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773; CLEM RJ, 1991, SCIENCE, V254, P1388, DOI 10.1126/science.1962198; Franke JD, 2005, CURR BIOL, V15, P2208, DOI 10.1016/j.cub.2005.11.064; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Greenhalgh DG, 1998, INT J BIOCHEM CELL B, V30, P1019, DOI 10.1016/S1357-2725(98)00058-2; Hrdlicka L, 2002, GENESIS, V34, P51, DOI 10.1002/gene.10125; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacinto A, 2001, NAT CELL BIOL, V3, pE117, DOI 10.1038/35074643; Jacinto A, 2000, CURR BIOL, V10, P1420, DOI 10.1016/S0960-9822(00)00796-X; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728; Peralta XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015004; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Reed BH, 2004, CURR BIOL, V14, P372, DOI 10.1016/j.cub.2004.02.029; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Stenn K., 1998, MOL BASIS EPITHELIAL, P111; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116	22	200	200	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1683	1686		10.1126/science.1157052	http://dx.doi.org/10.1126/science.1157052			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802000	Green Accepted			2022-12-28	WOS:000259300400038
J	Bhutta, ZA; Ali, S; Cousens, S; Ali, TM; Haider, BA; Rizvi, A; Okong, P; Bhutta, SZ; Black, RE				Bhutta, Zulfiqar A.; Ali, Samana; Cousens, Simon; Ali, Talaha M.; Haider, Batool Azra; Rizvi, Arjumand; Okong, Pius; Bhutta, Shereen Z.; Black, Robert E.			Alma-Ata: Rebirth and revision 6 - Interventions to address maternal, newborn, and child survival: what difference can integrated primary health care strategies make?	LANCET			English	Article							MILLENNIUM DEVELOPMENT GOALS; COST-EFFECTIVE INTERVENTIONS; EMERGENCY OBSTETRIC CARE; MIDDLE-INCOME COUNTRIES; KANGAROO MOTHER CARE; NEONATAL HEALTH; PSYCHOSOCIAL STIMULATION; ILLNESS IMCI; COMMUNITY; MORTALITY	Several recent reviews of maternal, newborn, and child health (MNCH) and mortality have emphasised that a large range of interventions are available with the potential to reduce deaths and disability. The emphasis within MNCH varies, with skilled care at facility levels recommended for saving maternal lives and scale-up of community and household care for improving newborn and child survival. Systematic review of new evidence on potentially useful interventions and delivery strategies identifies 37 key promotional, preventive, and treatment interventions and strategies for delivery in primary health care. Some are especially suitable for delivery through community support groups and health workers, whereas others can only be delivered by linking community-based strategies with functional first-level referral facilities. Case studies of MNCH indicators in Pakistan and Uganda show how primary health-care interventions can be used effectively. Inclusion of evidence-based interventions in MNCH programmes in primary health care at pragmatic coverage in these two countries could prevent 20-30% of all maternal deaths (up to 32% with capability for caesarean section at first-level facilities), 20-21% of newborn deaths, and 29-40% of all postneonatal deaths in children aged less than 5 years. Strengthening MNCH at the primary health-care level should be a priority for countries to reach their Millennium Development Goal targets for reducing maternal and child mortality.	[Bhutta, Zulfiqar A.; Ali, Samana; Ali, Talaha M.; Haider, Batool Azra; Rizvi, Arjumand] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan; [Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Okong, Pius] Nsambya Hosp, Dept Obstet & Gynaecol, Kampala, Uganda; [Bhutta, Shereen Z.] Jinnah Postgrad Med Ctr, Dept Obstet & Gynaecol, Karachi, Pakistan; [Black, Robert E.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA	Aga Khan University; University of London; London School of Hygiene & Tropical Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Bhutta, ZA (corresponding author), Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan.	zulfiqar.bhutta@aku.edu	Sandall, Jane/D-4146-2009	Sandall, Jane/0000-0003-2000-743X; Black, Robert/0000-0001-9926-7984; Rizvi, Arjumand/0000-0003-4553-8130	Partnership for Maternal, Newborn, and Child Health; Norwegian Agency for Development Cooperation and the Aga Khan University; Quratulain Humayun; Afshan Jabeen; Amina Zaidi	Partnership for Maternal, Newborn, and Child Health; Norwegian Agency for Development Cooperation and the Aga Khan University; Quratulain Humayun; Afshan Jabeen; Amina Zaidi	The funding for the literature review and development of The Lancet series for primary care integration was provided by the Partnership for Maternal, Newborn, and Child Health, the Norwegian Agency for Development Cooperation and the Aga Khan University. The funding agencies had no influence over the content and conclusions of the papers. In addition to the series steering committee, the authors are deeply grateful for the advice received at various stages from several individuals including joy Lawn (Saving Newborn Lives), Gary Darmstadt (Bill & Melinda Gates Foundation), Elizabeth Mason and Monir Islam (WHO), and Carine Ronsmans (London School of Hygiene and Tropical Medicine). The authors would like to acknowledge additional support provided by Quratulain Humayun, Afshan Jabeen, and Amina Zaidi, and advice on cost effectiveness by Aatekah Owais (Aga Khan University). The authors are grateful for the secretarial assistance of Sajjad Surani.	Adam T, 2005, BMJ-BRIT MED J, V331, P1107, DOI 10.1136/bmj.331.7525.1107; Adam T, 2005, B WORLD HEALTH ORGAN, V83, P369; Aghajanian A., 2007, Eastern Mediterranean Health Journal, V13, P1466; Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; Amin R, 1998, J DEV AREAS, V32, P221; Ashworth A, 2006, FOOD NUTR BULL, V27, pS24, DOI 10.1177/15648265060273S303; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS82, DOI 10.1038/sj.jp.7211275; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Bangash FK, 2003, J CHEM SOC PAKISTAN, V25, P1; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Belachew T, 2007, East Afr Med J, V84, P577; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI69, DOI 10.1093/heapol/czi053; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Buasai Supakorn, 2007, Promot Educ, V14, P250, DOI 10.1177/10253823070140041301; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; CONDEAGUDELO A, 2003, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD002771.PUB2]; COTTER A, 2001, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001808, DOI 10.1002/14651858.CD001808]; Cumbi Amelia, 2007, Hum Resour Health, V5, P27, DOI 10.1186/1478-4491-5-27; DAO HT, 2008, PUBLIC HLTH     0227; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Deorari AK, 2001, ANN TROP PAEDIATR, V21, P29, DOI 10.1080/02724930020028885; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; DULEY L, 2003, COCHRANE DB SYST REV, V2; Edejer TTT, 2005, BMJ-BRIT MED J, V331, P1177, DOI 10.1136/bmj.38652.550278.7C; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; Fegan GW, 2007, LANCET, V370, P1035, DOI 10.1016/S0140-6736(07)61477-9; Graham WJ, 2006, MATERNAL PERINATAL C, P499; Grilli R, 2002, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000389, DOI 10.1002/14651858.CD000389]; Gulmezoglu AM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub3; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Haines A, 2007, LANCET, V370, P911, DOI 10.1016/S0140-6736(07)61423-8; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hamadani JD, 2006, J NUTR, V136, P2645, DOI 10.1093/jn/136.10.2645; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Hesketh T, 1997, BRIT MED J, V314, P1543, DOI 10.1136/bmj.314.7093.1543; HILL Z, 2004, FAMILY COMMUNITY PRA; Hodnet, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000062, DOI 10.1002/14651858.CD000062]; Hofmeyr GJ, 2007, BJOG-INT J OBSTET GY, V114, P933, DOI 10.1111/j.1471-0528.2007.01389.x; HOFMEYR GJ, 2006, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD001059.PUB2; HOFMEYR GJ, 2004, BJOG, V112, P547; Huff-Rousselle M, 2001, INT J HEALTH PLAN M, V16, P33, DOI 10.1002/hpm.609; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Jeffery HE, 2004, MED EDUC, V38, P435, DOI 10.1046/j.1365-2923.2004.01785.x; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kendrick D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006020.pub3; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kobbe R, 2007, CLIN INFECT DIS, V45, pS16, DOI 10.1086/518575; KUMAR V, IN PRESS LANCET; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; LEATT P, 2002, INTEGRATED SERVICE D; Lengeler C, 2004, COCHRANE DB SYST REV, V2; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Mockenhaupt FP, 2007, ANTIMICROB AGENTS CH, V51, P3273, DOI 10.1128/AAC.00513-07; Mohindra KS, 2006, J EPIDEMIOL COMMUN H, V60, P1020, DOI 10.1136/jech.2006.047647; Nabyonga-Orem J, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-102; [National Institute of Population Studies (NIPS) Macro International Inc], 2008, PAK DEM HLTH SURV 20; Nixon J, 2004, INJURY PREV, V10, P43, DOI 10.1136/ip.2003.003822; O'Keefe DJ, 2007, J HEALTH COMMUN, V12, P623, DOI 10.1080/10810730701615198; Ogunbekun I, 1996, HEALTH POLICY PLANN, V11, P369, DOI 10.1093/heapol/11.4.369; Otchere SA, 2007, INT J GYNECOL OBSTET, V99, P165, DOI 10.1016/j.ijgo.2007.07.005; Otchere SA, 2007, INT J GYNECOL OBSTET, V99, P173, DOI 10.1016/j.ijgo.2007.07.004; Pattinson RC, 2006, J TROP PEDIATRICS, V52, P438, DOI 10.1093/tropej/fml032; Phillips Carl V, 2003, BMC Med Res Methodol, V3, P9, DOI 10.1186/1471-2288-3-9; Poobalan AS, 2007, BRIT J PSYCHIAT, V191, P378, DOI 10.1192/bjp.bp.106.032789; PRENDIVILLE WJ, 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000007, DOI 10.1002/14651858.CD000007]; Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schellenberg JA, 2003, LANCET, V361, P561, DOI 10.1016/S0140-6736(03)12515-9; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Shaw E, 2006, BIRTH-ISS PERINAT C, V33, P210, DOI 10.1111/j.1523-536X.2006.00106.x; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Sloan NL, 2008, PEDIATRICS, V121, pE1047, DOI 10.1542/peds.2007-0076; Soeters R, 2006, B WORLD HEALTH ORGAN, V84, P884; Spinks A, 2004, INJURY PREV, V10, P180, DOI 10.1136/ip.2003.004903; Tan A, 2005, COCHRANE DB SYST REV, V2; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; *UNICEF, 2008, COUNTD 2015 TRACK PR; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Walker SP, 2005, LANCET, V366, P1804, DOI 10.1016/S0140-6736(05)67574-5	96	232	237	0	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					972	989		10.1016/S0140-6736(08)61407-5	http://dx.doi.org/10.1016/S0140-6736(08)61407-5			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790320				2022-12-28	WOS:000259266900037
J	Bitz, CM; Fu, Q				Bitz, Cecilia M.; Fu, Qiang			Arctic warming aloft is data set dependent	NATURE			English	Letter							MSU CHANNEL-2; AMPLIFICATION		[Bitz, Cecilia M.; Fu, Qiang] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Bitz, CM (corresponding author), Univ Washington, Dept Atmospher Sci, 408 Atmospher Sci & Geophys Hall, Seattle, WA 98195 USA.	bitz@atmos.washington.edu	Fu, Qiang/W-5836-2019; Bitz, Cecilia M/S-8423-2016	Bitz, Cecilia M/0000-0002-9477-7499				Alexeev VA, 2005, CLIM DYNAM, V24, P655, DOI 10.1007/s00382-005-0018-3; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Cai M, 2007, CLIM DYNAM, V29, P375, DOI 10.1007/s00382-007-0238-9; Fu Q, 2004, NATURE, V429, P55, DOI 10.1038/nature02524; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Johanson CM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029108; Johanson CM, 2006, J CLIMATE, V19, P4234, DOI 10.1175/JCLI3866.1; Karl T. R., 2006, TEMPERATURE TRENDS L; Lemke P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P337; Mears CA, 2005, SCIENCE, V309, P1548, DOI 10.1126/science.1114772; Mears CA, 2003, J CLIMATE, V16, P3650, DOI 10.1175/1520-0442(2003)016<3650:AROTMC>2.0.CO;2; Overland J. E., 1994, GEOPHYS MONOGR SER, V84, P313, DOI DOI 10.1029/GM085P0313	12	32	32	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					E3	E4		10.1038/nature07258	http://dx.doi.org/10.1038/nature07258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784661				2022-12-28	WOS:000259090800036
J	Grant, AN; Bronnimann, S; Haimberger, L				Grant, A. N.; Bronnimann, S.; Haimberger, L.			Recent Arctic warming vertical structure contested	NATURE			English	Letter							TROPOSPHERIC TEMPERATURE		[Grant, A. N.; Bronnimann, S.] ETH, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Haimberger, L.] Univ Vienna, Dept Meteorol & Geophys, A-1090 Vienna, Austria	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Vienna	Grant, AN (corresponding author), ETH, Inst Atmospher & Climate Sci, Universitatstr 16, CH-8092 Zurich, Switzerland.	andrea.grant@env.ethz.ch	Brönnimann, Stefan/A-5737-2008; Grant, Andrea N/A-1693-2008	Grant, Andrea N/0000-0002-1553-596X; Bronnimann, Stefan/0000-0001-9502-7991				Bromwich DH, 2005, MON WEATHER REV, V133, P3562, DOI 10.1175/MWR3043.1; Durre I, 2006, J CLIMATE, V19, P53, DOI 10.1175/JCLI3594.1; Fu Q, 2004, NATURE, V429, P55, DOI 10.1038/nature02524; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; HAIMBERGER L, IN PRESS J CLIM; Haimberger L, 2007, J CLIMATE, V20, P1377, DOI 10.1175/JCLI4050.1; Mears CA, 2005, SCIENCE, V309, P1548, DOI 10.1126/science.1114772; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176	8	41	42	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					E2	E3		10.1038/nature07257	http://dx.doi.org/10.1038/nature07257			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784660				2022-12-28	WOS:000259090800035
J	Smith, N				Smith, Nathan			A blast wave from the 1843 eruption of eta Carinae	NATURE			English	Article							HOMUNCULUS-NEBULA; POPULATION-III; HIGH-VELOCITY; MASSIVE STAR; OUTER SHELL; SPECTROSCOPY; DISCOVERY; EMISSION; ANALOG; SHAPE	Very massive stars shed much of their mass in violent precursor eruptions(1) as luminous blue variables(2) ( LBVs) before reaching their most likely end as supernovae, but the cause of LBV eruptions is unknown. The nineteenth- century eruption of eta Carinae, the prototype of these events(3), ejected about 12 solar masses at speeds of 650 km s(-1), with a kinetic energy of almost 10(50) erg ( ref. 4). Some faster material with speeds up to 1,000 2,000 km s(-1) had previously been reported(5-8) but its full distribution was unknown. Here I report observations of much faster material with speeds up to 3,500-6,000 km s(-1), reaching farther from the star than the fastest material in previous reports(5). This fast material roughly doubles the kinetic energy of the nineteenth-century event and suggests that it released a blast wave now propagating ahead of the massive ejecta. As a result, eta Carinae's outer shell now mimics a low- energy supernova remnant. The eruption has usually been discussed in terms of an extreme wind driven by the star's luminosity(2,3,9,10), but the fast material reported here indicates that it may have been powered by a deep- seated explosion rivalling a supernova, perhaps triggered by the pulsational pair instability(11). This may alter interpretations of similar events seen in other galaxies.	[Smith, Nathan] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Smith, N (corresponding author), Univ Calif Berkeley, Dept Astron, 601 Campbell Hall, Berkeley, CA 94720 USA.	nathans@astro.berkeley.edu						Currie DG, 2002, ASTRON ASTROPHYS, V389, pL65, DOI 10.1051/0004-6361:20020805; Damineli A, 1997, NEW ASTRON, V2, P107, DOI 10.1016/S1384-1076(97)00008-0; DAVIDSON K, 1986, ASTROPHYS J, V305, P867, DOI 10.1086/164301; Davidson K, 1997, ANNU REV ASTRON ASTR, V35, P1, DOI 10.1146/annurev.astro.35.1.1; Davidson K, 2001, ASTRON J, V121, P1569, DOI 10.1086/319419; Foley RJ, 2007, ASTROPHYS J, V657, pL105, DOI 10.1086/513145; GOODRICH RW, 1989, ASTROPHYS J, V342, P908, DOI 10.1086/167646; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; HUMPHREYS RM, 1994, PUBL ASTRON SOC PAC, V106, P1025, DOI 10.1086/133478; MEABURN J, 1987, ASTRON ASTROPHYS, V181, P333; Morse JA, 2001, ASTROPHYS J, V548, pL207, DOI 10.1086/319092; Owocki SP, 2004, ASTROPHYS J, V616, P525, DOI 10.1086/424910; Pastorello A, 2007, NATURE, V447, P829, DOI 10.1038/nature05825; Pittard JM, 2002, ASTRON ASTROPHYS, V383, P636, DOI 10.1051/0004-6361:20020025; Seward FD, 2001, ASTROPHYS J, V553, P832, DOI 10.1086/320961; Shaviv NJ, 2000, ASTROPHYS J, V532, pL137, DOI 10.1086/312585; Smith N, 2004, ASTROPHYS J, V605, P854, DOI 10.1086/382671; Smith N, 2003, ASTRON J, V125, P1458, DOI 10.1086/346278; Smith N, 2003, ASTROPHYS J, V586, P432, DOI 10.1086/367641; Smith N, 2002, MON NOT R ASTRON SOC, V337, P1252, DOI 10.1046/j.1365-8711.2002.05966.x; Smith N, 2007, ASTROPHYS J, V666, P1116, DOI 10.1086/519949; Smith N, 2006, ASTROPHYS J, V645, pL45, DOI 10.1086/506523; Smith N, 2006, ASTROPHYS J, V645, pL41, DOI 10.1086/505934; Smith N, 2006, ASTROPHYS J, V644, P1151, DOI 10.1086/503766; Van Dyk SD, 2000, PUBL ASTRON SOC PAC, V112, P1532, DOI 10.1086/317727; WALBORN NR, 1978, ASTROPHYS J, V219, P498, DOI 10.1086/155806; WALBORN NR, 1976, ASTROPHYS J, V204, pL17, DOI 10.1086/182045; Weis K, 2001, ASTRON ASTROPHYS, V367, P566, DOI 10.1051/0004-6361:20000460; Woosley SE, 2007, NATURE, V450, P390, DOI 10.1038/nature06333	29	77	77	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					201	203		10.1038/nature07269	http://dx.doi.org/10.1038/nature07269			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784719	Green Submitted			2022-12-28	WOS:000259090800041
J	Andriole, DA; Whelan, AJ; Jeffe, DB				Andriole, Dorothy A.; Whelan, Alison J.; Jeffe, Donna B.			Characteristics and career intentions of the emerging MD/PhD workforce	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PHYSICIAN-SCIENTIST; MEDICAL-EDUCATION; STUDENTS; ATTITUDES; CHOICE; TRENDS; GOALS	Context MD/PhD program participants represent only a small proportion of all US medical students, yet they are expected to play a major role in the future physician-scientist workforce. The characteristics and career intentions of recent MD/ PhD program and other MD program graduates have not been compared. Objective To identify factors associated with MD/ PhD program graduation among recent medical graduates. Design, Setting, and Participants Deidentified data were obtained from a nationally representative sample of 88 575 US medical graduates who completed the national Association of American Medical Colleges Graduation Questionnaire from 2000-2006. Multivariate logistic regression was used to test responses to items regarding graduates' characteristics and career plans in association with program graduation, reporting adjusted odds ratios ( ORs). Main Outcome Measure MD/ PhD program graduation. Results Of the 79 104 respondents with complete data ( 71.7% of all 2000- 2006 graduates), 1833 ( 2.3%) were MD/ PhD program graduates. Variables associated with greater likelihood of MD/ PhD program graduation included planned substantial career involvement in research ( OR, 10.30; 95% confidence interval [ CI], 8.89- 11.93); lower educational debt ( compared with >=$150 000: $ 100000-$ 149 999, OR, 1.85; 95% CI, 1.35- 2.52; $ 50000-$99 999, OR, 5.50; 95% CI, 4.14- 7.29; $ 1-$49 999, OR, 17.50; 95% CI, 13.30-23.03; no debt, OR, 17.41; 95% CI, 13.22-22.92); and receipt of medical school scholarships or grants ( OR, 3.22; 95% CI, 2.82-3.69). Compared with planned training in internal medicine, MD/ PhD graduation was positively associated with planned training in dermatology, neurology, ophthalmology, pathology, pediatrics, or radiology. Variables associated with lower likelihood of MD/ PhD graduation included female sex ( OR, 0.68; 95% CI, 0.60- 0.77); race/ ethnicity underrepresented in medicine ( OR, 0.64; 95% CI, 0.52-0.80); and, compared with internal medicine, planned training in emergency medicine ( OR, 0.58; 95% CI, 0.40- 0.84) or surgery ( OR, 0.70; 95% CI, 0.57- 0.85). Conclusion Compared with graduates of other MD degree programs, MD/ PhD graduates tend to be less demographically diverse, have a lower debt burden, favor different medical specialties, and have greater planned career involvement in research.	[Andriole, Dorothy A.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Whelan, Alison J.; Jeffe, Donna B.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Whelan, Alison J.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Jeffe, Donna B.] Barnes Jewish Hosp, Hlth Behav & Outreach Core, Alvin J Siteman Canc Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Siteman Cancer Center; Washington University (WUSTL)	Andriole, DA (corresponding author), Washington Univ, Sch Med, Dept Surg, 660 S Euclid Ave,Campus Box 8210, St Louis, MO 63110 USA.	andrioled@wustl.edu	Jeffe, Donna B./AAI-3732-2020	Jeffe, Donna B./0000-0002-7642-3777				*AAMC GROUP ED AFF, GEA REG; Ahn J, 2007, ACAD MED, V82, P633, DOI 10.1097/ACM.0b013e318065b907; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; *AM PHYS SCI ASS, APSA FUND; Andrews NC, 2002, NAT MED, V8, P439, DOI 10.1038/nm0502-439; [Anonymous], 2015, AAMC GRAD QUEST; *ASS AM MED COLL, AAMC CURR DIR COMB D; *ASS AM MED COLL, WOM ENR GRAD US MED; Association of American Medical Colleges, 2006, MED SCH TEACH HOSP N; Brotherton SE, 2007, JAMA-J AM MED ASSOC, V298, P1081, DOI 10.1001/jama.298.9.1081; Committee on National Needs for Biomedical and Behavioral Scientists. Education and Career Studies Unit. Office of Scientific and Engineering Personnel. National Research Council, 2000, ADDR NAT CHANG NEEDS; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; GARRISON G, 2007, AAMC DATA MD PHD STU; Heinig SJ, 2007, NEW ENGL J MED, V357, P1042, DOI 10.1056/NEJMsb071774; HOWELL WLJ, 2005, AAMC EXAMINES LOW RE; JOLLY P, MED SCH TUITION YOUN; Ko M, 2005, ACAD MED, V80, P803, DOI 10.1097/00001888-200509000-00004; Ley TJ, 2005, JAMA-J AM MED ASSOC, V294, P1343, DOI 10.1001/jama.294.11.1343; Ley TJ, 2002, NEW ENGL J MED, V346, P368, DOI 10.1056/NEJM200201313460515; *NAT I GEN MED SCI, MSTP STUD CAR PROF A; National Institute of General Medical Sciences, MED SCI TRAIN PROGR; Newton DA, 2003, JAMA-J AM MED ASSOC, V290, P1179, DOI 10.1001/jama.290.9.1179; Richard GV, 2001, JAMA-J AM MED ASSOC, V285, P2249, DOI 10.1001/jama.285.17.2249; RUTH L, NATL RES SERVICE AWA; *SAN FRANC MATCH P, STAT OPHTH MATCH PRO; Smedley BD, 2004, NATIONS COMPELLING I; Szenas P, 2007, CHARTING OUTCOMES MA; Watt CD, 2005, ACAD MED, V80, P193, DOI 10.1097/00001888-200502000-00019; Whitcomb ME, 2007, ACAD MED, V82, P623, DOI 10.1097/ACM.0b013e318065b4ba; Zemlo TR, 2000, FASEB J, V14, P221, DOI 10.1096/fasebj.14.2.221	30	106	107	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1165	1173		10.1001/jama.300.10.1165	http://dx.doi.org/10.1001/jama.300.10.1165			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780845	Bronze			2022-12-28	WOS:000259038700009
J	Volpp, KG; Landrigan, CP				Volpp, Kevin G.; Landrigan, Christopher P.			Building physician work hour regulations from first principles and best evidence	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MEDICAL ERRORS; INTERNS; MORTALITY; PERFORMANCE; DURATION; SHIFTS; REFORM; RISK; CARE		[Volpp, Kevin G.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Vet Adm Hosp, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA; [Landrigan, Christopher P.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Landrigan, Christopher P.] Harvard Univ, Sch Med, Boston, MA USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Philadelphia Veterans Affairs Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Volpp, KG (corresponding author), Univ Penn, Sch Med, Dept Med, 1232 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu		Landrigan, Christopher/0000-0001-8386-4100; Volpp, Kevin/0000-0003-1423-4599	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS015906] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082637] Funding Source: NIH RePORTER; AHRQ HHS [U18 HS15906] Funding Source: Medline; NHLBI NIH HHS [R01 HL082637] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2006, PLOS MED, V3, P2440, DOI 10.1371/journal.pmed.0030487; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; *CMS OFF ACT, CBOS MARCH 2008 BAS; Dawson D, 1997, NATURE, V388, P235, DOI 10.1038/40775; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; *I MED, OPT GRAD MED TRAIN R; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; Petersen L A, 1998, Jt Comm J Qual Improv, V24, P77; Philibert I, 2005, SLEEP, V28, P1392, DOI 10.1093/sleep/28.11.1392; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Stickgold R, 2005, NATURE, V437, P1272, DOI 10.1038/nature04286; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975	15	23	23	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1197	1199		10.1001/jama.300.10.1197	http://dx.doi.org/10.1001/jama.300.10.1197			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780848	Green Accepted			2022-12-28	WOS:000259038700012
J	Green, CB; Takahashi, JS; Bass, J				Green, Carla B.; Takahashi, Joseph S.; Bass, Joseph			The meter of metabolism	CELL			English	Review							CIRCADIAN GENE-EXPRESSION; REV-ERB-ALPHA; DORSOMEDIAL HYPOTHALAMIC NUCLEUS; ARNT-LIKE PROTEIN-1; HIGH-FAT DIET; CLOCK GENE; SUPRACHIASMATIC NUCLEUS; PERIPHERAL-TISSUES; MESSENGER-RNA; RECIPROCAL REGULATION	The circadian system orchestrates the temporal organization of many aspects of physiology, including metabolism, in synchrony with the 24 hr rotation of the Earth. Like the metabolic system, the circadian system is a complex feedback network that involves interactions between the central nervous system and peripheral tissues. Emerging evidence suggests that circadian regulation is intimately linked to metabolic homeostasis and that dysregulation of circadian rhythms can contribute to disease. Conversely, metabolic signals also feed back into the circadian system, modulating circadian gene expression and behavior. Here, we review the relationship between the circadian and metabolic systems and the implications for cardiovascular disease, obesity, and diabetes.	[Takahashi, Joseph S.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA; [Green, Carla B.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Ctr Funct Genom, Evanston, IL 60208 USA; [Takahashi, Joseph S.; Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Bass, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Med, Evanston, IL 60208 USA; [Bass, Joseph] Evanston Hosp Corp, Evanston NW Healthcare Res Inst, Evanston, IL 60208 USA; [Bass, Joseph] Evanston Hosp Corp, Dept Med, Evanston, IL 60208 USA	Howard Hughes Medical Institute; Northwestern University; University of Virginia; Northwestern University; Northwestern University; Northwestern University; Feinberg School of Medicine; NorthShore University Health System; NorthShore University Health System	Takahashi, JS (corresponding author), Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA.	j-takahashi@northwestern.edu; j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878	National Institutes of Health [R01 GM076626, P50 MH074924, R01 MH078024, P01 AG011412, R01 HL075029]; Amylin Pharmaceuticals; Juvenile Diabetes Research Foundation International; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075029] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH078024, P50MH074924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amylin Pharmaceuticals(Bristol-Myers Squibb); Juvenile Diabetes Research Foundation International(Juvenile Diabetes Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank K. M. Ramsey and B. Marcheva for assistance with figures. This work was supported by National Institutes of Health grants R01 GM076626 and P50 MH074924 Project 4 to C. B. G., R01 MH078024 and P50 MH074924 (Director, Silvio O. Conte Center) to J. S. T., and P01 AG011412 Project 6 and R01 HL075029 to J. B. J. S. T. is an Investigator of the Howard Hughes Medical Institute. J. S. T is a cofounder of ReSet Therapeutics Inc. and C. B. G., J. S. T., and J. B. are members of its scientific advisory board. J. B. has also been an advisor and received research support from Amylin Pharmaceuticals and from the Juvenile Diabetes Research Foundation International.	Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Ahima RS, 2000, ANNU REV PHYSIOL, V62, P413, DOI 10.1146/annurev.physiol.62.1.413; Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Akanmu MA, 2006, NEUROSCI RES, V54, P165, DOI 10.1016/j.neures.2005.11.006; Akashi M, 2005, NAT STRUCT MOL BIOL, V12, P441, DOI 10.1038/nsmb925; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; Allison KC, 2007, OBESITY, V15, P1287, DOI 10.1038/oby.2007.150; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baggs JE, 2003, CURR BIOL, V13, P189, DOI 10.1016/S0960-9822(03)00014-9; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bartness TJ, 2001, J BIOL RHYTHM, V16, P196, DOI 10.1177/074873001129001908; Boudina S, 2007, DIABETES, V56, P2457, DOI 10.2337/db07-0481; Cailotto C, 2008, ENDOCRINOLOGY, V149, P1914, DOI 10.1210/en.2007-0816; Canaple L, 2006, MOL ENDOCRINOL, V20, P1715, DOI 10.1210/me.2006-0052; Castillo MR, 2004, AM J PHYSIOL-REG I, V287, pR551, DOI 10.1152/ajpregu.00247.2004; Challet E, 1999, AM J PHYSIOL-REG I, V276, pR1063, DOI 10.1152/ajpregu.1999.276.4.R1063; Challet E, 1997, J BIOL RHYTHM, V12, P65, DOI 10.1177/074873049701200108; Challet E, 2007, ENDOCRINOLOGY, V148, P5648, DOI 10.1210/en.2007-0804; Chang GQ, 2004, ENDOCRINOLOGY, V145, P3904, DOI 10.1210/en.2003-1582; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Curtis AM, 2007, P NATL ACAD SCI USA, V104, P3450, DOI 10.1073/pnas.0611680104; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Date Y, 1999, P NATL ACAD SCI USA, V96, P748, DOI 10.1073/pnas.96.2.748; Davidson AJ, 2006, CURR BIOL, V16, pR914, DOI 10.1016/j.cub.2006.09.058; Davidson AJ, 2006, AM J PHYSIOL-REG I, V290, pR1524, DOI 10.1152/ajpregu.00073.2006; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duez H, 2008, DIABETES VASC DIS RE, V5, P82, DOI 10.3132/dvdr.2008.0014; Durgan DJ, 2006, J BIOL CHEM, V281, P24254, DOI 10.1074/jbc.M601704200; Ellingsen T, 2007, J R SOC PROMO HEALTH, V127, P265, DOI 10.1177/1466424007083702; Elmquist JK, 1998, P NATL ACAD SCI USA, V95, P741, DOI 10.1073/pnas.95.2.741; Farooqi IS, 2007, SCIENCE, V317, P1355, DOI 10.1126/science.1144599; Feillet CA, 2006, CURR BIOL, V16, P2016, DOI 10.1016/j.cub.2006.08.053; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Fulton S, 2006, NEURON, V51, P811, DOI 10.1016/j.neuron.2006.09.006; Gamble KL, 2007, J NEUROSCI, V27, P12078, DOI 10.1523/JNEUROSCI.1109-07.2007; Garbarino-Pico E, 2007, RNA, V13, P745, DOI 10.1261/rna.286507; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gooley JJ, 2006, NAT NEUROSCI, V9, P398, DOI 10.1038/nn1651; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Green CB, 2007, P NATL ACAD SCI USA, V104, P9888, DOI 10.1073/pnas.0702448104; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Guan XM, 1997, MOL CELL ENDOCRINOL, V133, P1, DOI 10.1016/S0303-7207(97)00138-X; HAGAN MM, 2000, AM J PHYSIOL-REG I, V279, pR7; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Hirota T, 2002, J BIOL CHEM, V277, P44244, DOI 10.1074/jbc.M206233200; Holterhus PM, 2007, DIABETES CARE, V30, P568, DOI 10.2337/dc06-2105; Hong HK, 2007, PLOS GENET, V3, P324, DOI 10.1371/journal.pgen.0030033; Hoogerwerf WA, 2007, GASTROENTEROLOGY, V133, P1250, DOI 10.1053/j.gastro.2007.07.009; Horvath TL, 2005, CELL METAB, V1, P279, DOI 10.1016/j.cmet.2005.03.003; Inoue I, 2005, J ATHEROSCLER THROMB, V12, P169, DOI 10.5551/jat.12.169; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kalra SP, 1999, ENDOCR REV, V20, P68, DOI 10.1210/er.20.1.68; Kalra SP, 2004, NEUROPEPTIDES, V38, P201, DOI 10.1016/j.npep.2004.06.003; Kalsbeek A, 2004, J NEUROSCI, V24, P7604, DOI 10.1523/JNEUROSCI.5328-03.2004; Karlsson B, 2001, OCCUP ENVIRON MED, V58, P747, DOI 10.1136/oem.58.11.747; Kemp DM, 2002, MOL CELL ENDOCRINOL, V191, P157, DOI 10.1016/S0303-7207(02)00064-3; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1590, DOI 10.1152/ajpendo.00669.2006; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kita Y, 2002, PHARMACOGENETICS, V12, P55, DOI 10.1097/00008571-200201000-00008; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kondratov RV, 2007, CURR TOP DEV BIOL, V78, P173, DOI 10.1016/S0070-2153(06)78005-X; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Ladenheim EE, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740273; Lamont EW, 2005, NEUROSCIENCE, V132, P245, DOI 10.1016/j.neuroscience.2005.01.029; Landry GJ, 2007, BRAIN RES, V1141, P108, DOI 10.1016/j.brainres.2007.01.032; Laposky AD, 2008, FEBS LETT, V582, P142, DOI 10.1016/j.febslet.2007.06.079; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin TL, 2006, J BIOL CHEM, V281, P18933, DOI 10.1074/jbc.M512831200; Masaki T, 2004, DIABETES, V53, P2250, DOI 10.2337/diabetes.53.9.2250; Matsumoto M, 2006, J CLIN INVEST, V116, P2464, DOI 10.1172/JCI27047; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; McClung CA, 2005, P NATL ACAD SCI USA, V102, P9377, DOI 10.1073/pnas.0503584102; McDearmon EL, 2006, SCIENCE, V314, P1304, DOI 10.1126/science.1132430; McNamara P, 2001, CELL, V105, P877, DOI 10.1016/S0092-8674(01)00401-9; Mendoza J, 2005, J NEUROSCI, V25, P1514, DOI 10.1523/JNEUROSCI.4397-04.2005; Mendoza J, 2005, EUR J NEUROSCI, V22, P2855, DOI 10.1111/j.1460-9568.2005.04461.x; Mieda M, 2006, P NATL ACAD SCI USA, V103, P12150, DOI 10.1073/pnas.0604189103; MISTLBERGER RE, 1993, PHYSIOL BEHAV, V53, P509, DOI 10.1016/0031-9384(93)90145-6; Murphy KG, 2006, NATURE, V444, P854, DOI 10.1038/nature05484; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nyholm B, 1999, DIABETOLOGIA, V42, P1314, DOI 10.1007/s001250051444; Oishi K, 2006, FEBS LETT, V580, P127, DOI 10.1016/j.febslet.2005.11.063; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Penev PD, 1998, AM J PHYSIOL-HEART C, V275, pH2334; Pocai A, 2005, CELL METAB, V1, P53, DOI 10.1016/j.cmet.2004.11.001; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; Ramsey KM, 2007, ANNU REV NUTR, V27, P219, DOI 10.1146/annurev.nutr.27.061406.093546; Reddy AB, 2007, HEPATOLOGY, V45, P1478, DOI 10.1002/hep.21571; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reilly DF, 2007, ARTERIOSCL THROM VAS, V27, P1694, DOI 10.1161/ATVBAHA.107.144923; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Sakkou M, 2007, CELL METAB, V5, P450, DOI 10.1016/j.cmet.2007.05.007; Sandoval D, 2008, ANNU REV PHYSIOL, V70, P513, DOI 10.1146/annurev.physiol.70.120806.095256; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Shimba S, 2005, P NATL ACAD SCI USA, V102, P12071, DOI 10.1073/pnas.0502383102; Siepka SM, 2007, COLD SPRING HARB SYM, V72, P251, DOI 10.1101/sqb.2007.72.052; Sindelar DK, 2005, PEPTIDES, V26, P2597, DOI 10.1016/j.peptides.2005.04.018; Spiegel K, 2004, ANN INTERN MED, V141, P846, DOI 10.7326/0003-4819-141-11-200412070-00008; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Sun ZS, 1997, CELL, V90, P1003, DOI 10.1016/S0092-8674(00)80366-9; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Tang-Christensen M, 2004, ENDOCRINOLOGY, V145, P4645, DOI 10.1210/en.2004-0529; Tasali E, 2008, P NATL ACAD SCI USA, V105, P1044, DOI 10.1073/pnas.0706446105; Tei H, 1997, NATURE, V389, P512, DOI 10.1038/39086; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; van der Veen DR, 2006, P NATL ACAD SCI USA, V103, P3393, DOI 10.1073/pnas.0507825103; VanCauter E, 1997, ENDOCR REV, V18, P716, DOI 10.1210/er.18.5.716; Williams DL, 2006, DIABETES, V55, P3387, DOI 10.2337/db06-0558; Yamanaka A, 2003, NEURON, V38, P701, DOI 10.1016/S0896-6273(03)00331-3; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yannielli P, 2004, PROG NEUROBIOL, V74, P59, DOI 10.1016/j.pneurobio.2004.06.001; Yannielli PC, 2007, J NEUROSCI, V27, P2890, DOI 10.1523/JNEUROSCI.3913-06.2007; Yi CX, 2006, ENDOCRINOLOGY, V147, P283, DOI 10.1210/en.2005-1051; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005; Zheng X, 2007, P NATL ACAD SCI USA, V104, P15899, DOI 10.1073/pnas.0701599104; Zigman JM, 2006, J COMP NEUROL, V494, P528, DOI 10.1002/cne.20823; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	144	664	682	7	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					728	742		10.1016/j.cell.2008.08.022	http://dx.doi.org/10.1016/j.cell.2008.08.022			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775307	Bronze, Green Accepted			2022-12-28	WOS:000258947500014
J	Herzing, AA; Kiely, CJ; Carley, AF; Landon, P; Hutchings, GJ				Herzing, Andrew A.; Kiely, Christopher J.; Carley, Albert F.; Landon, Philip; Hutchings, Graham J.			Identification of active gold nanoclusters on iron oxide supports for CO oxidation	SCIENCE			English	Article							CATALYTIC-ACTIVITY; NANOPARTICLES; OXYGEN; TIO2(110); CHEMISTRY; CLUSTERS; TITANIA	Gold nanocrystals absorbed on metal oxides have exceptional properties in oxidation catalysis, including the oxidation of carbon monoxide at ambient temperatures, but the identification of the active catalytic gold species among the many present on real catalysts is challenging. We have used aberration- corrected scanning transmission electron microscopy to analyze several iron oxide- supported catalyst samples, ranging from those with little or no activity to others with high activities. High catalytic activity for carbon monoxide oxidation is correlated with the presence of bilayer clusters that are similar to 0.5 nanometer in diameter and contain only similar to 10 gold atoms. The activity of these bilayer clusters is consistent with that demonstrated previously with the use of model catalyst systems.	[Herzing, Andrew A.; Kiely, Christopher J.] Lehigh Univ, Ctr Adv Mat & Nanotechnol, Bethlehem, PA 18015 USA; [Herzing, Andrew A.] Natl Inst Stand & Technol, Surface & Microanal Sci Div, Gaithersburg, MD 20899 USA; [Carley, Albert F.; Landon, Philip; Hutchings, Graham J.] Cardiff Univ, Cardiff Catalysis Inst Sch Chem, Cardiff CF10 3AT, Wales	Lehigh University; National Institute of Standards & Technology (NIST) - USA; Cardiff University	Kiely, CJ (corresponding author), Lehigh Univ, Ctr Adv Mat & Nanotechnol, 5 E Packer Ave, Bethlehem, PA 18015 USA.	chk5@lehigh.edu; hutch@cardiff.ac.uk	Herzing, Andrew/D-6239-2012; Tong, Sherry/C-4462-2015; Carley, Albert/A-7372-2010	Kiely, Christopher/0000-0001-5412-0970	Engineering and Physical Sciences Research Council; NSF; NASA,; National Research Council Postdoctoral Associate	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF)); NASA,(National Aeronautics & Space Administration (NASA)); National Research Council Postdoctoral Associate	We thank the Athena project of the Engineering and Physical Sciences Research Council, NSF, NASA, and the National Research Council Postdoctoral Associate program for funding this work.	Abu Haija M, 2006, SURF SCI, V600, P1497, DOI 10.1016/j.susc.2006.02.003; Bondzie VA, 1999, CATAL LETT, V63, P143, DOI 10.1023/A:1019012903936; Bongiorno A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.106102; Chen MS, 2004, SCIENCE, V306, P252, DOI 10.1126/science.1102420; Corma A, 2006, SCIENCE, V313, P332, DOI 10.1126/science.1128383; Enache DI, 2006, SCIENCE, V311, P362, DOI 10.1126/science.1120560; Falsig H, 2008, ANGEW CHEM INT EDIT, V47, P4835, DOI 10.1002/anie.200801479; Guzman J, 2005, J AM CHEM SOC, V127, P3286, DOI 10.1021/ja043752s; Guzman J, 2004, J AM CHEM SOC, V126, P2672, DOI 10.1021/ja039426e; Hakkinen H, 2003, ANGEW CHEM INT EDIT, V42, P1297, DOI 10.1002/anie.200390334; Haruta M, 2004, GOLD BULL, V37, P27, DOI 10.1007/BF03215514; Haruta M, 2002, CATTECH, V6, P102, DOI 10.1023/A:1020181423055; Hashmi ASK, 2006, ANGEW CHEM INT EDIT, V45, P7896, DOI 10.1002/anie.200602454; Hodge NA, 2002, CATAL TODAY, V72, P133, DOI 10.1016/S0920-5861(01)00487-4; Hughes MD, 2005, NATURE, V437, P1132, DOI 10.1038/nature04190; Hutchings GJ, 2006, J CATAL, V242, P71, DOI 10.1016/j.jcat.2006.06.001; Janssens TVW, 2007, TOP CATAL, V44, P15, DOI 10.1007/s11244-007-0335-3; Matthey D, 2007, SCIENCE, V315, P1692, DOI 10.1126/science.1135752; MAYS CW, 1968, SURF SCI, V12, P134, DOI 10.1016/0039-6028(68)90119-2; Meyer R, 2004, GOLD BULL, V37, P72, DOI 10.1007/BF03215519; Pietron JJ, 2002, NANO LETT, V2, P545, DOI 10.1021/nl025536s; Rashkeev SN, 2007, PHYS REV B, V76, DOI [10.1103/PhysRevB.76.035438, 10.1103/physRevB.76.035438]; Schubert MM, 2001, J CATAL, V197, P113, DOI 10.1006/jcat.2000.3069; Valden M, 1998, SCIENCE, V281, P1647, DOI 10.1126/science.281.5383.1647; Varela M, 2005, ANNU REV MATER RES, V35, P539, DOI 10.1146/annurev.matsci.35.102103.090513; Wang SW, 2004, NAT MATER, V3, P143, DOI 10.1038/nmat1077; Yan WF, 2005, J PHYS CHEM B, V109, P10676, DOI 10.1021/jp044091o; Yoon B, 2005, SCIENCE, V307, P403, DOI 10.1126/science.1104168	28	1289	1295	36	1148	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1331	1335		10.1126/science.1159639	http://dx.doi.org/10.1126/science.1159639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772433				2022-12-28	WOS:000258914300043
J	Adilakshmi, T; Bellur, DL; Woodson, SA				Adilakshmi, Tadepalli; Bellur, Deepti L.; Woodson, Sarah A.			Concurrent nucleation of 16S folding and induced fit in 30S ribosome assembly	NATURE			English	Article							ESCHERICHIA-COLI RIBOSOMES; PARALLEL PATHWAYS; RNA; SUBUNIT; PROTEIN; VITRO; DOMAINS; S4	Rapidly growing cells produce thousands of new ribosomes each minute, in a tightly regulated process that is essential to cell growth(1,2). How the Escherichia coli 16S ribosomal RNA and the 20 proteins that make up the 30S ribosomal subunit can assemble correctly in a few minutes remains a challenging problem, partly because of the lack of real- time data on the earliest stages of assembly. By providing snapshots of individual RNA and protein interactions as they emerge in real time, here we show that 30S assembly nucleates concurrently from different points along the rRNA. Time- resolved hydroxyl radical footprinting(3) was used to map changes in the structure of the rRNA within 20 milliseconds after the addition of total 30S proteins. Helical junctions in each domain fold within 100 ms. In contrast, interactions surrounding the decoding site and between the 5', the central and the 3' domains require 2 - 200 seconds to form. Unexpectedly, nucleotides contacted by the same protein are protected at different rates, indicating that initial RNA - protein encounter complexes refold during assembly. Although early steps in assembly are linked to intrinsically stable rRNA structure, later steps correspond to regions of induced fit between the proteins and the rRNA.	[Adilakshmi, Tadepalli; Woodson, Sarah A.] Johns Hopkins Univ, TC Jenkins Dept Biophys, Baltimore, MD 21218 USA; [Bellur, Deepti L.] Johns Hopkins Univ, Program Cell Mol & Dev Biol & Biophys, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Woodson, SA (corresponding author), Johns Hopkins Univ, TC Jenkins Dept Biophys, 3400 N Charles St, Baltimore, MD 21218 USA.	swoodson@jhu.edu		Woodson, Sarah/0000-0003-0170-1987	National Institutes of Health [GM60819, P41-EB0001979.]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001979, P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Moss, A. Cukras, L. Cochella and R. Green for help with ribosome preparation and peptidyl transferase assays, P. Fleming for help with Calc-Surf software, and S. Gupta, M. Sullivan and M. Brenowitz for help with X-ray footprinting. This work was supported by the National Institutes of Health (NIH; GM60819). The NSLS X28C and the Center for Synchrotron Biosciences are supported by NIH P41-EB0001979.	Adilakshmi T, 2005, J MOL BIOL, V351, P508, DOI 10.1016/j.jmb.2005.06.020; Brodersen DE, 2002, J MOL BIOL, V316, P725, DOI 10.1006/jmbi.2001.5359; Cate JH, 1999, SCIENCE, V285, P2095, DOI 10.1126/science.285.5436.2095; Culver GM, 2003, BIOPOLYMERS, V68, P234, DOI 10.1002/bip.10221; DODD J, 1991, BIOCHIMIE, V73, P757, DOI 10.1016/0300-9084(91)90055-6; Dutca LM, 2008, J MOL BIOL, V376, P92, DOI 10.1016/j.jmb.2007.10.083; HELD WA, 1973, J BIOL CHEM, V248, P5720; Holmes KL, 2004, NAT STRUCT MOL BIOL, V11, P179, DOI 10.1038/nsmb719; Laederach A, 2006, J MOL BIOL, V358, P1179, DOI 10.1016/j.jmb.2006.02.075; NIERHAUS KH, 1991, BIOCHIMIE, V73, P739, DOI 10.1016/0300-9084(91)90054-5; Noller H. F, 1987, ESCHERICHIA COLI SAL, P104; NOWOTNY V, 1988, BIOCHEMISTRY-US, V27, P7051, DOI 10.1021/bi00418a057; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; POWERS T, 1993, J MOL BIOL, V232, P362, DOI 10.1006/jmbi.1993.1396; POWERS T, 1995, J BIOL CHEM, V270, P1238, DOI 10.1074/jbc.270.3.1238; POWERS T, 1995, RNA, V1, P194; Ralston CY, 2000, METHOD ENZYMOL, V317, P353; RAMAKRISHNAN V, 1986, SCIENCE, V231, P1562, DOI 10.1126/science.3513310; SAMAHA RR, 1994, P NATL ACAD SCI USA, V91, P7884, DOI 10.1073/pnas.91.17.7884; Sayers EW, 2000, BIOCHEMISTRY-US, V39, P13602, DOI 10.1021/bi0013391; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; STERN S, 1989, SCIENCE, V244, P783, DOI 10.1126/science.2658053; Talkington MWT, 2005, NATURE, V438, P628, DOI 10.1038/nature04261; TRAUB P, 1969, J MOL BIOL, V40, P391, DOI 10.1016/0022-2836(69)90161-2; Tullius TD, 2005, CURR OPIN CHEM BIOL, V9, P127, DOI 10.1016/j.cbpa.2005.02.009; Warner JR, 2001, COLD SPRING HARB SYM, V66, P567, DOI 10.1101/sqb.2001.66.567; Williamson JR, 2003, RNA, V9, P165, DOI 10.1261/rna.2164903; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	28	138	138	1	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 30	2008	455	7217					1268	1272		10.1038/nature07298	http://dx.doi.org/10.1038/nature07298			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18784650	Green Accepted			2022-12-28	WOS:000260462100051
J	Stratt, RM				Stratt, Richard M.			Chemistry - Nonlinear thinking about molecular energy transfer	SCIENCE			English	Editorial Material							SOLVATION DYNAMICS; COMPUTER-SIMULATION; CHARGE-TRANSFER; LIQUIDS; SOLVENT		[Stratt, Richard M.] Brown Univ, Dept Chem, Providence, RI 02912 USA	Brown University	Stratt, RM (corresponding author), Brown Univ, Dept Chem, Providence, RI 02912 USA.	Richard_Stratt@brown.edu						BADER JS, 1989, CHEM PHYS LETT, V157, P501, DOI 10.1016/S0009-2614(89)87399-3; Bragg AE, 2008, SCIENCE, V321, P1817, DOI 10.1126/science.1161511; CARTER EA, 1991, J CHEM PHYS, V94, P5961, DOI 10.1063/1.460431; CHANDLER D, 1987, INTRO MODERN STAT ME, pCH8; Deak JC, 2004, SCIENCE, V306, P473, DOI 10.1126/science.1102074; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; FONSECA T, 1994, J MOL LIQ, V60, P1, DOI 10.1016/0167-7322(94)00737-3; Geissler PL, 2000, J CHEM PHYS, V113, P9759, DOI 10.1063/1.1290136; Laird BB, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2747237; MARONCELLI M, 1991, J CHEM PHYS, V94, P2084, DOI 10.1063/1.459932; Moskun AC, 2006, SCIENCE, V311, P1907, DOI 10.1126/science.1123738; Smallwood CJ, 2003, J CHEM PHYS, V119, P11263, DOI 10.1063/1.1618733; Stratt RM, 1996, J PHYS CHEM-US, V100, P12981, DOI 10.1021/jp9608483; Tao GH, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2336780; Wang ZH, 2002, SCIENCE, V296, P2201, DOI 10.1126/science.1071293; Yan S, 2007, SCIENCE, V316, P1723, DOI 10.1126/science.1142313	16	11	11	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1789	1790		10.1126/science.1164544	http://dx.doi.org/10.1126/science.1164544			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818350				2022-12-28	WOS:000259501300026
J	de Ferranti, S; Ludwig, DS				de Ferranti, Sarah; Ludwig, David S.			Storm over statins - The controversy surrounding pharmacologic treatment of children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DISEASE		[de Ferranti, Sarah] Childrens Hosp, Prevent Cardiol Clin, Boston, MA 02115 USA; [de Ferranti, Sarah; Ludwig, David S.] Harvard Univ, Sch Med, Boston, MA USA; [Ludwig, David S.] Childrens Hosp, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital	de Ferranti, S (corresponding author), Childrens Hosp, Prevent Cardiol Clin, 300 Longwood Ave, Boston, MA 02115 USA.			Ludwig, David/0000-0003-3307-8544	NHLBI NIH HHS [T32 HL007572] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Lavizzo-Mourey R, 2007, JAMA-J AM MED ASSOC, V298, P920, DOI 10.1001/jama.298.8.920; Valenza M, 2006, PROG NEUROBIOL, V80, P165, DOI 10.1016/j.pneurobio.2006.09.005; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004	5	53	55	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1309	1312		10.1056/NEJMp0805953	http://dx.doi.org/10.1056/NEJMp0805953			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815394				2022-12-28	WOS:000259440900001
J	Davidson, LA				Davidson, Lance A.			Developmental biology - Apoptosis turbocharges epithelial morphogenesis	SCIENCE			English	Editorial Material							PROGRAMMED CELL-DEATH; DROSOPHILA		[Davidson, Lance A.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Davidson, LA (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	lad43+@pitt.edu			NICHD NIH HHS [R01 HD044750-04, R01 HD044750] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044750] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ABRAMS JM, 1993, DEVELOPMENT, V117, P29; Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; GLUCKSMANN A, 1951, BIOL REV, V26, P59, DOI 10.1111/j.1469-185X.1951.tb00774.x; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Kafer J, 2007, P NATL ACAD SCI USA, V104, P18549, DOI 10.1073/pnas.0704235104; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Rosenblatt J, 2001, CURR BIOL, V11, P1847, DOI 10.1016/S0960-9822(01)00587-5; Steller H, 2008, CELL DEATH DIFFER, V15, P1132, DOI 10.1038/cdd.2008.50; Tamada M, 2007, J CELL BIOL, V176, P27, DOI 10.1083/jcb.200609116; Toyama Y, 2008, SCIENCE, V321, P1683, DOI 10.1126/science.1157052; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319	15	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1641	1642		10.1126/science.1164583	http://dx.doi.org/10.1126/science.1164583			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801987	Green Accepted			2022-12-28	WOS:000259300400021
J	Froese, DG; Westgate, JA; Reyes, AV; Enkin, RJ; Preece, SJ				Froese, Duane G.; Westgate, John A.; Reyes, Alberto V.; Enkin, Randolph J.; Preece, Shari J.			Ancient permafrost and a future, warmer arctic	SCIENCE			English	Article									[Froese, Duane G.; Reyes, Alberto V.] Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T5M 0M3, Canada; [Westgate, John A.; Preece, Shari J.] Univ Toronto, Dept Geol, Toronto, ON M5S 3B1, Canada; [Enkin, Randolph J.] Geol Survey Canada Pacific, Sidney, BC V8L 4B2, Canada	University of Alberta; University of Toronto; Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada	Froese, DG (corresponding author), Univ Alberta, Dept Earth & Atmospher Sci, Edmonton, AB T5M 0M3, Canada.	duane.froese@ualberta.ca	Froese, Duane G/B-6038-2009	Reyes, Alberto/0000-0002-7838-4214	Natural Sciences and Engineering Research Council of Canada; Alberta Ingenuity New Faculty Award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Ingenuity New Faculty Award	Funding provided by Natural Sciences and Engineering Research Council of Canada grants to D.G.F. and J.A.W. and by an Alberta Ingenuity New Faculty Award to D.G.F.	Burn CR, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027077; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Lawrence DM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL025080; Osterkamp TE, 2005, GLOBAL PLANET CHANGE, V49, P187, DOI 10.1016/j.gloplacha.2005.09.001; Overpeck JT, 2005, EOS, V86, P309, DOI [10.1029/2005EO340001, DOI 10.1029/2005EO340001]; Zimov SA, 2006, SCIENCE, V312, P1612, DOI 10.1126/science.1128908	6	98	99	1	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1648	1648		10.1126/science.1157525	http://dx.doi.org/10.1126/science.1157525			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801991				2022-12-28	WOS:000259300400025
J	Payne, DJ				Payne, David J.			Microbiology - Desperately seeking new antibiotics	SCIENCE			English	Editorial Material									[Payne, David J.] GlaxoSmithKline Inc, Antibacterial Dis Performance Unit, Infect Dis Ctr Excellence, Collegeville, PA 19426 USA	GlaxoSmithKline	Payne, DJ (corresponding author), GlaxoSmithKline Inc, Antibacterial Dis Performance Unit, Infect Dis Ctr Excellence, Collegeville, PA 19426 USA.	david.j.payne@gsk.com						Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Hiratsuka T, 2008, SCIENCE, V321, P1670, DOI 10.1126/science.1160446; KLEVENS RM, 2007, JAMA-J AM MED ASSOC, V17, P1763; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Rasko DA, 2008, SCIENCE, V321, P1078, DOI 10.1126/science.1160354; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Taubes G, 2008, SCIENCE, V321, P356, DOI 10.1126/science.321.5887.356; The Royal Society, 2008, INN MECH TACKL ANT R	8	136	150	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1644	1645		10.1126/science.1164586	http://dx.doi.org/10.1126/science.1164586			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801989				2022-12-28	WOS:000259300400023
J	Black, IH				Black, Ian H.			The war goes on	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ian.black@vtmednet.org							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1280	1280		10.1001/jama.300.11.1280	http://dx.doi.org/10.1001/jama.300.11.1280			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799431				2022-12-28	WOS:000259231100001
J	Newson, AJ; Sheather, J				Newson, Ainsley J.; Sheather, Julian			The view of the BMJ's ethics committee	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFORMED-CONSENT		[Newson, Ainsley J.] Univ Bristol, Ctr Eth Med, Bristol BS6 6AU, Avon, England; [Sheather, Julian] British Med Assoc, London, England	University of Bristol	Newson, AJ (corresponding author), Univ Bristol, Ctr Eth Med, Bristol BS6 6AU, Avon, England.	ainsley.newson@bristol.ac.uk	Newson, Ainsley/AAQ-9177-2021	Newson, Ainsley/0000-0002-3460-772X				Antommaria AHM, 2004, HASTINGS CENT REP, V34, P28, DOI 10.2307/3528417; Bevan JC, 2004, CAN J ANAESTH, V51, P861, DOI 10.1007/BF03018880; *GEN MED COUNC, CONF PROT PROV INF F; Isaacs David, 2008, BMJ, V337, pa1231, DOI 10.1136/bmj.a1231; Rogers WA, 2003, J MED ETHICS, V29, P220, DOI 10.1136/jme.29.4.220; Smith R, 1998, BMJ-BRIT MED J, V316, P949, DOI 10.1136/bmj.316.7136.949; Yentis SM, 2004, ANAESTHESIA, V59, P316, DOI 10.1111/j.1365-2044.2004.03749.x	7	7	7	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2008	337	7670							a1232	10.1136/bmj.a1232	http://dx.doi.org/10.1136/bmj.a1232			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354DT	18779220				2022-12-28	WOS:000259619800035
J	Rahman, A; Malik, A; Sikander, S; Roberts, C; Creed, F				Rahman, Atif; Malik, Abid; Sikander, Siham; Roberts, Christopher; Creed, Francis			Cognitive behaviour therapy-based intervention by community health workers for mothers with depression and their infants in rural Pakistan: a cluster-randomised controlled trial	LANCET			English	Article							GLOBAL MENTAL-HEALTH; LOW-INCOME; POSTNATAL DEPRESSION; MATERNAL DEPRESSION; NUTRITIONAL-STATUS; PRIMARY-CARE; RISK-FACTORS; DISORDERS; SCALE; PREVALENCE	Background The treatment of perinatal depression is a public-health priority because of its high prevalence and association with disability and poor infant development. We integrated a cognitive behaviour therapy-based intervention into the routine work of community-based primary health workers in rural Pakistan and assessed the effect of this intervention on maternal depression and infant outcomes. Methods We randomly assigned 40 Union Council clusters in rural Rawalpindi, Pakistan, in equal numbers to intervention or control. Married women (aged 16-45 years) in their third trimester of pregnancy with perinatal depression were eligible to participate. In the intervention group, primary health workers were trained to deliver the psychological intervention, whereas in the control group untrained health workers made an equal number of visits to the depressed mothers. The primary outcomes were infant weight and height at G months and 12 months, and secondary outcome was maternal depression. The interviewers were unaware of what group the participants were assigned to. Analysis was by intention to treat. The study is registered as ISRCTN65316374. Findings The number of clusters per group was 20, with 463 mothers in the intervention group and 440 in the control group. At 6 months, 97 (23%) of 418 and 211(53 %) of 400 mothers in the intervention and control groups, respectively, met the criteria for major depression (adjusted odds ratio (OR) 0 . 22, 95% CI 0 . 14 to 0 . 36, p<0 . 0001). These effects were sustained at 12 months (111/412 [27%] vs 226/386 [59%], adjusted OR 0 . 23, 95% CI 0 . 15 to 0 . 36, p<0 . 0001).The differences in weight-for-age and height-for-age Z scores for infants in the two groups were not significant at 6 months (-0 . 83 vs -0 . 86, p=0 . 7 and -2.03 vs -2.16, p=0 . 3, respectively) or 12 months (-0 . 64 vs -0 . 8, p=0 . 3 and -1 . 10 vs -1 . 36, p=0.07, respectively). Interpretation This psychological intervention delivered by community-based primary health workers has the potential to be integrated into health systems in resource-poor settings. Funding Wellcome Trust.	[Rahman, Atif] Univ Liverpool, Sch Populat Community & Behav Sci, Child Mental Hlth Unit, Alder Hey Childrens NHS Fdn Trust, Liverpool L12 2AP, Merseyside, England; [Malik, Abid; Sikander, Siham] Human Dev Res Fdn, Islamabad, Pakistan; [Malik, Abid] Univ Sheffield, Sch Med & Biomed Sci, Sheffield, S Yorkshire, England; [Roberts, Christopher] Univ Manchester, Dept Epidemiol & Biostat, Manchester, Lancs, England; [Creed, Francis] Univ Manchester, Sch Med, Psychiat Res Grp, Manchester, Lancs, England	Alder Hey Children's NHS Foundation Trust; University of Liverpool; University of Sheffield; University of Manchester; University of Manchester	Rahman, A (corresponding author), Univ Liverpool, Sch Populat Community & Behav Sci, Child Mental Hlth Unit, Alder Hey Childrens NHS Fdn Trust, Eaton Rd, Liverpool L12 2AP, Merseyside, England.	Atif.Rahman@liverpool.ac.uk			Wellcome Trust, UK; Wellcome Trust Tropical Centre at the Liverpool School of Tropical Medicine	Wellcome Trust, UK(Wellcome Trust); Wellcome Trust Tropical Centre at the Liverpool School of Tropical Medicine(Wellcome Trust)	The study was funded by the Wellcome Trust, UK, through a career development fellowship in tropical medicine awarded to AR. The fellowship was awarded through the Wellcome Trust Tropical Centre at the Liverpool School of Tropical Medicine and hosted by the University of Manchester and the Institute of Psychiatry, Rawalpindi. We would like to thank the Human Development Research Foundation, Islamabad for logistic assistance; the Ministry of Health, Government of Punjab, for their permission to do this study; Fareed Minhas at Rawalpindi for his unflinching support and encouragement; and Zaeem Haq for assistance with the development of training materials and supervision of the Lady Health Workers.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; [Anonymous], 1986, B WORLD HEALTH ORGAN, V64, P929; Bhutta ZA ., 2004, MATERN CHILD HLTH J, V1; Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Chisholm D, 2007, LANCET, V370, P1241, DOI 10.1016/S0140-6736(07)61242-2; Churchill R, 2001, Health Technol Assess, V5, P1; Gorman LL, 2004, BRIT J PSYCHIAT, V184, pS17, DOI 10.1192/bjp.184.46.s17; GORSTEIN J, 1994, B WORLD HEALTH ORGAN, V72, P273; *GOV PAK, 1999, DISTR CENS REP RAW 1; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Husain N, 2006, ARCH WOMEN MENT HLTH, V9, P197, DOI 10.1007/s00737-006-0129-9; Jacob KS, 2007, LANCET, V370, P1061, DOI 10.1016/S0140-6736(07)61241-0; Karim S, 2004, INT REV PSYCHIATR, V16, P83, DOI 10.1080/09540260310001635131; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; KOHN R, 2004, B WORLD HEALTH ORGAN, V82, P866; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; *MIN HLTH GOV PAK, 2007, NAT PROGR FAM PLANN; Mirza I, 2004, BMJ-BRIT MED J, V328, P794, DOI 10.1136/bmj.328.7443.794; Patel V, 2007, LANCET, V370, P991, DOI 10.1016/S0140-6736(07)61240-9; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2007, ARCH DIS CHILD, V92, P24, DOI 10.1136/adc.2005.086579; Rahman A, 2003, J Pak Med Assoc, V53, P142; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2007, J AFFECT DISORDERS, V100, P115, DOI 10.1016/j.jad.2006.10.004; Rojas G, 2007, LANCET, V370, P1629, DOI 10.1016/S0140-6736(07)61685-7; Saxena S, 2007, LANCET, V370, P878, DOI 10.1016/S0140-6736(07)61239-2; SPITZER R. L., 1994, STRUCTURED CLIN INTE; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; *WHO, 1995, TECHN REP SER WHO, V854; World Health Organization, 2007, COMM HLTH WORK WHAT; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	33	554	558	2	70	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					902	909		10.1016/S0140-6736(08)61400-2	http://dx.doi.org/10.1016/S0140-6736(08)61400-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790313	Green Published			2022-12-28	WOS:000259266900030
J	Jordens, R; Strohmaier, N; Gunther, K; Moritz, H; Esslinger, T				Joerdens, Robert; Strohmaier, Niels; Guenther, Kenneth; Moritz, Henning; Esslinger, Tilman			A Mott insulator of fermionic atoms in an optical lattice	NATURE			English	Article							GAS	Strong interactions between electrons in a solid material can lead to surprising properties. A prime example is the Mott insulator, in which suppression of conductivity occurs as a result of interactions rather than a filled Bloch band(1). Proximity to the Mott insulating phase in fermionic systems is the origin of many intriguing phenomena in condensed matter physics(2), most notably high- temperature superconductivity(3). The Hubbard model(4), which encompasses the essential physics of the Mott insulator, also applies to quantum gases trapped in an optical lattice(5,6). It is therefore now possible to access this regime with tools developed in atomic physics. However, an atomic Mott insulator has so far been realized only with a gas of bosons(7), which lack the rich and peculiar nature of fermions. Here we report the formation of a Mott insulator of a repulsively interacting two- component Fermi gas in an optical lattice. It is identified by three features: a drastic suppression of doubly occupied lattice sites, a strong reduction of the compressibility inferred from the response of double occupancy to an increase in atom number, and the appearance of a gapped mode in the excitation spectrum. Direct control of the interaction strength allows us to compare the Mott insulating regime and the non- interacting regime without changing tunnel- coupling or confinement. Our results pave the way for further studies of the Mott insulator, including spin- ordering and ultimately the question of d- wave superfluidity(6,8).	[Joerdens, Robert; Strohmaier, Niels; Guenther, Kenneth; Moritz, Henning; Esslinger, Tilman] ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Guenther, Kenneth] Ecole Normale Super, Lab Kastler Brossel, F-75005 Paris, France	Swiss Federal Institutes of Technology Domain; ETH Zurich; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS)	Moritz, H (corresponding author), ETH, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	moritz@phys.ethz.ch	Esslinger, Tilman/M-9022-2016; Günter, Kenneth J./A-9016-2010; Moritz, Henning/E-7919-2010; Jördens, Robert/F-1066-2010	Esslinger, Tilman/0000-0002-8333-107X; Günter, Kenneth J./0000-0002-6332-8340; Moritz, Henning/0000-0002-4854-5806; Jördens, Robert/0000-0001-5333-0562	Swiss National Science Foundation (SNF); EU projects Optical Lattices and Quantum Information (OLAQUI); Scalable Quantum Computing with Light and Atoms ( SCALA); Quantum Science and Technology (QSIT) project of ETH Zurich	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); EU projects Optical Lattices and Quantum Information (OLAQUI); Scalable Quantum Computing with Light and Atoms ( SCALA); Quantum Science and Technology (QSIT) project of ETH Zurich	We thank J. Blatter, S. Huber, M. Kohl, C. Kollath, L. Pollet, N. Prokof'ev, M. Rigol, M. Sigrist, M. Troyer and W. Zwerger for discussions. Funding was provided by the Swiss National Science Foundation (SNF), the EU projects Optical Lattices and Quantum Information (OLAQUI) and Scalable Quantum Computing with Light and Atoms ( SCALA) and the Quantum Science and Technology (QSIT) project of ETH Zurich.	Bloch I, 2008, REV MOD PHYS, V80, P885, DOI 10.1103/RevModPhys.80.885; BRINKMAN WF, 1970, PHYS REV B-SOLID ST, V2, P1324, DOI 10.1103/PhysRevB.2.1324; Chin JK, 2006, NATURE, V443, P961, DOI 10.1038/nature05224; Gebhard F., 1997, MOTT METAL INSULATOR; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; Georges A., 2007, ULTRACOLD FERMI GASE, P477; Gerbier F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090401; Gerbier F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.120405; GIORGINI L, 2007, THEORY ULTRACOLD FER; Helmes RW, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056403; Hofstetter W, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.220407; HUBBARD J, 1963, PROC R SOC LON SER-A, V276, P238, DOI 10.1098/rspa.1963.0204; Huber SD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.050404; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Kohl M, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.031601; Kohl M, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.080403; Kollath C, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.041604; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Mott N.F., 1990, METAL INSULATOR TRAN; Regal CA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.230404; Rigol M, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130403; Stoferle T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.030401; Stoferle T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.130403; Strohmaier N, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.220601; Trebst S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.250402	28	790	792	0	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					204	U34		10.1038/nature07244	http://dx.doi.org/10.1038/nature07244			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784720	Green Submitted			2022-12-28	WOS:000259090800042
J	Arora, VM; Georgitis, E; Siddique, J; Vekhter, B; Woodruff, JN; Humphrey, HJ; Meltzer, DO				Arora, Vineet M.; Georgitis, Emily; Siddique, Juned; Vekhter, Ben; Woodruff, James N.; Humphrey, Holly J.; Meltzer, David O.			Association of workload of on-call medical interns with on-call sleep duration, shift duration, and participation in educational activities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RESIDENT DUTY HOURS; HOUR REGULATIONS; DELICATE BALANCE; PATIENT-CARE; TIME; ACTIGRAPHY; OUTCOMES; SERVICE; RISK; MORTALITY	Context Further restrictions in resident duty hours are being considered, and it is important to understand the association between workload, sleep loss, shift duration, and the educational time of on-call medical interns. Objective To assess whether increased on- call intern workload, as measured by the number of new admissions on- call and the number of previously admitted patients remaining on the service, was associated with reductions in on- call sleep, increased total shift duration, and lower likelihood of participation in educational activities. Design, Setting, and Participants Prospective cohort study of medical interns at a single US academic medical center from July 1, 2003, through June 24, 2005. Of the 81 interns, 56 participated ( 69%), for a total of 165 general medicine inpatient months resulting in 1100 call nights. Main Outcome Measures On- call sleep duration, estimated by wrist watch actigraphy; total shift duration, measured from paging logs; and participation in educational activities ( didactic lectures or bedside teaching), measured by experience sampling method via a personal digital assistant. Results Mean ( SD) sleep duration on- call was 2.8 ( 1.5) hours and mean ( SD) shift duration was 29.9 ( 1.7) hours. Interns reported spending 11% of their time in educational activities. Early in the academic year ( July to October), each new on- call admission was associated with less sleep (- 10.5 minutes [ 95% confidence interval {CI}, - 16.8 to - 4.2 minutes]; P <. 001) and a longer shift duration ( 13.2 minutes [ 95% CI, 3.2- 23.3 minutes]; P=. 01). A higher number of previously admitted patients remaining on the service was associated with a lower odds of participation in educational activities ( odds ratio, 0.82 [ 95% CI, 0.70- 0.96]; P=. 01]. Call nights during the week and early in the academic year were associated with the most sleep loss and longest shift durations. Conclusion In this study population, increased on- call workload was associated with more sleep loss, longer shift duration, and a lower likelihood of participation in educational activities.	[Arora, Vineet M.; Georgitis, Emily; Vekhter, Ben; Woodruff, James N.; Humphrey, Holly J.; Meltzer, David O.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Siddique, Juned] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Meltzer, David O.] Univ Chicago, Dept Econ & Publ Policy Studies, Chicago, IL 60637 USA; [Arora, Vineet M.; Humphrey, Holly J.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Arora, VM (corresponding author), 5841 S Maryland Ave,MC 2007,AMB B217, Chicago, IL 60637 USA.	varora@medicine.bsd.uchicago.edu	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393; Arora, Vineet/0000-0002-4745-7599	Department of Medicine, Pritzker School of Medicine, University of Chicago	Department of Medicine, Pritzker School of Medicine, University of Chicago(University of Chicago)	This study was funded by the Department of Medicine, Pritzker School of Medicine, University of Chicago.	*ACCR COUNC GRAD M, ACGME PROGR REQ RES; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; [Anonymous], 2006, SAS MIXED MODELS; Arora V, 2006, ANN INTERN MED, V144, P792, DOI 10.7326/0003-4819-144-11-200606060-00005; Ayas NT, 2006, JAMA-J AM MED ASSOC, V296, P1055, DOI 10.1001/jama.296.9.1055; Barger LK, 2005, NEW ENGL J MED, V352, P125, DOI 10.1056/NEJMoa041401; BELLINI LM, APDIM LEARNING ENV T; Dawson D, 2005, JAMA-J AM MED ASSOC, V294, P1104, DOI 10.1001/jama.294.9.1104; Dresselhaus TR, 1998, J GEN INTERN MED, V13, P534, DOI 10.1046/j.1525-1497.1998.00164.x; GUARISCO S, 1994, J GEN INTERN MED, V9, P272, DOI 10.1007/BF02599655; HEDEKER D, 2006, LONGITUDINAL DATA AN; Hektner JM, 2007, EXPERIENCE SAMPLING; Horwitz LI, 2007, ANN INTERN MED, V147, P97, DOI 10.7326/0003-4819-147-2-200707170-00163; *I MED, OPT GRAD MED TRAIN R; Landrigan CP, 2006, JAMA-J AM MED ASSOC, V296, P1063, DOI 10.1001/jama.296.9.1063; Lockley SW, 2007, JT COMM J QUAL PATIE, V33, P7, DOI 10.1016/S1553-7250(07)33109-7; Lockley SW, 2004, NEW ENGL J MED, V351, P1829, DOI 10.1056/NEJMoa041404; LOFGREN RP, 1990, J GEN INTERN MED, V5, P501, DOI 10.1007/BF02600880; LURIE N, 1989, NEW ENGL J MED, V320, P1673, DOI 10.1056/NEJM198906223202507; Meltzer D, 2002, ANN INTERN MED, V137, P866, DOI 10.7326/0003-4819-137-11-200212030-00007; Myers JS, 2006, ACAD MED, V81, P1052, DOI 10.1097/01.ACM.0000246687.03462.59; Okie S, 2007, NEW ENGL J MED, V356, P2665, DOI 10.1056/NEJMp078085; Ong M, 2007, ARCH INTERN MED, V167, P47, DOI 10.1001/archinte.167.1.47; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Reed DA, 2007, ARCH INTERN MED, V167, P1487, DOI 10.1001/archinte.167.14.1487; Reid K, 1999, SLEEP, V22, P378, DOI 10.1093/sleep/22.3.378; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sadeh A, 2002, SLEEP MED REV, V6, P113, DOI 10.1053/smrv.2001.0182; SADEH A, 1994, SLEEP, V17, P201, DOI 10.1093/sleep/17.3.201; SADEH A, 1995, SLEEP, V18, P288, DOI 10.1093/sleep/18.4.288; Schafer JL., 1997, ANAL INCOMPLETE MULT, DOI 10.1201/9781439821862; Schuberth JL, 2008, CIRCULATION, V117, P2637, DOI 10.1161/CIRCULATIONAHA.107.740357; Shetty KD, 2007, ANN INTERN MED, V147, P73, DOI 10.7326/0003-4819-147-2-200707170-00161; Volpp KG, 2008, CIRCULATION, V117, P2580, DOI 10.1161/CIRCULATIONAHA.108.777508; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Wayne DB, 2008, J GEN INTERN MED, V23, P1120, DOI 10.1007/s11606-008-0671-4; Wilde G J, 1998, Inj Prev, V4, P89	37	84	85	0	9	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1146	1153		10.1001/jama.300.10.1146	http://dx.doi.org/10.1001/jama.300.10.1146			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780843	Bronze			2022-12-28	WOS:000259038700007
J	Sacco, A; Doyonnas, R; Kraft, P; Vitorovic, S; Blau, HM				Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M.			Self-renewal and expansion of single transplanted muscle stem cells	NATURE			English	Article							SKELETAL-MUSCLE; SATELLITE CELLS; MYOBLASTS; FATE; RECONSTITUTION; HETEROGENEITY; EXPRESSION	Adult muscle satellite cells have a principal role in postnatal skeletal muscle growth and regeneration(1). Satellite cells reside as quiescent cells underneath the basal lamina that surrounds muscle fibres(2) and respond to damage by giving rise to transient amplifying cells ( progenitors) and myoblasts that fuse with myofibres. Recent experiments showed that, in contrast to cultured myoblasts, satellite cells freshly isolated(3-5) or satellite cells derived from the transplantation of one intact myofibre(6) contribute robustly to muscle repair. However, because satellite cells are known to be heterogeneous(4,6,7), clonal analysis is required to demonstrate stem cell function. Here we show that when a single luciferase- expressing muscle stem cell is transplanted into the muscle of mice it is capable of extensive proliferation, contributes to muscle fibres, and Pax7(+) luciferase(+) mononucleated cells can be readily re- isolated, providing evidence of muscle stem cell self- renewal. In addition, we show using in vivo bioluminescence imaging that the dynamics of muscle stem cell behaviour during muscle repair can be followed in a manner not possible using traditional retrospective histological analyses. By imaging luciferase activity, real- time quantitative and kinetic analyses show that donor- derived muscle stem cells proliferate and engraft rapidly after injection until homeostasis is reached. On injury, donor- derived mononucleated cells generate massive waves of cell proliferation. Together, these results show that the progeny of a single luciferase- expressing muscle stem cell can both self- renew and differentiate after transplantation in mice, providing new evidence at the clonal level that self- renewal is an autonomous property of a single adult muscle stem cell.	[Sacco, Alessandra; Doyonnas, Regis; Kraft, Peggy; Vitorovic, Stefan; Blau, Helen M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol,Stem Cell Inst, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Baxter Lab Genet Pharmacol,Stem Cell Inst, Stanford, CA 94305 USA.	hblau@stanford.edu		Doyonnas, Regis/0000-0002-3818-0807	NIH [AG009521, AG024987]; Baxter Foundation; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG024987, R01AG020961, R01AG009521] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Alkan for developing the single cell RT-PCR protocol, K. Koleckar, M. Pajcini and T. Doyle for technical support, T. Brazelton, F. Rossi and S. Corbel for comments on the manuscript, J. Ramunas for statistical analysis, and M. Lutolf and P. Gilbert for fabricating the hydrogel microwells. We also thank F. Rossi for providing the integrin-alpha<INF>7</INF>-PE- conjugated antibody, and C. Contag for providing the FLuc mice. This work was supported by NIH grants AG009521, AG024987 and by the Baxter Foundation.	Barberi T, 2007, NAT MED, V13, P642, DOI 10.1038/nm1533; BLAU HM, 1990, ADV EXP MED BIOL, V280, P201; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Cao YA, 2004, P NATL ACAD SCI USA, V101, P221, DOI 10.1073/pnas.2637010100; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Heslop L, 2000, J CELL SCI, V113, P2299; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; RANDO TA, 1995, EXP CELL RES, V220, P383, DOI 10.1006/excr.1995.1329; Sacco A, 2005, J CELL BIOL, V171, P483, DOI 10.1083/jcb.200506123; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; Tajbakhsh S, 1996, DEV DYNAM, V206, P291, DOI 10.1002/(SICI)1097-0177(199607)206:3<291::AID-AJA6>3.0.CO;2-D; WAKEFORD S, 1991, MUSCLE NERVE, V14, P42, DOI 10.1002/mus.880140108; Wehrman TS, 2006, NAT METHODS, V3, P295, DOI 10.1038/NMETH868; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zammit PS, 2002, EXP CELL RES, V281, P39, DOI 10.1006/excr.2002.5653	26	593	635	7	89	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	NOV 27	2008	456	7221					502	506		10.1038/nature07384	http://dx.doi.org/10.1038/nature07384			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	376FW	18806774	Green Accepted			2022-12-28	WOS:000261170500038
J	Grimson, A; Srivastava, M; Fahey, B; Woodcroft, BJ; Chiang, HR; King, N; Degnan, BM; Rokhsar, DS; Bartel, DP				Grimson, Andrew; Srivastava, Mansi; Fahey, Bryony; Woodcroft, Ben J.; Chiang, H. Rosaria; King, Nicole; Degnan, Bernard M.; Rokhsar, Daniel S.; Bartel, David P.			Early origins and evolution of microRNAs and Piwi-interacting RNAs in animals	NATURE			English	Article							EXPRESSION; GENOME; MECHANISM; EXPANSION; REVEALS; BIOGENESIS; COMPLEX; SIRNAS	In bilaterian animals, such as humans, flies and worms, hundreds of microRNAs ( miRNAs), some conserved throughout bilaterian evolution, collectively regulate a substantial fraction of the transcriptome. In addition to miRNAs, other bilaterian small RNAs, known as Piwi- interacting RNAs (piRNAs), protect the genome from transposons. Here we identify small RNAs from animal phyla that diverged before the emergence of the Bilateria. The cnidarian Nematostella vectensis ( starlet sea anemone), a close relative to the Bilateria, possesses an extensive repertoire of miRNA genes, two classes of piRNAs and a complement of proteins specific to small- RNA biology comparable to that of humans. The poriferan Amphimedon queenslandica ( sponge), one of the simplest animals and a distant relative of the Bilateria, also possesses miRNAs, both classes of piRNAs and a full complement of the small- RNA machinery. Animal miRNA evolution seems to have been relatively dynamic, with precursor sizes and mature miRNA sequences differing greatly between poriferans, cnidarians and bilaterians. Nonetheless, miRNAs and piRNAs have been available as classes of riboregulators to shape gene expression throughout the evolution and radiation of animal phyla.	[Grimson, Andrew; Chiang, H. Rosaria; Bartel, David P.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Grimson, Andrew; Chiang, H. Rosaria; Bartel, David P.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Fahey, Bryony; Woodcroft, Ben J.; Degnan, Bernard M.] Univ Queensland, Sch Integrat Biol, Brisbane, Qld 4072, Australia; [Srivastava, Mansi; King, Nicole; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Srivastava, Mansi; King, Nicole; Rokhsar, Daniel S.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Rokhsar, Daniel S.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); University of Queensland; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI	Bartel, DP (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dbartel@wi.mit.edu		Rokhsar, Daniel/0000-0002-8704-2224; Degnan, Bernard/0000-0001-7573-8518; Woodcroft, Ben/0000-0003-0670-7480	NIH postdoctoral fellowship; NIH; Center for Integrative Genomics; Gordon and Betty Moore Foundation; Australian Research Council; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067031] Funding Source: NIH RePORTER	NIH postdoctoral fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integrative Genomics; Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Australian Research Council(Australian Research Council); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Abedin and E. Begovic for preparing the Monosiga and Trichoplax samples, respectively, W. Johnston for technical assistance, and J. Grenier, C. Mayr, C. Jan and N. Lau for discussions. This work was supported by an NIH postdoctoral fellowship (A.G.), and by grants from the NIH (D.P.B.), Richard Melmon (M.S., N.K. and D.S.R.), the Center for Integrative Genomics (M.S. and D.S.R.), the Gordon and Betty Moore Foundation (N.K.) and the Australian Research Council (B.F., B.J.W. and B.M.D.). D.P.B. is an investigator of the Howard Hughes Medical Institute.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bourlat SJ, 2008, MOL PHYLOGENET EVOL, V49, P23, DOI 10.1016/j.ympev.2008.07.008; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Cerutti H, 2006, CURR GENET, V50, P81, DOI 10.1007/s00294-006-0078-x; Chen K, 2006, COLD SPRING HARB SYM, V71, P149, DOI 10.1101/sqb.2006.71.039; ENGLAND TE, 1977, P NATL ACAD SCI USA, V74, P4839, DOI 10.1073/pnas.74.11.4839; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494; Hertel J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-25; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; KEMPER B, 1976, NATURE, V262, P321, DOI 10.1038/262321a0; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Larroux C, 2008, MOL BIOL EVOL, V25, P980, DOI 10.1093/molbev/msn047; Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Yao MC, 2005, ANNU REV GENET, V39, P537, DOI 10.1146/annurev.genet.39.073003.095906; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	35	485	562	4	81	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1193	U15		10.1038/nature07415	http://dx.doi.org/10.1038/nature07415			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18830242	Green Accepted			2022-12-28	WOS:000260462100034
J	Tang, CB; Lennon, EM; Fredrickson, GH; Kramer, EJ; Hawker, CJ				Tang, Chuanbing; Lennon, Erin M.; Fredrickson, Glenn H.; Kramer, Edward J.; Hawker, Craig J.			Evolution of block copolymer lithography to highly ordered square arrays	SCIENCE			English	Article							DIBLOCK COPOLYMERS; BINARY BLENDS	The manufacture of smaller, faster, more efficient microelectronic components is a major scientific and technological challenge, driven in part by a constant need for smaller lithographically defined features and patterns. Traditional self-assembling approaches based on block copolymer lithography spontaneously yield nanometer-sized hexagonal structures, but these features are not consistent with the industry-standard rectilinear coordinate system. We present a modular and hierarchical self-assembly strategy, combining supramolecular assembly of hydrogen-bonding units with controlled phase separation of diblock copolymers, for the generation of nanoscale square patterns. These square arrays will enable simplified addressability and circuit interconnection in integrated circuit manufacturing and nanotechnology.	[Tang, Chuanbing; Lennon, Erin M.; Fredrickson, Glenn H.; Kramer, Edward J.; Hawker, Craig J.] Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA; [Lennon, Erin M.; Fredrickson, Glenn H.; Kramer, Edward J.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA; [Fredrickson, Glenn H.; Kramer, Edward J.; Hawker, Craig J.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA; [Hawker, Craig J.] Univ Calif Santa Barbara, Dept Chem & Biochem, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Fredrickson, GH (corresponding author), Univ Calif Santa Barbara, Mat Res Lab, Santa Barbara, CA 93106 USA.	ghf@mrl.ucsb.edu; edkramer@mrl.ucsb.edu; hawker@mrl.ucsb.edu	Tang, Chuanbing/AAY-4975-2020; Hawker, Craig J/G-4971-2011	Tang, Chuanbing/0000-0002-0242-8241; Hawker, Craig J/0000-0001-9951-851X	Nanoelectronics Research Initiative [1549 (SRC/NRI)]; Focus Center Research Program (FCRP) Center on Functional Engineered Nano Architectonics; NSF [UCSB MRL, DMR-0520415]	Nanoelectronics Research Initiative; Focus Center Research Program (FCRP) Center on Functional Engineered Nano Architectonics; NSF(National Science Foundation (NSF))	We thank E. Pressly and M. Dimitriou for synthesis assistance. Supported by the Nanoelectronics Research Initiative under contract RID#1549 (SRC/NRI), the Focus Center Research Program (FCRP) Center on Functional Engineered Nano Architectonics, and NSF under the Materials Research Science and Engineering Center program (UCSB MRL, DMR-0520415).	Abetz V, 2000, MACROMOL RAPID COMM, V21, P16, DOI 10.1002/(SICI)1521-3927(20000101)21:1<16::AID-MARC16>3.3.CO;2-J; Asari T, 2005, MACROMOLECULES, V38, P8811, DOI 10.1021/ma051156s; Bang J, 2007, MACROMOLECULES, V40, P7019, DOI 10.1021/ma0710737; Bang J, 2006, J AM CHEM SOC, V128, P7622, DOI 10.1021/ja0608141; Black CT, 2001, APPL PHYS LETT, V79, P409, DOI 10.1063/1.1383805; Cheng JY, 2006, ADV MATER, V18, P2505, DOI 10.1002/adma.200502651; Cheng JY, 2002, APPL PHYS LETT, V81, P3657, DOI 10.1063/1.1519356; Frielinghaus H, 2001, MACROMOLECULES, V34, P4907, DOI 10.1021/ma010233q; HAMM S, BUSINESSWEEK ONLINE; Hoogenboom R, 2008, CHEM COMMUN, P155, DOI 10.1039/b706855g; Ikkala O, 2004, CHEM COMMUN, P2131, DOI 10.1039/b403983a; Jeon HG, 1999, MACROMOLECULES, V32, P1803, DOI 10.1021/ma9816665; Kim SH, 2004, ADV MATER, V16, P226, DOI 10.1002/adma.200304906; Kim SO, 2003, NATURE, V424, P411, DOI 10.1038/nature01775; Kimishima I, 1999, MACROMOLECULES, V32, P2585; MAISEN MW, 1998, J CHEM PHYS, V108, P785; Mansky P, 1997, SCIENCE, V275, P1458, DOI 10.1126/science.275.5305.1458; Mao HM, 2005, FARADAY DISCUSS, V128, P149, DOI 10.1039/b403217a; MOGI Y, 1994, MACROMOLECULES, V27, P6755, DOI 10.1021/ma00101a013; MOGI Y, 1992, MACROMOLECULES, V25, P5408, DOI 10.1021/ma00046a043; Olmsted PD, 1999, EUROPHYS LETT, V45, P83, DOI 10.1209/epl/i1999-00135-4; Park M, 1997, SCIENCE, V276, P1401, DOI 10.1126/science.276.5317.1401; Park SM, 2007, MACROMOLECULES, V40, P5084, DOI 10.1021/ma0702344; Ryu DY, 2005, SCIENCE, V308, P236, DOI 10.1126/science.1106604; Segalman RA, 2005, MAT SCI ENG R, V48, P191, DOI 10.1016/j.mser.2004.12.003; Segalman RA, 2001, ADV MATER, V13, P1152, DOI 10.1002/1521-4095(200108)13:15<1152::AID-ADMA1152>3.0.CO;2-5; Skotnicki T, 2005, IEEE CIRCUITS DEVICE, V21, P16, DOI 10.1109/MCD.2005.1388765; Tang CB, 2008, MACROMOLECULES, V41, P4328, DOI 10.1021/ma800207n; Vaidya NY, 2000, MACROMOLECULES, V33, P3009, DOI 10.1021/ma9918755	29	545	574	6	339	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					429	432		10.1126/science.1162950	http://dx.doi.org/10.1126/science.1162950			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18818367				2022-12-28	WOS:000260094500043
J	Kritcher, AL; Neumayer, P; Castor, J; Doppner, T; Falcone, RW; Landen, OL; Lee, HJ; Lee, RW; Morse, EC; Ng, A; Pollaine, S; Price, D; Glenzer, SH				Kritcher, Andrea L.; Neumayer, Paul; Castor, John; Doppner, Tilo; Falcone, Roger W.; Landen, Otto L.; Lee, Hae Ja; Lee, Richard W.; Morse, Edward C.; Ng, Andrew; Pollaine, Steve; Price, Dwight; Glenzer, Siegfried H.			Ultrafast x-ray Thomson scattering of shock-compressed matter	SCIENCE			English	Article							NATIONAL-IGNITION-FACILITY; EQUATION-OF-STATE; TEMPERATURE; DEUTERIUM; LASER	Spectrally resolved scattering of ultrafast K-alpha x- rays has provided experimental validation of the modeling of the compression and heating of shocked matter. The elastic scattering component has characterized the evolution and coalescence of two shocks launched by a nanosecond laser pulse into lithium hydride with an unprecedented temporal resolution of 10 picoseconds. At shock coalescence, we observed rapid heating to temperatures of 25,000 kelvin when the scattering spectra show the collective plasmon oscillations that indicate the transition to the dense metallic plasma state. The plasmon frequency determines the material compression, which is found to be a factor of 3, thereby reaching conditions in the laboratory relevant for studying the physics of planetary formation.	[Kritcher, Andrea L.; Morse, Edward C.] Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94709 USA; [Kritcher, Andrea L.; Neumayer, Paul; Castor, John; Doppner, Tilo; Landen, Otto L.; Lee, Richard W.; Ng, Andrew; Pollaine, Steve; Price, Dwight; Glenzer, Siegfried H.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Falcone, Roger W.; Lee, Hae Ja; Lee, Richard W.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94709 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Berkeley	Kritcher, AL (corresponding author), Univ Calif Berkeley, Dept Nucl Engn, Berkeley, CA 94709 USA.	kritcher@berkeley.edu	Landen, Otto/AEX-9890-2022; Doeppner, Tilo/M-7435-2017	Landen, Otto/0000-0002-1499-8217; 	DOE grant; NA-16 Intermediate Facility Initiative [08-ERI-002, grant 08-LW-004]; Lawrence Scholar Program fellowship	DOE grant(United States Department of Energy (DOE)); NA-16 Intermediate Facility Initiative; Lawrence Scholar Program fellowship	This work was performed under the auspices of the U. S. Department of Energy ( DOE) by Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344. This work was further supported by a DOE grant, the NA-16 Intermediate Facility Initiative, grant 08-ERI-002, grant 08-LW-004, and the Lawrence Scholar Program fellowship.	Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; Akre R, 2008, PHYS REV SPEC TOP-AC, V11, DOI 10.1103/PhysRevSTAB.11.030703; BOHM D, 1949, PHYS REV, V75, P1851, DOI 10.1103/PhysRev.75.1851; Chen H, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.056402; Collins GW, 1998, SCIENCE, V281, P1178, DOI 10.1126/science.281.5380.1178; Connolly HC, 1998, SCIENCE, V280, P62, DOI 10.1126/science.280.5360.62; CROCKETT S, 2006, LAUR068403 LS AL NAT; Glenzer SH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.065002; Gregori G, 2007, HIGH ENERG DENS PHYS, V3, P99, DOI 10.1016/j.hedp.2007.02.006; Guillot T, 1999, SCIENCE, V286, P72, DOI 10.1126/science.286.5437.72; Holmes NC, 1995, PHYS REV B, V52, P15835, DOI 10.1103/PhysRevB.52.15835; ICHIMARU S, 1982, REV MOD PHYS, V54, P1017, DOI 10.1103/RevModPhys.54.1017; Knudson MD, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.225501; Landen OL, 2001, REV SCI INSTRUM, V72, P627, DOI 10.1063/1.1315641; LIEBERMAN DA, 1979, PHYS REV B, V20, P4798; Lindl JD, 2004, PHYS PLASMAS, V11, P339, DOI 10.1063/1.1578638; MacFarlane JJ, 2006, J QUANT SPECTROSC RA, V99, P381, DOI 10.1016/j.jqsrt.2005.05.031; McKay CP, 1997, SCIENCE, V276, P390, DOI 10.1126/science.276.5311.390; MORE RM, 1988, PHYS FLUIDS, V31, P3059, DOI 10.1063/1.866963; Moses EI, 2005, FUSION SCI TECHNOL, V47, P314, DOI 10.13182/FST47-314; Ogitsu T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.175502; SHEFFIELD J, 1975, PLASMA SCATTERING EL; STUART BC, 2006, C LAS EL IEEE LEOS L, P56; Tonks L, 1929, PHYS REV, V33, P195, DOI 10.1103/PhysRev.33.195; Wang Y, 2003, PHYS STATUS SOLIDI B, V235, P470, DOI 10.1002/pssb.200301604; Yu W, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/8/086209	26	162	165	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					69	71		10.1126/science.1161466	http://dx.doi.org/10.1126/science.1161466			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832640				2022-12-28	WOS:000259680200037
J	Mauri, L; Silbaugh, TS; Garg, P; Wolf, RE; Zelevinsky, K; Lovett, A; Varma, MR; Zhou, Z; Normand, SLT				Mauri, Laura; Silbaugh, Treacy S.; Garg, Pallav; Wolf, Robert E.; Zelevinsky, Katya; Lovett, Ann; Varma, Manu R.; Zhou, Zheng; Normand, Sharon-Lise T.			Drug-eluting or bare-metal stents for acute myocardial infarction	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ST-SEGMENT ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; RANDOMIZED-TRIALS; UNCOATED STENTS; THERAPY; ARTERY; METAANALYSIS; THROMBOSIS; ROUTINE; CLOPIDOGREL	Background: Studies comparing percutaneous coronary intervention (PCI) with drug-eluting and bare-metal coronary stents in acute myocardial infarction have been limited in size and duration. Methods: We identified all adults undergoing PCI with stenting for acute myocardial infarction between April 1, 2003, and September 30, 2004, at any acute care, nonfederal hospital in Massachusetts with the use of a state-mandated database of PCI procedures. We performed propensity-score matching on three groups of patients: all patients with acute myocardial infarction, all those with acute myocardial infarction with ST-segment elevation, and all those with acute myocardial infarction without ST-segment elevation. Propensity-score analyses were based on clinical, procedural, hospital, and insurance information collected at the time of the index procedure. Differences in the risk of death between patients receiving drug-eluting stents and those receiving bare-metal stents were determined from vital-statistics records. Results: A total of 7217 patients were treated for acute myocardial infarction (4016 with drug-eluting stents and 3201 with bare-metal stents). According to analysis of matched pairs, the 2-year, risk-adjusted mortality rates were lower for drug-eluting stents than for bare-metal stents among all patients with myocardial infarction (10.7% vs. 12.8%, P=0.02), among patients with myocardial infarction with ST-segment elevation (8.5% vs. 11.6%, P=0.008), and among patients with myocardial infarction without ST-segment elevation (12.8% vs. 15.6%, P=0.04). The 2-year, risk-adjusted rates of recurrent myocardial infarction were reduced in patients with myocardial infarction without ST-segment elevation who were treated with drug-eluting stents, and repeat revascularization rates were significantly reduced with the use of drug-eluting stents as compared with bare-metal stents in all groups. Conclusions: In patients presenting with acute myocardial infarction, treatment with drug-eluting stents is associated with decreased 2-year mortality rates and a reduction in the need for repeat revascularization procedures as compared with treatment with bare-metal stents.	[Mauri, Laura; Garg, Pallav; Varma, Manu R.; Zhou, Zheng] Brigham & Womens Hosp, Boston, MA 02115 USA; [Mauri, Laura] Harvard Univ, Clin Res Inst, Boston, MA 02115 USA; [Mauri, Laura; Silbaugh, Treacy S.; Wolf, Robert E.; Zelevinsky, Katya; Lovett, Ann; Normand, Sharon-Lise T.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Normand, Sharon-Lise T.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Mauri, L (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	lmauri1@partners.org	Garg, Pallav/G-3296-2011; mauri, laura/GPS-4868-2022	Garg, Pallav/0000-0001-9343-1763; Normand, Sharon-Lise/0000-0001-7027-4769	Massachusetts Department of Public Health [620022A4PRE]; Medtronic Vascular; Abbott Vascular; Boston Scientific; Cordis	Massachusetts Department of Public Health; Medtronic Vascular; Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific); Cordis	Supported by a Massachusetts Department of Public Health contract (620022A4PRE) with Dr. Normand, Ms. Lovett, Ms. Silbaugh, Ms. Zelevinsky, and Mr. Wolf. Dr. Mauri reports receiving lecture fees from Medtronic Vascular, Abbott Vascular, Boston Scientific, and Cordis. No other potential conflict of interest relevant to this article was reported. We thank Paul Dreyer, Ph. D., of the Massachusetts Department of Public Health and Kurt Barringhaus, M.D., Clifford J. Berger, M.D., David Cohen, M.D., Angela Corey, Jean Crossman, R. N., Daniel Fisher, M.D., Joseph Garasic, M. D., Jean-Pierre Geagea, M.D., Gregory Giugliano, M.D., Kalon Ho, M.D., Alice Jacobs, M.D., James Kirshenbaum, M.D., Josh Krasnow, M.D., Anthony Marks, M.D., Theo E. Meyer, M.D., Ph. D., Kathy Minahan, R.N., Zoran Nedelijkovic, M.D., Barbara Oxley, R.N., Thomas C. Piemonte, M.D., Kenneth Rosenfield, M.D., Pinak B. Shah, M.D., Samuel J. Shubrooks, Jr., M.D., James Waters, M.D., and Bonnie Weiner, M.D., of the Massachusetts Data Analysis Center PCI Data Adjudication Committee for their assistance; and the Division of Health Care Finance and Policy of the Commonwealth of Massachusetts for providing the billing data.	Abbott JD, 2007, J AM COLL CARDIOL, V50, P2029, DOI 10.1016/j.jacc.2007.07.071; Bavry AA, 2004, AM J CARDIOL, V93, P830, DOI 10.1016/j.amjcard.2003.12.019; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Chen MS, 2006, AM HEART J, V151, P1260, DOI 10.1016/j.ahj.2005.08.011; Cohen J., 1988, J AM STAT ASSOC, V2nd, DOI [DOI 10.2307/2290095, 10.1016/B978-0-12-179060-8.50007-4, DOI 10.1016/B978-0-12-179060-8.50007-4]; Cook S, 2007, CIRCULATION, V115, P2426, DOI 10.1161/CIRCULATIONAHA.106.658237; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Doyle B, 2007, CIRCULATION, V116, P2391, DOI 10.1161/CIRCULATIONAHA.107.707331; Grines CL, 2007, CIRCULATION, V115, P813, DOI 10.1161/CIRCULATIONAHA.106.180944; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Laarman GJ, 2006, NEW ENGL J MED, V355, P1105, DOI 10.1056/NEJMoa062598; Lemos PA, 2004, J AM COLL CARDIOL, V43, P704, DOI 10.1016/j.jacc.2003.12.022; MAURI L, IN PRESS CIRCULATION; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P2908, DOI 10.1001/jama.293.23.2908; Menichelli M, 2007, J AM COLL CARDIOL, V49, P1924, DOI 10.1016/j.jacc.2007.01.081; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008; Sianos G, 2007, J AM COLL CARDIOL, V50, P573, DOI 10.1016/j.jacc.2007.04.059; Slottow TLP, 2008, CARDIOVASC REVASCULA, V9, P24, DOI 10.1016/j.carrev.2007.06.002; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; STEG PG, 2007, EUR SOC CARD WORLD C; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; STONE GW, 2007, 19 ANNTRANSC CARD TH; Tu JV, 2007, NEW ENGL J MED, V357, P1393, DOI 10.1056/NEJMoa071076; Valgimigli M, 2005, JAMA-J AM MED ASSOC, V293, P2109, DOI 10.1001/jama.293.17.2109; van der Hoeven BL, 2008, J AM COLL CARDIOL, V51, P618, DOI 10.1016/j.jacc.2007.09.056	30	188	196	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1330	1342		10.1056/NEJMoa0801485	http://dx.doi.org/10.1056/NEJMoa0801485			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815397				2022-12-28	WOS:000259440900004
J	Chiaramonte, D				Chiaramonte, Delia			Who's afraid of the empowered patient?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dc@insightmedicalconsultants.com							0	7	7	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1393	1394		10.1001/jama.300.12.1393	http://dx.doi.org/10.1001/jama.300.12.1393			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812523				2022-12-28	WOS:000259410400001
J	Iglehart, JK				Iglehart, John K.			No place like home - Testing a new model of care delivery	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		*AM AC FAM PHYS, 2008 STAT MED HOM LE; *AM AC FAM PHYS, 2007, PAT CTR MED HOM HIST; American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; Hackbarth G, 2008, NEW ENGL J MED, V359, P3, DOI 10.1056/NEJMp0803749; *MED PAYM ADV COMM, 2008, REF DEL SYST	5	67	68	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1200	1202		10.1056/NEJMp0805225	http://dx.doi.org/10.1056/NEJMp0805225			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349DV	18799555				2022-12-28	WOS:000259259900002
J	Lee, TA; Pickard, AS; Au, DH; Bartle, B; Weiss, KB				Lee, Todd A.; Pickard, A. Simon; Au, David H.; Bartle, Brian; Weiss, Kevin B.			Risk for death associated with medications for recently diagnosed chronic obstructive pulmonary disease	ANNALS OF INTERNAL MEDICINE			English	Article							INHALED CORTICOSTEROIDS; BIASED SELECTION; MORTALITY; COPD; HEALTH; HOSPITALIZATIONS; EXACERBATIONS; METAANALYSIS; FLUTICASONE; IPRATROPIUM	Background: Concerns exist regarding increased risk for mortality associated with some chronic obstructive pulmonary disease (COPD) medications. Objective: To examine the association between various respiratory medications and risk for death in veterans with newly diagnosed COPD. Design: Nested case - control study in a cohort identified between 1 October 1999 and 30 September 2003 and followed through 30 September 2004 by using National Veterans Affairs inpatient, outpatient, pharmacy, and mortality databases; Centers for Medicare & Medicaid Services databases; and National Death Index Plus data. Cause of death was ascertained for a random sample of 40% of those who died during follow-up. Case patients were categorized on the basis of all-cause, respiratory, or cardiovascular death. Mortality risk associated with medications was assessed by using conditional logistic regression adjusted for comorbid conditions, health care use, and markers of COPD severity. Setting: U. S. Veterans Health Administration health care system. Participants: 32 130 case patients and 320 501 control participants in the all-cause mortality analysis. Of 11 897 patients with cause-of-death data, 2405 case patients had respiratory deaths and 3159 case patients had cardiovascular deaths. Measurements: All-cause mortality; respiratory and cardiovascular deaths; and exposure to COPD medications, inhaled corticosteroids, ipratropium, long-acting beta-agonists, and theophylline in the 6 months preceding death. Results: Adjusted odds ratios (ORs) for all-cause mortality were 0.80 (95% CI, 0.78 to 0.83) for inhaled corticosteroids, 1.11 ( CI, 1.08 to 1.15) for ipratropium, 0.92 (CI, 0.88 to 0.96) for long-acting beta-agonists, and 1.05 (CI, 0.99 to 1.10) for theophylline. Ipratropium was associated with increased cardiovascular deaths (OR, 1.34 [CI, 1.22 to 1.47]), whereas inhaled corticosteroids were associated with reduced risk for cardiovascular death ( OR, 0.80 [ CI, 0.72 to 0.88]). Results were consistent across sensitivity analyses. Limitations: Current smoking status and lung function were not measured. Misclassification of cause-specific mortality is unknown. Conclusion: The possible association between ipratropium and elevated risk for all-cause and cardiovascular death needs further study.	[Lee, Todd A.] Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; NW Univ Feinberg, Sch Med, Chicago, IL USA; Univ Illinois, Chicago, IL USA; Vet Affairs Puget Sound Hlth Care Syst, Seattle, WA USA; Univ Washington, Seattle, WA 98195 USA; Amer Board Med Specialties, Evanston, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Northwestern University; Feinberg School of Medicine; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Lee, TA (corresponding author), Vet Affairs Edward Hines Jr Hosp, 5000 S 5th Ave,151-H, Hines, IL 60141 USA.	todd.lee@va.gov		Pickard, A. Simon/0000-0001-5645-7091; Lee, Todd/0000-0003-3619-5367	the U. S. Department of Veterans Affairs Health Services Research and Development [IIR 03-307]	the U. S. Department of Veterans Affairs Health Services Research and Development(US Department of Veterans Affairs)	By the U. S. Department of Veterans Affairs Health Services Research and Development (IIR 03-307).	[Anonymous], 2000, PHARMACOEPIDEM DR S; Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; *CTR DRUG EV RES, 2008, EARL COMM ONG SAF RE; de Luise C, 2007, EUR J EPIDEMIOL, V22, P267, DOI 10.1007/s10654-007-9106-5; Decramer Marc, 2004, COPD, V1, P303, DOI 10.1081/COPD-200026934; Dhruva SS, 2008, ARCH INTERN MED, V168, P136, DOI 10.1001/archinternmed.2007.56; Doody MM, 2001, ANN EPIDEMIOL, V11, P46, DOI 10.1016/S1047-2797(00)00177-0; Ernst P, 2007, AM J RESP CRIT CARE, V176, P162, DOI 10.1164/rccm.200611-1630OC; Gartlehner G, 2006, ANN FAM MED, V4, P253, DOI 10.1370/afm.517; Gudmundsson G, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-109; HOSMER DW, 1989, APPL LOGISTIC REGRES, P187; Jensen HH, 2006, EUR RESPIR J, V28, P781, DOI 10.1183/09031936.06.00152205; JOO MJ, 2008, PATTERNS HEALTHCARE; Lee TA, 2007, ANN EPIDEMIOL, V17, P380, DOI 10.1016/j.annepidem.2007.01.033; Lee TA, 2006, CHEST, V129, P1509, DOI 10.1378/chest.129.6.1509; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; LUBIN JH, 1984, BIOMETRICS, V40, P63, DOI 10.2307/2530744; Mannino DM, 2003, THORAX, V58, P388, DOI 10.1136/thorax.58.5.388; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Ringbaek T, 2003, RESP MED, V97, P264, DOI 10.1053/rmed.2003.1423; ROBINS JM, 1986, BIOMETRICS, V42, P293, DOI 10.2307/2531050; Salpeter SR, 2006, CLIN REV ALLERG IMMU, V31, P219, DOI 10.1385/CRIAI:31:2:219; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Sathiakumar N, 1998, J OCCUP ENVIRON MED, V40, P808, DOI 10.1097/00043764-199809000-00010; Schneeweiss S, 2006, PHARMACOEPIDEM DR S, V15, P291, DOI 10.1002/pds.1200; Sin DD, 2005, THORAX, V60, P992, DOI 10.1136/thx.2005.045385; Sin DD, 2003, JAMA-J AM MED ASSOC, V290, P2301, DOI 10.1001/jama.290.17.2301; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Sin DD, 2000, THORAX, V55, P194, DOI 10.1136/thorax.55.3.194; Sohn Min-Woong, 2006, Popul Health Metr, V4, P2, DOI 10.1186/1478-7954-4-2; Sullivan SD, 2000, CHEST, V117, P5; Travers J, 2007, RESP MED, V101, P1313, DOI 10.1016/j.rmed.2006.10.011; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC	38	146	153	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					380	W73		10.7326/0003-4819-149-6-200809160-00004	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00004			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794557				2022-12-28	WOS:000259230200002
J	Gorman, SR; Craven, DE				Gorman, Stephen R.; Craven, Donald E.			Strongyloides stercoralis hyperinfection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gorman, Stephen R.; Craven, Donald E.] Lahey Clin Fdn, Med Ctr, Burlington, MA 01805 USA	Lahey Hospital & Medical Center	Gorman, SR (corresponding author), Lahey Clin Fdn, Med Ctr, Burlington, MA 01805 USA.	gormans@mercyme.com							0	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					E12	E12		10.1056/NEJMicm066791	http://dx.doi.org/10.1056/NEJMicm066791			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784094				2022-12-28	WOS:000259078200012
J	Madsbad, S				Madsbad, Sten			Treatment of type 2 diabetes with incretin-based therapies	LANCET			English	Editorial Material							HUMAN GLP-1 ANALOG; GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; LIRAGLUTIDE; SULFONYLUREA		[Madsbad, Sten] Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark; [Madsbad, Sten] Univ Copenhagen, DK-2650 Hvidovre, Denmark	University of Copenhagen; University of Copenhagen	Madsbad, S (corresponding author), Hvidovre Univ Hosp, Dept Endocrinol, DK-2650 Hvidovre, Denmark.	sten.madsbad@hvh.region.dk		Madsbad, Sten/0000-0002-5017-1815				Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Holst JJ, 2008, TRENDS MOL MED, V14, P161, DOI 10.1016/j.molmed.2008.01.003; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Madsbad S, 2008, CURR OPIN CLIN NUTR, V11, P491, DOI 10.1097/MCO.0b013e328302f414; Marre M, 2008, DIABETES, V57, pA4; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nauck MA, 2008, DIABETES, V57, pA150; Richter B, 2008, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD006739., DOI 10.1002/14651858.CD006739]; Russell-Jones D, 2008, DIABETES, V57, pA159; *US FDA, 2008, EX MARK BYETT INF; Zander M, 2002, LANCET, V359, P824, DOI 10.1016/S0140-6736(02)07952-7; Zinman B, 2008, DIABETOLOGIA, V51, pS359	14	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 7	2009	373	9662					438	439		10.1016/S0140-6736(08)61247-7	http://dx.doi.org/10.1016/S0140-6736(08)61247-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	18819704				2022-12-28	WOS:000263132800006
J	Charlton, MH				Charlton, Mary H.			Commentary: The technology of continuous glucose monitoring	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Charlton, Mary H.] Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England	Heart of England NHS Foundation Trust; University of Birmingham	Charlton, MH (corresponding author), Birmingham Heartlands Hosp, Ctr Diabet, Birmingham B9 5SS, W Midlands, England.	mary.charlton@heartofengland.nhs.uk						Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; *MEDTR MINIMED UK, 2006, INS PUMP THER CONT G; Ng JM, 2008, DIABETIC MED, V25, P239, DOI 10.1111/j.1464-5491.2007.02336.x; *NHS PURCH SUPPL A, 2008, 08008 CEP	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 18	2008	337	7675							a1733	10.1136/bmj.a1733	http://dx.doi.org/10.1136/bmj.a1733			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18818255	hybrid			2022-12-28	WOS:000260093900034
J	Maskin, E				Maskin, Eric			Economics - Can neural data improve economics?	SCIENCE			English	Editorial Material									[Maskin, Eric] Inst Adv Study, Sch Social Sci, Princeton, NJ 08540 USA	Institute for Advanced Study - USA	Maskin, E (corresponding author), Inst Adv Study, Sch Social Sci, Einstein Dr, Princeton, NJ 08540 USA.	maskin@ias.edu						Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Delgado MR, 2008, SCIENCE, V321, P1849, DOI 10.1126/science.1158860; gul f., 2005, CASE MINDLESS EC; Kagel J. H, 2008, AUCTIONS SURVEY EXPT; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7	5	3	3	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1788	1789		10.1126/science.1164688	http://dx.doi.org/10.1126/science.1164688			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818349				2022-12-28	WOS:000259501300025
J	Blau, HM				Blau, Helen M.			Cell therapies for muscular dystrophy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							STEM-CELLS; TRANSPLANTATION		[Blau, Helen M.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Blau, HM (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.							Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; GUSSONI E, 1992, NATURE, V356, P435, DOI 10.1038/356435a0; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282	5	20	20	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1403	1405		10.1056/NEJMcibr0805708	http://dx.doi.org/10.1056/NEJMcibr0805708			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815403				2022-12-28	WOS:000259440900015
J	Pederson, J; Young, R; Lucchitta, I; Beard, LS; Billingsley, G				Pederson, Joel; Young, Richard; Lucchitta, Ivo; Beard, L. Sue; Billingsley, George			Comment on "age and evolution of the Grand Canyon revealed by U-Pb dating of water table-type speleothems"	SCIENCE			English	Editorial Material									[Pederson, Joel] Utah State Univ, Dept Geol, Logan, UT 84322 USA; [Young, Richard] SUNY Coll Geneseo, Dept Geol Sci, Geneseo, NY 14454 USA; [Lucchitta, Ivo; Beard, L. Sue; Billingsley, George] US Geol Survey, Flagstaff, AZ 86001 USA	Utah System of Higher Education; Utah State University; State University of New York (SUNY) System; SUNY Geneseo; United States Department of the Interior; United States Geological Survey	Pederson, J (corresponding author), Utah State Univ, Dept Geol, Logan, UT 84322 USA.	joel.pederson@usu.edu						[Anonymous], 20055222 US GEOL SUR; BLACKWELDER E, 1934, GEOLOGICAL SOC AM B, V45, P551; Dorsey RJ, 2007, GEOLOGY, V35, P57, DOI 10.1130/G23139A.1; Faulds J.E., 2001, COLORADO RIVER ORIGI, P81; House P.J., 2005, INTERIOR W US GEOLOG, P357, DOI [10.1130/2005.fld006(17), DOI 10.1130/2005.FLD006(17)]; Hunt C. B., 1969, US GEOLOGICAL SURV C, P59, DOI DOI 10.3133/PP669C; LONGWELL CR, 1946, AM J SCI, V244, P817, DOI 10.2475/ajs.244.12.817; Lucchitta I., 1966, THESIS PENNSYLVANIA; LUCCHITTA I, 2004, COLORADO RIVER ORIGI, P65; McKee E. D., 1967, MUSEUM NO ARIZONA B, V44; MERRIAM R, 1965, J SEDIMENT PETROL, V35, P911; Pederson J. L., 2008, GSA TODAY, V18, DOI [10.1130/GSAT01803A.1, DOI 10.1130/GSAT01803A.1]; Polyak V, 2008, SCIENCE, V319, P1377, DOI 10.1126/science.1151248; Young R, 2004, COLORADO RIVER ORIGI, P7; YOUNG RA, 1978, GEOL SOC AM BULL, V89, P1745, DOI 10.1130/0016-7606(1978)89<1745:EAMCDA>2.0.CO;2	15	12	12	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896								10.1126/science.1158019	http://dx.doi.org/10.1126/science.1158019			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801983				2022-12-28	WOS:000259300400014
J	Mohr, JT; Krout, MR; Stoltz, BM				Mohr, Justin T.; Krout, Michael R.; Stoltz, Brian M.			Natural products as inspiration for the development of asymmetric catalysis	NATURE			English	Review							DIELS-ALDER REACTION; NEGISHI CROSS-COUPLINGS; AMINO-ACID-DERIVATIVES; ENANTIOSELECTIVE CONSTRUCTION; ORGANIC CATALYSIS; ALPHA-AMINO; HYDROGENATION; CYCLIZATION; TRIMETHYLENEMETHANE; ALKYLATIONS	Biologically active natural products often contain particularly challenging structural features and functionalities in terms of synthesis. Perhaps the greatest difficulties are those caused by issues of stereochemistry. A useful strategy for synthesizing such molecules is to devise methods of bond formation that provide opportunities for using enantioselective catalysis. In using this tactic, the desire for a particular target structure ultimately drives the development of catalytic methods. New enantioselective catalytic methods contribute to a greater fundamental understanding of how bonds can be constructed and lead to valuable synthetic technologies that are useful for a variety of applications.	[Mohr, Justin T.; Krout, Michael R.; Stoltz, Brian M.] CALTECH, Arnold & Mabel Beckman Lab Chem Synth, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Stoltz, BM (corresponding author), CALTECH, Arnold & Mabel Beckman Lab Chem Synth, Div Chem & Chem Engn, 1200 E Calif Blvd,MC 164-30, Pasadena, CA 91125 USA.	stoltz@caltech.edu		Mohr, Justin/0000-0002-7005-3322; Krout, Michael/0000-0002-0539-6986	National Institute of General Medical Sciences [R01GM080269-01]; Eli Lilly; Amgen; Abbott Laboratories; Boehringer Ingelheim; Merck; Bristol-Myers Squibb; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080269] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Eli Lilly(Eli Lilly); Amgen(Amgen); Abbott Laboratories(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the National Institute of General Medical Sciences (grant number R01GM080269-01), Eli Lilly ( which provided predoctoral fellowships to J.T.M. and M.R.K.), Amgen, Abbott Laboratories, Boehringer Ingelheim, Merck, Bristol-Myers Squibb and the California Institute of Technology for financial support.	AKUTAGAWA S, 2002, CATALYTIC ASYMMETRIC, P145; Allin SM, 2007, TETRAHEDRON LETT, V48, P5669, DOI 10.1016/j.tetlet.2007.06.034; Arp FO, 2005, J AM CHEM SOC, V127, P10482, DOI 10.1021/ja053751f; Austin JF, 2004, P NATL ACAD SCI USA, V101, P5482, DOI 10.1073/pnas.0308177101; Austin JF, 2002, J AM CHEM SOC, V124, P1172, DOI 10.1021/ja017255c; Behenna DC, 2004, J AM CHEM SOC, V126, P15044, DOI 10.1021/ja044812x; CARPENTER NE, 1989, J ORG CHEM, V54, P5846, DOI 10.1021/jo00286a009; Clausen AM, 2006, ORG PROCESS RES DEV, V10, P723, DOI 10.1021/op050232o; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Corey EJ, 2002, ANGEW CHEM INT EDIT, V41, P1650, DOI 10.1002/1521-3773(20020517)41:10<1650::AID-ANIE1650>3.0.CO;2-B; COREY EJ, 1968, J AM CHEM SOC, V90, P3245, DOI 10.1021/ja01014a053; Corey EJ, 1998, ANGEW CHEM INT EDIT, V37, P1987, DOI 10.1002/(SICI)1521-3773(19980817)37:15<1986::AID-ANIE1986>3.0.CO;2-Z; COREY EJ, 1987, J AM CHEM SOC, V109, P7925, DOI 10.1021/ja00259a075; COX ED, 1995, CHEM REV, V95, P1797, DOI 10.1021/cr00038a004; de Meijere A., 2004, METAL CATALYZED CROS, V2; Depew KM, 1999, J AM CHEM SOC, V121, P11953, DOI 10.1021/ja991558d; Diederich F., 2004, METAL CATALYZED CROS, V1; Diels O, 1928, LIEBIGS ANN CHEM, V460, P98; DOLLING UH, 1984, J AM CHEM SOC, V106, P446, DOI 10.1021/ja00314a045; Douglas CJ, 2004, P NATL ACAD SCI USA, V101, P5363, DOI 10.1073/pnas.0307113101; Dounay AB, 2005, J AM CHEM SOC, V127, P10186, DOI 10.1021/ja0533895; Dounay AB, 2003, CHEM REV, V103, P2945, DOI 10.1021/cr020039h; Dounay AB, 2008, J AM CHEM SOC, V130, P5368, DOI 10.1021/ja800163v; Drexler HJ, 2003, ORG PROCESS RES DEV, V7, P355, DOI 10.1021/op034011z; Drucker D, 2007, NAT REV DRUG DISCOV, V6, P109, DOI 10.1038/nrd2245; EDER U, 1971, ANGEW CHEM INT EDIT, V10, P496, DOI 10.1002/anie.197104961; Enquist JA, 2008, NATURE, V453, P1228, DOI 10.1038/nature07046; Erkkila A, 2007, CHEM REV, V107, P5416, DOI 10.1021/cr068388p; Evans DA, 2000, J AM CHEM SOC, V122, P10033, DOI 10.1021/ja002356g; Farina V, 2006, CHEM REV, V106, P2734, DOI 10.1021/cr040700c; Fischer C, 2005, J AM CHEM SOC, V127, P4594, DOI 10.1021/ja0506509; Frisch AC, 2005, ANGEW CHEM INT EDIT, V44, P674, DOI 10.1002/anie.200461432; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; HAJOS ZG, 1973, J ORG CHEM, V38, P3244, DOI 10.1021/jo00959a003; HASHIMOTO S, 1979, J CHEM SOC CHEM COMM, P437, DOI 10.1039/c39790000437; HAYASHI T, 1982, J AM CHEM SOC, V104, P180, DOI 10.1021/ja00365a033; Hayashi Y, 2002, CYCLOADDITION REACTIONS IN ORGANIC SYNTHESIS, P5; HECK RF, 1979, ACCOUNTS CHEM RES, V12, P146, DOI 10.1021/ar50136a006; Hino T., 1988, ALKALOIDS, V34, P1; HOVEYDA AH, 2000, STIMULATING CONCEPTS, P145; Hsiao Y, 2004, J AM CHEM SOC, V126, P9918, DOI 10.1021/ja047901i; HUGHES DL, 1987, J ORG CHEM, V52, P4745, DOI 10.1021/jo00230a017; Humphrey GR, 2006, CHEM REV, V106, P2875, DOI 10.1021/cr0505270; Jacobsen E. N., 2004, COMPREHENSIVE ASYMME, VI-III; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, VI-III; JACOBSEN EN, 2000, COMPREHENSIVE ASYMME, V1; Jensen KB, 2001, ANGEW CHEM INT EDIT, V40, P160, DOI 10.1002/1521-3773(20010105)40:1<160::AID-ANIE160>3.0.CO;2-S; JUARISTIC E, 2005, ENANTIOSELECTIVE SYN; KIRMANSJAH L, 2008, J AM CHEM SOC, V129, P11340; KISO Y, 1974, TETRAHEDRON LETT, P3; Knowles W.S., 2004, ASYMMETRIC CATALYSIS, P21; Le Marquand P, 2008, ANGEW CHEM INT EDIT, V47, P2926, DOI 10.1002/anie.200705481; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; LUBELL WD, 1991, TETRAHEDRON-ASYMMETR, V2, P543, DOI 10.1016/S0957-4166(00)86107-8; Luh TY, 2000, CHEM REV, V100, P3187, DOI 10.1021/cr990272o; Ma JA, 2003, ANGEW CHEM INT EDIT, V42, P4290, DOI 10.1002/anie.200301600; Maruoka K., 2008, ASYMMETRIC PHASE TRA; Mohr JT, 2005, ANGEW CHEM INT EDIT, V44, P6924, DOI 10.1002/anie.200502018; Mohr JT, 2007, CHEM-ASIAN J, V2, P1476, DOI 10.1002/asia.200700183; Mohr JT, 2007, ORG BIOMOL CHEM, V5, P3571, DOI 10.1039/b711159m; Najera C, 2007, CHEM REV, V107, P4584, DOI 10.1021/cr050580o; Negishi E.-I, 2002, HDB ORGANOPALLADIUM, V1-2; Netherton MR, 2005, TOP ORGANOMETAL CHEM, V14, P85; Nicolaou KC, 2002, ANGEW CHEM INT EDIT, V41, P1668, DOI 10.1002/1521-3773(20020517)41:10<1668::AID-ANIE1668>3.0.CO;2-Z; Noyori R, 2004, P NATL ACAD SCI USA, V101, P5356, DOI 10.1073/pnas.0307928100; NUGENT WA, 1993, SCIENCE, V259, P479, DOI 10.1126/science.259.5094.479; Overman AE, 1999, J AM CHEM SOC, V121, P7702; Overman LE, 2000, ANGEW CHEM INT EDIT, V39, P213, DOI 10.1002/(SICI)1521-3773(20000103)39:1<213::AID-ANIE213>3.0.CO;2-Z; OVERMAN LE, 1994, PURE APPL CHEM, V66, P1423, DOI 10.1351/pac199466071423; Palomo C, 2002, CHEM-EUR J, V8, P37, DOI 10.1002/1521-3765(20020104)8:1<36::AID-CHEM36>3.0.CO;2-L; Paras NA, 2001, J AM CHEM SOC, V123, P4370, DOI 10.1021/ja015717g; Pictet A, 1911, BER DTSCH CHEM GES, V44, P2030, DOI 10.1002/cber.19110440309; Raheem IT, 2008, ORG LETT, V10, P1577, DOI 10.1021/ol800256j; Raheem IT, 2007, J AM CHEM SOC, V129, P13404, DOI 10.1021/ja076179w; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; SATO Y, 1989, J ORG CHEM, V54, P4738, DOI 10.1021/jo00281a007; Saxton J.E., 1983, CHEM HETEROCYCLIC 4; Seayad J, 2006, J AM CHEM SOC, V128, P1086, DOI 10.1021/ja057444l; Senanayake CH, 1999, PROCESS CHEMISTRY IN THE PHARMACEUTICAL INDUSTRY, P347; Shultz CS, 2007, ACCOUNTS CHEM RES, V40, P1320, DOI 10.1021/ar700141v; Son S, 2008, J AM CHEM SOC, V130, P2756, DOI 10.1021/ja800103z; STORK G, 1951, J AM CHEM SOC, V73, P4501, DOI 10.1021/ja01153a552; Suh YG, 1999, ANGEW CHEM INT EDIT, V38, P3545, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3545::AID-ANIE3545>3.3.CO;2-S; Sundberg R.J., 1996, CHEM INDOLES; Taylor MS, 2004, J AM CHEM SOC, V126, P10558, DOI 10.1021/ja046259p; Taylor MS, 2004, P NATL ACAD SCI USA, V101, P5368, DOI 10.1073/pnas.0307893101; Trost BM, 2007, J AM CHEM SOC, V129, P12398, DOI 10.1021/ja0753389; Trost BM, 2007, J AM CHEM SOC, V129, P12396, DOI 10.1021/ja075335w; Trost BM, 2007, J AM CHEM SOC, V129, P3086, DOI 10.1021/ja070142u; Trost BM, 2006, J AM CHEM SOC, V128, P13328, DOI 10.1021/ja0640750; Trost BM, 2004, P NATL ACAD SCI USA, V101, P5348, DOI 10.1073/pnas.0306715101; TROST BM, 1979, J AM CHEM SOC, V101, P6429, DOI 10.1021/ja00515a046; TROST BM, 1979, J AM CHEM SOC, V101, P6432, DOI 10.1021/ja00515a047; VINEYARD BD, 1977, J AM CHEM SOC, V99, P5946, DOI 10.1021/ja00460a018; Wanner MJ, 2007, ANGEW CHEM INT EDIT, V46, P7485, DOI 10.1002/anie.200701808; WOODWARD RB, 1956, J AM CHEM SOC, V78, P2023, DOI 10.1021/ja01590a079; Xu F, 2004, J AM CHEM SOC, V126, P13002, DOI 10.1021/ja046488b; Yamago S., 2002, ORG REACT, V61, P1; YAMAMOTO A, 1989, TETRAHEDRON LETT, V30, P375, DOI 10.1016/S0040-4039(00)95206-7; YATES P, 1960, J AM CHEM SOC, V82, P4436, DOI 10.1021/ja01501a085; Yoon TP, 2003, SCIENCE, V299, P1691, DOI 10.1126/science.1083622; Zhou JR, 2003, J AM CHEM SOC, V125, P14726, DOI 10.1021/ja0389366	102	190	208	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					323	332		10.1038/nature07370	http://dx.doi.org/10.1038/nature07370			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800131	Green Accepted			2022-12-28	WOS:000259265200033
J	Nachman, RL; Rafii, S				Nachman, Ralph L.; Rafii, Shahin			Platelets, petechiae, and preservation of the vascular wall	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOTHELIAL GROWTH-FACTOR; CELL-CELL INTERACTIONS; BETA-CATENIN; MOLECULAR-ORGANIZATION; FUNCTIONAL-ROLE; VEGF; EXPRESSION; CADHERIN; JUNCTIONS; ANGIOGENESIS		[Nachman, Ralph L.; Rafii, Shahin] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Nachman, RL (corresponding author), Weill Cornell Med Coll, 1300 York Ave, New York, NY 10065 USA.	rlnachm@med.cornell.edu			Howard Hughes Medical Institute; Ansary Center for Stem Cell Therapeutics; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075234, P01HL072942, U01HL066952, R01HL061849, R01HL058707, P01HL059312, R21HL083222, R01HL097797, P50HL084936, P01HL067839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Center for Stem Cell Therapeutics; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by grants from the Howard Hughes Medical Institute, the Ansary Center for Stem Cell Therapeutics, and the National Heart, Lung, and Blood Institute (to Dr. Rafii). No potential conflict of interest relevant to this article was reported.	Anteby EY, 2004, MOL HUM REPROD, V10, P229, DOI 10.1093/molehr/gah031; Aoki S, 2007, BIOCHEM BIOPH RES CO, V358, P1054, DOI 10.1016/j.bbrc.2007.05.028; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Bdolah Y, 2004, SEMIN NEPHROL, V24, P548, DOI 10.1016/S0270-9295(04)00125-1; BUNDGAARD M, 1984, J ULTRA MOL STRUCT R, V88, P1, DOI 10.1016/S0022-5320(84)90177-1; Butros LJ, 2003, J PEDIAT HEMATOL ONC, V25, P660, DOI 10.1097/00043426-200308000-00017; Cannistra SA, 2008, J CLIN ONCOL, V26, P3665, DOI 10.1200/JCO.2008.17.2676; Cannistra SA, 2007, J CLIN ONCOL, V25, P5180, DOI 10.1200/JCO.2007.12.0782; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Choi HJ, 2006, J BIOL CHEM, V281, P1027, DOI 10.1074/jbc.M511338200; CITI S, 1993, J CELL BIOL, V121, P485, DOI 10.1083/jcb.121.3.485; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; Dejana E, 2000, INT J DEV BIOL, V44, P743; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dvorak HF, 2006, EXP CELL RES, V312, P522, DOI 10.1016/j.yexcr.2005.11.026; El Andaloussi A, 2001, EUR CYTOKINE NETW, V12, P268; Feistritzer C, 2005, BLOOD, V105, P3178, DOI 10.1182/blood-2004-10-3985; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gawaz M, 2008, J THROMB HAEMOST, V6, P235, DOI 10.1111/j.1538-7836.2007.02867.x; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gupta K, 1999, EXP CELL RES, V247, P495, DOI 10.1006/excr.1998.4359; Hainsworth JD, 2005, J CLIN ONCOL, V23, P7889, DOI 10.1200/JCO.2005.01.8234; Hisano N, 1999, BLOOD, V93, P4293, DOI 10.1182/blood.V93.12.4293.412k26_4293_4299; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; JAFFE EA, 1974, P NATL ACAD SCI USA, V71, P1906, DOI 10.1073/pnas.71.5.1906; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; JORIS I, 1987, AM J PATHOL, V126, P19; Junt T, 2007, SCIENCE, V317, P1767, DOI 10.1126/science.1146304; KAIPAINEN A, 1995, P NATL ACAD SCI USA, V92, P3566, DOI 10.1073/pnas.92.8.3566; Kaneko T, 2007, CANCER RES, V67, P9685, DOI 10.1158/0008-5472.CAN-07-1497; Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174; Kitchens C S, 1980, Prog Hemost Thromb, V5, P211; KITCHENS CS, 1977, J CLIN INVEST, V60, P1129, DOI 10.1172/JCI108864; Klagsbrun M, 2002, ADV EXP MED BIOL, V515, P33; Kolesnick R, 2003, ONCOGENE, V22, P5897, DOI 10.1038/sj.onc.1206702; KOLESNICK R, 1994, CELL, V77, P325, DOI 10.1016/0092-8674(94)90147-3; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 1997, CURR OPIN CELL BIOL, V9, P674, DOI 10.1016/S0955-0674(97)80121-4; Langer HF, 2007, ARTERIOSCL THROM VAS, V27, P1463, DOI 10.1161/ATVBAHA.107.141515; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Levine RJ, 2004, NEW ENGL J MED, V350, P672, DOI 10.1056/NEJMoa031884; Li WM, 2000, CYTOKINE, V12, P1017, DOI 10.1006/cyto.1999.0678; Liebner S, 2006, ARTERIOSCL THROM VAS, V26, P1431, DOI 10.1161/01.ATV.0000218510.04541.5e; Lilien J, 2005, CURR OPIN CELL BIOL, V17, P459, DOI 10.1016/j.ceb.2005.08.009; Lucerna M, 2007, BLOOD, V109, P122, DOI 10.1182/blood-2006-07-031773; Ma X, 2004, INVEST OPHTH VIS SCI, V45, P2915, DOI 10.1167/iovs.04-0128; Mason KD, 2007, CELL, V128, P1173, DOI 10.1016/j.cell.2007.01.037; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olofsson B, 1999, CURR OPIN BIOTECH, V10, P528, DOI 10.1016/S0958-1669(99)00024-5; Partanen TA, 2000, FASEB J, V14, P2087, DOI 10.1096/fj.99-1049com; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Rhee JS, 2004, THROMB HAEMOSTASIS, V92, P394, DOI 10.1160/TH03-04-0213; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Scappaticci FA, 2007, JNCI-J NATL CANCER I, V99, P1232, DOI 10.1093/jnci/djm086; Seipelt RG, 2005, J THORAC CARDIOV SUR, V129, P773, DOI 10.1016/j.jtcvs.2004.06.039; Sharma M, 2007, J BIOL CHEM, V282, P8545, DOI 10.1074/jbc.M610272200; Shay-Salit A, 2002, P NATL ACAD SCI USA, V99, P9462, DOI 10.1073/pnas.142224299; Singleton PA, 2005, FASEB J, V19, P1646, DOI 10.1096/fj.05-3928com; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; von Tell D, 2006, EXP CELL RES, V312, P623, DOI 10.1016/j.yexcr.2005.10.019; Yamashiro K, 2003, AM J PATHOL, V163, P253, DOI 10.1016/S0002-9440(10)63648-6	71	175	183	6	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1261	1270		10.1056/NEJMra0800887	http://dx.doi.org/10.1056/NEJMra0800887			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799560	Green Accepted			2022-12-28	WOS:000259259900009
J	Tzemos, N; Therrien, J; Yip, J; Thanassoulis, G; Tremblay, S; Jamorski, MT; Webb, GD; Siu, SC				Tzemos, Nikolaos; Therrien, Judith; Yip, James; Thanassoulis, George; Tremblay, Sonia; Jamorski, Michal T.; Webb, Gary D.; Siu, Samuel C.			Outcomes in adults with bicuspid aortic valves	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASCENDING AORTA; NATURAL-HISTORY; HEART-DISEASE; FOLLOW-UP; STENOSIS; DILATATION; COARCTATION; ECHOCARDIOGRAPHY; RECOMMENDATIONS; PREDICTORS	Context Bicuspid aortic valve is the most common congenital cardiac anomaly in the adult population. Cardiac outcomes in a contemporary population of adults with bicuspid aortic valve have not been systematically determined. Objective To determine the frequency and predictors of cardiac outcomes in a large consecutive series of adults with bicuspid aortic valve. Design, Setting, and Participants Cohort study examining cardiac outcomes in 642 consecutive ambulatory adults ( mean [ SD] age, 35 [ 16] years; 68% male) with bicuspid aortic valve presenting to a Canadian congenital cardiac center from 1994 through 2001 and followed up for a mean ( SD) period of 9 ( 5) years. Frequency and predictors of major cardiac events were determined by multivariate analysis. Mortality rate in the study group was compared with age- and sex- matched population estimates. Main Outcome Measures Mortality and cause of death were determined. Primary cardiac events were defined as the occurrence of any of the following complications: cardiac death, intervention on the aortic valve or ascending aorta, aortic dissection or aneurysm, or congestive heart failure requiring hospital admission during the follow- up period. Results During the follow- up period, there were 28 deaths ( mean [ SD], 4% [ 1%]). One or more primary cardiac events occurred in 161 patients ( mean [ SD], 25% [ 2%]), which included cardiac death in 17 patients ( mean [ SD], 3% [ 1%]), intervention on aortic valve or ascending aorta in 142 patients ( mean [ SD], 22% [ 2%]), aortic dissection or aneurysm in 11 patients ( mean [ SD], 2% [ 1%]), or congestive heart failure requiring hospital admission in 16 patients ( mean [ SD], 2% [ 1%]). Independent predictors of primary cardiac events were age older than 30 years ( hazard ratio [ HR], 3.01; 95% confidence interval [ CI], 2.15- 4.19; P <. 001), moderate or severe aortic stenosis ( HR, 5.67; 95% CI, 4.16- 7.80; P <. 001), and moderate or severe aortic regurgitation ( HR, 2.68; 95% CI, 1.93- 3.76; P <. 001). The 10- year survival rate of the study group ( mean [ SD], 96% [ 1%]) was not significantly different from population estimates ( mean [ SD], 97% [ 1%]; P=. 71). At last follow- up, 280 patients ( mean [ SD], 45% [ 2%]) had dilated aortic sinus and/ or ascending aorta. Conclusions In this study population of young adults with bicuspid aortic valve, age, severity of aortic stenosis, and severity of aortic regurgitation were independently associated with primary cardiac events. Over the mean follow- up duration of 9 years, survival rates were not lower than for the general population.	[Siu, Samuel C.] Univ Western Ontario Hosp, Div Cardiol, London, ON N6A 5A5, Canada; [Tzemos, Nikolaos; Jamorski, Michal T.; Siu, Samuel C.] Univ Toronto, Univ Hlth Network, Peter Munk Cardiac Ctr, Toronto, ON, Canada; [Tzemos, Nikolaos; Jamorski, Michal T.; Siu, Samuel C.] Univ Toronto, Univ Hlth Network, Toronto Congenital Cardiac Ctr Adults, Toronto, ON, Canada; [Yip, James] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Therrien, Judith; Thanassoulis, George; Tremblay, Sonia] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Dept Med, Montreal, PQ, Canada; [Webb, Gary D.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia Adult Congenital Heart Ctr, Dept Med, Philadelphia, PA 19104 USA; [Siu, Samuel C.] Univ Western Ontario, Div Cardiol, London, ON, Canada	Western University (University of Western Ontario); University of Toronto; Peter Munk Cardiac Centre; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Toronto Congenital Cardiac Centre for Adults; University Toronto Affiliates; University Health Network Toronto; National University of Singapore; McGill University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Western University (University of Western Ontario)	Siu, SC (corresponding author), Univ Western Ontario Hosp, Div Cardiol, C6-005,339 Windermere Rd, London, ON N6A 5A5, Canada.	Samuel.Siu@lhsc.on.ca	Siu, Sam C/G-3346-2011	Siu, Sam C/0000-0002-1104-3669	University of Toronto Department of Medicine; Fonds de Recherche en Sante du Quebec; Canadian Institutes of Health Research [53130]; Heart and Stroke Foundation of Canada [NA5662]	University of Toronto Department of Medicine(University of Toronto); Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada)	Dr Tzemos was partially supported by a fellowship grant from the University of Toronto Department of Medicine. Dr Thanassoulis was supported by a research fellowship from the Fonds de Recherche en Sante du Quebec. The study was supported by operating grants from the Canadian Institutes of Health Research (grant 53130) and the Heart and Stroke Foundation of Canada (grant NA5662).	Aboulhosn J, 2006, CIRCULATION, V114, P2412, DOI 10.1161/CIRCULATIONAHA.105.592089; Bireley WR, 2007, J MAGN RESON IMAGING, V26, P1480, DOI 10.1002/jmri.21085; Bonderman D, 1999, CIRCULATION, V99, P2138, DOI 10.1161/01.CIR.99.16.2138; Bonow RO, 2006, CIRCULATION, V114, pE84, DOI 10.1161/CIRCULATIONAHA.106.176857; FENOGLIO JJ, 1977, AM J CARDIOL, V39, P164, DOI 10.1016/S0002-9149(77)80186-0; Ferencik M, 2003, AM J CARDIOL, V92, P43, DOI 10.1016/S0002-9149(03)00462-4; Fernandes SM, 2004, J AM COLL CARDIOL, V44, P1648, DOI 10.1016/j.jacc.2004.05.063; Fernandes SM, 2007, J AM COLL CARDIOL, V49, P2211, DOI 10.1016/j.jacc.2007.01.090; Gurvitz M, 2004, AM J CARDIOL, V94, P1337, DOI 10.1016/j.amjcard.2004.07.130; Hager A, 2004, CHEST, V126, P1169, DOI 10.1378/chest.126.4.1169; Januzzi JL, 2004, J AM COLL CARDIOL, V43, P665, DOI 10.1016/j.jacc.2003.08.054; Keane MG, 2000, CIRCULATION, V102, P35; Konen E, 2004, AM J ROENTGENOL, V182, P1333, DOI 10.2214/ajr.182.5.1821333; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; LINDSAY J, 1988, AM J CARDIOL, V61, P182, DOI 10.1016/0002-9149(88)91327-6; Manuel DG, 2004, DIABETES CARE, V27, P407, DOI 10.2337/diacare.27.2.407; Manuel DG, 2003, CAN J CARDIOL, V19, P997; Matura LA, 2007, CIRCULATION, V116, P1663, DOI 10.1161/CIRCULATIONAHA.106.685487; Michelena HI, 2008, CIRCULATION, V117, P2776, DOI 10.1161/CIRCULATIONAHA.107.740878; MILLS P, 1978, BRIT HEART J, V40, P951; Nistri S, 1999, HEART, V82, P19, DOI 10.1136/hrt.82.1.19; Nkomo VT, 2003, ARTERIOSCL THROM VAS, V23, P351, DOI 10.1161/01.ATV.0000055441.28842.0A; Otto CM, 1997, CIRCULATION, V95, P2262, DOI 10.1161/01.CIR.95.9.2262; Pellikka PA, 2005, CIRCULATION, V111, P3290, DOI 10.1161/CIRCULATIONAHA.104.495903; QUINONES MA, 1981, CIRCULATION, V64, P744, DOI 10.1161/01.CIR.64.4.744; Roberts WC, 2005, CIRCULATION, V111, P920, DOI 10.1161/01.CIR.0000155623.48408.C5; ROBERTS WC, 1970, AM J CARDIOL, V26, P72, DOI 10.1016/0002-9149(70)90761-7; Rosenhek R, 2000, NEW ENGL J MED, V343, P611, DOI 10.1056/NEJM200008313430903; Sabet HY, 1999, MAYO CLIN PROC, V74, P14, DOI 10.4065/74.1.14; Schaefer BM, 2007, AM J CARDIOL, V99, P686, DOI 10.1016/j.amjcard.2006.09.118; THANASSOULIS G, IN PRESS NAT CLIN PR; Therrien J, 2001, CAN J CARDIOL, V17, P1029; Tutar E, 2005, AM HEART J, V150, P513, DOI 10.1016/j.ahj.2004.10.036; Ward C, 2000, HEART, V83, P81, DOI 10.1136/heart.83.1.81; Weyman AE, 1994, PRINCIPLES PRACTICE, P1289; Yap SC, 2007, INT J CARDIOL, V122, P224, DOI 10.1016/j.ijcard.2006.11.092; Zoghbi WA, 2003, J AM SOC ECHOCARDIOG, V16, P777, DOI 10.1016/S0894-7317(03)00335-3	37	392	415	0	11	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1317	1325		10.1001/jama.300.11.1317	http://dx.doi.org/10.1001/jama.300.11.1317			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799444				2022-12-28	WOS:000259231100027
J	Ramachandran, V; Chen, XM				Ramachandran, Vanitharani; Chen, Xuemei			Degradation of microRNAs by a family of exoribonucleases in Arabidopsis	SCIENCE			English	Article							RIBOSOMAL-RNA; 5.8S; METHYLATION; PROTEIN; YEAST; ERI1	microRNAs ( miRNAs) play crucial roles in numerous developmental and metabolic processes in plants and animals. The steady- state levels of miRNAs need to be properly controlled to ensure normal development. Whereas the framework of miRNA biogenesis is established, factors involved in miRNA degradation remain unknown. Here, we show that a family of exoribonucleases encoded by the SMALL RNA DEGRADING NUCLEASE ( SDN) genes degrades mature miRNAs in Arabidopsis. SDN1 acts specifically on single- stranded miRNAs in vitro and is sensitive to the 2'-O-methyl modification on the 3' terminal ribose of miRNAs. Simultaneous knockdown of three SDN genes in vivo results in elevated miRNA levels and pleiotropic developmental defects. Therefore, we have uncovered the enzymes that degrade miRNAs and demonstrated that miRNA turnover is crucial for plant development.	[Ramachandran, Vanitharani; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Inst Integrat Genome Biol, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu		Chen, Xuemei/0000-0002-5209-1157	NSF [MCB-0718029]; NIH [GM61146]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank L. Bi for technical assistance and T. Dinh, L. Ji, B. Yu, and B. Zheng for helpful discussions and careful reading of the manuscript. This work was supported by grants from NSF (MCB-0718029) and NIH (GM61146) to X. C.	Ansel KM, 2008, NAT STRUCT MOL BIOL, V15, P523, DOI 10.1038/nsmb.1417; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Faber AW, 2004, RNA, V10, P1946, DOI 10.1261/rna.7155904; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Gabel HW, 2008, NAT STRUCT MOL BIOL, V15, P531, DOI 10.1038/nsmb.1411; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; van Hoof A, 2000, EMBO J, V19, P1357, DOI 10.1093/emboj/19.6.1357; Wu HJ, 2000, J BIOL CHEM, V275, P36957, DOI 10.1074/jbc.M005494200; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130	17	307	324	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1490	1492		10.1126/science.1163728	http://dx.doi.org/10.1126/science.1163728			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787168	Green Accepted			2022-12-28	WOS:000259121800041
J	Thorne, PW				Thorne, Peter W.			Arctic tropospheric warming amplification?	NATURE			English	Letter							REANALYSIS; TEMPERATURE		[Thorne, Peter W.] Met Off Hadley Ctr, Exeter EX1 3PB, Devon, England	Met Office - UK; Hadley Centre	Thorne, PW (corresponding author), Met Off Hadley Ctr, Fitzroy Rd, Exeter EX1 3PB, Devon, England.	peter.thorne@metoffice.gov.uk	Thorne, Peter W/R-6823-2017; Thorne, Peter/F-2225-2014	Thorne, Peter W/0000-0003-0485-9798; Thorne, Peter/0000-0003-0485-9798				Bengtsson L, 2004, TELLUS A, V56, P456, DOI 10.1111/j.1600-0870.2004.00079.x; Bengtsson L, 2007, B AM METEOROL SOC, V88, P495, DOI 10.1175/BAMS-88-4-495; Christy JR, 2003, J ATMOS OCEAN TECH, V20, P613, DOI 10.1175/1520-0426(2003)20<613:EEOVOM>2.0.CO;2; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Karl T. R., 2006, TEMPERATURE TRENDS L; Lanzante JR, 1996, INT J CLIMATOL, V16, P1197, DOI 10.1002/(SICI)1097-0088(199611)16:11<1197::AID-JOC89>3.0.CO;2-L; Mears CA, 2005, SCIENCE, V309, P1548, DOI 10.1126/science.1114772; Mears CA, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031936; Onogi K, 2007, J METEOROL SOC JPN, V85, P369, DOI 10.2151/jmsj.85.369; SHERWOOD S, UNPUB INT J CLIMATOL; Thorne PW, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005753; Thorne PW, 2005, B AM METEOROL SOC, V86, P1437, DOI 10.1175/BAMS-86-10-1437; Uppala SM, 2005, Q J ROY METEOR SOC, V131, P2961, DOI 10.1256/qj.04.176	14	33	35	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					E1	E2		10.1038/nature07256	http://dx.doi.org/10.1038/nature07256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784659	Green Accepted			2022-12-28	WOS:000259090800034
J	Barzansky, B; Etzel, SI				Barzansky, Barbara; Etzel, Sylvia I.			Medical schools in the United States, 2007-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Barzansky, Barbara; Etzel, Sylvia I.] Amer Med Assoc, Div Undergrad Med Educ, Chicago, IL 60654 USA; [Barzansky, Barbara; Etzel, Sylvia I.] Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association; American Medical Association	Barzansky, B (corresponding author), Amer Med Assoc, Div Undergrad Med Educ, 515 N State St, Chicago, IL 60654 USA.	barbara.barzansky@ama-assn.org							0	18	19	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1221	1227		10.1001/jama.300.10.1221	http://dx.doi.org/10.1001/jama.300.10.1221			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780853				2022-12-28	WOS:000259038700017
J	Harland, RM				Harland, Richard M.			A protein scaffold plays matchmaker for chordin	CELL			English	Editorial Material								In this issue, Inomata et al. (2008) report that the scaffold protein Olfactomedin 1 (ONT1) recruits the Tolloid proteases to their substrate Chordin, an antagonist of bone morphogenetic proteins (BMPs), during development of the frog embryo. Consequently, ONT1 expression in the organizer of the late gastrula stabilizes the gradient of BMP signaling that is essential for dorsoventral patterning.	[Harland, Richard M.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Harland, Richard M.] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Harland, RM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	harland@berkeley.edu						Bachiller D, 2003, DEVELOPMENT, V130, P3567, DOI 10.1242/dev.00581; Ben-Zvi D, 2008, NATURE, V453, P1205, DOI 10.1038/nature07059; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Little Shawn C., 2006, Birth Defects Research, V78, P224, DOI 10.1002/bdrc.20079; Matus DQ, 2006, CURR BIOL, V16, P499, DOI 10.1016/j.cub.2006.01.052; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047	8	5	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					718	719		10.1016/j.cell.2008.08.024	http://dx.doi.org/10.1016/j.cell.2008.08.024			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775302	Bronze			2022-12-28	WOS:000258947500009
J	Prabhakar, S; Visel, A; Akiyama, JA; Shoukry, M; Lewis, KD; Holt, A; Plajzer-Frick, I; Morrison, H; FitzPatrick, DR; Afzal, V; Pennacchio, LA; Rubin, EM; Noonan, JP				Prabhakar, Shyam; Visel, Axel; Akiyama, Jennifer A.; Shoukry, Malak; Lewis, Keith D.; Holt, Amy; Plajzer-Frick, Ingrid; Morrison, Harris; FitzPatrick, David R.; Afzal, Veena; Pennacchio, Len A.; Rubin, Edward M.; Noonan, James P.			Human-specific gain of function in a developmental enhancer	SCIENCE			English	Article							NONCODING SEQUENCES; GENE-EXPRESSION; HUMAN GENOME; EVOLUTION; ADAPTATION; VERTEBRATE; ELEMENTS; MICE	Changes in gene regulation are thought to have contributed to the evolution of human development. However, in vivo evidence for uniquely human developmental regulatory function has remained elusive. In transgenic mice, a conserved noncoding sequence (HACNS1) that evolved extremely rapidly in humans acted as an enhancer of gene expression that has gained a strong limb expression domain relative to the orthologous elements from chimpanzee and rhesus macaque. This gain of function was consistent across two developmental stages in the mouse and included the presumptive anterior wrist and proximal thumb. In vivo analyses with synthetic enhancers, in which human- specific substitutions were introduced into the chimpanzee enhancer sequence or reverted in the human enhancer to the ancestral state, indicated that 13 substitutions clustered in an 81- base pair module otherwise highly constrained among terrestrial vertebrates were sufficient to confer the human- specific limb expression domain.	[Prabhakar, Shyam; Visel, Axel; Akiyama, Jennifer A.; Shoukry, Malak; Lewis, Keith D.; Holt, Amy; Plajzer-Frick, Ingrid; Afzal, Veena; Pennacchio, Len A.; Rubin, Edward M.; Noonan, James P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Morrison, Harris; FitzPatrick, David R.] Western Gen Hosp, MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland; [Pennacchio, Len A.; Rubin, Edward M.] US Dept Energy Joint Genome Inst, Walnut Creek, CA 94598 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of Edinburgh; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Rubin, EM (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA.	emrubin@lbl.gov; james.noonan@yale.edu	FitzPatrick, David R/C-7301-2013; Noonan, James/ABF-1320-2021; Visel, Axel/A-9398-2009	Visel, Axel/0000-0002-4130-7784; FitzPatrick, David R./0000-0003-4861-969X; Pennacchio, Len/0000-0002-8748-3732	National Heart, Lung and Blood Institute [HL066681]; National Human Genome Research Institute [HG003988]; Agency for Science, Technology, and Research of Singapore; American Heart Association postdoctoral fellowship; NIH National Research Service Award fellowship [1-F32-GM074367]; Department of Genetics, Yale University School of Medicine; MRC [MC_U127561093] Funding Source: UKRI; Medical Research Council [MC_U127561093] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM074367] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR)); American Heart Association postdoctoral fellowship(American Heart Association); NIH National Research Service Award fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Genetics, Yale University School of Medicine; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Pennacchio and Rubin laboratories for critical comments on the manuscript. Research was done under Department of Energy Contract DE-AC02-05CH11231, University of California, E. O. Lawrence Berkeley National Laboratory, and supported by National Heart, Lung and Blood Institute grant HL066681 and National Human Genome Research Institute grant HG003988 (L.A.P.); the Agency for Science, Technology, and Research of Singapore (S.P.); an American Heart Association postdoctoral fellowship (A.V.); and NIH National Research Service Award fellowship 1-F32-GM074367 and the Department of Genetics, Yale University School of Medicine (J.P.N.).	Bird CP, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r118; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boffelli D, 2004, NAT REV GENET, V5, P456, DOI 10.1038/nrg1350; Bush EC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-17; Carroll SB, 2003, NATURE, V422, P849, DOI 10.1038/nature01495; Galtier N, 2007, TRENDS GENET, V23, P273, DOI 10.1016/j.tig.2007.03.011; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; KOTHARY R, 1989, DEVELOPMENT, V105, P707; NEUBUSER A, 1995, DEV BIOL, V170, P701, DOI 10.1006/dbio.1995.1248; Nie ZZ, 2002, J BIOL CHEM, V277, P48965, DOI 10.1074/jbc.M202969200; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pollard KS, 2006, PLOS GENET, V2, P1599, DOI 10.1371/journal.pgen.0020168; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; TRINKAUS E, 1993, CAMBRIDGE ENCY HUMAN, P346; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Warming S, 2004, ONCOGENE, V23, P2727, DOI 10.1038/sj.onc.1207452; Wassarman KM, 1997, DEVELOPMENT, V124, P2923; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	25	221	226	2	46	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1346	1350		10.1126/science.1159974	http://dx.doi.org/10.1126/science.1159974			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772437	Green Accepted			2022-12-28	WOS:000258914300048
J	Huang, J; Lesser, CF; Lory, S				Huang, Jin; Lesser, Cammie F.; Lory, Stephen			The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth	NATURE			English	Article							III SECRETION; SACCHAROMYCES-CEREVISIAE; INFECTED CELLS; HELA-CELLS; YEAST; EXPRESSION; BACTERIAL; IDENTIFICATION; TRANSLOCATION; APOPTOSIS	Bacterial virulence determinants can be identified, according to the molecular Koch's postulates(1), if inactivation of a gene associated with a suspected virulence trait results in a loss in pathogenicity. This approach is commonly used with genetically tractable organisms. However, the current lack of tools for targeted gene disruptions in obligate intracellular microbial pathogens seriously hampers the identification of their virulence factors. Here we demonstrate an approach to studying potential virulence factors of genetically intractable organisms, such as Chlamydia. Heterologous expression of Chlamydia pneumoniae CopN in yeast and mammalian cells resulted in a cell cycle arrest, presumably owing to alterations in the microtubule cytoskeleton. A screen of a small molecule library identified two compounds that alleviated CopN-induced growth inhibition in yeast. These compounds interfered with C. pneumoniae replication in mammalian cells, presumably by 'knocking out' CopN function, revealing an essential role of CopN in the support of C. pneumoniae growth during infection. This work demonstrates the role of a specific chlamydial protein in virulence. The chemical biology approach described here can be used to identify virulence factors, and the reverse chemical genetic strategy can result in the identification of lead compounds for the development of novel therapeutics.	[Huang, Jin; Lesser, Cammie F.; Lory, Stephen] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA; [Lesser, Cammie F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Lory, S (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.	stephen_lory@hms.harvard.edu			NIAID NIH HHS [R01 AI064285-03, R01 AI064285] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064285] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		[Anonymous], 2003, METH MOL B; Campbell LA, 2004, NAT REV MICROBIOL, V2, P23, DOI 10.1038/nrmicro796; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Carabeo RA, 2002, INFECT IMMUN, V70, P3793, DOI 10.1128/IAI.70.7.3793-3803.2002; Chen YJ, 1996, EMBO J, V15, P3853, DOI 10.1002/j.1460-2075.1996.tb00759.x; CROCKER TT, 1965, J INFECT DIS, V115, P105, DOI 10.1093/infdis/115.2.105; Cross NA, 1999, ANTIMICROB AGENTS CH, V43, P2311, DOI 10.1128/AAC.43.9.2311; Day JB, 2003, MOL MICROBIOL, V47, P807, DOI 10.1046/j.1365-2958.2003.03343.x; Dorer RK, 2005, CURR BIOL, V15, P1070, DOI 10.1016/j.cub.2005.05.020; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; Fields KA, 2003, MOL MICROBIOL, V48, P671, DOI 10.1046/j.1365-2958.2003.03462.x; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Guichon A, 2001, J BACTERIOL, V183, P1269, DOI 10.1128/JB.183.4.1269-1276.2001; Hackstadt T, 1999, CHLAMYDIA, P101; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; HOROSCHAK KD, 1978, INFECT IMMUN, V19, P281, DOI 10.1128/IAI.19.1.281-286.1978; Hsia RC, 1997, MOL MICROBIOL, V25, P351, DOI 10.1046/j.1365-2958.1997.4701834.x; Huang J, 2002, P NATL ACAD SCI USA, V99, P3914, DOI 10.1073/pnas.062578399; Khan MA, 1996, J ANTIMICROB CHEMOTH, V37, P677, DOI 10.1093/jac/37.4.677; Lee VT, 1998, MOL MICROBIOL, V28, P593, DOI 10.1046/j.1365-2958.1998.00822.x; Lesser CF, 2001, EMBO J, V20, P1840, DOI 10.1093/emboj/20.8.1840; Li D, 2005, J MICROBIOL METH, V61, P17, DOI 10.1016/j.mimet.2004.10.020; Lugert R, 2004, MED MICROBIOL IMMUN, V193, P163, DOI 10.1007/s00430-003-0206-x; MILLER RK, 2003, METH MOL B, V241, P341; MOULDER JW, 1982, CHLAMYDIA INFECTI S1, V10, pS10; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oswald E, 2005, CURR OPIN MICROBIOL, V8, P83, DOI 10.1016/j.mib.2004.12.011; Perkins E, 2001, CANCER RES, V61, P4175; Peters J, 2007, TRENDS MICROBIOL, V15, P241, DOI 10.1016/j.tim.2007.04.005; Shafikhani SH, 2006, P NATL ACAD SCI USA, V103, P15605, DOI 10.1073/pnas.0605949103; Siggers KA, 2008, CELL HOST MICROBE, V4, P8, DOI 10.1016/j.chom.2008.06.004; Sisko JL, 2006, MOL MICROBIOL, V60, P51, DOI 10.1111/j.1365-2958.2006.05074.x; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tugendreich S, 2001, GENOME RES, V11, P1899, DOI 10.1101/gr.191601; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003; Verma A, 2003, INFECT IMMUN, V71, P5772, DOI 10.1128/IAI.71.10.5772-5784.2003; Zhang Hong, 2004, Methods Mol Biol, V241, P77	38	52	54	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					112	U10		10.1038/nature07355	http://dx.doi.org/10.1038/nature07355			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18830244	Green Accepted			2022-12-28	WOS:000260674000051
J	Esteve, J; Gross, C; Weller, A; Giovanazzi, S; Oberthaler, MK				Esteve, J.; Gross, C.; Weller, A.; Giovanazzi, S.; Oberthaler, M. K.			Squeezing and entanglement in a Bose-Einstein condensate	NATURE			English	Article							STATES	Entanglement, a key feature of quantum mechanics, is a resource that allows the improvement of precision measurements beyond the conventional bound attainable by classical means(1). This results in the standard quantum limit, which is reached in today's best available sensors of various quantities such as time(2) and position(3,4). Many of these sensors are interferometers in which the standard quantum limit can be overcome by using quantum-entangled states (in particular spin squeezed states(5,6)) at the two input ports. Bose-Einstein condensates of ultracold atoms are considered good candidates to provide such states involving a large number of particles. Here we demonstrate spin squeezed states suitable for atomic interferometry by splitting a condensate into a few parts using a lattice potential. Site-resolved detection of the atoms allows the measurement of the atom number difference and relative phase, which are conjugate variables. The observed fluctuations imply entanglement between the particles(7-9), a resource that would allow a precision gain of 3.8 dB over the standard quantum limit for interferometric measurements.	[Esteve, J.; Gross, C.; Weller, A.; Giovanazzi, S.; Oberthaler, M. K.] Heidelberg Univ, Kirchhoff Inst Phys, D-69120 Heidelberg, Germany	Ruprecht Karls University Heidelberg	Oberthaler, MK (corresponding author), Heidelberg Univ, Kirchhoff Inst Phys, Neuenheimer Feld 227, D-69120 Heidelberg, Germany.	entanglement@matterwave.de	Esteve, Jerome/G-1084-2014; Giovanazzi, Stefano/C-2158-2012; Gross, Christian/P-5475-2014	Esteve, Jerome/0000-0002-1556-8120; Gross, Christian/0000-0003-2292-5234	DFG; GIF; EC (MIDAS STREP); EC Marie-Curie program; Landesgraduiertenforderung Baden-Wurttemberg	DFG(German Research Foundation (DFG)); GIF(German-Israeli Foundation for Scientific Research and Development); EC (MIDAS STREP)(European CommissionEuropean Commission Joint Research Centre); EC Marie-Curie program(European Commission); Landesgraduiertenforderung Baden-Wurttemberg	We gratefully acknowledge support from the DFG, GIF and EC (MIDAS STREP). J. E. acknowledges support from the EC Marie-Curie program. C. G. acknowledges support from the Landesgraduiertenforderung Baden-Wurttemberg.	Arcizet O, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.133601; Chaudhury S, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.163002; Esteve J, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130403; FERNHOLZ T, 2008, SPIN SQUEEZING ATOMI; Gerbier F, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.090401; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Goda K, 2008, NAT PHYS, V4, P472, DOI 10.1038/nphys920; Greiner M, 2002, NATURE, V419, P51, DOI 10.1038/nature00968; Hald J, 1999, PHYS REV LETT, V83, P1319, DOI 10.1103/PhysRevLett.83.1319; Javanainen J, 1999, PHYS REV A, V60, P4902, DOI 10.1103/PhysRevA.60.4902; Jo GB, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.030407; Julsgaard B, 2001, NATURE, V413, P400, DOI 10.1038/35096524; KITAGAWA M, 1993, PHYS REV A, V47, P5138, DOI 10.1103/PhysRevA.47.5138; Korbicz JK, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.052319; Korbicz JK, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.120502; Kuzmich A, 2000, PHYS REV LETT, V85, P1594, DOI 10.1103/PhysRevLett.85.1594; Leibfried D, 2004, SCIENCE, V304, P1476, DOI 10.1126/science.1097576; Li W, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.040402; Meyer V, 2001, PHYS REV LETT, V86, P5870, DOI 10.1103/PhysRevLett.86.5870; Orzel C, 2001, SCIENCE, V291, P2386, DOI 10.1126/science.1058149; Reinaudi G, 2007, OPT LETT, V32, P3143, DOI 10.1364/OL.32.003143; Roos CF, 2004, SCIENCE, V304, P1478, DOI 10.1126/science.1097522; Santarelli C, 1999, PHYS REV LETT, V82, P4619, DOI 10.1103/PhysRevLett.82.4619; Sebby-Strabley J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.200405; Sorensen A, 2001, NATURE, V409, P63, DOI 10.1038/35051038; Sorensen AS, 2001, PHYS REV LETT, V86, P4431, DOI 10.1103/PhysRevLett.86.4431; Wang XG, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.012101; WINELAND DJ, 1994, PHYS REV A, V50, P67, DOI 10.1103/PhysRevA.50.67	28	572	576	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1216	1219		10.1038/nature07332	http://dx.doi.org/10.1038/nature07332			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18830245	Green Submitted			2022-12-28	WOS:000260462100038
J	Feehally, J; Griffith, KE; Lamb, EJ; O'Donoghue, DJ; Tomson, CRV				Feehally, J.; Griffith, K. E.; Lamb, E. J.; O'Donoghue, D. J.; Tomson, C. R. V.			Early detection of chronic kidney disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOMERULAR-FILTRATION-RATE; POPULATION; MANAGEMENT; EQUATIONS		[Feehally, J.] Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England; [Griffith, K. E.] Wenlock Terrace Surg, York, N Yorkshire, England; [Lamb, E. J.] E Kent Hosp NHS Trust, Canterbury, Kent, England; [O'Donoghue, D. J.] Dept Hlth, London SE1 6TE, England; [O'Donoghue, D. J.] Salford Royal Hosp NHS Trust, Salford, Lancs, England; [Tomson, C. R. V.] N Bristol Hosp NHS Trust, Bristol, Avon, England	University Hospitals of Leicester NHS Trust; University of Leicester; Salford Royal NHS Foundation Trust; Salford Royal Hospital	Feehally, J (corresponding author), Univ Hosp Leicester NHS Trust, Leicester LE5 4PW, Leics, England.	jf27@le.ac.uk		Tomson, Charles/0000-0002-0224-8726				[Anonymous], 2003, EPIDEMIOLOGY UNINITI; *DEP HLTH, 2004, NAT QUAL REQ DEL OUT, P1; Department of Health, 2005, NAT SERV FRAM LONG T, P1; Giles PD, 2007, BMJ-BRIT MED J, V334, P1198, DOI 10.1136/bmj.39226.400694.80; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; *INF CTR, 2007, NAT QUAL OUTC FRAM S; Joint Specialty Committee on Renal Medicine of the Royal College of Physicians and the Renal Association and the Royal College of General Practitioners, 2006, CHRON KIDN DIS AD UK; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; *KIDN DIS QUAL OUT, 2002, K DOQI CLIN PRACT GU; Klebe B, 2007, NEPHROL DIAL TRANSPL, V22, P2504, DOI 10.1093/ndt/gfm248; Lamb EJ, 2007, AGE AGEING, V36, P689, DOI 10.1093/ageing/afm121; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Mathew TH, 2007, MED J AUSTRALIA, V187, P459, DOI 10.5694/j.1326-5377.2007.tb01357.x; Murthy K, 2005, KIDNEY INT, V68, P1884, DOI 10.1111/j.1523-1755.2005.00608.x; *NHS EMPL, 2008, QUAL OUTC FRAM; Preiss DJ, 2007, ANN CLIN BIOCHEM, V44, P35, DOI 10.1258/000456307779595995; Quinn MP, 2008, NEPHROL DIAL TRANSPL, V23, P542, DOI 10.1093/ndt/gfm599; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P549, DOI 10.1093/ndt/gfm857; Richards N, 2008, NEPHROL DIAL TRANSPL, V23, P556, DOI 10.1093/ndt/gfm839; Sarnak MJ, 2003, AM J KIDNEY DIS, V41, pS11, DOI 10.1016/S0272-6386(03)00372-X; *SCOTT INT GUID NE, 2008, DIAGN MAN CHRON KIDN	21	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 11	2008	337	7674							a1618	10.1136/bmj.a1618	http://dx.doi.org/10.1136/bmj.a1618			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18829639				2022-12-28	WOS:000259903300031
J	Holt, TA; Holt, CJ				Holt, Tim A.; Holt, Claire J.			10-minute consultation - Raised blood glucose concentration	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Holt, Tim A.] Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England; [Holt, Claire J.] Kenyon Med Ctr, Coventry CV3 3AD, W Midlands, England	University of Warwick	Holt, TA (corresponding author), Univ Warwick, Hlth Sci Res Inst, Coventry CV4 7AL, W Midlands, England.	tim.holt@warwick.ac.uk							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1073	10.1136/bmj.a1073	http://dx.doi.org/10.1136/bmj.a1073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18818257				2022-12-28	WOS:000259903300039
J	Wahlgren, N; Ahmed, N; Davalos, A; Hacke, W; Millan, M; Muir, K; Roine, RO; Toni, D; Lees, KR				Wahlgren, Nils; Ahmed, Niaz; Davalos, Antoni; Hacke, Werner; Millan, Monica; Muir, Keith; Roine, Risto O.; Toni, Danilo; Lees, Kennedy R.		SITS Investigators	Thrombolysis with alteplase 3-4 center dot 5 h after acute ischaemic stroke (SITS-ISTR): an observational study	LANCET			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; CONTROLLED-TRIAL; DOUBLE-BLIND; ECASS II; THERAPY; ASSOCIATION; MULTICENTER; GUIDELINES; MANAGEMENT; ATLANTIS	Background Intravenous alteplase is approved for use within 3 h of ischaemic stroke onset, although a meta-analysis of randomised controlled trials suggests treatment benefit up to 4.5 h. We compared outcome in patients treated between 3 h and 4.5 h versus those treated within 3 h, who were recorded in the in the Safe Implementation of Treatments in Stroke (SITS), a prospective internet-based audit of the International Stroke Thrombolysis Registry (ISTR). Methods We compared 664 patients presenting with ischaemic stroke and given intravenous altepase (0.9 mg/kg total dose) between 3 h and 4.5 h with 11865 patients treated within 3 h. All patients were otherwise compliant with European summary of product characteristics criteria and had been documented in the international stroke treatment registry between Dec 25, 2002, and Nov 15, 2007. Outcome measures were symptomatic intracerebral haemorrhage within 24 h (haemorrhage type 2 associated with National Institutes of Health Stroke Scale [NIHSS] >= 4 points deterioration), and mortality and independence (modified Rankin scale of 0-2) at 3 months. Findings in the 3-4.5-h cohort, treatment was started at a median of 55 min later after symptom onset (195 min [IQR 187-210] vs 140 min [115-165], p<0.0001), median age was 3 years younger (65 years [55-73] vs 68 years [58-74], p<0.0001), and stroke severity was lower (NIHSS score 11 [7-16] vs 12 [8-17], p<0.0001) than in the 3-h cohort. We recorded no significant differences between the 3-4.5-h cohort and the within 3-h cohort for any outcome measure-rate of symptomatic intracerebral haemorrhage: 2.2% (14 of 649) versus 1.6% (183 of 11681) (odds ratio [OR] 1.18 [95% CI 0.89-1.55], p=0.24; adjusted OR 1.32 [1.00-1.75], p=0.052); mortality: 12.7% (70 of 551) versus 12.2% (1263 of 10368) (OR 1.02 [0.90-1.17]; p=0.72; adjusted OR 1.15 [1.00-1.33]; p=0.053); and independence: 58.0% (314 of 541) versus 56.3% (5756 of 10231) (OR 1.04 [0.95-1.13], p=0.42; adjusted OR 0.93 [0.84-1.031, p=0.18). Interpretation Alteplase remains safe when given at 3-4.5 h after ischaemic stroke, offering an opportunity for patients who cannot be treated within the standard 3-h timeframe. Funding Boehringer-Ingelheim, European Union Public Health Executive Authority.	[Wahlgren, Nils; Ahmed, Niaz] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden; [Davalos, Antoni; Millan, Monica] Hosp Badalona Germans Trias & Pujol, Dept Neurosci, Barcelona, Spain; [Hacke, Werner] Univ Heidelberg, Dept Neurol, Heidelberg, Germany; [Muir, Keith] Univ Glasgow, Div Clin Neurosci, Fac Med, Glasgow, Lanark, Scotland; [Lees, Kennedy R.] Univ Glasgow, Dept Med, Glasgow, Lanark, Scotland; [Roine, Risto O.] Univ Turku, Cent Hosp, Dept Neurol, FIN-20520 Turku, Finland; [Toni, Danilo] Univ Roma La Sapienza, Dept Neurol, Dept Neurol Sci, Rome, Italy	Karolinska Institutet; Hospital Germans Trias i Pujol; Ruprecht Karls University Heidelberg; University of Glasgow; University of Glasgow; University of Turku; Sapienza University Rome	Wahlgren, N (corresponding author), Karolinska Univ Hosp, SITS Int Coordinat Off, Dept Neurol, SE-17176 Stockholm, Sweden.	nils.wahlgren@karolinska.se	Hacke, Werner/ABE-8661-2020; Viana-Baptista, Miguel/AAW-6791-2020; Toni, Danilo/K-3151-2016; Muir, Keith W/A-7670-2011; Ahmed, Niaz/AAV-4361-2020; Ahmed, Niaz/G-6717-2013	Viana-Baptista, Miguel/0000-0001-6166-2073; Toni, Danilo/0000-0003-2735-8427; Muir, Keith W/0000-0001-9535-022X; Ahmed, Niaz/0000-0001-7970-0146	Boehringer-Ingelheim; European Union Public Health Executive Authority (PHEA)	Boehringer-Ingelheim(Boehringer Ingelheim); European Union Public Health Executive Authority (PHEA)(European Commission)	SITS-ISTR is funded by an unrestricted grant from Boehringer-Ingelheim, and by a grant from European Union Public Health Executive Authority (PHEA). Financial support was also provided through the regional agreement on medical training and research (ALF) between Stockholm County Council and the Karolinska Institute. Zoe A Preston received funding from Boehringer Ingelheim to provide editorial assistance in the coordination of the submission. The views expressed are those of the authors. Uppsala Clinical Research (UCR) centre (Sweden) develops, maintains, and upgrades the software for SITS register in close collaboration with SITS. UCR team members are Soren Gustavsson, Botond Pakucs, Olof Felton, and Niclas Eriksson. Alteplase (recombinant tissue plasminogen activator) is not approved in the USA or Europe for routine use in acute ischaemic stroke when initiated beyond 3 h from symptom onset. We thank all the SITS-ISTR investigators and their centres for their participation (webappendix), and all the patients who participated in SITS-ISTR.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Clark WM, 1999, JAMA-J AM MED ASSOC, V282, P2019, DOI 10.1001/jama.282.21.2019; Clark WM, 2000, STROKE, V31, P811, DOI 10.1161/01.STR.31.4.811; Hacke W, 1998, LANCET, V352, P1245, DOI 10.1016/S0140-6736(98)08020-9; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hacke W, 2004, LANCET, V363, P768; HACKE W, IN PRESS N ENGL J ME; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Larrue V, 2001, STROKE, V32, P438, DOI 10.1161/01.STR.32.2.438; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E; Schellinger PD, 2007, STROKE, V38, P2640, DOI 10.1161/STROKEAHA.107.483255; Uyttenboogaart M, 2007, J NEUROL SCI, V254, P28, DOI 10.1016/j.jns.2006.12.011; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; WAHLGREN N, 2008, IN PRESS STROKE; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Wardlaw JM, 2003, STROKE, V34, P1437, DOI 10.1161/01.STR.0000072513.72262.7E	19	428	455	1	22	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1303	1309		10.1016/S0140-6736(08)61339-2	http://dx.doi.org/10.1016/S0140-6736(08)61339-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18790527				2022-12-28	WOS:000260060500028
J	Zaman, K; Roy, E; Arifeen, SE; Rahman, M; Raqib, R; Wilson, E; Omer, SB; Shahid, NS; Breiman, RE; Steinhoff, MC				Zaman, K.; Roy, Eliza; Arifeen, Shams E.; Rahman, Mahbubur; Raqib, Rubhana; Wilson, Emily; Omer, Saad B.; Shahid, Nigar S.; Breiman, Robert E.; Steinhoff, Mark C.			Effectiveness of maternal influenza immunization in mothers and infants	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PNEUMOCOCCAL PNEUMONIA; RESPIRATORY-INFECTIONS; OUTPATIENT VISITS; PREGNANT-WOMEN; VACCINE; CHILDREN; HOSPITALIZATIONS; ILLNESS; VIRUS; ANTIBODY	Background: Young infants and pregnant women are at increased risk for serious consequences of influenza infection. Inactivated influenza vaccine is recommended for pregnant women but is not licensed for infants younger than 6 months of age. We assessed the clinical effectiveness of inactivated influenza vaccine administered during pregnancy in Bangladesh. Methods: In this randomized study, we assigned 340 mothers to receive either inactivated influenza vaccine (influenza-vaccine group) or the 23-valent pneumococcal polysaccharide vaccine (control group). Mothers were interviewed weekly to assess illnesses until 24 weeks after birth. Subjects with febrile respiratory illness were assessed clinically, and ill infants were tested for influenza antigens. We estimated the incidence of illness, incidence rate ratios, and vaccine effectiveness. Results: Mothers and infants were observed from August 2004 through December 2005. Among infants of mothers who received influenza vaccine, there were fewer cases of laboratory-confirmed influenza than among infants in the control group (6 cases and 16 cases, respectively), with a vaccine effectiveness of 63% (95% confidence interval [CI], 5 to 85). Respiratory illness with fever occurred in 110 infants in the influenza-vaccine group and 153 infants in the control group, with a vaccine effectiveness of 29% (95% CI, 7 to 46). Among the mothers, there was a reduction in the rate of respiratory illness with fever of 36% (95% CI, 4 to 57). Conclusions: Inactivated influenza vaccine reduced proven influenza illness by 63% in infants up to 6 months of age and averted approximately a third of all febrile respiratory illnesses in mothers and young infants. Maternal influenza immunization is a strategy with substantial benefits for both mothers and infants. (ClinicalTrials.gov number, NCT00142389.).	[Zaman, K.; Roy, Eliza; Arifeen, Shams E.; Rahman, Mahbubur; Raqib, Rubhana; Shahid, Nigar S.; Breiman, Robert E.] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Wilson, Emily; Omer, Saad B.; Steinhoff, Mark C.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Omer, Saad B.] Johns Hopkins Univ, Inst Vaccine Safety, Baltimore, MD USA; [Steinhoff, Mark C.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA	International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Steinhoff, MC (corresponding author), Childrens Hosp, Childrens Global Hlth Ctr, 3333 Burnet Ave,MLC 2048, Cincinnati, OH 45229 USA.	m.steinhoff@gmail.com	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Arifeen, Shams/0000-0002-5372-5932; Raqib, Rubhana/0000-0002-8116-4511	Bill and Melinda Gates Foundation; Department of Health and Human Services; National Vaccine Program Office; Wyeth Pharmaceuticals; Thrasher Research Fund; Aventis Pasteur; International Centre for Diarrheal Disease Research; Bloomberg School of Public Health at Johns Hopkins University; Merck; USAID; GlaxoSmithKline; Sanofi-Aventis	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Department of Health and Human Services; National Vaccine Program Office; Wyeth Pharmaceuticals(Wyeth); Thrasher Research Fund; Aventis Pasteur; International Centre for Diarrheal Disease Research; Bloomberg School of Public Health at Johns Hopkins University; Merck(Merck & Company); USAID(United States Agency for International Development (USAID)); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis)	Supported by the Bill and Melinda Gates Foundation, a cooperative agreement (HRN-A-0096-90006-00) with the U. S. Agency for International Development ( USAID), the Department of Health and Human Services, the National Vaccine Program Office, Wyeth Pharmaceuticals, the Thrasher Research Fund, Aventis Pasteur, the International Centre for Diarrheal Disease Research, and the Bloomberg School of Public Health at Johns Hopkins University.; Dr. Breiman reports receiving research support from Merck, the Bill and Melinda Gates Foundation, and USAID. Dr. Steinhoff, receiving research support from the Bill and Melinda Gates Foundation, USAID, the Thrasher Fund, Wyeth, GlaxoSmithKline, Sanofi-Aventis, and Merck and lecture fees from GlaxoSmithKline and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported.; We thank Dr. Mizanur Rahman, Prof. A. B. Bhuiyan, Dr. Kazi Nurun Nabi, and Dr. David Sack for their assistance in the project; Dr. L. Moulton for useful discussions and helpful advice; Dr. Shelia Salisbury for statistical assistance; Dr. Regina Rabinowitz for persistent support and useful suggestions; the field and data-management team for their efforts; and the families who participated in the project.	[Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Black SB, 2004, AM J PERINAT, V21, P333, DOI 10.1055/s-2004-831888; Brown AS, 2004, ARCH GEN PSYCHIAT, V61, P774, DOI 10.1001/archpsyc.61.8.774; Chiu SS, 2002, NEW ENGL J MED, V347, P2097, DOI 10.1056/NEJMoa020546; Dagan R, 2001, PEDIATR INFECT DIS J, V20, P951, DOI 10.1097/00006454-200110000-00008; ENGLUND JA, 1993, J INFECT DIS, V168, P647, DOI 10.1093/infdis/168.3.647; France EK, 2006, ARCH PEDIAT ADOL MED, V160, P1277, DOI 10.1001/archpedi.160.12.1277; Glezen WP, 1997, PEDIATR INFECT DIS J, V16, P1065, DOI 10.1097/00006454-199711000-00012; GROOTHUIS JR, 1991, PEDIATRICS, V87, P823; Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; HEIKKINEN T, 1991, AM J DIS CHILD, V145, P445, DOI 10.1001/archpedi.1991.02160040103017; HEINONEN OP, 1973, INT J EPIDEMIOL, V2, P229, DOI 10.1093/ije/2.3.229; HOWIE PW, 1990, BRIT MED J, V300, P11, DOI 10.1136/bmj.300.6716.11; HUQ F, 1990, REV INFECT DIS, V12, pS982; *INT CTR DIARRH DI, 2006, BANGLADESH ICDDR B H, V4, P1; Izurieta HS, 2000, NEW ENGL J MED, V342, P232, DOI 10.1056/NEJM200001273420402; JOHN TJ, 1991, REV INFECT DIS, V13, pS463; Kelly H, 2004, VACCINE, V22, P2192, DOI 10.1016/j.vaccine.2003.11.052; Lehmann D, 2003, VACCINE, V21, P3446, DOI 10.1016/S0264-410X(03)00348-7; Lindsay L, 2006, AM J EPIDEMIOL, V163, P838, DOI 10.1093/aje/kwj095; Lucero MG, 2005, LANCET, V365, P1113, DOI 10.1016/S0140-6736(05)71853-5; Munoz Flor M, 2003, Paediatr Respir Rev, V4, P99, DOI 10.1016/S1526-0542(03)00027-7; Munoz FM, 2005, AM J OBSTET GYNECOL, V192, P1098, DOI 10.1016/j.ajog.2004.12.019; Naleway AL, 2006, EPIDEMIOL REV, V28, P47, DOI 10.1093/epirev/mxj002; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Noyola DE, 2000, PEDIATR DEVEL PATHOL, V3, P162, DOI 10.1007/s100240050020; O'Brien KL, 2000, CLIN INFECT DIS, V30, P784, DOI 10.1086/313772; PICKERING LK, 2005, RED BOOK 2006 REPORT, P401; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; PUCK JM, 1980, J INFECT DIS, V142, P844, DOI 10.1093/infdis/142.6.844; REUMAN PD, 1987, PEDIATR INFECT DIS J, V6, P398, DOI 10.1097/00006454-198704000-00011; RILEY ID, 1981, REV INFECT DIS, V3, P233; Rodriguez WJ, 2002, PEDIATR INFECT DIS J, V21, P193, DOI 10.1097/00006454-200203000-00006; Scott JAG, 2007, VACCINE, V25, P2398, DOI 10.1016/j.vaccine.2006.09.008; SHAHID NS, 1995, LANCET, V346, P1252, DOI 10.1016/S0140-6736(95)91861-2; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Zangwill KM, 2004, PEDIATR INFECT DIS J, V23, P189, DOI 10.1097/01.inf.0000116292.46143.d6	41	873	912	1	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1555	1564		10.1056/NEJMoa0708630	http://dx.doi.org/10.1056/NEJMoa0708630			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FS	18799552				2022-12-28	WOS:000259903100004
J	Ahn, J; Brook, EJ				Ahn, Jinho; Brook, Edward J.			Atmospheric CO2 and climate on millennial time scales during the last glacial period	SCIENCE			English	Article							ICE-CORE; GREENLAND; ANTARCTICA; PACIFIC; RECORDS	Reconstructions of ancient atmospheric carbon dioxide (CO2) variations help us better understand how the global carbon cycle and climate are linked. We compared CO2 variations on millennial time scales between 20,000 and 90,000 years ago with an Antarctic temperature proxy and records of abrupt climate change in the Northern Hemisphere. CO2 concentration and Antarctic temperature were positively correlated over millennial- scale climate cycles, implying a strong connection to Southern Ocean processes. Evidence from marine sediment proxies indicates that CO2 concentration rose most rapidly when North Atlantic Deep Water shoaled and stratification in the Southern Ocean was reduced. These increases in CO2 concentration occurred during stadial (cold) periods in the Northern Hemisphere, several thousand years before abrupt warming events in Greenland.	[Ahn, Jinho; Brook, Edward J.] Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA	Oregon State University	Ahn, J (corresponding author), Oregon State Univ, Dept Geosci, Corvallis, OR 97331 USA.	jinhoahn@gmail.com	Brook, Edward/AAB-7807-2021		Gary Comer Science and Education Foundation; NSF [OPP 0337891, ATM 0602395]	Gary Comer Science and Education Foundation; NSF(National Science Foundation (NSF))	We thank K. Howell, Q. Ouada, J. Lee, and L. Mitchell for assistance in gas chromatographic analysis; the staff of the National Ice Core Lab for ice sampling and curation; and S. Terhune for invaluable technical assistance. We also thank P. Clark, A. Schmittner, A. Mix, N. Pisias, and J. Stoner (Oregon State University) for helpful discussions. Financial support was provided by the Gary Comer Science and Education Foundation, and NSF grants OPP 0337891 and ATM 0602395.	Ahn JH, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029551; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Blunier T, 2001, SCIENCE, V291, P109, DOI 10.1126/science.291.5501.109; BOND G, 1993, NATURE, V365, P143, DOI 10.1038/365143a0; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Grachev AM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029799; GROOTES PM, 1993, NATURE, V366, P552, DOI 10.1038/366552a0; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kohler P, 2005, CLIM DYNAM, V25, P689, DOI 10.1007/s00382-005-0058-8; Lambert F, 2008, NATURE, V452, P616, DOI 10.1038/nature06763; Marchal O, 1998, PALEOCEANOGRAPHY, V13, P225, DOI 10.1029/98PA00726; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001445; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rashid H, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000913; Robinson RS, 2007, QUATERNARY SCI REV, V26, P201, DOI 10.1016/j.quascirev.2006.08.005; Rothlisberger R, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020338; SAMTHEIN M, 2001, N N ATLANTIC CHANGIN, P365; SCHMITTNER A, 2007, AGU GEOPHYSICAL MONO, V173, P315; SEVERINGHAUS J, 2003, GEOPHYSICAL RES ABST, V5; Shackleton NJ, 2000, PALEOCEANOGRAPHY, V15, P565, DOI 10.1029/2000PA000513; Solomon S., 2007, CLIMATE CHANGE PHYS; Stauffer B, 1998, NATURE, V392, P59, DOI 10.1038/32133; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595	33	197	205	0	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					83	85		10.1126/science.1160832	http://dx.doi.org/10.1126/science.1160832			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18787135				2022-12-28	WOS:000259680200042
J	Gulick, RM; Lalezari, J; Goodrich, J; Clumeck, N; DeJesus, E; Horban, A; Nadler, J; Clotet, B; Karlsson, A; Wohlfeiler, M; Montana, JB; McHale, M; Sullivan, J; Ridgway, C; Felstead, S; Dunne, MW; van der Ryst, E; Mayer, H				Gulick, Roy M.; Lalezari, Jacob; Goodrich, James; Clumeck, Nathan; DeJesus, Edwin; Horban, Andrzej; Nadler, Jeffrey; Clotet, Bonaventura; Karlsson, Anders; Wohlfeiler, Michael; Montana, John B.; McHale, Mary; Sullivan, John; Ridgway, Caroline; Felstead, Steve; Dunne, Michael W.; van der Ryst, Elna; Mayer, Howard		MOTIVATE Study Teams	Maraviroc for previously treated patients with R5 HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TREATMENT-EXPERIENCED PATIENTS; DISEASE PROGRESSION; RESISTANT HIV-1; CLINICAL-TRIALS; CORECEPTOR USE; ANTIRETROVIRAL THERAPY; HEALTHY-VOLUNTEERS; CYP3A4 INHIBITORS; CCR5 INHIBITOR; EFFICACY	Background CC chemokine receptor 5 antagonists are a new class of antiretroviral agents. Methods We conducted two double- blind, placebo- controlled, phase 3 studies - Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment- Experienced Patients ( MOTIVATE) 1 and MOTIVATE 2 - with patients who had R5 human immunodeficiency virus type 1 ( HIV- 1) only. They had been treated with or had resistance to three antiretroviral- drug classes and had HIV- 1 RNA levels of more than 5000 copies per milliliter. The patients were randomly assigned to one of three antiretroviral regimens consisting of maraviroc once daily, maraviroc twice daily, or placebo, each of which included optimized background therapy ( OBT) based on treatment history and drug- resistance testing. Safety and efficacy were assessed after 48 weeks. Results A total of 1049 patients received the randomly assigned study drug; the mean baseline HIV- 1 RNA level was 72,400 copies per milliliter, and the median CD4 cell count was 169 per cubic millimeter. At 48 weeks, in both studies, the mean change in HIV- 1 RNA from baseline was greater with maraviroc than with placebo: - 1.66 and - 1.82 log(10) copies per milliliter with the once- daily and twice- daily regimens, respectively, versus - 0.80 with placebo in MOTIVATE 1, and - 1.72 and - 1.87 log(10) copies per milliliter, respectively, versus - 0.76 with placebo in MOTIVATE 2. More patients receiving maraviroc once or twice daily had HIV- 1 RNA levels of less than 50 copies per milliliter ( 42% and 47%, respectively, vs. 16% in the placebo group in MOTIVATE 1; 45% in both maraviroc groups vs. 18% in MOTIVATE 2; P< 0.001 for both comparisons in each study). The change from baseline in CD4 counts was also greater with maraviroc once or twice daily than with placebo ( increases of 113 and 122 per cubic millimeter, respectively, vs. 54 in MOTIVATE 1; increases of 122 and 128 per cubic millimeter, respectively, vs. 69 in MOTIVATE 2; P< 0.001 for both comparisons in each study). Frequencies of adverse events were similar among the groups. Conclusions Maraviroc, as compared with placebo, resulted in significantly greater suppression of HIV- 1 and greater increases in CD4 cell counts at 48 weeks in previously treated patients with R5 HIV- 1 who were receiving OBT. (ClinicalTrials. gov numbers, NCT00098306 and NCT00098722.).	[Gulick, Roy M.] Weill Cornell Med Coll, New York, NY 10065 USA; [Lalezari, Jacob] Quest Clin Res, San Francisco, CA USA; [Lalezari, Jacob] Univ Calif San Francisco, Mt Zion Hosp, San Francisco, CA 94143 USA; [Goodrich, James; Dunne, Michael W.; Mayer, Howard] Pfizer Global Res & Dev, New London, CT USA; [Clumeck, Nathan] Ctr Hosp Univ St Pierre, Brussels, Belgium; [DeJesus, Edwin] Orlando Immunol Ctr, Orlando, FL USA; [Horban, Andrzej] Wojewodzki Szpital Zakazny, Warsaw, Poland; [Nadler, Jeffrey] Univ S Florida, Coll Med, Tampa, FL USA; [Clotet, Bonaventura] Fdn Irsicaixa, Badalona, Spain; [Clotet, Bonaventura] Hosp Badalona Germans Trias & Pujol, Badalona, Spain; [Karlsson, Anders] Karolinska Univ Hosp, Stockholm, Sweden; [Wohlfeiler, Michael] Wohlfeiler Piperato & Assoc, N Miami Beach, FL USA; [McHale, Mary; Sullivan, John; Ridgway, Caroline; Felstead, Steve; van der Ryst, Elna] Pfizer Global Res & Dev, Sandwich, Kent, England	Cornell University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Medical Center at Mount Zion; Pfizer; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Orlando Immunology Center; State University System of Florida; University of South Florida; Institut de Recerca de la Sida - IrsiCaixa; Hospital Germans Trias i Pujol; Karolinska Institutet; Karolinska University Hospital; Pfizer	Gulick, RM (corresponding author), Weill Cornell Med Coll, Box 566,525 E 68th St, New York, NY 10065 USA.		Montaner, Julio/K-7621-2012; Dunne, Michael W/AAD-7418-2020; Pulido, Federico/B-8417-2009; Gisslen, Magnus/D-7454-2015	Dunne, Michael W/0000-0001-6186-5196; Pulido, Federico/0000-0002-7414-8812; Stapleton, Jack/0000-0002-2302-9055; Moutschen, Michel/0000-0002-6405-1785; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Easterbrook, Philippa/0000-0002-2603-5418; Koirala, Janak/0000-0002-3608-474X; Gisslen, Magnus/0000-0002-2357-1020; Leen, Clifford/0000-0001-8439-7719; Smiatacz, Tomasz/0000-0003-2793-3671	Abbott; Boehringer Ingelheim; Bristol-Myers Squibb; Gilead; GlaxoSmithKline; Merck; Monogram; Pfizer; Schering-Plough; Tibotec; Virco; ViroStatics; Roche; Janssen; Siemens; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI051966] Funding Source: NIH RePORTER	Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Monogram; Pfizer(Pfizer); Schering-Plough(Merck & CompanySchering Plough Corporation); Tibotec; Virco; ViroStatics; Roche(Roche Holding); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Siemens(Siemens AG); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Gulick reports receiving consulting fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Monogram, Pfizer, Schering-Plough, Tibotec, Virco, and ViroStatics and grant support from Boehringer Ingelheim, Gilead, Merck, Pfizer, Schering- Plough, and Tibotec. Dr. Lalezari reports receiving consulting and lecture fees from Pfizer. Dr. Goodrich and Ms. Ridgway report being employees of Pfizer, the study sponsor. Dr. Clumeck reports receiving consulting fees from Abbott, Gilead, Merck, and Pfizer. Dr. DeJesus reports receiving consulting fees from Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, and GlaxoSmithKline, lecture fees from Gilead, GlaxoSmithKline, and Merck, and grant support from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Pfizer, Roche, ScheringPlough, and Tibotec. Dr. Horban reports receiving consulting fees from Janssen. Dr. Nadler reports holding equity ownership and stock options in Gilead. Dr. Clotet reports receiving consulting fees from Boehringer Ingelheim, Bristol- Myers Squibb, Gilead, GlaxoSmithKline, Janssen, Merck, Pfizer, Roche, and Siemens, lecture fees from Bristol-Myers Squibb, Gilead, Janssen, Merck, and Roche, and grant support from Merck and Pfizer. Dr. Wohlfeiler reports receiving consulting and lecture fees from Abbott, Boehringer Ingelheim, Bristol- Myers Squibb, GlaxoSmithKline, Merck, Monogram, Pfizer, and Tibotec and lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Monogram, and Tibotec. Dr. McHale reports being previously employed by Pfizer and holding equity ownership and stock options in Pfizer. Mr. Sullivan and Drs. Felstead, Dunne, van der Ryst, and Mayer report being employees of Pfizer and holding equity ownership and stock options in Pfizer. No other potential conflict of interest relevant to this article was reported.; We thank the study participants as well as the study investigators and site staff at the 239 participating study sites ( for a complete list of the investigators, site staff, and study sites, see the Supplementary Appendix).	Abel S, 2008, BRIT J CLIN PHARMACO, V65, P27, DOI 10.1111/j.1365-2125.2008.03133.x; Abel S, 2008, BRIT J CLIN PHARMACO, V65, P38, DOI 10.1111/j.1365-2125.2008.03134.x; [Anonymous], 1992, MMWR Recomm Rep, V41, P1; Anonymous, 2005, Antiviral Chemistry & Chemotherapy, V16, P339; Blackham J, 2005, AIDS, V19, P487; Clotet B, 2008, LANCET, V371, P116; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Connor RI, 1997, J EXP MED, V185, P621, DOI 10.1084/jem.185.4.621; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Dean M, 1999, CANCER RES, V59, P3561; Dean M, 1996, SCIENCE, V274, P1069; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; *DEP HHS, 2006, AIDSINFO GUID US ANT; *DEP HHS, 2008, AIDSINFO GUID US ANT; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Fatkenheuer G, 2008, NEW ENGL J MED, V359, P1442, DOI 10.1056/NEJMoa0803154; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; Garred P, 1998, J RHEUMATOL, V25, P1462; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Goodrich JM, 2007, 45 ANN M INF DIS SOC; Gulick RM, 2007, J INFECT DIS, V196, P304, DOI 10.1086/518797; HAUBRICH R, 2008, 15 C RETR OPP INF BO; Huang YX, 1996, NAT MED, V2, P1240, DOI 10.1038/nm1196-1240; Husman AMD, 1997, ANN INTERN MED, V127, P882, DOI 10.7326/0003-4819-127-10-199711150-00004; JOHNSON M, 2008, 15 C RETR OPP INF BO; Lalezari JP, 2003, NEW ENGL J MED, V349, P1100; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; LIMOLI K, 2006, 16 INT AIDS C TOR AU; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; Melby T, 2006, J INFECT DIS, V194, P238, DOI 10.1086/504693; Mocroft A, 2000, AIDS, V14, P1545, DOI 10.1097/00002030-200007280-00010; Nelson M, 2005, JAIDS-J ACQ IMM DEF, V40, P404, DOI 10.1097/01.qai.0000185314.56556.c3; Nichols WG, 2008, ANTIMICROB AGENTS CH, V52, P858, DOI 10.1128/AAC.00821-07; *PFIZ, 2007, SELZ PRESCR INF; Philpott SM, 2003, CURR HIV RES, V1, P217, DOI 10.2174/1570162033485357; *REG COMPL CTR DIV, TABL GRAD SEV AD ADV; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Trinh L, 2008, 17 INT HIV DRUG RES; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; WHITCOMB JM, 2003, 10 C RETR OPP INF BO; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P1399; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035	43	585	609	0	51	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1429	U27		10.1056/NEJMoa0803152	http://dx.doi.org/10.1056/NEJMoa0803152			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832244	Green Accepted			2022-12-28	WOS:000259631700004
J	Anderson, GP				Anderson, Gary P.			Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease	LANCET			English	Review							BRONCHIAL EPITHELIAL-CELLS; EXHALED BREATH CONDENSATE; INNATE IMMUNE-RESPONSE; AIRWAY SMOOTH-MUSCLE; GENOME-WIDE LINKAGE; REGULATORY T-CELLS; BODY-MASS INDEX; ALLERGIC RHINITIS; RISK-FACTORS; LUNG-FUNCTION	Clinical asthma is very widely assumed to be the net result of excessive inflammation driven by aberrant T-helper-2 (Th2) immunity that leads to inflamed, remodelled airways and then functional derangement that, in turn, causes symptoms. This notion of disease is actually poorly supported by data, and there are substantial discrepancies and very poor correlation between inflammation, damage, functional impairment, and degree of symptoms. Furthermore, this problem is compounded by the poor understanding of the heterogeneity of clinical disease. Failure to recognise and discover the underlying mechanisms of these major variants or endotypes of asthma is, arguably, the major intellectual limitation to progress at present. Fortunately, both clinical research and animal models are very well suited to dissecting the cellular and molecular basis of disease endotypes. This approach is already suggesting entirely novel pathways to disease-eg, alternative macrophage specification, steroid refractory innate immunity the interleukin-17-regulatory T-cell axis, epidermal growth factor receptor co-amplification, and Th2-mimicking but non-T-cell, interleukins 18 and 33 dependent processes that can offer unexpected therapeutic opportunities for specific patient endotypes.	[Anderson, Gary P.] Univ Melbourne, Lung Dis Res Grp, Dept Med, Parkville, Vic 3010, Australia; [Anderson, Gary P.] Univ Melbourne, Lung Dis Res Grp, Dept Pharmacol, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne	Anderson, GP (corresponding author), Univ Melbourne, Lung Dis Res Grp, Dept Med, Parkville, Vic 3010, Australia.	gpa@unimelb.edu.au		Anderson, Gary/0000-0001-6580-3398	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	The author's research is funded by the National Health and Medical Research Council of Australia (NHMRC) via project and programme grants.	Alexander HL, 1921, ARCH INTERN MED, V27, P184, DOI 10.1001/archinte.1921.00100080047004; Alvarez MJ, 2000, ALLERGY, V55, P531, DOI 10.1034/j.1398-9995.2000.00534.x; Alvarez MJ, 2000, ALLERGY, V55, P355, DOI 10.1034/j.1398-9995.2000.00312.x; An SS, 2007, EUR RESPIR J, V29, P834, DOI 10.1183/09031936.00112606; ANDERSON GP, 1994, TRENDS PHARMACOL SCI, V15, P324, DOI 10.1016/0165-6147(94)90027-2; Anderson GP, 2000, AM J RESP CRIT CARE, V161, pS188, DOI 10.1164/ajrccm.161.supplement_2.a1q4-9; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Aoki H, 2008, BIOCHEM BIOPH RES CO, V367, P509, DOI 10.1016/j.bbrc.2008.01.012; Araya J, 2007, J CLIN INVEST, V117, P3551, DOI 10.1172/JCI32526; Balaci L, 2007, AM J HUM GENET, V80, P1103, DOI 10.1086/518259; Barbato A, 2006, AM J RESP CRIT CARE, V174, P975, DOI 10.1164/rccm.200602-189OC; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; Bateman ED, 2006, J ALLERGY CLIN IMMUN, V117, P563, DOI 10.1016/j.jaci.2005.11.036; Bateman ED, 2007, J ASTHMA, V44, P667, DOI 10.1080/02770900701554821; Beavitt SJE, 2005, J IMMUNOL, V175, P1867, DOI 10.4049/jimmunol.175.3.1867; Bel EH, 2004, CURR OPIN PULM MED, V10, P44, DOI 10.1097/00063198-200401000-00008; Bel EH, 2003, AM J RESP CRIT CARE, V168, P1265, DOI 10.1164/rccm.2309009; Bhavsar P, 2008, THORAX, V63, P784, DOI 10.1136/thx.2007.090027; Bisgaard H, 2007, RESP MED, V101, P1477, DOI 10.1016/j.rmed.2007.01.013; Bonnans C, 2007, AM J RESP CELL MOL, V36, P201, DOI 10.1165/rcmb.2006-0269TR; Bouzigon E, 2007, EUR RESPIR J, V30, P253, DOI 10.1183/09031936.00162206; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Braunstahl GJ, 2003, CLIN EXP ALLERGY, V33, P579, DOI 10.1046/j.1365-2222.2003.01652.x; Braunstahl GJ, 2001, AM J RESP CRIT CARE, V164, P858, DOI 10.1164/ajrccm.164.5.2006082; Brightling CE, 2002, NEW ENGL J MED, V346, P1699, DOI 10.1056/NEJMoa012705; BROWN HM, 1972, BRIT MED J, V1, P585, DOI 10.1136/bmj.1.5800.585; Brown JL, 2007, CLIN EXP ALLERGY, V37, P688, DOI 10.1111/j.1365-2222.2007.02695.x; Brown RH, 2006, J APPL PHYSIOL, V101, P30, DOI 10.1152/japplphysiol.01190.2005; Carraro S, 2007, AM J RESP CRIT CARE, V175, P986, DOI 10.1164/rccm.200606-769OC; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chiappara G, 2007, ALLERGY, V62, P787, DOI 10.1111/j.1398-9995.2007.01417.x; Cho SH, 2005, AM J RESP CRIT CARE, V171, P224, DOI 10.1164/rccm.200310-1416OC; Chupp GL, 2007, NEW ENGL J MED, V357, P2016, DOI 10.1056/NEJMoa073600; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Corbo GM, 2008, EPIDEMIOLOGY, V19, P747, DOI 10.1097/EDE.0b013e3181776213; COYLE AJ, 1995, AM J RESP CELL MOL, V13, P54, DOI 10.1165/ajrcmb.13.1.7598937; de Kluijver J, 2002, EUR RESPIR J, V20, P274, DOI 10.1183/09031936.02.00247202; Dehlink E, 2006, PEDIATRICS, V118, pE764, DOI 10.1542/peds.2006-0370; den Otter Joost J, 2007, Eur J Gen Pract, V13, P89; Denham S, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-38; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Ducharme FM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003137.pub3; Ernst M, 2002, J EXP MED, V196, P589, DOI 10.1084/jem.20020873; Gauvreau Gail M, 2002, Can Respir J, V9, P26; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grol MH, 1999, AM J RESP CRIT CARE, V160, P150, DOI 10.1164/ajrccm.160.1.9707103; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Haldar P, 2007, J ALLERGY CLIN IMMUN, V119, P1043, DOI 10.1016/j.jaci.2007.02.042; Hamada K, 2007, J TOXICOL ENV HEAL A, V70, P688, DOI 10.1080/15287390600974692; Hawkins GA, 2008, PHARMACOGENOMICS, V9, P349, DOI 10.2217/14622416.9.3.349; Hayashi N, 2007, P NATL ACAD SCI USA, V104, P14765, DOI 10.1073/pnas.0706378104; Henderson AC, 2003, J APPL PHYSIOL, V95, P873, DOI 10.1152/japplphysiol.00075.2003; Hersh CP, 2007, AM J RESP CRIT CARE, V176, P849, DOI 10.1164/rccm.200704-592OC; Hodge S, 2007, AM J RESP CELL MOL, V37, P748, DOI 10.1165/rcmb.2007-0025OC; Holloway AF, 2003, J EXP MED, V197, P413, DOI 10.1084/jem.20021039; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Ivanov S, 2007, AM J RESP CELL MOL, V36, P442, DOI 10.1165/rcmb.2006-0020OC; Jackola DR, 2007, HUM IMMUNOL, V68, P839, DOI 10.1016/j.humimm.2007.07.006; Jansen DF, 1999, AM J RESP CRIT CARE, V160, P259, DOI 10.1164/ajrccm.160.1.9811015; Kang MJ, 2008, J CLIN INVEST, V118, P2771, DOI 10.1172/JCI32709; Kassel O, 1999, EUR RESPIR J, V13, P951, DOI 10.1034/j.1399-3003.1999.13e04.x; Kicic A, 2006, AM J RESP CRIT CARE, V174, P1110, DOI 10.1164/rccm.200603-392OC; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Klotsman M, 2007, PHARMACOGENET GENOM, V17, P189, DOI 10.1097/FPC.0b013e3280120043; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; Krishnamoorthy N, 2008, NAT MED, V14, P565, DOI 10.1038/nm1766; Lapperre TS, 2004, AM J RESP CRIT CARE, V170, P499, DOI 10.1164/rccm.200401-112OC; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lemiere C, 2006, J ALLERGY CLIN IMMUN, V118, P1033, DOI 10.1016/j.jaci.2006.08.003; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Lewkowich IP, 2005, J EXP MED, V202, P1549, DOI 10.1084/jem.20051506; Linden A, 2005, EUR RESPIR J, V25, P159, DOI 10.1183/09031936.04.00032904; Liu K, 2008, J BIOL CHEM, V283, P9977, DOI 10.1074/jbc.M710257200; Lopuhaa CE, 2002, CLIN EXP ALLERGY, V32, P1720, DOI 10.1046/j.1365-2222.2002.01542.x; Louis E, 1999, CLIN EXP ALLERGY, V29, P660; Lutchen KR, 2001, AM J RESP CRIT CARE, V164, P207, DOI 10.1164/ajrccm.164.2.2008119; MacDonald C, 2007, ENVIRON HEALTH PERSP, V115, P1691, DOI 10.1289/ehp.10382; Mathur AN, 2007, J IMMUNOL, V178, P4901, DOI 10.4049/jimmunol.178.8.4901; McLean WHI, 2008, J ALLERGY CLIN IMMUN, V121, P1294, DOI 10.1016/j.jaci.2008.02.039; MEYERS DA, 2004, CHEST S2, V26, pS105; Miyaura H, 2002, J IMMUNOL, V168, P1087, DOI 10.4049/jimmunol.168.3.1087; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Munitz A, 2008, P NATL ACAD SCI USA, V105, P7240, DOI 10.1073/pnas.0802465105; Nakao I, 2008, J IMMUNOL, V180, P6262, DOI 10.4049/jimmunol.180.9.6262; Nakashima K, 2006, J HUM GENET, V51, P284, DOI 10.1007/s10038-005-0358-1; Nakashima Kazuko, 2006, Allergol Int, V55, P77, DOI 10.2332/allergolint.55.77; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Palmer LJ, 2000, EUR J HUM GENET, V8, P853, DOI 10.1038/sj.ejhg.5200551; Patel BD, 2006, THORAX, V61, P568, DOI 10.1136/thx.2005.053827; Pauwels RA, 1997, NEW ENGL J MED, V337, P1405, DOI 10.1056/NEJM199711133372001; Pavord ID, 2007, AM J RESP CRIT CARE, V176, P1185, DOI 10.1164/rccm.200704-571OC; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pedersen SE, 2007, J ALLERGY CLIN IMMUN, V120, P1036, DOI 10.1016/j.jaci.2007.07.016; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Piippo-Savolainen E, 2008, ACTA PAEDIATR, V97, P5, DOI 10.1111/j.1651-2227.2007.00558.x; Pillai SG, 2008, CLIN EXP ALLERGY, V38, P421, DOI 10.1111/j.1365-2222.2007.02918.x; Pillai SG, 2004, PHARMACOGENETICS, V14, P627, DOI 10.1097/00008571-200409000-00007; Pincus-Knackstedt MK, 2006, J IMMUNOL, V177, P8484, DOI 10.4049/jimmunol.177.12.8484; PLATTSMILLS TAE, 1999, IND AIR RES, P1; PSOTMA DS, 2007, GEND MED SB, V4, pS133; Raby BA, 2006, AM J RESP CRIT CARE, V173, P64, DOI 10.1164/rccm.200503-505OC; Rauh MJ, 2005, IMMUNITY, V23, P361, DOI 10.1016/j.immuni.2005.09.003; Sadeghnejad A, 2007, AM J RESP CRIT CARE, V176, P748, DOI 10.1164/rccm.200704-543OC; Scichilone N, 2005, AM J RESP CRIT CARE, V172, P693, DOI 10.1164/rccm.200407-955OC; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Siddiqui S, 2008, J ALLERGY CLIN IMMUN, V122, P335, DOI 10.1016/j.jaci.2008.05.020; Silverman EK, 2000, CHEST, V117, p273S, DOI 10.1378/chest.117.5_suppl_1.273S; Silverman EK, 2002, AM J HUM GENET, V70, P1229, DOI 10.1086/340316; Silverman EK, 2002, HUM MOL GENET, V11, P623, DOI 10.1093/hmg/11.6.623; Simpson JL, 2006, RESPIROLOGY, V11, P54, DOI 10.1111/j.1440-1843.2006.00784.x; Simpson JL, 2007, THORAX, V62, P211, DOI 10.1136/thx.2006.061358; Sly LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2836, DOI 10.2741/2276; Smit JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001720; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Tantisira KG, 2007, J ALLERGY CLIN IMMUN, V120, P1285, DOI 10.1016/j.jaci.2007.09.005; Tantisira KG, 2004, P NATL ACAD SCI USA, V101, P18099, DOI 10.1073/pnas.0408532102; Taveras EM, 2008, J ALLERGY CLIN IMMUN, V121, P1161, DOI 10.1016/j.jaci.2008.03.021; Tee AK, 2007, COCHRANE DB SYST REV, V3; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; ten Brinke A, 2008, CURR OPIN ALLERGY CL, V8, P63, DOI 10.1097/ACI.0b013e3282f3b5b5; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; TURATO G, 2008, AM J RESP CRIT CARE; van den Brandt J, 2007, AM J PATHOL, V170, P1041, DOI 10.2353/ajpath.2007.060804; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; von Leupoldt A, 2008, AM J RESP CRIT CARE, V177, P1026, DOI 10.1164/rccm.200712-1821OC; Wagers SS, 2007, J APPL PHYSIOL, V102, P221, DOI 10.1152/japplphysiol.01385.2005; Walker S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003559.pub3; Wang L, 2008, J ALLERGY CLIN IMMUN, V122, P400, DOI 10.1016/j.jaci.2008.04.011; Wardlaw AJ, 2002, CLIN SCI, V103, P201; Wark PAB, 2005, J EXP MED, V201, P937, DOI 10.1084/jem.20041901; Wenzel S, 2007, LANCET, V370, P1422, DOI 10.1016/S0140-6736(07)61600-6; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Winkler T, 2007, J APPL PHYSIOL, V103, P655, DOI 10.1152/japplphysiol.00041.2007; Wittke A, 2004, J IMMUNOL, V173, P3432, DOI 10.4049/jimmunol.173.5.3432; Wittke A, 2007, ARCH BIOCHEM BIOPHYS, V460, P306, DOI 10.1016/j.abb.2006.12.011; Woodruff Prescott G, 2008, Proc Am Thorac Soc, V5, P113, DOI 10.1513/pats.200705-059VS; Woolcock AJ, 2000, AM J RESP CRIT CARE, V161, pS215, DOI 10.1164/ajrccm.161.supplement_2.a1q4-14; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zanconato S, 2004, J ALLERGY CLIN IMMUN, V113, P257, DOI 10.1016/j.jaci.2003.10.046; Zhang N, 2007, J IMMUNOL, V179, P578, DOI 10.4049/jimmunol.179.1.578	150	679	717	2	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1107	1119		10.1016/S0140-6736(08)61452-X	http://dx.doi.org/10.1016/S0140-6736(08)61452-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805339				2022-12-28	WOS:000259648500037
J	Butman, JA; Linehan, WM; Lonser, RR				Butman, John A.; Linehan, W. Marston; Lonser, Russell R.			Neurologic manifestations of von Hippel-Lindau disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOLYMPHATIC SAC TUMORS; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR RECEPTOR; MORBID HEARING-LOSS; SUPPRESSOR GENE; NATURAL-HISTORY; SURGICAL-MANAGEMENT; GERMLINE MUTATIONS; INHIBITOR SU5416; SPINAL-CORD	von Hippel-Lindau disease ( VHL) is an autosomal- dominant neoplasia syndrome that is the result of a germline mutation of the VHL tumor suppressor gene on the short arm of chromosome 3. Patients with VHL are predisposed to develop lesions of the central nervous system and viscera. Central nervous system lesions include hemangioblastomas ( the most common tumor in VHL) and endolymphatic sac tumors ( ELSTs). Visceral manifestations include renal carcinomas and cysts, pancreatic neuroendocrine tumors and cysts, pheochromocytomas, and cystadenomas of the reproductive adnexal organs. Despite their benign pathology, hemangioblastomas and ELSTs are a frequent cause of morbidity and mortality in patients with VHL. Recent molecular biologic investigations into these VHL- associated central nervous system lesions provide new insight into their origin and development. Emerging data from serial imaging and clinical surveillance protocols provide insight into the natural history of these lesions. Because of the dissimilar pathobiology and clinical course between hemangioblastomas and ELSTs, the optimal management strategies for these neurologic manifestations of VHL are very different.	[Lonser, Russell R.] Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA; [Butman, John A.] NIH, Dept Diagnost Radiol, Ctr Clin, Bethesda, MD 20892 USA; [Linehan, W. Marston] NCI, Urol Oncol Branch, Canc Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lonser, RR (corresponding author), Natl Inst Neurol Disorders & Stroke, Surg Neurol Branch, NIH, 10 Center Dr,Bldg 10,Room 5D37, Bethesda, MD 20892 USA.	lonserr@ninds.nih.gov	Butman, John A/A-2694-2008; Butman, John/J-2780-2013	Butman, John/0000-0002-1547-9195	Intramural Research Program of the Clinical Center; National Institute of Neurologic Disorders and Stroke; National Cancer Institute at the National Institutes of Health.; NATIONAL CANCER INSTITUTE [ZIABC011028, Z01BC011089, Z01BC011038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003053] Funding Source: NIH RePORTER	Intramural Research Program of the Clinical Center; National Institute of Neurologic Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Cancer Institute at the National Institutes of Health.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the Clinical Center, the National Institute of Neurologic Disorders and Stroke, and the National Cancer Institute at the National Institutes of Health.	Aiello LP, 2002, OPHTHALMOLOGY, V109, P1745, DOI 10.1016/S0161-6420(02)01159-4; Aldape KD, 2007, WHO CLASSIFICATION T, P184; Ammerman JM, 2006, J NEUROSURG, V105, P248, DOI 10.3171/jns.2006.105.2.248; Blansfield JA, 2007, SURGERY, V142, P814, DOI 10.1016/j.surg.2007.09.012; BROWNE TR, 1976, ARCH NEUROL-CHICAGO, V33, P435, DOI 10.1001/archneur.1976.00500060041009; Butman JA, 2007, JAMA-J AM MED ASSOC, V298, P41, DOI 10.1001/jama.298.1.41; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Choi K, 1998, DEVELOPMENT, V125, P725; Choo D, 2004, J NEUROSURG, V100, P480, DOI 10.3171/jns.2004.100.3.0480; CHOYKE PL, 1995, RADIOLOGY, V194, P629, DOI 10.1148/radiology.194.3.7862955; DUAN DR, 1995, SCIENCE, V269, P1402, DOI 10.1126/science.7660122; Girmens JF, 2003, AM J OPHTHALMOL, V136, P194, DOI 10.1016/S0002-9394(03)00101-6; Glasker S, 2006, CANCER RES, V66, P4167, DOI 10.1158/0008-5472.CAN-05-3505; Glasker S, 2005, CANCER RES, V65, P10847, DOI 10.1158/0008-5472.CAN-05-1104; Gnarra JR, 1996, P NATL ACAD SCI USA, V93, P10589, DOI 10.1073/pnas.93.20.10589; HEFFNER DK, 1989, CANCER, V64, P2292, DOI 10.1002/1097-0142(19891201)64:11<2292::AID-CNCR2820641119>3.0.CO;2-#; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jagannathan J, 2008, J NEUROSURG, V108, P210, DOI 10.3171/JNS/2008/108/2/0210; Jarrell ST, 2006, J NEUROSURG, V105, P256, DOI 10.3171/jns.2006.105.2.256; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kim HJ, 2005, J NEUROSURG, V102, P503, DOI 10.3171/jns.2005.102.3.0503; KNUDSON AG, 1972, AM J HUM GENET, V24, P514; LAMIELL JM, 1989, MEDICINE, V68, P1; LATIF F, 1993, SCIENCE, V260, P1317, DOI 10.1126/science.8493574; Lohle PNM, 2000, NEURORADIOLOGY, V42, P639, DOI 10.1007/s002340000363; Lonser RR, 2005, ANN NEUROL, V58, P392, DOI 10.1002/ana.20584; Lonser RR, 2004, NEW ENGL J MED, V350, P2481, DOI 10.1056/NEJMoa040666; Lonser RR, 2003, J NEUROSURG, V98, P106, DOI 10.3171/jns.2003.98.1.0106; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Lonser RR, 2008, J NEUROSURG, V108, P751, DOI 10.3171/JNS/2008/108/4/0751; MAHER ER, 1991, J MED GENET, V28, P443, DOI 10.1136/jmg.28.7.443; Manski TJ, 1997, JAMA-J AM MED ASSOC, V277, P1461, DOI 10.1001/jama.277.18.1461; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Megerian CA, 2002, OTOL NEUROTOL, V23, P378, DOI 10.1097/00129492-200205000-00026; MELMON KL, 1964, AM J MED, V36, P595, DOI 10.1016/0002-9343(64)90107-X; NEUMANN HPH, 1991, LANCET, V337, P1052, DOI 10.1016/0140-6736(91)91705-Y; Niemela M, 1996, J NEUROSURG, V85, P591, DOI 10.3171/jns.1996.85.4.0591; Ohh M, 1998, MOL CELL, V1, P959, DOI 10.1016/S1097-2765(00)80096-9; Park DM, 2007, PLOS MED, V4, P333, DOI 10.1371/journal.pmed.0040060; Patrice SJ, 1996, INT J RADIAT ONCOL, V35, P493; Pause A, 1998, P NATL ACAD SCI USA, V95, P993, DOI 10.1073/pnas.95.3.993; Pause A, 1997, P NATL ACAD SCI USA, V94, P2156, DOI 10.1073/pnas.94.6.2156; REIFENBERGER G, 1995, AM J PATHOL, V147, P245; Richard S, 1998, J INTERN MED, V243, P547; Rodrigues S, 2004, OTOL NEUROTOL, V25, P599, DOI 10.1097/00129492-200407000-00030; SEIZINGER BR, 1988, NATURE, V332, P268, DOI 10.1038/332268a0; Sgambati MT, 2000, AM J HUM GENET, V66, P84, DOI 10.1086/302726; Stolle C, 1998, HUM MUTAT, V12, P417, DOI 10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K; Vortmeyer AO, 1997, HUM PATHOL, V28, P540, DOI 10.1016/S0046-8177(97)90075-7; Wait SD, 2004, ANN NEUROL, V55, P236, DOI 10.1002/ana.10807; Walther MM, 1999, J UROLOGY, V161, P1475, DOI 10.1016/S0022-5347(05)68930-6; Walther MM, 1999, J UROLOGY, V162, P659, DOI 10.1097/00005392-199909010-00004; Wanebo JE, 2003, J NEUROSURG, V98, P82, DOI 10.3171/jns.2003.98.1.0082; Weil RJ, 2003, J NEUROSURG, V98, P95, DOI 10.3171/jns.2003.98.1.0095; Woodward ER, 2007, BRAIN, V130, P836, DOI 10.1093/brain/awl362	55	72	74	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1334	1342		10.1001/jama.300.11.1334	http://dx.doi.org/10.1001/jama.300.11.1334			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799446	Green Accepted			2022-12-28	WOS:000259231100029
J	Vakil, N; Vaira, D				Vakil, Nimish; Vaira, Dino			Sequential therapy for Helicobacter pylori - Time to consider making the switch?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TRIPLE THERAPY; ERADICATION; MANAGEMENT; METAANALYSIS		[Vakil, Nimish] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Vaira, Dino] Univ Bologna, Bologna, Italy	University of Wisconsin System; University of Wisconsin Madison; University of Bologna	Vakil, N (corresponding author), Aurora Med Ctr, 945 N 12th St,Room 4040, Milwaukee, WI 53233 USA.	nvakil@wisc.edu						Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Duck WM, 2004, EMERG INFECT DIS, V10, P1088, DOI 10.3201/eid1006.030744; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; Laine L, 2003, AM J GASTROENTEROL, V98, P562, DOI [10.1016/S0002-9270(02)06010-0, 10.1111/j.1572-0241.2003.t01-1-07288.x]; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Rinaldi V, 1997, ALIMENT PHARM THERAP, V11, P929, DOI 10.1046/j.1365-2036.1997.00228.x; SANCHEZDELGADO J, AM J GASTROENTEROL, DOI DOI 10.1111/J.1572-0241.2008.01924X; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; Vakil N, 2004, ALIMENT PHARM THERAP, V20, P99, DOI 10.1111/j.1365-2036.2004.02029.x; Vakil N, 2007, GASTROENTEROLOGY, V133, P985, DOI 10.1053/j.gastro.2007.07.008; Van Der Poorten D, 2007, ALIMENT PHARM THER, V26, P1537, DOI 10.1111/j.1365-2036.2007.03531.x; Wu DC, 2008, GASTROENTEROLOGY, V134, pA24; Zullo A, 2007, GUT, V56, P1353, DOI 10.1136/gut.2007.125658	15	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1346	1347		10.1001/jama.300.11.1346	http://dx.doi.org/10.1001/jama.300.11.1346			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799448				2022-12-28	WOS:000259231100031
J	Goldfine, AB				Goldfine, Allison B.			Assessing the cardiovascular safety of diabetes therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Goldfine, Allison B.] Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02215 USA; [Goldfine, Allison B.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard Medical School	Goldfine, AB (corresponding author), Joslin Diabet Ctr, Sect Clin Res, Boston, MA 02215 USA.			Goldfine, Allison/0000-0002-0345-1048				Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; KLIMT CR, 1970, DIABETES, V19, P747; McAfee AT, 2007, PHARMACOEPIDEM DR S, V16, P711, DOI 10.1002/pds.1443; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987	5	85	86	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1092	1095		10.1056/NEJMp0805758	http://dx.doi.org/10.1056/NEJMp0805758			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784098				2022-12-28	WOS:000259078200004
J	Wheeler, TD; Stroock, AD				Wheeler, Tobias D.; Stroock, Abraham D.			The transpiration of water at negative pressures in a synthetic tree	NATURE			English	Article							SYSTEM; CAVITATION; RESISTANCE; CAPILLARY; TRANSPORT; SUCTION; PLANTS	Plant scientists believe that transpiration - the motion of water from the soil, through a vascular plant, and into the air - occurs by a passive, wicking mechanism. This mechanism is described by the cohesion- tension theory: loss of water by evaporation reduces the pressure of the liquid water within the leaf relative to atmospheric pressure; this reduced pressure pulls liquid water out of the soil and up the xylem to maintain hydration(1-3). Strikingly, the absolute pressure of the water within the xylem is often negative, such that the liquid is under tension and is thermodynamically metastable with respect to the vapour phase(1,4). Qualitatively, this mechanism is the same as that which drives fluid through the synthetic wicks that are key elements in technologies for heat transfer(5), fuel cells(6,7) and portable chemical systems(8-10). Quantitatively, the differences in pressure generated in plants to drive flow can be more than a hundredfold larger than those generated in synthetic wicks. Here we present the design and operation of a microfluidic system formed in a synthetic hydrogel. This synthetic 'tree' captures the main attributes of transpiration in plants: transduction of subsaturation in the vapour phase of water into negative pressures in the liquid phase, stabilization and flow of liquid water at large negative pressures (-1.0 MPa or lower), continuous heat transfer with the evaporation of liquid water at negative pressure, and continuous extraction of liquid water from subsaturated sources. This development opens the opportunity for technological uses of water under tension and for new experimental studies of the liquid state of water.	[Wheeler, Tobias D.; Stroock, Abraham D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA	Cornell University	Stroock, AD (corresponding author), Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY 14853 USA.	ads10@cornell.edu		Stroock, Abraham/0000-0002-8145-9977	Office of Naval Research Young Investigator Program; Camille and Henry Dreyfus Foundation; Corning Foundation; National Science Foundation (NSF); Nanobiotechnology Center; STC Program of the NSF [ECS-98767710]; Cornell Center for Materials Research; NSF [DMR- 0520404]	Office of Naval Research Young Investigator Program(Office of Naval Research); Camille and Henry Dreyfus Foundation; Corning Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); Nanobiotechnology Center; STC Program of the NSF; Cornell Center for Materials Research; NSF(National Science Foundation (NSF))	We thank M. A. Zwieniecki, N. M. Holbrook, P. J. Melcher, C. Cohen, K. J. Niklas, C. Cottin- Bizonne, A. Lassiter and F. Caupin for discussions and suggestions. Wethank G. Swan and E. Velez- Rosa for technical assistance with experiments. Support was provided by the Office of Naval Research Young Investigator Program and the Camille and Henry Dreyfus Foundation. T. D. W. acknowledges partial support by a graduate fellowship from the Corning Foundation. The experiments made use of the following facilities: Cornell NanoScale Science and Technology Facility (a member of the National Nanotechnology Infrastructure Network, supported by the National Science Foundation (NSF)), the Nanobiotechnology Center ( supported by the STC Program of the NSF under Agreement No. ECS-98767710) and the Cornell Center for Materials Research ( supported by the NSF under Award No. DMR- 0520404).	Arce A, 2004, PHYS CHEM CHEM PHYS, V6, P103, DOI 10.1039/b307996a; ASKENASY E, 1896, VERH NATURH MED VER, V5, P429; Aybar HS, 2005, DESALINATION, V180, P285, DOI 10.1016/j.desal.2005.01.009; Bohm, 1893, BER DEUT BOT GES, V11, P203; BRINKER CJ, 1989, SOL GEL SCI PHYS CHE; Caupin F, 2006, CR PHYS, V7, P1000, DOI 10.1016/j.crhy.2006.10.015; Chen J, 2004, J POWER SOURCES, V131, P155, DOI 10.1016/j.jpowsour.2004.01.007; De Paula J., 2002, ATKINS PHYS CHEM; Debenedetti P. G., 1996, METASTABLE LIQUIDS; Dixon H., 1894, PHILOS T ROYAL SOC B, V186, P563, DOI DOI 10.1098/RSTB.1895.0012; Effenhauser CS, 2002, BIOMED MICRODEVICES, V4, P27, DOI 10.1023/A:1014215728074; Errington JR, 2001, NATURE, V409, P318, DOI 10.1038/35053024; Flory P, 1955, PRINCIPLES POLYM CHE; Guan Y, 1997, CAN GEOTECH J, V34, P604, DOI 10.1139/t97-014; Guan YX, 2006, TALANTA, V68, P1384, DOI 10.1016/j.talanta.2005.08.021; HAYWARD ATJ, 1970, NATURE, V225, P376, DOI 10.1038/225376b0; Herbert E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041603; Holbrook NM, 1999, PLANT PHYSIOL, V120, P7, DOI 10.1104/pp.120.1.7; Jacobsen AL, 2007, ECOL MONOGR, V77, P99, DOI 10.1890/05-1879; Juncker D, 2002, ANAL CHEM, V74, P6139, DOI 10.1021/ac0261449; Karan K, 2007, ELECTROCHEM SOLID ST, V10, pB34, DOI 10.1149/1.2398728; Machin WD, 1998, CAN J CHEM, V76, P1578, DOI 10.1139/cjc-76-11-1578; McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q; Nobel P., 1999, PHYSICOCHEMICAL ENV, V2nd; Peterson G.P., 1994, INTRO HEAT PIPES; SCHOLANDER PF, 1965, SCIENCE, V148, P339, DOI 10.1126/science.148.3668.339; THUT HIRAM F., 1928, OHIO JOUR SCI, V28, P292; Zwieniecki MA, 2001, SCIENCE, V291, P1059, DOI 10.1126/science.1057175	28	340	350	20	355	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					208	212		10.1038/nature07226	http://dx.doi.org/10.1038/nature07226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784721				2022-12-28	WOS:000259090800043
J	Santiago, ML; Montano, M; Benitez, R; Messer, RJ; Yonemoto, W; Chesebro, B; Hasenkrug, KJ; Greene, WC				Santiago, Mario L.; Montano, Mauricio; Benitez, Robert; Messer, Ronald J.; Yonemoto, Wes; Chesebro, Bruce; Hasenkrug, Kim J.; Greene, Warner C.			Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection	SCIENCE			English	Article							FRIEND-VIRUS LEUKEMIA; RESISTANCE GENE; ENZYME APOBEC3G; RECOVERY; IDENTIFICATION; AFFINITY; VIREMIA; BLOCKS	Recovery from Friend virus 3 ( Rfv3) is a single autosomal gene encoding a resistance trait that influences retroviral neutralizing antibody responses and viremia. Despite extensive research for 30 years, the molecular identity of Rfv3 has remained elusive. Here, we demonstrate that Rfv3 is encoded by Apobec3. Apobec3 maps to the same chromosome region as Rfv3 and has broad inhibitory activity against retroviruses, including HIV. Not only did genetic inactivation of Apobec3 convert Rfv3- resistant mice to a susceptible phenotype, but Apobec3 was also found to be naturally disabled by aberrant messenger RNA splicing in Rfv3- susceptible strains. The link between Apobec3 and neutralizing antibody responses highlights an Apobec3- dependent mechanism of host protection that might extend to HIV and other human retroviral infections.	[Messer, Ronald J.; Chesebro, Bruce; Hasenkrug, Kim J.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA; [Santiago, Mario L.; Montano, Mauricio; Benitez, Robert; Yonemoto, Wes; Greene, Warner C.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Greene, Warner C.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Hasenkrug, KJ (corresponding author), NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, Hamilton, MT 59840 USA.	khasenkrug@nih.gov; wgreene@gladstone.ucsf.edu		Santiago, Mario L./0000-0001-7792-2706	NIAID Division of Intramural Research at NIH; NIH [R01 AI065329]	NIAID Division of Intramural Research at NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Transgenic Core Laboratory, the Animal Facility, and S. Espineda at the J. David Gladstone Institutes for technical assistance; L. Evans, J. Portis, R. Gallo, R. Locksley, and members of the Greene and Hasenkrug Laboratory for helpful discussions; and R. Givens, S. Cammack, and G. Howard for manuscript preparation. This work was supported by the NIAID Division of Intramural Research at NIH to K. J. H. and B. C., an NIH R01 AI065329 to W. C. G., and an NIH facility grant to the J. David Gladstone Institutes. Sequences are deposited in GenBank, with accession numbers EU707568 to EU707571.	Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; BRITT WJ, 1983, J EXP MED, V157, P1736, DOI 10.1084/jem.157.6.1736; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; CHESEBRO B, 1979, P NATL ACAD SCI USA, V76, P425, DOI 10.1073/pnas.76.1.425; CHESEBRO B, 1976, J EXP MED, V143, P73, DOI 10.1084/jem.143.1.73; CHESEBRO B, 1978, ADV COMP LEUKEMIA RE, P69; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; DOIG D, 1979, J EXP MED, V150, P10, DOI 10.1084/jem.150.1.10; Gonzalez-Fernandez A, 1998, IMMUNOLOGY, V93, P149; Hasenkrug KJ, 1999, J VIROL, V73, P6468, DOI 10.1128/JVI.73.8.6468-6473.1999; Hasenkrug KJ, 1997, P NATL ACAD SCI USA, V94, P7811, DOI 10.1073/pnas.94.15.7811; HASENKRUG KJ, 1995, J VIROL, V69, P2617, DOI 10.1128/JVI.69.4.2617-2620.1995; Kanari Y, 2005, AIDS, V19, P1015, DOI 10.1097/01.aids.0000174447.48003.dd; KIM YT, 1974, CLIN EXP IMMUNOL, V17, P329; Li W, 2006, J VIROL, V80, P5777, DOI 10.1128/JVI.02711-05; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; MONROE JG, 1984, IMMUNOL REV, V80, P103, DOI 10.1111/j.1600-065X.1984.tb00497.x; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Persons DA, 1999, NAT GENET, V23, P159, DOI 10.1038/13787; PORTIS JL, 1992, J ACQ IMMUN DEF SYND, V5, P1272, DOI 10.1097/00126334-199212000-00011; Rulli SJ, 2008, J VIROL, V82, P6566, DOI 10.1128/JVI.01357-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Super HJ, 1999, J VIROL, V73, P7848, DOI 10.1128/JVI.73.9.7848-7852.1999; VANDERGAAG HC, 1990, VIROLOGY, V177, P837, DOI 10.1016/0042-6822(90)90561-5; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	26	114	117	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1343	1346		10.1126/science.1161121	http://dx.doi.org/10.1126/science.1161121			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772436	Green Accepted			2022-12-28	WOS:000258914300047
J	Blumenthal, D				Blumenthal, David			Election 2008 - Primum non nocere - The McCain plan for health insecurity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							INSURANCE		[Blumenthal, David] Massachusetts Gen Hosp, Partners Healthcare Syst, Inst Hlth Policy, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Partners Healthcare System	Blumenthal, D (corresponding author), Massachusetts Gen Hosp, Partners Healthcare Syst, Inst Hlth Policy, Boston, MA 02114 USA.							Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; *C BUDG OFF, 2007, CBO PUBLICATION, V2908; Feldman R, 1997, J HUM RESOUR, V32, P635, DOI 10.2307/146424; Gruber J, 2004, J PUBLIC ECON, V88, P1273, DOI 10.1016/S0047-2727(02)00191-3; Royalty AB, 2000, J PUBLIC ECON, V75, P209, DOI 10.1016/S0047-2727(99)00060-2	5	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1645	1647		10.1056/NEJMp0806563	http://dx.doi.org/10.1056/NEJMp0806563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360EY	18815391	Bronze			2022-12-28	WOS:000260041400001
J	Crowe, E; Halpin, D; Stevens, P				Crowe, Emily; Halpin, David; Stevens, Paul		Guideline Dev Grp	Guidelines - Early identification and management of chronic kidney disease: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; RISK; POPULATION; MICROALBUMINURIA; INDIVIDUALS; PREVALENCE; MORTALITY; OUTCOMES; EVENTS		[Stevens, Paul] Kent & Canterbury Hosp, Canterbury CT1 3NG, Kent, England; [Crowe, Emily] Royal Coll Physicians, Natl Collaborating Ctr Chron Condit, London NW1 4LE, England; [Halpin, David] Royal Devon & Exeter Hosp, Exeter EX2 5DW, Devon, England	University of Kent; Royal College of Physicians; University of Exeter	Stevens, P (corresponding author), Kent & Canterbury Hosp, Canterbury CT1 3NG, Kent, England.	paul.stevens@ekht.nhs.uk		Wonderling, David/0000-0003-0315-6273	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Collaborating Centre for Chronic Conditions was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Arnlov J, 2005, CIRCULATION, V112, P969, DOI 10.1161/CIRCULATIONAHA.105.538132; Brantsma AH, 2008, J AM SOC NEPHROL, V19, P1785, DOI 10.1681/ASN.2007101065; Brantsma AH, 2008, NEPHROL DIAL TRANSPL, V23, P3851, DOI 10.1093/ndt/gfn356; Cirillo M, 2008, ARCH INTERN MED, V168, P617, DOI 10.1001/archinte.168.6.617; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Drey N, 2003, AM J KIDNEY DIS, V42, P677, DOI 10.1016/S0272-6386(03)00916-8; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Foster MC, 2007, ARCH INTERN MED, V167, P1386, DOI 10.1001/archinte.167.13.1386; Glassock RJ, 2008, NEPHROL DIAL TRANSPL, V23, P1117, DOI 10.1093/ndt/gfn086; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hallan S, 2007, ARCH INTERN MED, V167, P2490, DOI 10.1001/archinte.167.22.2490; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; John R, 2004, AM J KIDNEY DIS, V43, P825, DOI 10.1053/j.ajkd.2003.12.046; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Levey AS, 2007, CLIN CHEM, V53, P766, DOI 10.1373/clinchem.2006.077180; *NAT I HLTH CLIN E, 2006, AN MAN PEOPL CHRON K; National Institute for Health and Clinical Excellence, 2006, HYP MAN HYP AD PRIM; National Institute for Health and Clinical Excellence, 2008, TYP 2 DIAB MAN TYP 2; Stevens PE, 2007, KIDNEY INT, V72, P92, DOI 10.1038/sj.ki.5002273	22	117	133	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2008	337	7673							a1530	10.1136/bmj.a1530	http://dx.doi.org/10.1136/bmj.a1530			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18824486	Green Published			2022-12-28	WOS:000259798000039
J	Asplund, M				Asplund, Martin			Astronomy - The shining make-up of our star	SCIENCE			English	Editorial Material							SOLAR; ABUNDANCE; OXYGEN; PROJECT; LINES		[Asplund, Martin] Max Planck Inst Astrophys, D-85741 Garching, Germany	Max Planck Society	Asplund, M (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85741 Garching, Germany.	masplund@mpa-garching.mpg.de						ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Arnett D, 2005, ASTR SOC P, V336, P235; Asplund M, 2005, ASTR SOC P, V336, P25; Asplund M, 2004, ASTRON ASTROPHYS, V417, P751, DOI 10.1051/0004-6361:20034328; Ayres TR, 2008, ASTROPHYS J, V686, P731, DOI 10.1086/590950; Badnell NR, 2005, MON NOT R ASTRON SOC, V360, P458, DOI 10.1111/j.1365-2966.2005.08991.x; Basu S, 2008, PHYS REP, V457, P217, DOI 10.1016/j.physrep.2007.12.002; Caffau E, 2008, ASTRON ASTROPHYS, V488, P1031, DOI 10.1051/0004-6361:200809885; Centeno R, 2008, ASTROPHYS J LETT, V682, pL61, DOI 10.1086/590405; Drake JJ, 2005, NATURE, V436, P525, DOI 10.1038/nature03803; MELENDEZ J, 2008, ASTRON ASTROPHYS; PRESS WH, 1981, ASTROPHYS J, V248, P751, DOI 10.1086/159199; Prieto CA, 2001, ASTROPHYS J, V556, pL63, DOI 10.1086/322874; PRZYBILLA N, 2008, ASTRON ASTROPHYS	15	5	5	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					51	52		10.1126/science.1148787	http://dx.doi.org/10.1126/science.1148787			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832632				2022-12-28	WOS:000259680200029
J	Jensen, LJ; Bork, P				Jensen, Lars Juhl; Bork, Peer			Biochemistry - Not comparable, but complementary	SCIENCE			English	Editorial Material							PROTEIN-PROTEIN INTERACTIONS; SACCHAROMYCES-CEREVISIAE; YEAST; COMPLEXES; SYSTEM; MAP		[Jensen, Lars Juhl; Bork, Peer] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Jensen, Lars Juhl] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, DK-2200 Copenhagen, Denmark; [Bork, Peer] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany	European Molecular Biology Laboratory (EMBL); University of Copenhagen; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Jensen, LJ (corresponding author), European Mol Biol Lab, D-69117 Heidelberg, Germany.	peer.bork@embl.de	Bork, Peer/F-1813-2013; Jensen, Lars Juhl/C-6492-2008	Bork, Peer/0000-0002-2627-833X; Jensen, Lars Juhl/0000-0001-7885-715X				Bader JS, 2004, NAT BIOTECHNOL, V22, P78, DOI 10.1038/nbt924; Bork P, 2005, CELL, V121, P507, DOI 10.1016/j.cell.2005.05.001; de Lichtenberg U, 2005, SCIENCE, V307, P724, DOI 10.1126/science.1105103; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Reguly Teresa, 2006, J Biol, V5, P11, DOI 10.1186/jbiol36; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; von Mering C, 2002, NATURE, V417, P399, DOI 10.1038/nature750; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	15	45	45	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					56	57		10.1126/science.1164801	http://dx.doi.org/10.1126/science.1164801			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832636				2022-12-28	WOS:000259680200033
J	Graves, N; McGowan, JE				Graves, Nicholas; McGowan, John E., Jr.			Nosocomial Infection, the Deficit Reduction Act, and incentives for hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; PREVENTION; ECONOMICS; SAFETY		[Graves, Nicholas] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [McGowan, John E., Jr.] Emory Univ, Dept Epidemiol, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Queensland University of Technology (QUT); Emory University; Rollins School Public Health	Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave,Kelvin Grove Urban Village, Kelvin Grove, Qld 4059, Australia.	n.graves@qut.edu.au	Graves, Nicholas/A-3052-2011; mcgowan, john e/G-5404-2011	Graves, Nicholas/0000-0002-5559-3267				Anderson DJ, 2007, INFECT CONT HOSP EP, V28, P767, DOI 10.1086/518518; [Anonymous], 2007, EXTENDING CURE POLIC; Burke JP, 2003, NEW ENGL J MED, V348, P651, DOI 10.1056/NEJMhpr020557; Centers for Medicare and Medicaid Services, 2008, FED REGISTER, V73, P48434; Clements A, 2008, LANCET INFECT DIS, V8, P427, DOI 10.1016/S1473-3099(08)70151-8; Davis MM, 2008, INFECT CONT HOSP EP, V29, P395, DOI 10.1086/587966; Edwards JR, 2007, AM J INFECT CONTROL, V35, P290, DOI 10.1016/j.ajic.2007.04.001; Graves N, 2004, EMERG INFECT DIS, V10, P561, DOI 10.3201/eid1004.020754; Halton K, 2007, EMERG INFECT DIS, V13, P815, DOI 10.3201/eid1306.070048; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Persson U, 1999, ACTA ORTHOP SCAND, V70, P163, DOI 10.3109/17453679909011256; Pronovost PJ, 2008, JAMA-J AM MED ASSOC, V299, P2197, DOI 10.1001/jama.299.18.2197; Roberts RR, 1999, JAMA-J AM MED ASSOC, V281, P644, DOI 10.1001/jama.281.7.644; Zell BL, 2007, INFECT CONT HOSP EP, V28, P261, DOI 10.1086/513722	14	33	34	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1577	1579		10.1001/jama.300.13.1577	http://dx.doi.org/10.1001/jama.300.13.1577			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827214				2022-12-28	WOS:000259617700022
J	Hochman, M; Hochman, S; Bor, D; McCormick, D				Hochman, Michael; Hochman, Steven; Bor, David; McCormick, Danny			News media coverage of medication research - Reporting pharmaceutical company funding and use of generic medication names	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article; Proceedings Paper	New England Regional Meeting of the Society-General-Internal-Medicine	APR   14, 2008	Worcester, MA	Soc Gen Internal Med, New England Reg			CONFLICTS-OF-INTEREST; BIOMEDICAL-RESEARCH; DRUG NAMES; TRIALS; BRAND; SUBSTITUTION; ASSOCIATION; CONCLUSIONS; DISCLOSURE; JOURNALS	Context The news media are an important source of information about medical research for patients and even some physicians. Little is known about how frequently news articles report when medication research has received funding from pharmaceutical companies or how frequently news articles use generic vs brand medication names. Objectives To assess the reporting of pharmaceutical company funding and generic medication name use in news articles about medication studies and to determine the views of newspaper editors about these issues. Design, Setting, and Participants We reviewed US news articles from newspaper and online sources about all pharmaceutical company - funded medication studies published in the 5 most prominent general medical journals between April 1, 2004, and April 30, 2008. We also surveyed editors at the 100 most widely circulated newspapers in the United States. Main Outcome Measures The percentage of news articles indicating when studies have been pharmaceutical company - funded and the percentage that refer to medications by their generic vs brand names. Also the percentage of newspaper editors who indicate that their articles report pharmaceutical company funding; the percentage of editors who indicate that their articles refer to medications by generic names; and the percentage of newspapers with policies about these issues. Results Of the 306 news articles about medication research identified, 130 ( 42%; 95% confidence interval [ CI], 37%- 48%) did not report that the research had received company funding. Of the 277 of these articles reporting on medications with both generic and brand names, 186 ( 67%; 95% CI, 61%- 73%) referred to the study medications by their brand names in at least half of the medication references. Eighty-two of the 93 ( 88%) newspaper editors who responded to our survey reported that articles from their publications always or often indicated when studies had received company funding ( 95% CI, 80%- 94%), and 71 of 92 ( 77%) responding editors also reported that articles from their publications always or often referred to medications by the generic names ( 95% CI, 67%- 85%). However, only 3 of 92 newspapers ( 3%) had written policies stating that company funding sources of medical studies be reported ( 95% CI 1%- 9%), and 2 of 93 ( 2%) newspapers had written policies stating that medications should be referred to by their generic names ( 95% CI 1%- 8%). Conclusion News articles reporting on medication studies often fail to report pharmaceutical company funding and frequently refer to medications by their brand names despite newspaper editors' contention that this is not the case.	[Hochman, Michael; Bor, David; McCormick, Danny] Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA; [Hochman, Michael; Bor, David; McCormick, Danny] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Hochman, Steven] Pomona Coll, Claremont, CA 91711 USA	Harvard University; Cambridge Health Alliance; Harvard University; Claremont Colleges; Pomona College	Hochman, M (corresponding author), Cambridge Hosp, Dept Med, 1493 Cambridge St, Cambridge, MA 02139 USA.	miehochman@challiance.org						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; American Society of Hospital Pharmacists, 1993, AM J HOSP PHARM, V50, P305; Ancker JS, 2007, SCI ENG ETHICS, V13, P147, DOI 10.1007/s11948-007-9011-z; *ASS HLTH CAR JOUR, STAT PRINC; *AUD BUR CIRC, 2006, FAS FAX REP MAJ US N; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bromley J, 2006, MED J AUSTRALIA, V185, P687, DOI 10.5694/j.1326-5377.2006.tb00767.x; Cassels A, 2003, CAN MED ASSOC J, V168, P1133; Caulfield T, 2004, PLOS MED, V1, P178, DOI 10.1371/journal.pmed.0010038; Cooper RJ, 2006, J GEN INTERN MED, V21, P1248, DOI 10.1111/j.1525-1497.2006.00598.x; DeAngelis CD, 2008, JAMA-J AM MED ASSOC, V299, P1833, DOI 10.1001/jama.299.15.1833; DeAngelis CD, 2001, JAMA-J AM MED ASSOC, V286, P89, DOI 10.1001/jama.286.1.89; Gundersen L, 1998, ANN INTERN MED, V129, P677, DOI 10.7326/0003-4819-129-8-199810150-00042; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; HENRY J, 2001, PRESCRIPTION DRUG TR; Hesse BW, 2005, ARCH INTERN MED, V165, P2618, DOI 10.1001/archinte.165.22.2618; *I SAF MED PRACT, 2003, DRAFT GUID SAF EL CO, V8; *INT COMM MED J ED, 2007, UN REQ MAN SUBM BIOM; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; *LEAD DIR INC, 2007, NEWS MED YELL BOOK; Li M, 2008, HEALTH EDUC RES, V23, P543, DOI 10.1093/her/cym028; LIEBERMAN T, 2005, COLUMBIA JOURNAL JUL; Mott DA, 2002, MED CARE, V40, P662, DOI 10.1097/00005650-200208000-00006; Moynihan R, 2000, NEW ENGL J MED, V342, P1645, DOI 10.1056/NEJM200006013422206; *NAT I HLTH CAR MA, 2002, PRIM GEN DRUGS PAT P; PARKER WA, 1983, AM J HOSP PHARM, V40, P38, DOI 10.1093/ajhp/40.1.38; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Schwab M, 2002, ARCH INTERN MED, V162, P1065, DOI 10.1001/archinte.162.9.1065; Schwartz RS, 2008, NEW ENGL J MED, V358, P1850, DOI 10.1056/NEJMe0802618; Schwitzer G, 2008, PLOS MED, V5, P700, DOI 10.1371/journal.pmed.0050095; Sharma V, 2003, ARCH PEDIAT ADOL MED, V157, P257, DOI 10.1001/archpedi.157.3.257; Steinman MA, 2007, J GEN INTERN MED, V22, P645, DOI 10.1007/s11606-006-0074-3; Woloshin S, 2002, JAMA-J AM MED ASSOC, V287, P2856, DOI 10.1001/jama.287.21.2856; 2006, NATL J CITATION REPO	34	36	36	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1544	1550		10.1001/jama.300.13.1544	http://dx.doi.org/10.1001/jama.300.13.1544			7	Medicine, General & Internal	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827211				2022-12-28	WOS:000259617700018
J	Derkx, HP; Rethans, JJE; Muijtjens, AM; Maiburg, BH; Winkens, R; Van Rooij, HG; Knottnerus, JA				Derkx, Hay P.; Rethans, Jan-Joost E.; Muijtjens, Arno M.; Maiburg, Bas H.; Winkens, Ron; Van Rooij, Harrie G.; Knottnerus, J. Andre			Quality of clinical aspects of call handling at Dutch out of hours centres: cross sectional national study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TELEPHONE CONSULTATION; GENERAL-PRACTITIONERS; PRIMARY-CARE; SERVICE; SAFETY; TRIAGE; ADVICE	Objective To assess the quality of telephone triage by following the consecutive phases of its care process and the quality of the clinical questions asked about the patient's clinical condition, of the triage outcome, of the content of the home management advice, and of the safety net advice given at out of hours centres. Design Cross sectional national study using telephone incognito standardised patients. Setting The Netherlands. Participants 17 out of hours centres. Main outcome measures Percentages of clinical obligatory questions asked and items within home management and safety net advice, both in relation to pre-agreed standards, and of care advice given in relation to the required care advice. Results The telephone incognito standardised patients presented seven clinical cases three times each over a period of 12 months, making a total of 357 calls. The mean percentage of obligatory questions asked compared with the standard was 21%. Answers to questions about the clinical condition were not always correctly evaluated from a clinical viewpoint, either by triagists or by general practitioners. The quality of information on home management and safety net advice varied, but it was consistently poor for all cases and for all out of hours centres. Triagists achieved the appropriate triage outcome in 58% of calls. Conclusion In determining the outcome of the care process, triagists often reached a conclusion after asking a minimal number of questions. By analysing the quality of different phases within the process of telephone triage, evaluation of whether an appropriate triage outcome has been arrived at by means of good clinical reasoning or by an educated guess is possible. In terms of enhancing the overall clinical safety of telephone triage, apart from obtaining an appropriate clinical history, adequate home management and safety net advice must also be given.	[Derkx, Hay P.; Knottnerus, J. Andre] Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands; [Rethans, Jan-Joost E.] Maastricht Univ, Skillslab, Maastricht, Netherlands; [Muijtjens, Arno M.] Maastricht Univ, Dept Educ Dev & Res, Maastricht, Netherlands; [Maiburg, Bas H.] Maastricht Univ, Dept Gen Practitioner Vocat Training, Maastricht, Netherlands; [Winkens, Ron] Maastricht Univ, Ctr Qual Care Res, Dept Gen Practice, Maastricht, Netherlands; [Van Rooij, Harrie G.] Primary Care Out Hours Ctr, Tilburg, Netherlands	Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maastricht University	Derkx, HP (corresponding author), Maastricht Univ, Dept Gen Practice, Maastricht, Netherlands.	hay.derkx@medicinfo.nl	Knottnerus, Andre/F-4866-2013; Knottnerus, Johannes A/A-3829-2009					AITKEN ME, 1995, NEW ZEAL MED J, V108, P315; Belman S, 2005, ARCH PEDIAT ADOL MED, V159, P145, DOI 10.1001/archpedi.159.2.145; Belman S, 2002, AMBUL PEDIATR, V2, P396, DOI 10.1367/1539-4409(2002)002<0396:COTDBC>2.0.CO;2; Brennan R.L., 2001, GEN THEORY; Car J, 2004, QUAL SAF HEALTH CARE, V13, P2, DOI 10.1136/qshc.2003.009241; Carbajal R, 1996, ARCH PEDIATRIE, V3, P964, DOI 10.1016/0929-693X(96)81716-7; Chowdhury S., 2001, POWER 6 SIGMA; Christensen MB, 1998, BMJ-BRIT MED J, V316, P1502, DOI 10.1136/bmj.316.7143.1502; Crouch R, 1996, J ROY SOC MED, V89, P324, DOI 10.1177/014107689608900606; CROUCH R, 2000, THESIS U SURREY BRIG; Dale J, 2004, QUAL SAF HEALTH CARE, V13, P363, DOI 10.1136/qshc.2003.008003; Dale J, 1997, Br J Nurs, V6, P171; Edwards B, 1998, J CLIN NURS, V7, P51, DOI 10.1046/j.1365-2702.1998.00113.x; Fatovich DM, 1998, MED J AUSTRALIA, V169, P143, DOI 10.5694/j.1326-5377.1998.tb116015.x; Foster J, 1999, BRIT J GEN PRACT, V49, P111; GIESEN P, 2007, THESIS U NIJMEGEN NI; Grol R, 1997, BRIT MED J, V315, P418, DOI 10.1136/bmj.315.7105.418; HIGGS RH, 2003, BMJ; *HUIS GEN, 2000, NHG TEL; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Lattimer V, 1998, BMJ-BRIT MED J, V317, P1054; LEPROHON J, 1995, MED DECIS MAKING, V15, P240, DOI 10.1177/0272989X9501500307; Light Patricia A, 2005, J Pediatr Nurs, V20, P424; Moriarty H, 2003, BRIT J GEN PRACT, V53, P942; NEIGHBOUR R, 1987, INNER CONSULTATION D; OBRIEN RP, 1990, AM J EMERG MED, V8, P496, DOI 10.1016/0735-6757(90)90149-T; PARKIN JD, 1992, MED J AUSTRALIA, V156, P614, DOI 10.5694/j.1326-5377.1992.tb121458.x; POST J, 2004, THESIS U GRONINGEN G; Rethans JJ, 2007, MED EDUC, V41, P537, DOI 10.1111/j.1365-2929.2006.02689.x; Rethans JJ, 2002, MED EDUC, V36, P901, DOI 10.1046/j.1365-2923.2002.01316.x; Salisbury C, 2000, BRIT MED J, V320, P618, DOI 10.1136/bmj.320.7235.618; SILVERMANN J, 2000, SKILLS COMMUNICATING; TIJSSEN R, 2004, NHG TELEFOONWIJZER G; van der Vleuten C.P., 1990, TEACH LEARN MED, V2, P58, DOI [https://doi.org/10.1080/10401339009539432, DOI 10.1080/10401339009539432]; Viehweg TL, 2006, J ORAL MAXIL SURG, V64, P511, DOI 10.1016/j.joms.2005.11.031; Wahlberg A C, 1999, Int J Nurs Pract, V5, P164, DOI 10.1046/j.1440-172x.1999.00179.x; YANOVSKI SZ, 1992, PEDIATRICS, V89, P701	38	53	54	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2008	337	7671							a1264	10.1136/bmj.a1264	http://dx.doi.org/10.1136/bmj.a1264			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18790814	hybrid, Green Published			2022-12-28	WOS:000259622000032
J	Puwanarajah, P; Ali, A; Clelland, C; Hammersley, MS				Puwanarajah, Prasanna; Ali, Asif; Clelland, Colin; Hammersley, Maggie S.			No fire without smoke	LANCET			English	Editorial Material									[Ali, Asif] Milton Keynes Hosp Fdn Trust, Dept Med, Milton Keynes MK6 5LD, Bucks, England; [Clelland, Colin] John Radcliffe Hosp, Dept Pathol, Oxford OX3 9DU, England; [Puwanarajah, Prasanna; Hammersley, Maggie S.] John Radcliffe Hosp, Nuffield Dept Med, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Ali, A (corresponding author), Milton Keynes Hosp Fdn Trust, Dept Med, Milton Keynes MK6 5LD, Bucks, England.	asif.ali@mkhospital.nhs.uk						Bruce NC, 2004, WAVE RANDOM MEDIA, V14, P1, DOI 10.1088/0959-7174/14/1/001; CHEN B H, 1990, World Health Statistics Quarterly, V43, P127; Jindal S K, 2004, Indian J Chest Dis Allied Sci, V46, P137; Smith K.R., 2004, COMP QUANTIFICATION, V18, P1435; Smith KR, 2000, P NATL ACAD SCI USA, V97, P13286, DOI 10.1073/pnas.97.24.13286	5	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1120	1120		10.1016/S0140-6736(08)61453-1	http://dx.doi.org/10.1016/S0140-6736(08)61453-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805340				2022-12-28	WOS:000259648500038
J	Nolte, P; Stierle, A; Jin-Phillipp, NY; Kasper, N; Schulli, TU; Dosch, H				Nolte, P.; Stierle, A.; Jin-Phillipp, N. Y.; Kasper, N.; Schulli, T. U.; Dosch, H.			Shape changes of supported Rh nanoparticles during oxidation and reduction cycles	SCIENCE			English	Article							ADSORPTION; CATALYSTS; OXYGEN	The microscopic insight into how and why catalytically active nanoparticles change their shape during oxidation and reduction reactions is a pivotal challenge in the fundamental understanding of heterogeneous catalysis. We report an oxygen- induced shape transformation of rhodium nanoparticles on magnesium oxide ( 001) substrates that is lifted upon carbon monoxide exposure at 600 kelvin. A Wulff analysis of high- resolution in situ x- ray diffraction, combined with transmission electron microscopy, shows that this phenomenon is driven by the formation of a oxygen- rhodium- oxygen surface oxide at the rhodium nanofacets. This experimental access into the behavior of such nanoparticles during a catalytic cycle is useful for the development of improved heterogeneous catalysts.	[Nolte, P.; Stierle, A.; Jin-Phillipp, N. Y.; Kasper, N.; Dosch, H.] Max Planck Inst Met Res, D-70569 Stuttgart, Germany; [Schulli, T. U.] Comis Nacl Energia Atom, Inst Nanosci & Cryogenie, Serv Phys Mat & Microstruct, F-38054 Grenoble 09, France	Max Planck Society; CEA	Stierle, A (corresponding author), Max Planck Inst Met Res, Heisenbergstr 3, D-70569 Stuttgart, Germany.	stierle@mf.mpg.de	Stierle, Andreas/Q-2679-2018	Stierle, Andreas/0000-0002-0303-6282	European Union [NMP3-CT-2003-505670 (NANO2)]	European Union(European Commission)	We thank G. Richter and M. Pudleiner for the preparation of Rh/MgO reference samples, N. Jeutter for help with the x-ray experiments, and the European Union for financial support under contract no. NMP3-CT-2003-505670 (NANO2).	Ackermann MD, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.255505; Baumer M, 2007, PHYS CHEM CHEM PHYS, V9, P3541, DOI 10.1039/b700365j; Dri C, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2345058; Gandhi HS, 2003, J CATAL, V216, P433, DOI 10.1016/S0021-9517(02)00067-2; Gustafson J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.115442; Gustafson J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.126102; Hansen KH, 2002, SURF SCI, V505, P25, DOI 10.1016/S0039-6028(02)01437-1; Hansen PL, 2002, SCIENCE, V295, P2053, DOI 10.1126/science.1069325; Hendriksen BLM, 2004, SURF SCI, V552, P229, DOI 10.1016/j.susc.2004.01.025; Henry CR, 1998, SURF SCI REP, V31, P235; Kasper N, 2006, SURF SCI, V600, P2860, DOI 10.1016/j.susc.2006.05.030; Lundgren E, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.046101; Mittendorfer F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.233413; Newton MA, 2007, ANGEW CHEM INT EDIT, V46, P8629, DOI 10.1002/anie.200702134; Nokbin S, 2004, SURF SCI, V566, P977, DOI 10.1016/j.susc.2004.06.039; Over H, 2000, SCIENCE, V287, P1474, DOI 10.1126/science.287.5457.1474; Renaud G, 2003, SCIENCE, V300, P1416, DOI 10.1126/science.1082146; ROBINSON IK, 1992, REP PROG PHYS, V55, P599, DOI 10.1088/0034-4885/55/5/002; Rogal J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.046101; Rupprechter G, 1998, J CATAL, V173, P409, DOI 10.1006/jcat.1997.1917; Sporn M, 1998, SURF SCI, V416, P384, DOI 10.1016/S0039-6028(98)00574-3; Traa, 2008, HDB HETEROGENEOUS CA, DOI DOI 10.1002/9783527610044.HETCAT0130; Wang JG, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.256102; WINTERBO.WL, 1967, ACTA METALL MATER, V15, P303, DOI 10.1016/0001-6160(67)90206-4; Wulff G, 1901, Z KRYSTALLOGR MINERA, V34, P449, DOI 10.1524/zkri.1901.34.1.449	26	186	190	3	219	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1654	1658		10.1126/science.1160845	http://dx.doi.org/10.1126/science.1160845			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801992				2022-12-28	WOS:000259300400028
J	Wu, KM; Lu, YH; Feng, HQ; Jiang, YY; Zhao, JZ				Wu, Kong-Ming; Lu, Yan-Hui; Feng, Hong-Qiang; Jiang, Yu-Ying; Zhao, Jian-Zhou			Suppression of cotton bollworm in multiple crops in china in areas with Bt toxin-containing cotton	SCIENCE			English	Article							PEST-MANAGEMENT; SEASONAL ABUNDANCE; TRANSGENIC COTTON; PINK-BOLLWORM; RESISTANCE; HEMIPTERA; MIRIDAE; FIELD	Transgenic cotton that has been engineered to produce insecticidal toxins from Bacillus thuringiensis (Bt) and so to resist the pest cotton bollworm (Helicoverpa armigera) has been widely planted in Asia. Analysis of the population dynamics of H. armigera from 1992 to 2007 in China indicated that a marked decrease in regional outbreaks of this pest in multiple crops was associated with the planting of Bt cotton. The study area included six provinces in northern China with an annual total of 3 million hectares of cotton and 22 million hectares of other crops (corn, peanuts, soybeans, and vegetables) grown by more than 10 million resource- poor farmers. Our data suggest that Bt cotton not only controls H. armigera on transgenic cotton designed to resist this pest but also may reduce its presence on other host crops and may decrease the need for insecticide sprays in general.	[Wu, Kong-Ming; Lu, Yan-Hui; Feng, Hong-Qiang; Zhao, Jian-Zhou] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Jiang, Yu-Ying] Natl Agrotech Extens & Serv Ctr, Beijing 100026, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn		Zhao, Jianzhou/0000-0001-9136-2442; Lu, Yanhui/0000-0002-6552-0248; Feng, Hongqiang/0000-0002-1171-248X	973 Projects Grant [2007CB109204]; Ministry of Science and Technology of China; National Natural Science Foundation of China [30625028]	973 Projects Grant(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by 973 Projects Grant (2007CB109204) from the Ministry of Science and Technology of China and the National Natural Science Foundation of China (30625028). We thank A. M. Shelton (Cornell University) and two anonymous referees for comments and suggestions.	Carriere Y, 2005, PEST MANAG SCI, V61, P327, DOI 10.1002/ps.1039; Carriere Y, 2003, P NATL ACAD SCI USA, V100, P1519, DOI 10.1073/pnas.0436708100; *EPA, PEST NEWS STOR EPA A; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Gould F, 1997, P NATL ACAD SCI USA, V94, P3519, DOI 10.1073/pnas.94.8.3519; Gould F, 2000, NAT BIOTECHNOL, V18, P266, DOI 10.1038/73693; HOKKANEN HMT, 1991, ANNU REV ENTOMOL, V36, P119, DOI 10.1146/annurev.en.36.010191.001003; Huang JK, 2002, SCIENCE, V295, P674, DOI 10.1126/science.1067226; JAMES C, 2007, ISAAA BRIEFS, V37; Lu YH, 2008, CROP PROT, V27, P465, DOI 10.1016/j.cropro.2007.07.017; Shelton AM, 2006, ANNU REV ENTOMOL, V51, P285, DOI 10.1146/annurev.ento.51.110104.150959; Shelton AM, 2002, ANNU REV ENTOMOL, V47, P845, DOI 10.1146/annurev.ento.47.091201.145309; Tabashnik BE, 2005, P NATL ACAD SCI USA, V102, P15389, DOI 10.1073/pnas.0507857102; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Wu K, 2002, CROP PROT, V21, P997, DOI 10.1016/S0261-2194(02)00080-7; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2002, J ECON ENTOMOL, V95, P832, DOI 10.1603/0022-0493-95.4.832; Wu KM, 2007, J INVERTEBR PATHOL, V95, P220, DOI 10.1016/j.jip.2007.03.012	18	536	720	21	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1676	1678		10.1126/science.1160550	http://dx.doi.org/10.1126/science.1160550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801998				2022-12-28	WOS:000259300400035
J	Goldstein, MA; Herzog, DB; Misra, M; Sagar, P; Broder, J; Palmer, BA; Riggs, S				Goldstein, Mark A.; Herzog, David B.; Misra, Madhusmita; Sagar, Pallavi; Broder, Jennifer; Palmer, Brian A.; Riggs, Susanne			A man with weight loss and abdominal pain - Anorexia nervosa, with fecal impaction, bradycardia, delayed bone maturation, short stature, low bone density, and cerebral atrophy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EATING-DISORDERS; GROWTH-HORMONE; ADOLESCENTS; COMPLICATIONS; COMORBIDITY; OUTPATIENTS; METABOLISM; TUMORS; MALES		[Goldstein, Mark A.; Herzog, David B.; Misra, Madhusmita] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Herzog, David B.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Sagar, Pallavi] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Goldstein, Mark A.; Herzog, David B.; Misra, Madhusmita; Sagar, Pallavi; Broder, Jennifer; Palmer, Brian A.; Riggs, Susanne] Harvard Univ, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Goldstein, MA (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA.		Misra, Madhusmita/X-8807-2018	Misra, Madhusmita/0000-0002-9405-2981	Tercica; NATIONAL CENTER FOR RESEARCH RESOURCES [K23RR018851] Funding Source: NIH RePORTER	Tercica; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr. Misra reports receiving grant support from Tercica. No other potential conflict of interest relevant to this article was reported.	Adson DE, 1997, INT J EAT DISORDER, V21, P103, DOI 10.1002/(SICI)1098-108X(199703)21:2&lt;103::AID-EAT1&gt;3.0.CO;2-P; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andersen A E, 1999, J Gend Specif Med, V2, P47; Carlat DJ, 1997, AM J PSYCHIAT, V154, P1127; CASPER RC, 1987, J CLIN PSYCHIAT, V48, P119; CHIPKEVITCH E, 1994, BRAIN DEV-JPN, V16, P175, DOI 10.1016/0387-7604(94)90064-7; Crisp A, 2006, EUR EAT DISORD REV, V14, P163, DOI 10.1002/erv.703; Crook MA, 2001, NUTRITION, V17, P632, DOI 10.1016/S0899-9007(01)00542-1; DEVILE CJ, 1995, BRIT MED J, V311, P1359, DOI 10.1136/bmj.311.7016.1359; DEVUYST O, 1993, Q J MED, V86, P791; Douyon L, 2002, ENDOCRIN METAB CLIN, V31, P173, DOI 10.1016/S0889-8529(01)00023-8; GOLDSTEIN MA, 2007, MASSGENERAL HOSP CHI; Greulich WW., 1959, CALIF MED, V91, P53; Grinspoon S, 2002, J CLIN ENDOCR METAB, V87, P2883, DOI 10.1210/jc.87.6.2883; Herzog DB, 1996, PSYCHIAT CLIN N AM, V19, P843, DOI 10.1016/S0193-953X(05)70385-3; HERZOG DB, 2008, UNLOCKING MYSTERIES; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kaplan DW, 2003, PEDIATRICS, V111, P204, DOI 10.1542/peds.111.1.204; Katzman DK, 2005, INT J EAT DISORDER, V37, pS52, DOI 10.1002/eat.20118; Katzman DK, 1997, ARCH PEDIAT ADOL MED, V151, P793, DOI 10.1001/archpedi.1997.02170450043006; Lantzouni E, 2002, J ADOLESCENT HEALTH, V31, P162, DOI 10.1016/S1054-139X(02)00342-7; Lock J, 2005, INT J EAT DISORDER, V37, pS64, DOI 10.1002/eat.20122; Mickley D, 1996, INT J EAT DISORDER, V20, P325, DOI 10.1002/(SICI)1098-108X(199611)20:3&lt;325::AID-EAT13&gt;3.0.CO;2-Z; Miller KK, 2005, ARCH INTERN MED, V165, P561, DOI 10.1001/archinte.165.5.561; Misra M, 2004, J CLIN PSYCHIAT, V65, P1607, DOI 10.4088/JCP.v65n1205; Misra M, 2004, PEDIATRICS, V114, P1574, DOI 10.1542/peds.2004-0540; Misra M, 2003, J CLIN ENDOCR METAB, V88, P5615, DOI 10.1210/jc.2003-030532; Misra M, 2008, J CLIN ENDOCR METAB, V93, P3029, DOI 10.1210/jc.2008-0170; Modan-Moses D, 2003, PEDIATRICS, V111, P270, DOI 10.1542/peds.111.2.270; National Center for Health Statistics, 2000, 2000 CDC GROWTH CHAR; NUSSBAUM M, 1985, J ADOLESCENT HEALTH, V6, P453, DOI 10.1016/S0197-0070(85)80052-8; Panagiotopoulos C, 2000, PEDIATRICS, V105, P1100, DOI 10.1542/peds.105.5.1100; Soyka LA, 1999, J CLIN ENDOCR METAB, V84, P4489, DOI 10.1210/jc.84.12.4489; Steinhausen H-C, 2003, Eur Child Adolesc Psychiatry, V12 Suppl 1, pI91; Striegel-Moore RH, 2007, AM PSYCHOL, V62, P181, DOI 10.1037/0003-066X.62.3.181; Watson TL, 2000, AM J PSYCHIAT, V157, P1806, DOI 10.1176/appi.ajp.157.11.1806; Winston AP, 2006, INT J EAT DISORDER, V39, P606, DOI 10.1002/eat.20322; Work Group on Eating Disorders, 2006, PRACT GUID TREATM PA; Yager J, 2005, NEW ENGL J MED, V353, P1481, DOI 10.1056/NEJMcp050187; Yager J, 2006, PRACTICE GUIDELINE T, V3rd	40	13	14	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1272	1283		10.1056/NEJMcpc0804641	http://dx.doi.org/10.1056/NEJMcpc0804641			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799562				2022-12-28	WOS:000259259900013
J	Li, Y; Baledent, V; Barisic, N; Cho, Y; Fauque, B; Sidis, Y; Yu, G; Zhao, X; Bourges, P; Greven, M				Li, Y.; Baledent, V.; Barisic, N.; Cho, Y.; Fauque, B.; Sidis, Y.; Yu, G.; Zhao, X.; Bourges, P.; Greven, M.			Unusual magnetic order in the pseudogap region of the superconductor HgBa2CuO4+delta	NATURE			English	Article							STATES; MODEL	The pseudogap region of the phase diagram is an important unsolved puzzle in the field of high- transition- temperature (high-T-c) superconductivity, characterized by anomalous physical properties(1,2). There are open questions about the number of distinct phases and the possible presence of a quantum- critical point underneath the superconducting dome(3-5). The picture has remained unclear because there has not been conclusive evidence for a new type of order. Neutron scattering measurements for YBa2Cu3O6+delta (YBCO) resulted in contradictory claims of no(6,7) and weak(8,9) magnetic order, and the interpretation of muon spin relaxation measurements on YBCO10,11 and of circularly polarized photoemission experiments on Bi2Sr2CaCu2O8+delta ( refs 12, 13) has been controversial. Here we use polarized neutron diffraction to demonstrate for the model superconductor HgBa2CuO4+delta (Hg1201) that the characteristic temperature T* marks the onset of an unusual magnetic order. Together with recent results for YBCO14,15, this observation constitutes a demonstration of the universal existence of such a state. The findings appear to rule out theories that regard T* as a crossover temperature(16-18) rather than a phase transition temperature(19-21). Instead, they are consistent with a variant of previously proposed charge- current- loop order(19,20) that involves apical oxygen orbitals(22), and with the notion that many of the unusual properties arise from the presence of a quantum- critical point(3-5,19).	[Barisic, N.; Cho, Y.; Zhao, X.; Greven, M.] Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA; [Li, Y.; Yu, G.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Baledent, V.; Fauque, B.; Sidis, Y.; Bourges, P.] CEA Saclay, CNRS, Leon Brillouin Lab, F-91191 Gif Sur Yvette, France; [Barisic, N.] Univ Stuttgart, Inst Phys 1, D-70550 Stuttgart, Germany; [Cho, Y.] Pusan Natl Univ, BK21 Team Nano Fus Technol, Pusan 609735, South Korea; [Zhao, X.] Jilin Univ, State Key Lab Inorgan Synth & Preparat Chem, Coll Chem, Changchun 130012, Peoples R China; [Greven, M.] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA	Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Stuttgart; Pusan National University; Jilin University; Stanford University	Greven, M (corresponding author), Stanford Synchrotron Radiat Lab, Stanford, CA 94309 USA.	greven@stanford.edu	Barisic, Neven/E-4246-2015; Balédent, Victor/S-8894-2018; Cho, Yong Chan/W-5338-2019; Yu, Guichuan/K-4025-2014	Balédent, Victor/0000-0002-9437-434X; Cho, Yong Chan/0000-0003-3976-8343; Bourges, Philippe/0000-0001-9494-0789	US Department of Energy; National Science Foundation	US Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF))	We thank H. Alloul and C. Varma for comments. The work at Stanford University was supported by grants from the US Department of Energy and the National Science Foundation.	Aji V, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.224511; Anderson PW, 2004, J PHYS-CONDENS MAT, V16, pR755, DOI 10.1088/0953-8984/16/24/R02; Bobroff J, 1997, PHYS REV LETT, V78, P3757, DOI 10.1103/PhysRevLett.78.3757; Borisenko SV, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207001; Chakravarty S, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.094503; Eisaki H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.064512; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Laughlin RB, 1998, ADV PHYS, V47, P943, DOI 10.1080/000187398243483; Lee PA, 1999, PHYSICA C, V317, P194, DOI 10.1016/S0921-4534(99)00059-3; Lee SH, 1999, PHYS REV B, V60, P10405, DOI 10.1103/PhysRevB.60.10405; Liang RX, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180505; Mook HA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.020506; Mook HA, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.134509; Norman MR, 2005, ADV PHYS, V54, P715, DOI [10.1080/00018730500459906, 10.1080/00018730500489906]; PUTILIN SN, 1993, NATURE, V362, P226, DOI 10.1038/362226a0; Sachdev S, 2000, SCIENCE, V288, P475, DOI 10.1126/science.288.5465.475; Sidis Y, 2001, PHYS REV LETT, V86, P4100, DOI 10.1103/PhysRevLett.86.4100; Sonier JE, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.134501; Sonier JE, 2001, SCIENCE, V292, P1692, DOI 10.1126/science.1060844; Stock C, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.024505; Tallon JL, 2001, PHYSICA C, V349, P53, DOI 10.1016/S0921-4534(00)01524-0; Timusk T, 1999, REP PROG PHYS, V62, P61, DOI 10.1088/0034-4885/62/1/002; Varma CM, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.155113; Varma CM, 1997, PHYS REV B, V55, P14554, DOI 10.1103/PhysRevB.55.14554; WEBER C, ORBIAL CURRENTS EXTE; Zhao XD, 2006, ADV MATER, V18, P3243, DOI 10.1002/adma.200600931	30	232	234	5	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					372	375		10.1038/nature07251	http://dx.doi.org/10.1038/nature07251			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800135				2022-12-28	WOS:000259265200040
J	Walley, J; Lawn, JE; Tinker, A; de Francisco, A; Chopra, M; Rudan, I; Bhutta, ZA; Black, RE				Walley, John; Lawn, Joy E.; Tinker, Anne; de Francisco, Andres; Chopra, Mickey; Rudan, Igor; Bhutta, Zulfiqar A.; Black, Robert E.		Lancet Alma Ata Working Grp	Alma-Ata: Rebirth and revision 8 - Primary health care: making Alma-Ata a reality	LANCET			English	Article							MIDDLE-INCOME COUNTRIES; CHILD SURVIVAL; INTERVENTIONS; NEWBORN; DISEASE	The principles agreed at Alma-Ata 30 years ago apply just as much now as they did then. "Health for all" by the year 2000 was not achieved, and the Millennium Development Goals (MDGs) for 2015 will not be met in most low-income countries without substantial acceleration of primary health care. Factors have included insufficient political prioritisation of health, structural adjustment policies, poor governance, population growth, inadequate health systems, and scarce research and assessment on primary health care. We propose the following priorities for revitalising primary health care. Health-service infrastructure, including human resources and essential drugs, needs strengthening, and user fees should be removed for primary health-care services to improve use. A continuum of care for maternal, newborn, and child health services, including family planning, is needed. Evidence-based, integrated packages of community and primary curative and preventive care should be adapted to country contexts, assessed, and scaled up. Community participation and community health workers linked to strengthened primary-care facilities and first-referral services are needed. Furthermore, intersectoral action linking health and development is necessary, including that for better water, sanitation, nutrition, food security, and HIV control. Chronic diseases, mental health, and child development should be addressed. Progress should be measured and accountability assured. We prioritise research questions and suggest actions and measures for stakeholders both locally and globally, which are required to revitalise primary health care.	[Walley, John] Univ Leeds, Nuffield Ctr Hlth & Dev, Leeds Inst Hlth Sci, Leeds LS2 9LJ, W Yorkshire, England; [Lawn, Joy E.; Tinker, Anne] Save Children, Washington, DC USA; [Lawn, Joy E.; Tinker, Anne] Saving Newborn Lives, Cape Town, South Africa; [de Francisco, Andres] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Chopra, Mickey] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Rudan, Igor] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Rudan, Igor] Univ Edinburgh, Sch Med, Dept Publ Hlth Sci, Edinburgh, Midlothian, Scotland; [Bhutta, Zulfiqar A.] Aga Khan Univ Hosp, Dept Paediat & Child Hlth, Karachi, Pakistan; [Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	University of Leeds; Save the Children; University of Split; University of Edinburgh; Aga Khan University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Walley, J (corresponding author), Univ Leeds, Nuffield Ctr Hlth & Dev, Leeds Inst Hlth Sci, 101 Clarendon Rd, Leeds LS2 9LJ, W Yorkshire, England.	j.d.walley@leeds.ac.uk	Lawn, Joy/ABE-6382-2020; Walley, John D/AAY-1375-2021; Rudan, Igor/I-1467-2012	Lawn, Joy/0000-0002-4573-1443; Walley, John D/0000-0001-7290-0989; Rudan, Igor/0000-0001-6993-6884; Treweek, Shaun/0000-0002-7239-7241; Black, Robert/0000-0001-9926-7984; Patel, Vikram/0000-0003-1066-8584; Flottorp, Signe/0000-0003-2961-7461				*ALM AT, 1978, DECL ALM AT INT C PR; [Anonymous], 2001, ROAD MAP IMPL UN MIL; [Anonymous], COMMUNICATION; [Anonymous], MONITORING FINANCIAL; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2006, BMJ-BRIT MED J, V333, P839, DOI 10.1136/bmj.38979.379641.68; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Cleland J, 2006, LANCET, V368, P1810, DOI 10.1016/S0140-6736(06)69480-4; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; De Maeseneer J, 2008, BRIT MED J, V336, P518, DOI 10.1136/bmj.39496.444271.80; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Harries AD, 2004, BMJ-BRIT MED J, V329, P1163, DOI 10.1136/bmj.329.7475.1163; JAMISON DT, 2006, DIS CONTROL PRIORITY; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; LAVERACK G, 2008, HLTH PROMOTION PRACT; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lewin S, 2008, LANCET, V372, P928, DOI 10.1016/S0140-6736(08)61403-8; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MCPAKE B, 1992, IMPLEMENTING BAMAKO; MUSTAQUE A, 2006, B WORLD HEALTH ORGAN, V84, P677; Newell JN, 2004, B WORLD HEALTH ORGAN, V82, P92; *OXF POL MAN, 2002, EV PRIM MIN LAD HLTH; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; Rudan I, 2008, CROAT MED J, V49, P307, DOI 10.3325/cmj.2008.3.307; Sanders D, 2006, PLOS MED, V3, P719, DOI 10.1371/journal.pmed.0030186; Simms Chris, 2001, BITTEREST PILL ALL C; Taylor C., 2002, JUST LASTING CHANGE; Tomlinson M, 2007, PLOS MED, V4, P1293, DOI 10.1371/journal.pmed.0040259; UNAIDS, 2006, REP GLOB AIDS EP EX; Victora CG, 2007, EPIDEMIOLOGY, V18, P669, DOI 10.1097/EDE.0b013e318156c511; Walley J, 2007, B WORLD HEALTH ORGAN, V85, P424, DOI 10.2471/BLT.07.042531; *WHO, 2007, IMAI IMCI HLTH CTR P; WILER G, 2008, PLANNING HUMAN RESOU; World Health Organization, 2005, BANGK CHART HLTH PRO; World Health Organization, 2006, PREGN CHILDB POSTP N; World Health Organization, 1948, 3 WHO	43	151	156	1	39	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					1001	1007		10.1016/S0140-6736(08)61409-9	http://dx.doi.org/10.1016/S0140-6736(08)61409-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790322				2022-12-28	WOS:000259266900039
J	Brusatte, SL; Benton, MJ; Ruta, M; Lloyd, GT				Brusatte, Stephen L.; Benton, Michael J.; Ruta, Marcello; Lloyd, Graeme T.			Superiority, competition, and opportunism in the evolutionary radiation of dinosaurs	SCIENCE			English	Article							TRIASSIC-JURASSIC BOUNDARY; DISPARITY; DIVERSIFICATION; PATTERNS	The rise and diversification of the dinosaurs in the Late Triassic, from 230 to 200 million years ago, is a classic example of an evolutionary radiation with supposed competitive replacement. A comparison of evolutionary rates and morphological disparity of basal dinosaurs and their chief "competitors," the crurotarsan archosaurs, shows that dinosaurs exhibited lower disparity and an indistinguishable rate of character evolution. The radiation of Triassic archosaurs as a whole is characterized by declining evolutionary rates and increasing disparity, suggesting a decoupling of character evolution from body plan variety. The results strongly suggest that historical contingency, rather than prolonged competition or general " superiority," was the primary factor in the rise of dinosaurs.	[Brusatte, Stephen L.; Benton, Michael J.; Ruta, Marcello; Lloyd, Graeme T.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England	University of Bristol	Brusatte, SL (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	brusatte@uchicago.edu	Lloyd, Graeme/F-6677-2010; Lloyd, Graeme/E-1798-2011; Benton, Michael J/A-5639-2008; Brusatte, Stephen/O-9663-2014	Benton, Michael J/0000-0002-4323-1824; Brusatte, Stephen/0000-0001-7525-7319; Ruta, Marcello/0000-0002-6151-0704	Marshall Scholarship and Paleontological Society; UK Natural Environment Research Council; Royal Society; Natural Environment Research Council [NE/C518973/1] Funding Source: researchfish; NERC [NE/C518973/1] Funding Source: UKRI	Marshall Scholarship and Paleontological Society; UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Royal Society(Royal Society of London); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank R. Benson, M. Coates, P. Donoghue, M. Foote, M. LaBarbera, and S. Wang for discussion. Supported by the Marshall Scholarship and Paleontological Society (S.L.B.), the UK Natural Environment Research Council (M.J.B., M.R., G.T.L.), and the Royal Society (M.J.B., M.R.).	BAKKER RT, 1971, EVOLUTION, V25, P636, DOI 10.1111/j.1558-5646.1971.tb01922.x; BENTON MJ, 1983, Q REV BIOL, V58, P29, DOI 10.1086/413056; BENTON MJ, 1987, BIOL REV, V62, P305, DOI 10.1111/j.1469-185X.1987.tb00666.x; CHARIG AJ, 1984, S ZOOL SOC LONDON, V52, P597; Erwin DH, 2007, PALAEONTOLOGY, V50, P57, DOI 10.1111/j.1475-4983.2006.00614.x; FOOTE M, 1994, PALEOBIOLOGY, V20, P320, DOI 10.1017/S009483730001280X; FOOTE M, 1996, EVOLUTIONARY PALEOBI; Gould SJ, 2002, STRUCTURE EVOLUTIONA; Harmon LJ, 2003, SCIENCE, V301, P961, DOI 10.1126/science.1084786; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; Nesbitt SJ, 2006, P ROY SOC B-BIOL SCI, V273, P1045, DOI 10.1098/rspb.2005.3426; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Ruta M, 2006, P ROY SOC B-BIOL SCI, V273, P2107, DOI 10.1098/rspb.2006.3577; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; VALENTINE JW, 1980, PALEOBIOLOGY, V6, P444, DOI 10.1017/S0094837300003614; Wagner PJ, 1997, PALEOBIOLOGY, V23, P115, DOI 10.1017/S0094837300016675; Weishampel DB., 2004, DINOSAURIA; WILLS MA, 1994, PALEOBIOLOGY, V20, P93, DOI 10.1017/S009483730001263X	21	316	322	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1485	1488		10.1126/science.1161833	http://dx.doi.org/10.1126/science.1161833			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787166	Green Submitted, Green Accepted			2022-12-28	WOS:000259121800039
J	Scaillet, B; Pichavant, M; Cioni, R				Scaillet, B.; Pichavant, M.; Cioni, R.			Upward migration of Vesuvius magma chamber over the past 20,000 years	NATURE			English	Article							SOMMA-VESUVIUS; PLINIAN ERUPTION; MT-VESUVIUS; VOLCANOS; RECONSTRUCTION; PHENOCRYSTS; DYNAMICS; SYSTEM	Forecasting future eruptions of Vesuvius is an important challenge for volcanologists, as its reawakening could threaten the lives of 700,000 people living near the volcano(1,2). Critical to the evaluation of hazards associated with the next eruption is the estimation of the depth of the magma reservoir, one of the main parameters controlling magma properties and eruptive style. Petrological studies have indicated that during past activity, magma chambers were at depths between 3 and 16 km ( refs 3-7). Geophysical surveys have imaged some levels of seismic attenuation, the shallowest of which lies at 8-9 km depth(8), and these have been tentatively interpreted as levels of preferential magma accumulation. By using experimental phase equilibria, carried out on material from four main explosive events at Vesuvius, we show here that the reservoirs that fed the eruptive activity migrated from 7-8 km to 3-4 km depth between the AD 79 ( Pompeii) and AD 472 ( Pollena) events. If data from the Pomici di Base event 18.5 kyr ago(9) and the 1944 Vesuvius eruption(7) are included, the total upward migration of the reservoir amounts to 9-11 km. The change of preferential magma ponding levels in the upper crust can be attributed to differences in the volatile content and buoyancy of ascending magmas, as well as to changes in local stress field following either caldera formation(10) or volcano spreading(11). Reservoir migration, and the possible influence on feeding rates(12), should be integrated into the parameters used for defining expected eruptive scenarios at Vesuvius.	[Scaillet, B.; Pichavant, M.] CNRS, INSU, Inst Sci Terre Orleans, F-45071 Orleans 2, France; [Scaillet, B.; Pichavant, M.] Univ Orleans, Inst Sci Terre Orleans, F-45071 Orleans, France; [Cioni, R.] Dipartimento Sci Terra, I-09127 Cagliari, Italy; [Cioni, R.] INGV, Sez Pisa, I-56100 Pisa, Italy	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Orleans; Istituto Nazionale Geofisica e Vulcanologia (INGV)	Scaillet, B (corresponding author), CNRS, INSU, Inst Sci Terre Orleans, 1A Rue Ferollerie, F-45071 Orleans 2, France.	bscaille@cnrs-orleans.fr	Cioni, Raffaello/M-2880-2015; Cioni, Raffaello/A-6357-2012; Pichavant, Michel cha/C-1371-2012; Scaillet, Bruno/A-5846-2012	Cioni, Raffaello/0000-0002-2526-9095; Pichavant, Michel cha/0000-0001-8346-5302; Scaillet, Bruno/0000-0003-1561-0226	GNV; INGV; department of the Italian Civil Defense	GNV; INGV(Istituto Nazionale Geofisica e Vulcanologia (INGV)); department of the Italian Civil Defense	We thank R. Scandone for a review, and A. Sbrana, P. Marianelli and R. Santacroce for discussions. This projectwas financially supported by GNV and INGV funds and by the department of the Italian Civil Defense.	Auger E, 2001, SCIENCE, V294, P1510, DOI 10.1126/science.1064893; Barberi F., 1981, B VOLCANOL, V44, P295, DOI DOI 10.1007/BF02600566; BELKIN HE, 1985, AM MINERAL, V70, P288; Borgia A, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022155; Boschi E., 2006, EOS T AM GEOPHYS UN, V87, P417, DOI DOI 10.1029/2006EO400001; Carroll MR, 1997, AM MINERAL, V82, P549; Cioni R, 1998, J GEOPHYS RES-SOL EA, V103, P18277, DOI 10.1029/98JB01124; CIONI R, 1995, J PETROL, V36, P739, DOI 10.1093/petrology/36.3.739; Cioni R, 2000, CONTRIB MINERAL PETR, V140, P40, DOI 10.1007/s004100000167; CIVETTA L, 1991, B VOLCANOL, V53, P287, DOI 10.1007/BF00414525; Civetta L., 1992, ACTA VULCANOL, V2, P147; Fulignati P, 2007, J VOLCANOL GEOTH RES, V161, P289, DOI 10.1016/j.jvolgeores.2006.12.011; Fulignati P, 2004, J VOLCANOL GEOTH RES, V133, P13, DOI 10.1016/S0377-0273(03)00388-3; GARDNER JE, 1995, B VOLCANOL, V57, P1, DOI 10.1007/BF00298703; Heiken G, 1999, SCIENCE, V286, P1685, DOI 10.1126/science.286.5445.1685; Iacono-Marziano G, 2007, J VOLCANOL GEOTH RES, V161, P151, DOI 10.1016/j.jvolgeores.2006.12.001; Iacono-Marziano G, 2008, CONTRIB MINERAL PETR, V155, P719, DOI 10.1007/s00410-007-0267-8; Landi P, 1999, CONTRIB MINERAL PETR, V135, P179, DOI 10.1007/s004100050505; Marianelli P, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021667; Martel C, 1998, EARTH PLANET SC LETT, V156, P89, DOI 10.1016/S0012-821X(98)00003-X; Morgan DJ, 2004, EARTH PLANET SC LETT, V222, P933, DOI 10.1016/j.epsl.2004.03.030; Pinel V, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001751; ROLANDI G, 1993, J VOLCANOL GEOTH RES, V58, P183, DOI 10.1016/0377-0273(93)90107-3; ROSI M, 1983, J VOLCANOL GEOTH RES, V17, P249, DOI 10.1016/0377-0273(83)90071-9; ROSI M, 1993, J VOLCANOL GEOTH RES, V58, P151, DOI 10.1016/0377-0273(93)90106-2; SANTACROCE R, 1993, J PETROL, V34, P383, DOI 10.1093/petrology/34.2.383; Santacroce R., 1987, SOMMA VESUVIUS; SCAILLET B, 1992, AM MINERAL, V77, P647; Scaillet B, 1999, J PETROL, V40, P381, DOI 10.1093/petrology/40.3.381; Scandone R, 2008, J VOLCANOL GEOTH RES, V170, P167, DOI 10.1016/j.jvolgeores.2007.09.014; SIGURDSSON H, 1990, NATURE, V345, P519, DOI 10.1038/345519a0; Todesco M, 2002, B VOLCANOL, V64, P155, DOI 10.1007/s00445-001-0189-7; Ventura G, 1999, GEOPHYS RES LETT, V26, P3681, DOI 10.1029/1999GL005404	33	104	104	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 11	2008	455	7210					216	U39		10.1038/nature07232	http://dx.doi.org/10.1038/nature07232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784723	Green Submitted			2022-12-28	WOS:000259090800045
J	Hauer, KE; Durning, SJ; Kernan, WN; Fagan, MJ; Mintz, M; O'Sullivan, PS; Battistone, M; Defer, T; Elnicki, M; Harrell, H; Reddy, S; Boscardin, CK; Schwartz, MD				Hauer, Karen E.; Durning, Steven J.; Kernan, Walter N.; Fagan, Mark J.; Mintz, Matthew; O'Sullivan, Patricia S.; Battistone, Michael; DeFer, Thomas; Elnicki, Michael; Harrell, Heather; Reddy, Shalini; Boscardin, Christy K.; Schwartz, Mark D.			Factors associated with medical students' career choices regarding internal medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SPECIALTY CHOICE; CLERKSHIP; IMPACT; SATISFACTION; POWER	Context Shortfalls in the US physician workforce are anticipated as the population ages and medical students' interest in careers in internal medicine ( IM) has declined ( particularly general IM, the primary specialty serving older adults). The factors influencing current students' career choices regarding IM are unclear. Objectives To describe medical students' career decision making regarding IM and to identify modifiable factors related to this decision making. Design, Setting, and Participants Web- based cross- sectional survey of 1177 fourth- year medical students ( 82% response rate) at 11 US medical schools in spring 2007. Main Outcome Measures Demographics, debt, educational experiences, and number who chose or considered IM careers were measured. Factor analysis was performed to assess influences on career chosen. Logistic regression analysis was conducted to assess independent association of variables with IM career choice. Results Of 1177 respondents, 274 ( 23.2%) planned careers in IM, including 24 ( 2.0%) in general IM. Only 228 ( 19.4%) responded that their core IM clerkship made a career in general IM seem more attractive, whereas 574 ( 48.8%) responded that it made a career in subspecialty IM more attractive. Three factors influenced career choice regarding IM: educational experiences in IM, the nature of patient care in IM, and lifestyle. Students were more likely to pursue careers in IM if they were male ( odds ratio [ OR] 1.75; 95% confidence interval [ CI], 1.20- 2.56), were attending a private school ( OR, 1.88; 95% CI, 1.26- 2.83), were favorably impressed with their educational experience in IM ( OR, 4.57; 95% CI, 3.01- 6.93), reported favorable feelings about caring for IM patients ( OR, 8.72; 95% CI, 6.03- 12.62), or reported a favorable impression of internists' lifestyle ( OR, 2.00; 95% CI, 1.39- 2.87). Conclusions Medical students valued the teaching during IM clerkships but expressed serious reservations about IM as a career. Students who reported more favorable impressions of the patients cared for by internists, the IM practice environment, and internists' lifestyle were more likely to pursue a career in IM.	[Hauer, Karen E.; O'Sullivan, Patricia S.; Boscardin, Christy K.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Durning, Steven J.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Kernan, Walter N.] Yale Univ, New Haven, CT USA; [Fagan, Mark J.] Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA; [Mintz, Matthew] George Washington Univ, Washington, DC USA; [Battistone, Michael] Univ Utah, Salt Lake City, UT USA; [DeFer, Thomas] Washington Univ, St Louis, MO USA; [Elnicki, Michael] Univ Pittsburgh, Pittsburgh, PA USA; [Harrell, Heather] Univ Florida, Gainesville, FL USA; [Reddy, Shalini] Univ Chicago, Chicago, IL 60637 USA; [Schwartz, Mark D.] NYU, New York, NY USA	University of California System; University of California San Francisco; Uniformed Services University of the Health Sciences - USA; Yale University; Brown University; George Washington University; Utah System of Higher Education; University of Utah; Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University System of Florida; University of Florida; University of Chicago; New York University	Hauer, KE (corresponding author), Univ Calif San Francisco, Dept Med, 533 Parnassus Ave,U137,Box 0131, San Francisco, CA 94143 USA.	khauer@medicine.ucsf.edu		Boscardin, Christy/0000-0002-9070-8859; O'Sullivan, Patricia/0000-0002-8706-4095	The Shadyside Hospital Foundation of Pittsburgh, Pennsylvania; American Board of Internal Medicine (ABIM) Foundation	The Shadyside Hospital Foundation of Pittsburgh, Pennsylvania; American Board of Internal Medicine (ABIM) Foundation	The Shadyside Hospital Foundation of Pittsburgh, Pennsylvania, and the American Board of Internal Medicine (ABIM) Foundation funded the study.	*AM COLL PHYS, ADV MED HOM PAT CTR; [Anonymous], 2008, ANN INTERN MED, V148, P55, DOI 10.7326/0003-4819-148-1-200801010-00196; *ASS AM MED COLL, 2007 MED SCH GRAD QU; BLAND CJ, 1995, ACAD MED, V70, P620, DOI 10.1097/00001888-199507000-00013; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; Campos-Outcalt D, 1999, ACAD MED, V74, P1016, DOI 10.1097/00001888-199909000-00016; Choi Dongseok, 2006, BMC Med Educ, V6, P53, DOI 10.1186/1472-6920-6-53; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cooper RA, 2004, ANN INTERN MED, V141, P705, DOI 10.7326/0003-4819-141-9-200411020-00012; Darer JD, 2004, ACAD MED, V79, P541, DOI 10.1097/00001888-200406000-00009; Davis BE, 2001, ACAD MED, V76, P815, DOI 10.1097/00001888-200108000-00015; Dorsey ER, 2003, JAMA-J AM MED ASSOC, V290, P1173, DOI 10.1001/jama.290.9.1173; Elnicki DM, 1999, J GEN INTERN MED, V14, P341, DOI 10.1046/j.1525-1497.1999.00352.x; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Gazewood JD, 2002, FAM MED, V34, P673; Griffith CH, 2001, EVAL HEALTH PROF, V24, P61, DOI 10.1177/01632780122034795; Hadley Jack, 2002, Int J Health Care Finance Econ, V2, P37, DOI 10.1023/A:1015397413797; Hauer KE, 2008, J GEN INTERN MED, V23, P1101, DOI 10.1007/s11606-008-0640-y; Henderson MC, 1996, AM J MED, V101, P648, DOI 10.1016/S0002-9343(96)00334-8; Hojat M, 2004, ADV HEALTH SCI EDUC, V9, P241, DOI 10.1023/B:AHSE.0000038173.00909.f6; Hunt DD, 1996, ACAD MED, V71, P665, DOI 10.1097/00001888-199606000-00022; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Irby DM, 1996, ACAD MED, V71, P687; Jeffe DB, 2007, ACAD MED, V82, P888, DOI 10.1097/ACM.0b013e31812f797e; Kahn Marc J, 2006, MedGenMed, V8, P18; Keirns Carla C, 2008, Acad Med, V83, P498, DOI 10.1097/ACM.0b013e31816be3ab; Lipner RS, 2006, ANN INTERN MED, V144, P29, DOI 10.7326/0003-4819-144-1-200601030-00007; Mengel M B, 1995, Fam Med, V27, P652; MEURER LN, 1995, ACAD MED, V70, P388, DOI 10.1097/00001888-199505000-00015; Morrison JM, 1996, BRIT J GEN PRACT, V46, P721; *NAT RES MATCH PRO, ADV DAT TABL 2008 MA; Pham HH, 2004, ACAD MED, V79, P32, DOI 10.1097/00001888-200401000-00009; Rosenblatt RA, 2005, ACAD MED, V80, P815, DOI 10.1097/00001888-200509000-00006; ROSENTHAL MP, 1994, JAMA-J AM MED ASSOC, V271, P914, DOI 10.1001/jama.271.12.914; SCHWARTZ MD, 1995, J GEN INTERN MED, V10, P542, DOI 10.1007/BF02640362; SCHWARTZ MD, 1991, ANN INTERN MED, V114, P6, DOI 10.7326/0003-4819-114-1-6; Smith LG, 2005, AM J MED, V118, P439, DOI 10.1016/j.amjmed.2005.01.021; Sox HC, 2006, ANN INTERN MED, V144, P57, DOI 10.7326/0003-4819-144-1-200601030-00010; Thornton J, 2003, HEALTH ECON, V12, P67, DOI 10.1002/hec.682; Vidyarthi AR, 2006, ACAD MED, V81, P76, DOI 10.1097/00001888-200601000-00019; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713; Weeks WB, 2002, ACAD MED, V77, P312, DOI 10.1097/00001888-200204000-00010; Wetterneck TB, 2002, ARCH INTERN MED, V162, P649, DOI 10.1001/archinte.162.6.649; Zinn WM, 2001, ACAD MED, V76, P355, DOI 10.1097/00001888-200104000-00014	45	287	293	0	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1154	1164		10.1001/jama.300.10.1154	http://dx.doi.org/10.1001/jama.300.10.1154			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780844				2022-12-28	WOS:000259038700008
J	Lette, F; Dwyer, JP				Lette, Francois; Dwyer, Jamie P.			The fluid craze	LANCET			English	Editorial Material							HYPONATREMIA		[Lette, Francois; Dwyer, Jamie P.] Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA	Mayo Clinic	Lette, F (corresponding author), Mayo Clin, Coll Med, Dept Hypertens & Nephrol, Jacksonville, FL 32224 USA.	lette.francois@mayo.edu	Dwyer, Jamie/A-4799-2015	Dwyer, Jamie/0000-0002-8402-8961				Almond CSD, 2005, NEW ENGL J MED, V352, P1550, DOI 10.1056/NEJMoa043901; Bleser S, 2005, J FAM PRACTICE, V54, P691; Borghi L, 1996, J UROLOGY, V155, P839, DOI 10.1016/S0022-5347(01)66321-3; Chung BD, 1999, J CLIN GASTROENTEROL, V28, P29, DOI 10.1097/00004836-199901000-00006; COLERIDGESMITH PD, 1990, BRIT J SURG, V77, P1055, DOI 10.1002/bjs.1800770933; COMEROTA AJ, 1989, SURGERY, V106, P301; Decaux G, 2006, AM J MED, V119, pS79, DOI 10.1016/j.amjmed.2006.05.013; *I MED, 2005, DIET REF INT DRI WAT; JANVRIN SB, 1980, BRIT J SURG, V67, P690, DOI 10.1002/bjs.1800671004; Kurlansky M, 2003, SALT WORLD HIST; LANDGRAF H, 1994, AVIAT SPACE ENVIR MD, V65, P930; Lindeman RD, 2000, J GERONTOL A-BIOL, V55, pM361, DOI 10.1093/gerona/55.7.M361; Longe AC, 1997, E AFR MED J, V74, P487; Negoianu D, 2008, J AM SOC NEPHROL, V19, P1041, DOI 10.1681/ASN.2008030274; Noakes TD, 2006, BRIT J SPORT MED, V40, P567, DOI 10.1136/bjsm.2005.020354; Noakes TD, 2007, SPORTS MED, V37, P463, DOI 10.2165/00007256-200737040-00050; Sterns RH, 2006, AM J MED, V119, pS12, DOI 10.1016/j.amjmed.2006.05.003	17	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					782	784		10.1016/S0140-6736(08)61316-1	http://dx.doi.org/10.1016/S0140-6736(08)61316-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774404				2022-12-28	WOS:000259124900006
J	Ewald, SE; Lee, BL; Lau, L; Wickliffe, KE; Shi, GP; Chapman, HA; Barton, GM				Ewald, Sarah E.; Lee, Bettina L.; Lau, Laura; Wickliffe, Katherine E.; Shi, Guo-Ping; Chapman, Harold A.; Barton, Gregory M.			The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor	NATURE			English	Article							ANTIGEN PRESENTATION; STRANDED-RNA; CPG-DNA; TLR9; ER; TOLL-LIKE-RECEPTOR-9; RECOGNITION; CATHEPSINS; RESPONSES; MEMBRANE	Mammalian Toll-like receptors (TLRs) 3, 7, 8 and 9 initiate immune responses to infection by recognizing microbial nucleic acids(1,2); however, these responses come at the cost of potential autoimmunity owing to inappropriate recognition of self nucleic acids(3). The localization of TLR9 and TLR7 to intracellular compartments seems to have a role in facilitating responses to viral nucleic acids while maintaining tolerance to self nucleic acids, yet the cell biology regulating the transport and localization of these receptors remains poorly understood(4-6). Here we define the route by which TLR9 and TLR7 exit the endoplasmic reticulum and travel to endolysosomes in mouse macrophages and dendritic cells. The ectodomains of TLR9 and TLR7 are cleaved in the endolysosome, such that no full- length protein is detectable in the compartment where ligand is recognized. Notably, although both the full- length and cleaved forms of TLR9 are capable of binding ligand, only the processed form recruits MyD88 on activation, indicating that this truncated receptor, rather than the full- length form, is functional. Furthermore, conditions that prevent receptor proteolysis, including forced TLR9 surface localization, render the receptor non- functional. We propose that ectodomain cleavage represents a strategy to restrict receptor activation to endolysosomal compartments and prevent TLRs from responding to self nucleic acids.	[Ewald, Sarah E.; Lee, Bettina L.; Lau, Laura; Wickliffe, Katherine E.; Barton, Gregory M.] Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Shi, Guo-Ping] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Chapman, Harold A.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Chapman, Harold A.] Univ Calif San Francisco, Inst Cardiovasc Res, San Francisco, CA 94143 USA	University of California System; University of California Berkeley; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Barton, GM (corresponding author), Univ Calif Berkeley, Div Immunol & Pathogenesis, Dept Mol & Cell Biol, 405 Life Sci Addit, Berkeley, CA 94720 USA.	barton@berkeley.edu	Ewald, Sarah/AAM-8918-2020	Ewald, Sarah/0000-0002-5327-7578; Barton, Gregory/0000-0002-3793-0100	Novel Research Grant; The Lupus Research Institute; Hellman Faculty Fund; NIH [HL67204, CA009179, AI072429]; NATIONAL CANCER INSTITUTE [T32CA009179] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL067204] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072429] Funding Source: NIH RePORTER	Novel Research Grant; The Lupus Research Institute; Hellman Faculty Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Barton and Vance laboratories for discussions, S. Akira for providing TLR knockout mice, and R. Vance and R. Medzhitov for advice. We acknowledge the CHPS Imaging Core and P. Herzmark for assistance with microscopy. This work was supported by a Novel Research Grant from The Lupus Research Institute (G.M.B.), the Hellman Faculty Fund (G.M.B.), and NIH grants HL67204 (H.A.C.), CA009179 (S.E.E.) and AI072429 (G.M.B.).	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Asagiri M, 2008, SCIENCE, V319, P624, DOI 10.1126/science.1150110; Barton GM, 2006, NAT IMMUNOL, V7, P49, DOI 10.1038/ni1280; Bell JK, 2006, P NATL ACAD SCI USA, V103, P8792, DOI 10.1073/pnas.0603245103; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Clair JMS, 2006, BIOL CHEM, V387, P1143, DOI 10.1515/BC.2006.141; Deussing J, 1998, P NATL ACAD SCI USA, V95, P4516, DOI 10.1073/pnas.95.8.4516; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Hacker H, 1998, EMBO J, V17, P6230, DOI 10.1093/emboj/17.21.6230; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Juschke C, 2005, J CELL BIOL, V169, P613, DOI 10.1083/jcb.200503033; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Matsumoto F, 2008, BIOCHEM BIOPH RES CO, V367, P693, DOI 10.1016/j.bbrc.2007.12.130; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Shi GP, 1999, IMMUNITY, V10, P197, DOI 10.1016/S1074-7613(00)80020-5; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297	23	456	467	2	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 4	2008	456	7222					658	U88		10.1038/nature07405	http://dx.doi.org/10.1038/nature07405			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	378QW	18820679	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000261340000045
J	Hirota, K; Miyoshi, T; Kugou, K; Hoffman, CS; Shibata, T; Ohta, K				Hirota, Kouji; Miyoshi, Tomoichiro; Kugou, Kazuto; Hoffman, Charles S.; Shibata, Takehiko; Ohta, Kunihiro			Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs	NATURE			English	Article							BETA-GLOBIN LOCUS; PROTEIN-KINASE-A; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; INTERGENIC TRANSCRIPTION; RECOMBINATION HOTSPOT; GENE; ACTIVATION; RESOLUTION; ADE6-M26	Recent transcriptome analyses using high- density tiling arrays(1-3) and data from large- scale analyses of full- length complementary DNA libraries by the FANTOM3 consortium(4,5) demonstrate that many transcripts are non- coding RNAs ( ncRNAs). These transcriptome analyses indicate that many of the non- coding regions, previously thought to be functionally inert, are actually transcriptionally active regions with various features. Furthermore, most relatively large ( several kilobases) polyadenylated messenger RNA transcripts are transcribed from regions harbouring little coding potential. However, the function of such ncRNAs is mostly unknown and has been a matter of debate(2). Here we show that RNA polymerase II ( RNAPII) transcription of ncRNAs is required for chromatin remodelling at the fission yeast Schizosaccharomyces pombe fbp1(+) locus during transcriptional activation. The chromatin at fbp1(+) is progressively converted to an open configuration, as several species of ncRNAs are transcribed through fbp1(+). This is coupled with the translocation of RNAPII through the region upstream of the eventual fbp1(+) transcriptional start site. Insertion of a transcription terminator into this upstream region abolishes both the cascade of transcription of ncRNAs and the progressive chromatin alteration. Our results demonstrate that transcription through the promoter region is required to make DNA sequences accessible to transcriptional activators and to RNAPII.	[Hirota, Kouji; Kugou, Kazuto; Shibata, Takehiko; Ohta, Kunihiro] RIKEN, Adv Sci Inst, Mol & Cellular Biol Lab, Wako, Saitama 3510198, Japan; [Hirota, Kouji; Miyoshi, Tomoichiro; Kugou, Kazuto; Ohta, Kunihiro] Univ Tokyo, Dept Life Sci, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan; [Hoffman, Charles S.] Boston Coll, Dept Biol, Chestnut Hill, MA 02467 USA	RIKEN; University of Tokyo; Boston College	Hirota, K (corresponding author), Kyoto Univ, Grad Sch Med, Dept Radiat Genet, Sakyo Ku, Yoshida Konoe, Kyoto 6068501, Japan.	khirota@rg.med.kyoto-u.ac.jp; kohta@bio.c.u-tokyo.ac.jp		Hoffman, Charles/0000-0001-8700-1863; Kugou, Kazuto/0000-0002-7690-1249; Miyoshi, Tomoichiro/0000-0002-5319-7877	Ministry of Education, Culture, Sports, Science and Technology, Japan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046226] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank W. Lin for critically reading this manuscript. This work was supported by grants-in-aid for scientific research in a priority area, the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Ashe HL, 1997, GENE DEV, V11, P2494, DOI 10.1101/gad.11.19.2494; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625; Gribnau J, 2000, MOL CELL, V5, P377, DOI 10.1016/S1097-2765(00)80432-3; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; Hayashizaki Y, 2006, PLOS GENET, V2, P492, DOI 10.1371/journal.pgen.0020063; Higuchi T, 2002, MOL CELL BIOL, V22, P1, DOI 10.1128/MCB.22.1.1-11.2002; Hirota K, 2003, GENETICS, V165, P505; Hirota K, 2008, MOL BIOL CELL, V19, P1162, DOI 10.1091/mbc.E07-04-0377; Hirota K, 2007, EUKARYOT CELL, V6, P2072, DOI 10.1128/EC.00246-07; Hirota K, 2006, EUKARYOT CELL, V5, P1980, DOI 10.1128/EC.00272-06; Hoffman CS, 2005, BIOCHEM SOC T, V33, P257, DOI 10.1042/BST0330257; Janoo RTK, 2001, GENETICS, V157, P1205; Martens JA, 2003, CURR OPIN GENET DEV, V13, P136, DOI 10.1016/S0959-437X(03)00022-4; Miura F, 2006, P NATL ACAD SCI USA, V103, P17846, DOI 10.1073/pnas.0605645103; Neely LA, 2000, MOL CELL BIOL, V20, P6426, DOI 10.1128/MCB.20.17.6426-6434.2000; Sanchez-Elsner T, 2006, SCIENCE, V311, P1118, DOI 10.1126/science.1117705; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; TAKEDA T, 1987, P NATL ACAD SCI USA, V84, P3580, DOI 10.1073/pnas.84.11.3580; Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; WOLFFE AP, 1997, CHROMATIN STRUCTURE	24	197	205	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					130	U15		10.1038/nature07348	http://dx.doi.org/10.1038/nature07348			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18820678				2022-12-28	WOS:000260674000055
J	Paddock, M; O'Neil, B; Holwell, A				Paddock, Michael; O'Neil, Bernadette; Holwell, Andy			Actions speak louder than words	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Paddock, Michael; O'Neil, Bernadette] Kings Coll London, Sch Med, London WC2R 2LS, England; [Holwell, Andy] SW London & St Georges Mental Hlth NHS Trust, London, England	University of London; King's College London	Paddock, M (corresponding author), Kings Coll London, Sch Med, London WC2R 2LS, England.	michael.paddock@kcl.ac.uk	Paddock, Michael/HDN-7032-2022; Paddock, Michael/AAF-4175-2020	Paddock, Michael/0000-0003-4508-8803; Paddock, Michael/0000-0003-4508-8803					0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1882	10.1136/bmj.a1882	http://dx.doi.org/10.1136/bmj.a1882			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SN	18826973				2022-12-28	WOS:000259798000048
J	Hoffman, KA; Singer, BS				Hoffman, Kenneth A.; Singer, Brad S.			Magnetic source separation in Earth's outer core	SCIENCE			English	Article									[Hoffman, Kenneth A.] Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93407 USA; [Hoffman, Kenneth A.; Singer, Brad S.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA	California State University System; California Polytechnic State University San Luis Obispo; University of Wisconsin System; University of Wisconsin Madison	Hoffman, KA (corresponding author), Calif Polytech State Univ San Luis Obispo, Dept Phys, San Luis Obispo, CA 93407 USA.	khoffman@calpoly.edu	Singer, Bradley/F-4991-2012	Singer, Bradley/0000-0003-3595-5168	Cal Poly; University of Wisconsin-Madison; Geophysics Program of NSF	Cal Poly; University of Wisconsin-Madison; Geophysics Program of NSF	This study was supported by grants to Cal Poly and the University of Wisconsin-Madison from the Geophysics Program of NSF.	Courtillot V, 1992, EOS T AGU, V73, P337; GUBBINS DG, 2007, PALEOMAGNETISM, P159; Hoffman KA, 2004, GEOPHYS MONOGR SER, V145, P233, DOI 10.1029/145GM17; Singer BS, 2005, NATURE, V434, P633, DOI 10.1038/nature03431	4	25	25	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1800	1800		10.1126/science.1159777	http://dx.doi.org/10.1126/science.1159777			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818352				2022-12-28	WOS:000259501300028
J	Bush, A; Hedlin, G; Carlsen, KH; de Benedictis, F; Lodrup-Carlsen, K; Wilson, N				Bush, Andrew; Hedlin, Gunillo; Carlsen, Kai-Hon; de Benedictis, Fernando; Lodrup-Carlsen, Karin; Wilson, Nicola			Severe childhood asthma: a common international approach?	LANCET			English	Editorial Material							RECEPTOR-BINDING AFFINITY; TO-TREAT ASTHMA; MONOCLONAL-ANTIBODY; CHILDREN; HYPERRESPONSIVENESS; RESPONSIVENESS; EXPOSURE		[Bush, Andrew; Wilson, Nicola] Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6JJ, England; [Hedlin, Gunillo] Karolinska Inst, Ctr Allergy Res, Stockholm, Sweden; [Hedlin, Gunillo] Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Carlsen, Kai-Hon] Rikshosp Univ Hosp, Div Paediat, Voksentoppen, Oslo, Norway; [Carlsen, Kai-Hon; Lodrup-Carlsen, Karin] Univ Oslo, Fac Med, Oslo, Norway; [de Benedictis, Fernando] Salesi Childrens Hosp, Dept Paediat, Ancona, Italy; [Lodrup-Carlsen, Karin] Ullevaal Univ Hosp, Dept Paediat, Oslo, Norway	Royal Brompton Hospital; Karolinska Institutet; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo	Bush, A (corresponding author), Royal Brompton Hosp, Dept Paediat Resp Med, London SW3 6JJ, England.	a.bush@imperial.ac.uk			Medical Research Council [G0400503B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bracken M, 2007, THORAX, V62, pA21; Chaudhuri R, 2003, AM J RESP CRIT CARE, V168, P1308, DOI 10.1164/rccm.200304-503OC; Chinn S, 2007, AM J RESP CRIT CARE, V176, P20, DOI 10.1164/rccm.200612-1840OC; Chipps BE, 2007, J ALLERGY CLIN IMMUN, V119, P1156, DOI 10.1016/j.jaci.2006.12.668; Chung KF, 1999, EUR RESPIR J, V13, P1198; Dolan CM, 2004, ANN ALLERG ASTHMA IM, V92, P32, DOI 10.1016/S1081-1206(10)61707-3; KAM JC, 1993, J IMMUNOL, V151, P3460; Langley SJ, 2005, THORAX, V60, P17, DOI 10.1136/thx.2004.027839; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Nimmagadda SR, 1997, AM J RESP CRIT CARE, V155, P87, DOI 10.1164/ajrccm.155.1.9001294; Saglani S, 2006, EUR RESPIR J, V27, P29, DOI 10.1183/09031936.06.00030605; Suntharalingam G, 2006, NEW ENGL J MED, V355, P1018, DOI 10.1056/NEJMoa063842; Tomlinson JEM, 2005, THORAX, V60, P282, DOI 10.1136/thx.2004.033688; WARNER JO, 1995, BRIT MED J, V311, P663, DOI 10.1136/bmj.311.7006.663; World Health Organization, GLOB ALL CHRON RESP	16	70	70	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1019	1021		10.1016/S0140-6736(08)61422-1	http://dx.doi.org/10.1016/S0140-6736(08)61422-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805316				2022-12-28	WOS:000259648500009
J	Frey, U; Suki, B				Frey, Urs; Suki, Bela			Complexity of chronic asthma and chronic obstructive pulmonary disease: implications for risk assessment, and disease progression and control	LANCET			English	Review							EXHALED NITRIC-OXIDE; PEAK EXPIRATORY FLOW; HEALTH-CARE UTILIZATION; LUNG-FUNCTION DECLINE; AIRWAY HYPERRESPONSIVENESS; RESPIRATORY SYMPTOMS; HOSPITAL ADMISSION; COPD EXACERBATIONS; CHILDHOOD ASTHMA; EARLY PREDICTION	Although assessment of asthma control is important to guide treatment, it is difficult since the temporal pattern and risk of exacerbations are often unpredictable. In this Review, we summarise the classic methods to assess control with unidimensional and multidimensional approaches. Next, we show how ideas from the science of complexity can explain the seemingly unpredictable nature of bronchial asthma and emphysema, with implications for chronic obstructive pulmonary disease. We show that fluctuation analysis, a method used in statistical physics, can be used to gain insight into asthma as a dynamic disease of the respiratory system, viewed as a set of interacting subsystems (eg, inflammatory, immunological, and mechanical). The basis of the fluctuation analysis methods is the quantification of the long-term temporal history of lung function parameters. We summarise how this analysis can be used to assess the risk of future asthma episodes, with implications for asthma severity and control both in children and adults.	[Frey, Urs] Univ Hosp Bern, Dept Paediat, Inselspital, CH-3010 Bern, Switzerland; [Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	University of Bern; University Hospital of Bern; Boston University	Frey, U (corresponding author), Univ Hosp Bern, Dept Paediat, Inselspital, CH-3010 Bern, Switzerland.	urs.frey@insel.ch			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059215] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL059215, R01 HL059215-10] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Ayres Jon G, 2004, Paediatr Respir Rev, V5, P40, DOI 10.1016/j.prrv.2003.09.003; Bacharier LB, 2004, AM J RESP CRIT CARE, V170, P426, DOI 10.1164/rccm.200308-1178OC; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 1996, PHYS REV LETT, V76, P2192, DOI 10.1103/PhysRevLett.76.2192; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Barnes PJ, 2005, EUR RESPIR J, V25, P1084, DOI 10.1183/09031936.05.00139104; Barnes PJ, 2004, LANCET, V364, P564, DOI 10.1016/S0140-6736(04)16866-9; Bates JHT, 2007, AM J RESP CRIT CARE, V176, P617, DOI 10.1164/rccm.200611-1739OC; BELLIA V, 1984, RESPIRATION, V46, P328, DOI 10.1159/000194707; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bibi H, 2002, CHEST, V122, P1627, DOI 10.1378/chest.122.5.1627; Boser SR, 2005, AM J RESP CRIT CARE, V172, P817, DOI 10.1164/rccm.200411-1463OC; Bousquet J, 2005, CLIN EXP ALLERGY, V35, P723, DOI 10.1111/j.1365-2222.2005.02251.x; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Bush A, 2004, PEDIATR PULM, P30, DOI 10.1002/ppul.70039; Bush A, 2008, COPD, V5, P53, DOI 10.1080/15412550701815965; CALL RS, 1994, J ALLERGY CLIN IMMUN, V94, P1065, DOI 10.1016/0091-6749(94)90125-2; Carraro S, 2007, AM J RESP CRIT CARE, V175, P986, DOI 10.1164/rccm.200606-769OC; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chung KF, 1999, EUR RESPIR J, V13, P1198; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; Cote CG, 2007, CHEST, V131, P696, DOI 10.1378/chest.06-1610; Crimi E, 1998, AM J RESP CRIT CARE, V157, P4, DOI 10.1164/ajrccm.157.1.9703002; de Menezes MA, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.028701; Djukanovic R, 2004, AM J RESP CRIT CARE, V170, P583, DOI 10.1164/rccm.200312-1651OC; Donaldson GC, 2002, THORAX, V57, P847, DOI 10.1136/thorax.57.10.847; Dowson LJ, 2001, AM J RESP CRIT CARE, V164, P1805, DOI 10.1164/ajrccm.164.10.2106036; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Eid N, 2000, PEDIATRICS, V105, P354, DOI 10.1542/peds.105.2.354; Finkelman BS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001296; Fleming L, 2007, CURR OPIN ALLERGY CL, V7, P190, DOI 10.1097/ACI.0b013e3280895d0c; Frey U, 2005, NATURE, V438, P667, DOI 10.1038/nature04176; Frey U, 2007, CURR OPIN ALLERGY CL, V7, P223, DOI 10.1097/ACI.0b013e32810fd771; Fuhlbrigge AL, 2004, CURR OPIN PULM MED, V10, P1, DOI 10.1097/00063198-200401000-00002; Fuhlbrigge AL, 2001, J ALLERGY CLIN IMMUN, V107, P61, DOI 10.1067/mai.2001.111590; Fuhlbrigge AL, 2006, PEDIATRICS, V118, pE347, DOI 10.1542/peds.2005-2962; Gelb AF, 2008, CURR OPIN PULM MED, V14, P24, DOI 10.1097/MCP.0b013e3282f197df; Gent JF, 2003, JAMA-J AM MED ASSOC, V290, P1859, DOI 10.1001/jama.290.14.1859; GOLDBERGER AL, 1987, ANN NY ACAD SCI, V504, P195, DOI 10.1111/j.1749-6632.1987.tb48733.x; GOLDBERGER AL, 1987, YALE J BIOL MED, V60, P421; Goldenfeld N, 1999, SCIENCE, V284, P87, DOI 10.1126/science.284.5411.87; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Halonen M, 2006, ALLERGY ASTHMA PROC, V27, P328, DOI 10.2500/aap.2006.27.2888; Harrison Brian, 2005, Prim Care Respir J, V14, P303, DOI 10.1016/j.pcrj.2005.08.004; HORSFIELD K, 1990, J APPL PHYSIOL, V68, P1089; Ito S, 2006, AM J RESP CELL MOL, V34, P688, DOI 10.1165/rcmb.2006-0002OC; Jatakanon A, 2000, AM J RESP CRIT CARE, V161, P64, DOI 10.1164/ajrccm.161.1.9809100; Jones SL, 2001, AM J RESP CRIT CARE, V164, P738, DOI 10.1164/ajrccm.164.5.2012125; Juniper EF, 1999, EUR RESPIR J, V14, P902, DOI 10.1034/j.1399-3003.1999.14d29.x; Kaza V, 2007, CURR OPIN PULM MED, V13, P1; Kitaoka H, 1999, J APPL PHYSIOL, V87, P2207, DOI 10.1152/jappl.1999.87.6.2207; Kitch BT, 2004, CHEST, V126, P1875, DOI 10.1378/chest.126.6.1875; Lanfredi M, 1998, FRACTALS, V6, P151, DOI 10.1142/S0218348X98000195; Langsetmo L, 2008, AM J RESP CRIT CARE, V177, P396, DOI 10.1164/rccm.200708-1290OC; Latzin P, 2006, AM J RESP CRIT CARE, V174, P1292, DOI 10.1164/rccm.200606-782OC; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Leuppi JD, 2001, AM J RESP CRIT CARE, V163, P406, DOI 10.1164/ajrccm.163.2.9912091; Lewis RJ, 2001, ACAD EMERG MED, V8, P1179, DOI 10.1111/j.1553-2712.2001.tb01137.x; Lewis TC, 2005, ENVIRON HEALTH PERSP, V113, P1068, DOI 10.1289/ehp.7533; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Llewellin P, 2002, RESPIROLOGY, V7, P333, DOI 10.1046/j.1440-1843.2002.00417.x; Macklem PT, 2003, AM J RESP CRIT CARE, V167, P1164, DOI 10.1164/rccm.2301003; Macklem PT, 1996, AM J RESP CRIT CARE, V153, P83, DOI 10.1164/ajrccm.153.1.8542167; Makikallio TH, 2001, AM J CARDIOL, V87, P178, DOI 10.1016/S0002-9149(00)01312-6; Makris D, 2007, RESP MED, V101, P1305, DOI 10.1016/j.rmed.2006.10.012; Mandelbrot B.B., 1982, FRACTAL GEOMETRY NAT, P480; Mauroy B, 2004, NATURE, V427, P633, DOI 10.1038/nature02287; McCarren M, 1998, J CLIN EPIDEMIOL, V51, P107, DOI 10.1016/S0895-4356(97)00246-1; McCoy K, 2006, J ALLERGY CLIN IMMUN, V118, P1226, DOI 10.1016/j.jaci.2006.09.006; Miller MK, 2006, EUR RESPIR J, V28, P1145, DOI 10.1183/09031936.06.00145105; Miller MK, 2007, RESP MED, V101, P481, DOI 10.1016/j.rmed.2006.07.005; Mishima M, 1999, P NATL ACAD SCI USA, V96, P8829, DOI 10.1073/pnas.96.16.8829; Mortimer KM, 2001, PEDIATR PULM, V31, P190, DOI 10.1002/ppul.1028; Nair SJ, 2005, J PEDIATR-US, V147, P797, DOI 10.1016/j.jpeds.2005.07.023; *NAT ASTHM ED PREV, 1997, 974051A NIH NAT HEAR; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; Paull K, 2005, PEDIATR PULM, V39, P311, DOI 10.1002/ppul.20161; Payne DNR, 2001, THORAX, V56, P345, DOI 10.1136/thorax.56.5.345; Peng CK, 1995, J ELECTROCARDIOL, V28, P59, DOI 10.1016/S0022-0736(95)80017-4; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; PETSKY HL, 2008, COCHRANE DB SYST REV, V2, P6340; Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374; Pilotto LS, 2003, J ASTHMA, V40, P163, DOI 10.1081/JAS-120017987; Plaza V, 2002, EUR RESPIR J, V19, P846, DOI 10.1183/09031936.02.00241502; Proceedings of the ATS workshop on refractory asthma, 2000, AM J RESP CRIT CARE, V162, P2341, DOI DOI 10.1164/AJRCCM.162.6.ATS9-00; Raj J Usha, 2007, Am J Physiol Lung Cell Mol Physiol, V293, pL45, DOI 10.1152/ajplung.00139.2007; Rasmussen F, 2002, J ALLERGY CLIN IMMUN, V110, P220, DOI 10.1067/mai.2002.125295; Reddel HK, 2006, CURR OPIN PULM MED, V12, P75, DOI 10.1097/01.mcp.0000198065.65704.08; Roberts G, 2004, THORAX, V59, P752, DOI 10.1136/thx.2003.008722; ROBERTSON CF, 1992, PEDIATR PULM, V13, P95, DOI 10.1002/ppul.1950130207; Rodrigo G, 1997, AM J EMERG MED, V15, P8, DOI 10.1016/S0735-6757(97)90039-5; Rodrigo G, 1998, CHEST, V114, P1016, DOI 10.1378/chest.114.4.1016; Rosi E, 1999, J ALLERGY CLIN IMMUN, V103, P232, DOI 10.1016/S0091-6749(99)70496-3; RUSSELL NJ, 1986, THORAX, V41, P360, DOI 10.1136/thx.41.5.360; Saglani S, 2007, AM J RESP CRIT CARE, V176, P858, DOI 10.1164/rccm.200702-212OC; Saglani Sejal, 2002, Paediatr Respir Rev, V3, P248, DOI 10.1016/S1526-0542(02)00187-2; SAIDEL GM, 1975, J APPL PHYSIOL, V38, P328, DOI 10.1152/jappl.1975.38.2.328; Seely AJE, 2004, CRIT CARE, V8, pR367, DOI 10.1186/cc2948; Serrano J, 2006, EUR RESPIR J, V28, P296, DOI 10.1183/09031936.06.00008105; SHIM CS, 1980, AM J MED, V68, P11, DOI 10.1016/0002-9343(80)90155-2; Smaha DA, 2001, HEART LUNG, V30, P472, DOI 10.1067/mhl.2001.120369; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Sont JK, 1999, AM J RESP CRIT CARE, V159, P1043, DOI 10.1164/ajrccm.159.4.9806052; Spahn JD, 2004, AM J RESP CRIT CARE, V169, P784, DOI 10.1164/rccm.200309-1234OE; Stanley HE, 2002, P NATL ACAD SCI USA, V99, P2561, DOI 10.1073/pnas.022582899; Stout JW, 2006, ARCH PEDIAT ADOL MED, V160, P844, DOI 10.1001/archpedi.160.8.844; Suki B, 2003, AM J RESP CRIT CARE, V168, P516, DOI 10.1164/rccm.200208-908PP; SUKI B, 1994, NATURE, V368, P615, DOI 10.1038/368615a0; Taylor DR, 2006, J ALLERGY CLIN IMMUN, V117, P259, DOI 10.1016/j.jaci.2005.11.010; Taylor DR, 1998, THORAX, V53, P744, DOI 10.1136/thx.53.9.744; ten Brinke A, 2005, EUR RESPIR J, V26, P812, DOI 10.1183/09031936.05.00037905; Timonen KL, 2002, EUR RESPIR J, V19, P479, DOI 10.1183/09031936.02.00087802; Turner MO, 1998, AM J RESP CRIT CARE, V157, P540, DOI 10.1164/ajrccm.157.2.9703060; Twaddell SH, 1996, J PAEDIATR CHILD H, V32, P532, DOI 10.1111/j.1440-1754.1996.tb00968.x; Vahlkvist S, 2006, J ALLERGY CLIN IMMUN, V117, P1272, DOI 10.1016/j.jaci.2006.03.018; Van den Toorn LM, 2001, AM J RESP CRIT CARE, V164, P2107, DOI 10.1164/ajrccm.164.11.2006165; Varela M, 2005, CRIT CARE MED, V33, P2764, DOI 10.1097/01.CCM.0000190157.64486.03; Venegas JG, 2005, RESP PHYSIOL NEUROBI, V148, P57, DOI 10.1016/j.resp.2005.05.023; Venegas JG, 2005, NATURE, V434, P777, DOI 10.1038/nature03490; Vollmer WM, 1999, AM J RESP CRIT CARE, V160, P1647, DOI 10.1164/ajrccm.160.5.9902098; Vollmer WM, 2002, AM J RESP CRIT CARE, V165, P195, DOI 10.1164/ajrccm.165.2.2102127; Webb BT, 2007, HUM GENET, V121, P83, DOI 10.1007/s00439-006-0285-z; Wedzicha JA, 2007, LANCET, V370, P786, DOI 10.1016/S0140-6736(07)61382-8; Weibel ER, 1984, PATHWAY OXYGEN STRUC; WEST BJ, 1990, ANN BIOMED ENG, V18, P135, DOI 10.1007/BF02368426; Zacharasiewicz A, 2005, AM J RESP CRIT CARE, V171, P1077, DOI 10.1164/rccm.200409-1242OC; Zhang J, 2002, EUR RESPIR J, V20, P1102, DOI 10.1183/09031936.02.02402001; 2007, NIH PUBLICATION, P7; 1995, NIH PUBLICATION	134	103	113	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1088	1099		10.1016/S0140-6736(08)61450-6	http://dx.doi.org/10.1016/S0140-6736(08)61450-6			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805337	Green Accepted			2022-12-28	WOS:000259648500035
J	Cochran, JC; Kull, FJ				Cochran, Jared C.; Kull, F. Jon			Kinesin motors: No strain, no gain	CELL			English	Editorial Material								The processive movement of the dimeric motor protein kinesin 1 along microtubules requires communication between the two motor domains. Yildiz et al. (2008) now show that tension between the motor domains not only is necessary for normal processivity but also may be sufficient for motor motility under some conditions.	[Cochran, Jared C.; Kull, F. Jon] Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA	Dartmouth College	Cochran, JC (corresponding author), Dartmouth Coll, Dept Chem, Hanover, NH 03755 USA.	jared.cochran@dartmouth.edu; f.jon.kull@dartmouth.edu						Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Spudich JA, 2006, CELL, V126, P242, DOI 10.1016/j.cell.2006.07.009; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9	5	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					918	919		10.1016/j.cell.2008.09.005	http://dx.doi.org/10.1016/j.cell.2008.09.005			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805085	Bronze			2022-12-28	WOS:000259318100012
J	Yildiz, A; Tomishige, M; Gennerich, A; Vale, RD				Yildiz, Ahmet; Tomishige, Michio; Gennerich, Arne; Vale, Ronald D.			Intramolecular strain coordinates kinesin stepping behavior along microtubules	CELL			English	Article							HAND-OVER-HAND; PROCESSIVE MOTOR; DIMERIC KINESIN; ATP HYDROLYSIS; NECK LINKER; MYOSIN-V; MECHANISM; MOLECULE; FORCE; HEAD	Kinesin advances 8 nm along a microtubule per ATP hydrolyzed, but the mechanism responsible for coordinating the enzymatic cycles of kinesin's two identical motor domains remains unresolved. Here, we have tested whether such coordination is mediated by intramolecular tension generated by the "neck linkers,'' mechanical elements that span between the motor domains. When tension is reduced by extending the neck linkers with artificial peptides, the coupling between ATP hydrolysis and forward stepping is impaired and motor's velocity decreases as a consequence. However, speed recovers to nearly normal levels when external tension is applied by an optical trap. Remarkably, external load also induces bidirectional stepping of an immotile kinesin that lacks its mechanical element (neck linker) and fuel (ATP). Our results indicate that the kinesin motor domain senses and responds to strain in a manner that facilitates its plus-end-directed stepping and communication between its two motor domains.	[Yildiz, Ahmet; Tomishige, Michio; Gennerich, Arne; Vale, Ronald D.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Tomishige, Michio] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Vale, RD (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA.	vale@cmp.ucsf.edu	Gennerich, Arne/W-5488-2019; Yildiz, Ahmet/E-6167-2015	Yildiz, Ahmet/0000-0003-4792-174X	Jane Coffin Childs Memorial Fund; Burroughs Wellcome Fund; German Research Foundation [GE 1609/1]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038499, R01GM038499] Funding Source: NIH RePORTER	Jane Coffin Childs Memorial Fund; Burroughs Wellcome Fund(Burroughs Wellcome Fund); German Research Foundation(German Research Foundation (DFG)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank A. P. Carter and N. Zhang for their help with protein purification and cloning and J. Kerssemakers and M. Dogterom for supplying their step finding algorithm. This work has been supported by Jane Coffin Childs Memorial Fund (A.Y. and A.G.), Burroughs Wellcome Fund (A.Y.), German Research Foundation (GE 1609/1 [A.G.]), and the Howard Hughes Medical Institute.	Alonso MC, 2007, SCIENCE, V316, P120, DOI 10.1126/science.1136985; Asbury CL, 2003, SCIENCE, V302, P2130, DOI 10.1126/science.1092985; Block SM, 2003, P NATL ACAD SCI USA, V100, P2351, DOI 10.1073/pnas.0436709100; Block SM, 2007, BIOPHYS J, V92, P2986, DOI 10.1529/biophysj.106.100677; Carter NJ, 2005, NATURE, V435, P308, DOI 10.1038/nature03528; Carter NJ, 2006, CURR OPIN CELL BIOL, V18, P61, DOI 10.1016/j.ceb.2005.12.009; Crevel IMTC, 2004, EMBO J, V23, P23, DOI 10.1038/sj.emboj.7600042; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Gebhardt JCM, 2006, P NATL ACAD SCI USA, V103, P8680, DOI 10.1073/pnas.0510191103; Gennerich A, 2007, CELL, V131, P952, DOI 10.1016/j.cell.2007.10.016; Gilbert SP, 1998, BIOCHEMISTRY-US, V37, P792, DOI 10.1021/bi971117b; Guydosh NR, 2006, P NATL ACAD SCI USA, V103, P8054, DOI 10.1073/pnas.0600931103; Hackney DD, 2007, SCIENCE, V316, P58, DOI 10.1126/science.1141549; Hackney DD, 2005, P NATL ACAD SCI USA, V102, P18338, DOI 10.1073/pnas.0505288102; HACKNEY DD, 1994, J BIOL CHEM, V269, P16508; Hackney DD, 2003, BIOCHEMISTRY-US, V42, P12011, DOI 10.1021/bi0349118; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; Kaseda K, 2003, NAT CELL BIOL, V5, P1079, DOI 10.1038/ncb1067; Kawaguchi K, 2001, SCIENCE, V291, P667, DOI 10.1126/science.291.5504.667; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Klumpp LM, 2004, P NATL ACAD SCI USA, V101, P3444, DOI 10.1073/pnas.0307691101; Mori T, 2007, NATURE, V450, P750, DOI 10.1038/nature06346; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Reck-Peterson SL, 2006, CELL, V126, P335, DOI 10.1016/j.cell.2006.05.046; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Rock RS, 2001, P NATL ACAD SCI USA, V98, P13655, DOI 10.1073/pnas.191512398; Rosenfeld SS, 2003, J BIOL CHEM, V278, P18550, DOI 10.1074/jbc.M300849200; Rosenfeld SS, 2001, J BIOL CHEM, V276, P40167, DOI 10.1074/jbc.M103899200; Schief WR, 2004, P NATL ACAD SCI USA, V101, P1183, DOI 10.1073/pnas.0304369101; Schief WR, 2001, CURR OPIN CELL BIOL, V13, P19, DOI 10.1016/S0955-0674(00)00169-1; Schnitzer MJ, 1995, COLD SPRING HARB SYM, V60, P793, DOI 10.1101/SQB.1995.060.01.085; Schnitzer MJ, 1997, NATURE, V388, P386, DOI 10.1038/41111; Schuler B, 2005, P NATL ACAD SCI USA, V102, P2754, DOI 10.1073/pnas.0408164102; Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164; Spudich JA, 2006, CELL, V126, P242, DOI 10.1016/j.cell.2006.07.009; SVOBODA K, 1993, NATURE, V365, P721, DOI 10.1038/365721a0; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; T Valentine M, 2007, CURR OPIN CELL BIOL, V19, P75, DOI 10.1016/j.ceb.2006.12.011; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Tomishige M, 2006, NAT STRUCT MOL BIOL, V13, P887, DOI 10.1038/nsmb1151; Uemura S, 2003, NAT STRUCT BIOL, V10, P308, DOI 10.1038/nsb911; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Yildiz A, 2004, SCIENCE, V303, P676, DOI 10.1126/science.1093753; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	46	220	226	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1030	1041		10.1016/j.cell.2008.07.018	http://dx.doi.org/10.1016/j.cell.2008.07.018			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805095	Green Accepted, Bronze			2022-12-28	WOS:000259318100022
J	Zieg, J; Greer, PL; Greenberg, ME				Zieg, Janine; Greer, Paul L.; Greenberg, Michael E.			SnapShot: Ca2+-dependent transcription in neurons	CELL			English	Editorial Material									[Zieg, Janine; Greer, Paul L.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Zieg, J (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.							Chahrour M, 2008, SCIENCE, V320, P1224, DOI 10.1126/science.1153252; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Husi H, 2000, NAT NEUROSCI, V3, P661, DOI 10.1038/76615; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Ledo F, 2002, EMBO J, V21, P4583, DOI 10.1093/emboj/cdf440; Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200; Li SM, 2006, J NEUROSCI, V26, P1721, DOI 10.1523/JNEUROSCI.3990-05.2006; Meffert MK, 2003, NAT NEUROSCI, V6, P1072, DOI 10.1038/nn1110; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462	10	15	15	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6							1080.e2	10.1016/j.cell.2008.09.010	http://dx.doi.org/10.1016/j.cell.2008.09.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805099	Bronze			2022-12-28	WOS:000259318100026
J	Fisher, ES				Fisher, Elliott S.			Building a medical neighborhood for the medical home	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth Policy Res, Lebanon, NH 03766 USA	Dartmouth College	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Ctr Hlth Policy Res, Lebanon, NH 03766 USA.				NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG019783-08, P01 AG019783] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		American College of Physicians, 2007, JOINT PRINC PAT CTR; [Anonymous], 2008, CIGNA DARTM HITCHC L; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Underwood, 2008, MED HOME DISRUPTIVE	5	191	192	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1202	1205		10.1056/NEJMp0806233	http://dx.doi.org/10.1056/NEJMp0806233			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799556	Green Accepted			2022-12-28	WOS:000259259900003
J	Friedman, RA				Friedman, Richard A.			Role of physicians and mental health professionals in discussions of public figures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Friedman, Richard A.] Weill Cornell Med Coll, New York, NY 10065 USA	Cornell University	Friedman, RA (corresponding author), Weill Cornell Med Coll, Box 140,525 E 68th St, New York, NY 10065 USA.	rafriedm@med.cornell.edu						ALTMAN L, 1997, NY TIMES        1005; Altman L.K., 2008, NY TIMES        0803, pA1; *AM PSYCH ASS, 2008, PRINC MED ETH PRINC; American Psychological Association, 2002, AM PSYCHOL, V57, P1060, DOI 10.1037/0003-066X.57.12.1060; CARMICHAEL M, 2008, NEWSWEEK        0312; Frank Justin A., 2004, BUSH COUCH INSIDE MI; FROOMKIN D, 2004, WASHINGTON POST 0616; GOLEMAN D, 1991, NY TIMES        0129, P9; Goleman Daniel, 1991, N Y Times Web, pC15; Kaplan JT, 2007, NEUROPSYCHOLOGIA, V45, P55, DOI 10.1016/j.neuropsychologia.2006.04.024; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; KOCIENIEWSKI D, 2008, NY TIMES        0313, pA1; Post JM, 2002, PSYCHIAT CLIN N AM, V25, P635; 1964, FACT MAGAZINE    SEP, V1	14	17	17	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1348	1350		10.1001/jama.300.11.1348	http://dx.doi.org/10.1001/jama.300.11.1348			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	348ST	18799449				2022-12-28	WOS:000259231100032
J	Coovadia, H; Bland, R				Coovadia, Hoosen; Bland, Ruth			From Alma-Ata to Agincourt: primary health care in AIDS	LANCET			English	Editorial Material							HYPERTENSION; PREVALENCE; POPULATION; OBESITY		[Coovadia, Hoosen] Univ KwaZulu Natal, ZA-4013 Durban, South Africa; [Bland, Ruth] Africa Ctr, Mtubatuba, Kwazulu Natal, South Africa	University of Kwazulu Natal	Coovadia, H (corresponding author), Univ KwaZulu Natal, ZA-4013 Durban, South Africa.	coovadiah@ukzn.ac.za		Bland, Ruth/0000-0003-1675-9268				[Anonymous], 1996, GLOBAL BURDEN DIS CO; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Bhorat H., 2005, POVERTY WELL BEING P; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; CALDWELL J, 1990, INTRO THOUGHTS HLTH, pR11; Cooper R, 1997, AM J PUBLIC HEALTH, V87, P160, DOI 10.2105/AJPH.87.2.160; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Tollman SM, 2008, LANCET, V372, P893, DOI 10.1016/S0140-6736(08)61399-9; World Health Organization, 2004, WORLD HLTH REP 2004	12	16	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					866	868		10.1016/S0140-6736(08)61373-2	http://dx.doi.org/10.1016/S0140-6736(08)61373-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790293				2022-12-28	WOS:000259266900005
J	Heath, MR				Heath, Michael R.			Comment on "a global map of human impact on marine ecosystems"	SCIENCE			English	Editorial Material							MACKEREL		[Heath, Michael R.] Fisheries Res Serv, Marine Lab, Aberdeen AB11 9DB, Scotland		Heath, MR (corresponding author), Fisheries Res Serv, Marine Lab, 375 Victoria Rd, Aberdeen AB11 9DB, Scotland.	heathmr@marlab.ac.uk	Heath, Michael R/D-5765-2013	Heath, Michael/0000-0001-6602-3107				Andrews JM, 2006, CAN J FISH AQUAT SCI, V63, P1027, DOI 10.1139/F06-006; Beare DJ, 2002, ICES J MAR SCI, V59, P711, DOI 10.1006/jmsc.2002.1207; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; *FOOD AGR ORG, FISHSTAT PLUS UN SOF; Frederiksen M, 2004, J APPL ECOL, V41, P1129, DOI 10.1111/j.0021-8901.2004.00966.x; Greenstreet SPR, 2006, ICES J MAR SCI, V63, P573, DOI 10.1016/j.icesjms.2005.12.009; Hall S.J., 1999, EFFECTS FISHING MARI, P274, DOI [10.1002/1099-0755(200005/06)10:3%3C226::AID-AQC411%3E3.0.CO;2-9, DOI 10.1002/1099-0755(200005/06)10:3%3C226::AID-AQC411%3E3.0.CO;2-9]; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; *INT COUNC EXPL SE, 2007ACFM31 ICES CM; Jennings S, 1998, ADV MAR BIOL, V34, P201, DOI 10.1016/S0065-2881(08)60212-6; Uriarte A, 2001, FISH RES, V50, P129, DOI 10.1016/S0165-7836(00)00246-0; Watson R., 2001, FISHERIES CTR RES RE, V9, P1; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	13	9	9	4	82	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895								10.1126/science.1157390	http://dx.doi.org/10.1126/science.1157390			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787153	Green Accepted			2022-12-28	WOS:000259121800020
J	Hacker, JS				Hacker, Jacob S.			Speaking truth to power - The need for, and perils of, health policy expertise in the White House	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hacker, Jacob S.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Hacker, Jacob S.] Berkeley Law Sch Ctr Hlth Econ & Family Secur, Berkeley, CA USA	University of California System; University of California Berkeley	Hacker, JS (corresponding author), Univ Calif Berkeley, Berkeley, CA 94720 USA.							Caplan B, 2007, MYTH OF THE RATIONAL VOTER: WHY DEMOCRACIES CHOOSE BAD POLICIES, P1; MELBER A, 2008, NATION          0201; Neustadt RE, 1960, PRESIDENTIAL POWER; Rose Norman, 1994, CHURCHILL UNRULY LIF	4	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1085	1087		10.1056/NEJMp0805482	http://dx.doi.org/10.1056/NEJMp0805482			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346ON	18784095				2022-12-28	WOS:000259078200001
J	Olive, DL				Olive, David L.			Gonadotropin-releasing hormone agonists for endometriosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							LEUPROLIDE ACETATE; ADD-BACK; DEPOT LEUPROLIDE; GNRH AGONIST; PELVIC PAIN; THERAPY; ESTROGEN; TRIAL; MANAGEMENT; NAFARELIN	A 36- year- old woman presents with long- standing pelvic pain, including dysmenorrhea and pain with intercourse. She has previously received oral contraceptives and depot medroxyprogesterone for presumed endometriosis. This regimen has not relieved her pain, and she has had side effects, including continual abnormal uterine bleeding and fluid retention. She is referred to a reproductive endocrinologist for further investigation and treatment. After a careful review and examination to rule out other explanations for the patient's symptoms, the endocrinologist recommends the use of a gonadotropin- releasing hormone agonist combined with norethindrone acetate as empirical treatment for endometriosis.	[Olive, David L.] Wisconsin Fertil Inst, Middleton, WI 53562 USA		Olive, DL (corresponding author), Wisconsin Fertil Inst, 3146 Deming Way, Middleton, WI 53562 USA.	dlolive1@aol.com			Nobelpharma; Procter Gamble	Nobelpharma; Procter Gamble(Procter & Gamble)	Dr. Olive reports receiving lecture fees from Nobelpharma and consulting fees from Procter & Gamble. No other potential conflict of interest relevant to this article was reported.	*AG HLTH CAR POL R, 1995, AHCPR PUBL; *AM COLL OBST GYN, 1999, ACOG PRACT B, V11; Cutolo M, 2006, ANN NY ACAD SCI, V1089, P538, DOI 10.1196/annals.1386.043; DiVasta AD, 2007, J PEDIATR ADOL GYNEC, V20, P293, DOI 10.1016/j.jpag.2007.04.008; DLUGI AM, 1990, FERTIL STERIL, V54, P419; DOSWELL L, 1992, FERTIL STERIL, V57, P514; Duleba A J, 1996, J Am Assoc Gynecol Laparosc, V3, P205, DOI 10.1016/S1074-3804(96)80004-1; Hornstein MD, 1998, OBSTET GYNECOL, V91, P16, DOI 10.1016/S0029-7844(97)00620-0; HORNSTEIN MD, 1995, FERTIL STERIL, V63, P955, DOI 10.1016/S0015-0282(16)57530-X; Hornstein MD, 1997, FERTIL STERIL, V68, P860, DOI 10.1016/S0015-0282(97)00360-9; KODAMAN PH, 2005, ENDOMETRIOSIS CLIN P, P13; LEMAY A, 1984, FERTIL STERIL, V41, P863; Ling FW, 1999, OBSTET GYNECOL, V93, P51, DOI 10.1016/S0029-7844(98)00341-X; MAHUTTE NG, 2005, ENDOMETRIOSIS CLIN P, P79; MELDRUM DR, 1982, J CLIN ENDOCR METAB, V54, P1081, DOI 10.1210/jcem-54-5-1081; Newton C, 1996, FERTIL STERIL, V65, P1253, DOI 10.1016/S0015-0282(16)58351-4; Olive D, 2005, FUJITSU SCI TECH J, V41, P10; Olive DL, 2005, DRUGS TODAY, V40, P23; Olive DL, 2001, NEW ENGL J MED, V345, P266, DOI 10.1056/NEJM200107263450407; OLIVE DL, 2003, J IRISH SOC PHYS SUR, V32, P9; Oral E, 1997, OBSTET GYN CLIN N AM, V24, P219, DOI 10.1016/S0889-8545(05)70301-6; PARAZZINI F, 1994, AM J OBSTET GYNECOL, V171, P1205, DOI 10.1016/0002-9378(94)90133-3; Pierce SJ, 2000, FERTIL STERIL, V74, P964, DOI 10.1016/S0015-0282(00)01537-5; POKRAS R, 1997, VITAL HLTH STAT, V13; PRENTICE A, 2000, COCHRANE DB SYST REV, V2; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; Schlaff WD, 2006, FERTIL STERIL, V85, P314, DOI 10.1016/j.fertnstert.2005.07.1315; SCHRIOCK E, 1985, FERTIL STERIL, V44, P583; SHAW RW, 1983, BRIT MED J, V287, P1667, DOI 10.1136/bmj.287.6406.1667; Sherwin BB, 1997, NEUROLOGY, V48, pS21, DOI 10.1212/WNL.48.5_Suppl_7.21S; Sherwin BB, 1996, J CLIN ENDOCR METAB, V81, P2545, DOI 10.1210/jc.81.7.2545; Shi ZQ, 2006, BIOL REPROD, V74, P850, DOI 10.1095/biolreprod.105.044917; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Vercellini P, 1999, BRIT J OBSTET GYNAEC, V106, P672, DOI 10.1111/j.1471-0528.1999.tb08366.x; VERCELLINI P, 1993, FERTIL STERIL, V60, P75; WHEELER JM, 1989, J REPROD MED, V34, P41; WITZ CA, 2005, ENDOMETRIOSIS CLIN P, P61	37	30	35	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1136	1142		10.1056/NEJMct0803719	http://dx.doi.org/10.1056/NEJMct0803719			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784103				2022-12-28	WOS:000259078200009
J	Staley, KJ; Sims, KB; Grant, PE; Hedley-Whyte, ET; Barnett, SM; Rosenberg, ES; Caviness, VS; Aurora, S				Staley, Kevin J.; Sims, Katherine B.; Grant, P. Ellen; Hedley-Whyte, E. Tessa; Barnett, Sarah M.; Rosenberg, Eric S.; Caviness, Verne S., Jr.; Aurora, Sanjay			An infant with congenital deafness, lethargy, and hypothermia - Leigh's syndrome, intraventricular hemorrhage, and periventricular leukomalacia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPLEX-I DEFICIENCY; ACUTE NECROTIZING ENCEPHALOPATHY; MITOCHONDRIAL ENCEPHALOPATHY; OXIDATIVE-PHOSPHORYLATION; BACTERIAL-MENINGITIS; DISEASE; MUTATIONS; DISORDERS; CHILDREN; SUBUNIT		[Staley, Kevin J.; Sims, Katherine B.] Massachusetts Gen Hosp, Dept Pediat Neurol, Boston, MA 02114 USA; [Grant, P. Ellen] Massachusetts Gen Hosp, Dept Radiol, Div Pediat, Boston, MA 02114 USA; [Hedley-Whyte, E. Tessa] Massachusetts Gen Hosp, Dept Neuropathol, Boston, MA 02114 USA; [Staley, Kevin J.; Sims, Katherine B.] Harvard Univ, Sch Med, Dept Neurol, Cambridge, MA 02138 USA; [Grant, P. Ellen] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA; [Hedley-Whyte, E. Tessa] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University	Staley, KJ (corresponding author), Massachusetts Gen Hosp, Dept Pediat Neurol, Boston, MA 02114 USA.		Hedley-Whyte, E Tessa/AAJ-9975-2021; Grant, Peter/HIR-3733-2022	Hedley-Whyte, E Tessa/0000-0002-1687-8905; Grant, Patricia/0000-0003-1005-4013				Antonicka H, 2003, HUM MOL GENET, V12, P2693, DOI 10.1093/hmg/ddg284; BANKER BQ, 1962, ARCH NEUROL-CHICAGO, V7, P386, DOI 10.1001/archneur.1962.04210050022004; BARKOVICH AJ, 1993, AM J NEURORADIOL, V14, P1119; Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Coenen MJH, 2004, NEW ENGL J MED, V351, P2080, DOI 10.1056/NEJMoa041878; COHEN BH, 2000, MITOCHONDRIAL CYTOPA; DAGAN R, 1984, AM J DIS CHILD, V138, P483, DOI 10.1001/archpedi.1984.02140430059015; Dawson KG, 1999, PEDIATR INFECT DIS J, V18, P816, DOI 10.1097/00006454-199902000-00015; Debray FG, 2007, PEDIATRICS, V119, P722, DOI 10.1542/peds.2006-1866; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; DIMAURO S, 2006, MITOCHONDRIAL MED; DionisiVici C, 1997, ANN NEUROL, V42, P661, DOI 10.1002/ana.410420419; Feillet F, 1999, PEDIATR NEUROL, V20, P305, DOI 10.1016/S0887-8994(98)00162-3; Graves P, 2004, ACAD EMERG MED, V11, P131, DOI 10.1197/j.aem.2003.09.011; Haas RH, 2007, PEDIATRICS, V120, P1326, DOI 10.1542/peds.2007-0391; HOLTZMAN D, 1992, NEW ENGL J MED, V327, P261; Horvath R, 2006, J NEUROL NEUROSUR PS, V77, P74, DOI 10.1136/jnnp.2005.067041; JACKSON MJ, 1995, BRAIN, V118, P339, DOI 10.1093/brain/118.2.339; Jan W, 2003, NEURORADIOLOGY, V45, P634, DOI 10.1007/s00234-003-1035-8; KAUR B, 1992, SURV OPHTHALMOL, V37, P1, DOI 10.1016/0039-6257(92)90002-B; Kim-Han JS, 2006, STROKE, V37, P3057, DOI 10.1161/01.STR.0000252249.75409.79; Kim-Han JS, 2006, STROKE, V37, P2457, DOI 10.1161/01.STR.0000240674.99945.4e; KREUSSER KL, 1984, ANN NEUROL, V16, P361, DOI 10.1002/ana.410160315; LEIGH D, 1951, J NEUROL NEUROSUR PS, V14, P216, DOI 10.1136/jnnp.14.3.216; Loeffen J, 1998, AM J HUM GENET, V63, P1598, DOI 10.1086/302154; MATTHEWS PM, 1993, ANN NEUROL, V33, P652, DOI 10.1002/ana.410330616; McFarland R, 2004, ANN NEUROL, V55, P58, DOI 10.1002/ana.10787; MITOMAP, 2007, HUM MIT GEN DAT; Neilson DE, 2003, NEUROLOGY, V61, P226, DOI 10.1212/01.WNL.0000073544.28775.1A; Nelson KB, 2007, STROKE, V38, P742, DOI 10.1161/01.STR.0000247921.97794.5e; PHILIP G, 1973, LANCET, V2, P122; Rahman S, 1996, ANN NEUROL, V39, P343, DOI 10.1002/ana.410390311; RORABAUGH ML, 1993, PEDIATRICS, V92, P206; SCHATZ G, 1995, BBA-MOL BASIS DIS, V1271, P123, DOI 10.1016/0925-4439(95)00018-Y; Ugalde C, 2007, MOL GENET METAB, V90, P10, DOI 10.1016/j.ymgme.2006.08.003; Valanne L, 1998, AM J NEURORADIOL, V19, P369; VANERVEN PMM, 1987, CLIN NEUROL NEUROSUR, V89, P217, DOI 10.1016/S0303-8467(87)80020-3; VICTOR M, 1971, WERNICKEKORSAKOFF SY; Wong AM, 2006, AM J NEURORADIOL, V27, P1919; Zhu ZQ, 1998, NAT GENET, V20, P337, DOI 10.1038/3804; Zimmerman R A, 1994, Neuroimaging Clin N Am, V4, P349; ZIMMERMAN WD, 1993, LARYNGOSCOPE, V103, P87	42	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1156	1167		10.1056/NEJMcpc0804642	http://dx.doi.org/10.1056/NEJMcpc0804642			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784106				2022-12-28	WOS:000259078200013
J	Filippakopoulos, P; Kofler, M; Hantschel, O; Gish, GD; Grebien, F; Salah, E; Neudecker, P; Kay, LE; Turk, BE; Superti-Furga, G; Pawson, T; Knapp, S				Filippakopoulos, Panagis; Kofler, Michael; Hantschel, Oliver; Gish, Gerald D.; Grebien, Florian; Salah, Eidarus; Neudecker, Philipp; Kay, Lewis E.; Turk, Benjamin E.; Superti-Furga, Giulio; Pawson, Tony; Knapp, Stefan			Structural coupling of SH2-kinase domains links fes and Abl substrate recognition and kinase activation	CELL			English	Article							PROTEIN-TYROSINE KINASE; FUJINAMI SARCOMA-VIRUS; TERMINAL SRC KINASE; C-ABL; CELL-ADHESION; V-FPS; PROCESSIVE PHOSPHORYLATION; ACTIVE CONFORMATION; CRYSTAL-STRUCTURE; FAMILY KINASES	The SH2 domain of cytoplasmic tyrosine kinases can enhance catalytic activity and substrate recognition, but the molecular mechanisms by which this is achieved are poorly understood. We have solved the structure of the prototypic SH2-kinase unit of the human Fes tyrosine kinase, which appears specialized for positive signaling. In its active conformation, the SH2 domain tightly interacts with the kinase N-terminal lobe and positions the kinase alpha C helix in an active configuration through essential packing and electrostatic interactions. This interaction is stabilized by ligand binding to the SH2 domain. Our data indicate that Fes kinase activation is closely coupled to substrate recognition through cooperative SH2-kinase-substrate interactions. Similarly, we find that the SH2 domain of the active Abl kinase stimulates catalytic activity and substrate phosphorylation through a distinct SH2-kinase interface. Thus, the SH2 and catalytic domains of active Fes and Abl pro-oncogenic kinases form integrated structures essential for effective tyrosine kinase signaling.	[Hantschel, Oliver; Grebien, Florian; Superti-Furga, Giulio] Austrian Acad Sci, Ctr Mol Med, A-1090 Vienna, Austria; [Filippakopoulos, Panagis; Salah, Eidarus; Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Kofler, Michael; Gish, Gerald D.; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Neudecker, Philipp; Kay, Lewis E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knapp, Stefan] Univ Oxford, Dept Clin Pharmacol, Oxford OX3 7DQ, England	Austrian Academy of Sciences; University of Oxford; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Yale University; University of Toronto; University of Oxford	Superti-Furga, G (corresponding author), Austrian Acad Sci, Ctr Mol Med, Lazarettgasse 19, A-1090 Vienna, Austria.	gsuperti@cemm.oeaw.ac.at; pawson@mshri.on.ca; stefan.knapp@sgc.ox.ac.uk	Superti-Furga, Giulio/AAE-5681-2019; Neudecker, Philipp/G-5265-2013; Hantschel, Oliver D/H-4705-2013; Neudecker, Philipp/AAP-9005-2020; Grebien, Florian/H-9234-2019; Gish, Gerald D/C-7228-2017; Pawson, Tony J/E-4578-2013; Superti-Furga, Giulio/F-4755-2015; Knapp, Stefan/AAG-2347-2019; Hantschel, Oliver/M-7016-2019	Neudecker, Philipp/0000-0002-0557-966X; Hantschel, Oliver D/0000-0001-8569-8169; Neudecker, Philipp/0000-0002-0557-966X; Grebien, Florian/0000-0003-4289-2281; Superti-Furga, Giulio/0000-0002-0570-1768; Knapp, Stefan/0000-0001-5995-6494; Hantschel, Oliver/0000-0001-8569-8169; Filippakopoulos, Panagis/0000-0002-1515-1317	Canadian Institutes for Health Research (CIHR ) [MOP-6849, MOP-13466]; National Cancer Institute of Canada; Canadian Cancer Society; Genome Canada; Ontario Summit Award; Structural Genomics Consortium [1097737]; CIHR; Canadian Foundation for Innovation; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Foundation for Strategic Research; Wellcome Trust; Austrian Science Fund FWF [P18737-B11]	Canadian Institutes for Health Research (CIHR )(Canadian Institutes of Health Research (CIHR)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Genome Canada(Genome Canada); Ontario Summit Award; Structural Genomics Consortium(University of Toronto); CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Austrian Science Fund FWF(Austrian Science Fund (FWF))	We thank Neil Warner for synthesis of the Spots blot membrane and Cristina Virag for excellent technical assistance, Karel Dorey for the initial observation of a positive function of the Abl SH2 domain, and Bhushan Nagar and John Kuriyan for a long-standing collaboration on the role of the SH2 domain in Abl regulation. This research was supported by grants from the Canadian Institutes for Health Research (CIHR grant numbers MOP-6849 and MOP-13466); the National Cancer Institute of Canada with funds from the Canadian Cancer Society; Genome Canada through the Ontario Genomics Institute; and an Ontario Summit Award to T. P. T. P. is a Distinguished Scientist of the CIHR. S. K., E. S., and P. F. are funded by the Structural Genomics Consortium, a registered charity (number 1097737) that receives funds from the CIHR, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Foundation for Strategic Research, and the Wellcome Trust. G. S.-F., O. H., and F. G. are funded by the Austrian Science Fund FWF (grant number P18737-B11).	Bertrand JA, 2003, J MOL BIOL, V333, P393, DOI 10.1016/j.jmb.2003.08.031; BROOKSWILSON AR, 1989, MOL CELL BIOL, V9, P2214, DOI 10.1128/MCB.9.5.2214; Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012; DECLUE JE, 1987, P NATL ACAD SCI USA, V84, P9064, DOI 10.1073/pnas.84.24.9064; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DeLano W.L, PYMOL MOL GRAPHICS S; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eswaran J, 2008, STRUCTURE, V16, P115, DOI 10.1016/j.str.2007.10.026; Evans P., 2007, SCALA SCALE TOGETHER; FOSTER DA, 1985, CELL, V42, P105, DOI 10.1016/S0092-8674(85)80106-9; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; GREER P, 1994, MOL CELL BIOL, V14, P6755, DOI 10.1128/MCB.14.10.6755; Greer P, 2002, NAT REV MOL CELL BIO, V3, P278, DOI 10.1038/nrm783; GROFFEN J, 1983, VIROLOGY, V125, P480, DOI 10.1016/0042-6822(83)90219-2; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; HJERMSTAD SJ, 1993, ONCOGENE, V8, P2283; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Joseph RE, 2007, BIOCHEMISTRY-US, V46, P5455, DOI 10.1021/bi602512e; Jucker M, 1997, J BIOL CHEM, V272, P2104; KOCH CA, 1989, MOL CELL BIOL, V9, P4131, DOI 10.1128/MCB.9.10.4131; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; LEE WH, 1980, P NATL ACAD SCI-BIOL, V77, P2018, DOI 10.1073/pnas.77.4.2018; Lei M, 2005, STRUCTURE, V13, P769, DOI 10.1016/j.str.2005.03.007; LESLIE AGW, 2007, MOSFLM; Lin XF, 2006, J MOL BIOL, V357, P1263, DOI 10.1016/j.jmb.2006.01.046; Marquez JA, 2003, EMBO J, V22, P4616, DOI 10.1093/emboj/cdg448; MAYER BJ, 1995, CURR BIOL, V5, P296, DOI 10.1016/S0960-9822(95)00060-1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Moniakis J, 2001, GENE DEV, V15, P687, DOI 10.1101/gad.871001; Murray MJ, 2006, DEVELOPMENT, V133, P3063, DOI 10.1242/dev.02467; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Naba A, 2008, EMBO J, V27, P38, DOI 10.1038/sj.emboj.7601943; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parsons SA, 2007, IMMUNOLOGY, V122, P542, DOI 10.1111/j.1365-2567.2007.02670.x; Parsons SA, 2006, J LEUKOCYTE BIOL, V80, P1522, DOI 10.1189/jlb.0506350; Read RD, 1997, J BIOL CHEM, V272, P18498, DOI 10.1074/jbc.272.29.18498; SADOWSKI I, 1986, MOL CELL BIOL, V6, P4396, DOI 10.1128/MCB.6.12.4396; Sangrar W, 2007, MOL CELL BIOL, V27, P6140, DOI 10.1128/MCB.01744-06; Scott MP, 2000, BIOCHEMISTRY-US, V39, P14531, DOI 10.1021/bi001850u; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; SHIBUYA M, 1980, P NATL ACAD SCI-BIOL, V77, P6536, DOI 10.1073/pnas.77.11.6536; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Sondhi D, 1999, BIOCHEMISTRY-US, V38, P11147, DOI 10.1021/bi990827+; STONE JC, 1984, CELL, V37, P549, DOI 10.1016/0092-8674(84)90385-4; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Udell CM, 2006, J BIOL CHEM, V281, P20949, DOI 10.1074/jbc.M604252200; WEINMASTER G, 1984, CELL, V37, P559, DOI 10.1016/0092-8674(84)90386-6; WEINMASTER G, 1982, J CELL BIOCHEM, V20, P337, DOI 10.1002/jcb.240200404; Winberg G, 2000, MOL CELL BIOL, V20, P8526, DOI 10.1128/MCB.20.22.8526-8535.2000; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	54	146	150	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					793	803		10.1016/j.cell.2008.07.047	http://dx.doi.org/10.1016/j.cell.2008.07.047			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775312	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000258947500019
J	Jaakola, VP; Griffith, MT; Hanson, MA; Cherezov, V; Chien, EYT; Lane, JR; IJzerman, AP; Stevens, RC				Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Lane, J. Robert; IJzerman, Adriaan P.; Stevens, Raymond C.			The 2.6 Angstrom Crystal Structure of a Human A(2A) Adenosine Receptor Bound to an Antagonist	SCIENCE			English	Article							MUTAGENESIS; RESIDUES; INSIGHTS; TARGETS; PHARMACOLOGY; MECHANISMS; RHODOPSIN; PROTEINS; ZM241385; REVEALS	The adenosine class of heterotrimeric guanine nucleotide- binding protein ( G protein)- coupled receptors ( GPCRs) mediates the important role of extracellular adenosine in many physiological processes and is antagonized by caffeine. We have determined the crystal structure of the human A(2A) adenosine receptor, in complex with a high- affinity subtype- selective antagonist, ZM241385, to 2.6 angstrom resolution. Four disulfide bridges in the extracellular domain, combined with a subtle repacking of the transmembrane helices relative to the adrenergic and rhodopsin receptor structures, define a pocket distinct from that of other structurally determined GPCRs. The arrangement allows for the binding of the antagonist in an extended conformation, perpendicular to the membrane plane. The binding site highlights an integral role for the extracellular loops, together with the helical core, in ligand recognition by this class of GPCRs and suggests a role for ZM241385 in restricting the movement of a tryptophan residue important in the activation mechanism of the class A receptors.	[Jaakola, Veli-Pekka; Griffith, Mark T.; Hanson, Michael A.; Cherezov, Vadim; Chien, Ellen Y. T.; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Lane, J. Robert; IJzerman, Adriaan P.] Leiden Amsterdam Ctr Drug Res, Div Med Chem, NL-2300 RA Leiden, Netherlands	Scripps Research Institute; Leiden University; Leiden University - Excl LUMC	Stevens, RC (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	stevens@scripps.edu	soler, martha maricel m gomez/L-6025-2014; Stevens, Raymond/K-7272-2015; Cherezov, Vadim/L-9812-2013; IJzerman, Ad/ABG-1353-2020	soler, martha maricel m gomez/0000-0002-4412-8108; Stevens, Raymond/0000-0002-4522-8725; Cherezov, Vadim/0000-0002-5265-3914; IJzerman, Ad/0000-0002-1182-2259; Jaakola, Veli-Pekka/0000-0003-2943-6417; Lane, J. Robert/0000-0002-7361-7875	NIH Roadmap Initiative [P50 GM073197]; Protein Structure Initiative [U54 GM074961]; Dutch Top Institute Pharma; GPCR forum program [D1-105]; National Institutes of Health [GM075915]; National Science Foundation [IIS0308078]; Science Foundation Ireland [02-IN1-B266]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074961, R01GM089857, R01GM075915, P50GM073197] Funding Source: NIH RePORTER	NIH Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Protein Structure Initiative; Dutch Top Institute Pharma; GPCR forum program(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the NIH Roadmap Initiative grant P50 GM073197 for technology development, Protein Structure Initiative grant U54 GM074961 for target processing, and Pfizer (R.C.S.). A.P.IJ. and J.R.L. thank the Dutch Top Institute Pharma for financial support through the GPCR forum program (D1-105). The authors thank P. Kuhn for encouragement and support, J. Velasquez for help on molecular biology, T. Trinh and K. Allin for help on baculoviral expression, Q. Li and T. Mulder for biochemical and pharmacological characterization of the receptor constructs, A. Walker for assistance with manuscript preparation, and I. Wilson for scientific feedback and discussions. The authors acknowledge Y. Zheng, The Ohio State University, and M. Caffrey, University of Limerick, for the generous loan of the in meso robot [built with support from the National Institutes of Health (GM075915), the National Science Foundation (IIS0308078), and Science Foundation Ireland (02-IN1-B266)]; and J. Smith, R. Fischetti, and N. Sanishvili at the GM/CA-CAT beamline at the Advanced Photon Source, for assistance in development and use of the minibeam and beamtime. The GM/CA-CAT beamline (23-ID) is supported by the National Cancer Institute (Y1-CO-1020) and the National Institute of General Medical Sciences (Y1-GM-1104). Atomic coordinates and structure factors have been deposited in the Protein Data Bank with identification code 3EML. The authors, R.C.S., V.-P.J., M.T.G., M.A.H., and V.C. have filed a patent related to the crystals of human adenosine A<INF>2A</INF> receptor.	Audet M, 2008, NAT CHEM BIOL, V4, P397, DOI 10.1038/nchembio.97; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Benarroch EE, 2008, NEUROLOGY, V70, P231, DOI 10.1212/01.wnl.0000297939.18236.ec; BIRNBAUMER L, 1994, TEX HEART I J, V21, P16; Blum D, 2003, LANCET NEUROL, V2, P366, DOI 10.1016/S1474-4422(03)00411-3; Brown RA, 2008, BRIT J PHARMACOL, V153, pS446, DOI 10.1038/bjp.2008.22; Burstein ES, 1998, J BIOL CHEM, V273, P24322, DOI 10.1074/jbc.273.38.24322; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cohen BE, 2005, P NATL ACAD SCI USA, V102, P965, DOI 10.1073/pnas.0409469102; de Zwart M, 1999, DRUG DEVELOP RES, V48, P95, DOI 10.1002/(SICI)1098-2299(199911)48:3<95::AID-DDR1>3.0.CO;2-B; Dunwiddie TV, 2001, ANNU REV NEUROSCI, V24, P31, DOI 10.1146/annurev.neuro.24.1.31; DURING MJ, 1992, ANN NEUROL, V32, P618, DOI 10.1002/ana.410320504; Engel CK, 2002, BBA-BIOMEMBRANES, V1564, P38, DOI 10.1016/S0005-2736(02)00398-X; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Ferre S, 2008, FRONT BIOSCI-LANDMRK, V13, P2391, DOI 10.2741/2852; Ferre S, 2008, J NEUROCHEM, V105, P1067, DOI 10.1111/j.1471-4159.2007.05196.x; Fredholm BB, 2001, PHARMACOL REV, V53, P527; Fredholm BB, 2005, ANNU REV PHARMACOL, V45, P385, DOI 10.1146/annurev.pharmtox.45.120403.095731; Gao ZG, 2000, BIOCHEM PHARMACOL, V60, P669, DOI 10.1016/S0006-2952(00)00360-9; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Hernan MA, 2002, ANN NEUROL, V52, P276, DOI 10.1002/ana.10277; Jaakola VP, 2005, PROTEIN ENG DES SEL, V18, P103, DOI 10.1093/protein/gzi004; Jacobson KA, 2006, NAT REV DRUG DISCOV, V5, P247, DOI 10.1038/nrd1983; Jiang QL, 1997, J MED CHEM, V40, P2588, DOI 10.1021/jm970084v; Joost P, 2002, GENOME BIOL, V3; Kim JH, 1996, MOL PHARMACOL, V49, P683; KIM JH, 1995, J BIOL CHEM, V270, P13987, DOI 10.1074/jbc.270.23.13987; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Lahiria S, 2007, RESP PHYSIOL NEUROBI, V157, P123, DOI 10.1016/j.resp.2007.02.015; Magnani F, 2008, P NATL ACAD SCI USA, V105, P10744, DOI 10.1073/pnas.0804396105; Mantri M, 2008, J MED CHEM, V51, P4449, DOI 10.1021/jm701594y; Martinelli A, 2008, MED RES REV, V28, P247, DOI 10.1002/med.20106; Moro S, 2003, CHEM COMMUN, P2949, DOI 10.1039/b303439a; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Ongini E, 1999, N-S ARCH PHARMACOL, V359, P7, DOI 10.1007/PL00005326; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; POUCHER SM, 1995, BRIT J PHARMACOL, V115, P1096, DOI 10.1111/j.1476-5381.1995.tb15923.x; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Ratnaparkhi GS, 2000, BIOCHEMISTRY-US, V39, P12365, DOI 10.1021/bi000775k; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Sawynok J, 2003, PROG NEUROBIOL, V69, P313, DOI 10.1016/S0301-0082(03)00050-9; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Scholl DJ, 2000, BIOCHEM PHARMACOL, V60, P1647, DOI 10.1016/S0006-2952(00)00474-3; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105; Shi YR, 2008, J CEREBR BLOOD F MET, V28, P111, DOI 10.1038/sj.jcbfm.9600511; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Vogel R, 2008, J MOL BIOL, V380, P648, DOI 10.1016/j.jmb.2008.05.022; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Yuzlenko O, 2009, J COMPUT CHEM, V30, P14, DOI 10.1002/jcc.21001; Zezula J, 2008, BRIT J PHARMACOL, V153, pS184, DOI 10.1038/sj.bjp.0707674	52	1492	1548	1	160	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 21	2008	322	5905					1211	1217		10.1126/science.1164772	http://dx.doi.org/10.1126/science.1164772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	374HC	18832607	Green Accepted			2022-12-28	WOS:000261033400032
J	Gilbert, FJ; Astley, SM; Gillan, MGC; Agbaje, OF; Wallis, MG; James, J; Boggis, CRM; Duffy, SW				Gilbert, Fiona J.; Astley, Susan M.; Gillan, Maureen G. C.; Agbaje, Olorunsola F.; Wallis, Matthew G.; James, Jonathan; Boggis, Caroline R. M.; Duffy, Stephen W.		CADET II Grp	Single reading with computer-aided detection for screening mammography	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER DETECTION; 2 VIEW MAMMOGRAPHY; UNITED-KINGDOM; DETECTION CAD; PROGRAM; SENSITIVITY; ARBITRATION; DIAGNOSIS; TRIAL; DISAGREEMENTS	Background: The sensitivity of screening mammography for the detection of small breast cancers is higher when the mammogram is read by two readers rather than by a single reader. We conducted a trial to determine whether the performance of a single reader using a computer-aided detection system would match the performance achieved by two readers. Methods: The trial was designed as an equivalence trial, with matched-pair comparisons between the cancer-detection rates achieved by single reading with computer-aided detection and those achieved by double reading. We randomly assigned 31,057 women undergoing routine screening by film mammography at three centers in England to double reading, single reading with computer-aided detection, or both double reading and single reading with computer-aided detection, at a ratio of 1:1:28. The primary outcome measures were the proportion of cancers detected according to regimen and the recall rates within the group receiving both reading regimens. Results: The proportion of cancers detected was 199 of 227 (87.7%) for double reading and 198 of 227 (87.2%) for single reading with computer-aided detection (P=0.89). The overall recall rates were 3.4% for double reading and 3.9% for single reading with computer-aided detection; the difference between the rates was small but significant (P<0.001). The estimated sensitivity, specificity, and positive predictive value for single reading with computer-aided detection were 87.2%, 96.9%, and 18.0%, respectively. The corresponding values for double reading were 87.7%, 97.4%, and 21.1%. There were no significant differences between the pathological attributes of tumors detected by single reading with computer-aided detection alone and those of tumors detected by double reading alone. Conclusions: Single reading with computer-aided detection could be an alternative to double reading and could improve the rate of detection of cancer from screening mammograms read by a single reader. (ClinicalTrials.gov number, NCT00450359.).	[Gilbert, Fiona J.; Gillan, Maureen G. C.] Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Aberdeen AB25 2ZD, Scotland; [Astley, Susan M.] Univ Manchester, Dept Imaging Sci & Biomed Engn, Manchester, Lancs, England; [Agbaje, Olorunsola F.; Duffy, Stephen W.] Wolfson Inst Prevent Med, Dept Epidemiol Math & Stat, London, England; [Wallis, Matthew G.] Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England; [James, Jonathan] City Hosp Nottingham, Nottingham Breast Inst, Nottingham, England; [Boggis, Caroline R. M.] Wythenshawe Hosp, Nightingale Breast Screening Unit, Manchester M23 9LT, Lancs, England	University of Aberdeen; University of Manchester; University of London; Queen Mary University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Nottingham University Hospital NHS Trust; Nottingham City Hospital; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital	Gilbert, FJ (corresponding author), Univ Aberdeen, Aberdeen Biomed Imaging Ctr, Lilian Sutton Bldg, Aberdeen AB25 2ZD, Scotland.	f.j.gilbert@abdn.ac.uk		Gilbert, Fiona/0000-0002-0124-9962	Cancer Research UK [CRUK/03/010]; National Health Service Cancer Screening Programme; VuComp	Cancer Research UK(Cancer Research UK); National Health Service Cancer Screening Programme; VuComp	Supported by a grant from Cancer Research UK (CRUK/03/010) and by the National Health Service Cancer Screening Programme. Professor Gilbert reports being vice-chairman of the Royal College of Radiologists Breast Group, which advises on mammography standards in the United Kingdom; Dr. Wallis reports being president of the European Society for Breast Imaging and a member of the Royal College of Radiologists Breast Group, the National Health Service Breast Screening Programme (NHSBSP) Radiology Quality Assurance Group, the NHSBSP Evaluation Group, and the NHSBSP Association of Breast Surgeons at the British Association of Surgical Oncology Audit Group, all of which advise on and set standards for breast screening and breast imaging; Dr. Astley and Dr. Boggis report receiving fees from VuComp for digitizing and transmitting data, and consulting with Hologic with no remuneration; Dr. Astley reports being a past member of the former NHSBSP Digital Steering Group; and Drs. Gilbert, Astley, and Boggis report being loaned two CAD systems by R2 Technology (now Hologic) for 12 months in 2003 for the retrospective CADET I study. No other potential conflict of interest relevant to this article was reported.; We thank E. Fawcett-Gough, P. Shann, S. Berry, and S. Ferguson at Manchester and M. Wheaton and S. Wright at Warwickshire, Solihull, and Coventry for local assistance and data management; J. Matthews and L. Checkley at Nottingham, and the radiographers at all three centers for assistance with recruitment; the screening office managers and the radiographic, clerical, and secretarial staff at all three centers for their assistance with data collection; and the women at all three centers who consented to their mammograms being used in this study.	ANTTINEN I, 1993, CLIN RADIOL, V48, P414, DOI 10.1016/S0009-9260(05)81111-0; Astley S, 2004, P IWDM INT WORKSH DI, P231; Astley SM, 2004, CLIN RADIOL, V59, P390, DOI 10.1016/j.crad.2003.11.017; Bennett RL, 2006, CLIN RADIOL, V61, P1023, DOI 10.1016/j.crad.2006.09.006; Birdwell RL, 2005, RADIOLOGY, V236, P451, DOI 10.1148/radiol.2362040864; Birdwell RL, 2001, RADIOLOGY, V219, P192, DOI 10.1148/radiology.219.1.r01ap16192; Blanks RG, 1999, J MED SCREEN, V6, P152, DOI 10.1136/jms.6.3.152; Blanks RG, 1998, J MED SCREEN, V5, P195, DOI 10.1136/jms.5.4.195; *BLUECROSS BLUESHI, 2002, COMP AID DET CAD MAM; Brem RF, 2007, AM J ROENTGENOL, V189, P1142, DOI 10.2214/AJR.07.3118; Brem RF, 2003, AM J ROENTGENOL, V181, P687, DOI 10.2214/ajr.181.3.1810687; Brem RF, 2001, CLIN RADIOL, V56, P150, DOI 10.1053/crad.2000.0592; Burhenne LJW, 2000, RADIOLOGY, V215, P554; Castellino Ronald A, 2005, Cancer Imaging, V5, P17, DOI 10.1102/1470-7330.2005.0018; Ciatto S, 2005, J MED SCREEN, V12, P125, DOI 10.1258/0969141054855337; Ciatto S, 2003, EUR J RADIOL, V45, P135, DOI 10.1016/S0720-048X(02)00011-6; Ciatto S, 2007, NEW ENGL J MED, V357, P83; Cornford EJ, 2005, CLIN RADIOL, V60, P1182, DOI 10.1016/j.crad.2005.06.003; Cupples TE, 2005, AM J ROENTGENOL, V185, P944, DOI 10.2214/AJR.04.1300; Dean JC, 2006, AM J ROENTGENOL, V187, P20, DOI 10.2214/AJR.05.0111; Deans HE, 1998, BREAST, V7, P75, DOI 10.1016/S0960-9776(98)90060-1; Del Turco MR, 2002, EUR J CANCER, V38, pS31, DOI 10.1016/S0959-8049(02)81241-2; Destounis SV, 2004, RADIOLOGY, V232, P578, DOI 10.1148/radiol.2322030034; Duijm LEM, 2004, RADIOLOGY, V231, P564, DOI 10.1148/radiol.2312030665; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Freer TW, 2001, RADIOLOGY, V220, P781, DOI 10.1148/radiol.2203001282; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Garvican L, 2001, CLIN RADIOL, V56, P833, DOI 10.1053/crad.2001.0776; Georgian-Smith D, 2007, AM J ROENTGENOL, V189, P1135, DOI 10.2214/AJR.07.2393; Gilbert FJ, 2006, RADIOLOGY, V241, P47, DOI 10.1148/radiol.2411051092; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; Gur D, 2004, J NATL CANCER I, V96, P185, DOI 10.1093/jnci/djh067; Helvie M, 2007, RADIOL CLIN N AM, V45, P801, DOI 10.1016/j.rcl.2007.06.004; Houssami N, 2007, BREAST, V16, P219, DOI 10.1016/j.breast.2007.04.006; Huo ZM, 2002, RADIOLOGY, V224, P560, DOI 10.1148/radiol.2242010703; Ikeda DM, 2004, RADIOLOGY, V230, P811, DOI 10.1148/radiol.2303030254; Jiang YL, 2007, RADIOLOGY, V243, P360, DOI 10.1148/radiol.2432060253; Jones B, 1996, BRIT MED J, V313, P550; Karssemeijer N, 2003, RADIOLOGY, V227, P192, DOI 10.1148/radiol.2271011962; Khoo LAL, 2005, RADIOLOGY, V237, P444, DOI 10.1148/radiol.2372041362; Ko JM, 2006, AM J ROENTGENOL, V187, P1483, DOI 10.2214/AJR.05.1582; Lara LF, 2003, ARCH INTERN MED, V163, P2079, DOI 10.1001/archinte.163.17.2079; Lindfors KK, 2006, RADIOLOGY, V239, P710, DOI 10.1148/radiol.2393050670; Liston JC, 2003, CLIN RADIOL, V58, P474, DOI 10.1016/S0009-9260(03)00063-1; Malich A, 2006, EUR RADIOL, V16, P1449, DOI 10.1007/s00330-005-0089-x; McNemar Q, 1947, PSYCHOMETRIKA, V12, P153, DOI 10.1007/BF02295996; Moberg K, 2001, EUR J RADIOL, V39, P104, DOI 10.1016/S0720-048X(01)00291-1; Morton MJ, 2006, RADIOLOGY, V239, P375, DOI 10.1148/radiol.2392042121; Mucci B, 1999, BREAST, V8, P37, DOI 10.1016/S0960-9776(99)90337-5; *NAT HLTH SERV BRE, 2005, QUAL ASS GUID BREAST, V59; *NAT HLTH SERV BRE, 2004, ANN REV; Nishikawa RA, 2007, COMPUT MED IMAG GRAP, V31, P224, DOI 10.1016/j.compmedimag.2007.02.009; *R2 TECHN, 2007, HOL MAMM; Senn S., 2021, THE BLIND DAT; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Taylor P, 2008, EUR J CANCER, V44, P798, DOI 10.1016/j.ejca.2008.02.016; Thurfjell E, 1998, ACTA RADIOL, V39, P384; WALD NJ, 1995, BRIT MED J, V311, P1189, DOI 10.1136/bmj.311.7014.1189; *WORK PART RAD QUA, 2001, PUBL NHSBSP, V48; Yankaskas BC, 2004, J MED SCREEN, V11, P187, DOI 10.1258/0969141042467430	60	182	186	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1675	1684		10.1056/NEJMoa0803545	http://dx.doi.org/10.1056/NEJMoa0803545			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18832239				2022-12-28	WOS:000260041400006
J	Robertson, GP; Dale, VH; Doering, OC; Hamburg, SP; Melillo, JM; Wander, MM; Parton, WJ; Adler, PR; Barney, JN; Cruse, RM; Duke, CS; Fearnside, PM; Follett, RF; Gibbs, HK; Goldemberg, J; Mladenoff, DJ; Ojima, D; Palmer, MW; Sharpley, A; Wallace, L; Weathers, KC; Wiens, JA; Wilhelm, WW				Robertson, G. Philip; Dale, Virginia H.; Doering, Otto C.; Hamburg, Steven P.; Melillo, Jerry M.; Wander, Michele M.; Parton, William J.; Adler, Paul R.; Barney, Jacob N.; Cruse, Richard M.; Duke, Clifford S.; Fearnside, Philip M.; Follett, Ronald F.; Gibbs, Holly K.; Goldemberg, Jose; Mladenoff, David J.; Ojima, Dennis; Palmer, Michael W.; Sharpley, Andrew; Wallace, Linda; Weathers, Kathleen C.; Wiens, John A.; Wilhelm, Wallace W.			Agriculture - Sustainable biofuels Redux	SCIENCE			English	Editorial Material							CORN STOVER; LAND; BIOMASS; CARBON		[Robertson, G. Philip] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Robertson, G. Philip] Michigan State Univ, Dept Crop & Soil Sci, Hickory Corners, MI 49060 USA; [Dale, Virginia H.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Doering, Otto C.] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA; [Hamburg, Steven P.] Brown Univ, Ctr Environm Studies, Providence, RI 02906 USA; [Hamburg, Steven P.] Environm Def Fund, Boston, MA 01028 USA; [Melillo, Jerry M.] Marine Biol Lab, Ctr Ecosyst, Woods Hole, MA 02543 USA; [Wander, Michele M.] Univ Illinois, Urbana, IL 61801 USA; [Parton, William J.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Adler, Paul R.] USDA ARS, Pasture Syst & Watershed Management Res Unit, University Pk, PA 16802 USA; [Barney, Jacob N.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Cruse, Richard M.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Duke, Clifford S.] Ecol Soc Amer, Washington, DC 20036 USA; [Fearnside, Philip M.] Natl Inst Res Amazon INPA, BR-69011970 Manaus, Amazonas, Brazil; [Follett, Ronald F.] USDA ARS, Ft Collins, CO 80526 USA; [Gibbs, Holly K.] Univ Wisconsin, Ctr Sustainabil & Global Environm SAGE, Nelson Inst Environm Studies, Madison, WI 53726 USA; [Goldemberg, Jose] Univ Sao Paulo, Inst Eletrotecn & Energia, Sao Paulo, Brazil; [Mladenoff, David J.] Univ Wisconsin, Dept Forest & Wildlife Ecol, Madison, WI 53706 USA; [Ojima, Dennis] H John Heinz Ctr Sci Econ & Environm, Washington, DC 20006 USA; [Palmer, Michael W.] Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA; [Sharpley, Andrew] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Wallace, Linda] Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA; [Weathers, Kathleen C.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Wiens, John A.] PRBO Conservat Sci, Petaluma, CA 94954 USA; [Wilhelm, Wallace W.] Univ Nebraska, USDA ARS, Lincoln, NE 68583 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Oak Ridge National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Brown University; Environmental Defense Fund; Marine Biological Laboratory - Woods Hole; University of Illinois System; University of Illinois Urbana-Champaign; Colorado State University; United States Department of Agriculture (USDA); University of California System; University of California Davis; Iowa State University; Institute Nacional de Pesquisas da Amazonia; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Universidade de Sao Paulo; University of Wisconsin System; University of Wisconsin Madison; Oklahoma State University System; Oklahoma State University - Stillwater; University of Arkansas System; University of Arkansas Fayetteville; University of Oklahoma System; University of Oklahoma - Norman; Cary Institute of Ecosystem Studies; United States Department of Agriculture (USDA); University of Nebraska System; University of Nebraska Lincoln	Robertson, GP (corresponding author), Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA.	robertson@kbs.msu.edu	/AAD-2154-2020; Fearnside, Philip M/D-6559-2011; Palmer, Michael W/A-2519-2008; Ojima, Dennis/C-5272-2016; Robertson, G Philip/H-3885-2011; Barney, Jacob/C-2412-2008; Dale, Virginia H/GSO-3448-2022; Dale, Virginia H/ABI-6672-2020; Fearnside, Philip M/GQA-6023-2022; Dale, Virginia H/B-6023-2009; Noojipady, Praveen/B-2511-2010	Fearnside, Philip M/0000-0003-3672-9082; Robertson, G Philip/0000-0001-9771-9895; Barney, Jacob/0000-0003-2949-5003; Dale, Virginia H/0000-0002-4123-7202; Fearnside, Philip M/0000-0003-3672-9082; Adler, Paul/0000-0002-6787-631X				Barney JN, 2008, BIOSCIENCE, V58, P64, DOI 10.1641/B580111; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; Field CB, 2008, TRENDS ECOL EVOL, V23, P65, DOI 10.1016/j.tree.2007.12.001; Graham RL, 2007, AGRON J, V99, P1, DOI 10.2134/agronj2005.0222; Heaton EA, 2008, GLOBAL CHANGE BIOL, V14, P2000, DOI 10.1111/j.1365-2486.2008.01662.x; KANTER J, 2008, NY TIMES        0912; Kline KL, 2008, SCIENCE, V321, P199, DOI 10.1126/science.321.5886.199; Searchinger T, 2008, SCIENCE, V319, P1238, DOI 10.1126/science.1151861; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Wilhelm WW, 2007, AGRON J, V99, P1665, DOI 10.2134/agronj2007.0150	10	290	299	3	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					49	50		10.1126/science.1161525	http://dx.doi.org/10.1126/science.1161525			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832631				2022-12-28	WOS:000259680200028
J	Goldberger, ZD; Weinberger, SE; Nicosia, RF; Saint, S; Young, BA				Goldberger, Zachary D.; Weinberger, Steven E.; Nicosia, Roberto F.; Saint, Sanjay; Young, Bessie A.			Variations on a theme	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GLOMERULAR BASEMENT-MEMBRANE; GOODPASTURES-SYNDROME; ALVEOLAR HEMORRHAGE; ANTIBODY DISEASE; GLOMERULONEPHRITIS; EXPOSURE		[Goldberger, Zachary D.; Saint, Sanjay] Univ Michigan Hlth Syst, Dept Internal Med, Div Cardiovasc Med, CVC Cardiovasc Med, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI 48109 USA; [Saint, Sanjay] Univ Michigan Hlth Syst, Patient Safety Enhancement Program, Ann Arbor, MI 48109 USA; [Goldberger, Zachary D.; Young, Bessie A.] Vet Affairs Puget Sound Hlth Care Syst, Dept Med, Seattle, WA USA; [Nicosia, Roberto F.] Vet Affairs Puget Sound Hlth Care Syst, Pathol Serv, Seattle, WA USA; [Nicosia, Roberto F.] Vet Affairs Puget Sound Hlth Care Syst, Lab Serv, Seattle, WA USA; [Nicosia, Roberto F.] Vet Affairs Puget Sound Hlth Care Syst, Dept Pathol, Seattle, WA USA; [Young, Bessie A.] Vet Affairs Puget Sound Hlth Care Syst, Div Nephrol, Seattle, WA USA; Univ Washington, Sch Med, Seattle, WA USA; [Weinberger, Steven E.] Amer Coll Physicians, Philadelphia, PA USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; American College of Physicians	Goldberger, ZD (corresponding author), Univ Michigan Hlth Syst, Dept Internal Med, Div Cardiovasc Med, CVC Cardiovasc Med, 1500 E Med Ctr Dr,SPC 5853, Ann Arbor, MI 48109 USA.	zgoldber@med.umich.edu	SIMON, ../G-7364-2013; Young, Lucky\\1234/GNH-2046-2022; Saint, Sanjay/AAF-5126-2019	SIMON, ../0000-0003-2285-283X; 	Advanced Career Development Award; Health Services Research and Development Program of the Department of Veterans Affairs; National Institutes of Health [RO1 DK079745-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079745] Funding Source: NIH RePORTER	Advanced Career Development Award; Health Services Research and Development Program of the Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by an Advanced Career Development Award from the Health Services Research and Development Program of the Department of Veterans Affairs (to Dr. Saint) and a grant from the National Institutes of Health (RO1 DK079745-01, to Dr. Young).; No potential conflict of interest relevant to this article was reported.; We thank Drs. David Au, Vijay Reddy, and Heather Davidson for their care of the patient.	BOMBASSEI GJ, 1992, AM J IND MED, V21, P141, DOI 10.1002/ajim.4700210204; BOYCE NW, 1986, NEPHRON, V44, P22, DOI 10.1159/000183906; DONAGHY M, 1983, LANCET, V2, P1390; Fischer EG, 2006, AM J CLIN PATHOL, V125, P445, DOI 10.1309/NPTP-4UKV-7JU3-ELMQ; Goodpasture EW, 1919, AM J MED SCI, V158, P863, DOI 10.1097/00000441-191911000-00012; Hellmark T, 1997, NEPHROL DIAL TRANSPL, V12, P646, DOI 10.1093/ndt/12.4.646; JOHNSON JP, 1985, MEDICINE, V64, P219, DOI 10.1097/00005792-198507000-00003; Lazor R, 2007, MEDICINE, V86, P181, DOI 10.1097/md.0b013e318067da56; Levy JB, 2001, ANN INTERN MED, V134, P1033, DOI 10.7326/0003-4819-134-11-200106050-00009; Pagnoux C, 2005, MEDICINE, V84, P115, DOI 10.1097/01.md.0000158825.87055.0b; Pusey CD, 2003, KIDNEY INT, V64, P1535, DOI 10.1046/j.1523-1755.2003.00241.x; Salama AD, 2001, LANCET, V358, P917, DOI 10.1016/S0140-6736(01)06077-9; Serisier DJ, 2006, THORAX, V61, P636, DOI 10.1136/thx.2004.028985; STANTON M. C., 1958, AUSTRALASEAN ANN MED, V7, P132; STEVENSON A, 1995, QJM-MON J ASSOC PHYS, V88, P23	15	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1502	1507		10.1056/NEJMcps0708762	http://dx.doi.org/10.1056/NEJMcps0708762			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832249				2022-12-28	WOS:000259631700012
J	Leichsenring, F; Rabung, S				Leichsenring, Falk; Rabung, Sven			Effectiveness of long-term psychodynamic psychotherapy - A meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BORDERLINE PERSONALITY-DISORDER; RANDOMIZED CONTROLLED-TRIALS; DYNAMIC PSYCHOTHERAPY; PSYCHOANALYTIC-THERAPY; BEHAVIOR-THERAPY; FOLLOW-UP; OUTPATIENT PSYCHOTHERAPY; INTENSIVE PSYCHOTHERAPY; PSYCHOLOGICAL THERAPIES; PARTIAL HOSPITALIZATION	Context The place of long- term psychodynamic psychotherapy ( LTPP) within psychiatry is controversial. Convincing outcome research for LTPP has been lacking. Objective To examine the effects of LTPP, especially in complex mental disorders, ie, patients with personality disorders, chronic mental disorders, multiple mental disorders, and complex depressive and anxiety disorders ( ie, associated with chronic course and/ or multiple mental disorders), by performing a meta- analysis. Data Sources Studies of LTPP published between January 1, 1960, and May 31, 2008, were identified by a computerized search using MEDLINE, PsycINFO, and Current Contents, supplemented by contact with experts in the field. Study Selection Only studies that used individual psychodynamic psychotherapy lasting for at least a year, or 50 sessions; had a prospective design; and reported reliable outcome measures were included. Randomized controlled trials ( RCTs) and observational studies were considered. Twenty- three studies involving a total of 1053 patients were included ( 11 RCTs and 12 observational studies). Data Extraction Information on study characteristics and treatment outcome was extracted by 2 independent raters. Effect sizes were calculated for overall effectiveness, target problems, general psychiatric symptoms, personality functioning, and social functioning. To examine the stability of outcome, effect sizes were calculated separately for end- of- therapy and follow- up assessment. Results According to comparative analyses of controlled trials, LTPP showed significantly higher outcomes in overall effectiveness, target problems, and personality functioning than shorter forms of psychotherapy. With regard to overall effectiveness, a between- group effect size of 1.8 ( 95% confidence interval [ CI], 0.7- 3.4) indicated that after treatment with LTPP patients with complex mental disorders on average were better off than 96% of the patients in the comparison groups ( P=. 002). According to subgroup analyses, LTPP yielded significant, large, and stable within- group effect sizes across various and particularly complex mental disorders ( range, 0.78- 1.98). Conclusions There is evidence that LTPP is an effective treatment for complex mental disorders. Further research should address the outcome of LTPP in specific mental disorders and should include cost- effectiveness analyses.	[Leichsenring, Falk] Univ Giessen, Dept Psychosomat & Psychotherapy, D-35392 Giessen, Germany; [Rabung, Sven] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	Justus Liebig University Giessen; University of Hamburg; University Medical Center Hamburg-Eppendorf	Leichsenring, F (corresponding author), Univ Giessen, Dept Psychosomat & Psychotherapy, Ludwigstr 76, D-35392 Giessen, Germany.	falk.leichsenring@psycho.med.uni-giessen.de	Rabung, Sven/G-3187-2013	Rabung, Sven/0000-0001-5883-3070				Bachar E, 1999, J Psychother Pract Res, V8, P115; Barber JP, 1997, PSYCHOTHERAPY, V34, P133, DOI 10.1037/h0087774; Bateman A, 1999, AM J PSYCHIAT, V156, P1563, DOI 10.1176/ajp.156.10.1563; Bateman A, 2001, AM J PSYCHIAT, V158, P36, DOI 10.1176/appi.ajp.158.1.36; Bateman AW, 2003, B MENNINGER CLIN, V67, P187, DOI 10.1521/bumc.67.3.187.23439; BATTLE CC, 1966, AM J PSYCHOTHER, V20, P184, DOI 10.1176/appi.psychotherapy.1966.20.1.184; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Begg CB, 1995, HDB RES SYNTHESIS, P399; Benson K, 2000, NEW ENGL J MED, V342, P1878, DOI 10.1056/NEJM200006223422506; Berlin JA, 1997, LANCET, V350, P185, DOI 10.1016/S0140-6736(05)62352-5; Bond M, 2006, J NERV MENT DIS, V194, P21, DOI 10.1097/01.nmd.0000195345.27277.2f; BOND M, 1983, ARCH GEN PSYCHIAT, V40, P333; Bond M, 2004, AM J PSYCHIAT, V161, P1665, DOI 10.1176/appi.ajp.161.9.1665; Brockmann J, 2006, PSYCHOTHERAPEUT, V51, P15, DOI 10.1007/s00278-005-0454-x; Clarkin JF, 2001, J PERS DISORD, V15, P487, DOI 10.1521/pedi.15.6.487.19190; Clarkin JF, 2007, AM J PSYCHIAT, V164, P922, DOI 10.1176/appi.ajp.164.6.922; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Crits-Christoph P, 2000, HDB PSYCHOL CHANGE P, P455, DOI DOI 10.1016/J.JAD.2007.08.005; CRITSCHRISTOPH P, 1992, AM J PSYCHIAT, V149, P151; Dare C, 2001, BRIT J PSYCHIAT, V178, P216, DOI 10.1192/bjp.178.3.216; de Maat S, 2007, HARVARD REV PSYCHIAT, V15, P289, DOI 10.1080/10673220701811654; Derogatis L., 1977, SCL 90 R VERSION MAN; Duhrssen A.-M., 1965, NERVENARZT, V36, P166; Fonagy P, 2005, B MENNINGER CLIN, V69, P1, DOI 10.1521/bumc.69.1.1.62267; Gabbard GO, 2002, ARCH GEN PSYCHIAT, V59, P505, DOI 10.1001/archpsyc.59.6.505; Gabbard GO., 2004, LONG TERM PSYCHODYNA; Giesen-Bloo J, 2006, ARCH GEN PSYCHIAT, V63, P649, DOI 10.1001/archpsyc.63.6.649; Grande T, 2006, PSYCHOTHER RES, V16, P470, DOI 10.1080/10503300600608082; Grant BF, 2004, J CLIN PSYCHIAT, V65, P948; Gregory RJ, 2008, PSYCHOTHERAPY, V45, P28, DOI 10.1037/0033-3204.45.1.28; Gunderson JG, 1999, J AM PSYCHOANAL ASS, V47, P679; Hedges L.V., 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hedges LV, 1998, PSYCHOL METHODS, V3, P486, DOI 10.1037/1082-989X.3.4.486; Hedges LV, 1981, J EDUC STAT, V6, P107, DOI [10.2307/1164588, DOI 10.2307/1164588, 10.3102/10769986006002107]; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hoglend P, 2008, AM J PSYCHIAT, V165, P763, DOI 10.1176/appi.ajp.2008.07061028; Hoglend P, 2006, AM J PSYCHIAT, V163, P1739, DOI 10.1176/appi.ajp.163.10.1739; HUBER D, 2001, LANGZEIT PSYCHOTHERA, P260; Huber D., 2006, BOOK ABSTRACTS RES P, P154; Huedo-Medina TB, 2006, PSYCHOL METHODS, V11, P193, DOI 10.1037/1082-989X.11.2.193; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Kantojarvi L, 2006, J PERS DISORD, V20, P102, DOI 10.1521/pedi.2006.20.1.102; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Kernberg OF, 2002, ARCH GEN PSYCHIAT, V59, P497, DOI 10.1001/archpsyc.59.6.497; Knekt P, 2008, PSYCHOL MED, V38, P689, DOI 10.1017/S003329170700164X; Knekt P, 2008, J AFFECT DISORDERS, V107, P95, DOI 10.1016/j.jad.2007.08.005; KOPTA SM, 1994, J CONSULT CLIN PSYCH, V62, P1009, DOI 10.1037/0022-006X.62.5.1009; Korner A, 2006, COMPR PSYCHIAT, V47, P406, DOI 10.1016/j.comppsych.2006.01.003; LAMB WK, 2005, METAANALYSIS OUTCOME; Leichsenring F, 2005, INT J PSYCHOANAL, V86, P841, DOI 10.1516/RFEE-LKPN-B7TF-KPDU; Leichsenring F, 2005, INT J PSYCHOANAL, V86, P433, DOI 10.1516/XX6F-AU0W-KWM3-G6LU; Leichsenring F, 2004, ARCH GEN PSYCHIAT, V61, P1208, DOI 10.1001/archpsyc.61.12.1208; Leichsenring F, 2003, AM J PSYCHIAT, V160, P1223, DOI 10.1176/appi.ajp.160.7.1223; Leichsenring F, 2001, CLIN PSYCHOL REV, V21, P401, DOI 10.1016/S0272-7358(99)00057-4; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Levy KN, 2006, J CONSULT CLIN PSYCH, V74, P1027, DOI 10.1037/0022-006X.74.6.1027; Linehan MM, 2006, ARCH GEN PSYCHIAT, V63, P757, DOI 10.1001/archpsyc.63.7.757; LINEHAN MM, 1994, AM J PSYCHIAT, V151, P1771; Luborsky L, 2001, J AM PSYCHOANAL ASS, V49, P217, DOI 10.1177/00030651010490011401; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; MONSEN J, 1995, SCAND J PSYCHOL, V36, P256, DOI 10.1111/j.1467-9450.1995.tb00985.x; MONSEN JT, 1995, PSYCHOTHER RES, V5, P33, DOI 10.1080/10503309512331331126; Olfson M, 1997, AM J PSYCHIAT, V154, P1734, DOI 10.1176/ajp.154.12.1734; ORMEL J, 1994, JAMA-J AM MED ASSOC, V272, P1741, DOI 10.1001/jama.272.22.1741; Perry JC, 1999, AM J PSYCHIAT, V156, P1312; PETRAK F, 2007, VERHALTENSTHERAPIE, V17, pS19; PIPER WE, 1984, J CONSULT CLIN PSYCH, V52, P268, DOI 10.1037/0022-006X.52.2.268; Pocock SJ, 2000, NEW ENGL J MED, V342, P1907, DOI 10.1056/NEJM200006223422511; Puschner B, 2007, PSYCHOL PSYCHOTHER-T, V80, P51, DOI 10.1348/147608306X107593; Quintana SM, 2006, COUNS PSYCHOL, V34, P839, DOI 10.1177/0011000006286991; Rosenberg M.S., 1999, Q REV BIOL, V73, P126, DOI [10.1086/420179, DOI 10.1086/420179]; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; Rosenthal R, 1991, METAANALYTIC PROCEDU; Roth A., 2005, WHAT WORKS WHOM CRIT, V2nd; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; RUDOLF G, 1994, Z PSYCHOSOM MED PSYC, V40, P25; Sandell R, 2000, INT J PSYCHOANAL, V81, P921, DOI 10.1516/0020757001600291; SELIGMAN MEP, 1995, AM PSYCHOL, V50, P965, DOI 10.1037/0003-066X.50.12.965; Shadish W. R., 2001, EXPT QUASIEXPERIMENT, V2nd; Shadish WR, 2000, PSYCHOL BULL, V126, P512, DOI 10.1037//0033-2909.126.4.512; SHEA MT, 1992, ARCH GEN PSYCHIAT, V49, P782, DOI 10.1001/archpsyc.1992.01820100026006; SPSS Inc, 2006, SPSS 15 0 COMM SYNT; STEVENSON J, 1992, AM J PSYCHIAT, V149, P358; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Svartberg M, 2004, AM J PSYCHIAT, V161, P810, DOI 10.1176/appi.ajp.161.5.810; Vinnars B, 2005, AM J PSYCHIAT, V162, P1933, DOI 10.1176/appi.ajp.162.10.1933; WEISSMAN MM, 1976, ARCH GEN PSYCHIAT, V33, P1111; Westen D, 2004, PSYCHOL BULL, V130, P631, DOI 10.1037/0033-2909.130.4.631; Wilczek A, 2004, J AM PSYCHOANAL ASS, V52, P1163	90	429	436	2	125	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1551	1565		10.1001/jama.300.13.1551	http://dx.doi.org/10.1001/jama.300.13.1551			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354CY	18827212				2022-12-28	WOS:000259617700019
J	Alakeson, V				Alakeson, Vidhya			America's health choices	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material																		COHEN R, 2008, STATE REGIONAL NATL; Lake CC, 2008, HEALTH AFFAIR, V27, P693, DOI 10.1377/hlthaff.27.3.693; Long SK, 2008, HEALTH AFFAIR, V27, pW270, DOI 10.1377/hlthaff.27.4.w270; *ORG EC COOP DEV, 2008, OECD HLTH DAT 2008 S; SAAD L, 2007, NO INCR PUBL PRESS H	5	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1563	10.1136/bmj.a1563	http://dx.doi.org/10.1136/bmj.a1563			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18812369				2022-12-28	WOS:000259797600033
J	Fuccio, L; Laterza, L; Zagari, RM; Cennamo, V; Grilli, D; Bazzoli, F				Fuccio, L.; Laterza, L.; Zagari, R. M.; Cennamo, V.; Grilli, D.; Bazzoli, Franco			Treatment of Helicobacter pylori infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							DOSE TRIPLE THERAPY; ANTIBIOTIC-RESISTANCE; ERADICATION; METAANALYSIS; EFFICACY; AMOXICILLIN; MANAGEMENT; REGIMENS		[Fuccio, L.; Laterza, L.; Zagari, R. M.; Cennamo, V.; Bazzoli, Franco] Univ Bologna, Dept Internal Med & Gastroenterol, I-40138 Bologna, Italy; [Grilli, D.] Univ S Florida, Dept Econ, Tampa, FL 33620 USA	University of Bologna; State University System of Florida; University of South Florida	Bazzoli, F (corresponding author), Univ Bologna, Dept Internal Med & Gastroenterol, I-40138 Bologna, Italy.	franco.bazzoli@unibo.it	Fuccio, Lorenzo/A-2557-2010; cennamo, Vincenzo/AAC-7601-2022; Zagari, Rocco Maurizio/AAA-1836-2021	Fuccio, Lorenzo/0000-0001-8618-2447; 				Bazzoli F, 1998, ALIMENT PHARM THERAP, V12, P439; BAZZOLI F, 1994, EUR J GASTROEN HEPAT, V6, P773, DOI 10.1097/00042737-199409000-00004; Chey WD, 2007, AM J GASTROENTEROL, V102, P1808, DOI 10.1111/j.1572-0241.2007.01393.x; Fischbach L, 2007, ALIMENT PHARM THER, V26, P343, DOI 10.1111/j.1365-2036.2007.03386.x; Fischbach LA, 2004, ALIMENT PHARM THER, V20, P1071, DOI 10.1111/j.1365-2036.2004.02248.x; Fock KM, 2008, J GASTROEN HEPATOL, V23, P351, DOI 10.1111/j.1440-1746.2008.05314.x; Ford AC, 2004, AM J GASTROENTEROL, V99, P1833, DOI 10.1111/j.1572-0241.2004.40014.x; Fuccio L, 2007, ALIMENT PHARM THER, V25, P133, DOI 10.1111/j.1365-2036.2006.03183.x; Fuccio L, 2007, ANN INTERN MED, V147, P553, DOI 10.7326/0003-4819-147-8-200710160-00008; Gisbert JP, 2006, ALIMENT PHARM THER, V23, P35, DOI 10.1111/j.1365-2036.2006.02737.x; Gisbert JP, 2005, AM J GASTROENTEROL, V100, P2083, DOI 10.1111/j.1572-0241.2005.50043.x; Gisbert JP, 2004, ALIMENT PHARM THER, V20, P1001, DOI 10.1111/j.1365-2036.2004.02203.x; Jafri NS, 2008, ANN INTERN MED, V148, P923, DOI 10.7326/0003-4819-148-12-200806170-00226; LAMOULIATTE H, 1995, J CLIN GASTROENTEROL, V20, pS28, DOI 10.1097/00004836-199506001-00007; Malaty HM, 2007, BEST PRACT RES CL GA, V21, P205, DOI 10.1016/j.bpg.2006.10.005; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Megraud F, 2004, GUT, V53, P1374, DOI 10.1136/gut.2003.022111; Megraud Francis, 2005, Curr Infect Dis Rep, V7, P115, DOI 10.1007/s11908-005-0071-4; Moayyedi P, 2007, LANCET, V370, P1010, DOI 10.1016/S0140-6736(07)61455-X; Murakami K, 2008, J CLIN GASTROENTEROL, V42, P139, DOI 10.1097/MCG.0b013e31802cbc1a; Neri M, 2003, ALIMENT PHARM THER, V18, P821, DOI 10.1046/j.1365-2036.2003.01757.x; Rokkas T, 2007, HELICOBACTER, V12, P403; Romano M, 2003, CLIN GASTROENTEROL H, V1, P273, DOI 10.1016/S1542-3565(03)00131-9; Saad RJ, 2006, AM J GASTROENTEROL, V101, P488, DOI 10.1111/j.1572-0241.2006.00637.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Taylor JL, 1997, ARCH INTERN MED, V157, P87, DOI 10.1001/archinte.157.1.87; Toracchio S, 2000, ALIMENT PHARM THER, V14, P1639, DOI 10.1046/j.1365-2036.2000.00870.x; Vaira D, 2007, ANN INTERN MED, V146, P556, DOI 10.7326/0003-4819-146-8-200704170-00006; WONG BC, 2004, JAMA-J AM MED ASSOC, V291, P244; Zagari RM, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1400; Zagari RM, 2007, GUT, V56, P475, DOI 10.1136/gut.2006.102269	31	26	28	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1454	10.1136/bmj.a1454	http://dx.doi.org/10.1136/bmj.a1454			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18794181				2022-12-28	WOS:000259797600041
J	Delgado, MR; Schotter, A; Ozbay, EY; Phelps, EA				Delgado, Mauricio R.; Schotter, Andrew; Ozbay, Erkut Y.; Phelps, Elizabeth A.			Understanding overbidding: using the neural circuitry of reward to design economic auctions	SCIENCE			English	Article							DECISION; BRAIN; NEUROECONOMICS; PUNISHMENT; TRUST; TASK	We take advantage of our knowledge of the neural circuitry of reward to investigate a puzzling economic phenomenon: Why do people overbid in auctions? Using functional magnetic resonance imaging (fMRI), we observed that the social competition inherent in an auction results in a more pronounced blood oxygen level- dependent ( BOLD) response to loss in the striatum, with greater overbidding correlated with the magnitude of this response. Leveraging these neuroimaging results, we design a behavioral experiment that demonstrates that framing an experimental auction to emphasize loss increases overbidding. These results highlight a role for the contemplation of loss in understanding the tendency to bid "too high." Current economic theories suggest overbidding may result from either "joy of winning" or risk aversion. By combining neuroeconomic and behavioral economic techniques, we find that another factor, namely loss contemplation in a social context, may mediate overbidding in auctions.	[Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Delgado, Mauricio R.] Rutgers State Univ, Dept Psychol, Newark, NJ 07102 USA; [Schotter, Andrew] NYU, Dept Econ, New York, NY 10003 USA; [Schotter, Andrew] Ctr Expt Social Sci, New York, NY 10003 USA; [Ozbay, Erkut Y.] Univ Maryland, Dept Econ, College Pk, MD 20742 USA	New York University; Rutgers State University Newark; Rutgers State University New Brunswick; New York University; University System of Maryland; University of Maryland College Park	Phelps, EA (corresponding author), NYU, Dept Psychol, 6 Washington Pl, New York, NY 10003 USA.	liz.phelps@nyu.edu			James S. McDonnell Foundation; National Insttute of Mental Health; NIH [MH62104]; Seaver Foundation to NYU's Center for Brain Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062104] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Insttute of Mental Health; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Seaver Foundation to NYU's Center for Brain Imaging; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors would like to acknowledge support from the James S. McDonnell Foundation and National Insttute of Mental Health, NIH (MH62104) to E. A. P. and the support of the Seaver Foundation to NYU's Center for Brain Imaging. We also thank the Center for Experimental Social Science for its support. We are grateful to D. Schwarz for his efforts in the initial stages of collection and analysis of neuroimaging data. We thank J. Zakrzewski and K. Nearing for their assistance during data collection, M. Niznikiewicz for assistance during data analysis, and R. Advani for his programming help on the behavioral experiment.	Camerer C, 2005, J ECON LIT, V43, P9, DOI 10.1257/0022051053737843; Cassidy Ralph, 1967, AUCTIONS AUCTIONEERI; Cox J., 1982, RES EXPT EC, P1; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Delgado MR, 2003, COGN AFFECT BEHAV NE, V3, P27, DOI 10.3758/CABN.3.1.27; Delgado MR, 2005, NAT NEUROSCI, V8, P1611, DOI 10.1038/nn1575; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Fehr E, 2004, CURR OPIN NEUROBIOL, V14, P784, DOI 10.1016/j.conb.2004.10.007; Glimcher PW, 2004, SCIENCE, V306, P447, DOI 10.1126/science.1102566; Goeree JK, 2002, J ECON THEORY, V104, P247, DOI 10.1006/jeth.2001.2914; GUL F, HDB EC METH IN PRESS, V1; Haruno M, 2004, J NEUROSCI, V24, P1660, DOI 10.1523/JNEUROSCI.3417-03.2004; HUETTEL SA, 2004, FUNCTIONAL MAGNETIC, pR18; King-Casas B, 2005, SCIENCE, V308, P78, DOI 10.1126/science.1108062; Knutson B, 2003, NEUROIMAGE, V18, P263, DOI 10.1016/S1053-8119(02)00057-5; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Nieuwenhuis S, 2005, NEUROIMAGE, V25, P1302, DOI 10.1016/j.neuroimage.2004.12.043; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Phelps Elizabeth A., 1999, P295; Rubinstein A., 2006, ADV EC THEORY, P246; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Tricomi E, 2006, J COGNITIVE NEUROSCI, V18, P1029, DOI 10.1162/jocn.2006.18.6.1029	22	118	119	6	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1849	1852		10.1126/science.1158860	http://dx.doi.org/10.1126/science.1158860			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818362	Green Accepted			2022-12-28	WOS:000259501300042
J	Efferson, C; Lalive, R; Fehr, E				Efferson, Charles; Lalive, Rafael; Fehr, Ernst			The coevolution of cultural groups and ingroup favoritism	SCIENCE			English	Article							EVOLUTION; COOPERATION; PUNISHMENT; ALTRUISM; NORMS	Cultural boundaries have often been the basis for discrimination, nationalism, religious wars, and genocide. Little is known, however, about how cultural groups form or the evolutionary forces behind group affiliation and ingroup favoritism. Hence, we examine these forces experimentally and show that arbitrary symbolic markers, though initially meaningless, evolve to play a key role in cultural group formation and ingroup favoritism because they enable a population of heterogeneous individuals to solve important coordination problems. This process requires that individuals differ in some critical but unobservable way and that their markers be freely and flexibly chosen. If these conditions are met, markers become accurate predictors of behavior. The resulting social environment includes strong incentives to bias interactions toward others with the same marker, and subjects accordingly show strong ingroup favoritism. When markers do not acquire meaning as accurate predictors of behavior, players show a markedly reduced taste for ingroup favoritism. Our results support the prominent evolutionary hypothesis that cultural processes can reshape the selective pressures facing individuals and so favor the evolution of behavioral traits not previously advantaged.	[Efferson, Charles; Fehr, Ernst] Univ Zurich, Inst Empir Res Econ, CH-8006 Zurich, Switzerland; [Efferson, Charles] Santa Fe Inst, Santa Fe, NM 87501 USA; [Lalive, Rafael] Univ Lausanne, Dept Econ, CH-1015 Lausanne, Switzerland; [Fehr, Ernst] Collegium Helveticum, CH-8092 Zurich, Switzerland	University of Zurich; The Santa Fe Institute; University of Lausanne	Efferson, C (corresponding author), Univ Zurich, Inst Empir Res Econ, Blumlisalpstr 10, CH-8006 Zurich, Switzerland.	efferson@iew.uzh.ch		Efferson, Charles/0000-0001-8244-4497; Lalive, Rafael/0000-0003-1938-692X	Swiss National Science Foundation [105312-114107]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the Swiss National Science Foundation (105312-114107) and is part of the Research Priority Program "Foundations of Human Social Behavior-Altruism versus Egoism" at the University of Zurich. We thank S. Bowles for valuable comments on an earlier version of this article and R. McElreath for helpful insights during the initial stages of the project.	Axtell RL, 2001, SOCIAL DYNAMICS, P191; Barth Fredrik, 1969, ETHNIC GROUPS BOUND; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Blom DE, 2005, J ANTHROPOL ARCHAEOL, V24, P1, DOI 10.1016/j.jaa.2004.10.001; Bowles S., 2004, ROUNDTABLE SER BEHAV; BOWLES S, IS EQUAL OPPORTUNITY; Bowles S, 2006, SCIENCE, V314, P1569, DOI 10.1126/science.1134829; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Boyd R., 1985, CULTURE EVOLUTIONARY; Boyd R, 2005, ORIGIN EVOLUTION CUL; Boyd R., 1987, CULT ANTHROPOL, V2, P65, DOI [10.1525/can.1987.2.1.02a00070, DOI 10.1525/CAN.1987.2.1.02A00070]; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Correll J, 2006, J EXP SOC PSYCHOL, V42, P120, DOI 10.1016/j.jesp.2005.02.006; Dovidio JF, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P1, DOI 10.1002/9780470773963; Durham WH., 1991, COEVOLUTION GENES CU; Eicher J.B., 1995, DRESS ETHNICITY; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FUDENBERG D, 1986, ECONOMETRICA, V54, P533, DOI 10.2307/1911307; Glaeser EL, 2000, Q J ECON, V115, P811, DOI 10.1162/003355300554926; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; HEIZER RF, 1978, HDB N AM INDIANS CAL, P690; Hewstone M, 2002, ANNU REV PSYCHOL, V53, P575, DOI 10.1146/annurev.psych.53.100901.135109; Jorgensen J., 1980, W INDIANS; Jost JT, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P208, DOI 10.1002/9780470773963.ch13; Judd CM, 2005, ON THE NATURE OF PREJUDICE: FIFTY YEARS AFTER ALLPORT, P123; Kinzler KD, 2007, P NATL ACAD SCI USA, V104, P12577, DOI 10.1073/pnas.0705345104; Kunda Z., 1999, SOCIAL COGNITION MAK; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; Olding-Smee F. J., 2003, NICHE CONSTRUCTION N; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Richerson P. J., 2005, NOT GENES ALONE CULT; Schelling T., 1978, MICROMOTIVES MACROBE; Sherif M., 1961, INTERGROUP CONFLICT; SILVERMAN C, 1988, J AM FOLKLORE, V101, P261, DOI 10.2307/540467; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; Torres-Rouff C, 2002, CURR ANTHROPOL, V43, P163, DOI 10.1086/338290; Yamagishi T, 1999, ADV GROUP, V16, P161; Young H.P., 1998, INDIVIDUAL STRATEGY, DOI DOI 10.1515/9780691214252	40	202	205	3	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1844	1849		10.1126/science.1155805	http://dx.doi.org/10.1126/science.1155805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818361	Green Published			2022-12-28	WOS:000259501300041
J	Chiba, D; Sawicki, M; Nishitani, Y; Nakatani, Y; Matsukura, F; Ohno, H				Chiba, D.; Sawicki, M.; Nishitani, Y.; Nakatani, Y.; Matsukura, F.; Ohno, H.			Magnetization vector manipulation by electric fields	NATURE			English	Article							FERROMAGNETIC SEMICONDUCTOR; MEMORY DEVICE; (GA,MN)AS; ANISOTROPY	Conventional semiconductor devices use electric fields to control conductivity, a scalar quantity, for information processing. In magnetic materials, the direction of magnetization, a vector quantity, is of fundamental importance. In magnetic data storage, magnetization is manipulated with a current-generated magnetic field (Oersted-Ampere field), and spin current(1,2) is being studied for use in non- volatile magnetic memories(3,4). To make control of magnetization fully compatible with semiconductor devices, it is highly desirable to control magnetization using electric fields. Conventionally, this is achieved by means of magnetostriction produced by mechanically generated strain through the use of piezoelectricity(5-8). Multiferroics(9,10) have been widely studied in an alternative approach where ferroelectricity is combined with ferromagnetism. Magnetic- field control of electric polarization has been reported in these multiferroics using the magnetoelectric effect, but the inverse effect - direct electrical control of magnetization - has not so far been observed(11). Here we show that the manipulation of magnetization can be achieved solely by electric fields in a ferromagnetic semiconductor, (Ga,Mn)As. The magnetic anisotropy, which determines the magnetization direction, depends on the charge carrier (hole) concentration in (Ga,Mn) As. By applying an electric field using a metal - insulator - semiconductor structure(12-14), the hole concentration and, thereby, the magnetic anisotropy can be controlled, allowing manipulation of the magnetization direction.	[Chiba, D.; Sawicki, M.; Nishitani, Y.; Matsukura, F.; Ohno, H.] Tohoku Univ, Aoba Ku, Lab Nanoelect & Spintron, Res Inst Elect Commun, Sendai, Miyagi 9808577, Japan; [Chiba, D.; Matsukura, F.; Ohno, H.] Japan Sci & Technol Agcy, Chiyoda Ku, Semicond Spintron Project, Tokyo 1020075, Japan; [Sawicki, M.] Polish Acad Sci, Inst Phys, PL-02668 Warsaw, Poland; [Nakatani, Y.] Univ Electrocommun, Tokyo 1828585, Japan	Tohoku University; Japan Science & Technology Agency (JST); Polish Academy of Sciences; Institute of Physics - Polish Academy of Sciences; University of Electro-Communications - Japan	Ohno, H (corresponding author), Tohoku Univ, Aoba Ku, Lab Nanoelect & Spintron, Res Inst Elect Commun, Katahira 2-1-1, Sendai, Miyagi 9808577, Japan.	ohno@riec.tohoku.ac.jp	Sawicki, Maciej/F-5906-2013; Ohno, Hideo/E-6453-2010; Chiba, Daichi/D-3438-2015	Sawicki, Maciej/0000-0001-5740-3677; Ohno, Hideo/0000-0001-9688-8259; Chiba, Daichi/0000-0002-6631-5131	MEXT/JSPS; GCOE Program at Tohoku University; Research and Development for Next-Generation Information Technology Program (MEXT); Research Fellowship from JSPS	MEXT/JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); GCOE Program at Tohoku University; Research and Development for Next-Generation Information Technology Program (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Fellowship from JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We acknowledge discussion with M. Shirai. This work was supported in part by Grant-in-Aids from MEXT/JSPS, the GCOE Program at Tohoku University, the Research and Development for Next-Generation Information Technology Program (MEXT), and a Research Fellowship from JSPS.	Abolfath M, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.054418; Berger L, 1996, PHYS REV B, V54, P9353, DOI 10.1103/PhysRevB.54.9353; Chiba D, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2362971; Chiba D, 2003, SCIENCE, V301, P943, DOI 10.1126/science.1086608; Chu YH, 2008, NAT MATER, V7, P478, DOI 10.1038/nmat2184; Dietl T, 2000, SCIENCE, V287, P1019, DOI 10.1126/science.287.5455.1019; Dietl T, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.195205; Eerenstein W, 2006, NATURE, V442, P759, DOI 10.1038/nature05023; Goennenwein STB, 2008, PHYS STATUS SOLIDI-R, V2, P96, DOI 10.1002/pssr.200802011; Hamaya K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045201; Hashimoto Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.067202; Hayashi T, 2000, PHYSICA B, V284, P1175, DOI 10.1016/S0921-4526(99)02597-1; HOSOMI M, 2005, INT EL DEV M, V473, P459; KAWAHARA T, 2007, ISSCC, P480; Liu X, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.205204; Matsukura F, 2004, PHYSICA E, V21, P1032, DOI 10.1016/j.physe.2003.11.165; Matsukura F, 1998, PHYS REV B, V57, pR2037, DOI 10.1103/PhysRevB.57.R2037; Novosad V, 2000, J APPL PHYS, V87, P6400, DOI 10.1063/1.372719; Ohno H, 2000, NATURE, V408, P944, DOI 10.1038/35050040; Oiwa A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137202; Overby M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917481; Pappert K, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2437075; Sawicki M, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.121302; SCHRODER K, 1974, IEEE T MAGN, VMA10, P567, DOI 10.1109/TMAG.1974.1058455; Shen A, 1997, J CRYST GROWTH, V175, P1069, DOI 10.1016/S0022-0248(96)00967-0; Slonczewski JC, 1996, J MAGN MAGN MATER, V159, pL1, DOI 10.1016/0304-8853(96)00062-5; Tang HX, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.107201; Tokura Y, 2006, SCIENCE, V312, P1481, DOI 10.1126/science.1125227; Wang KY, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.217204; Welp U, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.167206	30	556	568	4	308	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					515	518		10.1038/nature07318	http://dx.doi.org/10.1038/nature07318			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818654				2022-12-28	WOS:000259449600042
J	Gault, F; Huttner, S				Gault, Fred; Huttner, Susanne			A cat's cradle for policy	NATURE			English	Editorial Material									[Huttner, Susanne] OECD, Sci Technol & Ind Directorate, F-75775 Paris 16, France	Organisation for Economic Co-operation & Development (OECD)		fgault@idrc.ca						MARBURGER J, 2007, SCI SCI INNOVATION P; OECD, 2002, FRASC MAN 2002 PROP; *OECD EUR, 2005, OSL MAN GUID COLL IN; Organizacion para la Cooperacion y el Desarrollo Economico (OECD), 1999, IMPL OECD JOBS STRAT	4	9	10	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					462	463		10.1038/455462a	http://dx.doi.org/10.1038/455462a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	351TU	18818635				2022-12-28	WOS:000259449600022
J	Dhalla, IA; Detsky, AS				Dhalla, Irfan A.; Detsky, Allan S.			Risks and benefits of importing prescription medications from lower-income countries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Detsky, Allan S.] Mt Sinai Hosp, Dept Med, Toronto, ON M5G 1X5, Canada; [Detsky, Allan S.] Univ Hlth Network, Toronto, ON, Canada; [Detsky, Allan S.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Dhalla, Irfan A.; Detsky, Allan S.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Detsky, AS (corresponding author), Mt Sinai Hosp, Dept Med, 427-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	adetsky@mtsinai.on.ca						AUSTIN I, 2007, NY TIMES        1213; Choudhry NK, 2005, JAMA-J AM MED ASSOC, V293, P358, DOI 10.1001/jama.293.3.358; DECKER S, 2008, RANBAXY DELAY GENERI; *GREENE W, 2007, 200705A US INT TRAD; Hopkins-Tanne J, 2008, BRIT MED J, V336, P1266, DOI 10.1136/bmj.39601.618241.DB; Ricardo David, 1821, PRINCIPLES POLITICAL, V3rd; STAGNITTI MN, STAT BRIEF 205 TREND; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; Yusuf S, 2004, AM HEART J, V148, P1, DOI 10.1016/j.ahj.2004.03.045; ZAMISKA N, 2007, WALL STREET J   1009; ZHANG D, 2007, SOFTWOOD LUMBAR WAR; 2007, MED AD NEWS      SEP	12	0	0	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1453	1455		10.1001/jama.300.12.1453	http://dx.doi.org/10.1001/jama.300.12.1453			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812537				2022-12-28	WOS:000259410400024
J	Stern, DA; Morgan, WJ; Halonen, M; Wright, AL; Martinez, FD				Stern, Debra A.; Morgan, Wayne J.; Halonen, Marilyn; Wright, Anne L.; Martinez, Fernando D.			Wheezing and bronchial hyper-responsiveness in early childhood as predictors of newly diagnosed asthma in early adulthood: a longitudinal birth-cohort study	LANCET			English	Article							1ST 6 YEARS; RISK-FACTORS; FOLLOW-UP; POPULATION; ILLNESS; ALLERGEN; CHILDREN; RATIO; LIFE	Background Incidence of asthma increases during early adulthood. We aimed to estimate the contributions of sex and early life factors to asthma diagnosed in young adults. Methods 1246 healthy newborn babies were enrolled in the Tucson Children's Respiratory Study. Parental characteristics, early-life wheezing phenotypes, airway function, and bronchial hyper-responsiveness to cold dry air and sensitisation to Alternaria alternata were determined before age 6 years. Physician-diagnosed asthma, both chronic and newly diagnosed, and airway function were recorded at age 22 years. Findings Of 1246 babies enrolled, 849 had follow-up data at 22 years. Average incidence of asthma at age 16-22 years was 12.6 per thousand person-years. 49 (27%) of all 181 cases of active asthma at 22 years were newly diagnosed, of which 35 (71%) were women. Asthma remittance by 22 years was higher in men than in women (multinomial odds ratio [M-OR] 2.0, 95% CI 1.2-3.2, p=0 . 008). Age at diagnosis was linearly associated with the ratio of forced expiratory volume at 1 s to forced vital capacity at age 22 years. Factors independently associated with chronic asthma at 22 years included onset at 6 years (7.4, 3 . 9-14. 0) and persistent wheezing (14.0, 6.8-28 . 0) in early life, sensitisation to A alternata (3.6, 2.1-6.4), low airway function at age 6 years (2.1, 1.1-3.9.), and bronchial hyper-responsiveness at 6 years (4 . 5, 1.9-10 . 0). Bronchial hyper-responsiveness (6.9, 2.3-21 . 0), low airway function at 6 years (2.8, 1.1-6.9), and late-onset (4 . 6, 1.7-12 . 0) and persistent wheezing (4 . 0, 1.2-14. 0) predicted newly diagnosed asthma at age 22 years. Interpretation Asthma with onset in early adulthood has its origins in early childhood. Funding National Heart Lung and Blood Institute.	[Stern, Debra A.; Morgan, Wayne J.; Halonen, Marilyn; Wright, Anne L.; Martinez, Fernando D.] Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Morgan, Wayne J.; Wright, Anne L.] Univ Arizona, Dept Pediat, Tucson, AZ USA	University of Arizona; University of Arizona Health Sciences; University of Arizona	Martinez, FD (corresponding author), Univ Arizona, Hlth Sci Ctr, Arizona Resp Ctr, Tucson, AZ 85724 USA.	fernando@arc.arizona.edu		Halonen, Marilyn/0000-0001-9606-935X	National Heart Lung and Blood Institute [HL-56177]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056177] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by grant HL-56177 from the National Heart Lung and Blood Institute. We gratefully acknowledge the contributions of Lynn Taussig who started the Tucson Children's Respiratory Study in 1980 We thank Bruce Saul for data management and our study nurses, Marilyn Lindell and Lydia de la Ossa, for data collection and participant follow-LIP.	Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; ANDERSON HR, 1992, THORAX, V47, P537, DOI 10.1136/thx.47.7.537; Avila L, 2005, J ASTHMA, V42, P543, DOI 10.1080/02770900500214791; Chen Y, 2002, AM J EPIDEMIOL, V155, P191, DOI 10.1093/aje/155.3.191; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Halonen M, 1997, AM J RESP CRIT CARE, V155, P1356, DOI 10.1164/ajrccm.155.4.9105079; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; King ME, 2004, PANMINERVA MED, V46, P97; LARSSON L, 1995, THORAX, V50, P260, DOI 10.1136/thx.50.3.260; Lombardi E, 1997, AM J RESP CRIT CARE, V156, P1863, DOI 10.1164/ajrccm.156.6.9612066; Martinez FD, 2003, NEW ENGL J MED, V349, P1473, DOI 10.1056/NEJMe030041; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Moore YF, 2004, IMMUNOGENETICS, V56, P1, DOI 10.1007/s00251-004-0661-6; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Nicolai T, 2003, PEDIATR ALLERGY IMMU, V14, P280, DOI 10.1034/j.1399-3038.2003.00047.x; Ownby DR, 1996, ANN ALLERG ASTHMA IM, V77, P304, DOI 10.1016/S1081-1206(10)63325-X; PATTEMORE PK, 1990, AM REV RESPIR DIS, V142, P549, DOI 10.1164/ajrccm/142.3.549; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Rasmussen F, 2002, AM J RESP CRIT CARE, V165, P1480, DOI 10.1164/rccm.2108009; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Strachan DP, 1996, BRIT MED J, V312, P1195; TAUSSIG LM, 1989, AM J EPIDEMIOL, V129, P1219, DOI 10.1093/oxfordjournals.aje.a115242; TOELLE BG, 1992, AM REV RESPIR DIS, V146, P633, DOI 10.1164/ajrccm/146.3.633; WRIGHT AL, 1989, AM J EPIDEMIOL, V129, P1232, DOI 10.1093/oxfordjournals.aje.a115243; Wright AL, 2006, PEDIATR PULM, V41, P318, DOI 10.1002/ppul.20373; Xuan W, 2000, AM J RESP CRIT CARE, V161, P1820, DOI 10.1164/ajrccm.161.6.9809118	27	276	281	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1058	1064		10.1016/S0140-6736(08)61447-6	http://dx.doi.org/10.1016/S0140-6736(08)61447-6			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805334	Green Accepted			2022-12-28	WOS:000259648500032
J	Cao, HM; Gerhold, K; Mayers, JR; Wiest, MM; Watkins, SM; Hotamisligil, GS				Cao, Haiming; Gerhold, Kristin; Mayers, Jared R.; Wiest, Michelle M.; Watkins, Steven M.; Hotamisligil, Goekhan S.			Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism	CELL			English	Article							ACID-BINDING PROTEIN; STEAROYL-COA DESATURASE; FATTY-ACIDS; INSULIN-RESISTANCE; DIABETES-MELLITUS; KNOCKOUT MICE; OBESITY; EXPRESSION; LIVER; DIET	Dysregulation of lipid metabolism in individual tissues leads to systemic disruption of insulin action and glucose metabolism. Utilizing quantitative lipidomic analyses and mice deficient in adipose tissue lipid chaperones aP2 and mal1, we explored how metabolic alterations in adipose tissue are linked to whole-body metabolism through lipid signals. A robust increase in de novo lipogenesis rendered the adipose tissue of these mice resistant to the deleterious effects of dietary lipid exposure. Systemic lipid profiling also led to identification of C16:In7-palmitoleate as an adipose tissue-derived lipid hormone that strongly stimulates muscle insulin action and suppresses hepatosteatosis. Our data reveal a lipid-mediated endocrine network and demonstrate that adipose tissue uses lipokines such as C16: In7-palmitoleate to communicate with distant organs and regulate systemic metabolic homeostasis.	[Cao, Haiming; Gerhold, Kristin; Mayers, Jared R.; Hotamisligil, Goekhan S.] Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Wiest, Michelle M.; Watkins, Steven M.] Lip Technol, W Sacramento, CA 95691 USA	Harvard University; Harvard T.H. Chan School of Public Health	Hotamisligil, GS (corresponding author), Harvard Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Cao, Haiming/P-4634-2016	Mayers, Jared/0000-0002-8607-1787	National Institutes of Health (NIH) [DK064360, DK71507-04]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064360, P30DK040561, R01DK064360, R90DK071507] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Deniz Hotamisligil for artistic rendition and design input. We gratefully acknowledge the assistance of Harold Emsheimer and UyenThao Nguyen (Lipomics Technologies) for their help with composing the figures and performing statistic analyses, respectively. We are grateful to the members of the Hotamisligil Lab for their input and contributions, especially Masato Furuhashi for his help with the hyperinsulinemic-euglycemic clamp studies and Rebecca Foote for administrative support. This work was supported by a National Institutes of Health (NIH) grant DK064360 (to G. S. H.), and H. C. is supported by a NIH roadmap fellowship (DK71507-04) and the American Diabetes Association. M. M. W. and S. M. W. are employees of Lipomics Technologies (West Sacramento, CA). G. S. H. serves as a member of the scientific advisory board at Lipomics Technologies.	Avramoglu RK, 2006, CLIN CHIM ACTA, V368, P1, DOI 10.1016/j.cca.2005.12.026; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Cao H, 2006, DIABETES, V55, P1915, DOI 10.2337/db05-1496; Chu K, 2006, MOL CELL BIOL, V26, P6786, DOI 10.1128/MCB.00077-06; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; FIELD CJ, 1984, NUTR RES, V4, P743, DOI 10.1016/S0271-5317(84)80050-0; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Ginsberg HN, 2006, OBESITY, V14, p41S, DOI 10.1038/oby.2006.281; Heinemann FS, 2003, PROSTAG LEUKOTR ESS, V68, P123, DOI 10.1016/S0952-3278(02)00262-4; Hiraoka-Yamamoto J, 2004, CLIN EXP PHARMACOL P, V31, P107, DOI 10.1111/j.1440-1681.2004.04121.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kuriyama H, 2005, CELL METAB, V1, P41, DOI 10.1016/j.cmet.2004.11.004; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Moraes RC, 2003, ENDOCRINOLOGY, V144, P4773, DOI 10.1210/en.2003-0456; Nadler ST, 2000, P NATL ACAD SCI USA, V97, P11371, DOI 10.1073/pnas.97.21.11371; Newberry EP, 2006, HEPATOLOGY, V44, P1191, DOI 10.1002/hep.21369; Ntambi JM, 1999, J LIPID RES, V40, P1549; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; Paillard F, 2008, NUTR METAB CARDIOVAS, V18, P436, DOI 10.1016/j.numecd.2007.02.017; Stein DT, 1997, J CLIN INVEST, V100, P398, DOI 10.1172/JCI119546; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P6970, DOI 10.1073/pnas.0602178103; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Warensjo E, 2005, DIABETOLOGIA, V48, P1999, DOI 10.1007/s00125-005-1897-x; Waters KM, 1997, BBA-LIPID LIPID MET, V1349, P33, DOI 10.1016/S0005-2760(97)00069-6; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200	31	776	812	3	114	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					933	944		10.1016/j.cell.2008.07.048	http://dx.doi.org/10.1016/j.cell.2008.07.048			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805087	Bronze, Green Accepted			2022-12-28	WOS:000259318100014
J	Costello, C; Gaines, SD; Lynham, J				Costello, Christopher; Gaines, Steven D.; Lynham, John			Can catch shares prevent fisheries collapse?	SCIENCE			English	Article							BIODIVERSITY LOSS; PROPERTY; IMPACTS	Recent reports suggest that most of the world's commercial fisheries could collapse within decades. Although poor fisheries governance is often implicated, evaluation of solutions remains rare. Bioeconomic theory and case studies suggest that rights- based catch shares can provide individual incentives for sustainable harvest that is less prone to collapse. To test whether catch- share fishery reforms achieve these hypothetical benefits, we have compiled a global database of fisheries institutions and catch statistics in 11,135 fisheries from 1950 to 2003. Implementation of catch shares halts, and even reverses, the global trend toward widespread collapse. Institutional change has the potential for greatly altering the future of global fisheries.	[Costello, Christopher] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Gaines, Steven D.] Univ Calif Santa Barbara, Inst Marine Sci, Santa Barbara, CA 93106 USA; [Lynham, John] Univ Calif Santa Barbara, Dept Econ, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Costello, C (corresponding author), Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, 4410 Bren Hall, Santa Barbara, CA 93106 USA.	costello@bren.ucsb.edu	Gaines, Steven/Y-3234-2019	Lynham, John/0000-0002-5816-9648	Paul G. Allen Family Foundation; Sea Around Us Project	Paul G. Allen Family Foundation; Sea Around Us Project	We thank the Paul G. Allen Family Foundation for generous financial support; the Sea Around Us Project for making the catch data publicly available; C. Wong and T. Kidman for helping to compile the database; B. Hansen for helpful comments; and J. Prince, K. Bonzon, and J. Toth for assisting with verifying the catch-share database.	Beddington JR, 2007, SCIENCE, V316, P1713, DOI 10.1126/science.1137362; CLARK CW, 1973, J POLIT ECON, V81, P950, DOI 10.1086/260090; de Mutsert K, 2008, P NATL ACAD SCI USA, V105, P2740, DOI 10.1073/pnas.0704354105; Festa D, 2008, ISSUES SCI TECHNOL, V24, P75; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Grafton RQ, 2007, SCIENCE, V318, P1601, DOI 10.1126/science.1146017; Grafton RQ, 2000, J LAW ECON, V43, P679, DOI 10.1086/467469; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; Griffith DR, 2008, FRONT ECOL ENVIRON, V6, P191, DOI 10.1890/050060; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Holker F, 2007, SCIENCE, V316, P1285, DOI 10.1126/science.1139114; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Newell RG, 2005, J ENVIRON ECON MANAG, V49, P437, DOI 10.1016/j.jeem.2004.06.005; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sanchirico James N., 2007, International Journal of Global Environmental Issues, V7, P106, DOI 10.1504/IJGENVI.2007.013569; Scott A, 1955, J POLIT ECON, V63, P116, DOI 10.1086/257653; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294	19	570	575	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1678	1681		10.1126/science.1159478	http://dx.doi.org/10.1126/science.1159478			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801999				2022-12-28	WOS:000259300400036
J	Sawaya, MR; Wojtowicz, WM; Andre, I; Qian, B; Wu, W; Baker, D; Eisenberg, D; Zipursky, SL				Sawaya, Michael R.; Wojtowicz, Woj M.; Andre, Ingemar; Qian, Bin; Wu, Wei; Baker, David; Eisenberg, David; Zipursky, S. Lawrence			A double S shape provides the structural basis for the extraordinary binding specificity of Dscam isoforms	CELL			English	Article							MOLECULAR DIVERSITY; PROTEIN STRUCTURES; CRYSTAL-STRUCTURE; AXON GUIDANCE; DROSOPHILA DSCAM; SELF-AVOIDANCE; RECOGNITION; REFINEMENT; SOFTWARE; ADHESION	Drosophila Dscam encodes a vast family of immunoglobulin (Ig)-containing proteins that exhibit isoform-specific homophilic binding. This diversity is essential for cell recognition events required for wiring the brain. Each isoform binds to itself but rarely to other isoforms. Specificity is determined by "matching'' of three variable Ig domains within an similar to 220 kD ectodomain. Here, we present the structure of the homophilic binding region of Dscam, comprising the eight N-terminal Ig domains (Dscam(1-8)). Dscam(1-8) forms a symmetric homodimer of S-shaped molecules. This conformation, comprising two reverse turns, allows each pair of the three variable domains to "match'' in an antiparallel fashion. Structural, genetic, and biochemical studies demonstrate that, in addition to variable domain "matching,'' intramolecular interactions between constant domains promote homophilic binding. These studies provide insight into how "matching'' at all three pairs of variable domains in Dscam mediates isoform-specific recognition.	[Sawaya, Michael R.; Eisenberg, David] Univ Calif Los Angeles, DOE Inst Genom & Prote, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Wojtowicz, Woj M.; Wu, Wei; Zipursky, S. Lawrence] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Dept Biol Chem, Los Angeles, CA 90095 USA; [Andre, Ingemar; Qian, Bin; Baker, David] Univ Washington, Howard Hughes Med Inst, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; United States Department of Energy (DOE); University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Eisenberg, D (corresponding author), Univ Calif Los Angeles, DOE Inst Genom & Prote, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu; lzipursky@mednet.ucla.edu	André, Ingemar/O-4777-2014; Baker, David/K-8941-2012	André, Ingemar/0000-0002-4753-8233; Baker, David/0000-0001-7896-6217; Sawaya, Michael/0000-0003-0874-9043; Zipursky, Stephen/0000-0001-5630-7181	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007185] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [GM07185, T32 GM007185] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabiola F, 2002, PROTEIN SCI, V11, P1415, DOI 10.1110/ps.4890102; Freigang J, 2000, CELL, V101, P425, DOI 10.1016/S0092-8674(00)80852-1; Hattori D, 2007, NATURE, V449, P223, DOI 10.1038/nature06099; Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013; Hummel T, 2003, NEURON, V37, P221, DOI 10.1016/S0896-6273(02)01183-2; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meijers R, 2007, NATURE, V449, P487, DOI 10.1038/nature06147; Mortl M, 2007, PROTEIN SCI, V16, P2174, DOI 10.1110/ps.072802707; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmucker D, 2000, CELL, V101, P671, DOI 10.1016/S0092-8674(00)80878-8; Schmucker D, 2007, NAT REV NEUROSCI, V8, P915, DOI 10.1038/nrn2256; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029; Su XD, 1998, SCIENCE, V281, P991, DOI 10.1126/science.281.5379.991; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021; Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026; Zhan XL, 2004, NEURON, V43, P673, DOI 10.1016/j.neuron.2004.07.020	26	84	85	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					1007	1018		10.1016/j.cell.2008.07.042	http://dx.doi.org/10.1016/j.cell.2008.07.042			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805093	Green Accepted, Bronze			2022-12-28	WOS:000259318100020
J	McDonald, FS; West, CP; Popkave, C; Kolars, JC				McDonald, Furman S.; West, Colin P.; Popkave, Carol; Kolars, Joseph C.			Educational debt and reported career plans among internal medicine residents	ANNALS OF INTERNAL MEDICINE			English	Article							SPECIALTY CHOICES; STUDENTS; INDEBTEDNESS; PHYSICIANS; DECISIONS; IMPACT	Background: Physicians often enter the workplace with substantial debt. The relationship between debt and reported career plans among internal medicine residents is unknown. Objective: To determine distributions of educational debt among internal medicine residents and associations of debt with reported career plans. Design: Cross-sectional survey using data from the annual Internal Medicine In-Training Examination Residents Questionnaire completed by U. S. categorical internal medicine residents. Setting: Categorical internal medicine residencies in the United States. Participants: 22 563 residents in their third ( final) year of residency, representing 74.1% of all eligible U. S. categorical internal medicine residents from 2003 through 2007. Measurements: Distributions of educational debt were tabulated. Proportions of residents choosing career plans were calculated for various levels of debt. Results: International medical graduates represented 48.7% of the cross section and had considerably less debt than U. S. medical graduates: 53.8% of U. S. medical graduates had debt of $ 100 000 or greater and 60.2% of international medical graduates had none. U. S. medical graduates with debt of $ 100 000 to $ 150 000 were less likely than those with no debt to choose a subspecialty career 57.5% vs. 63.5%). U. S. medical graduates with debt of $ 50 000 to $ 99 999 were more likely than those with no debt to choose a hospitalist career (8.5% vs. 6.2%), and this preference increased with increasing debt level (10.0% for those with >$150 000 debt). These associations are more pronounced for U. S. medical graduates than for international medical graduates. Limitation: The study addressed total educational debt, but not when it was incurred, and did not allow inferences related to causality. Conclusion: Educational debt is associated with differences in reported career plans among internal medicine residents.	[Kolars, Joseph C.] Mayo Clin, Rochester, MN 55905 USA; Amer Coll Physicians, Philadelphia, PA USA	Mayo Clinic; American College of Physicians	Kolars, JC (corresponding author), Mayo Clin, 200 1st St SW, Rochester, MN 55905 USA.	kolars.joseph@mayo.edu		Kolars, Joseph/0000-0002-2603-188X				*ASS AM MED COLL, 2007, MED SCH GRAD QUEST A; Baker LC, 1997, ACAD MED, V72, P1088, DOI 10.1097/00001888-199712000-00021; BAZZOLI GJ, 1985, J HEALTH ECON, V4, P1, DOI 10.1016/0167-6296(85)90020-7; BLAND CJ, 1995, ACAD MED, V70, P620, DOI 10.1097/00001888-199507000-00013; Colquitt WL, 1996, ACAD MED, V71, P400, DOI 10.1097/00001888-199604000-00023; Cooter R, 1998, ACAD MED, V73, P71, DOI 10.1097/00001888-199801000-00015; DIAL TH, 1994, ACAD MED, V69, P470, DOI 10.1097/00001888-199406000-00009; Diehl AK, 2006, J GEN INTERN MED, V21, P1045, DOI 10.1111/j.1525-1497.2006.00556.x; Frank E, 1999, J GEN INTERN MED, V14, P347, DOI 10.1046/j.1525-1497.1999.00339.x; Garibaldi RA, 2005, ACAD MED, V80, P507, DOI 10.1097/00001888-200505000-00021; Grosso LJ, 2004, TEACH LEARN MED, V16, P7, DOI 10.1207/s15328015tlm1601_3; JOLLY P, 2004, MED SCH TUITION YOUN; KASSEBAUM DG, 1993, ACAD MED, V68, P934, DOI 10.1097/00001888-199312000-00019; KASSEBAUM DG, 1993, ACAD MED, V68, P506, DOI 10.1097/00001888-199306000-00013; KASSEBAUM DG, 1994, ACAD MED, V69, P164; Marci CD, 1998, JAMA-J AM MED ASSOC, V280, P1879; MCLAUGHLIN MA, 1991, ACAD MED, V66, pS43, DOI 10.1097/00001888-199109000-00036; *MED GROUP MAN ASS, 2007, AC PRACT COMP PROD S, P48; Nelson HD, 1998, J GEN INTERN MED, V13, P39, DOI 10.1046/j.1525-1497.1998.00006.x; Rosenblatt RA, 2005, ACAD MED, V80, P815, DOI 10.1097/00001888-200509000-00006; ROSENTHAL MP, 1994, JAMA-J AM MED ASSOC, V271, P914, DOI 10.1001/jama.271.12.914; SILLIMAN RA, 1987, J MED EDUC, V62, P463; SPAR IL, 1993, ACAD MED, V68, P570, DOI 10.1097/00001888-199307000-00017; Tonkin Paul, 2006, Minn Med, V89, P46; TUDOR C, 1988, J MED EDUC, V63, P271; West CP, 2006, ANN INTERN MED, V145, P774, DOI 10.7326/0003-4819-145-10-200611210-00010; WIDGE A, 2003, REPORT AM MED ASS ME; RESIDENT FELLOW WORK; 2007, INTERNAL MED IN TRAI	29	42	42	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					416	W78		10.7326/0003-4819-149-6-200809160-00008	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00008			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794561				2022-12-28	WOS:000259230200006
J	Li, N; DiCarlo, JJ				Li, Nuo; DiCarlo, James J.			Unsupervised natural experience rapidly alters invariant object representation in visual cortex	SCIENCE			English	Article							MONKEY INFEROTEMPORAL CORTEX; INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; EYE-MOVEMENTS; NEURONAL RESPONSES; SINGLE NEURONS; RECOGNITION; SELECTIVITY; ATTENTION; SYSTEM	Object recognition is challenging because each object produces myriad retinal images. Responses of neurons from the inferior temporal cortex ( IT) are selective to different objects, yet tolerant ("invariant") to changes in object position, scale, and pose. How does the brain construct this neuronal tolerance? We report a form of neuronal learning that suggests the underlying solution. Targeted alteration of the natural temporal contiguity of visual experience caused specific changes in IT position tolerance. This unsupervised temporal slowness learning (UTL) was substantial, increased with experience, and was significant in single IT neurons after just 1 hour. Together with previous theoretical work and human object perception experiments, we speculate that UTL may reflect the mechanism by which the visual stream builds and maintains tolerant object representations.	[Li, Nuo; DiCarlo, James J.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Li, Nuo; DiCarlo, James J.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	DiCarlo, JJ (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dicarlo@mit.edu			NIH [R01-EY014970]; The McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE [R01EY014970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The McKnight Endowment Fund for Neuroscience; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank D. Cox, R. Desimone, N. Kanwisher, J. Maunsell, and N. Rust for helpful comments and discussion, and J. Deutsch, B. Kennedy, M. Maloof, and R. Marini for technical support. This work was supported by the NIH (grant R01-EY014970) and The McKnight Endowment Fund for Neuroscience.	Baker CI, 2002, NAT NEUROSCI, V5, P1210, DOI 10.1038/nn960; Cox DD, 2005, NAT NEUROSCI, V8, P1145, DOI 10.1038/nn1519; DiCarlo JJ, 2000, NAT NEUROSCI, V3, P814, DOI 10.1038/77722; Dill M, 1998, PERCEPT PSYCHOPHYS, V60, P65, DOI 10.3758/BF03211918; Dill M, 2001, PERCEPTION, V30, P707, DOI 10.1068/p2953; Edelman S, 1997, NEURAL COMPUT, V9, P701, DOI 10.1162/neco.1997.9.4.701; Erickson CA, 1999, J NEUROSCI, V19, P10404; Foldiak P, 1991, NEURAL COMPUT, V3, P194, DOI 10.1162/neco.1991.3.2.194; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Kobatake E, 1998, J NEUROPHYSIOL, V80, P324, DOI 10.1152/jn.1998.80.1.324; Kourtzi Z, 2006, CURR OPIN NEUROBIOL, V16, P152, DOI 10.1016/j.conb.2006.03.012; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; MASQUELIER T, 2007, 269 CBCL MIT; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Maunsell JHR, 2002, PHILOS T ROY SOC B, V357, P1063, DOI 10.1098/rstb.2002.1107; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Moore T, 1998, P NATL ACAD SCI USA, V95, P8981, DOI 10.1073/pnas.95.15.8981; Moore T, 2001, P NATL ACAD SCI USA, V98, P1273, DOI 10.1073/pnas.021549498; NAZIR T A, 1990, Spatial Vision, V5, P81, DOI 10.1163/156856890X00011; Op De Beeck H, 2000, J COMP NEUROL, V426, P505, DOI 10.1002/1096-9861(20001030)426:4<505::AID-CNE1>3.0.CO;2-M; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; RINGO JL, 1994, J NEUROPHYSIOL, V71, P1285, DOI 10.1152/jn.1994.71.3.1285; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; Ross J, 2001, TRENDS NEUROSCI, V24, P113, DOI 10.1016/S0166-2236(00)01685-4; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Seitz A, 2005, TRENDS COGN SCI, V9, P329, DOI 10.1016/j.tics.2005.05.010; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sigala N, 2002, NATURE, V415, P318, DOI 10.1038/415318a; Sprekeler H, 2007, PLOS COMPUT BIOL, V3, P1136, DOI 10.1371/journal.pcbi.0030112; Tanaka K, 2003, CEREB CORTEX, V13, P90, DOI 10.1093/cercor/13.1.90; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; Wallis G, 1997, PROG NEUROBIOL, V51, P167, DOI 10.1016/S0301-0082(96)00054-8; Wallis G, 1999, TRENDS COGN SCI, V3, P22, DOI 10.1016/S1364-6613(98)01261-3; Wallis G, 2001, P NATL ACAD SCI USA, V98, P4800, DOI 10.1073/pnas.071028598; Wiskott L, 2002, NEURAL COMPUT, V14, P715, DOI 10.1162/089976602317318938; Wyss R, 2006, PLOS BIOL, V4, P836, DOI 10.1371/journal.pbio.0040120; Yang TM, 2004, J NEUROSCI, V24, P1617, DOI 10.1523/JNEUROSCI.4442-03.2004	46	172	175	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1502	1507		10.1126/science.1160028	http://dx.doi.org/10.1126/science.1160028			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787171	Green Accepted			2022-12-28	WOS:000259121800045
J	Crutcher, RA; Shannon, SE; Clayton, J; Duop, DMT				Crutcher, Rodney A.; Shannon, Scott E.; Clayton, John; Duop, Daniel Madit Than			Sudanese physicians' reintegration programme	LANCET			English	Editorial Material							HEALTH		[Crutcher, Rodney A.] Univ Calgary, Hlth Sci Ctr, Calgary, AB T2N 4N1, Canada; [Clayton, John] Samaritans Purse Canada, Calgary, AB, Canada	University of Calgary; University of Manitoba; Children's Hospital Research Institute of Manitoba	Crutcher, RA (corresponding author), Univ Calgary, Hlth Sci Ctr, Calgary, AB T2N 4N1, Canada.	crutcher@ucalgary.ca						Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chen LC, 2005, NEW ENGL J MED, V353, P1850, DOI 10.1056/NEJMe058188; Connell J, 2007, SOC SCI MED, V64, P1876, DOI 10.1016/j.socscimed.2006.12.013; EVANS R, 2008, MEET F CASTRO PHYS P; Gleijeses Piero, 2002, CONFLICTING MISSIONS; LOMORO O, 2007, SUD CONS M 2 KART MA; Martineau T, 2004, HEALTH POLICY, V70, P1, DOI 10.1016/j.healthpol.2004.01.006; Mullan F, 2005, NEW ENGL J MED, V353, P1810, DOI 10.1056/NEJMsa050004; SIXTO FE, 2002, P 12 ANN M ASS STUD, V12, P325; Spiegel JM, 2004, J PUBLIC HEALTH POL, V25, P85, DOI 10.1057/palgrave.jphp.3190007	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					788	789		10.1016/S0140-6736(08)61319-7	http://dx.doi.org/10.1016/S0140-6736(08)61319-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774407				2022-12-28	WOS:000259124900009
J	Otis, L				Otis, Laura			The art of medicine - Going with your gut: some thoughts on language and the body	LANCET			English	Editorial Material									[Otis, Laura] Emory Univ, Dept English, Atlanta, GA 30322 USA	Emory University	Otis, L (corresponding author), Emory Univ, Dept English, N 302 Callaway Ctr, Atlanta, GA 30322 USA.	lotis@emory.edu						Lakof G., 1980, METAPHORS WE LIVE; Lakoff George., 1999, PHILOS FLESH EMBODIE; Pinker Steven, 1994, LANGUAGE INSTINCT; Shaw George Bernard, 2000, PYGMALION; WHORF Benjamin Lee, 1956, LANGUAGE THOUGHT REA	5	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					798	799		10.1016/S0140-6736(08)61327-6	http://dx.doi.org/10.1016/S0140-6736(08)61327-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	347FB	18782925	Bronze			2022-12-28	WOS:000259124900013
J	Castilla, J; Gonzalez-Romero, D; Saa, P; Morales, R; De Castro, J; Soto, C				Castilla, Joaquin; Gonzalez-Romero, Dennisse; Saa, Paula; Morales, Rodrigo; De Castro, Jorge; Soto, Claudio			Crossing the species barrier by PrPSc replication in vitro generates unique infectious Prions	CELL			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; CREUTZFELDT-JAKOB-DISEASE; CYCLIC AMPLIFICATION; MOLECULAR-BASIS; PROTEIN; SCRAPIE; TRANSMISSION; PATHOGENESIS; ADAPTATION; STRAINS	Prions are unconventional infectious agents composed exclusively of misfolded prion protein (PrPSc), which transmits the disease by propagating its abnormal conformation to the cellular prion protein (PrPC). A key characteristic of prions is their species barrier, by which prions from one species can only infect a limited number of other species. Here, we report the generation of infectious prions by interspecies transmission of PrPSc misfolding by in vitro PMCA amplification. Hamster PrPC misfolded by mixing with mouse PrPSc generated unique prions that were infectious to wild-type hamsters, and similar results were obtained in the opposite direction. Successive rounds of PMCA amplification result in adaptation of the in vitro-produced prions, in a process reminiscent of strain stabilization observed upon serial passage in vivo. Our results indicate that PMCA is a valuable tool for the investigation of cross-species transmission and suggest that species barrier and strain generation are determined by the propagation of PrP misfolding.	[Castilla, Joaquin; Gonzalez-Romero, Dennisse; Saa, Paula; Morales, Rodrigo; De Castro, Jorge; Soto, Claudio] Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA; [Saa, Paula] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain; [Morales, Rodrigo] Univ Chile, Santiago, Chile	University of Texas System; University of Texas Medical Branch Galveston; Autonomous University of Madrid; Universidad de Chile	Soto, C (corresponding author), Univ Texas Med Branch, Dept Neurol, Galveston, TX 77555 USA.	clsoto@utmb.edu	Saa, Paula/AAB-6607-2019; Castilla, Joaquin/D-5261-2011; Castilla, Joaquín/J-8414-2019; Morales, Rodrigo/K-7173-2015	Saa, Paula/0000-0001-6077-4532; Castilla, Joaquin/0000-0002-2216-1361; Castilla, Joaquín/0000-0002-2216-1361; 	National Institutes of Health [R01NS049173, P01AI77774]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI077774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG014359] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by National Institutes of Health grants R01NS049173 and P01AI77774 to C. S. C. S. is a founder of Amprion, Inc., a company focused on the development of a diagnosis for prion diseases through the use of the PMCA technology.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Brachmann A, 2005, EMBO J, V24, P3082, DOI 10.1038/sj.emboj.7600772; Bruce ME, 2003, BRIT MED BULL, V66, P99, DOI 10.1093/bmb/66.1.99; Buschmann A, 2005, BERL MUNCH TIERARZTL, V118, P365; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2006, METHOD ENZYMOL, V412, P3, DOI 10.1016/s0076-6879(06)12001-7; Chen SG, 2000, ARCH VIROL, P209; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Doherr MG, 2003, ACTA VET SCAND, P33; FOSTER JD, 1993, VET REC, V133, P339, DOI 10.1136/vr.133.14.339; Hill Andrew F., 2004, V11, P33; Hunter N, 2003, BRIT MED BULL, V66, P171, DOI 10.1093/bmb/66.1.171; Hunter N, 1998, MOL BIOTECHNOL, V9, P225, DOI 10.1007/BF02915795; Jones M, 2007, J PATHOL, V213, P21, DOI 10.1002/path.2204; KIMBERLIN RH, 1988, CIBA F SYMP, V135, P37; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; King CY, 2004, NATURE, V428, P319, DOI 10.1038/nature02391; Kurt TD, 2007, J VIROL, V81, P9605, DOI 10.1128/JVI.00635-07; Lund C, 2007, J NEUROSCI METH, V165, P183, DOI 10.1016/j.jneumeth.2007.06.005; Moore RA, 2005, ARCH VIROL, P187; Morales R, 2007, BBA-MOL BASIS DIS, V1772, P681, DOI 10.1016/j.bbadis.2006.12.006; Murayama Y, 2007, NEUROSCI LETT, V413, P270, DOI 10.1016/j.neulet.2006.11.056; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 2002, J INFECT DIS, V186, pS166, DOI 10.1086/344267; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Saa Paula, 2004, V299, P53; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Sarafoff NN, 2005, J BIOCHEM BIOPH METH, V63, P213, DOI 10.1016/j.jbbm.2005.05.004; Sigurdson CJ, 2007, BBA-MOL BASIS DIS, V1772, P610, DOI 10.1016/j.bbadis.2006.10.010; Soto C, 2005, FEBS LETT, V579, P638, DOI 10.1016/j.febslet.2004.12.035; Soto C, 2004, NAT MED, V10, pS63, DOI 10.1038/nm1069; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tanaka M, 2005, CELL, V121, P49, DOI 10.1016/j.cell.2005.03.008; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Weber P, 2007, VET MICROBIOL, V123, P346, DOI 10.1016/j.vetmic.2007.04.004; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Will RG, 1996, LANCET, V347, P921, DOI 10.1016/S0140-6736(96)91412-9; Williams ES, 2005, VET PATHOL, V42, P530, DOI 10.1354/vp.42-5-530; Xie ZL, 2006, J BIOL CHEM, V281, P4199, DOI 10.1074/jbc.M509052200	44	143	145	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					757	768		10.1016/j.cell.2008.07.030	http://dx.doi.org/10.1016/j.cell.2008.07.030			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775309	Bronze, Green Accepted			2022-12-28	WOS:000258947500016
J	Li, H; Wang, JL; Mor, G; Sklar, J				Li, Hui; Wang, Jinglan; Mor, Gil; Sklar, Jeffrey			A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells	SCIENCE			English	Article							PRE-MESSENGER-RNAS; ACUTE LEUKEMIAS; TRANSCRIPTION; TRANSLOCATIONS; SEQUENCE; CANCER; TESTIS	Chromosomal rearrangements that create gene fusions are common features of human tumors. The prevailing view is that the resultant chimeric transcripts and proteins are abnormal, tumor- specific products that provide tumor cells with a growth and/ or survival advantage. We show that normal endometrial stromal cells contain a specific chimeric RNA joining 5' exons of the JAZF1 gene on chromosome 7p15 to 3' exons of the Polycomb group gene JJAZ1/SUZ12 on chromosome 17q11 and that this RNA is translated into JAZF1-JJAZ1, a protein with anti- apoptotic activity. The JAZF1-JJAZ1 RNA appears to arise from physiologically regulated trans- splicing between precursor messenger RNAs for JAZF1 and JJAZ1. The chimeric RNA and protein are identical to those produced from a gene fusion found in human endometrial stromal tumors. These observations suggest that certain gene fusions may be pro- neoplastic owing to constitutive expression of chimeric gene products normally generated by trans- splicing of RNAs in developing tissues.	[Li, Hui; Wang, Jinglan; Sklar, Jeffrey] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06520 USA; [Mor, Gil] Yale Univ, Sch Med, Dept Obstet & Gynecol, New Haven, CT 06520 USA	Yale University; Yale University	Sklar, J (corresponding author), Yale Univ, Sch Med, Dept Pathol, 333 Cedar St, New Haven, CT 06520 USA.	jeffrey.sklar@yale.edu			National Cancer Institute [R01 CA85995]; NATIONAL CANCER INSTITUTE [R01CA085995] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the National Cancer Institute (grant R01 CA85995) and a generous gift from the Burnstein-Turnbull family. We thank M. Martel for assistance in the histologic evaluation of tissue samples; R. Means for providing the rhesus fibroblast cell line RF; P. Li for cytogenetic analysis; V. Patriub for technical assistance; and H. Taylor, J. Steitz, D. Mishler, E. Ullu, and A. Krensky for helpful discussion.	AGABIAN N, 1990, CELL, V61, P1157, DOI 10.1016/0092-8674(90)90674-4; Akopian AN, 1999, FEBS LETT, V445, P177, DOI 10.1016/S0014-5793(99)00126-X; BERNARD O, 1991, ONCOGENE, V6, P1477; BONEN L, 1993, FASEB J, V7, P40, DOI 10.1096/fasebj.7.1.8422973; Caudevilla C, 1998, P NATL ACAD SCI USA, V95, P12185, DOI 10.1073/pnas.95.21.12185; Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997; Finta C, 2002, J BIOL CHEM, V277, P5882, DOI 10.1074/jbc.M109175200; Fitzgerald C, 2006, J BIOL CHEM, V281, P38172, DOI 10.1074/jbc.M606010200; Flouriot G, 2002, J BIOL CHEM, V277, P26244, DOI 10.1074/jbc.M203513200; Frantz SA, 1999, P NATL ACAD SCI USA, V96, P5400, DOI 10.1073/pnas.96.10.5400; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Janz S, 2003, GENE CHROMOSOME CANC, V36, P211, DOI 10.1002/gcc.10178; Jehan Z, 2007, GENOME RES, V17, P433, DOI 10.1101/gr.5155706; Koontz JI, 2001, P NATL ACAD SCI USA, V98, P6348, DOI 10.1073/pnas.101132598; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; KRAUSE M, 1987, CELL, V49, P753, DOI 10.1016/0092-8674(87)90613-1; Krikun G, 2004, ENDOCRINOLOGY, V145, P2291, DOI 10.1210/en.2003-1606; Li H, 2007, P NATL ACAD SCI USA, V104, P20001, DOI 10.1073/pnas.0709986104; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Maniatis T, 2002, NATURE, V418, P236, DOI 10.1038/418236a; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Pardanani A, 2003, BLOOD, V102, P3093, DOI 10.1182/blood-2003-05-1627; PIEROTTI MA, 1992, P NATL ACAD SCI USA, V89, P1616, DOI 10.1073/pnas.89.5.1616; SUTTON RE, 1986, CELL, V47, P527, DOI 10.1016/0092-8674(86)90617-3; Takahara T, 2000, J BIOL CHEM, V275, P38067, DOI 10.1074/jbc.M002010200; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Zhang C, 2003, DNA CELL BIOL, V22, P303, DOI 10.1089/104454903322216653	27	206	221	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1357	1361		10.1126/science.1156725	http://dx.doi.org/10.1126/science.1156725			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772439				2022-12-28	WOS:000258914300051
J	Roguev, A; Bandyopadhyay, S; Zofall, M; Zhang, K; Fischer, T; Collins, SR; Qu, HJ; Shales, M; Park, HO; Hayles, J; Hoe, KL; Kim, DU; Ideker, T; Grewal, SI; Weissman, JS; Krogan, NJ				Roguev, Assen; Bandyopadhyay, Sourav; Zofall, Martin; Zhang, Ke; Fischer, Tamas; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Park, Han-Oh; Hayles, Jacqueline; Hoe, Kwang-Lae; Kim, Dong-Uk; Ideker, Trey; Grewal, Shiv I.; Weissman, Jonathan S.; Krogan, Nevan J.			Conservation and rewiring of functional modules revealed by an epistasis map in fission yeast	SCIENCE			English	Article							POLYMERASE-II HOLOENZYME; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; HISTONE-3 LYSINE-4; PROTEIN COMPLEXES; GENE-EXPRESSION; DNA-DAMAGE; CHECKPOINT; TRANSCRIPTION; ORGANIZATION	An epistasis map (E-MAP) was constructed in the fission yeast, Schizosaccharomyces pombe, by systematically measuring the phenotypes associated with pairs of mutations. This high-density, quantitative genetic interaction map focused on various aspects of chromosome function, including transcription regulation and DNA repair/replication. The E-MAP uncovered a previously unidentified component of the RNA interference (RNAi) machinery (rsh1) and linked the RNAi pathway to several other biological processes. Comparison of the S. pombe E-MAP to an analogous genetic map from the budding yeast revealed that, whereas negative interactions were conserved between genes involved in similar biological processes, positive interactions and overall genetic profiles between pairs of genes coding for physically associated proteins were even more conserved. Hence, conservation occurs at the level of the functional module (protein complex), but the genetic cross talk between modules can differ substantially.	[Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Program Bioinformat, La Jolla, CA 92093 USA; [Zofall, Martin; Zhang, Ke; Fischer, Tamas; Grewal, Shiv I.] NCI, Biochem & Mol Biol Lab, Canc Res Ctr, NIH, Bethesda, MD 20892 USA; [Collins, Sean R.; Weissman, Jonathan S.] Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Park, Han-Oh] Bioneer Corp, Taejon, South Korea; [Hayles, Jacqueline] London Res Inst, Canc Res UK, Cell Cycle Lab, London WC2A 3PX, England; [Hoe, Kwang-Lae; Kim, Dong-Uk] Korea Res Inst Biosci & Biotechnol, Genom Res Ctr, Taejon, South Korea; [Roguev, Assen; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Roguev, Assen; Collins, Sean R.; Qu, Hongjing; Shales, Michael; Weissman, Jonathan S.; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Howard Hughes Medical Institute; Cancer Research UK; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ideker, T (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	trey@bioeng.ucsd.edu; grewals@mail.nih.gov; weissman@cmp.ucsf.edu; krogan@cmpmail.ucsf.edu	Fischer, Tamas/A-7729-2016	Fischer, Tamas/0000-0002-7996-4042; Collins, Sean/0000-0002-4276-5840; Weissman, Jonathan/0000-0003-2445-670X; Ideker, Trey/0000-0002-1708-8454; Hoe, Kwang Lae/0000-0002-3943-4549	NIH [GM084279]; Sandler Family Foundation; Howard Hughes Medical Institute; National Cancer Institute; Center for Cancer Research; California Institute of Quantitative Biology; NATIONAL CANCER INSTITUTE [ZIABC010523, ZIABC011208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084279] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Institute of Quantitative Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Beltrao and G. Cagney for critical reading of the manuscript; M. Wiren and S. Forsburg for discussion; P. Kemmeren for setting up the web database; S. Wang, C. Wen, and D. Avdic for technical help; and F. Stewart for sharing unpublished data. This work was supported by NIH [National Institute of General Medical Sciences grant GM084279 (T.I. and N.J.K.)], the Sandler Family Foundation (N. J. K), the Howard Hughes Medical Institute (J.S.W.), National Cancer Institute (S.I.G.), Center for Cancer Research (S.I.G.), and the California Institute of Quantitative Biology (N.J.K.).	Ahmed S, 2007, GENETICS, V177, P1487, DOI 10.1534/genetics.107.078691; Asakawa K, 2006, MOL BIOL CELL, V17, P1421, DOI 10.1091/mbc.e05-08-0802; Bandyopadhyay S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000065; Cam HP, 2008, NATURE, V451, P431, DOI 10.1038/nature06499; Collins SR, 2007, NATURE, V446, P806, DOI 10.1038/nature05649; Collins SR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r63; Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4; Dul BE, 2007, J BIOL CHEM, V282, P18397, DOI 10.1074/jbc.M700729200; Gardiner J, 2007, TRAFFIC, V8, P1145, DOI 10.1111/j.1600-0854.2007.00605.x; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Ghavidel A, 2007, CELL, V131, P915, DOI 10.1016/j.cell.2007.09.042; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hansen KR, 2005, MOL CELL BIOL, V25, P590, DOI 10.1128/MCB.25.2.590-601.2005; Kaur R, 2001, MOL BIOL CELL, V12, P3744, DOI 10.1091/mbc.12.12.3744; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Majka J, 2003, P NATL ACAD SCI USA, V100, P2249, DOI 10.1073/pnas.0437148100; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Nagy PL, 2002, P NATL ACAD SCI USA, V99, P90, DOI 10.1073/pnas.221596698; Otero G, 1999, MOL CELL, V3, P109, DOI 10.1016/S1097-2765(00)80179-3; Pan XW, 2007, METHODS, V41, P206, DOI 10.1016/j.ymeth.2006.07.033; Penkett CJ, 2006, NUCLEIC ACIDS RES, V34, pW330, DOI 10.1093/nar/gkl311; Roguev A, 2004, MOL CELL PROTEOMICS, V3, P125, DOI 10.1074/mcp.M300081-MCP200; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Sakurai H, 1998, GENE, V221, P11, DOI 10.1016/S0378-1119(98)00449-1; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Sipiczki M, 2000, GENOME BIOL, V1, DOI DOI 10.1186/GB-2000-1-2-REVIEWS1011; Spahr H, 2000, J BIOL CHEM, V275, P1351, DOI 10.1074/jbc.275.2.1351; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Tischler J, 2008, NAT GENET, V40, P390, DOI 10.1038/ng.114; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Zofall M, 2006, MOL CELL, V22, P681, DOI 10.1016/j.molcel.2006.05.010	39	262	264	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					405	410		10.1126/science.1162609	http://dx.doi.org/10.1126/science.1162609			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18818364	Green Accepted			2022-12-28	WOS:000260094500037
J	Dong, XP; Cheng, XP; Mills, E; Delling, M; Wang, FD; Kurz, T; Xu, HX				Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Delling, Markus; Wang, Fudi; Kurz, Tino; Xu, Haoxing			The type IV mucolipidosis-associated protein TRPML1 is an endolysosomal iron release channel	NATURE			English	Article							RECEPTOR POTENTIAL CHANNEL; MEMBRANE-PROTEIN; MUTATIONS; METABOLISM; PATHWAY; DISEASE; MICE; SKIN	TRPML1 ( mucolipin 1, also known as MCOLN1) is predicted to be an intracellular late endosomal and lysosomal ion channel protein that belongs to the mucolipin subfamily of transient receptor potential ( TRP) proteins(1-3). Mutations in the human TRPML1 gene cause mucolipidosis type IV disease ( ML4)4,5.ML4 patients have motor impairment, mental retardation, retinal degeneration and iron- deficiency anaemia. Because aberrant iron metabolism may cause neural and retinal degeneration(6,7), it may be a primary cause of ML4 phenotypes. In most mammalian cells, release of iron from endosomes and lysosomes after iron uptake by endocytosis of Fe(3+)- bound transferrin receptors(6), or after lysosomal degradation of ferritin - iron complexes and autophagic ingestion of iron-containing macromolecules(6,8), is the chief source of cellular iron. The divalent metal transporter protein DMT1 ( also known as SLC11A2) is the only endosomal Fe(2+) transporter known at present and it is highly expressed in erythroid precursors(6,9). Genetic studies, however, suggest the existence of a DMT1-independent endosomal and lysosomal Fe(2+) transport protein(9). By measuring radiolabelled iron uptake, by monitoring the levels of cytosolic and intralysosomal iron and by directly patch- clamping the late endosomal and lysosomal membrane, here we show that TRPML1 functions as a Fe(2+) permeable channel in late endosomes and lysosomes. ML4 mutations are shown to impair the ability of TRPML1 to permeate Fe(2+) at varying degrees, which correlate well with the disease severity. A comparison of TRPML1(-/-) ML4 and control human skin fibroblasts showed a reduction in cytosolic Fe(2+) levels, an increase in intralysosomal Fe(2+) levels and an accumulation of lipofuscin- like molecules in TRPML1(-/-) cells. We propose that TRPML1 mediates a mechanism by which Fe(2+) is released from late endosomes and lysosomes. Our results indicate that impaired iron transportmay contribute to both haematological and degenerative symptoms of ML4 patients.	[Dong, Xian-Ping; Cheng, Xiping; Mills, Eric; Xu, Haoxing] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Delling, Markus] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA; [Wang, Fudi] Chinese Acad Sci, Inst Nutr Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Kurz, Tino] Linkoping Univ, Dept Pharmacol, Fac Hlth Sci, S-58185 Linkoping, Sweden	University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Linkoping University	Xu, HX (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 3089 Nat Sci Bldg Kraus,830 N Univ, Ann Arbor, MI 48109 USA.	haoxingx@umich.edu	Wang, Fudi/L-7888-2018; xu, hao/GWQ-7394-2022	Wang, Fudi/0000-0001-8730-0003; Dong, Xianping/0000-0002-4496-7104	Department of Molecular, Cellular; Developmental Biology and Biological Science Scholar Program; University of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572] Funding Source: NIH RePORTER	Department of Molecular, Cellular; Developmental Biology and Biological Science Scholar Program; University of Michigan(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported by start-up funds to H. X. from the Department of Molecular, Cellular, and Developmental Biology and Biological Science Scholar Program, University of Michigan. We thank U. Brunk, M. Saito, R. Hume, C. Duan, M. Akaaboune, J. Kuwada, S. Low, S. Punthambaker and S. Dellal for assistance, and D. Clapham, N. Andrews, L. DeFelice, L. Yue, D. Ren, C. Jiang and S. Xu for comments on an earlier version of the manuscript. We also thank K. Kiselyov for sharing his unpublished results on lysosomal iron staining of ML4 cells. We appreciate the encouragement and helpful comments from other members of the Xu laboratory.	Altarescu G, 2002, NEUROLOGY, V59, P306, DOI 10.1212/WNL.59.3.306; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Bargal R, 2002, NEUROPEDIATRICS, V33, P199, DOI 10.1055/s-2002-34496; Bassi MT, 2000, AM J HUM GENET, V67, P1110, DOI 10.1016/S0002-9297(07)62941-3; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chen CS, 1998, P NATL ACAD SCI USA, V95, P6373, DOI 10.1073/pnas.95.11.6373; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; GOLDIN E, 1995, PEDIATR RES, V37, P687, DOI 10.1203/00006450-199506000-00003; Goldin E, 2004, HUM MUTAT, V24, P460, DOI 10.1002/humu.20094; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Kress GJ, 2002, J NEUROSCI, V22, P5848; Kurz T, 2008, HISTOCHEM CELL BIOL, V129, P389, DOI 10.1007/s00418-008-0394-y; Lee DW, 2006, MOL INTERV, V6, P89, DOI 10.1124/mi.6.2.6; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Petrat F, 2000, ARCH BIOCHEM BIOPHYS, V376, P74, DOI 10.1006/abbi.2000.1711; Pryor PR, 2006, TRAFFIC, V7, P1388, DOI 10.1111/j.1600-0854.2006.00475.x; Saito M, 2007, J BIOL CHEM, V282, P27327, DOI 10.1074/jbc.M702557200; Sun M, 2000, HUM MOL GENET, V9, P2471, DOI 10.1093/hmg/9.17.2471; Venkatachalam K, 2006, J BIOL CHEM, V281, P17517, DOI 10.1074/jbc.M600807200; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Xu HX, 2004, PLOS BIOL, V2, P378, DOI 10.1371/journal.pbio.0020050; Zeevi DA, 2007, BBA-MOL BASIS DIS, V1772, P851, DOI 10.1016/j.bbadis.2007.01.004	25	374	382	2	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 16	2008	455	7215					992	U78		10.1038/nature07311	http://dx.doi.org/10.1038/nature07311			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18794901	Green Accepted, Green Published			2022-12-28	WOS:000260038300056
J	Mefford, HC; Sharp, AJ; Baker, C; Itsara, A; Jiang, ZS; Buysse, K; Huang, SW; Maloney, VK; Crolla, JA; Baralle, D; Collins, A; Mercer, C; Norga, K; de Ravel, T; Devriendt, K; Bongers, EMHF; de Leeuw, N; Reardon, W; Gimelli, S; Bena, F; Hennekam, RC; Male, A; Gaunt, L; Clayton-Smith, J; Simonic, I; Park, SM; Mehta, SG; Nik-Zainal, S; Woods, CG; Firth, HV; Parkin, G; Fichera, M; Reitano, S; Lo Giudice, M; Li, KE; Casuga, I; Broomer, A; Conrad, B; Schwerzmann, M; Raber, L; Gallati, S; Striano, P; Coppola, A; Tolmie, JL; Tobias, ES; Lilley, C; Armengol, L; Spysschaert, Y; Verloo, P; De Coene, A; Goossens, L; Mortier, G; Speleman, F; van Binsbergen, E; Nelen, MR; Hochstenbach, R; Poot, M; Gallagher, L; Gill, M; McClellan, J; King, MC; Regan, R; Skinner, C; Stevenson, RE; Antonarakis, SE; Chen, CF; Estivill, X; Menten, B; Gimelli, G; Gribble, S; Schwartz, S; Sutcliffe, JS; Walsh, T; Knight, SJL; Sebat, J; Romano, C; Schwartz, CE; Veltman, JA; de Vries, BBA; Vermeesch, JR; Barber, JCK; Willatt, L; Tassabehji, M; Eichler, EE				Mefford, Heather C.; Sharp, Andrew J.; Baker, Carl; Itsara, Andy; Jiang, Zhaoshi; Buysse, Karen; Huang, Shuwen; Maloney, Viv K.; Crolla, John A.; Baralle, Diana; Collins, Amanda; Mercer, Catherine; Norga, Koen; de Ravel, Thomy; Devriendt, Koen; Bongers, Ernie M. H. F.; de Leeuw, Nicole; Reardon, William; Gimelli, Stefania; Bena, Frederique; Hennekam, Raoul C.; Male, Alison; Gaunt, Lorraine; Clayton-Smith, Jill; Simonic, Ingrid; Park, Soo Mi; Mehta, Sarju G.; Nik-Zainal, Serena; Woods, C. Geoffrey; Firth, Helen V.; Parkin, Georgina; Fichera, Marco; Reitano, Santina; Lo Giudice, Mariangela; Li, Kelly E.; Casuga, Iris; Broomer, Adam; Conrad, Bernard; Schwerzmann, Markus; Raber, Lorenz; Gallati, Sabina; Striano, Pasquale; Coppola, Antonietta; Tolmie, John L.; Tobias, Edward S.; Lilley, Chris; Armengol, Lluis; Spysschaert, Yves; Verloo, Patrick; De Coene, Anja; Goossens, Linde; Mortier, Geert; Speleman, Frank; van Binsbergen, Ellen; Nelen, Marcel R.; Hochstenbach, Ron; Poot, Martin; Gallagher, Louise; Gill, Michael; McClellan, Jon; King, Mary-Claire; Regan, Regina; Skinner, Cindy; Stevenson, Roger E.; Antonarakis, Stylianos E.; Chen, Caifu; Estivill, Xavier; Menten, Bjorn; Gimelli, Giorgio; Gribble, Susan; Schwartz, Stuart; Sutcliffe, James S.; Walsh, Tom; Knight, Samantha J. L.; Sebat, Jonathan; Romano, Corrado; Schwartz, Charles E.; Veltman, Joris A.; de Vries, Bert B. A.; Vermeesch, Joris R.; Barber, John C. K.; Willatt, Lionel; Tassabehji, May; Eichler, Evan E.			Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COPY-NUMBER VARIATION; ARRAY-CGH; SEGMENTAL DUPLICATIONS; MENTAL-RETARDATION; MICRODELETION; DELETION; POLYMORPHISM; MUTATION; WIDE; HYBRIDIZATION	Background: Duplications and deletions in the human genome can cause disease or predispose persons to disease. Advances in technologies to detect these changes allow for the routine identification of submicroscopic imbalances in large numbers of patients. Methods: We tested for the presence of microdeletions and microduplications at a specific region of chromosome 1q21.1 in two groups of patients with unexplained mental retardation, autism, or congenital anomalies and in unaffected persons. Results: We identified 25 persons with a recurrent 1.35-Mb deletion within 1q21.1 from screening 5218 patients. The microdeletions had arisen de novo in eight patients, were inherited from a mildly affected parent in three patients, were inherited from an apparently unaffected parent in six patients, and were of unknown inheritance in eight patients. The deletion was absent in a series of 4737 control persons (P=1.1 x 10(-7))). We found considerable variability in the level of phenotypic expression of the microdeletion; phenotypes included mild-to-moderate mental retardation, microcephaly, cardiac abnormalities, and cataracts. The reciprocal duplication was enriched in nine children with mental retardation or autism spectrum disorder and other variable features (P=0.02). We identified three deletions and three duplications of the 1q21.1 region in an independent sample of 788 patients with mental retardation and congenital anomalies. Conclusions: We have identified recurrent molecular lesions that elude syndromic classification and whose disease manifestations must be considered in a broader context of development as opposed to being assigned to a specific disease. Clinical diagnosis in patients with these lesions may be most readily achieved on the basis of genotype rather than phenotype.	[Mefford, Heather C.; Baker, Carl; Itsara, Andy; Jiang, Zhaoshi; McClellan, Jon; King, Mary-Claire; Walsh, Tom; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Sch Med, Seattle, WA 98195 USA; [Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Sharp, Andrew J.; Antonarakis, Stylianos E.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gimelli, Stefania] Univ Hosp Geneva, CH-1211 Geneva, Switzerland; [Buysse, Karen; Mortier, Geert; Speleman, Frank; Menten, Bjorn] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Spysschaert, Yves; Verloo, Patrick; De Coene, Anja; Goossens, Linde] Ghent Univ Hosp, Div Pediat Neurol & Metab, B-9000 Ghent, Belgium; [Huang, Shuwen; Crolla, John A.; Barber, John C. K.] Salisbury Natl Hlth Serv NHS Fdn Trust, Natl Genet Reference Lab, Salisbury, Wilts, England; [Maloney, Viv K.; Crolla, John A.; Barber, John C. K.] Salisbury Natl Hlth Serv NHS Fdn Trust, Wessex Reg Genet Lab, Salisbury, Wilts, England; [Baralle, Diana; Collins, Amanda; Mercer, Catherine] Southampton Univ Hosp Trust, Wessex Clin Genet Serv, Southampton, Hants, England; [Hennekam, Raoul C.] UCL, London, England; [Male, Alison] Great Ormond St Hosp Sick Children, London WC1N 3JH, England; [Gaunt, Lorraine; Clayton-Smith, Jill] Univ Manchester, St Marys Hosp, Dept Clin Genet, Manchester M13 0JH, Lancs, England; [Tassabehji, May] Univ Manchester, St Marys Hosp, Acad Unit Med Genet, Manchester M13 0JH, Lancs, England; [Simonic, Ingrid; Park, Soo Mi; Mehta, Sarju G.; Nik-Zainal, Serena; Woods, C. Geoffrey; Firth, Helen V.; Parkin, Georgina; Willatt, Lionel] Addenbrookes Hosp NHS Trust, Cambridge, England; [Gribble, Susan] Wellcome Trust Sanger Inst, Cambridge, England; [Regan, Regina; Knight, Samantha J. L.] Churchill Hosp, Wellcome Trust Ctr Human Genet, Oxford OX3 7LJ, England; [Norga, Koen] Katholieke Univ Leuven, Childrens Hosp, Louvain, Belgium; [Norga, Koen] Katholieke Univ Leuven, Vlaams Interuniv Inst Biotechnol, Louvain, Belgium; [de Ravel, Thomy; Devriendt, Koen; Vermeesch, Joris R.] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Bongers, Ernie M. H. F.; de Leeuw, Nicole; Veltman, Joris A.; de Vries, Bert B. A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Binsbergen, Ellen; Nelen, Marcel R.; Hochstenbach, Ron; Poot, Martin] Univ Med Ctr, Utrecht, Netherlands; [Hennekam, Raoul C.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands; [Reardon, William] Our Ladys Hosp Sick Children, Dublin, Ireland; [Gallagher, Louise; Gill, Michael] St James Hosp, Dublin 8, Ireland; [Fichera, Marco; Reitano, Santina; Lo Giudice, Mariangela; Romano, Corrado] IRCCS, Assoc Oasi Maria Santissima, Troina, Italy; [Striano, Pasquale; Coppola, Antonietta] Univ Naples Federico II, Naples, Italy; [Striano, Pasquale] Osped Gaslini, Unita Neuromuscolare, Genoa, Italy; [Gimelli, Giorgio] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Li, Kelly E.; Casuga, Iris; Broomer, Adam; Chen, Caifu] Appl Biosyst Inc, Foster City, CA 94404 USA; [Conrad, Bernard; Gallati, Sabina] Bern Univ Childrens Hosp, Bern, Switzerland; [Schwerzmann, Markus; Raber, Lorenz] Univ Hosp Bern, Dept Cardiol, CH-3010 Bern, Switzerland; [Tolmie, John L.; Tobias, Edward S.; Lilley, Chris] Royal Hosp Sick Children, Glasgow G3 8SJ, Lanark, Scotland; [Armengol, Lluis; Estivill, Xavier] CIBERESP, Biomed Res Ctr Epidemiol & Publ Hlth, Barcelona, Spain; [Armengol, Lluis; Estivill, Xavier] Pompeu Fabra Univ, Barcelona, Spain; [Skinner, Cindy; Stevenson, Roger E.; Schwartz, Charles E.] Greenwood Genet Ctr, Greenwood, SC 29646 USA; [Schwartz, Stuart] Univ Chicago, Chicago, IL 60637 USA; [Sutcliffe, James S.] Vanderbilt Univ, Nashville, TN USA; [Sebat, Jonathan] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Geneva; University of Geneva; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Manchester; University of Manchester; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; Wellcome Trust Sanger Institute; University of Oxford; Wellcome Centre for Human Genetics; KU Leuven; KU Leuven; KU Leuven; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Our Ladys Children Hospital Crumlin; Trinity College Dublin; IRCCS Oasi Maria SS; University of Naples Federico II; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS Istituto Giannina Gaslini; Thermo Fisher Scientific; Applied Biosystems; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Glasgow; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Pompeu Fabra University; Greenwood Genetic Center; University of Chicago; Vanderbilt University; Cold Spring Harbor Laboratory	Eichler, EE (corresponding author), Univ Washington, Dept Genome Sci, Sch Med, Foege Bldg S413A,Box 355065,1705 NE Pacific St, Seattle, WA 98195 USA.	eee@gs.washington.edu	Striano, Pasquale/F-9117-2014; Menten, Björn/B-3072-2013; Fichera, Marco/K-9220-2016; Romano, Corrado/B-9695-2008; Estivill, Xavier/A-3125-2013; speleman, frank/AAR-5184-2020; Resource Center, NINDS Human Genetics/AGF-2474-2022; Veltman, Joris A/F-5128-2010; woods, christopher g/A-1361-2010; de Leeuw, N./L-4480-2015; Bongers, M.H.F./L-4214-2015; Schwerzmann, Markus/AAD-9368-2022; /AAB-8553-2019; Mortier, Geert/D-2542-2012; Sander-Effron, Samuel/AAX-2231-2020; Nelen, Marcel R./L-4542-2015; Sutcliffe, James S/C-1348-2012; Nik-Zainal, Serena/ABD-4437-2020; Tobias, Edward/D-4246-2009; Poot, Martin/F-9427-2010; Antonarakis, Stylianos E/N-8866-2014; Giudice, Mariangela Lo/D-4261-2017; Estivill, Xavier/E-2957-2012; Norga, Koenraad/D-1137-2017	Striano, Pasquale/0000-0002-6065-1476; Fichera, Marco/0000-0002-8225-6880; Romano, Corrado/0000-0003-1049-0683; Estivill, Xavier/0000-0002-0723-2256; speleman, frank/0000-0002-6628-8559; Veltman, Joris A/0000-0002-3218-8250; Schwerzmann, Markus/0000-0002-4006-8929; Mortier, Geert/0000-0001-9871-4578; Sutcliffe, James S/0000-0001-5200-6007; Tobias, Edward/0000-0003-2649-7695; Antonarakis, Stylianos E/0000-0001-8907-5823; Giudice, Mariangela Lo/0000-0001-5961-0362; de Ravel, Thomy/0000-0002-3361-3781; Nik-Zainal, Serena/0000-0001-5054-1727; Verloo, Patrick/0000-0003-2077-0275; Walsh, Tom/0000-0002-8875-0310; Gill, Michael/0000-0003-0206-5337; Gallagher, Louise/0000-0001-9462-2836; Menten, Bjorn/0000-0001-8182-659X; Reardon, Willie/0000-0001-7329-9179; King, Mary-Claire/0000-0001-9426-1743; Sebat, Jonathan/0000-0002-9087-526X; Norga, Koenraad/0000-0002-9231-0350; Vermeesch, Joris/0000-0002-3071-1191; Baralle, Diana/0000-0003-3217-4833; Knight, Samantha/0000-0002-6047-3462	National Institutes of Health [HD043569]; South Carolina Department of Disabilities and Special Needs; Wellcome Trust [061183]; Andre & Cyprien Foundation; University Hospitals of Geneva; European Union [219250]; AnEUploidy [037627]; Wellcome Trust; Health Research Board; Dutch Foundation for Brain Research [2008(1)34]; Oxford Partnership Comprehensive Biomedical Research Centre; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres; United Kingdom Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043569] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Carolina Department of Disabilities and Special Needs; Wellcome Trust(Wellcome TrustEuropean Commission); Andre & Cyprien Foundation; University Hospitals of Geneva; European Union(European Commission); AnEUploidy; Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Board; Dutch Foundation for Brain Research; Oxford Partnership Comprehensive Biomedical Research Centre; United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); United Kingdom Department of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by grants from the National Institutes of Health (HD043569, to Dr. Eichler), the South Carolina Department of Disabilities and Special Needs ( to Drs. Skinner, Stevenson, and Schwartz), the Wellcome Trust (061183, to Dr. Tassabehji), the Andre & Cyprien Foundation and the University Hospitals of Geneva ( to Drs. Antonarakis, Bena, and Gallati), and the European Union (project 219250, to Dr. Sharp; AnEUploidy project 037627, to Drs. Leeuw, Armengol, Antonarakis, Estivill, Veltman, and de Vries). The Irish Autism Study was funded by the Wellcome Trust and the Health Research Board (a grant to Drs. Gallagher and Gill). Dr. Poot was supported by a grant from the Dutch Foundation for Brain Research (Hersenstichting grant 2008(1)34); Drs. Regan and Knight, by the Oxford Partnership Comprehensive Biomedical Research Centre; Dr. Willatt, by the Cambridge Biomedical Research Centre, with funding from the United Kingdom Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme; Drs. Huang and Maloney, as part of the National Genetics Reference Laboratory (Wessex) by the United Kingdom Department of Health; Ms. Buysse, as a research assistant of the Research Foundation - Flanders (FWO-Vlaanderen); and Dr. Eichler, as an investigator of the Howard Hughes Medical Institute. The views expressed in this publication are those of the authors and not necessarily those of the United Kingdom Department of Health.; Drs. Mefford and Sharp report giving invited Webinars and seminars for NimbleGen, a manufacturer of microarrays; Drs. Li, Casuga, Broomer, and Chen report being employees of Applied Biosystems, manufacturer of the TaqMan assay and reagents; and Dr. Eichler reports being an invited speaker at an Applied Biosystems workshop on human copy- number variation. No other potential conflict of interest relevant to this article was reported. We thank Francesca Antonacci for performing fluorescence in situ hybridization analysis. This study used data from the SNP Database at the National Institute of Neurological Disorders and Stroke Human Genetics Resource Center DNA and Cell Line Repository ( http:// ccr. coriell. org/ ninds), as well as clinical data. The Illumina genotyping was performed in the laboratories of Drs. Singleton and Hardy ( National Institute of Aging [ NIA], Laboratory of Neurogenetics [ LNG]), Bethesda, MD.	Barber JCK, 2008, EUR J HUM GENET, V16, P18, DOI 10.1038/sj.ejhg.5201932; Bearden CE, 2004, AM J PSYCHIAT, V161, P1700, DOI 10.1176/appi.ajp.161.9.1700; Cheroki C, 2008, J MED GENET, V45, P228, DOI 10.1136/jmg.2007.051839; Christiansen J, 2004, CIRC RES, V94, P1429, DOI 10.1161/01.RES.0000130528.72330.5c; Cusco I, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-27; de Stahl TD, 2008, HUM MUTAT, V29, P398, DOI 10.1002/humu.20659; de Vries BBA, 2005, AM J HUM GENET, V77, P606, DOI 10.1086/491719; de Vries BBA, 2001, J MED GENET, V38, P145, DOI 10.1136/jmg.38.3.145; Doggett NA, 2006, GENOMICS, V88, P762, DOI 10.1016/j.ygeno.2006.07.012; Firouzi M, 2004, CIRC RES, V95, P29, DOI 10.1161/01.RES.0000141134.64811.0a; Friedman JM, 2006, AM J HUM GENET, V79, P500, DOI 10.1086/507471; Gothelf D, 2005, NAT NEUROSCI, V8, P1500, DOI 10.1038/nn1572; Gu H, 2003, CIRC RES, V93, P201, DOI 10.1161/01.RES.0000084852.65396.70; HANNES FD, 2008, J MED GENET     0611; Hauer RNW, 2006, ADV CARDIOL, V42, P284, DOI 10.1159/000092579; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Jiang Z, 2007, NAT GENET, V39, P1361, DOI 10.1038/ng.2007.9; Juang JM, 2007, INT J CARDIOL, V116, P107, DOI 10.1016/j.ijcard.2006.03.037; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Klopocki E, 2007, AM J HUM GENET, V80, P232, DOI 10.1086/510919; Koolen DA, 2006, NAT GENET, V38, P999, DOI 10.1038/ng1853; LICHTER P, 1990, SCIENCE, V247, P64, DOI 10.1126/science.2294592; Locke DP, 2006, AM J HUM GENET, V79, P275, DOI 10.1086/505653; Mefford HC, 2007, AM J HUM GENET, V81, P1057, DOI 10.1086/522591; Menten B, 2006, J MED GENET, V43, DOI 10.1136/jmg.2005.039453; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pinto D, 2008, HUM MOL GENET, V17, P466, DOI 10.1093/hmg/ddm321; Pinto D, 2007, HUM MOL GENET, V16, pR168, DOI 10.1093/hmg/ddm241; Ponnam SPG, 2007, J MED GENET, V44, DOI 10.1136/jmg.2007.050138; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Robin NH, 2005, J PEDIATR-US, V147, P90, DOI 10.1016/j.jpeds.2005.03.007; Rosenberg C, 2006, J MED GENET, V43, P180, DOI 10.1136/jmg.2005.032268; Schymick JC, 2007, LANCET NEUROL, V6, P322, DOI 10.1016/S1474-4422(07)70037-6; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Sharp AJ, 2007, HUM MOL GENET, V16, P567, DOI 10.1093/hmg/ddm016; Sharp AJ, 2006, NAT GENET, V38, P1038, DOI 10.1038/ng1862; Shiels A, 1998, AM J HUM GENET, V62, P526, DOI 10.1086/301762; Simon-Sanchez J, 2007, HUM MOL GENET, V16, P1, DOI 10.1093/hmg/ddl436; STEFANSSON H, 2008, NATURE          0730; STONE JL, 2008, NATURE          0730; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Turner DJ, 2008, NAT GENET, V40, P90, DOI 10.1038/ng.2007.40; Ullmann R, 2007, HUM MUTAT, V28, P674, DOI 10.1002/humu.20546; Vanita V, 2008, MOL VIS, V14, P323; Vissers LELM, 2003, AM J HUM GENET, V73, P1261, DOI 10.1086/379977; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Zogopoulos G, 2007, HUM GENET, V122, P345, DOI 10.1007/s00439-007-0404-5	53	555	571	0	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1685	U130		10.1056/NEJMoa0805384	http://dx.doi.org/10.1056/NEJMoa0805384			34	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360EY	18784092	Green Accepted, Green Published			2022-12-28	WOS:000260041400007
J	Thompson, A				Thompson, Anne			Commentary: Controversies in NICE guidance on attention-deficit/hyperactivity disorder	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thompson, Anne] Lincolnshire Partnership NHS Fdn Trust, Child & Family Serv, Lincoln LN2 5RT, England		Thompson, A (corresponding author), Lincolnshire Partnership NHS Fdn Trust, Child & Family Serv, Lincoln LN2 5RT, England.	anne.thompson@lpt.nhs.uk						*CHILDR AD MENT HL, 2008, IMPR MENT HLTH PSYCH; National Institute for Health and Clinical Excellence, 2008, ATT DEF HYP DIS DIAG; *SCOTT INT GUID NE, 2001, ATT DEF HYP DIS CHIL; Taylor E, 2004, EUR CHILD ADOLES PSY, V13, P7, DOI 10.1007/s00787-004-1002-x; Western Australia Commissioner for Children and Young People, 2020, NAT SERV FRAM CHILDR; 2002, BMJ             0216, P324	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1466	10.1136/bmj.a1466	http://dx.doi.org/10.1136/bmj.a1466			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SJ	18815171				2022-12-28	WOS:000259797600043
J	He, WZ; Ladinsky, MS; Huey-Tubman, KE; Jensen, GJ; McIntosh, JR; Bjorkman, PJ				He, Wanzhong; Ladinsky, Mark S.; Huey-Tubman, Kathryn E.; Jensen, Grant J.; McIntosh, J. Richard; Bjorkman, Pamela J.			FcRn-mediated antibody transport across epithelial cells revealed by electron tomography	NATURE			English	Article							CLATHRIN-COATED VESICLES; RAT-KIDNEY CELL; INTESTINAL TRANSPORT; FREEZE-SUBSTITUTION; IMMUNOGLOBULIN-G; NEONATAL RAT; 3 DIMENSIONS; YOUNG-RAT; RECEPTOR; FUSION	The neonatal Fc receptor ( FcRn) transports maternal IgG across epithelial barriers(1,2), thereby providing the fetus or newborn with humoral immunity before its immune system is fully functional. In newborn rats, FcRn transfers IgG from milk to blood by apical-to-basolateral transcytosis across intestinal epithelial cells. The pH difference between the apical ( pH 6.0-6.5) and basolateral ( pH 7.4) sides of intestinal epithelial cells facilitates the efficient unidirectional transport of IgG, because FcRn binds IgG at pH 6.0-6.5 but not at pH 7 or more(1,2). As milk passes through the neonatal intestine, maternal IgG is removed by FcRn-expressing cells in the proximal small intestine ( duodenum and jejunum); remaining proteins are absorbed and degraded by FcRn- negative cells in the distal small intestine ( ileum)(3-6). Here we use electron tomography to make jejunal transcytosis visible directly in space and time, developing new labelling and detection methods to map individual nanogold-labelled Fc within transport vesicles(7) and simultaneously to characterize these vesicles by immunolabelling. Combining electron tomography with a nonperturbing endocytic label allowed us to conclusively identify receptor- bound ligands, resolve interconnecting vesicles, determine whether a vesicle was microtubule- associated, and accurately trace FcRn- mediated transport of IgG. Our results present a complex picture in which Fc moves through networks of entangled tubular and irregular vesicles, only some of which are microtubuleassociated, as it migrates to the basolateral surface. New features of transcytosis are elucidated, including transport involving multivesicular body inner vesicles/ tubules and exocytosis through clathrin- coated pits. Markers for early, late and recycling endosomes each labelled vesicles in different and overlapping morphological classes, revealing spatial complexity in endo- lysosomal trafficking.	[He, Wanzhong; Huey-Tubman, Kathryn E.; Jensen, Grant J.; Bjorkman, Pamela J.] CALTECH, Div Biol 114 96, Pasadena, CA 91125 USA; [Huey-Tubman, Kathryn E.; Bjorkman, Pamela J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [He, Wanzhong] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Ladinsky, Mark S.; McIntosh, J. Richard] Univ Colorado, Boulder Lab 3D Elect Microscopy Cells, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; National University of Singapore; University of Colorado System; University of Colorado Boulder	Bjorkman, PJ (corresponding author), CALTECH, Div Biol 114 96, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	bjorkman@caltech.edu	McIntosh, Richard/GLN-3533-2022		National Institutes of Health [2 R37 AI041239-06A1, RR000592]; Max Planck Research Award; Gordon and Betty Moore Foundation; Agouron Institute; Caltech; National University of Singapore [R-154-000-339-133]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI041239] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Max Planck Research Award(Max Planck Society); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Agouron Institute(Pfizer); Caltech; National University of Singapore(National University of Singapore); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Mastronarde for advice about setting up SerialEM on the Caltech microscopes and three- dimensional modelling; C. Kivork for preparing Au-Fc and Au-dextran; B. Tivol for assistance with electron microscopes; M. Murphy for help with schematic figures; M. Morphew for contributions to silver enhancement methods; Y. Nie, A. Feuerabendt, A. Kules, C. Luna, K. McKenzie, R. Sander and L. Zinn-Bjorkman for segmenting tomograms; J. Vielmetter for SPR studies of Au-Fc; and F. Brodsky, F. Maxfield, S. Schmid and D. Tesar for discussions. This work was supported by the National Institutes of Health (2 R37 AI041239-06A1 to P.J.B. and RR000592 to J.R.M.), a Max Planck Research Award (P.J.B.), gifts from the Gordon and Betty Moore Foundation and the Agouron Institute to support electron microscopy at Caltech, and National University of Singapore AcRF start-up funds (R-154-000-339-133 to W.H.).	ALTSTIEL L, 1983, CELL, V32, P921, DOI 10.1016/0092-8674(83)90077-6; BENLOUNES N, 1995, BIOL NEONATE, V67, P254, DOI 10.1159/000244173; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Brodsky FM, 2001, ANNU REV CELL DEV BI, V17, P517, DOI 10.1146/annurev.cellbio.17.1.517; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; DANSCHER G, 1981, HISTOCHEMISTRY, V71, P1, DOI 10.1007/BF00592566; Fesce Riccardo, 1994, Trends in Cell Biology, V4, P1, DOI 10.1016/0962-8924(94)90025-6; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; GREENE LE, 1990, J BIOL CHEM, V265, P6682; HALLIDAY R, 1955, PROC R SOC SER B-BIO, V143, P408, DOI 10.1098/rspb.1955.0020; He WZ, 2007, J STRUCT BIOL, V160, P103, DOI 10.1016/j.jsb.2007.07.004; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; HUBER AH, 1993, J MOL BIOL, V230, P1077, DOI 10.1006/jmbi.1993.1220; HULL BE, 1979, J CELL BIOL, V81, P67, DOI 10.1083/jcb.81.1.67; JONES EA, 1972, J CLIN INVEST, V51, P2916, DOI 10.1172/JCI107116; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ladinsky MS, 2007, METHOD CELL BIOL, V79, P543, DOI 10.1016/S0091-679X(06)79021-5; Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135; Mari M, 2008, TRAFFIC, V9, P380, DOI 10.1111/j.1600-0854.2007.00686.x; Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; McCarthy KM, 2000, J CELL SCI, V113, P1277; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Morphew M, 2008, J MICROSC-OXFORD, V230, P263, DOI 10.1111/j.1365-2818.2008.01983.x; Murk JLAN, 2003, P NATL ACAD SCI USA, V100, P13332, DOI 10.1073/pnas.2232379100; Ober RJ, 2004, P NATL ACAD SCI USA, V101, P11076, DOI 10.1073/pnas.0402970101; RODEWALD R, 1984, J CELL BIOL, V99, pS159, DOI 10.1083/jcb.99.1.159s; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODEWALD R, 1970, J CELL BIOL, V45, P635, DOI 10.1083/jcb.45.3.635; RODEWALD R, 1973, J CELL BIOL, V58, P189, DOI 10.1083/jcb.58.1.189; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Sokac AM, 2006, MOL BIOL CELL, V17, P1495, DOI 10.1091/mbc.E05-10-0908; Stoorvogel W, 1996, J CELL BIOL, V132, P21, DOI 10.1083/jcb.132.1.21; TOKUYASU KT, 1986, J MICROSC-OXFORD, V143, P139, DOI 10.1111/j.1365-2818.1986.tb02772.x	37	122	131	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					542	U53		10.1038/nature07255	http://dx.doi.org/10.1038/nature07255			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818657	Green Accepted			2022-12-28	WOS:000259449600048
J	Nakamura, T; Noguchi, T; Tsuchiyama, A; Ushikubo, T; Kita, NT; Valley, JW; Zolensky, ME; Kakazu, Y; Sakamoto, K; Mashio, E; Uesugi, K; Nakano, T				Nakamura, Tomoki; Noguchi, Takaaki; Tsuchiyama, Akira; Ushikubo, Takayuki; Kita, Noriko T.; Valley, John W.; Zolensky, Michael E.; Kakazu, Yuki; Sakamoto, Kanako; Mashio, Etsuko; Uesugi, Kentaro; Nakano, Tsukasa			Chondrulelike objects in short-period comet 81P/Wild 2	SCIENCE			English	Article							COMET 81P/WILD-2; OXYGEN-ISOTOPE; CARBONACEOUS CHONDRITE; OLIVINE; MINERALOGY; STARDUST; SAMPLES; INCLUSIONS; DIFFUSION; PETROLOGY	The Stardust spacecraft returned cometary samples that contain crystalline material, but the origin of the material is not yet well understood. We found four crystalline particles from comet 81P/ Wild 2 that were apparently formed by flash- melting at a high temperature and are texturally, mineralogically, and compositionally similar to chondrules. Chondrules are submillimeter particles that dominate chondrites and are believed to have formed in the inner solar nebula. The comet particles show oxygen isotope compositions similar to chondrules in carbonaceous chondrites that compose the middle- to- outer asteroid belt. The presence of the chondrulelike objects in the comet suggests that chondrules have been transported out to the cold outer solar nebula and spread widely over the early solar system.	[Nakamura, Tomoki; Kakazu, Yuki; Sakamoto, Kanako] Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan; [Noguchi, Takaaki] Ibaraki Univ, Coll Sci, Bunkyo Ku, Mito, Ibaraki 3108512, Japan; [Tsuchiyama, Akira; Mashio, Etsuko] Osaka Univ, Dept Earth & Space Sci, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; [Ushikubo, Takayuki; Kita, Noriko T.; Valley, John W.] Univ Wisconsin, Dept Geol & Geophys, Madison, WI 53706 USA; [Zolensky, Michael E.] NASA, Lyndon B Johnson Space Ctr, Astromat Res & Explorat Sci, Houston, TX 77058 USA; [Uesugi, Kentaro] Japan Synchrotron Radiat Res Inst, SPring 8, Sayo, Hyogo 6795198, Japan; [Nakano, Tsukasa] Natl Inst Adv Ind Sci & Technol, Geol Survey Japan, Tsukuba, Ibaraki 3058567, Japan	Kyushu University; Ibaraki University; Osaka University; University of Wisconsin System; University of Wisconsin Madison; National Aeronautics & Space Administration (NASA); NASA JOHNSON SPACE CENTER; Japan Synchrotron Radiation Research Institute; National Institute of Advanced Industrial Science & Technology (AIST)	Nakamura, T (corresponding author), Kyushu Univ, Fac Sci, Dept Earth & Planetary Sci, Fukuoka 8128581, Japan.	tomoki@geo.kyushu-u.ac.jp	Kita, Noriko/H-8035-2016; Valley, John W./B-3466-2011	Kita, Noriko/0000-0002-0204-0765; Valley, John W./0000-0003-3530-2722; Ushikubo, Takayuki/0000-0002-5934-5076; Zolensky, Michael/0000-0002-3181-1303; Noguchi, Takaaki/0000-0001-7211-2595	Japan Society for the Promotion of Science; NASA Stardust Sample Analysis; Cosmochemistry Programs; NSF	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NASA Stardust Sample Analysis(National Aeronautics & Space Administration (NASA)); Cosmochemistry Programs; NSF(National Science Foundation (NSF))	We thank K. Nakamura-Messenger, T. Iwazumi, Y. Wakabayashi, A. Koyama, T. Mori, Y. Suzuki, A. Takeuchi, Y. Terada, H. Nagahara, and H. Yoshida for technical support; M. Sekiya, H. Miura, and M. Uesugi for discussion; and KEK and SPring-8 for experiments. This work was supported by the Japan Society for the Promotion of Science, the NASA Stardust Sample Analysis, and Cosmochemistry Programs. The Wisconsin Secondary Ion Mass Spectrometer Laboratory is partly supported by NSF.	Aleon J, 2007, EARTH PLANET SC LETT, V263, P114, DOI 10.1016/j.epsl.2007.09.003; Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; Brearley A.J., 1998, PLANETARY MAT, p3; Brownlee D, 2006, SCIENCE, V314, P1711, DOI 10.1126/science.1135840; Chizmadia LJ, 2002, METEORIT PLANET SCI, V37, P1781, DOI 10.1111/j.1945-5100.2002.tb01163.x; Clayton R. N., 1985, LUNAR PLANET SCI, VXVI, P142; CLAYTON RN, 1991, GEOCHIM COSMOCHIM AC, V55, P2317, DOI 10.1016/0016-7037(91)90107-G; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Dohmen R, 2007, PHYS CHEM MINER, V34, P409, DOI 10.1007/s00269-007-0158-6; Flynn GJ, 2006, SCIENCE, V314, P1731, DOI 10.1126/science.1136141; Gaffey M.J., 1989, ASTEROIDS, P98; GERARD O, 1989, J GEOPHYS RES-SOLID, V94, P4119, DOI 10.1029/JB094iB04p04119; Grossman J. N., 1988, METEORITES EARLY SOL, P619; GROSSMAN JN, 1988, EARTH PLANET SC LETT, V91, P33, DOI 10.1016/0012-821X(88)90149-5; Hayashi C., 1985, PROTOSTARS PLANETS, VII, P1100; Iida A, 2001, ICARUS, V153, P430, DOI 10.1006/icar.2001.6682; Jones RH, 2004, GEOCHIM COSMOCHIM AC, V68, P3423, DOI 10.1016/j.gca.2004.01.013; JOSWIAK DJ, 2007, 38 LUN PLAN SCI C LE; KLOCK W, 1989, NATURE, V339, P126, DOI 10.1038/339126a0; Krolikowska M, 2006, ASTRON ASTROPHYS, V448, P401, DOI 10.1051/0004-6361:20053756; MCKEEGAN KD, 39 LUN PLAN SCI C; McKeegan KD, 2006, SCIENCE, V314, P1724, DOI 10.1126/science.1135992; Nakamura T, 2008, METEORIT PLANET SCI, V43, P247, DOI 10.1111/j.1945-5100.2008.tb00620.x; Shu FH, 1997, SCIENCE, V277, P1475, DOI 10.1126/science.277.5331.1475; SMYTH JR, 1974, AM MINERAL, V59, P345; Tomeoka K, 2008, METEORIT PLANET SCI, V43, P273, DOI 10.1111/j.1945-5100.2008.tb00622.x; WEISBERG MK, 1991, GEOCHIM COSMOCHIM AC, V55, P2657, DOI 10.1016/0016-7037(91)90380-N; Zolensky ME, 2006, SCIENCE, V314, P1735, DOI 10.1126/science.1135842; [No title captured]	30	207	207	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1664	1667		10.1126/science.1160995	http://dx.doi.org/10.1126/science.1160995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801994				2022-12-28	WOS:000259300400031
J	Napoli, I; Mercaldo, V; Boyl, PP; Eleuteri, B; Zalfa, F; De Rubeis, S; Di Marino, D; Mohr, E; Massimi, M; Falconi, M; Witke, W; Costa-Mattioli, M; Sonenberg, N; Achsel, T; Bagni, C				Napoli, Ilaria; Mercaldo, Valentina; Boyl, Pietro Pilo; Eleuteri, Boris; Zalfa, Francesca; De Rubeis, Silvia; Di Marino, Daniele; Mohr, Evita; Massimi, Marzia; Falconi, Mattia; Witke, Walter; Costa-Mattioli, Mauro; Sonenberg, Nahum; Achsel, Tilmann; Bagni, Claudia			The fragile X syndrome protein represses activity-dependent translation through CYFIP1, a new 4E-BP	CELL			English	Article							MENTAL-RETARDATION PROTEIN; INITIATION-FACTOR 4E; MESSENGER-RNA; DROSOPHILA CUP; BC1 RNA; BINDING; FMRP; LOCALIZATION; STABILITY; PATHWAY	Strong evidence indicates that regulated mRNA translation in neuronal dendrites underlies synaptic plasticity and brain development. The fragile X mental retardation protein (FMRP) is involved in this process; here, we show that it acts by inhibiting translation initiation. A binding partner of FMRP, CYFIP1/Sra1, directly binds the translation initiation factor eIF4E through a domain that is structurally related to those present in 4E-BP translational inhibitors. Brain cytoplasmic RNA 1 (BC1), another FMRP binding partner, increases the affinity of FMRP for the CYFIP1-eIF4E complex in the brain. Levels of proteins encoded by known FMRP target mRNAs are increased upon reduction of CYFIP1 in neurons. Translational repression is regulated in an activity-dependent manner because BDNF or DHPG stimulation of neurons causes CYFIP1 to dissociate from eIF4E at synapses, thereby resulting in protein synthesis. Thus, the translational repression activity of FMRP in the brain is mediated, at least in part, by CYFIP1.	[Napoli, Ilaria; Mercaldo, Valentina; Eleuteri, Boris; Zalfa, Francesca; Achsel, Tilmann; Bagni, Claudia] IRCCS, Fdn Santa Lucia, Dept Expt Neurosci, I-00143 Rome, Italy; [Napoli, Ilaria; De Rubeis, Silvia; Di Marino, Daniele; Falconi, Mattia] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Napoli, Ilaria; Mercaldo, Valentina; Boyl, Pietro Pilo; De Rubeis, Silvia; Achsel, Tilmann; Bagni, Claudia] Catholic Univ Louvain VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium; [Zalfa, Francesca; Bagni, Claudia] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Mohr, Evita] Univ Hosp Hamburg Eppendorf, Dept Anat Cellular Neurobiol 1, D-20246 Hamburg, Germany; [Massimi, Marzia; Witke, Walter] European Mol Biol Lab, Mouse Biol Unit, I-00016 Monterotondo, Italy; [Costa-Mattioli, Mauro; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1V6, Canada	IRCCS Santa Lucia; University of Rome Tor Vergata; Flanders Institute for Biotechnology (VIB); University of Rome Tor Vergata; University of Hamburg; University Medical Center Hamburg-Eppendorf; European Molecular Biology Laboratory (EMBL); McGill University	Bagni, C (corresponding author), IRCCS, Fdn Santa Lucia, Dept Expt Neurosci, I-00143 Rome, Italy.	claudia.bagni@med.kuleuven.be	Di Marino, Daniele/AAB-9653-2019; Di Marino, Daniele/ABB-2333-2020; De Rubeis, Silvia/E-9852-2013; Cabrera, Mariel/GMX-2706-2022; Mercaldo, Valentina/AAA-6000-2019; Zalfa, Francesca/J-7759-2018	Di Marino, Daniele/0000-0001-6961-3129; De Rubeis, Silvia/0000-0001-9383-6883; Zalfa, Francesca/0000-0002-1922-9468; Pilo Boyl, Pietro/0000-0002-7535-4802; Bagni, Claudia/0000-0002-4419-210X; Napoli, Ilaria/0000-0002-0649-1950; FALCONI, MATTIA/0000-0002-3990-4758	FP6 Marie Curie fellowship [MEST-CT-2004-504640]; Conquer Fragile X Foundation; Telethon [GGP05269]; Ministero della Sanita e dell' Universita (FIRB); Flanders Interuniversity Institute for Biotechnology (VIB)	FP6 Marie Curie fellowship(European Commission); Conquer Fragile X Foundation; Telethon(Fondazione Telethon); Ministero della Sanita e dell' Universita (FIRB); Flanders Interuniversity Institute for Biotechnology (VIB)	We thank Rasmus Herlo, Adriana Gambardella, and Emanuela Pasciuto for sharing preliminary data and Antonio Totaro and Caroline Lacoux for some help with protein purifications. We are grateful to Ben Oostra for the FMR1 KO mice and to Jurgen Brosius for the BC1 KO mice. We thank Kris Dickson for critical reading of the manuscript and discussion, Jesus Avila, Itzhak Fisher, and Gary Bassell for MAP1B antibodies, Stefano Biffo for eIF6/p27 antibody, Sebastian Munk for helping us with the confocal images, Nicola Gray and Fatima Gebauer for the MS2 reporter constructs, Oswald Steward for the full-length Arc cDNA, and Massimo Regoli for assistance with the statistical analysis. We thank Giorgio Bernardi for his support. M. M. was supported by a FP6 Marie Curie MEST-CT-2004-504640 fellowship. P. P. B. was partially supported by Conquer Fragile X Foundation. C. B. is supported by grants from the following agencies: Telethon (GGP05269), Ministero della Sanita e dell' Universita (FIRB), and Flanders Interuniversity Institute for Biotechnology (VIB).	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Altmann M, 1997, EMBO J, V16, P1114, DOI 10.1093/emboj/16.5.1114; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; BAKKER CE, 1994, CELL, V78, P23; Banko JL, 2007, NEUROBIOL LEARN MEM, V87, P248, DOI 10.1016/j.nlm.2006.08.012; Bogdan S, 2004, DEVELOPMENT, V131, P3981, DOI 10.1242/dev.01274; Boyl PP, 2007, EMBO J, V26, P2991, DOI 10.1038/sj.emboj.7601737; Centonze D, 2008, BIOL PSYCHIAT, V63, P963, DOI 10.1016/j.biopsych.2007.09.008; Centonze D, 2007, J NEUROSCI, V27, P8885, DOI 10.1523/JNEUROSCI.0548-07.2007; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Ferraiuolo MA, 2005, J CELL BIOL, V170, P913, DOI 10.1083/jcb.200504039; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gradi A, 1998, P NATL ACAD SCI USA, V95, P11089, DOI 10.1073/pnas.95.19.11089; HAGHIGHAT A, 1995, EMBO J, V14, P5701, DOI 10.1002/j.1460-2075.1995.tb00257.x; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Johnson EM, 2006, J NEUROSCI RES, V83, P929, DOI 10.1002/jnr.20806; Jung MY, 2006, MOL CELL BIOL, V26, P4277, DOI 10.1128/MCB.02470-05; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Kunda P, 2003, CURR BIOL, V13, P1867, DOI 10.1016/j.cub.2003.10.005; Lin AC, 2008, CURR OPIN NEUROBIOL, V18, P60, DOI 10.1016/j.conb.2008.05.004; Lu R, 2004, P NATL ACAD SCI USA, V101, P15201, DOI 10.1073/pnas.0404995101; MADER S, 1995, MOL CELL BIOL, V15, P4990; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Martin KC, 2000, CURR OPIN NEUROBIOL, V10, P587, DOI 10.1016/S0959-4388(00)00128-8; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Nakamura A, 2004, DEV CELL, V6, P69, DOI 10.1016/S1534-5807(03)00400-3; Narayanan U, 2007, J NEUROSCI, V27, P14349, DOI 10.1523/JNEUROSCI.2969-07.2007; Nelson MR, 2004, EMBO J, V23, P150, DOI 10.1038/sj.emboj.7600026; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Nowicki ST, 2007, J DEV BEHAV PEDIATR, V28, P133, DOI 10.1097/01.DBP.0000267563.18952.c9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RICHTER JD, 2007, TRANSLATIONAL CONTRO, P489; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Schratt GM, 2004, J NEUROSCI, V24, P7366, DOI 10.1523/JNEUROSCI.1739-04.2004; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Steward O, 2003, NEURON, V40, P347, DOI 10.1016/S0896-6273(03)00635-4; Takei N, 2001, J BIOL CHEM, V276, P42818, DOI 10.1074/jbc.M103237200; Tashiro A, 2004, MOL CELL NEUROSCI, V26, P429, DOI 10.1016/j.mcn.2004.04.001; Tomoo K, 2005, BBA-PROTEINS PROTEOM, V1753, P191, DOI 10.1016/j.bbapap.2005.07.023; WEILER IJ, 1993, P NATL ACAD SCI USA, V90, P7168, DOI 10.1073/pnas.90.15.7168; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; West NC, 2002, J MOL BIOL, V321, P423, DOI 10.1016/S0022-2836(02)00542-9; Westmark CJ, 2007, PLOS BIOL, V5, P629, DOI 10.1371/journal.pbio.0050052; Yin Y, 2002, P NATL ACAD SCI USA, V99, P2368, DOI 10.1073/pnas.042693699; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zalfa F, 2007, NAT NEUROSCI, V10, P578, DOI 10.1038/nn1893; Zhang MQ, 2007, P NATL ACAD SCI USA, V104, P10057, DOI 10.1073/pnas.0700169104; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X	58	419	427	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1042	1054		10.1016/j.cell.2008.07.031	http://dx.doi.org/10.1016/j.cell.2008.07.031			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805096	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000259318100023
J	Steensma, EA; Wu, FM				Steensma, Elizabeth A.; Wu, Fred M.			Colonic saccular diverticula	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Steensma, Elizabeth A.; Wu, Fred M.] Brigham & Womens Hosp, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Steensma, EA (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.	fred.wu@cardio.chboston.org		Wu, Fred/0000-0002-4580-8199					0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					E13	E13		10.1056/NEJMicm075753	http://dx.doi.org/10.1056/NEJMicm075753			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799553				2022-12-28	WOS:000259259900010
J	Lawn, JE; Rohde, J; Rifkin, S; Were, M; Paul, VK; Chopra, M				Lawn, Joy E.; Rohde, Jon; Rifkin, Susan; Were, Miriam; Paul, Vinod K.; Chopra, Mickey			Alma-Ata: Rebirth and revision 1 - Alma-Ata 30 years on: revolutionary, relevant, and time to revitalise	LANCET			English	Article							PRIMARY-HEALTH-CARE; CHILD SURVIVAL; COMMUNITY PARTICIPATION; NEONATAL SURVIVAL; LOW-INCOME; NEWBORN; COUNTDOWN; DISEASE; AFRICA; CALL	In this paper, we revisit the revolutionary principles-equity, social justice, and health for all; community participation; health promotion; appropriate use of resources; and intersectoral action-raised by the 1978 Alma-Ata Declaration, a historic event for health and primary health care. Old health challenges remain and new priorities have emerged (eg, HIV/AIDS, chronic diseases, and mental health), ensuring that the tenets of Alma-Ata remain relevant. We examine 30 years of changes in global policy to identify the lessons learned that are of relevance today, particularly for accelerated scale-up of primary health-care services necessary to achieve the Millennium Development Goals, the modern iteration of the "health for all" goals. Health has moved from under-investment, to single disease focus, and now to increased funding and multiple new initiatives. For primary health care, the debate of the past two decades focused on selective (or vertical) versus comprehensive (horizontal) delivery, but is now shifting towards combining the strengths of both approaches in health systems. Debates of Community versus facility-based health care are starting to shift towards building integrated health systems. Achievement of high and equitable coverage of integrated primary health-care services requires consistent political and financial commitment, incremental implementation based on local epidemiology, use of data to direct priorities and assess progress, especially at district level, and effective linkages with communities and non-health sectors. Community participation and intersectoral engagement seem to be the weakest strands in primary health care. Burgeoning task lists for primary health-care workers require long-term human resource planning and better training and supportive supervision. Essential drugs policies have made an important contribution to primary health care, but other appropriate technology lags behind. Revitalisng Alma-Ata and learning from three decades of experience is crucial to reach the ambitious goal of health for all in all countries, both rich and poor.	[Lawn, Joy E.] Saving Newborn Lives Save Children US, Cape Town, South Africa; [Lawn, Joy E.] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England; [Rohde, Jon] Management Sci Hlth, Boston, MA USA; [Rohde, Jon] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Rifkin, Susan] London Sch Econ, London WC2A 2AE, England; [Were, Miriam] Natl AIDS Control Council, Nairobi, Kenya; [Were, Miriam] AMREF, Nairobi, Kenya; [Paul, Vinod K.] All India Inst Med Sci, New Delhi, India	Save the Children; University of London; University College London; Bangladesh Rural Advancement Committee BRAC; BRAC University; University of London; London School Economics & Political Science; African Medical & Research Foundation (AMREF); All India Institute of Medical Sciences (AIIMS) New Delhi	Lawn, JE (corresponding author), 11 S Way, Cape Town, South Africa.	joylawn@yahoo.co.uk	Rifkin, Susan B/T-7863-2019; Lawn, Joy/ABE-6382-2020	Rifkin, Susan B/0000-0001-5482-7829; Lawn, Joy/0000-0002-4573-1443; Were, Miriam/0000-0001-5811-9424	Bill & Melinda Gates Foundation; Saving Newborn Lives/Save the Children-US	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Saving Newborn Lives/Save the Children-US	JL is funded through a grant from the Bill & Melinda Gates Foundation through Saving Newborn Lives/Save the Children-US. We thank the Lancet Alma-Ata Working Group for helpful inputs on an earlier draft.	[Anonymous], 1993, WORLD DEV REPORT 199; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Cueto M, 2004, AM J PUBLIC HEALTH, V94, P1864, DOI 10.2105/AJPH.94.11.1864; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Gilson L, 2005, BMJ-BRIT MED J, V331, P762, DOI 10.1136/bmj.331.7519.762; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Horton R, 2004, LANCET, V364, P2071, DOI 10.1016/S0140-6736(04)17560-0; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Koblinsky M, 2006, LANCET, V368, P1377, DOI 10.1016/S0140-6736(06)69382-3; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, LANCET, V368, P1474, DOI 10.1016/S0140-6736(06)69387-2; Mahler H., 2008, COMMUNICATION   0520; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Martines J, 2005, LANCET, V365, P1189, DOI 10.1016/S0140-6736(05)71882-1; MORLEY D, 1983, PRACTISING HLTH ALL; Muldoon LK, 2006, CAN J PUBLIC HEALTH, V97, P409, DOI 10.1007/BF03405354; Newell KW., 1975, HLTH PEOPLE; *OECD, 2005, PAR DECL AID EFF OEC; *PAHO, 2007, REN PRIM HLTH CAR AM; Palmer N, 2004, LANCET, V364, P1365, DOI 10.1016/S0140-6736(04)17195-X; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rifkin SB, 1996, ACTA TROP, V61, P79, DOI 10.1016/0001-706X(95)00105-N; ROHDE J, 1993, REACHING HLTH ALL; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosato M, 2008, LANCET, V372, P962, DOI 10.1016/S0140-6736(08)61406-3; ROSENFIELD A, 1985, LANCET, V2, P83; SACHS ID, 2001, MACROECONOMICS HLTH; Salama P, 2008, LANCET, V371, P1219, DOI 10.1016/S0140-6736(08)60534-6; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Sibley L, 2004, SOC SCI MED, V59, P1757, DOI 10.1016/j.socscimed.2004.02.009; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Victora CG, 2004, AM J PUBLIC HEALTH, V94, P400, DOI 10.2105/AJPH.94.3.400; Walley J, 2008, LANCET, V372, P1001, DOI 10.1016/S0140-6736(08)61409-9; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; WERE M, PRINC MAH AW C 2008; Were MC, 2008, AIDS CARE, V20, P677, DOI 10.1080/09540120701687067; Wibulpolprasert S, 2008, B WORLD HEALTH ORGAN, V86, P3, DOI 10.2471/BLT.07.049239; World Health Organisation, 2005, WORLD HLTH REP MAK E; World Health Organization, 1948, PREAMBL CONST WHO IN; World Health Organization (WHO), 1978, INT C PRIM HLTH CAR	49	198	206	0	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					917	927		10.1016/S0140-6736(08)61402-6	http://dx.doi.org/10.1016/S0140-6736(08)61402-6			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790315				2022-12-28	WOS:000259266900032
J	Garber, A; Henry, R; Ratner, R; Garcia-Hernandez, PA; Rodriguez-Pattzi, H; Olvera-Alvarez, I; Hale, PM; Zdravkovic, M; Bode, B				Garber, Alan; Henry, Robert; Ratner, Robert; Garcia-Hernandez, Pedro A.; Rodriguez-Pattzi, Hiromi; Olvera-Alvarez, Israel; Hale, Paula M.; Zdravkovic, Milan; Bode, Bruce		LEAD-3 Mono Study Grp	Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial	LANCET			English	Article							GLUCAGON-LIKE PEPTIDE-1; IMPROVES GLYCEMIC CONTROL; GLP-1 ANALOG LIRAGLUTIDE; EXENATIDE EXENDIN-4; TREATED PATIENTS; METFORMIN; WEIGHT; RISK; PHARMACOKINETICS; NN2211	Background New treatments for type 2 diabetes mellitus are needed to retain insulin-glucose coupling and lower the risk of weight gain and hypoglycaemia. We aimed to investigate the safety and efficacy of liraglutide as monotherapy for this disorder. Methods in a double-blind, double-dummy, active-control, parallel-group study, 746 patients with early type 2 diabetes were randomly assigned to once daily liraglutide (1 . 2 mg [n=251] or 1. 8 mg [n=247]) or glimepiride 8 mg (n=248) for 52 weeks. The primary outcome was change in proportion of glycosylated haemoglobin (HbA(1c)). Analysis was done by intention-to- treat. This trial is registered with ClinicalTrials.gov, number NTC00294723. Findings At 52 weeks, HbA(1c) decreased by 0 . 51% (SD 1 . 20%) with glimepiride, compared with 0 . 84% (1.23%) with liraglutide 1.2 mg (difference 4.33%; 95% CI -0 . 53 to -0 . 13, p=0 . 0014) and 1. 14% (1. 24%) with liraglutide 1. 8 mg (-0.62; -0.83 to -0.42, p<0.0001). Five patients in the liraglutide 1.2 mg, and one in 1.8 mg groups discontinued treatment because of vomiting, whereas none in the glimepiride group did so. Interpretation Liraglutide is safe and effective as initial pharmacological therapy for type 2 diabetes mellitus and leads to greater reductions in HbA(1c) weight, hypoglycaemia, and blood pressure than does glimepiride. Funding Novo Nordisk A/S.	[Garber, Alan] Baylor Coll Med, Houston, TX 77030 USA; [Henry, Robert] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Ratner, Robert] Georgetown Univ, Sch Med, Hyattsville, MD USA; [Garcia-Hernandez, Pedro A.] Hosp Univ Monterrey, Monterrey, Mexico; [Rodriguez-Pattzi, Hiromi] Inst Mexicano Invest Clin, Mexico City, DF, Mexico; [Olvera-Alvarez, Israel] COMOP, Ctr Atenc Pacientes Osteosol, Hipodromo, Mexico; [Hale, Paula M.] Novo Nordisk Inc, Princeton, NJ USA; [Zdravkovic, Milan] Novo Nordisk AS, DK-2820 Gentofte, Denmark; [Bode, Bruce] Atlanta Diabet Assoc, Atlanta, GA USA	Baylor College of Medicine; University of California System; University of California San Diego; Georgetown University; Universidad Autonoma de Nuevo Leon; University Hospital Autonomous University of Nuevo Leon; Novo Nordisk; Novo Nordisk	Garber, A (corresponding author), Baylor Coll Med, 1709 Dryden Rd,Suite 1000, Houston, TX 77030 USA.	agarber@bcm.tmc.edu						Agerso H, 2002, DIABETOLOGIA, V45, P195, DOI 10.1007/s00125-001-0719-z; *AM PHARM INC, BYETT PRESCR INF; Aschner P, 2006, DIABETES CARE, V29, P2632, DOI 10.2337/dc06-0703; Bode BW, 2008, DIABETOLOGIA, V51, pS357; Brancati F, 2003, CONTROL CLIN TRIALS, V24, P610, DOI 10.1016/S0197-2456(03)00064-3; Brodows R, 2008, DIABETES, V57, pA145; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; DEFRONZO RA, 1995, NEW ENGL J MED, V333, P541, DOI 10.1056/NEJM199508313330902; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; JACOBSEN LV, 2007, DIABETES S1, V56, pA137; Juhl CB, 2002, DIABETES, V51, P424, DOI 10.2337/diabetes.51.2.424; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Knudsen LB, 2000, J MED CHEM, V43, P1664, DOI 10.1021/jm9909645; Merck and Co. Inc, JAN PRESCR INF; Monnier L, 2003, DIABETES CARE, V26, P881, DOI 10.2337/diacare.26.3.881; Retnakaran R, 2006, DIABETES, V55, P1832, DOI 10.2337/db05-1620; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593	19	812	905	3	80	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 7	2009	373	9662					473	481		10.1016/S0140-6736(08)61246-5	http://dx.doi.org/10.1016/S0140-6736(08)61246-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	404EF	18819705				2022-12-28	WOS:000263132800030
J	Nanto-Salonen, K; Kupila, A; Simell, S; Siljander, H; Salonsaari, T; Hekkala, A; Korhonen, S; Erkkola, R; Sipila, JI; Haavisto, L; Siltala, M; Tuominen, J; Hakalax, J; Hyoty, H; Ilonen, J; Veijola, R; Simell, T; Knip, M; Simell, O				Nanto-Salonen, Kirsti; Kupila, Antti; Simell, Satu; Siljander, Heli; Salonsaari, Tiina; Hekkala, Anne; Korhonen, Sari; Erkkola, Risto; Sipila, Jukka I.; Haavisto, Lotta; Siltala, Marja; Tuominen, Juhani; Hakalax, Jari; Hyoty, Heikki; Ilonen, Jorma; Veijola, Riitta; Simell, Tuula; Knip, Mikael; Simell, Olli			Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial	LANCET			English	Article							BETA-CELL FUNCTION; ORAL INSULIN; TRANSFER MODEL; GENETIC RISK; DIAGNOSIS; MELLITUS; HLA-DQB1; THERAPY; FINLAND; MARKERS	Background In mouse models of diabetes, prophylactic administration of insulin reduced incidence of the disease. We investigated whether administration of nasal insulin decreased the incidence of type 1 diabetes, in children with HLA genotypes and autoantibodies increasing the risk of the disease. Methods At three university hospitals in Turku, Oulu, and Tampere (Finland), we analysed cord blood samples of 116720 consecutively born infants, and 3430 of their siblings, for the HLA-DQB1 susceptibility alleles for type 1 diabetes. 17 397 infants and 1613 siblings had increased genetic risk, of whom 11225 and 1574, respectively, consented to screening of diabetes-associated autoantibodies at every 3-12 months. in a double-blind trial, we randomly assigned 224 infants and 40 siblings positive for two or more autoantibodies, in consecutive samples, to receive short-acting human insulin (1 unit/kg; n=115 and n=22) or placebo (n=109 and n=18) once a day intranasally. We used a restricted randomisation, stratified by site, with permuted blocks of size two. Primary endpoint was diagnosis of diabetes. Analysis was by intention to treat. The study was terminated early because insulin had no beneficial effect. This study is registered with ClinicalTrials.gov, number NCT00223613. Findings Median duration of the intervention was 1.8 years (range 0-9-7). Diabetes was diagnosed in 49 index children randomised to receive insulin, and in 47 randomised to placebo (hazard ratio [HRI 1.14; 95% Cl 0.73-1-77). 42 and 38 of these children, respectively, continued treatment until diagnosis, with yearly rates of diabetes onset of 16.8% (95% Cl 11 . 7-21.9) and 15.3% (10 . 5-20.2). Seven siblings were diagnosed with diabetes in the insulin group, versus six in the placebo group (HR 1 . 93; 0 - 56-6.77). In all randomised children, diabetes was diagnosed in 56 in the insulin group, and 53 in the placebo group (HR 0 . 98; 0 . 67-1.43, p=0 . 91). Interpretation In children with HLA-conferred susceptibility to diabetes, administration of nasal insulin, started soon after detection of autoantibodies, could not be shown to prevent or delay type 1 diabetes. Funding International: juvenile Diabetes Research Foundation International; European Union; Novo Nordisk Foundation. Finland: Academy of Finland; TEKES National Technology Agency of Finland; Special Research Funds for University Hospitals in Finland; Finnish Office for Health Technology Assessment; Diabetes Research Foundation, Finland; Sigrid Juselius Foundation; Emil Aaltonen Foundation; Jalmari and Rauha Ahokas Foundation; Signe and Ane Gyllenberg Foundation; the Research Foundation of Orion Corporation; Foundation for Pediatric Research; Pdivikki and Sakari Sohlberg Foundation.	[Nanto-Salonen, Kirsti; Kupila, Antti; Simell, Satu; Hakalax, Jari; Simell, Tuula; Simell, Olli] Univ Turku, Dept Paediat, FI-20521 Turku, Finland; [Erkkola, Risto] Univ Turku, Dept Obstet & Gynecol, FI-20521 Turku, Finland; [Sipila, Jukka I.; Haavisto, Lotta] Univ Turku, Dept Otorhinolaryngol, FI-20521 Turku, Finland; [Siltala, Marja; Tuominen, Juhani] Univ Turku, Dept Stat, FI-20521 Turku, Finland; [Ilonen, Jorma] Univ Turku, Immunogenet Lab, FI-20521 Turku, Finland; [Kupila, Antti] Paijat Hame Cent Hosp, Dept Paediat, Lahti, Finland; [Siljander, Heli; Knip, Mikael] Univ Helsinki, Hosp Children & Adolescents, Helsinki, Finland; [Siljander, Heli; Salonsaari, Tiina; Knip, Mikael] Tampere Univ Hosp, Dept Paediat, Tampere, Finland; [Hyoty, Heikki] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Hyoty, Heikki] Univ Tampere, Sch Med, Dept Virol, FIN-33101 Tampere, Finland; [Hekkala, Anne; Korhonen, Sari; Veijola, Riitta] Univ Oulu, Dept Paediat, Oulu, Finland; [Ilonen, Jorma] Univ Kuopio, Dept Clin Microbiol, FIN-70211 Kuopio, Finland	University of Turku; University of Turku; University of Turku; University of Turku; University of Turku; Paijat Hame Central Hospital; University of Helsinki; Tampere University; Tampere University Hospital; Tampere University; Tampere University Hospital; Tampere University; University of Oulu; University of Eastern Finland	Nanto-Salonen, K (corresponding author), Univ Turku, Dept Paediat, POB 52, FI-20521 Turku, Finland.	kirsti.nanto-salonen@tyks.fi	Knip, Mikael/AAL-3773-2020	Hyoty, Heikki/0000-0003-0370-4145; Saarinen, Maiju/0000-0003-3346-3688; Knip, Mikael/0000-0003-0474-0033	Diabetes Research Foundation International [4-1998-274, 4-1999-731, 4-2001-435]; European Union [BMH4-CT98-3314]; Novo Nordisk Foundation; Academy of Finland [68292]; TEKES National Technology Agency of Finland; Special Research Funds for University Hospitals in Finland; Finnish Office for Health Technology Assessment; Diabetes Research Foundation, Finland; Sigrid Juselius Foundation (Finland); Emil Aaltonen Foundation (Finland); Jalmari and Raulia Ahokas Foundation (Finland); Signe and Ane Cyllenberg Foundation (Finland); Research Foundation of Orion Corporation (Finland); Foundation for Pediatric Research (Finland); Paivikki and Sakari Sohlberg Foundation (Finland)	Diabetes Research Foundation International; European Union(European Commission); Novo Nordisk Foundation; Academy of Finland(Academy of FinlandNovo Nordisk Foundation); TEKES National Technology Agency of Finland(Finnish Funding Agency for Technology & Innovation (TEKES)); Special Research Funds for University Hospitals in Finland; Finnish Office for Health Technology Assessment; Diabetes Research Foundation, Finland; Sigrid Juselius Foundation (Finland)(Sigrid Juselius Foundation); Emil Aaltonen Foundation (Finland); Jalmari and Raulia Ahokas Foundation (Finland); Signe and Ane Cyllenberg Foundation (Finland); Research Foundation of Orion Corporation (Finland); Foundation for Pediatric Research (Finland); Paivikki and Sakari Sohlberg Foundation (Finland)	This work was supported by grants from juvenile Diabetes Research Foundation International (grants 4-1998-274, 4-1999-731, 4-2001-435); European Union (grant BMH4-CT98-3314); Novo Nordisk Foundation; Academy of Finland (grant 68292); TEKES National Technology Agency of Finland; Special Research Funds for University Hospitals in Finland; Finnish Office for Health Technology Assessment; Diabetes Research Foundation, Finland; Sigrid Juselius Foundation (Finland); Emil Aaltonen Foundation (Finland); Jalmari and Raulia Ahokas Foundation (Finland); Signe and Ane Cyllenberg Foundation (Finland); the Research Foundation of Orion Corporation (Finland): Foundation for Pediatric Research (Finland); and Paivikki and Sakari Sohlberg Foundation (Finland). We thank Jussi Huttunen (Helsinki, Finland, former Head of the National Public Health Institute, Helsinki, Finland), Mika Scheinin (Department of Clinical Pharmacology, University of Turku, Turku, Finland), and Hans Akerblom (Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland) for their activity in the data and safety monitoring board for the study; the dedicated personnel of the DIPP study in Turku, Oulu, and Tampere; and the study children and their families for their essential contribution.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Bellmann K, 1998, DIABETOLOGIA, V41, P844, DOI 10.1007/s001250050997; Bergerot I, 1996, ANN NY ACAD SCI, V778, P362, DOI 10.1111/j.1749-6632.1996.tb21144.x; Bowman MA, 1996, DIABETES, V45, P205, DOI 10.2337/diabetes.45.2.205; Chaillous L, 2000, LANCET, V356, P545, DOI 10.1016/S0140-6736(00)02579-4; Ergun-Longmire B, 2004, ANN NY ACAD SCI, V1029, P260, DOI 10.1196/annals.1309.057; Faria Ana M. C., 2006, Inflammation & Allergy Drug Targets, V5, P179; Gale EAM, 1996, J PEDIATR ENDOCR MET, V9, P375; Gavin JR, 1997, DIABETES CARE, V20, P1183; Hekkala A, 2007, DIABETES CARE, V30, P861, DOI 10.2337/dc06-2281; HILBERG O, 1989, J APPL PHYSIOL, V66, P295, DOI 10.1152/jappl.1989.66.1.295; Ilonen J, 1996, DIABETES CARE, V19, P795, DOI 10.2337/diacare.19.8.795; Karounos DG, 1997, J CLIN INVEST, V100, P1344, DOI 10.1172/JCI119654; KELLER RJ, 1993, LANCET, V341, P927, DOI 10.1016/0140-6736(93)91215-8; Kersten Gideon, 2004, Expert Rev Vaccines, V3, P453, DOI 10.1586/14760584.3.4.453; Keskinen P, 2002, DIABETOLOGIA, V45, P1639, DOI 10.1007/s00125-002-0981-8; Knip M, 2005, DIABETES, V54, pS125, DOI 10.2337/diabetes.54.suppl_2.S125; Kukko M, 2005, J CLIN ENDOCR METAB, V90, P2712, DOI 10.1210/jc.2004-1371; Kupila A, 2003, DIABETES-METAB RES, V19, P415, DOI 10.1002/dmrr.397; Kupila A, 2002, DIABETES, V51, P646, DOI 10.2337/diabetes.51.3.646; Ludvigsson J, 2007, PEDIATR DIABETES, V8, P34, DOI 10.1111/j.1399-5448.2007.00299.x; Nejentsev S, 1999, DIABETIC MED, V16, P985, DOI 10.1046/j.1464-5491.1999.00186.x; Polanski M, 1997, J AUTOIMMUN, V10, P339, DOI 10.1006/jaut.1997.0148; Pozzilli P, 2000, DIABETOLOGIA, V43, P1000, DOI 10.1007/s001250051482; Simonen P, 2006, ARCH PEDIAT ADOL MED, V160, P1131, DOI 10.1001/archpedi.160.11.1131; Skyler JS, 2005, DIABETES CARE, V28, P1630, DOI 10.2337/diacare.28.7.1630; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Tiittanen M, 2006, DIABETES, V55, P3446, DOI 10.2337/db06-0132; Veijola R, 1996, J CLIN INVEST, V98, P2489, DOI 10.1172/JCI119067; Weiner HL, 2004, ANN NY ACAD SCI, V1029, P211, DOI 10.1196/annals.1309.053	31	265	278	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1746	1755		10.1016/S0140-6736(08)61309-4	http://dx.doi.org/10.1016/S0140-6736(08)61309-4			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	374XV	18814906				2022-12-28	WOS:000261077900024
J	Stadtfeld, M; Nagaya, M; Utikal, J; Weir, G; Hochedlinger, K				Stadtfeld, Matthias; Nagaya, Masaki; Utikal, Jochen; Weir, Gordon; Hochedlinger, Konrad			Induced Pluripotent Stem Cells Generated Without Viral Integration	SCIENCE			English	Article							FIBROBLASTS; EXPRESSION; INDUCTION; LIVER	Pluripotent stem cells have been generated from mouse and human somatic cells by viral expression of the transcription factors Oct4, Sox2, Klf4, and c-Myc. A major limitation of this technology is the use of potentially harmful genome- integrating viruses. We generated mouse induced pluripotent stem ( iPS) cells from fibroblasts and liver cells by using nonintegrating adenoviruses transiently expressing Oct4, Sox2, Klf4, and c- Myc. These adenoviral iPS ( adeno- iPS) cells show DNA demethylation characteristic of reprogrammed cells, express endogenous pluripotency genes, form teratomas, and contribute to multiple tissues, including the germ line, in chimeric mice. Our results provide strong evidence that insertional mutagenesis is not required for in vitro reprogramming. Adenoviral reprogramming may provide an improved method for generating and studying patient- specific stem cells and for comparing embryonic stem cells and iPS cells.	[Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Harvard Univ, Stem Cell Inst, Cambridge, MA 02138 USA; [Nagaya, Masaki; Weir, Gordon] Joslin Diabet Ctr, Sect Islet Transplantat & Cell Biol, Boston, MA 02115 USA; [Stadtfeld, Matthias; Utikal, Jochen; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Stadtfeld, Matthias; Nagaya, Masaki; Utikal, Jochen; Weir, Gordon; Hochedlinger, Konrad] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard Medical School	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Utikal, Jochen/0000-0001-5316-0241; Stadtfeld, Matthias/0000-0002-5852-9906	Schering postdoctoral fellowship; Mildred Scheel postdoctoral fellowship; Juvenile Diabetes Research Foundation; NIH Director's Innovator Award; Harvard Stem Cell Institute; Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Schering postdoctoral fellowship; Mildred Scheel postdoctoral fellowship(Deutsche Krebshilfe); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); NIH Director's Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Hock for critical comments on the manuscript and L. Prickett and K. Folz-Donahue for expert help with flow cytometry. We are especially grateful to J. Lee of the Harvard Gene Therapy Initiative for help with the generation of adenoviral vectors. M. S. was supported by a Schering postdoctoral fellowship, J.U. was supported by a Mildred Scheel postdoctoral fellowship and M.N. and G.W. received support from the Juvenile Diabetes Research Foundation. Support to K.H. was from the NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation and the V Foundation. The authors are filing a patent based on the results reported in this paper.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; EMINLI S, 2008, STEM CELLS IN P 0617; Gupta S, 2000, SEMIN CANCER BIOL, V10, P161; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Harui A, 1999, J VIROL, V73, P6141, DOI 10.1128/JVI.73.7.6141-6146.1999; Hawley RG, 2008, MOL THER, V16, P1354, DOI 10.1038/mt.2008.142; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; LI QT, 1993, HUM GENE THER, V4, P403, DOI 10.1089/hum.1993.4.4-403; Louis N, 1997, VIROLOGY, V233, P423, DOI 10.1006/viro.1997.8597; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; STADTFELD M, 2008, CURR BIOL; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamada S, 2006, ENDOCR J, V53, P789, DOI 10.1507/endocrj.K06-116; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	28	1190	1432	6	206	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 7	2008	322	5903					945	949		10.1126/science.1162494	http://dx.doi.org/10.1126/science.1162494			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DI	18818365	Green Accepted			2022-12-28	WOS:000260674100048
J	Chin, L; Meyerson, M; Aldape, K; Bigner, D; Mikkelsen, T; VandenBerg, S; Kahn, A; Penny, R; Ferguson, ML; Gerhard, DS; Getz, G; Brennan, C; Taylor, BS; Winckler, W; Park, P; Ladanyi, M; Hoadley, KA; Verhaak, RGW; Hayes, DN; Spellman, PT; Absher, D; Weir, BA; Ding, L; Wheeler, D; Lawrence, MS; Cibulskis, K; Mardis, E; Zhang, JH; Wilson, RK; Donehower, L; Wheeler, DA; Purdom, E; Wallis, J; Laird, PW; Herman, JG; Schuebel, KE; Weisenberger, DJ; Baylin, SB; Schultz, N; Yao, J; Wiedemeyer, R; Weinstein, J; Sander, C; Gibbs, RA; Gray, J; Kucherlapati, R; Lander, ES; Myers, RM; Perou, CM; McLendon, R; Friedman, A; Van Meir, EG; Brat, DJ; Mastrogianakis, GM; Olson, JJ; Lehman, N; Yung, WKA; Bogler, O; Berger, M; Prados, M; Muzny, D; Morgan, M; Scherer, S; Sabo, A; Nazareth, L; Lewis, L; Hall, O; Zhu, YM; Ren, YR; Alvi, O; Yao, JQ; Hawes, A; Jhangiani, S; Fowler, G; San Lucas, A; Kovar, C; Cree, A; Dinh, H; Santibanez, J; Joshi, V; Gonzalez-Garay, ML; Miller, CA; Milosavljevic, A; Sougnez, C; Fennell, T; Mahan, S; Wilkinson, J; Ziaugra, L; Onofrio, R; Bloom, T; Nicol, R; Ardlie, K; Baldwin, J; Gabriel, S; Fulton, RS; McLellan, MD; Larson, DE; Shi, XQ; Abbott, R; Fulton, L; Chen, K; Koboldt, DC; Wendl, MC; Meyer, R; Tang, YZ; Lin, L; Osborne, JR; Dunford-Shore, BH; Miner, TL; Delehaunty, K; Markovic, C; Swift, G; Courtney, W; Pohl, C; Abbott, S; Hawkins, A; Leong, S; Haipek, C; Schmidt, H; Wiechert, M; Vickery, T; Scott, S; Dooling, DJ; Chinwalla, A; Weinstock, GM; O'Kelly, M; Robinson, J; Alexe, G; Beroukhim, R; Carter, S; Chiang, D; Gould, J; Gupta, S; Korn, J; Mermel, C; Mesirov, J; Monti, S; Nguyen, H; Parkin, M; Reich, M; Stransky, N; Garraway, L; Golub, T; Protopopov, A; Perna, I; Aronson, S; Sathiamoorthy, N; Ren, G; Kim, H; Kong, SK; Xiao, YH; Kohane, IS; Seidman, J; Cope, L; Pan, F; Van Den Berg, D; Van Neste, L; Yi, JM; Li, JZ; Southwick, A; Brady, S; Aggarwal, A; Chung, T; Sherlock, G; Brooks, JD; Jakkula, LR; Lapuk, AV; Marr, H; Dorton, S; Choi, YG; Han, J; Ray, A; Wang, V; Durinck, S; Robinson, M; Wang, NJ; Vranizan, K; Peng, V; Van Name, E; Fontenay, GV; Ngai, J; Conboy, JG; Parvin, B; Feiler, HS; Speed, TP; Socci, ND; Olshen, A; Lash, A; Reva, B; Antipin, Y; Stukalov, A; Gross, B; Cerami, E; Wang, WQ; Qin, LX; Seshan, VE; Villafania, L; Cavatore, M; Borsu, L; Viale, A; Gerald, W; Topal, MD; Qi, Y; Balu, S; Shi, Y; Wu, G; Bittner, M; Shelton, T; Lenkiewicz, E; Morris, S; Beasley, D; Sanders, S; Sfeir, R; Chen, J; Nassau, D; Feng, L; Hickey, E; Schaefer, C; Madhavan, S; Buetow, K; Barker, A; Vockley, J; Compton, C; Vaught, J; Fielding, P; Collins, F; Good, P; Guyer, M; Ozenberger, B; Peterson, J; Thomson, E				Chin, L.; Meyerson, M.; Aldape, K.; Bigner, D.; Mikkelsen, T.; VandenBerg, S.; Kahn, A.; Penny, R.; Ferguson, M. L.; Gerhard, D. S.; Getz, G.; Brennan, C.; Taylor, B. S.; Winckler, W.; Park, P.; Ladanyi, M.; Hoadley, K. A.; Verhaak, R. G. W.; Hayes, D. N.; Spellman, Paul T.; Absher, D.; Weir, B. A.; Ding, L.; Wheeler, D.; Lawrence, M. S.; Cibulskis, K.; Mardis, E.; Zhang, Jinghui; Wilson, R. K.; Donehower, L.; Wheeler, D. A.; Purdom, E.; Wallis, J.; Laird, P. W.; Herman, J. G.; Schuebel, K. E.; Weisenberger, D. J.; Baylin, S. B.; Schultz, N.; Yao, Jun; Wiedemeyer, R.; Weinstein, J.; Sander, C.; Gibbs, R. A.; Gray, J.; Kucherlapati, R.; Lander, E. S.; Myers, R. M.; Perou, C. M.; McLendon, Roger; Friedman, Allan; Van Meir, Erwin G; Brat, Daniel J; Mastrogianakis, Gena Marie; Olson, Jeffrey J; Lehman, Norman; Yung, W. K. Alfred; Bogler, Oliver; Berger, Mitchel; Prados, Michael; Muzny, Donna; Morgan, Margaret; Scherer, Steve; Sabo, Aniko; Nazareth, Lynn; Lewis, Lora; Hall, Otis; Zhu, Yiming; Ren, Yanru; Alvi, Omar; Yao, Jiqiang; Hawes, Alicia; Jhangiani, Shalini; Fowler, Gerald; San Lucas, Anthony; Kovar, Christie; Cree, Andrew; Dinh, Huyen; Santibanez, Jireh; Joshi, Vandita; Gonzalez-Garay, Manuel L.; Miller, Christopher A.; Milosavljevic, Aleksandar; Sougnez, Carrie; Fennell, Tim; Mahan, Scott; Wilkinson, Jane; Ziaugra, Liuda; Onofrio, Robert; Bloom, Toby; Nicol, Rob; Ardlie, Kristin; Baldwin, Jennifer; Gabriel, Stacey; Fulton, Robert S.; McLellan, Michael D.; Larson, David E.; Shi, Xiaoqi; Abbott, Rachel; Fulton, Lucinda; Chen, Ken; Koboldt, Daniel C.; Wendl, Michael C.; Meyer, Rick; Tang, Yuzhu; Lin, Ling; Osborne, John R.; Dunford-Shore, Brian H.; Miner, Tracie L.; Delehaunty, Kim; Markovic, Chris; Swift, Gary; Courtney, William; Pohl, Craig; Abbott, Scott; Hawkins, Amy; Leong, Shin; Haipek, Carrie; Schmidt, Heather; Wiechert, Maddy; Vickery, Tammi; Scott, Sacha; Dooling, David J.; Chinwalla, Asif; Weinstock, George M.; O'Kelly, Michael; Robinson, Jim; Alexe, Gabriele; Beroukhim, Rameen; Carter, Scott; Chiang, Derek; Gould, Josh; Gupta, Supriya; Korn, Josh; Mermel, Craig; Mesirov, Jill; Monti, Stefano; Nguyen, Huy; Parkin, Melissa; Reich, Michael; Stransky, Nicolas; Garraway, Levi; Golub, Todd; Protopopov, Alexei; Perna, Ilana; Aronson, Sandy; Sathiamoorthy, Narayan; Ren, Georgia; Kim, Hyunsoo; Kong, Sek Won; Xiao, Yonghong; Kohane, Isaac S.; Seidman, Jon; Cope, Leslie; Pan, Fei; Van Den Berg, David; Van Neste, Leander; Yi, Joo Mi; Li, Jun Z.; Southwick, Audrey; Brady, Shannon; Aggarwal, Amita; Chung, Tisha; Sherlock, Gavin; Brooks, James D.; Jakkula, Lakshmi R.; Lapuk, Anna V.; Marr, Henry; Dorton, Shannon; Choi, Yoon Gi; Han, Ju; Ray, Amrita; Wang, Victoria; Durinck, Steffen; Robinson, Mark; Wang, Nicholas J.; Vranizan, Karen; Peng, Vivian; Van Name, Eric; Fontenay, Gerald V.; Ngai, John; Conboy, John G.; Parvin, Bahram; Feiler, Heidi S.; Speed, Terence P.; Socci, Nicholas D.; Olshen, Adam; Lash, Alex; Reva, Boris; Antipin, Yevgeniy; Stukalov, Alexey; Gross, Benjamin; Cerami, Ethan; Wang, Wei Qing; Qin, Li-Xuan; Seshan, Venkatraman E.; Villafania, Liliana; Cavatore, Magali; Borsu, Laetitia; Viale, Agnes; Gerald, William; Topal, Michael D.; Qi, Yuan; Balu, Sai; Shi, Yan; Wu, George; Bittner, Michael; Shelton, Troy; Lenkiewicz, Elizabeth; Morris, Scott; Beasley, Debbie; Sanders, Sheri; Sfeir, Robert; Chen, Jessica; Nassau, David; Feng, Larry; Hickey, Erin; Schaefer, Carl; Madhavan, Subha; Buetow, Ken; Barker, Anna; Vockley, Joseph; Compton, Carolyn; Vaught, Jim; Fielding, Peter; Collins, Francis; Good, Peter; Guyer, Mark; Ozenberger, Brad; Peterson, Jane; Thomson, Elizabeth		Canc Genome Atlas Res Network; Tissue Source Sites; Genome Sequencing Ctr; Canc Genome Characterization Ctr; Project Teams	Comprehensive genomic characterization defines human glioblastoma genes and core pathways	NATURE			English	Article							MISMATCH REPAIR; NF1 GENE; SOMATIC MUTATIONS; MALIGNANT GLIOMAS; HIGH-FREQUENCY; PIK3CA GENE; MGMT; INACTIVATION; TEMOZOLOMIDE; CANCER	Human cancer cells typically harbour multiple chromosomal aberrations, nucleotide substitutions and epigenetic modifications that drive malignant transformation. The Cancer Genome Atlas ( TCGA) pilot project aims to assess the value of large- scale multi- dimensional analysis of these molecular characteristics in human cancer and to provide the data rapidly to the research community. Here we report the interim integrative analysis of DNA copy number, gene expression and DNA methylation aberrations in 206 glioblastomas - the most common type of primary adult brain cancer - and nucleotide sequence aberrations in 91 of the 206 glioblastomas. This analysis provides new insights into the roles of ERBB2, NF1 and TP53, uncovers frequent mutations of the phosphatidylinositol- 3- OH kinase regulatory subunit gene PIK3R1, and provides a network view of the pathways altered in the development of glioblastoma. Furthermore, integration of mutation, DNA methylation and clinical treatment data reveals a link between MGMT promoter methylation and a hypermutator phenotype consequent to mismatch repair deficiency in treated glioblastomas, an observation with potential clinical implications. Together, these findings establish the feasibility and power of TCGA, demonstrating that it can rapidly expand knowledge of the molecular basis of cancer.	[Chin, L.; Meyerson, M.; Winckler, W.; Verhaak, R. G. W.; Weir, B. A.; Wiedemeyer, R.; Beroukhim, Rameen; Chiang, Derek; Mermel, Craig; Garraway, Levi] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chin, L.; Yao, Jun; Protopopov, Alexei; Perna, Ilana; Ren, Georgia; Xiao, Yonghong] Dana Farber Canc Inst, Ctr Appl Canc Sci, Belfer Inst innovat Canc Sci, Boston, MA 02115 USA; [Chin, L.; Robinson, Jim; Alexe, Gabriele; Carter, Scott] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Meyerson, M.; Getz, G.; Winckler, W.; Verhaak, R. G. W.; Weir, B. A.; Lawrence, M. S.; Lander, E. S.; O'Kelly, Michael; Beroukhim, Rameen; Chiang, Derek; Gould, Josh; Gupta, Supriya; Korn, Josh; Mermel, Craig; Mesirov, Jill; Monti, Stefano; Nguyen, Huy; Parkin, Melissa; Reich, Michael; Stransky, Nicolas; Garraway, Levi; Golub, Todd] Harvard Univ, Cambridge, MA 02142 USA; [Bigner, D.; McLendon, Roger] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Friedman, Allan] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Mikkelsen, T.] Henry Ford Hosp, Dept Neurol Surg, Detroit, MI 48202 USA; [VandenBerg, S.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Aldape, K.] Univ Texas Houston MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Yung, W. K. Alfred] Univ Texas Houston MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Bogler, Oliver] Univ Texas Houston MD Anderson Canc Ctr, Dept Neurosurg, Houston, TX 77030 USA; [Kahn, A.; Sfeir, Robert; Chen, Jessica; Nassau, David; Feng, Larry; Hickey, Erin] SRA Int, Fairfax, VA 22033 USA; NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20852 USA; [Collins, Francis; Good, Peter; Guyer, Mark; Ozenberger, Brad; Peterson, Jane; Thomson, Elizabeth] NIH, Natl Human Genome Res Inst, Bethesda, MD 20892 USA; [Gerhard, D. S.; Barker, Anna; Vockley, Joseph; Compton, Carolyn; Vaught, Jim; Fielding, Peter] NCI, NIH, Bethesda, MD 20892 USA; [Penny, R.; Shelton, Troy; Lenkiewicz, Elizabeth; Morris, Scott; Beasley, Debbie; Sanders, Sheri] Int Genom Consortium, Phoenix, AZ 85004 USA; [Ferguson, M. L.] MLF Consulting, Arlington, MA 02474 USA; [Ding, L.; Mardis, E.; Wilson, R. K.; Wallis, J.; Fennell, Tim; Baldwin, Jennifer; Fulton, Robert S.; McLellan, Michael D.; Larson, David E.; Shi, Xiaoqi; Abbott, Rachel; Fulton, Lucinda; Chen, Ken; Koboldt, Daniel C.; Wendl, Michael C.; Meyer, Rick; Tang, Yuzhu; Lin, Ling; Osborne, John R.; Dunford-Shore, Brian H.; Miner, Tracie L.; Delehaunty, Kim; Markovic, Chris; Swift, Gary; Courtney, William; Pohl, Craig; Abbott, Scott; Hawkins, Amy; Leong, Shin; Haipek, Carrie; Schmidt, Heather; Wiechert, Maddy; Vickery, Tammi; Scott, Sacha; Dooling, David J.; Chinwalla, Asif; Weinstock, George M.] Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA; Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21231 USA; [Park, P.; Aronson, Sandy; Sathiamoorthy, Narayan; Kim, Hyunsoo; Kohane, Isaac S.] Harvard Univ, Sch Med, Partners Healthcare Ctr Genet & Genom, Boston, MA 02115 USA; [Park, P.; Kucherlapati, R.; Kohane, Isaac S.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Park, P.; Kong, Sek Won; Kohane, Isaac S.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Brennan, C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg, New York, NY 10065 USA; [Taylor, B. S.; Schultz, N.; Sander, C.; Socci, Nicholas D.; Lash, Alex; Reva, Boris; Antipin, Yevgeniy; Stukalov, Alexey; Gross, Benjamin; Cerami, Ethan; Wang, Wei Qing; Gerald, William] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA; [Taylor, B. S.] Weill Cornell Grad Sch Med Sci, Dept Physiol & Biophys, New York, NY 10065 USA; [Ladanyi, M.; Borsu, Laetitia] Mem Sloan Kettering Canc Ctr, Dept Pathol, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Spellman, Paul T.; Gray, J.; Jakkula, Lakshmi R.; Lapuk, Anna V.; Marr, Henry; Dorton, Shannon; Han, Ju; Ray, Amrita; Durinck, Steffen; Wang, Nicholas J.; Fontenay, Gerald V.; Conboy, John G.; Parvin, Bahram; Feiler, Heidi S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Purdom, E.; Wang, Victoria; Speed, Terence P.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 95720 USA; [Choi, Yoon Gi; Vranizan, Karen; Peng, Vivian; Van Name, Eric; Ngai, John] Univ Calif Berkeley, Dept Mol & Cellular Biol, Berkeley, CA 95720 USA; [Robinson, Mark; Speed, Terence P.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Southwick, Audrey; Brady, Shannon; Aggarwal, Amita; Chung, Tisha; Sherlock, Gavin] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Brooks, James D.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Wheeler, D.; Donehower, L.; Wheeler, D. A.] Baylor Coll Med, Human Genome Sequencing Ctr, Dept Mol Virol & Microbiol, Houston, TX 77030 USA; [Perou, C. M.; Miller, Christopher A.; Milosavljevic, Aleksandar] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Perou, C. M.; Milosavljevic, Aleksandar] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; Univ N Carolina, Dept Genet, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Hoadley, K. A.; Topal, Michael D.] Univ N Carolina, Dept Pathol & Lab Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Qi, Yuan] Univ N Carolina, Dept Internal Med, Lineberger Comprehens Canc Ctr, Div Med Oncol, Chapel Hill, NC 27599 USA; [Hayes, D. N.; Herman, J. G.; Schuebel, K. E.; Baylin, S. B.; Yi, Joo Mi] Johns Hopkins Univ, Div Canc Biol, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Cope, Leslie] Johns Hopkins Univ, Biometry & Clin Trials Div, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21231 USA; [Van Neste, Leander] Univ Ghent, Fac Biosci & Engn, Dept Mol Biotechnol, B-9000 Ghent, Belgium; [Van Meir, Erwin G; Mastrogianakis, Gena Marie; Olson, Jeffrey J] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G; Olson, Jeffrey J] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G; Brat, Daniel J; Olson, Jeffrey J] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Brat, Daniel J] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Laird, P. W.; Weisenberger, D. J.; Pan, Fei; Van Den Berg, David] Univ So Calif, USC Epigenome Ctr, Los Angeles, CA 90089 USA; [Lehman, Norman] Henry Ford Hosp, Dept Pathol, Detroit, MI 48202 USA; [Berger, Mitchel; Prados, Michael] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Cibulskis, K.; Sougnez, Carrie] MIT, Eli & Edythe L Broad Inst, Canc Genome Project, Cambridge, MA 02142 USA; [Sougnez, Carrie] MIT, Eli & Edythe L Broad Inst, Med Resequencing Project, Cambridge, MA 02142 USA; [Lander, E. S.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Lander, E. S.] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA; [Golub, Todd] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Seidman, Jon] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Absher, D.; Myers, R. M.] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Olshen, Adam; Qin, Li-Xuan; Seshan, Venkatraman E.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10065 USA; [Villafania, Liliana; Cavatore, Magali; Viale, Agnes] Mem Sloan Kettering Canc Ctr, Genom Core Lab, New York, NY 10065 USA; [Bittner, Michael] Translat Genom Res Inst, Computat Biol Div, Phoenix, AZ 85004 USA; [Zhang, Jinghui; Schaefer, Carl; Madhavan, Subha; Buetow, Ken] NCI, Ctr Biomed Informat & Informat Technol, Rockville, MD 20852 USA; [Weinstein, J.] Univ Texas Houston MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Li, Jun Z.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kong, Sek Won] Childrens Hosp, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Duke University; Duke University; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; SRA International; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); International Genomics Consortium; Washington University (WUSTL); Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Walter & Eliza Hall Institute; Stanford University; Stanford University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Ghent University; Emory University; Emory University; Emory University; Emory University; University of Southern California; Henry Ford Health System; Henry Ford Hospital; University of California System; University of California San Francisco; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; HudsonAlpha Institute for Biotechnology; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Translational Genomics Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Texas System; UTMD Anderson Cancer Center; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital	Chin, L (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu; matthew_meyerson@dfci.harvard.edu	Mermel, Craig/AAZ-7322-2020; Chen, Ken/A-1074-2009; Verhaak, Roel/ABE-7058-2020; Chen, Ken/AAU-1432-2021; Speed, Terence P/B-8085-2009; Perou, Charles M/H-9934-2014; Stukalov, Alexey/AAS-3208-2021; Robinson, Mark D/A-6432-2015; Reva, Boris/AAB-8932-2022; Brennan, Cameron/R-7082-2019; Schultz, Nikolaus/ABE-6347-2020; Lehman, Norman L/A-7351-2015; Kohane, Isaac Kohane/K-3716-2012; Wilson, Richard K./AAF-4139-2019; Wheeler, David A/M-9740-2018; Zhang, Jing/HII-4294-2022; Miller, Christopher A./A-1060-2009; Califano, Andrea/F-7239-2012; Mardis, Elaine/W-2202-2019; Robinson, Mark D./O-2254-2019; Wendl, Michael C/A-2741-2008; Sander, Chris/H-1452-2011; Laird, Peter W/G-8683-2012; Zhang, Jing/GWZ-7332-2022; Sherlock, Gavin J/E-9110-2012; Cibulskis, Kristian/AAC-7380-2019; Reva, Boris A./B-6436-2014; Prados, Michael/N-5220-2019; Lawrence, Michael/AAC-8202-2020; Weisenberger, Daniel/AAA-8314-2020; Ladanyi, Marc/AAG-8585-2019; Mesirov, Jill/AGF-7626-2022; Meyerson, Matthew L/E-7123-2012; Van Den Berg, David J/G-8598-2017; Weinstock, George M/C-6314-2013; Kucherlapati, Raju/ABC-8807-2021; Chiang, Derek/L-6452-2019	Mermel, Craig/0000-0002-0816-3395; Chen, Ken/0000-0003-4013-5279; Speed, Terence P/0000-0002-5403-7998; Perou, Charles M/0000-0001-9827-2247; Stukalov, Alexey/0000-0002-4981-8124; Robinson, Mark D/0000-0002-3048-5518; Brennan, Cameron/0000-0003-4064-8891; Kohane, Isaac Kohane/0000-0003-2192-5160; Wilson, Richard K./0000-0002-1992-1358; Wheeler, David A/0000-0002-9056-6299; Miller, Christopher A./0000-0003-4266-6700; Robinson, Mark D./0000-0002-3048-5518; Sander, Chris/0000-0001-6059-6270; Laird, Peter W/0000-0001-9117-3641; Reva, Boris A./0000-0002-8805-389X; Weisenberger, Daniel/0000-0001-8303-2603; Van Den Berg, David J/0000-0002-5404-5218; Weinstock, George M/0000-0002-2997-4592; Chinwalla, Asif/0000-0001-7831-3996; Weinstein, John/0000-0001-9401-6908; Nicol, Robert/0000-0003-1932-1392; MCLELLAN, MICHAEL/0000-0002-2703-8784; Larson, David/0000-0001-7934-5906; Bogler, Oliver/0000-0002-3700-0480; Sherlock, Gavin/0000-0002-1692-4983; Gonzalez-Garay, Manuel/0000-0003-3412-0353; Lash, Alex/0000-0003-3787-1590; Hoadley, Katherine/0000-0002-1216-477X; Li, Jun/0000-0001-6727-0812; Cibulskis, Kristian/0000-0003-1343-1582; Park, Peter/0000-0001-9378-960X; Hayes, D. Neil/0000-0001-6203-7771; Van Meir, Erwin G./0000-0003-2444-7707; Reich, Michael/0000-0003-4735-5514; Lehman, Norman/0000-0001-8394-2607	United States National Institutes of Health [U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA126544, U24CA126546, U24CA126551, U24CA126554, U24CA126561, U24CA126563]; NATIONAL CANCER INSTITUTE [ZIHBC010470, R01CA099041, U24CA126551, U24CA126546, U24CA126544, U24CA126554, U24CA126543, U24CA126563, U24CA126561, U24CA143848] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, U54HG003273, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of TCGA's External Scientific Committee, the Glioblastoma Disease Working Group (http:// cancergenome.nih.gov/components) and D. N. Louis for discussions; A. Mirick, J. Melone and C. Collins for administrative coordination of TCGA activities; and L. Gaffney for graphic art. This work was supported by the following grants from the United States National Institutes of Health: U54HG003067, U54HG003079, U54HG003273, U24CA126543, U24CA126544, U24CA126546, U24CA126551, U24CA126554, U24CA126561 and U24CA126563.	Bader AG, 2006, P NATL ACAD SCI USA, V103, P1475, DOI 10.1073/pnas.0510857103; Bader AG, 2005, NAT REV CANCER, V5, P921, DOI 10.1038/nrc1753; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Cahill DP, 2007, CLIN CANCER RES, V13, P2038, DOI 10.1158/1078-0432.CCR-06-2149; Casorelli I, 2008, ANTI-CANCER AGENT ME, V8, P368, DOI 10.2174/187152008784220276; Diehn M, 2008, P NATL ACAD SCI USA, V105, P5213, DOI 10.1073/pnas.0801279105; Drablos F, 2004, DNA REPAIR, V3, P1389, DOI 10.1016/j.dnarep.2004.05.004; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fahsold R, 2000, AM J HUM GENET, V66, P790, DOI 10.1086/302809; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Gallia GL, 2006, MOL CANCER RES, V4, P709, DOI 10.1158/1541-7786.MCR-06-0172; Getz G, 2007, SCIENCE, V317, DOI 10.1126/science.1138764; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hirose Y, 2003, J NEUROSURG, V98, P591, DOI 10.3171/jns.2003.98.3.0591; Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799; HUMPHREY PA, 1990, P NATL ACAD SCI USA, V87, P4207, DOI 10.1073/pnas.87.11.4207; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Kaina B, 2007, DNA REPAIR, V6, P1079, DOI 10.1016/j.dnarep.2007.03.008; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lee JC, 2006, PLOS MED, V3, P2264, DOI 10.1371/journal.pmed.0030485; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liang Y, 2005, P NATL ACAD SCI USA, V102, P5814, DOI 10.1073/pnas.0402870102; Liu ZN, 2006, CELL CYCLE, V5, P675, DOI 10.4161/cc.5.7.2605; Maher EA, 2006, CANCER RES, V66, P11502, DOI 10.1158/0008-5472.CAN-06-2072; Messiaen LM, 2000, HUM MUTAT, V15, P541, DOI 10.1002/1098-1004(200006)15:6<541::AID-HUMU6>3.3.CO;2-E; Mischel PS, 2003, BRAIN PATHOL, V13, P52; Mischel PS, 2003, CANCER BIOL THER, V2, P242, DOI 10.4161/cbt.2.3.369; Mizoguchi M, 2004, BRAIN PATHOL, V14, P372, DOI 10.1111/j.1750-3639.2004.tb00080.x; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nutt CL, 2003, CANCER RES, V63, P1602; PEGG AE, 1995, PROG NUCLEIC ACID RE, V51, P167, DOI 10.1016/S0079-6603(08)60879-X; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Philp AJ, 2001, CANCER RES, V61, P7426; Reilly KM, 2000, NAT GENET, V26, P109, DOI 10.1038/79075; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Side L, 1997, NEW ENGL J MED, V336, P1713, DOI 10.1056/NEJM199706123362404; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stommel JM, 2007, SCIENCE, V318, P287, DOI 10.1126/science.1142946; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; TAYLOR BS, PLOS 1 IN PRESS; Thiel G, 1995, ANTICANCER RES, V15, P2495; Upadhyaya M, 1997, HUM GENET, V99, P88; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; Yang JL, 2008, INT J CANCER, V123, P258, DOI 10.1002/ijc.23535; Zhang HJ, 2008, BREAST CANCER RES TR, V112, P217, DOI 10.1007/s10549-007-9847-6; Zhu Y, 2005, CANCER CELL, V8, P119, DOI 10.1016/j.ccr.2005.07.004	50	5373	5506	23	621	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1061	1068		10.1038/nature07385	http://dx.doi.org/10.1038/nature07385			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18772890	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000260252600035
J	Wen, L; Ley, RE; Volchkov, PY; Stranges, PB; Avanesyan, L; Stonebraker, AC; Hu, CY; Wong, FS; Szot, GL; Bluestone, JA; Gordon, JI; Chervonsky, AV				Wen, Li; Ley, Ruth E.; Volchkov, Pavel Yu.; Stranges, Peter B.; Avanesyan, Lia; Stonebraker, Austin C.; Hu, Changyun; Wong, F. Susan; Szot, Gregory L.; Bluestone, Jeffrey A.; Gordon, Jeffrey I.; Chervonsky, Alexander V.			Innate immunity and intestinal microbiota in the development of Type 1 diabetes	NATURE			English	Article							PANCREATIC LYMPH-NODES; T-CELL REACTIVITY; GUT MICROBIOME; MICE; OBESITY; MOUSE; IDENTIFICATION; DIVERSITY; TOLL; RECOGNITION	Type 1 diabetes (T1D) is a debilitating autoimmune disease that results from T- cell- mediated destruction of insulin- producing beta-cells. Its incidence has increased during the past several decades in developed countries(1,2), suggesting that changes in the environment ( including the human microbial environment) may influence disease pathogenesis. The incidence of spontaneous T1D in nonobese diabetic ( NOD) mice can be affected by the microbial environment in the animal housing facility(3) or by exposure to microbial stimuli, such as injection with mycobacteria or various microbial products(4,5). Here we show that specific pathogen-free NOD mice lacking MyD88 protein ( an adaptor for multiple innate immune receptors that recognize microbial stimuli) do not develop T1D. The effect is dependent on commensal microbes because germ- free MyD88- negative NOD mice develop robust diabetes, whereas colonization of these germ- free MyD88- negative NOD mice with a defined microbial consortium ( representing bacterial phyla normally present in human gut) attenuates T1D. Wealso find thatMyD88 deficiency changes the composition of the distal gut microbiota, and that exposure to the microbiota of specific pathogen- free MyD88negativeNODdonors attenuates T1D in germ- free NOD recipients. Together, these findings indicate that interaction of the intestinal microbes with the innate immune system is a critical epigenetic factor modifying T1D predisposition.	[Volchkov, Pavel Yu.; Stranges, Peter B.; Avanesyan, Lia; Chervonsky, Alexander V.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Stranges, Peter B.; Avanesyan, Lia; Stonebraker, Austin C.; Chervonsky, Alexander V.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wong, F. Susan] Univ Bristol, Sch Med Sci, Dept Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Szot, Gregory L.; Bluestone, Jeffrey A.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Wen, Li; Hu, Changyun] Yale Univ, Sch Med, Endocrinol Sect, New Haven, CT 06520 USA; [Ley, Ruth E.; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci, St Louis, MO 63108 USA	University of Chicago; Jackson Laboratory; University of Bristol; University of California System; University of California San Francisco; Yale University; Washington University (WUSTL)	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu	Volchkov, Pavel Y/H-4743-2013; hu, changyun/B-1189-2011; Ley, Ruth E/M-8542-2014	Ley, Ruth E/0000-0002-9087-1672; Wen, Li/0000-0002-8805-2934; Stranges, Peter Benjamin/0000-0003-1377-7321; Wong, F. Susan/0000-0002-2812-8845; Chervonsky, Alexander/0000-0001-7547-871X; Szot, Gregory/0000-0002-3921-049X	ADA [1-05-RA-142]; JDRF [19-2006-1075, 4-2005-1168, 2005-204, 2007-353]; NIH [DK45735, R37 AI46643, P30 DK63720, DK30292, DK70977, DK063452]; W.M. Keck Foundation; NIH/NIDDK Digestive Disease Research Core Center [DK42086]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI046643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063720, P30DK045735, R01DK070977, R01DK030292, R37DK030292, P30DK042086, P30DK056341, R21DK063452] Funding Source: NIH RePORTER	ADA(American Diabetes Association); JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); NIH/NIDDK Digestive Disease Research Core Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are thankful to A. Putnam, T. Park, D. Schumann, M. Prokhorovich, W. Du, D. O'Donnell, M. Karlsson and S. Wagoner for help with experiments, and S. Dryden Perkins and M. Garcia for assistance with sequence analysis. This work was supported by the ADA grant 1-05-RA-142 to L.W.; JDRF grant 19-2006-1075 to L.W. and F.S.W.; Animal Genetic Core of Diabetes Endocrinology Research Center (NIH grant DK45735) to L.W.; NIH grants R37 AI46643 and P30 DK63720 as well as the JDRF 4-2005-1168 grant to J.A.B.; NIH grants DK30292 and DK70977, and a W.M. Keck Foundation award to J.I.G.; NIH grant DK063452 to A.V.C.; JDRF grants 2005-204 and 2007-353 to A.V.C.; and the NIH/NIDDK Digestive Disease Research Core Center grant DK42086.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amrani A, 1999, J CLIN INVEST, V103, P1201, DOI 10.1172/JCI6266; Calcinaro F, 2005, DIABETOLOGIA, V48, P1565, DOI 10.1007/s00125-005-1831-2; Dewhirst FE, 1999, APPL ENVIRON MICROB, V65, P3287; Dojka MA, 1998, APPL ENVIRON MICROB, V64, P3869; FUNDA DP, 2007, P 13 INT C IMM BRAZ; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Gray DHD, 2007, P NATL ACAD SCI USA, V104, P18193, DOI 10.1073/pnas.0709160104; HASKINS K, 1990, SCIENCE, V249, P1433, DOI 10.1126/science.2205920; Hoglund P, 1999, J EXP MED, V189, P331, DOI 10.1084/jem.189.2.331; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kanagawa O, 2002, J IMMUNOL, V168, P6159, DOI 10.4049/jimmunol.168.12.6159; KARVONEN M, 1993, DIABETOLOGIA, V36, P883, DOI 10.1007/BF02374468; Kim HS, 2007, IMMUNITY, V27, P321, DOI 10.1016/j.immuni.2007.06.010; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Ludwig W, 2004, NUCLEIC ACIDS RES, V32, P1363, DOI 10.1093/nar/gkh293; MCINERNEY MF, 1991, DIABETES, V40, P715, DOI 10.2337/diabetes.40.6.715; Patterson CC, 2001, DIABETOLOGIA, V44, pB9, DOI 10.1007/PL00002961; Petkov PM, 2004, GENOME RES, V14, P1806, DOI 10.1101/gr.2825804; POZZILLI P, 1993, IMMUNOL TODAY, V14, P193, DOI 10.1016/0167-5699(93)90160-M; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; SADELAIN MWJ, 1990, DIABETES, V39, P583, DOI 10.2337/diabetes.39.5.583; Stratmann T, 2003, J CLIN INVEST, V112, P902, DOI 10.1172/JCI200318337; Strober W, 2004, NAT MED, V10, P898, DOI 10.1038/nm0904-898; SUZUKI T, 1985, IMMUNE DEFICIENT ANI, P112; Takaki T, 2004, J IMMUNOL, V173, P2530, DOI 10.4049/jimmunol.173.4.2530; Turley SJ, 2005, P NATL ACAD SCI USA, V102, P17729, DOI 10.1073/pnas.0509006102; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	40	1393	1469	19	514	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1109	U10		10.1038/nature07336	http://dx.doi.org/10.1038/nature07336			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806780	Green Accepted			2022-12-28	WOS:000260252600045
J	Antos, JR				Antos, Joseph R.			Election 2008: Symptomatic relief, but no cure - The Obama health care reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Antos, Joseph R.] Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA; [Antos, Joseph R.] Maryland Hlth Serv Cost Rev Commiss, Baltimore, MD USA; [Antos, Joseph R.] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA	American Enterprise Institute for Public Policy Research; University of North Carolina; University of North Carolina Chapel Hill	Antos, JR (corresponding author), Amer Enterprise Inst Publ Policy Res, Washington, DC 20036 USA.								0	2	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 16	2008	359	16					1648	1650		10.1056/NEJMp0806561	http://dx.doi.org/10.1056/NEJMp0806561			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	360EY	18815392				2022-12-28	WOS:000260041400002
J	Avvakumov, GV; Walker, JR; Xue, S; Li, YJ; Duan, SL; Bronner, C; Arrowsmith, CH; Dhe-Paganon, S				Avvakumov, George V.; Walker, John R.; Xue, Sheng; Li, Yanjun; Duan, Shili; Bronner, Christian; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano			Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1	NATURE			English	Article							BINDING; ICBP90; TARGET; CELLS; DNMT1; NP95; CPG	Epigenetic inheritance in mammals is characterized by high- fidelity replication of CpG methylation patterns during development(1,2). UHRF1 ( also known as ICBP90 in humans and Np95 in mouse)(3) is an E3 ligase important for the maintenance of global and local DNA methylation in vivo(4,5). The preferential affinity of UHRF1 for hemi- methylated DNA over symmetrically methylated DNA by means of its SET and RING- associated ( SRA) domain(6) and its association with the maintenance DNA methyltransferase 1 ( DNMT1) suggests a role in replication of the epigenetic code(4,5,7). Here we report the 1.7 angstrom crystal structure of the apo SRA domain of human UHRF1 and a 2.2 angstrom structure of its complex with hemi- methylated DNA, revealing a previously unknown reading mechanism for methylated CpG sites ( mCpG). The SRA - DNA complex has several notable structural features including a binding pocket that accommodates the 5-methylcytosine that is flipped out of the duplex DNA. Two specialized loops reach through the resulting gap in the DNA from both the major and the minor grooves to read the other three bases of the CpG duplex. The major groove loop confers both specificity for the CpG dinucleotide and discrimination against methylation of deoxycytidine of the complementary strand. The structure, along with mutagenesis data, suggests how UHRF1 acts as a key factor for DNMT1 maintenance methylation through recognition of a fundamental unit of epigenetic inheritance, mCpG.	[Avvakumov, George V.; Walker, John R.; Xue, Sheng; Li, Yanjun; Arrowsmith, Cheryl H.; Dhe-Paganon, Sirano] Univ Toronto, Struct Genom Consortium, Toronto, ON M5G 1L5, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L5, Canada; [Duan, Shili; Arrowsmith, Cheryl H.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L5, Canada; [Bronner, Christian] Univ Louis Pasteur Strasbourg 1, Dept Pharmacol & Pharmacochim Interact Cellulaire, Fac Pharm, CNRS,IGL,UMR 7175, F-67401 Illkirch Graffenstaden, France; [Dhe-Paganon, Sirano] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L5, Canada	University of Toronto; Structural Genomics Consortium; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toronto	Dhe-Paganon, S (corresponding author), Univ Toronto, Struct Genom Consortium, 100 Coll St, Toronto, ON M5G 1L5, Canada.	sirano.dhepaganon@utoronto.ca	Bronner, Christian/R-8488-2016	Bronner, Christian/0000-0002-3101-9279; Arrowsmith, Cheryl/0000-0002-4971-3250; /0000-0002-5255-895X	Canadian Institutes for Health Research; Canadian Foundation for Innovation; Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut; Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; Wellcome Trust; Canadian Cancer Society	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Genomics Institute; GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut; Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Wellcome Trust(Wellcome TrustEuropean Commission); Canadian Cancer Society(Canadian Cancer Society (CCS))	We thank F. Chedin, A. Edwards and R. Klose for discussions, and A. Dong for collecting data at the synchrotron. Diffraction data were measured at the Advanced Photon Source (Argonne, Illinois), which was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract no. DE-AC02-06CH11357. The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. This research was also supported by the Canadian Cancer Society (S.D. and C.H.A.).	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Hoang C, 2001, CELL, V107, P929, DOI 10.1016/S0092-8674(01)00618-3; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; Karagianni P, 2008, MOL CELL BIOL, V28, P705, DOI 10.1128/MCB.01598-07; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; RAZIN A, 1980, SCIENCE, V210, P604, DOI 10.1126/science.6254144; ROBERTS RJ, 1995, CELL, V82, P9, DOI 10.1016/0092-8674(95)90046-2; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Terwilliger TC, 2001, ACTA CRYSTALLOGR D, V57, P1755, DOI 10.1107/S0907444901013737; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Unoki M, 2004, ONCOGENE, V23, P7601, DOI 10.1038/sj.onc.1208053; Unoki M, 2008, RADIAT RES, V169, P240, DOI 10.1667/RR1209.1; Yoder JA, 1997, J MOL BIOL, V270, P385, DOI 10.1006/jmbi.1997.1125	22	340	354	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					822	U13		10.1038/nature07273	http://dx.doi.org/10.1038/nature07273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18772889				2022-12-28	WOS:000259854900052
J	Entwistle, VA; Carter, SM; Trevena, L; Flitcroft, K; Irwig, L; McCaffery, K; Salkeld, G				Entwistle, Vikki A.; Carter, Stacy M.; Trevena, Lyndal; Flitcroft, Kathy; Irwig, Les; McCaffery, Kirsten; Salkeld, Glenn			Communicating about screening	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFORMED CHOICE; DECISION-MAKING; INFORMATION		[Entwistle, Vikki A.] Univ Dundee, Social Dimens Hlth Inst, Dundee DD1 4HJ, Scotland; [Entwistle, Vikki A.] Univ St Andrews, Dundee DD1 4HJ, Scotland; [Carter, Stacy M.] Univ Sydney, Ctr Values Eth & Law Med, Sydney, NSW 2006, Australia; [Carter, Stacy M.; Trevena, Lyndal; Flitcroft, Kathy; Irwig, Les; McCaffery, Kirsten; Salkeld, Glenn] Univ Sydney, Sch Publ Hlth, Screening & Diagnost Test Evaluat Program, Sydney, NSW 2006, Australia	University of Dundee; University of St Andrews; University of Sydney; University of Sydney	Entwistle, VA (corresponding author), Univ Dundee, Social Dimens Hlth Inst, Dundee DD1 4HJ, Scotland.	v.a.entwistle@dundee.ac.uk	McCaffery, Kirsten/K-7945-2019; Flitcroft, Kathy/ABB-8542-2020; Carter, Stacy/A-6544-2011; Entwistle, Vikki Ann/I-9266-2019	McCaffery, Kirsten/0000-0003-2696-5006; Carter, Stacy/0000-0003-2617-8694; Entwistle, Vikki Ann/0000-0002-0856-4025; Trevena, Lyndal/0000-0003-1419-1832	Chief Scientist Office [HSRU2] Funding Source: Medline	Chief Scientist Office		Appiah KA, 2005, ETHICS OF IDENTITY, P1; BAIER A, 1986, ETHICS, V96, P231, DOI 10.1086/292745; Barratt A, 2004, BMJ-BRIT MED J, V329, P507, DOI 10.1136/bmj.329.7464.507; Beauchamp T L, 2012, PRINCIPLES BIOMEDICA; Douglas K, 2007, NEW SCI, V194, P35, DOI 10.1016/S0262-4079(07)61134-8; Entwistle V, 2001, Health Expect, V4, P109, DOI 10.1046/j.1369-6513.2001.00141.x; Entwistle V, 2008, SOC SCI MED, V66, P362, DOI 10.1016/j.socscimed.2007.09.001; Hargreaves KM, 2005, HEALTH EXPECT, V8, P161, DOI 10.1111/j.1369-7625.2005.00324.x; Irwig L, 2006, BMJ-BRIT MED J, V332, P1148, DOI 10.1136/bmj.332.7550.1148; Jepson RG, 2007, SOC SCI MED, V65, P890, DOI 10.1016/j.socscimed.2007.04.009; Kukla R, 2005, HASTINGS CENT REP, V35, P34, DOI 10.2307/3527761; Kukla R, 2007, HASTINGS CENT REP, V37, P27, DOI 10.1353/hcr.2007.0074; Meyers Diana T, 1989, SELF SOC PERSONAL CH; *NHS CANC SCREEN P, 2007, BREAST SCREEN FACTS; Raffle A E, 2001, Health Expect, V4, P92, DOI 10.1046/j.1369-6513.2001.00138.x; Rimer BK, 2004, CANCER-AM CANCER SOC, V101, P1214, DOI 10.1002/cncr.20512; Schwartz B., 2004, PARADOX CHOICE WHY M; *SENS SCI, 2008, MAK SENS TEST; Stoljar Natalie, 2000, RELATIONAL AUTONOMY, P98; *UK NAT SCREEN PRO, 2007, SCREEN TESTS YOUR BA; Woodrow C, 2008, HEALTH EXPECT, V11, P16, DOI 10.1111/j.1369-7625.2007.00474.x; Wright EB, 2004, BMJ-BRIT MED J, V328, P864, DOI 10.1136/bmj.38046.771308.7C	22	68	68	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2008	337	7673							a1591	10.1136/bmj.a1591	http://dx.doi.org/10.1136/bmj.a1591			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SN	18809589	Green Submitted			2022-12-28	WOS:000259798000033
J	Dienstag, JL				Dienstag, Jules L.			Drug therapy - Hepatitis B virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SEVERELY DECOMPENSATED CIRRHOSIS; AWAITING LIVER-TRANSPLANTATION; EXTENDED LAMIVUDINE TREATMENT; ALPHA-INTERFERON TREATMENT; ADEFOVIR DIPIVOXIL ADV; LONG-TERM THERAPY; TENOFOVIR DF TDF; E-ANTIGEN; VIRAL SUPPRESSION; NATURAL-HISTORY		[Dienstag, Jules L.] Massachusetts Gen Hosp, Gastrointestinal Unit, Med Serv, Boston, MA 02114 USA; [Dienstag, Jules L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Dienstag, Jules L.] Harvard Univ, Sch Med, Off Dean Med Educ, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Dienstag, JL (corresponding author), Massachusetts Gen Hosp, Gastrointestinal Unit, Med Serv, Jackson 7,55 Fruit St, Boston, MA 02114 USA.	jdienstag@partners.org	Franzeck, Fabian C/B-5055-2011	Dienstag, Jules/0000-0001-7024-0980				BEASLEY RP, 1981, LANCET, V2, P1129; Bourne EJ, 2007, J VIRAL HEPATITIS, V14, P55, DOI 10.1111/j.1365-2893.2006.00775.x; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chu CJ, 2002, HEPATOLOGY, V35, P1274, DOI 10.1053/jhep.2002.33161; Chu CJ, 2003, GASTROENTEROLOGY, V125, P444, DOI 10.1016/S0016-5085(03)00895-3; Chung YH, 2006, J HEPATOL, V44, pS25, DOI 10.1016/S0168-8278(06)80054-1; Colonno RJ, 2007, J HEPATOL, V46, pS294, DOI 10.1016/S0168-8278(07)62379-4; de Franchis R, 2003, J HEPATOL, V39, pS3, DOI 10.1016/S0168-8278(03)00378-7; Degertekin B, 2007, ANN INTERN MED, V147, P62, DOI 10.7326/0003-4819-147-1-200707030-00011; Dienstag JL, 2003, HEPATOLOGY, V37, P748, DOI 10.1053/jhep.2003.50117; Dienstag JL, 1999, NEW ENGL J MED, V341, P1256, DOI 10.1056/NEJM199910213411702; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dienstag JL, 1999, HEPATOLOGY, V30, P1082, DOI 10.1002/hep.510300427; Dienstag JL, 2005, HARRISONS PRINCIPALS, VII, P1822; Dienstag JL, 2007, CLIN DRUG INVEST, V27, P35, DOI 10.2165/00044011-200727010-00003; Dusheiko G, 2003, J HEPATOL, V39, pS116, DOI 10.1016/S0168-8278(03)00314-3; FATTOVICH G, 1986, HEPATOLOGY, V6, P167, DOI 10.1002/hep.1840060203; Flink HJ, 2006, AM J GASTROENTEROL, V101, P297, DOI 10.1111/j.1572-0241.2006.00418.x; Fontana RJ, 2002, LIVER TRANSPLANT, V8, P433, DOI 10.1053/jlts.2002.32983; Fung SK, 2006, J HEPATOL, V44, P283, DOI 10.1016/j.jhep.2005.10.018; Fung SK, 2004, J VIRAL HEPATITIS, V11, P432, DOI 10.1111/j.1365-2893.2004.00556.x; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; GANEM D, 2004, NEW ENGL J MED, V351, P351; Gauthier J, 1999, J INFECT DIS, V180, P1757, DOI 10.1086/315147; Ghany M, 2007, GASTROENTEROLOGY, V132, P1574, DOI 10.1053/j.gastro.2007.02.039; Gish RG, 2007, GASTROENTEROLOGY, V133, P1437, DOI 10.1053/j.gastro.2007.08.025; GREENBERG HB, 1976, NEW ENGL J MED, V295, P517, DOI 10.1056/NEJM197609022951001; HADZIYANNIS S, 1990, J HEPATOL, V11, pS133, DOI 10.1016/0168-8278(90)90180-Y; Hadziyannis SJ, 2003, SEMIN LIVER DIS, V23, P81, DOI 10.1055/s-2003-37584; Hadziyannis SJ, 2003, NEW ENGL J MED, V348, P800, DOI 10.1056/NEJMoa021812; Hadziyannis SJ, 2005, NEW ENGL J MED, V352, P2673, DOI 10.1056/NEJMoa042957; Hadziyannis SJ, 2001, HEPATOLOGY, V34, P617, DOI 10.1053/jhep.2001.27834; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Heathcote EJ, 2007, HEPATOLOGY, V46, p861A; Hirsch MS, 2007, NEW ENGL J MED, V356, P2641, DOI 10.1056/NEJMe078045; Hoofnagle JH, 2007, HEPATOLOGY, V45, P1056, DOI 10.1002/hep.21627; HOOFNAGLE JH, 1982, ANN INTERN MED, V96, P447, DOI 10.7326/0003-4819-96-4-447; HOOFNAGLE JH, 1981, ANN INTERN MED, V94, P744, DOI 10.7326/0003-4819-94-6-744; HOOFNAGLE JH, 1993, GASTROENTEROLOGY, V104, P1116, DOI 10.1016/0016-5085(93)90281-G; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Kao JH, 2000, GASTROENTEROLOGY, V118, P554, DOI 10.1016/S0016-5085(00)70261-7; Keeffe EB, 2007, CLIN GASTROENTEROL H, V5, P890, DOI 10.1016/j.cgh.2007.05.004; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kim WR, 2007, HEPATOLOGY, V46, p238A; KORENMAN J, 1991, ANN INTERN MED, V114, P629, DOI 10.7326/0003-4819-114-8-629; Koziel MJ, 2007, NEW ENGL J MED, V356, P1445, DOI 10.1056/NEJMra065142; Kuo A, 2004, CLIN GASTROENTEROL H, V2, P266, DOI 10.1016/S1542-3565(04)00017-5; Kweon YO, 2002, J HEPATOL, V36, P714; Kweon YO, 2001, J HEPATOL, V35, P749, DOI 10.1016/S0168-8278(01)00218-5; Lai CL, 2007, NEW ENGL J MED, V357, P2576, DOI 10.1056/NEJMoa066422; Lai CL, 2007, ANN INTERN MED, V147, P58, DOI 10.7326/0003-4819-147-1-200707030-00010; Lai CL, 2006, HEPATOLOGY, V44, p222A; Lai CL, 1998, NEW ENGL J MED, V339, P61, DOI 10.1056/NEJM199807093390201; Lai CL, 2002, GASTROENTEROLOGY, V123, P1831, DOI 10.1053/gast.2002.37058; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2005, GASTROENTEROLOGY, V129, P528, DOI 10.1053/j.gastro.2005.05.053; Lai CL, 2006, NEW ENGL J MED, V354, P1863; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lau DTY, 1998, HEPATOLOGY, V28, P1121, DOI 10.1002/hep.510280430; Lau GKK, 2003, GASTROENTEROLOGY, V125, P1742, DOI 10.1053/j.gastro.2003.09.026; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Leung N. W. Y., 1997, Hepatology, V26, p357A; Leung NWY, 2001, HEPATOLOGY, V33, P1527, DOI 10.1053/jhep.2001.25084; Liaw YF, 2005, LIVER INT, V25, P472, DOI 10.1111/j.1478-3231.2005.01134.x; Liaw YF, 2000, GASTROENTEROLOGY, V119, P172, DOI 10.1053/gast.2000.8559; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lim SG, 2006, ARCH INTERN MED, V166, P49, DOI 10.1001/archinte.166.1.49; Locarnini S, 2003, J HEPATOL, V39, pS124, DOI 10.1016/S0168-8278(03)00318-0; Lok AS, 2007, HEPATOLOGY, V46, P254, DOI 10.1002/hep.21698; Lok ASF, 2007, HEPATOLOGY, V45, P1347, DOI 10.1002/hep.21738; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; Lok ASF, 2003, GASTROENTEROLOGY, V125, P1714, DOI 10.1053/j.gastro.2003.09.033; LOK ASF, 1987, GASTROENTEROLOGY, V92, P1839, DOI 10.1016/0016-5085(87)90613-5; LOK ASF, 1991, GASTROENTEROLOGY, V100, P182, DOI 10.1016/0016-5085(91)90599-G; Malekzadeh R, 2004, CLIN GASTROENTEROL H, V2, P344, DOI 10.1016/S1542-3565(04)00066-7; Manesis EK, 2001, GASTROENTEROLOGY, V121, P101, DOI 10.1053/gast.2001.25524; Manno M, 2004, GASTROENTEROLOGY, V127, P756, DOI 10.1053/j.gastro.2004.06.021; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2007, J HEPATOL, V46, pS25, DOI 10.1016/S0168-8278(07)61651-1; Marcellin P, 2003, NEW ENGL J MED, V348, P808, DOI 10.1056/NEJMoa020681; Marcellin P, 2007, HEPATOLOGY, V46, p290A; McMahon MA, 2007, NEW ENGL J MED, V356, P2614, DOI 10.1056/NEJMoa067710; Min Albert D, 2007, Clin Liver Dis, V11, P851, DOI 10.1016/j.cld.2007.08.003; Mommeja-Marin H, 2003, HEPATOLOGY, V37, P1309, DOI 10.1053/jhep.2003.50208; Nguyen MH, 2005, HEPATOLOGY, V42, p593A; Niederau C, 1996, NEW ENGL J MED, V334, P1422, DOI 10.1056/NEJM199605303342202; Papatheodoridis GV, 2001, J HEPATOL, V34, P306, DOI 10.1016/S0168-8278(00)00094-5; Pawlotsky JM, 2008, GASTROENTEROLOGY, V134, P405, DOI 10.1053/j.gastro.2007.11.036; Perrillo R, 2004, GASTROENTEROLOGY, V126, P81, DOI 10.1053/j.gastro.2003.10.050; PERRILLO R, 1995, GASTROENTEROLOGY, V109, P908, DOI 10.1016/0016-5085(95)90401-8; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Perrillo RP, 2006, CLIN GASTROENTEROL H, V4, P233, DOI 10.1016/S1542-3565(05)00983-3; Perrillo RP, 2006, HEPATOLOGY, V43, pS182, DOI 10.1002/hep.20970; PERRILLO RP, 1990, NEW ENGL J MED, V323, P295, DOI 10.1056/NEJM199008023230503; PERRILLO RP, 1990, HEPATOLOGY, V12, P1433, DOI 10.1002/hep.1840120626; Peters MG, 2004, GASTROENTEROLOGY, V126, P91, DOI 10.1053/j.gastro.2003.10.051; Rapti I, 2007, HEPATOLOGY, V45, P307, DOI 10.1002/hep.21534; Rizzetto M, 2005, J HEPATOL, V42, P173, DOI 10.1016/j.jhep.2004.10.006; Ryu SH, 2003, J HEPATOL, V39, P614, DOI 10.1016/S0168-8278(03)00394-5; Schalm SW, 2000, GUT, V46, P562, DOI 10.1136/gut.46.4.562; Schiff ER, 2003, J HEPATOL, V38, P818, DOI 10.1016/S0168-8278(03)00076-X; SEEGER C, 1986, SCIENCE, V232, P477, DOI 10.1126/science.3961490; Sherman M, 2006, GASTROENTEROLOGY, V130, P2039, DOI 10.1053/j.gastro.2006.04.007; Suzuki Y, 2005, J MED VIROL, V76, P33, DOI 10.1002/jmv.20320; Tassopoulos NC, 1999, HEPATOLOGY, V29, P889, DOI 10.1002/hep.510290321; van Zonneveld M, 2004, HEPATOLOGY, V39, P804, DOI 10.1002/hep.20128; Villeneuve JP, 2000, HEPATOLOGY, V31, P207, DOI 10.1002/hep.510310130; Westland C, 2003, GASTROENTEROLOGY, V125, P107, DOI 10.1016/S0016-5085(03)00700-5; Westland CE, 2003, HEPATOLOGY, V38, P96, DOI 10.1053/jhep.2003.50288; WONG DKH, 1993, ANN INTERN MED, V119, P312, DOI 10.7326/0003-4819-119-4-199308150-00011; Yao FY, 2000, J HEPATOL, V33, P301, DOI 10.1016/S0168-8278(00)80371-2; Yao FY, 2001, HEPATOLOGY, V34, P411, DOI 10.1053/jhep.2001.26512; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051; Yim HJ, 2006, HEPATOLOGY, V43, pS173, DOI 10.1002/hep.20956; Yoo BC, 2005, HEPATOLOGY, V42, p270A; Yoo BC, 2005, HEPATOLOGY, V42, p268A; Yuen MF, 2004, HEPATOLOGY, V39, P1694, DOI 10.1002/hep.20240; Yuen MF, 2004, HEPATOLOGY, V40, P767, DOI 10.1002/hep.20389	122	714	775	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1486	1500		10.1056/NEJMra0801644	http://dx.doi.org/10.1056/NEJMra0801644			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832247				2022-12-28	WOS:000259631700009
J	Gandin, V; Miluzio, A; Barbieri, AM; Beugnet, A; Kiyokawa, H; Marchisio, PC; Biffo, S				Gandin, Valentina; Miluzio, Annarita; Barbieri, Anna Maria; Beugnet, Anne; Kiyokawa, Hiroaki; Marchisio, Pier Carlo; Biffo, Stefano			Eukaryotic initiation factor 6 is rate-limiting in translation, growth and transformation	NATURE			English	Article							INITIATION FACTOR-6; PROTEIN; P27(BBP); TRANSDUCTION; ACTIVATION; MECHANISMS; EXPRESSION; STRESS; CELLS; BOP1	Cell growth and proliferation require coordinated ribosomal biogenesis and translation. Eukaryotic initiation factors ( eIFs) control translation at the rate- limiting step of initiation(1,2). So far, only two eIFs connect extracellular stimuli to global translation rates(3): eIF4E acts in the eIF4F complex and regulates binding of capped messenger RNA to 40S subunits, downstream of growth factors(4,5), and eIF2 controls loading of the ternary complex on the 40S subunit and is inhibited on stress stimuli(6,7). No eIFs have been found to link extracellular stimuli to the activity of the large 60S ribosomal subunit. eIF6 binds 60S ribosomes precluding ribosome joining in vitro(8-10). However, studies in yeasts showed that eIF6 is required for ribosome biogenesis rather than translation(11-14). Here we show that mammalian eIF6 is required for efficient initiation of translation, in vivo. eIF6 null embryos are lethal at preimplantation. Heterozygous mice have 50% reduction of eIF6 levels in all tissues, and show reduced mass of hepatic and adipose tissues due to a lower number of cells and to impaired G1/S cell cycle progression. eIF6(+/-) cells retain sufficient nucleolar eIF6 and normal ribosome biogenesis. The liver of eIF6(+/-) mice displays an increase of 80S in polysomal profiles, indicating a defect in initiation of translation. Consistently, isolated hepatocytes have impaired insulin- stimulated translation. Heterozygous mouse embryonic fibroblasts recapitulate the organism phenotype and have normal ribosome biogenesis, reduced insulin- stimulated translation, and delayed G1/S phase progression. Furthermore, eIF6(+/-) cells are resistant to oncogene- induced transformation. Thus, eIF6 is the first eIF associated with the large 60S subunit that regulates translation in response to extracellular signals.	[Gandin, Valentina; Miluzio, Annarita; Barbieri, Anna Maria; Beugnet, Anne; Marchisio, Pier Carlo; Biffo, Stefano] Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, I-20132 Milan, Italy; [Kiyokawa, Hiroaki] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Marchisio, Pier Carlo] Univ Vita Salute, Sch Med, I-20132 Milan, Italy; [Biffo, Stefano] Univ Piemonte Orientale, DISAV, I-15100 Alessandria, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Northwestern University; Feinberg School of Medicine; Vita-Salute San Raffaele University; University of Eastern Piedmont Amedeo Avogadro	Biffo, S (corresponding author), Ist Sci San Raffaele, Mol Histol & Cell Growth Lab, Via Olgettina 58, I-20132 Milan, Italy.	stefano.biffo@hsr.it	Barbieri, Anna Maria/AAA-6328-2020	Kiyokawa, Hiroaki/0000-0002-7942-6455; Miluzio, Annarita/0000-0002-2838-2659; biffo, stefano/0000-0002-3780-1050; Gandin, Valentina/0000-0003-2627-1303	AIRC [05-360]; TELETHON [GGB05043, CARIPLO, NIH-RO10578]; NATIONAL CANCER INSTITUTE [R01CA112282] Funding Source: NIH RePORTER	AIRC(Fondazione AIRC per la ricerca sul cancro); TELETHON(Fondazione Telethon); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants AIRC (S.B., P.C.M.), TELETHON GGB05043, CARIPLO 0578 (S.B.) and NIH-RO1 (H.K.). A. B. is supported by grant AICR 05-360. The manuscript has been improved thanks to suggestions from N. Offenhaeuser and A. Boletta. We are indebted to P. G. Pelicci for anti-NPM antibodies, H. Hirai for preliminary soft agar assays, S. Modina for blastocyst preparation, M. Vidali for hepatocytes preparation, M. Malosio for insulin receptor antibodies, S. Gregori for FACS analysis, D. Bartel for reporter constructs, G. Manfioletti for HMGA2 antibodies and F. Loreni for rpS19 antibodies. We acknowledge L. Magri for preliminary experiments, and V. Volta and S. Grosso for suggestions.	Basu U, 2001, MOL CELL BIOL, V21, P1453, DOI 10.1128/MCB.21.5.1453-1462.2001; Betts DH, 1998, DEV BIOL, V197, P77, DOI 10.1006/dbio.1998.8874; Biffo S, 1997, J BIOL CHEM, V272, P30314, DOI 10.1074/jbc.272.48.30314; Ceci M, 2003, NATURE, V426, P579, DOI 10.1038/nature02160; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; CLARK RL, 1980, BIOCHEM J, V190, P615, DOI 10.1042/bj1900615; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; De Palma M, 2002, METHOD ENZYMOL, V346, P514; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gorrini C, 2005, P NATL ACAD SCI USA, V102, P9200, DOI 10.1073/pnas.0409513102; Harris MN, 2004, BLOOD, V104, P1314, DOI 10.1182/blood-2004-01-0046; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Mamane Y, 2006, ONCOGENE, V25, P6416, DOI 10.1038/sj.onc.1209888; Menne TF, 2007, NAT GENET, V39, P486, DOI 10.1038/ng1994; Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024; Rim JS, 2005, FASEB J, V19, P1205, DOI 10.1096/fj.04-3204fje; RUSSELL DW, 1979, J BIOL CHEM, V254, P8796; Sanvito F, 1999, J CELL BIOL, V144, P823, DOI 10.1083/jcb.144.5.823; Sanvito F, 2000, CANCER RES, V60, P510; Senger B, 2001, MOL CELL, V8, P1363, DOI 10.1016/S1097-2765(01)00403-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Si K, 1999, MOL CELL BIOL, V19, P1416; Sonenberg N, 2006, SCIENCE, V314, P428, DOI 10.1126/science.1134031; Strezoska Z, 2002, J BIOL CHEM, V277, P29617, DOI 10.1074/jbc.M204381200; Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000; VALENZUELA DM, 1982, J BIOL CHEM, V257, P7712; Volta V, 2005, BIOCHEM BIOPH RES CO, V337, P89, DOI 10.1016/j.bbrc.2005.09.012; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Wood LC, 1999, J BIOL CHEM, V274, P11653, DOI 10.1074/jbc.274.17.11653; Yang YL, 2007, CELL PROLIFERAT, V40, P397, DOI 10.1111/j.1365-2184.2007.00443.x; Zou XH, 2002, GENE DEV, V16, P2923, DOI 10.1101/gad.1033002	33	161	164	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 2	2008	455	7213					684	U81		10.1038/nature07267	http://dx.doi.org/10.1038/nature07267			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18784653	Green Accepted			2022-12-28	WOS:000259639700051
J	Rank, B				Rank, Brian			Exective physicals - Bad medicine on three count(s)	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rank, Brian] Hlth Partners Med Grp & Clin, Minneapolis, MN USA		Rank, B (corresponding author), Hlth Partners Med Grp & Clin, Minneapolis, MN USA.							*AG HEALTHC RES QU, 2004, SCREEN COR HEART DIS; BRINK S, 2008, LOS ANGELES TIM 0218, pF1; Wennberg JE, 2006, CARE PATIENTS SEVERE	3	16	16	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1424	1425		10.1056/NEJMp0806270	http://dx.doi.org/10.1056/NEJMp0806270			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832242				2022-12-28	WOS:000259631700002
J	Aldaye, FA; Palmer, AL; Sleiman, HF				Aldaye, Faisal A.; Palmer, Alison L.; Sleiman, Hanadi F.			Assembling materials with DNA as the guide	SCIENCE			English	Review							NANOPARTICLE ARRAYS; ARTIFICIAL DNA; NANOSTRUCTURES; NANOARRAYS; METAL; NANOARCHITECTURES; CRYSTALLIZATION; CONNECTIVITY; ORGANIZATION; COMPLEXES	DNA's remarkable molecular recognition properties and structural features make it one of the most promising templates to pattern materials with nanoscale precision. The emerging field of DNA nanotechnology strips this molecule from any preconceived biological role and exploits its simple code to generate addressable nanostructures in one, two, and three dimensions. These structures have been used to precisely position proteins, nanoparticles, transition metals, and other functional components into deliberately designed patterns. They can also act as templates for the growth of nanowires, aid in the structural determination of proteins, and provide new platforms for genomics applications. The field of DNA nanotechnology is growing in a number of directions, carrying with it the promise to substantially affect materials science and biology.	[Aldaye, Faisal A.; Sleiman, Hanadi F.] McGill Univ, Dept Chem, Montreal, PQ H3A 2K6, Canada; [Palmer, Alison L.] Canadian Inst Adv Res, Toronto, ON M5G 1Z8, Canada	McGill University; Canadian Institute for Advanced Research (CIFAR)	Sleiman, HF (corresponding author), McGill Univ, Dept Chem, 801 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	hanadi.sleiman@mcgill.ca						Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481; Aldaye FA, 2007, J AM CHEM SOC, V129, P13376, DOI 10.1021/ja075966q; Aldaye FA, 2007, J AM CHEM SOC, V129, P4130, DOI 10.1021/ja070017i; Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0; Chaput JC, 1999, P NATL ACAD SCI USA, V96, P10614, DOI 10.1073/pnas.96.19.10614; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; Chhabra R, 2007, J AM CHEM SOC, V129, P10304, DOI 10.1021/ja072410u; Choi JS, 2004, J AM CHEM SOC, V126, P8606, DOI 10.1021/ja048537q; Chworos A, 2004, SCIENCE, V306, P2068, DOI 10.1126/science.1104686; Cohen JD, 2008, J AM CHEM SOC, V130, P402, DOI 10.1021/ja0772400; Deng ZX, 2004, ANGEW CHEM INT EDIT, V43, P4068, DOI 10.1002/anie.200460257; Ding K, 2007, ANGEW CHEM INT EDIT, V46, P1172, DOI 10.1002/anie.200603064; Douglas SM, 2007, P NATL ACAD SCI USA, V104, P6644, DOI 10.1073/pnas.0700930104; Eckardt LH, 2002, NATURE, V420, P286, DOI 10.1038/420286a; Endo M, 2005, ANGEW CHEM INT EDIT, V44, P6074, DOI 10.1002/anie.200501034; Fahlman RP, 2002, J AM CHEM SOC, V124, P4610, DOI 10.1021/ja012618u; Goodman RP, 2008, NAT NANOTECHNOL, V3, P93, DOI 10.1038/nnano.2008.3; Gothelf KV, 2004, J AM CHEM SOC, V126, P1044, DOI 10.1021/ja038333u; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; He Y, 2006, J AM CHEM SOC, V128, P12664, DOI 10.1021/ja065467+; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Lehn JM, 2007, CHEM SOC REV, V36, P151, DOI 10.1039/b616752g; Li ZY, 2002, J AM CHEM SOC, V124, P746, DOI 10.1021/ja017319j; Lin CX, 2007, J AM CHEM SOC, V129, P14475, DOI 10.1021/ja0760980; Lin CX, 2006, CHEMPHYSCHEM, V7, P1641, DOI 10.1002/cphc.200600260; Malo J, 2005, ANGEW CHEM INT EDIT, V44, P3057, DOI 10.1002/anie.200463027; Mitra D, 2004, ANGEW CHEM INT EDIT, V43, P5804, DOI 10.1002/anie.200460255; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Pinto YY, 2005, NANO LETT, V5, P2399, DOI 10.1021/nl0515495; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Rothemund PWK, 2004, PLOS BIOL, V2, P2041, DOI 10.1371/journal.pbio.0020424; Scheffler M, 1999, ANGEW CHEM INT EDIT, V38, P3312; Seeman NC, 2003, NATURE, V421, P427, DOI 10.1038/nature01406; Sharma J, 2006, ANGEW CHEM INT EDIT, V45, P730, DOI 10.1002/anie.200503208; Shchepinov MS, 1999, NUCLEIC ACIDS RES, V27, P3035, DOI 10.1093/nar/27.15.3035; Shi JF, 1997, ANGEW CHEM INT EDIT, V36, P111, DOI 10.1002/anie.199701111; Shih WM, 2004, NATURE, V427, P618, DOI 10.1038/nature02307; Stewart KM, 2004, ANGEW CHEM INT EDIT, V43, P5808, DOI 10.1002/anie.200460399; Tanaka K, 2003, SCIENCE, V299, P1212, DOI 10.1126/science.1080587; Tanaka K, 2006, NAT NANOTECHNOL, V1, P190, DOI 10.1038/nnano.2006.141; Wang W, 2003, J AM CHEM SOC, V125, P5248, DOI 10.1021/ja0341900; Weizmann Y, 2008, P NATL ACAD SCI USA, V105, P5289, DOI 10.1073/pnas.0800723105; Williams BAR, 2007, ANGEW CHEM INT EDIT, V46, P3051, DOI 10.1002/anie.200603919; Yan H, 2003, SCIENCE, V301, P1882, DOI 10.1126/science.1089389; Yin P, 2008, NATURE, V451, P318, DOI 10.1038/nature06451; Zheng JW, 2006, NANO LETT, V6, P1502, DOI 10.1021/nl060994c; Zimmermann J, 2008, ANGEW CHEM INT EDIT, V47, P3626, DOI 10.1002/anie.200702682; 1960, Patent No. 60960000	49	803	837	10	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1795	1799		10.1126/science.1154533	http://dx.doi.org/10.1126/science.1154533			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818351				2022-12-28	WOS:000259501300027
J	Langlais, B; Amit, H				Langlais, Benoit; Amit, Hagay			Planetary science - The past Martian dynamo	SCIENCE			English	Editorial Material							EARTHS INNER-CORE; MAGNETIC-FIELD; MARS; FLOW		[Langlais, Benoit] Univ Nantes, Lab Planetol & Geodynam, CNRS, UMR 6112, F-44322 Nantes 3, France; [Amit, Hagay] Inst Phys Globe, CNRS, UMR 7154, F-75252 Paris 5, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Nantes Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Cite	Langlais, B (corresponding author), Univ Nantes, Lab Planetol & Geodynam, CNRS, UMR 6112, F-44322 Nantes 3, France.	benoit.langlais@univ-nantes.fr; hagay@ipgp.jussieu.fr	Langlais, Benoit/O-6650-2019; Langlais, Benoit/K-5366-2012	Langlais, Benoit/0000-0001-5207-304X; Langlais, Benoit/0000-0001-5207-304X				Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Amit H, 2006, PHYS EARTH PLANET IN, V155, P120, DOI 10.1016/j.pepi.2005.10.006; Aubert J, 2008, NATURE, V454, P758, DOI 10.1038/nature07109; Gubbins D, 2007, PHYS EARTH PLANET IN, V162, P256, DOI 10.1016/j.pepi.2007.04.014; Harder H, 1996, NATURE, V380, P507, DOI 10.1038/380507a0; JOHNSON CL, 2008, GEOCHEM GEOPHYS GEOS, V9; Kiefer WS, 2008, NATURE, V453, P1191, DOI 10.1038/4531191a; LANGLAIS B, 2004, J GEOPHYS RES, V109; LEBLANC F, 2008, ASTROBIOLOGY; Niu FL, 2001, NATURE, V410, P1081, DOI 10.1038/35074073; Olson P, 2002, GEOPHYS J INT, V151, P809, DOI 10.1046/j.1365-246X.2002.01818.x; QUESNEL Y, 2007, EUR PLANET SCI C, V2; Roberts JH, 2007, ICARUS, V190, P24, DOI 10.1016/j.icarus.2007.03.002; STANLEY S, 2004, NATURE, V151, P428; Stanley S, 2008, SCIENCE, V321, P1822, DOI 10.1126/science.1161119; Stewart AJ, 2007, SCIENCE, V316, P1323, DOI 10.1126/science.1140549; TAKLEY PJ, 2008, EUR PLANET SCI C, V3	17	5	5	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1784	1785		10.1126/science.1162874	http://dx.doi.org/10.1126/science.1162874			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818346				2022-12-28	WOS:000259501300022
J	Stanley, S; Elkins-Tanton, L; Zuber, MT; Parmentier, EM				Stanley, Sabine; Elkins-Tanton, Linda; Zuber, Maria T.; Parmentier, E. Marc			Mars' paleomagnetic field as the result of a single-hemisphere dynamo	SCIENCE			English	Article							CRUSTAL DICHOTOMY; CUMULATE OVERTURN; MAGNETIC-FIELD; CONVECTION; IMPACT; OCEAN; EARTH; TOPOGRAPHY; EVOLUTION; ORIGIN	Mars' crustal magnetic field was most likely generated by dynamo action in the planet's early history. Unexplained characteristics of the field include its strength, concentration in the southern hemisphere, and lack of correlation with any surface features except for the hemispheric crustal dichotomy. We used numerical dynamo modeling to demonstrate that the mechanisms proposed to explain crustal dichotomy formation can result in a single- hemisphere dynamo. This dynamo produces strong magnetic fields in only the southern hemisphere. This magnetic field morphology can explain why Mars' crustal magnetic field intensities are substantially stronger in the southern hemisphere without relying on any postdynamo mechanisms.	[Stanley, Sabine] Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada; [Elkins-Tanton, Linda; Zuber, Maria T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Parmentier, E. Marc] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA	University of Toronto; Massachusetts Institute of Technology (MIT); Brown University	Stanley, S (corresponding author), Univ Toronto, Dept Phys, Toronto, ON M5S 1A7, Canada.	stanley@physics.utoronto.ca	Elkins-Tanton, Linda/C-5508-2008	Elkins-Tanton, Linda/0000-0003-4008-1098; Stanley, Sabine/0000-0003-0469-4401	National Science and Engineering Research Council (NSERC) of Canada; Canadian Foundation for Innovation; Ontario Research Fund	National Science and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Ontario Research Fund	S. S. is partially funded by the National Science and Engineering Research Council (NSERC) of Canada. The numerical simulations in this study were performed on supercomputing resources partially funded by the Canadian Foundation for Innovation (CFI) and the Ontario Research Fund (ORF).	Acuna MH, 1999, SCIENCE, V284, P790, DOI 10.1126/science.284.5415.790; Andrews-Hanna JC, 2008, NATURE, V453, P1212, DOI 10.1038/nature07011; Daradich A, 2008, ICARUS, V194, P463, DOI 10.1016/j.icarus.2007.10.017; Dehant V, 2007, SPACE SCI REV, V129, P279, DOI 10.1007/s11214-007-9163-9; Edgar LA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031466; Elkins-Tanton LT, 2005, EARTH PLANET SC LETT, V236, P1, DOI 10.1016/j.epsl.2005.04.044; Elkins-Tanton LT, 2003, METEORIT PLANET SCI, V38, P1753, DOI 10.1111/j.1945-5100.2003.tb00013.x; FREY H, 1988, GEOPHYS RES LETT, V15, P229, DOI 10.1029/GL015i003p00229; Frey HV, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002449; Glatzmaier GA, 1999, NATURE, V401, P885, DOI 10.1038/44776; Grote E, 2000, PHYS REV E, V62, P4457, DOI 10.1103/PhysRevE.62.4457; Ke Y, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002631; Kuang WJ, 1999, J COMPUT PHYS, V153, P51, DOI 10.1006/jcph.1999.6274; Kuang WL, 1997, NATURE, V389, P371, DOI 10.1038/38712; Kulikov YN, 2007, SPACE SCI REV, V129, P207, DOI 10.1007/s11214-007-9192-4; Langlais B, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2003JE002048; Langlais B, 2007, PLANET SPACE SCI, V55, P270, DOI 10.1016/j.pss.2006.03.008; Nimmo F, 2001, J GEOPHYS RES-PLANET, V106, P12315, DOI 10.1029/2000JE001325; Perron JT, 2007, NATURE, V447, P840, DOI 10.1038/nature05873; Quesnel Y, 2007, PLANET SPACE SCI, V55, P258, DOI 10.1016/j.pss.2006.02.004; Roberts JH, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002668; Solomon SC, 2005, SCIENCE, V307, P1214, DOI 10.1126/science.1101812; Sprenke KF, 2005, ICARUS, V174, P486, DOI 10.1016/j.icarus.2004.11.009; Watters TR, 2007, ANNU REV EARTH PL SC, V35, P621, DOI 10.1146/annurev.earth.35.031306.140220; WATTERS WA, IN PRESS J GEOPHYS R; Weiss BP, 2002, EARTH PLANET SC LETT, V201, P449, DOI 10.1016/S0012-821X(02)00728-8; WILHELMS DE, 1984, NATURE, V309, P138, DOI 10.1038/309138a0; Zhong SJ, 2001, EARTH PLANET SC LETT, V189, P75, DOI 10.1016/S0012-821X(01)00345-4; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	29	86	90	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1822	1825		10.1126/science.1161119	http://dx.doi.org/10.1126/science.1161119			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818355				2022-12-28	WOS:000259501300034
J	Steinbrook, R				Steinbrook, Robert			Election 2008: Campaign contributions, lobbying, and the US Health sector - An update	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												rsteinbrook@attglobal.net						*HJ KAIS FAM FDN, 2008, KAIS HLTH TRACK POLL; HOLMAN C, 2008, PART CONV FREE FOR A; Oberlander J, 2008, NEW ENGL J MED, V359, P781, DOI 10.1056/NEJMp0804659; SANDBURG B, 2008, FDA LEGISLATIVE 0825; Steinbrook R, 2007, NEW ENGL J MED, V357, P736, DOI 10.1056/NEJMp078151	5	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1313	1315		10.1056/NEJMp0807073	http://dx.doi.org/10.1056/NEJMp0807073			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	351QZ	18815395				2022-12-28	WOS:000259440900002
J	Sofi, F; Cesari, F; Abbate, R; Gensini, GF; Casini, A				Sofi, Francesco; Cesari, Francesca; Abbate, Rosanna; Gensini, Gian Franco; Casini, Alessandro			Adherence to Mediterranean diet and health status: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article								Objective To systematically review all the prospective cohort studies that have analysed the relation between adherence to a Mediterranean diet, mortality, and incidence of chronic diseases in a primary prevention setting. Design Meta- analysis of prospective cohort studies. Data sources English and non- English publications in PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials from 1966 to 30 June 2008. Studies reviewed Studies that analysed prospectively the association between adherence to a Mediterranean diet, mortality, and incidence of diseases; 12 studies, with a total of 1 574 299 subjects followed for a time ranging from three to 18 years were included. Results The cumulative analysis among eight cohorts ( 514 816 subjects and 33 576 deaths) evaluating overall mortality in relation to adherence to a Mediterranean diet showed that a two point increase in the adherence score was significantly associated with a reduced risk of mortality ( pooled relative risk 0.91, 95% confidence interval 0.89 to 0.94). Likewise, the analyses showed a beneficial role for greater adherence to a Mediterranean diet on cardiovascular mortality ( pooled relative risk 0.91, 0.87 to 0.95), incidence of or mortality from cancer ( 0.94, 0.92 to 0.96), and incidence of Parkinson's disease and Alzheimer's disease ( 0.87, 0.80 to 0.96). Conclusions Greater adherence to a Mediterranean diet is associated with a significant improvement in health status, as seen by a significant reduction in overall mortality ( 9%), mortality from cardiovascular diseases ( 9%), incidence of or mortality from cancer ( 6%), and incidence of Parkinson's disease and Alzheimer's disease ( 13%). These results seem to be clinically relevant for public health, in particular for encouraging a Mediterranean- like dietary pattern for primary prevention of major chronic diseases.	[Sofi, Francesco; Cesari, Francesca; Abbate, Rosanna] Univ Florence, Dept Med & Surg Crit Care, Thrombosis Ctr, I-50134 Florence, Italy; [Sofi, Francesco; Casini, Alessandro] Univ Careggi, Azienda Osped, Reg Agcy Nutr, Florence, Italy; [Gensini, Gian Franco] Onlus IRCCS, Don Carlo Gnocchi Fdn, Florence, Italy; [Casini, Alessandro] Univ Florence, Dept Clin Pathophysiol, Unit Clin Nutr, Florence, Italy; [Sofi, Francesco; Abbate, Rosanna; Casini, Alessandro] Univ Florence, Ctr Interdipartimentale Ric & Valorizzazione Alim, Florence, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; IRCCS Fondazione Don Carlo Gnocchi Onlus; University of Florence; University of Florence	Sofi, F (corresponding author), Univ Florence, Dept Med & Surg Crit Care, Thrombosis Ctr, Viale Morgagni 85, I-50134 Florence, Italy.	francescosofi@gmail.com	Sofi, Francesco/J-3941-2016; Nicolescu, Alina/M-8562-2017; Sofi, Francesco/W-4610-2019; Deleanu, Calin/G-7446-2011; Cesari, Francesca/K-7974-2016; Birzan, Liviu/H-3653-2013	Sofi, Francesco/0000-0001-7113-7424; Nicolescu, Alina/0000-0001-7022-8893; Sofi, Francesco/0000-0001-7113-7424; Deleanu, Calin/0000-0001-8206-5227; Cesari, Francesca/0000-0002-3616-6219; Birzan, Liviu/0000-0002-3479-6567				Bach A, 2006, PUBLIC HEALTH NUTR, V9, P132, DOI 10.1079/PHN2005936; de Lorgeril M, 1999, CIRCULATION, V99, P779, DOI 10.1161/01.CIR.99.6.779; Genkinger JM, 2007, PLOS MED, V4, P1883, DOI 10.1371/journal.pmed.0040345; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Lichtenstein AH, 2006, CIRCULATION, V114, P82, DOI 10.1161/CIRCULATIONAHA.106.176158; Serra-Majem L, 2006, NUTR REV, V64, pS27, DOI 10.1301/nr.2006.feb.S27-S47; Sofi F, 2005, EUR J CLIN NUTR, V59, P584, DOI 10.1038/sj.ejcn.1602112; US Department of Health and Human Services and USDA, 2005, DIET GUID AM 2005; WHO/ FAO, 2003, DIET NUTR PREV CHRON, P916; WILLETT WC, 1995, AM J CLIN NUTR, V61, p1402S, DOI 10.1093/ajcn/61.6.1402S; Willett WC, 2006, PUBLIC HEALTH NUTR, V9, P105, DOI 10.1079/PHN2005931	13	943	963	3	135	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2008	337	7671							a1344	10.1136/bmj.a1344	http://dx.doi.org/10.1136/bmj.a1344			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18786971	Green Published, hybrid			2022-12-28	WOS:000259622000031
J	Busche, MA; Eichhoff, G; Adelsberger, H; Abramowski, D; Wiederhold, KH; Haass, C; Staufenbiel, M; Konnerth, A; Garaschuk, O				Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Abramowski, Dorothee; Wiederhold, Karl-Heinz; Haass, Christian; Staufenbiel, Matthias; Konnerth, Arthur; Garaschuk, Olga			Clusters of hyperactive neurons near amyloid plaques in a mouse model of Alzheimer's disease	SCIENCE			English	Article							IN-VIVO; A-BETA; LINKED MUTATIONS; VISUAL-CORTEX; SYNAPSE LOSS; OLIGOMERS; MICE; NETWORKS; MEMORY; DISRUPTION	The neurodegeneration observed in Alzheimer's disease has been associated with synaptic dismantling and progressive decrease in neuronal activity. We tested this hypothesis in vivo by using two- photon Ca(2+) imaging in a mouse model of Alzheimer's disease. Although a decrease in neuronal activity was seen in 29% of layer 2/3 cortical neurons, 21% of neurons displayed an unexpected increase in the frequency of spontaneous Ca(2+) transients. These "hyperactive" neurons were found exclusively near the plaques of amyloid beta-depositing mice. The hyperactivity appeared to be due to a relative decrease in synaptic inhibition. Thus, we suggest that a redistribution of synaptic drive between silent and hyperactive neurons, rather than an overall decrease in synaptic activity, provides a mechanism for the disturbed cortical function in Alzheimer's disease.	[Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Konnerth, Arthur; Garaschuk, Olga] Tech Univ Munich, Inst Neurowissensch, D-80802 Munich, Germany; [Abramowski, Dorothee; Wiederhold, Karl-Heinz; Staufenbiel, Matthias] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Haass, Christian] Univ Munich, Dept Biochem, Lab Neurodegenerat Dis Res, Adolf Butenandt Inst, D-80336 Munich, Germany; [Busche, Marc Aurel; Eichhoff, Gerhard; Adelsberger, Helmuth; Haass, Christian; Konnerth, Arthur; Garaschuk, Olga] Ctr Integrated Prot Sci, D-81377 Munich, Germany	Technical University of Munich; Novartis; University of Munich; University of Munich	Konnerth, A (corresponding author), Tech Univ Munich, Inst Neurowissensch, D-80802 Munich, Germany.	arthur.konnerth@lrz.tum.de	Eichhoff, Gerhard/L-4075-2019; Garaschuk, Olga/G-5633-2015	Busche, Marc Aurel/0000-0002-4416-7553	Deutsche Forschungsgemeinschaft [SFB 596, GA 654/1-1, HO 2156/2-1]; Helmholtz Gemeinschaft.	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Gemeinschaft.(Helmholtz Association)	A. K. is a Carl-von-Linde Fellow of the Institute for Advanced Study of the TUM. We thank L. B. Cohen for comments on the manuscript. Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 596, GA 654/1-1, and HO 2156/2-1) and the Helmholtz Gemeinschaft.	Amatniek JC, 2006, EPILEPSIA, V47, P867, DOI 10.1111/j.1528-1167.2006.00554.x; Anderson J, 2000, NAT NEUROSCI, V3, P617, DOI 10.1038/75797; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; Arns M, 1999, BEHAV BRAIN RES, V106, P151, DOI 10.1016/S0166-4328(99)00103-5; Chang EH, 2006, P NATL ACAD SCI USA, V103, P3410, DOI 10.1073/pnas.0507313103; Christie RH, 2001, J NEUROSCI, V21, P858, DOI 10.1523/JNEUROSCI.21-03-00858.2001; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Eichhoff G, 2008, EUR J NUCL MED MOL I, V35, pS99, DOI 10.1007/s00259-007-0709-6; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Ji DY, 2007, NAT NEUROSCI, V10, P100, DOI 10.1038/nn1825; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kerr JND, 2005, P NATL ACAD SCI USA, V102, P14063, DOI 10.1073/pnas.0506029102; Kuchibhotla KV, 2008, NEURON, V59, P214, DOI 10.1016/j.neuron.2008.06.008; Lozsadi DA, 2006, DEMENT GERIATR COGN, V22, P121, DOI 10.1159/000093664; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Meyer-Luehmann M, 2008, NATURE, V451, P720, DOI 10.1038/nature06616; Nelson O, 2007, J CLIN INVEST, V117, P1230, DOI 10.1172/JCI30447; Nimmrich V, 2008, J NEUROSCI, V28, P788, DOI 10.1523/JNEUROSCI.4771-07.2008; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Phinney AL, 1999, J NEUROSCI, V19, P8552; Prvulovic D, 2005, PSYCHIAT RES-NEUROIM, V140, P97, DOI 10.1016/j.pscychresns.2005.06.006; Sato TR, 2007, PLOS BIOL, V5, P1440, DOI 10.1371/journal.pbio.0050189; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Silverman DHS, 2001, JAMA-J AM MED ASSOC, V286, P2120, DOI 10.1001/jama.286.17.2120; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Stosiek C, 2003, P NATL ACAD SCI USA, V100, P7319, DOI 10.1073/pnas.1232232100; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wirths O, 2008, NEUROBIOL AGING, V29, P891, DOI 10.1016/j.neurobiolaging.2006.12.004	40	679	694	1	59	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1686	1689		10.1126/science.1162844	http://dx.doi.org/10.1126/science.1162844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802001				2022-12-28	WOS:000259300400039
J	Duda, DM; Borg, LA; Scott, DC; Hunt, HW; Hammel, M; Schulman, BA				Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Hammel, Michal; Schulman, Brenda A.			Structural insights into NEDD8 activation of Cullin-RING ligases: Conformational control of conjugation	CELL			English	Article							UBIQUITIN-LIKE PROTEINS; E3 LIGASE; SACCHAROMYCES-CEREVISIAE; CUL5-RBX2 MODULES; GENOME-WIDE; IN-VIVO; COMPLEX; SCF; BINDING; DOMAIN	Cullin-RING ligases (CRLs) comprise the largest ubiquitin E3 subclass, in which a central cullin subunit links a substrate-binding adaptor with an E2-binding RING. Covalent attachment of the ubiquitin-like protein NEDD8 to a conserved C-terminal domain (ctd) lysine stimulates CRL ubiquitination activity and prevents binding of the inhibitor CAND1. Here we report striking conformational rearrangements in the crystal structure of NEDD8 similar to CuI5(ctd)-Rbx1 and SAXS analysis of NEDD8 similar to CuI1(ctd)-Rbx1 relative to their unmodified counterparts. In NEDD8ylated CRL structures, the cullin WHB and Rbx1 RING subdomains are dramatically reoriented, eliminating a CAND1-binding site and imparting multiple potential catalytic geometries to an associated E2. Biochemical analyses indicate that the structural malleability is important for both CRL NEDD8ylation and subsequent ubiquitination activities. Thus, our results point to a conformational control of CRL activity, with ligation of NEDD8 shifting equilibria to disfavor inactive CAND1-bound closed architectures, and favor dynamic, open forms that promote polyubiquitination.	[Duda, David M.; Scott, Daniel C.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA; [Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Duda, David M.; Borg, Laura A.; Scott, Daniel C.; Hunt, Harold W.; Schulman, Brenda A.] St Jude Childrens Res Hosp, Dept Genet Tumor Cell Biol, Memphis, TN 38105 USA; [Hammel, Michal] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Schulman, BA (corresponding author), St Jude Childrens Res Hosp, Howard Hughes Med Inst, Memphis, TN 38105 USA.	brenda.schulman@stjude.org		Hammel, Michal/0000-0002-5610-9289	U.S. DOE [DE-AC02-05CH11231]; NSLS [DE-AC02-98CH10886]; American Lebanese Syrian Associated Charities of St. Jude,; NIH [P30CA021765, R01GM069530]; Howard Hughes Medical Institute; Beckman Young Investigator Award; Pew Scholar Award; Phillip and Elizabeth Gross Foundation; DOD [DAMD17-03-0420]; American Cancer Society; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069530] Funding Source: NIH RePORTER	U.S. DOE(United States Department of Energy (DOE)); NSLS; American Lebanese Syrian Associated Charities of St. Jude,(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Beckman Young Investigator Award; Pew Scholar Award; Phillip and Elizabeth Gross Foundation; DOD(United States Department of Defense); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. King and S. Zhou for mass spectrometry/Edman sequencing, J. Endicott for cdk2 plasmid, C. Ross and Staff at ALS 8.2.1, ALS 12.3.1, and NSLS X25 beamlines, V. Pagala, P. Murray, R. Deshaies, Z.Q. Pan, J. W. Harper, M. Lee, B. Dye, D. Miller, S. Bozeman, and members of the Schulman lab for assistance, advice, and/or discussions. ALS is supported by U.S. DOE Contract No. DE-AC02-05CH11231, and NSLS by DE-AC02-98CH10886. This work was supported in part by American Lebanese Syrian Associated Charities of St. Jude, by NIH P30CA021765 to St. Jude, the Howard Hughes Medical Institute, a Beckman Young Investigator Award, a Pew Scholar Award, the Phillip and Elizabeth Gross Foundation, the NIH (R01GM069530), and DOD (DAMD17-03-0420) to B. A. S. and by an American Cancer Society fellowship to D.M.D. B.A.S. is an Investigator of the Howard Hughes Medical Institute.	Amir RE, 2002, J BIOL CHEM, V277, P23253, DOI 10.1074/jbc.M200967200; Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Bornstein G, 2006, P NATL ACAD SCI USA, V103, P11515, DOI 10.1073/pnas.0603921103; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Du FY, 2002, P NATL ACAD SCI USA, V99, P14110, DOI 10.1073/pnas.172527399; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; Gray WM, 2002, PLANT CELL, V14, P2137, DOI 10.1105/tpc.003178; Hammel M, 2005, J BIOL CHEM, V280, P38562, DOI 10.1074/jbc.M503168200; Hammel M, 2007, PROTEIN SCI, V16, P2605, DOI 10.1110/ps.073170807; Hao B, 2005, MOL CELL, V20, P9, DOI 10.1016/j.molcel.2005.09.003; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Huang DT, 2008, NAT STRUCT MOL BIOL, V15, P280, DOI 10.1038/nsmb.1387; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Huang DT, 2005, MOL CELL, V17, P341, DOI 10.1016/j.molcel.2004.12.020; Jones J, 2008, J PROTEOME RES, V7, P1274, DOI 10.1021/pr700749v; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kamura T, 1999, GENE DEV, V13, P2928, DOI 10.1101/gad.13.22.2928; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kawakami T, 2001, EMBO J, V20, P4003, DOI 10.1093/emboj/20.15.4003; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2007, CURR OPIN STRUC BIOL, V17, P665, DOI 10.1016/j.sbi.2007.09.001; KRATKY O, 1949, RONTGENUNTERSUCHUNG, P1106; Kurz T, 2005, NATURE, V435, P1257, DOI 10.1038/nature03662; Laplaza JM, 2004, BIOCHEM J, V377, P459, DOI 10.1042/BJ20030755; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Liu JD, 2002, MOL CELL, V10, P1511, DOI 10.1016/S1097-2765(02)00783-9; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Morimoto M, 2000, BIOCHEM BIOPH RES CO, V270, P1093, DOI 10.1006/bbrc.2000.2576; Morimoto M, 2003, BIOCHEM BIOPH RES CO, V301, P392, DOI 10.1016/S0006-291X(02)03051-6; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pan ZQ, 2004, ONCOGENE, V23, P1985, DOI 10.1038/sj.onc.1207414; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Podust VN, 2000, P NATL ACAD SCI USA, V97, P4579, DOI 10.1073/pnas.090465597; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; Read MA, 2000, MOL CELL BIOL, V20, P2326, DOI 10.1128/MCB.20.7.2326-2333.2000; Sakata E, 2007, NAT STRUCT MOL BIOL, V14, P167, DOI 10.1038/nsmb1191; Scaglione KM, 2007, MOL CELL BIOL, V27, P5860, DOI 10.1128/MCB.01555-06; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang XJ, 2005, METHOD ENZYMOL, V399, P433, DOI 10.1016/S0076-6879(05)99030-7; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Wu K, 2000, J BIOL CHEM, V275, P32317, DOI 10.1074/jbc.M004847200; Wu K, 2002, J BIOL CHEM, V277, P516, DOI 10.1074/jbc.M108008200; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zheng JY, 2002, MOL CELL, V10, P1519, DOI 10.1016/S1097-2765(02)00784-0; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	62	554	568	4	47	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					995	1006		10.1016/j.cell.2008.07.022	http://dx.doi.org/10.1016/j.cell.2008.07.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805092	Bronze, Green Accepted			2022-12-28	WOS:000259318100019
J	Duester, G				Duester, Gregg			Retinoic acid synthesis and signaling during early organogenesis	CELL			English	Review							EMBRYONIC STEM-CELLS; VITAMIN-A HOMEOSTASIS; BODY AXIS EXTENSION; RAR DOUBLE MUTANTS; BINDING-PROTEIN; RESPONSE ELEMENT; FGF SIGNALS; HINDBRAIN DEVELOPMENT; PANCREAS DEVELOPMENT; SEGMENTATION CLOCK	Retinoic acid, a derivative of vitamin A, is an essential component of cell-cell signaling during vertebrate organogenesis. In early development, retinoic acid organizes the trunk by providing an instructive signal for posterior neuroectoderm and foregut endoderm and a permissive signal for trunk mesoderm differentiation. At later stages, retinoic acid contributes to the development of the eye and other organs. Recent studies suggest that retinoic acid may act primarily in a paracrine manner and provide insight into the cell-cell signaling networks that control differentiation of pluripotent cells.	Burnham Inst Med Res, Dev & Aging Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Duester, G (corresponding author), Burnham Inst Med Res, Dev & Aging Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	duester@burnham.org		Duester, Gregg/0000-0003-4335-3650	NIH [GM062848, EY013969]; California Institute of Regenerative Medicine [RS1-00193]; NATIONAL EYE INSTITUTE [R01EY013969] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062848] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I am grateful to past and present members of my laboratory for provocative discussions. Funding was provided by NIH grants GM062848 and EY013969 and California Institute of Regenerative Medicine grant RS1-00193.	Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Ang HL, 1996, J BIOL CHEM, V271, P9526, DOI 10.1074/jbc.271.16.9526; Arnhold Thomas, 1996, Life Sciences, V59, pPL169, DOI 10.1016/0024-3205(96)00408-0; Batourina E, 2005, NAT GENET, V37, P1082, DOI 10.1038/ng1645; Batourina E, 2001, NAT GENET, V27, P74, DOI 10.1038/83792; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Brondani V, 2002, J MOL BIOL, V319, P715, DOI 10.1016/S0022-2836(02)00376-5; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai C, 2007, DEV DYNAM, V236, P3255, DOI 10.1002/dvdy.21306; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Chen F, 2007, DEVELOPMENT, V134, P2969, DOI 10.1242/dev.006221; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; CONLON RA, 1992, DEVELOPMENT, V116, P357; DERSCH H, 1993, DEV BIOL, V160, P424, DOI 10.1006/dbio.1993.1318; Dickman ED, 1997, DEVELOPMENT, V124, P3111; Diez del Corral R, 2003, NEURON, V40, P65; Dubrulle J, 2001, CELL, V106, P219, DOI 10.1016/S0092-8674(01)00437-8; Dupe V, 2001, DEVELOPMENT, V128, P2199; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Germain P, 2002, NATURE, V415, P187, DOI 10.1038/415187a; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gibert Y, 2006, DEVELOPMENT, V133, P2649, DOI 10.1242/dev.02438; Hernandez RE, 2007, DEVELOPMENT, V134, P177, DOI 10.1242/dev.02706; Hernandez RE, 2004, DEVELOPMENT, V131, P4511, DOI 10.1242/dev.01297; Hochgreb T, 2003, DEVELOPMENT, V130, P5363, DOI 10.1242/dev.00750; Houle M, 2003, DEVELOPMENT, V130, P6555, DOI 10.1242/dev.00889; Ilagan R, 2006, DEVELOPMENT, V133, P2435, DOI 10.1242/dev.02408; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Keegan BR, 2005, SCIENCE, V307, P247, DOI 10.1126/science.1101573; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; KRUMLAUF R, 1993, TRENDS GENET, V9, P106, DOI 10.1016/0168-9525(93)90203-T; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Maden M, 1996, CURR BIOL, V6, P417, DOI 10.1016/S0960-9822(02)00509-2; MADEN M, 1982, NATURE, V295, P672, DOI 10.1038/295672a0; Malpel S, 2000, DEVELOPMENT, V127, P3057; Marletaz F, 2006, INT J BIOL SCI, V2, P38; Marquardt T, 2001, CELL, V106, P651, DOI 10.1016/S0092-8674(01)00499-8; MARSHALL H, 1994, NATURE, V370, P567, DOI 10.1038/370567a0; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Matt N, 2005, DEVELOPMENT, V132, P4789, DOI 10.1242/dev.02031; MENDELSOHN C, 1994, DEVELOPMENT, V120, P2749; Mercader N, 2000, DEVELOPMENT, V127, P3961; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Mic FA, 2002, DEVELOPMENT, V129, P2271; Mic FA, 2004, J BIOL CHEM, V279, P26698, DOI 10.1074/jbc.M401920200; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Molotkov A, 2006, DEVELOPMENT, V133, P1901, DOI 10.1242/dev.02328; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Molotkov A, 2004, BIOCHEM J, V383, P295, DOI 10.1042/BJ20040621; Molotkov A, 2002, J BIOL CHEM, V277, P13804, DOI 10.1074/jbc.M112039200; Molotkov A, 2002, P NATL ACAD SCI USA, V99, P5337, DOI 10.1073/pnas.082093299; Molotkova N, 2005, MECH DEVELOP, V122, P145, DOI 10.1016/j.mod.2004.10.008; Molotkova N, 2007, DEV BIOL, V303, P601, DOI 10.1016/j.ydbio.2006.11.035; Niederreither K, 2000, DEVELOPMENT, V127, P75; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2002, DEVELOPMENT, V129, P3563; Niederreither K, 2001, DEVELOPMENT, V128, P1019; Novitch BG, 2003, NEURON, V40, P81, DOI 10.1016/j.neuron.2003.08.006; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Olivera-Martinez I, 2007, DEVELOPMENT, V134, P2125, DOI 10.1242/dev.000216; Park EJ, 2006, DEVELOPMENT, V133, P2419, DOI 10.1242/dev.02367; Pourquie O, 2003, SCIENCE, V301, P328, DOI 10.1126/science.1085887; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; RONG PM, 1992, DEVELOPMENT, V115, P657; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Ryckebusch L, 2008, P NATL ACAD SCI USA, V105, P2913, DOI 10.1073/pnas.0712344105; Sandell LL, 2007, GENE DEV, V21, P1113, DOI 10.1101/gad.1533407; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; SIMEONE A, 1990, NATURE, V346, P763, DOI 10.1038/346763a0; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Sirbu IO, 2008, DEV DYNAM, V237, P1627, DOI 10.1002/dvdy.21570; SIVE HL, 1990, GENE DEV, V4, P932, DOI 10.1101/gad.4.6.932; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Stafford D, 2006, DEVELOPMENT, V133, P949, DOI 10.1242/dev.02263; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; STUDER M, 1994, SCIENCE, V265, P1728, DOI 10.1126/science.7916164; Tabin C, 2007, GENE DEV, V21, P1433, DOI 10.1101/gad.1547407; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; Uehara M, 2007, DEV BIOL, V302, P399, DOI 10.1016/j.ydbio.2006.09.045; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Wang ZX, 2006, DEV BIOL, V297, P433, DOI 10.1016/j.ydbio.2006.05.019; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wiellette EL, 2003, DEVELOPMENT, V130, P3821, DOI 10.1242/dev.00572; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0; Zhang M, 2001, J BIOL CHEM, V276, P44083, DOI 10.1074/jbc.M105748200; Zhang M, 2007, FASEB J, V21, P2886, DOI 10.1096/fj.06-7964com	98	736	793	3	120	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					921	931		10.1016/j.cell.2008.09.002	http://dx.doi.org/10.1016/j.cell.2008.09.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805086	Bronze, Green Accepted			2022-12-28	WOS:000259318100013
J	Stuber, GD; Klanker, M; de Ridder, B; Bowers, MS; Joosten, RN; Feenstra, MG; Bonci, A				Stuber, Garret D.; Klanker, Marianne; de Ridder, Bram; Bowers, M. Scott; Joosten, Ruud N.; Feenstra, Matthijs G.; Bonci, Antonello			Reward-predictive cues enhance excitatory synaptic strength onto midbrain dopamine neurons	SCIENCE			English	Article							VENTRAL TEGMENTAL AREA; LONG-TERM POTENTIATION; NUCLEUS-ACCUMBENS; COCAINE-SEEKING; GLUTAMATE; LTP; AMPHETAMINE; DEPRESSION; RATS	Using sensory information for the prediction of future events is essential for survival. Midbrain dopamine neurons are activated by environmental cues that predict rewards, but the cellular mechanisms that underlie this phenomenon remain elusive. We used in vivo voltammetry and in vitro patch- clamp electrophysiology to show that both dopamine release to reward predictive cues and enhanced synaptic strength onto dopamine neurons develop over the course of cue- reward learning. Increased synaptic strength was not observed after stable behavioral responding. Thus, enhanced synaptic strength onto dopamine neurons may act to facilitate the transformation of neutral environmental stimuli to salient reward- predictive cues.	[Stuber, Garret D.; de Ridder, Bram; Bowers, M. Scott; Bonci, Antonello] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA; [Klanker, Marianne; Joosten, Ruud N.; Feenstra, Matthijs G.] Royal Netherlands Acad Arts & Sci, Netherlands Inst Neurosci, Amsterdam, Netherlands; [Bonci, Antonello] Univ Calif San Francisco, Wheeler Ctr Neurobiol Drug Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute for Neuroscience (NIN-KNAW); University of California System; University of California San Francisco	Bonci, A (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Dept Neurol, Emeryville, CA 94608 USA.	antonello.bonci@ucsf.edu	Stuber, Garret/E-1160-2011	Bowers, M Scott/0000-0003-0047-6765; Stuber, Garret/0000-0003-1730-4855	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco; Van Den Houtenfonds; Netherlands Organisation for Scientific Research, NWO;  [DA021937];  [DA015096]; NATIONAL INSTITUTE ON DRUG ABUSE [F32DA021937, R01DA015096] Funding Source: NIH RePORTER	State of California for medical research on alcohol and substance abuse through the University of California, San Francisco(University of California System); Van Den Houtenfonds; Netherlands Organisation for Scientific Research, NWO(Netherlands Organization for Scientific Research (NWO)); ; ; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank H. Fields, F. W. Hopf, P. Janak, and K. Tye for helpful comments and R. Sadler and L. Wang for technical assistance. This work was supported by DA021937 (G.D.S.), DA015096 (A.B.), funds from the State of California for medical research on alcohol and substance abuse through the University of California, San Francisco (A.B.), the Van Den Houtenfonds (M.G.F.), and the Netherlands Organisation for Scientific Research, NWO (M.G.F.).	Bonci A, 1999, J NEUROSCI, V19, P3723; Borgland SL, 2004, J NEUROSCI, V24, P7482, DOI 10.1523/JNEUROSCI.1312-04.2004; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Cheng JJ, 2003, EUR J NEUROSCI, V18, P1306, DOI 10.1046/j.1460-9568.2003.02849.x; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Di Ciano P, 2004, EUR J NEUROSCI, V19, P1661, DOI 10.1111/j.1460-9568.2004.03232.x; Harris GC, 2003, NEUROPSYCHOPHARMACOL, V28, P73, DOI 10.1038/sj.npp.1300011; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; Jones S, 2000, J NEUROSCI, V20, P5575, DOI 10.1523/JNEUROSCI.20-15-05575.2000; Liu QS, 2005, NATURE, V437, P1027, DOI 10.1038/nature04050; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MARNELI M, 2007, SCIENCE, V317, P530; Overton PG, 1997, BRAIN RES REV, V25, P312, DOI 10.1016/S0165-0173(97)00039-8; Schuchard M, 1998, NEUROMODULATION, V1, P46, DOI 10.1111/j.1525-1403.1998.tb00029.x; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Thomas MJ, 2000, J NEUROSCI, V20, P5581, DOI 10.1523/JNEUROSCI.20-15-05581.2000; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; You ZB, 2007, J NEUROSCI, V27, P10546, DOI 10.1523/JNEUROSCI.2967-07.2007; Yun IA, 2004, J NEUROSCI, V24, P2923, DOI 10.1523/JNEUROSCI.5282-03.2004; Zhang XF, 1997, J PHARMACOL EXP THER, V281, P699	23	223	224	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1690	1692		10.1126/science.1160873	http://dx.doi.org/10.1126/science.1160873			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18802002	Green Accepted			2022-12-28	WOS:000259300400040
J	Houk, KN; Cheong, PHY				Houk, K. N.; Cheong, Paul Ha-Yeon			Computational prediction of small-molecule catalysts	NATURE			English	Article							ALDOL REACTIONS; AQUEOUS SOLVATION; ESTER AMINOLYSIS; MECHANISM; DESIGN; ENANTIOSELECTIVITY; CYCLOADDITION; SUBSTITUENT; SELECTIVITY; MODELS	Most organic and organometallic catalysts have been discovered through serendipity or trial and error, rather than by rational design. Computational methods, however, are rapidly becoming a versatile tool for understanding and predicting the roles of such catalysts in asymmetric reactions. Such methods should now be regarded as a first line of attack in the design of catalysts.	[Houk, K. N.; Cheong, Paul Ha-Yeon] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Houk, KN (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	houk@chem.ucla.edu			University of California, Los Angeles; National Institute of General Medical Sciences [CHE-0548209]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036700, R01GM036700] Funding Source: NIH RePORTER	University of California, Los Angeles(University of California System); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to the University of California, Los Angeles, as well as to the National Institute of General Medical Sciences (grant GM 36700) and the National Science Foundation (grant CHE-0548209), for financial support. We also thank C. Legault for the use of CY Lview, and M. Tarini, P. Cignoni and C. Montani for assistance in using QuteMol.	Anderson CD, 2008, ORG LETT, V10, P2749, DOI 10.1021/ol800875k; Bahmanyar S, 2001, J AM CHEM SOC, V123, P12911, DOI 10.1021/ja011714s; Bahmanyar S, 2001, J AM CHEM SOC, V123, P11273, DOI 10.1021/ja011403h; *C LEG, 2007, CYLVIEW V 1 0B; Cheong PHY, 2006, ORG LETT, V8, P811, DOI 10.1021/ol052861o; Cheong PHY, 2005, SYNTHESIS-STUTTGART, P1533, DOI 10.1055/s-2005-865332; Clemente FR, 2004, ANGEW CHEM INT EDIT, V43, P5766, DOI 10.1002/anie.200460916; Corbeil CR, 2008, ANGEW CHEM INT EDIT, V47, P2635, DOI 10.1002/anie.200704774; Cramer CJ., 2004, ESSENTIALS COMPUTATI; *DELANO SCI, 2007, PYMOL MOL GRAPH SYST; Fleming EM, 2008, J ORG CHEM, V73, P948, DOI 10.1021/jo702154m; *GAUSS, 2004, GAUSS 03 REV C 02; Harriman DJ, 2007, TETRAHEDRON LETT, V48, P689, DOI 10.1016/j.tetlet.2006.11.101; Ianni JC, 2006, ANGEW CHEM INT EDIT, V45, P5502, DOI 10.1002/anie.200600329; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kozlowski MC, 2003, J AM CHEM SOC, V125, P6614, DOI 10.1021/ja0293195; Mitsumori S, 2006, J AM CHEM SOC, V128, P1040, DOI 10.1021/ja056984f; MUKHERJEE D, 1988, J AM CHEM SOC, V110, P3328, DOI 10.1021/ja00218a069; Murakami M, 2004, J ORG CHEM, V69, P587, DOI 10.1021/jo035433+; Murakami M, 2001, ANGEW CHEM INT EDIT, V40, P189, DOI 10.1002/1521-3773(20010105)40:1<189::AID-ANIE189>3.0.CO;2-L; Pitcock WH, 2008, J AM CHEM SOC, V130, P5821, DOI 10.1021/ja800856p; Rankin KN, 2002, J PHYS CHEM A, V106, P5155, DOI 10.1021/jp020079p; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; RUDOLF K, 1987, J ORG CHEM, V52, P3708, DOI 10.1021/jo00392a047; Schreiner PR, 2002, ORG LETT, V4, P217, DOI 10.1021/ol017117s; Shinisha CB, 2007, ORG BIOMOL CHEM, V5, P1287, DOI 10.1039/b701688c; Takano Y, 2005, J CHEM THEORY COMPUT, V1, P70, DOI 10.1021/ct049977a; Tang Z, 2003, J AM CHEM SOC, V125, P5262, DOI 10.1021/ja034528q; Tantillo DJ, 1998, CURR OPIN CHEM BIOL, V2, P743, DOI 10.1016/S1367-5931(98)80112-9; Tarini M, 2006, IEEE T VIS COMPUT GR, V12, P1237, DOI 10.1109/TVCG.2006.115; van Erp TS, 2003, J CHEM PHYS, V118, P8831, DOI 10.1063/1.1567258; Wang LH, 1996, LIEBIGS ANN-RECL, P1501; Wang YY, 2007, J AM CHEM SOC, V129, P10060, DOI 10.1021/ja072505w; WEIK MH, 1961, 3 SURVEY DOMESTIC EL, P526; Yu ZX, 2008, J AM CHEM SOC, V130, P2378, DOI 10.1021/ja076444d; Zhao Y, 2008, ACCOUNTS CHEM RES, V41, P157, DOI 10.1021/ar700111a; Zipse H, 1996, LIEBIGS ANN, P1511	37	244	244	5	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					309	313		10.1038/nature07368	http://dx.doi.org/10.1038/nature07368			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800129	Green Accepted			2022-12-28	WOS:000259265200031
J	de Montalembert, M				de Montalembert, Mariane			Management of sickle cell disease	BMJ-BRITISH MEDICAL JOURNAL			English	Review							ACUTE CHEST SYNDROME; STROKE; RISK; HYDROXYUREA; CHILDREN; ANEMIA; TRANSFUSIONS; PREVENTION; PREDICT; IMPACT		[de Montalembert, Mariane] Hop Necker Enfants Malad, Serv Pediat Gen, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	de Montalembert, M (corresponding author), Hop Necker Enfants Malad, Serv Pediat Gen, F-75015 Paris, France.	mariane.demontal@nck.aphp.fr						Adamkiewicz TV, 2008, PEDIATRICS, V121, P562, DOI 10.1542/peds.2007-0018; Adamkiewicz TV, 2003, J PEDIATR-US, V143, P438, DOI 10.1067/S0022-3476(03)00331-7; ADAMS R, 1992, NEW ENGL J MED, V326, P605, DOI 10.1056/NEJM199202273260905; Adams RJ, 2005, NEW ENGL J MED, V353, P2769; Adams RJ, 1998, NEW ENGL J MED, V339, P5, DOI 10.1056/NEJM199807023390102; [Anonymous], 1987, JAMA, V258, P1205; Ballas SK, 2005, HEMATOL ONCOL CLIN N, V19, P785, DOI 10.1016/j.hoc.2005.07.008; BELLET PS, 1995, NEW ENGL J MED, V333, P699, DOI 10.1056/NEJM199509143331104; CHARACHE S, 1995, NEW ENGL J MED, V332, P1317, DOI 10.1056/NEJM199505183322001; CHINEGWUNDOH FI, 2004, COCHRANE DB SYST REV; DAVIES EG, 2004, COCHRANE DB SYST REV; de Montalembert M, 2006, HAEMATOLOGICA, V91, P125; Dunlop RJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003350.pub2; Ferster A, 1996, BLOOD, V88, P1960, DOI 10.1182/blood.V88.6.1960.bloodjournal8861960; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Halasa NB, 2007, CLIN INFECT DIS, V44, P1428, DOI 10.1086/516781; HIRST C, 2002, COCHRANE DB SYST REV; Jacobson SJ, 1997, LANCET, V350, P1358, DOI 10.1016/S0140-6736(97)08462-6; Kato GJ, 2007, BLOOD REV, V21, P37, DOI 10.1016/j.blre.2006.07.001; KOSHY M, 1995, BLOOD, V86, P3676, DOI 10.1182/blood.V86.10.3676.bloodjournal86103676; Kutlar A, 2007, HEMOGLOBIN, V31, P209, DOI 10.1080/03630260701290233; Lal A, 2005, POSTGRADUATE HAEMATOLOGY, 5TH EDITION, P104, DOI 10.1002/9780470987056.ch7; Lees C M, 2000, Cochrane Database Syst Rev, pCD001913; Miller ST, 2001, J PEDIATR-US, V139, P785, DOI 10.1067/mpd.2001.119593; National cholesterol education program National heart lung and blood institute National institutes of health, 2002, 3 REP NAT CHOL ED PR; Neonato MG, 2000, EUR J HAEMATOL, V65, P155, DOI 10.1034/j.1600-0609.2000.90210.x; Ohene-Frempong K, 1998, BLOOD, V91, P288; PEGELOW CH, 1995, J PEDIATR-US, V126, P896, DOI 10.1016/S0022-3476(95)70204-0; Rees DC, 2003, BRIT J HAEMATOL, V120, P744, DOI 10.1046/j.1365-2141.2003.04193.x; Sebastiani P, 2007, BLOOD, V110, P2727, DOI 10.1182/blood-2007-04-084921; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Sun PM, 2001, AM J OBSTET GYNECOL, V184, P1127, DOI 10.1067/mob.2001.115477; Thomas VJ, 2002, BRIT J HEALTH PSYCH, V7, P345, DOI 10.1348/135910702760213724; Vandenplas Y, 2008, ARCH DIS CHILD, V93, P93, DOI 10.1136/adc.2006.110999corr1; VICHINSKY E, 1988, PEDIATRICS, V81, P749; Vichinsky EP, 2000, NEW ENGL J MED, V342, P1855, DOI 10.1056/NEJM200006223422502; VICHINSKY EP, 1995, NEW ENGL J MED, V333, P206, DOI 10.1056/NEJM199507273330402	37	21	25	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 13	2008	337	7670							a1397	10.1136/bmj.a1397	http://dx.doi.org/10.1136/bmj.a1397			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354DT	18779222				2022-12-28	WOS:000259619800041
J	Pfeffer, WT; Harper, JT; O'Neel, S				Pfeffer, W. T.; Harper, J. T.; O'Neel, S.			Kinematic constraints on glacier contributions to 21st-century sea-level rise	SCIENCE			English	Article							LARGE TIDEWATER GLACIER; GREENLAND ICE-SHEET; HYDROLOGIC BASIS; RAPID MOTION	On the basis of climate modeling and analogies with past conditions, the potential for multimeter increases in sea level by the end of the 21st century has been proposed. We consider glaciological conditions required for large sea- level rise to occur by 2100 and conclude that increases in excess of 2 meters are physically untenable. We find that a total sea- level rise of about 2 meters by 2100 could occur under physically possible glaciological conditions but only if all variables are quickly accelerated to extremely high limits. More plausible but still accelerated conditions lead to total sea- level rise by 2100 of about 0.8 meter. These roughly constrained scenarios provide a "most likely" starting point for refinements in sea- level forecasts that include ice flow dynamics.	[Pfeffer, W. T.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA; [Harper, J. T.] Univ Montana, Dept Geosci, Missoula, MT 59812 USA; [O'Neel, S.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of Colorado System; University of Colorado Boulder; University of Montana System; University of Montana; University of California System; University of California San Diego; Scripps Institution of Oceanography	Pfeffer, WT (corresponding author), Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA.	pfeffer@tintin.colorado.edu		Harper, Joel/0000-0002-2151-8509	NSF [OPP-0327345, OPP-0622351, OPP-0612506, OPP-0454789]; University of Colorado Faculty Fellowship; Greens Foundation at Scripps Institution of Oceanography	NSF(National Science Foundation (NSF)); University of Colorado Faculty Fellowship; Greens Foundation at Scripps Institution of Oceanography	This work was supported by NSF grants OPP-0327345 and OPP-0622351 and a University of Colorado Faculty Fellowship (W.T.P.), NSF grants OPP-0612506 and OPP-0454789 (J.T.H.), and the Greens Foundation at Scripps Institution of Oceanography (S.O.). E. Rignot generously supplied Greenland surface velocity data.	Bamber JL, 2001, J GEOPHYS RES-ATMOS, V106, P33773, DOI 10.1029/2001JD900054; Bard E, 1996, NATURE, V382, P241, DOI 10.1038/382241a0; Hansen JE, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024002; Hansen J, 2007, PHILOS T R SOC A, V365, P1925, DOI 10.1098/rsta.2007.2052; HOPE ER, 1963, ENGLISH TRANSLATION; Howat IM, 2007, SCIENCE, V315, P1559, DOI 10.1126/science.1138478; Joughin I, 2004, NATURE, V432, P608, DOI 10.1038/nature03130; KAMB B, 1985, SCIENCE, V227, P469, DOI 10.1126/science.227.4686.469; KAMB B, 1994, J GEOPHYS RES-SOL EA, V99, P15231, DOI 10.1029/94JB00467; MEIER M, 1994, J GEOPHYS RES-SOL EA, V99, P15219, DOI 10.1029/94JB00237; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; MEIER MF, 1987, J GEOPHYS RES-SOLID, V92, P9051, DOI 10.1029/JB092iB09p09051; Mount J., 2005, SAN FRANC ESTUARY WA, V3, DOI 10.15447/sfews.2005v3iss1art7; O'Neel S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031370; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; RIGNOT E, 2007, COMMUNICATION; Rignot E, 2008, NAT GEOSCI, V1, P106, DOI 10.1038/ngeo102; ROTOTAYEV KP, 1963, PRIRODA, V11, P84; Solomon S., 2007, PHYS SCI BASIS WORKI; Thomas R, 2000, SCIENCE, V289, P426, DOI 10.1126/science.289.5478.426	22	582	598	2	134	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1340	1343		10.1126/science.1159099	http://dx.doi.org/10.1126/science.1159099			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772435				2022-12-28	WOS:000258914300046
J	Shipman, C; Gysels, M; White, P; Worth, A; Murray, SA; Barclay, S; Forrest, S; Shepherd, J; Dale, J; Dewar, S; Peters, M; White, S; Richardson, A; Lorenz, K; Koffman, J; Higginson, IJ				Shipman, Cathy; Gysels, Marjolein; White, Patrick; Worth, Allison; Murray, Scott A.; Barclay, Stephen; Forrest, Sarah; Shepherd, Jonathan; Dale, Jeremy; Dewar, Steve; Peters, Marilyn; White, Suzanne; Richardson, Alison; Lorenz, Karl; Koffman, Jonathan; Higginson, Irene J.			Improving generalist end of life care: national consultation with practitioners, commissioners, academics, and service user groups	BRITISH MEDICAL JOURNAL			English	Article							PRIMARY PALLIATIVE CARE; GOLD-STANDARDS-FRAMEWORK; CANCER; DEATH; COMMUNICATION; COUNTRIES; TRENDS; FAMILY; PLACE; DIE	Objective To identify major concerns of national and local importance in the provision, commissioning, research, and use of generalist end of life care. Design A national consultation and prioritising exercise using a modified form of the nominal group technique. Participants Healthcare practitioners, commissioners, academics, and representatives of user and voluntary groups. Setting Primary and secondary care, specialist palliative care, and academic and voluntary sectors in England and Scotland. Results 74% of those invited ( 210/ 285) participated. The stage of life to which "end of life care" referred was not understood in a uniform way. Perceptions ranged from a period of more than a year to the last few days of life. Prominent concerns included difficulties in prognosis and the availability of adequate support for patients with advanced non- malignant disease. Generalists in both primary and secondary care were usually caring for only a few patients approaching the end of life at any one time at a point in time. It was therefore challenging to maintain skills and expertise particularly as educational opportunities were often limited. End of life care took place among many other competing and incentivised activities for general practitioners in the community. More needs to be known about models of end of life care and how these can be integrated in a generalist's workload. A greater evidence base is needed about the effectiveness and application of current tools such as the gold standards framework and Liverpool care pathway and about models of palliation in patients with diseases other than cancer. Conclusions Definitions of end of life care need clarification and standardisation. A greater evidence base is needed to define models of good practice together with a commitment to provide education and training and adequate resources for service provision. More needs to be known about the context of provision and the influence of competing priorities and incentives.	[Shipman, Cathy; Gysels, Marjolein; Koffman, Jonathan; Higginson, Irene J.] Kings Coll London, Dept Palliat Care Policy & Rehabil, Weston Educ Ctr, London SE5 9RJ, England; [Shipman, Cathy; White, Patrick; Peters, Marilyn; White, Suzanne] Kings Coll London, Dept Gen Practice & Primary Care, London SE11 6SP, England; [Worth, Allison; Murray, Scott A.] Univ Edinburgh, Primary Palliat Care Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Barclay, Stephen; Forrest, Sarah] Univ Cambridge, Gen Practice & Primary Care Res Unit, Dept Publ Hlth & Primary Care, Cambridge CB2 2SR, England; [Shepherd, Jonathan; Dale, Jeremy] Univ Warwick, Ctr Primary Hlth Care Studies, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England; [Dewar, Steve] Kings Fund, London W1G 0AN, England; [Richardson, Alison] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London SE1 8WA, England; [Lorenz, Karl] Univ Calif Los Angeles, Sch Med, VA Greater Los Angeles Healthcare Syst, Los Angeles, CA 90073 USA	University of London; King's College London; University of London; King's College London; University of Edinburgh; University of Cambridge; University of Warwick; University of London; King's College London; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Shipman, C (corresponding author), Kings Coll London, Dept Palliat Care Policy & Rehabil, Weston Educ Ctr, London SE5 9RJ, England.	Catherine.shipman@kcl.ac.uk	Higginson, Irene J/C-7309-2012; green, sam/C-2608-2008; White, Patrick/AAN-7799-2020	Higginson, Irene J/0000-0002-3687-1313; White, Patrick/0000-0002-2047-8787; Gysels, Marjolein/0000-0002-2355-1732; Barclay, Stephen/0000-0002-4505-7743; Koffman, Jonathan/0000-0001-8513-5681; Dale, Jeremy/0000-0001-9256-3553	National Institute of Health Research Service Development and Organisation research and development programme	National Institute of Health Research Service Development and Organisation research and development programme(National Institute for Health Research (NIHR))	National Institute of Health Research Service Development and Organisation research and development programme.	ADDINGTONHALL J, 1995, PALLIATIVE MED, V9, P295, DOI 10.1177/026921639500900404; ADDINGTONHALL J, 1995, STROKE, V26, P2242, DOI 10.1161/01.STR.26.12.2242; Armitage M, 2007, CLIN MED, V7, P436, DOI 10.7861/clinmedicine.7-5-436; BARCLAY S, 2001, PALLIATIVE CARE NONC; Brazil K, 2007, J PALLIAT CARE, V23, P113, DOI 10.1177/082585970702300206; CARTWRIGHT A, 1991, J PUBLIC HEALTH MED, V13, P81; Clark D, 2000, PALLIATIVE MED, V14, P479, DOI 10.1191/026921600701536408; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; DAVIES E, 2004, PALLIATIVE CARE SOLI; *DEP HLTH, 2006, BETT END LIF CAR PAT; *DEP HLTH, 2007, CHOIC MATT 2007 8 PU; Department of Health, 2007, OP FRAM 2007 08 PCT; Department of Health, 2008, END LIF CAR STRAT PR; Espinosa-Roca AA, 2006, BRIT MED J, V332, P668, DOI 10.1136/bmj.332.7542.668; Flory J, 2004, HEALTH AFFAIR, V23, P194, DOI 10.1377/hlthaff.23.3.194; Forrest S, 2007, BRIT J GEN PRACT, V57, P503; Gomes B, 2006, BMJ-BRIT MED J, V332, P515, DOI 10.1136/bmj.38740.614954.55; Gomes B, 2008, PALLIATIVE MED, V22, P33, DOI 10.1177/0269216307084606; Hansford P, 2007, END LIFE CARE, V1, P1; HEAM J, 1998, PALLIATIVE MED, V12, P317; Higginson I J, 2000, J Palliat Med, V3, P287, DOI 10.1089/jpm.2000.3.287; HIGGINSON IJ, 2007, 1 NIHR SERV DEL ORG; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Lorenz Karl A, 2005, J Palliat Med, V8 Suppl 1, pS4; Mahmood-Yousuf K, 2008, BRIT J GEN PRACT, V58, P256, DOI 10.3399/bjgp08X279760; Munday D, 2007, FAM PRACT, V24, P486, DOI 10.1093/fampra/cmm045; Murray SA, 2004, BMJ-BRIT MED J, V329, P1056, DOI 10.1136/bmj.329.7474.1056; Murray SA, 2003, BRIT MED J, V326, P368, DOI 10.1136/bmj.326.7385.368; *NHS CONF, 2005, LEAD EDG, P12; *OFF NAT STAT, 2007, MORT STAT REV REG GE; RICHARDS M, 2007, END LIFE CARE STRATE; *ROYAL COLL PHYS W, 2007, PALL CAR SERV M NEED; *SCOTT PARTN PALL, 2006, MAK GOOD CAR BETT NA; Scottish Government, 2007, BETT HLTH BETT CAR; Scottish Partnership for Palliative Care, 2006, JOIN THINK JOIN CAR; *SDO RES SUMM, 2007, CAR PROV GEN END LIF; SHIPMAN C, 2007, 3 NIHR SERV DEL ORG; Shugarman LR, 2005, CLIN GERIATR MED, V21, P255, DOI 10.1016/j.cger.2004.08.008; St John of God Health Care, 2019, OUR VIS; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Wang XS, 2004, J PAIN SYMPTOM MANAG, V27, P125, DOI 10.1016/j.jpainsymman.2003.06.002; Wennberg JE, 2004, BMJ-BRIT MED J, V328, P607, DOI 10.1136/bmj.328.7440.607	42	111	111	0	15	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1720	10.1136/bmj.a1720	http://dx.doi.org/10.1136/bmj.a1720			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18829640	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000259903300032
J	Hashimoto, H; Horton, JR; Zhang, X; Bostick, M; Jacobsen, SE; Cheng, XD				Hashimoto, Hideharu; Horton, John R.; Zhang, Xing; Bostick, Magnolia; Jacobsen, Steven E.; Cheng, Xiaodong			The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helix	NATURE			English	Article							ADENINE METHYLTRANSFERASE; SUBSTRATE-RECOGNITION; BINDING DOMAIN; METHYLATED DNA; TARGET BASE; PROTEIN; CELLS; NP95; ESTABLISHMENT; MAINTENANCE	Maintenance methylation of hemimethylated CpG dinucleotides at DNA replication forks is the key to faithful mitotic inheritance of genomic methylation patterns. UHRF1 ( ubiquitin- like, containing PHD and RING finger domains 1) is required for maintenance methylation by interacting with DNA nucleotide methyltransferase 1 ( DNMT1), the maintenance methyltransferase, and with hemi-methylated CpG, the substrate for DNMT1 ( refs 1 and 2). Here we present the crystal structure of the SET and RING- associated ( SRA) domain of mouse UHRF1 in complex with DNA containing a hemimethylated CpGsite. The DNA is contacted in both the major and minor grooves by two loops that penetrate into the middle of the DNA helix. The 5- methylcytosine has flipped completely out of the DNA helix and is positioned in a binding pocket with planar stacking contacts, Watson - Crick polar hydrogen bonds and van der Waals interactions specific for 5- methylcytosine. Hence, UHRF1 contains a previously unknown DNA- binding module and is the first example of a non- enzymatic, sequence- specific DNA- binding protein domain to use the base flipping mechanism to interact with DNA.	[Hashimoto, Hideharu; Horton, John R.; Zhang, Xing; Cheng, Xiaodong] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Bostick, Magnolia; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	Emory University; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Cheng, XD (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	xcheng@emory.edu	Horton, John R/ABB-4770-2020; hashimoto, hal/C-2079-2012; Horton, John/F-2375-2010; Hu, Ruogu/B-2203-2008	hashimoto, hal/0000-0002-5674-5779; Horton, John/0000-0001-9749-8068	National Institutes of Health [GM049245, GM060398]; NIH-NSRA Fellowship [CA1263022]; Howard Hughes Medical Institute; Georgia Research Alliance Eminent Scholar; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060398, R01GM049245, R37GM060398] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NSRA Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Georgia Research Alliance Eminent Scholar; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. M. Blumenthal for critical comments. The Emory University School of Medicine supported the use of SER- CAT beamlines. This work was supported by grant GM049245 to X. C. from the National Institutes of Health ( NIH). Work in the Jacobsen laboratory is funded by the NIH grant GM060398. M. B. is funded by NIH-NSRA Fellowship number CA1263022. S. E. J. is an Investigator of the Howard Hughes Medical Institute and X. C. is a Georgia Research Alliance Eminent Scholar.	Achour M, 2008, ONCOGENE, V27, P2187, DOI 10.1038/sj.onc.1210855; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen T, 2006, CURR TOP MICROBIOL, V301, P179; Cheng CC, 1996, CONTROL ENG PRACT, V4, P645, DOI 10.1016/0967-0661(96)00046-9; Cheng XD, 2001, NUCLEIC ACIDS RES, V29, P3784, DOI 10.1093/nar/29.18.3784; Cheng XD, 2008, STRUCTURE, V16, P341, DOI 10.1016/j.str.2008.01.004; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Ho KL, 2008, MOL CELL, V29, P525, DOI 10.1016/j.molcel.2007.12.028; Horton JR, 2006, J MOL BIOL, V358, P559, DOI 10.1016/j.jmb.2006.02.028; Horton JR, 2005, CELL, V121, P349, DOI 10.1016/j.cell.2005.02.021; Jeltsch A, 2006, CURR TOP MICROBIOL, V301, P203; Johnson LM, 2007, CURR BIOL, V17, P379, DOI 10.1016/j.cub.2007.01.009; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KLIMASAUSKAS S, 1995, NUCLEIC ACIDS RES, V23, P1388, DOI 10.1093/nar/23.8.1388; KLIMASAUSKAS S, 1994, CELL, V76, P357, DOI 10.1016/0092-8674(94)90342-5; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lee TT, 2005, CELL, V120, P599, DOI 10.1016/j.cell.2004.12.037; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102; Mousli M, 2003, BRIT J CANCER, V89, P120, DOI 10.1038/sj.bjc.6601068; Muto M, 2002, J BIOL CHEM, V277, P34549, DOI 10.1074/jbc.M205189200; Ohki I, 2001, CELL, V105, P487, DOI 10.1016/S0092-8674(01)00324-5; Ooi SKT, 2008, CURR BIOL, V18, pR174, DOI 10.1016/j.cub.2007.12.045; Otwinowski Z, 2003, ACTA CRYSTALLOGR A, V59, P228, DOI 10.1107/S0108767303005488; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Unoki M, 2008, RADIAT RES, V169, P240, DOI 10.1667/RR1209.1; Werner RM, 2000, BIOCHEMISTRY-US, V39, P12585, DOI 10.1021/bi001532v; Woo HR, 2007, GENE DEV, V21, P267, DOI 10.1101/gad.1512007; Yang CG, 2008, NATURE, V452, P961, DOI 10.1038/nature06889; Yang Z, 2003, NAT STRUCT BIOL, V10, P849, DOI 10.1038/nsb973	36	303	313	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 9	2008	455	7214					826	U14		10.1038/nature07280	http://dx.doi.org/10.1038/nature07280			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18772888	Green Accepted			2022-12-28	WOS:000259854900053
J	Watts, G				Watts, Geoff			What happened to the polypill?	BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR-DISEASE					geoff@scileg.freeserve.co.uk						Rodgers A, 2003, BMJ-BRIT MED J, V326, P1407, DOI 10.1136/bmj.326.7404.1407; *U AUCKL CLIN TRIA, 2008, PILL PIL PROGR IMPR; Wald NJ, 2003, BMJ-BRIT MED J, V326, P1419, DOI 10.1136/bmj.326.7404.1419	3	7	8	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1822	10.1136/bmj.a1822	http://dx.doi.org/10.1136/bmj.a1822			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18819953				2022-12-28	WOS:000259798000030
J	Renaud, P; Leong, P				Renaud, Philippe; Leong, Paul			Chemistry - A light touch catalyzes asymmetric carbon-carbon bond formation	SCIENCE			English	Editorial Material							ALDEHYDES; ORGANOCATALYSIS; ACTIVATION		[Renaud, Philippe; Leong, Paul] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland	University of Bern	Renaud, P (corresponding author), Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland.	philippe.renaud@ioc.unibe.ch; paul.leong@ioc.unibe.ch	Renaud, Philippe/N-7747-2014	Renaud, Philippe/0000-0002-9069-7109				Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696; Brase S., 2007, ASYMMETRIC SYNTHESIS; Hoveyda A. H., 2004, COMPREHENSIVE ASYMME, p207?233; Jang HY, 2007, J AM CHEM SOC, V129, P7004, DOI 10.1021/ja0719428; JURIS A, 1988, COORDIN CHEM REV, V84, P85, DOI 10.1016/0010-8545(88)80032-8; Kim H, 2008, J AM CHEM SOC, V130, P398, DOI 10.1021/ja077212h; Nicewicz DA, 2008, SCIENCE, V322, P77, DOI 10.1126/science.1161976; Sibi MP, 2007, J AM CHEM SOC, V129, P4124, DOI 10.1021/ja069245n; Vignola N, 2004, J AM CHEM SOC, V126, P450, DOI 10.1021/ja0392566	9	31	32	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					55	56		10.1126/science.1164403	http://dx.doi.org/10.1126/science.1164403			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832635				2022-12-28	WOS:000259680200032
J	Wang, HJ; Xi, XK; Kleinhammes, A; Wu, Y				Wang, Hai-Jing; Xi, Xue-Kui; Kleinhammes, Alfred; Wu, Yue			Temperature-induced hydrophobic-hydrophilic transition observed by water adsorption	SCIENCE			English	Article							WALLED CARBON NANOTUBES; CONFINEMENT; ISOTHERMS; NANOPORES; MOLECULES; NMR	The properties of nanoconfined and interfacial water in the proximity of hydrophobic surfaces play a pivotal role in a variety of important phenomena such as protein folding. Water inside single- walled carbon nanotubes ( SWNTs) can provide an ideal system for investigating such nanoconfined interfacial water on hydrophobic surfaces, provided that the nanotubes can be opened without introducing excess defects. Here, we report a hydrophobic- hydrophilic transition upon cooling from 22 degrees C to 8 degrees C via the observation of water adsorption isotherms in SWNTs measured by nuclear magnetic resonance. A considerable slowdown in molecular reorientation of such adsorbed water was also detected. The observed transition demonstrates that the structure of interfacial water could depend sensitively on temperature, which could lead to intriguing temperature dependences involving interfacial water on hydrophobic surfaces.	[Wang, Hai-Jing; Xi, Xue-Kui; Kleinhammes, Alfred; Wu, Yue] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Wu, Y (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.	yuewu@physics.unc.edu	Wang, Haijing/Y-6389-2019; Wang, Hai-Jing/C-2531-2009	Wang, Hai-Jing/0000-0002-9863-0144	NSF [DMR 0513915]	NSF(National Science Foundation (NSF))	This work was supported by NSF under contract DMR 0513915. We thank O. Zhou for help in SWNTs synthesis.	Abragam A., 1961, PRINCIPLES NUCL MAGN; Baugh J, 2001, SCIENCE, V294, P1505, DOI 10.1126/science.1065373; BEAGLEHOLE D, 1992, J PHYS CHEM-US, V96, P3395, DOI 10.1021/j100187a040; Birkett GR, 2007, J PHYS CHEM C, V111, P5735, DOI 10.1021/jp068479q; Byl O, 2006, J AM CHEM SOC, V128, P12090, DOI 10.1021/ja057856u; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chen Q, 2008, NANO LETT, V8, P1902, DOI 10.1021/nl080569e; Geng HZ, 2004, CHEM PHYS LETT, V399, P109, DOI 10.1016/j.cplett.2004.09.150; GREGG S. J., 1982, AUFLAGE, V2nd; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Hummer G, 2001, NATURE, V414, P188, DOI 10.1038/35102535; Jensen TR, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086101; Kleinhammes A, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.075418; Koga K, 2002, PHYSICA A, V314, P462, DOI 10.1016/S0378-4371(02)01074-9; Kolesnikov AI, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035503; KORB JP, 1993, J CHEM PHYS, V98, P2411, DOI 10.1063/1.464169; KUBO R, 1954, J PHYS SOC JPN, V9, P888, DOI 10.1143/JPSJ.9.888; Kurita T, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.205424; Maniwa Y, 2005, CHEM PHYS LETT, V401, P534, DOI 10.1016/j.cplett.2004.11.112; Maniwa Y, 2007, NAT MATER, V6, P135, DOI 10.1038/nmat1823; Mao SH, 2006, CHEM PHYS LETT, V421, P513, DOI 10.1016/j.cplett.2006.02.011; Mashl RJ, 2003, NANO LETT, V3, P589, DOI 10.1021/nl0340226; Ohba T, 2004, J AM CHEM SOC, V126, P1560, DOI 10.1021/ja038842w; Pires J, 2003, ADSORPTION, V9, P303, DOI 10.1023/A:1026219813234; Rezus YLA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148301; Striolo A, 2005, ADSORPTION, V11, P397, DOI 10.1007/s10450-005-5957-9; Takaiwa D, 2008, P NATL ACAD SCI USA, V105, P39, DOI 10.1073/pnas.0707917105; Tang XP, 2000, SCIENCE, V288, P492, DOI 10.1126/science.288.5465.492; Tsai CJ, 2002, CRIT REV BIOCHEM MOL, V37, P55, DOI 10.1080/10409230290771456; Vartapetyan RS, 1995, USP KHIM+, V64, P1055	30	154	155	9	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					80	83		10.1126/science.1162412	http://dx.doi.org/10.1126/science.1162412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832642				2022-12-28	WOS:000259680200041
J	Galvin, RS				Galvin, Robert S.			Election 2008 - Still in the game - Harnessing employer inventiveness in US Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Galvin, Robert S.] Gen Elect, Fairfield, CT 06828 USA; [Galvin, Robert S.] Yale Univ, Sch Med, New Haven, CT USA	General Electric; Yale University	Galvin, RS (corresponding author), Gen Elect, Fairfield, CT 06828 USA.							Blumenthal D, 2006, NEW ENGL J MED, V355, P82, DOI 10.1056/NEJMhpr060703; Fronstin P., 2006, 2 ANN EBRI COMMONWEA; Galvin RS, 2006, HEALTH AFFAIR, V25, P1548, DOI 10.1377/hlthaff.25.6.1548; Lee PV, 2006, HEALTH AFFAIR, V25, pW544, DOI 10.1377/hlthaff.25.w544; Whitmore H, 2007, HEALTH AFFAIR, V26, P295	5	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1421	1423		10.1056/NEJMp0805021	http://dx.doi.org/10.1056/NEJMp0805021			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354ID	18832241				2022-12-28	WOS:000259631700001
J	Faller, BA; Atkinson, JP				Faller, Bryan A.; Atkinson, John P.			New-onset clubbing associated with lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Faller, Bryan A.; Atkinson, John P.] Washington Univ, Sch Med, St Louis, MO 63110 USA	Washington University (WUSTL)	Faller, BA (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.	bryan.faller@fccc.edu		Atkinson, John/0000-0002-2514-3441					0	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					E15	E15		10.1056/NEJMicm066228	http://dx.doi.org/10.1056/NEJMicm066228			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815393				2022-12-28	WOS:000259440900009
J	Gradishar, WJ; Bellon, JR; Gadd, MA; D'Alessandro, HA; Braaten, K; Smith, BL; Harris, NL				Gradishar, William J.; Bellon, Jennifer R.; Gadd, Michele A.; D'Alessandro, Helen Anne; Braaten, Kristina; Smith, Barbara L.; Harris, Nancy Lee			A woman with a mass in the breast and a solitary lesion in the spine - Breast cancer with minimal metastatic disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Conference on Breast Cancer - Current Controversies and New Horizons	JUL 12, 2007	Boston, MA				ADJUVANT ENDOCRINE THERAPY; ESTROGEN-RECEPTOR STATUS; LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; PREMENOPAUSAL PATIENTS; PRIMARY TUMOR; SURGICAL RESECTION; HEPATIC RESECTION; CORD COMPRESSION; LOCAL THERAPY		[Gradishar, William J.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Gradishar, William J.] Feinberg Sch Med, Chicago, IL USA; [Bellon, Jennifer R.] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; [Bellon, Jennifer R.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Gadd, Michele A.] Massachusetts Gen Hosp, Dept Surg Oncol, Boston, MA 02114 USA; [D'Alessandro, Helen Anne] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Braaten, Kristina] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bellon, Jennifer R.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA 02115 USA; [Gadd, Michele A.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [D'Alessandro, Helen Anne] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Braaten, Kristina] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Gradishar, WJ (corresponding author), Northwestern Univ, Dept Med, Chicago, IL 60611 USA.							Aapro M, 2008, ANN ONCOL, V19, P420, DOI 10.1093/annonc/mdm442; Abe O, 2005, LANCET, V366, P2087; Adam R, 2006, ANN SURG, V244, P897, DOI 10.1097/01.sla.0000246847.02058.1b; Andrews DW, 2004, LANCET, V363, P1665, DOI 10.1016/S0140-6736(04)16250-8; Babiera GV, 2006, ANN SURG ONCOL, V13, P776, DOI 10.1245/ASO.2006.03.033; Bardou VJ, 2003, J CLIN ONCOL, V21, P1973, DOI 10.1200/JCO.2003.09.099; Blumenschein GR, 1997, CLIN CANCER RES, V3, P2633; Carmichael AR, 2003, EUR J SURG ONCOL, V29, P17, DOI 10.1053/ejso.2002.1339; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Esteva FJ, 2004, BREAST CANCER RES, V6, P109, DOI 10.1186/bcr777; Fields RC, 2007, ANN SURG ONCOL, V14, P3345, DOI 10.1245/s10434-007-9527-0; Friedel G, 2002, EUR J CARDIO-THORAC, V22, P335, DOI 10.1016/S1010-7940(02)00331-7; Gerszten PC, 2007, SPINE, V32, P193, DOI 10.1097/01.brs.0000251863.76595.a2; Gnerlich J, 2007, ANN SURG ONCOL, V14, P2187, DOI 10.1245/s10434-007-9438-0; Greenberg PAC, 1996, J CLIN ONCOL, V14, P2197, DOI 10.1200/JCO.1996.14.8.2197; Hanrahan EO, 2005, CANCER-AM CANCER SOC, V104, P1158, DOI 10.1002/cncr.21305; Harvey JM, 1999, J CLIN ONCOL, V17, P1474, DOI 10.1200/JCO.1999.17.5.1474; HELLMAN S, 1995, J CLIN ONCOL, V13, P8, DOI 10.1200/JCO.1995.13.1.8; HOLMES EA, 1994, BREAST DIS, V7, P7; INGLE JN, 1986, J CLIN ONCOL, V4, P178, DOI 10.1200/JCO.1986.4.2.178; Isaacs C, 2001, SEMIN ONCOL, V28, P53, DOI 10.1053/sonc.2001.20742; JORDAN VC, 1991, J NATL CANCER I, V83, P1488, DOI 10.1093/jnci/83.20.1488; KAUFMANN M, 1991, ONKOLOGIE, V14, P22; Khan SA, 2002, SURGERY, V132, P620, DOI 10.1067/msy.2002.127544; Klijn JGM, 2000, JNCI-J NATL CANCER I, V92, P903, DOI 10.1093/jnci/92.11.903; KLIJN JGM, 1984, BREAST CANCER RES TR, V4, P209, DOI 10.1007/BF01806487; LANZA LA, 1992, ANN THORAC SURG, V54, P244, DOI 10.1016/0003-4975(92)91377-L; Ludwig C, 2003, EUR J SURG ONCOL, V29, P532, DOI 10.1016/S0748-7983(03)00074-X; Martinez SR, 2006, AM J SURG, V191, P281, DOI 10.1016/j.amjsurg.2005.08.030; Nieto Y, 2002, J CLIN ONCOL, V20, P707, DOI 10.1200/JCO.20.3.707; Patchell RA, 2005, LANCET, V366, P643, DOI 10.1016/S0140-6736(05)66954-1; PAVLAKIS N, 2002, COCHRANE DB SYST REV, V1; Pocard M, 2000, EUR J SURG ONCOL, V26, P155, DOI 10.1053/ejso.1999.0761; PRITCHARD KI, 1980, CANCER TREAT REP, V64, P787; Punglia RS, 2007, NEW ENGL J MED, V356, P2399, DOI 10.1056/NEJMra065241; Raab R, 1998, ANTICANCER RES, V18, P2231; Rades D, 2007, J CLIN ONCOL, V25, P50, DOI 10.1200/JCO.2006.08.7155; Rapiti E, 2006, J CLIN ONCOL, V24, P2743, DOI 10.1200/JCO.2005.04.2226; RASMUSSEN BB, 1987, AM J CLIN PATHOL, V87, P155, DOI 10.1093/ajcp/87.2.155; Rubin P, 2006, SEMIN RADIAT ONCOL, V16, P120, DOI 10.1016/j.semradonc.2005.12.007; Sawka CA, 1997, BREAST CANCER RES TR, V44, P211, DOI 10.1023/A:1005895813401; SWENERTON KD, 1979, CANCER RES, V39, P1552; Taylor CW, 1998, J CLIN ONCOL, V16, P994, DOI 10.1200/JCO.1998.16.3.994; Vlastos G, 2004, ANN SURG ONCOL, V11, P869, DOI 10.1245/ASO.2004.01.007; Yamauchi H, 2001, J CLIN ONCOL, V19, P2334, DOI 10.1200/JCO.2001.19.8.2334	45	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1382	1391		10.1056/NEJMcpc0805308	http://dx.doi.org/10.1056/NEJMcpc0805308			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	351QZ	18815400				2022-12-28	WOS:000259440900010
J	Katz, MH				Katz, Mitchell H.			Banning tobacco sales in pharmacies - The right prescription	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SMOKING; ACCEPTABILITY; CIGARETTES; ADULTS		[Katz, Mitchell H.] San Francisco Dept Publ Hlth, San Francisco, CA 94102 USA	San Francisco Department of Public Health	Katz, MH (corresponding author), San Francisco Dept Publ Hlth, 101 Grove St,Room 308, San Francisco, CA 94102 USA.	mitch.katz@sfdph.org						Albers AB, 2004, TOB CONTROL, V13, P347, DOI 10.1136/tc.2003.007336; Alesci NL, 2003, PREV MED, V36, P272, DOI 10.1016/S0091-7435(02)00029-4; BRANDECKER M, NY PHARM COULD BANNE; *CAL MED ASS FDN, 2000, PRESCR CHANG CAL REA; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; DAVIS RM, 1992, TOB CONTROL, V1, P84; Eule B, 2004, TOB CONTROL, V13, P429, DOI 10.1136/tc.2004.007872; Farkas AJ, 2000, JAMA-J AM MED ASSOC, V284, P717, DOI 10.1001/jama.284.6.717; Fong, 2008, WALL STREET J, pB1; Hudmon KS, 2006, TOB CONTROL, V15, P35, DOI 10.1136/tc.2005.012278; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; NATION NI, 2008, MARIN INDEPENDE 0801; *NCI, MON NCI, V19; SCHROEDER SA, 1978, AM J PUBLIC HEALTH, V68, P494, DOI 10.2105/AJPH.68.5.494; TAYLOR MC, BANNING CIGARETTE SA	15	24	24	1	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1451	1453		10.1001/jama.300.12.1451	http://dx.doi.org/10.1001/jama.300.12.1451			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812536				2022-12-28	WOS:000259410400023
J	Hyde, R				Hyde, Rob			Profile - Erika von Mutius: reshaping the landscape of asthma research	LANCET			English	Biographical-Item												rob@rob-hyde.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1029	1029		10.1016/S0140-6736(08)61428-2	http://dx.doi.org/10.1016/S0140-6736(08)61428-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805318				2022-12-28	WOS:000259648500013
J	Szefler, S; Mitchell, H; Sorkness, CA; Gergen, PJ; O'Connor, GT; Morgan, WJ; Kattan, M; Pongracic, JA; Teach, SJ; Bloomberg, GR; Eggleston, PA; Gruchalla, RS; Kercsmar, CM; Liu, AH; Wildfire, JJ; Curry, MD; Busse, WW				Szefler, Stanley J.; Mitchell, Herman; Sorkness, Christine A.; Gergen, Peter J.; O'Connor, George T.; Morgan, Wayne J.; Kattan, Meyer; Pongracic, Jacqueline A.; Teach, Stephen J.; Bloomberg, Gordon R.; Eggleston, Peyton A.; Gruchalla, Rebecca S.; Kercsmar, Carolyn M.; Liu, Andrew H.; Wildfire, Jeremy J.; Curry, Matthew D.; Busse, William W.			Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial	LANCET			English	Article							SCHOOL-AGE-CHILDREN; CHILDHOOD ASTHMA; DIFFICULT ASTHMA; THERAPY; INFLAMMATION; MONTELUKAST; PREVALENCE; MORBIDITY; STEROIDS; SYSTEM	Background Preliminary evidence is equivocal about the role of exhaled nitric oxide (NO) in clinical asthma management. We aimed to assess whether measurement of exhaled NO, as a biomarker of airway inflammation, could increase the effectiveness of asthma treatment, when used as an adjunct to clinical care based on asthma guidelines for inner-city adolescents and young adults. Methods We did a randomised, double-blind, parallel-group trial at ten centres in the USA. We screened 780 inner-city patients, aged 12-20 years, who had persistent asthma. All patients completed a run-in period of 3 weeks on a regimen based on standard treatment. 546 eligible participants who adhered to treatment during this run-in period were then randomly assigned to 46 weeks of either standard treatment, based on the guidelines of the National Asthma Education and Prevention Program (NAEPP), or standard treatment modified on the basis of measurements of fraction of exhaled NO. The primary outcome was the number of days with asthma symptoms. We analysed patients on an intention-to-treat basis. This trial is registered with clinicaltrials.gov, number NCT00114413. Findings During the 46-week treatment period, the mean number of days with asthma symptoms did not differ between the treatment groups (1.93 [95% Cl 1.74 to 2.11] in the NO monitoring group vs 1.89 [1.71 to 2.07] in the control group; difference 0.04 [-0.22 to 0.29], p=0.780). Other symptoms, pulmonary function, and asthma exacerbations did not differ between groups. Patients in the NO monitoring group received higher doses of inhaled corticosteroids (difference 119 mu g per day, 95% CI 49 to 189, p=0-001) than controls. Adverse events did not differ between treatment groups (p> 0 . 1 for all adverse events). Interpretation Conventional asthma management resulted in good control of symptoms in most participants. The addition of fraction of exhaled NO as an indicator of control of asthma resulted in higher doses of inhaled corticosteroids, without clinically important improvements in symptomatic asthma control. Funding US National Institute of Allergy and Infectious Diseases, US National Institutes of Health.	[Szefler, Stanley J.; Liu, Andrew H.] Natl Jewish Hlth, Dept Pediat, Denver, CO 80206 USA; [Mitchell, Herman; Wildfire, Jeremy J.; Curry, Matthew D.] Rho, Chapel Hill, NC USA; [Sorkness, Christine A.; Busse, William W.] Univ Wisconsin, Madison, WI USA; [Gergen, Peter J.] NIAID, Bethesda, MD 20892 USA; [O'Connor, George T.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Morgan, Wayne J.] Univ Arizona, Coll Med, Tucson, AZ USA; [Kattan, Meyer] Columbia Univ, New York, NY USA; [Pongracic, Jacqueline A.] Childrens Mem Hosp, Chicago, IL 60614 USA; [Teach, Stephen J.] Childrens Natl Med Ctr, Washington, DC 20010 USA; [Bloomberg, Gordon R.] Washington Univ, St Louis, MO USA; [Eggleston, Peyton A.] Johns Hopkins Univ, Baltimore, MD USA; [Gruchalla, Rebecca S.] Univ Texas Dallas, SW Med Ctr, Dallas, TX USA; [Kercsmar, Carolyn M.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	National Jewish Health; Rho; University of Wisconsin System; University of Wisconsin Madison; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Boston University; University of Arizona; Columbia University; Ann & Robert H. Lurie Children's Hospital of Chicago; Children's National Health System; Washington University (WUSTL); Johns Hopkins University; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Szefler, S (corresponding author), Natl Jewish Hlth, Dept Pediat, 1400 Jackson St,Room J313, Denver, CO 80206 USA.	szeflers@njc.org		O'Connor, George/0000-0002-6476-3926	Division of Allergy, Immunology, and Transplantation at the US National Institute of Allergy and Infectious Diseases; National Institutes of Health [NO1-AI-25496, NO1-Al-25482, M01 RR00533]; National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI025496] Funding Source: NIH RePORTER	Division of Allergy, Immunology, and Transplantation at the US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The study was funded by the Division of Allergy, Immunology, and Transplantation at the US National Institute of Allergy and Infectious Diseases, National Institutes of Health, under Contracts number NO1-AI-25496 and NO1-Al-25482, and by the National Center for Research Resources, National Institutes of Health, under grant M01 RR00533. GlaxoSmithKline donated study drugs and Lincoln Diagnostics donated skin-testing materials. We thank all study staff and consultants, study participants, and their families.	Akinbami, 2006, STATE CHILDHOOD ASTH, V381; Akinbami LJ, 2002, PEDIATRICS, V110, P315, DOI 10.1542/peds.110.2.315; American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Bratton DL, 1999, PEDIATR PULM, V28, P402, DOI 10.1002/(SICI)1099-0496(199912)28:6<402::AID-PPUL3>3.0.CO;2-V; Cloutier MM, 2002, CHEST, V122, P1571, DOI 10.1378/chest.122.5.1571; Covar RA, 2003, J PEDIATR-US, V142, P469, DOI 10.1067/mpd.2003.187; Crater SE, 1999, AM J RESP CRIT CARE, V159, P806, DOI 10.1164/ajrccm.159.3.9805103; Evans R, 1999, J PEDIATR-US, V135, P332, DOI 10.1016/S0022-3476(99)70130-7; Fitzpatrick AM, 2006, J ALLERGY CLIN IMMUN, V118, P1218, DOI 10.1016/j.jaci.2006.08.019; Fritsch M, 2006, PEDIATR PULM, V41, P855, DOI 10.1002/ppul.20455; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Jones CA, 2007, J ALLERGY CLIN IMMUN, V119, P1445, DOI 10.1016/j.jaci.2007.02.031; Jones SL, 2001, AM J RESP CRIT CARE, V164, P738, DOI 10.1164/ajrccm.164.5.2012125; Jones SL, 2002, EUR RESPIR J, V20, P601, DOI 10.1183/09031936.02.00285302; Kharitonov SA, 1996, AM J RESP CRIT CARE, V153, P454, DOI 10.1164/ajrccm.153.1.8542158; Kharitonov SA, 1996, EUR RESPIR J, V9, P196, DOI 10.1183/09031936.96.09020196; Maniscalco M, 2007, RESP PHYSIOL NEUROBI, V156, P370, DOI 10.1016/j.resp.2006.10.003; MASSARO AF, 1995, AM J RESP CRIT CARE, V152, P800, DOI 10.1164/ajrccm.152.2.7633745; Meyts I, 2003, PEDIATR PULM, V36, P283, DOI 10.1002/ppul.10317; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; *NAT ASTHM ED PREV, 2007, 3 NIH NAT HEART LUNG; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Payne DNR, 2001, AM J RESP CRIT CARE, V164, P1376, DOI 10.1164/ajrccm.164.8.2101145; PETSKY HL, 2008, COCHRANE DB SYST REV, V2, P6340; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Silkoff PE, 2004, J ALLERGY CLIN IMMUN, V114, P1241, DOI 10.1016/j.jaci.2004.08.042; Silkoff PE, 2001, CHEST, V119, P1322, DOI 10.1378/chest.119.5.1322; Sippel JM, 2000, J ALLERGY CLIN IMMUN, V106, P645, DOI 10.1067/mai.2000.109618; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Stirling RG, 1998, THORAX, V53, P1030, DOI 10.1136/thx.53.12.1030; Strunk RC, 2003, J ALLERGY CLIN IMMUN, V112, P883, DOI 10.1016/j.jaci.2003.08.014; Szefler SJ, 2005, J ALLERGY CLIN IMMUN, V115, P233, DOI 10.1016/j.jaci.2004.11.014; van Rensen ELJ, 1999, THORAX, V54, P403, DOI 10.1136/thx.54.5.403; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Zacharasiewicz A, 2005, AM J RESP CRIT CARE, V171, P1077, DOI 10.1164/rccm.200409-1242OC	38	342	351	0	15	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1065	1072		10.1016/S0140-6736(08)61448-8	http://dx.doi.org/10.1016/S0140-6736(08)61448-8			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805335	Green Accepted			2022-12-28	WOS:000259648500033
J	Golbeck, J				Golbeck, Jennifer			Computer science - Weaving a Web of trust	SCIENCE			English	Editorial Material									[Golbeck, Jennifer] Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Golbeck, J (corresponding author), Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA.	jgolbeck@umd.edu						Deutsch M., 1973, RESOLUTION CONFLICT; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; GOBLE CA, 2007, WORKS 07 P 2 WORKSH, P1, DOI DOI 10.1145/1273360.1273361; GOLBECK J, 2004, P 1 C EM ANT; Golbeck J, 2006, LECT NOTES COMPUT SC, V3986, P93; GRAY N, 2007, SEMANTIC KNOWLEDGE U; KUTER U, 2007, P NAT C ART INT AAAI; Levien R, 1998, PROCEEDINGS OF THE SEVENTH USENIX SECURITY SYMPOSIUM, P229; Lim A., 2005, P 2005 ACM S APPL CO; Marti S, 2005, THESIS STANFORD U; Mitchell M, 2006, ARTIF INTELL, V170, P1194, DOI 10.1016/j.artint.2006.10.002; Sztompka P., 1999, TRUST SOCIOLOGICAL T; Ziegler CN, 2007, DECIS SUPPORT SYST, V43, P460, DOI 10.1016/j.dss.2006.11.003; [No title captured]	14	43	57	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1640	1641		10.1126/science.1163357	http://dx.doi.org/10.1126/science.1163357			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801986				2022-12-28	WOS:000259300400020
J	Huicho, L; Scherpbier, RW; Nkowane, AM; Victora, CG				Huicho, Luis; Scherpbier, Robert W.; Nkowane, A. Mwansa; Victora, Cesar G.		Multi Country Evaluation IMCI Stud	How much does quality of child care vary between health workers with differing durations of training? An observational multicountry study	LANCET			English	Article							INTEGRATED MANAGEMENT; HUMAN-RESOURCES; ILLNESS	Background Countries with high rates of child mortality tend to have shortages of qualified health workers. Little rigorous evidence has been done to assess how much the quality of care varies between types of health workers. We compared the performance of different categories of health workers who are trained in Integrated Management of Childhood Illness (IMCI). Methods We analysed data obtained from first-level health facility surveys in Bangladesh (2003), Brazil (2000), Uganda (2002), and Tanzania (2000). We compared the clinical performance of health workers with longer duration of preservice training (those with >4 years of post-secondary education in Brazil or >3 years in the other three countries) and shorter duration (all other health workers providing clinical care). We calculated quality of care with indicators of assessment, classification, and management of sick children according to IMCI guidelines. Every child was examined twice, by the IMCI-trained health worker being assessed and by a gold-standard supervisor. Findings 272 children were included in Bangladesh, 147 in Brazil, 231 in Tanzania, and 612 in Uganda. The proportions of children correctly managed by health workers with longer duration of preservice training in Brazil were 57.8% (n=43) versus 83.7% (n=61) for those with shorter duration of training (p=0 . 008), and 23 . 1 % (n=47) versus 32 . 6 (n=134) (p=0 . 03) in Uganda. In Tanzania, those with longer duration of training did better than did those with shorter duration in integrated assessment of sick children (mean index of integrated assessment 0 . 94 (SD 0 . 15] vs 0 . 88 [0. 13]; p=0.004). In Bangladesh, both categories of health worker did much the same in all clinical tasks. We recorded no significant difference in clinical performance in all; the other clinical tasks in the four countries. Interpretation IMCI training is associated with much the same quality of child care across different health worker categories, irrespective of the duration and level of preservice training. Strategies for scaling up IMCI and other child-survival interventions might rely on health workers with shorter duration of preservice training being deployed in underserved areas. Funding Bill & Melinda Gates Foundation and the US Agency for International Development.	[Huicho, Luis] Univ Nacl Mayor San Marcos, Lima 14, Peru; [Huicho, Luis] Univ Peruana Cayetano Heredia, Lima, Peru; [Huicho, Luis] Inst Salud Nino, Lima, Peru; [Scherpbier, Robert W.] WHO, Dept Child & Adolescent Hlth & Dev, CH-1211 Geneva, Switzerland; [Nkowane, A. Mwansa] WHO, Human Resources Hlth Dept, CH-1211 Geneva, Switzerland; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	Universidad Nacional Mayor de San Marcos; Universidad Peruana Cayetano Heredia; University of Geneva; World Health Organization; World Health Organization; Universidade Federal de Pelotas	Huicho, L (corresponding author), Univ Nacl Mayor San Marcos, Av Brasil 600,L105, Lima 14, Peru.	lhuicho@gmail.com	Victora, Cesar G/D-4476-2013; Victora, Cesar Gomes/Y-2455-2019; Huicho, Luis/AAD-7353-2019; Hallal, Pedro C/A-3249-2011	Victora, Cesar G/0000-0002-2465-2180; Victora, Cesar Gomes/0000-0002-2465-2180; Hallal, Pedro C/0000-0003-1470-6461; Huicho, Luis/0000-0002-5272-5885	Bill & Melinda Gates Foundation; US Agency for International Development	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Agency for International Development(United States Agency for International Development (USAID))	This paper is part of the Multi-Country Evaluation (MCE) of IMCI Effectiveness, Cost and Impact, which is arranged and coordinated by the WHO Department of Child and Adolescent Health and Development. The NICE is financially supported by the Bill & Melinda Gates Foundation and the US Agency for International Development. We thank Taghreed Adam (WHO Department of Health Systems Financing) for her critical and constructive comments on the paper; Robert Black, David Evans, Jean Pierre Habicht, Patrick Vaughan, Technical Advisers of the Multi-Country Evaluation of IMCI, Elizabeth Mason (Director of the WHO Department of Child and Adolescent Health and Development), and Jean Yan (Coordinator of Health Professions Networks, Nursing, and Midwifery team, WHO Human Resources for Health Department) for their continuous technical support; and Jennifer Bryce, who conceptualised the NICE and managed it until 2002; Alice Ryan, who continues to assist the MCE, for her organisational skills; and the numerous colleagues who were involved in study management and data collection in Bangladesh, Brazil, Uganda, and Tanzania, without whom we would not have had the rich data that form the foundation of this paper.	Amaral João, 2004, Cad. Saúde Pública, V20, pS209, DOI 10.1590/S0102-311X2004000800016; Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; Armspach D, 2004, J IRAN CHEM SOC, V1, P10, DOI 10.1007/BF03245765; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI5, DOI 10.1093/heapol/czi055; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI69, DOI 10.1093/heapol/czi053; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; CHOWDHURY EK, 2008, LANCET          0819, DOI DOI 10.1016/S0140-6736(08)61166-6; Dal Poz Mario R, 2006, Hum Resour Health, V4, P21, DOI 10.1186/1478-4491-4-21; *DEP EC SOC AFF UN, WORLD URB PROSP 2005; Diallo Khassoum, 2003, Hum Resour Health, V1, P3, DOI 10.1186/1478-4491-1-3; Dovlo Delanyo, 2004, Hum Resour Health, V2, P7, DOI 10.1186/1478-4491-2-7; Dussault Gilles, 2006, Hum Resour Health, V4, P12, DOI 10.1186/1478-4491-4-12; El Arifeen S, 2004, LANCET, V364, P1595, DOI 10.1016/S0140-6736(04)17312-1; Freedman Lynn P, 2002, J Am Med Womens Assoc (1972), V57, P154; Gouws E, 2005, SOC SCI MED, V61, P613, DOI 10.1016/j.socscimed.2004.12.019; Gove S, 1997, B WORLD HEALTH ORGAN, V75, P7; Gupta Neeru, 2003, Hum Resour Health, V1, P5, DOI 10.1186/1478-4491-1-5; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Khoury S A, 2004, East Mediterr Health J, V10, P372; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Mullan F, 2007, LANCET, V370, P2158, DOI 10.1016/S0140-6736(07)60785-5; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Tugwell P, 2006, BMJ-BRIT MED J, V332, P358, DOI 10.1136/bmj.332.7537.358; Tulloch J, 1999, LANCET, V354, pS16; *UNICEF, UNICEF JOINT HLTH NU; Victora CG, 2004, LANCET, V364, P1541, DOI 10.1016/S0140-6736(04)17279-6; *WHO, 2005, GLOB HLTH ATL; World Health Organisation, 2008, TASK SHIFT GLOB REC; World Health Organization, 2006, WORLD HLTH STAT 2006; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	34	72	73	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					910	916		10.1016/S0140-6736(08)61401-4	http://dx.doi.org/10.1016/S0140-6736(08)61401-4			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790314				2022-12-28	WOS:000259266900031
J	Zillikens, MC; Wijbenga, A				Zillikens, M. Carola; Wijbenga, Anke			Extracapsular hemorrhage from a parathyroid adenoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zillikens, M. Carola; Wijbenga, Anke] Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Zillikens, MC (corresponding author), Erasmus MC, NL-3000 CA Rotterdam, Netherlands.	m.c.zillikens@erasmusmc.nl							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1155	1155		10.1056/NEJMicm075840	http://dx.doi.org/10.1056/NEJMicm075840			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784105				2022-12-28	WOS:000259078200011
J	Clark, AM; Thompson, DR				Clark, Alexander M.; Thompson, David R.			The future of management programmes for heart failure	LANCET			English	Editorial Material									[Clark, Alexander M.] Univ Alberta, Fac Nursing, Edmonton, AB T6R 2RG, Canada; [Thompson, David R.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Thompson, David R.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Alberta; University of Leicester; University of Leicester	Clark, AM (corresponding author), Univ Alberta, Fac Nursing, Edmonton, AB T6R 2RG, Canada.	Alex.Clark@ualberta.ca	Thompson, David R/C-6320-2009; Thompson, David R/E-2431-2018	Thompson, David R/0000-0001-8518-6307; Clark, Alexander/0000-0002-2860-0492				Clark AM, 2007, HEALTH-LONDON, V11, P513, DOI 10.1177/1363459307080876; Holland R, 2005, HEART, V91, P899, DOI 10.1136/hrt.2004.048389; Holland R, 2007, BRIT MED J, V334, P1098, DOI 10.1136/bmj.39164.568183.AE; Jaarsma T, 2008, ARCH INTERN MED, V168, P316, DOI 10.1001/archinternmed.2007.83; Ledwidge M, 2005, EUR J HEART FAIL, V7, P385, DOI 10.1016/j.ejheart.2004.10.022; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; Nguyen V, 2007, J CARD FAIL, V13, P287, DOI 10.1016/j.cardfail.2007.01.002; Nucifora G, 2006, J CARDIOVASC MED, V7, P614, DOI 10.2459/01.JCM.0000237910.34000.58; Pawson R., 1997, REALISTIC EVALUATION; Smith B, 2005, AM J MANAG CARE, V11, P701; Taylor S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002752.pub2; Yu DSF, 2006, EUR HEART J, V27, P596, DOI 10.1093/eurheartj/ehi656	13	36	41	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 6	2008	372	9641					784	786		10.1016/S0140-6736(08)61317-3	http://dx.doi.org/10.1016/S0140-6736(08)61317-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774405				2022-12-28	WOS:000259124900007
J	Penna, A; Demuro, A; Yeromin, AV; Zhang, SYL; Safrina, O; Parker, I; Cahalan, MD				Penna, Aubin; Demuro, Angelo; Yeromin, Andriy V.; Zhang, Shenyuan L.; Safrina, Olga; Parker, Ian; Cahalan, Michael D.			The CRAC channel consists of a tetramer formed by Stim-induced dimerization of Orai dimers	NATURE			English	Article							CA2+ SENSOR; STORE; SUBUNIT; ARCHITECTURE; PROTEIN; PORE	Ca2+-release- activated Ca2+ (CRAC) channels underlie sustained Ca2+ signalling in lymphocytes and numerous other cells after Ca2+ liberation from the endoplasmic reticulum (ER). RNA interference screening approaches identified two proteins, Stim(1,2) and Orai(3-5), that together form the molecular basis for CRAC channel activity(6,7). Stim senses depletion of the ER Ca2+ store and physically relays this information by translocating from the ER to junctions adjacent to the plasma membrane(1,8,9), and Orai embodies the pore of the plasma membrane calcium channel(10-12). A close interaction between Stim and Orai, identified by co-immunoprecipitation(12) and by Forster resonance energy transfer(13), is involved in the opening of the Ca2+ channel formed by Orai subunits. Most ion channels are multimers of pore- forming subunits surrounding a central channel, which are preassembled in the ER and transported in their final stoichiometry to the plasma membrane. Here we show, by biochemical analysis after cross- linking in cell lysates and intact cells and by using non- denaturing gel electrophoresis without cross- linking, that Orai is predominantly a dimer in the plasma membrane under resting conditions. Moreover, single- molecule imaging of green fluorescent protein (GFP)- tagged Orai expressed in Xenopus oocytes showed predominantly two- step photobleaching, again consistent with a dimeric basal state. In contrast, co- expression of GFP- tagged Orai with the carboxy terminus of Stim as a cytosolic protein to activate the Orai channel without inducing Ca2+ store depletion or clustering of Orai into punctae yielded mostly four- step photobleaching, consistent with a tetrameric stoichiometry of the active Orai channel. Interaction with the C terminus of Stim thus induces Orai dimers to dimerize, forming tetramers that constitute the Ca2+-selective pore. This represents a new mechanism in which assembly and activation of the functional ion channel are mediated by the same triggering molecule.	[Penna, Aubin; Yeromin, Andriy V.; Zhang, Shenyuan L.; Safrina, Olga; Parker, Ian; Cahalan, Michael D.] Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA; [Demuro, Angelo; Parker, Ian] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92697 USA; [Cahalan, Michael D.] Univ Calif Irvine, Ctr Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Cahalan, MD (corresponding author), Univ Calif Irvine, Dept Physiol & Biophys, Irvine, CA 92697 USA.	mcahalan@uci.edu	penna, aubin/AAD-2550-2019; PENNA, aubin/E-2208-2018	penna, aubin/0000-0002-1070-5990; PENNA, aubin/0000-0002-1070-5990	National Institutes of Health; George E. Hewitt Foundation; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS014609] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George E. Hewitt Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank L. Forrest for assistance in cell culture; T. Holmes and S. Leverrier for discussion during the course of the study; A. Amcheslavsky, A. Froger, K. Kalman and K. Cahalan for help with oocytes; W. Jiang for assistance in some of the co-immunoprecipitation experiments; M. Ramjeesingh for help with the PFO-PAGE technique; F.-A. Rassendren for the P2X2 construct; and E. Isacoff and M. Ulbrich for discussion and help during a pilot photobleaching study. This work was supported by grants from the National Institutes of Health (M.D.C. and I.P.) and by a fellowship from the George E. Hewitt Foundation (A.P.).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002; Dargan Sheila L., 2006, V322, P103; Demuro A, 2005, J BIOMED OPT, V10, DOI 10.1117/1.1846074; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Kedei N, 2001, J BIOL CHEM, V276, P28613, DOI 10.1074/jbc.M103272200; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Newbolt A, 1998, J BIOL CHEM, V273, P15177, DOI 10.1074/jbc.273.24.15177; Nielsen PA, 2002, J BIOL CHEM, V277, P38272, DOI 10.1074/jbc.M205348200; PARKER I, 1985, PROC R SOC SER B-BIO, V223, P279, DOI 10.1098/rspb.1985.0002; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raab-Graham KF, 1998, J BIOL CHEM, V273, P19699, DOI 10.1074/jbc.273.31.19699; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	31	294	305	0	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 6	2008	456	7218					116	U12		10.1038/nature07338	http://dx.doi.org/10.1038/nature07338			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18820677	Green Accepted, Green Submitted			2022-12-28	WOS:000260674000052
J	Bercovich, D; Ganmore, I; Scott, LM; Wainreb, G; Birger, Y; Elimelech, A; Chen, SC; Cazzaniga, G; Biondi, A; Basso, G; Cario, G; Schrappe, M; Stanulla, M; Strehl, S; Haas, OA; Mann, G; Binder, V; Borkhardt, A; Kempski, H; Trka, J; Bielorei, B; Avigad, S; Stark, B; Smith, O; Dastugue, N; Bourquin, JP; Ben Tal, N; Green, AR; Izraeli, S				Bercovich, Dani; Ganmore, Ithamar; Scott, Linda M.; Wainreb, Gilad; Birger, Yehudit; Elimelech, Arava; Chen, Shochat; Cazzaniga, Giovanni; Biondi, Andrea; Basso, Giuseppe; Cario, Gunnar; Schrappe, Martin; Stanulla, Martin; Strehl, Sabine; Haas, Oskar A.; Mann, Georg; Binder, Vera; Borkhardt, Arndt; Kempski, Helena; Trka, Jan; Bielorei, Bella; Avigad, Smadar; Stark, Batia; Smith, Owen; Dastugue, Nicole; Bourquin, Jean-Pierre; Ben Tal, Nir; Green, Anthony R.; Izraeli, Shai			Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome	LANCET			English	Article							MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; MEGAKARYOBLASTIC LEUKEMIA; ACQUIRED MUTATIONS; GATA1; EXPRESSION; CHILDREN; RECEPTOR	Background Children with Down's syndrome have a greatly increased risk of acute megakaryoblastic and acute lymphoblastic leukaemias. Acute megakaryoblastic leukaemia in Down's syndrome is characterised by a somatic mutation in GATA1. Constitutive activation of the JAK/STAT (Janus kinase and signal transducer and activator of transcription) pathway occurs in several haematopoietic malignant diseases. We tested the hypothesis that mutations in JAK2 might be a common molecular event in acute lymphoblastic leukaemia associated with Down's syndrome. Methods JAK2 DNA mutational analysis was done on diagnostic bone marrow samples obtained from 88 patients with Down's syndrome-associated acute lymphoblastic: leukaemia; and 216 patients with sporadic acute lymphoblastic: leukaemia, Down's syndrome-associated acute megakaryoblastic leukaemia, and essential thrombocythaemia. Functional consequences of identified mutations were studied in mouse haematopoietic progenitor cells. Findings Somatically acquired JAK2 mutations were identified in 16 (18%) patients with Down's syndrome-associated acute lymphoblastic leukaemia. The only patient with non-Down's syndrome-associated leukaemia but with a JAK2 mutation had an isochromosome 21q. Children with a JAK2 mutation were younger (mean [SE] age 4.5 years [0 . 86] vs 8.6 years [0 . 59], p<0 . 0001) at diagnosis. Five mutant alleles were identified, each affecting a highly conserved arginine residue (R683). These mutations immortalised primary mouse haematopoietic progenitor cells in vitro, and caused constitutive Jak/Stat activation and cytokine-independent growth of BaF3 cells, which was sensitive to pharmacological inhibition with JAK inhibitor 1. In modelling studies of the JAK2 pseudokinase domain, R683 was situated in an exposed conserved region separated from the one implicated in myeloproliferative disorders. Interpretation A specific genotype- phenotype association exists between the type of somatic mutation within the JAK2 pseudokinase domain and the development of B-lymphoid or myeloid neoplasms. Somatically acquired R683 JAK2 mutations define a distinct acute lymphoblastic leukaemia subgroup that is uniquely associated with trisomy 21. JAK2 inhibitors could be useful for treatment of this leukaemia. Funding Israel Trade Ministry, Israel Science Ministry, Jewish National Fund UK, Sam Waxman Cancer Research Foundation, Israel Science Foundation, Israel Cancer Association, Curtis Katz, Constantiner Institute for Molecular Genetics, German-Israel Foundation, and European Commission FP6 Integrated Project EUROHEAR.	[Ganmore, Ithamar; Birger, Yehudit; Bielorei, Bella; Izraeli, Shai] Chaim Sheba Med Ctr, Dept Paediat Haematol Oncol, IL-52621 Tel Hashomer, Israel; [Ganmore, Ithamar; Birger, Yehudit; Bielorei, Bella; Izraeli, Shai] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Bercovich, Dani; Elimelech, Arava; Chen, Shochat] Migal Galilee Biotechnol Ctr, Human Mol Genet & Pharmacogenet Lab, Kiryat Shmona, Israel; [Bercovich, Dani; Elimelech, Arava; Chen, Shochat] Tel Hai Acad Coll, Tel Hai, Israel; [Wainreb, Gilad; Ben Tal, Nir] Tel Aviv Univ, Dept Biochem, Fac Life Sci, IL-69978 Tel Aviv, Israel; [Scott, Linda M.; Green, Anthony R.] Cambridge Inst Med Res, Cambridge, England; [Cazzaniga, Giovanni; Biondi, Andrea] Univ Milano Bicocca, Hosp San Gerardo, Res Ctr Tettamanti, Paediat Clin, Monza, Italy; [Basso, Giuseppe] Univ Padua, Dept Paediat, Lab Oncohaematol, Padua, Italy; [Cario, Gunnar; Schrappe, Martin] Univ Hosp Schleswig Holstein, Dept Paediat, Kiel, Germany; [Stanulla, Martin] Hannover Med Sch, Dept Paediat Haematol & Oncol, D-3000 Hannover, Germany; [Strehl, Sabine; Haas, Oskar A.; Mann, Georg] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Binder, Vera; Borkhardt, Arndt] Univ Dusseldorf, Clin Paediat Oncol Haematol & Clin Immunol, Childrens Univ Hosp, Dusseldorf, Germany; [Kempski, Helena] Great Ormond St Hosp Sick Children, Inst Child Hlth, London WC1N 3JH, England; [Trka, Jan] Charles Univ Prague, Sch Med 2, Dept Paediat Haematol & Oncol, Prague, Czech Republic; [Trka, Jan] Univ Hosp Motol, Motol, Czech Republic; [Avigad, Smadar; Stark, Batia] Schneider Childrens Hosp, Dept Paediat Haematooncol, Petah Tiqwa, Israel; [Smith, Owen] Univ Dublin Trinity Coll, Dept Haematol, Dublin 2, Ireland; [Dastugue, Nicole] Univ Hosp Ctr Toulouse, Toulouse, France; [Bourquin, Jean-Pierre] Univ Zurich, Dept Paediat Oncol, Univ Childrens Hosp, Zurich, Switzerland	Chaim Sheba Medical Center; Chaim Sheba Medical Center; Tel Hai Academy College; Tel Aviv University; University of Cambridge; University of Milano-Bicocca; University of Padua; University of Kiel; Schleswig Holstein University Hospital; Hannover Medical School; Saint Anna Children's Hospital; Heinrich Heine University Dusseldorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Charles University Prague; Motol University Hospital; Trinity College Dublin; CHU de Toulouse; University Children's Hospital Zurich; University of Zurich	Izraeli, S (corresponding author), Chaim Sheba Med Ctr, Dept Paediat Haematol Oncol, IL-52621 Tel Hashomer, Israel.	sizraeli@sheba.health.gov.il	Schrappe, Martin/ABA-6144-2020; Binder, Vera/N-2078-2015; Trka, Jan/Y-4820-2019; Smith, Owen/AAU-8929-2020; Stanulla, Martin/N-4674-2017; Schrappe, Martin/A-8109-2010; Scott, Linda/D-9777-2012; Bourquin, Jean-Pierre/C-2802-2011; Biondi, Andrea/K-9997-2016; Stanulla, Martin/D-2528-2010; Biondi, Andrea/AAX-1865-2020; Cario, Gunnar/D-2535-2010; Haas, Oskar/AAM-5794-2020; Cazzaniga, Giovanni/K-6338-2016	Stanulla, Martin/0000-0002-3834-0727; Scott, Linda/0000-0003-0334-1479; Bourquin, Jean-Pierre/0000-0001-6571-6227; Biondi, Andrea/0000-0002-6757-6173; Ben-Tal, Nir/0000-0001-6901-832X; Cazzaniga, Giovanni/0000-0003-2955-4528; Green, Anthony/0000-0002-9795-0218; Strehl, Sabine/0000-0002-0179-0628; BASSO, GIUSEPPE/0000-0002-2634-9302	Israel Trade Ministry; Israel Science Ministry; Jewish National Fund UK; Sam Waxman Cancer Research Foundation; Israel Science Foundation; Israel Cancer Association; Constantiner Institute for Molecular Genetics; German-Israel Foundation; European Commission FP6 Integrated Project EURCHEAR [LSHG-CT-20054-512063]; Cancer Research UK [8961] Funding Source: researchfish; Medical Research Council [G0300723B] Funding Source: researchfish	Israel Trade Ministry; Israel Science Ministry; Jewish National Fund UK; Sam Waxman Cancer Research Foundation; Israel Science Foundation(Israel Science Foundation); Israel Cancer Association; Constantiner Institute for Molecular Genetics; German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); European Commission FP6 Integrated Project EURCHEAR(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study is an international BFM study. This study has been done as part fulfilment of the requirement for a PhD degree by IG at the Faculty ofmedicine, Tel-Aviv University. We thank Wei Tong, Drorit Neuman, Connie Eavs, and James Griffin for the gifts of reagents; and Inna Muler, Cohava Cohen, Gil Smooha, Nir Gefen, Itamar Goldstein, and Dasa Janousek for their assistance. This study was partly funded by grants from Israel Trade Ministry (to DB) and Israel Science Ministry, Jewish National Fund UK, Sam Waxman Cancer Research Foundation, Israel Science Foundation, Israel Cancer Association (to S I), Curtis Katz (to SI), Constantiner Institute for Molecular Genetics (to IG), and German-Israel Foundation (to Sl and AB). NBT received support from the European Commission FP6 Integrated Project EURCHEAR, LSHG-CT-20054-512063.	Bercovich D, 2003, GENET TEST, V7, P189, DOI 10.1089/109065703322537197; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Dai XZ, 2007, J IMMUNOL, V179, P1068, DOI 10.4049/jimmunol.179.2.1068; DANDREA AD, 1991, MOL CELL BIOL, V11, P1980, DOI 10.1128/MCB.11.4.1980; Flex E, 2008, J EXP MED, V205, P751, DOI 10.1084/jem.20072182; Forestier E, 2008, BLOOD, V111, P1575, DOI 10.1182/blood-2007-09-114231; Giordanetto F, 2002, PROTEIN ENG, V15, P727, DOI 10.1093/protein/15.9.727; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Hasle H, 2001, LANCET ONCOL, V2, P429, DOI 10.1016/S1470-2045(00)00435-6; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Izraeli S, 2007, BLOOD CELL MOL DIS, V39, P156, DOI 10.1016/j.bcmd.2007.04.004; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Malinge S, 2007, BLOOD, V109, P2202, DOI 10.1182/blood-2006-09-045963; Norton A, 2007, BLOOD, V110, P1077, DOI 10.1182/blood-2007-03-080374; Pardanani A, 2008, LEUKEMIA, V22, P23, DOI 10.1038/sj.leu.2404948; PRIEST JH, 1988, HUM GENET, V81, P1, DOI 10.1007/BF00283718; Pui CH, 2001, LANCET ONCOL, V2, P597, DOI 10.1016/S1470-2045(01)00516-2; Rainis L, 2003, BLOOD, V102, P981, DOI 10.1182/blood-2002-11-3599; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Vyas P, 2006, EARLY HUM DEV, V82, P767, DOI 10.1016/j.earlhumdev.2006.09.016; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Whitlock JA, 2005, BLOOD, V106, P4043, DOI 10.1182/blood-2003-10-3446	29	249	253	0	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 25	2008	372	9648					1484	1492		10.1016/S0140-6736(08)61341-0	http://dx.doi.org/10.1016/S0140-6736(08)61341-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	370ZJ	18805579				2022-12-28	WOS:000260801300025
J	Murphy, HR; Rayman, G; Lewis, K; Kelly, S; Johal, B; Duffield, K; Fowler, D; Campbell, PJ; Temple, RC				Murphy, Helen R.; Rayman, Gerry; Lewis, Karen; Kelly, Susan; Johal, Balroop; Duffield, Katherine; Fowler, Duncan; Campbell, Peter J.; Temple, Rosemary C.			Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GESTATIONAL-AGE INFANTS; BIRTH-WEIGHT; GLYCEMIC CONTROL; MATERNAL GLUCOSE; TYPE-1; MELLITUS; OUTCOMES; MACROSOMIA; INSULIN; NATIONWIDE	Objective To evaluate the effectiveness of continuous glucose monitoring during pregnancy on maternal glycaemic control, infant birth weight, and risk of macrosomia in women with type 1 and type 2 diabetes. Design Prospective, open label randomised controlled trial. Setting Two secondary care multidisciplinary obstetric clinics for diabetes in the United Kingdom. Participants 71 women with type 1 diabetes (n=46) or type 2 diabetes (n=25) allocated to antenatal care plus continuous glucose monitoring (n=38) or to standard antenatal care (n=33). Intervention Continuous glucose monitoring was used as an educational tool to inform shared decision making and future therapeutic changes at intervals of 4-6 weeks during pregnancy. All other aspects of antenatal care were equal between the groups. Main outcome measures The primary outcome was maternal glycaemic control during the second and third trimesters from measurements of HbA(1c) levels every four weeks. Secondary outcomes were birth weight and risk of macrosomia using birthweight standard deviation scores and customised birthweight centiles. Statistical analyses were done on an intention to treat basis. Results Women randomised to continuous glucose monitoring had lower mean HbA(1c) levels from 32 to 36 weeks' gestation compared with women randomised to standard antenatal care: 5.8% (SD 0.6) v 6.4% (SD 0.7). Compared with infants of mothers in the control arm those of mothers in the intervention arm had decreased mean birthweight standard deviation scores (0.9 v 1.6; effect size 0.7 SD, 95% confidence interval 0.0 to 1.3), decreased median customised birthweight centiles (69% v 93%), and a reduced risk of macrosomia (odds ratio 0.36, 95% confidence interval 0.13 to 0.98). Conclusion Continuous glucose monitoring during pregnancy is associated with improved glycaemic control in the third trimester, lower birth weight, and reduced risk of macrosomia. Trial registration Current Controlled Trials ISRCTN84461581.	[Murphy, Helen R.; Rayman, Gerry; Lewis, Karen; Fowler, Duncan] Ipswich Hosp NHS Trust, Dept Diabet & Endocrinol, Ipswich, Suffolk, England; [Kelly, Susan] Ipswich Hosp NHS Trust, Dept Diabet, Ipswich, Suffolk, England; [Kelly, Susan; Johal, Balroop] Ipswich Hosp NHS Trust, Dept Obstet, Ipswich, Suffolk, England; [Duffield, Katherine; Temple, Rosemary C.] Elsie Bertram Diabet Ctr, Norwich, Norfolk, England; [Duffield, Katherine; Temple, Rosemary C.] Norwich Univ Hosp NHS Trust, Norwich, Norfolk, England; [Campbell, Peter J.] Wellcome Trust Sanger Inst, Cambridge, England	Ipswich Hospital NHS Trust; Ipswich Hospital; Ipswich Hospital NHS Trust; Ipswich Hospital; Ipswich Hospital NHS Trust; Ipswich Hospital; Wellcome Trust Sanger Institute	Murphy, HR (corresponding author), Ipswich Hosp NHS Trust, Dept Diabet & Endocrinol, Ipswich, Suffolk, England.	Helen.Murphy@ipswichhospital.nhs.uk						Boulet SL, 2003, AM J OBSTET GYNECOL, V188, P1372, DOI 10.1067/mob.2003.302; BUCKLER JMH, 1994, ARCH DIS CHILD, V71, P516, DOI 10.1136/adc.71.6.516; CEMACH, 2005, CONF ENQ MAT CHILD H; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; COMBS CA, 1992, DIABETES CARE, V15, P1251, DOI 10.2337/diacare.15.10.1251; DEVECIANA M, 1995, NEW ENGL J MED, V333, P1237, DOI 10.1056/NEJM199511093331901; Diabetes Research in Children Network (DIRECNET) Study Group, 2003, Diabetes Technol Ther, V5, P781; Evers IM, 2002, DIABETOLOGIA, V45, P1484, DOI 10.1007/s00125-002-0958-7; Farrar D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005542; Herranz L, 2007, DIABETES RES CLIN PR, V75, P42, DOI 10.1016/j.diabres.2006.05.019; Hovorka R, 2006, DIABETIC MED, V23, P1, DOI 10.1111/j.1464-5491.2005.01672.x; Hovorka R, 2007, AM J PHYSIOL-ENDOC M, V293, pE610, DOI 10.1152/ajpendo.00546.2006; Howorka K, 2001, DIABETIC MED, V18, P965, DOI 10.1046/j.1464-5491.2001.00621.x; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Johnstone FD, 2006, OBSTET GYNECOL, V107, P1297, DOI 10.1097/01.AOG.0000218706.38886.10; Jolly MC, 2003, EUR J OBSTET GYN R B, V111, P9, DOI 10.1016/S0301-2115(03)00154-4; JOVANOVICPETERSON L, 1991, AM J OBSTET GYNECOL, V164, P103, DOI 10.1016/0002-9378(91)90637-7; *JUV DIAB RES FDN, 2008, N ENGL J MED    0908; Kerssen A, 2006, DIABETOLOGIA, V49, P25, DOI 10.1007/s00125-005-0057-7; Kerssen A, 2007, DIABETES CARE, V30, P1069, DOI 10.2337/dc05-1985; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; LANGER O, 1991, AM J OBSTET GYNECOL, V165, P831, DOI 10.1016/0002-9378(91)90424-P; Macintosh MCM, 2006, BRIT MED J, V333, P177, DOI 10.1136/bmj.38856.692986.AE; Manderson JG, 2003, AM J OBSTET GYNECOL, V189, P507, DOI 10.1067/S0002-9378(03)00497-6; Murphy HR, 2007, DIABETES CARE, V30, P2785, DOI 10.2337/dc07-0500; Murtaugh MA, 2003, DIABETES CARE, V26, P187, DOI 10.2337/diacare.26.1.187; Persson B, 1996, BRIT J OBSTET GYNAEC, V103, P427, DOI 10.1111/j.1471-0528.1996.tb09768.x; Roland JM, 2005, DIABETIC MED, V22, P1774, DOI 10.1111/j.1464-5491.2005.01784.x; Sachedina N, 2003, DIABETIC MED, V20, P1012, DOI 10.1046/j.1464-5491.2003.01037.x; Sacks DA, 2006, AM J OBSTET GYNECOL, V194, P501, DOI 10.1016/j.ajog.2005.07.042; Temple RC, 2006, DIABETES CARE, V29, P1744, DOI 10.2337/dc05-2265; Van Assche EA, 1998, J PERINAT MED, V26, P337; *W MIDL PER I NHS, 2007, GEST NETW; Yogev Y, 2003, DIABETIC MED, V20, P558, DOI 10.1046/j.1464-5491.2003.00959.x; Yogev Y, 2003, OBSTET GYNECOL, V101, P633, DOI 10.1016/S0029-7844(02)02714-X; 2008, NICE GUIDELINE 63 DI	36	206	210	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 18	2008	337	7675							a1680	10.1136/bmj.a1680	http://dx.doi.org/10.1136/bmj.a1680			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360YE	18818254	hybrid, Green Published			2022-12-28	WOS:000260093900033
J	Fatkenheuer, G; Nelson, M; Lazzarin, A; Konourina, I; Hoepelman, AIM; Lampiris, H; Hirschel, B; Tebas, P; Raffi, F; Trottier, B; Bellos, N; Saag, M; Cooper, DA; Westby, M; Tawadrous, M; Sullivan, JF; Ridgway, C; Dunne, MW; Felstead, S; Mayer, H; van der Ryst, E				Faetkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; Hoepelman, Andy I. M.; Lampiris, Harry; Hirschel, Bernard; Tebas, Pablo; Raffi, Francois; Trottier, Benoit; Bellos, Nicholaos; Saag, Michael; Cooper, David A.; Westby, Mike; Tawadrous, Margaret; Sullivan, John F.; Ridgway, Caroline; Dunne, Michael W.; Felstead, Steve; Mayer, Howard; van der Ryst, Elna		MOTIVATE 1 Study Team; MOTIVATE 2 Study Team	Subgroup analyses of Maraviroc in previously treated R5 HIV-1 infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXPERIENCED HIV-1-INFECTED PATIENTS; ACTIVE ANTIRETROVIRAL THERAPY; DRUG-RESISTANT HIV-1; TMC125 ETRAVIRINE; PROGNOSTIC VALUE; CCR5 ANTAGONIST; DOUBLE-BLIND; EFFICACY; VIRUS; HEPATITIS	Background We conducted subanalyses of the combined results of the Maraviroc versus Optimized Therapy in Viremic Antiretroviral Treatment- Experienced Patients (MOTIVATE) 1 and MOTIVATE 2 studies to better characterize the efficacy and safety of maraviroc in key subgroups of patients. Methods We analyzed pooled data from week 48 from the two studies according to sex, race or ethnic group, clade, CC chemokine receptor 5 (CCR5) delta32 genotype, viral load at the time of screening, the use or nonuse of enfuvirtide in optimized background therapy (OBT), the baseline CD4 cell count, the number of active antiretroviral drugs coadministered, the first use of selected background agents, and tropism at baseline. Changes in viral tropism and the CD4 count at treatment failure were evaluated. Data on aminotransferase levels in patients coinfected with hepatitis B virus (HBV) or hepatitis C virus (HCV) were also analyzed. Results A treatment benefit of maraviroc plus OBT over placebo plus OBT was shown in all subgroups, including patients with a low CD4 cell count at baseline, those with a high viral load at screening, and those who had not received active agents in OBT. Analyses of the virologic response according to the first use of selected background drugs showed the additional benefit of adding a potent new drug to maraviroc at the initiation of maraviroc therapy. More patients in whom maraviroc failed had a virus binding to the CXC chemokine receptor 4 (CXCR4) at failure, but there was no evidence of a decrease in the CD4 cell count at failure in such patients as compared with those in whom placebo failed. Subanalyses involving patients coinfected with HBV or HCV revealed no evidence of excess hepatotoxic effects as compared with baseline. Conclusions Subanalyses of pooled data from week 48 indicate that maraviroc provides a valuable treatment option for a wide spectrum of patients with R5 HIV-1 infection who have been treated previously. (ClinicalTrials. gov numbers, NCT00098306 and NCT00098722.).	[Faetkenheuer, Gerd] Universitatsklin Koln, D-50924 Cologne, Germany; [Nelson, Mark] Chelsea & Westminster Hosp, London, England; [Konourina, Irina; Westby, Mike; Sullivan, John F.; Ridgway, Caroline; Felstead, Steve; van der Ryst, Elna] Pfizer Global Res & Dev, Sandwich, Kent, England; [Lazzarin, Adriano] Ist Ric & Cura Carattere Sci San Raffaele, Milan, Italy; [Hoepelman, Andy I. M.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Lampiris, Harry] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Lampiris, Harry] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Hirschel, Bernard] Univ Hosp Geneva, Geneva, Switzerland; [Tebas, Pablo] Univ Penn, Philadelphia, PA 19104 USA; [Raffi, Francois] Med Univ Nantes, Hotel Dieu, Univ Hosp, Nantes, France; [Trottier, Benoit] Clin Med Lactuel, Montreal, PQ, Canada; [Bellos, Nicholaos] SW Infect Dis Assoc, Dallas, TX USA; [Saag, Michael] Univ Alabama Birmingham, Birmingham, AL USA; [Tawadrous, Margaret; Dunne, Michael W.; Mayer, Howard] Pfizer Global Res & Dev, New London, CT USA; [Cooper, David A.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW, Australia	University of Cologne; Imperial College London; Pfizer; Utrecht University; Utrecht University Medical Center; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Geneva; University of Pennsylvania; Nantes Universite; CHU de Nantes; University of Alabama System; University of Alabama Birmingham; Pfizer; University of New South Wales Sydney; Kirby Institute	Fatkenheuer, G (corresponding author), Universitatsklin Koln, D-50924 Cologne, Germany.	g.faetkenheuer@uni-koeln.de	Dunne, Michael W/AAD-7418-2020; Tawadrous, Margaret/AAY-3551-2020; Montaner, Julio/K-7621-2012; LAZZARIN, Adriano/K-3607-2018; Pulido, Federico/B-8417-2009; Gisslen, Magnus/D-7454-2015	Dunne, Michael W/0000-0001-6186-5196; LAZZARIN, Adriano/0000-0003-2551-7754; Smiatacz, Tomasz/0000-0003-2793-3671; Pulido, Federico/0000-0002-7414-8812; Koirala, Janak/0000-0002-3608-474X; Tebas, Pablo/0000-0001-5345-7942; Easterbrook, Philippa/0000-0002-2603-5418; Gonzalez-Garcia, Juan/0000-0002-3652-002X; Gisslen, Magnus/0000-0002-2357-1020; Moutschen, Michel/0000-0002-6405-1785; Leen, Clifford/0000-0001-8439-7719; Stapleton, Jack/0000-0002-2302-9055	Gilead Sciences; GlaxoSmithKline; Monogram Biosciences; Pfizer; Roche; Schering-Plough; Tibotec; Bristol-Myers Squibb; Abbott; Boehringer Ingelheim; Merck Sharp Dohme; JanssenCilag; Novartis; VGX Pharmaceuticals; Wyeth; Avexa; Panacos; Progenics; Virco; Achillion Pharmaceuticals; Serono; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI051966] Funding Source: NIH RePORTER	Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Monogram Biosciences; Pfizer(Pfizer); Roche(Roche Holding); Schering-Plough(Merck & CompanySchering Plough Corporation); Tibotec; Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Merck Sharp Dohme(Merck & Company); JanssenCilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Novartis(Novartis); VGX Pharmaceuticals; Wyeth(Wyeth); Avexa; Panacos; Progenics; Virco; Achillion Pharmaceuticals; Serono; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Dr. Fatkenheuer reports receiving consulting fees from Gilead Sciences, GlaxoSmithKline, Monogram Biosciences, Pfizer, Roche, Schering-Plough, Tibotec, and Bristol-Myers Squibb, lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Pfizer, Schering-Plough, and Tibotec, and grant support from Pfizer; Dr. Nelson, receiving consulting fees from Merck Sharp & Dohme, Pfizer, Abbott, Roche, Gilead Sciences, Bristol- Myers Squibb, GlaxoSmithKline, and Boehringer Ingelheim, lecture fees from Merck Sharp & Dohme, Pfizer, Abbott, Gilead Sciences, Bristol-Myers Squibb, and Roche, and grant support from Gilead Sciences, Pfizer, Tibotec, and Merck Sharp & Dohme; Dr. Lazzarin, receiving consulting fees from Abbott, GlaxoSmithKline, Bristol- Myers Squibb, and JanssenCilag and lecture fees from Roche, Boehringer Ingelheim, and Gilead Sciences; Dr. Hoepelman, receiving consulting fees from Pfizer, Bristol-Myers Squibb, Novartis, and Tibotec and lecture fees from Gilead Sciences and Roche; Dr. Lampiris, receiving consulting fees from Abbott and Boehringer Ingelheim, lecture fees from Merck Sharp & Dohme, Monogram Biosciences, and Boehringer Ingelheim, and grant support from Gilead Sciences, Roche, Pfizer; and Tibotec; Dr. Hirschel, receiving consulting fees from Merck Sharp & Dohme, Tibotec, Pfizer, and Bristol-Myers Squibb and lecture fees from GlaxoSmithKline; Dr. Tebas, receiving consulting fees from VGX Pharmaceuticals, Merck Sharp & Dohme, Bristol-Myers Squibb, Tibotec, and Boehringer Ingelheim and grant support from Wyeth, Pfizer, Roche, and GlaxoSmithKline; Dr. Trottier, receiving consulting and lecture fees from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Pfizer, Roche, and Tibotec; Dr. Bellos, receiving consulting and lecture fees from GlaxoSmithKline, Pfizer, and Tibotec and grant support from Gilead Sciences, Abbott, and GlaxoSmithKline; Dr. Saag, receiving consulting fees from Avexa, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Monogram Biosciences, Panacos, Pfizer, Progenics, Roche, Tibotec, and Virco and grant support from Achillion Pharmaceuticals, Boehringer Ingelheim, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, Panacos, Pfizer, Progenics, Roche, Serono, and Tibotec; Dr. Cooper, holding stock and stock options in Pfizer and receiving consulting fees and grant support from Pfizer; Dr. Westby, being an employee of Pfizer and holding stock options in Pfizer; Drs. Tawadrous, Konourina, Dunne, Felstead, Mayer, and van der Ryst and Mr. Sullivan, being employees of Pfizer and holding stock and stock options in Pfizer; and Ms. Ridgway, being an employee of Pfizer. No other potential conflict of interest relevant to this article was reported.; We thank the study participants as well as the study investigators and site staff at the 239 participating study sites (for a complete list of the investigators, site staff, and study sites, see the Supplementary Appendix).	Ajuebor MN, 2007, AM J PATHOL, V170, P1975, DOI 10.2353/ajpath.2007.060690; Clotet B, 2008, LANCET, V371, P116; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Deeks SG, 2003, AIDS, V17, P361, DOI 10.1097/00002030-200302140-00010; *DEP HHS, 2007, GUID US ANT AG HIV 1; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319; FATKENHEUER G, 2008, 15 C RETR OPP INF BO; Goodrich JM, 2007, 45 ANN M INF DIS SOC; Goulding C, 2005, GUT, V54, P1157, DOI 10.1136/gut.2004.055699; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; GULICK R, 2007, 4 IAS C HIV PATH TRE; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Hicks CB, 2006, LANCET, V368, P466, DOI 10.1016/S0140-6736(06)69154-X; Konopnicki D, 2005, AIDS, V19, P593, DOI 10.1097/01.aids.0000163936.99401.fe; KOOT M, 1993, ANN INTERN MED, V118, P681, DOI 10.7326/0003-4819-118-9-199305010-00004; Lalezari JP, 2003, NEW ENGL J MED, V349, P1100; Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026; Lazzarin A, 2003, NEW ENGL J MED, V348, P2186, DOI 10.1056/NEJMoa035211; Lazzarin A, 2007, LANCET, V370, P39, DOI 10.1016/S0140-6736(07)61048-4; Madruga JV, 2007, LANCET, V370, P29, DOI 10.1016/S0140-6736(07)61047-2; MCFADYEN L, 2007, 11 EUR AIDS C MADR O; Mocroft A, 2005, ANTIVIR THER, V10, P779; Moreno C, 2005, HEPATOLOGY, V42, P854, DOI 10.1002/hep.20865; *REG COMPL CTR, DIV AIDS TABL GRAD S; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Tierney C, 2003, J INFECT DIS, V187, P144, DOI 10.1086/345870; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weatherley B., 2008, 9 INT WORKSH CLIN PH; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Westby M, 2007, CURR OPIN HIV AIDS, V2, P137, DOI 10.1097/COH.0b013e3280142007; Wheeler J, 2007, ANTIVIR THER, V12, P233; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P1399; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Woitas RP, 2002, GASTROENTEROLOGY, V122, P1721, DOI 10.1053/gast.2002.33660	38	282	290	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1442	U46		10.1056/NEJMoa0803154	http://dx.doi.org/10.1056/NEJMoa0803154			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832245				2022-12-28	WOS:000259631700005
J	Halberda, J; Mazzocco, MMM; Feigenson, L				Halberda, Justin; Mazzocco, Michele M. M.; Feigenson, Lisa			Individual differences in non-verbal number acuity correlate with maths achievement	NATURE			English	Article							CHILDREN; SKILLS; REPRESENTATIONS	Human mathematical competence emerges from two representational systems. Competence in some domains of mathematics, such as calculus, relies on symbolic representations that are unique to humans who have undergone explicit teaching(1,2). More basic numerical intuitions are supported by an evolutionarily ancient approximate number system that is shared by adults(3-6), infants(7) and non- human animals(8-13) - these groups can all represent the approximate number of items in visual or auditory arrays without verbally counting, and use this capacity to guide everyday behaviour such as foraging. Despite the widespread nature of the approximate number system both across species and across development, it is not known whether some individuals have a more precise non- verbal 'number sense' than others. Furthermore, the extent to which this system interfaces with the formal, symbolic maths abilities that humans acquire by explicit instruction remains unknown. Here we show that there are large individual differences in the non- verbal approximation abilities of 14- year- old children, and that these individual differences in the present correlate with children's past scores on standardized maths achievement tests, extending all the way back to kindergarten. Moreover, this correlation remains significant when controlling for individual differences in other cognitive and performance factors. Our results show that individual differences in achievement in school mathematics are related to individual differences in the acuity of an evolutionarily ancient, unlearned approximate number sense. Further research will determine whether early differences in number sense acuity affect later maths learning, whether maths education enhances number sense acuity, and the extent to which tertiary factors can affect both.	[Halberda, Justin; Mazzocco, Michele M. M.; Feigenson, Lisa] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Mazzocco, Michele M. M.] Kennedy Krieger Inst, Baltimore, MD 21211 USA	Johns Hopkins University; Kennedy Krieger Institute	Halberda, J (corresponding author), Johns Hopkins Univ, Ames Hall,3400 N Charles St, Baltimore, MD 21218 USA.	halberda@jhu.edu	Mazzocco, Michele/AAI-5597-2021	Halberda, Justin/0000-0002-5619-3249	National Institutes of Health [RO1 HD 034061]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD034061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Longitudinal data collection was supported by a National Institutes of Health grant RO1 HD 034061 to M. M. We thank the Baltimore County Public School District and the children and parents who participated in this research, D. Naimen and R. Goodman for help with modelling, and L. Stapleton for help with statistical analyses.	Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Brannon EM, 2001, PSYCHOL SCI, V12, P238, DOI 10.1111/1467-9280.00342; Brannon EM, 1998, SCIENCE, V282, P746, DOI 10.1126/science.282.5389.746; Carey S, 2004, DAEDALUS-US, V133, P59, DOI 10.1162/001152604772746701; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Dehaene S, 1998, TRENDS NEUROSCI, V21, P355, DOI 10.1016/S0166-2236(98)01263-6; Dehaene S., 2011, NUMBER SENSE MIND CR; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Espy KA, 2004, DEV NEUROPSYCHOL, V26, P465, DOI 10.1207/s15326942dn2601_6; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Fias W., 2005, HDB MATH COGNITION, P43; Gallistel C. R., 1990, ORG LEARNING; Ginsburg P., 1990, TEST EARLY MATH ABIL; Gordon P, 2004, SCIENCE, V306, P496, DOI 10.1126/science.1094492; HALBERDA J, IN PRESS DEV PSYCHOL; Kurdek LA, 2001, J EDUC PSYCHOL, V93, P451, DOI 10.1037/0022-0663.93.3.451; Lachance JA, 2006, LEARN INDIVID DIFFER, V16, P195, DOI 10.1016/j.lindif.2005.12.001; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Mazzocco MMM, 2007, CHILD NEUROPSYCHOL, V13, P18, DOI 10.1080/09297040600611346; Mazzocco MMM, 2003, ANN DYSLEXIA, V53, P218, DOI 10.1007/s11881-003-0011-7; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Nieder A, 2004, P NATL ACAD SCI USA, V101, P7457, DOI 10.1073/pnas.0402239101; Pica P, 2004, SCIENCE, V306, P499, DOI 10.1126/science.1102085; Wechsler D., 2007, WASI 2 WECHSLER ABBR; Wilson Anna J, 2006, Behav Brain Funct, V2, P19, DOI 10.1186/1744-9081-2-19; WOODCOCK RW, 1989, JOHNSON PSYCHOEDUCAT; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9	27	923	938	12	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					665	U62		10.1038/nature07246	http://dx.doi.org/10.1038/nature07246			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	354KY	18776888				2022-12-28	WOS:000259639700047
J	Hampton, T				Hampton, Tracy			Researchers devise innovative method to overcome cancer-related drug resistance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																		Dubikovskaya EA, 2008, P NATL ACAD SCI USA, V105, P12128, DOI 10.1073/pnas.0805374105; PARK IH, 2008, CELL            0807; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Wiik AC, 2008, GENOME RES, V18, P1415, DOI 10.1101/gr.074302.107; Zhou CC, 2008, NAT MED, V14, P855, DOI 10.1038/nm.1856	6	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1507	1508		10.1001/jama.300.13.1507	http://dx.doi.org/10.1001/jama.300.13.1507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827202				2022-12-28	WOS:000259617700004
J	Heng, HHQ				Heng, Henry H. Q.			The conflict between complex systems and reductionism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER; BIOLOGY; BREAST		[Heng, Henry H. Q.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48201 USA	Wayne State University	Heng, HHQ (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, 3226 Scott Hall,540 E Canfield, Detroit, MI 48201 USA.	hheng@med.wayne.edu						Bear HD, 2003, ANN SURG ONCOL, V10, P334, DOI 10.1245/ASO.2003.02.023; Coffey DS, 1998, NAT MED, V4, P882, DOI 10.1038/nm0898-882; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GOLDBERGER AL, NONLINEAR DYNAMICS F; Heng HHQ, 2007, BIOESSAYS, V29, P783, DOI 10.1002/bies.20610; Heng HHQ, 2006, J CELL PHYSIOL, V208, P461, DOI 10.1002/jcp.20685; HEPPNER GH, 1984, CANCER RES, V44, P2259; Mazzocchi F, 2008, EMBO REP, V9, P10, DOI 10.1038/sj.embor.7401147; Mittra I, 2007, NAT CLIN PRACT ONCOL, V4, P203, DOI 10.1038/ncponc0772; Savage L, 2008, JNCI-J NATL CANCER I, V100, P519, DOI DOI 10.1093/JNCI/DJN137; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Ye CJ, 2007, CYTOGENET GENOME RES, V118, P237, DOI 10.1159/000108306	14	71	73	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1580	1581		10.1001/jama.300.13.1580	http://dx.doi.org/10.1001/jama.300.13.1580			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827215				2022-12-28	WOS:000259617700023
J	Kaklamani, VG; Wisinski, KB; Sadim, M; Gulden, C; Do, A; Offit, K; Baron, JA; Ahsan, H; Mantzoros, C; Pasche, B				Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Do, Albert; Offit, Kenneth; Baron, John A.; Ahsan, Habibul; Mantzoros, Christos; Pasche, Boris			Variants of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes and colorectal cancer risk	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GROWTH-FACTOR-I; CORONARY-ARTERY-DISEASE; IGF-I; PLASMA ADIPONECTIN; METABOLIC SYNDROME; BINDING PROTEIN-3; RECTAL-CANCER; COLON-CANCER; APM1 GENE; C-PEPTIDE	Context Current epidemiological evidence suggests an association between obesity, hyperinsulinemia, and colorectal cancer risk. Adiponectin is a hormone secreted by the adipose tissue, and serum levels are inversely correlated with obesity and hyperinsulinemia. While there is evidence of an association between circulating adiponectin levels and colorectal cancer risk, no association between genes of the adiponectin pathway and colorectal cancer have been reported to date. Objective To determine the association of 10 haplotype-tagging single-nucleotide polymorphisms (SNPs) of the adiponectin (ADIPOQ) and adiponectin receptor 1 (ADIPOR1) genes with colorectal cancer risk. Design, Setting, and Patients Two case-control studies including patients with a diagnosis of colorectal cancer and controls were recruited between 2000 and 2007. Case-control study 1 included a total of 441 patients with a diagnosis of colorectal cancer and 658 controls; both groups were of Ashkenazi Jewish ancestry and from new York, New York. Case-control study 2 included 199 patients with a diagnosis of colorectal cancer and 199 controls from Chicago, Illinois, matched 1:1 for sex, age, and ethnicity. Main Outcome Measures ADIPOQ and ADIPOR1 SNP frequency among cases and controls. Results In study 1, after adjustment for age, sex, and SNPs from the same gene, 3 ADIPOQ SNPs and 1 ADIPOR1 SNP were associated with colorectal cancer risk: rs266729 (adjusted odds ratio [AOR], 0.72; 95% confidence interval [CI], 0.55-0.95) and rs822396 (AOR, 0.37; 95% CI, 0.14-1.00) were associated with decreased risk whereas rs822395 (AOR, 1.76; 95% CI, 1.09-2.84) and rs1342387 (AOR, 1.79; 95% CI, 1.18-2.72) were associated with increased risk. In study 2, after adjustment for age, sex, race, and SNPs from the same gene, the ADIPOQ SNP rs266729 was associated with a decreased colorrectal cancer risk of similar magnitude as in study 1 (AOR, 0.52; 95% CI, 0.34-0.78). Combined analysis of both studies shows an association of rs266729 with decreased colorectal cancer risk (AOR, 0.73; 95% Ci, 0.53-0.99). Conclusion The SNP rs266729, which tags the 5' flanking region of the ADIPOQ gene, is associated with decreased colorectal cancer risk. .	[Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Pasche, Boris] Northwestern Univ, Canc Genet Program, Div Hematol & Oncol, Dept Med, Chicago, IL 60611 USA; [Kaklamani, Virginia G.; Wisinski, Kari B.; Sadim, Maureen; Gulden, Cassandra; Pasche, Boris] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Do, Albert; Mantzoros, Christos] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Endocrinol & Metab,Dept Med, Boston, MA USA; [Offit, Kenneth] Mem Sloan Kettering Canc Ctr, Dept Med, Clin Genet Serv, New York, NY 10021 USA; [Baron, John A.] Dartmouth Med Sch, Dept Med & Community, Hanover, NH USA; [Baron, John A.] Dartmouth Med Sch, Dept Community & Family Med, Hanover, NH USA; [Ahsan, Habibul] Univ Chicago, Dept Hlth Studies Med & Human Genet, Chicago, IL 60637 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Dartmouth College; Dartmouth College; University of Chicago	Pasche, B (corresponding author), Univ Alabama Birmingham, Div Hematol Oncol, 1802 6th Ave S,NP 2666, Birmingham, AL 35294 USA.	Boris.Pasche@ccc.uab.edu	Mantzoros, Christos/Y-2902-2019		Walter S. Mander Foundation (Chicago, Illinois); National Institutes of Health [CA112520, CA108741, DK081913, DK79929, DK 58785]; American Institute for Cancer Research; Beth Israel Deaconess Medical Center; Lynn Sage Foundation; American Society of Clinical Oncology Career Development Award; Niehaus Clinical Cancer Genetics Initiative; NATIONAL CANCER INSTITUTE [R01CA112520, R01CA108741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK058785, R01DK058785, R01DK079929, K24DK081913] Funding Source: NIH RePORTER	Walter S. Mander Foundation (Chicago, Illinois); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Institute for Cancer Research; Beth Israel Deaconess Medical Center; Lynn Sage Foundation; American Society of Clinical Oncology Career Development Award; Niehaus Clinical Cancer Genetics Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Walter S. Mander Foundation (Chicago, Illinois); grants CA112520, CA108741, DK081913, DK79929, DK 58785 from the National Institutes of Health; the Jeannik M. Littlefield-AACR Grant in Metastatic Colon Cancer Research from the American Institute for Cancer Research; a discretionary grant from Beth Israel Deaconess Medical Center; the Lynn Sage Foundation and the American Society of Clinical Oncology Career Development Award; and the Niehaus Clinical Cancer Genetics Initiative.	Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Crimmins NA, 2007, OBES REV, V8, P419, DOI 10.1111/j.1467-789X.2007.00348.x; Drew JE, 2007, AM J PHYSIOL-GASTR L, V293, pG682, DOI 10.1152/ajpgi.00231.2007; Fenton JI, 2008, INT J CANCER, V122, P2437, DOI 10.1002/ijc.23436; Filippi E, 2005, J MOL MED, V83, P711, DOI 10.1007/s00109-005-0667-z; Giovannucci E, 2000, CANCER EPIDEM BIOMAR, V9, P345; Hara K, 2002, DIABETES, V51, P536, DOI 10.2337/diabetes.51.2.536; Heid IM, 2006, DIABETES, V55, P375, DOI 10.2337/diabetes.55.02.06.db05-0747; Kaklamani VG, 2008, CANCER RES, V68, P3178, DOI 10.1158/0008-5472.CAN-08-0533; Laken SJ, 1997, NAT GENET, V17, P79, DOI 10.1038/ng0997-79; Larsson SC, 2007, AM J CLIN NUTR, V86, P556, DOI 10.1093/ajcn/86.3.556; LEE IM, 1992, J NATL CANCER I, V84, P1326, DOI 10.1093/jnci/84.17.1326; Lukanova A, 2006, CANCER EPIDEM BIOMAR, V15, P401, DOI 10.1158/1055-9965.EPI-05-0836; Ma J, 2004, JNCI-J NATL CANCER I, V96, P546, DOI 10.1093/jnci/djh082; Ma J, 2000, GROWTH HORM IGF RES, V10, pS28, DOI 10.1016/S1096-6374(00)90013-3; MacInnis RJ, 2004, CANCER EPIDEM BIOMAR, V13, P553; Manousos O, 1999, INT J CANCER, V83, P15, DOI 10.1002/(SICI)1097-0215(19990924)83:1<15::AID-IJC4>3.0.CO;2-Y; Menzaghi C, 2002, DIABETES, V51, P2306, DOI 10.2337/diabetes.51.7.2306; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Moschos SJ, 2002, ONCOLOGY-BASEL, V63, P317, DOI 10.1159/000066230; Pischon T, 2007, OBESITY, V15, P2051, DOI 10.1038/oby.2007.244; Pischon T, 2006, J NATL CANCER I, V98, P920, DOI 10.1093/jnci/djj246; Pollak MN, 2004, NAT REV CANCER, V4, P505, DOI 10.1038/nrc1387; Qi L, 2006, DIABETES, V55, P1512, DOI 10.2337/db05-1520; Sandhu MS, 2002, J NATL CANCER I, V94, P972; Soccio T, 2006, DIABETES, V55, P2763, DOI 10.2337/db06-0613; Vasseur F, 2002, HUM MOL GENET, V11, P2607, DOI 10.1093/hmg/11.21.2607; Vona-Davis L, 2007, OBES REV, V8, P395, DOI 10.1111/j.1467-789X.2007.00396.x; Wei EK, 2005, JNCI-J NATL CANCER I, V97, P1688, DOI 10.1093/jnci/dji376; Wei EK, 2005, CANCER EPIDEM BIOMAR, V14, P850, DOI 10.1158/1055-9965.EPI-04-0661; Williams CJ, 2008, ENDOCR-RELAT CANCER, V15, P289, DOI 10.1677/ERC-07-0197	31	105	111	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1523	1531		10.1001/jama.300.13.1523	http://dx.doi.org/10.1001/jama.300.13.1523			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827209	Green Accepted, Bronze			2022-12-28	WOS:000259617700016
J	Weisfeldt, ML; Ornato, JP				Weisfeldt, Myron L.; Ornato, Joseph P.			Closed-chest cardiac massage: Progress measured by the exceptions	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOPULMONARY-RESUSCITATION; ARREST; SURVIVAL		[Weisfeldt, Myron L.] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21287 USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Dept Emergency Med, Richmond, VA USA	Johns Hopkins University; Johns Hopkins Medicine; Virginia Commonwealth University	Weisfeldt, ML (corresponding author), Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21287 USA.	mlw5@jhmi.edu						Bobrow BJ, 2008, JAMA-J AM MED ASSOC, V299, P1158, DOI 10.1001/jama.299.10.1158; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; DELUNA AB, 1989, AM HEART J, V117, P151, DOI 10.1016/0002-8703(89)90670-4; GUERCI AD, 1989, J AM COLL CARDIOL, V14, P790, DOI 10.1016/0735-1097(89)90127-7; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Hazinski MF, 2005, CIRCULATION, V112, pIV206, DOI 10.1161/CIRCULATIONAHA.105.170809; Holzer M, 2002, NEW ENGL J MED, V346, P549; Kim C, 2001, CIRCULATION, V104, P2699, DOI 10.1161/hc4701.099784; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; OMATO JP, 2003, RESUSCITATION, V56, P135; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; SLADEN A, 1984, JAMA-J AM MED ASSOC, V251, P3137, DOI 10.1001/jama.251.23.3137; Weisfeldt ML, 2002, JAMA-J AM MED ASSOC, V288, P3035, DOI 10.1001/jama.288.23.3035; Youngquist ST, 2008, RESUSCITATION, V76, P376, DOI 10.1016/j.resuscitation.2007.08.022	15	6	6	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1582	1584		10.1001/jama.300.13.1582	http://dx.doi.org/10.1001/jama.300.13.1582			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827216				2022-12-28	WOS:000259617700024
J	Bragg, AE; Cavanagh, MC; Schwartz, BJ				Bragg, Arthur E.; Cavanagh, Molly C.; Schwartz, Benjamin J.			Linear response breakdown in solvation dynamics induced by atomic electron-transfer reactions	SCIENCE			English	Article							TO-SOLVENT DYNAMICS; OPTICAL-SPECTRA; TETRAHYDROFURAN; NA; WATER; LIQUIDS; IODIDE; ROLES; BAND	The linear response (LR) approximation, which predicts identical relaxation rates from all nonequilibrium initial conditions that relax to the same equilibrium state, underlies dominant models of how solvation influences chemical reactivity. We experimentally tested the validity of LR for the solvation that accompanies partial electron transfer to and from a monatomic solute in solution. We photochemically prepared the species with stoichiometry Na(0) in liquid tetrahydrofuran by both adding an electron to Na(+) and removing an electron from Na(-). Because atoms lack nuclear degrees of freedom, ultrafast changes in the Na(0) absorption spectrum reflected the solvation that began from our two initial nonequilibrium conditions. We found that the solvation of Na(0) occurs more rapidly from Na(+) than Na(-), constituting a breakdown of LR. This indicates that Marcus theory would fail to describe electron- transfer processes for this and related chemical systems.	[Bragg, Arthur E.; Cavanagh, Molly C.; Schwartz, Benjamin J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Schwartz, BJ (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.	schwartz@chem.ucla.edu		Schwartz, Benjamin/0000-0003-3257-9152	NSF [CHE-0603766]	NSF(National Science Foundation (NSF))	This research was funded by NSF under grant number CHE-0603766. The authors thank R. E. Larsen for useful discussions and a critical reading of the manuscript.	Aherne D, 2000, J PHYS CHEM B, V104, P5382, DOI 10.1021/jp000326u; Barthel ER, 2003, CHEM PHYS LETT, V375, P435, DOI 10.1016/S0009-2614(03)00922-9; Bedard-Hearn MJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.130403; Bedard-Hearn MJ, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2358131; Bedard-Hearn MJ, 2003, J PHYS CHEM A, V107, P4773, DOI 10.1021/jp034383+; BEDARDHEARN MJ, 2005, J CHEM PHYS, V122; BOCKRATH B, 1973, J PHYS CHEM-US, V77, P1002, DOI 10.1021/j100627a007; Bowron DT, 2006, J AM CHEM SOC, V128, P5119, DOI 10.1021/ja0583057; Bragg AE, 2008, J PHYS CHEM A, V112, P3530, DOI 10.1021/jp712039u; Bragg AE, 2008, J PHYS CHEM B, V112, P483, DOI 10.1021/jp076934s; CATTERALL R, 1970, J CHEM PHYS, V52, P1003, DOI 10.1063/1.1672992; Cavanagh MC, 2007, J PHYS CHEM A, V111, P5144, DOI 10.1021/jp071132i; Chandler D., 1987, INTRO MODERN STAT ME; FONSECA T, 1991, J PHYS CHEM-US, V95, P2116, DOI 10.1021/j100159a007; Geissler PL, 2000, J CHEM PHYS, V113, P9759, DOI 10.1063/1.1290136; JOU FY, 1979, CAN J CHEM, V57, P591, DOI 10.1139/v79-095; Laird BB, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2747237; Larsen DS, 2001, J CHEM PHYS, V114, P8008, DOI 10.1063/1.1359240; LOK MT, 1972, J PHYS CHEM-US, V76, P2975, DOI 10.1021/j100665a009; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; MARONCELLI M, 1993, J MOL LIQ, V57, P1, DOI 10.1016/0167-7322(93)80045-W; Martini IB, 2001, SCIENCE, V293, P462, DOI 10.1126/science.1061612; Moskun AC, 2006, SCIENCE, V311, P1907, DOI 10.1126/science.1123738; NAGARAJAN V, 1987, J CHEM PHYS, V86, P3183, DOI 10.1063/1.452029; Reynolds L, 1996, J PHYS CHEM-US, V100, P10337, DOI 10.1021/jp953110e; Shoshana O, 2006, PHYS CHEM CHEM PHYS, V8, P2599, DOI 10.1039/b602933g; Stratt RM, 1996, J PHYS CHEM-US, V100, P12981, DOI 10.1021/jp9608483; Tao GH, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2336780; Underwood DF, 2005, J PHYS CHEM A, V109, P3295, DOI 10.1021/jp044187i	29	66	67	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1817	1822		10.1126/science.1161511	http://dx.doi.org/10.1126/science.1161511			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818354				2022-12-28	WOS:000259501300033
J	Deleglise, S; Dotsenko, I; Sayrin, C; Bernu, J; Brune, M; Raimond, JM; Haroche, S				Deleglise, Samuel; Dotsenko, Igor; Sayrin, Clement; Bernu, Julien; Brune, Michel; Raimond, Jean-Michel; Haroche, Serge			Reconstruction of non-classical cavity field states with snapshots of their decoherence	NATURE			English	Article							WIGNER FUNCTION; QUANTUM STATE; ENTANGLEMENT; TOMOGRAPHY	The state of a microscopic system encodes its complete quantum description, from which the probabilities of all measurement outcomes are inferred. Being a statistical concept, the state cannot be obtained from a single system realization, but can instead be reconstructed(1) from an ensemble of copies through measurements on different realizations(2-4). Reconstructing the state of a set of trapped particles shielded from their environment is an important step in the investigation of the quantum - classical boundary(5). Although trapped- atom state reconstructions(6-8) have been achieved, it is challenging to perform similar experiments with trapped photons because cavities that can store light for very long times are required. Here we report the complete reconstruction and pictorial representation of a variety of radiation states trapped in a cavity in which several photons survive long enough to be repeatedly measured. Atoms crossing the cavity one by one are used to extract information about the field. We obtain images of coherent states(9), Fock states with a definite photon number and 'Schrodinger cat' states ( superpositions of coherent states with different phases(10)). These states are equivalently represented by their density matrices or Wigner functions(11). Quasi- classical coherent states have a Gaussian- shaped Wigner function, whereas the Wigner functions of Fock and Schrodinger cat states show oscillations and negativities revealing quantum interferences. Cavity damping induces decoherence that quickly washes out such oscillations(5). We observe this process and follow the evolution of decoherence by reconstructing snapshots of Schrodinger cat states at successive times. Our reconstruction procedure is a useful tool for further decoherence and quantum feedback studies of fields trapped in one or two cavities.	[Deleglise, Samuel; Dotsenko, Igor; Sayrin, Clement; Bernu, Julien; Brune, Michel; Raimond, Jean-Michel; Haroche, Serge] Univ Paris 06, CNRS, Lab Kastler Brossel, Ecole Normale Super, F-75231 Paris 05, France; [Dotsenko, Igor; Haroche, Serge] Coll France, F-75231 Paris 05, France	UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; College de France	Haroche, S (corresponding author), Univ Paris 06, CNRS, Lab Kastler Brossel, Ecole Normale Super, 24 Rue Lhomond, F-75231 Paris 05, France.	haroche@lkb.ens.fr	Deléglise, Samuel X/B-1599-2015	Deléglise, Samuel X/0000-0002-8680-5170; Sayrin, Clement/0000-0002-9747-5912; RAIMOND, Jean-Michel/0000-0002-4289-3455; Dotsenko, Igor/0000-0002-5074-6447	Agence Nationale pour la Recherche; Japan Science and Technology Agency; European Union; Integrated Projects SCALA; CONQUEST; Delegation Generale pour l'Armement	Agence Nationale pour la Recherche(French National Research Agency (ANR)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); European Union(European Commission); Integrated Projects SCALA; CONQUEST; Delegation Generale pour l'Armement	This work was supported by the Agence Nationale pour la Recherche (ANR), by the Japan Science and Technology Agency (JST) and by the European Union under the Integrated Projects SCALA and CONQUEST. S. D. is funded by the Delegation Generale pour l'Armement (DGA).	Bertet P, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.200402; Brune M, 1996, PHYS REV LETT, V77, P4887, DOI 10.1103/PhysRevLett.77.4887; Buzek V, 2000, J MOD OPTIC, V47, P2823, DOI 10.1080/09500340008232199; Buzek V., 1995, PROG OPTICS, V34, P1, DOI DOI 10.1016/S0079-6638(08)70324-X; Davidovich L, 1996, PHYS REV A, V53, P1295, DOI 10.1103/PhysRevA.53.1295; DUNN TJ, 1995, PHYS REV LETT, V74, P884, DOI 10.1103/PhysRevLett.74.884; GLAUBER RJ, 1963, PHYS REV, V131, P2766, DOI 10.1103/PhysRev.131.2766; Guerlin C, 2007, NATURE, V448, P889, DOI 10.1038/nature06057; Haffner H, 2005, NATURE, V438, P643, DOI 10.1038/nature04279; Haroche S., 2006, EXPLORING QUANTUM; KIM MS, 1992, PHYS REV A, V46, P4239, DOI 10.1103/PhysRevA.46.4239; Kuhr S, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2724816; Kurtsiefer C, 1997, NATURE, V386, P150, DOI 10.1038/386150a0; Lutterbach LG, 1997, PHYS REV LETT, V78, P2547, DOI 10.1103/PhysRevLett.78.2547; Lvovsky AI, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.050402; Milman P, 2005, EUR PHYS J D, V32, P233, DOI 10.1140/epjd/e2004-00171-6; Morinaga M, 1999, PHYS REV LETT, V83, P4037, DOI 10.1103/PhysRevLett.83.4037; Ourjoumtsev A, 2007, NATURE, V448, P784, DOI 10.1038/nature06054; Ourjoumtsev A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.213601; Paris MGA, 2004, LECT NOTES PHYS, V649, P1; Raimond JM, 2001, REV MOD PHYS, V73, P565, DOI 10.1103/RevModPhys.73.565; Schleich W. P., 2001, QUANTUM OPTICS PHASE; SMITHEY DT, 1993, PHYS REV LETT, V70, P1244, DOI 10.1103/PhysRevLett.70.1244; Zavatta A, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.053821; Zippilli S, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.052101; Zurek WH, 2003, REV MOD PHYS, V75, P715, DOI 10.1103/RevModPhys.75.715	28	405	414	2	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					510	514		10.1038/nature07288	http://dx.doi.org/10.1038/nature07288			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818653	Green Submitted, Green Published			2022-12-28	WOS:000259449600041
J	Beasley, R; Clayton, T; Crane, J; von Mutius, E; Lai, CKW; Montefort, S; Stewart, A				Beasley, Richard; Clayton, Tadd; Crane, Julian; von Mutius, Erika; Lai, Christopher K. W.; Montefort, Stephen; Stewart, Alistair		ISAAC Phase Three Study Grp	Association between paracetamol use in infancy and childhood, and risk of asthma, rhinoconjunctivitis, and eczema in children aged 6-7 years: analysis from Phase Three of the ISAAC programme	LANCET			English	Article							WORLDWIDE VARIATIONS; ALLERGIC DISEASES; ACETAMINOPHEN USE; EARLY-LIFE; DRUG-USE; PREVALENCE; SYMPTOMS; ASPIRIN; IBUPROFEN; MANAGEMENT	Background Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma. Methods As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, rhinoconjunctivitis, and eczema, and several risk factors, including the use of paracetamol for fever in the child's first year of life and the frequency of paracetamol use in the past 12 months. The primary outcome variable was the odds ratio (OR) of asthma symptoms in these children associated with the use of paracetamol for fever in the first year of life, as calculated by logistic regression. Findings 205 487 children aged 6-7 years from 73 centres in 31. countries were included in the analysis. In the multivariate analyses, use of paracetamol for fever in the first year of life was associated with an increased risk of asthma symptoms when aged 6-7 years (OR 1.46 [95% Cl 1.36-1.56]). Current use of paracetamol was associated with a dose-dependent increased risk of asthma symptoms (1.61 [1.46-1.77] and 3.23 [2.9]-3.60] for medium and high use vs no use, respectively). Use of paracetamol was similarly associated with the risk of severe asthma symptoms, with population-attributable risks between 22% and 38%. Paracetamol use, both in the first year of life and in children aged 6-7 years, was also associated with an increased risk of symptoms of rhinoconjunctivitis and eczema. Interpretation Use of paracetamol in the first year of life and in later childhood, is associated with risk of asthma, rhinoconjunctivitis, and eczema at age 6 to 7 years. We suggest that exposure to paracetamol might be a risk factor for the development of asthma in childhood. Funding The BUPA Foundation, the Health Research Council of New Zealand, the Asthma and Respiratory Foundation of New Zealand, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, Glaxo Wellcome New Zealand, the New Zealand Lottery Board, Astra Zeneca New Zealand, and Glaxo Wellcome international Medical Affairs.	[Beasley, Richard] Med Res Inst New Zealand, Wellington 6143, New Zealand; [Clayton, Tadd] Univ Auckland, Fac Med & Hlth Sci, Auckland 1, New Zealand; [Crane, Julian] Univ Otago, Dept Med, Wellington, New Zealand; [von Mutius, Erika] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany; [Lai, Christopher K. W.] Univ Hong Kong, Dept Med & Therapeut, Hong Kong, Peoples R China; [Montefort, Stephen] Univ Malta, Dept Med, Msida, Malta; [Stewart, Alistair] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	Medical Research Institute Of New Zealand; University of Auckland; University of Otago; University of Munich; University of Hong Kong; University of Malta; University of Auckland	Beasley, R (corresponding author), Med Res Inst New Zealand, POB 10055, Wellington 6143, New Zealand.	Richard.Beasley@mrinz.ac.nz	Ellwood, Philippa/G-7555-2015; Martínez-Gimeno, Antonio/A-9416-2010; Masjedi, Mohammad Reza/J-9776-2017; Garcia-Almaraz, Roberto/G-8506-2018; Anderson, Hugh R/A-7417-2016; González-Díaz, Sandra Nora/H-3271-2018; Steriu, Andreea/AAQ-5127-2021; Clayton, Tadd O/B-7914-2009; Wong, Gary WK/AAY-9207-2020; Beasley, Richard/AAH-3908-2019	Ellwood, Philippa/0000-0002-1994-4023; Martínez-Gimeno, Antonio/0000-0003-4051-1860; Masjedi, Mohammad Reza/0000-0002-6871-382X; Garcia-Almaraz, Roberto/0000-0001-5828-1771; González-Díaz, Sandra Nora/0000-0002-3612-0042; Steriu, Andreea/0000-0002-2998-8644; Wong, Gary WK/0000-0001-5939-812X; Beasley, Richard/0000-0003-0337-406X; Huang, Jing-Long/0000-0001-9280-920X; Huang, Jing-Long/0000-0002-3530-7753; von Mutius, Erika/0000-0002-8893-4515; brunekreef, bert/0000-0001-9908-0060; Mallol, Javier/0000-0003-2528-8672; Garcia-Marcos, Luis/0000-0002-0925-3851; Pearce, Neil/0000-0002-9938-7852; Pattemore, Philip/0000-0002-4968-1287; Masjedi, Mohammadreza/0000-0003-4964-3851; williams, hywel/0000-0002-5646-3093	ISAAC International Data Centre (IIDC) is The BUPA Foundation	ISAAC International Data Centre (IIDC) is The BUPA Foundation	We thank the children and parents who participated in ISAAC Phase Three, and the school staff for their coordination and assistance. The authors also acknowledge and thank die many funding bodies throughout the world that supported the individual ISAAC centres, collaborators, and their meetings. Currently, the main source of funding for the ISAAC International Data Centre (IIDC) is The BUPA Foundation. Many funding bodies in New Zealand have contributed to support the IIDC during the periods of fieldwork arid data compilation: the Health Research Council of New Zealand, the Asthma arid Respiratory Foundation of New Zealand, the Child Health Research Foundation, the Hawke's Bay Medical Research Foundation, the Waikato Medical Research Foundation, GlaxoWellcome New Zealand, the New Zealand Lottery Board, and Astra Zeneca New Zealand. GlaxoWellcome International Medical Affairs supported the regional coordination for Phase Three and the IIDC.	AGYEPONG IA, 1994, ACTA TROP, V58, P317, DOI 10.1016/0001-706X(94)90025-6; Ajayi I O, 2006, Afr J Med Med Sci, V35, P85; Allmers H, 2005, J ALLERGY CLIN IMMUN, V116, P859, DOI 10.1016/j.jaci.2005.07.019; Anderson HR, 2008, INT J EPIDEMIOL, V37, P573, DOI 10.1093/ije/dyn039; ARROWSMITH JB, 1987, PEDIATRICS, V79, P858; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2000, J ALLERGY CLIN IMMUN, V105, pS466, DOI 10.1016/S0091-6749(00)90044-7; Benichou J, 2001, STAT METHODS MED RES, V10, P195, DOI 10.1191/096228001680195157; Benoni Giuseppina, 2005, Pediatr Med Chir, V27, P67; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Cohet C, 2004, J EPIDEMIOL COMMUN H, V58, P852, DOI 10.1136/jech.2003.019182; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Del-Rio-Navarro BE, 2007, J INVEST ALLERG CLIN, V17, P77; Dodge R, 1996, J ALLERGY CLIN IMMUN, V98, P48, DOI 10.1016/S0091-6749(96)70225-7; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Ellwood P, 2005, INT J TUBERC LUNG D, V9, P10; Eneli I, 2005, CHEST, V127, P604, DOI 10.1378/chest.127.2.604; Fawole O I, 2001, West Afr J Med, V20, P152; GARCIAMARCOS L, 2008, INT ARCH ALLERGY IMM; Koniman R, 2007, PEDIAT ALLERG IMM-UK, V18, P128, DOI 10.1111/j.1399-3038.2006.00484.x; Kuschnir FC, 2007, PEDIAT ALLERG IMM-UK, V18, P142, DOI 10.1111/j.1399-3038.2006.00477.x; Lagerlov Per, 2004, Tidsskr Nor Laegeforen, V124, P1620; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; Li SF, 2000, PEDIATR EMERG CARE, V16, P394, DOI 10.1097/00006565-200012000-00003; Maison P, 1998, EUR J CLIN PHARMACOL, V54, P659, DOI 10.1007/s002280050530; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matricardi PM, 2002, ASTHMA: CRITICAL DEBATES, P3; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; Newson RB, 2000, EUR RESPIR J, V16, P817, DOI 10.1183/09031936.00.16581700; Nuttall SL, 2003, J CLIN PHARM THER, V28, P289, DOI 10.1046/j.1365-2710.2003.00493.x; Nuttall SL, 2003, J CLIN PHARM THER, V28, P251, DOI 10.1046/j.1365-2710.2003.00492.x; OLOUGHLIN EV, 1995, J PAEDIATR CHILD H, V31, P189, DOI 10.1111/j.1440-1754.1995.tb00783.x; Pandolfini C, 2005, EUR J PEDIATR, V164, P552, DOI 10.1007/s00431-005-1698-8; REBORDOSA C, 2007, AM J RESP CRIT CARE, V175, pA80; SETTIPANE GA, 1983, AM J MED, V74, P102, DOI 10.1016/0002-9343(83)90537-5; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Shaheen SO, 2000, THORAX, V55, P266, DOI 10.1136/thorax.55.4.266; Shaheen SO, 2002, THORAX, V57, P958, DOI 10.1136/thorax.57.11.958; Sherriff A, 2001, INT J EPIDEMIOL, V30, P1473, DOI 10.1093/ije/30.6.1473; Stein R, 1999, LANCET, V354, P541, DOI 10.1016/S0140-6736(98)10321-5; Strachan DP, 1997, PEDIAT ALLERG IMM-UK, V8, P161, DOI 10.1111/j.1399-3038.1997.tb00156.x; Taddio A, 2007, PEDIATRICS, V120, pE637, DOI 10.1542/peds.2006-3351; Taylor BJ, 1996, J PAEDIATR CHILD H, V32, P316, DOI 10.1111/j.1440-1754.1996.tb02561.x; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4; VEDANTHAN PK, 1977, J ALLERGY CLIN IMMUN, V60, P8, DOI 10.1016/0091-6749(77)90077-X; Vennemann MMT, 2005, ARCH DIS CHILD, V90, P520, DOI 10.1136/adc.2004.065581; Vlaski E, 2007, IRAN J ALLERGY ASTHM, V6, P143; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILLIAMS LA, 1991, ASHP MIDY CLIN M, V26; Wong GWK, 2007, CLIN EXP ALLERGY, V37, P174, DOI 10.1111/j.1365-2222.2007.02649.x; Young S, 2000, EUR RESPIR J, V15, P151, DOI 10.1034/j.1399-3003.2000.15a28.x	54	259	266	0	34	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1039	1048		10.1016/S0140-6736(08)61445-2	http://dx.doi.org/10.1016/S0140-6736(08)61445-2			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805332				2022-12-28	WOS:000259648500030
J	Haydon, DJ; Stokes, NR; Ure, R; Galbraith, G; Bennett, JM; Brown, DR; Baker, PJ; Barynin, VV; Rice, DW; Sedelnikova, SE; Heal, JR; Sheridan, JM; Aiwale, ST; Chauhan, PK; Srivastava, A; Taneja, A; Collins, I; Errington, J; Czaplewski, LG				Haydon, David J.; Stokes, Neil R.; Ure, Rebecca; Galbraith, Greta; Bennett, James M.; Brown, David R.; Baker, Patrick J.; Barynin, Vladimir V.; Rice, David W.; Sedelnikova, Sveta E.; Heal, Jonathan R.; Sheridan, Joseph M.; Aiwale, Sachin T.; Chauhan, Pramod K.; Srivastava, Anil; Taneja, Amit; Collins, Ian; Errington, Jeff; Czaplewski, Lloyd G.			An inhibitor of FtsZ with potent and selective anti-staphylococcal activity	SCIENCE			English	Article							DIVISION PROTEIN FTSZ; CELL-DIVISION; SMALL-MOLECULE; ANTIBIOTICS; TUBULIN; CYTOKINESIS; DISCOVERY; INSIGHTS; TARGET	FtsZ is an essential bacterial guanosine triphosphatase and homolog of mammalian beta-tubulin that polymerizes and assembles into a ring to initiate cell division. We have created a class of small synthetic antibacterials, exemplified by PC190723, which inhibits FtsZ and prevents cell division. PC190723 has potent and selective in vitro bactericidal activity against staphylococci, including methicillin- and multi- drug- resistant Staphylococcus aureus. The putative inhibitor- binding site of PC190723 was mapped to a region of FtsZ that is analogous to the Taxol- binding site of tubulin. PC190723 was efficacious in an in vivo model of infection, curing mice infected with a lethal dose of S. aureus. The data validate FtsZ as a target for antibacterial intervention and identify PC190723 as suitable for optimization into a new anti- staphylococcal therapy.	[Haydon, David J.; Stokes, Neil R.; Ure, Rebecca; Galbraith, Greta; Bennett, James M.; Brown, David R.; Collins, Ian; Errington, Jeff; Czaplewski, Lloyd G.] Prolysis, Oxford OX5 1PF, England; [Baker, Patrick J.; Barynin, Vladimir V.; Rice, David W.; Sedelnikova, Sveta E.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Heal, Jonathan R.; Sheridan, Joseph M.] Prosarix, Cambridge CB22 7ZE, England; [Aiwale, Sachin T.; Chauhan, Pramod K.; Srivastava, Anil; Taneja, Amit] Jubilant Chemsys, Noida 201301, India; [Errington, Jeff] Univ Newcastle, Fac Med Sci, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	University of Sheffield; Newcastle University - UK	Stokes, NR (corresponding author), Prolysis, Begbroke Sci Pk, Oxford OX5 1PF, England.	neil.stokes@prolysis.com	Errington, Jeff/G-1832-2011; Stokes, Neil/ABA-4660-2020	Errington, Jeff/0000-0002-6977-9388; Bennett, James/0000-0003-1396-8400; Baker, Patrick/0000-0003-1995-5643	L. Clay and East Hill Management (Boston, MA, USA); Wellcome Trust under the Seeding Drug Discovery Initiative; UK Biotechnology and Biological Sciences Research Council; UK Department of Trade and Industry;  [AppGen55]	L. Clay and East Hill Management (Boston, MA, USA); Wellcome Trust under the Seeding Drug Discovery Initiative(Wellcome Trust); UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); UK Department of Trade and Industry; 	We thank various colleagues for assistance and advice and S. Ruston for support. This work was funded by investments from L. Clay and East Hill Management (Boston, MA, USA), The Wellcome Trust under the Seeding Drug Discovery Initiative, and a grant (AppGen55) in applied genomics from the UK Biotechnology and Biological Sciences Research Council and the UK Department of Trade and Industry. D. J. H., N.R.S., R.U., G.G., J.M.B., D.R.B., I.C., and L.G.C. are or have been paid employees of Prolysis. In addition, each has been offered share options in the company. J. E. founded Prolysis and retains an equity stake (in terms of shares issued) in the organization. He is the chief scientific officer and a director of Prolysis, and for this part-time role he is paid as a consultant. All other coauthors (that is, those not affiliated with Prolysis) do not declare any conflicts of interest. The evaluation of compound activity in vivo was performed by MDS Pharma Services. Compounds are the subject of patent application PCT/GB2007/001012. The atomic coordinates and structure factors of B. subtilis FtsZ have been deposited with the Protein Data Bank under the accession numbers 2vxy and r2vxysf. The sequences of the ftsZ wild-type and mutant strains have been deposited in GenBank with the accession numbers EU914258 to EU914264.	ARNOS LA, 1999, CHEM BIOL, V6, pR65; Downing KH, 2000, ANNU REV CELL DEV BI, V16, P89, DOI 10.1146/annurev.cellbio.16.1.89; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Ito H, 2006, MICROBIOL IMMUNOL, V50, P759, DOI 10.1111/j.1348-0421.2006.tb03851.x; Lappchen T, 2005, BIOCHEMISTRY-US, V44, P7879, DOI 10.1021/bi047297o; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Lowe J, 1998, NATURE, V391, P203, DOI 10.1038/34472; Margalit DN, 2004, P NATL ACAD SCI USA, V101, P11821, DOI 10.1073/pnas.0404439101; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; O'Neill AJ, 2004, EXPERT OPIN INV DRUG, V13, P1045, DOI 10.1517/13543784.13.8.1045; Ohashi Y, 1999, J BACTERIOL, V181, P1348, DOI 10.1128/JB.181.4.1348-1351.1999; Oliva MA, 2007, J MOL BIOL, V373, P1229, DOI 10.1016/j.jmb.2007.08.056; Paradis-Bleau C, 2007, BIOORGAN MED CHEM, V15, P1330, DOI 10.1016/j.bmc.2006.11.015; Stokes NR, 2005, J BIOL CHEM, V280, P39709, DOI 10.1074/jbc.M506741200; Vollmer W, 2006, APPL MICROBIOL BIOT, V73, P37, DOI 10.1007/s00253-006-0586-0; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200	17	339	358	4	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1673	1675		10.1126/science.1159961	http://dx.doi.org/10.1126/science.1159961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	349RG	18801997				2022-12-28	WOS:000259300400034
J	Hiratsuka, T; Furihata, K; Ishikawa, J; Yamashita, H; Itoh, N; Seto, H; Dairi, T				Hiratsuka, Tomoshige; Furihata, Kazuo; Ishikawa, Jun; Yamashita, Haruyuki; Itoh, Nobuya; Seto, Haruo; Dairi, Tohru			An alternative menaquinone biosynthetic pathway operating in microorganisms	SCIENCE			English	Article							COMPLETE GENOME SEQUENCE; STREPTOMYCES-COELICOLOR A3(2); HELICOBACTER-PYLORI; VITAMIN-K; METABOLISM	In microorganisms, menaquinone is an obligatory component of the electron- transfer pathway. It is derived from chorismate by seven enzymes in Escherichia coli. However, a bioinformatic analysis of whole genome sequences has suggested that some microorganisms, including pathogenic species such as Helicobacter pylori and Campylobacter jejuni, do not have orthologs of the men genes, even though they synthesize menaquinone. We deduced the outline of this alternative pathway in a nonpathogenic strain of Streptomyces by bioinformatic screening, gene knockouts, shotgun cloning with isolated mutants, and in vitro studies with recombinant enzymes. As humans and commensal intestinal bacteria, including lactobacilli, lack this pathway, it represents an attractive target for the development of chemotherapeutics.	[Hiratsuka, Tomoshige; Itoh, Nobuya; Dairi, Tohru] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan; [Furihata, Kazuo] Univ Tokyo, Div Agr & Agr Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Ishikawa, Jun] Natl Inst Infect Dis, Shinjuku Ku, Dept Bioact Mol, Tokyo 1628640, Japan; [Yamashita, Haruyuki] ADEKA Corp, Adv Mat Res & Dev Lab, Arakawa Ku, Tokyo 1168553, Japan; [Seto, Haruo] Tokyo Univ Agr, Setagaya Ku, Fac Appl Biosci, Tokyo 1568502, Japan	Toyama Prefectural University; University of Tokyo; National Institute of Infectious Diseases (NIID); Tokyo University of Agriculture	Dairi, T (corresponding author), Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan.	dairi@pu-toyama.ac.jp	Hiratsuka, Tomoshige/C-7447-2017; Dairi, Tohru/A-5448-2012	Dairi, Tohru/0000-0002-3406-7970	Grant-in-Aid for Scientific Research (B); Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics"; Ministry of Education, Culture, Sports, Science and Technology of Japan; Urakami Foundation; Skylark Food Science Institute	Grant-in-Aid for Scientific Research (B)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics"(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Urakami Foundation(Urakami Foundation); Skylark Food Science Institute	This work was supported in part by a Grant-in-Aid for Scientific Research (B) to S. H. and by a Grant-in-Aid for Scientific Research on Priority Areas "Applied Genomics" from the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Urakami Foundation, and the Skylark Food Science Institute to T.D. Author contributions: T.H., H.S., and T.D. conceived and designed the experiments; T.H., K.F., J.I., H.S., and T. D. performed the experiments; T.H., K.F., H.Y., N.I., H.S., and T.D. analyzed the data; and H.S. and T.D. wrote the paper. The DNA sequences determined and characterized in this study have been deposited in the DDBJ, EMBL, and GenBank data banks as follows: SCO4506, AB447888; SCO4327, AB447889; SCO4550, AB447890; SCO4326, AB447891; TTHA0556, AB447892; TTHA1568, AB447893.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; BENTLEY R, 1982, MICROBIOL REV, V46, P241, DOI 10.1128/MMBR.46.3.241-280.1982; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Borodina I, 2005, GENOME RES, V15, P820, DOI 10.1101/gr.3364705; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; COLLINS MD, 1977, J GEN MICROBIOL, V100, P221, DOI 10.1099/00221287-100-2-221; Cranenburg ECM, 2007, THROMB HAEMOSTASIS, V98, P120, DOI 10.1160/TH07-04-0266; Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956; HOPWOOD DA, 1985, GENE MANIPULATION ST; Hosokawa N, 1999, CHEM PHARM BULL, V47, P1032; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lamson Davis W, 2003, Altern Med Rev, V8, P303; Macheroux P, 1999, PLANTA, V207, P325, DOI 10.1007/s004250050489; Marcelli SW, 1996, FEMS MICROBIOL LETT, V138, P59; Meganathan R, 2001, VITAM HORM, V61, P173; MOSS CW, 1990, J CLIN MICROBIOL, V28, P395, DOI 10.1128/JCM.28.2.395-397.1990; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Plaza SM, 2005, ALTERN MED REV, V10, P24; Seto H, 2008, J AM CHEM SOC, V130, P5614, DOI 10.1021/ja710207s; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483	22	177	188	1	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896					1670	1673		10.1126/science.1160446	http://dx.doi.org/10.1126/science.1160446			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801996				2022-12-28	WOS:000259300400033
J	Lewin, S; Lavis, JN; Oxman, AD; Bastias, G; Chopra, M; Ciapponi, A; Flottorp, S; Marti, SG; Pantoja, T; Rada, G; Souza, N; Treweek, S; Wiysonge, CS; Haines, A				Lewin, Simon; Lavis, John N.; Oxman, Andrew D.; Bastias, Gabriel; Chopra, Mickey; Ciapponi, Agustin; Flottorp, Signe; Garcia Marti, Sebastian; Pantoja, Tomas; Rada, Gabriel; Souza, Nathan; Treweek, Shaun; Wiysonge, Charles S.; Haines, Andy			Alma-Ata: Rebirth and revision 2 - Supporting the delivery of cost-effective interventions in primary health-care systems in low-income and middle-income countries: an overview of systematic reviews	LANCET			English	Article							PRIVATE FOR-PROFIT; CONDITIONAL CASH TRANSFERS; EDUCATIONAL OUTREACH; HUMAN-RESOURCES; IMPLEMENTATION; QUALITY; MORTALITY; IMPROVE; WORKING	Strengthening health systems is a key challenge to improving the delivery of cost-effective interventions in primary health care and achieving the vision of the Alma-Ata Declaration. Effective governance, financial and delivery arrangements within health systems, and effective implementation strategies are needed urgently in low-income and middle-income countries. This overview summarises the evidence from systematic reviews of health systems arrangements and implementation strategies, with a particular focus on evidence relevant to primary health care in such settings. Although evidence is sparse, there are several promising health systems arrangements and implementation strategies for strengthening primary health care. However, their introduction must be accompanied by rigorous evaluations. The evidence base needs urgently to be strengthened, synthesised, and taken into account in policy and practice, particularly for the benefit of those who have been excluded from the health care advances of recent decades.	[Lewin, Simon] London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Lewin, Simon; Chopra, Mickey] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Lavis, John N.; Souza, Nathan] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Lavis, John N.] McMaster Univ, Dept Polit Sci, Hamilton, ON, Canada; [Lavis, John N.] McMaster Univ, Ctr Hlth Econ & Policy Anal, Hamilton, ON, Canada; [Oxman, Andrew D.] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Bastias, Gabriel] Catholic Univ Chile, Dept Publ Hlth, Sch Med, Santiago, Chile; [Ciapponi, Agustin; Garcia Marti, Sebastian] Inst Clin Effectiveness & Hlth Policy IECS, Buenos Aires, DF, Argentina; [Ciapponi, Agustin] Iberoamer Cochrane Network, Buenos Aires, DF, Argentina; [Flottorp, Signe; Treweek, Shaun] Norwegian Knowledge Ctr Hlth Serv, Oslo, Norway; [Pantoja, Tomas] Pontificia Univ Catolica Chile, Dept Family Med, Sch Med, Santiago, Chile; [Rada, Gabriel] Pontificia Univ Catolica Chile, Dept Internal Med, Sch Med, Santiago, Chile; [Souza, Nathan] McMaster Univ, Hlth Res Methodol PhD Programme, Hamilton, ON, Canada; [Treweek, Shaun] Univ Dundee, Div Hlth Sci Res & Educ, Dundee, Scotland; [Wiysonge, Charles S.] MRC S Africa, S African Cochrane Ctr, Cape Town, South Africa; [Haines, Andy] London Sch Hyg & Trop Med, Directors Off, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; McMaster University; McMaster University; McMaster University; Norwegian Knowledge Centre for Health Services; Pontificia Universidad Catolica de Chile; Norwegian Knowledge Centre for Health Services; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; McMaster University; University of Dundee; University of London; London School of Hygiene & Tropical Medicine	Lewin, S (corresponding author), London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.		Oxman, Andrew/Y-3004-2019; Treweek, Shaun/AAE-8006-2019; Lavis, John N/I-7555-2013; Wiysonge, Charles Shey U/A-3843-2008; Bastias, Gabriel/AHC-3908-2022; Bastias, Gabriel/GWU-9255-2022; Pantoja, Tomas/GVS-4108-2022	Oxman, Andrew/0000-0002-5608-5061; Treweek, Shaun/0000-0002-7239-7241; Lavis, John N/0000-0001-7917-3657; Wiysonge, Charles Shey U/0000-0002-1273-4779; Bastias, Gabriel/0000-0001-8551-5844; Pantoja, Tomas/0000-0002-5473-3053; Ciapponi, Agustin/0000-0001-5142-6122; Flottorp, Signe/0000-0003-2961-7461; Haines, Andy/0000-0002-8053-4605; Rada, Gabriel/0000-0003-2435-0710	European Commission's 6th Framework INCO programme [031939]	European Commission's 6th Framework INCO programme	Sarah Rosenbaum and Claire Glenton for development and user testing of the SUPPORT summary template. Peer reviewers who commented on the draft SUPPORT summaries. The SUPPORT project is supported by the European Commission's 6th Framework INCO programme, contract 031939. John Lavis receives salary support as the Canada Research Chair in Knowledge Transfer and Exchange.	AKBARI A, 2005, COCHRANE DB SYST REV, V3, P5471; Althabe F, 2008, NEW ENGL J MED, V358, P1929, DOI 10.1056/NEJMsa071456; Althabe F, 2008, PAEDIATR PERINAT EP, V22, P42, DOI 10.1111/j.1365-3016.2007.00912.x; [Anonymous], 1978, INT C PRIM HLTH CAR; Atun RA, 2008, POLICY BRIEF DO VERT; Austvoll-Dahlgren A, 2008, COCHRANE DB SYST REV, V1, P7017; Beaglehole R, 2008, LANCET, V372, P940, DOI 10.1016/S0140-6736(08)61404-X; Becerra-Posada F, 2004, LANCET, V364, P997, DOI 10.1016/S0140-6736(04)17026-8; BENNETT S, 2007, WHAT IS HLTH POLICY; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bosch-Capblanch X, 2008, TROP MED INT HEALTH, V13, P369, DOI 10.1111/j.1365-3156.2008.02012.x; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; Calnan M, 2003, POLICY POLIT, V31, P185, DOI 10.1332/030557303765371672; Chopra M, 2008, LANCET, V371, P668, DOI 10.1016/S0140-6736(08)60305-0; Crawford MJ, 2002, BRIT MED J, V325, P1263, DOI 10.1136/bmj.325.7375.1263; DeMaeseneer J, 2007, PRIMARY HLTH CARE ST; Devereaux PJ, 2002, CAN MED ASSOC J, V166, P1399; Devereaux PJ, 2004, CAN MED ASSOC J, V170, P1817, DOI 10.1503/cmaj.1040722; Devereaux PJ, 2002, JAMA-J AM MED ASSOC, V288, P2449, DOI 10.1001/jama.288.19.2449; DIOP J, COMMUNITY BASED HLTH; Fairall LR, 2005, BMJ-BRIT MED J, V331, P750, DOI 10.1136/bmj.331.7519.750; FORSETLUND L, IN PRESS COCHRANE DA; *GAVI ALL, HLTH SYST STRENGTH; *GLOB FUND FIGHT A, TUB MAL FACT SHEET G; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; GROBLER LA, 2005, COCHRANE DB SYST REV, V1; Grol R, 2003, LANCET, V362, P1225, DOI 10.1016/S0140-6736(03)14546-1; Gruen R L, 2004, Cochrane Database Syst Rev, pCD003798, DOI 10.1002/14651858.CD003798.pub2; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Haines A, 2004, B WORLD HEALTH ORGAN, V82, P724; Haines A, 2004, BMJ-BRIT MED J, V329, P394, DOI 10.1136/bmj.329.7462.394; Hamid M, 2005, LANCET, V366, P1758, DOI 10.1016/S0140-6736(05)67709-4; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Horrocks S, 2002, BRIT MED J, V324, P819, DOI 10.1136/bmj.324.7341.819; Hulscher ME., 2001, COCHRANE DB SYST REV, V1; JAMTVEDT G, 2006, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000259.PUB2; KAUFMAN D, 1999, 2196 WORLD BANK; LAGARDE M, EVIDENCE SYSTEMATIC; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lavis JN, 2004, LANCET, V364, P1615, DOI 10.1016/S0140-6736(04)17317-0; Lavis JN, 2002, MILBANK Q, V80, P125, DOI 10.1111/1468-0009.00005; Lavis John, 2005, J Health Serv Res Policy, V10 Suppl 1, P35, DOI 10.1258/1355819054308549; Lavis JN, 2006, B WORLD HEALTH ORGAN, V84, P620, DOI 10.2471/BLT.06.030312; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Lewin S., 2006, LAY HLTH WORKERS PRI; McIntyre D., 2007, LEARNING EXPERIENCE; Morgan LM, 2001, HEALTH POLICY PLANN, V16, P221, DOI 10.1093/heapol/16.3.221; Morris SS, 2004, J NUTR, V134, P2336, DOI 10.1093/jn/134.9.2336; Narasimhan V, 2004, LANCET, V363, P1469, DOI 10.1016/S0140-6736(04)16108-4; NICE, 2008, COMM ENG IMPR HLTH; Nilsen ES, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004563.pub2; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Ooms G, 2008, GLOBALIZATION HEALTH, V4, DOI 10.1186/1744-8603-4-6; Patouillard Edith, 2007, Int J Equity Health, V6, P17, DOI 10.1186/1475-9276-6-17; Petersen LA, 2006, ANN INTERN MED, V145, P265, DOI 10.7326/0003-4819-145-4-200608150-00006; Sanders DM, 2005, BRIT MED J, V331, P755, DOI 10.1136/bmj.331.7519.755; SAVEDOFF W, 2006, WHEN WE WILL EVER LE; Schmidt JO, 2006, TROP MED INT HEALTH, V11, P1327, DOI 10.1111/j.1365-3156.2006.01661.x; SHAW B, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD005470; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; *SUPPORT COLL, SUPP POL REL REV TRI; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; Travis P., 2002, BETTER STEWARDSHIP C; Vann JCJ, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003941.pub2; Walker DG, 2005, J COMMUN HEALTH, V30, P221, DOI 10.1007/s10900-004-1960-4; Walt G, 1981, INTRO PRIMARY HLTH C; Waters H, 2003, HEALTH POLICY PLANN, V18, P127, DOI 10.1093/heapol/czg017; *WHO EUR, 2006, 9 FUT FOR HLTH SYST; *WORLD BANK, 2004, MILL DEV COALS HLTH; World Health Organisation, 2007, TASK SHIFT RAT RED T; World Health Organization, 2004, WORLD REP KNOWL BETT; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Zakus JDL, 1998, HEALTH POLICY PLANN, V13, P1, DOI 10.1093/heapol/13.1.1; Zwarenstein M, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-30	75	139	147	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					928	939		10.1016/S0140-6736(08)61403-8	http://dx.doi.org/10.1016/S0140-6736(08)61403-8			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790316	Green Accepted			2022-12-28	WOS:000259266900033
J	Rohde, J; Cousens, S; Chopra, M; Tangcharoensathien, V; Black, R; Bhutta, ZA; Lawn, JE				Rohde, Jon; Cousens, Simon; Chopra, Mickey; Tangcharoensathien, Viroj; Black, Robert; Bhutta, Zulfiqar A.; Lawn, Joy E.			Alma-Ata: Rebirth and revision 4 - 30 years after Alma-Ata: has primary health care worked in countries?	LANCET			English	Article							CHILD SURVIVAL; MATERNAL MORTALITY; SOUTH-AFRICA; COUNTDOWN; PAYMENTS; NEWBORN; ASIA; ANGOLA; DEATH; POOR	We assessed progress for primary health care in countries since Alma-Ata. First we analysed life expectancy relative to national income and HIV prevalence to identify overachieving and underachieving countries. Then we focused on the 30 low-income and middle-income countries with the highest average yearly reduction of mortality among children less than 5 years of age, describing coverage and equity of primary health care as well as non-health sector actions. These 30 countries have scaled up selective primary health care (eg, immunisation, family planning), and 14 have progressed to comprehensive primary health care, marked by high coverage of skilled attendance at birth. Good governance and progress in non-health sectors are seen in almost all of the 14 countries identified with a comprehensive primary health care system. However, these 30 countries include those that are making progress despite very low income per person, political instability, and high HIV/AIDS prevalence. Thailand has the highest average yearly reduction in mortality among children less than 5 years of age (8.5%) and has achieved universal coverage of immunisation and skilled birth attendance, with low inequity. Lessons learned from all these countries include the need for a nationally agreed package of prioritised and phased primary health care that all stakeholders are committed to implementing, attention to district management systems, and consistent investment in primary health-care extension workers linked to the health system. More detailed analysis and evaluation within and across countries would be invaluable in guiding investments for primary health care, and expediting progress towards the Millennium Development Goals and "health for all".	[Rohde, Jon] Management Sci Hlth, Boston, MA USA; [Rohde, Jon] BRAC Univ, James P Grant Sch Publ Hlth, Dhaka, Bangladesh; [Cousens, Simon] London Sch Hyg & Trop Med, London WC1, England; [Lawn, Joy E.] MRC S Africa, Hlth Syst Res Unit, Cape Town, South Africa; [Tangcharoensathien, Viroj] Minist Publ Hlth, Int Hlth Policy Programme, Bangkok, Thailand; [Black, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Black, Robert] Aga Khan Univ, Karachi, Pakistan; [Lawn, Joy E.] Saving Newborn Lives & Save Children US, Cape Town, South Africa; [Lawn, Joy E.] Inst Child Hlth, London, England	Bangladesh Rural Advancement Committee BRAC; BRAC University; University of London; London School of Hygiene & Tropical Medicine; Ministry of Public Health - Thailand; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Aga Khan University; Save the Children; University of London; University College London	Lawn, JE (corresponding author), 11 South Way, Cape Town, South Africa.	joylawn@yahoo.co.uk	Lawn, Joy/ABE-6382-2020	Lawn, Joy/0000-0002-4573-1443; Black, Robert/0000-0001-9926-7984	Bill & Melinda Gates Foundation; Saving Newborn Lives and Save the Children-US	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation); Saving Newborn Lives and Save the Children-US	JEL has received funding through a grant from the Bill & Melinda Gates Foundation through Saving Newborn Lives and Save the Children-US. No funding was received for this work, apart from travel expenses to one meeting provided through Partnership for Maternal, Newborn and Child Health, originally with money provided by Norwegian Agency for Development Cooperation. We are grateful to The Lancet Alma-Ata Working Group for helpful comments on a previous draft.	Ali MM, 2003, POP STUD-J DEMOG, V57, P217, DOI 10.1080/0032472032000097119; Bhutta Z, 2004, BRIT MED J, V328, P777, DOI 10.1136/bmj.328.7443.777; Bhutta ZA, 2004, ARCH DIS CHILD, V89, P483, DOI 10.1136/adc.2003.045732; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bradshaw D, 2008, LANCET, V371, P1294, DOI 10.1016/S0140-6736(08)60564-4; Brown P, 2003, B WORLD HEALTH ORGAN, V81, P849; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Burnham G, 2006, LANCET, V368, P1421, DOI 10.1016/S0140-6736(06)69491-9; Chilopora Garvey, 2007, Hum Resour Health, V5, P17, DOI 10.1186/1478-4491-5-17; CHOWDHURY M, 2001, POVERTY INEQUALITY H, P312; CHOWDHURY M, 2002, COMMUNITY BASED HLTH, P61; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; Ekman B, 2008, LANCET, V372, P990, DOI 10.1016/S0140-6736(08)61408-7; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; *GLOB FUND AIDS TU, GLOB FUNDS GRANTS IM; Greco G, 2008, LANCET, V371, P1268, DOI 10.1016/S0140-6736(08)60561-9; Grein T, 2003, BRIT MED J, V327, P650, DOI 10.1136/bmj.327.7416.650; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; HARRIES AD, 2004, BMJ-BRIT MED J, V329, P1118; Hatt L, 2007, B WORLD HEALTH ORGAN, V85, P774, DOI 10.2471/BLT.06.033472; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Horton R, 2008, LANCET, V371, P1217, DOI 10.1016/S0140-6736(08)60533-4; Houweling TAJ, 2007, B WORLD HEALTH ORGAN, V85, P745, DOI 10.2471/BLT.06.038588; Knippenberg R, 2005, LANCET, V365, P1087, DOI 10.1016/S0140-6736(05)74233-1; Lawn JE, 2008, LANCET, V372, P917, DOI 10.1016/S0140-6736(08)61402-6; Liljestrand J, 2004, J PUBLIC HEALTH POL, V25, P299, DOI 10.1057/palgrave.jphp.3190030; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; Masanja H, 2008, LANCET, V371, P1276, DOI 10.1016/S0140-6736(08)60562-0; MORLEY D, 1983, PRACTISING HLTH ALL; ROHDE J, 1993, REACHING HLTH ALL; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Sepulveda J, 2006, LANCET, V368, P2017, DOI 10.1016/S0140-6736(06)69569-X; Shankar A, 2008, LANCET, V371, P1226, DOI 10.1016/S0140-6736(08)60538-3; Tangcharoensathien V., 2007, ACHIEVING UNIVERSAL; Transparency International, CORR PERC IND 2007; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Victora CG, 2007, LANCET, V370, P1113, DOI 10.1016/S0140-6736(07)61492-5; WHITEFORD L, 2008, PRIMARY HEALTHCARE C	42	161	165	0	34	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					950	961		10.1016/S0140-6736(08)61405-1	http://dx.doi.org/10.1016/S0140-6736(08)61405-1			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790318				2022-12-28	WOS:000259266900035
J	Lloyd, S				Lloyd, Seth			Enhanced sensitivity of photodetection via quantum illumination	SCIENCE			English	Article								The use of quantum- mechanically entangled light to illuminate objects can provide substantial enhancements over unentangled light for detecting and imaging those objects in the presence of high levels of noise and loss. Each signal sent out is entangled with an ancilla, which is retained. Detection takes place via an entangling measurement on the returning signal together with the ancilla. This paper shows that for photodetection, quantum illumination with m bits of entanglement can in principle increase the effective signal- to- noise ratio by a factor of 2(m), an exponential improvement over unentangled illumination. The enhancement persists even when noise and loss are so great that no entanglement survives at the detector.	[Lloyd, Seth] WM Keck Ctr Extreme Quantum Informat Proc xQIT, Dept Mech Engn, Cambridge, MA 02139 USA		Lloyd, S (corresponding author), WM Keck Ctr Extreme Quantum Informat Proc xQIT, Dept Mech Engn, MIT 3-160, Cambridge, MA 02139 USA.	slloyd@mit.edu			W. M. Keck foundation; Hewlett Packard; Defense Advanced Research Projects Agency	W. M. Keck foundation(W.M. Keck Foundation); Hewlett Packard; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the W. M. Keck foundation, Hewlett Packard, and Defense Advanced Research Projects Agency. The author thanks B. Erkmen, V. Giovannetti, S. Guha, L. Maccone, S. Pirandola, J. Shapiro, S.-H. Tan, M. Tsang, and H. Yuen for useful discussions.	Audenaert KMR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.160501; BENNETT CH, 1992, PHYS REV LETT, V69, P2881, DOI 10.1103/PhysRevLett.69.2881; Bennett CH, 2002, IEEE T INFORM THEORY, V48, P2637, DOI 10.1109/TIT.2002.802612; Calsamiglia J, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.032311; Choi SK, 1999, PHYS REV LETT, V83, P1938, DOI 10.1103/PhysRevLett.83.1938; D'Ariano GM, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.052302; Dayan B, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.023005; Fei HB, 1997, PHYS REV LETT, V78, P1679, DOI 10.1103/PhysRevLett.78.1679; Gatti A, 2000, J OPT B-QUANTUM S O, V2, P196, DOI 10.1088/1464-4266/2/2/323; Giovannetti V, 2004, SCIENCE, V306, P1330, DOI 10.1126/science.1104149; Mosset A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.223603; Sacchi MF, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.014305; Sacchi MF, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062340; Scully M.O., 1997, QUANTUM OPT	14	485	503	6	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1463	1465		10.1126/science.1160627	http://dx.doi.org/10.1126/science.1160627			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787162				2022-12-28	WOS:000259121800032
J	Annas, GJ				Annas, George J.			Military medical ethics - Physician first, last, always	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Annas, George J.] Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA	Boston University	Annas, GJ (corresponding author), Boston Univ, Sch Publ Hlth, Dept Hlth Law Bioeth & Human Rights, Boston, MA 02215 USA.			Annas, George/0000-0001-5836-7831				Beam TE, 2003, MILITARY MED ETHICS; Benedek DM, 2007, MIL MED, V172, P681; Crosby SS, 2007, JAMA-J AM MED ASSOC, V298, P563, DOI 10.1001/jama.298.5.563; *DEP DEF, 2006, 231008E DEP DEF; London L, 2006, CAMB Q HEALTHC ETHIC, V15, P381	5	37	37	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1087	1090		10.1056/NEJMp0805975	http://dx.doi.org/10.1056/NEJMp0805975			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	346ON	18784096				2022-12-28	WOS:000259078200002
J	Vermorken, JB; Mesia, R; Rivera, F; Remenar, E; Kawecki, A; Rottey, S; Erfan, J; Zabolotnyy, D; Kienzer, HR; Cupissol, D; Peyrade, F; Benasso, M; Vynnychenko, I; De Raucourt, D; Bokemeyer, C; Schueler, A; Amellal, N; Hitt, R				Vermorken, Jan B.; Mesia, Ricard; Rivera, Fernando; Remenar, Eva; Kawecki, Andrzej; Rottey, Sylvie; Erfan, Jozsef; Zabolotnyy, Dmytro; Kienzer, Heinz-Roland; Cupissol, Didier; Peyrade, Frederic; Benasso, Marco; Vynnychenko, Ihor; De Raucourt, Dominique; Bokemeyer, Carsten; Schueler, Armin; Amellal, Nadia; Hitt, Ricardo			Platinum-based chemotherapy plus cetuximab in head and neck cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMA; PHASE-II MULTICENTER; ANTIBODY CETUXIMAB; ONCOLOGY-GROUP; SINGLE-AGENT; COPY NUMBER; CISPLATIN; RECURRENT; FLUOROURACIL	Background: Cetuximab is effective in platinum-resistant recurrent or metastatic squamous-cell carcinoma of the head and neck. We investigated the efficacy of cetuximab plus platinum-based chemotherapy as first-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck. Methods: We randomly assigned 220 of 442 eligible patients with untreated recurrent or metastatic squamous-cell carcinoma of the head and neck to receive cisplatin (at a dose of 100 mg per square meter of body-surface area on day 1) or carboplatin (at an area under the curve of 5 mg per milliliter per minute, as a 1-hour intravenous infusion on day 1) plus fluorouracil (at a dose of 1000 mg per square meter per day for 4 days) every 3 weeks for a maximum of 6 cycles and 222 patients to receive the same chemotherapy plus cetuximab (at a dose of 400 mg per square meter initially, as a 2-hour intravenous infusion, then 250 mg per square meter, as a 1-hour intravenous infusion per week) for a maximum of 6 cycles. Patients with stable disease who received chemotherapy plus cetuximab continued to receive cetuximab until disease progression or unacceptable toxic effects, whichever occurred first. Results: Adding cetuximab to platinum-based chemotherapy with fluorouracil (platinum-fluorouracil) significantly prolonged the median overall survival from 7.4 months in the chemotherapy-alone group to 10.1 months in the group that received chemotherapy plus cetuximab (hazard ratio for death, 0.80; 95% confidence interval, 0.64 to 0.99; P=0.04). The addition of cetuximab prolonged the median progression-free survival time from 3.3 to 5.6 months (hazard ratio for progression, 0.54; P<0.001) and increased the response rate from 20% to 36% (P<0.001). The most common grade 3 or 4 adverse events in the chemotherapy-alone and cetuximab groups were anemia (19% and 13%, respectively), neutropenia (23% and 22%), and thrombocytopenia (11% in both groups). Sepsis occurred in 9 patients in the cetuximab group and in 1 patient in the chemotherapy-alone group (P=0.02). Of 219 patients receiving cetuximab, 9% had grade 3 skin reactions and 3% had grade 3 or 4 infusion-related reactions. There were no cetuximab-related deaths. Conclusions: As compared with platinum-based chemotherapy plus fluorouracil alone, cetuximab plus platinum-fluorouracil chemotherapy improved overall survival when given as first-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck. (ClinicalTrials.gov number, NCT00122460.).	[Vermorken, Jan B.] Univ Antwerp Hosp, Dept Med Oncol, B-2650 Edegem, Belgium; [Rottey, Sylvie] Ghent Univ Hosp, B-9000 Ghent, Belgium; [Mesia, Ricard] Hosp Llobregat, Inst Catala Oncol, Barcelona, Spain; [Rivera, Fernando] Hosp Univ Marques de Valdecilla, Santander, Spain; [Hitt, Ricardo] Hosp 12 Octubre, E-28041 Madrid, Spain; [Remenar, Eva] Orszagos Onkol Intezet, Budapest, Hungary; [Erfan, Jozsef] Szabolcs Szatmar Bereg Megyei Josa Andras Korh, Nyiregyhaza, Hungary; [Kawecki, Andrzej] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Zabolotnyy, Dmytro] Ukraine Acad Med Sci, Inst Otolaryngol, Kiev, Ukraine; [Vynnychenko, Ihor] Sumy Reg Oncol Ctr, Sumy, Ukraine; [Kienzer, Heinz-Roland] Kaiser Franz Josef Spital, Ludwig Boltzmann Inst Appl Canc Res, Vienna, Austria; [Cupissol, Didier] Ctr Val Aurelle, Paul Lamarque Serv Oncol, Montpellier, France; [Peyrade, Frederic] Ctr Antoine Lacassagne, F-06054 Nice, France; [De Raucourt, Dominique] Ctr Francois Baclesse, F-14021 Caen, France; [Benasso, Marco] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Bokemeyer, Carsten] Universitaetskrankenhaus Hamburg Eppendorf, Hamburg, Germany; [Schueler, Armin; Amellal, Nadia] Merck, Darmstadt, Germany	University of Antwerp; Ghent University; Ghent University Hospital; Catalan Institute of Oncology; University of Barcelona; Hospital Universitario Marques de Valdecilla (HUMV); Hospital Universitario 12 de Octubre; Maria Sklodowska-Curie National Research Institute of Oncology; National Academy of Medical Sciences of Ukraine; Kolomiychenko Institute of Otolaryngology of the National Academy of Medical Sciences of Ukraine; Ministry of Education & Science of Ukraine; Sumy State University; Kaiser-Franz-Josef Hospital; Ludwig Boltzmann Institute; UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Centre Antoine Lacassagne; UNICANCER; Centre Francois Baclesse; University of Genoa; IRCCS AOU San Martino IST; University of Hamburg; University Medical Center Hamburg-Eppendorf; Merck & Company; Merck & Company Germany	Vermorken, JB (corresponding author), Univ Antwerp Hosp, Dept Med Oncol, Wilrijkstr 10, B-2650 Edegem, Belgium.	jan.b.vermorken@uza.be	Vynnychenko, Ihor O/E-1684-2012	Vynnychenko, Ihor O/0000-0002-2339-6509; Schueler, Armin/0000-0003-3833-5757	Merck (Darmstadt)	Merck (Darmstadt)(Merck & Company)	Supported by Merck (Darmstadt).	Baselga J, 2005, J CLIN ONCOL, V23, P5568, DOI 10.1200/JCO.2005.07.119; Bourhis J, 2006, J CLIN ONCOL, V24, P2866, DOI 10.1200/JCO.2005.04.3547; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; Burtness B, 2006, J CLIN ONCOL, V24, P724; Chung CH, 2006, J CLIN ONCOL, V24, P4170, DOI 10.1200/JCO.2006.07.2587; COLLETT D, 2003, MODELLING SURVIVAL D, P49; FAN Z, 1993, CANCER RES, V53, P4637; FORASTIERE AA, 1992, J CLIN ONCOL, V10, P1245, DOI 10.1200/JCO.1992.10.8.1245; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Herbst RS, 2005, J CLIN ONCOL, V23, P5578, DOI 10.1200/JCO.2005.07.120; JACOBS C, 1992, J CLIN ONCOL, V10, P257, DOI 10.1200/JCO.1992.10.2.257; Kang X, 2007, J CLIN ONCOL S, V25, p128s; Kimura H, 2007, CANCER SCI, V98, P1275, DOI 10.1111/j.1349-7006.2007.00510.x; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Lokich J, 1998, ANN ONCOL, V9, P13, DOI 10.1023/A:1008215213739; Lokich J, 1998, ANN ONCOL, V9, P341, DOI 10.1023/A:1017142015279; Sato J D, 1983, Mol Biol Med, V1, P511; Schantz SPHL, 2001, CANC PRINCIPLES PRAC, P797; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; WITTES RE, 1977, CANCER TREAT REP, V61, P359; Zhang W, 2007, J CLIN ONCOL, V25, P3712, DOI 10.1200/JCO.2006.08.8021	24	2317	2387	1	101	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1116	1127		10.1056/NEJMoa0802656	http://dx.doi.org/10.1056/NEJMoa0802656			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784101				2022-12-28	WOS:000259078200007
J	Hirschtick, R				Hirschtick, Robert			Extremities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rober@northwestern.edu						Berkwits M, 2000, ANN INTERN MED, V133, P755, DOI 10.7326/0003-4819-133-9-200011070-00039; LOCKE J, ESSAY HUMAN UNDERSTA, pCH3; *NAT PUBL RAD, ACR ACR; Seddon AM, 2002, JAMA-J AM MED ASSOC, V288, P2377, DOI 10.1001/jama.288.19.2377; Stanbrook MB, 2006, NEW ENGL J MED, V355, P101, DOI 10.1056/NEJMc053420	5	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1125	1126		10.1001/jama.300.10.1125	http://dx.doi.org/10.1001/jama.300.10.1125			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780838				2022-12-28	WOS:000259038700001
J	Ma, A				Ma, Averil			Unresolved ER stress inflames the intestine	CELL			English	Editorial Material							INFLAMMATION; HOMEOSTASIS; MICE	Intestinal epithelial cells interact with both microbes in the gut lumen and host immune cells. In this issue, Kaser et al. (2008) link a key mediator of endoplasmic reticulum stress, the protein XBP1, with survival of intestinal secretory epithelial cells and inflammatory bowel disease.	Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu						Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Garabedian EM, 1997, J BIOL CHEM, V272, P23729, DOI 10.1074/jbc.272.38.23729; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	8	10	11	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					724	725		10.1016/j.cell.2008.08.023	http://dx.doi.org/10.1016/j.cell.2008.08.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775305	Bronze			2022-12-28	WOS:000258947500012
J	Turnbaugh, PJ; Gordon, JI				Turnbaugh, Peter J.; Gordon, Jeffrey I.			An invitation to the marriage of metagenomics and metabolomics	CELL			English	Article							MICROBIOME	Metagenomics seeks to characterize the composition of microbial communities, their operations, and their dynamically coevolving relationships with the habitats they occupy without having to culture community members. Uniting metagenomics with analyses of the products of microbial community metabolism (metabolomics) will shed light on how microbial communities function in a variety of environments, including the human body.	[Turnbaugh, Peter J.; Gordon, Jeffrey I.] Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA	Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Ctr Genome Sci, St Louis, MO 63108 USA.	jgordon@wustl.edu		Turnbaugh, Peter/0000-0002-0888-2875				DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; DRAKE HL, 2006, PROKARYOTES, V2, P354, DOI DOI 10.1007/0-387-30742-7_13; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Godzik A, 2007, CELL MOL LIFE SCI, V64, P2505, DOI 10.1007/s00018-007-7211-y; Hooper SD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002607; Hosokawa T, 2007, P ROY SOC B-BIOL SCI, V274, P1979, DOI 10.1098/rspb.2007.0620; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Pedros-Alio C, 2006, TRENDS MICROBIOL, V14, P257, DOI 10.1016/j.tim.2006.04.007; Prentice AM, 2008, J CLIN INVEST, V118, P1322, DOI 10.1172/JCI34034; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Rezzi S, 2007, J PROTEOME RES, V6, P4469, DOI 10.1021/pr070431h; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Tyson GW, 2005, APPL ENVIRON MICROB, V71, P6319, DOI 10.1128/AEM.71.10.6319-6324.2005; Tyson GW, 2004, NATURE, V428, P37, DOI 10.1038/nature02340; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Willenbrock H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r267; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Wu D, 2006, PLOS BIOL, V4, P1079, DOI 10.1371/journal.pbio.0040188; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156; Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016	32	168	179	4	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					708	713		10.1016/j.cell.2008.08.025	http://dx.doi.org/10.1016/j.cell.2008.08.025			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775300	Bronze			2022-12-28	WOS:000258947500007
J	Disson, O; Grayo, S; Huillet, E; Nikitas, G; Langa-Vives, F; Dussurget, O; Ragon, M; Le Monnier, A; Babinet, C; Cossart, P; Lecuit, M				Disson, Olivier; Grayo, Solene; Huillet, Eugenie; Nikitas, Georgios; Langa-Vives, Francina; Dussurget, Olivier; Ragon, Marie; Le Monnier, Alban; Babinet, Charles; Cossart, Pascale; Lecuit, Marc			Conjugated action of two species-specific invasion proteins for fetoplacental listeriosis	NATURE			English	Article							SURFACE PROTEIN; E-CADHERIN; MONOCYTOGENES; INTERNALIN; RECEPTOR; ENTRY; MODEL; INIB; SUFFICIENT; PREGNANCY	The ability to cross host barriers is an essential virulence determinant of invasive microbial pathogens. Listeria monocytogenes is a model microorganism that crosses human intestinal and placental barriers, and causes severe maternofetal infections by an unknown mechanism(1). Several studies have helped to characterize the bacterial invasion proteins InlA and InlB(2). However, their respective species specificity has complicated investigations on their in vivo role(3,4). Here we describe two novel and complementary animal models for human listeriosis: the gerbil, a natural host for L. monocytogenes, and a knock- in mouse line ubiquitously expressing humanized E- cadherin. Using these two models, we uncover the essential and interdependent roles of InlA and InlB in fetoplacental listeriosis, and thereby decipher the molecular mechanism underlying the ability of a microbe to target and cross the placental barrier.	[Disson, Olivier; Grayo, Solene; Huillet, Eugenie; Nikitas, Georgios; Dussurget, Olivier; Cossart, Pascale; Lecuit, Marc] Inst Pasteur, Grp Microorganismes & Barrieres Hote, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Disson, Olivier; Grayo, Solene; Nikitas, Georgios; Lecuit, Marc] Inserm Avenir, U604, F-75015 Paris, France; [Grayo, Solene; Ragon, Marie; Le Monnier, Alban; Lecuit, Marc] Inst Pasteur, Ctr Natl Reference Listeria, F-75015 Paris, France; [Huillet, Eugenie; Dussurget, Olivier; Cossart, Pascale] INSERM, U604, F-75015 Paris, France; [Huillet, Eugenie; Dussurget, Olivier; Cossart, Pascale] INRA, USC2020, F-75015 Paris, France; [Langa-Vives, Francina] Inst Pasteur, Ctr Ingn Genet Murine, F-75015 Paris, France; [Babinet, Charles] Inst Pasteur, Dev Biol Unit, F-75015 Paris, France; [Lecuit, Marc] Univ Paris 05, Ctr Infectiol Necker Pasteur, Serv Malad Infect & Trop, Hop Necker Enfants Malad,Assistance Publ Hop Pari, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lecuit, M (corresponding author), Inst Pasteur, Grp Microorganismes & Barrieres Hote, Unite Interact Bacteries Cellules, F-75015 Paris, France.	mlecuit@pasteur.fr	Disson, Olivier/H-6359-2016; Disson, Olivier/P-9935-2019; Lecuit, Marc/M-4126-2019; Lecuit, Marc/J-4073-2013	Disson, Olivier/0000-0002-7791-9782; Lecuit, Marc/0000-0002-4491-1063; Lecuit, Marc/0000-0002-4491-1063; LE MONNIER, Alban/0000-0001-6181-281X; Dussurget, Olivier/0000-0001-9924-0837	Institut Pasteur, Inserm; INRA; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute international research scholar	Institut Pasteur, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); INRA; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute international research scholar(Howard Hughes Medical Institute)	This paper is dedicated to the memory of Charles Babinet, our friend and colleague, who died a few days before the submission of thismanuscript. We thank his collaborators S. Vandormael- Pournin, C. Kress and M. Cohen- Tannoudji, as well as L. Larue and S. Tajbakhsh for help in generating the knock- in mice. We thank C. Hill for the gift of the pPL2lux- P<INF>hlyA</INF> plasmid, M.-A. Nahori for help with animal experiments, P. Roux for help with confocal imaging, P.- M. Lledo and M. Gabellec for help with vibratome sectioning, V. Masse for help with statistical analysis and O. Lortholary for his support. We also thank S. Mostowy for reading the paper. This work received financial support from the Institut Pasteur, Inserm and INRA. O. Disson received financial support from the Fondation pour la Recherche Medicale (FRM) and Inserm, P.C. is an Howard Hughes Medical Institute international research scholar and M.L. is a recipient of an Inserm interface contract.	Abram M, 2003, FEMS IMMUNOL MED MIC, V35, P177, DOI 10.1016/S0928-8244(02)00449-2; Athman R, 2005, CELL MICROBIOL, V7, P1109, DOI 10.1111/j.1462-5822.2005.00535.x; Bakardjiev AI, 2004, INFECT IMMUN, V72, P489, DOI 10.1128/IAI.72.1.489-497.2004; Bierne H, 2002, J CELL SCI, V115, P3357; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; Braun L, 1998, MOL MICROBIOL, V27, P1077, DOI 10.1046/j.1365-2958.1998.00750.x; Cossart P, 2003, TRENDS CELL BIOL, V13, P23, DOI 10.1016/S0962-8924(02)00006-5; Dramsi S, 1998, INFECT IMMUN, V66, P4461; Glaser P, 2001, SCIENCE, V294, P849; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Jacquet C, 2004, J INFECT DIS, V189, P2094, DOI 10.1086/420853; Jonquieres R, 2001, MOL MICROBIOL, V42, P955, DOI 10.1046/j.1365-2958.2001.02704.x; Khelef N, 2006, CELL MICROBIOL, V8, P457, DOI 10.1111/j.1462-5822.2005.00634.x; Le Monnier A, 2007, INFECT IMMUN, V75, P950, DOI 10.1128/IAI.01570-06; Lecuit M, 2004, P NATL ACAD SCI USA, V101, P6152, DOI 10.1073/pnas.0401434101; Lecuit M, 2002, TRENDS MOL MED, V8, P537, DOI 10.1016/S1471-4914(02)02413-9; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Lecuit M, 1999, EMBO J, V18, P3956, DOI 10.1093/emboj/18.14.3956; Lecuit M, 1997, INFECT IMMUN, V65, P5309, DOI 10.1128/IAI.65.12.5309-5319.1997; Lecuit M, 2007, MICROBES INFECT, V9, P1216, DOI 10.1016/j.micinf.2007.05.009; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; Mylonakis E, 2002, MEDICINE, V81, P260, DOI 10.1097/00005792-200207000-00002; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Perez-Garcia CC, 2003, LAB ANIM-UK, V37, P68, DOI 10.1258/002367703762226719; Pirie JHH., 1927, PUBLICATIONS S AFRIC, V3, P163; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; RUBIN LL, 1991, J CELL BIOL, V115, P1725, DOI 10.1083/jcb.115.6.1725; Schubert WD, 2002, CELL, V111, P825, DOI 10.1016/S0092-8674(02)01136-4; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001	30	184	190	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 23	2008	455	7216					1114	1118		10.1038/nature07303	http://dx.doi.org/10.1038/nature07303			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806773				2022-12-28	WOS:000260252600046
J	Kunkes, EL; Simonetti, DA; West, RM; Serrano-Ruiz, JC; Gartner, CA; Dumesic, JA				Kunkes, Edward L.; Simonetti, Dante A.; West, Ryan M.; Serrano-Ruiz, Juan Carlos; Gartner, Christian A.; Dumesic, James A.			Catalytic conversion of biomass to monofunctional hydrocarbons and targeted liquid-fuel classes	SCIENCE			English	Article							ALKANES; HYDROGENATION; CONDENSATION; METAL; REDUCTION; ETHANOL; MIBK	It is imperative to develop more efficient processes for conversion of biomass to liquid fuels, such that the cost of these fuels would be competitive with the cost of fuels derived from petroleum. We report a catalytic approach for the conversion of carbohydrates to specific classes of hydrocarbons for use as liquid transportation fuels, based on the integration of several flow reactors operated in a cascade mode, where the effluent from the one reactor is simply fed to the next reactor. This approach can be tuned for production of branched hydrocarbons and aromatic compounds in gasoline, or longer-chain, less highly branched hydrocarbons in diesel and jet fuels. The liquid organic effluent from the first flow reactor contains monofunctional compounds, such as alcohols, ketones, carboxylic acids, and heterocycles, that can also be used to provide reactive intermediates for fine chemicals and polymers markets.	[Kunkes, Edward L.; Simonetti, Dante A.; West, Ryan M.; Serrano-Ruiz, Juan Carlos; Gartner, Christian A.; Dumesic, James A.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Dumesic, JA (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA.	dumesic@engr.wisc.edu	Serrano-Ruiz, Juan Carlos/U-6297-2018; Gaertner, Christian/A-7509-2011	Serrano-Ruiz, Juan Carlos/0000-0002-9078-7390; 	U.S. Department of Energy Office of Basic Energy Sciences; NSF Chemical and Transport Systems Division of the Directorate for Engineering; German Academic Exchange Service (DAAD); Spanish Ministry of Science and Innovation	U.S. Department of Energy Office of Basic Energy Sciences(United States Department of Energy (DOE)); NSF Chemical and Transport Systems Division of the Directorate for Engineering(National Science Foundation (NSF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by the U.S. Department of Energy Office of Basic Energy Sciences and the NSF Chemical and Transport Systems Division of the Directorate for Engineering. We thank M. Mavrikakis for valuable discussions throughout this project, and E.I. Gurbuz for help with flow reactor experiments. J.C.S.-R. thanks the Spanish Ministry of Science and Innovation for postdoctoral support; C.A.G. thanks the German Academic Exchange Service (DAAD) for a scholarship. J.A.D. owns founders stock in Virent Energy Systems, a company with interest in the area of this research. The Wisconsin Alumni Research Foundation at University of Wisconsin has applied for a patent based partly on the work described here.	Alcala R, 2003, J CATAL, V218, P178, DOI 10.1016/S0021-9517(03)00090-3; Barlow M. T., 1983, Fuel composition. Eur. Pat., Patent No. [EP0082689, 0082689]; BARRATT DJ, 1999, Patent No. 5925152; Bartholomew CH, 2006, FUNDAMENTALS OF INDUSTRIAL CATALYTIC PROCESSES, 2ND EDITION, P1, DOI 10.1002/9780471730071; BOND GC, 1965, J CATAL, V4, P211, DOI 10.1016/0021-9517(65)90011-4; BRIDGWATER AV, 1994, APPL CATAL A-GEN, V116, P5, DOI 10.1016/0926-860X(94)80278-5; Carlini C, 2004, J MOL CATAL A-CHEM, V220, P215, DOI 10.1016/j.molcata.2004.05.034; Cho CS, 2005, J MOL CATAL A-CHEM, V240, P55, DOI 10.1016/j.molcata.2005.06.043; Czernik S, 2004, ENERG FUEL, V18, P590, DOI 10.1021/ef034067u; Davda RR, 2005, APPL CATAL B-ENVIRON, V56, P171, DOI 10.1016/j.apcatb.2004.04.027; Di Cosimo JI, 2002, J CATAL, V208, P114, DOI 10.1006/jcat.2002.3551; Gayubo AG, 2004, IND ENG CHEM RES, V43, P2610, DOI 10.1021/ie030791o; Hamelinck CN, 2004, ENERGY, V29, P1743, DOI 10.1016/j.energy.2004.01.002; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huber GW, 2004, ANGEW CHEM INT EDIT, V43, P1549, DOI 10.1002/anie.200353050; Klass DL., 1998, BIOMASS RENEWABLE EN; Lopez J, 2002, J CATAL, V208, P30, DOI 10.1006/jcat.2002.3563; MCMURRY J, 2000, ORGANIC CHEM, P938; Nagashima O, 2005, J MOL CATAL A-CHEM, V227, P231, DOI 10.1016/j.molcata.2004.10.042; Nikolopoulos AA, 2005, APPL CATAL A-GEN, V296, P128, DOI 10.1016/j.apcata.2005.08.022; Pallassana V, 2002, J CATAL, V209, P289, DOI 10.1006/jcat.2002.3585; Perrard A, 2007, APPL CATAL A-GEN, V331, P100, DOI 10.1016/j.apcata.2007.07.033; POWELL SG, 1948, J AM CHEM SOC, V70, P3627, DOI 10.1021/ja01191a027; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Roman-Leshkov Y, 2006, SCIENCE, V312, P1933, DOI 10.1126/science.1126337; TAKIZAWA TH, 1994, Patent No. 5925152; West RM, 2008, CHEMSUSCHEM, V1, P417, DOI 10.1002/cssc.200800001; Zhang JL, 2005, J AM CHEM SOC, V127, P12480, DOI 10.1021/ja053695i	28	763	832	19	596	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 17	2008	322	5900					417	421		10.1126/science.1159210	http://dx.doi.org/10.1126/science.1159210			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18801970				2022-12-28	WOS:000260094500040
J	Grantham, JJ				Grantham, Jared J.			Autosomal dominant polycystic kidney disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRACRANIAL ANEURYSMS; VOLUME PROGRESSION; EPITHELIAL-CELLS; RENAL CYSTS; FOLLOW-UP; MANAGEMENT; PAIN; NANOBACTERIA; PATHOGENESIS; EXCRETION		[Grantham, Jared J.] Univ Kansas, Med Ctr, Kidney Inst, Kansas City, KS 66160 USA; [Grantham, Jared J.] Univ Kansas, Med Ctr, Dept Internal Med, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Grantham, JJ (corresponding author), Univ Kansas, Med Ctr, Kidney Inst, 3901 Rainbow Blvd, Kansas City, KS 66160 USA.	jgrantha@kumc.edu			NIDDK/NIH [5U01DK056943-08]; Genzyme; Otsuka Pharm; Bio-Med Valley; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK056943] Funding Source: NIH RePORTER	NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Genzyme(Sanofi-AventisGenzyme Corporation); Otsuka Pharm(Otsuka Pharmaceutical); Bio-Med Valley; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by NIDDK/NIH 5U01DK056943-08.; Dr. Grantham reports receiving consulting fees from Genzyme, Otsuka Pharm, and Bio-Med Valley and grant support from Otsuka Pharm. No other potential conflict of interest relevant to this article was reported.; I thank F. Winklhofer, C. Wang, and B. Cowley for helpful discussions.	Bajwa ZH, 2004, KIDNEY INT, V66, P1561, DOI 10.1111/j.1523-1755.2004.00921.x; Bajwa ZH, 2001, KIDNEY INT, V60, P1631, DOI 10.1046/j.1523-1755.2001.00985.x; Belibi FA, 2004, KIDNEY INT, V66, P964, DOI 10.1111/j.1523-1755.2004.00843.x; Belibi FA, 2002, J AM SOC NEPHROL, V13, P2723, DOI 10.1097/01.ASN.0000025282.48298.7B; Berl T, 2008, J AM SOC NEPHROL, V19, P1076, DOI 10.1681/ASN.2007091042; Brasier JL, 1997, J CLIN INVEST, V99, P194, DOI 10.1172/JCI119147; Casale P, 2008, J ENDOUROL, V22, P991, DOI 10.1089/end.2007.0359; Cheong B, 2007, CLIN J AM SOC NEPHRO, V2, P38, DOI 10.2215/CJN.00930306; De Rycke M, 2005, MOL HUM REPROD, V11, P65, DOI 10.1093/molehr/gah128; Fick-Brosnahan GM, 2001, KIDNEY INT, V59, P1654, DOI 10.1046/j.1523-1755.2001.0590051654.x; GABOW PA, 1992, AM J KIDNEY DIS, V20, P140, DOI 10.1016/S0272-6386(12)80541-5; GARDNER KD, 1991, KIDNEY INT, V39, P718, DOI 10.1038/ki.1991.87; GATTONE VH, 1995, AM J KIDNEY DIS, V25, P302, DOI 10.1016/0272-6386(95)90013-6; Gibbs GF, 2004, KIDNEY INT, V65, P1621, DOI 10.1111/j.1523-1755.2004.00572.x; Gibson P, 1998, NEPHROL DIAL TRANSPL, V13, P2455, DOI 10.1093/ndt/13.10.2455; Grantham JJ, 2006, CLIN J AM SOC NEPHRO, V1, P148, DOI 10.2215/CJN.00330705; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Harris PC, 2006, J AM SOC NEPHROL, V17, P3013, DOI 10.1681/ASN.2006080835; Hateboer N, 1999, LANCET, V353, P103, DOI 10.1016/S0140-6736(98)03495-3; Hjelle JT, 2000, KIDNEY INT, V57, P2360, DOI 10.1046/j.1523-1755.2000.00096.x; Igarashi P, 2002, J AM SOC NEPHROL, V13, P2384, DOI 10.1097/01.ASN.0000028643.17901.42; Kelleher CL, 2004, AM J HYPERTENS, V17, P1029, DOI 10.1016/j.amjhyper.2004.06.020; LEVINE E, 1981, AM J KIDNEY DIS, V1, P99, DOI 10.1016/S0272-6386(81)80036-4; Manz F, 2003, EUR J CLIN NUTR, V57, pS10, DOI 10.1038/sj.ejcn.1601896; Ng CS, 2000, J UROLOGY, V163, P726, DOI 10.1016/S0022-5347(05)67792-0; O'Neill WC, 2005, AM J KIDNEY DIS, V46, P1058, DOI 10.1053/j.ajkd.2005.08.026; OUE F, 1995, GASTROENTEROLOGY, V108, P487, DOI 10.1016/0016-5085(95)90078-0; Perrone RD, 2001, AM J KIDNEY DIS, V38, P777, DOI 10.1053/ajkd.2001.27720; Pirson Y, 2002, J AM SOC NEPHROL, V13, P269, DOI 10.1681/ASN.V131269; Putnam WC, 2007, J AM SOC NEPHROL, V18, P934, DOI 10.1681/ASN.2006111218; Qian F, 1999, MOL GENET METAB, V68, P237, DOI 10.1006/mgme.1999.2896; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; SCHIEVINK WI, 1992, J AM SOC NEPHROL, V3, P88; Schrier R, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000018407.60002.B9; Schrier RW, 2003, KIDNEY INT, V63, P678, DOI 10.1046/j.1523-1755.2003.00776.x; Seeman T, 2003, BLOOD PRESS MONIT, V8, P107, DOI 10.1097/00126097-200306000-00003; SKLAR AH, 1987, AM J KIDNEY DIS, V10, P81, DOI 10.1016/S0272-6386(87)80036-7; Torres V. E., 2008, KIDNEY, P1428; TORRES VE, 1993, AM J KIDNEY DIS, V22, P513, DOI 10.1016/S0272-6386(12)80922-X; Torres VE, 2008, CLIN J AM SOC NEPHRO, V3, P1212, DOI 10.2215/CJN.05281107; Vora N, 2008, AM J KIDNEY DIS, V51, P307, DOI 10.1053/j.ajkd.2007.09.010; Wood HM, 2006, WORLD J UROL, V24, P51, DOI 10.1007/s00345-005-0041-3; Zeltner R, 2008, NEPHROL DIAL TRANSPL, V23, P573, DOI 10.1093/ndt/gfm731; Zhao X, 2008, CLIN J AM SOC NEPHRO, V3, P146, DOI 10.2215/CJN.03430807; Zheng D, 2003, J AM SOC NEPHROL, V14, P2588, DOI 10.1097/01.ASN.0000088720.61783.19	46	364	392	1	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1477	1485		10.1056/NEJMcp0804458	http://dx.doi.org/10.1056/NEJMcp0804458			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832246				2022-12-28	WOS:000259631700008
J	Oard, DW				Oard, Douglas W.			Social science - Unlocking the potential of the spoken word	SCIENCE			English	Editorial Material									[Oard, Douglas W.] Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA; [Oard, Douglas W.] Univ Maryland, Inst Adv Comp Studies, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Oard, DW (corresponding author), Univ Maryland, Coll Informat Studies, College Pk, MD 20742 USA.	oard@umd.edu						Bell G, 2007, SCI AM, V296, P58, DOI 10.1038/scientificamerican0307-58; HACKFORD R, 1952, PLATOS PHAEDRUS; HOOKER FJ, 1996, READING PAST ANCIENT; Lieberman P, 2007, CURR ANTHROPOL, V48, P39, DOI 10.1086/509092; LIN WH, 2002, JOINT C DIG LIB JCDL; ROSEN J, 2008, NY TIMES        0327	6	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1787	1788		10.1126/science.1157353	http://dx.doi.org/10.1126/science.1157353			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818348				2022-12-28	WOS:000259501300024
J	Morris, EJ; Ji, JY; Yang, FJ; Di Stefano, L; Herr, A; Moon, NS; Kwon, EJ; Haigis, KM; Naar, AM; Dyson, NJ				Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Kwon, Eun-Jeong; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.			E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8	NATURE			English	Article							COLON-CANCER; EXPRESSION; ACTIVATION; PROTEIN; GENE; APC; P53; SPECIFICITY; DROSOPHILA; MEDIATOR	The E2F1 transcription factor can promote proliferation or apoptosis when activated, and is a key downstream target of the retinoblastoma tumour suppressor protein ( pRB). Here we show that E2F1 is a potent and specific inhibitor of beta-catenin/T-cell factor (TCF)- dependent transcription, and that this function contributes to E2F1- induced apoptosis. E2F1 deregulation suppresses beta-catenin activity in an adenomatous polyposis coli ( APC)/glycogen synthase kinase- 3 ( GSK3)- independent manner, reducing the expression of key beta-catenin targets including c- MYC. This interaction explains why colorectal tumours, which depend on beta- catenin transcription for their abnormal proliferation, keep RB1 intact. Remarkably, E2F1 activity is also repressed by cyclin- dependent kinase- 8 ( CDK8), a colorectal oncoprotein(1). Elevated levels of CDK8 protect beta-catenin/TCF-dependent transcription from inhibition by E2F1. Thus, by retaining RB1 and amplifying CDK8, colorectal tumour cells select conditions that collectively suppress E2F1 and enhance the activity of beta-catenin.	[Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.] Massachusetts Gen Hosp, Ctr Canc, Mol Oncol Lab, Charlestown, MA 02129 USA; [Morris, Erick J.; Ji, Jun-Yuan; Yang, Fajun; Di Stefano, Luisa; Herr, Anabel; Moon, Nam-Sung; Haigis, Kevin M.; Naar, Anders M.; Dyson, Nicholas J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Yang, Fajun; Naar, Anders M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Kwon, Eun-Jeong] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Kwon, Eun-Jeong] Vincent Ctr Reprod Biol, Boston, MA 02114 USA; [Haigis, Kevin M.] Massachusetts Gen Hosp, Ctr Canc, Lab Mol Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Dyson, NJ (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Mol Oncol Lab, 13th St,Bldg 149, Charlestown, MA 02129 USA.	dyson@helix.mgh.harvard.edu	Di Stefano, Luisa/ABB-6457-2020	Di Stefano, Luisa/0000-0003-3437-9066; Morris, Erick/0000-0002-3566-5630; Ji, Jun-yuan/0000-0002-4483-4336; Moon, Nam-Sung/0000-0002-0455-927X	Ruth L. Kirschstein Award; Tosteson Postdoctoral Fellowship; MGH ECOR Fund for Medical Discovery; Career Development award; Harvard Gastrointestinal Specialized Program of Research Excellence [P50-CA127003]; Saltonstall Foundation; National Institutes of Health [GM81607, GM053203, GM071449]; NATIONAL CANCER INSTITUTE [P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071449, R01GM081607, R01GM053203] Funding Source: NIH RePORTER	Ruth L. Kirschstein Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tosteson Postdoctoral Fellowship; MGH ECOR Fund for Medical Discovery; Career Development award; Harvard Gastrointestinal Specialized Program of Research Excellence; Saltonstall Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank many investigators for their gifts of cell lines, plasmids and fly stocks, especially S. Artavanis-Tsakonas. We thank D. Rennie and the Massachusetts General Hospital Cutaneous Biology Research Center Transgenic Fly Core for embryo injections, and B. Fowle for his help with SEM imaging. We thank A. McClatchey, J. Settleman, C. Seum and T. Orr-Weaver for their gifts of antibodies. We thank our colleagues at the Massachusetts General Hospital (MGH) Cancer Center for discussions. E.J.M. and J.-Y.J. are supported in part by a Ruth L. Kirschstein Award and a Tosteson Postdoctoral Fellowship, respectively. L. D. S. is supported by the MGH ECOR Fund for Medical Discovery. N.-S.M. is a Leukemia and Lymphoma Society Special Fellow. K.M.H. was supported by a Career Development award from the Harvard Gastrointestinal Specialized Program of Research Excellence (GI-SPORE) (P50-CA127003). N.J.D. was supported by a scholarship from the Saltonstall Foundation. This study was supported by grants from the National Institutes of Health to N.J.D. (GM81607, GM053203) and A. M. N. (GM071449).	Black EP, 2005, P NATL ACAD SCI USA, V102, P15948, DOI 10.1073/pnas.0504300102; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Di Stefano L, 2003, EMBO J, V22, P6289, DOI 10.1093/emboj/cdg613; Dick FA, 2000, MOL CELL BIOL, V20, P3715, DOI 10.1128/MCB.20.10.3715-3727.2000; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Faux MC, 2004, J CELL SCI, V117, P427, DOI 10.1242/jcs.00862; Freeman M, 2001, EMBO REP, V2, P157, DOI 10.1093/embo-reports/kve019; GOPE R, 1990, J NATL CANCER I, V82, P310, DOI 10.1093/jnci/82.4.310; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Hallstrom TC, 2008, CANCER CELL, V13, P11, DOI 10.1016/j.ccr.2007.11.031; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hughes TA, 2005, BIOCHEM BIOPH RES CO, V329, P1267, DOI 10.1016/j.bbrc.2005.02.102; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kucherlapati MH, 2006, CANCER RES, V66, P3576, DOI 10.1158/0008-5472.CAN-05-2699; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Liu J, 2001, MOL CELL, V7, P927, DOI 10.1016/S1097-2765(01)00241-6; Malik S, 2005, TRENDS BIOCHEM SCI, V30, P256, DOI 10.1016/j.tibs.2005.03.009; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Rother K, 2004, ONCOGENE, V23, P3376, DOI 10.1038/sj.onc.1207464; Sadot E, 2001, MOL CELL BIOL, V21, P6768, DOI 10.1128/MCB.21.20.6768-6781.2001; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Ueda Y, 2001, BIOCHEM BIOPH RES CO, V283, P327, DOI 10.1006/bbrc.2001.4788; Williams JP, 2006, MOL CELL BIOL, V26, P1170, DOI 10.1128/MCB.26.4.1170-1182.2006	29	234	238	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					552	U67		10.1038/nature07310	http://dx.doi.org/10.1038/nature07310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18794899	Green Accepted, Green Submitted			2022-12-28	WOS:000259449600050
J	Crump, JA; Sugarman, J				Crump, John A.; Sugarman, Jeremy			Ethical considerations for short-term experiences by trainees in global health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STUDENTS; WORLD		[Crump, John A.] Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Dept Med, Durham, NC 27710 USA; [Crump, John A.] Duke Univ, Duke Global Hlth Inst, Durham, NC 27710 USA; [Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Ctr, Moshi, Tanzania; [Crump, John A.] Tumaini Univ, Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA; [Sugarman, Jeremy] Johns Hopkins Univ, Dept Med, Baltimore, MD USA	Duke University; Duke University; Kilimanjaro Christian Medical Centre; Johns Hopkins University; Johns Hopkins University	Crump, JA (corresponding author), Duke Univ, Med Ctr, Div Infect Dis & Int Hlth, Dept Med, Box 3867, Durham, NC 27710 USA.	crump017@mc.duke.edu	Crump, John A./AAZ-6412-2020; Crump, John A./AAZ-6289-2020	Crump, John A./0000-0002-4529-102X; Crump, John A./0000-0002-4529-102X; Sugarman, Jeremy/0000-0001-7022-8332	FIC NIH HHS [D43 TW006732-08] Funding Source: Medline; NIAID NIH HHS [U01 AI069484, U01 AI062563-04, U01 AI069484-06, U01 AI062563] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW006732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069484, U01AI062563] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*ASS AM MED COLL, MEMB MED SCH; Decamp M, 2007, HASTINGS CENT REP, V37, P21, DOI 10.1353/hcr.2007.0096; Dwyer J, 2005, BIOETHICS, V19, P460, DOI 10.1111/j.1467-8519.2005.00458.x; Dwyer J, 2003, BIOETHICS, V17, P432, DOI 10.1111/1467-8519.00359; Haq C, 2000, FAM MED, V32, P566; Harris JJ, 2003, SOC SCI MED, V56, P905, DOI 10.1016/S0277-9536(02)00090-4; Kanter SL, 2008, ACAD MED, V83, P115, DOI 10.1097/01.ACM.0000305155.66318.58; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1, DOI 10.1596/978-0-8213-6262-4; McAlister CC, 2006, CLIN INVEST MED, V29, P185; Pinto AD, 2009, DEV WORLD BIOETH, V9, P1, DOI 10.1111/j.1471-8847.2007.00209.x; Singer PA, 2001, BRIT MED J, V322, P747, DOI 10.1136/bmj.322.7289.747; Singer PA, 2000, BRIT MED J, V321, P282, DOI 10.1136/bmj.321.7256.282; Suchdev P, 2007, AMBUL PEDIATR, V7, P317, DOI 10.1016/j.ambp.2007.04.003; Sugarman Jeremy, 2007, RES ETHICS REV, V3, P84, DOI DOI 10.1177/174701610700300305; Wilkinson D, 1999, BRIT MED J, V318, P139, DOI 10.1136/bmj.318.7177.139	15	142	142	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1456	1458		10.1001/jama.300.12.1456	http://dx.doi.org/10.1001/jama.300.12.1456			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812538	Green Accepted			2022-12-28	WOS:000259410400025
J	Adcock, IM; Caramori, G; Chung, KF				Adcock, Ian M.; Caramori, Gaetano; Chung, K. Fan			New targets for drug development in asthma	LANCET			English	Review							HISTONE DEACETYLASE ACTIVITY; INDUCED AIRWAY INFLAMMATION; ALLERGEN-INDUCED RESPONSES; SEVERE PERSISTENT ASTHMA; RETRACTED ARTICLE. SEE; T-CELL DIFFERENTIATION; KAPPA-B KINASE-2; INHALED CORTICOSTEROIDS; TNF-ALPHA; TRANSCRIPTION FACTORS	Asthma is a chronic inflammatory disease that affects about 300 million people worldwide, a total that is expected to rise to about 400 million over the next 15-20 years. Most asthmatic individuals respond well to the currently available treatments of inhaled corticosteroids and beta-adrenergic agonists; however, 5-10% have severe disease that responds poorly. Improved knowledge of asthma mechanisms has led to the recognition of different asthma phenotypes that might reflect distinct types of inflammation, explaining the effectiveness of anti-leucotrienes and the anti-IgE monoclonal antibody omalizumab in some patients. However, more knowledge of the inflammatory mechanisms within the airways is required. Improvements in available therapies-such as the development of fast-onset, once-a-day combination drugs with better safety profiles-will occur. Other drugs, such as inhaled p38 MAPK inhibitors and anti-oxidants, that target specific pathways or mediators could prove useful as monotherapies, but could also, in combination with corticosteroids, reduce the corticosteroid insensitivity often seen in severe asthma. Biological agents directed against the interleukin-13 pathway and new immunoregulatory agents that modulate functions of T-regulatory and T-helper-17 cells are likely to be successful. Patient-specific treatments will depend on the development of discriminatory handprints of distinct asthma subtypes and are probably over the horizon. Although a cure is unlikely to be developed in the near future, a greater understanding of disease mechanisms could bring such a situation nearer to reality.	[Adcock, Ian M.; Chung, K. Fan] Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, London SW3 6LY, England; [Adcock, Ian M.; Chung, K. Fan] Kings & Imperial Coll, MRC Asthma UK Ctr Allerg Mech Asthma, London, ON, Canada; [Caramori, Gaetano] Univ Ferrara, Ctr Res Asthma & COPD, I-44100 Ferrara, Italy	Imperial College London; University of Ferrara	Adcock, IM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Airways Dis Sect, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	Ian.Adcock@imperial.ac.uk	Chung, Kian Fan/I-8456-2019; Adcock, Ian/L-3217-2019; Chung, Kian Fan/B-1872-2012; Caramori, Gaetano/AAS-8611-2020	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Caramori, Gaetano/0000-0002-9807-327X; Adcock, Ian/0000-0003-2101-8843	Asthma UK; UK Medical Research Council; Royal Society; University of Ferrara; Wellcome Trust.; Medical Research Council [G0400503B] Funding Source: researchfish	Asthma UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); University of Ferrara; Wellcome Trust.(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Paul A Kirkham who wrote the section on oxidative stress. PAK is a Royal Society industrial Fellow on secondment from Novartis and holds shares in Novartis. Novartis do not work in the area of oxidative stress. We also thank members of the Department of Airways Disease, NHLI, Imperial College London, for helpful discussions. Work in the authors' laboratories in this area is funded by Asthma UK, the UK Medical Research Council, the Royal Society, the University of Ferrara, and the Wellcome Trust.	Abraham B, 2003, EUR RESPIR J, V22, P470, DOI 10.1183/09031936.03.00261903; Adcock IM, 2006, EUR J PHARMACOL, V533, P118, DOI 10.1016/j.ejphar.2005.12.054; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Akdis CA, 2006, CHEM IMMUNOL ALLERGY, V91, P195; Barnes PJ, 2007, J ALLERGY CLIN IMMUN, V119, P1055, DOI 10.1016/j.jaci.2007.01.015; Barnes PJ, 2006, TRENDS MOL MED, V12, P515, DOI 10.1016/j.molmed.2006.09.006; Barnes PJ, 2006, BRIT J PHARMACOL, V148, P245, DOI 10.1038/sj.bjp.0706736; BARNES PJ, 1995, NEW ENGL J MED, V332, P868, DOI 10.1056/NEJM199503303321307; Barnes PJ, 1996, EUR RESPIR J, V9, P636, DOI 10.1183/09031936.96.09040636; Bateman ED, 2004, AM J RESP CRIT CARE, V170, P836, DOI 10.1164/rccm.200401-033OC; BELLETTATO C, 2003, EUR RESPIR J, V22, pS565; Belvisi MG, 2006, EUR J PHARMACOL, V533, P101, DOI 10.1016/j.ejphar.2005.12.048; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; BHAVSAR P, 2008, THORAX, V39, P312; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; Birrell MA, 2005, AM J RESP CRIT CARE, V172, P962, DOI 10.1164/rccm.200412-1647OC; Borish LC, 2001, J ALLERGY CLIN IMMUN, V107, P963, DOI 10.1067/mai.2001.115624; Bourdin A, 2007, J ALLERGY CLIN IMMUN, V119, P1367, DOI 10.1016/j.jaci.2007.01.055; Bousquet J, 2006, ALLERGY, V61, P72, DOI 10.1111/j.1398-9995.2005.00931.x; Brasier AR, 2008, J ALLERGY CLIN IMMUN, V121, P30, DOI 10.1016/j.jaci.2007.10.015; Bryan SA, 2000, LANCET, V356, P2149, DOI 10.1016/S0140-6736(00)03497-8; Bundschuh DS, 2001, J PHARMACOL EXP THER, V297, P280; Caramori G, 2001, EUR RESPIR J, V18, P466, DOI 10.1183/09031936.01.00040701; Caramori Gaetano, 2008, J Occup Med Toxicol, V3 Suppl 1, pS6, DOI 10.1186/1745-6673-3-S1-S6; Chatila TA, 2008, J ALLERGY CLIN IMMUN, V121, P812, DOI 10.1016/j.jaci.2008.02.025; Chung K Fan, 2004, Treat Respir Med, V3, P279, DOI 10.2165/00151829-200403050-00002; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Chung KF, 1999, EUR RESPIR J, V13, P1198; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Cosio BG, 2004, AM J RESP CRIT CARE, V170, P141, DOI 10.1164/rccm.200305-659OC; Cosio BG, 2004, J EXP MED, V200, P689, DOI 10.1084/jem.20040416; Costello PS, 1996, ONCOGENE, V13, P2595; Cousins DJ, 2008, J ALLERGY CLIN IMMUN, V121, P803, DOI 10.1016/j.jaci.2008.02.008; Culpitt SV, 2003, THORAX, V58, P942, DOI 10.1136/thorax.58.11.942; Dahlen SE, 2006, EUR J PHARMACOL, V533, P40, DOI 10.1016/j.ejphar.2005.12.070; Das AM, 2006, J PHARMACOL EXP THER, V318, P411, DOI 10.1124/jpet.105.099812; Derendorf H, 2007, J CLIN PHARMACOL, V47, P782, DOI 10.1177/0091270007299763; Diamant Z, 2005, CLIN EXP ALLERGY, V35, P1080, DOI 10.1111/j.1365-2222.2005.02296.x; Dragonieri S, 2007, J ALLERGY CLIN IMMUN, V120, P856, DOI 10.1016/j.jaci.2007.05.043; Erpenbeck VJ, 2006, INT ARCH ALLERGY IMM, V139, P306, DOI 10.1159/000091602; Evans DJ, 1996, THORAX, V51, P1178, DOI 10.1136/thx.51.12.1178; Eynott PR, 2003, BRIT J PHARMACOL, V140, P1373, DOI 10.1038/sj.bjp.0705569; Feleszko W, 2006, EUR J PHARMACOL, V533, P308, DOI 10.1016/j.ejphar.2005.12.062; Finan PM, 2004, BIOCHEM SOC T, V32, P378, DOI 10.1042/BST0320378; Flood-Page P, 2003, J CLIN INVEST, V112, P1029, DOI 10.1172/JCI200317974; Frew AJ, 2008, NEW ENGL J MED, V358, P2259, DOI 10.1056/NEJMct0708337; Gagliardo R, 2003, AM J RESP CRIT CARE, V168, P1190, DOI 10.1164/rccm.200205-479OC; Gauvreau GM, 2008, AM J RESP CRIT CARE, V177, P952, DOI 10.1164/rccm.200708-1251OC; Gauvreau GM, 2006, AM J RESP CRIT CARE, V174, P15, DOI 10.1164/rccm.200601-057OC; Hakonarson H, 2005, P NATL ACAD SCI USA, V102, P14789, DOI 10.1073/pnas.0409904102; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Hammad H, 2008, NAT REV IMMUNOL, V8, P193, DOI 10.1038/nri2275; Hammad H, 2007, J EXP MED, V204, P357, DOI 10.1084/jem.20061196; Hart LA, 1998, AM J RESP CRIT CARE, V158, P1585, DOI 10.1164/ajrccm.158.5.9706116; Ho IC, 2007, CELL MOL IMMUNOL, V4, P15; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Horne R, 2006, CHEST, V130, p65S, DOI 10.1378/chest.130.1_suppl.65S; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Hsu CH, 2007, ADV EXP MED BIOL, V595, P471; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Ito K, 2006, J ALLERGY CLIN IMMUN, V117, P522, DOI 10.1016/j.jaci.2006.01.032; Ito K, 2006, J EXP MED, V203, P7, DOI 10.1084/jem.20050466; Ito K, 2005, NEW ENGL J MED, V352, P1967, DOI 10.1056/NEJMoa041892; Ito K, 2007, J PHARMACOL EXP THER, V321, P1, DOI 10.1124/jpet.106.111674; Jayaram L, 2005, EUR RESPIR J, V25, P41, DOI 10.1183/09031936.04.00008104; Johnson M, 2006, J ALLERGY CLIN IMMUN, V117, P18, DOI 10.1016/j.jaci.2005.11.012; Johnston SL, 2006, NEW ENGL J MED, V354, P1589, DOI 10.1056/NEJMoa044080; Kallinich T, 2005, CLIN EXP ALLERGY, V35, P26, DOI 10.1111/j.1365-2222.2004.02132.x; Kamel N, 2008, EUR RESPIR J, V31, P924, DOI 10.1183/09031936.00033208; Kharitonov Sergei A, 2004, Proc Am Thorac Soc, V1, P191, DOI 10.1513/pats.200402-011MS; King MR, 2006, J IMMUNOL, V176, P2765, DOI 10.4049/jimmunol.176.5.2765; Kips JC, 2003, AM J RESP CRIT CARE, V167, P1655, DOI 10.1164/rccm.200206-525OC; Kirkham P, 2006, PHARMACOL THERAPEUT, V111, P476, DOI 10.1016/j.pharmthera.2005.10.015; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Krieg AM, 2006, NAT REV DRUG DISCOV, V5, P471, DOI 10.1038/nrd2059; Lagente Vincent, 2004, Curr Opin Investig Drugs, V5, P537; Lazarus SC, 2007, AM J RESP CRIT CARE, V175, P783, DOI 10.1164/rccm.200511-1746OC; Leckie MJ, 2000, LANCET, V356, P2144, DOI 10.1016/S0140-6736(00)03496-6; Lever R, 2002, NAT REV DRUG DISCOV, V1, P140, DOI 10.1038/nrd724; Levy BD, 2007, FASEB J, V21, P3877, DOI 10.1096/fj.07-8653com; Li LB, 2004, J ALLERGY CLIN IMMUN, V114, P1059, DOI 10.1016/j.jaci.2004.08.005; Lim S, 1998, LANCET, V352, P113, DOI 10.1016/S0140-6736(98)85018-6; Liu YJ, 2007, ANNU REV IMMUNOL, V25, P193, DOI 10.1146/annurev.immunol.25.022106.141718; Maneechotesuwan K, 2007, J IMMUNOL, V178, P2491, DOI 10.4049/jimmunol.178.4.2491; Mantel PY, 2007, PLOS BIOL, V5, P2847, DOI 10.1371/journal.pbio.0050329; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; Matera MG, 2007, DRUGS, V67, P503, DOI 10.2165/00003495-200767040-00002; Medina-Tato DA, 2006, DRUG DISCOV TODAY, V11, P866, DOI 10.1016/j.drudis.2006.08.008; MEJA KK, 2008, AM J RESP CELL MOL B, V63, P784; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Miner JN, 2007, P NATL ACAD SCI USA, V104, P19244, DOI 10.1073/pnas.0705517104; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moore WC, 2007, J ALLERGY CLIN IMMUN, V119, P405, DOI 10.1016/j.jaci.2006.11.639; Morjaria JB, 2008, THORAX, V63, P584, DOI 10.1136/thx.2007.086314; Nakamura Y, 1999, J ALLERGY CLIN IMMUN, V103, P215, DOI 10.1016/S0091-6749(99)70493-8; Nath P, 2005, EUR J PHARMACOL, V506, P273, DOI 10.1016/j.ejphar.2004.11.040; Nevin BJ, 2004, PULM PHARMACOL THER, V17, P219, DOI 10.1016/j.pupt.2004.04.002; Norris V, 2005, J ALLERGY CLIN IMMUN, V116, P761, DOI 10.1016/j.jaci.2005.04.045; Numerof RP, 2006, BIODRUGS, V20, P93, DOI 10.2165/00063030-200620020-00004; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Panina-Bordignon P, 2001, J CLIN INVEST, V107, P1357, DOI 10.1172/JCI12655; Paul-Clark MJ, 2003, J IMMUNOL, V171, P3245, DOI 10.4049/jimmunol.171.6.3245; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; Pettipher R, 2007, NAT REV DRUG DISCOV, V6, P313, DOI 10.1038/nrd2266; Poole JA, 2005, J ALLERGY CLIN IMMUN, V116, P780, DOI 10.1016/j.jaci.2005.07.007; Postma DS, 2008, N-S ARCH PHARMACOL, V378, P203, DOI 10.1007/s00210-008-0302-y; Qiu YS, 2007, THORAX, V62, P475, DOI 10.1136/thx.2006.066670; Quarcoo D, 2004, J ALLERGY CLIN IMMUN, V114, P288, DOI 10.1016/j.jaci.2004.03.055; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Radulovic S, 2008, J ALLERGY CLIN IMMUN, V121, P1467, DOI 10.1016/j.jaci.2008.03.013; Rahman I, 2006, BIOCHEM PHARMACOL, V72, P1439, DOI 10.1016/j.bcp.2006.07.004; Ravensberg AJ, 2006, ALLERGY, V61, P1097, DOI 10.1111/j.1398-9995.2006.01146.x; Ravensberg AJ, 2005, J ALLERGY CLIN IMMUN, V115, P779, DOI 10.1016/j.jaci.2004.11.045; Reichardt HM, 2001, EMBO J, V20, P7168, DOI 10.1093/emboj/20.24.7168; Rosenwasser LJ, 2005, CLIN REV ALLERG IMMU, V29, P61, DOI 10.1385/CRIAI:29:1:061; Rothenberg ME, 2008, NEW ENGL J MED, V358, P1215, DOI 10.1056/NEJMoa070812; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; Simpson JL, 2008, AM J RESP CRIT CARE, V177, P148, DOI 10.1164/rccm.200707-1134OC; Singh D, 2007, AM J RESP CRIT CARE, V176, P988, DOI 10.1164/rccm.200704-588OC; Solit DB, 2008, DRUG DISCOV TODAY, V13, P38, DOI 10.1016/j.drudis.2007.10.007; Sousa AR, 1999, J ALLERGY CLIN IMMUN, V104, P565, DOI 10.1016/S0091-6749(99)70325-8; Sthoeger ZM, 2007, ISRAEL MED ASSOC J, V9, P472; Sugiura H, 2008, J ALLERGY CLIN IMMUN, V121, P355, DOI 10.1016/j.jaci.2007.11.009; Suissa S, 2001, J ALLERGY CLIN IMMUN, V107, P937, DOI 10.1067/mai.2001.115653; Therien AG, 2008, AM J RESP CELL MOL, V39, P26, DOI 10.1165/rcmb.2007-0240OC; Tliba O, 2008, AM J RESP CELL MOL, V38, P463, DOI 10.1165/rcmb.2007-0226OC; Tomita K, 2002, CLIN IMMUNOL, V102, P258, DOI 10.1006/clim.2001.5176; Tsitoura DC, 2004, J CLIN INVEST, V113, P619, DOI 10.1172/JCI200418975; Tudhope SJ, 2007, J IMMUNOL, V179, P6237, DOI 10.4049/jimmunol.179.9.6237; Usami A, 2006, PHARMACOLOGY, V77, P33, DOI 10.1159/000092376; Usmani OS, 2005, AM J RESP CRIT CARE, V172, P704, DOI 10.1164/rccm.200408-1041OC; Wegmann M, 2007, AM J RESP CELL MOL, V36, P61, DOI 10.1165/rcmb.2006-0188OC; Wenzel SE, 2007, AM J RESP CRIT CARE, V175, P570, DOI 10.1164/rccm.200607-909OC; Wenzel SE, 2006, LANCET, V368, P804, DOI 10.1016/S0140-6736(06)69290-8; Wenzel SE, 1999, AM J RESP CRIT CARE, V160, P1001, DOI 10.1164/ajrccm.160.3.9812110; Wu AC, 2007, J ALLERGY CLIN IMMUN, V120, P1146, DOI 10.1016/j.jaci.2007.07.055; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Yamamoto N, 2003, J PHARMACOL EXP THER, V306, P1174, DOI 10.1124/jpet.103.052316; Ying S, 1997, EUR J IMMUNOL, V27, P3507, DOI 10.1002/eji.1830271252; Yousefi S, 1996, J EXP MED, V183, P1407, DOI 10.1084/jem.183.4.1407	142	179	188	1	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1073	1087		10.1016/S0140-6736(08)61449-X	http://dx.doi.org/10.1016/S0140-6736(08)61449-X			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805336				2022-12-28	WOS:000259648500034
J	Pavord, ID; Shaw, DE; Gibson, PG; Taylor, DR				Pavord, Ian D.; Shaw, Dominick E.; Gibson, Peter G.; Taylor, D. Robin			Inflammometry to assess airway diseases	LANCET			English	Editorial Material							EXHALED NITRIC-OXIDE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC ASTHMA; INFLAMMATION; SPUTUM; EXACERBATIONS; CHILDREN; PREDNISOLONE; COUNTS; ADULTS		[Pavord, Ian D.; Shaw, Dominick E.] Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England; [Gibson, Peter G.] John Hunter Hosp, Hunter Med Res Inst, Dept Resp & Sleep Med, New Lambton, NSW, Australia; [Taylor, D. Robin] Univ Otago, Dunedin Sch Med, Dept Med, Dunedin, New Zealand	University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; Hunter Medical Research Institute; John Hunter Hospital; University of Newcastle; University of Otago	Pavord, ID (corresponding author), Glenfield Gen Hosp, Dept Resp Med Allergy & Thorac Surg, Univ Hosp Leicester NHS Trust, Leicester LE3 9QP, Leics, England.	ian.pavord@uhl-tr.nhs.uk	shaw, dominick/N-1293-2014; gibson, peter/G-6194-2014	shaw, dominick/0000-0003-4106-8469; gibson, peter/0000-0001-5865-489X; Pavord, Ian/0000-0002-4288-5973				Berry MA, 2005, CLIN EXP ALLERGY, V35, P1175, DOI 10.1111/j.1365-2222.2005.02314.x; Brightling CE, 2000, LANCET, V356, P1480, DOI 10.1016/S0140-6736(00)02872-5; Brightling CE, 2000, EUR RESPIR J, V15, P682, DOI 10.1034/j.1399-3003.2000.15d10.x; BROWN HM, 1958, LANCET, V2, P1245; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Hunter CJ, 2002, CHEST, V121, P1051, DOI 10.1378/chest.121.4.1051; Jayaram L, 2006, EUR RESPIR J, V27, P483, DOI 10.1183/09031936.06.00137704; Pavord ID, 2006, EUR RESPIR J, V27, P884, DOI 10.1183/09031936.06.00128105; Pavord ID, 1999, LANCET, V353, P2213, DOI 10.1016/S0140-6736(99)01813-9; Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374; Pijnenburg MW, 2005, AM J RESP CRIT CARE, V172, P831, DOI 10.1164/rccm.200503-458OC; Shaw DE, 2007, AM J RESP CRIT CARE, V176, P231, DOI 10.1164/rccm.200610-1427OC; Siva R, 2007, EUR RESPIR J, V29, P906, DOI 10.1183/09031936.00146306; Smith AD, 2005, AM J RESP CRIT CARE, V172, P453, DOI 10.1164/rccm.200411-1498OC; Smith AD, 2005, NEW ENGL J MED, V352, P2163, DOI 10.1056/NEJMoa043596; Szefler SJ, 2002, J ALLERGY CLIN IMMUN, V109, P410, DOI 10.1067/mai.2002.122635; Zacharasiewicz A, 2005, AM J RESP CRIT CARE, V171, P1077, DOI 10.1164/rccm.200409-1242OC	17	65	68	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1017	1019		10.1016/S0140-6736(08)61421-X	http://dx.doi.org/10.1016/S0140-6736(08)61421-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805315				2022-12-28	WOS:000259648500008
J	Del Bene, F; Wehman, AM; Link, BA; Baier, H				Del Bene, Filippo; Wehman, Ann M.; Link, Brian A.; Baier, Herwig			Regulation of neurogenesis by interkinetic nuclear migration through an apical-basal Notch gradient	CELL			English	Article							CELL-FATE DETERMINATION; RETINAL GANGLION-CELL; ZEBRAFISH; PROGENITOR; NUMB; GLIOGENESIS; EXPRESSION; DIVISION; MUTATION; REVEALS	The different cell types in the central nervous system develop from a common pool of progenitor cells. The nuclei of progenitors move between the apical and basal surfaces of the neuroepithelium in phase with their cell cycle, a process termed interkinetic nuclear migration (INM). In the retina of zebrafish mikre oko (mok) mutants, in which the motor protein Dynactin-1 is disrupted, interkinetic nuclei migrate more rapidly and deeply to the basal side and more slowly to the apical side. We found that Notch signaling is predominantly activated on the apical side in both mutants and wild-type. Mutant progenitors are, thus, less exposed to Notch and exit the cell cycle prematurely. This leads to an overproduction of early-born retinal ganglion cells (RGCs) at the expense of later-born interneurons and glia. Our data indicate that the function of INM is to balance the exposure of progenitor nuclei to neurogenic versus proliferative signals.	[Link, Brian A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Neurosci, San Francisco, CA 94158 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Genet Program, San Francisco, CA 94158 USA; [Del Bene, Filippo; Wehman, Ann M.; Baier, Herwig] Univ Calif San Francisco, Dept Physiol, Program Dev Biol, San Francisco, CA 94158 USA	Medical College of Wisconsin; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Link, BA (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	blink@mcw.edu; herwig.baier@ucsf.edu	Wehman, Ann M/J-7860-2019; del bene, filippo/D-1245-2010	Wehman, Ann M/0000-0001-9826-4132; del bene, filippo/0000-0001-8551-2846	NEI NIH HHS [R01 EY012406-09, EY012406, R01 EY013855, R01 EY013855-04, R01 EY012406-05, R01 EY012406, EY01467, R01 EY013855-06, EY013855] Funding Source: Medline; NINDS NIH HHS [R01 NS053358-02, R01 NS053358] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY013855, R01EY012406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053358] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUSTIN CP, 1995, DEVELOPMENT, V121, P3637; Baye LM, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-28; Baye LM, 2008, BRAIN RES, V1192, P29, DOI 10.1016/j.brainres.2007.05.021; Baye LM, 2007, J NEUROSCI, V27, P10143, DOI 10.1523/JNEUROSCI.2754-07.2007; Berdnik D, 2002, DEV CELL, V3, P221, DOI 10.1016/S1534-5807(02)00215-0; Bort R, 2006, DEV BIOL, V290, P44, DOI 10.1016/j.ydbio.2005.11.006; Brown NL, 2001, DEVELOPMENT, V128, P2497; Burns KA, 2005, EUR J NEUROSCI, V21, P803, DOI 10.1111/j.1460-9568.2005.03907.x; Cepko CL, 1996, P NATL ACAD SCI USA, V93, P589, DOI 10.1073/pnas.93.2.589; CHITNIS AB, 1995, MOL CELL NEUROSCI, V6, P311, DOI 10.1006/mcne.1995.1024; Doerre G, 2001, J NEUROSCI, V21, P6745, DOI 10.1523/JNEUROSCI.21-17-06745.2001; Draper BW, 2001, GENESIS, V30, P154, DOI 10.1002/gene.1053; Edlund T, 1999, CELL, V96, P211, DOI 10.1016/S0092-8674(00)80561-9; Emery G, 2005, CELL, V122, P763, DOI 10.1016/j.cell.2005.08.017; Fan SS, 1997, DEVELOPMENT, V124, P1497; Frade JM, 2002, PROG BRAIN RES, V136, P67; Furukawa T, 2000, NEURON, V26, P383, DOI 10.1016/S0896-6273(00)81171-X; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603; Guo M, 1996, NEURON, V17, P27, DOI 10.1016/S0896-6273(00)80278-0; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; HO RK, 1990, NATURE, V348, P728, DOI 10.1038/348728a0; HOLT CE, 1988, NEURON, V1, P15, DOI 10.1016/0896-6273(88)90205-X; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Kawakami K, 2004, METHOD CELL BIOL, V77, P201; Kay JN, 2001, NEURON, V30, P725, DOI 10.1016/S0896-6273(01)00312-9; Kim J, 2005, SCIENCE, V308, P1927, DOI 10.1126/science.1110175; King SJ, 2000, NAT CELL BIOL, V2, P20, DOI 10.1038/71338; Koster RW, 2001, DEV BIOL, V233, P329, DOI 10.1006/dbio.2001.0242; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Marquardt T, 2002, TRENDS NEUROSCI, V25, P32, DOI 10.1016/S0166-2236(00)02028-2; Masai I, 2000, NEURON, V27, P251, DOI 10.1016/S0896-6273(00)00034-9; Masai I, 2003, DEVELOPMENT, V130, P2479, DOI 10.1242/dev.00465; McGill MA, 2003, J BIOL CHEM, V278, P23196, DOI 10.1074/jbc.M302827200; MCGRAIL M, 1995, J CELL BIOL, V131, P411, DOI 10.1083/jcb.131.2.411; Meng A, 1999, METHOD CELL BIOL, V60, P133; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Murciano A, 2002, MOL CELL NEUROSCI, V21, P285, DOI 10.1006/mcne.2002.1174; Muto A, 2006, DEV BIOL, V292, P90, DOI 10.1016/j.ydbio.2005.12.050; Nelson BR, 2006, DEV NEUROSCI-BASEL, V28, P128, DOI 10.1159/000090759; Nichols JT, 2007, TRAFFIC, V8, P959, DOI 10.1111/j.1600-0854.2007.00592.x; Ohnuma S, 2002, DEVELOPMENT, V129, P2435; Passini MA, 1997, J COMP NEUROL, V388, P495, DOI 10.1002/(SICI)1096-9861(19971124)388:3<495::AID-CNE11>3.0.CO;2-L; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Perron M, 2000, CELL MOL LIFE SCI, V57, P215, DOI 10.1007/PL00000685; Poggi L, 2005, J CELL BIOL, V171, P991, DOI 10.1083/jcb.200509098; Poggi L, 2005, CURR OPIN CELL BIOL, V17, P676, DOI 10.1016/j.ceb.2005.09.004; Reugels AM, 2006, DEV DYNAM, V235, P934, DOI 10.1002/dvdy.20699; Sauer FC, 1935, J COMP NEUROL, V62, P377, DOI 10.1002/cne.900620207; Scheer N, 2001, DEVELOPMENT, V128, P1099; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Starr DA, 2005, BIOESSAYS, V27, P1136, DOI 10.1002/bies.20312; Takke C, 1999, DEVELOPMENT, V126, P1811; Tokunaga A, 2004, J NEUROCHEM, V90, P142, DOI 10.1111/j.1471-4159.2004.02470.x; Tsujikawa M, 2007, P NATL ACAD SCI USA, V104, P14819, DOI 10.1073/pnas.0700178104; TURNER DL, 1990, NEURON, V4, P833, DOI 10.1016/0896-6273(90)90136-4; TURNER DL, 1987, NATURE, V328, P131, DOI 10.1038/328131a0; Vetter ML, 2001, SEMIN CELL DEV BIOL, V12, P491, DOI 10.1006/scdb.2001.0273; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wehman AM, 2005, DEV BIOL, V281, P53, DOI 10.1016/j.ydbio.2005.02.010; Wehman AM, 2007, DEV BIOL, V303, P144, DOI 10.1016/j.ydbio.2006.10.043; Wei XY, 2004, DEV BIOL, V269, P286, DOI 10.1016/j.ydbio.2004.01.017; WETTS R, 1988, SCIENCE, V239, P1142, DOI 10.1126/science.2449732; Whited JL, 2004, DEVELOPMENT, V131, P4677, DOI 10.1242/dev.01366; Xiao T, 2005, DEVELOPMENT, V132, P2955, DOI 10.1242/dev.01861; Yan RT, 2005, MOL NEUROBIOL, V32, P157, DOI 10.1385/MN:32:2:157; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	68	238	239	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					1055	1065		10.1016/j.cell.2008.07.017	http://dx.doi.org/10.1016/j.cell.2008.07.017			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805097	Green Accepted, Bronze			2022-12-28	WOS:000259318100024
J	Ludwig, DS; Kabat-Zinn, J				Ludwig, David S.; Kabat-Zinn, Jon			Mindfulness in medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							STRESS REDUCTION; MEDITATION; PROGRAM		[Ludwig, David S.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Kabat-Zinn, Jon] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	Harvard University; Boston Children's Hospital; University of Massachusetts System; University of Massachusetts Worcester	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544				Creswell JD, 2007, PSYCHOSOM MED, V69, P560, DOI 10.1097/PSY.0b013e3180f6171f; Davidson RJ, 2003, PSYCHOSOM MED, V65, P564, DOI 10.1097/01.PSY.0000077505.67574.E3; Epstein RM, 1999, JAMA-J AM MED ASSOC, V282, P833, DOI 10.1001/jama.282.9.833; Grepmair L, 2007, PSYCHOTHER PSYCHOSOM, V76, P332, DOI 10.1159/000107560; Groopman J, 2007, DOCTORS THINK; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Ospina Maria B, 2007, Evid Rep Technol Assess (Full Rep), P1; Proulx Kathryn, 2008, Eat Disord, V16, P52, DOI 10.1080/10640260701773496; Santorelli S, 1998, HEAL THY SELF; Shapiro SL, 1998, J BEHAV MED, V21, P581, DOI 10.1023/A:1018700829825; Speca M, 2000, PSYCHOSOM MED, V62, P613, DOI 10.1097/00006842-200009000-00004; Tang YY, 2007, P NATL ACAD SCI USA, V104, P17152, DOI 10.1073/pnas.0707678104; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; Wansink B, 2005, OBES RES, V13, P93, DOI 10.1038/oby.2005.12	15	470	477	7	189	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1350	1352		10.1001/jama.300.11.1350	http://dx.doi.org/10.1001/jama.300.11.1350			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	348ST	18799450				2022-12-28	WOS:000259231100033
J	Nygaard, I; Barber, MD; Burgio, KL; Kenton, K; Meikle, S; Schaffer, J; Spino, C; Whitehead, WE; Wu, J; Brody, DJ				Nygaard, Ingrid; Barber, Matthew D.; Burgio, Kathryn L.; Kenton, Kimberly; Meikle, Susan; Schaffer, Joseph; Spino, Cathie; Whitehead, William E.; Wu, Jennifer; Brody, Debra J.		Pelvic Floor Disorders Network	Prevalence of symptomatic pelvic floor disorders in US women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; FEMALE URINARY-INCONTINENCE; FECAL INCONTINENCE; GENITAL PROLAPSE; ORGAN PROLAPSE; ANAL INCONTINENCE; NATIONAL-HEALTH; SEVERITY INDEX; RISK-FACTORS; COMMUNITY	Context Pelvic floor disorders ( urinary incontinence, fecal incontinence, and pelvic organ prolapse) affect many women. No national prevalence estimates derived from the same population- based sample exists for multiple pelvic floor disorders in women in the United States. Objective To provide national prevalence estimates of symptomatic pelvic floor disorders in US women. Design, Setting, and Participants A cross- sectional analysis of 1961 nonpregnant women ( >= 20 years) who participated in the 2005- 2006 National Health and Nutrition Examination Survey, a nationally representative survey of the US noninstitutionalized population. Women were interviewed in their homes and then underwent standardized physical examinations in a mobile examination center. Urinary incontinence ( score of >= 3 on a validated incontinence severity index, constituting moderate to severe leakage), fecal incontinence ( at least monthly leakage of solid, liquid, or mucous stool), and pelvic organ prolapse ( seeing/ feeling a bulge in or outside the vagina) symptoms were assessed. Main Outcome Measures Weighted prevalence estimates of urinary incontinence, fecal incontinence, and pelvic organ prolapse symptoms. Results The weighted prevalence of at least 1 pelvic floor disorder was 23.7% ( 95% confidence interval [ CI], 21.2%- 26.2%), with 15.7% of women ( 95% CI, 13.2%-18.2%) experiencing urinary incontinence, 9.0% of women ( 95% CI, 7.3%- 10.7%) experiencing fecal incontinence, and 2.9% of women ( 95% CI, 2.1%- 3.7%) experiencing pelvic organ prolapse. The proportion of women reporting at least 1 disorder increased incrementally with age, ranging from 9.7% ( 95% CI, 7.8%- 11.7%) in women between ages 20 and 39 years to 49.7% ( 95% CI, 40.3%- 59.1%) in those aged 80 years or older ( P <. 001), and parity ( 12.8% [ 95% CI, 9.0%- 16.6%], 18.4% [ 95% CI, 12.9%- 23.9%], 24.6% [ 95% CI, 19.5%- 29.8%], and 32.4% [ 95% CI, 27.8%-37.1%] for 0, 1, 2, and 3 or more deliveries, respectively; P <. 001). Overweight and obese women were more likely to report at least 1 pelvic floor disorder than normal weight women ( 26.3% [ 95% CI, 21.7%- 30.9%], 30.4% [ 95% CI, 25.8%- 35.0%], and 15.1% [ 95% CI, 11.6%- 18.7%], respectively; P <. 001). We detected no differences in prevalence by racial/ ethnic group. Conclusion Pelvic floor disorders affect a substantial proportion of women and increase with age.	[Nygaard, Ingrid] Univ Utah, Sch Med, Dept Obstet & Gynecol, Salt Lake City, UT 84132 USA; [Barber, Matthew D.] Obstet Gynecol & Womens Hlth Inst, Cleveland, OH USA; [Barber, Matthew D.] Cleveland Clin, Cleveland, OH 44106 USA; [Burgio, Kathryn L.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Burgio, Kathryn L.] Dept Vet Affairs, Birmingham, AL USA; [Kenton, Kimberly] Loyola Univ, Stritch Sch Med, Dept Obstet & Gynecol, Maywood, IL 60153 USA; [Kenton, Kimberly] Loyola Univ, Stritch Sch Med, Dept Urol, Maywood, IL 60153 USA; [Meikle, Susan] NICHHD, Bethesda, MD 20892 USA; [Schaffer, Joseph] Univ Texas SW Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Spino, Cathie] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Whitehead, William E.] Univ N Carolina, Sch Med, Dept Internal Med, Chapel Hill, NC USA; [Wu, Jennifer] Duke Univ, Sch Med, Dept Obstet & Gynecol, Durham, NC USA; [Brody, Debra J.] Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Utah System of Higher Education; University of Utah; Cleveland Clinic Foundation; University of Alabama System; University of Alabama Birmingham; Loyola University Chicago; Loyola University Chicago; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Nygaard, I (corresponding author), Univ Utah, Sch Med, Dept Obstet & Gynecol, 30 N 1900 E, Salt Lake City, UT 84132 USA.	ingrid.nygaard@hsc.utah.edu	Wu, Jennifer/GRX-1831-2022	Wu, Jennifer/0000-0002-3171-1054; Wu, Jennifer/0000-0002-4477-3932	Eunice Kennedy Shriver NICHD [U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, U10 HD41267, U10 HD54136, U10 HD54214, U10 HD54215]; National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health Office of Research on Women's Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U10HD054214, U10HD041250, U10HD054136, U10HD041267, U10HD041261, UG1HD041267, U10HD054215] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD041248, U01HD041249, U10HD041263, U10HD041269, U10HD041268] Funding Source: NIH RePORTER	Eunice Kennedy Shriver NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health Office of Research on Women's Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH Office of Research on Women's Health (ORWH)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by grants U01 HD41249, U10 HD41268, U10 HD41248, U10 HD41250, U10 HD41261, U10 HD41263, U10 HD41269, U10 HD41267, U10 HD54136, U10 HD54214, and U10 HD54215 from the Eunice Kennedy Shriver NICHD and funding from the National Institute of Diabetes and Digestive and Kidney Diseases and the National Institutes of Health Office of Research on Women's Health.	Abramov Y, 2005, OBSTET GYNECOL, V106, P726, DOI 10.1097/01.AOG.0000161367.65261.16; Anger JT, 2006, J UROLOGY, V175, P601, DOI 10.1016/S0022-5347(05)00242-9; [Anonymous], 2000, Eur J Obstet Gynecol Reprod Biol, V93, P135; Barber MD, 2006, AM J OBSTET GYNECOL, V195, P942, DOI 10.1016/j.ajog.2006.02.050; Barber MD, 2001, AM J OBSTET GYNECOL, V185, P1388, DOI 10.1067/mob.2001.118659; Bharucha AE, 2005, GASTROENTEROLOGY, V129, P42, DOI 10.1053/j.gastro.2005.04.006; Boreham MK, 2005, AM J OBSTET GYNECOL, V192, P1637, DOI 10.1016/j.ajog.2004.11.030; Bradley CS, 2005, OBSTET GYNECOL, V106, P759, DOI 10.1097/01.AOG.0000180183.03897.72; Dooley Y, 2008, J UROLOGY, V179, P656, DOI 10.1016/j.juro.2007.09.081; Ellerkmann RM, 2001, AM J OBSTET GYNECOL, V185, P1332, DOI 10.1067/mob.2001.119078; Eva UF, 2003, ACTA OBSTET GYN SCAN, V82, P280, DOI 10.1034/j.1600-0412.2003.00103.x; FANTL J, 1996, PUBLICATION US DEP H; Ghetti C, 2005, AM J OBSTET GYNECOL, V193, P53, DOI 10.1016/j.ajog.2004.12.004; Goode PS, 2005, J AM GERIATR SOC, V53, P629, DOI 10.1111/j.1532-5415.2005.53211.x; Graham CA, 2001, AM J OBSTET GYNECOL, V185, P116, DOI 10.1067/mob.2001.114914; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; Hendrix SL, 2002, AM J OBSTET GYNECOL, V186, P1160, DOI 10.1067/mob.2002.123819; Hunskaar S, 2005, INCONTINENCE, VOLS 1 AND 2, P255; Luber KM, 2001, AM J OBSTET GYNECOL, V184, P1496, DOI 10.1067/mob.2001.114868; Lukacz ES, 2006, OBSTET GYNECOL, V107, P1253, DOI 10.1097/01.AOG.0000218096.54169.34; MacLennan AH, 2000, BRIT J OBSTET GYNAEC, V107, P1460, DOI 10.1111/j.1471-0528.2000.tb11669.x; Mant J, 1997, BRIT J OBSTET GYNAEC, V104, P579, DOI 10.1111/j.1471-0528.1997.tb11536.x; Melville JL, 2005, OBSTET GYNECOL, V106, P585, DOI 10.1097/01.AOG.0000173985.39533.37; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Olsen AL, 1997, OBSTET GYNECOL, V89, P501, DOI 10.1016/S0029-7844(97)00058-6; Ostbye T, 2004, CAN J AGING, V23, P319, DOI 10.1353/cja.2005.0024; Quander CR, 2005, AM J GASTROENTEROL, V100, P905, DOI 10.1111/j.1572-0241.2005.30511.x; Rockwood TH, 2000, DIS COLON RECTUM, V43, P9, DOI 10.1007/BF02237236; Rockwood TH, 1999, DIS COLON RECTUM, V42, P1525, DOI 10.1007/BF02236199; Rortveit G, 2001, OBSTET GYNECOL, V98, P1004, DOI 10.1016/S0029-7844(01)01566-6; Samuelsson EC, 1999, AM J OBSTET GYNECOL, V180, P299, DOI 10.1016/S0002-9378(99)70203-6; Sandvik H, 2000, NEUROUROL URODYNAM, V19, P137, DOI 10.1002/(SICI)1520-6777(2000)19:2<137::AID-NAU4>3.0.CO;2-G; Sandvik H, 2006, INT UROGYNECOL J, V17, P520, DOI 10.1007/s00192-005-0060-z; Shah AD, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.042; Swift S, 2005, AM J OBSTET GYNECOL, V192, P795, DOI 10.1016/j.ajog.2004.10.602; Swift SE, 2003, AM J OBSTET GYNECOL, V189, P372, DOI 10.1067/S0002-9378(03)00698-7; Swithinbank LV, 1999, WORLD J UROL, V17, P225, DOI 10.1007/s003450050137; Teunissen TAM, 2004, INT UROGYNECOL J, V15, P10, DOI 10.1007/s00192-003-1106-8; Thom DH, 2006, J UROLOGY, V175, P259, DOI 10.1016/S0022-5347(05)00039-X; United States Census Bureau, US INT PROJ AG SEX R; Varma MG, 2006, DIS COLON RECTUM, V49, P841, DOI 10.1007/s10350-006-0535-0; Waetjen LE, 2007, AM J EPIDEMIOL, V165, P309, DOI 10.1093/aje/kwk018	42	1084	1121	1	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 17	2008	300	11					1311	1316		10.1001/jama.300.11.1311	http://dx.doi.org/10.1001/jama.300.11.1311			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348ST	18799443	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000259231100026
J	Robertson, NJ; Nakakeeto, M; Hagmann, C; Cowan, FM; Acolet, D; Iwata, O; Allen, E; Elbourne, D; Costello, A; Jacobs, I				Robertson, Nicola J.; Nakakeeto, Margaret; Hagmann, Cornelia; Cowan, Frances M.; Acolet, Dominique; Iwata, Osuke; Allen, Elizabeth; Elbourne, Diana; Costello, Anthony; Jacobs, Ian			Therapeutic hypothermia for birth asphyxia in low-resource settings: a pilot randomised controlled trial	LANCET			English	Letter							HYPOXIC-ISCHEMIC ENCEPHALOPATHY; NEONATAL ENCEPHALOPATHY; NEWBORN		[Robertson, Nicola J.; Nakakeeto, Margaret; Hagmann, Cornelia; Jacobs, Ian] Uganda Womens Hlth Initiat, Kampala, Uganda; [Robertson, Nicola J.; Hagmann, Cornelia; Iwata, Osuke; Jacobs, Ian] UCL, EGA UCL Inst Womens Hlth, London WC1E 7HX, England; [Nakakeeto, Margaret] Mulago Hosp, Neonatal Unit, Kampala, Uganda; [Cowan, Frances M.; Acolet, Dominique] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, Dept Paediat & Imaging Sci, London, England; [Allen, Elizabeth; Elbourne, Diana] London Sch Hyg & Trop Med, Med Stat Unit, London WC1, England; [Costello, Anthony] Inst Child Hlth, Int Perinatal Care Unit, London, England	University of London; University College London; Mulago National Referral Hospital; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London	Robertson, NJ (corresponding author), Uganda Womens Hlth Initiat, Kampala, Uganda.	n.robertson@ucl.ac.uk	Robertson, Nicola/GWR-2021-2022	Jacobs, Ian/0000-0002-5005-2672				BURNARD ED, 1958, BRIT MED J, V2, P1197, DOI 10.1136/bmj.2.5106.1197; Dubowitz L, 1998, J PEDIATR-US, V133, P406, DOI 10.1016/S0022-3476(98)70279-3; Ellis M, 2000, BMJ-BRIT MED J, V320, P1229, DOI 10.1136/bmj.320.7244.1229; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Horn AR, 2006, SAMJ S AFR MED J, V96, P976; IWATA S, IN PRESS ARCH DIS CH; JACOBS S, 2007, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD003311.PUB2; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; SCHULZKE S, 2007, BMC PEDIAT, V5, P30; Shah PS, 2007, ARCH PEDIAT ADOL MED, V161, P951, DOI 10.1001/archpedi.161.10.951; Shankaran S, 2005, NEW ENGL J MED, V353, P1574, DOI 10.1056/NEJMcps050929; Thompson CM, 1997, ACTA PAEDIATR, V86, P757, DOI 10.1111/j.1651-2227.1997.tb08581.x	12	130	136	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 6	2008	372	9641					801	803		10.1016/S0140-6736(08)61329-X	http://dx.doi.org/10.1016/S0140-6736(08)61329-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	347FB	18774411				2022-12-28	WOS:000259124900015
J	Inomata, H; Haraguchi, T; Sasai, Y				Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki			Robust stability of the embryonic axial pattern requires a secreted scaffold for chordin degradation	CELL			English	Article							DORSALIZING-MORPHOGENETIC-PROTEIN; SPEMANN ORGANIZER; NEURAL INDUCTION; XENOPUS EMBRYOS; GASTRULATION; INHIBITION; MOVEMENTS; CLEAVAGE; SIGNALS; BIOLOGY	Dorsal axial formation during vertebrate embryogenesis exhibits robust resistance to perturbations in patterning signals. However, how such stability is supported at the molecular level remains largely elusive. Here we show that Xenopus ONT1, an Olfactomedin-class secreted protein, stabilizes axial formation by restricting Chordin activity on the dorsal side. When ONT1 function is attenuated, the embryo becomes hyperdorsalized by a normally subeffective dose of Chordin. ONT1 binds Chordin and BMP1/Tolloid-class proteinases (B1TP) via distinct domains and acts as a secreted scaffold that enhances B1TP-mediated Chordin degradation by facilitating enzyme-substrate association. ONT1 is indispensable for fine-tuning BMP signaling in the axial tissue, and a similar role has been suggested for dorsally expressed BMPs such as ADMP. Simultaneous inhibition of ONT1 and dorsally expressed BMPs (ADMP and BMP2) synergistically caused drastic dorsalization. These results indicate that stable axial formation depends on two compensatory regulatory pathways involving ONT1/B1TP and dorsally expressed BMPs.	[Inomata, Hidehiko; Haraguchi, Tomoko; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan	RIKEN	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Inomata, Hidehiko/N-7390-2015		MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We would like to thank Drs. M. Hibi and G. Sheng for invaluable comments, Dr. L. Dale for the Xlr plasmid, Drs. N. Sasai and M. Ikeya for critical reading, Dr. M. Sakuragi for chick ONT1 information, and Ms. M. Suzuki for Xenopus husbandry. This work was supported by grants in aid from MEXT, the Kobe Cluster Project, and the Leading Project (Y. S.).	Barembaum M, 2000, NAT CELL BIOL, V2, P219, DOI 10.1038/35008643; Blitz IL, 2000, DEV BIOL, V223, P120, DOI 10.1006/dbio.2000.9740; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; COOKE J, 1975, J EMBRYOL EXP MORPH, V33, P147; COOKE J, 1973, J EMBRYOL EXP MORPH, V30, P49; De Robertis EM, 2004, ANNU REV CELL DEV BI, V20, P285, DOI 10.1146/annurev.cellbio.20.011403.154124; Dosch R, 2000, MECH DEVELOP, V90, P195, DOI 10.1016/S0925-4773(99)00245-2; FERRELL JE, 2000, SCI STKE, pPE1; GALLERA J, 1974, EXPERIENTIA, V30, P183, DOI 10.1007/BF01927723; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ge Gaoxiang, 2006, Birth Defects Research, V78, P47, DOI 10.1002/bdrc.20060; Heasman J, 2006, DEVELOPMENT, V133, P1205, DOI 10.1242/dev.02304; Horikawa K, 2006, NATURE, V441, P719, DOI 10.1038/nature04861; Joubin K, 1999, CELL, V98, P559, DOI 10.1016/S0092-8674(00)80044-6; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kitano H, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100179; Lee HX, 2006, CELL, V124, P147, DOI 10.1016/j.cell.2005.12.018; Lele Z, 2001, DEV DYNAM, V222, P681, DOI 10.1002/dvdy.1222; Marom K, 2005, DEV BIOL, V282, P442, DOI 10.1016/j.ydbio.2005.03.024; Moos M, 1995, DEVELOPMENT, V121, P4293; Muraoka O, 2006, NAT CELL BIOL, V8, P329, DOI 10.1038/ncb1379; Niehrs C, 2002, NATURE, V417, P35, DOI 10.1038/417035a; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; Piccolo S, 1997, CELL, V91, P407, DOI 10.1016/S0092-8674(00)80424-9; Plouhinec JL, 2007, MOL BIOSYST, V3, P454, DOI 10.1039/b701571b; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Sakuragi M, 2006, MECH DEVELOP, V123, P114, DOI 10.1016/j.mod.2005.11.005; Salic AN, 1997, DEVELOPMENT, V124, P4739; Spemann H, 1903, ARCH ENTWICKLUNG ORG, V16, P551, DOI 10.1007/BF02301267; Spemann H, 2001, INT J DEV BIOL, V45, P13; Tsuda H, 2002, NEURON, V33, P515, DOI 10.1016/S0896-6273(02)00590-1; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Zenga LC, 2005, FEBS LETT, V579, P5443, DOI 10.1016/j.febslet.2005.08.064	34	86	92	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					854	865		10.1016/j.cell.2008.07.008	http://dx.doi.org/10.1016/j.cell.2008.07.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775317	Bronze			2022-12-28	WOS:000258947500024
J	Yoder, A; Yu, DY; Dong, L; Iyer, SR; Xu, XH; Kelly, J; Liu, J; Wang, WF; Vorster, PJ; Agulto, L; Stephany, DA; Cooper, JN; Marsh, JW; Wu, YT				Yoder, Alyson; Yu, Dongyang; Dong, Li; Iyer, Subashini R.; Xu, Xuehua; Kelly, Jeremy; Liu, Juan; Wang, Weifeng; Vorster, Paul J.; Agulto, Liane; Stephany, David A.; Cooper, James N.; Marsh, Jon W.; Wu, Yuntao			HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells	CELL			English	Article							IMMUNOLOGICAL SYNAPSE; CHEMOKINE; PROTEIN; ENTRY; NEF; LYMPHOCYTES; INFECTION; COMPLEX; CXCR4; PHOSPHORYLATION	Binding of the HIV envelope to the chemokine coreceptors triggers membrane fusion and signal transduction. The fusion process has been well characterized, yet the role of coreceptor signaling remains elusive. Here, we describe a critical function of the chemokine coreceptor signaling in facilitating HIV infection of resting CD4 T cells. We find that static cortical actin in resting T cells represents a restriction and that HIV utilizes the G alpha i-dependent signaling from the chemokine coreceptor CXCR4 to activate a cellular actin-depolymerizing factor, cofilin, to overcome this restriction. HIV envelope-mediated cofilin activation and actin dynamics are important for a postentry process that leads to viral nuclear localization. Inhibition of HIV-mediated actin rearrangement markedly diminishes viral latent infection of resting T cells. Conversely, induction of active cofilin greatly facilitates it. These findings shed light on viral exploitation of cellular machinery in resting T cells, where chemokine receptor signaling becomes obligatory.	[Marsh, Jon W.; Wu, Yuntao] NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA; [Yoder, Alyson; Yu, Dongyang; Dong, Li; Iyer, Subashini R.; Kelly, Jeremy; Liu, Juan; Wang, Weifeng; Vorster, Paul J.; Agulto, Liane; Cooper, James N.] George Mason Univ, Dept Mol & Microbiol, Manassas, VA 20110 USA; [Xu, Xuehua] NIAID, Immunogenet Lab, NIH, Rockville, MD 20851 USA; [Stephany, David A.] NIAID, Flow Cytometry Sect, NIH, Bethesda, MD 20892 USA; [Marsh, Jon W.; Wu, Yuntao] NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); George Mason University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)	Marsh, JW (corresponding author), NIMH, Sect Mol Virol, Lab Cellular & Mol Regulat, Bethesda, MD 20892 USA.	marshj@mail.nih.gov; ywu8@gmu.edu	xu, xuehua/R-1163-2019; wang, weifeng/N-4140-2013	xu, xuehua/0000-0002-3863-9593; Love, Zelda/0000-0002-2478-7720	National Defense Science and Engineering Fellowship; GMU; NIMH/NIH; NIAID [AI069981]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002629] Funding Source: NIH RePORTER	National Defense Science and Engineering Fellowship(United States Department of Defense); GMU; NIMH/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank the George Mason University (GMU) Student Health Center; the Department of Transfusion Medicine, the National Institutes of Health (NIH); V. Chandhoke and C. Bailey for blood donation; the NIH AIDS Research and Reference Reagent Program for reagents; H. A. Nash of the National Institute of Mental Health (NIMH)/NIH; K. Jeang of the National Institute of Allergy and Infectious Diseases (NIAID)/NIH; D. Rekosh of the University of Virginia; L. Liotta, E. Petricoin and D. Cox for comments; T. Meckel and T. Jin of NIAID/NIH for confocal microscopy and imaging analyses; K. L. Holmes of NIAID/NIH for fusion assay; A. Biancotto and L. Margolis of the National Institute of Child Health and Human Development/NIH for tonsillar T cells; Y. Samstag for protocols; and A. Wu for digital graphic design. A. Y. was supported by the National Defense Science and Engineering Fellowship. This work was supported by GMU, the Intramural Program of the NIMH/NIH, and in part by the Public Health Service grant AI069981 from NIAID to Y. W.	Alkhatib G, 1997, VIROLOGY, V234, P340, DOI 10.1006/viro.1997.8673; Ambach A, 2000, EUR J IMMUNOL, V30, P3422, DOI 10.1002/1521-4141(2000012)30:12<3422::AID-IMMU3422>3.0.CO;2-J; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Babcock GJ, 2001, J BIOL CHEM, V276, P38433, DOI 10.1074/jbc.M106229200; Balabanian K, 2004, J IMMUNOL, V173, P7150, DOI 10.4049/jimmunol.173.12.7150; Bamburg JR, 2002, TRENDS CELL BIOL, V12, P598, DOI 10.1016/S0962-8924(02)02404-2; BAMBURG JR, 1980, FEBS LETT, V121, P178, DOI 10.1016/0014-5793(80)81292-0; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Bukrinskaya A, 1998, J EXP MED, V188, P2113, DOI 10.1084/jem.188.11.2113; Cameron LA, 2000, NAT REV MOL CELL BIO, V1, P110, DOI 10.1038/35040061; Campbell EM, 2004, J VIROL, V78, P5745, DOI 10.1128/JVI.78.11.5745-5755.2004; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Cicala C, 2002, P NATL ACAD SCI USA, V99, P9380, DOI 10.1073/pnas.142287999; Cocchi F, 1996, NAT MED, V2, P1244, DOI 10.1038/nm1196-1244; DE BP, 1993, J BIOL CHEM, V268, P5703; Eckstein DA, 2001, IMMUNITY, V15, P671, DOI 10.1016/S1074-7613(01)00217-5; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; FENYO EM, 1988, J VIROL, V62, P4414; Ganesh L, 2003, NATURE, V426, P853, DOI 10.1038/nature02171; Gerlach LO, 2001, J BIOL CHEM, V276, P14153, DOI 10.1074/jbc.M010429200; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; GRAY LS, 1989, J IMMUNOL, V142, P1631; HOTTIGER M, 1995, NUCLEIC ACIDS RES, V23, P736; Kreisberg JF, 2006, J EXP MED, V203, P865, DOI 10.1084/jem.20051856; KUBBIES M, 1989, EUR J IMMUNOL, V19, P1393, DOI 10.1002/eji.1830190807; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Liu R, 1996, CELL, V86, P367, DOI 10.1016/S0092-8674(00)80110-5; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Naghavi MH, 2005, GENE DEV, V19, P1105, DOI 10.1101/gad.1290005; Naghavi MH, 2007, EMBO J, V26, P41, DOI 10.1038/sj.emboj.7601475; Nishimura Y, 2005, P NATL ACAD SCI USA, V102, P8000, DOI 10.1073/pnas.0503233102; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; SAMSTAG Y, 1994, P NATL ACAD SCI USA, V91, P4494, DOI 10.1073/pnas.91.10.4494; Schrager JA, 1999, P NATL ACAD SCI USA, V96, P8167, DOI 10.1073/pnas.96.14.8167; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Spina CA, 1997, J CLIN INVEST, V99, P1774, DOI 10.1172/JCI119342; Symons M, 1996, CELL, V84, P723, DOI 10.1016/S0092-8674(00)81050-8; Tobiume M, 2003, J VIROL, V77, P10645, DOI 10.1128/JVI.77.19.10645-10650.2003; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Wilk T, 1999, J VIROL, V73, P1931, DOI 10.1128/JVI.73.3.1931-1940.1999; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu Y, 2007, CURR HIV RES, V5, P394; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	48	215	220	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					782	792		10.1016/j.cell.2008.06.036	http://dx.doi.org/10.1016/j.cell.2008.06.036			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775311	Bronze, Green Accepted			2022-12-28	WOS:000258947500018
J	Rowland, HD; King, WP; Pethica, JB; Cross, GLW				Rowland, Harry D.; King, William P.; Pethica, John B.; Cross, Graham L. W.			Molecular Confinement Accelerates Deformation of Entangled Polymers During Squeeze Flow	SCIENCE			English	Article							VISCOSITY; BEHAVIOR; MELTS; SIZE	The squeezing of polymers in narrow gaps is important for the dynamics of nanostructure fabrication by nanoimprint embossing and the operation of polymer boundary lubricants. We measured stress versus strain behavior while squeezing entangled polystyrene films to large strains. In confined conditions where films were prepared to a thickness less than the size of the bulk macromolecule, resistance to deformation was markedly reduced for both solid- glass forging and liquid- melt molding. For melt flow, we further observed a complete inversion of conventional polymer viscosity scaling with molecular weight. Our results show that squeeze flow is accelerated at small scales by an unexpected influence of film thickness in polymer materials.	[Pethica, John B.; Cross, Graham L. W.] Univ Dublin Trinity Coll, Sch Phys, Dublin 2, Ireland; [Pethica, John B.; Cross, Graham L. W.] Univ Dublin Trinity Coll, CRANN, Dublin 2, Ireland; [Rowland, Harry D.; King, William P.] Univ Illinois, Dept Mech Sci & Engn, Urbana, IL 61801 USA	Trinity College Dublin; Trinity College Dublin; University of Illinois System; University of Illinois Urbana-Champaign	Cross, GLW (corresponding author), Univ Dublin Trinity Coll, Sch Phys, Dublin 2, Ireland.	graham.cross@tcd.ie	Cross, Graham LW/B-9447-2008; Cross, Graham/AAC-6310-2022	Cross, Graham LW/0000-0003-2299-6091; King, William/0000-0001-8606-1290	Science Foundation of Ireland [00/PI.1/C028]; NSF [CMMI 07-32114, DMI 0328162]; Center for Nanoscale Chemical-Electrical-Mechanical Manufacturing Systems; NSF Faculty Early Career Development [CBET 07- 31930]; U.S. Department of Energy Presidential Early Career Award for Scientists and Engineers	Science Foundation of Ireland(Science Foundation Ireland); NSF(National Science Foundation (NSF)); Center for Nanoscale Chemical-Electrical-Mechanical Manufacturing Systems; NSF Faculty Early Career Development(National Science Foundation (NSF)); U.S. Department of Energy Presidential Early Career Award for Scientists and Engineers(United States Department of Energy (DOE))	Supported by Science Foundation of Ireland grant 00/PI.1/C028, NSF grants CMMI 07-32114 and DMI 0328162, the Center for Nanoscale Chemical-Electrical-Mechanical Manufacturing Systems, NSF Faculty Early Career Development grant CBET 07- 31930, and a U. S. Department of Energy Presidential Early Career Award for Scientists and Engineers. H.D. R. is vice president for engineering, Endotronix Inc., Peoria, IL.	Bach A, 2003, J RHEOL, V47, P429, DOI 10.1122/1.1545072; BOYCE MC, 1997, PHYS GLASSY POLYM, P213; Brown HR, 1996, MACROMOLECULES, V29, P798, DOI 10.1021/ma951123k; Chou SY, 1996, SCIENCE, V272, P85, DOI 10.1126/science.272.5258.85; Crist B., 1997, PHYS GLASSY POLYM, P155; Cross GLW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1868074; Cross GLW, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2830028; Cross GLW, 2006, J PHYS D APPL PHYS, V39, pR363, DOI 10.1088/0022-3727/39/20/R01; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Doi M., 1988, THEORY POLYM DYNAMIC; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Engmann J, 2005, J NON-NEWTON FLUID, V132, P1, DOI 10.1016/j.jnnfm.2005.08.007; Forrest SR, 2004, NATURE, V428, P911, DOI 10.1038/nature02498; Frank B, 1996, MACROMOLECULES, V29, P6531, DOI 10.1021/ma960749n; Guo LJ, 2004, J PHYS D APPL PHYS, V37, pR123, DOI 10.1088/0022-3727/37/11/R01; Heyderman LJ, 2000, MICROELECTRON ENG, V54, P229, DOI 10.1016/S0167-9317(00)00414-7; KAWANA S, 2001, PHYS REV E STAT NONL, V63; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Macosko C. W., 1994, RHEOLOGY PRINCIPLES; Nielsen JK, 2006, J RHEOL, V50, P453, DOI 10.1122/1.2206711; PEANASKY J, 1994, LANGMUIR, V10, P3874, DOI 10.1021/la00022a078; Rowland HD, 2008, ACS NANO, V2, P419, DOI 10.1021/nn700211g; Rowland HD, 2005, J MICROMECH MICROENG, V15, P2414, DOI 10.1088/0960-1317/15/12/025; Scheer HC, 2001, P SOC PHOTO-OPT INS, V4349, P86, DOI 10.1117/12.425080; Schuh CA, 2007, ACTA MATER, V55, P4067, DOI 10.1016/j.actamat.2007.01.052; Schulz H, 2003, MICROELECTRON ENG, V67-8, P657, DOI 10.1016/S0167-9317(03)00128-X; Si L, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.127801; Sills S, 2004, J CHEM PHYS, V120, P5334, DOI 10.1063/1.1647047; Stafford CM, 2004, NAT MATER, V3, P545, DOI 10.1038/nmat1175; Tapadia P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.016001; Tuteja A, 2007, MACROMOLECULES, V40, P9427, DOI 10.1021/ma071313i; Wang SQ, 1999, ADV POLYM SCI, V138, P227; WU JBC, 1976, J MATER SCI, V11, P434, DOI 10.1007/BF00540924	33	104	110	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 31	2008	322	5902					720	724		10.1126/science.1157945	http://dx.doi.org/10.1126/science.1157945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	368EW	18832609				2022-12-28	WOS:000260605200042
J	Heath, I				Heath, Iona			The emperor's new constitution	BRITISH MEDICAL JOURNAL			English	Editorial Material												iona.heath@dsl.pipex.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1857	10.1136/bmj.a1857	http://dx.doi.org/10.1136/bmj.a1857			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18826974				2022-12-28	WOS:000259798000031
J	Berenbaum, MR; Eisner, T				Berenbaum, May R.; Eisner, Thomas			Ecology - Bugs' bugs	SCIENCE			English	Editorial Material									[Berenbaum, May R.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Eisner, Thomas] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	University of Illinois System; University of Illinois Urbana-Champaign; Cornell University	Berenbaum, MR (corresponding author), Univ Illinois, Dept Entomol, 320 Morrill Hall, Urbana, IL 61801 USA.	maybe@life.uiuc.edu; te14@cornell.edu						Currie CR, 2006, SCIENCE, V311, P81, DOI 10.1126/science.1119744; ERWIN T L, 1980, Coleopterists Bulletin, V34, P305; Linnaeus C, 1766, SYSTEMA NATURAE REGN; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Scott JJ, 2008, SCIENCE, V322, P63, DOI 10.1126/science.1160423; ZIMMERMANN JO, 1868, T AM ENTOMOL SOC, V2, P141	6	22	24	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 3	2008	322	5898					52	53		10.1126/science.1164873	http://dx.doi.org/10.1126/science.1164873			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832633				2022-12-28	WOS:000259680200030
J	Cassou, C				Cassou, Christophe			Intraseasonal interaction between the Madden-Julian Oscillation and the North Atlantic Oscillation	NATURE			English	Article							WEATHER REGIMES; ATMOSPHERIC BLOCKING; VARIABILITY; PREDICTION; WAVE; DYNAMICS; PATTERNS; WINTER; FLOW; NAO	Bridging the traditional gap between the spatio- temporal scales of weather and climate is a significant challenge facing the atmospheric community. In particular, progress in both medium- range and seasonal- to- interannual climate prediction relies on our understanding of recurrent weather patterns and the identification of specific causes responsible for their favoured occurrence, persistence or transition. Within this framework, I here present evidence that the main climate intra- seasonal oscillation in the tropics - the Madden - Julian Oscillation(1,2) ( MJO) - controls part of the distribution and sequences of the four daily weather regimes defined over the North Atlantic - European region in winter(3). North Atlantic Oscillation(4) ( NAO) regimes are the most affected, allowing for medium- range predictability of their phase far exceeding the limit of around one week that is usually quoted. The tropical - extratropical lagged relationship is asymmetrical. Positive NAO events mostly respond to a mid- latitude low- frequency wave train initiated by the MJO in the western - central tropical Pacific and propagating eastwards. Precursors for negative NAO events are found in the eastern tropical Pacific - western Atlantic, leading to changes along the North Atlantic storm track. Wave- breaking diagnostics tend to support the MJO preconditioning and the role of transient eddies in setting the phase of the NAO. I present a simple statistical model to quantitatively assess the potential predictability of the daily NAO index or the sign of the NAO regimes when they occur. Forecasts are successful in similar to 70 per cent of the cases based on the knowledge of the previous similar to 12- day MJO phase used as a predictor. This promising skill could be of importance considering the tight link(4) between weather regimes and both mean conditions and the chances of extreme events occurring over Europe. These findings are useful for further stressing the need to better simulate and forecast the tropical coupled ocean - atmosphere dynamics, which is a source of medium- to- long range predictability and is the Achilles' heel of the current seamless prediction suites(5-7).	[Cassou, Christophe] CERFACS, CNRS, Global Change & Climate Modelling Project, F-31057 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CERFACS	Cassou, C (corresponding author), CERFACS, CNRS, Global Change & Climate Modelling Project, 42 Ave G Coriolis, F-31057 Toulouse, France.	cassou@cerfacs.fr	CASSOU, Christophe/AAP-6409-2020		CNRS; European Union's Sixth Framework Programme ( DYNAMITE and ENSEMBLES)	CNRS(Centre National de la Recherche Scientifique (CNRS)); European Union's Sixth Framework Programme ( DYNAMITE and ENSEMBLES)(European Commission)	The author wishes to thank L. Terray, G. Riviere, R. Madden, G. Madec and C. Perigaud for discussions. The author also thanks F. Chauvin, H. Douville and S. Valcke for comments on the manuscript. The author is very grateful to O. Mestre and J.- P. Ceron for their help with statistics. The figures were produced using the NCL software developed at NCAR. This work was supported by CNRS and by the European Union's Sixth Framework Programme ( DYNAMITE and ENSEMBLES).	Benedict JJ, 2004, J ATMOS SCI, V61, P121, DOI 10.1175/1520-0469(2004)061<0121:SVOTNA>2.0.CO;2; Croci-Maspoli M, 2007, CLIM DYNAM, V29, P713, DOI 10.1007/s00382-007-0259-4; Feldstein SB, 2003, Q J ROY METEOR SOC, V129, P901, DOI 10.1256/qj.02.76; FERRANTI L, 1990, J ATMOS SCI, V47, P2177, DOI 10.1175/1520-0469(1990)047<2177:TEIAWT>2.0.CO;2; Franzke C, 2004, J ATMOS SCI, V61, P145, DOI 10.1175/1520-0469(2004)061<0145:ITNAOA>2.0.CO;2; Higgins RW, 1997, J CLIMATE, V10, P223, DOI 10.1175/1520-0442(1997)010<0223:PNPCAA>2.0.CO;2; HOSKINS BJ, 1993, J ATMOS SCI, V50, P1661, DOI 10.1175/1520-0469(1993)050<1661:RWPOAR>2.0.CO;2; HURRELL JW, 1995, SCIENCE, V269, P676, DOI 10.1126/science.269.5224.676; Lin JL, 2006, J CLIMATE, V19, P2665, DOI 10.1175/JCLI3735.1; MADDEN RA, 1994, MON WEATHER REV, V112, P1109; Matthews AJ, 2004, Q J ROY METEOR SOC, V130, P1991, DOI 10.1256/qj.02.123; MICHELANGELI PA, 1995, J ATMOS SCI, V52, P1237, DOI 10.1175/1520-0469(1995)052<1237:WRRAQS>2.0.CO;2; Molteni F, 2006, PREDICTABILITY OF WEATHER AND CLIMATE, P365, DOI 10.1017/CBO9780511617652.015; Philipp A, 2007, J CLIMATE, V20, P4065, DOI 10.1175/JCLI4175.1; REINHOLD BB, 1982, MON WEATHER REV, V110, P1105, DOI 10.1175/1520-0493(1982)110<1105:DOWRQS>2.0.CO;2; Riviere G, 2007, J ATMOS SCI, V64, P241, DOI 10.1175/JAS3850.1; SARDESHMUKH PD, 1988, J ATMOS SCI, V45, P1228, DOI 10.1175/1520-0469(1988)045<1228:TGOGRF>2.0.CO;2; Scherrer SC, 2006, INT J CLIMATOL, V26, P233, DOI 10.1002/joc.1250; SIMON SJ, 2008, SEASONAL CLIMATE FOR, P163; Slonosky VC, 2001, GEOPHYS RES LETT, V28, P807, DOI 10.1029/2000GL012063; Straus DM, 2007, J CLIMATE, V20, P2251, DOI 10.1175/JCLI4070.1; Tyrrell C, 1996, J ATMOS SCI, V53, P2735, DOI 10.1175/1520-0469(1996)053<2735:LBTCAV>2.0.CO;2; VAUTARD R, 1990, MON WEATHER REV, V118, P2056, DOI 10.1175/1520-0493(1990)118<2056:MWROTN>2.0.CO;2; Vitart F, 2007, MON WEATHER REV, V135, P2700, DOI 10.1175/MWR3415.1; Waliser D, 2006, B AM METEOROL SOC, V87, P425, DOI 10.1175/BAMS-87-4-425; Wheeler MC, 2004, MON WEATHER REV, V132, P1917, DOI 10.1175/1520-0493(2004)132<1917:AARMMI>2.0.CO;2; Woollings T, 2008, J ATMOS SCI, V65, P609, DOI 10.1175/2007JAS2347.1; Zhang CD, 2005, REV GEOPHYS, V43, DOI 10.1029/2004RG000158; Zhou ST, 2005, J CLIMATE, V18, P143, DOI 10.1175/JCLI3251.1	29	492	508	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					523	527		10.1038/nature07286	http://dx.doi.org/10.1038/nature07286			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818656				2022-12-28	WOS:000259449600044
J	Lieberman, DA; Holub, JL; Moravec, MD; Eisen, GM; Peters, D; Morris, CD				Lieberman, David A.; Holub, Jennifer L.; Moravec, Matthew D.; Eisen, Glenn M.; Peters, Dawn; Morris, Cynthia D.			Prevalence of colon polyps detected by colonoscopy screening in asymptomatic black and white patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COLORECTAL-CANCER; AFRICAN-AMERICANS; ANATOMICAL DISTRIBUTION; MEDICARE POPULATION; ADENOMATOUS POLYPS; UNITED-STATES; SURVEILLANCE; LOCATION; PATTERNS; GENDER	Context Compared with white individuals, black men and women have a higher incidence and mortality from colorectal cancer and may develop cancer at a younger age. Colorectal cancer screening might be less effective in black individuals, if there are racial differences in the age- adjusted prevalence and location of cancer precursor lesions. Objectives To determine and compare the prevalence rates and location of polyps sized more than 9 mm in diameter in asymptomatic black and white individuals who received colonoscopy screening. Design, Setting, and Patients Colonoscopy data were prospectively collected from 67 adult gastrointestinal practice sites in the United States using a computerized endoscopic report generator between January 1, 2004, and December 31, 2005. Data were transmitted to a central data repository, where all asymptomatic white ( n = 80 061) and black ( n= 5464) patients who had received screening colonoscopy were identified. Main Outcome Measures Prevalence and location of polyps sized more than 9 mm, adjusted for age, sex, and family history of colorectal cancer in a multivariate analysis. Results Both black men and women had a higher prevalence of polyps sized more than 9 mm in diameter compared with white men and women ( 422 [ 7.7%] vs 4964 [ 6.2%]; P <. 001). Compared with white patients, the adjusted odds ratio ( OR) for black men was 1.16 ( 95% confidence interval [ CI], 1.01- 1.34) and the adjusted OR for black women was 1.62 ( 95% CI, 1.39- 1.89). Black and white patients had a similar risk of proximal polyps sized more than 9 mm( OR, 1.13; 95% CI, 0.93- 1.38). However, in a subanalysis of patients older than 60 years, proximal polyps sized more than 9 mm were more likely prevalent in black men ( P=. 03) and women ( P <. 001) compared with white men and women. Conclusion Compared with white individuals, black men and women undergoing screening colonoscopy have a higher risk of polyps sized more than 9 mm, and black individuals older than 60 years are more likely to have proximal polyps sized more than 9 mm.	[Lieberman, David A.] Portland VA Med Ctr, Div Gastroenterol, Portland, OR 97239 USA; [Lieberman, David A.; Holub, Jennifer L.; Moravec, Matthew D.; Eisen, Glenn M.] Oregon Hlth & Sci Univ, Div Gastroenterol & Hepatol, Portland, OR 97201 USA; [Peters, Dawn] Oregon Hlth & Sci Univ, Div Biostat, Dept Publ Hlth & Prevent Med, Portland, OR 97201 USA; [Morris, Cynthia D.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University	Lieberman, DA (corresponding author), Portland VA Med Ctr, Div Gastroenterol, 1037 SW Vet Hosp Rd,P3-GI, Portland, OR 97239 USA.	lieberma@ohsu.edu			National Institute of Diabetes and Digestive and Kidney Diseases [UO1 DK57132, R33-DK61778-01]; AstraZeneca; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R33DK061778, U01DK057132] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants UO1 DK57132 and R33-DK61778-01 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) since 1999, and funding from AstraZeneca.	Agrawal S, 2005, AM J GASTROENTEROL, V100, P1432; Agrawal S, 2005, AM J GASTROENTEROL, V100, P515, DOI 10.1111/j.1572-0241.2005.41829.x; Ananthakrishnan AN, 2007, ARCH INTERN MED, V167, P258, DOI 10.1001/archinte.167.3.258; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; FENNERTY MB, 1993, AM J GASTROENTEROL, V88, P496; Imperiale TF, 2000, NEW ENGL J MED, V343, P169, DOI 10.1056/NEJM200007203430302; Jass JR, 2004, CLIN GASTROENTEROL H, V2, P1, DOI 10.1016/S1542-3565(03)00284-2; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; JEPSON C, 1991, AM J PUBLIC HEALTH, V81, P501, DOI 10.2105/AJPH.81.4.501; JOHNSON H, 1986, CANCER, V58, P997, DOI 10.1002/1097-0142(19860815)58:4<997::AID-CNCR2820580435>3.0.CO;2-2; Kim DH, 2007, AM J ROENTGENOL, V188, P940, DOI 10.2214/AJR.06.0764; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Lieberman DA, 2000, NEW ENGL J MED, V343, P162, DOI 10.1056/NEJM200007203430301; McMahon LF, 1999, MED CARE, V37, P712, DOI 10.1097/00005650-199907000-00011; Nelson RL, 1997, CANCER-AM CANCER SOC, V80, P193, DOI 10.1002/(SICI)1097-0142(19970715)80:2<193::AID-CNCR4>3.0.CO;2-V; OZICK LA, 1995, AM J GASTROENTEROL, V90, P758; Regula J, 2006, NEW ENGL J MED, V355, P1863, DOI 10.1056/NEJMoa054967; Rex DK, 2000, GASTROINTEST ENDOSC, V51, P524, DOI 10.1016/S0016-5107(00)70283-5; Schoen RE, 1997, GASTROINTEST ENDOSC, V46, P492, DOI 10.1016/S0016-5107(97)70002-6; Sonnenberg A, 2008, GASTROINTEST ENDOSC, V67, P489, DOI 10.1016/j.gie.2007.08.041; Theuer CP, 2001, GASTROENTEROLOGY, V120, P848, DOI 10.1053/gast.2001.22535; THOMAS CR, 1992, ARCH SURG-CHICAGO, V127, P1241; Thornton JG, 2007, J NATL MED ASSOC, V99, P723; Weber TK, 1999, JAMA-J AM MED ASSOC, V281, P2316, DOI 10.1001/jama.281.24.2316	24	159	161	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1417	1422		10.1001/jama.300.12.1417	http://dx.doi.org/10.1001/jama.300.12.1417			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812532	Green Accepted, Bronze			2022-12-28	WOS:000259410400019
J	Houpt, ER; Guerrant, RL				Houpt, Eric R.; Guerrant, Richard L.			Technology in global health: the need for essential diagnostics	LANCET			English	Editorial Material									[Houpt, Eric R.; Guerrant, Richard L.] Univ Virginia, Sch Med, Ctr Global Hlth, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA	University of Virginia	Houpt, ER (corresponding author), Univ Virginia, Sch Med, Ctr Global Hlth, Div Infect Dis & Int Hlth, Charlottesville, VA 22908 USA.	erh6k@virginia.edu			NIAID NIH HHS [R01 AI071373, R01 AI071373-04] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI071373] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barry M, 2008, NEW ENGL J MED, V359, P784, DOI 10.1056/NEJMp0804650; Checkley W, 2008, INT J EPIDEMIOL, V37, P816, DOI 10.1093/ije/dyn099; Cohen J, 2006, SCIENCE, V311, P162, DOI 10.1126/science.311.5758.162; Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229; Guerrant RL, 2008, NUTR REV, V66, P487, DOI 10.1111/j.1753-4887.2008.00082.x; KAUFMAN L, 1968, APPL MICROBIOL, V16, P1907, DOI 10.1128/AEM.16.12.1907-1912.1968; Kisenge PR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-39; Reidenberg MM, 2007, CLIN PHARMACOL THER, V81, P603, DOI 10.1038/sj.clpt.6100106; Ricci Karen A, 2006, Nature, V444 Suppl 1, P29	9	12	12	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					873	874		10.1016/S0140-6736(08)61377-X	http://dx.doi.org/10.1016/S0140-6736(08)61377-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790297	Green Accepted			2022-12-28	WOS:000259266900009
J	Tollman, SM; Kahn, K; Sartorius, B; Collinson, MA; Clark, SJ; Garenne, ML				Tollman, Stephen M.; Kahn, Kathleen; Sartorius, Benn; Collinson, Mark A.; Clark, Samuel J.; Garenne, Michel L.			Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study	LANCET			English	Article							RISK-FACTORS; DEMOGRAPHIC SURVEILLANCE; STROKE; HYPERTENSION; TUBERCULOSIS; PREVALENCE; AGINCOURT; DISEASE; BURDEN; TRENDS	Background In southern Africa, a substantial health transition is underway, with the heavy burden of chronic infectious illness (HIV/AIDS and tuberculosis) paralleled by the growing threat of non-communicable diseases. We investigated the extent and nature of this health transition and considered the implications for primary health care. Methods Health and sociodemographic surveillance started in the Agincourt subdistrict, rural South Africa, in 1992. In a population of 70000, deaths (n=6153) were rigorously monitored with a validated verbal autopsy instrument to establish probable cause. We used age-standardised analyses to investigate the dynamics of the mortality transition by comparing the period 2002-05 with 1992-94. Findings Mortality from chronic non-communicable disease ranked highest in adults aged 50 years and older in 1992-94 (41% of deaths [123/298]), whereas acute diarrhoea and malnutrition accounted for 37% of deaths (59/158) in children younger than 5 years. Since then, all-cause mortality increased substantially (risk ratio 1.87 [95% CI 1 . 73-2.03]; p<0.0001) because of a six-fold rise in deaths from infectious disease affecting most age and sex groups (5.98 [4.85-7.38]; p<0 . 0001), and a modest increase in deaths from non-communicable disease (1 . 15 [0.99-1.33]; p=0.066). The change in female risk of death from HIV and tuberculosis (15.06 [8.88-27.76]; p<0 . 0001) was almost double that of the change in male risk (8.13 [5.55-12.36]; p<0 . 0001). The burden of disorders requiring chronic care increased disproportionately compared with that requiring acute care (2.63 [2.30-3 . 01]; p<0. 0001 vs 1 . 31 [1.12-1.55]; p=0 . 0003). Interpretation Mortality from non-communicable disease remains prominent despite the sustained increase in deaths from chronic infectious disease. The implications for primary health-care systems are substantial, with integrated chronic care based on scaled-up delivery of antiretroviral therapy needed to address this expanding burden. Funding The Wellcome Trust, UK; University of the Witwatersrand, Medical Research Council, and Anglo American and De Beers Chairman's Fund, South Africa; the European Union; Andrew W Mellon Foundation, Henry I Kaiser Family Foundation, and National Institute on Aging, National Institutes of Health, USA.	[Tollman, Stephen M.; Kahn, Kathleen; Sartorius, Benn; Collinson, Mark A.; Clark, Samuel J.; Garenne, Michel L.] Univ Witwatersrand, Fac Hlth Sci, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, ZA-2193 Johannesburg, South Africa; [Tollman, Stephen M.; Kahn, Kathleen] Umea Univ, Umea, Sweden; [Clark, Samuel J.] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Clark, Samuel J.] Univ Colorado, Inst Behav Sci, Boulder, CO 80309 USA; [Garenne, Michel L.] Inst Pasteur, Paris, France; [Garenne, Michel L.] Inst Rech Dev, Paris, France	University of Witwatersrand; Umea University; University of Washington; University of Washington Seattle; University of Colorado System; University of Colorado Boulder; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut de Recherche pour le Developpement (IRD)	Tollman, SM (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC Wits Rural Publ Hlth & Hlth Transit Res Unit, Sch Publ Hlth, 7 York Rd, ZA-2193 Johannesburg, South Africa.	Stephen.Tollman@wits.ac.za	Swaibu, Ramadhani A/H-3164-2011; GARENNE, Michel/A-7712-2013; Clark, Samuel J/A-8419-2009	GARENNE, Michel/0000-0001-6073-7803; Clark, Samuel J/0000-0002-4929-6231; Tollman, Stephen/0000-0003-0744-7588; Kahn, Kathleen/0000-0003-3339-3931	Wellcome Trust, UK [058893/Z/99/A, 069683/Z/02/Z]; University of the Witwatersrand; Medical Research Council, South Africa; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD057246, R24HD042828] Funding Source: NIH RePORTER	Wellcome Trust, UK(Wellcome Trust); University of the Witwatersrand; Medical Research Council, South Africa; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The Agincourt health and sociodemographic surveillance system including conduct of verbal autopsies is funded by The Wellcome Trust, UK (Grant number 058893/Z/99/A and 069683/Z/02/Z) and the University of the Witwatersrand and Medical Research Council, South Africa. Initial support for the surveillance system, as part of health systems research and development, was provided by the Anglo American and De Beers Chairman's Fund, South Africa; the European Union; and Andrew W Mellon Foundation, Henry J Kaiser Family Foundation, and National Institute on Aging, National Institutes of Health, USA. We value the contribution of community leaders, study communities, supervisors, and field workers. Myles Connor synthesised published information for the discussion on vascular risk factors and morbidity, and produced the webtable on vascular risk factors. John Pettifor and Myles Connor provided expert advice on classifying causes of death by their health-care requirements. Conversations with Sharon Form, Helen Schneider, and Margaret Thorogood benefited preparation of this report.	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Bateman C, 2008, SAMJ S AFR MED J, V98, P17; Bonita R, 1997, STROKE, V28, P1898, DOI 10.1161/01.STR.28.10.1898; BRADSHAW D, 2004, S AFRICAN BURDEN DIS; Briggs CJ, 2006, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003318.PUB2; Cappuccio FP, 2004, HYPERTENSION, V43, P1017, DOI 10.1161/01.HYP.0000126176.03319.d8; CLARK S, 2002, POPULATION HLTH DEV, V1, P51; Clark SJ, 2007, SCAND J PUBLIC HEALT, V35, P35, DOI 10.1080/14034950701355619; Collinson MA, 2007, SCAND J PUBLIC HEALT, V35, P77, DOI 10.1080/14034950701356401; Connor MD, 2004, STROKE, V35, P627, DOI 10.1161/01.STR.0000117096.61838.C7; Connor MD, 2007, LANCET NEUROL, V6, P269, DOI 10.1016/S1474-4422(07)70002-9; Edwards R, 2000, J HYPERTENS, V18, P145, DOI 10.1097/00004872-200018020-00003; Epping-Jordan JE, 2005, LANCET, V366, P1667, DOI 10.1016/S0140-6736(05)67342-4; Epping-Jordan JE, 2004, QUAL SAF HEALTH CARE, V13, P299, DOI 10.1136/qshc.2004.010744; Farmer P, 2001, LANCET, V358, P404, DOI 10.1016/S0140-6736(01)05550-7; Fowkes FGR, 2006, EUR J CARDIOV PREV R, V13, P964, DOI 10.1097/01.hjr.0000201511.28590.9f; Frenk J, 2006, LANCET, V368, P954, DOI 10.1016/S0140-6736(06)69376-8; Garenne ML, 2007, SCAND J PUBLIC HEALT, V35, P68, DOI 10.1080/14034950701355650; Hundt GL, 2004, J BIOSOC SCI, V36, P433, DOI 10.1017/S0021932004006662; International Working Group, 2002, INT MAN AD AD ILLN I; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; Janssens B, 2007, B WORLD HEALTH ORGAN, V85, P880, DOI 10.2471/BLT.06.036574; Kahn K, 2000, TROP MED INT HEALTH, V5, P824, DOI 10.1046/j.1365-3156.2000.00638.x; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P26, DOI 10.1080/14034950701355668; MBEKI T, 2008, STATE NATION ADDRESS; Pronyk PM, 2004, INT J TUBERC LUNG D, V8, P796; Pronyk PM, 2001, INT J TUBERC LUNG D, V5, P619; Russell S, 2004, AM J TROP MED HYG, V71, P147, DOI 10.4269/ajtmh.2004.71.147; Setel PW, 2004, AM J PUBLIC HEALTH, V94, P384, DOI 10.2105/AJPH.94.3.384; Sliwa K, 2008, LANCET, V371, P915, DOI 10.1016/S0140-6736(08)60417-1; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Tesfaye F, 2007, J HUM HYPERTENS, V21, P28, DOI 10.1038/sj.jhh.1002104; Thorogood M, 2004, B WORLD HEALTH ORGAN, V82, P503; Thorogood M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-326; Tollman SM, 1999, AIDS, V13, P1091, DOI 10.1097/00002030-199906180-00013; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; VANRENSBURG HCJ, 2006, ACTA ACAD S1; Velkoff VA, 2006, AGING SUB SAHARAN AF; Walker RW, 2000, LANCET, V355, P1684, DOI 10.1016/S0140-6736(00)02240-6; Walker RW, 2003, STROKE, V34, P1604, DOI 10.1161/01.STR.0000077943.63718.67; WHO, 2002, INNOVATIVE CARE CHRO; WHO (World Health Organization), 1978, PRIM HLTH CAR REP IN; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	44	153	156	2	25	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					893	901		10.1016/S0140-6736(08)61399-9	http://dx.doi.org/10.1016/S0140-6736(08)61399-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790312	Green Published			2022-12-28	WOS:000259266900029
J	Brotherton, SE; Etzel, SI				Brotherton, Sarah E.; Etzel, Sylvia I.			Graduate Medical Education, 2007-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brotherton, Sarah E.; Etzel, Sylvia I.] Amer Med Assoc, Div Grad Med Educ, Chicago, IL 60654 USA	American Medical Association	Brotherton, SE (corresponding author), Amer Med Assoc, Div Grad Med Educ, 515 N State St, Chicago, IL 60654 USA.	sarah.brotherton@ama-assn.org							0	57	57	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1228	1243		10.1001/jama.300.10.1228	http://dx.doi.org/10.1001/jama.300.10.1228			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	345ZR	18780854				2022-12-28	WOS:000259038700018
J	Rosenfield, K; Jaff, MR				Rosenfield, Kenneth; Jaff, Michael R.			An 82-Year-Old Woman With Worsening Hypertension Review of Renal Artery Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; ATHEROSCLEROTIC RENOVASCULAR DISEASE; STENT PLACEMENT; BLOOD-PRESSURE; BALLOON ANGIOPLASTY; ISCHEMIC NEPHROPATHY; NATURAL-HISTORY; FOLLOW-UP; MANAGEMENT; SURVIVAL	Renal artery stenosis ( RAS) is a common disorder in adults with atherosclerosis and is associated with hypertension, impaired renal function, congestive heart failure, and angina pectoris. The incidence of RAS is increasing because of the aging of the US population and increasing prevalence of atherosclerosis. The case of Mrs S, an 82- year-old woman with long- standing hypertension and unilateral RAS detected by magnetic resonance angiography, illustrates the challenges surrounding indications for revascularization. The discussion reviews the clinical presentation and natural history of RAS and strategies for diagnosis. The role of medical therapy, surgery, and endovascular therapy are reviewed, particularly in the context of guidelines and systematic reviews to help clinicians and patients facing this challenging decision.	[Rosenfield, Kenneth] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA; [Rosenfield, Kenneth; Jaff, Michael R.] Harvard Univ, Sch Med, Boston, MA USA; [Jaff, Michael R.] Massachusetts Gen Hosp, Vasc Ctr, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Rosenfield, K (corresponding author), Massachusetts Gen Hosp, Div Cardiol, 55 Fruit St,GRB 800, Boston, MA 02114 USA.	krosenfield@fastmail.us			Sidney R. Rabb Charitable Trust; Sidney and Esther Rabb Charitable Foundation	Sidney R. Rabb Charitable Trust; Sidney and Esther Rabb Charitable Foundation	This Clinical Crossroads was made possible by a grant from the Sidney R. Rabb Charitable Trust and the Sidney and Esther Rabb Charitable Foundation.	Balk E, 2006, ANN INTERN MED, V145, P901, DOI 10.7326/0003-4819-145-12-200612190-00143; Bates MC, 2007, CATHETER CARDIO INTE, V69, P1037, DOI 10.1002/ccd.21121; Blum U, 1997, NEW ENGL J MED, V336, P459, DOI 10.1056/NEJM199702133360702; Bolduc JP, 2005, AM J ROENTGENOL, V184, P931, DOI 10.2214/ajr.184.3.01840931; Broome DR, 2007, AM J ROENTGENOL, V188, P586, DOI 10.2214/AJR.06.1094; Burket MW, 2000, AM HEART J, V139, P64, DOI 10.1016/S0002-8703(00)90310-7; CAMBRIA RP, 1994, J VASC SURG, V20, P76, DOI 10.1016/0741-5214(94)90178-3; CANZANELLO VJ, 1989, HYPERTENSION, V13, P163, DOI 10.1161/01.HYP.13.2.163; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Conlon PJ, 1998, J AM SOC NEPHROL, V9, P252; Cooper CJ, 2008, CIRCULATION, V117, P2752, DOI 10.1161/CIRCULATIONAHA.107.730259; Cooper CJ, 2006, AM HEART J, V152, P59, DOI 10.1016/j.ahj.2005.09.011; DAVIS BA, 1979, NEW ENGL J MED, V301, P1273, DOI 10.1056/NEJM197912063012307; DORROS G, 1995, AM J CARDIOL, V75, P1051, DOI 10.1016/S0002-9149(99)80723-1; Edwards MS, 2005, ARCH INTERN MED, V165, P207, DOI 10.1001/archinte.165.2.207; Franklin SS, 1997, CIRCULATION, V96, P308; GEDROYC WMW, 1995, CLIN RADIOL, V50, P436, DOI 10.1016/S0009-9260(05)83158-7; Greco BA, 1996, SEMIN NEPHROL, V16, P2; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hansen KJ, 2000, J VASC SURG, V32, P472, DOI 10.1067/mva.2000.108637; Harden PN, 1997, LANCET, V349, P1133, DOI 10.1016/S0140-6736(96)10093-3; HENNEQUIN LM, 1994, RADIOLOGY, V191, P713, DOI 10.1148/radiology.191.3.8184051; Hirsch AT, ACC AHA GUIDELINES M; Holden A, 2003, J VASC SURG, V38, P962, DOI 10.1016/S0741-5214(03)00606-2; HOLLENBERG NK, 1988, AM J HYPERTENS, V1, pS338, DOI 10.1093/ajh/1.4.338S; Iannone LA, 1996, CATHETER CARDIO DIAG, V37, P243, DOI 10.1002/(SICI)1097-0304(199603)37:3<243::AID-CCD3>3.0.CO;2-C; Ivanovic V, 2003, J VASC INTERV RADIOL, V14, P217, DOI 10.1097/01.RVI.0000058324.82956.2a; Lederman RJ, 2001, AM HEART J, V142, P314, DOI 10.1067/mhj.2001.116958; Lim, 2000, Curr Interv Cardiol Rep, V2, P130; Muray S, 2002, AM J KIDNEY DIS, V39, P60, DOI 10.1053/ajkd.2002.29881; OLIN JW, 1995, ANN INTERN MED, V122, P833, DOI 10.7326/0003-4819-122-11-199506010-00004; Radermacher J, 2001, NEW ENGL J MED, V344, P410, DOI 10.1056/NEJM200102083440603; Rihal CS, 2002, MAYO CLIN PROC, V77, P309, DOI 10.4065/77.4.309; Rocha-Singh K, 2005, J AM COLL CARDIOL, V46, P776, DOI 10.1016/j.jacc.2004.11.073; Rocha-Singh KJ, 1999, CATHETER CARDIO INTE, V47, P167, DOI 10.1002/(SICI)1522-726X(199906)47:2<167::AID-CCD7>3.0.CO;2-R; Rodriguez-Lopez JA, 1999, J VASC SURG, V29, P617, DOI 10.1016/S0741-5214(99)70306-X; Rundback JH, 1998, J VASC INTERV RADIOL, V9, P413, DOI 10.1016/S1051-0443(98)70292-1; Safian RD, 2001, NEW ENGL J MED, V344, P431, DOI 10.1056/NEJM200102083440607; SCOBLE JE, 1989, CLIN NEPHROL, V31, P119; Silva JA, 2005, CIRCULATION, V111, P328, DOI 10.1161/01.CIR.0000153271.77341.9F; SIMON N, 1972, J AMER MED ASSOC, V220, P1209, DOI 10.1001/jama.220.9.1209; SOS TA, 1983, NEW ENGL J MED, V309, P274, DOI 10.1056/NEJM198308043090504; Tan KT, 2002, CLIN RADIOL, V57, P617, DOI 10.1053/crad.2002.0941; TEXTOR SC, 1990, CARDIOVASC DRUG THER, V4, P229, DOI 10.1007/BF01857637; The AO, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Tuttle KR, 1998, AM J KIDNEY DIS, V32, P611, DOI 10.1016/S0272-6386(98)70025-3; van de Ven PJG, 1999, LANCET, V353, P282, DOI 10.1016/S0140-6736(98)04432-8; van Jaarsveld BC, 2000, NEW ENGL J MED, V342, P1007, DOI 10.1056/NEJM200004063421403; Vasbinder GBC, 2004, ANN INTERN MED, V141, P674, DOI 10.7326/0003-4819-141-9-200411020-00007; White CJ, 2006, CIRCULATION, V114, P1892, DOI 10.1161/CIRCULATIONAHA.106.178777; White CJ, 1997, J AM COLL CARDIOL, V30, P1445, DOI 10.1016/S0735-1097(97)00348-3; Zahringer M, 2007, J ENDOVASC THER, V14, P460, DOI 10.1177/152660280701400405; ZIERLER RE, 1994, J VASC SURG, V19, P250, DOI 10.1016/S0741-5214(94)70100-8	53	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 5	2008	300	17					2036	2044		10.1001/jama.300.13.jrr80009	http://dx.doi.org/10.1001/jama.300.13.jrr80009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	368EX	18827196				2022-12-28	WOS:000260605400024
J	McColl, K				McColl, Karen			Fighting the brain drain	BRITISH MEDICAL JOURNAL			English	Editorial Material												karen@karenmccoll.co.uk						[Anonymous], 2008, KAMP DECL AG GLOB AC; Buchan J., 2004, INT RECRUITMENT HLTH; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; DAMBISA YM, 2007, 44 EQ; Dovlo D., 2005, NURSING WORKFORCE SU; *GLOB HLTH WORKF A, 2008, SCAL SAV LIV; *GLOB HLTH WORKF A, 2008, COUNTR CAS STUD GHAN; *HLTH WORKF ADV IN, 2008, ADDR HLTH WORKF CRIS; *HLTH WORKF ADV IN, 2004, ADDR HLTH WORKF CRIS; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; *WORLD MED ASS WOR, 2008, GUID INC HLTH PROF	11	6	6	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 25	2008	337	7676							a1496	10.1136/bmj.a1496	http://dx.doi.org/10.1136/bmj.a1496			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	363WS	18794182				2022-12-28	WOS:000260298800028
J	Chaturvedi, N; Porta, M; Klein, R; Orchard, T; Fuller, J; Parving, HH; Bilous, R; Sjolie, AK				Chaturvedi, Nish; Porta, Massimo; Klein, Ronald; Orchard, Trevor; Fuller, John; Parving, Hans Henrik; Bilous, Rudy; Sjolie, Anne Katrin		DIRECT Programme Study Grp	Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials	LANCET			English	Article							RENIN-ANGIOTENSIN SYSTEM; CARDIOVASCULAR-DISEASE; RISK-FACTORS; BLOOD-FLOW; HYPERTENSION; MORTALITY; COMPLICATIONS; LISINOPRIL; FAILURE	Background Results of previous studies suggest that renin-angiotensin system blockers might reduce the burden of diabetic retinopathy. We therefore designed the DIabetic REtinopathy Candesartan Trials (DIRECT) Programme to assess whether candesartan could reduce the incidence and progression of retinopathy in type 1 diabetes. Methods Two randomised, double-blind, parallel-design, placebo-controlled trials were done in 309 centres worldwide. Participants with normotensive, normoalbuminuric type 1 diabetes without retinopathy were recruited to the DIRECT-Prevent I trial and those with existing retinopathy were recruited to DIRECT-Protect 1, and were assigned to candesartan 16 mg once a day or matching placebo. After I month, the dose was doubled to 32 mg. Investigators and participants were unaware of the treatment allocation status. The primary endpoints were incidence and progression of retinopathy and were defined as at least a two-step and at least a three-step increase on the Early Treatment Diabetic Retinopathy Study (ETDRS) scale, respectively. These trials are registered with ClinicalTrials.gov, numbers NCT00252733 for DIRECT-Prevent 1 and NCT00252720 for DIRECT-Protect 1. Findings 1421 participants (aged 18-50 years) were randomly assigned to candesartan (n=711) or to placebo (n=710) in DIRECT-Prevent 1, and 1905 (aged 18-55 years) to candesartan (n=951) or to placebo (n=954) in DIRECT-Protect 1. Incidence of retinopathy was seen in 178 (25%) participants in the candesartan group versus 217 (31%) in the placebo group. Progression of retinopathy occurred in 127 (13%) participants in the candesartan group versus 124 (13%) in the placebo group. Hazard ratio (HR for candesartan vs placebo) was 0.82 (95% CI 0.67-1.00, p=0.0508) for incidence of retinopathy and 1.02 (0.80-1.31, p=0.85) for progression of retinopathy. The post-hoc outcome of at least a three-step increase for incidence yielded an HR of 0.65 (0.48-0.87, p=0.0034), which was attenuated but still significant after adjustment for baseline characteristics (0.71, 0.53-0.95, p=0.046). Final ETDRS level was more likely to have improved with candesartan treatment in both DIRECT-Prevent 1 (odds 1.16, 95% CI 1.05-1.30, p=0.0048) and DIRECT-Protect 1 (1.12, 95% CI 1.01-1.25, p=0.0264). Adverse events did not differ between the treatment groups. Interpretation Although candesartan reduces the incidence of retinopathy, we did not see a beneficial effect on retinopathy progression.	[Chaturvedi, Nish] Imperial Coll Healthcare NHS Trust, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London W2 1PG, England; [Porta, Massimo] Univ Turin, Dept Internal Med, Turin, Italy; [Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Orchard, Trevor] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Fuller, John] UCL, Dept Epidemiol & Publ Hlth, London, England; [Parving, Hans Henrik] Univ Copenhagen Hosp, Dept Med Endocrinol, DK-2100 Copenhagen, Denmark; [Bilous, Rudy] S Cleveland Hosp, Audrey Collins Teaching Unit, Middlesbrough, Cleveland, England; [Sjolie, Anne Katrin] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark	Imperial College London; University of Turin; University of Wisconsin System; University of Wisconsin Madison; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London; University of Copenhagen; University of Southern Denmark; Odense University Hospital	Chaturvedi, N (corresponding author), Imperial Coll Healthcare NHS Trust, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London W2 1PG, England.	n.chaturvedi@imperial.ac.uk	Lyudmila, Suplotova A/J-3596-2014; Schäffler, Andreas/W-2384-2019; Chaturvedi, Nishi/C-7761-2013; Anděl, Michal/E-4305-2012; Dagdelen, Selcuk/A-9432-2017; Porta, Massimo/G-6146-2011; Dedov, Ivan I/D-3729-2014; Aldington, Steve J/G-7828-2012	Lyudmila, Suplotova A/0000-0001-9253-8075; Dagdelen, Selcuk/0000-0002-0513-1750; Dedov, Ivan I/0000-0002-8175-7886; Aldington, Steve J/0000-0003-1808-3580; Porta, Massimo/0000-0002-3407-6017; Keymeulen, Bart/0000-0002-8671-4527; kerlan, veronique/0000-0001-8105-6628; rossing, peter/0000-0002-1531-4294; Klein, Ronald/0000-0002-4428-6237; orchard, trevor/0000-0001-9552-3215	AstraZeneca; Takeda	AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd)	The study was jointly funded by AstraZeneca and Takeda. We would like to thank the team at the Retinopathy Grading Centre, Imperial College London, UK, specifically Steve Aldington and his team. Without their skills, patience, hard work, and attention to detail, the DIRECT Programme would not have been possible.	ALDINGTON SJ, 1995, DIABETOLOGIA, V38, P437, DOI 10.1007/BF00410281; Alioum A, 1996, BIOMETRICS, V52, P512, DOI 10.2307/2532891; [Anonymous], 1991, Ophthalmology, V98, P823; [Anonymous], 1991, Ophthalmology, V98, P786; Belcher G, 1997, J HUM HYPERTENS, V11, pS85; Bursell SE, 1996, INVEST OPHTH VIS SCI, V37, P886; Chaturvedi N, 2001, ANN INTERN MED, V134, P370, DOI 10.7326/0003-4819-134-5-200103060-00009; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Grann M, 2005, INT J LAW PSYCHIAT, V28, P442, DOI 10.1016/j.ijlp.2004.03.011; Hovind P, 2003, DIABETES CARE, V26, P1258, DOI 10.2337/diacare.26.4.1258; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; KAWAGISHI T, 1995, DIABETES CARE, V18, P1544, DOI 10.2337/diacare.18.12.1544; Klein BEK, 2004, ARCH INTERN MED, V164, P1917, DOI 10.1001/archinte.164.17.1917; KLEIN R, 1995, ARCH OPHTHALMOL-CHIC, V113, P1386, DOI 10.1001/archopht.1995.01100110046024; Klein R, 2001, ARCH OPHTHALMOL-CHIC, V119, P547; Kohner EM, 1999, DIABETOLOGIA, V42, P1107, DOI 10.1007/s001250051278; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Luckie R, 2007, DIABETIC MED, V24, P1086, DOI 10.1111/j.1464-5491.2007.02180.x; Mogensen CE, 2000, BRIT MED J, V321, P1440, DOI 10.1136/bmj.321.7274.1440; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Porta M, 2001, DIABETOLOGIA, V44, P2203, DOI 10.1007/s001250100030; Prevost G, 2005, DIABETES METAB, V31, P479, DOI 10.1016/S1262-3636(07)70219-7; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sjolie AK, 2002, J RENIN-ANGIO-ALDO S, V3, P255; Skrivarhaug T, 2006, DIABETOLOGIA, V49, P2281, DOI 10.1007/s00125-006-0364-7; Soedamah-Muthu SS, 2006, DIABETES CARE, V29, P798, DOI 10.2337/diacare.29.04.06.dc05-1433; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Sun JG, 2005, SCAND J STAT, V32, P49, DOI 10.1111/j.1467-9469.2005.00414.x; Tokmakova M, 2006, CURR OPIN CARDIOL, V21, P268, DOI 10.1097/01.hco.0000231394.79609.24; van Hecke MV, 2005, DIABETES CARE, V28, P1383, DOI 10.2337/diacare.28.6.1383; Warnold I, 2005, J RENIN-ANGIO-ALDO S, V6, P25; Wellner JA, 1997, J AM STAT ASSOC, V92, P945, DOI 10.2307/2965558; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275	34	335	355	1	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1394	1402		10.1016/S0140-6736(08)61412-9	http://dx.doi.org/10.1016/S0140-6736(08)61412-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18823656				2022-12-28	WOS:000260228200025
J	Kemp, AM; Dunstan, F; Harrison, S; Morris, S; Mann, M; Rolfe, K; Datta, S; Thomas, DP; Sibert, JR; Maguire, S				Kemp, Alison M.; Dunstan, Frank; Harrison, Sara; Morris, Susan; Mann, Mala; Rolfe, Kim; Datta, Shalini; Thomas, D. Phillip; Sibert, Jonathan R.; Maguire, Sabine			Patterns of skeletal fractures in child abuse: systematic review	BRITISH MEDICAL JOURNAL			English	Review							CLASSIC METAPHYSEAL LESION; REGIONAL APPROACH; INFANTS; MALTREATMENT; TIBIA	Objectives To systematically review published studies to identify the characteristics that distinguish fractures in children resulting from abuse and those not resulting from abuse, and to calculate a probability of abuse for individual fracture types. Design Systematic review. Data sources All language literature search of Medline, Medline in Process, Embase, Assia, Caredata, Child Data, CINAHL, ISI Proceedings, Sciences Citation, Social Science Citation Index, SIGLE, Scopus, TRIP, and Social Care Online for original study articles, references, textbooks, and conference abstracts until May 2007. Study selection Comparative studies of fracture at different bony sites, sustained in physical abuse and from other causes in children < 18 years old were included. Review articles, expert opinion, postmortem studies, and studies in adults were excluded. Data extraction and synthesis Each study had two independent reviews ( three if disputed) by specialist reviewers including paediatricians, paediatric radiologists, orthopaedic surgeons, and named nurses in child protection. Each study was critically appraised by using data extraction sheets, critical appraisal forms, and evidence sheets based on NHS Centre for Reviews and Dissemination guidance. Meta- analysis was done where possible. A random effects model was fitted to account for the heterogeneity between studies. Results In total, 32 studies were included. Fractures resulting from abuse were recorded throughout the skeletal system, most commonly in infants (< 1 year) and toddlers ( between 1 and 3 years old). Multiple fractures were more common in cases of abuse. Once major trauma was excluded, rib fractures had the highest probability for abuse ( 0.71, 95% confidence interval 0.42 to 0.91). The probability of abuse given a humeral fracture lay between 0.48 ( 0.06 to 0.94) and 0.54 ( 0.20 to 0.88), depending on the definition of abuse used. Analysis of fracture type showed that supracondylar humeral fractures were less likely to be inflicted. For femoral fractures, the probability was between 0.28 ( 0.15 to 0.44) and 0.43 ( 0.32 to 0.54), depending on the definition of abuse used, and the developmental stage of the child was an important discriminator. The probability for skull fractures was 0.30 ( 0.19 to 0.46); the most common fractures in abuse and non- abuse were linear fractures. Insufficient comparative studies were available to allow calculation of a probability of abuse for other fracture types. Conclusion When infants and toddlers present with a fracture in the absence of a confirmed cause, physical abuse should be considered as a potential cause. No fracture, on its own, can distinguish an abusive from a non- abusive cause. During the assessment of individual fractures, the site, fracture type, and developmental stage of the child can help to determine the likelihood of abuse. The number of high quality comparative research studies in this field is limited, and further prospective epidemiology is indicated.	[Kemp, Alison M.; Dunstan, Frank; Rolfe, Kim; Sibert, Jonathan R.; Maguire, Sabine] Cardiff Univ, Univ Wales Hosp, Clin Epidemiologyinterdisciplinary Res Grp, Welsh Child Protect Systemat Rev Grp,Sch Med, Cardiff CF 2XX, Wales; [Harrison, Sara; Morris, Susan; Datta, Shalini] Cardiff Univ, Dept Radiol, Cardiff & Vale NHS Trust, Sch Med, Cardiff CF 2XX, Wales; [Mann, Mala] Cardiff Univ, Support Unit Res Evidence, Cardiff CF 2XX, Wales; [Thomas, D. Phillip] Cardiff Univ, Dept Orthopaed, Cardiff & Vale NHS Trust, Sch Med, Cardiff CF 2XX, Wales	Cardiff University; Cardiff University; Cardiff University; Cardiff University	Kemp, AM (corresponding author), Cardiff Univ, Univ Wales Hosp, Clin Epidemiologyinterdisciplinary Res Grp, Welsh Child Protect Systemat Rev Grp,Sch Med, Cardiff CF 2XX, Wales.	kempam@cf.ac.uk			National Society for the Prevention of Cruelty to Children	National Society for the Prevention of Cruelty to Children	National Society for the Prevention of Cruelty to Children, which is independent of the study group.	Belfer RA, 2001, AM J EMERG MED, V19, P122, DOI 10.1053/ajem.2001.21345; Bishop N, 2007, ARCH DIS CHILD, V92, P251, DOI 10.1136/adc.2006.106120; CAFFEY J, 1946, AM J ROENTGENOL, V56, P163; Carty H, 2002, EUR RADIOL, V12, P2919, DOI 10.1007/s00330-002-1436-9; Day Fiona, 2006, J Clin Forensic Med, V13, P55, DOI 10.1016/j.jcfm.2005.08.001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; FELDMAN KW, 1984, PEDIATRICS, V73, P339; Fleiss J L, 1993, Stat Methods Med Res, V2, P121, DOI 10.1177/096228029300200202; HOBBS CJ, 1984, ARCH DIS CHILD, V59, P246, DOI 10.1136/adc.59.3.246; Ingram JD, 2000, EMERG RADIOL, V7, P42; KING J, 1988, J PEDIATR ORTHOPED, V8, P585; Kleinman PK, 1996, AM J ROENTGENOL, V166, P421, DOI 10.2214/ajr.166.2.8553960; Kleinman PK, 1996, AM J ROENTGENOL, V167, P1399, DOI 10.2214/ajr.167.6.8956566; Kleinman PK, 1998, AM J ROENTGENOL, V170, P43, DOI 10.2214/ajr.170.1.9423596; Kleinman PK, 1996, AM J ROENTGENOL, V166, P1207, DOI 10.2214/ajr.166.5.8615271; Maguire S, 2005, ARCH DIS CHILD, V90, P182, DOI 10.1136/adc.2003.044065; Mallett S, 2006, BMJ-BRIT MED J, V333, P413, DOI 10.1136/bmj.38895.467130.55; MERTEN DF, 1983, RADIOLOGY, V146, P377, DOI 10.1148/radiology.146.2.6849085; *NHS CTR REV DISS, 2001, 4 CRD U YORK; Rennie L, 2007, INJURY, V38, P913, DOI 10.1016/j.injury.2007.01.036; Royal College of Radiologists Royal College of Paediatrics and Child Health., 2008, STAND RAD INV SUSP N; Sidebotham P, 2003, CHILD ABUSE NEGLECT, V27, P337, DOI 10.1016/S0145-2134(03)00010-3; Taitz J, 2004, J PAEDIATR CHILD H, V40, P170, DOI 10.1111/j.1440-1754.2004.00332.x	23	260	263	3	29	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 11	2008	337	7674							a1518	10.1136/bmj.a1518	http://dx.doi.org/10.1136/bmj.a1518			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	358FU	18832412	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000259903300035
J	Albrechtsen, S; Rasmussen, S; Thoresen, S; Irgens, LM; Iversen, OE				Albrechtsen, Susanne; Rasmussen, Svein; Thoresen, Steinar; Irgens, Lorentz M.; Iversen, Ole Erik			Pregnancy outcome in women before and after cervical conisation: population based cohort study	BRITISH MEDICAL JOURNAL			English	Article							INTRAEPITHELIAL NEOPLASIA; PRETERM DELIVERY	Objectives To examine the consequences of cervical conisation in terms of adverse outcome in subsequent pregnancies. Design Population based cohort study. Data sources Data on cervical conisation derived from the Cancer Registry of Norway and on pregnancy outcome from the Medical Birth Registry of Norway, 1967- 2003. 15 108 births occurred in women who had previously undergone cervical conisation and 57 136 who subsequently underwent cervical conisation. In the same period there were 2 164 006 births to women who had not undergone relevant treatment ( control). Results The proportion of preterm delivery was 17.2% in women who gave birth after cervical conisation versus 6.7% in women who gave birth before cervical conisation and 6.2% in women who had not undergone cervical conisation. The relative risk of a late abortion (< 24 weeks' gestation) was 4.0 ( 95% confidence interval 3.3 to 4.8) in women who gave birth after cervical conisation compared with no cervical conisation. The relative risk of delivery was 4.4 ( 3.8 to 5.0) at 24- 27 weeks, 3.4 ( 3.1 to 3.7) at 28- 32 weeks, and 2.5 ( 2.4 to 2.6) at 33- 36 weeks. The relative risk of preterm delivery declined during the study period and especially of delivery before 28 weeks' gestation. Conclusion Cervical conisation influences outcome in subsequent pregnancies in terms of an increased risk of preterm delivery, especially in the early gestational age groups in which the clinical significance is highest. A careful clinical approach should be taken in the selection of women for cervical conisation and in the clinical care of pregnancies after a cervical conisation.	[Albrechtsen, Susanne; Rasmussen, Svein; Iversen, Ole Erik] Univ Bergen, Dept Obstet & Gynecol, Haukeland Univ Hosp, Inst Clin Med, N-5021 Bergen, Norway; [Albrechtsen, Susanne; Rasmussen, Svein; Thoresen, Steinar; Irgens, Lorentz M.] Univ Bergen, Med Birth Registry Norway, Dept Publ Hlth & Primary Hlth Care, N-5021 Bergen, Norway; [Albrechtsen, Susanne; Rasmussen, Svein; Irgens, Lorentz M.] Norwegian Inst Publ Hlth, Bergen, Norway; [Thoresen, Steinar] Canc Registry Norway, Oslo, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Norwegian Institute of Public Health (NIPH); University of Oslo	Albrechtsen, S (corresponding author), Univ Bergen, Dept Obstet & Gynecol, Haukeland Univ Hosp, Inst Clin Med, N-5021 Bergen, Norway.	Susanne.Albrechtsen@Helse-Bergen.no	Albrechtsen, Susanne/H-4680-2019		Norwegian Cancer Society	Norwegian Cancer Society(Norwegian Cancer Society)	Norwegian Cancer Society.	Forsmo S, 1996, ACTA OBSTET GYN SCAN, V75, P139, DOI 10.3109/00016349609033306; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; Irgens LM, 2000, ACTA OBSTET GYN SCAN, V79, P435, DOI 10.1034/j.1600-0412.2000.079006435.x; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; KRISTENSEN J, 1993, ACTA OBSTET GYN SCAN, V72, P640, DOI 10.3109/00016349309021157; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; LUND E, 1986, Tidsskrift for den Norske Laegeforening, V106, P543; *MED BIRTH REG NOR, 1998, BIRTH NORW 30 YEARS; OSTOR AG, 1993, INT J GYNECOL PATHOL, V12, P186; Rockhill B, 1998, AM J PUBLIC HEALTH, V88, P15, DOI 10.2105/AJPH.88.1.15; Royston P, 1998, ULTRASOUND OBST GYN, V11, P30, DOI 10.1046/j.1469-0705.1998.11010030.x; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; VOLLSET SE, 1993, STAT MED, V12, P809, DOI 10.1002/sim.4780120902; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690	14	118	122	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1343	10.1136/bmj.a1343	http://dx.doi.org/10.1136/bmj.a1343			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18801869	Green Published, hybrid			2022-12-28	WOS:000259798000037
J	Lasserson, DS; Chandratheva, A; Giles, MF; Mant, D; Rothwell, PM				Lasserson, Daniel S.; Chandratheva, Arvind; Giles, Matthew F.; Mant, David; Rothwell, Peter M.			Influence of general practice opening hours on delay in seeking medical attention after transient ischaemic attack (TIA) and minor stroke: prospective population based study	BRITISH MEDICAL JOURNAL			English	Article							RISK; KNOWLEDGE; ADMISSION; TIME; MULTICENTER; EMERGENCY; SYMPTOMS; SERVICES; BEHAVIOR	Objective To assess the influence of general practice opening hours on healthcare seeking behaviour after transient ischaemic attack ( TIA) and minor stroke and feasibility of clinical assessment within 24 hours of symptom onset. Design Population based prospective incidence study ( Oxford vascular study). Setting Nine general practices in Oxfordshire. Participants 91 000 patients followed from 1 April 2002 to 31 March 2006. Main outcome measures Events that occurred overnight and at weekends ( out of hours) and events that occurred during surgery hours. Results Among 359 patients with TIA and 434 with minor stroke, the median ( interquartile range) timeto call a general practitioner after an event during surgery hours was 4.0 ( 1.0-45.5) hours, and 68% of patients with events during surgery hours called within 24 hours of onset of symptoms. Median ( interquartile range) time to call a general practitioner after events out of hours was 24.8 ( 9.0- 54.5) hours for patients who waited to contact their registered practice compared with 1.0 ( 0.3- 2.6) hour in those who used an emergency general practitioner service ( P< 0.001). In patients with events out of hours who waited to see their own general practitioner, seeking attention within 24 hours was considerably less likely for events at weekends than weekdays ( odds ratio 0.10, 95% confidence interval 0.05 to 0.21): 70% with events Monday to Friday, 33% on Sundays, and none on Saturdays. Thirteen patients who had events out of hours and did not seek emergency care had a recurrent stroke before they sought medical attention. A primary care centre open 8 am- 8 pm seven days a week would have offered cover to 73 patients who waited until surgery hours to call their general practitioner, reducing median delay from 50.1 hours to 4.0 hours in that group and increasing those calling within 24 hours from 34% to 68%. Conclusions General practitioners' opening hours influence patients' healthcare seeking behaviour after TIA and minor stroke. Current opening hours can increase delay in assessment. Improved access to primary care and public education about the need for emergency care are required if the relevant targets in the national stroke strategy are to be met.	[Lasserson, Daniel S.; Mant, David] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [Chandratheva, Arvind; Giles, Matthew F.; Rothwell, Peter M.] Univ Oxford, Dept Clin Neurol, Stroke Prevent Res Unit, John Radcliffe Hosp, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Lasserson, DS (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	daniel.lasserson@dphpc.ox.ac.uk	Lasserson, Daniel S/T-8978-2017; Rothwell, Peter/ABE-5913-2020; Mant, David CA/C-7763-2009	Rothwell, Peter/0000-0001-9739-9211; 	National Institute for Health Research (NIHR) School for Primary Care Research; UK Stroke Association; Dunhill Medical Trust; Medical Research Council; Oxford Biomedical Research Centre; National Institute for Health Research [CL-2007-13-007] Funding Source: researchfish	National Institute for Health Research (NIHR) School for Primary Care Research(National Institute for Health Research (NIHR)); UK Stroke Association; Dunhill Medical Trust(Dunhill Medical Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Biomedical Research Centre; National Institute for Health Research(National Institute for Health Research (NIHR))	DSL was funded by the National Institute for Health Research (NIHR) School for Primary Care Research funding scheme and MFG was funded by the UK Stroke Association. The Oxford vascular study is funded by the UK Stroke Association, the Dunhill Medical Trust, the National Institute of Health Research, the Medical Research Council, and the Oxford Biomedical Research Centre.	BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Coull AJ, 2004, BMJ-BRIT MED J, V328, P326, DOI 10.1136/bmj.37991.635266.44; *DEP HLTH, 2007, OUR NHS OUR FUT NHS; Department of Health, 2007, NAT STROK STRAT; Department of Health, 2003, DEL INV GEN PRACT IM; Department of Health, 2007, NHS ENGL OP FRAM 200; Derex L, 2002, STROKE, V33, P153, DOI 10.1161/hs0102.100533; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Giles MF, 2006, STROKE, V37, P1254, DOI 10.1161/01.STR.0000217388.57851.62; Harraf F, 2002, BMJ-BRIT MED J, V325, P17, DOI 10.1136/bmj.325.7354.17; Johnston SC, 2000, JAMA-J AM MED ASSOC, V284, P2901, DOI 10.1001/jama.284.22.2901; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; Marx JJ, 2008, J NEUROL, V255, P378, DOI 10.1007/s00415-008-0673-5; Mosley I, 2007, STROKE, V38, P361, DOI 10.1161/01.STR.0000254528.17405.cc; *NAT I HLTH CLIN E, 2008, NICE CLIN GUIDELINE; Ritter MA, 2007, NEUROL RES, V29, P476, DOI 10.1179/016164107X163202; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, NEUROLOGY, V64, P817, DOI 10.1212/01.WNL.0000152985.32732.EE; Rothwell PM, 2004, LANCET, V363, P1925, DOI 10.1016/S0140-6736(04)16405-2; Schroeder EB, 2000, STROKE, V31, P2591, DOI 10.1161/01.STR.31.11.2591; Wester P, 1999, STROKE, V30, P40, DOI 10.1161/01.STR.30.1.40	22	50	51	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	OCT 4	2008	337	7673							a1569	10.1136/bmj.a1569	http://dx.doi.org/10.1136/bmj.a1569			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18801867	hybrid, Green Published			2022-12-28	WOS:000259798000035
J	Scheen, AJ				Scheen, Andre J.			Exenatide once weekly in type 2 diabetes	LANCET			English	Editorial Material							PEPTIDE-1 RECEPTOR AGONISTS; CONSENSUS ALGORITHM; MELLITUS; THERAPY; MANAGEMENT; INSULIN; HYPERGLYCEMIA; ADJUSTMENT; INITIATION		[Scheen, Andre J.] Univ Liege, Div Diabet Nutr & Metab Disorders, Dept Med, CHU Sart Tilman, B-4000 Liege, Belgium	University of Liege	Scheen, AJ (corresponding author), Univ Liege, Div Diabet Nutr & Metab Disorders, Dept Med, CHU Sart Tilman, B-4000 Liege, Belgium.	andre.scheen@chu.ulg.ac.be						Cvetkovic RS, 2007, DRUGS, V67, P935, DOI 10.2165/00003495-200767060-00008; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; DRUCKER DJ, 2008, LANCET          0908, DOI DOI 10.1016/S0140-6736(08)61206-4; Edwards KL, 2008, PHARMACOTHERAPY, V28, P506, DOI 10.1592/phco.28.4.506; Guerci B, 2008, ANN ENDOCRINOL-PARIS, V69, P201, DOI 10.1016/j.ando.2008.03.004; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Home P, 2008, BRIT MED J, V336, P1306, DOI 10.1136/bmj.39560.442095.AD; Nathan DM, 2008, DIABETOLOGIA, V51, P8, DOI 10.1007/s00125-007-0873-z; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; Nathan DM, 2007, NEW ENGL J MED, V356, P437, DOI 10.1056/NEJMp068294; Odegard PS, 2007, DIABETES EDUCATOR, V33, P1014, DOI 10.1177/0145721707308407; Peyrot M, 2005, DIABETES CARE, V28, P2673, DOI 10.2337/diacare.28.11.2673; Van Gaal LF, 2008, EUR J ENDOCRINOL, V158, P773, DOI 10.1530/EJE-07-0804; VISBOLL T, 2007, EXPERT OPIN INV DRUG, V16, P231	14	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 4	2008	372	9645					1197	1198		10.1016/S0140-6736(08)61207-6	http://dx.doi.org/10.1016/S0140-6736(08)61207-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	357YB	18782642	Green Submitted			2022-12-28	WOS:000259882000005
J	van Veen, M; Steyerberg, EW; Ruige, M; van Meurs, AHJ; Roukema, J; van der Lei, J; Moll, HA				van Veen, M.; Steyerberg, Ewout W.; Ruige, Madelon; van Meurs, Alfred H. J.; Roukema, Jolt; van der Lei, Johan; Moll, Henriette A.			Manchester triage system in paediatric emergency care: prospective observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CANADIAN TRIAGE; ACUITY SCALE; DEPARTMENT TRIAGE; CHILDREN; RISK; RELIABILITY; AGREEMENT; VALIDITY; PATIENT; FEVER	Objective To validate use of the Manchester triage system in paediatric emergency care. Design Prospective observational study. Setting Emergency departments of a university hospital and a teaching hospital in the Netherlands, 2006- 7. Participants 17 600 children ( aged < 16) visiting an emergency department over 13 months ( university hospital) and seven months ( teaching hospital). Intervention Nurses triaged 16 735/ 17 600 patients ( 95%) using a computerised Manchester triage system, which calculated urgency levels from the selection of discriminators embedded in flowcharts for presenting problems. Nurses over- ruled the urgency level in 1714 ( 10%) children, who were excluded from analysis. Complete data for the reference standard were unavailable in 1467 ( 9%) children leaving 13 554 patients for analysis. Main outcome measures Urgency according to the Manchester triage system compared with a predefined and independently assessed reference standard for five urgency levels. This reference standard was based on a combination of vital signs at presentation, potentially life threatening conditions, diagnostic resources, therapeutic interventions, and follow- up. Sensitivity, specificity, and likelihood ratios for high urgency ( immediate and very urgent) and 95% confidence intervals for subgroups based on age, use of flowcharts, and discriminators. Results The Manchester urgency level agreed with the reference standard in 4582 of 13 554 ( 34%) children; 7311 ( 54%) were over- triaged and 1661 ( 12%) under-triaged. The likelihood ratio was 3.0 ( 95% confidence interval 2.8 to 3.2) for high urgency and 0.5 ( 0.4 to 0.5) for low urgency; though the likelihood ratios were lower for those presenting with a medical problem ( 2.3 ( 2.2 to 2.5) v 12.0 ( 7.8 to 18.0) for trauma) and in younger children ( 2.4 ( 1.9 to 2.9) at 0- 3 months v 5.4 ( 4.5 to 6.5) at 8- 16 years). Conclusions The Manchester triage system has moderate validity in paediatric emergency care. It errs on the safe side, with much more over- triage than under- triage compared with an independent reference standard for urgency. Triage of patients with a medical problem or in younger children is particularly difficult.	[van Veen, M.; Roukema, Jolt; Moll, Henriette A.] Univ Med Ctr Rotterdam, Dept Paediat, Erasmus Sch Ctr, Sophia Childrens Hosp, NL-3000 CB Rotterdam, Netherlands; [Steyerberg, Ewout W.] Univ Med Ctr Rotterdam, Ctr Med Decis Making, Erasmus MC, NL-3000 CA Rotterdam, Netherlands; [Ruige, Madelon; van Meurs, Alfred H. J.] Juliana Childrens Hosp, Haga Hosp, Dept Paediat, NL-2506 LP The Hague, Netherlands; [van der Lei, Johan] Univ Med Ctr Rotterdam, Dept Med Informat, Erasmus MC, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Erasmus University Rotterdam; Erasmus MC; Haga Hospital; Erasmus University Rotterdam; Erasmus MC	Moll, HA (corresponding author), Univ Med Ctr Rotterdam, Dept Paediat, Erasmus Sch Ctr, Sophia Childrens Hosp, POB 2060, NL-3000 CB Rotterdam, Netherlands.	h.a.moll@erasmusmc.nl	Roukema, Jolt/C-2258-2018; Steyerberg, Ewout/C-1509-2018	Roukema, Jolt/0000-0001-6971-7892; Steyerberg, Ewout/0000-0002-7787-0122	Netherlands Organization for Health Research and Development (ZonMw); Erasmus University Medical Centre, Rotterdam, Netherlands.	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Erasmus University Medical Centre, Rotterdam, Netherlands.(Netherlands Government)	Netherlands Organization for Health Research and Development (ZonMw), and Erasmus University Medical Centre, Rotterdam, Netherlands.	Adams SL, 1996, JAMA-J AM MED ASSOC, V276, P493, DOI 10.1001/jama.276.6.493; Armon K, 2001, ARCH DIS CHILD, V85, P132, DOI 10.1136/adc.85.2.132; Baumann MR, 2005, ACAD EMERG MED, V12, P219, DOI 10.1197/j.aem.2004.09.023; Bergeron S, 2004, PEDIATR EMERG CARE, V20, P514, DOI 10.1097/01.pec.0000136067.07081.ae; BINDMAN AB, 1995, BRIT MED J, V311, P404, DOI 10.1136/bmj.311.7002.404; Chamberlain JM, 2005, PEDIATRICS, V115, P388, DOI 10.1542/peds.2004-0586; Cooke MW, 1999, J ACCID EMERG MED, V16, P179; Cooper RJ, 2004, ANN EMERG MED, V44, P524, DOI 10.1016/j.annemergmed.2004.07.432; Durojaiye Linda, 2002, Emerg Med (Fremantle), V14, P67, DOI 10.1046/j.1442-2026.2002.00261.x; Gilboy N, 2005, J EMERG NURS, V31, P357, DOI 10.1016/j.jen.2005.05.011; Glasziou PP, 2001, DECISION MAKING HLTH; Gorelick LH, 2001, ACAD EMERG MED, V8, P156, DOI 10.1111/j.1553-2712.2001.tb01281.x; Gouin S, 2005, AM J EMERG MED, V23, P243, DOI 10.1016/j.ajem.2004.02.046; Gravel J, 2008, CAN J EMERG MED, V10, P32; Gravel J, 2007, ACAD EMERG MED, V14, P864, DOI 10.1197/j.aem.2007.06.018; Hostetler MA, 2007, PEDIATR EMERG CARE, V23, P507, DOI 10.1097/01.pec.0000280518.36408.74; Jimenez Josep Gomez, 2003, CJEM, V5, P315; Mackway-Jones K, 1997, EMERGENCY TRIAGE; Mackway-Jones K., 2001, ADV PAEDIAT LIFE SUP, V3rd ed; MACKWAYJONES K, 2002, TRIAGE SPOEDEISENDE; Maldonado T, 2004, PEDIATRICS, V114, P356, DOI 10.1542/peds.114.2.356; Maningas PA, 2006, J EMERG MED, V31, P353, DOI 10.1016/j.jemermed.2006.01.011; McGovern MC, 2004, ARCH DIS CHILD, V89, P1043, DOI 10.1136/adc.2003.031740; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Roukema J, 2006, EMERG MED J, V23, P906, DOI 10.1136/emj.2006.038877; *STAT NETH, STAT LOC DISTR; Sur DK, 2007, AM FAM PHYSICIAN, V75, P1805; Trautner BW, 2006, PEDIATRICS, V118, P34, DOI 10.1542/peds.2005-2823; Twomey M, 2007, EMERG MED J, V24, P477, DOI 10.1136/emj.2007.046383; van der Wulp I, 2008, EMERG MED J, V25, P431, DOI 10.1136/emj.2007.055228; Vergouwe Y, 2005, J CLIN EPIDEMIOL, V58, P475, DOI 10.1016/j.jclinepi.2004.06.017; Windle J, 2003, EMERG MED J, V20, P119, DOI 10.1136/emj.20.2.119	32	101	102	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2008	337	7673							a1501	10.1136/bmj.a1501	http://dx.doi.org/10.1136/bmj.a1501			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18809587	Green Published, hybrid			2022-12-28	WOS:000259798000034
J	Norenzayan, A; Shariff, AF				Norenzayan, Ara; Shariff, Azim F.			The origin and evolution of religious prosociality	SCIENCE			English	Review							ANONYMOUS ECONOMIC GAME; BEHAVIOR; COOPERATION; PSYCHOLOGY; PUNISHMENT; SOCIETIES; ALTRUISM; CUES	We examine empirical evidence for religious prosociality, the hypothesis that religions facilitate costly behaviors that benefit other people. Although sociological surveys reveal an association between self- reports of religiosity and prosociality, experiments measuring religiosity and actual prosocial behavior suggest that this association emerges primarily in contexts where reputational concerns are heightened. Experimentally induced religious thoughts reduce rates of cheating and increase altruistic behavior among anonymous strangers. Experiments demonstrate an association between apparent profession of religious devotion and greater trust. Cross- cultural evidence suggests an association between the cultural presence of morally concerned deities and large group size in humans. We synthesize converging evidence from various fields for religious prosociality, address its specific boundary conditions, and point to unresolved questions and novel predictions.	[Norenzayan, Ara; Shariff, Azim F.] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada	University of British Columbia	Norenzayan, A (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	ara@psych.ubc.ca		Shariff, Azim/0000-0003-4444-460X	Social Sciences and Humanities Research Council of Canada [410-2007-0222]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	We thank S. Atran, S. Heine, J. Henrich, M. Schaller, R. Sosis, and three anonymous reviewers for their comments and criticisms. The writing of this article was supported by a Social Sciences and Humanities Research Council of Canada grant (410-2007-0222) to the first author.	Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bateson M, 2006, BIOL LETTERS, V2, P412, DOI 10.1098/rsbl.2006.0509; BATSON CD, 1989, J PERS SOC PSYCHOL, V57, P873, DOI 10.1037/0022-3514.57.5.873; Batson CharlesDaniel., 1993, RELIG INDIVIDUAL; BERG J, 1995, GAME ECON BEHAV, V10, P122, DOI 10.1006/game.1995.1027; Bering JM, 2006, BEHAV BRAIN SCI, V29, P453, DOI 10.1017/S0140525X06009101; Boyd R, 2002, J THEOR BIOL, V215, P287, DOI 10.1006/jtbi.2001.2515; Boyer Pascal, 2001, RELIG EXPLAINED; Brooks A. C., 2006, WHO REALLY CARES SUR; Choi JK, 2007, SCIENCE, V318, P636, DOI 10.1126/science.1144237; DARLEY JM, 1973, J PERS SOC PSYCHOL, V27, P100, DOI 10.1037/h0034449; Dunbar RIM, 2003, ANNU REV ANTHROPOL, V32, P163, DOI 10.1146/annurev.anthro.32.061002.093158; Durkheim E., 1995, ELEMENTARY FORMS REL; Edgell P, 2006, AM SOCIOL REV, V71, P211, DOI 10.1177/000312240607100203; Ensminger J, 1997, J INST THEOR ECON, V153, P4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gintis H, 2003, EVOL HUM BEHAV, V24, P153, DOI 10.1016/S1090-5138(02)00157-5; GREIF A, 1993, AM ECON REV, V83, P525; Guthrie Stewart E., 1993, FACES CLOUDS; Haidt J, 2007, SCIENCE, V316, P998, DOI 10.1126/science.1137651; Haley KJ, 2005, EVOL HUM BEHAV, V26, P245, DOI 10.1016/j.evolhumbehav.2005.01.002; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Henrich N., 2007, WHY HUMANS COOPERATE; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Hoffman E, 1996, AM ECON REV, V86, P653; IANNACCONE LR, 1992, J POLIT ECON, V100, P271, DOI 10.1086/261818; Irons W., 2001, EVOLUTION CAPACITY C, P292; JOHNSON DDP, 2006, EVOLUTIONARY PSYCHOL, V4, P219, DOI DOI 10.1177/147470490600400119; Keltner D, 2001, EMO SOC BEH, P192; Monsma SV., 2007, INTERDISCIPLINARY J, V3, P3; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Putnam RD., 2000, BOWLING ALONE COLLAP; Randolph-Seng Brandon, 2007, INT J PSYCHOL RELIG, V17, P303, DOI [DOI 10.1080/10508610701572812, 10.1080/10508610701572812]; Roes FL, 2003, EVOL HUM BEHAV, V24, P126, DOI 10.1016/S1090-5138(02)00134-4; Shariff AF, 2007, PSYCHOL SCI, V18, P803, DOI 10.1111/j.1467-9280.2007.01983.x; Smith RJ, 1996, CURR ANTHROPOL, V37, P451, DOI 10.1086/204505; Snarey J, 1996, J SCI STUD RELIG, V35, P85, DOI 10.2307/1387077; Sosis R, 2003, EVOL ANTHROPOL, V12, P264, DOI 10.1002/evan.10120; Sosis R, 2003, CURR ANTHROPOL, V44, P713, DOI 10.1086/379260; Sosis R, 2003, CROSS-CULT RES, V37, P211, DOI 10.1177/1069397103037002003; TAN JHW, IN PRESS J EC PSYCHO; Trimble DE, 1997, EDUC PSYCHOL MEAS, V57, P970, DOI 10.1177/0013164497057006007; Wilson David Sloan., 2002, DARWINS CATHEDRAL	44	540	545	4	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					58	62		10.1126/science.1158757	http://dx.doi.org/10.1126/science.1158757			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	355AE	18832637				2022-12-28	WOS:000259680200034
J	Rogers, CS; Stoltz, DA; Meyerholz, DK; Ostedgaard, LS; Rokhlina, T; Taft, PJ; Rogan, MP; Pezzulo, AA; Karp, PH; Itani, OA; Kabel, AC; Wohlford-Lenane, CL; Davis, GJ; Hanfland, RA; Smith, TL; Samuel, M; Wax, D; Murphy, CN; Rieke, A; Whitworth, K; Uc, A; Starner, TD; Brogden, KA; Shilyansky, J; McCray, PB; Zabner, J; Prather, RS; Welsh, MJ				Rogers, Christopher S.; Stoltz, David A.; Meyerholz, David K.; Ostedgaard, Lynda S.; Rokhlina, Tatiana; Taft, Peter J.; Rogan, Mark P.; Pezzulo, Alejandro A.; Karp, Philip H.; Itani, Omar A.; Kabel, Amanda C.; Wohlford-Lenane, Christine L.; Davis, Greg J.; Hanfland, Robert A.; Smith, Tony L.; Samuel, Melissa; Wax, David; Murphy, Clifton N.; Rieke, August; Whitworth, Kristin; Uc, Aliye; Starner, Timothy D.; Brogden, Kim A.; Shilyansky, Joel; McCray, Paul B., Jr.; Zabner, Joseph; Prather, Randall S.; Welsh, Michael J.			Disruption of the CFTR gene produces a model of cystic fibrosis in newborn pigs	SCIENCE			English	Article							INFLAMMATION; INFANTS; LOCALIZATION; PANCREAS; DISEASE	Almost two decades after CFTR was identified as the gene responsible for cystic fibrosis ( CF), we still lack answers to many questions about the pathogenesis of the disease, and it remains incurable. Mice with a disrupted CFTR gene have greatly facilitated CF studies, but the mutant mice do not develop the characteristic manifestations of human CF, including abnormalities of the pancreas, lung, intestine, liver, and other organs. Because pigs share many anatomical and physiological features with humans, we generated pigs with a targeted disruption of both CFTR alleles. Newborn pigs lacking CFTR exhibited defective chloride transport and developed meconium ileus, exocrine pancreatic destruction, and focal biliary cirrhosis, replicating abnormalities seen in newborn humans with CF. The pig model may provide opportunities to address persistent questions about CF pathogenesis and accelerate discovery of strategies for prevention and treatment.	[Rogers, Christopher S.; Stoltz, David A.; Ostedgaard, Lynda S.; Rokhlina, Tatiana; Taft, Peter J.; Rogan, Mark P.; Pezzulo, Alejandro A.; Karp, Philip H.; Itani, Omar A.; Kabel, Amanda C.; Davis, Greg J.; Zabner, Joseph; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA; [Meyerholz, David K.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pathol, Iowa City, IA 52242 USA; [Karp, Philip H.; Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA; [Wohlford-Lenane, Christine L.; Uc, Aliye; Starner, Timothy D.; McCray, Paul B., Jr.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pediat, Iowa City, IA 52242 USA; [Hanfland, Robert A.; Smith, Tony L.; Shilyansky, Joel] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Surg, Iowa City, IA 52242 USA; [Samuel, Melissa; Wax, David; Murphy, Clifton N.; Rieke, August; Whitworth, Kristin; Prather, Randall S.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Brogden, Kim A.] Univ Iowa, Coll Dent, Dept Periodont, Iowa City, IA 52242 USA; [Brogden, Kim A.] Univ Iowa, Coll Dent, Dow Inst Dent Res, Iowa City, IA 52242 USA; [Welsh, Michael J.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA	University of Iowa; University of Iowa; Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Missouri System; University of Missouri Columbia; University of Iowa; University of Iowa; University of Iowa	Welsh, MJ (corresponding author), Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA.	michael-welsh@uiowa.edu	Prather, Randall S/B-4528-2012; Meyerholz, David/J-8131-2019	Meyerholz, David/0000-0003-1552-3253; Zabner, Joseph/0000-0002-9606-1339; Pezzulo, Alejandro/0000-0001-7544-5109; Welsh, Michael/0000-0002-1646-6206; Ostedgaard, Lynda/0000-0001-7717-3442; Prather, Randall/0000-0002-6012-4035; Uc, Aliye/0000-0003-2004-5743; Shilyansky, Joel/0000-0003-0766-4785; Starner, Timothy/0000-0002-1933-7477; McCray, Paul/0000-0002-4067-577X; Stoltz, David/0000-0003-0893-9015	National Heart Lung and Blood Institute [HL51670]; National Institute of Diabetes and Digestive and Kidney Diseases [DK54759]; Food for the 21st Century, the Cystic Fibrosis Foundation; NIH [HL07638]; National Institute of Allergy and Infectious Diseases [AI076671]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024979] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007638, P01HL051670] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI076671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE014390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051315, P30DK054759] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Food for the 21st Century, the Cystic Fibrosis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Arias, E. Bagnall, J. Bartlett, B. Bauer, T. Bohnert, E. Burnight, K. Dobbs, C. Dohrn, L. Dowell, L. Gakhar, D. Guilliams, Y. Hao, S. C. Isom, S. Jones, S. Korte, B. Kussman, J. Launspach, M. Linville, E. Mahan, T. Mayhew, C. McHughes, K. Munson, M. Parker, C. Randak, S. Ramachandran, J. Ross, A. Small, L. Spate, D. Vermeer, E. Walters, and J. Whyte for excellent assistance. We thank our patients with CF for inspiration, and we also thank Cystic Fibrosis Foundation Therapeutics and R. Bridges for the gift of GlyH-101. This work was supported by the National Heart Lung and Blood Institute (grant HL51670), the National Institute of Diabetes and Digestive and Kidney Diseases (grant DK54759), Food for the 21st Century, the Cystic Fibrosis Foundation, and HHMI. C. S. R. was supported by NIH training grant HL07638. D. A. S. is a Parker B. Francis Fellow and was supported by the National Institute of Allergy and Infectious Diseases (grant AI076671). M. J. W. is an Investigator of the HHMI. C.S.R., R.S.P., M.J.W., and the University of Iowa Foundation have applied for a patent related to the work reported in this paper, and C. S. R. and M. J. W. are founders of Exemplar Genetics, a company that is licensing materials and technology related to this work. C. S. R. is currently Director of Research and Development at Exemplar Genetics.	Aldallal N, 2002, AM J RESP CRIT CARE, V166, P1248, DOI 10.1164/rccm.200206-627OC; Andersen DH, 1938, AM J DIS CHILD, V56, P344, DOI 10.1001/archpedi.1938.01980140114013; Armstrong DS, 2005, PEDIATR PULM, V40, P500, DOI 10.1002/ppul.20294; Blackman SM, 2006, GASTROENTEROLOGY, V131, P1030, DOI 10.1053/j.gastro.2006.07.016; Clarke LL, 1996, LAB ANIM SCI, V46, P612; CRAWFORD I, 1991, P NATL ACAD SCI USA, V88, P9262, DOI 10.1073/pnas.88.20.9262; DENNING GM, 1992, J CLIN INVEST, V89, P339, DOI 10.1172/JCI115582; Grubb Barbara R., 1999, Physiological Reviews, V79, pS193; Guilbault C, 2007, AM J RESP CELL MOL, V36, P1, DOI 10.1165/rcmb.2006-0184TR; Ibrahim Z, 2006, XENOTRANSPLANTATION, V13, P488, DOI 10.1111/j.1399-3089.2006.00346.x; IMRIE JR, 1979, AM J PATHOL, V95, P697; Karp Philip H, 2002, Methods Mol Biol, V188, P115; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Oppenheimer E H, 1975, Perspect Pediatr Pathol, V2, P241; OPPENHEIMER EH, 1975, J PEDIATR-US, V86, P683, DOI 10.1016/S0022-3476(75)80351-9; Quinton Paul M., 1999, Physiological Reviews, V79, pS3; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rogers CS, 2008, AM J PHYSIOL-LUNG C, V295, pL240, DOI 10.1152/ajplung.90203.2008; Rogers CS, 2008, J CLIN INVEST, V118, P1571, DOI 10.1172/JCI34773; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Stecenko AA, 2001, INFLAMMATION, V25, P145, DOI 10.1023/A:1011080229374; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; Welsh MJ, 2001, METABOLIC MOL BASES, P5121; Wilschanski M, 1998, J ROY SOC MED, V91, P40, DOI 10.1177/014107689809134S07	26	573	612	1	77	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1837	1841		10.1126/science.1163600	http://dx.doi.org/10.1126/science.1163600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818360	Green Accepted			2022-12-28	WOS:000259501300039
J	Olsen, SM; Hansen, B; Quadfasel, D; Osterhus, S				Olsen, Steffen M.; Hansen, Bogi; Quadfasel, Detlef; Osterhus, Svein			Observed and modelled stability of overflow across the Greenland-Scotland ridge	NATURE			English	Article							MERIDIONAL OVERTURNING CIRCULATION; NORTH-ATLANTIC; DEEP-WATER; FAROE; VARIABILITY	Across the Greenland - Scotland ridge there is a continuous flow of cold dense water, termed 'overflow', from the Nordic seas to the Atlantic Ocean(1). This is a main contributor to the production of North Atlantic Deep Water(2) that feeds the lower limb of the Atlantic meridional overturning circulation, which has been predicted to weaken as a consequence of climate change(3,4). The two main overflow branches pass the Denmark Strait and the Faroe Bank channel. Here we combine results from direct current measurements in the Faroe Bank channel(5) for 1995 - 2005 with an ensemble hindcast experiment(6) for 1948 - 2005 using an ocean general circulation model. For the overlapping period we find a convincing agreement between model simulations and observations on monthly to interannual timescales. Both observations and model data show no significant trend in volume transport. In addition, for the whole 1948 - 2005 period, the model indicates no persistent trend in the Faroe Bank channel overflow or in the total overflow transport, in agreement with the few available historical observations. Deepening isopycnals in the Norwegian Sea have tended to decrease the pressure difference across the Greenland - Scotland ridge(7), but this has been compensated for by the effect of changes in sea level. In contrast with earlier studies(7,8), we therefore conclude that the Faroe Bank channel overflow, and also the total overflow, did not decrease consistently from 1950 to 2005, although the model does show a weakening total Atlantic meridional overturning circulation as a result of changes south of the Greenland - Scotland ridge.	[Olsen, Steffen M.] Danish Meteorol Inst, DK-2100 Copenhagen, Denmark; [Hansen, Bogi] Faroese Fisheries Lab, FO-110 Torshavn, Faroe Islands, Denmark; [Quadfasel, Detlef] Univ Hamburg, Zentrum Meeres & Klimaforsch, D-20146 Hamburg, Germany; [Osterhus, Svein] Univ Bergen, Bjerknes Ctr Climate Res, NO-5014 Bergen, Norway	Danish Meteorological Institute DMI; University of Hamburg; Bjerknes Centre for Climate Research; University of Bergen	Olsen, SM (corresponding author), Danish Meteorol Inst, Lyngbyvej 100, DK-2100 Copenhagen, Denmark.	smo@dmi.dk		Osterhus, Svein/0000-0001-9915-2685	European Commission; Danish Environmental Ministry; Nordic Council in the project Arctic-Atlantic Exchanges (ARATEX); German Federal Ministry of Education and Research ( BMBF); North Atlantic Project; Research Council of Norway; POCAHONTAS; CNES	European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Environmental Ministry; Nordic Council in the project Arctic-Atlantic Exchanges (ARATEX); German Federal Ministry of Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF)); North Atlantic Project; Research Council of Norway(Research Council of Norway); POCAHONTAS; CNES(Centre National D'etudes Spatiales)	This work was partly supported by the European Commission as part of the MOEN (Meridional Overturning Exchange with the Nordic Seas) project, the Danish Environmental Ministry through the Danish Cooperation for Environment in the Arctic (DANCEA) programme, the Nordic Council in the project Arctic-Atlantic Exchanges (ARATEX), the German Federal Ministry of Education and Research ( BMBF) in the North Atlantic Project, and the Research Council of Norway in the projects BIAC ( Bipolar Atlantic Thermohaline Circulation) and POCAHONTAS ( Polar Climate and Heat Transport). The altimeter products used were produced by Ssalto/Duacs and distributed by Aviso with support from CNES (http://aviso.oceanobs.com).	BORENAS KM, 1988, J GEOPHYS RES-OCEANS, V93, P1281, DOI 10.1029/JC093iC02p01281; Bryden HL, 2005, NATURE, V438, P655, DOI 10.1038/nature04385; Crease J., 1965, DEEP-SEA RES, V12, P143; Cunningham SA, 2007, SCIENCE, V317, P935, DOI 10.1126/science.1141304; DICKSON RR, 1994, J GEOPHYS RES-OCEANS, V99, P12319, DOI 10.1029/94JC00530; Dooley H. D., 1981, DTSCH HYDROGR Z, V34, P41, DOI DOI 10.1007/BF02226585; Girton JB, 2006, J PHYS OCEANOGR, V36, P2340, DOI 10.1175/JPO2969.1; Gregory JM, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023209; Hansen B, 2004, SCIENCE, V305, P953, DOI 10.1126/science.1100085; Hansen B, 2001, NATURE, V411, P927, DOI 10.1038/35082034; Hansen B, 2007, PROG OCEANOGR, V75, P817, DOI 10.1016/j.pocean.2007.09.004; Hermann F., 1967, RAPPORT PROCE VERBAU, V157, P139; Jakobsen PK, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001554; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Marsland SJ, 2003, OCEAN MODEL, V5, P91, DOI 10.1016/S1463-5003(02)00015-X; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Meincke J., 1978, DEUT HYDROGR Z, V31, P50, DOI [10.1007/BF02226000, DOI 10.1007/BF02226000]; Olsen SM, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003838; Perkins H, 1998, J GEOPHYS RES-OCEANS, V103, P21531, DOI 10.1029/98JC00890; Saunders P M., 2001, OCEAN CIRCULATION CL, V77, P401; SAUNDERS PM, 1990, J PHYS OCEANOGR, V20, P29, DOI 10.1175/1520-0485(1990)020<0029:COFTFB>2.0.CO;2; Sherwin TJ, 2008, DEEP-SEA RES PT I, V55, P396, DOI 10.1016/j.dsr.2007.12.006; Vellinga M., 2008, ARCTIC SUBARCTIC OCE, P289, DOI DOI 10.1007/978-1-4020-6774-7_13; VONSTORACH H, 1999, STAT ANAL CLIMATE RE; Whitehead JA, 1998, REV GEOPHYS, V36, P423, DOI 10.1029/98RG01014	25	75	77	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					519	U35		10.1038/nature07302	http://dx.doi.org/10.1038/nature07302			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818655				2022-12-28	WOS:000259449600043
J	Scheerer, P; Park, JH; Hildebrand, PW; Kim, YJ; Krauss, N; Choe, HW; Hofmann, KP; Ernst, OP				Scheerer, Patrick; Park, Jung Hee; Hildebrand, Peter W.; Kim, Yong Ju; Krauss, Norbert; Choe, Hui-Woog; Hofmann, Klaus Peter; Ernst, Oliver P.			Crystal structure of opsin in its G-protein-interacting conformation	NATURE			English	Article							HETEROTRIMERIC G-PROTEIN; CATALYZED TRANSDUCIN ACTIVATION; CARBOXYLIC-ACID GROUP; ALPHA-SUBUNIT; NUCLEOTIDE EXCHANGE; COUPLED RECEPTOR; SQUID RHODOPSIN; DARK-ADAPTATION; PROTON UPTAKE; BINDING-SITE	Opsin, the ligand- free form of the G- protein- coupled receptor rhodopsin, at low pH adopts a conformationally distinct, active G- protein- binding state known as Ops*. A synthetic peptide derived from the main binding site of the heterotrimeric G protein - the carboxy terminus of the alpha-subunit (G alpha CT) - stabilizes Ops*. Here we present the 3.2 angstrom crystal structure of the bovine Ops* - G alpha CT peptide complex. G alpha CT binds to a site in opsin that is opened by an outward tilt of transmembrane helix ( TM) 6, a pairing of TM5 and TM6, and a restructured TM7 - helix 8 kink. Contacts along the inner surface of TM5 and TM6 induce an alpha- helical conformation in G alpha CT with a C- terminal reverse turn. Main- chain carbonyl groups in the reverse turn constitute the centre of a hydrogen- bonded network, which links the two receptor regions containing the conserved E( D) RY and NPxxY(x)(5,6)F motifs. On the basis of the Ops* - G alpha CT structure and known conformational changes in G alpha, we discuss signal transfer from the receptor to the G protein nucleotide- binding site.	[Scheerer, Patrick; Park, Jung Hee; Hildebrand, Peter W.; Kim, Yong Ju; Choe, Hui-Woog; Hofmann, Klaus Peter; Ernst, Oliver P.] Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, D-10117 Berlin, Germany; [Krauss, Norbert] Univ London Queen Mary Coll, Sch Biol & Chem Sci, London E1 4NS, England; [Choe, Hui-Woog] Chonbuk Natl Univ, Dept Chem, Coll Nat Sci, Chonju 561756, South Korea; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10115 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of London; Queen Mary University London; Jeonbuk National University; Humboldt University of Berlin	Ernst, OP (corresponding author), Charite Univ Med Berlin, Inst Med Phys & Biophys CC2, Charitepl 1, D-10117 Berlin, Germany.	hwchoe@chonbuk.ac.kr; klaus_peter.hofmann@charite.de; oliver.ernst@charite.de	soler, martha maricel m gomez/L-6025-2014	soler, martha maricel m gomez/0000-0002-4412-8108; Krauss, Norbert/0000-0002-7128-4632; Scheerer, Patrick/0000-0001-5028-2075	Protein Structure Factory; Freie Universitat Berlin [BL 14.1, BL 14.2]; Deutsche Forschungsgemeinschaft [Sfb449, Sfb740]; DFG-KOSEF international cooperation [ER 294/1-1, F01-2004-000-10054-0]; CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	Protein Structure Factory; Freie Universitat Berlin; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG-KOSEF international cooperation(Korea Science and Engineering Foundation); CBNU; Leibniz Graduate School of Molecular Biophysics, Berlin	We thank J. Engelmann and C. Koch for technical assistance; P. Henklein for peptide synthesis; C. Enenkel and M. Sommer for critically reading the manuscript; U. Muller and the scientific staff of the Protein Structure Factory and the Freie Universitat Berlin at beamlines BL 14.1 and BL 14.2 at BESSY for continuous support of the project. This work was supported by the Deutsche Forschungsgemeinschaft Sfb449 ( to O.P.E.), Sfb740 ( to O.P.E. and K.P.H.), DFG-KOSEF international cooperation ER 294/1-1 ( to O.P.E.) and F01-2004-000-10054-0 ( to H.-W.C.), and CBNU funds for overseas research 2006-2007 ( to H.-W.C.) and a fellowship of the Leibniz Graduate School of Molecular Biophysics, Berlin ( to Y.J.K.).	Acharya S, 1997, J BIOL CHEM, V272, P6519, DOI 10.1074/jbc.272.10.6519; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Cai K, 2001, P NATL ACAD SCI USA, V98, P4877, DOI 10.1073/pnas.051632898; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; DELEAN A, 1980, J BIOL CHEM, V255, P7108; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ernst OP, 2000, J BIOL CHEM, V275, P1937, DOI 10.1074/jbc.275.3.1937; FAHMY K, 1993, BIOCHEMISTRY-US, V32, P7229, DOI 10.1021/bi00079a020; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1990, SCIENCE, V250, P123, DOI 10.1126/science.2218504; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; HAMM HE, 1988, SCIENCE, V241, P832, DOI 10.1126/science.3136547; Heck M, 2001, J BIOL CHEM, V276, P10000, DOI 10.1074/jbc.M009475200; Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200; Herrmann R, 2006, VISION RES, V46, P4582, DOI 10.1016/j.visres.2006.07.027; Herrmann R, 2006, J BIOL CHEM, V281, P30234, DOI 10.1074/jbc.M600797200; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Hofmann KP, 2006, TRENDS BIOCHEM SCI, V31, P497, DOI 10.1016/j.tibs.2006.07.006; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P2001, DOI 10.1073/pnas.0608599104; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kisselev OG, 1998, P NATL ACAD SCI USA, V95, P4270, DOI 10.1073/pnas.95.8.4270; KISSELEV OG, 1994, J BIOL CHEM, V269, P21399; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Koenig BW, 2002, J MOL BIOL, V322, P441, DOI 10.1016/S0022-2836(02)00745-3; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lamb TD, 2004, PROG RETIN EYE RES, V23, P307, DOI 10.1016/j.preteyeres.2004.03.001; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Murakami M, 2007, ACTA CRYSTALLOGR F, V63, P475, DOI 10.1107/S1744309107017423; Nakamichi H, 2006, P NATL ACAD SCI USA, V103, P12729, DOI 10.1073/pnas.0601765103; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Natochin M, 2001, J NEUROCHEM, V77, P202, DOI 10.1046/j.1471-4159.2001.00221.x; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Oldham WM, 2006, NAT STRUCT MOL BIOL, V13, P772, DOI 10.1038/nsmb1129; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Ridge KD, 2006, J BIOL CHEM, V281, P7635, DOI 10.1074/jbc.M509851200; Sachs K, 2000, METHOD ENZYMOL, V315, P238; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101	58	895	916	3	165	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					497	U30		10.1038/nature07330	http://dx.doi.org/10.1038/nature07330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818650				2022-12-28	WOS:000259449600038
J	Stefanescu, A; Kanbach, G; Slowikowska, A; Greiner, J; McBreen, S; Sala, G				Stefanescu, A.; Kanbach, G.; Slowikowska, A.; Greiner, J.; McBreen, S.; Sala, G.			Very fast optical flaring from a possible new Galactic magnetar	NATURE			English	Article							RAY; TELESCOPE; OUTBURST; MISSION	Highly luminous rapid flares are characteristic of processes around compact objects like white dwarfs, neutron stars and black holes. In the high- energy regime of X- rays and gamma-rays, outbursts with variabilities on timescales of seconds or less are routinely observed, for example in gamma-ray bursts(1) or soft gamma-ray repeaters(2). At optical wavelengths, flaring activity on such timescales has not been observed, other than from the prompt phase of one exceptional gamma-ray burst(3). This is mostly due to the fact that outbursts with strong, fast flaring are usually discovered in the high- energy regime; most optical follow-up observations of such transients use instruments with integration times exceeding tens of seconds, which are therefore unable to resolve fast variability. Here we show the observation of extremely bright and rapid optical flaring in the Galactic transient(4-7) SWIFT J195509.6+261406. Our optical light curves are phenomenologically similar to high- energy light curves of soft gamma-ray repeaters and anomalous X- ray pulsars(8), which are thought to be neutron stars with extremely high magnetic fields ( magnetars). This suggests that similar processes are in operation, but with strong emission in the optical, unlike in the case of other known magnetars.	[Stefanescu, A.; Kanbach, G.; Greiner, J.; McBreen, S.; Sala, G.] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Slowikowska, A.] Fdn Res & Technol Hellas, IESL, GR-71110 Iraklion, Greece; [Slowikowska, A.] Copernicus Astron Ctr, PL-87100 Torun, Poland	Max Planck Society; Foundation for Research & Technology - Hellas (FORTH)	Stefanescu, A (corresponding author), Max Planck Inst Extraterr Phys, POB 1312, D-85741 Garching, Germany.	astefan@mpe.mpg.de; gok@mpe.mpg.de	; Slowikowska, Agnieszka/Q-4350-2017	McBreen, Sheila/0000-0002-1477-618X; Slowikowska, Agnieszka/0000-0003-4525-3178	OPTICON; Marie Curie Transfer of Knowledge Fellowship; Marie Curie Intra-European Fellowship; DLR.	OPTICON; Marie Curie Transfer of Knowledge Fellowship(European Commission); Marie Curie Intra-European Fellowship(European Commission); DLR.(Helmholtz AssociationGerman Aerospace Centre (DLR))	We thank the Skinakas Observatory for their support and allocation of telescope time, and acknowledge the allocation of Chandra DDT time. We thank F. Schrey, T. Kougentakis and G. Paterakis for technical support, A. de Ugarte Postigo for access to private data taken simultaneous to some of our observations and A. Castro-Tirado for discussions. Skinakas Observatory is a collaborative project of the University of Crete, the Foundation for Research and Technology - Hellas, and the Max-Planck-Institute for Extraterrestrial Physics. A. Stefanescu acknowledges support from OPTICON. A. Slowikowska acknowledges support of the European Union through a Marie Curie Transfer of Knowledge Fellowship within the Sixth Framework Programme. S. McB. acknowledges the support of the European Union through a Marie Curie Intra-European Fellowship within the Sixth Framework Programme. G. S. is supported through DLR.	Barthelmy SD, 2005, SPACE SCI REV, V120, P143, DOI 10.1007/s11214-005-5096-3; Beloborodov AM, 2007, ASTROPHYS J, V657, P967, DOI 10.1086/508917; Burrows DN, 2005, SPACE SCI REV, V120, P165, DOI 10.1007/s11214-005-5097-2; Durant M, 2006, ASTROPHYS J, V652, P576, DOI 10.1086/507605; Hurley K, 1999, ASTROPHYS J, V510, pL107, DOI 10.1086/311821; Kanbach G, 2008, ASTROPHYS SPACE SC L, V351, P153; KANN DA, 2007, 6505 GCN; Kasliwal MM, 2008, ASTROPHYS J, V678, P1127, DOI 10.1086/526407; Kaspi VM, 2007, ASTROPHYS SPACE SCI, V308, P1, DOI 10.1007/s10509-007-9309-y; Kaspi VM, 2003, ASTROPHYS J, V588, pL93, DOI 10.1086/375683; Kosugi G, 2005, ASTROPHYS J, V623, pL125, DOI 10.1086/430171; KOUVELIOTOU C, 2003, XRAY BINARIES GAMMA, P413; MARKWARDT CB, 2007, ASTRONOM TELEGR, P1102; Meszaros P, 2006, REP PROG PHYS, V69, P2259, DOI 10.1088/0034-4885/69/8/R01; POSTIGO AD, 2007, 6501 GCN; Racusin JL, 2008, NATURE, V455, P183, DOI 10.1038/nature07270; Testa V, 2008, ASTRON ASTROPHYS, V482, P607, DOI 10.1051/0004-6361:20078692; Uemura M, 2004, PUBL ASTRON SOC JPN, V56, P823, DOI 10.1093/pasj/56.5.823; Uemura M., 2005, INFORM B VARIABLE ST, V5626, P1; Weisskopf MC, 2002, PUBL ASTRON SOC PAC, V114, P1, DOI 10.1086/338108; [No title captured]; [No title captured]; [No title captured]	24	31	31	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					503	505		10.1038/nature07308	http://dx.doi.org/10.1038/nature07308			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818651	Green Submitted			2022-12-28	WOS:000259449600039
J	Yang, DS; Lao, CS; Zewail, AH				Yang, Ding-Shyue; Lao, Changshi; Zewail, Ahmed H.			4D electron diffraction reveals correlated unidirectional Behavior in zinc oxide nanowires	SCIENCE			English	Article							ZNO; CRYSTALLOGRAPHY; NANOSTRUCTURES; NANOCRYSTALS; MICROSCOPY; DYNAMICS; GROWTH; ARRAYS; ROUTE	The confined electronic structure of nanoscale materials has increasingly been shown to induce behavior quite distinct from that of bulk analogs. Direct atomic- scale visualization of nanowires of zinc oxide was achieved through their unique pancake- type diffraction by using four- dimensional (4D) ultrafast electron crystallography. After electronic excitation of this wide- gap photonic material, the wires were found to exhibit colossal expansions, two orders of magnitude higher than that expected at thermal equilibrium; the expansion is highly anisotropic, a quasi- one- dimensional behavior, and is facilitated by the induced antibonding character. By reducing the density of nanowires, the expansions reach even larger values and occur at shorter times, suggesting a decrease of the structural constraint in transient atomic motions. This unanticipated ultrafast carrier- driven expansion highlights the optoelectronic consequences of nanoscale morphologies.	[Yang, Ding-Shyue; Lao, Changshi; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	Zewail@caltech.edu	Yang, Ding-Shyue/A-8648-2010	Yang, Ding-Shyue/0000-0003-2713-9128; gaber, sarah/0000-0002-5995-7291	NSF; Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the NSF and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center at Caltech. We wish to thank Z.L. Wang for providing the samples, which were made by P. Fei and S. Xu, and K. Xu for the help with the SEM measurement in J.R. Heath's laboratory at Caltech.	Adachi S., 2004, HDB PHYS PROPERTIES; Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Baum P, 2007, SCIENCE, V318, P788, DOI 10.1126/science.1147724; Baum P, 2006, P NATL ACAD SCI USA, V103, P16105, DOI 10.1073/pnas.0607451103; Carbone F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.035501; Cui Y, 2001, SCIENCE, V293, P1289, DOI 10.1126/science.1062711; Gedik N, 2007, SCIENCE, V316, P425, DOI 10.1126/science.1138834; Greene LE, 2005, NANO LETT, V5, P1231, DOI 10.1021/nl050788p; Gu B, 2008, J APPL PHYS, V103, DOI 10.1063/1.2903576; He J, 2005, OPT EXPRESS, V13, P9235, DOI 10.1364/OPEX.13.009235; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; ICHIMIYA A, 2004, REFLECTION HIGH ENER, P20; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Lee HW, 2007, CHEM PHYS LETT, V447, P86, DOI 10.1016/j.cplett.2007.08.086; MULLER E, 2006, MICROSCOPY SEMICONDU, P303; Murray CB, 2000, ANNU REV MATER SCI, V30, P545, DOI 10.1146/annurev.matsci.30.1.545; Ozgur U, 2005, J APPL PHYS, V98, DOI 10.1063/1.1992666; Si X, 2008, CHINESE PHYS B, V17, P1291, DOI 10.1088/1674-1056/17/4/024; STEIGERWALD ML, 1990, ACCOUNTS CHEM RES, V23, P183, DOI 10.1021/ar00174a003; Tang J, 2007, J PHYS CHEM C, V111, P8957, DOI 10.1021/jp073015t; Wang XD, 2005, J AM CHEM SOC, V127, P7920, DOI 10.1021/ja050807x; Wang ZL, 2007, MATER TODAY, V10, P20, DOI 10.1016/S1369-7021(07)70076-7; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; WANG ZL, 1996, REFLECTION ELECT MIC; Warren B, 1990, XRAY DIFFRACTION, P253; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Xia YN, 2003, ADV MATER, V15, P353, DOI 10.1002/adma.200390087; Yang DS, 2007, J PHYS CHEM C, V111, P4889, DOI 10.1021/jp067466+; Zewail AH, 2006, ANNU REV PHYS CHEM, V57, P65, DOI 10.1146/annurev.physchem.57.032905.104748; Zhang CF, 2006, OPT LETT, V31, P3345, DOI 10.1364/OL.31.003345	30	62	62	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1660	1664		10.1126/science.1162049	http://dx.doi.org/10.1126/science.1162049			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801993				2022-12-28	WOS:000259300400030
J	Fox, AR; Bart, SC; Meyer, K; Cummins, CC				Fox, Alexander R.; Bart, Suzanne C.; Meyer, Karsten; Cummins, Christopher C.			Towards uranium catalysts	NATURE			English	Review							C-H-ACTIVATION; VALENT ORGANOURANIUM COMPLEXES; HYDROGEN-DEUTERIUM EXCHANGE; ALKYNE PI-COMPLEX; TERMINAL ALKYNES; CARBON-MONOXIDE; ORGANOACTINIDE COMPLEXES; TRIVALENT URANIUM; BOND ACTIVATION; COORDINATION CHEMISTRY	The forefront of research into the complexes of uranium reveals chemical transformations that challenge and expand our view of this unique element. Certain ligands form multiple bonds to uranium, and small, inert molecules such as nitrogen and carbon dioxide become reactive when in complex with the metal. Such complexes provide clues to the catalytic future of uranium, in which the applications of the element extend far beyond the nuclear industry. Most excitingly, the ability of uranium to use its outermost f electrons for binding ligands might enable the element to catalyse reactions that are impossible with conventional, transition- metal catalysts.	[Fox, Alexander R.; Cummins, Christopher C.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Bart, Suzanne C.; Meyer, Karsten] Univ Erlangen Nurnberg, Dept Chem & Pharm, D-91058 Erlangen, Germany	Massachusetts Institute of Technology (MIT); University of Erlangen Nuremberg	Cummins, CC (corresponding author), MIT, Dept Chem, Room 6-435,77 Massachusetts Ave, Cambridge, MA 02139 USA.	ccummins@mit.edu	Meyer, Karsten/G-2570-2012; Cummins, Christopher/J-2961-2014	Meyer, Karsten/0000-0002-7844-2998; Cummins, Christopher/0000-0003-2568-3269	National Science Foundation [CHE-0724158]; US Department of Energy [DE-FG02-O4ER 15537]; German Research Foundation DFG [ME-1754/2-1]; Sonderforschungsbereich [583]; Massachusetts Institute for Technology for the Alan Davison Graduate Fellowship; Alexander von Humboldt Foundation for a postdoctoral fellowship	National Science Foundation(National Science Foundation (NSF)); US Department of Energy(United States Department of Energy (DOE)); German Research Foundation DFG(German Research Foundation (DFG)); Sonderforschungsbereich(German Research Foundation (DFG)); Massachusetts Institute for Technology for the Alan Davison Graduate Fellowship; Alexander von Humboldt Foundation for a postdoctoral fellowship(Alexander von Humboldt Foundation)	We thank the National Science Foundation (grant number CHE-0724158), the US Department of Energy (grant number DE-FG02-O4ER 15537), the German Research Foundation (DFG; grant number ME-1754/2-1) and the Sonderforschungsbereich (grant number 583) for financial support. A. R. F. acknowledges Massachusetts Institute for Technology for the Alan Davison Graduate Fellowship. S. C. B. acknowledges the Alexander von Humboldt Foundation for a postdoctoral fellowship.	Andrea T, 2008, CHEM SOC REV, V37, P550, DOI 10.1039/b614969n; ARNEY DSJ, 1995, J AM CHEM SOC, V117, P9448, DOI 10.1021/ja00142a011; ARNEY DSJ, 1992, J AM CHEM SOC, V114, P10068, DOI 10.1021/ja00051a053; Arnold PL, 2008, NATURE, V451, P315, DOI 10.1038/nature06467; Barnea E, 2006, ORGANOMETALLICS, V25, P320, DOI 10.1021/om050966p; Barnea E, 2004, J AM CHEM SOC, V126, P10860, DOI 10.1021/ja046604a; Barnea E, 2006, COORDIN CHEM REV, V250, P855, DOI 10.1016/j.ccr.2005.12.007; BART SC, J AM CHEM S IN PRESS; Bart SC, 2008, STRUCT BOND, V127, P119, DOI 10.1007/430_2007_081; BRENNAN JG, 1986, J AM CHEM SOC, V108, P335, DOI 10.1021/ja00262a046; BRENNAN JG, 1985, J AM CHEM SOC, V107, P514, DOI 10.1021/ja00288a047; BRUNO JW, 1984, INORG CHIM A-F-BLOCK, V94, P271, DOI 10.1016/S0020-1693(00)87455-1; Burns C. J., 2006, CHEM ACTINIDE TRANSA, P2911; CALDERAZZO F, 1978, INORG CHEM, V17, P471, DOI 10.1021/ic50180a052; Castro-Rodriguez I, 2006, ANGEW CHEM INT EDIT, V45, P2389, DOI 10.1002/anie.200501667; Castro-Rodriguez I, 2005, J AM CHEM SOC, V127, P11242, DOI 10.1021/ja053497r; Castro-Rodriguez I, 2004, SCIENCE, V305, P1757, DOI 10.1126/science.1102602; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P15734, DOI 10.1021/ja0379316; Castro-Rodriguez I, 2003, J AM CHEM SOC, V125, P4565, DOI 10.1021/ja028342n; Chirik PJ, 2007, DALTON T, P16, DOI 10.1039/b613514e; CILIBERTO E, 1992, ORGANOMETALLICS, V11, P1727, DOI 10.1021/om00040a050; Cloke FGN, 2002, J AM CHEM SOC, V124, P9352, DOI 10.1021/ja027000e; COTTINGHAM PL, 1973, IND ENG CHEM PROD RD, V12, P41, DOI 10.1021/i360045a005; COTTON FA, 1999, ADV INORG CHEM, P635; CRAMER RE, 1982, ORGANOMETALLICS, V1, P869, DOI 10.1021/om00066a020; Crawford MJ, 2005, ANGEW CHEM INT EDIT, V44, P7874, DOI 10.1002/anie.200502484; Dash AK, 2000, J ORGANOMET CHEM, V604, P83, DOI 10.1016/S0022-328X(00)00207-2; Dash AK, 1999, ORGANOMETALLICS, V18, P4724, DOI 10.1021/om990655c; DEACON GB, 1986, INORG CHIM ACTA, V111, P193, DOI 10.1016/S0020-1693(00)84651-4; DORMOND A, 1987, J ORGANOMET CHEM, V329, P187, DOI 10.1016/S0022-328X(00)99792-4; Eikey RA, 2003, COORDIN CHEM REV, V243, P83, DOI 10.1016/S0010-8545(03)00048-1; Ephritikhine M, 1997, CHEM REV, V97, P2193, DOI 10.1021/cr960366n; Ephritikhine M, 2006, DALTON T, P2501, DOI 10.1039/b603463b; Evans N, 2002, J HIGH ENERGY PHYS; Evans WJ, 2007, ORGANOMETALLICS, V26, P4287, DOI 10.1021/om700382a; Evans WJ, 2007, ORGANOMETALLICS, V26, P3568, DOI 10.1021/om7003139; Evans WJ, 2005, SCIENCE, V309, P1835, DOI 10.1126/science.1116452; Evans WJ, 2003, J AM CHEM SOC, V125, P13831, DOI 10.1021/ja036631l; FAGAN PJ, 1981, J AM CHEM SOC, V103, P6650, DOI 10.1021/ja00412a021; Fogg DE, 2004, COORDIN CHEM REV, V248, P2365, DOI 10.1016/j.ccr.2004.05.012; Haber F., 1909, German patent, Patent No. [DE 229126, 229126]; Harris D. C., 1978, SYMMETRY SPECTROSCOP; Haskel A, 1999, J AM CHEM SOC, V121, P3025, DOI 10.1021/ja983640z; Haskel A, 1996, ORGANOMETALLICS, V15, P3773, DOI 10.1021/om960182z; Haskel A, 1999, J AM CHEM SOC, V121, P3014, DOI 10.1021/ja9836390; Hayton TW, 2006, J AM CHEM SOC, V128, P12622, DOI 10.1021/ja064400j; Hayton TW, 2006, J AM CHEM SOC, V128, P10549, DOI 10.1021/ja0629155; Hayton TW, 2005, SCIENCE, V310, P1941, DOI 10.1126/science.1120069; HE MY, 1985, J AM CHEM SOC, V107, P641, DOI 10.1021/ja00289a016; Kiplinger JL, 2007, J ALLOY COMPD, V444, P477, DOI 10.1016/j.jallcom.2007.04.272; Kiplinger JL, 2002, ORGANOMETALLICS, V21, P5978, DOI 10.1021/om0206610; Korobkov I, 2002, ANGEW CHEM INT EDIT, V41, P3433, DOI 10.1002/1521-3773(20020916)41:18<3433::AID-ANIE3433>3.0.CO;2-V; Lam OP, 2008, J AM CHEM SOC, V130, P2806, DOI 10.1021/ja0766472; Lescop C, 1999, J ORGANOMET CHEM, V580, P137, DOI 10.1016/S0022-328X(98)01139-5; LIN Z, 1990, J AM CHEM SOC, V112, P5515, DOI 10.1021/ja00170a015; LIN ZR, 1987, J AM CHEM SOC, V109, P7979, DOI 10.1021/ja00260a007; Louie J, 2002, J AM CHEM SOC, V124, P15188, DOI 10.1021/ja027438e; Lukens WW, 1996, J AM CHEM SOC, V118, P901, DOI 10.1021/ja9531283; MacKay BA, 2004, CHEM REV, V104, P385, DOI 10.1021/cr020610c; Mindiola DJ, 2008, ANGEW CHEM INT EDIT, V47, P1557, DOI 10.1002/anie.200704987; MOLOY KG, 1985, INORG CHIM A-F-BLOCK, V110, P127, DOI 10.1016/S0020-1693(00)84568-5; Nocton G, 2008, ANGEW CHEM INT EDIT, V47, P3040, DOI 10.1002/anie.200705742; NOLAN SP, 1991, ORGANOMETALLICS, V10, P1450, DOI 10.1021/om00051a042; Odom AL, 1998, J AM CHEM SOC, V120, P5836, DOI 10.1021/ja980095t; PAOLUCCI G, 1984, J ORGANOMET CHEM, V272, P363, DOI 10.1016/0022-328X(84)80480-5; PARRY J, 1995, J AM CHEM SOC, V117, P2649, DOI 10.1021/ja00114a030; Peters RG, 1999, J AM CHEM SOC, V121, P5585, DOI 10.1021/ja9844581; Pohlki F, 2003, CHEM SOC REV, V32, P104, DOI 10.1039/b200386b; Pool JA, 2005, J AM CHEM SOC, V127, P1338, DOI 10.1021/ja044153o; Pool JA, 2004, J AM CHEM SOC, V126, P14326, DOI 10.1021/ja045566s; Pool JA, 2006, J ALLOY COMPD, V418, P178, DOI 10.1016/j.jallcom.2005.08.092; Roussel P, 1998, J AM CHEM SOC, V120, P1070, DOI 10.1021/ja972933+; Roussel P, 2002, J CHEM SOC DALTON, P1423, DOI 10.1039/b108584k; Schrock RR, 2005, ACCOUNTS CHEM RES, V38, P955, DOI 10.1021/ar0501121; SCHROCK RR, 1986, ACCOUNTS CHEM RES, V19, P342, DOI 10.1021/ar00131a003; SIKORA DJ, 1981, J AM CHEM SOC, V103, P1265, DOI 10.1021/ja00395a068; SIMPSON SJ, 1979, J AM CHEM SOC, V101, P7728, DOI 10.1021/ja00520a023; SIMPSON SJ, 1981, INORG CHEM, V20, P2991, DOI 10.1021/ic50223a047; SIMPSON SJ, 1981, J AM CHEM SOC, V103, P4063, DOI 10.1021/ja00404a014; SMITH GM, 1986, J AM CHEM SOC, V108, P6805, DOI 10.1021/ja00281a059; Spencer LP, 2008, J AM CHEM SOC, V130, P2930, DOI 10.1021/ja7107454; Straub T, 1996, J CHEM SOC DALTON, P2541, DOI 10.1039/dt9960002541; STRAUB T, 1995, J AM CHEM SOC, V117, P6364, DOI 10.1021/ja00128a029; Stubbert BD, 2003, ORGANOMETALLICS, V22, P4836, DOI 10.1021/om034093f; Stubbert BD, 2007, J AM CHEM SOC, V129, P4253, DOI 10.1021/ja0665444; Summerscales OT, 2006, SCIENCE, V311, P829, DOI 10.1126/science.1121784; Summerscales OT, 2006, J AM CHEM SOC, V128, P9602, DOI 10.1021/ja063222r; Takimoto M, 2002, J AM CHEM SOC, V124, P10008, DOI 10.1021/ja026620c; Thetford R, 2003, J NUCL MATER, V320, P44, DOI 10.1016/S0022-3115(03)00170-3; Wang JX, 2006, J AM CHEM SOC, V128, P9350, DOI 10.1021/ja063443x; Wang JQ, 1999, ORGANOMETALLICS, V18, P2407, DOI 10.1021/om980973w; Wang JX, 2002, CHEM-EUR J, V8, P5384, DOI 10.1002/1521-3765(20021202)8:23<5384::AID-CHEM5384>3.0.CO;2-X; Warner BP, 1998, ANGEW CHEM INT EDIT, V37, P959, DOI 10.1002/(SICI)1521-3773(19980420)37:7<959::AID-ANIE959>3.0.CO;2-D; WEYDERT M, 1995, ORGANOMETALLICS, V14, P3942, DOI 10.1021/om00008a046; ZALKIN A, 1988, ACTA CRYSTALLOGR C, V44, P1553, DOI 10.1107/S0108270188005116; Zi GF, 2005, ORGANOMETALLICS, V24, P4602, DOI 10.1021/om050427k; Zi GF, 2005, ORGANOMETALLICS, V24, P4251, DOI 10.1021/om050406q	97	335	338	4	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					341	349		10.1038/nature07372	http://dx.doi.org/10.1038/nature07372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800133	Green Submitted			2022-12-28	WOS:000259265200035
J	McPake, B; Mensah, K				McPake, Barbara; Mensah, Kwadwo			Task shifting in health care in resource-poor countries	LANCET			English	Editorial Material									[McPake, Barbara] Queen Margaret Univ, Inst Int Hlth & Dev, Edinburgh EH21 6UU, Midlothian, Scotland; [Mensah, Kwadwo] Yak Aky Management Consultancy Serv, Kumasi, Ghana	Queen Margaret University	McPake, B (corresponding author), Queen Margaret Univ, Inst Int Hlth & Dev, Edinburgh EH21 6UU, Midlothian, Scotland.	bmcpake@qmuc.ac.uk	McPake, Barbara/AAE-8655-2021	McPake, Barbara/0000-0002-9904-1077				Cumbi Amelia, 2007, Hum Resour Health, V5, P27, DOI 10.1186/1478-4491-5-27; Fenton PM, 2003, BRIT MED J, V327, P587, DOI 10.1136/bmj.327.7415.587; *GHAN MIN HLTH, 2002, HUM RES POL STRAT HL; Hongoro C, 2004, LANCET, V364, P1451, DOI 10.1016/S0140-6736(04)17229-2; HONGORO C, 2006, HLTH WORKERS BUILDIN, P1309; Huicho L, 2008, LANCET, V372, P910, DOI 10.1016/S0140-6736(08)61401-4; Stanback J, 2005, FINAL REPORT SAFETY; *UG EP C CATH SECR, 2005, FIN REP TASK FORC RE	8	86	87	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					870	871		10.1016/S0140-6736(08)61375-6	http://dx.doi.org/10.1016/S0140-6736(08)61375-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790295				2022-12-28	WOS:000259266900007
J	Gonzalez-Reyes, A; Casanova, J				Gonzalez-Reyes, Acaimo; Casanova, Jordi			Developmental biology - Return to the proliferative pool	SCIENCE			English	Editorial Material							STEM-CELLS; DROSOPHILA; PANCREAS; RENEWAL		[Gonzalez-Reyes, Acaimo] CSIC UPO, Ctr Andaluz Biol Desarrollo, Seville, Spain; [Casanova, Jordi] CSIC, Inst Mol Biol, Barcelona, Spain; [Casanova, Jordi] Inst Recerca Biomed, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; CSIC - Andalusian Center for Developmental Biology (CABD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Gonzalez-Reyes, A (corresponding author), CSIC UPO, Ctr Andaluz Biol Desarrollo, Seville, Spain.	jcrbmc@cid.csic.es	Gonzalez-Reyes, Acaimo/L-1993-2014; Casanova, Jordi/L-5181-2014	Gonzalez-Reyes, Acaimo/0000-0003-3048-0968; Casanova, Jordi/0000-0001-6121-8589				Alison MR, 2004, CELL PROLIFERAT, V37, P1, DOI 10.1111/j.1365-2184.2004.00297.x; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Guha A, 2008, P NATL ACAD SCI USA, V105, P10832, DOI 10.1073/pnas.0805111105; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025; Weaver M, 2008, SCIENCE, V321, P1496, DOI 10.1126/science.1158712; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	8	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1450	1451		10.1126/science.1163623	http://dx.doi.org/10.1126/science.1163623			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787155				2022-12-28	WOS:000259121800025
J	Haddad, RI; Shin, DM				Haddad, Robert I.; Shin, Dong M.			Recent advances in head and neck cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-RECEPTOR; MODULATED RADIATION-THERAPY; LYMPH-NODE METASTASIS; LOCALLY ADVANCED HEAD; MULTICENTER PHASE-II; HUMAN-PAPILLOMAVIRUS; PROTEIN-KINASE; CONCURRENT CHEMOTHERAPY; PREMALIGNANT LESIONS		[Haddad, Robert I.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Haddad, Robert I.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Haddad, Robert I.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shin, Dong M.] Emory Univ, Dept Hematol Oncol, Winship Canc Inst, Atlanta, GA 30322 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Emory University	Haddad, RI (corresponding author), Dana Farber Canc Inst, 44 Binney St, Boston, MA 02115 USA.	robert_haddad@dfci.harvard.edu	Ray, Dana M/C-3470-2013; Shin, Dong Moon/G-9649-2013; Teh, Muy-Teck/B-9284-2016	Shin, Dong Moon/0000-0002-8245-4174; Teh, Muy-Teck/0000-0002-7725-8355; Haddad, Robert/0000-0003-1413-0079	ImClone Systems; Bristol-Myers Squibb; Sanofi-Aventis	ImClone Systems(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Sanofi-Aventis(Sanofi-Aventis)	Dr. Haddad reports receiving consulting fees from ImClone Systems and Bristol-Myers Squibb and lecture fees from Sanofi-Aventis and Bristol-Myers Squibb; and Dr. Shin, lecture fees from Bristol-Myers Squibb and Sanofi-Aventis. No other potential conflict of interest relevant to this article was reported. We thank Drs. Anthea Hammond and Souheil El-Chemaly for their critical reading of and assistance with the preparation of the manuscript.	Adelstein DJ, 2003, J CLIN ONCOL, V21, P92, DOI 10.1200/JCO.2003.01.008; Al-Sarraf M, 1998, J CLIN ONCOL, V16, P1310, DOI 10.1200/JCO.1998.16.4.1310; Ang K, 2007, INT J RADIAT ONCOL, V69, pS12, DOI 10.1016/j.ijrobp.2007.07.023; Ang KK, 2002, CANCER RES, V62, P7350; Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Bernier J, 2005, HEAD NECK-J SCI SPEC, V27, P843, DOI 10.1002/hed.20279; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Braakhuis BJM, 2003, CANCER RES, V63, P1727; Burtness B, 2005, J CLIN ONCOL, V23, P8646, DOI 10.1200/JCO.2005.02.4646; CALLENDER T, 1994, CANCER-AM CANCER SOC, V74, P152, DOI 10.1002/1097-0142(19940701)74:1<152::AID-CNCR2820740124>3.0.CO;2-K; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Choi HR, 2003, AM J SURG PATHOL, V27, P1216, DOI 10.1097/00000478-200309000-00004; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cohen EEW, 2003, J CLIN ONCOL, V21, P1980, DOI 10.1200/JCO.2003.10.051; COHEN S, 1980, J BIOL CHEM, V255, P4834; Cooper JS, 2004, NEW ENGL J MED, V350, P1937, DOI 10.1056/NEJMoa032646; COPPER MP, 1995, ARCH OTOLARYNGOL, V121, P157; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dittmann K, 2005, J BIOL CHEM, V280, P31182, DOI 10.1074/jbc.M506591200; Diwakar N, 2005, ORAL ONCOL, V41, P416, DOI 10.1016/j.oraloncology.2004.10.009; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Eisbruch A, 2005, NAT CLIN PRACT ONCOL, V2, P34, DOI 10.1038/ncponc0058; El-Naggar AK, 1997, DIAGN MOL PATHOL, V6, P305, DOI 10.1097/00019606-199712000-00001; ElNaggar AK, 1996, CLIN CANCER RES, V2, P903; ElNaggar AK, 1996, AM J PATHOL, V148, P2067; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; FORASTIERE A, 2002, NEW ENGL J MED, V346, P788; Forastiere AA, 2006, J CLIN ONCOL, V24, p284S; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Garden AS, 2007, INT J RADIAT ONCOL, V67, P438, DOI 10.1016/j.ijrobp.2006.08.078; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gasco M, 2003, ORAL ONCOL, V39, P222, DOI 10.1016/S1368-8375(02)00163-X; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Guleng B, 2005, CANCER RES, V65, P5864, DOI 10.1158/0008-5472.CAN-04-3833; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; Herbst RS, 2002, CANCER-AM CANCER SOC, V94, P1593, DOI 10.1002/cncr.10372; Jang SJ, 2001, ONCOGENE, V20, P2235, DOI 10.1038/sj.onc.1204311; Janot F, 1996, BRIT J CANCER, V73, P531, DOI 10.1038/bjc.1996.92; Jin C, 2002, CANCER GENET CYTOGEN, V132, P85, DOI 10.1016/S0165-4608(01)00535-0; Jin YT, 1999, ORAL ONCOL, V35, P251, DOI 10.1016/S1368-8375(98)00112-2; Katayama A, 2004, CLIN CANCER RES, V10, P634, DOI 10.1158/1078-0432.CCR-0864-02; Kerbel R, 2002, NAT REV CANCER, V2, P727, DOI 10.1038/nrc905; KESSIS TD, 1993, P NATL ACAD SCI USA, V90, P3988, DOI 10.1073/pnas.90.9.3988; Koch WM, 1999, LARYNGOSCOPE, V109, P1544, DOI 10.1097/00005537-199910000-00002; LAI SL, 1995, ONCOL REP, V2, P1115; Laird AD, 2000, CANCER RES, V60, P4152; Lee NY, 2006, INT J RADIAT ONCOL, V66, P966, DOI 10.1016/j.ijrobp.2006.06.040; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Li GJ, 2004, CARCINOGENESIS, V25, P1911, DOI 10.1093/carcin/bgh197; Li MF, 2002, CLIN CANCER RES, V8, P3570; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Mao L, 1996, NAT MED, V2, P682, DOI 10.1038/nm0696-682; MASUI H, 1984, CANCER RES, V44, P1002; MENDELSOHN J, 1988, PROG ALLERGY, V45, P147; Mendenhall WM, 2006, J CLIN ONCOL, V24, P2618, DOI 10.1200/JCO.2005.04.7225; Mosher William D, 2005, Adv Data, P1; O'Donnell RK, 2005, ONCOGENE, V24, P1244, DOI 10.1038/sj.onc.1208285; Papadimitrakopoulou VA, 2001, CLIN CANCER RES, V7, P3127; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Perrone F, 2007, CLIN CANCER RES, V13, P4313; Pignon JP, 2007, INT J RADIAT ONCOL, V69, pS112, DOI 10.1016/j.ijrobp.2007.04.088; Pignon JP, 2000, LANCET, V355, P949, DOI 10.1016/S0140-6736(00)90011-4; Posner MR, 2007, NEW ENGL J MED, V357, P1705, DOI 10.1056/NEJMoa070956; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; Seiden MV, 2007, GYNECOL ONCOL, V104, P727, DOI 10.1016/j.ygyno.2006.10.019; SHAH JP, 1990, AM J SURG, V160, P405, DOI 10.1016/S0002-9610(05)80554-9; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Soulieres D, 2004, J CLIN ONCOL, V22, P77, DOI 10.1200/JCO.2004.06.075; STEWART S, 2007, P AM ASS CANC RES AN; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Tseng JE, 2001, CANCER-AM CANCER SOC, V92, P2364, DOI 10.1002/1097-0142(20011101)92:9<2364::AID-CNCR1584>3.0.CO;2-P; Uchida D, 2003, EXP CELL RES, V290, P289, DOI 10.1016/S0014-4827(03)00344-6; VERMORKEN J, 2007, EUR J CANCER, V5, P4; VERMORKEN J, 2007, 43 ANN M AM SOC CLIN; Vermorken JB, 2007, NEW ENGL J MED, V357, P1695, DOI 10.1056/NEJMoa071028; Vermorken JB, 2007, J CLIN ONCOL, V25, P2171, DOI 10.1200/JCO.2006.06.7447; Vokes EE, 2005, J CLIN ONCOL, V23, p501S; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang XH, 2006, ORAL ONCOL, V42, P740, DOI 10.1016/j.oraloncology.2005.11.018; Weber A, 2003, PATHOL RES PRACT, V199, P391, DOI 10.1078/0344-0338-00435; WILLIAMS R, 1993, J BIOL CHEM, V268, P18213; Zhang ZD, 2004, CANCER EPIDEM BIOMAR, V13, P1081	90	688	706	0	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1143	1154		10.1056/NEJMra0707975	http://dx.doi.org/10.1056/NEJMra0707975			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784104				2022-12-28	WOS:000259078200010
J	Zilberman, D; Coleman-Derr, D; Ballinger, T; Henikoff, S				Zilberman, Daniel; Coleman-Derr, Devin; Ballinger, Tracy; Henikoff, Steven			Histone H2A.Z and DNA methylation are mutually antagonistic chromatin marks	NATURE			English	Article							GENOME-WIDE; VARIANT; ARABIDOPSIS; NUCLEOSOME; PROMOTERS; GENES; EUCHROMATIN; DYNAMICS; YEAST	Eukaryotic chromatin is separated into functional domains differentiated by post- translational histone modifications, histone variants and DNA methylation(1-6). Methylation is associated with repression of transcriptional initiation in plants and animals, and is frequently found in transposable elements. Proper methylation patterns are crucial for eukaryotic development(4,5), and aberrant methylation- induced silencing of tumour suppressor genes is a common feature of human cancer(7). In contrast to methylation, the histone variant H2A. Z is preferentially deposited by the Swr1 ATPase complex near 59 ends of genes where it promotes transcriptional competence(8-20). How DNA methylation and H2A.Z influence transcription remains largely unknown. Here we show that in the plant Arabidopsis thaliana regions of DNA methylation are quantitatively deficient in H2A.Z. Exclusion of H2A.Z is seen at sites of DNA methylation in the bodies of actively transcribed genes and in methylated transposons. Mutation of the MET1 DNA methyltransferase, which causes both losses and gains of DNA methylation(4,5), engenders opposite changes ( gains and losses) in H2A.Z deposition, whereas mutation of the PIE1 subunit of the Swr1 complex that deposits H2A.Z(17) leads to genome- wide hypermethylation. Our findings indicate that DNA methylation can influence chromatin structure and effect gene silencing by excluding H2A.Z, and that H2A.Z protects genes from DNA methylation.	[Zilberman, Daniel; Coleman-Derr, Devin] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Ballinger, Tracy; Henikoff, Steven] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Ballinger, Tracy; Henikoff, Steven] Howard Hughes Med Inst, Seattle, WA 98109 USA	University of California System; University of California Berkeley; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute	Zilberman, D (corresponding author), Univ Calif Berkeley, 211 Koshland Hall, Berkeley, CA 94720 USA.	daniel.zilberman@nature.berkely.edu; steveh@fhcrc.org	Hu, Ruogu/B-2203-2008	Zilberman, Daniel/0000-0002-0123-8649; Henikoff, Steven/0000-0002-7621-8685	NSF	NSF(National Science Foundation (NSF))	We thank J. Henikoff and B. Nguyen for help with computational analyses, P. Talbert for assistance with cytology, T. Bryson and A. Morgan for technical support, M. Gehring and B. Staskawicz for the root culture protocol, R. Deal and R. Meagher for H2A.Z antibodies, the FHCRC DNA array facility for carrying out microarray hybridizations, and M. Orozco for transgenic lines. D.C.-D. is supported by an NSF predoctoral fellowship. D. Z. is a Leukemia and Lymphoma Society fellow.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein E, 2006, BIOCHEM CELL BIOL, V84, P505, DOI 10.1139/O06-085; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Brickner DG, 2007, PLOS BIOL, V5, P704, DOI 10.1371/journal.pbio.0050081; Buck MJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-r97; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Gehring M, 2007, BBA-GENE STRUCT EXPR, V1769, P276, DOI 10.1016/j.bbaexp.2007.01.009; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Guillemette B, 2006, BIOCHEM CELL BIOL, V84, P528, DOI 10.1139/O06-077; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Malik HS, 2003, NAT STRUCT BIOL, V10, P882, DOI 10.1038/nsb996; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Vaughn MW, 2007, PLOS BIOL, V5, P1617, DOI 10.1371/journal.pbio.0050174; Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104; Xiao WY, 2003, DEV CELL, V5, P891, DOI 10.1016/S1534-5807(03)00361-7; Zhang HY, 2005, CELL, V123, P219, DOI 10.1016/j.cell.2005.08.036; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	30	394	408	3	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 6	2008	456	7218					125	U14		10.1038/nature07324	http://dx.doi.org/10.1038/nature07324			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	369DH	18815594	Green Accepted			2022-12-28	WOS:000260674000054
J	Landray, MJ; Haynes, RJ				Landray, Martin J.; Haynes, Richard J.			Commentary: Controversies in NICE guidance on chronic kidney disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Landray, Martin J.; Haynes, Richard J.] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Landray, Martin J.; Haynes, Richard J.] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Haynes, Richard J.] Churchill Hosp, Oxford Kidney Unit, Oxford OX3 7LE, England	University of Oxford; University of Oxford; University of Oxford	Landray, MJ (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England.	martin.landray@ctsu.ox.ac.uk		Landray, Martin/0000-0001-6646-827X; Haynes, Richard/0000-0002-1179-0023	MRC [MC_U137686853] Funding Source: UKRI; British Heart Foundation Funding Source: Medline; Medical Research Council [MC_U137686853] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baigent C, 2003, KIDNEY INT, V63, pS207, DOI 10.1046/j.1523-1755.63.s84.4.x; Glassock RJ, 2008, CLIN J AM SOC NEPHRO, V3, P1563, DOI 10.2215/CJN.00960208; Himmelfarb J, 2007, JAMA-J AM MED ASSOC, V297, P2630, DOI 10.1001/jama.297.23.2630; O'Hare AM, 2007, J AM SOC NEPHROL, V18, P2758, DOI 10.1681/ASN.2007040422; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60	5	3	4	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2008	337	7673							a1793	10.1136/bmj.a1793	http://dx.doi.org/10.1136/bmj.a1793			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	356SN	18824482				2022-12-28	WOS:000259798000040
J	Marano, N; Plikaytis, BD; Martin, SW; Rose, C; Semenova, VA; Martin, SK; Freeman, AE; Li, H; Mulligan, MJ; Parker, SD; Babcock, J; Keitel, W; El Sahly, H; Poland, GA; Jacobson, RM; Keyserling, HL; Soroka, SD; Fox, SP; Stamper, JL; McNeil, MM; Perkins, BA; Messonnier, N; Quinn, CP				Marano, Nina; Plikaytis, Brian D.; Martin, Stacey W.; Rose, Charles; Semenova, Vera A.; Martin, Sandra K.; Freeman, Alison E.; Li, Han; Mulligan, Mark J.; Parker, Scott D.; Babcock, Janiine; Keitel, Wendy; El Sahly, Hana; Poland, Gregory A.; Jacobson, Robert M.; Keyserling, Harry L.; Soroka, Stephen D.; Fox, Sarah P.; Stamper, John L.; McNeil, Michael M.; Perkins, Bradley A.; Messonnier, Nancy; Quinn, Conrad P.		Anthrax Vaccine Res Program Workin	Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months - A randomized trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SIDED TESTS PROCEDURE; MULTIPLE IMPUTATION; PROTECTIVE ANTIGEN; ADVERSE EVENTS; IMMUNOGLOBULIN-G; CORRELATE; IMMUNITY; ROUTE; MODEL; POWER	Context In 1999, the US Congress directed the Centers for Disease Control and Prevention to conduct a pivotal safety and efficacy study of anthrax vaccine adsorbed ( AVA). Objective To determine the effects on serological responses and injection site adverse events ( AEs) resulting from changing the route of administration of AVA from subcutaneous ( SQ) to intramuscular ( IM) and omitting the week 2 dose from the licensed schedule. Design, Setting, and Participants Assessment of the first 1005 enrollees in a multisite, randomized, double- blind, noninferiority, phase 4 human clinical trial ( ongoing from May 2002). Intervention Healthy adults received AVA by the SQ ( reference group) or IM route at 0, 2, and 4 weeks and 6 months ( 4- SQ or 4- IM; n= 165- 170 per group) or at a reduced 3- dose schedule ( 3- IM; n= 501). A control group ( n= 169) received saline injections at the same time intervals. Main Outcome Measures Noninferiority at week 8 and month 7 of anti protective antigen IgG geometric mean concentration ( GMC), geometric mean titer ( GMT), and proportion of responders with a 4- fold rise in titer (% 4 x R). Reactogenicity outcomes were proportions of injection site and systemic AEs. Results At week 8, the 4- IM group ( GMC, 90.8 mu g/mL; GMT, 1114.8; % 4 x R, 97.7) was noninferior to the 4- SQ group ( GMC, 105.1 mu g/mL; GMT, 1315.4;% 4 x R, 98.8) for all 3 primary end points. The 3- IM group was noninferior for only the % 4 x R ( GMC, 52.2 mu g/mL; GMT, 650.6;% 4 x R, 94.4). At month 7, all groups were noninferior to the licensed regimen for all end points. Solicited injection site AEs assessed during examinations occurred at lower proportions in the 4- IM group compared with 4- SQ. The odds ratio for ordinal end point pain reported immediately after injection was reduced by 50% for the 4- IM vs 4- SQ groups ( P <. 001). Route of administration did not significantly influence the occurrence of systemic AEs. Conclusions The 4- IM and 3- IM regimens of AVA provided noninferior immunological priming by month 7 when compared with the 4- SQ licensed regimen. Intramuscular administration significantly reduced the occurrence of injection site AEs. Trial Registration clinicaltrials. gov Identifier: NCT00119067.	[Marano, Nina; Plikaytis, Brian D.; Martin, Stacey W.; Rose, Charles; Semenova, Vera A.; Martin, Sandra K.; Freeman, Alison E.; Li, Han; Soroka, Stephen D.; Fox, Sarah P.; Stamper, John L.; McNeil, Michael M.; Perkins, Bradley A.; Messonnier, Nancy; Quinn, Conrad P.] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Mulligan, Mark J.; Parker, Scott D.] Univ Alabama Birmingham, Birmingham, AL USA; [Babcock, Janiine] Walter Reed Army Inst Res, Silver Spring, MD USA; [Keitel, Wendy; El Sahly, Hana] Baylor Coll Med, Dept Mol Virol, Houston, TX 77030 USA; [Keitel, Wendy; El Sahly, Hana] Baylor Coll Med, Dept Microbiol, Houston, TX 77030 USA; [Keitel, Wendy; El Sahly, Hana] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Poland, Gregory A.; Jacobson, Robert M.] Mayo Clin, Rochester, MN USA; [Keyserling, Harry L.] Emory Univ, Sch Med, Atlanta, GA 30322 USA	Centers for Disease Control & Prevention - USA; University of Alabama System; University of Alabama Birmingham; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; Emory University	Quinn, CP (corresponding author), Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd,MS-D11, Atlanta, GA 30333 USA.	cquinn@cdc.gov	Moon, James E./B-6810-2011; Mulligan, Mark/V-9275-2019	Moon, James E./0000-0002-9274-4554; McNeil, Michael/0000-0003-0713-8312; Jacobson, Robert/0000-0002-6355-8752	Centers for Disease Control and Prevention; Atlanta Research and Education Foundation (AREF), Atlanta, Georgia	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Atlanta Research and Education Foundation (AREF), Atlanta, Georgia	The study was funded through the Centers for Disease Control and Prevention (CDC). Mr Soroka and Ms Fox were funded through the Atlanta Research and Education Foundation (AREF), Atlanta, Georgia.	Baylor NW, 2002, VACCINE, V20, pS18, DOI 10.1016/S0264-410X(02)00166-4; BELL BP, PREVENTION HEPATITIS; BRACHMAN PS, 1962, AM J PUBLIC HEALTH N, V52, P632, DOI 10.2105/AJPH.52.4.632; Broder KR., PREVENTING TETANUS D; *CDCP, 2000, MMWR-MORBID MORTAL W, V49, P341; Collet JP, 2000, B WORLD HEALTH ORGAN, V78, P178; *COMM ASS SAF EFF, 2002, ANTHR VACC IS IT SAF; *COMM ASS SAF EFF, 2002, ASS CDC ANTHR VACC S; FARRINGTON CP, 1990, STAT MED, V9, P1447, DOI 10.1002/sim.4780091208; Geier MR, 2004, HEPATO-GASTROENTEROL, V51, P762; Gorse GJ, 2006, VACCINE, V24, P5950, DOI 10.1016/j.vaccine.2006.05.044; Grabenstein JD, 2003, IMMUNOL ALLERGY CLIN, V23, P713, DOI 10.1016/S0889-8561(03)00093-6; Gupta R K, 1995, Pharm Biotechnol, V6, P229; Horne AD, 2001, CLIN INFECT DIS, V33, pS306, DOI 10.1086/322566; Hornung R.W., 1990, APPL OCCUP ENV HYG, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587]; Little SF, 2004, VACCINE, V22, P422, DOI 10.1016/j.vaccine.2003.07.004; Mahan CM, 2004, ANN EPIDEMIOL, V14, P81, DOI 10.1016/S1047-2797(03)00124-8; Nass M, 1999, INFECT DIS CLIN N AM, V13, P187, DOI 10.1016/S0891-5520(05)70050-7; PHILLIPS KF, 1990, J PHARMACOKINET BIOP, V18, P137, DOI 10.1007/BF01063556; Pichichero ME, 2005, JAMA-J AM MED ASSOC, V293, P3003, DOI 10.1001/jama.293.24.3003; Pitt MLM, 2001, VACCINE, V19, P4768, DOI 10.1016/S0264-410X(01)00234-1; Pittman PR, 2002, VACCINE, V20, pS48, DOI 10.1016/S0264-410X(02)00172-X; Pittman PR, 2002, VACCINE, V20, P1412, DOI 10.1016/S0264-410X(01)00462-5; Pittman PR, 2001, VACCINE, V20, P972, DOI 10.1016/S0264-410X(01)00387-5; Plikaytis BD, ELISA WINDOWS USERS; PUZISS M, 1963, J BACTERIOL, V85, P230, DOI 10.1128/JB.85.1.230-236.1963; Quinn CP, 2004, J INFECT DIS, V190, P1228, DOI 10.1086/423937; Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380; QUINN CP, 1988, TOPLEY WILSONS MICRO, V3, P799; Rubin DB, 2003, STAT NEERL, V57, P3, DOI 10.1111/1467-9574.00217; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Semenova VA, 2004, CLIN DIAGN LAB IMMUN, V11, P919, DOI 10.1128/CDLI.11.5.919-923.2004; Sever JL, 2004, PHARMACOEPIDEM DR S, V13, P825, DOI 10.1002/pds.936; Shah C, 2004, AM J HEMATOL, V77, P204, DOI 10.1002/ajh.20153; Soroka SD, 2005, BAC ACT05 INT C BAC; Van Buuren S, 2006, J STAT COMPUT SIM, V76, P1049, DOI 10.1080/10629360600810434; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; WRIGHT GG, 1954, J IMMUNOL, V72, P263; 1997, FED REG, V62, P17624	40	76	80	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1532	1543		10.1001/jama.300.13.1532	http://dx.doi.org/10.1001/jama.300.13.1532			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827210	Bronze			2022-12-28	WOS:000259617700017
J	Montalvo, G; Avanzini, F; Anselmi, M; Prandi, R; Ibarra, S; Marquez, M; Armani, D; Moreira, JM; Caicedo, C; Roncaglioni, MC; Colombo, F; Camisasca, P; Milani, V; Quimi, S; Gonzabay, F; Tognoni, G				Montalvo, Gregorio; Avanzini, Fausto; Anselmi, Mariella; Prandi, Rosanna; Ibarra, Samuel; Marquez, Monica; Armani, Daniela; Moreira, Juan-Martin; Caicedo, Cynthia; Roncaglioni, Maria Carla; Colombo, Fabio; Camisasca, Paola; Milani, Valentina; Quimi, Simon; Gonzabay, Felix; Tognoni, Gianni			Diagnostic evaluation of people with hypertension in low income country: cohort study of "essential" method of risk stratification	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLOBAL BURDEN; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; ADULT DEATHS; DISABILITY; MORTALITY; PREVENTION; INTERHEART; MANAGEMENT	Objectives To explore the predictive power of a risk stratification method for people with hypertension based on "essential" procedures ( that is, available in economically less developed areas of the world), comparing it in the same population with the results given by the method suggested by the 1999 World Health Organization-International Society of Hypertension ( WHO-ISH) guidelines. Design Prospective cohort study of outcomes according to cardiovascular risk profile at baseline. Setting Primary care in a poor rural area of the Ecuadorian forest. Participants 504 people with hypertension prospectively monitored for a mean of 6.7 ( SD 2.3) years. Interventions Essential data included blood pressure, medical history, smoking, age, sex, and diagnosis of diabetes; the WHO- ISH methods additionally included measurement of fasting blood glucose, total cholesterol, and creatinine, urinalysis, and electrocardiography. Main outcome measures Cardiovascular events and total deaths. Results With both methods there was a highly significant association between the level of predicted risk and the incidence of cardiovascular events and of total deaths: up to three quarters of all cardiovascular events and two thirds of all deaths were reported among people classified as at high or very high risk with either method. The predictive discrimination of the essential method is comparable with the WHO- ISH with C statistics ( 95% confidence interval) of 0.788 ( 0.721 to 0.855) and 0.744 ( 0.673 to 0.815), respectively, for cardiovascular events and 0.747 ( 0.678 to 0.816) and 0.705 ( 0.632 to 0.778) for total mortality. Conclusions The risk stratification of patients with hypertension with an essential package of variables ( that is, available and practicable even in the economically less developed areas of the world) serves at least as well as the more comprehensive method proposed by WHO- ISH.	[Montalvo, Gregorio; Anselmi, Mariella; Prandi, Rosanna; Marquez, Monica; Armani, Daniela; Moreira, Juan-Martin; Caicedo, Cynthia] Ctr Epidemiol Comunitaria & Med Trop CECOMET, Esmeraldas, Ecuador; [Avanzini, Fausto; Roncaglioni, Maria Carla; Colombo, Fabio; Camisasca, Paola] Ist Ric Farmacol Mario Negri, Lab Ric Med Gen, I-20156 Milan, Italy; [Anselmi, Mariella] Osped S Cuore, Ctr Malatt Trop, I-37034 Verona, Italy; [Ibarra, Samuel; Caicedo, Cynthia; Quimi, Simon; Gonzabay, Felix] Minist Salud Publ, Sist Local Salud, Borbon, Ecuador; [Milani, Valentina] Ist Ric Farmacol Mario Negri, Lab Stat Med, I-20156 Milan, Italy; [Tognoni, Gianni] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Avanzini, F (corresponding author), Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Via Masa 19, I-20156 Milan, Italy.	avanzini@marionegri.it	roncaglioni, maria carla/AAB-1875-2020; Milani, Valentina/AAB-5367-2019	roncaglioni, maria carla/0000-0002-2029-7847; Milani, Valentina/0000-0002-2989-981X; Avanzini, Fausto/0000-0002-4029-2891				Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; [Anonymous], 1996, World Health Organ Tech Rep Ser, V862, P1; [Anonymous], 1977, World Health Organ Tech Rep Ser, P1; Anselmi M, 2003, LANCET, V361, P1186, DOI 10.1016/S0140-6736(03)12918-2; Chalmers J, 1999, J HYPERTENS, V17, P151; CHANDRAMOHAN D, 1994, INT J EPIDEMIOL, V23, P213, DOI 10.1093/ije/23.2.213; Charlton RW, 2001, S AFR MED J, V91, P163; Cuspidi C, 2001, Ital Heart J, V2, P702; Douglas JG, 2003, ARCH INTERN MED, V163, P525, DOI 10.1001/archinte.163.5.525; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Gajalakshmi V, 2006, INT J EPIDEMIOL, V35, P748, DOI 10.1093/ije/dyl112; Gaziano TA, 2005, CIRCULATION, V112, P3547, DOI 10.1161/CIRCULATIONAHA.105.591792; Gaziano TA, 2005, CIRCULATION, V112, P3569, DOI 10.1161/CIRCULATIONAHA.105.535922; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Lemogoum D, 2003, J HYPERTENS, V21, P1993, DOI 10.1097/00004872-200311000-00003; LEVY D, 1990, CIRCULATION, V81, P815, DOI 10.1161/01.CIR.81.3.815; Marmot MG, 2006, JAMA-J AM MED ASSOC, V295, P1304, DOI 10.1001/jama.295.11.1304; Murray CJL, 2003, LANCET, V361, P717, DOI 10.1016/S0140-6736(03)12655-4; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *PREV CARD DIS, 2007, GUID ASS MAN CARD RI; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Steyn K, 2005, CIRCULATION, V112, P3554, DOI 10.1161/CIRCULATIONAHA.105.563452; Verdecchia P, 1998, J AM COLL CARDIOL, V31, P383, DOI 10.1016/S0735-1097(97)00493-2; *WHO, 2002, INT MAN CARD RISK RE; Yang GH, 2006, INT J EPIDEMIOL, V35, P741, DOI 10.1093/ije/dyi181; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Yusuf S, 2004, AM HEART J, V148, P1, DOI 10.1016/j.ahj.2004.03.045; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488	33	8	8	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1387	10.1136/bmj.a1387	http://dx.doi.org/10.1136/bmj.a1387			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18805835	hybrid, Green Published			2022-12-28	WOS:000259797600039
J	Firestein, R; Bass, AJ; Kim, SY; Dunn, IF; Silver, SJ; Guney, I; Freed, E; Ligon, AH; Vena, N; Ogino, S; Chheda, MG; Tamayo, P; Finn, S; Shrestha, Y; Boehm, JS; Jain, S; Bojarski, E; Mermel, C; Barretina, J; Chan, JA; Baselga, J; Tabernero, J; Root, DE; Fuchs, CS; Loda, M; Shivdasani, RA; Meyerson, M; Hahn, WC				Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Silver, Serena J.; Guney, Isil; Freed, Ellen; Ligon, Azra H.; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Tamayo, Pablo; Finn, Stephen; Shrestha, Yashaswi; Boehm, Jesse S.; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Baselga, Jose; Tabernero, Josep; Root, David E.; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.			CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity	NATURE			English	Article							GENE-EXPRESSION; C-MYC; ACTIVATION; APC; IDENTIFICATION; MUTATIONS; PATHWAY; COMPLEX; CELLS; MELANOMA	Aberrant activation of the canonical WNT/beta-catenin pathway occurs in almost all colorectal cancers and contributes to their growth, invasion and survival(1,2). Although dysregulated beta-catenin activity drives colon tumorigenesis, further genetic perturbations are required to elaborate full malignant transformation(3). To identify genes that both modulate beta-catenin activity and are essential for colon cancer cell proliferation, we conducted two loss-of-function screens in human colon cancer cells and compared genes identified in these screens with an analysis of copy number alterations in colon cancer specimens. One of these genes, CDK8, which encodes a member of the mediator complex(4), is located at 13q12.13, a region of recurrent copy number gain in a substantial fraction of colon cancers. Here we show that the suppression of CDK8 expression inhibits proliferation in colon cancer cells characterized by high levels of CDK8 and beta-catenin hyperactivity. CDK8 kinase activity was necessary for beta-catenin-driven transformation and for expression of several beta-catenin transcriptional targets. Together these observations suggest that therapeutic interventions targeting CDK8 may confer a clinical benefit in beta-catenin-driven malignancies.	[Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Freed, Ellen; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Shrestha, Yashaswi; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Firestein, Ron; Ligon, Azra H.; Ogino, Shuji; Finn, Stephen; Chan, Jennifer A.; Loda, Massimo; Meyerson, Matthew] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Bass, Adam J.; Kim, So Young; Shivdasani, Ramesh A.; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Dunn, Ian F.] Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Freed, Ellen; Ligon, Azra H.; Vena, Natalie; Ogino, Shuji; Chheda, Milan G.; Finn, Stephen; Shrestha, Yashaswi; Jain, Supriya; Bojarski, Emeric; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Fuchs, Charles S.; Loda, Massimo; Shivdasani, Ramesh A.; Meyerson, Matthew; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Chheda, Milan G.] Massachusetts Gen Hosp, Dept Neurooncol, Boston, MA 02114 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Guney, Isil; Shrestha, Yashaswi; Mermel, Craig; Barretina, Jordi; Root, David E.; Fuchs, Charles S.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Firestein, Ron; Bass, Adam J.; Kim, So Young; Dunn, Ian F.; Silver, Serena J.; Guney, Isil; Chheda, Milan G.; Tamayo, Pablo; Shrestha, Yashaswi; Boehm, Jesse S.; Mermel, Craig; Barretina, Jordi; Chan, Jennifer A.; Root, David E.; Meyerson, Matthew; Hahn, William C.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Baselga, Jose; Tabernero, Josep] Hosp Gen Valle Hebron, Dept Med Oncol, Barcelona 08035, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Hospital Universitari Vall d'Hebron	Hahn, WC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, 44 Binney St, Boston, MA 02115 USA.	william_hahn@dfci.harvard.edu	Finn, Stephen/V-3236-2019; Meyerson, Matthew L/E-7123-2012; Tabernero, Josep/AAG-5026-2019; Mermel, Craig/AAZ-7322-2020; Barretina, Jordi/A-7192-2013	Finn, Stephen/0000-0002-8628-5814; Tabernero, Josep/0000-0002-2495-8139; Mermel, Craig/0000-0002-0816-3395; Barretina, Jordi/0000-0002-3478-4080; Ogino, Shuji/0000-0002-3909-2323	US NCI/NIH [R33CA128625]; NIH [T32]; GI SPORE Career Development [P50CA127003]; Harvard-MIT Clinical Investigator Training Program Fellowship; Department of Defense Prostate Cancer Postdoctoral Fellowships; Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships; K12 award; NATIONAL CANCER INSTITUTE [K08CA134931, R33CA128625, T32CA009172, P50CA127003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	US NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GI SPORE Career Development; Harvard-MIT Clinical Investigator Training Program Fellowship; Department of Defense Prostate Cancer Postdoctoral Fellowships(United States Department of Defense); Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships; K12 award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Shin for technical assistance with immunohistochemistry, M. Miri for assistance with sample collection and G. Getz for assistance with SNP array analysis. This work was supported in part by a grant from the US NCI/NIH R33CA128625 (W.C.H.), T32 NIH grant (R.F.) and a GI SPORE Career Development Grant (P50CA127003; R.F.), a Harvard-MIT Clinical Investigator Training Program Fellowship (A.J.B), Department of Defense Prostate Cancer Postdoctoral Fellowships (I.G. and S.Y.K.), Warren-Whitman- Richardson, Hagerty Foundation Research Fellowships (I.F.D.) and K12 award (M.G.C.). J.B. is a Beatriu de Pinos Fellow of the Departament d'Educacio i Universitats de la Generalita de Catalunya.	Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Chiang MY, 2006, MOL CELL BIOL, V26, P6261, DOI 10.1128/MCB.02478-05; Conaway RC, 2005, TRENDS BIOCHEM SCI, V30, P250, DOI 10.1016/j.tibs.2005.03.002; Damalas A, 2001, EMBO J, V20, P4912, DOI 10.1093/emboj/20.17.4912; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gold MO, 1998, NUCLEIC ACIDS RES, V26, P3784, DOI 10.1093/nar/26.16.3784; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hino S, 2003, J BIOL CHEM, V278, P14066, DOI 10.1074/jbc.M213265200; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Murakami T, 2001, BIOCHEM BIOPH RES CO, V288, P8, DOI 10.1006/bbrc.2001.5719; Rowan AJ, 2000, P NATL ACAD SCI USA, V97, P3352, DOI 10.1073/pnas.97.7.3352; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Sparks AB, 1998, CANCER RES, V58, P1130; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TASSAN JP, 1995, P NATL ACAD SCI USA, V92, P8871, DOI 10.1073/pnas.92.19.8871; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508	30	499	528	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					547	U60		10.1038/nature07179	http://dx.doi.org/10.1038/nature07179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18794900	Green Accepted			2022-12-28	WOS:000259449600049
J	Nichol, G; Thomas, E; Callaway, CW; Hedges, J; Powell, JL; Aufderheide, TP; Rea, T; Lowe, R; Brown, T; Dreyer, J; Davis, D; Idris, A; Stiell, I				Nichol, Graham; Thomas, Elizabeth; Callaway, Clifton W.; Hedges, Jerris; Powell, Judy L.; Aufderheide, Tom P.; Rea, Tom; Lowe, Robert; Brown, Todd; Dreyer, John; Davis, Dan; Idris, Ahamed; Stiell, Ian			Regional variation in out-of-hospital cardiac arrest incidence and outcome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY MEDICAL-SERVICES; AMERICAN-HEART-ASSOCIATION; MYOCARDIAL-INFARCTION; SOCIOECONOMIC-STATUS; COMATOSE SURVIVORS; DISEASE; CARE; RESUSCITATION; MORTALITY; COMMITTEE	Context The health and policy implications of regional variation in incidence and outcome of out-of-hospital cardiac arrest remain to be determined. Objective To evaluate whether cardiac arrest incidence and outcome differ across geographic regions. Design, Setting, and Patients Prospective observational study ( the Resuscitation Outcomes Consortium) of all out- of- hospital cardiac arrests in 10 North American sites ( 8 US and 2 Canadian) from May 1, 2006, to April 30, 2007, followed up to hospital discharge, and including data available as of June 28, 2008. Cases ( aged 0- 108 years) were assessed by organized emergency medical services ( EMS) personnel, did not have traumatic injury, and received attempts at external defibrillation or chest compressions or resuscitation was not attempted. Census data were used to determine rates adjusted for age and sex. Main Outcome Measures Incidence rate, mortality rate, case- fatality rate, and survival to discharge for patients assessed or treated by EMS personnel or with an initial rhythm of ventricular fibrillation. Results Among the 10 sites, the total catchment population was 21.4 million, and there were 20 520 cardiac arrests. A total of 11 898 ( 58.0%) had resuscitation attempted; 2729 ( 22.9% of treated) had initial rhythm of ventricular fibrillation or ventricular tachycardia or rhythms that were shockable by an automated external defibrillator; and 954 ( 4.6% of total) were discharged alive. The median incidence of EMS- treated cardiac arrest across sites was 52.1 ( interquartile range [ IQR], 48.0- 70.1) per 100 000 population; survival ranged from 3.0% to 16.3%, with a median of 8.4% ( IQR, 5.4%- 10.4%). Median ventricular fibrillation incidence was 12.6 ( IQR, 10.6- 5.2) per 100 000 population; survival ranged from 7.7% to 39.9%, with a median of 22.0% ( IQR, 15.0%- 24.4%), with significant differences across sites for incidence and survival ( P <. 001). Conclusion In this study involving 10 geographic regions in North America, there were significant and important regional differences in out- of- hospital cardiac arrest incidence and outcome.	[Nichol, Graham] Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Seattle, WA 98104 USA; [Nichol, Graham; Thomas, Elizabeth; Powell, Judy L.] Univ Washington, Clin Trial Ctr, Dept Biostat, Seattle, WA 98195 USA; [Rea, Tom] Seattle King Cty Dept Publ Hlth, Seattle, WA USA; [Callaway, Clifton W.] Univ Pittsburgh, Pittsburgh, PA USA; [Hedges, Jerris; Lowe, Robert] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Brown, Todd] Univ Alabama Birmingham, Birmingham, AL USA; [Dreyer, John] Univ Western Ontario, London, ON, Canada; [Davis, Dan] Univ Calif San Diego, San Diego, CA 92103 USA; [Idris, Ahamed] SW Texas State Univ, Dallas, TX USA; [Stiell, Ian] Univ Ottawa, Dept Emergency Med, Ottawa, ON, Canada	Harborview Medical Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Oregon Health & Science University; Medical College of Wisconsin; University of Alabama System; University of Alabama Birmingham; Western University (University of Western Ontario); University of California System; University of California San Diego; Texas State University System; Texas State University San Marcos; University of Ottawa	Nichol, G (corresponding author), Univ Washington, Harborview Ctr Prehosp Emergency Care, Dept Med, Box 359727,325 9th Ave, Seattle, WA 98104 USA.	nichol@u.washington.edu	Nichol, Graham/Z-4996-2019; Lowe, Robert A/A-4926-2008; Hedges, Jerris/AAC-1847-2021	Lowe, Robert A/0000-0002-4732-9634; Idris, Ahamed/0000-0001-7113-6499; Callaway, Clifton/0000-0002-3309-1573; Stiell, Ian/0000-0002-2583-6408	National Heart, Lung, and Blood Institute [5U01 HL077863, 5U01 HL077881, 5U01 HL077871, 5U01 HL077873, 5U01 HL077872, 5U01 HL077866, 5U01 HL077908, 5U01 HL077867, 5U01 HL077885]; National Institute of Neurological Disorders and Stroke; Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; American Heart Association; Heart and Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077872, U01HL077871, U01HL077867, U01HL077866, U01HL077863, U01HL077873, U01HL077908, U01HL077881, U01HL077885] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by a cooperative agreement (grants 5U01 HL077863, HL077881, HL077871, HL077873, HL077872, HL077866, HL077908, HL077867, HL077885, and HL077885) with the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, the Canadian Institutes of Health Research Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the American Heart Association, and the Heart and Stroke Foundation of Canada. Medtronic Physio-Control Inc loaned equipment to several EMS agencies participating in the Alabama ROC site. These devices were used routinely in the course of the EMS duties and were not exclusively for ROC, but they were also used with ROC patients.	BECKER LB, 1993, NEW ENGL J MED, V329, P600, DOI 10.1056/NEJM199308263290902; Bergner L, 1983, Am J Emerg Med, V1, P259, DOI 10.1016/0735-6757(83)90101-8; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Brooks SC, 2007, CIRCULATION, V116, P934; Domanski MJ, 2003, J CARD FAIL, V9, P354, DOI 10.1054/S1071-9164(03)00133-7; Dorian P, 2002, NEW ENGL J MED, V346, P884, DOI 10.1056/NEJMoa013029; Dunne RB, 2007, RESUSCITATION, V72, P59, DOI 10.1016/j.resuscitation.2006.04.017; EISENBERG MS, 1990, ANN EMERG MED, V19, P179, DOI 10.1016/S0196-0644(05)81805-0; EKSTROM L, 1994, RESUSCITATION, V27, P181, DOI 10.1016/0300-9572(94)90031-0; FRANDSEN F, 1991, CARDIOLOGY, V79, P256, DOI 10.1159/000174888; Galea S, 2007, AM J EPIDEMIOL, V166, P534, DOI 10.1093/aje/kwm102; Govindarajan A, 2003, ANN EMERG MED, V41, P481, DOI 10.1067/mem.2003.108; Graham J. W., 1999, STAT STRATEGIES SMAL, V50, P1, DOI DOI 10.1177/0013164496056006006; GRAY AJ, 1987, BRIT MED J, V294, P1133, DOI 10.1136/bmj.294.6580.1133; Grmec S, 2007, RESUSCITATION, V72, P404, DOI 10.1016/j.resuscitation.2006.07.012; Hallstrom AP, 2004, NEW ENGL J MED, V351, P637; Herlitz J, 2003, HEART, V89, P25, DOI 10.1136/heart.89.1.25; Holzer M, 2002, NEW ENGL J MED, V346, P549; Hsu JWY, 1996, ANN EMERG MED, V28, P597, DOI 10.1016/S0196-0644(96)70080-X; Institute of Medicine, 2006, EM MED SERV CROSSR; Jacobs I, 2004, CIRCULATION, V110, P3385, DOI 10.1161/01.CIR.0000147236.85306.15; Knafelj R, 2007, RESUSCITATION, V74, P227, DOI 10.1016/j.resuscitation.2007.01.016; Kudenchuk PJ, 1999, NEW ENGL J MED, V341, P871, DOI 10.1056/NEJM199909163411203; Laurent I, 2005, J AM COLL CARDIOL, V46, P432, DOI 10.1016/j.jacc.2005.04.039; Little R. J. A., 1987, STAT ANAL MISSING DA; LOMBARDI G, 1994, JAMA-J AM MED ASSOC, V271, P678; Luepker RV, 2000, JAMA-J AM MED ASSOC, V284, P60, DOI 10.1001/jama.284.1.60; Menon V, 2006, AM J MED, V119, P584, DOI 10.1016/j.amjmed.2006.01.018; Mitchell LB, 2003, J AM COLL CARDIOL, V42, P81, DOI 10.1016/S0735-1097(03)00498-4; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; Nichol G, 1999, ANN EMERG MED, V34, P517, DOI 10.1016/S0196-0644(99)80054-7; Nichol G, 2008, CIRCULATION, V117, P2299, DOI 10.1161/CIRCULATIONAHA.107.189472; O'Connor GT, 1999, JAMA-J AM MED ASSOC, V281, P627, DOI 10.1001/jama.281.7.627; PEDERSEN TR, 1994, LANCET, V344, P1383; Rea TD, 2004, AM J CARDIOL, V93, P1455, DOI 10.1016/j.amjcard.2004.03.002; Rea TD, 2003, CIRCULATION, V107, P2780, DOI 10.1161/01.CIR.0000070950.17208.2A; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rosamond WD, 1998, NEW ENGL J MED, V339, P861, DOI 10.1056/NEJM199809243391301; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Singh GK, 2002, INT J EPIDEMIOL, V31, P600, DOI 10.1093/ije/31.3.600; Soo LH, 1999, EUR HEART J, V20, P535, DOI 10.1053/euhj.1998.1334; Spaulding CM, 1997, NEW ENGL J MED, V336, P1629, DOI 10.1056/NEJM199706053362302; Stiell IG, 2009, ANN EMERG MED, V53, P241, DOI 10.1016/j.annemergmed.2008.03.018; Stiell IG, 1998, ANN EMERG MED, V32, P180, DOI 10.1016/S0196-0644(98)70135-0; TILLINGHAST SJ, 1991, AM J EPIDEMIOL, V134, P851, DOI 10.1093/oxfordjournals.aje.a116160; Ting HH, 2007, CIRCULATION, V116, P729, DOI 10.1161/CIRCULATIONAHA.107.699934; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; VANDERHOEVEN JG, 1995, NETH J MED, V46, P123, DOI 10.1016/0300-2977(94)00106-J; Wilkins R., 2002, HLTH REP S, V13, P45	50	1448	1513	1	52	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1423	1431		10.1001/jama.300.12.1423	http://dx.doi.org/10.1001/jama.300.12.1423			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812533	Green Accepted, Bronze			2022-12-28	WOS:000259410400020
J	Cox, P; Jones, C				Cox, Peter; Jones, Chris			Climate change - Illuminating the modern dance of climate and CO2	SCIENCE			English	Editorial Material							CARBON-CYCLE FEEDBACKS		[Cox, Peter] Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England; [Jones, Chris] Hadley Ctr, Met Off, Exeter EX1 3PB, Devon, England	University of Exeter; Met Office - UK; Hadley Centre	Cox, P (corresponding author), Univ Exeter, Sch Engn Comp & Math, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk; chris.d.jones@metoffice.gov.uk	Jones, Chris/I-2983-2014; Cox, Peter Michae;/B-3299-2012	Jones, Chris/0000-0002-7141-9285; Cox, Peter Michae;/0000-0002-0679-2219	Natural Environment Research Council [earth010002, earth010004] Funding Source: researchfish; NERC [earth010004, earth010002] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Archer D, 1997, GEOPHYS RES LETT, V24, P405, DOI 10.1029/97GL00168; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; ETHERIDGE DM, 1993, J GEOPHYS RES, V101, P4115; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Fung IY, 2005, P NATL ACAD SCI USA, V102, P11201, DOI 10.1073/pnas.0504949102; Jones CD, 2001, GLOBAL BIOGEOCHEM CY, V15, P453, DOI 10.1029/2000GB001281; Jones CD, 2001, J CLIMATE, V14, P4113, DOI 10.1175/1520-0442(2001)014<4113:TCCRTE>2.0.CO;2; Jones CD, 2006, TELLUS B, V58, P603, DOI 10.1111/j.1600-0889.2006.00215.x; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Scheffer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025044; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497	12	69	70	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1642	1644		10.1126/science.1158907	http://dx.doi.org/10.1126/science.1158907			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801988				2022-12-28	WOS:000259300400022
J	Oxley, DR; Smith, KB; Alford, JR; Hibbing, MV; Miller, JL; Scalora, M; Hatemi, PK; Hibbing, JR				Oxley, Douglas R.; Smith, Kevin B.; Alford, John R.; Hibbing, Matthew V.; Miller, Jennifer L.; Scalora, Mario; Hatemi, Peter K.; Hibbing, John R.			Political attitudes vary with physiological traits	SCIENCE			English	Article							DISEASE-AVOIDANCE; GENETIC-VARIATION; AMYGDALA; FEAR; ANXIETY; SUPPORT; THREAT	Although political views have been thought to arise largely from individuals' experiences, recent research suggests that they may have a biological basis. We present evidence that variations in political attitudes correlate with physiological traits. In a group of 46 adult participants with strong political beliefs, individuals with measurably lower physical sensitivities to sudden noises and threatening visual images were more likely to support foreign aid, liberal immigration policies, pacifism, and gun control, whereas individuals displaying measurably higher physiological reactions to those same stimuli were more likely to favor defense spending, capital punishment, patriotism, and the Iraq War. Thus, the degree to which individuals are physiologically responsive to threat appears to indicate the degree to which they advocate policies that protect the existing social structure from both external ( outgroup) and internal ( norm- violator) threats.	[Oxley, Douglas R.; Smith, Kevin B.; Miller, Jennifer L.; Hibbing, John R.] Univ Nebraska, Dept Polit Sci, Lincoln, NE 68588 USA; [Alford, John R.] Rice Univ, Dept Polit Sci, Houston, TX 77251 USA; [Hibbing, Matthew V.] Univ Illinois, Dept Polit Sci, Urbana, IL 61801 USA; [Scalora, Mario] Univ Nebraska, Dept Psychol, Lincoln, NE 68588 USA; [Hatemi, Peter K.] Virginia Inst Psychiat & Behav Genet, Richmond, VA 23298 USA	University of Nebraska System; University of Nebraska Lincoln; Rice University; University of Illinois System; University of Illinois Urbana-Champaign; University of Nebraska System; University of Nebraska Lincoln; Virginia Commonwealth University	Hibbing, JR (corresponding author), Univ Nebraska, Dept Polit Sci, Lincoln, NE 68588 USA.	jhibbing@unl.edu	Alford, John R/A-2561-2009; sarinopoulos, isidoros/B-5453-2010; Hibbing, Matthew/AAF-3930-2020	Hatemi, Peter/0000-0001-6514-2614; Oxley, Douglas/0000-0003-2258-2112	NSF [SES-0721378, SES-0721707]; ManTech Corporation; University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	NSF(National Science Foundation (NSF)); ManTech Corporation; University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	We thank E. Whitaker, C. Jacobs, B. Sexton, K. A. Espy, J. Brehm, D. Bulling, and the James Long Company for their invaluable assistance. Financial support was provided by the NSF (SES-0721378 and SES-0721707), the ManTech Corporation, and the University of Nebraska-Lincoln's Strategic Research Cluster Grant program.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; [Anonymous], 1915, BODILY CHANGES PAIN; Bracha HS, 2005, J AFFECT DISORDERS, V88, P119, DOI 10.1016/j.jad.2005.05.013; Bradley MM, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P581, DOI 10.1017/CBO9780511546396.025; CAMPBELL A, 1960, AM VOETER; Converse P.E, 1964, IDEOLOGY DISCONTENT; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Eaves L, 1999, Twin Res, V2, P62, DOI 10.1375/twin.2.2.62; Fahmy S, 2006, VIS COMMUN Q, V13, P4, DOI 10.1207/s15551407vcq1301_2; Faulkner J, 2004, GROUP PROCESS INTERG, V7, P333, DOI 10.1177/1368430204046142; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; GROSSER GH, 1971, THREAT IMPENDING DIS; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Huddy L, 2005, AM J POLIT SCI, V49, P593, DOI 10.2307/3647734; Jost JT, 2006, AM PSYCHOL, V61, P651, DOI 10.1037/0003-066X.61.7.651; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Landau MJ, 2004, PERS SOC PSYCHOL B, V30, P1136, DOI 10.1177/0146167204267988; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Larson CL, 2006, BIOL PSYCHIAT, V60, P410, DOI 10.1016/j.biopsych.2006.03.079; Lemche E, 2006, HUM BRAIN MAPP, V27, P623, DOI 10.1002/hbm.20206; Lodge M, 2005, POLIT PSYCHOL, V26, P455, DOI 10.1111/j.1467-9221.2005.00426.x; Mainen ZF, 2007, NAT NEUROSCI, V10, P1511, DOI 10.1038/nn1207-1511; Marcus G.E., 2000, AFFECTIVE INTELLIGEN; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; McDermott R., 2004, PERSPECT POLIT, V2, P691, DOI DOI 10.1017/S1537592704040459; MILLER A, 2007, DEV PSYCHOPHYSIOLOGY; Navarrete CD, 2006, EVOL HUM BEHAV, V27, P270, DOI 10.1016/j.evolhumbehav.2005.12.001; Page B, 1992, RATIONAL PUBLIC; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; PRATTO F, 1994, J PERS SOC PSYCHOL, V67, P741, DOI 10.1037/0022-3514.67.4.741; Stenner K., 2005, AUTHORITARIAN DYNAMI; Thase M.E., 1995, HDB DEPRESSION; Westen D., 2007, PUBLIC AFFAIRS; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; Zaller JohnR., 1992, NATURE ORIGINS MASS	38	303	307	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 19	2008	321	5896					1667	1670		10.1126/science.1157627	http://dx.doi.org/10.1126/science.1157627			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	349RG	18801995	Green Published			2022-12-28	WOS:000259300400032
J	Que, L; Tolman, WB				Que, Lawrence, Jr.; Tolman, William B.			Biologically inspired oxidation catalysis	NATURE			English	Review							ALPHA-HYDROXYLATING MONOOXYGENASE; NONHEME IRON CATALYSTS; SOLUBLE METHANE MONOOXYGENASE; DOPAMINE BETA-MONOOXYGENASE; OLEFIN CIS-DIHYDROXYLATION; HEME-CONTAINING OXYGENASES; DINUCLEAR COPPER CENTER; GALACTOSE-OXIDASE; HYDROGEN-PEROXIDE; AEROBIC OXIDATION	The development of processes for selective hydrocarbon oxidation is a goal that has long been pursued. An additional challenge is to make such processes environmentally friendly, for example by using nontoxic reagents and energy- efficient catalytic methods. Excellent examples are naturally occurring iron- or copper- containing metalloenzymes, and extensive studies have revealed the key chemical principles that underlie their efficacy as catalysts for aerobic oxidations. Important inroads have been made in applying this knowledge to the development of synthetic catalysts that model enzyme function. Such biologically inspired hydrocarbon oxidation catalysts hold great promise for wide- ranging synthetic applications.	[Que, Lawrence, Jr.; Tolman, William B.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Que, Lawrence, Jr.; Tolman, William B.] Univ Minnesota, Ctr Met Biocatalysis, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Que, L (corresponding author), Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA.	larryque@umn.edu; wtolman@umn.edu			US Department of Energy; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047365] Funding Source: NIH RePORTER	US Department of Energy(United States Department of Energy (DOE)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work on biologically inspired oxidation catalysis carried out in the laboratory of L. Q. is supported by the US Department of Energy, and support for copper oxidation chemistry in the laboratory of W. B. T. is provided by the National Institutes of Health.	Abu-Omar MM, 2005, CHEM REV, V105, P2227, DOI 10.1021/cr040653o; ANDERSSON KK, 1991, NEW J CHEM, V15, P411; Anilkumar G, 2007, CHEM COMMUN, P289, DOI 10.1039/b612048b; [Anonymous], 2000, COORDIN CHEM REV, P200; Arakawa H, 2001, CHEM REV, V101, P953, DOI 10.1021/cr000018s; Arends IWCE, 2006, ADV INORG CHEM, V58, P235, DOI 10.1016/S0898-8838(05)58006-1; Balasubramanian R, 2007, ACCOUNTS CHEM RES, V40, P573, DOI 10.1021/ar700004s; Battaini G, 2006, ADV INORG CHEM, V58, P185, DOI 10.1016/S0898-8838(05)58005-X; Beauvais LG, 2005, J AM CHEM SOC, V127, P7370, DOI 10.1021/ja050865i; Brazeau BJ, 2004, ARCH BIOCHEM BIOPHYS, V428, P22, DOI 10.1016/j.abb.2004.03.034; Chanda A, 2008, INORG CHEM, V47, P3669, DOI 10.1021/ic7022902; Chaudhuri P, 2005, BIOL CHEM, V386, P1023, DOI 10.1515/BC.2005.118; Chaudhuri P, 1999, ANGEW CHEM INT EDIT, V38, P1095, DOI 10.1002/(SICI)1521-3773(19990419)38:8<1095::AID-ANIE1095>3.0.CO;2-I; Chaudhuri P, 1999, J AM CHEM SOC, V121, P9599, DOI 10.1021/ja991481t; Chaudhuri P, 1998, ANGEW CHEM INT EDIT, V37, P2217, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2217::AID-ANIE2217>3.0.CO;2-D; Chen K, 2001, J AM CHEM SOC, V123, P6327, DOI 10.1021/ja010310x; Chen K, 2002, J AM CHEM SOC, V124, P3026, DOI 10.1021/ja0120025; Chen K., 2002, DALTON T, P672; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen P, 2004, J AM CHEM SOC, V126, P4991, DOI 10.1021/ja031564g; Collins TJ, 2002, ACCOUNTS CHEM RES, V35, P782, DOI 10.1021/ar010079s; Conley B. L., 2006, ACTIVATION SMALL MOL, P235; Costas M, 2004, CHEM REV, V104, P939, DOI 10.1021/cr020628n; Cramer CJ, 2007, ACCOUNTS CHEM RES, V40, P601, DOI 10.1021/ar700008c; Crespo A, 2006, J AM CHEM SOC, V128, P12817, DOI 10.1021/ja062876x; Cuff ME, 1998, J MOL BIOL, V278, P855, DOI 10.1006/jmbi.1998.1647; DAWSON JH, 1988, SCIENCE, V240, P433, DOI 10.1126/science.3358128; de Boer JW, 2007, INORG CHEM, V46, P6353, DOI 10.1021/ic7003613; de Boer JW, 2005, J AM CHEM SOC, V127, P7990, DOI 10.1021/ja050990u; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Evans JP, 2003, J BIOL CHEM, V278, P49691, DOI 10.1074/jbc.M300797200; FABRICE T, 2007, EUR J INORG CHEM, P2379; Fenton H., 1884, J CHEM SOC, V65, P889; Ferraro DJ, 2005, BIOCHEM BIOPH RES CO, V338, P175, DOI 10.1016/j.bbrc.2005.08.222; Gelalcha FG, 2007, ANGEW CHEM INT EDIT, V46, P7293, DOI 10.1002/anie.200701235; Granata A, 2006, CHEM-EUR J, V12, P2504, DOI 10.1002/chem.200501097; Hatcher LQ, 2006, ADV INORG CHEM, V58, P131, DOI 10.1016/S0898-8838(05)58004-8; Higashimura H, 2005, J POLYM SCI POL CHEM, V43, P1955, DOI 10.1002/pola.20647; Higashimura H, 2000, APPL CATAL A-GEN, V194, P427, DOI 10.1016/S0926-860X(99)00388-9; Higashimura H, 1998, J AM CHEM SOC, V120, P8529, DOI 10.1021/ja981283m; Higashimura H, 2000, MACROMOLECULES, V33, P1986, DOI 10.1021/ma991635p; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; Jazdzewski BA, 2000, COORDIN CHEM REV, V200, P633, DOI 10.1016/S0010-8545(00)00342-8; Jiang N, 2005, ORG LETT, V7, P3689, DOI 10.1021/ol051293+; Karlsson A, 2003, SCIENCE, V299, P1039, DOI 10.1126/science.1078020; Klinman JP, 2006, J BIOL CHEM, V281, P3013, DOI 10.1074/jbc.R500011200; Koval IA, 2006, CHEM SOC REV, V35, P814, DOI 10.1039/b516250p; Krebs C, 2007, ACCOUNTS CHEM RES, V40, P484, DOI 10.1021/ar700066p; Lane BS, 2002, J AM CHEM SOC, V124, P11946, DOI 10.1021/ja025956j; Lane BS, 2003, CHEM REV, V103, P2457, DOI 10.1021/cr020471z; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; MAGNUS KA, 1994, CHEM REV, V94, P727, DOI 10.1021/cr00027a009; Mahadevan V, 2000, CURR OPIN CHEM BIOL, V4, P228, DOI 10.1016/S1367-5931(99)00080-0; Marko IE, 2004, ADV INORG CHEM, V56, P211, DOI 10.1016/S0898-8838(04)56007-5; Marko IE, 2004, ANGEW CHEM INT EDIT, V43, P1588, DOI 10.1002/anie.200353458; Mas-Balleste R, 2008, DALTON T, P1828, DOI 10.1039/b802587h; Mas-Balleste R, 2007, J AM CHEM SOC, V129, P15964, DOI 10.1021/ja075115i; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Merkx M, 2001, ANGEW CHEM INT EDIT, V40, P2782, DOI 10.1002/1521-3773(20010803)40:15<2782::AID-ANIE2782>3.0.CO;2-P; Meunier B., 2000, PORPHYRIN HDB, V4, P119; Meunier B., 2000, BIOMIMETIC OXIDATION; Mirica LM, 2005, SCIENCE, V308, P1890, DOI 10.1126/science.1112081; Mirica LM, 2004, CHEM REV, V104, P1013, DOI 10.1021/cr020632z; Nam W, 2003, J ORG CHEM, V68, P7903, DOI 10.1021/jo034493c; Paine TK, 2004, DALTON T, P2092, DOI 10.1039/b403953j; Piera J, 2008, ANGEW CHEM INT EDIT, V47, P3506, DOI 10.1002/anie.200700604; Prigge ST, 2004, SCIENCE, V304, P864, DOI 10.1126/science.1094583; Punniyamurthy T, 2008, COORDIN CHEM REV, V252, P134, DOI 10.1016/j.ccr.2007.04.003; Punniyamurthy T, 2005, CHEM REV, V105, P2329, DOI 10.1021/cr050523v; Que L, 2004, J BIOL INORG CHEM, V9, P643, DOI 10.1007/s00775-004-0579-3; Ragagnin G, 2002, TETRAHEDRON, V58, P3985, DOI 10.1016/S0040-4020(02)00250-8; Rogers MS, 2007, BIOCHEMISTRY-US, V46, P4606, DOI 10.1021/bi062139d; Rokhsana D, 2008, J BIOL INORG CHEM, V13, P371, DOI 10.1007/s00775-007-0325-8; Rolff M, 2008, ANGEW CHEM INT EDIT, V47, P2344, DOI 10.1002/anie.200705533; Rompel A, 1999, J BIOL INORG CHEM, V4, P56, DOI 10.1007/s007750050289; Ryu JY, 2002, CHEM COMMUN, P1288, DOI 10.1039/b203154j; Sheldon R. A., 2007, GREEN CHEM CATALYSIS; Sheldon RA, 2006, J MOL CATAL A-CHEM, V251, P200, DOI 10.1016/j.molcata.2006.02.016; Shibasaki Y, 2007, MACROMOLECULES, V40, P5322, DOI 10.1021/ma0703960; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Sono M, 1996, CHEM REV, V96, P2841, DOI 10.1021/cr9500500; Sorokin AB, 2008, CHEM COMMUN, P2562, DOI 10.1039/b804405h; Srinivas KA, 2002, CHEM COMMUN, P2456, DOI 10.1039/b207072n; Stephenson NA, 2005, J AM CHEM SOC, V127, P8635, DOI 10.1021/ja043380n; Suzuki K, 2008, ANGEW CHEM INT EDIT, V47, P1887, DOI 10.1002/anie.200705061; Taktak S, 2007, INORG CHEM, V46, P2929, DOI 10.1021/ic070094e; Tanase S, 2006, ADV INORG CHEM, V58, P29, DOI 10.1016/S0898-8838(05)58002-4; de Oliveira FT, 2007, SCIENCE, V315, P835, DOI 10.1126/science.1133417; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Wang YD, 1998, SCIENCE, V279, P537, DOI 10.1126/science.279.5350.537; Wang YD, 1996, J AM CHEM SOC, V118, P13097, DOI 10.1021/ja9621354; White MC, 2001, J AM CHEM SOC, V123, P7194, DOI 10.1021/ja015884g; Whittaker JW, 2005, ARCH BIOCHEM BIOPHYS, V433, P227, DOI 10.1016/j.abb.2004.08.034; Whittaker JW, 2003, CHEM REV, V103, P2347, DOI 10.1021/cr020425z; Whittaker MM, 2001, BIOCHEMISTRY-US, V40, P7140, DOI 10.1021/bi010303l; Wolfe MD, 2003, J BIOL CHEM, V278, P829, DOI 10.1074/jbc.M209604200; Yamazaki S, 2003, J AM CHEM SOC, V125, P13034, DOI 10.1021/ja036425d; Yoshizawa K, 2006, INORG CHEM, V45, P3034, DOI 10.1021/ic0521168	99	1061	1064	28	601	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 18	2008	455	7211					333	340		10.1038/nature07371	http://dx.doi.org/10.1038/nature07371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800132				2022-12-28	WOS:000259265200034
J	Sokol, DK				Sokol, Daniel K.			Argus and the cyclops in the clinic	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sokol, Daniel K.] Univ London St Georges Hosp, London WC1E 7HU, England	St Georges University London	Sokol, DK (corresponding author), Univ London St Georges Hosp, London WC1E 7HU, England.	daniel.sokol@talk21.com						Coldicott Y, 2003, BRIT MED J, V326, P97, DOI 10.1136/bmj.326.7380.97; Weiner SJ, 2004, J GEN INTERN MED, V19, P281, DOI 10.1111/j.1525-1497.2004.30261.x; 1919, J MED ETHICS, V18, P148	3	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 13	2008	337	7670							a1562	10.1136/bmj.a1562	http://dx.doi.org/10.1136/bmj.a1562			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354DT	18782841				2022-12-28	WOS:000259619800032
J	Chen, CH; Budas, GR; Churchill, EN; Disatnik, MH; Hurley, TD; Mochly-Rosen, D				Chen, Che-Hong; Budas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Hurley, Thomas D.; Mochly-Rosen, Daria			Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart	SCIENCE			English	Article							PROTEIN-KINASE-C; RAT-HEART; EPSILON; CARDIOPROTECTION; INHIBITION; PROTECTION; ETHANOL; CLONING; PKC	There is substantial interest in the development of drugs that limit the extent of ischemia- induced cardiac damage caused by myocardial infarction or by certain surgical procedures. Here, using an unbiased proteomic search, we identified mitochondrial aldehyde dehydrogenase 2 ( ALDH2) as an enzyme whose activation correlates with reduced ischemic heart damage in rodent models. A high- throughput screen yielded a small- molecule activator of ALDH2 ( Alda- 1) that, when administered to rats before an ischemic event, reduced infarct size by 60%, most likely through its inhibitory effect on the formation of cytotoxic aldehydes. In vitro, Alda- 1 was a particularly effective activator of ALDH2*2, an inactive mutant form of the enzyme that is found in 40% of East Asian populations. Thus, pharmacologic enhancement of ALDH2 activity may be useful for patients with wild- type or mutant ALDH2 who are subjected to cardiac ischemia, such as during coronary bypass surgery.	[Chen, Che-Hong; Budas, Grant R.; Churchill, Eric N.; Disatnik, Marie-Helene; Mochly-Rosen, Daria] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Hurley, Thomas D.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA	Stanford University; Indiana University System; Indiana University-Purdue University Indianapolis	Mochly-Rosen, D (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	mochly@stanford.edu		Mochly-Rosen, Daria/0000-0002-6691-8733; HURLEY, THOMAS/0000-0002-5942-1163	NIH [AA11147]; Stanford's SPARK Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA011147, R01AA011147] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford's SPARK Program; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank K. Inagaki and C. L. Murriel for initial studies; D. Solow-Cordero for the high-throughput screen; and F. Conti, D. Cheng, and A. Masoud Sadaghiani for the biochemical characterization of Alda-1. Supported by NIH grant AA11147 (to D.M.-R.) and by Stanford's SPARK Program (C.-H.C.). D.M.-R. is the founder and a shareholder of KAI Pharmaceuticals; however, none of the work described here was done in collaboration with, or with support from, this company. C.-H.C., T.D.H., and D.M.-R. are listed as inventors in three pending patents filed by Stanford University that are related to this work.	Blasi P, 2002, MOL GENET METAB, V76, P348, DOI 10.1016/S1096-7192(02)00105-1; Bolli R, 2007, AM J PHYSIOL-HEART C, V292, pH19, DOI 10.1152/ajpheart.00712.2006; Chen CH, 1999, P NATL ACAD SCI USA, V96, P12784, DOI 10.1073/pnas.96.22.12784; Chen CH, 2001, J MOL CELL CARDIOL, V33, P581, DOI 10.1006/jmcc.2000.1330; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Chen ZQ, 2005, P NATL ACAD SCI USA, V102, P12159, DOI 10.1073/pnas.0503723102; DEITRICH RA, 1976, BIOCHEM PHARMACOL, V25, P2733, DOI 10.1016/0006-2952(76)90265-3; Doorn JA, 2006, CHEM RES TOXICOL, V19, P102, DOI 10.1021/tx0501839; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Downey JM, 2007, HEART FAIL REV, V12, P181, DOI 10.1007/s10741-007-9025-2; DUESTER G, 1984, P NATL ACAD SCI-BIOL, V81, P4055, DOI 10.1073/pnas.81.13.4055; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; Gray MO, 1997, J BIOL CHEM, V272, P30945, DOI 10.1074/jbc.272.49.30945; Hill M, 2001, CIRCULATION, V104, P694, DOI 10.1161/hc3201.092218; HSU LC, 1985, P NATL ACAD SCI USA, V82, P3771, DOI 10.1073/pnas.82.11.3771; Jaburek M, 2006, CIRC RES, V99, P878, DOI 10.1161/01.RES.0000245106.80628.d3; Larson HN, 2005, J BIOL CHEM, V280, P30550, DOI 10.1074/jbc.M502345200; Lucas DT, 1998, P NATL ACAD SCI USA, V95, P510, DOI 10.1073/pnas.95.2.510; Nakano A, 2000, PHARMACOL THERAPEUT, V86, P263, DOI 10.1016/S0163-7258(00)00058-9	19	568	620	6	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1493	1495		10.1126/science.1158554	http://dx.doi.org/10.1126/science.1158554			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787169	Green Accepted			2022-12-28	WOS:000259121800042
J	Trumbore, SE; Czimczik, CI				Trumbore, Susan E.; Czimczik, Claudia I.			Geology - An uncertain future for soil carbon	SCIENCE			English	Editorial Material							ORGANIC-MATTER; CYCLE FEEDBACK; DYNAMICS; RELEASE; STORAGE; MODEL		[Trumbore, Susan E.; Czimczik, Claudia I.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Trumbore, SE (corresponding author), Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA.	setrumbo@uci.edu; czimczik@uci.edu	Trumbore, Susan/B-1948-2013	Czimczik, Claudia/0000-0002-8251-6603				Brantley SL, 2008, SCIENCE, V321, P1454, DOI 10.1126/science.1161132; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Dutta K, 2006, GLOBAL CHANGE BIOL, V12, P2336, DOI 10.1111/j.1365-2486.2006.01259.x; Ekschmitt K, 2005, GEODERMA, V128, P167, DOI 10.1016/j.geoderma.2004.12.024; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gleixner G, 2002, ORG GEOCHEM, V33, P357, DOI 10.1016/S0146-6380(01)00166-8; Harden JW, 2000, GLOBAL CHANGE BIOL, V6, P174, DOI 10.1046/j.1365-2486.2000.06019.x; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Holmes KW, 2005, BIOGEOCHEMISTRY, V74, P173, DOI 10.1007/s10533-004-3544-x; Kleber M, 2007, BIOGEOCHEMISTRY, V85, P9, DOI 10.1007/s10533-007-9103-5; Kogel-Knabner I, 2002, SOIL BIOL BIOCHEM, V34, P139, DOI 10.1016/S0038-0717(01)00158-4; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; SCHLESINGER WH, 1990, NATURE, V348, P232, DOI 10.1038/348232a0; Six J, 2002, PLANT SOIL, V241, P155, DOI 10.1023/A:1016125726789; Torn MS, 1997, NATURE, V389, P170, DOI 10.1038/38260	16	165	177	27	260	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1455	1456		10.1126/science.1160232	http://dx.doi.org/10.1126/science.1160232			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787159				2022-12-28	WOS:000259121800029
J	Chakraborty, S; Ahmed, M; Jackson, TL; Thiemens, MH				Chakraborty, Subrata; Ahmed, Musahid; Jackson, Teresa L.; Thiemens, Mark H.			Experimental test of self-shielding in vacuum ultraviolet photodissociation of CO	SCIENCE			English	Article							CARBON-MONOXIDE; SOLAR-SYSTEM; ACCIDENTAL PREDISSOCIATION; OXYGEN ISOTOPES; INTERSTELLAR CO; DIPOLE-MOMENTS; FRACTIONATION; STATES; TRANSITION; NEBULA	Self- shielding of carbon monoxide ( CO) within the nebular disk has been proposed as the source of isotopically anomalous oxygen in the solar reservoir and the source of meteoritic oxygen isotopic compositions. A series of CO photodissociation experiments at the Advanced Light Source show that vacuum ultraviolet ( VUV) photodissociation of CO produces large wavelength- dependent isotopic fractionation. An anomalously enriched atomic oxygen reservoir can thus be generated through CO photodissociation without self- shielding. In the presence of optical self- shielding of VUV light, the fractionation associated with CO dissociation dominates over self- shielding. These results indicate the potential role of photochemistry in early solar system formation and may help in the understanding of oxygen isotopic variations in Genesis solar- wind samples.	[Chakraborty, Subrata; Jackson, Teresa L.; Thiemens, Mark H.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ahmed, Musahid] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA	University of California System; University of California San Diego; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Thiemens, MH (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	mthiemens@ucsd.edu	Ahmed, Musahid/A-8733-2009	Ahmed, Musahid/0000-0003-1216-673X	NASA [NNX07AJ81G]; Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division of the U. S. Department of Energy [DE-AC02-05CH11231]	NASA(National Aeronautics & Space Administration (NASA)); Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division of the U. S. Department of Energy(United States Department of Energy (DOE))	This work was supported by NASA grant NNX07AJ81G under Origins and by the director, Office of Energy Research, Office of Basic Energy Sciences, Chemical Sciences Division of the U. S. Department of Energy under contract DE-AC02-05CH11231. Three reviewers are thanked for helpful suggestions that improved the manuscript.	ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Baker J, 2005, CHEM PHYS LETT, V415, P296, DOI 10.1016/j.cplett.2005.09.015; BAKER J, 1993, CHEM PHYS, V178, P569, DOI 10.1016/0301-0104(93)85093-N; BAKER J, 1994, J MOL SPECTROSC, V165, P75, DOI 10.1006/jmsp.1994.1111; BALLY J, 1982, ASTROPHYS J, V255, P143, DOI 10.1086/159812; BHATTACHARYA SK, 1989, Z NATURFORSCH A, V44, P435; Bhattacharya SK, 2000, GEOPHYS RES LETT, V27, P1459, DOI 10.1029/1999GL010793; Cacciani P, 1998, ASTROPHYS J, V499, pL223, DOI 10.1086/311378; CACCIANI P, 1995, J CHEM PHYS, V102, P8308, DOI 10.1063/1.468823; CLAYTON RN, 1993, ANNU REV EARTH PL SC, V21, P115, DOI 10.1146/annurev.earth.21.1.115; Clayton RN, 2002, NATURE, V415, P860, DOI 10.1038/415860b; COOPER DL, 1987, J CHEM PHYS, V87, P424, DOI 10.1063/1.453587; Federman SR, 2003, ASTROPHYS J, V591, P986, DOI 10.1086/375483; KIRBY K, 1989, J CHEM PHYS, V90, P4895, DOI 10.1063/1.456584; LETZELTER C, 1987, CHEM PHYS, V114, P273, DOI 10.1016/0301-0104(87)80117-9; Lewis BR, 2002, J CHEM PHYS, V116, P3286, DOI 10.1063/1.1436106; Lim GI, 1999, J CHEM PHYS, V111, P456, DOI 10.1063/1.479325; Lyons JR, 2005, NATURE, V435, P317, DOI 10.1038/nature03557; MELLINGER A, 1994, J CHEM PHYS, V101, P104, DOI 10.1063/1.468184; NAVON O, 1985, EARTH PLANET SC LETT, V73, P1, DOI 10.1016/0012-821X(85)90030-5; Pandey A, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2206584; Sakamoto N, 2007, SCIENCE, V317, P231, DOI 10.1126/science.1142021; SIMMONS JD, 1974, J MOL SPECTROSC, V49, P167, DOI 10.1016/0022-2852(74)90105-2; THIEMENS MH, 1983, SCIENCE, V219, P1073, DOI 10.1126/science.219.4588.1073; Turnidge ML, 1998, J CHEM PHYS, V108, P485, DOI 10.1063/1.475411; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; Warin S, 1996, ASTRON ASTROPHYS, V308, P535; Wilson S, 1977, INT J QUANTUM CHEM, V12, P609, DOI 10.1002/qua.560120403; Young ED, 2001, PHILOS T ROY SOC A, V359, P2095, DOI 10.1098/rsta. 2001.0900; Young ED, 2002, GEOCHIM COSMOCHIM AC, V66, P1095, DOI 10.1016/S0016-7037(01)00832-8; Young ED, 2007, EARTH PLANET SC LETT, V262, P468, DOI 10.1016/j.epsl.2007.08.011; YU Y, 1995, GEOCHIM COSMOCHIM AC, V59, P2095, DOI 10.1016/0016-7037(95)00129-8; Yurimoto H, 2004, SCIENCE, V305, P1763, DOI 10.1126/science.1100989	34	64	64	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 5	2008	321	5894					1328	1331		10.1126/science.1159178	http://dx.doi.org/10.1126/science.1159178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772432				2022-12-28	WOS:000258914300042
J	Hsu, PP; Sabatini, DM				Hsu, Peggy P.; Sabatini, David M.			Cancer cell metabolism: Warburg and beyond	CELL			English	Article							AEROBIC GLYCOLYSIS; PYRUVATE-KINASE; TUMOR-GROWTH; RAG GTPASES; C-MYC; EXPRESSION; HYPOXIA; OVEREXPRESSION; ACTIVATION; PROTEIN	Described decades ago, the Warburg effect of aerobic glycolysis is a key metabolic hallmark of cancer, yet its significance remains unclear. In this Essay, we re-examine the Warburg effect and establish a framework for understanding its contribution to the altered metabolism of cancer cells.	[Hsu, Peggy P.; Sabatini, David M.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Hsu, Peggy P.; Sabatini, David M.] Broad Inst, Cambridge, MA 02142 USA; [Sabatini, David M.] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	sabatini@w.mit.edu		/0000-0002-1446-7256	NATIONAL CANCER INSTITUTE [R01CA129105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA129105, R01 CA129105-02] Funding Source: Medline; NIGMS NIH HHS [T32 GM007753] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Fais S, 2007, CANCER RES, V67, P10627, DOI 10.1158/0008-5472.CAN-07-1805; Fang J, 2006, MOL PHARMACOL, V70, P2108, DOI 10.1124/mol.106.026245; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fukumura D, 2001, CANCER RES, V61, P6020; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Galperin MY, 2006, MOL MICROBIOL, V59, P5, DOI 10.1111/j.1365-2958.2005.04950.x; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gordan JD, 2007, CANCER CELL, V12, P108, DOI 10.1016/j.ccr.2007.07.006; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; KAELIN WG, 2008, J MOL CELL, V30, P393; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Koehler SE, 2004, MOL PHARMACOL, V66, P620; Koukourakis MI, 2006, CANCER RES, V66, P632, DOI 10.1158/0008-5472.CAN-05-3260; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Philp A, 2005, J EXP BIOL, V208, P4561, DOI 10.1242/jeb.01961; Pollard PJ, 2005, HUM MOL GENET, V14, P2231, DOI 10.1093/hmg/ddi227; Rarnanathan A, 2005, P NATL ACAD SCI USA, V102, P5992, DOI 10.1073/pnas.0502267102; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Stanbrough M, 2006, CANCER RES, V66, P2815, DOI 10.1158/0008-5472.CAN-05-4000; WARBURG O, 1956, SCIENCE, V124, P269; Wiesener MS, 2001, CANCER RES, V61, P5215; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095; Zhong H, 1999, CANCER RES, V59, P5830	41	1636	1721	9	345	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					703	707		10.1016/j.cell.2008.08.021	http://dx.doi.org/10.1016/j.cell.2008.08.021			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775299	Bronze			2022-12-28	WOS:000258947500006
J	Johnson, CE; Kornbluth, S				Johnson, Carrie E.; Kornbluth, Sally			Caspase cleavage is not for everyone	CELL			English	Editorial Material							ACTIVATION	During apoptosis, caspases cleave cellular substrates to break down and package the apoptotic cell for removal. Reporting in Cell, Mahrus et al. (2008) and Dix et al. (2008) use new approaches that identify hundreds of previously unrecognized caspase substrates, many of which appear to produce polypeptide fragments with potentially new functional activities.	[Johnson, Carrie E.; Kornbluth, Sally] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA	Duke University	Kornbluth, S (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA.	kornb001@mc.duke.edu						Chen YR, 1999, ONCOGENE, V18, P7370, DOI 10.1038/sj.onc.1203116; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; D'Amours D, 2001, J CELL SCI, V114, P3771; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; Dix MM, 2008, CELL, V134, P679, DOI 10.1016/j.cell.2008.06.038; Luthi AU, 2007, CELL DEATH DIFFER, V14, P641, DOI 10.1038/sj.cdd.4402103; Woo EJ, 2004, MOL CELL, V14, P531, DOI 10.1016/S1097-2765(04)00258-8	7	19	19	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5					720	721		10.1016/j.cell.2008.08.019	http://dx.doi.org/10.1016/j.cell.2008.08.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775303	Bronze			2022-12-28	WOS:000258947500010
J	Pan, WJ; Choi, SC; Wang, H; Qin, YB; Volpicelli-Daley, L; Swan, L; Lucast, L; Khoo, C; Zhang, XW; Li, L; Abrams, CS; Sokol, SY; Wu, DQ				Pan, Weijun; Choi, Sun-Cheol; Wang, He; Qin, Yuanbo; Volpicelli-Daley, Laura; Swan, Laura; Lucast, Louise; Khoo, Cynthia; Zhang, Xiaowu; Li, Lin; Abrams, Charles S.; Sokol, Sergei Y.; Wu, Dianqing			Wnt3a-mediated formation of phosphatidylinositol 4,5-bisphosphate regulates LRP6 phosphorylation	SCIENCE			English	Article							WNT SIGNALING PATHWAY; DOMAIN; MEMBRANE	The canonical Wnt-beta-catenin signaling pathway is initiated by inducing phosphorylation of one of the Wnt receptors, low- density lipoprotein receptor- related protein 6 ( LRP6), at threonine residue 1479 ( Thr(1479)) and serine residue 1490 (Ser(1490)). By screening a human kinase small interfering RNA library, we identified phosphatidylinositol 4- kinase type II alpha and phosphatidylinositol- 4- phosphate 5- kinase type I (PIP5KI) as required for Wnt3a-induced LRP6 phosphorylation at Ser1490 in mammalian cells and confirmed that these kinases are important for Wnt signaling in Xenopus embryos. Wnt3a stimulates the formation of phosphatidylinositol 4,5-bisphosphates [PtdIns (4,5)P-2] through frizzled and dishevelled, the latter of which directly interacted with and activated PIP5KI. In turn, PtdIns (4,5)P-2 regulated phosphorylation of LRP6 at Thr(1479) and Ser(1490). Therefore, our study reveals a signaling mechanism for Wnt to regulate LRP6 phosphorylation.	[Pan, Weijun; Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Choi, Sun-Cheol; Sokol, Sergei Y.] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA; [Wang, He; Qin, Yuanbo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, State Key Lab Mol Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Wang, He; Qin, Yuanbo; Li, Lin] Chinese Acad Sci, Shanghai Inst Biol Sci, Ctr Cell Signaling, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Volpicelli-Daley, Laura; Swan, Laura; Lucast, Louise] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Volpicelli-Daley, Laura; Swan, Laura; Lucast, Louise] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Khoo, Cynthia; Abrams, Charles S.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Zhang, Xiaowu] Cell Signaling Technol, Danvers, MA 01923 USA	Yale University; Icahn School of Medicine at Mount Sinai; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Yale University; Howard Hughes Medical Institute; Yale University; University of Pennsylvania	Wu, DQ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	dan.wu@yale.edu		Swan, Laura/0000-0002-6312-6263; Sokol, Sergei/0000-0002-3963-9202	NIH [AR051476, CA132317, HL080706, NS36251, DA018343]; National Institute on Drug Abuse to Yale Neuroproteomics Center; Ministry of Science and Technology of China [2002CB513000]; National Science Foundation of China [30521005]; NATIONAL CANCER INSTITUTE [R01CA132317, R01CA139395] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036251, R37NS036251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA018343] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse to Yale Neuroproteomics Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. De Camilli for making available resources from his lab in connection to this work, discussion, and critical reading of the manuscript; Z. Li, M. Orsulak, Y. Zhang, L. Tang, W. Liu, Y. Xi, F. Nie, Y. Wu, and X. Gan for technical assistance; and D. Sussman, C. Carpenter, R. Grosschedl, T. Balla, B. Williams, M. F. Roussel, X. He, C. Niehrs, R. Nusse, and J. Nathans for providing experimental materials. This work was supported by grants from NIH (AR051476, CA132317, HL080706, NS36251, and DA018343), the National Institute on Drug Abuse to Yale Neuroproteomics Center, the Ministry of Science and Technology of China (2002CB513000), and the National Science Foundation of China (30521005).	Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Cong F, 2004, DEVELOPMENT, V131, P5103, DOI 10.1242/dev.01318; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Doughman RL, 2003, J MEMBRANE BIOL, V194, P77, DOI 10.1007/s00232-003-2027-7; Harland R, 1997, ANNU REV CELL DEV BI, V13, P611, DOI 10.1146/annurev.cellbio.13.1.611; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hsuan JJ, 1998, ADV CANCER RES, V74, P167, DOI 10.1016/S0065-230X(08)60767-8; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nusse R, 2005, NATURE, V438, P747, DOI 10.1038/438747a; Pan WJ, 2004, CELL RES, V14, P324, DOI 10.1038/sj.cr.7290232; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Yokoyama Noriko, 2007, J Mol Signal, V2, P11, DOI 10.1186/1750-2187-2-11; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	22	147	152	1	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1350	1353		10.1126/science.1160741	http://dx.doi.org/10.1126/science.1160741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772438	Green Accepted			2022-12-28	WOS:000258914300049
J	Pastalkova, E; Itskov, V; Amarasingham, A; Buzsaki, G				Pastalkova, Eva; Itskov, Vladimir; Amarasingham, Asohan; Buzsaki, Gyoergy			Internally generated cell assembly sequences in the rat hippocampus	SCIENCE			English	Article							PHASE PRECESSION; PATH-INTEGRATION; PYRAMIDAL CELLS; ENTORHINAL CORTEX; ENSEMBLE ACTIVITY; UNIT-ACTIVITY; MEMORY; NEURONS; SPACE; DYNAMICS	A long- standing conjecture in neuroscience is that aspects of cognition depend on the brain's ability to self- generate sequential neuronal activity. We found that reliably and continually changing cell assemblies in the rat hippocampus appeared not only during spatial navigation but also in the absence of changing environmental or body- derived inputs. During the delay period of a memory task, each moment in time was characterized by the activity of a particular assembly of neurons. Identical initial conditions triggered a similar assembly sequence, whereas different conditions gave rise to different sequences, thereby predicting behavioral choices, including errors. Such sequences were not formed in control ( nonmemory) tasks. We hypothesize that neuronal representations, evolved for encoding distance in spatial navigation, also support episodic recall and the planning of action sequences.	[Pastalkova, Eva; Itskov, Vladimir; Amarasingham, Asohan; Buzsaki, Gyoergy] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick	Buzsaki, G (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, 197 Univ Ave, Newark, NJ 07102 USA.	buzsaki@axon.rutgers.edu		Buzsaki, Gyorgy/0000-0002-3100-4800; Itskov, Vladimir/0000-0002-7619-7255	NIH [NS34994, MH54671]; NSF [SBE 0542013]; James S. McDonnell Foundation; Swartz Foundation; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034994] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); James S. McDonnell Foundation; Swartz Foundation; Robert Leet and Clara Guthrie Patterson Trust; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank H. Hirase for sharing his data and C. Curto, C. Geisler, S. Ozen, S. Fujisawa, K. Mizuseki, A. Sirota, D. W. Sullivan, and R. L. Wright for comments. Supported by NIH (NS34994 and MH54671), NSF (SBE 0542013), the James S. McDonnell Foundation, NSF (A.A.), the Swartz Foundation (V.I.), and the Robert Leet and Clara Guthrie Patterson Trust (E.P.).	Abbott LF, 2004, NATURE, V431, P796, DOI 10.1038/nature03010; Abeles M., 1991, CORTICOTRONICS NEURA; Ainge JA, 2007, HIPPOCAMPUS, V17, P988, DOI 10.1002/hipo.20301; [Anonymous], 1983, CANADIAN PSYCHOL; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; Czurko A, 1999, EUR J NEUROSCI, V11, P344, DOI 10.1046/j.1460-9568.1999.00446.x; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Eichenbaum H, 1999, NEURON, V23, P209, DOI 10.1016/S0896-6273(00)80773-4; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Geisler C, 2007, P NATL ACAD SCI USA, V104, P8149, DOI 10.1073/pnas.0610121104; Gothard KM, 1996, J NEUROSCI, V16, P8027; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Hirase H, 1999, EUR J NEUROSCI, V11, P4373, DOI 10.1046/j.1460-9568.1999.00853.x; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Huxter J, 2003, NATURE, V425, P828, DOI 10.1038/nature02058; Huxter JR, 2008, NAT NEUROSCI, V11, P587, DOI 10.1038/nn.2106; Kreiman G, 2000, NATURE, V408, P357, DOI 10.1038/35042575; Levy WB, 2005, NEURAL NETWORKS, V18, P1242, DOI 10.1016/j.neunet.2005.08.005; LI XG, 1994, J COMP NEUROL, V339, P181, DOI 10.1002/cne.903390204; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Louie K, 2001, NEURON, V29, P145, DOI 10.1016/S0896-6273(01)00186-6; Maurer AP, 2006, J NEUROSCI, V26, P13485, DOI 10.1523/JNEUROSCI.2882-06.2006; McNaughton BL, 1996, J EXP BIOL, V199, P173; MCNAUGHTON BL, 1983, EXP BRAIN RES, V52, P41; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; MULLER RU, 1987, J NEUROSCI, V7, P1935; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J, 1996, NATURE, V381, P425, DOI 10.1038/381425a0; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SQUIRE LR, 1992, PSYCHOL REV, V99, P195, DOI 10.1037/0033-295X.99.2.195; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Zugaro MB, 2005, NAT NEUROSCI, V8, P67, DOI 10.1038/nn1369	40	709	711	2	75	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1322	1327		10.1126/science.1159775	http://dx.doi.org/10.1126/science.1159775			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772431	Green Accepted			2022-12-28	WOS:000258914300041
J	Russell, ARB; Steer, PJ				Russell, A. R. Bedford; Steer, P. J.			Antibiotics in preterm labour - the ORACLE speaks	LANCET			English	Editorial Material							BROAD-SPECTRUM ANTIBIOTICS; PRELABOR RUPTURE; RANDOMIZED TRIAL; CESAREAN-SECTION; MEMBRANES; TERM		[Steer, P. J.] Univ London Imperial Coll Sci Technol & Med, Div Surg Anaesthet Oncol & Reprod Med, Fac Med, London SW10 9NH, England; [Steer, P. J.] Chelsea & Westminster NHS Fdn Trust, London SW10 9NH, England; [Russell, A. R. Bedford] Warwick Med Sch, Warwick, England; [Russell, A. R. Bedford] Heart England NHS Trust, Neonatol Unit, Birmingham, W Midlands, England	Imperial College London; Imperial College London; University of Warwick; Heart of England NHS Foundation Trust	Steer, PJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Surg Anaesthet Oncol & Reprod Med, Fac Med, London SW10 9NH, England.	p.steer@imperial.ac.uk						Agnew G, 2006, OBSTET GYNECOL, V108, P452, DOI 10.1097/01.AOG.0000232163.87409.27; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Hannah M, 2001, LANCET, V357, P973, DOI 10.1016/S0140-6736(00)04253-7; Hannah ME, 2000, LANCET, V356, P1375, DOI 10.1016/S0140-6736(00)02840-3; *HLTH PROT AG, 2007, HLTH PROT REP, V1, P9; Inder T E, 2000, Semin Neonatol, V5, P3, DOI 10.1053/siny.1999.0112; Jacobsson B, 2004, BEST PRACT RES CL OB, V18, P425, DOI 10.1016/j.bpobgyn.2004.02.011; KENYON S, 2008, LANCET          0918; Kenyon SL, 2001, LANCET, V357, P989, DOI 10.1016/S0140-6736(00)04234-3; Kenyon SL, 2001, LANCET, V357, P979, DOI 10.1016/S0140-6736(00)04233-1; LIGGINS GC, 1972, PEDIATRICS, V50, P515; PEARSON A, 2004, CDR WEEKLY, V15, P4; Russell ARB, 2006, BJOG-INT J OBSTET GY, V113, P758, DOI 10.1111/j.1471-0528.2006.00952.x; Steer PJ, 2005, BMJ-BRIT MED J, V331, P645, DOI 10.1136/bmj.331.7518.645; Tan S, 2003, LANCET, V361, P437, DOI 10.1016/S0140-6736(03)12420-8	15	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 11	2008	372	9646					1276	1278		10.1016/S0140-6736(08)61248-9	http://dx.doi.org/10.1016/S0140-6736(08)61248-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	360MB	18804275				2022-12-28	WOS:000260060500005
J	Heavey, J; Gupta, N				Heavey, Jon; Gupta, Naren			Ludwig's angina	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Heavey, Jon; Gupta, Naren] Univ Virginia, Charlottesville, VA 22903 USA	University of Virginia	Heavey, J (corresponding author), Univ Virginia, Charlottesville, VA 22903 USA.	heavey@alum.dartmouth.org							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1501	1501		10.1056/NEJMicm065036	http://dx.doi.org/10.1056/NEJMicm065036			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832248				2022-12-28	WOS:000259631700010
J	Coumou, D; Driesner, T; Heinrich, CA				Coumou, D.; Driesner, T.; Heinrich, C. A.			The structure and dynamics of mid-ocean ridge hydrothermal systems	SCIENCE			English	Article							DE-FUCA RIDGE; HEAT-TRANSPORT; FLUID-FLOW; CIRCULATION; CONSTRAINTS; CONVECTION; PLUMES	Sub-seafloor hydrothermal convection at mid- ocean ridges transfers 25% of the Earth's heat flux and can form massive sulfide ore deposits. Their three- dimensional ( 3D) structure and transient dynamics are uncertain. Using 3D numerical simulations, we demonstrated that convection cells self- organize into pipelike upflow zones surrounded by narrow zones of focused and relatively warm downflow. This configuration ensures optimal heat transfer and efficient metal leaching for ore- deposit formation. Simulated fluid- residence times are as short as 3 years. The concentric flow geometry results from nonlinearities in fluid properties, and this may influence the behavior of other fluid- flow systems in Earth's crust.	[Coumou, D.; Driesner, T.; Heinrich, C. A.] ETH, Dept Earth Sci, CH-9082 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Coumou, D (corresponding author), ETH, Dept Earth Sci, Clausiusstr 25, CH-9082 Zurich, Switzerland.	coumou@pik-potsdam.de	Heinrich, Christoph A/D-3921-2014; Coumou, Dim/ABE-6666-2020; Driesner, Thomas/N-6361-2016	Heinrich, Christoph A/0000-0001-5838-4607; Coumou, Dim/0000-0003-2155-8495; 	Swiss National Science Foundation [200020-107955]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (grant 200020-107955). The authors thank S. Geiger for providing the mesh depicted in Fig. 1 and S. Ingebritsen, P. Weiss, L. Cathles, and three anonymous reviewers for useful discussions as well as careful proofreading of earlier versions of the manuscript.	Baker ET, 1996, J GEOPHYS RES-SOL EA, V101, P8685, DOI 10.1029/95JB03746; BUSSE FH, 1972, J FLUID MECH, V54, P521, DOI 10.1017/S0022112072000850; Coogan LA, 2006, AM J SCI, V306, P389, DOI 10.2475/06.2006.01; COUMOU D, 2008, THESIS EIDGENOSSISCH; Coumou D, 2006, EARTH PLANET SC LETT, V245, P218, DOI 10.1016/j.epsl.2006.02.044; Fisher A.T., 2003, DAHL WORKSH REP EN M, P29; Fontaine FJ, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001601; Fontaine FJ, 2001, EARTH PLANET SC LETT, V184, P407, DOI 10.1016/S0012-821X(00)00332-0; Franklin JM, 2005, ONE 100 ANNIVERSARY, P523; GINSTER U, 1994, J GEOPHYS RES-SOL EA, V99, P4937, DOI 10.1029/93JB02800; Glickson DA, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001588; HAAR G, 1989, NBS NRC STEAM TABLES; Hannington M.D., 1995, GEOPHYS MONOGRAPH, V91, P115, DOI DOI 10.1029/GM091P0115; HEMLEY JJ, 1992, ECON GEOL BULL SOC, V87, P1, DOI 10.2113/gsecongeo.87.1.1; Ingebritsen S.E., 2006, GROUNDWATER GEOLOGIC; INGEBRITSEN SE, 1994, GEOPHYS RES LETT, V21, P2199, DOI 10.1029/94GL02002; JOHNSON HP, 1993, GEOPHYS RES LETT, V20, P1875, DOI 10.1029/93GL00734; Jupp T, 2000, NATURE, V403, P880, DOI 10.1038/35002552; Jupp TE, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002697; Kadko D, 1998, GEOCHIM COSMOCHIM AC, V62, P1521, DOI 10.1016/S0016-7037(98)00088-X; Kadko D, 2007, GEOCHIM COSMOCHIM AC, V71, P6019, DOI 10.1016/j.gca.2007.09.018; Kelley DS, 2002, ANNU REV EARTH PL SC, V30, P385, DOI 10.1146/annurev.earth.30.091201.141331; LOWELL RP, 1995, J GEOPHYS RES-SOL EA, V100, P327, DOI 10.1029/94JB02222; MALKUS WVR, 1954, PROC R SOC LON SER-A, V225, P196, DOI 10.1098/rspa.1954.0197; NEHLIG P, 1988, MAR GEOL, V84, P209, DOI 10.1016/0025-3227(88)90102-8; Rabinowicz M, 1999, J GEOPHYS RES-SOL EA, V104, P29275, DOI 10.1029/1999JB900259; Rabinowicz M, 1998, J GEOPHYS RES-SOL EA, V103, P24045, DOI 10.1029/98JB01484; Ramondenc P, 2006, EARTH PLANET SC LETT, V245, P487, DOI 10.1016/j.epsl.2006.03.023; SINTON JM, 1992, J GEOPHYS RES-SOL EA, V97, P197, DOI 10.1029/91JB02508; STEIN CA, 1994, J GEOPHYS RES-SOL EA, V99, P3081, DOI 10.1029/93JB02222; Tivey MA, 2002, GEOLOGY, V30, P979, DOI 10.1130/0091-7613(2002)030<0979:CMRSSO>2.0.CO;2; Tolstoy M, 2008, NATURE, V451, P181, DOI 10.1038/nature06424; TRAVIS BJ, 1991, GEOPHYS RES LETT, V18, P1441, DOI 10.1029/91GL01776; Van Ark EM, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB004210; Wilcock WSD, 2004, GEOPHYS MONOGR SER, V144, P51, DOI 10.1029/144GM05; Wilcock WSD, 1998, J GEOPHYS RES-SOL EA, V103, P2585, DOI 10.1029/97JB03252	36	99	102	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1825	1828		10.1126/science.1159582	http://dx.doi.org/10.1126/science.1159582			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818356				2022-12-28	WOS:000259501300035
J	Oppenheim, J				Oppenheim, Jonathan			Physics - For quantum information, two wrongs can make a right	SCIENCE			English	Editorial Material									[Oppenheim, Jonathan] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	University of Cambridge	Oppenheim, J (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England.	jono@damtp.cam.ac.uk						Bennett CH., 1984, P IEEE INT C COMP SY, P175; Eggeling T, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.097905; EKERT AK, 1991, PHYS REV LETT, V67, P661, DOI 10.1103/PhysRevLett.67.661; Horodecki K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.110502; Horodecki K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.160502; Smith G, 2008, SCIENCE, V321, P1812, DOI 10.1126/science.1162242; Smith G, 2008, IEEE T INFORM THEORY, V54, P4208, DOI 10.1109/TIT.2008.928269	7	13	13	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1783	1784		10.1126/science.1164543	http://dx.doi.org/10.1126/science.1164543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818345	Green Submitted			2022-12-28	WOS:000259501300021
J	Dacunha, A				Dacunha, Anthony			Periungual fibromas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material												adacunha@aol.com							0	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1381	1381		10.1056/NEJMicm073405	http://dx.doi.org/10.1056/NEJMicm073405			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815399				2022-12-28	WOS:000259440900008
J	Stossel, TP				Stossel, Thomas P.			The discovery of statins	CELL			English	Editorial Material							COENZYME-A REDUCTASE; 3-HYDROXY-3-METHYLGLUTARYL-COENZYME-A REDUCTASE; HYPOCHOLESTEROLEMIC ACTIVITY; ML-236B; CHOLESTEROL; HYPERCHOLESTEROLEMIA; INHIBITION; INVIVO		Harvard Univ, Brigham & Womens Hosp, Dept Med, Translat Med Unit,Med Sch, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Stossel, TP (corresponding author), Harvard Univ, Brigham & Womens Hosp, Dept Med, Translat Med Unit,Med Sch, Boston, MA 02115 USA.	tstossel@partners.org						BILHEIMER DW, 1979, J CLIN INVEST, V64, P524, DOI 10.1172/JCI109490; Brown MS, 2004, ATHEROSCLEROSIS SUPP, V5, P13, DOI 10.1016/j.atherosclerosissup.2004.08.007; BROWN MS, 1978, J BIOL CHEM, V253, P1121; ENDO A, 1976, FEBS LETT, V72, P323, DOI 10.1016/0014-5793(76)80996-9; ENDO A, 1976, J ANTIBIOT, V29, P1346, DOI 10.7164/antibiotics.29.1346; ENDO A, 1979, BIOCHIM BIOPHYS ACTA, V575, P266; ENDO A, 1977, EUR J BIOCHEM, V77, P31, DOI 10.1111/j.1432-1033.1977.tb11637.x; Fox KAA, 2007, JAMA-J AM MED ASSOC, V297, P1892, DOI 10.1001/jama.297.17.1892; FREDRICKSON D, 1971, NEW ENGL J MED, V276, P215; FREDRICKSON D, 1971, NEW ENGL J MED, V276, P148; FREDRICKSON D, 1971, NEW ENGL J MED, V276, P94; GOLDSTEIN JL, 1977, ANNU REV BIOCHEM, V46, P897, DOI 10.1146/annurev.bi.46.070177.004341; PEDERSEN TR, 1994, LANCET, V344, P1383; STEINBERG DS, 2007, CAT AM AMPHIB REPT, P1; TOBERT JA, 1982, J CLIN INVEST, V69, P913, DOI 10.1172/JCI110530; YAMAMOTO A, 1980, ATHEROSCLEROSIS, V35, P259, DOI 10.1016/0021-9150(80)90124-0; ZYCHER B, 2008, MED PROGR REPORTS, P1	17	53	57	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					903	905		10.1016/j.cell.2008.09.008	http://dx.doi.org/10.1016/j.cell.2008.09.008			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805080	Bronze			2022-12-28	WOS:000259318100007
J	Rosenthal, MB				Rosenthal, Meredith B.			Beyond pay for performance - Emerging models of provider-payment reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Rosenthal, Meredith B.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Rosenthal, MB (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Rosenthal, Meredith/0000-0003-3410-0184				American Academy of Family Physicians; American Academy of Pediatrics; American College of Physicians; American Osteopathic Association, 2007, JOINT PRINC PAT CTR; Casale AS, 2007, ANN SURG, V246, P613, DOI 10.1097/SLA.0b013e318155a996; ELLIS RP, 1986, J HEALTH ECON, V5, P129, DOI 10.1016/0167-6296(86)90002-0; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2	5	123	124	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1197	1200		10.1056/NEJMp0804658	http://dx.doi.org/10.1056/NEJMp0804658			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349DV	18799554				2022-12-28	WOS:000259259900001
J	Mallet, V; Gilgenkrantz, H; Serpaggi, J; Verkarre, V; Vallet-Pichard, A; Fontaine, H; Pol, S				Mallet, Vincent; Gilgenkrantz, Helene; Serpaggi, Jeanne; Verkarre, Virginie; Vallet-Pichard, Anais; Fontaine, Helene; Pol, Stanislas			Brief communication: The relationship of regression of cirrhosis to outcome in chronic hepatitis C	ANNALS OF INTERNAL MEDICINE			English	Article							VIRUS-RELATED CIRRHOSIS; SUSTAINED VIROLOGICAL RESPONSE; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; INTERFERON-ALPHA; REVERSIBILITY; THERAPY; RIBAVIRIN; REVERSAL; MANAGEMENT	Background: The effect of regression of cirrhosis in chronic hepatitis C is unknown. Objective: To evaluate the relation between regression of cirrhosis and clinical outcome in patients with chronic hepatitis C after antiviral therapy. Design: A cohort of patients with cirrhosis treated between 1988 and 2001. Setting: Hepatology unit of a tertiary care center in France. Patients: 96 patients with chronic hepatitis C and biopsy-proven cirrhosis (METAVIR score F4) who were treated with an interferon-based regimen and had at least 1 posttreatment liver biopsy. Patients were followed until November 2006. Measurements: Occurrence of a combined end point of liver-related events (ascites, hepatic encephalopathy, variceal bleeding, spontaneous bacterial peritonitis, hepatocellular carcinoma, or liver transplantation) and death in patients with regression of cirrhosis (defined as a decrease from 4 to <= 2 METAVIR units on post-therapy liver biopsy). Results: The median follow-up was 118 months (interquartile range, 86 to 138 months). Eighteen patients had regression of cirrhosis. The incidence of the combined end point per 100 patient-years was 0 in patients with regression of cirrhosis and 4 in patients without regression of cirrhosis (P = 0.002, log-rank test). The transplantation-free survival rate at 10 years was 100% in patients with regression of cirrhosis and 74.2% in patients without regression of cirrhosis (P = 0.025). Limitations: Selection of patients was retrospective; selection and survival biases may have influenced the estimates of the overall rate of regression of cirrhosis. The low number of patients who experienced regression of cirrhosis precludes analysis of factors that could predict regression of cirrhosis. Conclusion: Regression of cirrhosis occurs after antiviral therapy in some patients with chronic hepatitis C. Regression is associated with decreased disease-related morbidity and improved survival.	[Pol, Stanislas] Univ Paris 05, Hop Cochin, INSERM, U567,AP HP, F-75014 Paris, France; Hop Necker Enfants Malad, AP HP, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Pol, S (corresponding author), Univ Paris 05, Hop Cochin, INSERM, U567,AP HP, 27 Rue Faubourg St Jacques, F-75014 Paris, France.	stanislas.pol@cch.aphp.fr	Gilgenkrantz, Helene/G-5534-2017; Mallet, Vincent/G-4623-2011	gilgenkrantz, helene/0000-0001-6770-4561; Mallet, Vincent/0000-0003-2219-9201				BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bellentani S, 2001, J HEPATOL, V35, P531, DOI 10.1016/S0168-8278(01)00151-9; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Bruno S, 2007, HEPATOLOGY, V45, P579, DOI 10.1002/hep.21492; Desmet VJ, 2004, J HEPATOL, V40, P860, DOI 10.1016/j.jhep.2004.03.007; Dienstag JL, 2003, GASTROENTEROLOGY, V124, P105, DOI 10.1053/gast.2003.50013; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; El Braks R, 2007, WORLD J GASTROENTERO, V13, P5648, DOI 10.3748/wjg.v13.i42.5648; Farci P, 2004, GASTROENTEROLOGY, V126, P1740, DOI 10.1053/j.gastro.2004.03.017; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Fontaine H, 2000, LANCET, V356, P41, DOI 10.1016/S0140-6736(00)02434-X; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; Gines P, 2004, NEW ENGL J MED, V350, P1646, DOI 10.1056/NEJMra035021; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Kaplan MM, 1997, ANN INTERN MED, V126, P682, DOI 10.7326/0003-4819-126-9-199705010-00002; Mallet VO, 2007, ANTIVIR THER, V12, P279; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; ORLANDO R, 1990, J CLIN GASTROENTEROL, V12, P47; Papatheodoridis GV, 2001, ALIMENT PHARM THER, V15, P689, DOI 10.1046/j.1365-2036.2001.00979.x; Pol S, 2004, HUM PATHOL, V35, P107, DOI 10.1016/j.humpath.2003.08.012; POWELL LW, 1970, AUSTRALAS ANN MED, V19, P54; Poynard T, 2000, HEPATOLOGY, V32, P1131, DOI 10.1053/jhep.2000.19347; Poynard T, 2002, GASTROENTEROLOGY, V122, P1303, DOI 10.1053/gast.2002.33023; Regev A, 2002, AM J GASTROENTEROL, V97, P2614, DOI 10.1111/j.1572-0241.2002.06038.x; Serpaggi J, 2006, HUM PATHOL, V37, P1519, DOI 10.1016/j.humpath.2006.07.007; Shiratori Y, 2003, ANN INTERN MED, V138, P299, DOI 10.7326/0003-4819-138-4-200302180-00008; SOYER MT, 1976, SURGERY, V79, P601; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Valla DC, 1999, HEPATOLOGY, V29, P1870, DOI 10.1002/hep.510290616; Velazquez RF, 2003, HEPATOLOGY, V37, P520, DOI 10.1053/jhep.2003.50093; Veldt BJ, 2007, ANN INTERN MED, V147, P677, DOI 10.7326/0003-4819-147-10-200711200-00003	31	233	243	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 16	2008	149	6					399	W76		10.7326/0003-4819-149-6-200809160-00006	http://dx.doi.org/10.7326/0003-4819-149-6-200809160-00006			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	348SM	18794559				2022-12-28	WOS:000259230200004
J	Dey, N; Nazif, TM; Sharpe, B				Dey, Neelendu; Nazif, Tamim M.; Sharpe, Bradley			Stranded in San Francisco	LANCET			English	Editorial Material									[Dey, Neelendu] Univ Calif San Francisco, Div Gastroenterol, Dept Med, San Francisco, CA 94143 USA; [Nazif, Tamim M.; Sharpe, Bradley] Univ Calif San Francisco, Div Hosp Med, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dey, N (corresponding author), Univ Calif San Francisco, Div Gastroenterol, Dept Med, 505 Parnassus Ave,Box 0119,Moffitt M-987, San Francisco, CA 94143 USA.	dey@post.harvard.edu		Dey, Neelendu/0000-0001-8825-5689; Nazif, Tamim/0000-0003-1239-2489				Hirschmann JV, 1999, J AM ACAD DERMATOL, V41, P895, DOI 10.1016/S0190-9622(99)70244-6; Luhrmann TM, 2008, AM J PSYCHIAT, V165, P15, DOI 10.1176/appi.ajp.2007.07071166; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P8; TIENARI P, 1994, BRIT J PSYCHIAT S, V23, P20	4	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					1008	1008		10.1016/S0140-6736(08)61410-5	http://dx.doi.org/10.1016/S0140-6736(08)61410-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790323				2022-12-28	WOS:000259266900040
J	Kim, JS; LaGrange, T; Reed, BW; Taheri, ML; Armstrong, MR; King, WE; Browning, ND; Campbell, GH				Kim, Judy S.; LaGrange, Thomas; Reed, Bryan W.; Taheri, Mitra L.; Armstrong, Michael R.; King, Wayne E.; Browning, Nigel D.; Campbell, Geoffrey H.			Imaging of transient structures using nanosecond in situ TEM	SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPY; AL; FOILS; NI; KINETICS; GROWTH; CARBON; PHASE	The microstructure and properties of a material depend on dynamic processes such as defect motion, nucleation and growth, and phase transitions. Transmission electron microscopy (TEM) can spatially resolve these nanoscale phenomena but lacks the time resolution for direct observation. We used a photoemitted electron pulse to probe dynamic events with "snapshot" diffraction and imaging at 15- nanosecond resolution inside of a dynamic TEM. With the use of this capability, the moving reaction front of reactive nanolaminates is observed in situ. Time- resolved images and diffraction show a transient cellular morphology in a dynamically mixing, self- propagating reaction front, revealing brief phase separation during cooling, and thus provide insights into the mechanisms driving the self- propagating high- temperature synthesis.	[Kim, Judy S.; LaGrange, Thomas; Reed, Bryan W.; Taheri, Mitra L.; Armstrong, Michael R.; King, Wayne E.; Browning, Nigel D.; Campbell, Geoffrey H.] Lawrence Livermore Natl Lab, Div Mat Sci & Technol, Livermore, CA 94550 USA; [Kim, Judy S.; Browning, Nigel D.] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA	United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University of California System; University of California Davis	Kim, JS (corresponding author), Lawrence Livermore Natl Lab, Div Mat Sci & Technol, Livermore, CA 94550 USA.	kim46@llnl.gov	Campbell, Geoffrey/F-7681-2010; Reed, Bryan W/C-6442-2013; Armstrong, Michael/I-9454-2012; Taheri, Mitra/F-1321-2011	Browning, Nigel/0000-0003-0491-251X; Armstrong, Michael/0000-0003-2375-1491	Office of Science; Office of Basic Energy Sciences; Division of Materials Sciences and Engineering of the DOE [DE-AC52-07NA27344]; Lawrence Scholar Program at LLNL	Office of Science(United States Department of Energy (DOE)); Office of Basic Energy Sciences(United States Department of Energy (DOE)); Division of Materials Sciences and Engineering of the DOE(United States Department of Energy (DOE)); Lawrence Scholar Program at LLNL	This work was performed under the auspices of the U. S. Department of Energy (DOE) by LLNL and supported by the Office of Science, Office of Basic Energy Sciences, Division of Materials Sciences and Engineering of the DOE under contract DE-AC52-07NA27344. J.S.K. is supported by the Lawrence Scholar Program at LLNL. The authors thank K.J.M. Blobaum and T.W. Barbee for valuable discussions, P. Ramsey for materials fabrication, and R.M. Shuttlesworth and B.J. Pyke for their support and expertise in mechanical and laser technologies.	ANSELMITAMBURINI U, 1989, J APPL PHYS, V66, P5039, DOI 10.1063/1.343777; Armstrong MR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2712838; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; Bostanjoglo O, 2000, ULTRAMICROSCOPY, V81, P141, DOI 10.1016/S0304-3991(99)00180-1; Boyes ED, 1997, ULTRAMICROSCOPY, V67, P219, DOI 10.1016/S0304-3991(96)00099-X; Gavens AJ, 2000, J APPL PHYS, V87, P1255, DOI 10.1063/1.372005; Haider M, 1998, ULTRAMICROSCOPY, V75, P53, DOI 10.1016/S0304-3991(98)00048-5; HIRSCH PB, 1956, PHILOS MAG, V1, P677, DOI 10.1080/14786435608244003; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; King WE, 2005, J APPL PHYS, V97, DOI 10.1063/1.1927699; LaGrange T, 2007, ACTA MATER, V55, P5211, DOI 10.1016/j.actamat.2007.05.043; LaGrange T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2236263; LANGER JS, 1980, REV MOD PHYS, V52, P1, DOI 10.1103/RevModPhys.52.1; Michaelsen C, 1997, J PHYS D APPL PHYS, V30, P3167, DOI 10.1088/0022-3727/30/23/001; Minor AM, 2002, J ELECTRON MATER, V31, P958, DOI 10.1007/s11664-002-0028-4; Perring L, 1999, INTERMETALLICS, V7, P1235, DOI 10.1016/S0966-9795(99)00026-6; Sharma R, 2004, APPL PHYS LETT, V84, P990, DOI 10.1063/1.1646465; Singleton M. F., 1990, BINARY ALLOY PHASE D, V1, P181; SUNDQUIST BE, 1968, ACTA METALL MATER, V16, P1413, DOI 10.1016/0001-6160(68)90037-0; Trenkle JC, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2099544; Wang J, 2004, J APPL PHYS, V95, P248, DOI 10.1063/1.1629390; Wei H, 2004, ACTA MATER, V52, P2645, DOI 10.1016/j.actamat.2004.02.012; WIEHS TP, 1998, HDB THIN FILM PROCES; Zhao SJ, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2359438	25	226	231	5	225	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1472	1475		10.1126/science.1161517	http://dx.doi.org/10.1126/science.1161517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787163				2022-12-28	WOS:000259121800035
J	Arbyn, M; Kyrgiou, M; Simoens, C; Raifu, AO; Koliopoulos, G; Martin-Hirsch, P; Prendiville, W; Paraskevaidis, E				Arbyn, M.; Kyrgiou, M.; Simoens, C.; Raifu, A. O.; Koliopoulos, G.; Martin-Hirsch, P.; Prendiville, W.; Paraskevaidis, E.			Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOOP ELECTROSURGICAL EXCISION; CARBON-DIOXIDE LASER; BACTERIAL VAGINOSIS; PRETERM BIRTH; COLD KNIFE; RISK; WOMEN; CONIZATION; INFECTIONS; MANAGEMENT	Objective To assess the relative risk of perinatal mortality, severe preterm delivery, and low birth weight associated with previous treatment for precursors of cervical cancer. Data sources Medline and Embase citation tracking from January 1960 to December 2007. Selection criteria Eligible studies had data on severe pregnancy outcomes for women with and without previous treatment for cervical intraepithelial neoplasia. Considered outcomes were perinatal mortality, severe preterm delivery (< 32/ 34 weeks), extreme preterm delivery (< 28/ 30 weeks), and low birth weight (< 2000 g, < 1500 g, and < 1000 g). Excisional and ablative treatment procedures were distinguished. Results One prospective cohort and 19 retrospective studies were retrieved. Cold knife conisation was associated with a significantly increased risk of perinatal mortality ( relative risk 2.87, 95% confidence interval 1.42 to 5.81) and a significantly higher risk of severe preterm delivery ( 2.78, 1.72 to 4.51), extreme preterm delivery ( 5.33, 1.63 to 17.40), and low birth weight of < 2000 g ( 2.86, 1.37 to 5.97). Laser conisation, described in only one study, was also followed by a significantly increased chance of low birth weight of < 2000 g and < 1500 g. Large loop excision of the transformation zone and ablative treatment with cryotherapy or laser were not associated with a significantly increased risk of serious adverse pregnancy outcomes. Ablation by radical diathermy was associated with a significantly higher frequency of perinatal mortality, severe and extreme preterm delivery, and low birth weight below 2000 g or 1500 g. Conclusions In the treatment of cervical intraepithelial neoplasia, cold knife conisation and probably both laser conisation and radical diathermy are associated with an increased risk of subsequent perinatal mortality and other serious pregnancy outcomes, unlike laser ablation and cryotherapy. Large loop excision of the transformation zone cannot be considered as completely free of adverse outcomes.	[Arbyn, M.; Simoens, C.; Raifu, A. O.] Sci Inst Publ Hlth, Brussels, Belgium; [Arbyn, M.] IARC, European Cooperat Dev & Implementat Canc Screenin, Lyon, France; [Kyrgiou, M.; Martin-Hirsch, P.] Cent Lancashire Teaching Hosp, Dept Obstet & Gynaecol, Preston, Lancs, England; [Koliopoulos, G.; Paraskevaidis, E.] Univ Hosp Ioannina, Dept Obstet & Gynaecol, Ioannina, Greece; [Prendiville, W.] Coombe Womens Hosp, Dept Obstet & Gynaecol, Dublin, Ireland	World Health Organization; International Agency for Research on Cancer (IARC); University Hospital Ioannina; Trinity College Dublin	Arbyn, M (corresponding author), Sci Inst Publ Hlth, Brussels, Belgium.	Marc.Arbyn@iph.fgov.be	Arbyn, Marc/B-6887-2009; Paraskevaidis, Evangelos/ABH-4990-2020		European Commission (Directorate of SANCO, Luxembourg, Grand- Duche du Luxembourg); DWTC/SSTC ( Federal Services for Scientific, Cultural and Technical Affairs, Brussels, Belgium); Gynaecological Cancer Cochrane Review Collaboration, Bath; IWT ( Institute for the Promotion of Innovation by Science and Technology in Flanders); FNRS (Fonds national de la Recherche scientifique)	European Commission (Directorate of SANCO, Luxembourg, Grand- Duche du Luxembourg)(European CommissionEuropean Commission Joint Research Centre); DWTC/SSTC ( Federal Services for Scientific, Cultural and Technical Affairs, Brussels, Belgium)(Belgian Federal Science Policy Office); Gynaecological Cancer Cochrane Review Collaboration, Bath; IWT ( Institute for the Promotion of Innovation by Science and Technology in Flanders)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); FNRS (Fonds national de la Recherche scientifique)(Fonds de la Recherche Scientifique - FNRS)	European Commission (Directorate of SANCO, Luxembourg, Grand- Duche du Luxembourg) through the ECCG ( European cooperation on development and implementation of cancer screening and prevention guidelines); FP6 network of excellence "CCPRB" ( cancer control using population based registries and biobanks) though the University of Lund, Sweden; DWTC/SSTC ( Federal Services for Scientific, Cultural and Technical Affairs, Brussels, Belgium); Gynaecological Cancer Cochrane Review Collaboration, Bath; IWT ( Institute for the Promotion of Innovation by Science and Technology in Flanders) through " SIMID," a strategic basic research project (ref 060081); and FNRS (Fonds national de la Recherche scientifique), through TELEVIE, Brussels, Belgium ( ref 7.4.628.07.F).	Arbyn M, 2005, GYNECOL ONCOL, V99, pS7, DOI 10.1016/j.ygyno.2005.07.033; Arbyn M, 2004, JNCI-J NATL CANCER I, V96, P280, DOI 10.1093/jnci/djh037; Arbyn M, 2006, VACCINE, V24, P78, DOI 10.1016/j.vaccine.2006.05.117; BOSTOFTE E, 1986, ACTA OBSTET GYN SCAN, V65, P199, DOI 10.3109/00016348609155170; COCHRAN WG, 1954, BIOMETRICS, V10, P101, DOI 10.2307/3001666; Crane JMG, 2003, OBSTET GYNECOL, V102, P1058, DOI 10.1016/S0029-7844(03)00741-5; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; GOMEZ R, 1995, CLIN PERINATOL, V22, P281; HAFFENDEN DK, 1993, BRIT J OBSTET GYNAEC, V100, P1059, DOI 10.1111/j.1471-0528.1993.tb15153.x; Herbert A, 1999, CYTOPATHOLOGY, V10, P161, DOI 10.1046/j.1365-2303.1999.00169.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604; International Agency for Research on Cancer (IARC), 2005, IARC HDB CANC PREV, V10, P45; JORDAN J, 2008, EUROPEAN GUIDELINES, P191; Kalliala I, 2005, BRIT MED J, V331, P1183, DOI 10.1136/bmj.38663.459039.7C; Kekki M, 2001, OBSTET GYNECOL, V97, P643, DOI 10.1016/S0029-7844(01)01321-7; KRISTENSEN GB, 1990, OBSTET GYNECOL, V76, P1009; KRISTENSEN J, 1993, OBSTET GYNECOL, V81, P1005; Kunz R, 1998, BRIT MED J, V317, P1185, DOI 10.1136/bmj.317.7167.1185; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Lamont RF, 2007, BJOG-INT J OBSTET GY, V114, P775, DOI 10.1111/j.1471-0528.2007.01367.x; LAUPACIS A, 1988, NEW ENGL J MED, V318, P1728, DOI 10.1056/NEJM198806303182605; Mariategui J, 2008, INT J GYNECOL OBSTET, V100, P24, DOI 10.1016/j.ijgo.2007.07.009; Martin-Hirsch P, 1999, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001318, DOI 10.1002/14651858.CD001318]; MATSUNAGA J, 1987, BRIT J OBSTET GYNAEC, V94, P168, DOI 10.1111/j.1471-0528.1987.tb02345.x; Nohr B, 2007, ACTA OBSTET GYN SCAN, V86, P596, DOI 10.1080/00016340701279145; Paraskevaidis E, 2004, CANCER TREAT REV, V30, P205, DOI 10.1016/j.ctrv.2003.07.008; Paraskevaidis E, 2007, BJOG-INT J OBSTET GY, V114, P3, DOI 10.1111/j.1471-0528.2006.01178.x; Paraskevaidis E, 2002, GYNECOL ONCOL, V86, P10, DOI 10.1006/gyno.2002.6650; Paraskevaidis E, 2002, EUR J OBSTET GYN R B, V102, P88, DOI 10.1016/S0301-2115(01)00574-7; Praest J, 1979, Ugeskr Laeger, V141, P3509; PRENDIVILLE W, 1989, BRIT J OBSTET GYNAEC, V96, P1054, DOI 10.1111/j.1471-0528.1989.tb03380.x; PRENDIVILLE W, 2000, CME J GYNECOL ONCOL, V5, P85; PRENDIVILLE W, 2003, COLPOSCOPY MANAGEMEN; Raio L, 1997, OBSTET GYNECOL, V90, P978, DOI 10.1016/S0029-7844(97)00489-4; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; Sadler L, 2007, J PERINAT MED, V35, P5, DOI 10.1515/JPM.2007.001; Sasieni P., 2006, CURR DIAGN PATHOL, V12, P114, DOI [10.1016/j.cdip.2005.12.006, DOI 10.1016/J.CDIP.2005.12.006]; SINGER A, 2000, LOWER GENITAL TRACT; Soutter WP, 2006, INT J CANCER, V118, P2048, DOI 10.1002/ijc.21604; Steichen TJ, 2004, STATA J, V4, P124, DOI 10.1177/1536867X0400400203; Strander B, 2007, BMJ-BRIT MED J, V335, P1077, DOI 10.1136/bmj.39363.471806.BE; Sutton AJAK, 2000, METHODS METAANALYSIS; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Viikki M, 2000, ACTA ONCOL, V39, P71, DOI 10.1080/028418600431003; Wright TC, 2002, JAMA-J AM MED ASSOC, V287, P2120, DOI 10.1001/jama.287.16.2120	47	486	502	1	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2008	337	7673							a1284	10.1136/bmj.a1284	http://dx.doi.org/10.1136/bmj.a1284			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18801868	Green Published, hybrid			2022-12-28	WOS:000259798000036
J	Scott, JJ; Oh, DC; Yuceer, MC; Klepzig, KD; Clardy, J; Currie, CR				Scott, Jarrod J.; Oh, Dong-Chan; Yuceer, M. Cetin; Klepzig, Kier D.; Clardy, Jon; Currie, Cameron R.			Bacterial protection of beetle-fungus mutualism	SCIENCE			English	Article							SOUTHERN PINE-BEETLE		[Oh, Dong-Chan; Clardy, Jon] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Scott, Jarrod J.; Currie, Cameron R.] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yuceer, M. Cetin] Mississippi State Univ, Dept Forestry, Mississippi State, MS 39762 USA; [Klepzig, Kier D.] So Res Stn, US Dept Agr Forest Serv, Pineville, LA 71360 USA	Harvard University; Harvard Medical School; University of Wisconsin System; University of Wisconsin Madison; Mississippi State University; United States Department of Agriculture (USDA); United States Forest Service	Clardy, J (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.	jon_clardy@hms.harvard.edu; currie@bact.wisc.edu		Scott, Jarrod/0000-0001-9863-1318	U. S. Department of Agriculture; NIH; NSF; NATIONAL CANCER INSTITUTE [R01CA024487] Funding Source: NIH RePORTER	U. S. Department of Agriculture(United States Department of Agriculture (USDA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Adams, S. Adams, C. Booth, E. Caldera, J. Ensign, C. Hsu, Y. Kang, A. Lawrence, W. Monroe, P. Jeffreys, M. Palmisano, A. Pinto, M. Poulsen, K. Raffa, D. Stone, and E. Vallery for assistance. Support provided by the U. S. Department of Agriculture (C.R.C., K.D.K., and M.C.Y.), NIH (J.C.), and NSF (C.R.C.). We have a patent application submitted on mycangimycin.	Coombs JT, 2003, APPL ENVIRON MICROB, V69, P5603, DOI 10.1128/AEM.69.9.5603-5608.2003; Currie CR, 1999, NATURE, V398, P701, DOI 10.1038/19519; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Hofstetter RW, 2006, OECOLOGIA, V147, P679, DOI 10.1007/s00442-005-0312-0; Kaltenpoth M, 2005, CURR BIOL, V15, P475, DOI 10.1016/j.cub.2004.12.084; Klepzig KD, 1997, APPL ENVIRON MICROB, V63, P621, DOI 10.1128/AEM.63.2.621-627.1997; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019	7	347	368	7	155	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 3	2008	322	5898					63	63		10.1126/science.1160423	http://dx.doi.org/10.1126/science.1160423			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	355AE	18832638	Green Accepted			2022-12-28	WOS:000259680200035
J	Cars, O; Hogberg, LD; Murray, M; Nordberg, O; Sivaraman, S; Lundborg, CS; So, AD; Tomson, G				Cars, Otto; Hogberg, Liselotte Diaz; Murray, Mary; Nordberg, Olle; Sivaraman, Satya; Lundborg, Cecilia Stalsby; So, Anthony D.; Tomson, Goran			Meeting the challenge of antibiotic resistance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTIONS; TIME		[Cars, Otto] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Hogberg, Liselotte Diaz] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Murray, Mary] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia; [Nordberg, Olle] Dag Hammarskjold Fdn, Uppsala, Sweden; [Lundborg, Cecilia Stalsby] Karolinska Inst, Dept Publ Hlth Sci, Div Int Hlth IHCAR, Stockholm, Sweden; [Lundborg, Cecilia Stalsby] Nordic Sch Publ Hlth, Gothenburg, Sweden; [So, Anthony D.] Duke Univ, Program Global Hlth & Technol Access, Terry Sanford Inst Publ Policy, Durham, NC USA; [Tomson, Goran] Karolinska Inst, MMC, Stockholm, Sweden	Uppsala University; Uppsala University; University of South Australia	Cars, O (corresponding author), Uppsala Univ, Dept Med Sci, Uppsala, Sweden.	otto.cars@medsci.uu.se		Tomson, Goran/0000-0001-9222-3604; Stalsby Lundborg, Cecilia/0000-0001-6525-1861				[Anonymous], 2007, EXTENDING CURE POLIC; [Anonymous], 2001, WHO GLOB STRAT CONT; Awad AI, 2006, EUR J CLIN PHARMACOL, V62, P135, DOI 10.1007/s00228-005-0089-4; Bavestrello L, 2002, REV MED CHILE, V130, P1265; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; Butaye P, 2006, MICROBES INFECT, V8, P1891, DOI 10.1016/j.micinf.2005.12.020; Canton R, 2006, CURR OPIN MICROBIOL, V9, P466, DOI 10.1016/j.mib.2006.08.011; Carbon C, 2002, CLIN MICROBIOL INFEC, V8, P92, DOI 10.1046/j.1469-0691.8.s.2.8.x; Cars O, 2007, ESCMID NEWS, V2, P22; Chen Chih-Jung, 2005, Journal of Microbiology Immunology and Infection, V38, P376; Del Mar C, 2007, BMJ-BRIT MED J, V335, P407, DOI 10.1136/bmj.39307.642963.80; Dollman WB, 2005, MED J AUSTRALIA, V182, P617, DOI 10.5694/j.1326-5377.2005.tb06847.x; *EUR CDPC, 2007, ANN EP REP COMM DIS; Grigoryan L, 2006, EMERG INFECT DIS, V12, P452, DOI 10.3201/eid1203.050992; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; HARBARTH S, 2005, EMERG INFECT DIS, V11; Hawkey PM, 1998, LANCET, V351, P1298, DOI 10.1016/S0140-6736(98)22018-6; Huovinen P, 1998, BRIT MED J, V317, P613, DOI 10.1136/bmj.317.7159.613; Infectious Diseases Society of America, 2004, BAD BUGS NO DRUGS; Macfarlane J, 1997, BMJ-BRIT MED J, V315, P1211, DOI 10.1136/bmj.315.7117.1211; Molstad S, 2008, LANCET INFECT DIS, V8, P125, DOI 10.1016/S1473-3099(08)70017-3; Moran M, 2005, PLOS MED, V2, P828, DOI 10.1371/journal.pmed.0020302; Nasrin D, 2002, BRIT MED J, V324, P28, DOI 10.1136/bmj.324.7328.28; *NAT STAT, MRSA DEATHS DECR 200; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Outterson K, 2007, LANCET INFECT DIS, V7, P559, DOI 10.1016/S1473-3099(07)70188-3; Payne D, 2004, CURR OPIN MICROBIOL, V7, P435, DOI 10.1016/j.mib.2004.08.017; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; *REACT ACT ANT RES, 2007, BURD RES MULT GRAM N; Sjolund M, 2003, ANN INTERN MED, V139, P483, DOI 10.7326/0003-4819-139-6-200309160-00011; Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937; TREPKA M, 2001, PEDIATRICS, V107, P6; *WHO, 2000, REP INF DIS 2000 OV; World Health Organization, 2007, WORLD HLTH REP 2007; *WORLD HLTH ASS, 1998, EM OTH COMM DIS ANT; *WORLD HLTH ASS, 2005, IMPR CONT ANT RES; Zaidi AKM, 2005, LANCET, V365, P1175, DOI 10.1016/S0140-6736(05)71881-X; 2007, 21 CENTURY	38	103	106	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 27	2008	337	7672							a1438	10.1136/bmj.a1438	http://dx.doi.org/10.1136/bmj.a1438			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18801866				2022-12-28	WOS:000259797600036
J	Bryant, MJ; Hammond, KA; Bocian, KM; Rettig, MF; Miller, CA; Cardullo, RA				Bryant, M. J.; Hammond, K. A.; Bocian, K. M.; Rettig, M. F.; Miller, C. A.; Cardullo, R. A.			Assessment - School performance will fail to meet legislated benchmarks	SCIENCE			English	Editorial Material							ACCOUNTABILITY		[Bryant, M. J.; Hammond, K. A.; Miller, C. A.; Cardullo, R. A.] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Bocian, K. M.] Univ Calif Riverside, ALPHA Ctr, Riverside, CA 92521 USA; [Rettig, M. F.] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA; [Bryant, M. J.] Calif Inst Arts, Sch Crit Studies, Valencia, CA 91355 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Cardullo, RA (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	cardullo@ucr.edu	Cardullo, Richard/GVT-2950-2022	Cardullo, Richard/0000-0003-4104-6147				*CA DEP ED, 2007, 07098 CAL DEP ED; Chudowsky N., 2008, MANY STATES HAVE TAK; Cronin J., 2007, PROFICIENCY ILLUSION; *CTR ED POL, 2007, ANSW QUEST MATT MOST; FULLER B, 2007, ED RES, V36, P269; Kim J.S., 2005, ED RES, V34, P3, DOI DOI 10.3102/0013189X034008003; Kimmelman P.L., 2006, IMPLEMENTING NCLB CR; Linn Robert L., 2002, EDUC RESEARCHER, V31, P3; *NAT COMM EXC ED, 2003, NAT RISK IMP ED REF; Powers JM, 2003, EDUC POLICY, V17, P558, DOI 10.1177/0895904803256789; Resnick Lauren B., 2006, ED MEASUREMENT ISSUE, V25, P33; Russell M, 2004, TEACH COLL REC, V106, P2102, DOI 10.1111/j.1467-9620.2004.00429.x; Sadler PM, 2007, SCIENCE, V317, P457, DOI 10.1126/science.1144214; STULICH S, 2007, NATL ASSESSMENT TITL	14	5	6	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1781	1782		10.1126/science.1161033	http://dx.doi.org/10.1126/science.1161033			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	352MM	18818344				2022-12-28	WOS:000259501300020
J	McIvor, RA; Chapman, KR				McIvor, R. Andrew; Chapman, Kenneth R.			The coming of age of asthma guidelines	LANCET			English	Editorial Material							ACTING BETA-AGONISTS; SAFETY		[McIvor, R. Andrew] McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada; [Chapman, Kenneth R.] Univ Toronto, Asthma & Airway Ctr, Univ Hlth Network, Toronto, ON, Canada	McMaster University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	McIvor, RA (corresponding author), McMaster Univ, St Josephs Healthcare, Firestone Inst Resp Hlth, Hamilton, ON L8N 4A6, Canada.	amcivor@stjosham.on.ca						Bateman ED, 2008, EUR RESPIR J, V31, P143, DOI 10.1183/09031936.00138707; *BRIT THOR SOC, 2008, BRIT GUID MAN ASTHM; Chapman KR, 2008, EUR RESPIR J, V31, P320, DOI 10.1183/09031936.00039707; Ernst P, 2006, ANN INTERN MED, V145, P692, DOI 10.7326/0003-4819-145-9-200611070-00012; Graham ID, 2006, J CONTIN EDUC HEALTH, V26, P13, DOI 10.1002/chp.47; Guyatt G, 2006, CHEST, V129, P174, DOI 10.1378/chest.129.1.174; HARGREAVE FE, 1990, J ALLERGY CLIN IMMUN, V85, P1098, DOI 10.1016/0091-6749(90)90056-A; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; McIvor RA, 1998, AM J RESP CRIT CARE, V158, P924; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126	10	10	10	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1021	1022		10.1016/S0140-6736(08)61423-3	http://dx.doi.org/10.1016/S0140-6736(08)61423-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805317				2022-12-28	WOS:000259648500010
J	Hartwig, JF				Hartwig, John F.			Carbon-heteroatom bond formation catalysed by organometallic complexes	NATURE			English	Review							FORMING REDUCTIVE ELIMINATION; C-O BOND; CROSS-COUPLING REACTIONS; ARYL HALIDES; PALLADIUM(II)-CATALYZED EXCHANGE; ASYMMETRIC HYDROAMINATION; ISOMERIZATION-REACTIONS; AMIDATE COMPLEXES; METAL-COMPLEXES; H BONDS	At one time the synthetic chemist's last resort, reactions catalysed by transition metals are now the preferred method for synthesizing many types of organic molecule. A recent success in this type of catalysis is the discovery of reactions that form bonds between carbon and heteroatoms ( such as nitrogen, oxygen, sulphur, silicon and boron) via complexes of transition metals with amides, alkoxides, thiolates, silyl groups or boryl groups. The development of these catalytic processes has been supported by the discovery of new elementary reactions that occur at metal - heteroatom bonds and by the identification of factors that control these reactions. Together, these findings have led to new synthetic processes that are in daily use and have formed a foundation for the development of processes that are likely to be central to synthetic chemistry in the future.	[Hartwig, John F.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Hartwig, JF (corresponding author), Univ Illinois, Dept Chem, 600 S Mathews Ave, Urbana, IL 61801 USA.	jhartwig@uiuc.edu			NIGMS NIH HHS [R01 GM058108-12, R01 GM058108] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058108] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AIZAWA M, 1986, J CHEM SOC CHEM COMM, P1315, DOI 10.1039/c39860001315; Amin SB, 2007, J AM CHEM SOC, V129, P10102, DOI 10.1021/ja0740465; ARNDTSEN BA, 1995, ACCOUNTS CHEM RES, V28, P154, DOI 10.1021/ar00051a009; Beletskaya IP, 2004, COORDIN CHEM REV, V248, P2337, DOI 10.1016/j.ccr.2004.09.014; Bistri O, 2008, ANGEW CHEM INT EDIT, V47, P586, DOI 10.1002/anie.200704018; BOGER DL, 1984, TETRAHEDRON LETT, V25, P3175; BRYNDZA HE, 1988, CHEM REV, V88, P1163, DOI 10.1021/cr00089a009; CASALNUOVO AL, 1988, J AM CHEM SOC, V110, P6738, DOI 10.1021/ja00228a022; Chen HY, 2000, SCIENCE, V287, P1995, DOI 10.1126/science.287.5460.1995; Collman J.P., 1987, PRINCIPLES APPL ORGA; Corey E.J., 1995, LOGIC CHEM SYNTHESIS; Correa A, 2007, ANGEW CHEM INT EDIT, V46, P8862, DOI 10.1002/anie.200703299; Crabtree RH, 2005, ORGANOMETALLIC CHEMISTRY OF THE TRANSITION METALS, 4TH EDITION, P1, DOI 10.1002/0471718769; Culkin DA, 2004, ORGANOMETALLICS, V23, P3398, DOI 10.1021/om049726k; Davies DL, 2005, J AM CHEM SOC, V127, P13754, DOI 10.1021/ja052047w; de Vries JG, 2001, CAN J CHEM, V79, P1086, DOI 10.1139/v01-033; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; Dick AR, 2006, TETRAHEDRON, V62, P2439, DOI 10.1016/j.tet.2005.11.027; Dick AR, 2005, J AM CHEM SOC, V127, P12790, DOI 10.1021/ja0541940; Driver MS, 1997, J AM CHEM SOC, V119, P8232, DOI 10.1021/ja971057x; Driver MS, 1996, J AM CHEM SOC, V118, P7217, DOI 10.1021/ja960937t; FRANCIS JW, 1992, ORGANOMETALLICS, V11, P2832, DOI 10.1021/om00044a024; FRANCIS JW, 1991, ORGANOMETALLICS, V10, P3498, DOI 10.1021/om00056a019; Fujita K, 2006, J AM CHEM SOC, V128, P9044, DOI 10.1021/ja062333n; Fulton JR, 2002, ACCOUNTS CHEM RES, V35, P44, DOI 10.1021/ar000132x; GAGNE MR, 1989, J AM CHEM SOC, V111, P4108, DOI 10.1021/ja00193a056; GAGNE MR, 1992, J AM CHEM SOC, V114, P275, DOI 10.1021/ja00027a036; Giri R, 2005, ANGEW CHEM INT EDIT, V44, P2112, DOI 10.1002/anie.200462884; Goldman AS, 2006, SCIENCE, V312, P257, DOI 10.1126/science.1123787; Gott AL, 2008, CHEM COMMUN, P1422, DOI 10.1039/b718373a; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; GURAM AS, 1995, ANGEW CHEM INT EDIT, V34, P1348, DOI 10.1002/anie.199513481; Hamed O, 1997, J ORG CHEM, V62, P7082, DOI 10.1021/jo971051q; Hartwig J. F., 2002, HDB ORGANOPALLADIUM, V1, P1051; Hartwig J.F., 2002, MODERN ARENE CHEM, P107; Hartwig J. F., 2002, HDB ORGANOPALLADIUM, V1, P1097, DOI DOI 10.1002/0471212466.CH43; Hartwig JF, 2005, J AM CHEM SOC, V127, P2538, DOI 10.1021/ja045090c; Hartwig JF, 1999, J ORG CHEM, V64, P5575, DOI 10.1021/jo990408i; Hartwig JF, 1998, ACCOUNTS CHEM RES, V31, P852, DOI 10.1021/ar970282g; Hartwig JF, 2007, INORG CHEM, V46, P1936, DOI 10.1021/ic061926w; HASENHUETTL GL, 2005, KIRKOTHMER ENCY CHEM, DOI DOI 10.1002/0471238961.0601201908011905.A01.PUB2; Hayashi T, 2004, J AM CHEM SOC, V126, P3036, DOI 10.1021/ja031946m; Henry P. M., 2002, HDB ORGANOPALLADIUM; HILLHOUSE GL, 1984, J AM CHEM SOC, V106, P5472, DOI 10.1021/ja00331a015; Holland PL, 1999, COMMENT INORG CHEM, V21, P115, DOI 10.1080/02603599908020418; Hong S, 2004, ACCOUNTS CHEM RES, V37, P673, DOI 10.1021/ar040051r; Hoveyda AH, 2007, NATURE, V450, P243, DOI 10.1038/nature06351; Huheey J.E., 1993, INORGANIC CHEM; Hull KL, 2006, J AM CHEM SOC, V128, P7134, DOI 10.1021/ja061943k; Hultzsch KC, 2005, ADV SYNTH CATAL, V347, P367, DOI 10.1002/adsc.200404261; Ishiyama T, 2003, J ORGANOMET CHEM, V680, P3, DOI 10.1016/S0022-328X(03)00176-1; Ittel SD, 2000, CHEM REV, V100, P1169, DOI 10.1021/cr9804644; JEN KY, 1986, J CHEM SOC CHEM COMM, P1346, DOI 10.1039/c39860001346; JESKE G, 1985, J AM CHEM SOC, V107, P8091, DOI 10.1021/ja00312a050; Jira R., 2002, APPL HOMOGENEOUS CAT, P386; JONES WD, 1984, J AM CHEM SOC, V106, P1650, DOI 10.1021/ja00318a018; Kakiuchi F, 2003, ADV SYNTH CATAL, V345, P1077, DOI 10.1002/adsc.200303094; Kataoka N, 2002, J ORG CHEM, V67, P5553, DOI 10.1021/jo025732j; Kim JY, 2005, ORG LETT, V7, P1737, DOI 10.1021/ol050294z; King AO, 2004, TOP ORGANOMETAL CHEM, V6, P205; Knowles W.S., 2004, ASYMMETRIC CATALYSIS, P21; KOSUGI M, 1983, CHEM LETT, P927, DOI 10.1246/cl.1983.927; Labinger JA, 2002, NATURE, V417, P507, DOI 10.1038/417507a; Liu GS, 2007, J AM CHEM SOC, V129, P6328, DOI 10.1021/ja070424u; LOUIE J, 1995, TETRAHEDRON LETT, V36, P3609, DOI 10.1016/0040-4039(95)00605-C; Mann G, 1998, J AM CHEM SOC, V120, P9205, DOI 10.1021/ja981428p; Mann G, 1999, J AM CHEM SOC, V121, P3224, DOI 10.1021/ja984321a; McQuade DT, 2000, CHEM REV, V100, P2537, DOI 10.1021/cr9801014; Mecking S, 2001, ANGEW CHEM INT EDIT, V40, P534; Muci AR, 2002, TOP CURR CHEM, V219, P131, DOI 10.1007/3-540-45313-X_5; Muller T. E., 2003, ENCY CATALYSIS, V3, P518; Nakhla JS, 2006, J AM CHEM SOC, V128, P2893, DOI 10.1021/ja057489m; Nishiyama M, 1998, TETRAHEDRON LETT, V39, P617, DOI 10.1016/S0040-4039(97)10659-1; Ojima I, 1998, CHEM FUNCT, V2, P1687, DOI 10.1002/0470857250.ch29; Pawlikowski AV, 2007, J AM CHEM SOC, V129, P10382, DOI 10.1021/ja069191h; Periana RA, 1998, SCIENCE, V280, P560, DOI 10.1126/science.280.5363.560; Polse JL, 1998, J AM CHEM SOC, V120, P13405, DOI 10.1021/ja981489n; Roesky PW, 2003, ANGEW CHEM INT EDIT, V42, P2708, DOI 10.1002/anie.200301637; SATO M, 1986, J CHEM SOC CHEM COMM, P873, DOI 10.1039/c39860000873; Sen A, 1998, ACCOUNTS CHEM RES, V31, P550, DOI 10.1021/ar970290x; Shen QL, 2006, J AM CHEM SOC, V128, P10028, DOI 10.1021/ja064005t; Shen QL, 2005, ANGEW CHEM INT EDIT, V44, P1371, DOI 10.1002/anie.200462629; Shilov AE, 1997, CHEM REV, V97, P2879, DOI 10.1021/cr9411886; Singer RA, 2006, TETRAHEDRON LETT, V47, P3727, DOI 10.1016/j.tetlet.2006.03.132; Stahl SS, 1998, ANGEW CHEM INT EDIT, V37, P2181, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2180::AID-ANIE2180>3.0.CO;2-A; Stambuli JR, 2007, ANGEW CHEM INT EDIT, V46, P7674, DOI 10.1002/anie.200702809; Stambuli JP, 2002, ANGEW CHEM INT EDIT, V41, P4746, DOI 10.1002/anie.200290036; Trend RM, 2005, J AM CHEM SOC, V127, P17778, DOI 10.1021/ja055534k; WALSH PJ, 1992, J AM CHEM SOC, V114, P1708, DOI 10.1021/ja00031a026; WENZEL TT, 1986, J AM CHEM SOC, V108, P4856, DOI 10.1021/ja00276a025; Whitfield SR, 2007, J AM CHEM SOC, V129, P15142, DOI 10.1021/ja077866q; Williams BS, 2001, J AM CHEM SOC, V123, P2576, DOI 10.1021/ja003366k; Wolfe JP, 2007, EUR J ORG CHEM, V2007, P571, DOI 10.1002/ejoc.200600767; Wolfe JP, 1996, J AM CHEM SOC, V118, P7215, DOI 10.1021/ja9608306; Wood MC, 2007, ANGEW CHEM INT EDIT, V46, P354, DOI 10.1002/anie.200603017; Zapf A, 2004, CHEM COMMUN, P38, DOI 10.1039/b311268n; Zhao J, 2005, SCIENCE, V307, P1080, DOI 10.1126/science.1109389; Zhao PJ, 2006, J AM CHEM SOC, V128, P9642, DOI 10.1021/ja063347w; Zhao PJ, 2005, J AM CHEM SOC, V127, P12066, DOI 10.1021/ja052473h	99	777	785	8	338	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					314	322		10.1038/nature07369	http://dx.doi.org/10.1038/nature07369			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800130	Green Accepted			2022-12-28	WOS:000259265200032
J	Rosato, M; Laverack, G; Grabman, LH; Tripathy, P; Nair, N; Mwansambo, C; Azad, K; Morrison, J; Bhutta, Z; Perry, H; Rifkin, S; Costello, A				Rosato, Mikey; Laverack, Glenn; Grabman, Lisa Howard; Tripathy, Prasanta; Nair, Nirmala; Mwansambo, Charles; Azad, Kishwar; Morrison, Joanna; Bhutta, Zulfiqar; Perry, Henry; Rifkin, Susan; Costello, Anthony			Alma-Ata: Rebirth and revision 5 - Community participation: lessons for maternal, newborn, and child health	LANCET			English	Article							SURVIVAL 1; MORTALITY; CARE; INTERVENTION; MANAGEMENT; EDUCATION; EMPOWERMENT; PERCEPTIONS; BANGLADESH; STRATEGIES	Primary health care was ratified as the health policy of WHO member states in 1978.(1) Participation in health care was a key principle in the Alma-Ata Declaration. In developing countries, antenatal, delivery, and postnatal experiences for women usually take place in communities rather than health facilities. Strategies to improve maternal and child health should therefore involve the community as a complement to any facility-based component. The fourth article of the Declaration stated that, "people have the right and duty to participate individually and collectively in the planning and implementation of their health care", and the seventh article stated that primary health care "requires and promotes maximum community and individual self-reliance and participation in the planning, organization, operation and control of primary health care". But is community participation an essential prerequisite for better health outcomes or simply a useful but non-essential companion to the delivery of treatments and preventive health education? Might it be essential only as a transitional strategy: crucial for the poorest and most deprived populations but largely irrelevant once health care systems are established? Or is the failure to incorporate community participation into large-scale primary health care programmes a major reason for why we are failing to achieve Millennium Development Goals (MDGs) 4 and 5 for reduction of maternal and child mortality?	[Rosato, Mikey; Morrison, Joanna; Costello, Anthony] UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London WC1N 1EH, England; [Laverack, Glenn] Univ Auckland, Dept Social & Community Hlth, Sch Populat Hlth, Auckland 1, New Zealand; [Tripathy, Prasanta; Nair, Nirmala] Ekjut Project, Chakradhapur, Jharkhand, India; [Mwansambo, Charles] Univ Malawi, Dept Paediat, Kamuzu Cent Hosp, Lilongwe, Malawi; [Azad, Kishwar] Bangladesh Diabet Assoc, Perinatal Care Project, Dhaka, Bangladesh; [Bhutta, Zulfiqar] Aga Khan Univ, Dept Pediat, Karachi, Pakistan; [Perry, Henry] Future Generat, Franklin, WV USA	University of London; University College London; University of Auckland; University of Malawi; Aga Khan University	Costello, A (corresponding author), UCL, Inst Child Hlth, Ctr Int Hlth & Dev, London WC1N 1EH, England.	a.costello@ich.ucl.ac.uk	Rifkin, Susan B/T-7863-2019	Rifkin, Susan B/0000-0001-5482-7829; Morrison, Joanna/0000-0002-9241-8863; Laverack, Glenn/0000-0001-6784-234X				Ali M, 2001, SOC SCI MED, V52, P267, DOI 10.1016/S0277-9536(00)00120-9; [Anonymous], 1998, Health Millions, V24, P29; [Anonymous], 1978, INT C PRIM HLTH CAR; Arole M., 1975, Health by the people, P70; Arole M, 2002, JUST LASTING CHANGE, P150; Ashworth A, 2006, FOOD NUTR BULL, V27, pS24, DOI 10.1177/15648265060273S303; BANG A, 2002, JUST LASTING CHANGE, P161; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BANG AT, 1990, LANCET, V336, P201, DOI 10.1016/0140-6736(90)91733-Q; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhandari N, 2004, J NUTR, V134, P2342; Bhattacharyya K, 2001, COMMUNITY HLTH WORKE; Bhutta ZA, 2008, B WORLD HEALTH ORGAN, V86, P452, DOI 10.2471/BLT.07.045849; Binka FN, 1996, TROP MED INT HEALTH, V1, P147; Bolam A, 1998, BRIT MED J, V316, P805, DOI 10.1136/bmj.316.7134.805; Borghi J, 2005, LANCET, V366, P1882, DOI 10.1016/S0140-6736(05)67758-6; Britton C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001141.pub3; Bryce J, 2005, HLTH POLICY PLAN S1, V20, pi5, DOI [10.1093/heapol/czi055, DOI 10.1093/HEAPOL/CZI055]; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; BYRANT JH, IN PRESS ENCY PUBLIC; Chowdhury A.M.R., 1996, SIMPLE SOLUTION TEAC; COE AB, 2001, HLTH RIGHTS REALITIE; *CORE GROUP, SCAL SCAL CORE GROUP; Costello A, 2006, LANCET, V368, P1477, DOI 10.1016/S0140-6736(06)69388-4; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; FAWZI WW, 1993, JAMA-J AM MED ASSOC, V269, P898, DOI 10.1001/jama.269.7.898; Freedman LP, 2007, LANCET, V370, P1383, DOI 10.1016/S0140-6736(07)61581-5; GEE D, PARK SCHEME SEEKS MO; GONZALES F, SCALING WARMI PROJEC; GOTTLIEB J, 2007, CASE 4 REDUCING CHIL; GRYBOSKI N, 2006, HLTH B POPULATION RE, V3; Hadi A, 2003, B WORLD HEALTH ORGAN, V81, P183; Hill K, 2007, LANCET, V370, P1311, DOI 10.1016/S0140-6736(07)61572-4; Howard-Grabman L, 2007, DEMYSTIFYING COMMUNI; HOWARDGRABMAN I, 2003, MOBILISE COMMUNITIES; HOWARDGRABMAN L, 2002, SAVE CHILDREN WARMI; HUSEIN K, 1993, SOC SCI MED, V36, P585, DOI 10.1016/0277-9536(93)90055-9; ISRAEL BA, 1994, HEALTH EDUC QUART, V21, P149, DOI 10.1177/109019819402100203; JACKSON T, 1989, COMMUNITY HEALTH ST, V13, P66, DOI 10.1111/j.1753-6405.1989.tb00178.x; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Klawiter M, 2004, SOCIOL HEALTH ILL, V26, P845, DOI 10.1111/j.1467-9566.2004.421_1.x; LABONTE R, 1998, COMMUNITY DEV APPROA; Labonte R, 1990, CANADIAN REV SOCIAL, V26, P64; Labonte R., 1993, HLTH PROMOTION EMPOW; LAVERACK G, 1999, THESIS DEAKIN U MELB; Laverack Glen, 2004, HLTH PROMOTION PRACT; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lengeler C, 2004, COCHRANE DB SYST REV, V2; LEVINE R, 2007, WHAT WORKS WORKING G; Litsios S, 2004, AM J PUBLIC HEALTH, V94, P1884, DOI 10.2105/AJPH.94.11.1884; Litsios S, 2002, INT J HEALTH SERV, V32, P709, DOI 10.2190/RP8C-L5UB-4RAF-NRH2; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; MARCHIONE T, 1999, SCALING SCALING OVER; Morrison Joanna, 2005, BMC Pregnancy Childbirth, V5, P6, DOI 10.1186/1471-2393-5-6; MORROW A, 2003, COMMUNITY BASED STRA; O'Rourke K, 1998, Rev Panam Salud Publica, V3, P9; Renkert S, 2001, HEALTH PROMOT INT, V16, P381, DOI 10.1093/heapro/16.4.381; Rifkin S., 2001, PARTNERS PLANNING; RISSEL C, 1994, HEALTH PROMOT INT, V9, P39, DOI 10.1093/heapro/9.1.39; Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X; Rosato M, 2006, LANCET, V368, P1180, DOI 10.1016/S0140-6736(06)69475-0; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Sidel V. W., 1975, Health by the people, P1; Taylor C., 2002, JUST LASTING CHANGE; *UNICEF, 2007, STAT WORLDS CHILDR 2, P28; Uvin P, 1996, HUM ORGAN, V55, P344, DOI 10.17730/humo.55.3.v44334362401041t; Wafula EM, 2000, E AFR MED J, V77, P37; Wallerstein N, 1992, Am J Health Promot, V6, P197; WALSH JA, 1979, NEW ENGL J MED, V301, P967, DOI 10.1056/NEJM197911013011804; Walt G, 1990, COMMUNITY HLTH WORKE; WERE M, 2007, JUST LASTING CHANGE, P168; WERNER D, VILLAGE HLTH WORKER; Weston J., 1997, QUESTIONING SOLUTION	76	220	221	0	21	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					962	971		10.1016/S0140-6736(08)61406-3	http://dx.doi.org/10.1016/S0140-6736(08)61406-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790319				2022-12-28	WOS:000259266900036
J	Sullivan, E				Sullivan, Erin			The art of medicine - Melancholy, medicine, and the arts	LANCET			English	Editorial Material									[Sullivan, Erin] UCL, Wellcome Trust Ctr Hist Med, London NW1 2BE, England	University of London; University College London	Sullivan, E (corresponding author), UCL, Wellcome Trust Ctr Hist Med, London NW1 2BE, England.	erin.sullivan@ucl.ac.uk						Jamison K. R., 1993, TOUCHED FIRE MANIC D, DOI [10.4135/9781483349985.n388, DOI 10.4135/9781483349985.N388]; Klibansky Raymond, 1964, SATURN MELANCHOLY ST; Radden J, 2000, NATURE MELANCHOLY AR; SIMONTON DK, 2005, PSYCHIAT TIMES  0601	4	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					884	885		10.1016/S0140-6736(08)61385-9	http://dx.doi.org/10.1016/S0140-6736(08)61385-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18795420				2022-12-28	WOS:000259266900015
J	[Anonymous]				[Anonymous]			A renaissance in primary health care	LANCET			English	Editorial Material																			0	9	10	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					863	863						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349FO	18790289				2022-12-28	WOS:000259266900001
J	Steinmetz, T; Wilken, T; Araujo-Hauck, C; Holzwarth, R; Hansch, TW; Pasquini, L; Manescau, A; D'Odorico, S; Murphy, MT; Kentischer, T; Schmidt, W; Udem, T				Steinmetz, Tilo; Wilken, Tobias; Araujo-Hauck, Constanza; Holzwarth, Ronald; Haensch, Theodor W.; Pasquini, Luca; Manescau, Antonio; D'Odorico, Sandro; Murphy, Michael T.; Kentischer, Thomas; Schmidt, Wolfgang; Udem, Thomas			Laser frequency combs for astronomical observations	SCIENCE			English	Article							FINE-STRUCTURE CONSTANT; COSMOLOGICAL PARAMETERS; REDSHIFT; DECELERATION; CALIBRATION; SUPERNOVAE; PRECISION; COMPANION; GALAXIES	A direct measurement of the universe's expansion history could be made by observing in real time the evolution of the cosmological redshift of distant objects. However, this would require measurements of Doppler velocity drifts of similar to 1 centimeter per second per year, and astronomical spectrographs have not yet been calibrated to this tolerance. We demonstrated the first use of a laser frequency comb for wavelength calibration of an astronomical telescope. Even with a simple analysis, absolute calibration is achieved with an equivalent Doppler precision of similar to 9 meters per second at similar to 1.5 micrometers- beyond state- of- the- art accuracy. We show that tracking complex, time- varying systematic effects in the spectrograph and detector system is a particular advantage of laser frequency comb calibration. This technique promises an effective means for modeling and removal of such systematic effects to the accuracy required by future experiments to see direct evidence of the universe's putative acceleration.	[Steinmetz, Tilo; Wilken, Tobias; Holzwarth, Ronald; Haensch, Theodor W.; Udem, Thomas] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Steinmetz, Tilo; Holzwarth, Ronald] Menlo Syst GmbH, D-82152 Martinsried, Germany; [Araujo-Hauck, Constanza; Pasquini, Luca; Manescau, Antonio; D'Odorico, Sandro] European So Observ, D-85748 Garching, Germany; [Murphy, Michael T.] Swinburne Univ Technol, Ctr Astrophys & Supercomp, Hawthorn, Vic 3122, Australia; [Kentischer, Thomas; Schmidt, Wolfgang] Kiepenheuer Inst Sonnenphys, D-79104 Freiburg, Germany	Max Planck Society; Menlo Systems GmbH; European Southern Observatory; Swinburne University of Technology; Kiepenheuer Institut fur Sonnenphysik	Udem, T (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	thu@mpq.mpg.de	Schmidt, Wolfgang/A-7272-2015; Murphy, Michael/B-8832-2008	Murphy, Michael/0000-0002-7040-5498				BAHCALL JN, 1965, ASTROPHYS J, V142, P1677, DOI 10.1086/148460; Braje DA, 2008, EUR PHYS J D, V48, P57, DOI 10.1140/epjd/e2008-00099-9; Chand H, 2004, ASTRON ASTROPHYS, V417, P853, DOI 10.1051/0004-6361:20035701; Levshakov SA, 2006, ASTRON ASTROPHYS, V449, P879, DOI 10.1051/0004-6361:20053827; Li CH, 2008, NATURE, V452, P610, DOI 10.1038/nature06854; Liske J, 2008, MON NOT R ASTRON SOC, V386, P1192, DOI 10.1111/j.1365-2966.2008.13090.x; Loeb A, 1998, ASTROPHYS J, V499, pL111, DOI 10.1086/311375; Lovis C, 2007, ASTRON ASTROPHYS, V468, P1115, DOI 10.1051/0004-6361:20077249; LOVIS C, 2006, P SOC PHOTO-OPT INS, V6269, pP6909; Marcy GW, 1996, ASTROPHYS J, V464, pL147, DOI 10.1086/310096; Murphy MT, 2007, MON NOT R ASTRON SOC, V380, P839, DOI 10.1111/j.1365-2966.2007.12147.x; Murphy MT, 2003, MON NOT R ASTRON SOC, V345, P609, DOI 10.1046/j.1365-8711.2003.06970.x; Peacock JA, 2001, NATURE, V410, P169, DOI 10.1038/35065528; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Reinhold E, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.151101; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; SANDAGE A, 1962, ASTROPHYS J, V136, P319, DOI 10.1086/147385; SCHMIDT PO, IN PRESS ESO INSTR C; Schroter E. H., 1985, VISTAS ASTRON, V28, P519; SIZER T, 1989, IEEE J QUANTUM ELECT, V25, P97, DOI 10.1109/3.16246; Spergel DN, 2003, ASTROPHYS J SUPPL S, V148, P175, DOI 10.1086/377226; THOMPSON RI, 1975, ASTROPHYS LETT COMM, V16, P3; Udem T, 2002, NATURE, V416, P233, DOI 10.1038/416233a; Udem T, 1999, PHYS REV LETT, V82, P3568, DOI 10.1103/PhysRevLett.82.3568; Webb JK, 1999, PHYS REV LETT, V82, P884, DOI 10.1103/PhysRevLett.82.884; [No title captured]	29	480	501	4	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 5	2008	321	5894					1335	1337		10.1126/science.1161030	http://dx.doi.org/10.1126/science.1161030			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	344GG	18772434	Green Submitted			2022-12-28	WOS:000258914300044
J	Sjolie, AK; Klein, R; Porta, M; Orchard, T; Fuller, J; Parving, HH; Bilous, R; Chaturvedi, N				Sjolie, Anne Katrin; Klein, Ronald; Porta, Massimo; Orchard, Trevor; Fuller, John; Parving, Hans Henrik; Bilous, Rudy; Chaturvedi, Nish		DIRECT Programme Study Grp	Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial	LANCET			English	Article							ENDOTHELIAL GROWTH-FACTOR; BLOOD-PRESSURE CONTROL; ANGIOTENSIN-II; RISK-FACTORS; MORTALITY; LOSARTAN; DISEASE; ARTERY; RENIN; HYPERTENSION	Background Diabetic retinopathy remains a leading cause of visual loss in people of working age. We examined whether candesartan treatment could slow the progression and, secondly, induce regression of retinopathy in people with type 2 diabetes. Methods We did a randomised, double-blind, parallel-group, placebo-controlled trial in 309 centres worldwide. We recruited normoalbuminuric, normotensive, or treated hypertensive people with type 2 diabetes with mild to moderately severe retinopathy and assigned them to candesartan 16 mg once a day or placebo. After a month, the dose was doubled to 32 mg once per day. Investigators and patients were unaware of the treatment allocation status. Progression of retinopathy was the primary endpoint, and regression was a secondary endpoint. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT00252694. Findings 1905 participants (aged 37-75 years) were randomised to candesartan (n=951) or placebo (n=954). 161 (17%) patients in the candesartan group and 182 (19%) in the placebo group had progression of retinopathy by three steps or more on the Early Treatment Diabetic Retinopathy Study scale. The risk of progression of retinopathy was non-significantly reduced by 13% in patients on candesartan compared with those on placebo (hazard ratio [HR] 0.87, 95% CI 0.70-1.08, p=0.20). Regression on active treatment was increased by 34% (1.34, 1.08-1.68, p=0.009). HRs were not attenuated by adjustment for baseline risk factors or changes in blood pressure during the trial. An overall change towards less severe retinopathy by the end of the trial was observed in the candesartan group (odds 1.17, 95% CI 1.05-1.30, p=0.003). Adverse events did not differ between the treatment groups. Interpretation Treatment with candesartan in type 2 diabetic patients with mild to moderate retinopathy might induce improvement of retinopathy.	[Sjolie, Anne Katrin] Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark; [Klein, Ronald] Univ Wisconsin, Dept Ophthalmol & Visual Sci, Madison, WI USA; [Porta, Massimo] Univ Turin, Dept Internal Med, Turin, Italy; [Orchard, Trevor] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15261 USA; [Fuller, John] UCL, Dept Epidemiol & Publ Hlth, London, England; [Parving, Hans Henrik] Copenhagen Univ Hosp, Dept Med Endocrinol, Copenhagen, Denmark; [Bilous, Rudy] S Cleveland Hosp, Audrey Collins Teaching Unit, Middlesbrough, Cleveland, England; [Chaturvedi, Nish] Imperial Coll Healthcare NHS Trust, Int Ctr Circulatory Hlth, Natl Heart & Lung Inst, London, England	University of Southern Denmark; Odense University Hospital; University of Wisconsin System; University of Wisconsin Madison; University of Turin; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of London; University College London; University of Copenhagen; Imperial College London	Sjolie, AK (corresponding author), Odense Univ Hosp, Dept Ophthalmol, DK-5000 Odense, Denmark.	A.K.Sjoelie@ouh.regionsyddanmark.dk	Schäffler, Andreas/W-2384-2019; Aldington, Steve J/G-7828-2012; Lyudmila, Suplotova A/J-3596-2014; Dagdelen, Selcuk/A-9432-2017; Anděl, Michal/E-4305-2012; Porta, Massimo/G-6146-2011; Chaturvedi, Nishi/C-7761-2013; Dedov, Ivan I/D-3729-2014	Aldington, Steve J/0000-0003-1808-3580; Lyudmila, Suplotova A/0000-0001-9253-8075; Dagdelen, Selcuk/0000-0002-0513-1750; Dedov, Ivan I/0000-0002-8175-7886; rossing, peter/0000-0002-1531-4294; orchard, trevor/0000-0001-9552-3215; kerlan, veronique/0000-0001-8105-6628; Keymeulen, Bart/0000-0002-8671-4527; Porta, Massimo/0000-0002-3407-6017; Bek, Toke/0000-0002-0409-2534; Klein, Ronald/0000-0002-4428-6237	AstraZeneca; Takeda	AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd)	This study as jointly funded by AstraZeneca and Takeda. We thank the team at the Retinopathy Grading Centre, Imperial College London, specifically Steve Aldington.	Aiello LP, 1998, DIABETES CARE, V21, P143, DOI 10.2337/diacare.21.1.143; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Alioum A, 1996, BIOMETRICS, V52, P512, DOI 10.2307/2532891; [Anonymous], 1978, Ophthalmology, V85, P82; [Anonymous], 1991, Ophthalmology, V98, P823; [Anonymous], 1991, Ophthalmology, V98, P786; Ariff B, 2006, STROKE, V37, P2381, DOI 10.1161/01.STR.0000236839.69658.c5; Belcher G, 1997, J HUM HYPERTENS, V11, pS85; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Cuspidi C, 2002, J HYPERTENS, V20, P2293, DOI 10.1097/00004872-200211000-00030; DEINUM J, 1990, ENDOCRINOLOGY, V126, P1673, DOI 10.1210/endo-126-3-1673; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Funatsu H, 2002, BRIT J OPHTHALMOL, V86, P311, DOI 10.1136/bjo.86.3.311; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Gerstein HC, 2000, LANCET, V355, P253; Grann M, 2005, INT J LAW PSYCHIAT, V28, P442, DOI 10.1016/j.ijlp.2004.03.011; Henricsson M, 1997, DIABETIC MED, V14, P576, DOI 10.1002/(SICI)1096-9136(199707)14:7<576::AID-DIA385>3.0.CO;2-G; Julius S, 2006, NEW ENGL J MED, V354, P1685, DOI 10.1056/NEJMoa060838; Klein R, 1999, ARCH OPHTHALMOL-CHIC, V117, P1487; Knudsen ST, 2003, J INTERN MED, V254, P147, DOI 10.1046/j.1365-2796.2003.01192.x; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Matthews DR, 2004, ARCH OPHTHALMOL-CHIC, V122, P1631; Moravski CJ, 2000, HYPERTENSION, V36, P1099, DOI 10.1161/01.HYP.36.6.1099; Nagisa Y, 2001, DIABETOLOGIA, V44, P883, DOI 10.1007/s001250100556; Nakamura H, 2005, EUR J PHARMACOL, V512, P239, DOI 10.1016/j.ejphar.2005.02.047; OBRIEN RG, P 31 ANN SAS US GROU; Ohno T, 2008, ANN THORAC SURG, V85, P681, DOI 10.1016/j.athoracsur.2007.07.066; Ohno T, 2007, ANN THORAC SURG, V84, P1474, DOI 10.1016/j.athoracsur.2007.06.029; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Prevost G, 2005, DIABETES METAB, V31, P479, DOI 10.1016/S1262-3636(07)70219-7; Rajala U, 2000, DIABETES CARE, V23, P957, DOI 10.2337/diacare.23.7.957; Ruggenenti P, 2004, NEW ENGL J MED, V351, P1941, DOI 10.1056/NEJMoa042167; Sarlos S, 2005, INVEST OPHTH VIS SCI, V46, P1069, DOI 10.1167/iovs.04-0885; Schrier RW, 2002, KIDNEY INT, V61, P1086, DOI 10.1046/j.1523-1755.2002.00213.x; Sjolie AK, 2002, J RENIN-ANGIO-ALDO S, V3, P255; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006257; Sun JG, 2005, SCAND J STAT, V32, P49, DOI 10.1111/j.1467-9469.2005.00414.x; Sundell J, 2004, DIABETOLOGIA, V47, P725, DOI 10.1007/s00125-004-1340-8; Svensson P, 2001, HYPERTENSION, V38, pE28, DOI 10.1161/hy1101.099502; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Warnold I, 2005, J RENIN-ANGIO-ALDO S, V6, P25; Wellner JA, 1997, J AM STAT ASSOC, V92, P945, DOI 10.2307/2965558; *WHO, 2006, DIAB FACT SHEET NUMB; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275	48	339	354	1	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 18	2008	372	9647					1385	1393		10.1016/S0140-6736(08)61411-7	http://dx.doi.org/10.1016/S0140-6736(08)61411-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	362WP	18823658				2022-12-28	WOS:000260228200024
J	Wilson, MD; Barbosa-Morais, NL; Schmidt, D; Conboy, CM; Vanes, L; Tybulewicz, VLJ; Fisher, EMC; Tavare, S; Odom, DT				Wilson, Michael D.; Barbosa-Morais, Nuno L.; Schmidt, Dominic; Conboy, Caitlin M.; Vanes, Lesley; Tybulewicz, Victor L. J.; Fisher, Elizabeth M. C.; Tavare, Simon; Odom, Duncan T.			Species-specific transcription in mice carrying human chromosome 21	SCIENCE			English	Article							FACTOR-BINDING SITES; HUMAN GENOME; HISTONE-H3 LYSINE-4; EVO-DEVO; EVOLUTION; CHROMATIN; RECOGNITION; RESOLUTION; REVEALS; DOMAIN	Homologous sets of transcription factors direct conserved tissue-specific gene expression, yet transcription factor-binding events diverge rapidly between closely related species. We used hepatocytes from an aneuploid mouse strain carrying human chromosome 21 to determine, on a chromosomal scale, whether interspecies differences in transcriptional regulation are primarily directed by human genetic sequence or mouse nuclear environment. Virtually all transcription factor-binding locations, landmarks of transcription initiation, and the resulting gene expression observed in human hepatocytes were recapitulated across the entire human chromosome 21 in the mouse hepatocyte nucleus. Thus, in homologous tissues, genetic sequence is largely responsible for directing transcriptional programs; interspecies differences in epigenetic machinery, cellular environment, and transcription factors themselves play secondary roles.	[Wilson, Michael D.; Barbosa-Morais, Nuno L.; Schmidt, Dominic; Tavare, Simon; Odom, Duncan T.] Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Cambridge CB2 0RE, England; [Barbosa-Morais, Nuno L.; Schmidt, Dominic; Tavare, Simon; Odom, Duncan T.] Hutchison MRC Res Ctr, Dept Oncol, Cambridge CB2 0XZ, England; [Conboy, Caitlin M.] Univ Minnesota, Sch Med, Med Sci Training Program, Minneapolis, MN 55455 USA; [Vanes, Lesley; Tybulewicz, Victor L. J.] Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England; [Fisher, Elizabeth M. C.] UCL, Neurol Inst, London WC1N 3BG, England; [Tavare, Simon] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge CB3 0WA, England	Cancer Research UK; CRUK Cambridge Institute; University of Cambridge; University of Minnesota System; University of Minnesota Twin Cities; MRC National Institute for Medical Research; University of London; University College London; University of Cambridge	Odom, DT (corresponding author), Li Ka Shing Ctr, Canc Res UK, Cambridge Res Inst, Robinson Way, Cambridge CB2 0RE, England.	duncan.odom@cancer.org.uk	Barbosa-Morais, Nuno L/I-2743-2013; Wilson, Michael D/K-6294-2014; Fisher, Elizabeth MC/C-2168-2008; Pillay, Nischalan/F-9536-2012	Barbosa-Morais, Nuno L/0000-0002-1215-0538; Wilson, Michael D/0000-0002-4015-3066; Fisher, Elizabeth MC/0000-0003-2850-9936; Tybulewicz, Victor/0000-0003-2439-0798; Conboy, Caitlin/0000-0001-8280-056X; Odom, Duncan/0000-0001-6201-5599	European Research Council; Royal Society Wolfson Research Merit Award; Hutchison Whampoa; Medical Research Council; Wellcome Trust; University of Cambridge; Cancer Research U.K.; Medical Research Council [MC_U117527252, G0601056] Funding Source: researchfish; MRC [MC_U117527252, G0601056] Funding Source: UKRI	European Research Council(European Research Council (ERC)European Commission); Royal Society Wolfson Research Merit Award(Royal Society of London); Hutchison Whampoa; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); University of Cambridge(University of Cambridge); Cancer Research U.K.(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to E. Jacobsen, R. Stark, I. Spiteri, B. Liu, J. Marioni, A. Lynch, J. Hadfield, N. Matthews, the Cambridge Research Institute (CRI) Genomics Core, CRI Bioinformatics Core, and Camgrid for technical assistance, and B. Gottgens and J. Ferrer for insightful advice. Supported by the European Research Council (D.T.O.); Royal Society Wolfson Research Merit Award (S.T.); Hutchison Whampoa (D.T.O., ST); Medical Research Council (E.F.,VT); Wellcome Trust (E.F., V.T.); University of Cambridge (D.T.O., D.S., N.B.M., S.T.); and Cancer Research U.K. (D.T.O., M.D.W., N.B.M., S.T., D.S.). Data deposited under ArrayExpress accession numbers E-TABM-473 and E-TABM-474. M.D.W., N.B.M., D.S., D.T.O., and C.M.C. designed and performed experiments; N.B.M., M.D.W., and D.S. analyzed the data; L.V., V.T., M.D.W., and E.F. created, prepared, and provided Tc1 mouse tissues; and M.D.W., N.B.M., D.T.O., and S.T. wrote the manuscript. D.T.O. oversaw the work. The authors declare no competing interests.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Borneman AR, 2007, SCIENCE, V317, P815, DOI 10.1126/science.1140748; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; Davidson EH, 2006, SCIENCE, V311, P796, DOI 10.1126/science.1113832; Eeckhoute J, 2003, NUCLEIC ACIDS RES, V31, P6640, DOI 10.1093/nar/gkg850; Elnitski L, 2006, GENOME RES, V16, P1455, DOI 10.1101/gr.4140006; Gilad Y, 2006, NATURE, V440, P242, DOI 10.1038/nature04559; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Kampa D, 2004, GENOME RES, V14, P331, DOI 10.1101/gr.2094104; Khaitovich P, 2005, SCIENCE, V309, P1850, DOI 10.1126/science.1108296; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Moses AM, 2006, PLOS COMPUT BIOL, V2, P1219, DOI 10.1371/journal.pcbi.0020130; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Park CC, 2008, NAT GENET, V40, P421, DOI 10.1038/ng.113; Rada-Iglesias A, 2005, HUM MOL GENET, V14, P3435, DOI 10.1093/hmg/ddi378; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Sladek FM, 1999, MOL CELL BIOL, V19, P6509; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Zaret KS, 2000, MECH DEVELOP, V92, P83, DOI 10.1016/S0925-4773(99)00326-3	28	214	218	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 17	2008	322	5900					434	438		10.1126/science.1160930	http://dx.doi.org/10.1126/science.1160930			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360YK	18787134	Green Accepted			2022-12-28	WOS:000260094500045
J	Ni, KK; Ospelkaus, S; de Miranda, MHG; Pe'er, A; Neyenhuis, B; Zirbel, JJ; Kotochigova, S; Julienne, PS; Jin, DS; Ye, J				Ni, K. -K.; Ospelkaus, S.; de Miranda, M. H. G.; Pe'er, A.; Neyenhuis, B.; Zirbel, J. J.; Kotochigova, S.; Julienne, P. S.; Jin, D. S.; Ye, J.			A high phase-space-density gas of polar molecules	SCIENCE			English	Article							DIPOLAR GASES; STATE	A quantum gas of ultracold polar molecules, with long-range and anisotropic interactions, not only would enable explorations of a large class of many-body physics phenomena but also could be used for quantum information processing. We report on the creation of an ultracold dense gas of potassium-rubidium ((40)K(87)Rb) polar molecules. Using a single step of STIRAP (stimulated Raman adiabatic passage) with two-frequency laser irradiation, we coherently transfer extremely weakly bound KRb molecules to the rovibrational ground state of either the triplet or the singlet electronic ground molecular potential. The polar molecular gas has a peak density of 10(12) per cubic centimeter and an expansion-determined translational temperature of 350 nanokelvin. The polar molecules have a permanent electric dipole moment, which we measure with Stark spectroscopy to be 0.052(2) Debye (1 Debye = 3.336 x 10(-30) coulomb-meters) for the triplet rovibrational ground state and 0.566(17) Debye for the singlet rovibrational ground state.	[Ni, K. -K.; Ospelkaus, S.; de Miranda, M. H. G.; Pe'er, A.; Neyenhuis, B.; Zirbel, J. J.; Jin, D. S.; Ye, J.] Natl Inst Stand & Technol, JILA, Boulder, CO 80309 USA; [Ni, K. -K.; Ospelkaus, S.; de Miranda, M. H. G.; Pe'er, A.; Neyenhuis, B.; Zirbel, J. J.; Jin, D. S.; Ye, J.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Kotochigova, S.] Temple Univ, Dept Phys, Philadelphia, PA 19122 USA; [Julienne, P. S.] NIST, Joint Quantum Inst, Gaithersburg, MD 20899 USA; [Julienne, P. S.] Univ Maryland, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institute of Standards & Technology (NIST) - USA; University System of Maryland; University of Maryland College Park	Jin, DS (corresponding author), Natl Inst Stand & Technol, JILA, 325 Broadway, Boulder, CO 80309 USA.	jin@jilau1.colorado.edu; ye@jila.colorado.edu	Ye, Jun/C-3312-2011; Julienne, Paul S/E-9378-2012; de Miranda, Marcio H. G./J-8293-2016	Ye, Jun/0000-0003-0076-2112; Julienne, Paul S/0000-0002-5494-1442; de Miranda, Marcio H. G./0000-0002-4502-3623; Pe'er, Asaf/0000-0001-8667-0889	NSF; NIST; Air Force Office of Scientific Research; W. M. Keck Foundation; Alexander von Humboldt Foundation; CAPES/Fulbright; Office of Naval Research	NSF(National Science Foundation (NSF)); NIST(National Institute of Standards & Technology (NIST) - USA); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); W. M. Keck Foundation(W.M. Keck Foundation); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); CAPES/Fulbright(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Office of Naval Research(Office of Naval Research)	This work has been supported by NSF, NIST, the Air Force Office of Scientific Research, and the W. M. Keck Foundation. We thank D. Wang for experimental assistance, J. Bohn for discussion, and H. J. Kimble and P. Zoller for reading the manuscript. K.-K.N. and B.N. acknowledge support from NSF, S.O. from the Alexander von Humboldt Foundation, M.H.G.de.M. from the CAPES/Fulbright, and P.S.J. from the Office of Naval Research.	Amiot C, 2000, J MOL SPECTROSC, V203, P126, DOI 10.1006/jmsp.2000.8145; Andre A, 2006, NAT PHYS, V2, P636, DOI 10.1038/nphys386; Aymar M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1903944; Baranov MA, 2008, PHYS REP, V464, P71, DOI 10.1016/j.physrep.2008.04.007; Bergeman T, 2004, EUR PHYS J D, V31, P179, DOI 10.1140/epjd/e2004-00155-6; Bethlem HL, 1999, PHYS REV LETT, V83, P1558, DOI 10.1103/PhysRevLett.83.1558; Buchler HP, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.060404; Cundiff ST, 2003, REV MOD PHYS, V75, P325, DOI 10.1103/RevModPhys.75.325; Danzl JG, 2008, SCIENCE, V321, P1062, DOI 10.1126/science.1159909; DeMille D, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.067901; Ferlaino F, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.039903; Foreman SM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.153601; Inouye S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.183201; Kohler T, 2006, REV MOD PHYS, V78, P1311, DOI 10.1103/RevModPhys.78.1311; Kotochigova S, 2003, PHYS REV A, V68, DOI 10.1103/PhysRevA.68.022501; Lahaye T, 2007, NATURE, V448, P672, DOI 10.1038/nature06036; Ospelkaus C, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120402; Ospelkaus S, 2008, NAT PHYS, V4, P622, DOI 10.1038/nphys997; Pashov A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022511; Ronen S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.043607; Sage JM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.203001; Santos L, 2000, PHYS REV LETT, V85, P1791, DOI 10.1103/PhysRevLett.85.1791; Sawyer BC, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253002; Stuhler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.150406; Stwalley WC, 2004, EUR PHYS J D, V31, P221, DOI 10.1140/epjd/e2004-00147-6; Ticknor C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133202; Vitanov NV, 2001, ADV ATOM MOL OPT PHY, V46, P55, DOI 10.1016/S1049-250X(01)80063-X; Wang D, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.032511; Weinstein JD, 1998, NATURE, V395, P148, DOI 10.1038/25949; Winkler K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.043201; Wynar R, 2000, SCIENCE, V287, P1016, DOI 10.1126/science.287.5455.1016; Yelin SF, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.050301; Zirbel JJ, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.013416; Zirbel JJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.143201	34	1436	1443	6	193	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	OCT 10	2008	322	5899					231	235		10.1126/science.1163861	http://dx.doi.org/10.1126/science.1163861			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18801969	Green Submitted			2022-12-28	WOS:000259902300040
J	Papadakis, M; Whyte, G; Sharma, S				Papadakis, Michael; Whyte, Greg; Sharma, Sanjay			Preparticipation screening for cardiovascular abnormalities in young competitive athletes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							SUDDEN CARDIAC DEATH; HYPERTROPHIC CARDIOMYOPATHY; ELECTROCARDIOGRAPHIC PATTERNS; OF-CARDIOLOGY; PREVALENCE; RISK; RECOMMENDATIONS; ARRHYTHMIAS; RELEVANCE; STATEMENT		[Papadakis, Michael; Sharma, Sanjay] Kings Coll Hosp London, London SE5 9RS, England; [Papadakis, Michael; Sharma, Sanjay] Univ Hosp Lewisham, London, England; [Whyte, Greg] Northwick Pk Hosp & Clin Res Ctr, CRY Sports Cardiol Ctr, Olymp Med Inst, London, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; Imperial College London	Sharma, S (corresponding author), Kings Coll Hosp London, Denmark Hill, London SE5 9RS, England.	ssharma21@hotmail.com		Sharma, Sanjay/0000-0002-3630-6138				Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P2256, DOI 10.1016/j.jacc.2007.12.061; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; BEMADET P, 1995, J CARDIOVASC PHAR S1, V25, pS3; BERAL V, 2006, NHSBSP PUBLICATION, V61; Bille K, 2006, EUR J CARDIOV PREV R, V13, P859, DOI 10.1097/01.hjr.0000238397.50341.4a; Brewer NT, 2007, ANN INTERN MED, V146, P502, DOI 10.7326/0003-4819-146-7-200704030-00006; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; CORRADO D, 2004, COST EFFECTIVENESS A; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; DECEUNINCK M, 2008, SUDDEN CARDIAC DEATH; Estes NAM, 2001, J CARDIOVASC ELECTR, V12, P1208, DOI 10.1046/j.1540-8167.2001.01208.x; Fuller CM, 2000, MED SCI SPORT EXER, V32, P887; Fuller CM, 1997, MED SCI SPORT EXER, V29, P1131, DOI 10.1097/00005768-199709000-00003; Magalski A, 2008, J AM COLL CARDIOL, V51, P2250, DOI 10.1016/j.jacc.2008.01.065; Marcus FI, 2000, J ELECTROCARDIOL, V33, P1, DOI 10.1054/jelc.2000.20360; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; Maron BJ, 1998, J AM COLL CARDIOL, V32, P1881, DOI 10.1016/S0735-1097(98)00491-4; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; McNaughton-Collins M, 2004, AM J MED, V117, P719, DOI 10.1016/j.amjmed.2004.06.036; Pelliccia A, 2000, CIRCULATION, V102, P278; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; WILSON JMG, 1968, WHO CHRON, V22, P473; Wilson MG, 2008, BRIT J SPORT MED, V42, P207, DOI 10.1136/bjsm.2007.039420	29	33	33	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 4	2008	337	7673							a1596	10.1136/bmj.a1596	http://dx.doi.org/10.1136/bmj.a1596			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SN	18824487				2022-12-28	WOS:000259798000038
J	Poon, VY; Klassen, MP; Shen, K				Poon, Vivian Y.; Klassen, Matthew P.; Shen, Kang			UNC-6/netrin and its receptor UNC-5 locally exclude presynaptic components from dendrites	NATURE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; NETRIN RECEPTOR; AXON GUIDANCE; COLORECTAL-CANCER; SYNAPSE FORMATION; DROSOPHILA; ENCODES; WNT; EXPRESSION	Polarity is an essential feature of many cell types, including neurons that receive information from local inputs within their dendrites and propagate nerve impulses to distant targets through a single axon. It is generally believed that intrinsic structural differences between axons and dendrites dictate the polarized localization of axonal and dendritic proteins(1). However, whether extracellular cues also instruct this process in vivo has not been explored. Here we show that the axon guidance cue UNC-6/netrin and its receptor UNC-5 act throughout development to exclude synaptic vesicle and active zone proteins from the dendrite of the Caenorhabditis elegans motor neuron DA9, which is proximal to a source of UNC- 6/ netrin. In unc- 6/ netrin and unc- 5 loss- of-function mutants, presynaptic components mislocalize to the DA9 dendrite. In addition, ectopically expressed UNC- 6/ netrin, acting through UNC- 5, is sufficient to exclude endogenous synapses from adjacent subcellular domains within the DA9 axon. Furthermore, this anti- synaptogenic activity is interchangeable with that of LIN- 44/ Wnt despite being transduced through different receptors, suggesting that extracellular cues such as netrin and Wnts not only guide axon navigation but also regulate the polarized accumulation of presynaptic components through local exclusion.	[Poon, Vivian Y.; Klassen, Matthew P.; Shen, Kang] Stanford Univ, Sch Med, Neurosci Program, Stanford, CA 94305 USA; [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University	Shen, K (corresponding author), Stanford Univ, Sch Med, Neurosci Program, 300 Pasteur Dr, Stanford, CA 94305 USA.	kangshen@stanford.edu			W. M. Keck Foundation; McKnight Endowment Fund; Searle Scholar Award; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048392] Funding Source: NIH RePORTER	W. M. Keck Foundation(W.M. Keck Foundation); McKnight Endowment Fund; Searle Scholar Award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the W. M. Keck Foundation, the McKnight Endowment Fund, the Searle Scholar Award and the Howard Hughes Medical Institute. We thank the International Caenorhabditis Genetic Center and M. Chalfie for strains. We further thank M. Chalfie for sharing unpublished results on the silencing system. We also thank C. Gao and Y. Fu for technical assistance, and T. Clandinin, C. Bargmann, S. McConnell, and members of the Shen laboratory for comments on the manuscript.	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Chan SSY, 1996, CELL, V87, P187, DOI 10.1016/S0092-8674(00)81337-9; Colavita A, 1998, SCIENCE, V281, P706, DOI 10.1126/science.281.5377.706; Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762; Fox RM, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-42; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9; Jin YS, 1999, J NEUROSCI, V19, P539; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Manitt C, 2006, J NEUROSCI RES, V84, P1808, DOI 10.1002/jnr.21070; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Mello C, 1995, METHOD CELL BIOL, V48, P451; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Paganoni S, 2003, J NEUROSCI RES, V73, P429, DOI 10.1002/jnr.10674; Phelan P, 2005, BBA-BIOMEMBRANES, V1711, P225, DOI 10.1016/j.bbamem.2004.10.004; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; Sieburth D, 2005, NATURE, V436, P510, DOI 10.1038/nature03809; Su MW, 2000, DEVELOPMENT, V127, P585; Sym M, 1999, CELL, V98, P25, DOI 10.1016/S0092-8674(00)80603-0; Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025; Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5; Whangbo J, 1999, MOL CELL, V4, P851, DOI 10.1016/S1097-2765(00)80394-9; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086	29	102	114	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 2	2008	455	7213					669	U68		10.1038/nature07291	http://dx.doi.org/10.1038/nature07291			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	354KY	18776887	Green Accepted			2022-12-28	WOS:000259639700048
J	Tamborlane, WV; Beck, RW; Bode, BW; Buckingham, B; Chase, HP; Clemons, R; Fiallo-Scharer, R; Fox, LA; Gilliam, LK; Hirsch, IB; Huang, ES; Kollman, C; Kowalski, AJ; Laffel, L; Lawrence, JM; Lee, J; Mauras, N; O'Grady, M; Ruedy, KJ; Tansey, M; Tsalikian, E; Weinzimer, S; Wilson, DM; Wolpert, H; Wysocki, T; Xing, DY				Tamborlane, William V.; Beck, Roy W.; Bode, Bruce W.; Buckingham, Bruce; Chase, H. Peter; Clemons, Robert; Fiallo-Scharer, Rosanna; Fox, Larry A.; Gilliam, Lisa K.; Hirsch, Irl B.; Huang, Elbert S.; Kollman, Craig; Kowalski, Aaron J.; Laffel, Lori; Lawrence, Jean M.; Lee, Joyce; Mauras, Nelly; O'Grady, Michael; Ruedy, Katrina J.; Tansey, Michael; Tsalikian, Eva; Weinzimer, Stuart; Wilson, Darrell M.; Wolpert, Howard; Wysocki, Tim; Xing, Dongyuan		Juvenile Diabet Res Fdn Continuous	Continuous glucose monitoring and intensive treatment of type 1 diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GLYCEMIC CONTROL; PEDIATRIC-PATIENTS; YOUTH; ACCURACY; SYSTEM; IMPACT; TRIAL	Background The value of continuous glucose monitoring in the management of type 1 diabetes mellitus has not been determined. Methods In a multicenter clinical trial, we randomly assigned 322 adults and children who were already receiving intensive therapy for type 1 diabetes to a group with continuous glucose monitoring or to a control group performing home monitoring with a blood glucose meter. All the patients were stratified into three groups according to age and had a glycated hemoglobin level of 7.0 to 10.0%. The primary outcome was the change in the glycated hemoglobin level at 26 weeks. Results The changes in glycated hemoglobin levels in the two study groups varied markedly according to age group ( P = 0.003), with a significant difference among patients 25 years of age or older that favored the continuous- monitoring group ( mean difference in change, - 0.53%; 95% confidence interval [ CI], - 0.71 to - 0.35; P< 0.001). The between- group difference was not significant among those who were 15 to 24 years of age ( mean difference, 0.08; 95% CI, - 0.17 to 0.33; P = 0.52) or among those who were 8 to 14 years of age ( mean difference, - 0.13; 95% CI, - 0.38 to 0.11; P = 0.29). Secondary glycated hemoglobin outcomes were better in the continuous- monitoring group than in the control group among the oldest and youngest patients but not among those who were 15 to 24 years of age. The use of continuous glucose monitoring averaged 6.0 or more days per week for 83% of patients 25 years of age or older, 30% of those 15 to 24 years of age, and 50% of those 8 to 14 years of age. The rate of severe hypoglycemia was low and did not differ between the two study groups; however, the trial was not powered to detect such a difference. Conclusions Continuous glucose monitoring can be associated with improved glycemic control in adults with type 1 diabetes. Further work is needed to identify barriers to effectiveness of continuous monitoring in children and adolescents. ( ClinicalTrials. gov number, NCT00406133.).	[Beck, Roy W.; Kollman, Craig; Ruedy, Katrina J.; Xing, Dongyuan] Jaeb Ctr Hlth Res, Tampa, FL 33647 USA; [Chase, H. Peter; Fiallo-Scharer, Rosanna] Univ Colorado, Barbara Davis Ctr Childhood Diabet, Denver, CO 80202 USA; [Laffel, Lori] Joslin Diabet Ctr, Pediat Adolescent & Young Adult Sect, Boston, MA 02215 USA; [Buckingham, Bruce; Wilson, Darrell M.] Stanford Univ, Stanford, CA 94305 USA; [Tansey, Michael; Tsalikian, Eva] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Wolpert, Howard] Joslin Diabet Ctr, Adult Sect, Boston, MA 02215 USA; [Gilliam, Lisa K.; Hirsch, Irl B.] Univ Washington, Seattle, WA 98195 USA; [Fox, Larry A.; Mauras, Nelly; Wysocki, Tim] Nemours Childrens Clin, Jacksonville, FL USA; [Bode, Bruce W.] Atlanta Diabet Assoc, Atlanta, GA USA; [Clemons, Robert; Lawrence, Jean M.] Kaiser Permanente, San Diego, CA USA; [Weinzimer, Stuart] Yale Univ, Sch Med, New Haven, CT USA; [Huang, Elbert S.; O'Grady, Michael] Univ Chicago, Natl Opin Res Ctr, Chicago, IL 60637 USA; [Lee, Joyce] Univ Michigan, Ann Arbor, MI 48109 USA	JAEB Center For Health Research; University of Colorado System; University of Colorado Denver; Harvard University; Joslin Diabetes Center, Inc.; Stanford University; University of Iowa; Harvard University; Joslin Diabetes Center, Inc.; University of Washington; University of Washington Seattle; Kaiser Permanente; Yale University; University of Chicago; University of Michigan System; University of Michigan	Beck, RW (corresponding author), Jaeb Ctr Hlth Res, 15310 Amberly Dr 350, Tampa, FL 33647 USA.	rbeck@jaeb.org	Meltzer, David/C-2926-2009	Meltzer, David/0000-0003-2790-7393; Buckingham, Bruce/0000-0003-4581-4887; Tansey, Michael/0000-0002-8157-8423; Messer, Laurel/0000-0001-7493-0989; Tsalikian, Eva/0000-0003-3429-2796; Fox, Larry/0000-0002-2254-6560; Lawrence, Jean/0000-0002-2480-8480	Juvenile Diabetes Research Foundation [22-2006-1107, 22-2006-1117, 22-20061112, 22-2006-1123, 01-2006-8031]; Abbott Diabetes Care; Lifescan; Medtronic; DexCom; Novo Nordisk; Sanofi-Aventis; Symlin; Roche; Charles Hood Foundation; AstraZeneca	Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Abbott Diabetes Care(Abbott Laboratories); Lifescan; Medtronic(Medtronic); DexCom; Novo Nordisk(Novo Nordisk); Sanofi-Aventis(Sanofi-Aventis); Symlin; Roche(Roche Holding); Charles Hood Foundation; AstraZeneca(AstraZeneca)	Supported by grants (22-2006-1107, 22-2006-1117, 22-20061112, 22-2006-1123, and 01-2006-8031) from the Juvenile Diabetes Research Foundation.; Dr. Tamborlane reports receiving consulting fees from Abbott Diabetes Care and Lifescan and consulting and lecture fees and grant support from Medtronic; Dr. Bode, receiving consulting and lecture fees, travel reimbursement, and grant support from Abbott Diabetes Care and Medtronic and grant support from DexCom; Dr. Buckingham, receiving lecture fees and grant support from Abbott Diabetes Care, lecture and consulting fees and grant support from Medtronic, and consulting fees from Novo Nordisk and serving on an advisory board for Lifescan; Dr. Chase, receiving lecture fees from Abbott Diabetes Care and Sanofi-Aventis and grant support from Symlin; Dr. Fiallo-Scharer, receiving supplies for research from Abbott Diabetes Care and Medtronic; Dr. Fox, receiving supplies for research from Abbott Diabetes Care; Dr. Hirsch, receiving consulting fees and travel reimbursement from Abbott Diabetes Care and grant support from Medtronic; Dr. Laffel, receiving consulting fees from Lifescan and Roche, consulting and lecture fees from Abbott Diabetes Care, consulting fees and grant support from Medtronic, and grant support from the Charles Hood Foundation; Dr. Mauras, receiving grant support from AstraZeneca; Dr. Weinzimer, receiving lecture fees and travel reimbursement from Medtronic; Dr. Wilson, receiving equipment and software from Abbott Diabetes Care and Medtronic and grant support from Medtronic; and Dr. Wolpert, receiving consulting fees from Abbott Diabetes Care and grant support from Medtronic. No other potential conflict of interest relevant to this article was reported.	*AM DIAB ASS, 2008, STAND MED CAR DIAB 2, V31, pS12; Anderson BJ, 2002, DIABETIC MED, V19, P635, DOI 10.1046/j.1464-5491.2002.00752.x; [Anonymous], 1995, DIABETES, V44, P968; Bode BW, 2005, DIABETES CARE, V28, P2361, DOI 10.2337/diacare.28.10.2361; Boland E, 2001, DIABETES CARE, V24, P1858, DOI 10.2337/diacare.24.11.1858; Buckingham B, 2008, PEDIATR DIABETES, V9, P142, DOI 10.1111/j.1399-5448.2007.00301.x; Cryer PE, 2004, NEW ENGL J MED, V350, P2272, DOI 10.1056/NEJMra031354; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Deis D, 2006, DIABETES CARE, V29, P2730, DOI 10.2337/dc06-1134; DirecNet Study Grp, 2007, J PEDIATR-US, V151, P388, DOI 10.1016/j.jpeds.2007.03.047; Garg S, 2006, DIABETES CARE, V29, P44, DOI 10.2337/diacare.29.01.06.dc05-1686; Gibb I, 1999, CLIN CHEM, V45, P1833; Halvorson M, 2007, J PEDIATR-US, V150, P103, DOI 10.1016/j.jpeds.2006.08.069; Insabella G, 2007, PEDIATR DIABETES, V8, P228, DOI 10.1111/j.1399-5448.2007.00266.x; Izuora KE, 2005, DIABETES CARE, V28, P714, DOI 10.2337/diacare.28.3.714; Kaufman FR, 2002, J PEDIATR-US, V141, P625, DOI 10.1067/mpd.2002.129175; Klonoff DC, 2005, DIABETES CARE, V28, P1231, DOI 10.2337/diacare.28.5.1231; Kovatchev B, 2008, DIABETES CARE, V31, P1160, DOI 10.2337/dc07-2401; Kovatchev Boris P, 2005, Diabetes Technol Ther, V7, P849, DOI 10.1089/dia.2005.7.849; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Laffel LMB, 2003, J PEDIATR-US, V142, P409, DOI 10.1067/mpd.2003.138; Little R. J. A., 1987, STAT ANAL MISSING DA; Moreland EC, 2004, J PEDIATR ENDOCR MET, V17, P1533; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Petitti DB, 2007, ARCH PEDIAT ADOL MED, V161, P159, DOI 10.1001/archpedi.161.2.159; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Tamborlane WV, 2008, DIABETES TECHNOL THE, V10, P310, DOI 10.1089/dia.2007.0302; Thompson CJ, 1996, DIABETES CARE, V19, P876, DOI 10.2337/diacare.19.8.876; Weinzimer S, 2008, DIABETES CARE, V31, P525, DOI 10.2337/dc07-1995; Wilson DM, 2007, DIABETES CARE, V30, P59, DOI 10.2337/dc06-1407; Wysocki T, 2008, J PEDIATR PSYCHOL, V33, P875, DOI 10.1093/jpepsy/jsn024	31	963	993	1	130	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					1464	U65						21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18779236				2022-12-28	WOS:000259631700007
J	Hardin, LS				Hardin, Lowell S.			Meetings that changed the world: Bellagio 1969: The green revolution	NATURE			English	Editorial Material									[Hardin, Lowell S.] Purdue Univ, Int Programs Agr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Hardin, LS (corresponding author), Purdue Univ, Int Programs Agr, W Lafayette, IN 47907 USA.	lhardin@purdue.edu							0	14	17	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 25	2008	455	7212					470	471		10.1038/455470a	http://dx.doi.org/10.1038/455470a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818641	Bronze			2022-12-28	WOS:000259449600028
J	Herbst, RS; Heymach, JV; Lippman, SM				Herbst, Roy S.; Heymach, John V.; Lippman, Scott M.			Molecular origins of cancer: Lung cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-FACTOR-RECEPTOR; TYROSINE KINASE INHIBITORS; GENE COPY NUMBER; BRONCHIOALVEOLAR STEM-CELLS; DRUG-RESISTANCE MUTATION; MESSENGER-RNA EXPRESSION; DNA METHYLATION MARKERS; ACQUIRED-RESISTANCE; DOMAIN MUTATIONS; PROMOTER HYPERMETHYLATION		[Herbst, Roy S.; Heymach, John V.; Lippman, Scott M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, Houston, TX 77030 USA; [Herbst, Roy S.; Heymach, John V.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Lippman, Scott M.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Clin Canc Prevent, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Lippman, SM (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Unit 432, 1515 Holcombe Blvd, Houston, TX 77030 USA.	slippman@mdanderson.org	Heymach, John/AAG-2361-2019	Heymach, John/0000-0001-9068-8942	Bristol-Myers Squibb; ImClone; Genentech; Amgen; AstraZeneca; OSI; GlaxoSmithKline	Bristol-Myers Squibb(Bristol-Myers Squibb); ImClone; Genentech(Roche HoldingGenentech); Amgen(Amgen); AstraZeneca(AstraZeneca); OSI(Astellas Pharmaceuticals); GlaxoSmithKline(GlaxoSmithKline)	Dr. Herbst reports receiving consulting fees and research grants from Bristol-Myers Squibb, ImClone, Genentech, Amgen, AstraZeneca, and OSI and lecture fees from Genentech; Dr. Heymach, serving on advisory boards for and receiving research grants from AstraZeneca, Pfizer, and GlaxoSmithKline and serving on an advisory board for Genentech; and Dr. Lippman, serving on advisory boards for OSI and Genentech. No other potential conflict of interest relevant to this article was reported.; We thank Lauren A. Byers, Balvindar S. Johal, and Ignacio I. Wistuba for their careful comments and other contributions regarding aspects of this work; and Bich N. Tran, Suzanne E. Davis, and Kendall Morse for their contributions to the preparation of the manuscript.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bailey-Wilson JE, 2004, AM J HUM GENET, V75, P460, DOI 10.1086/423857; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Beane J, 2008, CANCER PREV RES, V1, P56, DOI 10.1158/1940-6207.CAPR-08-0011; Beau-Faller M, 2008, J THORAC ONCOL, V3, P331, DOI 10.1097/JTO.0b013e318168d9d4; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Belinsky SA, 2007, BRIT J CANCER, V96, P1278, DOI 10.1038/sj.bjc.6603721; Belinsky SA, 2006, CANCER RES, V66, P3338, DOI 10.1158/0008-5472.CAN-05-3408; Belinsky SA, 2003, CANCER RES, V63, P7089; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bhutani M, 2008, CANCER PREV RES, V1, P39, DOI 10.1158/1940-6207.CAPR-08-0058; Bianchi F, 2004, CLIN CANCER RES, V10, P6023, DOI 10.1158/1078-0432.CCR-04-0619; Brock MV, 2008, NEW ENGL J MED, V358, P1118, DOI 10.1056/NEJMoa0706550; Brose MS, 2002, CANCER RES, V62, P6997; BYERS L, 2008, AM ASS CANC RES ANN; Cappuzzo F, 2005, J CLIN ONCOL, V23, P5007, DOI 10.1200/JCO.2005.09.111; CAPPUZZO F, 2008, J CLIN ONCOL S, V26, pS589; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; Chen XQ, 1996, NAT MED, V2, P1033; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dowlati A, 2008, CLIN CANCER RES, V14, P1407, DOI 10.1158/1078-0432.CCR-07-1154; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Franklin WA, 1997, J CLIN INVEST, V100, P2133, DOI 10.1172/JCI119748; Franklin WA, 1997, J CLIN INVEST, V100, P2639; Gautschi O, 2004, J CLIN ONCOL, V22, P4157, DOI 10.1200/JCO.2004.11.123; Ghaffar H, 2003, CLIN CANCER RES, V9, P2998; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; Godin-Heymann N, 2007, CANCER RES, V67, P7319, DOI 10.1158/0008-5472.CAN-06-4625; Gregorc V, 2008, CLIN PHARMACOL THER, V83, P477, DOI 10.1038/sj.clpt.6100320; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Guo MZ, 2004, CLIN CANCER RES, V10, P5131, DOI 10.1158/1078-0432.CCR-03-0763; Heist RS, 2008, J CLIN ONCOL, V26, P856, DOI 10.1200/JCO.2007.13.5947; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Herbst RS, 2007, NEW ENGL J MED, V356, P76, DOI 10.1056/NEJMe068218; HEYMACH J, IN PRESS J CLIN ONCO; Heymach J.V., 2008, J CLIN ONCOL, V26, P165; Heymach JV, 2007, J CLIN ONCOL, V25, P4270, DOI 10.1200/JCO.2006.10.5122; HEYMACH JV, 2008, J CLIN ONCOL S, V26, pS426; Hirsch FR, 2008, J CLIN ONCOL, V26, P3351, DOI 10.1200/JCO.2007.14.0111; Hoogsteen IJ, 2007, CLIN ONCOL-UK, V19, P385, DOI 10.1016/j.clon.2007.03.001; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hwang SJ, 2003, HUM GENET, V113, P238, DOI 10.1007/s00439-003-0968-7; Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jeong EG, 2006, INT J CANCER, V119, P2986, DOI 10.1002/ijc.22257; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ji HB, 2006, P NATL ACAD SCI USA, V103, P7817, DOI 10.1073/pnas.0510284103; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Keith RL, 2000, CLIN CANCER RES, V6, P1616; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; KIM ES, 2008, IN PRESS LANCET; Kim JS, 2006, CANCER RES, V66, P4049, DOI 10.1158/0008-5472.CAN-05-3813; Koivunen JP, 2008, BRIT J CANCER, V99, P245, DOI 10.1038/sj.bjc.6604469; Kong-Beltran M, 2006, CANCER RES, V66, P283, DOI 10.1158/0008-5472.CAN-05-2749; Kwak EL, 2005, P NATL ACAD SCI USA, V102, P7665, DOI 10.1073/pnas.0502860102; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Licchesi JDF, 2008, CLIN CANCER RES, V14, P2570, DOI 10.1158/1078-0432.CCR-07-2033; Liu G, 2008, PHARMACOGENOMICS J, V8, P129, DOI 10.1038/sj.tpj.6500444; Ludovini V, 2008, J THORAC ONCOL, V3, P365, DOI 10.1097/JTO.0b013e318168c7d0; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Ma PC, 2003, CANCER RES, V63, P6272; Machida EO, 2007, CANCER RES, V67, P427, DOI 10.1158/0008-5472.CAN-67-1-COR; Machida EO, 2006, CANCER RES, V66, P6210, DOI 10.1158/0008-5472.CAN-05-4447; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Maley CC, 2006, NAT GENET, V38, P468, DOI 10.1038/ng1768; Mao L, 1997, J NATL CANCER I, V89, P857, DOI 10.1093/jnci/89.12.857; Matsumoto S, 2007, ONCOGENE, V26, P5911, DOI 10.1038/sj.onc.1210418; Merrick DT, 2005, LUNG CANCER, V48, P31, DOI 10.1016/j.lungcan.2004.07.049; Meyerson M, 2005, J CLIN ONCOL, V23, P3219, DOI 10.1200/JCO.2005.15.511; Morgillo F, 2007, CLIN CANCER RES, V13, P2795, DOI 10.1158/1078-0432.CCR-06-2077; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Park IW, 1999, J NATL CANCER I, V91, P1863, DOI 10.1093/jnci/91.21.1863; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; PIRKER R, 2008, J CLIN ONCOL S, V26, pS1006; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Pore N, 2006, CANCER RES, V66, P3197, DOI 10.1158/0008-5472.CAN-05-3090; Potti A, 2007, NEW ENGL J MED, V356, P201; Potti A, 2007, NAT MED, V13, P1388, DOI 10.1038/nm1107-1388; Ramirez JL, 2005, J CLIN ONCOL, V23, P9105, DOI 10.1200/JCO.2005.02.2905; RIELY GJ, IN PRESS CLIN CANC R; Sakuma Y, 2007, MODERN PATHOL, V20, P967, DOI 10.1038/modpathol.3800929; SANDERS BM, 1989, BRIT J CANCER, V60, P358, DOI 10.1038/bjc.1989.285; Sandler A, 2007, NEW ENGL J MED, V356, P318; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sato M, 2007, J THORAC ONCOL, V2, P327, DOI 10.1097/01.JTO.0000263718.69320.4c; Seike M, 2007, JNCI-J NATL CANCER I, V99, P1257, DOI 10.1093/jnci/djm083; Sequist LV, 2007, J CLIN ONCOL, V25, P587, DOI 10.1200/JCO.2006.07.3585; Shah U, 2008, CANCER RES, V68, P3562, DOI 10.1158/0008-5472.CAN-07-6620; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Simon G, 2007, J CLIN ONCOL, V25, P2741, DOI 10.1200/JCO.2006.08.2099; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Soung YH, 2006, INT J CANCER, V118, P1426, DOI 10.1002/ijc.21507; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Spira A, 2007, NAT MED, V13, P361, DOI 10.1038/nm1556; Spitz MR, 2003, CANCER EPIDEM BIOMAR, V12, P689; STRICTER RM, 2008, IN PRESS CANC PREV P; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Taguchi F, 2007, J NATL CANCER I, V99, P838, DOI 10.1093/jnci/djk195; TANG X, 2008, AM ASS CANC RES ANN; Tang XM, 2008, CANCER PREV RES, V1, P192, DOI 10.1158/1940-6207.CAPR-08-0032; Tang XN, 2005, CANCER RES, V65, P7568, DOI 10.1158/0008-5472.CAN-05-1705; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Tsao MS, 2006, NEW ENGL J MED, V355, P1746; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Vikis H, 2007, CANCER RES, V67, P4665, DOI 10.1158/0008-5472.CAN-07-0217; Viloria-Petit A, 2001, CANCER RES, V61, P5090; WANG SE, 2006, CANCER CELL, V10, P52; Weihua Z, 2008, CANCER CELL, V13, P385, DOI 10.1016/j.ccr.2008.03.015; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weiss GJ, 2008, ANN ONCOL, V19, P1053, DOI 10.1093/annonc/mdn006; West KA, 2004, CANCER RES, V64, P446, DOI 10.1158/0008-5472.CAN-03-3241; Westra W H, 2000, Respir Res, V1, P163, DOI 10.1186/rr28; Wislez M, 2005, CANCER RES, V65, P3226, DOI 10.1158/0008-5472.CAN-04-4420; Wistuba II, 2000, CLIN CANCER RES, V6, P2604; Wistuba II, 2002, ONCOGENE, V21, P7298, DOI 10.1038/sj.onc.1205806; YAMAMOTO H, IN PRESS CANC RES; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yanagisawa K, 2007, JNCI-J NATL CANCER I, V99, P858, DOI 10.1093/jnci/djk197; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Yang Y, 2008, MOL CANCER THER, V7, P952, DOI 10.1158/1535-7163.MCT-07-2045; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yildiz PB, 2007, J THORAC ONCOL, V2, P893, DOI 10.1097/JTO.0b013e31814b8be7; Yu DK, 2008, CLIN CANCER RES, V14, P2878, DOI 10.1158/1078-0432.CCR-07-1612; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang SM, 2008, CANCER RES, V68, P740, DOI 10.1158/0008-5472.CAN-07-2989; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411; Zhou X, 2008, CLIN TRIALS, V5, P181, DOI 10.1177/1740774508091815; Zudaire I, 2008, HISTOL HISTOPATHOL, V23, P33, DOI 10.14670/HH-23.33	142	1935	2063	10	309	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	SEP 25	2008	359	13					1367	1380		10.1056/NEJMra0802714	http://dx.doi.org/10.1056/NEJMra0802714			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351QZ	18815398				2022-12-28	WOS:000259440900007
J	Singh, S; Loke, YK; Furberg, CD				Singh, Sonal; Loke, Yoon K.; Furberg, Curt D.			Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease - A systematic review and meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							ONCE-DAILY TIOTROPIUM; SPIROMETRIC EFFICACY; BETA-AGONISTS; MORTALITY; COPD; EXACERBATIONS; SALMETEROL; HOSPITALIZATIONS; FLUTICASONE; PROPIONATE	Context Inhaled anticholinergics ( ipratropium bromide or tiotropium bromide) are widely used in patients with chronic obstructive pulmonary disease ( COPD) but their effect on the risk of cardiovascular outcomes is unknown. Objective To ascertain the cardiovascular risks of inhaled anticholinergics, including cardiovascular death, myocardial infarction ( MI), and stroke. Data Sources Systematic searches were conducted on March 19, 2008, of relevant articles in MEDLINE, the Cochrane Database of systematic reviews, regulatory authority Web sites in the United States and the United Kingdom, and manufacturers' trial registries with no date restrictions. Study Selection Randomized controlled trials of any inhaled anticholinergic for treatment of COPD that had at least 30 days of treatment and reported on cardiovascular events. Data Extraction The primary outcome was a composite of cardiovascular death, MI, or stroke. The secondary outcome was all- cause mortality. Relative risks ( RRs) were estimated using fixed- effects models and statistical heterogeneity was estimated with the I-2 statistic. Data Synthesis After a detailed screening of 103 articles, 17 trials enrolling 14 783 patients were analyzed. Follow- up duration ranged from 6 weeks to 5 years. Cardiovascular death, MI, or stroke occurred in 135 of 7472 patients ( 1.8%) receiving inhaled anticholinergics and 86 of 7311 patients ( 1.2%) receiving control therapy ( RR, 1.58 [ 95% confidence interval {CI}, 1.21- 2.06]; P ,. 001, I-2= 0%). Among individual components of the primary end point, inhaled anticholinergics significantly increased the risk of MI ( RR, 1.53 [ 95% CI 1.05- 2.23]; P=. 03, I-2= 0%) and cardiovascular death ( RR, 1.80 [ 95% CI, 1.17- 2.77]; P=. 008, I2= 0%) without a statistically significant increase in the risk of stroke ( RR, 1.46 [ 95% CI, 0.81- 2.62]; P=. 20, I-2= 0%). All- cause mortality was reported in 149 of the patients treated with inhaled anticholinergics ( 2.0%) and 115 of the control patients ( 1.6%) ( RR, 1.26 [ 95% CI, 0.99- 1.61]; P=. 06, I-2 = 2%). A sensitivity analysis restricted to 5 long- term trials ( > 6 months) confirmed the significantly increased risk of cardiovascular death, MI, or stroke ( 2.9% of patients treated with anticholinergics vs 1.8% of the control patients; RR, 1.73 [ 95% CI, 1.27- 2.36]; P <. 001, I-2 = 0%). Conclusion Inhaled anticholinergics are associated with a significantly increased risk of cardiovascular death, MI, or stroke among patients with COPD.	[Singh, Sonal] Wake Forest Univ, Sch Med, Dept Med, Winston Salem, NC 27157 USA; [Furberg, Curt D.] Wake Forest Univ, Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Loke, Yoon K.] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England	Wake Forest University; Wake Forest University; University of East Anglia	Singh, S (corresponding author), Wake Forest Univ, Sch Med, Dept Med, 1 Med Ctr Blvd, Winston Salem, NC 27157 USA.	sosingh@wfubmc.edu	Singh, Sonal/A-4614-2008	Singh, Sonal/0000-0003-0912-941X				Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P333, DOI 10.1164/rccm.2110093; Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71; Barr RG, 2006, THORAX, V61, P854, DOI 10.1136/thx.2006.063271; Barr RG, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002876.pub2; Bateman ED, 2008, PULM PHARMACOL THER, V21, P20, DOI 10.1016/j.pupt.2006.10.001; *BOEHR ING, ANN REP 2007; *BOEHR ING INT, TRIAL RES; Boekholdt SM, 2004, ARTERIOSCL THROM VAS, V24, P1503, DOI 10.1161/01.ATV.0000134294.54422.2e; Brusasco V, 2003, THORAX, V58, P399, DOI 10.1136/thorax.58.5.399; Brusasco V, 2005, THORAX, V60, P105; Calverley PMA, 2007, NEW ENGL J MED, V356, P775, DOI 10.1056/NEJMoa063070; Casaburi R, 2002, EUR RESPIR J, V19, P217, DOI 10.1183/09031936.02.00269802; Casaburi R, 2000, CHEST, V118, P1294, DOI 10.1378/chest.118.5.1294; Chan CKN, 2007, CAN RESPIR J, V14, P465, DOI 10.1155/2007/192961; *COM INH AER STUD, 1994, CHEST, V105, P1411; Covelli H, 2005, PHARMACOTHERAPY, V25, P1708, DOI 10.1592/phco.2005.25.12.1708; Curkendall SM, 2006, ANN EPIDEMIOL, V16, P63, DOI 10.1016/j.annepidem.2005.04.008; de Luise C, 2007, EUR J EPIDEMIOL, V22, P267, DOI 10.1007/s10654-007-9106-5; Decramer Marc, 2004, COPD, V1, P303, DOI 10.1081/COPD-200026934; Donohue JF, 2002, CHEST, V122, P47, DOI 10.1378/chest.122.1.47; EBIKRYSTON KL, 1988, J CLIN EPIDEMIOL, V41, P251, DOI 10.1016/0895-4356(88)90129-1; *GLAXOSMITHKLINE, CLIN TRIAL REG MULT; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huiart L, 2005, CHEST, V128, P2640, DOI 10.1378/chest.128.4.2640; Jara M, 2007, DRUG SAFETY, V30, P1151, DOI 10.2165/00002018-200730120-00007; Kesten S, 2006, CHEST, V130, P1695, DOI 10.1378/chest.130.6.1695; LEE TA, 2007, OUTC ASS SALM US OBS; LOKE YK, 2006, COCHRANE HDB SYSTEMA; Macie Christine, 2008, Int J Chron Obstruct Pulmon Dis, V3, P163; Mahler DA, 1999, CHEST, V115, P957, DOI 10.1378/chest.115.4.957; Mancini GBJ, 2006, J AM COLL CARDIOL, V47, P2554, DOI 10.1016/j.jacc.2006.04.039; Mannino DM, 2005, SEMIN RESP CRIT CARE, V26, P204, DOI 10.1055/s-2005-869539; McQuay HJ, 1997, ANN INTERN MED, V126, P712, DOI 10.7326/0003-4819-126-9-199705010-00007; Moita J, 2008, PULM PHARMACOL THER, V21, P146, DOI 10.1016/j.pupt.2007.04.003; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Niewoehner DE, 2005, ANN INTERN MED, V143, P317, DOI 10.7326/0003-4819-143-5-200509060-00007; Powrie DJ, 2007, EUR RESPIR J, V30, P472, DOI 10.1183/09031936.00023907; Rodrigo GJ, 2007, PULM PHARMACOL THER, V20, P495, DOI 10.1016/j.pupt.2006.02.003; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1554/04-602; Salpeter SR, 2006, J GEN INTERN MED, V21, P1011, DOI 10.1111/j.1525-1497.2006.00507.x; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Sidney S, 2005, CHEST, V128, P2068, DOI 10.1378/chest.128.4.2068; Sin DD, 2003, CIRCULATION, V107, P1514, DOI 10.1161/01.CIR.0000056767.69054.B3; US Food and Drug Administration Web site, EARL COMM ONG SAF RE; Voshaar T, 2008, RESP MED, V102, P32, DOI 10.1016/j.rmed.2007.08.009; Wedzicha JA, 2008, AM J RESP CRIT CARE, V177, P19, DOI 10.1164/rccm.200707-973OC; Wilt TJ, 2007, ANN INTERN MED, V147, P639, DOI 10.7326/0003-4819-147-9-200711060-00009	48	370	385	2	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 24	2008	300	12					1439	1450		10.1001/jama.300.12.1439	http://dx.doi.org/10.1001/jama.300.12.1439			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	351FR	18812535				2022-12-28	WOS:000259410400022
J	von Mutius, E				von Mutius, Erika			Rhinitis as predictor of adult-onset asthma	LANCET			English	Editorial Material							INDEPENDENT RISK-FACTOR; ALLERGIC RHINITIS; FOLLOW-UP; IMMUNOTHERAPY; CHILDREN; PAT; RHINOCONJUNCTIVITIS; SENSITIZATION; LIFE		[von Mutius, Erika] Univ Munich, Childrens Hosp, D-80337 Munich, Germany	University of Munich	von Mutius, E (corresponding author), Univ Munich, Childrens Hosp, D-80337 Munich, Germany.	Erika.von.Mutius@med.uni-muenchen.de		von Mutius, Erika/0000-0002-8893-4515				Bonness S, 2007, CURR OPIN ALLERGY CL, V7, P382, DOI 10.1097/ACI.0b013e3282a643c3; Bousquet J, 2008, ALLERGY, V63, P8, DOI 10.1111/j.1398-9995.2007.01620.x; Grembiale RD, 2000, AM J RESP CRIT CARE, V162, P2048, DOI 10.1164/ajrccm.162.6.9909087; Guerra S, 2002, J ALLERGY CLIN IMMUN, V109, P419, DOI 10.1067/mai.2002.121701; Illi S, 2006, LANCET, V368, P763, DOI 10.1016/S0140-6736(06)69286-6; Jacobsen L, 2007, ALLERGY, V62, P943, DOI 10.1111/j.1398-9995.2007.01451.x; Kusel MMH, 2007, J ALLERGY CLIN IMMUN, V119, P1105, DOI 10.1016/j.jaci.2006.12.669; Leynaert B, 1999, J ALLERGY CLIN IMMUN, V104, P301, DOI 10.1016/S0091-6749(99)70370-2; Moller C, 2002, J ALLERGY CLIN IMMUN, V109, P251, DOI 10.1067/mai.2002.121317; Niggemann B, 2006, ALLERGY, V61, P855, DOI 10.1111/j.1398-9995.2006.01068.x; Novembre E, 2004, J ALLERGY CLIN IMMUN, V114, P851, DOI 10.1016/j.jaci.2004.07.012; Shaaban R, 2008, LANCET, V372, P1049, DOI 10.1016/S0140-6736(08)61446-4; Weidinger S, 2008, J ALLERGY CLIN IMMUN, V121, P1203, DOI 10.1016/j.jaci.2008.02.014; WRIGHT AL, 1994, PEDIATRICS, V94, P895	14	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 20	2008	372	9643					1012	1014		10.1016/S0140-6736(08)61418-X	http://dx.doi.org/10.1016/S0140-6736(08)61418-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805312				2022-12-28	WOS:000259648500005
J	Isberg, RR				Isberg, Ralph R.			Lasker-Koshland Award to 21st century microbe master	CELL			English	Editorial Material							GENETIC-ANALYSIS; BORDETELLA-PERTUSSIS; ESCHERICHIA-COLI; MOLECULAR NATURE; BACTERIAL; PATHOGENICITY; DETERMINANTS; ENTEROTOXIN; YERSINIA		[Isberg, Ralph R.] Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA; [Isberg, Ralph R.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Howard Hughes Medical Institute; Tufts University; Tufts University	Isberg, RR (corresponding author), Tufts Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02111 USA.	ralph.isberg@tufts.edu						Amieva MR, 2003, SCIENCE, V300, P1430, DOI 10.1126/science.1081919; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; CROSA JH, 1973, J BACTERIOL, V115, P904, DOI 10.1128/JB.115.3.904-911.1973; DALLAS WS, 1979, NATURE, V277, P406, DOI 10.1038/277406a0; Falkow S, 1970, N Engl J Med, V282, P693; FALKOW S, 1988, REV INFECT DIS, V10, pS274; Falkow S, 2004, NAT REV MICROBIOL, V2, P67, DOI 10.1038/nrmicro799; FALKOW S, 1961, GENETICS, V46, P703; FALKOW S, 1966, J MOL BIOL, V17, P102, DOI 10.1016/S0022-2836(66)80097-9; GILL R, 1978, J BACTERIOL, V136, P742, DOI 10.1128/JB.136.2.742-756.1978; ISBERG RR, 1985, CURR TOP MICROBIOL, V118, P1; JONES BD, 1994, J EXP MED, V180, P15, DOI 10.1084/jem.180.1.15; PORTNOY DA, 1983, J INFECT DIS, V148, P297, DOI 10.1093/infdis/148.2.297; SO M, 1976, J BACTERIOL, V128, P463, DOI 10.1128/JB.128.1.463-472.1976; WEISS AA, 1984, INFECT IMMUN, V43, P263, DOI 10.1128/IAI.43.1.263-269.1984	15	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 19	2008	134	6					907	910		10.1016/j.cell.2008.09.009	http://dx.doi.org/10.1016/j.cell.2008.09.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805081	Bronze			2022-12-28	WOS:000259318100008
J	Olefsky, JM				Olefsky, Jerrold M.			Fat talks, liver and muscle listen	CELL			English	Editorial Material							INSULIN ACTION	Fat metabolism and glucose homeostasis are processes that are highly interconnected. Cao et al. (2008) now take this concept a step further by identifying a fatty acid metabolite generated in adipose tissue that regulates insulin sensitivity in liver and muscle.	Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Olefsky, JM (corresponding author), Univ Calif San Diego, 9500 Gilman Dr, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD012303, P50HD012303] Funding Source: NIH RePORTER; NICHD NIH HHS [U54 HD012303, P50 HD012303] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Dimopoulos N, 2006, BIOCHEM J, V399, P473, DOI 10.1042/BJ20060244; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; MCGARRY JD, 1992, SCIENCE, V258, P766, DOI 10.1126/science.1439783; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Schenk S, 2008, J CLIN INVEST, V118, P2992, DOI 10.1172/JCI34260; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200	9	40	41	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 19	2008	134	6					914	916		10.1016/j.cell.2008.09.001	http://dx.doi.org/10.1016/j.cell.2008.09.001			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	349YB	18805083	Bronze			2022-12-28	WOS:000259318100010
J	Pearthree, PA; Spencer, JE; Faulds, JE; House, PK				Pearthree, Philip A.; Spencer, Jon E.; Faulds, James E.; House, P. Kyle			Comment on "age and evolution of the Grand Canyon revealed by U-Pb dating of water table-type speleothems"	SCIENCE			English	Editorial Material									[Pearthree, Philip A.; Spencer, Jon E.] Arizona Geol Survey, Tucson, AZ 85701 USA; [Faulds, James E.; House, P. Kyle] Univ Nevada, Nevada Bur Mines & Geol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Pearthree, PA (corresponding author), Arizona Geol Survey, 416 W Congress St,Suite 100, Tucson, AZ 85701 USA.	phil.pearthree@azgs.az.gov		House, Peter/0000-0002-0019-8075				Duebendorfer EM, 1998, GEOL SOC AM BULL, V110, P1574, DOI 10.1130/0016-7606(1998)110<1574:VIDASO>2.3.CO;2; Faulds J.E., 2001, COLORADO RIVER ORIGI, P81; Faulds J.E., 2001, COLORADO RIVER ORIGI, P93; Faulds JE, 1997, J GEOL, V105, P19, DOI 10.1086/606145; FAULDS JE, 2008, GEOLOGICAL SOC AM FI, V11, P119, DOI DOI 10.1130/2008.FLD011(06); Karlstrom KE, 2007, GEOL SOC AM BULL, V119, P1283, DOI 10.1130/0016-7606(2007)119[1283:AAFSOQ]2.0.CO;2; Lucchitta I., 1987, GEOL SOC AM CENTENNI, P365; Pederson J. L., 2008, GSA TODAY, V18, DOI [10.1130/GSAT01803A.1, DOI 10.1130/GSAT01803A.1]; Polyak V, 2008, SCIENCE, V319, P1377, DOI 10.1126/science.1151248; Spencer J.E., 2001, COLORADO RIVER ORIGI, P89; Young R. A., 2001, COLORADO RIVER ORIGI, V12, P199	11	7	8	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 19	2008	321	5896								10.1126/science.1158862	http://dx.doi.org/10.1126/science.1158862			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349RG	18801984				2022-12-28	WOS:000259300400015
J	Patel, V; Kirkwood, B				Patel, Vikram; Kirkwood, Betty			Perinatal depression treated by community health workers	LANCET			English	Editorial Material							MENTAL-HEALTH; INDIA; MOTHERS		[Patel, Vikram; Kirkwood, Betty] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Patel, V (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	vikram.patel@lshtm.ac.uk		Kirkwood, Betty/0000-0001-5274-6072; Patel, Vikram/0000-0003-1066-8584				Bolton P, 2003, JAMA-J AM MED ASSOC, V289, P3117, DOI 10.1001/jama.289.23.3117; Chandran M, 2002, BRIT J PSYCHIAT, V181, P499, DOI 10.1192/bjp.181.6.499; Patel V, 2006, BRIT J PSYCHIAT, V188, P284, DOI 10.1192/bjp.bp.105.012096; Patel V, 2004, BMJ-BRIT MED J, V328, P820, DOI 10.1136/bmj.328.7443.820; Patel V, 2002, AM J PSYCHIAT, V159, P43, DOI 10.1176/appi.ajp.159.1.43; Prince M, 2007, LANCET, V370, P859, DOI 10.1016/S0140-6736(07)61238-0; Rahman A, 2007, ARCH WOMEN MENT HLTH, V10, P211, DOI 10.1007/s00737-007-0193-9; Rahman A, 2003, PSYCHOL MED, V33, P1161, DOI 10.1017/S0033291703008286; Rahman A, 2008, LANCET, V372, P902, DOI 10.1016/S0140-6736(08)61400-2; Rahman A, 2008, TROP MED INT HEALTH, V13, P579, DOI 10.1111/j.1365-3156.2008.02036.x; Summerfield D, 2008, BRIT J PSYCHIAT, V192, P326, DOI 10.1192/bjp.bp.107.046961	11	17	17	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 13	2008	372	9642					868	869		10.1016/S0140-6736(08)61374-4	http://dx.doi.org/10.1016/S0140-6736(08)61374-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790294				2022-12-28	WOS:000259266900006
J	Munck, E; Bominaar, EL				Munck, Eckard; Bominaar, Emile L.			Chemistry - Bringing stability to highly reduced iron-sulfur clusters	SCIENCE			English	Editorial Material							AZOTOBACTER-VINELANDII; FE PROTEIN; NITROGENASE; ANALOG; MOSSBAUER; EPR		[Munck, Eckard; Bominaar, Emile L.] Carnegie Mellon Univ, Dept Chem, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Munck, E (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th St, Pittsburgh, PA 15213 USA.	emunck@cmu.edu; eb7g@andrew.cmu.edu						Angove HC, 1997, J AM CHEM SOC, V119, P8730, DOI 10.1021/ja9712837; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Deng L, 2008, J AM CHEM SOC, V130, P9878, DOI 10.1021/ja802111w; Guo ML, 2002, J AM CHEM SOC, V124, P12100, DOI 10.1021/ja026478f; Hans M, 2008, J BIOL INORG CHEM, V13, P563, DOI 10.1007/s00775-008-0345-z; HERSKOVITZ T, 1972, P NATL ACAD SCI USA, V69, P2437, DOI 10.1073/pnas.69.9.2437; Howard JB, 2006, P NATL ACAD SCI USA, V103, P17088, DOI 10.1073/pnas.0603978103; Lowery TJ, 2006, P NATL ACAD SCI USA, V103, P17131, DOI 10.1073/pnas.0603223103; OSULLIVAN T, 1985, J AM CHEM SOC, V107, P4096, DOI 10.1021/ja00299a066; Rao PV, 2004, CHEM REV, V104, P527, DOI 10.1021/cr020615+; Scott TA, 2005, P NATL ACAD SCI USA, V102, P9741, DOI 10.1073/pnas.0504258102; Strop P, 2001, BIOCHEMISTRY-US, V40, P651, DOI 10.1021/bi0016467; Yoo SJ, 1999, J AM CHEM SOC, V121, P2534, DOI 10.1021/ja9837405	13	19	19	1	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 12	2008	321	5895					1452	1453		10.1126/science.1163868	http://dx.doi.org/10.1126/science.1163868			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787157				2022-12-28	WOS:000259121800027
J	Kirkley, A; Birmingham, TB; Litchfield, RB; Giffin, JR; Willits, KR; Wong, CJ; Feagan, BG; Donner, A; Griffin, SH; D'Ascanio, LM; Pope, JE; Fowler, PJ				Kirkley, Alexandra; Birmingham, Trevor B.; Litchfield, Robert B.; Giffin, J. Robert; Willits, Kevin R.; Wong, Cindy J.; Feagan, Brian G.; Donner, Allan; Griffin, Sharon H.; D'Ascanio, Linda M.; Pope, Janet E.; Fowler, Peter J.			A randomized trial of arthroscopic surgery for osteoarthritis of the knee	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTHRITIS; QUESTIONNAIRE; PATIENT; DEBRIDEMENT; IMPROVEMENT; CRITERIA; OUTCOMES; THERAPY; INDEX; HIP	Background: The efficacy of arthroscopic surgery for the treatment of osteoarthritis of the knee is unknown. Methods: We conducted a single-center, randomized, controlled trial of arthroscopic surgery in patients with moderate-to-severe osteoarthritis of the knee. Patients were randomly assigned to surgical lavage and arthroscopic debridement together with optimized physical and medical therapy or to treatment with physical and medical therapy alone. The primary outcome was the total Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) score (range, 0 to 2400; higher scores indicate more severe symptoms) at 2 years of follow-up. Secondary outcomes included the Short Form-36 (SF-36) Physical Component Summary score (range, 0 to 100; higher scores indicate better quality of life). Results: Of the 92 patients assigned to surgery, 6 did not undergo surgery. Of the 86 patients assigned to control treatment, all received only physical and medical therapy. After 2 years, the mean (+/-SD) WOMAC score for the surgery group was 874+/-624, as compared with 897+/-583 for the control group (absolute difference [surgery-group score minus control-group score], -23+/-605; 95% confidence interval [CI], -208 to 161; P=0.22 after adjustment for baseline score and grade of severity). The SF-36 Physical Component Summary scores were 37.0+/-11.4 and 37.2+/-10.6, respectively (absolute difference, -0.2+/-11.1; 95% CI, -3.6 to 3.2; P=0.93). Analyses of WOMAC scores at interim visits and other secondary outcomes also failed to show superiority of surgery. Conclusions: Arthroscopic surgery for osteoarthritis of the knee provides no additional benefit to optimized physical and medical therapy. (ClinicalTrials.gov number, NCT00158431.). N Engl J Med 2008;359:1097-107.	[Kirkley, Alexandra; Birmingham, Trevor B.; Litchfield, Robert B.; Giffin, J. Robert; Willits, Kevin R.; Griffin, Sharon H.; D'Ascanio, Linda M.; Fowler, Peter J.] Univ Western Ontario, Fowler Kennedy Sport Med Clin, 3M Ctr, London, ON N6A 5K8, Canada; [Birmingham, Trevor B.] Univ Western Ontario, Fac Hlth Sci, London, ON N6A 5K8, Canada; [Wong, Cindy J.; Feagan, Brian G.; Donner, Allan] Univ Western Ontario, Robarts Clin Trials, Robarts Res Inst, London, ON N6A 5K8, Canada; [Kirkley, Alexandra; Litchfield, Robert B.; Giffin, J. Robert; Willits, Kevin R.; Fowler, Peter J.] Univ Western Ontario, Dept Surg, London, ON N6A 5K8, Canada; [Feagan, Brian G.; Pope, Janet E.] Univ Western Ontario, Dept Med, London, ON N6A 5K8, Canada; [Feagan, Brian G.; Donner, Allan] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON N6A 5K8, Canada; [Pope, Janet E.] St Josephs Hlth Care, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Litchfield, RB (corresponding author), Univ Western Ontario, Fowler Kennedy Sport Med Clin, 3M Ctr, London, ON N6A 5K8, Canada.	rlitchf@uwo.ca; bfeagan@robarts.ca	Litchfield, Robert/L-5867-2015; Feagan, Brian/G-3292-2011; Giffin, J. Robert/H-9522-2013; Pope, Janet/G-3342-2011; Griffin, Sharon/ABC-4345-2021; Birmingham, Trevor/G-3409-2013; Feagan, Brian G/M-4283-2015	Litchfield, Robert/0000-0002-7291-2610; Giffin, J. Robert/0000-0002-8227-0009; Pope, Janet/0000-0003-1479-5302; Birmingham, Trevor/0000-0002-3300-7677; 	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Supported by the Canadian Institutes of Health Research.	Agresti A, 2005, J R STAT SOC C-APPL, V54, P691, DOI 10.1111/j.1467-9876.2005.05437.x; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; ALTMAN RD, 1987, ARTHRITIS RHEUM-US, V30, P1214, DOI 10.1002/art.1780301103; Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Angst F, 2002, J RHEUMATOL, V29, P131; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bellamy N, 1995, WOMAC OSTEOARTHRITIS; Bhattacharyya T, 2003, J BONE JOINT SURG AM, V85A, P4, DOI 10.2106/00004623-200301000-00002; BLACKBURN WD, 1994, J RHEUMATOL, V21, P675; Chambers KG, 2002, NEW ENGL J MED, V347, P1717; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Ellis Thomas J, 2003, Curr Womens Health Rep, V3, P63; Ewing W, 2002, NEW ENGL J MED, V347, P1717; Felson DT, 2006, NEW ENGL J MED, V354, P2520; Felson DT, 2002, NEW ENGL J MED, V347, P132, DOI 10.1056/NEJMe020055; Gillespie William J, 2003, ACP J Club, V138, P49; GOLDSMITH CH, 1993, J RHEUMATOL, V20, P561; HAWKER G, IN PRESS J BONE JOIN; HOCHBERG MC, 1995, ARTHRITIS RHEUM, V38, P1541, DOI 10.1002/art.1780381104; Jackson RW, 2002, NEW ENGL J MED, V347, P1717; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kelly MA, 2006, J ARTHROPLASTY, V21, P9, DOI 10.1016/j.arth.2006.02.086; Kirkley A, 1999, J BONE JOINT SURG AM, V81A, P539, DOI 10.2106/00004623-199904000-00012; LORIG K, 1989, ARTHRITIS RHEUM, V32, P37, DOI 10.1002/anr.1780320107; LORIG K, 2000, ARTHRITIS HELPBOOK T; Morse LJ, 2002, NEW ENGL J MED, V347, P1718; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752; Poehling GG, 2002, ARTHROSCOPY, V18, P683, DOI 10.1053/jars.2002.36247; Ryzewicz M, 2007, CLIN ORTHOP RELAT R, P123, DOI 10.1097/BLO.0b013e31802fb9f3; *SAS I, 2001, SAS SYST SOFTW VERS; Siparsky P, 2007, CLIN ORTHOP RELAT R, P107, DOI 10.1097/BLO.0b013e31802fc18c; TORRANCE GW, 1987, J CHRON DIS, V40, P593, DOI 10.1016/0021-9681(87)90019-1; TUGWELL P, 1987, J RHEUMATOL, V14, P446; Van Baar ME, 1999, ARTHRITIS RHEUM-US, V42, P1361, DOI 10.1002/1529-0131(199907)42:7<1361::AID-ANR9>3.0.CO;2-9; Verhoeven AC, 2000, J RHEUMATOL, V27, P2801; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; 1963, ATLAS STANDARD RADIO, V2	39	445	471	1	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1097	1107		10.1056/NEJMoa0708333	http://dx.doi.org/10.1056/NEJMoa0708333			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	18784099				2022-12-28	WOS:000259078200005
J	Singer, RH				Singer, Robert H.			Highways for mRNA transport	CELL			English	Editorial Material							LOCALIZATION; CELLS	Two new studies reveal the role of microtubule polarity in the asymmetric localization of mRNAs. In this issue of Cell, Zimyanin et al. (2008) show that the asymmetric localization of oskar mRNA in fruit fly oocytes results from a slight bias in the direction of its transport. Meanwhile, Messitt et al. (2008) reporting in Developmental Cell find a subpopulation of microtubules that is critical for the asymmetric distribution of Vg1 mRNA in frog oocytes.	[Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA; [Singer, Robert H.] Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Dept Cell Biol & Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Singer, RH (corresponding author), Albert Einstein Coll Med, Gruss Lipper Biophoton Ctr, Dept Anat & Struct Biol, Bronx, NY 10461 USA.	rhsinger@aecom.yu.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084364] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM084364-17, R01 GM084364-15A1, R01 GM084364-18, R01 GM084364-16, R01 GM084364] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Dictenberg JB, 2008, DEV CELL, V14, P926, DOI 10.1016/j.devcel.2008.04.003; Eliscovich C, 2008, NAT CELL BIOL, V10, P858, DOI 10.1038/ncb1746; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; Fusco D, 2003, CURR BIOL, V13, P161, DOI 10.1016/S0960-9822(02)01436-7; MESSITT TJ, 2008, DEV CELL; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Shav-Tal Y, 2004, SCIENCE, V304, P1797, DOI 10.1126/science.1099754; Weil TT, 2008, CURR BIOL, V18, P1055, DOI 10.1016/j.cub.2008.06.046	9	11	11	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					722	723		10.1016/j.cell.2008.08.020	http://dx.doi.org/10.1016/j.cell.2008.08.020			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775304	Bronze, Green Accepted			2022-12-28	WOS:000258947500011
J	Lobino, M; Korystov, D; Kupchak, C; Figueroa, E; Sanders, BC; Lvovsky, AI				Lobino, Mirko; Korystov, Dmitry; Kupchak, Connor; Figueroa, Eden; Sanders, Barry C.; Lvovsky, A. I.			Complete characterization of quantum-optical processes	SCIENCE			English	Article							EQUIVALENCE	The technologies of quantum information and quantum control are rapidly improving, but full exploitation of their capabilities requires complete characterization and assessment of processes that occur within quantum devices. We present a method for characterizing, with arbitrarily high accuracy, and quantum optical process. Our protocol recovers complete knowledge of the process by studying, via homodyne tomography, its effect on a set of coherent states, that is, classical fields produced by common laser sources. We demonstrate the capability of our protocol by evaluating and experimentally verifying the effect of a test process on squeezed vacuum.	[Lobino, Mirko; Korystov, Dmitry; Kupchak, Connor; Figueroa, Eden; Sanders, Barry C.; Lvovsky, A. I.] Univ Calgary, Inst Quantum Informat Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Lvovsky, AI (corresponding author), Univ Calgary, Inst Quantum Informat Sci, Calgary, AB T2N 1N4, Canada.	lvov@ucalgary.ca	Lvovsky, Alexander/C-6830-2008; Lobino, Mirko/C-6503-2008; Sanders, Barry C/A-3891-2008	Lvovsky, Alexander/0000-0003-3165-6654; Lobino, Mirko/0000-0001-8091-8951; Sanders, Barry C/0000-0002-8326-8912	Natural Sciences and Engineering Research Council; Canadian Institute for Advanced Research; Informatics Circle of Research Excellence; Alberta Ingenuity Fund; Canada Foundation for Innovation; QuantumWorks	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Informatics Circle of Research Excellence; Alberta Ingenuity Fund; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); QuantumWorks	This work was supported by Natural Sciences and Engineering Research Council, Canadian Institute for Advanced Research (CIFAR), Informatics Circle of Research Excellence (iCORE), Alberta Ingenuity Fund, Canada Foundation for Innovation, and QuantumWorks. A.I.L. is a CIFAR scholar, and B.C.S. is a CIFAR associate.	Altepeter JB, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.193601; Appel J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093602; Appel J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.035802; Childs AM, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.012314; D'Ariano GM, 2001, PHYS REV LETT, V86, P4195, DOI 10.1103/PhysRevLett.86.4195; De Martini F, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062307; Gisin N, 2002, REV MOD PHYS, V74, P145, DOI 10.1103/RevModPhys.74.145; GLAUBER RJ, 1963, PHYS REV LETT, V10, P84, DOI 10.1103/PhysRevLett.10.84; KLAUDER JR, 1966, PHYS REV LETT, V16, P534, DOI 10.1103/PhysRevLett.16.534; Knill E, 2001, NATURE, V409, P46, DOI 10.1038/35051009; Leonhardt U., 1997, MEASURING QUANTUM ST; Lvovsky AI, 2004, J OPT B-QUANTUM S O, V6, pS556, DOI 10.1088/1464-4266/6/6/014; Mitchell MW, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.120402; Mohseni M, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.032322; Myrskog SH, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.013615; Nielsen MA, 1998, NATURE, V396, P52, DOI 10.1038/23891; Riebe M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.220407; Sudarshan E. C. G., 1963, PHYS REV LETT, V10, P277, DOI 10.1103/PhysRevLett.10.277; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259	22	105	106	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 24	2008	322	5901					563	566		10.1126/science.1162086	http://dx.doi.org/10.1126/science.1162086			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363WV	18818366	Green Submitted, Green Published			2022-12-28	WOS:000260299100036
J	Lin, GN; Xu, N; Xi, RW				Lin, Guonan; Xu, Na; Xi, Rongwen			Paracrine Wingless signalling controls self-renewal of Drosophila intestinal stem cells	NATURE			English	Article							EXPRESSION; ARMADILLO; NICHE; PROTEIN; MIDGUT; SHAGGY; ROLES; FATES	In the Drosophila midgut, multipotent intestinal stem cells (ISCs) that are scattered along the epithelial basement membrane maintain tissue homeostasis by their ability to steadily produce daughters that differentiate into either enterocytes or enteroendocrine cells, depending on the levels of Notch activity(1-3). However, the mechanisms controlling ISC self- renewal remain elusive. Here we show that a canonical Wnt signalling pathway controls ISC self-renewal. The ligand Wingless (Wg) is specifically expressed in the circular muscles next to ISCs, separated by a thin layer of basement membrane. Reduced function of wg causes ISC quiescence and differentiation, whereas wg overexpression produces excessive ISC- like cells that express high levels of the Notch ligand, Delta. Clonal analysis shows that the main downstream components of the Wg pathway, including Frizzled, Dishevelled and Armadillo, are autonomously required for ISC self- renewal. Furthermore, epistatic analysis suggests that Notch acts downstream of the Wg pathway and a hierarchy of Wg/Notch signalling pathways controls the balance between self- renewal and differentiation of ISCs. These data suggest that the underlying circular muscle constitutes the ISC niche, which produce Wg signals that act directly on ISCs to promote ISC self-renewal. This study demonstrates markedly conserved mechanisms regulating ISCs from Drosophila to mammals. The identification of the Drosophila ISC niche and the principal self- renewal signal will facilitate further understanding of intestinal homeostasis control and tumorigenesis.	[Lin, Guonan; Xu, Na; Xi, Rongwen] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Lin, Guonan] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Lin, Guonan] Chinese Acad Med Sci, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College	Xi, RW (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhongguancun Life Sci Pk, Beijing 102206, Peoples R China.	xirongwen@nibs.ac.cn			Chinese Ministry of Science and Technology [2007AA02Z1A2]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China)	We thank G. Struhl, L. Cooley, S. Hayashi, T. Xie, the Bloomington Stock Center for fly stocks, and members of the Xi laboratory for comments and discussions. This work was supported by an '863' grant 2007AA02Z1A2 to R.X. from the Chinese Ministry of Science and Technology.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BEJSOVEC A, 1991, DEVELOPMENT, V113, P471; Bhanot P, 1999, DEVELOPMENT, V126, P4175; Bourouis M, 2002, GENESIS, V34, P99, DOI 10.1002/gene.10114; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen CM, 1999, DEVELOPMENT, V126, P5441; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Heslip TR, 1997, DEVELOPMENT, V124, P1069; KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Nikolova G, 2007, TRENDS CELL BIOL, V17, P19, DOI 10.1016/j.tcb.2006.11.005; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pai LM, 1997, DEVELOPMENT, V124, P2255; PEIFER M, 1990, CELL, V63, P1167, DOI 10.1016/0092-8674(90)90413-9; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Song XQ, 2003, DEVELOPMENT, V130, P3259, DOI 10.1242/dev.00524; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X	24	249	254	3	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 23	2008	455	7216					1119	U11		10.1038/nature07329	http://dx.doi.org/10.1038/nature07329			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	363FG	18806781				2022-12-28	WOS:000260252600047
J	Collins, J				Collins, John			Modern approaches to teaching and learning anatomy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MEDICAL-SCHOOL; DISSECTION		[Collins, John] Royal Australasian Coll Surg, Melbourne, Vic 3000, Australia		Collins, J (corresponding author), Royal Australasian Coll Surg, Melbourne, Vic 3000, Australia.	john.collins@surgeons.org						*AUSTR COMM MED AU, 2006, WIMAX FOR, P1; BARROWS H S, 1968, British Journal of Medical Education, V2, P33; Collins JP, 2007, ANZ J SURG, V77, P497, DOI 10.1111/j.1445-2197.2007.04171.x; CRESSWELL A, 2007, AUSTRALIAN      0105; de Bere SR, 2006, SOC SCI MED, V63, P76, DOI 10.1016/j.socscimed.2005.12.011; Dobson R., 2007, BMJ-BRIT MED J, V334, P12; Ellis H, 2001, CLIN ANAT, V14, P149, DOI 10.1002/1098-2353(200103)14:2<149::AID-CA1023>3.0.CO;2-U; *GEN MED COUNC, 2003, TOM DOCT; Goodwin H, 2000, BRIT J SURG, V87, P977, DOI 10.1046/j.1365-2168.2000.01562.x; Gunderman RB, 2005, ACAD MED, V80, P745, DOI 10.1097/00001888-200508000-00008; McHanwell S, 2007, EUR J ANAT, V11, P3; McLachlan JC, 2006, MED EDUC, V40, P243, DOI 10.1111/j.1365-2929.2006.02401.x; MONKHOUSE WS, 1992, LANCET, V340, P834, DOI 10.1016/0140-6736(92)92695-C; Older J, 2004, SURG-J R COLL SURG E, V2, P79, DOI 10.1016/S1479-666X(04)80050-7; Raftery AT, 2007, SURGERY, V25, P1, DOI DOI 10.1016/J.MPSUR.2006.11.002; Ramsden P., 2003, LEARNING TEACH HIGHE; Reidenberg Joy S., 2002, Anatomical Record, V269, P81; Rizzolo Lawrence J, 2006, Anat Rec B New Anat, V289, P215, DOI 10.1002/ar.b.20117; Terrell Mark, 2006, Anatomical Record Part B:The New Anatomist, V289, P252, DOI 10.1002/ar.b.20116; Weatherall DJ, 2006, MED EDUC, V40, P195, DOI 10.1111/j.1365-2929.2006.02399.x; Winkelmann A, 2007, MED EDUC, V41, P15, DOI 10.1111/j.1365-2929.2006.02625.x	21	103	108	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2008	337	7671							a1310	10.1136/bmj.a1310	http://dx.doi.org/10.1136/bmj.a1310			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	354EP	18782839				2022-12-28	WOS:000259622000029
J	Lau, S				Lau, Susanne			Transition from childhood to adult asthma	LANCET			English	Editorial Material							1ST 6 YEARS; LUNG-FUNCTION; PHENOTYPES; BIRTH		[Lau, Susanne] Charite, Dept Paediat Pneumol & Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Lau, S (corresponding author), Charite, Dept Paediat Pneumol & Immunol, D-13353 Berlin, Germany.	Susanne.lau@charite.de						Dijkstra A, 2006, THORAX, V61, P105, DOI 10.1136/thx.2004.039271; Goksor E, 2008, PEDIATR PULM, V43, P396, DOI 10.1002/ppul.20798; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Haland G, 2006, NEW ENGL J MED, V355, P1682, DOI 10.1056/NEJMoa052885; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Matricardi PM, 2008, EUR RESPIR J, V32, P585, DOI 10.1183/09031936.00066307; Morgan WJ, 2005, AM J RESP CRIT CARE, V172, P1253, DOI 10.1164/rccm.200504-525OC; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Spycher BD, 2008, EUR RESPIR J, V31, P974, DOI 10.1183/09031936.00153507; Stein RT, 1997, THORAX, V52, P946, DOI 10.1136/thx.52.11.946; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6	11	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1014	1015		10.1016/S0140-6736(08)61419-1	http://dx.doi.org/10.1016/S0140-6736(08)61419-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805313				2022-12-28	WOS:000259648500006
J	Zagari, RM; Fuccio, L; Bazzoli, F				Zagari, Rocco Maurizio; Fuccio, Lorenzo; Bazzoli, Franco			Investigating dyspepsia	BMJ-BRITISH MEDICAL JOURNAL			English	Review							HELICOBACTER-PYLORI INFECTION; UPPER GASTROINTESTINAL CANCER; GASTROESOPHAGEAL REFLUX DISEASE; PROTON PUMP INHIBITOR; PRIMARY-CARE; UNINVESTIGATED DYSPEPSIA; ANTISECRETORY THERAPY; FUNCTIONAL DYSPEPSIA; RANDOMIZED-TRIAL; MANAGEMENT	Around 25-40% of adults have chronic and recurrent dyspeptic symptoms Most patients have no structural lesions and malignancy is rare, especially in Western populations Two empirical strategies show results - a non- invasive test for H pylori and treatment of H pylori positive patients with eradication therapy (test and treat), and empirical treatment with proton pump inhibitors The C-13- urea breath test and stool antigen test are the recommended non- invasive tests for H pylori infection. Patients should stop proton pump inhibitors two weeks before and antibiotics four weeks before performing either of these tests.	[Zagari, Rocco Maurizio; Fuccio, Lorenzo; Bazzoli, Franco] Univ Bologna, Dept Internal Med & Gastroenterol, I-40138 Bologna, Italy	University of Bologna	Bazzoli, F (corresponding author), Univ Bologna, Dept Internal Med & Gastroenterol, I-40138 Bologna, Italy.	franco.bazzoli@unibo.it	Fuccio, Lorenzo/A-2557-2010; Zagari, Rocco Maurizio/AAA-1836-2021	Fuccio, Lorenzo/0000-0001-8618-2447; 				Andrews CN, 2005, GASTROENTEROLOGY, V128, pA456, DOI 10.1053/j.gastro.2005.09.020; Baron JH, 2008, EUR J GASTROEN HEPAT, V20, P180, DOI 10.1097/MEG.0b013e3282f246a2; Bramble MG, 2000, GUT, V46, P464, DOI 10.1136/gut.46.4.464; Casburn-Jones AC, 2006, EUR J GASTROEN HEPAT, V18, P645, DOI 10.1097/00042737-200606000-00011; Chiba N, 2008, BMJ-BRIT MED J, V336, P623, DOI 10.1136/bmj.39497.622720.80; Delaney B, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001961.pub2; Delaney BC, 2008, BMJ-BRIT MED J, V336, P651, DOI 10.1136/bmj.39479.640486.AE; FUCCIO L, 2008, IN PRESS BMJ, V337, pA1454; Gisbert JP, 2004, ALIMENT PHARM THER, V20, P1001, DOI 10.1111/j.1365-2036.2004.02203.x; Gisbert JP, 2004, HELICOBACTER, V9, P347, DOI 10.1111/j.1083-4389.2004.00235.x; Ikenberry SO, 2007, GASTROINTEST ENDOSC, V66, P1071, DOI 10.1016/j.gie.2007.07.007; Jarbol DE, 2006, INT J TECHNOL ASSESS, V22, P362, DOI 10.1017/S0266462306051269; Jarbol DE, 2006, AM J GASTROENTEROL, V101, P1200, DOI 10.1038/ajg2006227; Kapoor N, 2005, GUT, V54, P40, DOI 10.1136/gut.2004.039438; Kjeldsen HC, 2007, INT J TECHNOL ASSESS, V23, P376, DOI 10.1017/S0266462307070420; KLAUSER AG, 1990, LANCET, V335, P205, DOI 10.1016/0140-6736(90)90287-F; Loy CT, 1996, AM J GASTROENTEROL, V91, P1138; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; McColl K, 2000, HELICOBACTER, V5, pS11; Moayyedi P, 2006, JAMA-J AM MED ASSOC, V295, P1566, DOI 10.1001/jama.295.13.1566; Moayyedi P, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002096.pub2, 10.1002/14651858.CD002096.pub4]; Moayyedi P, 2001, GASTROENTEROLOGY, V121, P1120, DOI 10.1053/gast.2001.29332; National Institute for Health and Clinical Excellence, 2004, DYSP MAN DYSP AD PRI, P17; Phull PS, 2006, ALIMENT PHARM THERAP, V23, P229, DOI 10.1111/j.1365-2036.2006.02744.x; Sung J, 2007, AM J GASTROENTEROL, V102, P473, DOI 10.1111/j.1572-0241.2007.01088_1.x; TACK J, 2005, AM J GASTROENTEROL, V100, P2324; Tack J, 2006, GASTROENTEROLOGY, V130, P1466, DOI 10.1053/j.gastro.2005.11.059; Talley NJ, 1998, J GASTROEN HEPATOL, V13, P335, DOI 10.1111/j.1440-1746.1998.tb00644.x; Thomson ABR, 2003, ALIMENT PHARM THER, V17, P1481, DOI 10.1046/j.1365-2036.2003.01646.x; van Zanten SJOV, 2005, CAN J GASTROENTEROL, V19, P285, DOI 10.1155/2005/674607	30	9	9	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	SEP 20	2008	337	7671							a1400	10.1136/bmj.a1400	http://dx.doi.org/10.1136/bmj.a1400			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354EP	18794180				2022-12-28	WOS:000259622000034
J	Arasteh, K; Des Jarlais, DC				Arasteh, Kamyar; Des Jarlais, Don C.			Injecting drug use, HIV, and what to do about it	LANCET			English	Editorial Material									[Arasteh, Kamyar; Des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10038 USA	Harvard University; Beth Israel Deaconess Medical Center	Arasteh, K (corresponding author), Beth Israel Deaconess Med Ctr, Baron Edmond de Rothschild Chem Dependency Inst, New York, NY 10038 USA.	karasteh@chpnet.org						Abdool R., 2006, AFRICAN J DRUG ALCOH, V5; Aceijas C, 2004, AIDS, V18, P2295, DOI 10.1097/00002030-200411190-00010; DESJARLAIS DC, 1995, JAMA-J AM MED ASSOC, V274, P1226, DOI 10.1001/jama.274.15.1226; Hien NT, 2004, AIDS EDUC PREV, V16, P137, DOI 10.1521/aeap.16.3.5.137.35527; Kruglov YV, 2008, SEX TRANSM INFECT, V84, pI37, DOI 10.1136/sti.2008.031195; Lu F, 2006, SEX TRANSM INFECT, V82, pIII87, DOI 10.1136/sti.2006.020404; MATHERS BM, 2008, LANCET          0924, DOI DOI 10.1016/S0140-6736(08)61311-2; Qian Han-Zhu, 2006, Harm Reduct J, V3, P4, DOI 10.1186/1477-7517-3-4; Quan VM, 2000, J ACQ IMMUN DEF SYND, V25, P360, DOI 10.1097/00126334-200012010-00011; Szekeres G, 2008, AIDS, V22, pS9, DOI 10.1097/01.aids.0000327432.82795.92; UNAIDS, 2008, REP GLOB AIDS EP; *WHO, 2003, HIV AIDS AS PAC REG, P43	12	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 15	2008	372	9651					1709	1710		10.1016/S0140-6736(08)61312-4	http://dx.doi.org/10.1016/S0140-6736(08)61312-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	374XV	18817969				2022-12-28	WOS:000261077900004
J	Lin, YX; Bloodgood, BL; Hauser, JL; Lapan, AD; Koon, AC; Kim, TK; Hu, LS; Malik, AN; Greenberg, ME				Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Lapan, Ariya D.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.			Activity-dependent regulation of inhibitory synapse development by Npas4	NATURE			English	Article							NEUROTROPHIC FACTOR; CRITICAL PERIOD; MICE DEFICIENT; 65-KDA ISOFORM; VISUAL-CORTEX; PLASTICITY; TRANSCRIPTION; EXPRESSION; GENES; MOUSE	Neuronal activity regulates the development and maturation of excitatory and inhibitory synapses in the mammalian brain. Several recent studies have identified signalling networks within neurons that control excitatory synapse development. However, less is known about the molecular mechanisms that regulate the activity- dependent development of GABA (gamma-aminobutyric acid)- releasing inhibitory synapses. Here we report the identification of a transcription factor, Npas4, that plays a role in the development of inhibitory synapses by regulating the expression of activity- dependent genes, which in turn control the number of GABA- releasing synapses that form on excitatory neurons. These findings demonstrate that the activity- dependent gene program regulates inhibitory synapse development, and suggest a new role for this program in controlling the homeostatic balance between synaptic excitation and inhibition.	[Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, Boston, MA 02115 USA; [Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Lin, Yingxi; Bloodgood, Brenda L.; Hauser, Jessica L.; Koon, Alex C.; Kim, Tae-Kyung; Hu, Linda S.; Malik, Athar N.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Lapan, Ariya D.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Malik, Athar N.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, FM Kirby Neurobiol Ctr, Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Kim, Tae-Kyung/AAX-4230-2020	Kim, Tae-Kyung/0000-0001-5161-9864; Hauser Chatterjee, Jessica/0000-0002-9992-1736; Bloodgood, Brenda/0000-0002-4797-9119; /0000-0002-7002-1275; Koon, Alex/0000-0002-4274-7052	F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital; Nancy Lurie Marks Family Foundation; Lefler Foundation postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award; Helen Hay Whitney postdoctoral fellowship; National Science Foundation Graduate Research Fellowship; Jane Coffin Childs Memorial Fund; Mental Retardation Research Center [HD18655]; National Institutes of Health [NS27572, NS48276]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048276, P01NS047572] Funding Source: NIH RePORTER	F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital; Nancy Lurie Marks Family Foundation; Lefler Foundation postdoctoral fellowship; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney postdoctoral fellowship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Jane Coffin Childs Memorial Fund; Mental Retardation Research Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Greenberg laboratory for suggestions; S. Paradis, J. M. Gray, S. S. Margolis, J. Zieg and C. M. Fletcher for reading the manuscript; S. Vasquez for preparing primary neuronal cell cultures; M. Thompson, Y. Zhou and H. Ye for assistance in generating Npas4<SUP>-/-</SUP> mice; T. Diefenbach and the Neurobiology Program Imaging Center for assistance with confocal microscopy; M. Fagiolini for help with dissection of the visual cortex; and X. J. Liu and C. Chen for help with electrophysiology. M. E. G. acknowledges the generous support of the F. M. Kirby Foundation to the Neurobiology Program of the Children's Hospital and support from the Nancy Lurie Marks Family Foundation. This work was supported by a Lefler Foundation postdoctoral fellowship (Y.L.), a Ruth L. Kirschstein National Research Service Award and a Helen Hay Whitney postdoctoral fellowship (B.L.B.), a National Science Foundation Graduate Research Fellowship (A.D.L.), the Jane Coffin Childs Memorial Fund (T.- K.K.) and Mental Retardation Research Center grant HD18655 and National Institutes of Health grants NS27572 and NS48276 (M.E.G.).	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; BENEVENTO LA, 1995, BRAIN RES, V689, P172, DOI 10.1016/0006-8993(95)00553-3; Benson DL, 1996, J NEUROSCI, V16, P6424; Brown P, 1996, BRAIN, V119, P309, DOI 10.1093/brain/119.1.309; Burrone J, 2002, NATURE, V420, P414, DOI 10.1038/nature01242; Buschges A, 1998, CURR OPIN NEUROBIOL, V8, P733, DOI 10.1016/S0959-4388(98)80115-3; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Flood WD, 2004, EUR J NEUROSCI, V20, P1819, DOI 10.1111/j.1460-9568.2004.03646.x; Foeller E, 2004, CURR OPIN NEUROBIOL, V14, P89, DOI 10.1016/j.conb.2004.01.011; Gomeza J, 2003, NEURON, V40, P797, DOI 10.1016/S0896-6273(03)00673-1; Hensch TK, 2005, NAT REV NEUROSCI, V6, P877, DOI 10.1038/nrn1787; Hester I, 2007, BRAIN RES, V1135, P1, DOI 10.1016/j.brainres.2006.11.083; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kash SF, 1997, P NATL ACAD SCI USA, V94, P14060, DOI 10.1073/pnas.94.25.14060; Kash SF, 1999, P NATL ACAD SCI USA, V96, P1698, DOI 10.1073/pnas.96.4.1698; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kenet T, 2007, P NATL ACAD SCI USA, V104, P7646, DOI 10.1073/pnas.0701944104; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Liu QR, 2006, BRAIN RES, V1067, P1, DOI 10.1016/j.brainres.2005.10.004; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Marty S, 2000, J NEUROSCI, V20, P8087; Micheva KD, 1997, CAN J PHYSIOL PHARM, V75, P470, DOI 10.1139/cjpp-75-5-470; Mohler H, 2006, J RECEPT SIG TRANSD, V26, P731, DOI 10.1080/10799890600920035; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Seil FJ, 1996, EXP NEUROL, V138, P327, DOI 10.1006/exnr.1996.0071; Seil FJ, 2000, J NEUROSCI, V20, P5367, DOI 10.1523/JNEUROSCI.20-14-05367.2000; Shamloo M, 2006, EUR J NEUROSCI, V24, P2705, DOI 10.1111/j.1460-9568.2006.05172.x; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Wassef A, 2003, J CLIN PSYCHOPHARM, V23, P601, DOI 10.1097/01.jcp.0000095349.32154.a5; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; WORLEY PF, 1990, PROG BRAIN RES, V86, P277; Xia ZG, 1996, J NEUROSCI, V16, P5425; Zhou PC, 2007, NEURON, V55, P53, DOI 10.1016/j.neuron.2007.05.030; Zito K, 2002, NEURON, V35, P1015, DOI 10.1016/S0896-6273(02)00903-0	50	383	392	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 30	2008	455	7217					1198	U23		10.1038/nature07319	http://dx.doi.org/10.1038/nature07319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366DZ	18815592	Green Accepted			2022-12-28	WOS:000260462100035
J	Gostin, L				Gostin, Lawrence			The right to bear arms - Constitutional law, politics, and public health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gostin, Lawrence] Georgetown Univ, Ctr Law, Oneill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, L (corresponding author), Georgetown Univ, Ctr Law, Oneill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu						Azrael D, 2000, SOC SCI MED, V50, P285, DOI 10.1016/S0277-9536(99)00283-X; BLOOMBERG MR, 2008, WALL STREET J   0630, pA11; Centers for Disease Control and Prevention, 2005, WEB BAS INJ STAT QUE; Cook PJ, 2000, GUN VIOLENCE REAL CO; HEMENWAY D, 2004, PRIVATE GUNS PUBLIC, P197; Hoyert Donna L, 2006, Natl Vital Stat Rep, V54, P1; LIPTAK A, 2008, NY TIMES        0525, pA1; MARTIN J, 2008, CBS NEWS        0701; Wiebe DJ, 2003, ACCIDENT ANAL PREV, V35, P711, DOI 10.1016/S0001-4575(02)00049-0; Wintemute GJ, 2008, NEW ENGL J MED, V358, P1421, DOI 10.1056/NEJMp0800859; 1999, NY TIMES        1221, pA28	11	3	3	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 1	2008	300	13					1575	1577		10.1001/jama.300.13.1575	http://dx.doi.org/10.1001/jama.300.13.1575			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354CY	18827213				2022-12-28	WOS:000259617700021
J	Nesbit, J; Bradford, M				Nesbit, Jeff; Bradford, Monica			2008 visualization challenge	SCIENCE			English	Editorial Material									[Nesbit, Jeff] Natl Sci Fdn, Off Legislat & Publ Affairs, Arlington, VA 22230 USA	National Science Foundation (NSF)	Nesbit, J (corresponding author), Natl Sci Fdn, Off Legislat & Publ Affairs, 4201 Wilson Blvd, Arlington, VA 22230 USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1767	1775		10.1126/science.321.5897.1767	http://dx.doi.org/10.1126/science.321.5897.1767			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818336				2022-12-28	WOS:000259501300011
J	Cai, L; Dalal, CK; Elowitz, MB				Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.			Frequency-modulated nuclear localization bursts coordinate gene regulation	NATURE			English	Article							TRANSCRIPTION FACTOR; PROTEIN EXPRESSION; GLOBAL ANALYSIS; CALCINEURIN; YEAST; OSCILLATIONS; VARIABILITY; NOISE; CELLS; DEPENDENCE	In yeast, the transcription factor Crz1 is dephosphorylated and translocates into the nucleus in response to extracellular calcium. Here we show, using time- lapse microscopy, that Crz1 exhibits short bursts of nuclear localization ( typically lasting 2 min) that occur stochastically in individual cells and propagate to the expression of downstream genes. Strikingly, calcium concentration controls the frequency, but not the duration, of localization bursts. Using an analytic model, we also show that this frequency modulation of bursts ensures proportional expression of multiple target genes across a wide dynamic range of expression levels, independent of promoter characteristics. We experimentally confirm this theory with natural and synthetic Crz1 target promoters. Another stress- response transcription factor, Msn2, exhibits similar, but largely uncorrelated, localization bursts under calcium stress suggesting that frequency- modulation regulation of localization bursts may be a general control strategy used by the cell to coordinate multi- gene responses to external signals.	[Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Howard Hughes Med Inst, Div Biol, Pasadena, CA 91125 USA; [Cai, Long; Dalal, Chiraj K.; Elowitz, Michael B.] CALTECH, Dept Appl Phys, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Elowitz, MB (corresponding author), CALTECH, Howard Hughes Med Inst, Div Biol, M-C 114-96, Pasadena, CA 91125 USA.	melowitz@caltech.edu		Dalal, Chiraj/0000-0002-3624-8409	Beckman Fellows Program at Caltech; National Institutes of Health [R01GM079771]; National Centers of Systems Biology, and the Packard Foundation [P50 GM068763]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079771, P50GM068763] Funding Source: NIH RePORTER	Beckman Fellows Program at Caltech; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Centers of Systems Biology, and the Packard Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Cyert for the CDRE and Crz1 mutant plasmids, K. Cunningham for the Crz1 overexpression plasmid pLE66, J. Stadler for the pGW845FRET plasmid, S. Ramanathan for image analysis code, and K. Thorn, C.- L. Guo and L. LeBon for technical assistance. We thank U. Alon, M. Carlson, M. Cyert, H. Garcia, R. Kishony, G. Lahav, J.-G. Ojalvo, I. Riedel-Kruse, B. Shraiman, G. Suel, members of the laboratory, and especially N. Friedman for discussions. L. C. is supported by the Beckman Fellows Program at Caltech. This work was supported by National Institutes of Health grants R01GM079771 and P50 GM068763 for National Centers of Systems Biology, and the Packard Foundation.	Adrian ED, 1926, J PHYSIOL-LONDON, V61, P151, DOI 10.1113/jphysiol.1926.sp002281; Armstrong EH, 1936, P IRE, V24, P689, DOI 10.1109/JRPROC.1936.227383; Bar-Even A, 2006, NAT GENET, V38, P636, DOI 10.1038/ng1807; Boustany LM, 2002, GENE DEV, V16, P608, DOI 10.1101/gad.967602; BREUDER T, 1994, P NATL ACAD SCI USA, V91, P5372, DOI 10.1073/pnas.91.12.5372; Cai L, 2006, NATURE, V440, P358, DOI 10.1038/nature04599; Cyert MS, 2001, J BIOL CHEM, V276, P20805, DOI 10.1074/jbc.R100012200; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; FEWTRELL C, 1993, ANNU REV PHYSIOL, V55, P427, DOI 10.1146/annurev.physiol.55.1.427; Friedman N, 2005, PLOS BIOL, V3, P1261, DOI 10.1371/journal.pbio.0030238; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Hersen P, 2008, P NATL ACAD SCI USA, V105, P7165, DOI 10.1073/pnas.0710770105; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Jacquet M, 2003, J CELL BIOL, V161, P497, DOI 10.1083/jcb.200303030; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; Kaufmann BB, 2007, CURR OPIN GENET DEV, V17, P107, DOI 10.1016/j.gde.2007.02.007; Kyriakis JM, 2007, BBA-MOL CELL RES, V1773, P1238, DOI 10.1016/j.bbamcr.2006.11.003; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Nachman I, 2007, CELL, V131, P544, DOI 10.1016/j.cell.2007.09.044; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rodriguez AJ, 2006, J CELL BIOL, V175, P67, DOI 10.1083/jcb.200512137; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Roy J, 2007, MOL CELL, V25, P889, DOI 10.1016/j.molcel.2007.02.014; Sarpeshkar R, 1998, NEURAL COMPUT, V10, P1601, DOI 10.1162/089976698300017052; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Song GB, 1999, J GUID CONTROL DYNAM, V22, P433, DOI 10.2514/2.4415; Stathopoulos AM, 1997, GENE DEV, V11, P3432, DOI 10.1101/gad.11.24.3432; Stathopoulos-Gerontides A, 1999, GENE DEV, V13, P798, DOI 10.1101/gad.13.7.798; Suel GM, 2007, SCIENCE, V315, P1716, DOI 10.1126/science.1137455; Wiesenberger G, 2007, EUKARYOT CELL, V6, P592, DOI 10.1128/EC.00382-06; Yoshimoto H, 2002, J BIOL CHEM, V277, P31079, DOI 10.1074/jbc.M202718200; Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623	48	352	359	2	70	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 25	2008	455	7212					485	U16		10.1038/nature07292	http://dx.doi.org/10.1038/nature07292			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	351TU	18818649	Green Accepted			2022-12-28	WOS:000259449600036
J	Barr, RG				Barr, R. Graham			Does paracetamol cause asthma in children? Time to remove the guesswork	LANCET			English	Editorial Material							ADULT-ONSET ASTHMA; INTOLERANT ASTHMA; ASPIRIN; ACETAMINOPHEN; POLYMORPHISMS; ASSOCIATION; PREVALENCE; IBUPROFEN; HEALTH		[Barr, R. Graham] Columbia Univ, Med Ctr, New York, NY 10032 USA	Columbia University	Barr, RG (corresponding author), Columbia Univ, Med Ctr, New York, NY 10032 USA.	rgb9@columbia.edu						Barr RG, 2007, AM J RESP CRIT CARE, V175, P120, DOI 10.1164/rccm.200603-411OC; Barr RG, 2004, AM J RESP CRIT CARE, V169, P836, DOI 10.1164/rccm.200304-596OC; Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Jenkins C, 2004, BMJ-BRIT MED J, V328, P434, DOI 10.1136/bmj.328.7437.434; Jinnai N, 2004, HUM MOL GENET, V13, P3203, DOI 10.1093/hmg/ddh332; Kim SH, 2005, CLIN EXP ALLERGY, V35, P585, DOI 10.1111/j.1365-2222.2005.02220.x; KORDANSKY D, 1978, ANN INTERN MED, V88, P508, DOI 10.7326/0003-4819-88-4-508; Kurth T, 2008, THORAX, V63, P514, DOI 10.1136/thx.2007.091447; Lesko SM, 1999, PEDIATRICS, V104, part. no., DOI 10.1542/peds.104.4.e39; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; MORSE NM, 1978, BERICHTE DTSCH CHEM, V11, P232; Park JS, 2005, PHARMACOGENET GENOM, V15, P483, DOI 10.1097/01.fpc.0000166456.84905.a0; Varner AE, 1998, ANN ALLERG ASTHMA IM, V81, P347, DOI 10.1016/S1081-1206(10)63127-4	14	16	16	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 20	2008	372	9643					1011	1012		10.1016/S0140-6736(08)61417-8	http://dx.doi.org/10.1016/S0140-6736(08)61417-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354OI	18805311				2022-12-28	WOS:000259648500004
J	van Weel, C; De Maeseneer, J; Roberts, R				van Weel, Chris; De Maeseneer, Jan; Roberts, Richard			Integration of personal and community health care	LANCET			English	Editorial Material							GUIDELINES		[van Weel, Chris] Radboud Univ Nijmegen, Med Ctr, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands; [De Maeseneer, Jan] Univ Ghent, Dept Family Med & Primary Hlth Care, B-9000 Ghent, Belgium; [De Maeseneer, Jan] Network Towards Unity Hlth, Maastricht, Netherlands; [Roberts, Richard] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Radboud University Nijmegen; Ghent University; University of Wisconsin System; University of Wisconsin Madison	van Weel, C (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Gen Practice, NL-6500 HB Nijmegen, Netherlands.	c.vanweel@hag.umcn.nl	van Weel, Chris/D-4375-2009	van Weel, Chris/0000-0003-3653-4701				[Anonymous], 1978, INT C PRIM HLTH CAR; Art B, 2007, ED HLTH, V20, P1; BADIA JG, 1996, ALLMANMEDICIN S18, V17, P22; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; CHAN M, 2006, COMMUNICATION   1109; Gorey TM, 2004, ANN FAM MED, V2, pS3, DOI 10.1370/afm.130; Green LA, 2001, NEW ENGL J MED, V344, P2021, DOI 10.1056/NEJM200106283442611; McWhinney I, 1997, TXB FAMILY MED; SIEGRIST J, 2006, SOCIAL INEQUALITIES; Starfield B, 2005, MILBANK Q, V83, P457, DOI 10.1111/j.1468-0009.2005.00409.x; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1	11	25	25	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 13	2008	372	9642					871	872		10.1016/S0140-6736(08)61376-8	http://dx.doi.org/10.1016/S0140-6736(08)61376-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	349FO	18790296				2022-12-28	WOS:000259266900008
J	Forde, SE; Beardmore, RE; Gudelj, I; Arkin, SS; Thompson, JN; Hurst, LD				Forde, Samantha E.; Beardmore, Robert E.; Gudelj, Ivana; Arkin, Sinan S.; Thompson, John N.; Hurst, Laurence D.			Understanding the limits to generalizability of experimental evolutionary models	NATURE			English	Article							HOST-PARASITOID INTERACTION; ESCHERICHIA-COLI; BACTERIA; COEVOLUTION; PHAGE; COMMUNITIES; ADAPTATION; RESISTANCE; GENETICS; VIRUS	Given the difficulty of testing evolutionary and ecological theory in situ, in vitro model systems are attractive alternatives(1); however, can we appraise whether an experimental result is particular to the in vitro model, and, if so, characterize the systems likely to behave differently and understand why? Here we examine these issues using the relationship between phenotypic diversity and resource input in the T7 - Escherichia coli co- evolving system as a case history. We establish a mathematical model of this interaction, framed as one instance of a super- class of host - parasite co- evolutionary models, and show that it captures experimental results. By tuning this model, we then ask how diversity as a function of resource input could behave for alternative co- evolving partners ( for example, E. coli with lambda bacteriophages). In contrast to populations lacking bacteriophages, variation in diversity with differences in resources is always found for co- evolving populations, supporting the geographic mosaic theory of co- evolution(2). The form of this variation is not, however, universal. Details of infectivity are pivotal: in T7 - E. coli with a modified gene- for- gene interaction, diversity is low at high resource input, whereas, for matching- allele interactions, maximal diversity is found at high resource input. A combination of in vitro systems and appropriately configured mathematical models is an effective means to isolate results particular to the in vitro system, to characterize systems likely to behave differently and to understand the biology underpinning those alternatives.	[Hurst, Laurence D.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Forde, Samantha E.; Thompson, John N.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA; [Beardmore, Robert E.; Gudelj, Ivana; Arkin, Sinan S.] Univ London Imperial Coll Sci Technol & Med, Dept Math, London SW7 2AZ, England; [Gudelj, Ivana] Univ Bath, Dept Math Sci, Bath BA2 7AY, Avon, England	University of Bath; University of California System; University of California Santa Cruz; Imperial College London; University of Bath	Hurst, LD (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	l.d.hurst@bath.ac.uk	; Hurst, Laurence/F-9215-2010	Arkin, Sinan/0000-0001-7805-4015; Hurst, Laurence/0000-0002-1002-1054	NERC Advanced Fellowship; ORS award; Department of Mathematics at Imperial College London; National Science Foundation [DEB 0515598]; EPSRC [EP/F037856/1] Funding Source: UKRI; NERC [NE/E013007/2] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F037856/1] Funding Source: researchfish; Natural Environment Research Council [NE/B501998/2, NE/B501998/1, NE/E013007/2] Funding Source: researchfish	NERC Advanced Fellowship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ORS award; Department of Mathematics at Imperial College London; National Science Foundation(National Science Foundation (NSF)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank A. Buckling, S. Nuismer, K. Rich, J. Hoeksema and C. Jessup for their comments on an earlier version of this manuscript. L. D. H. is a Royal Society Wolfson Research Merit Award Holder. I. G. is supported by a NERC Advanced Fellowship. S. S. A. is funded by an ORS award and a studentship for the Department of Mathematics at Imperial College London. S. E. F. and J. N. T. are supported by the National Science Foundation DEB 0515598.	Agrawal A, 2002, EVOL ECOL RES, V4, P79; Bohannan BJM, 2002, ANTON LEEUW INT J G, V81, P107, DOI 10.1023/A:1020585711378; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; CHAO L, 1977, ECOLOGY, V58, P369, DOI 10.2307/1935611; Ferris MT, 2007, GENETICS, V176, P1013, DOI 10.1534/genetics.106.064634; Forde SE, 2007, AM NAT, V169, P794, DOI 10.1086/516848; Forde SE, 2004, NATURE, V431, P841, DOI 10.1038/nature02906; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; KRUGER DH, 1981, MICROBIOL REV, V45, P9; LENSKI RE, 1985, AM NAT, V125, P585, DOI 10.1086/284364; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Poullain V, 2008, EVOLUTION, V62, P1, DOI 10.1111/j.1558-5646.2007.00260.x; Qimron U, 2006, P NATL ACAD SCI USA, V103, P19039, DOI 10.1073/pnas.0609428103; Sasaki A, 1999, P ROY SOC B-BIOL SCI, V266, P455, DOI 10.1098/rspb.1999.0659; SEN K, 1991, J BACTERIOL, V173, P926, DOI 10.1128/jb.173.2.926-928.1991; SPANAKIS E, 1987, J GEN MICROBIOL, V133, P353; TAMAKI S, 1971, J BACTERIOL, V105, P968, DOI 10.1128/JB.105.3.968-975.1971; Thompson J.N., 2005, INTERSPEC INTERACT; Wade MJ, 2007, NAT REV GENET, V8, P185, DOI 10.1038/nrg2031; Weitz JS, 2005, P NATL ACAD SCI USA, V102, P9535, DOI 10.1073/pnas.0504062102; Yoshida T, 2004, P ROY SOC B-BIOL SCI, V271, P1947, DOI 10.1098/rspb.2004.2818	21	32	33	0	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	SEP 11	2008	455	7210					220	U44		10.1038/nature07152	http://dx.doi.org/10.1038/nature07152			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	346SZ	18784724	Green Submitted			2022-12-28	WOS:000259090800046
J	Berger, JM				Berger, James M.			SnapShot: Nucleic acid helicases and translocases	CELL			English	Editorial Material							MECHANISMS		Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Berger, JM (corresponding author), Univ Calif Berkeley, Calif Inst Quantitat Biol, Berkeley, CA 94720 USA.				NIGMS NIH HHS [R01 GM071747] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071747] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burroughs A. M., 2007, V3, P48, DOI 10.1159/000107603; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Gallant P, 2007, TRENDS CELL BIOL, V17, P187, DOI 10.1016/j.tcb.2007.02.005; Lohman TM, 2008, NAT REV MOL CELL BIO, V9, P391, DOI 10.1038/nrm2394; Mackintosh SG, 2006, NUCLEIC ACIDS RES, V34, P4154, DOI 10.1093/nar/gkl501; Patel SS, 2006, J BIOL CHEM, V281, P18265, DOI 10.1074/jbc.R600008200; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300	10	31	34	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 5	2008	134	5							888.e1	10.1016/j.cell.2008.08.027	http://dx.doi.org/10.1016/j.cell.2008.08.027			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775318	Green Accepted, Bronze			2022-12-28	WOS:000258947500027
J	Moldon, A; Malapeira, J; Gabrielli, N; Gogol, M; Gomez-Escoda, B; Ivanova, T; Seidel, C; Ayte, J				Moldon, Alberto; Malapeira, Jordi; Gabrielli, Natalia; Gogol, Madelaine; Gomez-Escoda, Blanca; Ivanova, Tsvetomira; Seidel, Chris; Ayte, Jose			Promoter-driven splicing regulation in fission yeast	NATURE			English	Article							FORKHEAD TRANSCRIPTION FACTORS; DNA-BINDING-DOMAIN; RNA-POLYMERASE-II; SCHIZOSACCHAROMYCES-POMBE; BUDDING YEASTS; MEIOSIS; PROGRAM; SPORULATION; PROTEINS; ENCODES	The meiotic cell cycle is modified from the mitotic cell cycle by having a pre- meiotic S phase that leads to high levels of recombination, two rounds of nuclear division with no intervening DNA synthesis and a reductional pattern of chromosome segregation. Rem1 is a cyclin that is only expressed during meiosis in the fission yeast Schizosaccharomyces pombe. Cells in which rem1 has been deleted show decreased intragenic meiotic recombination and a delay at the onset of meiosis I ( ref. 1). When ectopically expressed in mitotically growing cells, Rem1 induces a G1 arrest followed by severe mitotic catastrophes. Here we show that rem1 expression is regulated at the level of both transcription and splicing, encoding two proteins with different functions depending on the intron retention. We have determined that the regulation of rem1 splicing is not dependent on any transcribed region of the gene. Furthermore, when the rem1 promoter is fused to other intron-containing genes, the chimaeras show a meiotic- specific regulation of splicing, exactly the same as endogenous rem1. This regulation is dependent on two transcription factors of the forkhead family, Mei4 ( ref. 2) and Fkh2 ( ref. 3). Whereas Mei4 induces both transcription and splicing of rem1, Fkh2 is responsible for the intron retention of the transcript during vegetative growth and the pre- meiotic S phase.	[Moldon, Alberto; Malapeira, Jordi; Gabrielli, Natalia; Gomez-Escoda, Blanca; Ivanova, Tsvetomira; Ayte, Jose] Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, Barcelona 08003, Spain; [Gogol, Madelaine] Stowers Inst, Kansas City, MO 64110 USA	Pompeu Fabra University; Stowers Institute for Medical Research	Ayte, J (corresponding author), Univ Pompeu Fabra, Oxidat Stress & Cell Cycle Grp, C Doctor Aiguader 88, Barcelona 08003, Spain.	jose.ayte@upf.edu	Ayte, Jose/L-5217-2014; Gomez-Escoda, Blanca/T-1256-2019; Malapeira, Jordi/I-7956-2014	Ayte, Jose/0000-0002-6354-0536; Gomez Escoda, Blanca/0000-0001-9999-0806; Malapeira, Jordi/0000-0003-3503-1272; Gogol, Madelaine/0000-0002-8738-0995	Ministerio de Ciencia y Tecnologia [BFU2006-01785]; Consolider-Ingenio	Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Consolider-Ingenio(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	We thank P. Nurse, K. Gould, C. Query, N. Kaufer, H. Murakami and C. McInerny for strains and plasmids; J. Wuand Y. Zhurinskiy for help and advice on ChIPs; E. Hidalgo, J. Valcarcel, J. Vilardell and G. Gil for critical reading of the manuscript; and members of the Oxidative Stress and Cell Cycle Group at Universitat Pompeu Fabra and P. Nurse's laboratory at Rockefeller University for suggestions and comments. We acknowledge the technical support of M. Carmona and K. Zueckert-Gaudenz. J. A. is supported by a contract Ramon y Cajal from the Ministerio de Educacion y Ciencia. This work was supported by grants from the Ministerio de Ciencia y Tecnologia (BFU2006-01785) and the Consolider-Ingenio 2007-0020.	Averbeck N, 2005, MOL CELL, V18, P491, DOI 10.1016/j.molcel.2005.04.007; Ayte J, 2001, NAT CELL BIOL, V3, P1043, DOI 10.1038/ncb1201-1043; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Buck V, 2004, J CELL SCI, V117, P5623, DOI 10.1242/jcs.01473; Bulmer R, 2004, EUKARYOT CELL, V3, P944, DOI 10.1128/EC.3.4.944-954.2004; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Castillo EA, 2002, MOL MICROBIOL, V45, P243, DOI 10.1046/j.1365-2958.2002.03020.x; Chu S, 1998, SCIENCE, V282, P699, DOI 10.1126/science.282.5389.699; Cramer P, 1997, P NATL ACAD SCI USA, V94, P11456, DOI 10.1073/pnas.94.21.11456; Harigaya Y, 2006, NATURE, V442, P45, DOI 10.1038/nature04881; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Horie S, 1998, MOL CELL BIOL, V18, P2118, DOI 10.1128/MCB.18.4.2118; Huang T, 2002, EMBO J, V21, P5516, DOI 10.1093/emboj/cdf555; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Malapeira J, 2005, MOL CELL BIOL, V25, P6330, DOI 10.1128/MCB.25.15.6330-6337.2005; Mata J, 2002, NAT GENET, V32, P143, DOI 10.1038/ng951; MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morillon A, 2003, SCIENCE, V300, P492, DOI 10.1126/science.1081379; Murakami H, 1999, GENE DEV, V13, P2581, DOI 10.1101/gad.13.19.2581; Newo ANS, 2007, NUCLEIC ACIDS RES, V35, P1391, DOI 10.1093/nar/gkl1144; NIELSEN O, 1990, EMBO J, V9, P1401, DOI 10.1002/j.1460-2075.1990.tb08255.x; Ohi MD, 2002, MOL CELL BIOL, V22, P2011, DOI 10.1128/MCB.22.7.2011-2024.2002; Primig M, 2000, NAT GENET, V26, P415, DOI 10.1038/82539; Ribar B, 1997, GENE, V202, P1, DOI 10.1016/S0378-1119(97)00390-9; Sinibaldi R, 2001, Methods Mol Biol, V170, P211; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Szilagyi Z, 2005, GENE, V348, P101, DOI 10.1016/j.gene.2004.12.043	29	63	63	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 16	2008	455	7215					997	U83		10.1038/nature07325	http://dx.doi.org/10.1038/nature07325			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	360DW	18815595	Green Submitted, Green Published			2022-12-28	WOS:000260038300057
J	Tierney, JE; Russell, JM; Huang, YS; Damste, JSS; Hopmans, EC; Cohen, AS				Tierney, Jessica E.; Russell, James M.; Huang, Yongsong; Damste, Jaap S. Sinninghe; Hopmans, Ellen C.; Cohen, Andrew S.			Northern hemisphere controls on tropical southeast African climate during the past 60,000 years	SCIENCE			English	Article							INTERTROPICAL CONVERGENCE ZONE; LAST; PRECIPITATION; DIPOLE; RECORD; MODEL	The processes that control climate in the tropics are poorly understood. We applied compound-specific hydrogen isotopes (delta D) and the TEX86 (tetraether index of 86 carbon atoms) temperature proxy to sediment cores from Lake Tanganyika to independently reconstruct precipitation and temperature variations during the past 60,000 years. Tanganyika temperatures follow Northern Hemisphere insolation and indicate that warming in tropical southeast Africa during the last glacial termination began to increase similar to 3000 years before atmospheric carbon dioxide concentrations. delta D data show that this region experienced abrupt changes in hydrology coeval with orbital and millennial-scale events recorded in Northern Hemisphere monsoonal climate records. This implies that precipitation in tropical southeast Africa is more strongly controlled by changes in Indian Ocean sea surface temperatures and the winter Indian monsoon than by migration of the Intertropical Convergence Zone.	[Tierney, Jessica E.; Russell, James M.; Huang, Yongsong] Brown Univ, Dept Geol Sci, Providence, RI 02912 USA; [Damste, Jaap S. Sinninghe; Hopmans, Ellen C.] Netherlands Inst Sea Res, NIOZ, Dept Marine Organ Biogeochem, NL-1790 AB Den Burg, Netherlands; [Cohen, Andrew S.] Univ Arizona, Dept Geosci, Tucson, AZ 85721 USA	Brown University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); University of Arizona	Tierney, JE (corresponding author), Brown Univ, Dept Geol Sci, Providence, RI 02912 USA.	Jessica_Tierney@brown.edu	Damste, Jaap S Sinninghe/F-6128-2011	Damste, Jaap S Sinninghe/0000-0002-8683-1854; Tierney, Jessica/0000-0002-9080-9289	Nyanza Project [NSF-ATM 0223920, BIO 0383765]; National Defense Science and Engineering Graduate Fellowship;  [NSF-EAR 0639474]	Nyanza Project; National Defense Science and Engineering Graduate Fellowship; 	We thank two anonymous reviewers for their insightful comments; S. Schouten, S. Clemens, and T. Herbert for their suggestions on earlier drafts of the manuscript; and M. Alexandre, N. Meyer, J. Ossebaar, and I. Castaneda for analytical assistance. This research was supported by NSF-EAR 0639474 to J.R., the Nyanza Project (grants NSF-ATM 0223920 and BIO 0383765, to A.C.), and the National Defense Science and Engineering Graduate Fellowship to J.T. The authors declare that they have no competing financial interests.	Abram NJ, 2007, NATURE, V445, P299, DOI 10.1038/nature05477; Alley RB, 1999, ANNU REV EARTH PL SC, V27, P149, DOI 10.1146/annurev.earth.27.1.149; Barker P, 2003, QUATERNARY SCI REV, V22, P823, DOI 10.1016/S0277-379(03)00010-6; Bonnefille R, 2000, GLOBAL PLANET CHANGE, V26, P25, DOI 10.1016/S0921-8181(00)00032-1; Brown ET, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031240; Bush ABG, 2002, GLOBAL PLANET CHANGE, V32, P331, DOI 10.1016/S0921-8181(02)00074-7; Castaneda IS, 2007, GEOLOGY, V35, P823, DOI 10.1130/G23916A.1; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; Garcin Y, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025531; Gasse F, 2000, QUATERNARY SCI REV, V19, P189, DOI 10.1016/S0277-3791(99)00061-X; Haug GH, 2001, SCIENCE, V293, P1304, DOI 10.1126/science.1059725; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Higginson MJ, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001031; Hou JZ, 2008, GEOCHIM COSMOCHIM AC, V72, P3503, DOI 10.1016/j.gca.2008.04.030; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Kim JH, 2008, GEOCHIM COSMOCHIM AC, V72, P1154, DOI 10.1016/j.gca.2007.12.010; Lea DW, 2003, SCIENCE, V301, P1361, DOI 10.1126/science.1088470; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moy CM, 2002, NATURE, V420, P162, DOI 10.1038/nature01194; Powers LA, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL022014; Powers LA, 2004, GEOLOGY, V32, P613, DOI 10.1130/G20434.1; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43854; Schefuss E, 2005, NATURE, V437, P1003, DOI 10.1038/nature03945; Shuman B, 2006, QUATERNARY SCI REV, V25, P2992, DOI 10.1016/j.quascirev.2006.02.021; Tierney JE, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029508; Vuille M, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2005JD006022; Wang X, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2007GL030766, 10.1029/2007GL031149]; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Webster PJ, 1998, J GEOPHYS RES-OCEANS, V103, P14451, DOI 10.1029/97JC02719; Yancheva G, 2007, NATURE, V445, P74, DOI 10.1038/nature05431; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220; Zhu Y, 1998, MON WEATHER REV, V126, P725, DOI 10.1175/1520-0493(1998)126<0725:APAFMF>2.0.CO;2	32	414	433	6	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 10	2008	322	5899					252	255		10.1126/science.1160485	http://dx.doi.org/10.1126/science.1160485			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	358FK	18787132				2022-12-28	WOS:000259902300046
J	Mimitou, EP; Symington, LS				Mimitou, Eleni P.; Symington, Lorraine S.			Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing	NATURE			English	Article							SACCHAROMYCES-CEREVISIAE; HOMOLOGOUS RECOMBINATION; SYNDROME HELICASE; MRE11 COMPLEX; REPAIR; CHECKPOINT; PROTEINS; DAMAGE; YEAST; INTERACTS	DNA ends exposed after introduction of double- strand breaks ( DSBs) undergo 5 '-3 ' nucleolytic degradation to generate single- stranded DNA, the substrate for binding by the Rad51 protein to initiate homologous recombination. This process is poorly understood in eukaryotes, but several factors have been implicated, including the Mre11 complex ( Mre11 - Rad50 - Xrs2/ NBS1), Sae2/ CtIP/ Ctp1 and Exo1. Here we demonstrate that yeast Exo1 nuclease and Sgs1 helicase function in alternative pathways for DSB processing. Novel, partially resected intermediates accumulate in a double mutant lacking Exo1 and Sgs1, which are poor substrates for homologous recombination. The early processing step that generates partly resected intermediates is dependent on Sae2. When Sae2 is absent, in addition to Exo1 and Sgs1, unprocessed DSBs accumulate and homology- dependent repair fails. These results suggest a two- step mechanism for DSB processing during homologous recombination. First, the Mre11 complex and Sae2 remove a small oligonucleotide( s) from the DNA ends to form an early intermediate. Second, Exo1 and/ or Sgs1 rapidly process this intermediate to generate extensive tracts of single- stranded DNA that serve as substrate for Rad51.	[Mimitou, Eleni P.; Symington, Lorraine S.] Columbia Univ, Med Ctr, Dept Microbiol, New York, NY 10032 USA	Columbia University	Symington, LS (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	lss5@columbia.edu			National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041784] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank M. Lichten, J. McCusker, A. Rattray and R. Rothstein for gifts of strains and plasmids, and W. K. Holloman and R. Rothstein for comments on the manuscript. This study was supported by a grant from the National Institutes of Health.	Amundsen SK, 2003, CELL, V112, P741, DOI 10.1016/S0092-8674(03)00197-1; Baron U, 2000, METHOD ENZYMOL, V327, P401, DOI 10.1016/S0076-6879(00)27292-3; Bennett RJ, 1999, J MOL BIOL, V289, P235, DOI 10.1006/jmbi.1999.2739; Borde V, 1999, MOL CELL BIOL, V19, P4832; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Clerici M, 2006, EMBO REP, V7, P212, DOI 10.1038/sj.embor.7400593; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Ivanov EL, 1996, GENETICS, V142, P693; Jazayeri A, 2008, EMBO J, V27, P1953, DOI 10.1038/emboj.2008.128; Karmakar P, 2006, BIOCHEM BIOPH RES CO, V348, P62, DOI 10.1016/j.bbrc.2006.07.037; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Lee SE, 1998, CELL, V94, P399, DOI 10.1016/S0092-8674(00)81482-8; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Llorente B, 2004, MOL CELL BIOL, V24, P9682, DOI 10.1128/MCB.24.21.9682-9694.2004; Lobachev KS, 2002, CELL, V108, P183, DOI 10.1016/S0092-8674(02)00614-1; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mozlin AM, 2008, GENETICS, V178, P113, DOI 10.1534/genetics.107.082677; Mullen JR, 2000, GENETICS, V154, P1101; Nelms BE, 1998, SCIENCE, V280, P590, DOI 10.1126/science.280.5363.590; NICKOLOFF JA, 1989, J MOL BIOL, V207, P527, DOI 10.1016/0022-2836(89)90462-2; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Rattray AJ, 2001, GENETICS, V158, P109; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Sherman F., 1986, METHODS YEAST GENETI; Tran PT, 2004, DNA REPAIR, V3, P1549, DOI 10.1016/j.dnarep.2004.05.015; van Brabant AJ, 2000, BIOCHEMISTRY-US, V39, P14617, DOI 10.1021/bi0018640; Vaze MB, 2002, MOL CELL, V10, P373, DOI 10.1016/S1097-2765(02)00593-2; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; WHITE CI, 1990, EMBO J, V9, P663, DOI 10.1002/j.1460-2075.1990.tb08158.x; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	37	742	753	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 9	2008	455	7214					770	U3		10.1038/nature07312	http://dx.doi.org/10.1038/nature07312			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	357OB	18806779	Green Accepted			2022-12-28	WOS:000259854900040
J	Obama, B				Obama, Barack			Modern health care for all Americans	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	19	20	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 9	2008	359	15					1537	1541		10.1056/NEJMp0807677	http://dx.doi.org/10.1056/NEJMp0807677			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	358FS	18815388				2022-12-28	WOS:000259903100001
J	Karoui, M; Bucur, PO				Karoui, Mehdi; Bucur, Petru Octav			Pneumopericardium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Karoui, Mehdi; Bucur, Petru Octav] Hop Henri Mondor, F-94010 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Karoui, M (corresponding author), Hop Henri Mondor, F-94010 Creteil, France.								0	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	OCT 2	2008	359	14					E16	E16		10.1056/NEJMicm074422	http://dx.doi.org/10.1056/NEJMicm074422			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	354ID	18832240				2022-12-28	WOS:000259631700011
J	Christakis, NA				Christakis, Nicholas A.			Valuing the well connected	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Christakis, Nicholas A.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Christakis, Nicholas A.] Mt Auburn Hosp, Cambridge, MA USA	Harvard University; Harvard University; Mount Auburn Hospital	Christakis, NA (corresponding author), Harvard Univ, Sch Med, Cambridge, MA 02138 USA.	christak@hcp.med.harvard.edu	Christakis, Nicholas A/C-3205-2009						0	2	2	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	SEP 27	2008	337	7672							a1675	10.1136/bmj.a1675	http://dx.doi.org/10.1136/bmj.a1675			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	356SJ	18812367				2022-12-28	WOS:000259797600035
J	Cai, WW; Piner, RD; Stadermann, FJ; Park, S; Shaibat, MA; Ishii, Y; Yang, DX; Velamakanni, A; An, SJ; Stoller, M; An, JH; Chen, DM; Ruoff, RS				Cai, Weiwei; Piner, Richard D.; Stadermann, Frank J.; Park, Sungjin; Shaibat, Medhat A.; Ishii, Yoshitaka; Yang, Dongxing; Velamakanni, Aruna; An, Sung Jin; Stoller, Meryl; An, Jinho; Chen, Dongmin; Ruoff, Rodney S.			Synthesis and solid-state NMR structural characterization of C-13-labeled graphite oxide	SCIENCE			English	Article							CARBON FORMATION; GRAPHENE; SURFACE; GROWTH; NICKEL; PRECIPITATION; REDUCTION; LAYERS	The detailed chemical structure of graphite oxide ( GO), a layered material prepared from graphite almost 150 years ago and a precursor to chemically modified graphenes, has not been previously resolved because of the pseudo- random chemical functionalization of each layer, as well as variations in exact composition. Carbon-13 (C-13) solid- state nuclear magnetic resonance ( SSNMR) spectra of GO for natural abundance C-13 have poor signal- to- noise ratios. Approximately 100% C-13- labeled graphite was made and converted to C-13- labeled GO, and C-13 SSNMR was used to reveal details of the chemical bonding network, including the chemical groups and their connections. Carbon-13-labeled graphite can be used to prepare chemically modified graphenes for C-13 SSNMR analysis with enhanced sensitivity and for fundamental studies of C-13-labeled graphite and graphene.	[Cai, Weiwei; Piner, Richard D.; Park, Sungjin; Yang, Dongxing; Velamakanni, Aruna; Stoller, Meryl; An, Jinho; Ruoff, Rodney S.] Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA; [Cai, Weiwei; Piner, Richard D.; Park, Sungjin; Yang, Dongxing; Velamakanni, Aruna; Stoller, Meryl; An, Jinho; Ruoff, Rodney S.] Univ Texas Austin, Texas Mat Inst, Austin, TX 78712 USA; [Cai, Weiwei; Chen, Dongmin] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100080, Peoples R China; [Stadermann, Frank J.] Washington Univ, Space Sci Lab, Dept Phys, St Louis, MO 63130 USA; [Shaibat, Medhat A.; Ishii, Yoshitaka] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [An, Sung Jin] Pohang Univ Sci & Technol, Natl Creat Res Initiat Ctr Semicond Nanorods, Pohang 790784, South Korea; [An, Sung Jin] Pohang Univ Sci & Technol, Dept Mat Sci & Engn, Pohang 790784, South Korea	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Chinese Academy of Sciences; Institute of Physics, CAS; Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Ruoff, RS (corresponding author), Univ Texas Austin, Dept Mech Engn, Austin, TX 78712 USA.	r.ruoff@mail.utexas.edu	Park, Sungjin/GQO-9291-2022; Ruoff, Rodney/ABE-6532-2020; Park, Sungjin/A-2790-2009; Piner, Richard/Y-2520-2019; Ruoff, Rodney S/B-7605-2009; An, Sung Jin/A-2869-2009; Ishii, Yoshitaka/F-4558-2014	Park, Sungjin/0000-0002-1447-4536; Ruoff, Rodney/0000-0002-6599-6764; Park, Sungjin/0000-0002-1447-4536; Ruoff, Rodney S/0000-0002-6599-6764; An, Sung Jin/0000-0002-5114-1933; Ishii, Yoshitaka/0000-0002-7724-6469	Cambridge Isotopes Laboratories, Inc; Defense Advanced Research Projects Agency Center on Nanoscale Science and Technology for Integrated Micro/NanoElectromechanical Transducers [HR0011-06-1-0048]; Defense University Research Instrumentation Program; Dreyfus Foundation Teacher-Scholar Award program; NSF CAREER program [CHE 449952]; Korea Science and Engineering Foundation; National Creative Research Initiative Project [R16-2004-00401001-0]; Ministry of Science and Technology, Korea	Cambridge Isotopes Laboratories, Inc; Defense Advanced Research Projects Agency Center on Nanoscale Science and Technology for Integrated Micro/NanoElectromechanical Transducers(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Defense University Research Instrumentation Program; Dreyfus Foundation Teacher-Scholar Award program; NSF CAREER program(National Science Foundation (NSF)NSF - Office of the Director (OD)); Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); National Creative Research Initiative Project(Korea Science and Engineering Foundation); Ministry of Science and Technology, Korea(Ministry of Science & Technology (MOST), Republic of Korea)	<SUP>13</SUP>CH<INF>4</INF> was provided through a research grant from Cambridge Isotopes Laboratories, Inc. We (R.S.R.) wish to acknowledge The University of Texas for startup funds and for partial support by the Defense Advanced Research Projects Agency Center on Nanoscale Science and Technology for Integrated Micro/NanoElectromechanical Transducers (HR0011-06-1-0048). The WiTec Micro-Raman instrument was acquired by an Air Force Office of Scientific Research, Defense University Research Instrumentation Program grant. Y.I. appreciates support from the Dreyfus Foundation Teacher-Scholar Award program and the NSF CAREER program (CHE 449952). S.J.A. was financially supported by the Korea Science and Engineering Foundation under the National Creative Research Initiative Project (R16-2004-00401001-0) of the Ministry of Science and Technology, Korea. J. Goodenough and A. Ruoff commented on an early version of this manuscript.	ANGERMANN HH, 1993, APPL SURF SCI, V70-1, P163, DOI 10.1016/0169-4332(93)90419-C; Anton R, 2005, J MATER RES, V20, P1837, DOI 10.1557/JMR.2005.0229; BARBANGELO A, 1992, MAT SCI ENG A-STRUCT, V156, P217, DOI 10.1016/0921-5093(92)90154-S; Bonnet F, 2003, MATER CORROS, V54, P870, DOI 10.1002/maco.200303742; Brodie B. C., 1860, ANN CHIM PHYS, V59, P466; Dikin DA, 2007, NATURE, V448, P457, DOI 10.1038/nature06016; FEDOSEEV DV, 1979, CARBON, V17, P453, DOI 10.1016/0008-6223(79)90033-2; FUJITA D, 1992, SURF INTERFACE ANAL, V19, P430, DOI 10.1002/sia.740190180; FUJITA D, 1994, J VAC SCI TECHNOL A, V12, P2134, DOI 10.1116/1.579150; KLINK C, 1995, SURF SCI, V342, P250, DOI 10.1016/0039-6028(95)00697-4; Lerf A, 1998, J PHYS CHEM B, V102, P4477, DOI 10.1021/jp9731821; McAllister MJ, 2007, CHEM MATER, V19, P4396, DOI 10.1021/cm0630800; Obraztsov AN, 2007, CARBON, V45, P2017, DOI 10.1016/j.carbon.2007.05.028; Oudghiri-Hassani H, 2007, J POWER SOURCES, V171, P850, DOI 10.1016/j.jpowsour.2007.07.016; Sinclair R, 2002, MICROSC MICROANAL, V8, P288, DOI 10.1017/S1431927602020226; Stankovich S, 2006, J MATER CHEM, V16, P155, DOI 10.1039/b512799h; Stankovich S, 2007, CARBON, V45, P1558, DOI 10.1016/j.carbon.2007.02.034; Stankovich S, 2006, CARBON, V44, P3342, DOI 10.1016/j.carbon.2006.06.004; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Szabo T, 2006, CHEM MATER, V18, P2740, DOI 10.1021/cm060258+; Yudasaka M, 1998, J VAC SCI TECHNOL A, V16, P2463, DOI 10.1116/1.581367	21	992	1025	11	691	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 26	2008	321	5897					1815	1817		10.1126/science.1162369	http://dx.doi.org/10.1126/science.1162369			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818353				2022-12-28	WOS:000259501300032
J	Han, BW; Herrin, BR; Cooper, MD; Wilson, IA				Han, Byung Woo; Herrin, Brantley R.; Cooper, Max D.; Wilson, Ian A.			Antigen recognition by variable lymphocyte receptors	SCIENCE			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LAMPREY; ANTIBODY; BINDING; PROTEIN; DOMAIN; DIVERSIFICATION; DIVERSITY; EVOLUTION	Variable lymphocyte receptors ( VLRs) rather than antibodies play the primary role in recognition of antigens in the adaptive immune system of jawless vertebrates. Combinatorial assembly of leucine- rich repeat ( LRR) gene segments achieves the required repertoire for antigen recognition. We have determined a crystal structure for a VLR- antigen complex, VLR RBC36 in complex with the H- antigen trisaccharide from human blood type O erythrocytes, at 1.67 angstrom resolution. RBC36 binds the H- trisaccharide on the concave surface of the LRR modules of the solenoid structure where three key hydrophilic residues, multiple van der Waals interactions, and the highly variable insert of the carboxyl- terminal LRR module determine antigen recognition and specificity. The concave surface assembled from the most highly variable regions of the LRRs, along with diversity in the sequence and length of the highly variable insert, can account for the recognition of diverse antigens by VLRs.	[Han, Byung Woo; Wilson, Ian A.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Han, Byung Woo; Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Herrin, Brantley R.; Cooper, Max D.] Emory Univ, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Herrin, Brantley R.; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA	Scripps Research Institute; Scripps Research Institute; Emory University; Emory University	Wilson, IA (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	wilson@scripps.edu		Herrin, Brantley/0000-0002-1842-6806	NIH [AI42266, AI072435]; Georgia Research Alliance; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, T32AI007051, R01AI072435, R01AI042266] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R. L. Stanfield, X. Dai, and X. Zhu for help with data collection and analysis; M. N. Alder for help with VLR cDNA library preparation; J. Paulson and R. McBride for helpful comments and suggestions; and J. Vanhnasy, B. Droese, and H.-J. Kim for technical support and advice. Portions of this research were carried out at the Stanford Synchrotron Radiation Laboratory (SSRL), operated by Stanford University on behalf of the U. S. Department of Energy, Office of Basic Energy Sciences. Supported by NIH grants AI42266 (I.A.W.) and AI072435 (M.D.C.), the Georgia Research Alliance (M.D.C.), and the Skaggs Institute for Chemical Biology (I.A.W.). This is Scripps Research Institute manuscript 19581-MB. Coordinates and structure factors have been deposited in the Protein Data Bank (PDB) with accession code 3E6J.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bell JK, 2005, P NATL ACAD SCI USA, V102, P10976, DOI 10.1073/pnas.0505077102; BOFFA GA, 1967, NATURE, V214, P700, DOI 10.1038/214700b0; *CHEM COMP GROUP, 2003, MOL OP ENV MOE VERS; Choe J, 2005, SCIENCE, V309, P581, DOI 10.1126/science.1115253; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Duan XQ, 2002, BIOCHEMISTRY-US, V41, P706, DOI 10.1021/bi015784n; VON GARA P., 1931, Zeitschrift fur Immunitatsforschung und Experimentelle Therapie, V71, P1; Garcia KC, 1999, ANNU REV IMMUNOL, V17, P369, DOI 10.1146/annurev.immunol.17.1.369; GELIN BR, 1979, BIOCHEMISTRY-US, V18, P1256, DOI 10.1021/bi00574a022; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; POLLARA B, 1970, J IMMUNOL, V105, P738; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; WILSON IA, 1993, CURR OPIN STRUC BIOL, V3, P113, DOI 10.1016/0959-440X(93)90210-C; WILSON IA, 1994, CURR OPIN STRUC BIOL, V4, P857, DOI 10.1016/0959-440X(94)90267-4; WU TT, 1993, PROTEINS, V16, P1, DOI 10.1002/prot.340160102; YAMAMOTO F, 1992, BIOCHEM BIOPH RES CO, V187, P366, DOI 10.1016/S0006-291X(05)81502-5	28	133	148	1	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 26	2008	321	5897					1834	1837		10.1126/science.1162484	http://dx.doi.org/10.1126/science.1162484			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	352MM	18818359	Green Accepted			2022-12-28	WOS:000259501300038
J	Johnson, CD; Chen, MH; Toledano, AY; Heiken, JP; Dachman, A; Kuo, MD; Menias, CO; Siewert, B; Cheema, JI; Obregon, RG; Fidler, JL; Zimmerman, P; Horton, KM; Coakley, K; Iyer, RB; Hara, AK; Halvorsen, RA; Casola, G; Yee, J; Herman, BA; Burgart, LJ; Limburg, PJ				Johnson, C. Daniel; Chen, Mei-Hsiu; Toledano, Alicia Y.; Heiken, Jay P.; Dachman, Abraham; Kuo, Mark D.; Menias, Christine O.; Siewert, Betina; Cheema, Jugesh I.; Obregon, Richard G.; Fidler, Jeff L.; Zimmerman, Peter; Horton, Karen M.; Coakley, Kevin; Iyer, Revathy B.; Hara, Amy K.; Halvorsen, Robert A., Jr.; Casola, Giovanna; Yee, Judy; Herman, Benjamin A.; Burgart, Lawrence J.; Limburg, Paul J.			Accuracy of CT colonography for detection of large adenomas and cancers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMPUTED TOMOGRAPHIC COLONOGRAPHY; CONTRAST BARIUM ENEMA; EXTRACOLONIC FINDINGS; VIRTUAL COLONOSCOPY; ASYMPTOMATIC ADULTS; COLORECTAL POLYPS; SERRATED ADENOMA; SCREEN DETECTION; PREVALENCE; SENSITIVITY	Background: Computed tomographic (CT) colonography is a noninvasive option in screening for colorectal cancer. However, its accuracy as a screening tool in asymptomatic adults has not been well defined. Methods: We recruited 2600 asymptomatic study participants, 50 years of age or older, at 15 study centers. CT colonographic images were acquired with the use of standard bowel preparation, stool and fluid tagging, mechanical insufflation, and multidetector-row CT scanners (with 16 or more rows). Radiologists trained in CT colonography reported all lesions measuring 5 mm or more in diameter. Optical colonoscopy and histologic review were performed according to established clinical protocols at each center and served as the reference standard. The primary end point was detection by CT colonography of histologically confirmed large adenomas and adenocarcinomas (10 mm in diameter or larger) that had been detected by colonoscopy; detection of smaller colorectal lesions (6 to 9 mm in diameter) was also evaluated. Results: Complete data were available for 2531 participants (97%). For large adenomas and cancers, the mean (+/-SE) per-patient estimates of the sensitivity, specificity, positive and negative predictive values, and area under the receiver-operating-characteristic curve for CT colonography were 0.90+/-0.03, 0.86+/-0.02, 0.23+/-0.02, 0.99+/-<0.01, and 0.89+/-0.02, respectively. The sensitivity of 0.90 (i.e., 90%) indicates that CT colonography failed to detect a lesion measuring 10 mm or more in diameter in 10% of patients. The per-polyp sensitivity for large adenomas or cancers was 0.84+/-0.04. The per-patient sensitivity for detecting adenomas that were 6 mm or more in diameter was 0.78. Conclusions: In this study of asymptomatic adults, CT colonographic screening identified 90% of subjects with adenomas or cancers measuring 10 mm or more in diameter. These findings augment published data on the role of CT colonography in screening patients with an average risk of colorectal cancer. (ClinicalTrials.gov number, NCT00084929; American College of Radiology Imaging Network [ACRIN] number, 6664.).	[Johnson, C. Daniel; Hara, Amy K.] Mayo Clin Arizona, Scottsdale, AZ 85259 USA; [Chen, Mei-Hsiu; Herman, Benjamin A.] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Toledano, Alicia Y.] Biostat Consulting, Toronto, ON, Canada; [Heiken, Jay P.; Menias, Christine O.] Washington Univ, Mallinckrodt Inst Radiol, St Louis, MO 63130 USA; [Dachman, Abraham] Univ Chicago, Chicago, IL 60637 USA; [Kuo, Mark D.] Scottsdale Med Imaging, Scottsdale, AZ USA; [Siewert, Betina] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Cheema, Jugesh I.] Yale Univ, New Haven, CT USA; [Obregon, Richard G.] Radiol Imaging Assoc, Denver, CO USA; [Fidler, Jeff L.; Limburg, Paul J.] Mayo Clin Rochester, Rochester, MN USA; [Zimmerman, Peter] Univ Calif Los Angeles, Los Angeles, CA USA; [Horton, Karen M.] Johns Hopkins Univ, Baltimore, MD USA; [Coakley, Kevin] Mem Med Ctr, Springfield, IL 62781 USA; [Iyer, Revathy B.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Halvorsen, Robert A., Jr.] Virginia Commonwealth Univ, Richmond, VA USA; [Casola, Giovanna] Univ Calif San Diego, San Diego, CA 92103 USA; [Yee, Judy] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Yee, Judy] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Burgart, Lawrence J.] Abbott NW Hosp, Minneapolis, MN 55407 USA	Mayo Clinic; Mayo Clinic Phoenix; Brown University; Washington University (WUSTL); University of Chicago; Harvard University; Beth Israel Deaconess Medical Center; Yale University; Mayo Clinic; University of California System; University of California Los Angeles; Johns Hopkins University; University of Texas System; UTMD Anderson Cancer Center; Virginia Commonwealth University; University of California System; University of California San Diego; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Johnson, CD (corresponding author), Mayo Clin Arizona, Scottsdale, AZ 85259 USA.			Dachman, Abraham/0000-0002-7035-2752; Chen, Mei-Hsiu/0000-0003-0566-073X	National Cancer Institute; American College of Radiology Imaging Network; Philips Healthcare; International Conference on Alzheimer's Disease (ICAD); GE Healthcare; ICAD; E-Z-EM; Olympus; Fujinon; Bracco Diagnostics; NATIONAL CANCER INSTITUTE [U01CA080098] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American College of Radiology Imaging Network(General Electric); Philips Healthcare; International Conference on Alzheimer's Disease (ICAD); GE Healthcare(General ElectricGE Healthcare); ICAD; E-Z-EM; Olympus; Fujinon; Bracco Diagnostics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by a grant from the National Cancer Institute in cooperation with the American College of Radiology Imaging Network.; Dr. Johnson and Dr. Hara report holding patents and license agreements with and receiving royalties from GE Healthcare, which produces CT colonography software. Dr. Dachman reports receiving grant support from Philips Healthcare and the International Conference on Alzheimer's Disease (ICAD), receiving consulting fees and fees for service on advisory boards from GE Healthcare, ICAD, and E-Z-EM, receiving lecture fees from Philips Healthcare, and holding a patent for computer-aided detection of polyps. Dr. Fidler reports receiving grant support from E-Z-EM. Dr. Limburg reports receiving grant support from Olympus and Fujinon, receiving consulting fees and fees for service on an advisory board from Clinica del Sol, and being listed as a coinvestigator on a U. S. patent for a new colorectal approach to cancer screening. Dr. Heiken reports receiving grant support from Bracco Diagnostics and GE Healthcare and consulting fees, fees for service on an advisory board, fees for patents, and royalties from Mallinckrodt, holding four patents for software used on contrast injectors for CT (two patents have been sold and two are licensed, with royalties received from Mallinckrodt), and serving on the board of directors of the Society of Gastrointestinal Radiologists. Dr. Yee reports receiving grant support and lecture fees from GE Healthcare. No other potential conflict of interest relevant to this article was reported.; We thank the many people at the headquarters of the American College of Radiology Imaging Network and at the recruiting sites for their important contributions to the study; the radiologists, gastroenterologists, and research associates at the clinical sites; Bruce Hillman, Mitchell Schnall, Steven King, Charles Apgar, Donna Hartfeil, Nancy Fredericks, Jamie Downs, Tina Taylor, Maria Oh, Rex Welsh, Tim Welsh, Fraser Wilton, Anthony Levering, James Gimpel, Cheryl Crozier, Mary Kelly Truran, Chris Steward, Josephine Schloesser, Sharlene Snowdon, Dave Vanness, Ronald Summers, Richard Farrell, David Rubin, Joel G. Fletcher, and Debora Shreve; and Constantine Gatsonis, Ilana Gareen, and Meridith Blevins, members of the American College of Radiology Biostatistics Center.	Ahn C, 1997, J PERIODONTAL RES, V32, P351, DOI 10.1111/j.1600-0765.1997.tb00544.x; Burling D, 2006, RADIOLOGY, V239, P464, DOI 10.1148/radiol.2392051101; Butterly LF, 2006, CLIN GASTROENTEROL H, V4, P343, DOI 10.1016/j.cgh.2005.12.021; COTTON DB, 2004, JAMA-J AM MED ASSOC, V291, P1713; FLETCHER JG, 2005, RAD SOC N AM 91 SCI; Gluecker TM, 2003, GASTROENTEROLOGY, V124, P911, DOI 10.1053/gast.2003.50158; Hara AK, 2000, RADIOLOGY, V215, P353, DOI 10.1148/radiology.215.2.r00ap33353; Hellstrom M, 2004, AM J ROENTGENOL, V182, P631, DOI 10.2214/ajr.182.3.1820631; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Johnson CD, 2004, CLIN GASTROENTEROL H, V2, P314, DOI 10.1016/S1542-3565(04)00061-8; Johnson CD, 2003, GASTROENTEROLOGY, V125, P311, DOI 10.1016/S0016-5085(03)00894-1; JOHNSON CD, 6664 ACRIN; Li SC, 2007, ARCH PATHOL LAB MED, V131, P440; Obuchowski NA, 1996, AM J ROENTGENOL, V166, P517, DOI 10.2214/ajr.166.3.8623619; Pickhardt PJ, 2006, RADIOLOGY, V239, P313, DOI 10.1148/radiol.2392052002; Pickhardt PJ, 2003, NEW ENGL J MED, V349, P2191, DOI 10.1056/NEJMoa031618; Rajapaksa RC, 2004, J CLIN GASTROENTEROL, V38, P767, DOI 10.1097/01.mcg.0000139035.38568.18; Rockey DC, 2005, LANCET, V365, P305; Smith RA, 2007, CA-CANCER J CLIN, V57, P90, DOI 10.3322/canjclin.57.2.90; Torlakovic EE, 2008, AM J SURG PATHOL, V32, P491; Torlakovic EE, 2008, AM J SURG PATHOL, V32, P21, DOI 10.1097/PAS.0b013e318157f002; *US PREV SERV TASK, GUIDE CLIN PREV SERV; van Rijn JC, 2006, AM J GASTROENTEROL, V101, P343, DOI 10.1111/j.1572-0241.2006.00390.x; Winawer S, 2003, GASTROENTEROLOGY, V124, P544, DOI 10.1053/gast.2003.50044; Xiong T, 2005, BRIT J RADIOL, V78, P22, DOI 10.1259/bjr/67998962; Yee J, 2005, RADIOLOGY, V236, P519, DOI 10.1148/radiol.2362040166	26	716	734	1	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1207	1217		10.1056/NEJMoa0800996	http://dx.doi.org/10.1056/NEJMoa0800996			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799557	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000259259900004
J	MacMillan, DWC				MacMillan, David W. C.			The advent and development of organocatalysis	NATURE			English	Article							ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC EPOXIDATION; ORGANIC CATALYSIS; STRATEGIES	The use of small organic molecules as catalysts has been known for more than a century. But only in the past decade has organocatalysis become a thriving area of general concepts and widely applicable asymmetric reactions. Here I present my opinion on why the field of organocatalysis has blossomed so dramatically over the past decade.	[MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Frick Lab 116, Princeton, NJ 08540 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Frick Lab 116, Princeton, NJ 08540 USA.				National Institute of General Medical Sciences [R01 GM078201-01-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078201] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	I thank the National Institute of General Medical Sciences (grant number R01 GM078201- 01- 01) for financial support, and Merck Research Laboratories and Bristol- Myers Squibb for gifts. I also thank H. Kim, R. Knowles, D. Carerra and J. Van Humbeck for their help in the preparation of the manuscript.	Ahrendt KA, 2000, J AM CHEM SOC, V122, P4243, DOI 10.1021/ja000092s; Beeson TD, 2007, SCIENCE, V316, P582, DOI 10.1126/science. 1142696; Berkessel A, 2005, ASYMMETRIC ORGANOCATALYSIS: FROM BIOMIMETIC CONCEPTS TO APPLICATIONS IN ASYMMETRIC SYNTHESIS, P1, DOI 10.1002/3527604677; Corey EJ, 1999, ORG LETT, V1, P157, DOI 10.1021/ol990623l; Denmark SE, 1997, J ORG CHEM, V62, P8288, DOI 10.1021/jo971781y; DOLLING UH, 1984, J AM CHEM SOC, V106, P446, DOI 10.1021/ja00314a045; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; Eder U., 1971, [No title captured], Patent No. [2014757, DE 2014757]; Enders D, 2007, ANGEW CHEM INT EDIT, V46, P1570, DOI 10.1002/anie.200603129; Hajos Z.G., 1971, [No title captured], Patent No. [2102623, DE 2102623]; HAJOS ZG, 1974, J ORG CHEM, V39, P1615, DOI 10.1021/jo00925a003; HIEMSTRA H, 1981, J AM CHEM SOC, V103, P417, DOI 10.1021/ja00392a029; Huang Y, 2005, J AM CHEM SOC, V127, P15051, DOI 10.1021/ja055545d; Jang HY, 2007, J AM CHEM SOC, V129, P7004, DOI 10.1021/ja0719428; Kim H, 2008, J AM CHEM SOC, V130, P398, DOI 10.1021/ja077212h; King HD, 2005, ORG LETT, V7, P3437, DOI 10.1021/ol051000c; Lelais G, 2006, ALDRICHIM ACTA, V39, P79; List B, 2000, J AM CHEM SOC, V122, P2395, DOI 10.1021/ja994280y; List B, 2000, J AM CHEM SOC, V122, P9336, DOI 10.1021/ja001923x; Miller SJ, 1998, J AM CHEM SOC, V120, P1629, DOI 10.1021/ja973892k; Mukherjee S, 2007, CHEM REV, V107, P5471, DOI 10.1021/cr0684016; NARASAKA K, 1992, CHEM LETT, P2099, DOI 10.1246/cl.1992.2099; OKU JI, 1981, J CHEM SOC CHEM COMM, P229, DOI 10.1039/c39810000229; Raheem IT, 2007, J AM CHEM SOC, V129, P13404, DOI 10.1021/ja076179w; Reisman SE, 2008, J AM CHEM SOC, V130, P7198, DOI 10.1021/ja801514m; SEEBACH D, 1990, ANGEW CHEM INT EDIT, V29, P1320, DOI 10.1002/anie.199013201; Sigman MS, 1998, J AM CHEM SOC, V120, P4901, DOI 10.1021/ja980139y; Tu Y, 1996, J AM CHEM SOC, V118, P9806, DOI 10.1021/ja962345g; Wenzel AG, 2002, J AM CHEM SOC, V124, P12964, DOI 10.1021/ja028353g; Yang D, 1996, J AM CHEM SOC, V118, P491, DOI 10.1021/ja9529549	30	1820	1831	61	833	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 18	2008	455	7211					304	308		10.1038/nature07367	http://dx.doi.org/10.1038/nature07367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	349EX	18800128				2022-12-28	WOS:000259265200030
J	Wroblewski, RL; Sticca, RP				Wroblewski, Robert L.; Sticca, Robert P.			Primary small-bowel enterolithiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wroblewski, Robert L.; Sticca, Robert P.] Univ N Dakota, Sch Med, Grand Forks, ND 58203 USA	University of North Dakota Grand Forks	Wroblewski, RL (corresponding author), Univ N Dakota, Sch Med, Grand Forks, ND 58203 USA.	rsticca@medicine.nodak.edu							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 18	2008	359	12					1271	1271		10.1056/NEJMicm073403	http://dx.doi.org/10.1056/NEJMicm073403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	349DV	18799561				2022-12-28	WOS:000259259900012
J	Parens, E; Johnston, J; Moses, J				Parens, Erik; Johnston, Josephine; Moses, Jacob			Ethics - Do we need "synthetic bioethics"?	SCIENCE			English	Editorial Material									[Parens, Erik; Johnston, Josephine; Moses, Jacob] Hastings Ctr, Garrison, NY 10524 USA		Parens, E (corresponding author), Hastings Ctr, Garrison, NY 10524 USA.	parense@thehastingscenter.org		Moses, Jacob/0000-0001-8089-3870; Johnston, Josephine/0000-0002-7411-6992				Balmer A., 2008, SYNTHETIC BIOL SOCIA; Boldt J, 2008, NAT BIOTECHNOL, V26, P387, DOI 10.1038/nbt0408-387; Bugl H, 2007, NAT BIOTECHNOL, V25, P627, DOI 10.1038/nbt0607-627; Church G, 2005, NATURE, V438, P423, DOI 10.1038/438423a; ETC Group, 2007, EXTR GEN ENG INTR SY, P28; Garfinkel M.S., 2007, SYNTHETIC GENOMICS O; Macoubrie J, 2005, INFORMED PUBLIC PERC; Maurer SM, 2007, B ATOM SCI, V63, P16, DOI 10.2968/063006004; Parens E, 1999, Hastings Cent Rep, V29, pS1, DOI 10.2307/3527746; PARENS E, IN PRESS ETHICAL ISS	10	15	17	2	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	SEP 12	2008	321	5895					1449	1449		10.1126/science.1163821	http://dx.doi.org/10.1126/science.1163821			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	347DW	18787154				2022-12-28	WOS:000259121800024
J	Saha, S; Guiton, G; Wimmers, PF; Wilkerson, L				Saha, Somnath; Guiton, Gretchen; Wimmers, Paul F.; Wilkerson, LuAnn			Student body racial and ethnic composition and diversity-related outcomes in US medical schools	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CULTURAL COMPETENCE; EDUCATION; PERSPECTIVES; IMPACT; POLICY	Context Many medical schools assert that a racially and ethnically diverse student body is an important element in educating physicians to meet the needs of a diverse society. However, there is limited evidence addressing the educational effects of student body racial diversity. Objective To determine whether student body racial and ethnic diversity is associated with diversity- related outcomes among US medical students. Design, Setting, and Participants A Web- based survey ( Graduation Questionnaire) administered by the Association of American Medical Colleges of 20 112 graduating medical students ( 64% of all graduating students in 2003 and 2004) from 118 allopathic medical schools in the United States. Historically black and Puerto Rican medical schools were excluded. Main Outcome Measures Students' self- rated preparedness to care for patients from other racial and ethnic backgrounds, attitudes about equity and access to care, and intent to practice in an underserved area. Results White students within the highest quintile for student body racial and ethnic diversity, measured by the proportion of underrepresented minority ( URM) students, were more likely to rate themselves as highly prepared to care for minority populations than those in the lowest diversity quintile ( 61.1% vs 53.9%, respectively; P <. 001; adjusted odds ratio [ OR], 1.33; 95% confidence interval [ CI], 1.13- 1.57). This association was strongest in schools in which students perceived a positive climate for interracial interaction. White students in the highest URM quintile were also more likely to have strong attitudes endorsing equitable access to care ( 54.8% vs 44.2%, respectively; P <. 001; adjusted OR, 1.42; 95% CI, 1.15- 1.74). For nonwhite students, after adjustment there were no significant associations between student body URM proportions and diversity- related outcomes. Student body URM proportions were not associated with white or nonwhite students' plans to practice in underserved communities, although URM students were substantially more likely than white or nonwhite/ non- URM students to plan to serve the underserved ( 48.7% vs 18.8% vs 16.2%, respectively; P <. 001). Conclusion Student body racial and ethnic diversity within US medical schools is associated with outcomes consistent with the goal of preparing students to meet the needs of a diverse population.	[Saha, Somnath] Oregon Hlth & Sci Univ, Gen Internal Med Sect, Portland VA Med Ctr, Dept Med, Portland, OR 97239 USA; [Guiton, Gretchen] Univ Colorado, Sch Med, Educ Dev & Res Off, Denver, CO USA; [Wimmers, Paul F.; Wilkerson, LuAnn] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Saha, S (corresponding author), Oregon Hlth & Sci Univ, Gen Internal Med Sect, Portland VA Med Ctr, Dept Med, P3HSRD,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	sahas@ohsu.edu			Advanced Research Career Development award; US Department of Veterans Affairs Health Services Research and Development Service	Advanced Research Career Development award; US Department of Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Dr Saha was supported by an Advanced Research Career Development award from the US Department of Veterans Affairs Health Services Research and Development Service when this study was conducted. The Association of American Medical Colleges (AAMC) collected and manages the Graduation Questionnaire data analyzed for this study. Dr Saha has served on Advisory Committees for AAMC initiatives related to medical school diversity.	*ASS AM MED COLL, AAMC 2004 MED SCH GR; Beach MC, 2006, ROLE RELATIONSHIP CU; Betancourt JR, 2006, ACAD MED, V81, P499, DOI 10.1097/01.ACM.0000225211.77088.cb; Bollinger LC, 2003, ACAD MED, V78, P431, DOI 10.1097/00001888-200305000-00002; Castillo-Page L, 2006, DIVERSITY PHYS WORKF; Chang MJ, 1999, J COLL STUDENT DEV, V40, P377; Cohen JJ, 2003, JAMA-J AM MED ASSOC, V289, P1143, DOI 10.1001/jama.289.9.1143; Cohen JJ, 2002, HEALTH AFFAIR, V21, P90, DOI 10.1377/hlthaff.21.5.90; COLEMAN AL, 2008, ROADMAP DIVERSITY KE; Elam CL, 2001, ACAD MED, V76, P60, DOI 10.1097/00001888-200101000-00017; Fernandez A, 2004, J GEN INTERN MED, V19, P167, DOI 10.1111/j.1525-1497.2004.30266.x; Ferrante JM, 2000, J AM BOARD FAM PRACT, V13, P408, DOI DOI 10.3122/15572625-13-6-408; Guiton G, 2007, ACAD MED, V82, pS85, DOI 10.1097/ACM.0b013e31813ffe1e; Gurin P, 2002, HARVARD EDUC REV, V72, P330, DOI 10.17763/haer.72.3.01151786u134n051; He J, 1999, NEW ENGL J MED, V340, P920, DOI 10.1056/NEJM199903253401204; HOWELL WLJ, 2005, AAMC REPORTER; Hung R, 2007, ACAD MED, V82, P184, DOI 10.1097/ACM.0b013e31802d936a; Hurtado S, 1998, REV HIGH EDUC, V21, P279, DOI 10.1353/rhe.1998.0003; *I MED, 2003, UN TREATM CONFR RAC; Ko M, 2007, J GEN INTERN MED, V22, P625, DOI 10.1007/s11606-007-0154-z; Milem JF., 2003, COMPELLING INTEREST, P126, DOI [10.1515/9780804764537-009, DOI 10.1515/9780804764537-009]; O'Campo P, 2008, AM J EPIDEMIOL, V167, P155, DOI 10.1093/aje/kwm277; RISING J, COMMUNICATION; ROSENBLATT RA, 1992, JAMA-J AM MED ASSOC, V268, P1559, DOI 10.1001/jama.268.12.1559; Saha S, 2008, J GEN INTERN MED, V23, P367; Saha S, 2008, HEALTH AFFAIR, V27, P234, DOI 10.1377/hlthaff.27.1.234; SLEVIN P, 2008, WASHINGTON POST 0326, pA2; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; *US BUR CENS, PROJ POP US RAC HISP; Weissman JS, 2005, JAMA-J AM MED ASSOC, V294, P1058, DOI 10.1001/jama.294.9.1058; Whitla DK, 2003, ACAD MED, V78, P460, DOI 10.1097/00001888-200305000-00007	31	242	243	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 10	2008	300	10					1135	1145		10.1001/jama.300.10.1135	http://dx.doi.org/10.1001/jama.300.10.1135			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	345ZR	18780842	Bronze			2022-12-28	WOS:000259038700006
J	Cai, L; Makhov, AM; Schafer, DA; Bear, JE				Cai, Liang; Makhov, Alexander M.; Schafer, Dorothy A.; Bear, James E.			Coronin 1B antagonizes cortactin and remodels Arp2/3-containing actin branches in lamellipodia	CELL			English	Article							REFLECTION FLUORESCENCE MICROSCOPY; ARP2/3 COMPLEX; CELL MOTILITY; F-ACTIN; PROTEIN; NUCLEATION; NETWORKS; MYCOBACTERIA; DISSOCIATION; FILAMENTS	The dendritic actin network generated by the Arp2/3 complex in lamellipodia underlies formation of protrusions, directional sensing, and migration. While the generation of this network is well studied, the mechanisms regulating network disassembly are poorly understood. We report that Coronin 1B disassembles Arp2/3-containing actin filament branches by inducing Arp2/3 dissociation. This activity is antagonized by Cortactin, a filament branch stabilizer. Consistent with this biochemical competition, depletion of both proteins partially rescues defects in lamellipodial dynamics observed upon depletion of either protein alone. Coronin 1B targets actin branches in a manner that is mutually exclusive with the Arp2/3 complex and alters the branch angle. We conclude that Coronin 1B replaces the Arp2/3 complex at actin filament branches as the dendritic network matures and drives the turnover of branched actin networks.	[Cai, Liang; Bear, James E.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Makhov, Alexander M.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Biol, Charlottesville, VA 22904 USA; [Schafer, Dorothy A.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22904 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Virginia; University of Virginia	Bear, JE (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA.	jbear@email.unc.edu			NIH [CA16086, GM31819, GM067222, GM083035]; Sontag Foundation; Carolina Center for Cancer Nanotechnology Excellence (NCI) [1U54CA119343]; NATIONAL CANCER INSTITUTE [P30CA016086, U54CA119343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM083035, R01GM067222] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sontag Foundation; Carolina Center for Cancer Nanotechnology Excellence (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge F. Gertler, S. Rogers, R. Cheney, and members of the Bear lab for critical comments on this manuscript; M. Welch for the p41Arc antibody; and the substantial assistance of Jack Griffith in the LCCC Electron Microscopy core (supported by NIH CA16086 and GM31819). This work was supported by NIH grants to D. A. S. (GM067222) and J. E. B. (GM083035). J. E. B. is also supported by the Sontag Foundation and the Carolina Center for Cancer Nanotechnology Excellence (NCI, 1U54CA119343).	Amann KJ, 2001, P NATL ACAD SCI USA, V98, P15009, DOI 10.1073/pnas.211556398; Anes E, 2003, NAT CELL BIOL, V5, P793, DOI 10.1038/ncb1036; Blanchoin L, 2000, CURR BIOL, V10, P1273, DOI 10.1016/S0960-9822(00)00749-1; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Cai L, 2007, J CELL SCI, V120, P1779, DOI 10.1242/jcs.007641; Cai L, 2007, CELL, V128, P915, DOI 10.1016/j.cell.2007.01.031; Cosen-Binker LI, 2006, PHYSIOLOGY, V21, P352, DOI 10.1152/physiol.00012.2006; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Gallegos LL, 2006, J BIOL CHEM, V281, P30947, DOI 10.1074/jbc.M603741200; Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026; Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Kuhn JR, 2005, BIOPHYS J, V88, P1387, DOI 10.1529/biophysj.104.047399; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Martin AC, 2006, NAT CELL BIOL, V8, P826, DOI 10.1038/ncb1443; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pollard TD, 2000, ANNU REV BIOPH BIOM, V29, P545, DOI 10.1146/annurev.biophys.29.1.545; Ponti A, 2004, SCIENCE, V305, P1782, DOI 10.1126/science.1100533; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Weed SA, 2000, J CELL BIOL, V151, P29, DOI 10.1083/jcb.151.1.29; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133	27	155	159	1	19	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	SEP 5	2008	134	5					828	842		10.1016/j.cell.2008.06.054	http://dx.doi.org/10.1016/j.cell.2008.06.054			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	344SL	18775315	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000258947500022
J	Karim, Z; Gerard, B; Bakouh, N; Alili, R; Leroy, C; Beck, L; Silve, C; Planelles, G; Urena-Torres, P; Grandchamp, B; Friedlander, G; Prie, D				Karim, Zoubida; Gerard, Benedicte; Bakouh, Naziha; Alili, Rohia; Leroy, Christine; Beck, Laurent; Silve, Caroline; Planelles, Gabrielle; Urena-Torres, Pablo; Grandchamp, Bernard; Friedlander, Gerard; Prie, Dominique			NHERF1 mutations and responsiveness of renal parathyroid hormone	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGULATORY FACTOR-I; PHOSPHATE-TRANSPORT; RECEPTOR; COTRANSPORTER; PTH; IIA; CALCIUM; INTERNALIZATION; NEPHROLITHIASIS; EXPRESSION	Impaired renal phosphate reabsorption, as measured by dividing the tubular maximal reabsorption of phosphate by the glomerular filtration rate (TmP/GFR), increases the risks of nephrolithiasis and bone demineralization. Data from animal models suggest that sodium-hydrogen exchanger regulatory factor 1 (NHERF1) controls renal phosphate transport. We sequenced the NHERF1 gene in 158 patients, 94 of whom had either nephrolithiasis or bone demineralization. We identified three distinct mutations in seven patients with a low TmP/GFR value. No patients with normal TmP/GFR values had mutations. The mutants expressed in cultured renal cells increased the generation of cyclic AMP (cAMP) by parathyroid hormone (PTH) and inhibited phosphate transport. These NHERF1 mutations suggest a previously unrecognized cause of renal phosphate loss in humans.	[Karim, Zoubida; Bakouh, Naziha; Alili, Rohia; Leroy, Christine; Beck, Laurent; Planelles, Gabrielle; Urena-Torres, Pablo; Friedlander, Gerard; Prie, Dominique] Univ Paris 05, INSERM, Unite 845, Fac Med, Paris, France; [Gerard, Benedicte; Silve, Caroline; Grandchamp, Bernard] Assistance Publ Hop Paris, Hop Bichat Claude Bernard, Paris, France; [Urena-Torres, Pablo; Friedlander, Gerard; Prie, Dominique] Assistance Publ Hop Paris, Hop Necker Enfants Malad, Paris, France; [Friedlander, Gerard] Assistance Publ Hop Paris, Hop Europeen Georges Pompidou, Paris, France; [Silve, Caroline] Univ Paris Diderot, INSERM Unite 773, Unite Format & Rech Med, Paris, France; [Grandchamp, Bernard] Univ Paris Diderot, Inst Federat Rech 02, Paris, France; [Urena-Torres, Pablo] Clin Landy, St Ouen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Prie, D (corresponding author), Hop Necker Enfants Malad, Serv Explorat Fonctionelles, 149 Rue Sevres, F-75015 Paris, France.	prie@necker.fr	BECK, Laurent/P-2952-2014; Planelles, Gabrielle/F-9603-2013	BECK, Laurent/0000-0002-6730-2762; Planelles, Gabrielle/0000-0002-7314-8837; KARIM, Zoubida/0000-0002-3724-5592; Bastepe, Murat/0000-0002-2643-3504; Friedlander, Gerard/0000-0002-6854-4261	INSERM; Universit, Paris Descartes; Association Laboratoire de Recherches Physiologiques; l'Agence Nationale pour la Recherche [ANR-07-PHYSIO-017-01]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Universit, Paris Descartes; Association Laboratoire de Recherches Physiologiques; l'Agence Nationale pour la Recherche(French National Research Agency (ANR))	Supported by a grant from INSERM, Universit, Paris Descartes, Association Laboratoire de Recherches Physiologiques, and l'Agence Nationale pour la Recherche (ANR-07-PHYSIO-017-01).	ARMBRECHT HJ, 1984, AM J PHYSIOL, V246, pE102; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Capuano P, 2007, AM J PHYSIOL-CELL PH, V292, pC927, DOI 10.1152/ajpcell.00126.2006; Cunningham R, 2005, AM J PHYSIOL-RENAL, V289, pF933, DOI 10.1152/ajprenal.00005.2005; Cunninghan R, 2004, J BIOL CHEM, V279, P37815, DOI 10.1074/jbc.M405893200; DEVERNEJOUL MC, 1982, CALCIFIED TISSUE INT, V34, P219, DOI 10.1007/BF02411240; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Isogai Y, 1996, J BONE MINER RES, V11, P1384; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Lee KC, 1996, AM J PHYSIOL-RENAL, V270, pF186, DOI 10.1152/ajprenal.1996.270.1.F186; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Prie D, 2004, CURR OPIN NEPHROL HY, V13, P675, DOI 10.1097/00041552-200411000-00015; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Prie D, 2001, KIDNEY INT, V60, P272, DOI 10.1046/j.1523-1755.2001.00796.x; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Sun C, 2005, J PEPT RES, V65, P411, DOI 10.1111/j.1399-3011.2005.00240.x; VANDOP C, 1989, SEMIN NEPHROL, V9, P168; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; Weinman EJ, 2006, AM J PHYSIOL-RENAL, V291, pF254; Weinman EJ, 2007, J CLIN INVEST, V117, P3412, DOI 10.1172/JCI32738; Weinman EJ, 2006, AM J PHYSIOL-RENAL, V290, pF838, DOI 10.1152/ajprenal.00374.2005; Weinman EJ, 2002, PATHOBIOLOGY, V70, P314, DOI 10.1159/000071271	26	127	130	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 11	2008	359	11					1128	1135		10.1056/NEJMoa0802836	http://dx.doi.org/10.1056/NEJMoa0802836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	346ON	19073985				2022-12-28	WOS:000259078200008
